{
  "model": "tr_ars.message",
  "pk": "7fa6840d-14bb-4d85-b6ed-b47ba843a93e",
  "fields": {
    "name": "ara-arax",
    "code": 200,
    "status": "Done",
    "actor": 2,
    "timestamp": "2022-08-23T20:06:09.338Z",
    "data": {
      "id": "https://arax.ncats.io/api/arax/v1.2/response/60032",
      "info": null,
      "logs": [
        {
          "code": "",
          "level": "DEBUG",
          "message": "in query_return_message",
          "timestamp": "2022-08-23T20:06:09.608961"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "asynchronous Query launching on incoming Query",
          "timestamp": "2022-08-23T20:06:09.608993"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Creating an empty template TRAPI Response",
          "timestamp": "2022-08-23T20:06:09.609013"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Examine input Query for needed information for dispatch",
          "timestamp": "2022-08-23T20:06:11.177153"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Validating the input query graph",
          "timestamp": "2022-08-23T20:06:11.177217"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Deserializing message",
          "timestamp": "2022-08-23T20:06:11.177244"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Found input query_graph. Interpreting it and generating ARAXi processing plan to answer it",
          "timestamp": "2022-08-23T20:06:11.177409"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Assessing the QueryGraph for basic information",
          "timestamp": "2022-08-23T20:06:11.225140"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Found 2 nodes and 1 edges",
          "timestamp": "2022-08-23T20:06:11.225337"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "The QueryGraph reference template is: n00(ids)-e00()-n01(categories=biolink:ChemicalEntity)",
          "timestamp": "2022-08-23T20:06:11.225420"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Found input processing plan. Sending to the ProcessingPlanExecutor",
          "timestamp": "2022-08-23T20:06:11.225551"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Entering execute_processing_plan",
          "timestamp": "2022-08-23T20:06:11.225587"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "A single Message is ready and in hand",
          "timestamp": "2022-08-23T20:06:14.760452"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Found actions",
          "timestamp": "2022-08-23T20:06:14.777378"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Parsing input actions list",
          "timestamp": "2022-08-23T20:06:14.826654"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Parsing action: expand()",
          "timestamp": "2022-08-23T20:06:14.826719"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Parsing action: overlay(action=compute_ngd, virtual_relation_label=N1, subject_qnode_key=disease, object_qnode_key=drug)",
          "timestamp": "2022-08-23T20:06:14.842477"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Parsing action: resultify()",
          "timestamp": "2022-08-23T20:06:14.904829"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Parsing action: filter_results(action=limit_number_of_results, max_results=500)",
          "timestamp": "2022-08-23T20:06:14.904923"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Everything seems in order to begin processing the query asynchronously. Processing will continue and Response will be posted to https://ars-prod.transltr.io/ars/api/messages/7fa6840d-14bb-4d85-b6ed-b47ba843a93e",
          "timestamp": "2022-08-23T20:06:18.535326"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Processing action 'expand' with parameters {'': 'true'}",
          "timestamp": "2022-08-23T20:06:21.732882"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Applying Expand to Message with parameters {'kp': None, 'edge_key': ['treats'], 'node_key': [], 'prune_threshold': None, 'kp_timeout': None, 'return_minimal_metadata': False}",
          "timestamp": "2022-08-23T20:06:21.733695"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Making sure QG only uses canonical predicates",
          "timestamp": "2022-08-23T20:06:21.733803"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Calling XDTD from Expand for qedge treats (has knowledge_type == inferred) and the subject is MONDO:0007947",
          "timestamp": "2022-08-23T20:06:21.734004"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Adding a QueryNode to Message with input parameters {'key': 'creative_DTD_qnode_0', 'ids': None, 'name': None, 'categories': None, 'is_set': 'true', 'option_group_id': 'creative_DTD_option_group_0'}",
          "timestamp": "2022-08-23T20:06:23.454785"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Adding a QueryNode to Message with input parameters {'key': 'creative_DTD_qnode_1', 'ids': None, 'name': None, 'categories': None, 'is_set': 'true', 'option_group_id': 'creative_DTD_option_group_0'}",
          "timestamp": "2022-08-23T20:06:23.570350"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Adding a QueryEdge to Message with parameters {'key': 'creative_DTD_qedge_0', 'subject': 'drug', 'object': 'creative_DTD_qnode_0', 'predicates': None, 'option_group_id': 'creative_DTD_option_group_0', 'exclude': None}",
          "timestamp": "2022-08-23T20:06:23.684663"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Adding a QueryEdge to Message with parameters {'key': 'creative_DTD_qedge_1', 'subject': 'creative_DTD_qnode_0', 'object': 'creative_DTD_qnode_1', 'predicates': None, 'option_group_id': 'creative_DTD_option_group_0', 'exclude': None}",
          "timestamp": "2022-08-23T20:06:23.684739"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Adding a QueryEdge to Message with parameters {'key': 'creative_DTD_qedge_2', 'subject': 'creative_DTD_qnode_1', 'object': 'disease', 'predicates': None, 'option_group_id': 'creative_DTD_option_group_0', 'exclude': None}",
          "timestamp": "2022-08-23T20:06:23.684780"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Decorating nodes with metadata from KG2c",
          "timestamp": "2022-08-23T20:06:23.711207"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Looking up corresponding KG2c nodes in sqlite",
          "timestamp": "2022-08-23T20:06:23.831259"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding attributes to nodes in the KG",
          "timestamp": "2022-08-23T20:06:23.835448"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Decorating edges with EPC info from KG2c",
          "timestamp": "2022-08-23T20:06:23.907353"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Identified 482 edges to decorate",
          "timestamp": "2022-08-23T20:06:23.908694"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Looking up EPC edge info in KG2c sqlite",
          "timestamp": "2022-08-23T20:06:24.025177"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Got 390 rows back from KG2c sqlite",
          "timestamp": "2022-08-23T20:06:24.031757"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding attributes to edges in the KG",
          "timestamp": "2022-08-23T20:06:24.031943"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Applying Resultifier to Message with parameters {'ignore_edge_direction': 'true'}",
          "timestamp": "2022-08-23T20:06:24.116596"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Expanded qedges are {'creative_DTD_qedge_1', 'creative_DTD_qedge_2', 'creative_DTD_qedge_0', 'treats'}, expanded qnodes are {'disease', 'creative_DTD_qnode_0', 'creative_DTD_qnode_1', 'drug'}; will resultify only this sub-QG",
          "timestamp": "2022-08-23T20:06:24.116747"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Building helper indexes for faster lookup of edges",
          "timestamp": "2022-08-23T20:06:24.117982"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Grabbing only required portion of QG",
          "timestamp": "2022-08-23T20:06:24.121098"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Required qnodes are {'disease', 'drug'}, required qedges are {'treats'}",
          "timestamp": "2022-08-23T20:06:24.121193"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Creating result graphs for required portion of QG",
          "timestamp": "2022-08-23T20:06:24.121238"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Constructing result graphs qnode by qnode",
          "timestamp": "2022-08-23T20:06:24.122565"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Initiating result graphs with nodes for disease (is_set=False)",
          "timestamp": "2022-08-23T20:06:24.122598"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Current count of result graphs is 1",
          "timestamp": "2022-08-23T20:06:24.122620"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding a layer to each result graph for qnode drug (is_set=False)",
          "timestamp": "2022-08-23T20:06:24.122644"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Current count of result graphs is 17",
          "timestamp": "2022-08-23T20:06:24.123198"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Done assigning nodes to result graphs",
          "timestamp": "2022-08-23T20:06:24.123223"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding edges to result graphs",
          "timestamp": "2022-08-23T20:06:24.123236"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Created 17 required result graphs",
          "timestamp": "2022-08-23T20:06:24.123330"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Distinct option groups detected in the QG are: {'creative_DTD_option_group_0'}",
          "timestamp": "2022-08-23T20:06:24.123355"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "For option group creative_DTD_option_group_0, qnodes are {'disease', 'creative_DTD_qnode_0', 'creative_DTD_qnode_1', 'drug'}, qedges are {'creative_DTD_qedge_1', 'creative_DTD_qedge_2', 'creative_DTD_qedge_0', 'treats'}",
          "timestamp": "2022-08-23T20:06:24.123397"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Creating result graphs for option group creative_DTD_option_group_0",
          "timestamp": "2022-08-23T20:06:24.123453"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Constructing result graphs qnode by qnode",
          "timestamp": "2022-08-23T20:06:24.128582"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding a layer to each result graph for qnode creative_DTD_qnode_0 (is_set=True)",
          "timestamp": "2022-08-23T20:06:24.128651"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Current count of result graphs is 17",
          "timestamp": "2022-08-23T20:06:24.129642"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding a layer to each result graph for qnode creative_DTD_qnode_1 (is_set=True)",
          "timestamp": "2022-08-23T20:06:24.129677"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Current count of result graphs is 17",
          "timestamp": "2022-08-23T20:06:24.131329"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Done assigning nodes to result graphs",
          "timestamp": "2022-08-23T20:06:24.131356"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding edges to result graphs",
          "timestamp": "2022-08-23T20:06:24.131370"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Created 17 option group creative_DTD_option_group_0 result graphs",
          "timestamp": "2022-08-23T20:06:24.132808"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Required non-set qnodes are: ['disease', 'drug']",
          "timestamp": "2022-08-23T20:06:24.132843"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Merging option group result graphs into required result graphs with matching non-set qnodes",
          "timestamp": "2022-08-23T20:06:24.132897"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "There are a total of 17 result graphs after merging",
          "timestamp": "2022-08-23T20:06:24.133675"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Loading final result graphs into TRAPI object model",
          "timestamp": "2022-08-23T20:06:24.133697"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Resultify created 17 results",
          "timestamp": "2022-08-23T20:06:24.137376"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Cleaning up the KG to remove nodes not used in the results",
          "timestamp": "2022-08-23T20:06:24.137625"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "After cleaning, the KG contains 158 nodes and 499 edges",
          "timestamp": "2022-08-23T20:06:24.138192"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Applying Infer to Message with parameters {'action': 'drug_treatment_graph_expansion', 'node_curie': 'MONDO:0007947', 'qedge_id': 'treats', 'n_drugs': 50, 'n_paths': 20}",
          "timestamp": "2022-08-23T20:06:24.139368"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Query graph is {'edges': {'creative_DTD_qedge_0': {'constraints': [],\n                                    'exclude': False,\n                                    'knowledge_type': None,\n                                    'object': 'creative_DTD_qnode_0',\n                                    'option_group_id': 'creative_DTD_option_group_0',\n                                    'predicates': None,\n                                    'subject': 'drug'},\n           'creative_DTD_qedge_1': {'constraints': [],\n                                    'exclude': False,\n                                    'knowledge_type': None,\n                                    'object': 'creative_DTD_qnode_1',\n                                    'option_group_id': 'creative_DTD_option_group_0',\n                                    'predicates': None,\n                                    'subject': 'creative_DTD_qnode_0'},\n           'creative_DTD_qedge_2': {'constraints': [],\n                                    'exclude': False,\n                                    'knowledge_type': None,\n                                    'object': 'disease',\n                                    'option_group_id': 'creative_DTD_option_group_0',\n                                    'predicates': None,\n                                    'subject': 'creative_DTD_qnode_1'},\n           'treats': {'constraints': [],\n                      'exclude': None,\n                      'knowledge_type': 'inferred',\n                      'object': 'disease',\n                      'option_group_id': None,\n                      'predicates': ['biolink:treats'],\n                      'subject': 'drug'}},\n 'nodes': {'creative_DTD_qnode_0': {'categories': None,\n                                    'constraints': [],\n                                    'ids': None,\n                                    'is_set': True,\n                                    'name': None,\n                                    'option_group_id': 'creative_DTD_option_group_0'},\n           'creative_DTD_qnode_1': {'categories': None,\n                                    'constraints': [],\n                                    'ids': None,\n                                    'is_set': True,\n                                    'name': None,\n                                    'option_group_id': 'creative_DTD_option_group_0'},\n           'disease': {'categories': ['biolink:Disease'],\n                       'constraints': [],\n                       'ids': ['MONDO:0007947'],\n                       'is_set': False,\n                       'name': None,\n                       'option_group_id': None},\n           'drug': {'categories': ['biolink:NamedThing'],\n                    'constraints': [],\n                    'ids': None,\n                    'is_set': False,\n                    'name': None,\n                    'option_group_id': None}}}",
          "timestamp": "2022-08-23T20:06:24.140895"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of nodes in KG is 158",
          "timestamp": "2022-08-23T20:06:24.140953"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of nodes in KG by type is Counter({'biolink:Protein': 59, 'biolink:SmallMolecule': 40, 'biolink:Drug': 14, 'biolink:Disease': 12, 'biolink:BiologicalEntity': 12, 'biolink:PhysiologicalProcess': 11, 'biolink:ChemicalEntity': 2, 'biolink:OrganismTaxon': 2, 'biolink:DiseaseOrPhenotypicFeature': 1, 'biolink:Polypeptide': 1, 'biolink:GeneFamily': 1, 'biolink:AnatomicalEntity': 1, 'biolink:NamedThing': 1, 'biolink:RNAProduct': 1})",
          "timestamp": "2022-08-23T20:06:24.141141"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG is 499",
          "timestamp": "2022-08-23T20:06:24.141164"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG by type is Counter({'biolink:physically_interacts_with': 99, 'biolink:entity_negatively_regulates_entity': 82, 'biolink:gene_associated_with_condition': 81, 'biolink:affects': 61, 'biolink:entity_positively_regulates_entity': 56, 'biolink:treats': 29, 'biolink:subclass_of': 17, 'biolink:has_participant': 17, 'biolink:manifestation_of': 11, 'biolink:has_part': 10, 'biolink:increases_activity_of': 8, 'biolink:causes': 5, 'biolink:decreases_activity_of': 5, 'biolink:directly_interacts_with': 5, 'biolink:colocalizes_with': 4, 'biolink:disrupts': 3, 'biolink:interacts_with': 3, 'biolink:same_as': 1, 'biolink:derives_from': 1, 'biolink:located_in': 1})",
          "timestamp": "2022-08-23T20:06:24.141504"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG with attributes is 499",
          "timestamp": "2022-08-23T20:06:24.141644"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG by attribute Counter({None: 1424, 'biolink:aggregator_knowledge_source': 499, 'biolink:original_edge_information': 390, 'biolink:publications': 334, 'bts:sentence': 201, 'provided_by': 17, 'biolink:computed_value': 17, 'probability_treats': 17, 'EDAM:data_0951': 17})",
          "timestamp": "2022-08-23T20:06:24.143330"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Processing action 'overlay' with parameters {'action': 'compute_ngd', 'virtual_relation_label': 'N1', 'subject_qnode_key': 'disease', 'object_qnode_key': 'drug'}",
          "timestamp": "2022-08-23T20:06:24.143457"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Applying Overlay to Message with parameters {'action': 'compute_ngd', 'virtual_relation_label': 'N1', 'subject_qnode_key': 'disease', 'object_qnode_key': 'drug'}",
          "timestamp": "2022-08-23T20:06:24.143495"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Computing NGD",
          "timestamp": "2022-08-23T20:06:24.401679"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Computing the normalized Google distance: weighting edges based on subject/object node co-occurrence frequency in PubMed abstracts",
          "timestamp": "2022-08-23T20:06:24.401743"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Narrowing down disease--drug node pairs to overlay",
          "timestamp": "2022-08-23T20:06:24.401780"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Identified 17 node pairs to overlay (with help of resultify)",
          "timestamp": "2022-08-23T20:06:24.564521"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Canonicalizing curies of relevant nodes using NodeSynonymizer",
          "timestamp": "2022-08-23T20:06:24.565053"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Extracting PMID lists from sqlite database for relevant nodes",
          "timestamp": "2022-08-23T20:06:25.156165"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Looping through 17 node pairs and calculating NGD values",
          "timestamp": "2022-08-23T20:06:25.245039"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "More than 30 publications found for some edges limiting to 30...",
          "timestamp": "2022-08-23T20:06:25.339013"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "NGD values successfully added to edges",
          "timestamp": "2022-08-23T20:06:25.349014"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Decorating edges with EPC info from KG2c",
          "timestamp": "2022-08-23T20:06:25.349133"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Identified 17 edges to decorate",
          "timestamp": "2022-08-23T20:06:25.349455"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Looking up EPC edge info in KG2c sqlite",
          "timestamp": "2022-08-23T20:06:25.466134"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Got 0 rows back from KG2c sqlite",
          "timestamp": "2022-08-23T20:06:25.466697"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding attributes to edges in the KG",
          "timestamp": "2022-08-23T20:06:25.466738"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Query graph is {'edges': {'N1': {'constraints': [],\n                  'exclude': None,\n                  'knowledge_type': None,\n                  'object': 'drug',\n                  'option_group_id': None,\n                  'predicates': ['biolink:has_normalized_google_distance_with'],\n                  'subject': 'disease'},\n           'creative_DTD_qedge_0': {'constraints': [],\n                                    'exclude': False,\n                                    'knowledge_type': None,\n                                    'object': 'creative_DTD_qnode_0',\n                                    'option_group_id': 'creative_DTD_option_group_0',\n                                    'predicates': None,\n                                    'subject': 'drug'},\n           'creative_DTD_qedge_1': {'constraints': [],\n                                    'exclude': False,\n                                    'knowledge_type': None,\n                                    'object': 'creative_DTD_qnode_1',\n                                    'option_group_id': 'creative_DTD_option_group_0',\n                                    'predicates': None,\n                                    'subject': 'creative_DTD_qnode_0'},\n           'creative_DTD_qedge_2': {'constraints': [],\n                                    'exclude': False,\n                                    'knowledge_type': None,\n                                    'object': 'disease',\n                                    'option_group_id': 'creative_DTD_option_group_0',\n                                    'predicates': None,\n                                    'subject': 'creative_DTD_qnode_1'},\n           'treats': {'constraints': [],\n                      'exclude': None,\n                      'knowledge_type': 'inferred',\n                      'object': 'disease',\n                      'option_group_id': None,\n                      'predicates': ['biolink:treats'],\n                      'subject': 'drug'}},\n 'nodes': {'creative_DTD_qnode_0': {'categories': None,\n                                    'constraints': [],\n                                    'ids': None,\n                                    'is_set': True,\n                                    'name': None,\n                                    'option_group_id': 'creative_DTD_option_group_0'},\n           'creative_DTD_qnode_1': {'categories': None,\n                                    'constraints': [],\n                                    'ids': None,\n                                    'is_set': True,\n                                    'name': None,\n                                    'option_group_id': 'creative_DTD_option_group_0'},\n           'disease': {'categories': ['biolink:Disease'],\n                       'constraints': [],\n                       'ids': ['MONDO:0007947'],\n                       'is_set': False,\n                       'name': None,\n                       'option_group_id': None},\n           'drug': {'categories': ['biolink:NamedThing'],\n                    'constraints': [],\n                    'ids': None,\n                    'is_set': False,\n                    'name': None,\n                    'option_group_id': None}}}",
          "timestamp": "2022-08-23T20:06:25.475480"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of nodes in KG is 158",
          "timestamp": "2022-08-23T20:06:25.475705"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of nodes in KG by type is Counter({'biolink:Protein': 59, 'biolink:SmallMolecule': 40, 'biolink:Drug': 14, 'biolink:Disease': 12, 'biolink:BiologicalEntity': 12, 'biolink:PhysiologicalProcess': 11, 'biolink:ChemicalEntity': 2, 'biolink:OrganismTaxon': 2, 'biolink:DiseaseOrPhenotypicFeature': 1, 'biolink:Polypeptide': 1, 'biolink:GeneFamily': 1, 'biolink:AnatomicalEntity': 1, 'biolink:NamedThing': 1, 'biolink:RNAProduct': 1})",
          "timestamp": "2022-08-23T20:06:25.475972"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG is 516",
          "timestamp": "2022-08-23T20:06:25.475997"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG by type is Counter({'biolink:physically_interacts_with': 99, 'biolink:entity_negatively_regulates_entity': 82, 'biolink:gene_associated_with_condition': 81, 'biolink:affects': 61, 'biolink:entity_positively_regulates_entity': 56, 'biolink:treats': 29, 'biolink:subclass_of': 17, 'biolink:has_participant': 17, 'biolink:has_normalized_google_distance_with': 17, 'biolink:manifestation_of': 11, 'biolink:has_part': 10, 'biolink:increases_activity_of': 8, 'biolink:causes': 5, 'biolink:decreases_activity_of': 5, 'biolink:directly_interacts_with': 5, 'biolink:colocalizes_with': 4, 'biolink:disrupts': 3, 'biolink:interacts_with': 3, 'biolink:same_as': 1, 'biolink:derives_from': 1, 'biolink:located_in': 1})",
          "timestamp": "2022-08-23T20:06:25.476478"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG with attributes is 516",
          "timestamp": "2022-08-23T20:06:25.476652"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG by attribute Counter({None: 1441, 'provided_by': 34, 'probability_treats': 17, 'normalized_google_distance': 17, 'publications': 17, 'virtual_relation_label': 17, 'defined_datetime': 17})",
          "timestamp": "2022-08-23T20:06:25.477834"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Processing action 'resultify' with parameters {'': 'true'}",
          "timestamp": "2022-08-23T20:06:25.477878"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Applying Resultifier to Message with parameters {'': 'true'}",
          "timestamp": "2022-08-23T20:06:25.477907"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Clearing previous results and computing a new set of results",
          "timestamp": "2022-08-23T20:06:25.477937"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Expanded qedges are {'creative_DTD_qedge_1', 'N1', 'creative_DTD_qedge_0', 'creative_DTD_qedge_2', 'treats'}, expanded qnodes are {'disease', 'creative_DTD_qnode_0', 'creative_DTD_qnode_1', 'drug'}; will resultify only this sub-QG",
          "timestamp": "2022-08-23T20:06:25.478788"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Building helper indexes for faster lookup of edges",
          "timestamp": "2022-08-23T20:06:25.480157"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Grabbing only required portion of QG",
          "timestamp": "2022-08-23T20:06:25.481993"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Required qnodes are {'disease', 'drug'}, required qedges are {'N1', 'treats'}",
          "timestamp": "2022-08-23T20:06:25.482102"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Creating result graphs for required portion of QG",
          "timestamp": "2022-08-23T20:06:25.482152"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Constructing result graphs qnode by qnode",
          "timestamp": "2022-08-23T20:06:25.483632"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Initiating result graphs with nodes for disease (is_set=False)",
          "timestamp": "2022-08-23T20:06:25.483683"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Current count of result graphs is 1",
          "timestamp": "2022-08-23T20:06:25.483706"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding a layer to each result graph for qnode drug (is_set=False)",
          "timestamp": "2022-08-23T20:06:25.483731"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Current count of result graphs is 17",
          "timestamp": "2022-08-23T20:06:25.484433"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Done assigning nodes to result graphs",
          "timestamp": "2022-08-23T20:06:25.484459"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding edges to result graphs",
          "timestamp": "2022-08-23T20:06:25.484474"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Created 17 required result graphs",
          "timestamp": "2022-08-23T20:06:25.484622"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Distinct option groups detected in the QG are: {'creative_DTD_option_group_0'}",
          "timestamp": "2022-08-23T20:06:25.484650"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "For option group creative_DTD_option_group_0, qnodes are {'disease', 'creative_DTD_qnode_0', 'creative_DTD_qnode_1', 'drug'}, qedges are {'creative_DTD_qedge_1', 'N1', 'creative_DTD_qedge_0', 'creative_DTD_qedge_2', 'treats'}",
          "timestamp": "2022-08-23T20:06:25.484694"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Creating result graphs for option group creative_DTD_option_group_0",
          "timestamp": "2022-08-23T20:06:25.484745"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Constructing result graphs qnode by qnode",
          "timestamp": "2022-08-23T20:06:25.490613"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding a layer to each result graph for qnode creative_DTD_qnode_0 (is_set=True)",
          "timestamp": "2022-08-23T20:06:25.490717"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Current count of result graphs is 17",
          "timestamp": "2022-08-23T20:06:25.492128"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding a layer to each result graph for qnode creative_DTD_qnode_1 (is_set=True)",
          "timestamp": "2022-08-23T20:06:25.492213"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Current count of result graphs is 17",
          "timestamp": "2022-08-23T20:06:25.494574"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Done assigning nodes to result graphs",
          "timestamp": "2022-08-23T20:06:25.494667"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Adding edges to result graphs",
          "timestamp": "2022-08-23T20:06:25.494689"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Created 17 option group creative_DTD_option_group_0 result graphs",
          "timestamp": "2022-08-23T20:06:25.496968"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Required non-set qnodes are: ['disease', 'drug']",
          "timestamp": "2022-08-23T20:06:25.497068"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Merging option group result graphs into required result graphs with matching non-set qnodes",
          "timestamp": "2022-08-23T20:06:25.497136"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "There are a total of 17 result graphs after merging",
          "timestamp": "2022-08-23T20:06:25.498561"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Loading final result graphs into TRAPI object model",
          "timestamp": "2022-08-23T20:06:25.498630"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Resultify created 17 results",
          "timestamp": "2022-08-23T20:06:25.505204"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Cleaning up the KG to remove nodes not used in the results",
          "timestamp": "2022-08-23T20:06:25.505825"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "After cleaning, the KG contains 158 nodes and 516 edges",
          "timestamp": "2022-08-23T20:06:25.506657"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Running experimental reranker on results",
          "timestamp": "2022-08-23T20:06:25.506696"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Starting to rank results",
          "timestamp": "2022-08-23T20:06:25.506754"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Summary of available edge metrics: {'probability_treats': {'minimum': 0.6276978176547819, 'maximum': 0.8754322646824302}, 'normalized_google_distance': {'minimum': 0.3888452667502981, 'maximum': 0.9872829896467136}}",
          "timestamp": "2022-08-23T20:06:25.518256"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Results have been ranked and sorted",
          "timestamp": "2022-08-23T20:06:25.575796"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Processing action 'filter_results' with parameters {'action': 'limit_number_of_results', 'max_results': '500'}",
          "timestamp": "2022-08-23T20:06:25.575894"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Before filtering, there are 17 results",
          "timestamp": "2022-08-23T20:06:25.575923"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Limiting Number of Results",
          "timestamp": "2022-08-23T20:06:25.578645"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Filtering excess results above max result limit",
          "timestamp": "2022-08-23T20:06:25.578689"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "KG successfully pruned to match results",
          "timestamp": "2022-08-23T20:06:25.580102"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Successfully limited the number of results",
          "timestamp": "2022-08-23T20:06:25.580176"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Applying Overlay to Message with parameters {'action': 'limit_number_of_results', 'max_results': 500, 'prune_kg': True}",
          "timestamp": "2022-08-23T20:06:25.580211"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Query graph is {'edges': {'N1': {'constraints': [],\n                  'exclude': None,\n                  'knowledge_type': None,\n                  'object': 'drug',\n                  'option_group_id': None,\n                  'predicates': ['biolink:has_normalized_google_distance_with'],\n                  'subject': 'disease'},\n           'creative_DTD_qedge_0': {'constraints': [],\n                                    'exclude': False,\n                                    'knowledge_type': None,\n                                    'object': 'creative_DTD_qnode_0',\n                                    'option_group_id': 'creative_DTD_option_group_0',\n                                    'predicates': None,\n                                    'subject': 'drug'},\n           'creative_DTD_qedge_1': {'constraints': [],\n                                    'exclude': False,\n                                    'knowledge_type': None,\n                                    'object': 'creative_DTD_qnode_1',\n                                    'option_group_id': 'creative_DTD_option_group_0',\n                                    'predicates': None,\n                                    'subject': 'creative_DTD_qnode_0'},\n           'creative_DTD_qedge_2': {'constraints': [],\n                                    'exclude': False,\n                                    'knowledge_type': None,\n                                    'object': 'disease',\n                                    'option_group_id': 'creative_DTD_option_group_0',\n                                    'predicates': None,\n                                    'subject': 'creative_DTD_qnode_1'},\n           'treats': {'constraints': [],\n                      'exclude': None,\n                      'knowledge_type': 'inferred',\n                      'object': 'disease',\n                      'option_group_id': None,\n                      'predicates': ['biolink:treats'],\n                      'subject': 'drug'}},\n 'nodes': {'creative_DTD_qnode_0': {'categories': None,\n                                    'constraints': [],\n                                    'ids': None,\n                                    'is_set': True,\n                                    'name': None,\n                                    'option_group_id': 'creative_DTD_option_group_0'},\n           'creative_DTD_qnode_1': {'categories': None,\n                                    'constraints': [],\n                                    'ids': None,\n                                    'is_set': True,\n                                    'name': None,\n                                    'option_group_id': 'creative_DTD_option_group_0'},\n           'disease': {'categories': ['biolink:Disease'],\n                       'constraints': [],\n                       'ids': ['MONDO:0007947'],\n                       'is_set': False,\n                       'name': None,\n                       'option_group_id': None},\n           'drug': {'categories': ['biolink:NamedThing'],\n                    'constraints': [],\n                    'ids': None,\n                    'is_set': False,\n                    'name': None,\n                    'option_group_id': None}}}",
          "timestamp": "2022-08-23T20:06:25.581652"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of nodes in KG is 158",
          "timestamp": "2022-08-23T20:06:25.581713"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of nodes in KG by type is Counter({'biolink:Protein': 59, 'biolink:SmallMolecule': 40, 'biolink:Drug': 14, 'biolink:Disease': 12, 'biolink:BiologicalEntity': 12, 'biolink:PhysiologicalProcess': 11, 'biolink:ChemicalEntity': 2, 'biolink:OrganismTaxon': 2, 'biolink:DiseaseOrPhenotypicFeature': 1, 'biolink:Polypeptide': 1, 'biolink:GeneFamily': 1, 'biolink:AnatomicalEntity': 1, 'biolink:NamedThing': 1, 'biolink:RNAProduct': 1})",
          "timestamp": "2022-08-23T20:06:25.581944"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG is 508",
          "timestamp": "2022-08-23T20:06:25.581966"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG by type is Counter({'biolink:physically_interacts_with': 99, 'biolink:entity_negatively_regulates_entity': 82, 'biolink:gene_associated_with_condition': 74, 'biolink:affects': 61, 'biolink:entity_positively_regulates_entity': 56, 'biolink:treats': 29, 'biolink:subclass_of': 17, 'biolink:has_participant': 17, 'biolink:has_normalized_google_distance_with': 17, 'biolink:manifestation_of': 11, 'biolink:has_part': 10, 'biolink:increases_activity_of': 8, 'biolink:causes': 5, 'biolink:decreases_activity_of': 5, 'biolink:directly_interacts_with': 5, 'biolink:colocalizes_with': 4, 'biolink:interacts_with': 3, 'biolink:disrupts': 2, 'biolink:same_as': 1, 'biolink:derives_from': 1, 'biolink:located_in': 1})",
          "timestamp": "2022-08-23T20:06:25.582351"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG with attributes is 508",
          "timestamp": "2022-08-23T20:06:25.582543"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Number of edges in KG by attribute Counter({None: 1416, 'provided_by': 34, 'probability_treats': 17, 'normalized_google_distance': 17, 'publications': 17, 'virtual_relation_label': 17, 'defined_datetime': 17})",
          "timestamp": "2022-08-23T20:06:25.583883"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Storing resulting Message",
          "timestamp": "2022-08-23T20:06:25.584004"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Writing response record to MySQL",
          "timestamp": "2022-08-23T20:06:25.584030"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Writing response JSON to S3 bucket",
          "timestamp": "2022-08-23T20:06:25.967718"
        },
        {
          "code": "",
          "level": "DEBUG",
          "message": "Wrote /responses/60032.json in 1.044138077646494 seconds",
          "timestamp": "2022-08-23T20:06:27.270263"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Result was stored with id 60032. It can be viewed at https://arax.ncats.io/?r=60032",
          "timestamp": "2022-08-23T20:06:27.272016"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Processing is complete and resulted in 17 results.",
          "timestamp": "2022-08-23T20:06:27.272068"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Processing is complete. Attempting to send the result to the callback URL.",
          "timestamp": "2022-08-23T20:06:27.272092"
        },
        {
          "code": "",
          "level": "INFO",
          "message": "Attempting to send to callback URL: https://ars-prod.transltr.io/ars/api/messages/7fa6840d-14bb-4d85-b6ed-b47ba843a93e",
          "timestamp": "2022-08-23T20:06:27.272113"
        }
      ],
      "type": "translator_reasoner_response",
      "status": "OK",
      "context": "https://raw.githubusercontent.com/biolink/biolink-model/master/context.jsonld",
      "message": {
        "results": [
          {
            "id": null,
            "score": 0.9607843137254902,
            "essence": "LOSARTAN POTASSIUM",
            "row_data": [
              0.961,
              "LOSARTAN POTASSIUM",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_16",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_1",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-UniProtKB:Q13315",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-CHEMBL.TARGET:CHEMBL3988637",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:physically_interacts_with-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-UMLS:C0597357",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:decreases_activity_of-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-FMA:63891",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:has_part-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P37173",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:63891-biolink:entity_negatively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-FMA:67303",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:directly_interacts_with-UniProtKB:P36897",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:interacts_with-UniProtKB:P11047",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0005648",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:colocalizes_with-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0001384",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:affects-MESH:D009154",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:directly_interacts_with-UniProtKB:P37173",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P02452",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q13315-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0005392",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL3988637-biolink:entity_negatively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:63891-biolink:entity_negatively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:entity_positively_regulates_entity-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL3988637-biolink:entity_negatively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q13315-biolink:entity_positively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P62736",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL3988637-biolink:entity_positively_regulates_entity-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0005648",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:has_part-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q13315-biolink:entity_negatively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q13315-biolink:physically_interacts_with-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:colocalizes_with-UniProtKB:Q14766",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:63891-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-DOID:0080685",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL3988637-biolink:entity_negatively_regulates_entity-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P61812-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:DOID:0080685-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P35228-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08253-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P02452-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005392-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005648-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P11047-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005392-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D009154-biolink:causes-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P36897-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q15796-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67303-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P50052-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q14766-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P62736-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P37173-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001384-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001384-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005648-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P14780-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:DOID:0080685-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P84022-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL995"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "UMLS:C0597357"
                },
                {
                  "id": "UniProtKB:Q13315"
                },
                {
                  "id": "FMA:63891"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "CHEMBL.TARGET:CHEMBL3988637"
                },
                {
                  "id": "UniProtKB:P30556"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:P14780"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P35228"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "MONDO:0008375"
                },
                {
                  "id": "UniProtKB:P08253"
                },
                {
                  "id": "UniProtKB:Q15796"
                },
                {
                  "id": "MESH:D009154"
                },
                {
                  "id": "UniProtKB:P84022"
                },
                {
                  "id": "UniProtKB:P36897"
                },
                {
                  "id": "UniProtKB:P62736"
                },
                {
                  "id": "MONDO:0005648"
                },
                {
                  "id": "UniProtKB:P50052"
                },
                {
                  "id": "UniProtKB:Q14766"
                },
                {
                  "id": "FMA:67303"
                },
                {
                  "id": "DOID:0080685"
                },
                {
                  "id": "MONDO:0001384"
                },
                {
                  "id": "UniProtKB:P61812"
                },
                {
                  "id": "MONDO:0005392"
                },
                {
                  "id": "UniProtKB:P11047"
                },
                {
                  "id": "UniProtKB:P37173"
                },
                {
                  "id": "UniProtKB:P02452"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.9019607843137256,
            "essence": "beta-adrenergic antagonist",
            "row_data": [
              0.902,
              "beta-adrenergic antagonist",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_14",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_0",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-CHEBI:35942",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:affects-MESH:D014664",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:physically_interacts_with-FMA:67243",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:physically_interacts_with-FMA:61799",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:physically_interacts_with-UMLS:C0007412",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-CHEBI:35457",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL2391146",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-UMLS:C0007412",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:physically_interacts_with-CHEBI:35457",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:physically_interacts_with-UniProtKB:P29474",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL408403",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:disrupts-UMLS:C0011065",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-UMLS:C0597357",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P29474-biolink:entity_positively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:has_part-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:increases_activity_of-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P29474-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P29474-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0007412-biolink:causes-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:61799-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35942-biolink:entity_positively_regulates_entity-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014664-biolink:has_participant-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:affects-MESH:D009154",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0011065-biolink:affects-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014664-biolink:has_participant-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:increases_activity_of-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67243-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:entity_positively_regulates_entity-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35942-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:61799-biolink:entity_positively_regulates_entity-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:61799-biolink:causes-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:has_part-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P29474-biolink:physically_interacts_with-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2391146-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P01137",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P61812-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D009154-biolink:causes-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q15796-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P35228-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P50052-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08253-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P14780-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P84022-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "CHEBI:35530"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "CHEBI:35457"
                },
                {
                  "id": "UMLS:C0011065"
                },
                {
                  "id": "UMLS:C0597357"
                },
                {
                  "id": "UniProtKB:P29474"
                },
                {
                  "id": "MESH:D014664"
                },
                {
                  "id": "CHEBI:35942"
                },
                {
                  "id": "FMA:61799"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL408403"
                },
                {
                  "id": "FMA:67243"
                },
                {
                  "id": "UMLS:C0007412"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL2391146"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:Q15796"
                },
                {
                  "id": "MESH:D009154"
                },
                {
                  "id": "UniProtKB:P12821"
                },
                {
                  "id": "UniProtKB:P14780"
                },
                {
                  "id": "UniProtKB:P84022"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P35228"
                },
                {
                  "id": "UniProtKB:P50052"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "UniProtKB:P61812"
                },
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "UniProtKB:P30556"
                },
                {
                  "id": "UniProtKB:P08253"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.823529411764706,
            "essence": "EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor",
            "row_data": [
              0.824,
              "EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_10",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_3",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:Q13315",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL406291",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL408403",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_positively_regulates_entity-UniProtKB:P29474",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:physically_interacts_with-UniProtKB:P29474",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_positively_regulates_entity-UniProtKB:Q9BYF1",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-CHEBI:35942",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:treats-CHEMBL.TARGET:CHEMBL376",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:disrupts-UMLS:C0011065",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:affects-UMLS:C0600520",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:affects-UMLS:C0232164",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P29474-biolink:entity_positively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:increases_activity_of-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q9BYF1-biolink:subclass_of-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P29474-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P29474-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q9BYF1-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35942-biolink:entity_positively_regulates_entity-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL406291-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0232164-biolink:affects-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0011065-biolink:affects-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q9BYF1-biolink:has_part-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:increases_activity_of-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q13315-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0600520-biolink:affects-MONDO:0001298",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q9BYF1-biolink:physically_interacts_with-UniProtKB:P37173",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q9BYF1-biolink:colocalizes_with-UniProtKB:P37173",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35942-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q13315-biolink:entity_positively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P04040",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q13315-biolink:entity_negatively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P29474-biolink:physically_interacts_with-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q13315-biolink:physically_interacts_with-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P01137",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P35228-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P50052-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001298-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08253-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P37173-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001298-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P14780-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04040-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "CHEBI:35457"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL406291"
                },
                {
                  "id": "UMLS:C0600520"
                },
                {
                  "id": "UMLS:C0011065"
                },
                {
                  "id": "UniProtKB:Q13315"
                },
                {
                  "id": "UniProtKB:Q9BYF1"
                },
                {
                  "id": "UniProtKB:P29474"
                },
                {
                  "id": "CHEMBL.TARGET:CHEMBL376"
                },
                {
                  "id": "CHEBI:35942"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL408403"
                },
                {
                  "id": "UMLS:C0232164"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:P12821"
                },
                {
                  "id": "UniProtKB:P37173"
                },
                {
                  "id": "UniProtKB:P14780"
                },
                {
                  "id": "MONDO:0001298"
                },
                {
                  "id": "UniProtKB:P35228"
                },
                {
                  "id": "UniProtKB:P50052"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "UniProtKB:P04040"
                },
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "UniProtKB:P30556"
                },
                {
                  "id": "UniProtKB:P08253"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.7058823529411765,
            "essence": "Calcium channel blockers",
            "row_data": [
              0.706,
              "Calcium channel blockers",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_5",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_6",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:affects-MESH:D014664",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-UniProtKB:P08684",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL2391146",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-CHEBI:35457",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL2146121",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-FMA:62343",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL160",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1200402",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:physically_interacts_with-CHEBI:35457",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:affects-UMLS:C0232804",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL408403",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:causes-MESH:D014664",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:treats-CHEMBL.TARGET:CHEMBL376",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:entity_positively_regulates_entity-CHEMBL.COMPOUND:CHEMBL2146121",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1428",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021566-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL2146121",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:62343-biolink:physically_interacts_with-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:increases_activity_of-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08684-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014664-biolink:has_participant-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:62343-biolink:entity_positively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014664-biolink:has_participant-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:increases_activity_of-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1428-biolink:affects-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0232804-biolink:affects-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL160-biolink:affects-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P04040",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2146121-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1200402-biolink:affects-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL160-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2391146-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL160-biolink:affects-UniProtKB:P30556",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P35228-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P50052-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08253-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04040-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P14780-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "VANDF:4021566"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "CHEBI:35457"
                },
                {
                  "id": "UMLS:C0232804"
                },
                {
                  "id": "CHEMBL.TARGET:CHEMBL376"
                },
                {
                  "id": "FMA:62343"
                },
                {
                  "id": "UniProtKB:P08684"
                },
                {
                  "id": "MESH:D014664"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL408403"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL2146121"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1428"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL160"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1200402"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL2391146"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:P12821"
                },
                {
                  "id": "UniProtKB:P14780"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P35228"
                },
                {
                  "id": "UniProtKB:P50052"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "UniProtKB:P04040"
                },
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "UniProtKB:P30556"
                },
                {
                  "id": "UniProtKB:P08253"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.6862745098039215,
            "essence": "PREDNISONE",
            "row_data": [
              0.686,
              "PREDNISONE",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_3",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_8",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:affects-UniProtKB:P02649",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:61799",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL403664",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:affects-UniProtKB:P04083",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:83365",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:affects-UniProtKB:P01579",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL578",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:74637",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL51483",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:affects-FMA:81101",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:67243",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL3039598",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:affects-UniProtKB:P18075",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:82839",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL2367706",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-RXNORM:72260",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:increases_activity_of-UniProtKB:P04150",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1201365",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:67238",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:FMA:81101-biolink:gene_associated_with_condition-MONDO:0005648",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67238-biolink:physically_interacts_with-UniProtKB:P00441",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04150-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:affects-UniProtKB:P51787",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:81101-biolink:gene_associated_with_condition-MONDO:0004910",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:72260-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL578-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P18075-biolink:gene_associated_with_condition-MONDO:0008475",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:61799-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04083-biolink:interacts_with-UniProtKB:P02452",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01579-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P18075-biolink:entity_negatively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL403664-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67238-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67243-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P02649-biolink:gene_associated_with_condition-DOID:0080685",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2367706-biolink:increases_activity_of-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:81101-biolink:directly_interacts_with-UniProtKB:P02452",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:74637-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL51483-biolink:affects-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3039598-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201365-biolink:decreases_activity_of-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:61799-biolink:entity_positively_regulates_entity-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201365-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:61799-biolink:causes-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:81101-biolink:gene_associated_with_condition-MONDO:0001298",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67238-biolink:affects-UniProtKB:P00441",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:82839-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL403664-biolink:affects-UniProtKB:Q15796",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:DOID:0080685-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008475-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0004910-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P00441-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001298-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P02452-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P51787-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001298-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005648-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0004910-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q15796-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005648-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:DOID:0080685-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL635"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "RXNORM:72260"
                },
                {
                  "id": "UniProtKB:P18075"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL3039598"
                },
                {
                  "id": "UniProtKB:P04150"
                },
                {
                  "id": "UniProtKB:P02649"
                },
                {
                  "id": "FMA:67238"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL51483"
                },
                {
                  "id": "FMA:81101"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL578"
                },
                {
                  "id": "FMA:82839"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL2367706"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL403664"
                },
                {
                  "id": "FMA:61799"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1201365"
                },
                {
                  "id": "UniProtKB:P01579"
                },
                {
                  "id": "FMA:74637"
                },
                {
                  "id": "FMA:67243"
                },
                {
                  "id": "FMA:83365"
                },
                {
                  "id": "UniProtKB:P04083"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:Q15796"
                },
                {
                  "id": "DOID:0080685"
                },
                {
                  "id": "UniProtKB:P12821"
                },
                {
                  "id": "MONDO:0001298"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P02452"
                },
                {
                  "id": "MONDO:0005648"
                },
                {
                  "id": "UniProtKB:P51787"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "MONDO:0008475"
                },
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "UniProtKB:P00441"
                },
                {
                  "id": "MONDO:0004910"
                },
                {
                  "id": "MONDO:0008375"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.6666666666666666,
            "essence": "HYDROCORTISONE",
            "row_data": [
              0.667,
              "HYDROCORTISONE",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_7",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_14",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:affects-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:affects-UniProtKB:P46531",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:physically_interacts_with-UniProtKB:P08235",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:affects-UniProtKB:P04114",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:affects-UniProtKB:P01019",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:increases_activity_of-UniProtKB:P04083",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:increases_activity_of-UniProtKB:P08235",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:physically_interacts_with-UniProtKB:P05019",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:entity_positively_regulates_entity-UniProtKB:P08235",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:physically_interacts_with-FMA:264829",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:entity_negatively_regulates_entity-UniProtKB:P05019",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:entity_negatively_regulates_entity-FMA:264829",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-MONDO:0001298",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P46531-biolink:gene_associated_with_condition-DOID:0080685",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-DOID:0080685",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P37173",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-FMA:67303",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:physically_interacts_with-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:directly_interacts_with-UniProtKB:P36897",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:interacts_with-UniProtKB:P11047",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01019-biolink:gene_associated_with_condition-DOID:0080685",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0005648",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04083-biolink:interacts_with-UniProtKB:P02452",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:colocalizes_with-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0001384",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:directly_interacts_with-UniProtKB:P37173",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P02452",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0005392",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01019-biolink:directly_interacts_with-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:gene_associated_with_condition-MONDO:0001384",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-MONDO:0002076",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04114-biolink:gene_associated_with_condition-MONDO:0001298",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:gene_associated_with_condition-MONDO:0005392",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08235-biolink:gene_associated_with_condition-MONDO:0001298",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P62736",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:colocalizes_with-UniProtKB:Q14766",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P46531-biolink:gene_associated_with_condition-MONDO:0005648",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_negatively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P61812-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:DOID:0080685-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P35228-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001298-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08253-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P02452-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0002076-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005392-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005648-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001298-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P11047-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005392-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P36897-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q15796-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67303-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P50052-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q14766-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P62736-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P37173-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001384-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001384-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0002076-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005648-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P14780-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:DOID:0080685-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P84022-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1641"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "UniProtKB:P08235"
                },
                {
                  "id": "UniProtKB:P46531"
                },
                {
                  "id": "UniProtKB:P05019"
                },
                {
                  "id": "UniProtKB:P01019"
                },
                {
                  "id": "FMA:264829"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "UniProtKB:P04114"
                },
                {
                  "id": "UniProtKB:P04083"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:P14780"
                },
                {
                  "id": "UniProtKB:P35228"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "MONDO:0008375"
                },
                {
                  "id": "UniProtKB:P08253"
                },
                {
                  "id": "UniProtKB:Q15796"
                },
                {
                  "id": "UniProtKB:P84022"
                },
                {
                  "id": "MONDO:0001298"
                },
                {
                  "id": "UniProtKB:P36897"
                },
                {
                  "id": "UniProtKB:P62736"
                },
                {
                  "id": "MONDO:0005648"
                },
                {
                  "id": "UniProtKB:P50052"
                },
                {
                  "id": "UniProtKB:Q14766"
                },
                {
                  "id": "FMA:67303"
                },
                {
                  "id": "DOID:0080685"
                },
                {
                  "id": "MONDO:0001384"
                },
                {
                  "id": "MONDO:0002076"
                },
                {
                  "id": "UniProtKB:P61812"
                },
                {
                  "id": "MONDO:0005392"
                },
                {
                  "id": "UniProtKB:P37173"
                },
                {
                  "id": "UniProtKB:P11047"
                },
                {
                  "id": "UniProtKB:P02452"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.6274509803921569,
            "essence": "METHYLPREDNISOLONE",
            "row_data": [
              0.627,
              "METHYLPREDNISOLONE",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_12",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_11",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL506569",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL1641",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:affects-UniProtKB:P02778",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1201365",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:affects-UniProtKB:P10415",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:affects-UniProtKB:P01106",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL123558",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:increases_activity_of-UniProtKB:P04083",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-RXNORM:72260",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL228792",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL403664",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:affects-UniProtKB:P01579",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:treats-MESH:D000375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-FMA:83365",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-DRUGBANK:DB06205",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL160",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1256391",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:affects-UniProtKB:P04637",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04637-biolink:entity_positively_regulates_entity-MESH:D009154",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D000375-biolink:has_participant-UniProtKB:P37173",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01106-biolink:interacts_with-UniProtKB:P53814",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL228792-biolink:entity_negatively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:affects-UniProtKB:P51787",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL506569-biolink:affects-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:72260-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D000375-biolink:has_participant-UniProtKB:P10600",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04083-biolink:interacts_with-UniProtKB:P02452",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P02778-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01579-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04637-biolink:physically_interacts_with-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P10415-biolink:physically_interacts_with-UniProtKB:P00441",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL403664-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:DRUGBANK:DB06205-biolink:entity_negatively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL160-biolink:affects-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL123558-biolink:physically_interacts_with-UniProtKB:P51787",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL403664-biolink:affects-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201365-biolink:decreases_activity_of-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1256391-biolink:entity_negatively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201365-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL123558-biolink:affects-UniProtKB:P51787",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:affects-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01106-biolink:physically_interacts_with-UniProtKB:P37173",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL160-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04637-biolink:gene_associated_with_condition-MONDO:0008213",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL160-biolink:affects-UniProtKB:P30556",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P00441-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P02452-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08253-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P51787-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P10600-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P84022-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D009154-biolink:causes-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q15796-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008213-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P37173-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008213-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P53814-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1201081"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "UniProtKB:P02778"
                },
                {
                  "id": "UniProtKB:P01106"
                },
                {
                  "id": "DRUGBANK:DB06205"
                },
                {
                  "id": "RXNORM:72260"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1641"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL123558"
                },
                {
                  "id": "UniProtKB:P04637"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL403664"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL506569"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1256391"
                },
                {
                  "id": "UniProtKB:P10415"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1201365"
                },
                {
                  "id": "UniProtKB:P01579"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL228792"
                },
                {
                  "id": "FMA:83365"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL160"
                },
                {
                  "id": "UniProtKB:P04083"
                },
                {
                  "id": "MESH:D000375"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:Q15796"
                },
                {
                  "id": "MESH:D009154"
                },
                {
                  "id": "UniProtKB:P12821"
                },
                {
                  "id": "UniProtKB:P37173"
                },
                {
                  "id": "UniProtKB:P84022"
                },
                {
                  "id": "UniProtKB:P51787"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P02452"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "UniProtKB:P53814"
                },
                {
                  "id": "MONDO:0008213"
                },
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "UniProtKB:P00441"
                },
                {
                  "id": "UniProtKB:P10600"
                },
                {
                  "id": "UniProtKB:P30556"
                },
                {
                  "id": "MONDO:0008375"
                },
                {
                  "id": "UniProtKB:P08253"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.6274509803921569,
            "essence": "antihypertensive agent",
            "row_data": [
              0.627,
              "antihypertensive agent",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_4",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_7",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:CHEBI:35674-biolink:entity_negatively_regulates_entity-CHEBI:35457",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35674-biolink:affects-MESH:D006439",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35674-biolink:affects-UMLS:C0232804",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35674-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL408403",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35674-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL408403",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0232804-biolink:affects-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:increases_activity_of-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P50052",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D006439-biolink:affects-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:increases_activity_of-UniProtKB:P50052",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P35228-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P50052-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08253-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P14780-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "CHEBI:35674"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "CHEBI:35457"
                },
                {
                  "id": "MESH:D006439"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL408403"
                },
                {
                  "id": "UMLS:C0232804"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:P12821"
                },
                {
                  "id": "UniProtKB:P14780"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P35228"
                },
                {
                  "id": "UniProtKB:P50052"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "UniProtKB:P30556"
                },
                {
                  "id": "UniProtKB:P08253"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.6078431372549019,
            "essence": "Dexamethasone",
            "row_data": [
              0.608,
              "Dexamethasone",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_13",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_5",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-FMA:264829",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:3264-biolink:entity_positively_regulates_entity-FMA:264825",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-UniProtKB:P05019",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-UniProtKB:P05362",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-UniProtKB:P15692",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:3264-biolink:entity_positively_regulates_entity-CHEMBL.COMPOUND:CHEMBL3322001",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-UniProtKB:P35354",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:3264-biolink:entity_positively_regulates_entity-FMA:264829",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-FMA:264827",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-MONDO:0001298",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-DOID:0080685",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264825-biolink:gene_associated_with_condition-MONDO:0005648",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P35354-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P37173",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-FMA:67303",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:physically_interacts_with-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:directly_interacts_with-UniProtKB:P36897",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:interacts_with-UniProtKB:P11047",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264827-biolink:entity_positively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0005648",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264825-biolink:entity_negatively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3322001-biolink:entity_positively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:colocalizes_with-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P15692-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264827-biolink:gene_associated_with_condition-MONDO:0002076",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0001384",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P15692-biolink:entity_negatively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:directly_interacts_with-UniProtKB:P37173",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264827-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P02452",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0005392",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-MONDO:0002076",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P15692-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:gene_associated_with_condition-MONDO:0001384",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264825-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05019-biolink:gene_associated_with_condition-MONDO:0005392",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264827-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P62736",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:colocalizes_with-UniProtKB:Q14766",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P05362-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:264829-biolink:entity_negatively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P61812-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:DOID:0080685-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P35228-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001298-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08253-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P02452-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0002076-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005392-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005648-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001298-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P11047-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005392-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P36897-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q15796-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67303-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q14766-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P62736-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P37173-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001384-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001384-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0002076-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005648-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P14780-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:DOID:0080685-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P84022-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "RXNORM:3264"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "UniProtKB:P05362"
                },
                {
                  "id": "UniProtKB:P05019"
                },
                {
                  "id": "UniProtKB:P15692"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL3322001"
                },
                {
                  "id": "FMA:264825"
                },
                {
                  "id": "UniProtKB:P35354"
                },
                {
                  "id": "FMA:264829"
                },
                {
                  "id": "FMA:264827"
                },
                {
                  "id": "UniProtKB:P01137"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:P14780"
                },
                {
                  "id": "UniProtKB:P35228"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "MONDO:0008375"
                },
                {
                  "id": "UniProtKB:P08253"
                },
                {
                  "id": "UniProtKB:Q15796"
                },
                {
                  "id": "UniProtKB:P84022"
                },
                {
                  "id": "MONDO:0001298"
                },
                {
                  "id": "UniProtKB:P36897"
                },
                {
                  "id": "UniProtKB:P62736"
                },
                {
                  "id": "MONDO:0005648"
                },
                {
                  "id": "UniProtKB:Q14766"
                },
                {
                  "id": "FMA:67303"
                },
                {
                  "id": "DOID:0080685"
                },
                {
                  "id": "MONDO:0001384"
                },
                {
                  "id": "MONDO:0002076"
                },
                {
                  "id": "UniProtKB:P61812"
                },
                {
                  "id": "MONDO:0005392"
                },
                {
                  "id": "UniProtKB:P37173"
                },
                {
                  "id": "UniProtKB:P11047"
                },
                {
                  "id": "UniProtKB:P02452"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.4901960784313726,
            "essence": "INSULIN ASPART",
            "row_data": [
              0.49,
              "INSULIN ASPART",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_9",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_10",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-UniProtKB:P08069",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:increases_activity_of-UniProtKB:P06213",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1256940",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-FMA:83365",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:subclass_of-FMA:83365",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL118",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-RXNORM:10759",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:affects-UniProtKB:P08069",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1200382",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-UniProtKB:P06213",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL405110",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL25",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL3989410",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL46516",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-RXNORM:235758",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1641",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL729",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-FMA:67243",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:subclass_of-CHEMBL.COMPOUND:CHEMBL2369717",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1428",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1697788",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1697788-biolink:affects-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:235758-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:10759-biolink:affects-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:235758-biolink:decreases_activity_of-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1200382-biolink:decreases_activity_of-UniProtKB:P51787",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL729-biolink:affects-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2369717-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:affects-UniProtKB:P51787",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2369717-biolink:derives_from-FMA:67303",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL405110-biolink:affects-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL46516-biolink:affects-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1697788-biolink:decreases_activity_of-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1697788-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3989410-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1428-biolink:affects-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08069-biolink:gene_associated_with_condition-MONDO:0001210",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67243-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83365-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2369717-biolink:has_part-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL25-biolink:affects-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:235758-biolink:physically_interacts_with-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1200382-biolink:entity_negatively_regulates_entity-UniProtKB:P51787",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P06213-biolink:directly_interacts_with-FMA:63018",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1256940-biolink:affects-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:affects-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL118-biolink:affects-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08069-biolink:gene_associated_with_condition-MONDO:0008213",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3989410-biolink:affects-UniProtKB:P30556",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:MONDO:0001210-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q15796-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008213-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67303-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P35228-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008213-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P51787-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001210-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:63018-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P14780-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P84022-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "ATC:A10AB05"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1256940"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL405110"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL118"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL2369717"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1641"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL46516"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL729"
                },
                {
                  "id": "UniProtKB:P06213"
                },
                {
                  "id": "RXNORM:10759"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL3989410"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1697788"
                },
                {
                  "id": "UniProtKB:P08069"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1428"
                },
                {
                  "id": "FMA:67243"
                },
                {
                  "id": "FMA:83365"
                },
                {
                  "id": "RXNORM:235758"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1200382"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL25"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:Q15796"
                },
                {
                  "id": "UniProtKB:P12821"
                },
                {
                  "id": "UniProtKB:P84022"
                },
                {
                  "id": "UniProtKB:P14780"
                },
                {
                  "id": "UniProtKB:P35228"
                },
                {
                  "id": "UniProtKB:P51787"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "FMA:63018"
                },
                {
                  "id": "MONDO:0008213"
                },
                {
                  "id": "FMA:67303"
                },
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "UniProtKB:P30556"
                },
                {
                  "id": "MONDO:0001210"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.4509803921568627,
            "essence": "Anticoagulants",
            "row_data": [
              0.451,
              "Anticoagulants",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_0",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_9",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:VANDF:4021557-biolink:physically_interacts_with-UniProtKB:P07204",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021557-biolink:physically_interacts_with-FMA:82839",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021557-biolink:entity_negatively_regulates_entity-MESH:D015539",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:VANDF:4021557-biolink:affects-UBERON:0000178",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:FMA:82839-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P07204-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UBERON:0000178-biolink:has_part-UniProtKB:P04040",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D015539-biolink:has_participant-UniProtKB:P02461",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P02461-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04040-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "VANDF:4021557"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "UBERON:0000178"
                },
                {
                  "id": "UniProtKB:P07204"
                },
                {
                  "id": "FMA:82839"
                },
                {
                  "id": "MESH:D015539"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:P04040"
                },
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P02461"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.4313725490196078,
            "essence": "GONADORELIN HYDROCHLORIDE",
            "row_data": [
              0.431,
              "GONADORELIN HYDROCHLORIDE",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_15",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_13",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_positively_regulates_entity-CHEBI:33699",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_positively_regulates_entity-FMA:83358",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:physically_interacts_with-UMLS:C0597357",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:has_part-CHEBI:33699",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_negatively_regulates_entity-FMA:83358",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:physically_interacts_with-CHEBI:33699",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:affects-MESH:D013091",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_negatively_regulates_entity-FMA:83375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:located_in-CHEMBL.TARGET:CHEMBL376",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:treats-UMLS:C0039005",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:physically_interacts_with-FMA:74644",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_positively_regulates_entity-FMA:83375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:affects-UniProtKB:P60953",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:treats-CHEMBL.TARGET:CHEMBL376",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_positively_regulates_entity-UniProtKB:P01100",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_positively_regulates_entity-UniProtKB:P18146",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:CHEBI:33699-biolink:entity_positively_regulates_entity-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:74644-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:33699-biolink:physically_interacts_with-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:has_part-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:entity_positively_regulates_entity-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83358-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01100-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P18146-biolink:gene_associated_with_condition-MONDO:0001384",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:33699-biolink:entity_positively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01100-biolink:physically_interacts_with-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:affects-MESH:D009154",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:74644-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:74644-biolink:entity_negatively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0039005-biolink:has_part-FMA:67303",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:74644-biolink:causes-MONDO:0005392",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:33699-biolink:entity_negatively_regulates_entity-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:entity_positively_regulates_entity-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:Q15796",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:74644-biolink:affects-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:83375-biolink:physically_interacts_with-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P60953-biolink:gene_associated_with_condition-MONDO:0005392",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P04040",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:has_part-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01100-biolink:gene_associated_with_condition-MONDO:0005392",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P35228",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D013091-biolink:has_participant-UniProtKB:P12821",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P61812-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005392-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D009154-biolink:causes-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q15796-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67303-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P35228-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005392-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001384-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0001384-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P14780-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04040-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P84022-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL3182731"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "UMLS:C0039005"
                },
                {
                  "id": "UniProtKB:P01100"
                },
                {
                  "id": "UMLS:C0597357"
                },
                {
                  "id": "CHEMBL.TARGET:CHEMBL376"
                },
                {
                  "id": "UniProtKB:P60953"
                },
                {
                  "id": "FMA:83358"
                },
                {
                  "id": "FMA:83375"
                },
                {
                  "id": "CHEBI:33699"
                },
                {
                  "id": "UniProtKB:P18146"
                },
                {
                  "id": "MESH:D013091"
                },
                {
                  "id": "FMA:74644"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "MESH:D009154"
                },
                {
                  "id": "UniProtKB:Q15796"
                },
                {
                  "id": "UniProtKB:P12821"
                },
                {
                  "id": "UniProtKB:P14780"
                },
                {
                  "id": "UniProtKB:P84022"
                },
                {
                  "id": "MONDO:0001384"
                },
                {
                  "id": "FMA:67303"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P35228"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "MONDO:0005392"
                },
                {
                  "id": "UniProtKB:P61812"
                },
                {
                  "id": "UniProtKB:P04040"
                },
                {
                  "id": "MONDO:0005009"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.411764705882353,
            "essence": "Factor VIIa",
            "row_data": [
              0.412,
              "Factor VIIa",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_11",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_16",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2108334-biolink:subclass_of-RXNORM:8031",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:RXNORM:8031-biolink:entity_negatively_regulates_entity-FMA:67303",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:8031-biolink:physically_interacts_with-FMA:67303",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:8031-biolink:affects-MESH:D009154",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:8031-biolink:entity_positively_regulates_entity-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:RXNORM:8031-biolink:entity_positively_regulates_entity-UniProtKB:P14780",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08253-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67303-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P14780-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D009154-biolink:causes-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL2108334"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "RXNORM:8031"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "FMA:67303"
                },
                {
                  "id": "MESH:D009154"
                },
                {
                  "id": "UniProtKB:P14780"
                },
                {
                  "id": "UniProtKB:P08253"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.392156862745098,
            "essence": "Hyperbaric Oxygen (substance)",
            "row_data": [
              0.392,
              "Hyperbaric Oxygen (substance)",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_8",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_4",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:UMLS:C0279328-biolink:entity_positively_regulates_entity-UMLS:C0302600",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0279328-biolink:subclass_of-CHEMBL.COMPOUND:CHEMBL1234886",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0279328-biolink:entity_positively_regulates_entity-MESH:D014945",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P61812",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1234886-biolink:physically_interacts_with-UniProtKB:P04040",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P10600",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0302600-biolink:has_participant-UniProtKB:P08253",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P37173",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P02461",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P36897",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014945-biolink:has_participant-FMA:63018",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P02452",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0302600-biolink:has_participant-UniProtKB:P01133",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1234886-biolink:entity_negatively_regulates_entity-UniProtKB:P04040",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:Q15796",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:UniProtKB:P61812-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P36897-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q15796-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P08253-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P02452-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P37173-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P02461-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P10600-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:63018-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P04040-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P84022-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "UMLS:C0279328"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "MESH:D014945"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1234886"
                },
                {
                  "id": "UMLS:C0302600"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:Q15796"
                },
                {
                  "id": "UniProtKB:P37173"
                },
                {
                  "id": "UniProtKB:P84022"
                },
                {
                  "id": "UniProtKB:P36897"
                },
                {
                  "id": "UniProtKB:P01133"
                },
                {
                  "id": "UniProtKB:P02452"
                },
                {
                  "id": "UniProtKB:P61812"
                },
                {
                  "id": "FMA:63018"
                },
                {
                  "id": "UniProtKB:P02461"
                },
                {
                  "id": "UniProtKB:P04040"
                },
                {
                  "id": "UniProtKB:P10600"
                },
                {
                  "id": "UniProtKB:P08253"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.37254901960784315,
            "essence": "PROCATEROL HYDROCHLORIDE",
            "row_data": [
              0.373,
              "PROCATEROL HYDROCHLORIDE",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_1",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_2",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL1711",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:affects-UniProtKB:Q16665",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:same_as-CHEMBL.COMPOUND:CHEMBL1322218",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1711",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:affects-UniProtKB:P07550",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:entity_negatively_regulates_entity-FMA:61799",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1322218-biolink:affects-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:61799-biolink:causes-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q16665-biolink:gene_associated_with_condition-MONDO:0008375",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q16665-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:61799-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q16665-biolink:colocalizes_with-UniProtKB:P84022",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P07550-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1711-biolink:physically_interacts_with-UniProtKB:P00441",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1322218-biolink:affects-UniProtKB:P01137",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:61799-biolink:entity_positively_regulates_entity-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1711-biolink:affects-UniProtKB:P00441",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P84022-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P00441-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0008375-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL3249705"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1322218"
                },
                {
                  "id": "UniProtKB:Q16665"
                },
                {
                  "id": "FMA:61799"
                },
                {
                  "id": "UniProtKB:P07550"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1711"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "UniProtKB:P12821"
                },
                {
                  "id": "UniProtKB:P84022"
                },
                {
                  "id": "UniProtKB:P01137"
                },
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "UniProtKB:P00441"
                },
                {
                  "id": "MONDO:0008375"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.35294117647058826,
            "essence": "serotonin uptake inhibitor",
            "row_data": [
              0.353,
              "serotonin uptake inhibitor",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_2",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_15",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:CHEBI:50949-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1201082",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:50949-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1709",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:50949-biolink:physically_interacts_with-FMA:67238",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201082-biolink:affects-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67238-biolink:physically_interacts_with-UniProtKB:P00441",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67238-biolink:treats-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:FMA:67238-biolink:affects-UniProtKB:P00441",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1709-biolink:affects-UniProtKB:P12821",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201082-biolink:affects-UniProtKB:P35228",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P00441-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P35228-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "CHEBI:50949"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1201082"
                },
                {
                  "id": "CHEMBL.COMPOUND:CHEMBL1709"
                },
                {
                  "id": "FMA:67238"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "UniProtKB:P00441"
                },
                {
                  "id": "UniProtKB:P12821"
                },
                {
                  "id": "UniProtKB:P35228"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          },
          {
            "id": null,
            "score": 0.3137254901960784,
            "essence": "Antiplatelet Agents",
            "row_data": [
              0.314,
              "Antiplatelet Agents",
              "['biolink:NamedThing']"
            ],
            "confidence": null,
            "score_name": null,
            "description": "No description available",
            "reasoner_id": "ARAX",
            "result_group": null,
            "edge_bindings": {
              "N1": [
                {
                  "id": "N1_6",
                  "attributes": null
                }
              ],
              "treats": [
                {
                  "id": "creative_DTD_prediction_12",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_0": [
                {
                  "id": "infores:rtx-kg2:UMLS:C0085826-biolink:entity_negatively_regulates_entity-CHEBI:35457",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0085826-biolink:entity_negatively_regulates_entity-UniProtKB:Q9H244",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UMLS:C0085826-biolink:entity_negatively_regulates_entity-MESH:D015539",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_1": [
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:P30556",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MESH:D015539-biolink:has_participant-UniProtKB:P02461",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:Q9H244-biolink:gene_associated_with_condition-MONDO:0005009",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:P12821",
                  "attributes": null
                }
              ],
              "creative_DTD_qedge_2": [
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P02461-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                },
                {
                  "id": "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947",
                  "attributes": null
                }
              ]
            },
            "node_bindings": {
              "drug": [
                {
                  "id": "UMLS:C0085826"
                }
              ],
              "disease": [
                {
                  "id": "MONDO:0007947"
                }
              ],
              "creative_DTD_qnode_0": [
                {
                  "id": "CHEBI:35457"
                },
                {
                  "id": "UniProtKB:Q9H244"
                },
                {
                  "id": "MESH:D015539"
                }
              ],
              "creative_DTD_qnode_1": [
                {
                  "id": "MONDO:0005009"
                },
                {
                  "id": "UniProtKB:P12821"
                },
                {
                  "id": "UniProtKB:P30556"
                },
                {
                  "id": "UniProtKB:P02461"
                }
              ]
            },
            "score_direction": null,
            "essence_category": "['biolink:NamedThing']",
            "result_group_similarity_score": null
          }
        ],
        "query_graph": {
          "edges": {
            "N1": {
              "object": "drug",
              "exclude": null,
              "subject": "disease",
              "predicates": [
                "biolink:has_normalized_google_distance_with"
              ],
              "constraints": [],
              "knowledge_type": null,
              "option_group_id": null
            },
            "treats": {
              "object": "disease",
              "exclude": null,
              "subject": "drug",
              "predicates": [
                "biolink:treats"
              ],
              "constraints": [],
              "knowledge_type": "inferred",
              "option_group_id": null
            },
            "creative_DTD_qedge_0": {
              "object": "creative_DTD_qnode_0",
              "exclude": false,
              "subject": "drug",
              "predicates": null,
              "constraints": [],
              "knowledge_type": null,
              "option_group_id": "creative_DTD_option_group_0"
            },
            "creative_DTD_qedge_1": {
              "object": "creative_DTD_qnode_1",
              "exclude": false,
              "subject": "creative_DTD_qnode_0",
              "predicates": null,
              "constraints": [],
              "knowledge_type": null,
              "option_group_id": "creative_DTD_option_group_0"
            },
            "creative_DTD_qedge_2": {
              "object": "disease",
              "exclude": false,
              "subject": "creative_DTD_qnode_1",
              "predicates": null,
              "constraints": [],
              "knowledge_type": null,
              "option_group_id": "creative_DTD_option_group_0"
            }
          },
          "nodes": {
            "drug": {
              "ids": null,
              "name": null,
              "is_set": false,
              "categories": [
                "biolink:NamedThing"
              ],
              "constraints": [],
              "option_group_id": null
            },
            "disease": {
              "ids": [
                "MONDO:0007947"
              ],
              "name": null,
              "is_set": false,
              "categories": [
                "biolink:Disease"
              ],
              "constraints": [],
              "option_group_id": null
            },
            "creative_DTD_qnode_0": {
              "ids": null,
              "name": null,
              "is_set": true,
              "categories": null,
              "constraints": [],
              "option_group_id": "creative_DTD_option_group_0"
            },
            "creative_DTD_qnode_1": {
              "ids": null,
              "name": null,
              "is_set": true,
              "categories": null,
              "constraints": [],
              "option_group_id": "creative_DTD_option_group_0"
            }
          }
        },
        "knowledge_graph": {
          "edges": {
            "N1_0": {
              "object": "VANDF:4021557",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "0.769718882486894",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [
                    "PMID:26123456",
                    "PMID:18686210",
                    "PMID:32188418",
                    "PMID:17257923",
                    "PMID:12852802",
                    "PMID:19049741",
                    "PMID:17597390",
                    "PMID:10426224",
                    "PMID:15313937",
                    "PMID:26947541",
                    "PMID:25909269",
                    "PMID:32980987",
                    "PMID:12199039"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_1": {
              "object": "CHEMBL.COMPOUND:CHEMBL3249705",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "inf",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_2": {
              "object": "CHEBI:50949",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "inf",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_3": {
              "object": "CHEMBL.COMPOUND:CHEMBL635",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "0.8749650365701039",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [
                    "PMID:25781946",
                    "PMID:21107118"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_4": {
              "object": "CHEBI:35674",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "0.7120286624221328",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [
                    "PMID:32867844",
                    "PMID:29433732",
                    "PMID:20189193",
                    "PMID:28099082",
                    "PMID:19662746",
                    "PMID:30412443",
                    "PMID:25779879",
                    "PMID:23121584",
                    "PMID:23877552",
                    "PMID:25612980",
                    "PMID:24398790",
                    "PMID:11903305",
                    "PMID:18377545",
                    "PMID:20687182",
                    "PMID:30763216",
                    "PMID:26506064",
                    "PMID:30270167",
                    "PMID:22471392",
                    "PMID:21561700",
                    "PMID:29948025",
                    "PMID:24388607"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_5": {
              "object": "VANDF:4021566",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "0.7165954511460824",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [
                    "PMID:22471392",
                    "PMID:18579813",
                    "PMID:23200711",
                    "PMID:17503882",
                    "PMID:18347371",
                    "PMID:16939678",
                    "PMID:20926894",
                    "PMID:16555694",
                    "PMID:26506064",
                    "PMID:7790334",
                    "PMID:10235096",
                    "PMID:11683774"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_6": {
              "object": "UMLS:C0085826",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "inf",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_7": {
              "object": "CHEMBL.COMPOUND:CHEMBL1641",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "0.9872829896467136",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [
                    "PMID:21281193"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_8": {
              "object": "UMLS:C0279328",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "inf",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_9": {
              "object": "ATC:A10AB05",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "inf",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_10": {
              "object": "CHEBI:35457",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "0.6495652871024692",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [
                    "PMID:17503882",
                    "PMID:21276043",
                    "PMID:23083542",
                    "PMID:19717156",
                    "PMID:21281193",
                    "PMID:15842990",
                    "PMID:16555694",
                    "PMID:15529906",
                    "PMID:26632386",
                    "PMID:11568070",
                    "PMID:17911499",
                    "PMID:23674060",
                    "PMID:22111324",
                    "PMID:24531548",
                    "PMID:23444191",
                    "PMID:22471392",
                    "PMID:21152098",
                    "PMID:18579813",
                    "PMID:21493863",
                    "PMID:12368744",
                    "PMID:18347371",
                    "PMID:12505586",
                    "PMID:33238262",
                    "PMID:25109242"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_11": {
              "object": "CHEMBL.COMPOUND:CHEMBL2108334",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "0.736959395970346",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [
                    "PMID:15888865"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_12": {
              "object": "CHEMBL.COMPOUND:CHEMBL1201081",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "0.8737225014176804",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [
                    "PMID:25238161"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_13": {
              "object": "RXNORM:3264",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "inf",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_14": {
              "object": "CHEBI:35530",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "0.5126092630819421",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [
                    "PMID:25935877",
                    "PMID:9272326",
                    "PMID:7778824",
                    "PMID:23930893",
                    "PMID:31129614",
                    "PMID:9793038",
                    "PMID:23083542",
                    "PMID:22500376",
                    "PMID:29110304",
                    "PMID:19717156",
                    "PMID:16265257",
                    "PMID:8740914",
                    "PMID:18606132",
                    "PMID:18575928",
                    "PMID:18801726",
                    "PMID:27274304",
                    "PMID:25174594",
                    "PMID:16325700",
                    "PMID:17170502",
                    "PMID:29198406",
                    "PMID:11865681",
                    "PMID:8451670",
                    "PMID:22111324",
                    "PMID:30115424",
                    "PMID:17643619",
                    "PMID:21443687",
                    "PMID:16601194",
                    "PMID:17892982",
                    "PMID:21617273",
                    "PMID:30651002"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_15": {
              "object": "CHEMBL.COMPOUND:CHEMBL3182731",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "inf",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "N1_16": {
              "object": "CHEMBL.COMPOUND:CHEMBL995",
              "subject": "MONDO:0007947",
              "predicate": "biolink:has_normalized_google_distance_with",
              "attributes": [
                {
                  "value": "0.3888452667502981",
                  "value_url": "https://arax.ncats.io/api/rtx/v1/ui/#/PubmedMeshNgd",
                  "attributes": null,
                  "description": "\n        Normalized google distance is a metric based on edge subject/object node co-occurrence in abstracts of all [PubMed](https://pubmed.ncbi.nlm.nih.gov/) articles. \n        The formula can be found here on [wikipedia.](https://en.wikipedia.org/wiki/Normalized_Google_distance) \n        Where in this case f(x,y) is the number of PubMed abstracts both concepts apear in, f(x)/f(y) are the number of abstracts individual concepts apear in, and N is the number of pubmed articles times the average numbver of search terms per article (27 million * 20).\n        ",
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_2526",
                  "original_attribute_name": "normalized_google_distance"
                },
                {
                  "value": [
                    "PMID:25935877",
                    "PMID:25988230",
                    "PMID:20189193",
                    "PMID:28099082",
                    "PMID:28768908",
                    "PMID:23930893",
                    "PMID:25238161",
                    "PMID:32650901",
                    "PMID:20006934",
                    "PMID:22259224",
                    "PMID:24931486",
                    "PMID:26724512",
                    "PMID:23321647",
                    "PMID:27187761",
                    "PMID:18606132",
                    "PMID:25780791",
                    "PMID:27274304",
                    "PMID:18630721",
                    "PMID:27704402",
                    "PMID:31606871",
                    "PMID:24531548",
                    "PMID:30115424",
                    "PMID:21493862",
                    "PMID:21493863",
                    "PMID:16601194",
                    "PMID:17892982",
                    "PMID:25613431",
                    "PMID:29948025",
                    "PMID:30651002",
                    "PMID:22550139"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": "publications"
                },
                {
                  "value": "N1",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "biolink:Unknown",
                  "original_attribute_name": "virtual_relation_label"
                },
                {
                  "value": "2022-08-23 20:06:25",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "metatype:Datetime",
                  "original_attribute_name": "defined_datetime"
                },
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                }
              ]
            },
            "creative_DTD_prediction_0": {
              "object": "MONDO:0007947",
              "subject": "CHEBI:35530",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.8754322646824302",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_1": {
              "object": "MONDO:0007947",
              "subject": "CHEMBL.COMPOUND:CHEMBL995",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.7905051309984323",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_2": {
              "object": "MONDO:0007947",
              "subject": "CHEMBL.COMPOUND:CHEMBL3249705",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.7844976843364428",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_3": {
              "object": "MONDO:0007947",
              "subject": "CHEBI:35457",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6886732713673765",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_4": {
              "object": "MONDO:0007947",
              "subject": "UMLS:C0279328",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6847824260314249",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_5": {
              "object": "MONDO:0007947",
              "subject": "RXNORM:3264",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6767596681688031",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_6": {
              "object": "MONDO:0007947",
              "subject": "VANDF:4021566",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6726561103456832",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_7": {
              "object": "MONDO:0007947",
              "subject": "CHEBI:35674",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6620705663312032",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_8": {
              "object": "MONDO:0007947",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6607766030581691",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_9": {
              "object": "MONDO:0007947",
              "subject": "VANDF:4021557",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6603475181432489",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_10": {
              "object": "MONDO:0007947",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6467654449393072",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_11": {
              "object": "MONDO:0007947",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6441244292557962",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_12": {
              "object": "MONDO:0007947",
              "subject": "UMLS:C0085826",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6409655892642695",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_13": {
              "object": "MONDO:0007947",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6376848675408138",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_14": {
              "object": "MONDO:0007947",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.637536115244054",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_15": {
              "object": "MONDO:0007947",
              "subject": "CHEBI:50949",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6276996654481525",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "creative_DTD_prediction_16": {
              "object": "MONDO:0007947",
              "subject": "CHEMBL.COMPOUND:CHEMBL2108334",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:arax",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:arax",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": "provided_by"
                },
                {
                  "value": true,
                  "value_url": null,
                  "attributes": null,
                  "description": "This edge is a container for a computed value between two nodes that is not directly attachable to other edges.",
                  "value_type_id": "metatype:Boolean",
                  "attribute_source": "infores:arax-reasoner-ara",
                  "attribute_type_id": "biolink:computed_value",
                  "original_attribute_name": null
                },
                {
                  "value": "0.6276978176547819",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "EDAM:data_0951",
                  "original_attribute_name": "probability_treats"
                }
              ]
            },
            "infores:rtx-kg2:FMA:61799-biolink:causes-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "FMA:61799",
              "predicate": "biolink:causes",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0028351---SEMMEDDB:causes---UMLS:C0242698---SEMMEDDB:",
                    "UMLS:C0028351---SEMMEDDB:causes---UMLS:C0018801---SEMMEDDB:",
                    "UMLS:C0028351---SEMMEDDB:causes---UMLS:C0018802---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1324064",
                    "PMID:7995660",
                    "PMID:9811407",
                    "PMID:10235092",
                    "PMID:11464453",
                    "PMID:2083593",
                    "PMID:9247528",
                    "PMID:10338466",
                    "PMID:10353135",
                    "PMID:8141354",
                    "PMID:25801343"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1324064": {
                      "sentence": "beta-Adrenoceptor desensitization in human heart failure is thought to be secondary to raised noradrenaline levels in these patients.",
                      "object score": 901,
                      "subject score": 851,
                      "publication date": "1992 May"
                    },
                    "PMID:2083593": {
                      "sentence": "[Norepinephrine-induced heart failure and the protective effect of taurine].",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "1990"
                    },
                    "PMID:7995660": {
                      "sentence": "Norepinephrine-induced left ventricular dysfunction in anesthetized and conscious, sedated dogs.",
                      "object score": 875,
                      "subject score": 875,
                      "publication date": "1994 Jun 01"
                    },
                    "PMID:8141354": {
                      "sentence": "This study was conducted to determine whether increased myocardial energy demand plays a role in norepinephrine (NE)-induced left ventricular (LV) dysfunction.",
                      "object score": 875,
                      "subject score": 875,
                      "publication date": "1994 Feb"
                    },
                    "PMID:9247528": {
                      "sentence": "Rest norepinephrine and epinephrine levels, left ventricular ejection fraction and heart failure etiology were not related to insulin sensitivity.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "1997 Aug"
                    },
                    "PMID:9811407": {
                      "sentence": "This study was conducted to determine whether norepinephrine-induced left ventricular (LV) dysfunction reverses with time and whether the histopathologic condition and the cardiac dysfunction produced by high doses of norepinephrine are causally related.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1998 Oct"
                    },
                    "PMID:10235092": {
                      "sentence": "In conclusion, our study demonstrates that insulin resistance is a common feature of CHF most likely due to elevated plasma norepinephrine and tumor necrosis factor-alpha concentrations, and that IMGU is an independent prognostic factor in CHF.",
                      "object score": 850,
                      "subject score": 851,
                      "publication date": "1999 May 01"
                    },
                    "PMID:10338466": {
                      "sentence": "This animal model will be valuable in testing whether NE is required for the pathogenesis of heart failure through mating strategies that cross the dbh-/- mouse into genetically engineered models of heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 May 25"
                    },
                    "PMID:10353135": {
                      "sentence": "These measurements were repeated after left ventricular dysfunction was induced using a norepinephrine (5 micrograms/kg per min) infusion (study 2).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 May"
                    },
                    "PMID:11464453": {
                      "sentence": "In contrast, TH (-/-) mutant mice die at perinatal period due to heart failure caused by norepinephrine deficiency in the sympathetic neurons (Kobayashi et al, J Biol Chem 270, 27235-27243, 1995).",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2000 Dec"
                    },
                    "PMID:25801343": {
                      "sentence": "When the failure causes the balance to be polarised in favour of the effect of plasma noradrenaline that is believed to cause inflammatory diseases like dilator cardiac failure, renal hypertension, varicose veins and aneurysms; when it causes it to be polarised in favour of the effect of neuronal noradrenaline that is believed to cause genetic diseases like hypertrophic cardiopathy, pulmonary hypertension and stenoses and when, in pregnancy, a factor causes the polarity to favour plasma noradrenaline in all the maternal tissues except the uterus and conceptus, where it favours neuronal noradrenaline, that is believed to cause preeclampsia.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "2015 Nov"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:61799-biolink:treats-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "FMA:61799",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0028351---SEMMEDDB:treats---UMLS:C0018801---SEMMEDDB:",
                    "UMLS:C0028351---SEMMEDDB:treats---UMLS:C0018802---SEMMEDDB:",
                    "UMLS:C0028351---SEMMEDDB:treats---UMLS:C0242698---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8651095",
                    "PMID:2063731",
                    "PMID:8281675",
                    "PMID:12693727",
                    "PMID:1598872",
                    "PMID:1469643",
                    "PMID:28887775",
                    "PMID:3687797",
                    "PMID:21070923",
                    "PMID:10676687",
                    "PMID:11782855",
                    "PMID:6375188",
                    "PMID:10652968",
                    "PMID:12605013",
                    "PMID:6699464",
                    "PMID:8500238",
                    "PMID:8863872",
                    "PMID:23152801",
                    "PMID:1674899",
                    "PMID:2832444"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:835465": {
                      "sentence": "I was approximately four times as potent as NE and this ratio was not altered in CHF dogs.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "1977 Feb"
                    },
                    "PMID:1378116": {
                      "sentence": "In previous studies, ibopamine decreased resting plasma NE in patients with congestive heart failure (CHF), whereas plasma NE was not altered by ibopamine in healthy volunteers.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "1992 Mar"
                    },
                    "PMID:1444157": {
                      "sentence": "The purpose of this study was to investigate circadian changes in noradrenaline (norepinephrine) levels in patients presenting with congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Jun"
                    },
                    "PMID:1752293": {
                      "sentence": "Blunted circulatory responses to increased NE concentration in NYHA class III patients might relate to a decreased cardiac responsiveness to sympathetic activity in severe CHF patients.",
                      "object score": 875,
                      "subject score": 623,
                      "publication date": "1991 Oct"
                    },
                    "PMID:2063731": {
                      "sentence": "Plasma norepinephrine was elevated in the patients with congestive heart failure, 475 +/- 189 pg/ml, and did not change during head-down tilt.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1991 Jul"
                    },
                    "PMID:2138208": {
                      "sentence": "A significant correlation was observed between gamma 2-MSH-LI and noradrenaline, and between h-alpha ANP-LI and noradrenaline in patients with CHF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 Mar"
                    },
                    "PMID:2174309": {
                      "sentence": "The apparent secretion rate of noradrenaline was elevated in the patients with congestive heart failure (4.75 +/- 1.95 versus 1.78 +/- 0.18 nmol min-1 m-2, P less than 0.05), whereas the clearance rate of noradrenaline was similar in the two groups (1.26 +/- 0.27 versus 1.16 +/- 0.02 l min-1 m-2, not significant).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 Nov"
                    },
                    "PMID:2200276": {
                      "sentence": "There appears to be an enhanced effect of DMI on NE clearance in CHF patients.",
                      "object score": 916,
                      "subject score": 888,
                      "publication date": "1990 Aug"
                    },
                    "PMID:2541267": {
                      "sentence": "Plasma concentration of norepinephrine, cyclic AMP, cyclic GMP and ANP significantly increased in patients with congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Feb"
                    },
                    "PMID:2546698": {
                      "sentence": "The ratio of the exercise increments in HR and NE, and indirect index of sinoatrial node sympathetic responsiveness, was markedly reduced in CHF patients and was inversely related to the severity of exercise impairment.",
                      "object score": 916,
                      "subject score": 694,
                      "publication date": "1989 Aug"
                    },
                    "PMID:2782251": {
                      "sentence": "This study examines the relation between the change in clinical status and the change in plasma norepinephrine concentration in patients with congestive heart failure (CHF) receiving standard medical therapy.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1989 Sep 15"
                    },
                    "PMID:2832444": {
                      "sentence": "Resting plasma norepinephrine was markedly elevated in CHF patients (837 +/- 208 ng/liter), but not in normal subjects (142 +/- 32 ng/liter); and the increase in +dP/dt caused by IC dobutamine was inversely related to resting plasma norepinephrine levels (r = -0.653; P less than 0.001).",
                      "object score": 916,
                      "subject score": 851,
                      "publication date": "1988 Apr"
                    },
                    "PMID:3303889": {
                      "sentence": "Thus, myocardial norepinephrine is not uniformly reduced in patients with severe CHF, and further attempts to delineate the factors regulating myocardial catecholamine concentration and adrenergic function in such patients are needed.",
                      "object score": 916,
                      "subject score": 888,
                      "publication date": "1987 Aug 01"
                    },
                    "PMID:3377075": {
                      "sentence": "To evaluate the mechanisms responsible for the high plasma NE in CHF, NE kinetics were studied in 19 patients with CHF and 18 normal subjects during a 90-min steady-state intravenous infusion of tracer [3H]NE of high specific activity.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "1988 Jun"
                    },
                    "PMID:3526857": {
                      "sentence": "Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1986 Aug 01"
                    },
                    "PMID:3687797": {
                      "sentence": "Return of plasma norepinephrine to normal after resolution of congestive heart failure in congenital heart disease.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1987 Dec 01"
                    },
                    "PMID:3948363": {
                      "sentence": "There is marked regional variation, inapparent from measurements of plasma norepinephrine concentration, in sympathetic nerve activity in patients with congestive heart failure.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1986 Apr"
                    },
                    "PMID:6127908": {
                      "sentence": "The lowest mean NA content was found in patients with CHF.",
                      "object score": 1000,
                      "subject score": 580,
                      "publication date": "1982"
                    },
                    "PMID:8529064": {
                      "sentence": "Plasma free NA, DA and total DA levels were correlated positively with age in control subjects but not in the hypertensive nor CHF patients.",
                      "object score": 916,
                      "subject score": 802,
                      "publication date": "1995 Jun"
                    },
                    "PMID:8863872": {
                      "sentence": "Circulating noradrenaline and beta-adrenergic receptors in children with congestive heart failure.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1996 Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:67238-biolink:treats-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "FMA:67238",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0023570---SEMMEDDB:treats---UMLS:C0023212---SEMMEDDB:",
                    "UMLS:C0023570---SEMMEDDB:treats---UMLS:C0018801---SEMMEDDB:",
                    "UMLS:C0013030---SEMMEDDB:treats---UMLS:C0018801---SEMMEDDB:",
                    "UMLS:C0023570---SEMMEDDB:treats---UMLS:C0018802---SEMMEDDB:",
                    "UMLS:C0023570---SEMMEDDB:treats---UMLS:C0242698---SEMMEDDB:",
                    "UMLS:C0013030---SEMMEDDB:treats---UMLS:C0018802---SEMMEDDB:",
                    "UMLS:C0013030---SEMMEDDB:treats---UMLS:C0242698---SEMMEDDB:",
                    "CHEMBL.COMPOUND:CHEMBL59---biolink:treats---MESH:D006333---identifiers_org_registry:chembl.compound",
                    "UMLS:C0013030---SEMMEDDB:treats---UMLS:C0023212---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11206729",
                    "PMID:2483439",
                    "PMID:858184",
                    "PMID:2818455",
                    "PMID:6678068",
                    "PMID:8198935",
                    "PMID:4061011",
                    "PMID:2890392",
                    "PMID:8699631",
                    "PMID:20042425",
                    "PMID:2455315",
                    "PMID:8891854",
                    "PMID:18375720",
                    "PMID:1280744",
                    "PMID:8101236",
                    "PMID:10803731",
                    "PMID:2920591",
                    "PMID:33476310",
                    "PMID:27056656",
                    "PMID:264198"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:354838": {
                      "sentence": "These data indicate that dopamine is effective in some patients with refractive congestive heart failure associated with acute oliguric renal failure and that the prognosis may be improved.",
                      "object score": 923,
                      "subject score": 1000,
                      "publication date": "1978 Aug"
                    },
                    "PMID:858184": {
                      "sentence": "Thus combined dopamine with NP treatment considerably raises low CI while markedly reducing elevated LVEDP and provides a potentially efficacious pharmacologic modality for the treatment of severe congestive heart failure due to left ventricular dysfunction.",
                      "object score": 916,
                      "subject score": 790,
                      "publication date": "1977 Jun"
                    },
                    "PMID:1155341": {
                      "sentence": "Dobutamine, a derivative of dopamine, was infused at a rate of 10 mug/kg per min in 15 patients with severe congestive heart failure.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "1975 Aug"
                    },
                    "PMID:1280744": {
                      "sentence": "The purpose of this study was to investigate the relationship between dopamine (DA) exposure and myocardial catecholamine and neuropeptide Y (NPY) concentrations in patients with severe congestive heart failure due to idiopathic dilated cardiomyopathy (IDC).",
                      "object score": 916,
                      "subject score": 694,
                      "publication date": "1992"
                    },
                    "PMID:1359528": {
                      "sentence": "It is used, like dopamine, in the treatment of congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Aug 29-Sep 5"
                    },
                    "PMID:1361484": {
                      "sentence": "Although both levodopa and fenoldopam have shown beneficial hemodynamic effects, these agents cannot be recommended for general use in patients with congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Dec"
                    },
                    "PMID:2478806": {
                      "sentence": "Dopamine (DA) has been used for more than 25 years for treatment of congestive heart failure (CHF).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989"
                    },
                    "PMID:2483439": {
                      "sentence": "Finally, preclinical and clinical data of DA agonists and prodrugs are evaluated to estimate current and future roles of DA, DA agonists, and DA prodrugs in the treatment of congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989"
                    },
                    "PMID:2818455": {
                      "sentence": "The successful treatment of congestive heart failure with intravenous dopamine in the acute setting has prompted investigation into the development and use of oral dopamine analogs.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1989"
                    },
                    "PMID:2908484": {
                      "sentence": "Second, selective DA1 and relatively selective DA2 agonists and agonists with different combinations of DA and receptor activity other than DA have been synthesized and are being investigated for the treatment of congestive heart failure and hypertension.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988"
                    },
                    "PMID:3264036": {
                      "sentence": "She developed congestive heart failure after cholecystectomy, and marked improvement was noted by treatment with oxygen, digoxin, furosemide, and dopamine.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988 Aug"
                    },
                    "PMID:3878193": {
                      "sentence": "Calcium solutions, dopamine, and dobutamine are frequently used to treat congestive heart failure in horses.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1985 Aug"
                    },
                    "PMID:3976704": {
                      "sentence": "These findings suggest that although endogenous norepinephrine and dopamine levels are frequently elevated in patients with heart failure, reflecting enhanced sympathetic activity, catecholamine levels do not reflect the severity of heart failure.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1985 Mar"
                    },
                    "PMID:8198935": {
                      "sentence": "To determine the potential therapeutic use of DA in elderly subjects with CCF, we studied 17 patients (5 male) aged 79.9 years (range 68 to 93 years) admitted to hospital for inpatient treatment of CCF resistant to diuretic and angiotensin converting enzyme inhibitor therapy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Mar"
                    },
                    "PMID:8529064": {
                      "sentence": "Plasma free NA, DA and total DA levels were correlated positively with age in control subjects but not in the hypertensive nor CHF patients.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "1995 Jun"
                    },
                    "PMID:8897961": {
                      "sentence": "Therefore, the influence of two different positive inotropic interventions, dobutamine and dopamine, on ventricular-vascular coupling was examined in 15 patients with congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Oct"
                    },
                    "PMID:10752764": {
                      "sentence": "The sick neonate with persistent oliguria and CHF should be treated with intravenous dopamine.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2000 Mar"
                    },
                    "PMID:11206729": {
                      "sentence": "To address this question, we measured plasma IL-6 levels before and after therapeutic administration of dopamine and betablockers in patients with CHF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000"
                    },
                    "PMID:11829216": {
                      "sentence": "The response to treatment with dopamine was excellent, and the congestive heart failure was gradually ameliorated, followed by improvement in her atopic dermatitis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Dec"
                    },
                    "PMID:21043392": {
                      "sentence": "The patient was then treated with intrapericardial drainage and received dopamine and diuretics for congestive heart failure; she responded well to this treatment and was discharged in good condition.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2010"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:67243-biolink:treats-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "FMA:67243",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0014563---SEMMEDDB:treats---UMLS:C0023212---SEMMEDDB:",
                    "CHEMBL.COMPOUND:CHEMBL679---biolink:treats---MESH:D006333---identifiers_org_registry:chembl.compound",
                    "UMLS:C0014563---SEMMEDDB:treats---UMLS:C0018802---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8207366",
                    "PMID:6861302",
                    "PMID:2910096",
                    "PMID:8723018",
                    "PMID:8395686"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2910096": {
                      "sentence": "PATIENTS AND METHODS: Plasma levels of the sympathetic neurotransmitters norepinephrine and epinephrine and of the sympathetic co-transmitter NPY were measured in 17 patients with CHF and 14 healthy control subjects at rest and after maximal exercise.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Jan"
                    },
                    "PMID:6861302": {
                      "sentence": "Reduced aortocoronary sinus extraction of epinephrine in patients with left ventricular failure secondary to long-term pressure or volume overload.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1983 Aug"
                    },
                    "PMID:8207366": {
                      "sentence": "DESIGN: Plasma levels of noradrenaline, adrenaline, neuropeptide Y, substance P, calcitonin gene-related peptide, vasopressin and atrial natriuretic peptide were measured in patients presenting with CHF and related to survival time.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Jun"
                    },
                    "PMID:8395686": {
                      "sentence": "[Effect of captopril and lisinopril on adrenergic receptor density and serum norepinephrine and epinephrine in patients with congestive heart disease].",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Jan 18-25"
                    },
                    "PMID:8723018": {
                      "sentence": "Preoperatively, plasma levels of both noradrenaline and adrenaline were significantly higher in patients with CHF compared with the control group.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Dec"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:74637-biolink:treats-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "FMA:74637",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL1201621---biolink:treats---MESH:D006333---identifiers_org_registry:chembl.compound",
                    "UMLS:C0169964---SEMMEDDB:treats---UMLS:C0018801---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:33099227",
                    "PMID:28778993",
                    "PMID:8596546"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8596546": {
                      "sentence": "METHODS: Seven patients with idiopathic dilated cardiomyopathy and moderate-to-severe heart failure were studied at base line, after three months of therapy with human growth hormone, and three months after the discontinuation of growth hormone.",
                      "object score": 824,
                      "subject score": 1000,
                      "publication date": "1996 Mar 28"
                    },
                    "PMID:28778993": {
                      "sentence": "HGH concentration was increased in elderly women with heart failure following consumption of a meal replacement containing protein, carbohydrate, and fat.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2017 Aug"
                    },
                    "PMID:33099227": {
                      "sentence": "METHODS: In a double-blind, placebo-controlled trial, we randomly assigned 37 patients (mean age 66 years; 95% male) with ischemic HF (ejection fraction [EF] < 40%) to a 9-month treatment with either recombinant human GH (1.4 mg every other day) or placebo, with subsequent 3-month treatment-free follow-up.",
                      "object score": 901,
                      "subject score": 928,
                      "publication date": "2020 Oct 11"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:74644-biolink:causes-MONDO:0005392": {
              "object": "MONDO:0005392",
              "subject": "FMA:74644",
              "predicate": "biolink:causes",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0025219---SEMMEDDB:causes---UMLS:C0037932---SEMMEDDB:",
                    "UMLS:C0025219---SEMMEDDB:causes---UMLS:C0036439---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9201831",
                    "PMID:10975432",
                    "PMID:7822371",
                    "PMID:10528372",
                    "PMID:11484109",
                    "PMID:8727187",
                    "PMID:21416282",
                    "PMID:12973138",
                    "PMID:8883197",
                    "PMID:28376758",
                    "PMID:19680092"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7822371": {
                      "sentence": "Our findings suggest that melatonin deficiency contributes to the aetiology of this experimental scoliosis, probably by interfering with the normally symmetrical growth of the proprioceptive system involving the paraspinal muscles and the spine.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1995 Jan"
                    },
                    "PMID:8727187": {
                      "sentence": "CONCLUSION: Although melatonin deficiency may cause scoliosis in the chicken, this study suggests that it is not a mechanism in the pathogenesis of adolescent idiopathic scoliosis in humans.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1996 May 15"
                    },
                    "PMID:8883197": {
                      "sentence": "SUMMARY OF BACKGROUND DATA: Recent studies using the chick as the animal model have suggested that the pineal gland and its main product, melatonin, might be involved in the cause of scoliosis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Sep 01"
                    },
                    "PMID:9201831": {
                      "sentence": "CONCLUSION: Serotonin deficit secondary to a defect of melatonin may have disturbed postural muscle tone or postural equilibrium resulting in scoliosis in pinealectomized chicken.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Jun 15"
                    },
                    "PMID:10528372": {
                      "sentence": "CONCLUSIONS: Melatonin deficiency secondary to pinealectomy alone does not produce scoliosis if the quadrupedal condition is maintained.",
                      "object score": 1000,
                      "subject score": 840,
                      "publication date": "1999 Oct 01"
                    },
                    "PMID:10975432": {
                      "sentence": "The literature on the possible consequences of disordered melatonin production in relation to Sudden Infant Death Syndrome, fetal origins of adult disease, and scoliosis is critically reviewed.",
                      "object score": 1000,
                      "subject score": 828,
                      "publication date": "2000 Aug"
                    },
                    "PMID:11484109": {
                      "sentence": "A drop in melatonin level after parathyroidectomy may have been the cause of spinal curvature progression in this patient.",
                      "object score": 901,
                      "subject score": 694,
                      "publication date": "2001"
                    },
                    "PMID:12973138": {
                      "sentence": "OBJECTIVE: To determine whether suppression of melatonin secretion without surgery in chickens can result in scoliosis development.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2003 Sep 01"
                    },
                    "PMID:19680092": {
                      "sentence": "SUMMARY OF BACKGROUND DATA: Melatonin and calmodulin are potential key molecules in scoliosis etiology.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2009 Aug 15"
                    },
                    "PMID:21416282": {
                      "sentence": "The data regarding human melatonin levels are mixed at best, and the melatonin deficiency as a causative factor in the etiology of scoliosis cannot be supported.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2011 May"
                    },
                    "PMID:28376758": {
                      "sentence": "Meanwhile, this study indicates that a decreased melatonin level is not the primary cause of scoliosis, but that it may increase the likelihood and severity of scoliosis.",
                      "object score": 1000,
                      "subject score": 623,
                      "publication date": "2017 04 04"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:74644-biolink:treats-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "FMA:74644",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL45---biolink:treats---MESH:D006333---identifiers_org_registry:chembl.compound",
                    "UMLS:C0025219---SEMMEDDB:treats---UMLS:C0018802---SEMMEDDB:",
                    "UMLS:C0025219---SEMMEDDB:treats---UMLS:C0018801---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:29111293",
                    "PMID:14709797",
                    "PMID:24942291",
                    "PMID:32618134",
                    "PMID:27450357"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:14709797": {
                      "sentence": "CONCLUSIONS: The results suggest that circulating melatonin levels are low in patients with CHF.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "2003 Dec"
                    },
                    "PMID:24942291": {
                      "sentence": "The antiremodeling effect of melatonin may be of potential benefit in patients with heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Sep"
                    },
                    "PMID:27450357": {
                      "sentence": "Low circulating levels of melatonin are reported in individuals with CAD, arterial hypertension, and congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Mar"
                    },
                    "PMID:29111293": {
                      "sentence": "It is likely that increasing melatonin levels may act as a compensatory mechanism in pediatric children with heart failure.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "2018 Jul - Aug"
                    },
                    "PMID:32618134": {
                      "sentence": "CONCLUSIONS: The results of this comprehensive study might elucidate the safety of oral melatonin in patients with HF and provide some evidence on its effectiveness as an adjunctive therapy to enhance the well-being of these patients.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2020 Jul 02"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:83365-biolink:treats-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "FMA:83365",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL1201631---biolink:treats---MESH:D006333---identifiers_org_registry:chembl.compound",
                    "UMLS:C0021641---SEMMEDDB:treats---UMLS:C0018801---SEMMEDDB:",
                    "UMLS:C0021641---SEMMEDDB:treats---UMLS:C0018802---SEMMEDDB:",
                    "UMLS:C0021641---SEMMEDDB:treats---UMLS:C0023212---SEMMEDDB:",
                    "UMLS:C0021641---SEMMEDDB:treats---UMLS:C0242698---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30701607",
                    "PMID:15645206",
                    "PMID:7892548",
                    "PMID:18568311",
                    "PMID:9293950",
                    "PMID:4789732",
                    "PMID:29625946",
                    "PMID:24916838",
                    "PMID:29488676",
                    "PMID:20407209",
                    "PMID:30963973",
                    "PMID:9820994",
                    "PMID:967882",
                    "PMID:1022666",
                    "PMID:12848074",
                    "PMID:13678929",
                    "PMID:22187237",
                    "PMID:27230644",
                    "PMID:22785609",
                    "PMID:4116822"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:967882": {
                      "sentence": "Infusions of insulin reversed cardiac failure and maintained normal performance in spite of wide ranges in glucose concentration (5-120 mg%).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1976 Sep"
                    },
                    "PMID:1022666": {
                      "sentence": "Role of glucose and insulin in the management of congestive heart failure (a preliminary communication).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1976 Oct"
                    },
                    "PMID:1463229": {
                      "sentence": "[The use of ultra-high doses of insulin for the treatment of severe heart failure during cardiosurgical interventions].",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1992 May-Jun"
                    },
                    "PMID:4116822": {
                      "sentence": "Insulin and glucose in the treatment of heart-failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1972 Nov 04"
                    },
                    "PMID:4650847": {
                      "sentence": "It is suggested that insulin, glucose, and potassium given by the intravenous route in adequate dosage forms a useful adjunct to the management of severe congestive heart failure.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "1972 Sep 16"
                    },
                    "PMID:4789732": {
                      "sentence": "Role of glucose and insulin in the management of congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1973 Oct"
                    },
                    "PMID:7892548": {
                      "sentence": "Highly selective beta-1 receptor-blocking agents have only little influence on the lipid metabolism; however, if prescribed in diabetic patients treated with insulin, in patients with cardiac failure or in asthmatic patients, close supervision is mandatory.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Mar 07"
                    },
                    "PMID:9293950": {
                      "sentence": "This concept is supported by clinical observations on the beneficial effects of a solution containing glucose, insulin, and potassium (GIK) for treatment of refractory left ventricular contractile failure after hypothermic ischemic arrest during cardiac surgery.",
                      "object score": 857,
                      "subject score": 1000,
                      "publication date": "1997 Aug 04"
                    },
                    "PMID:9820994": {
                      "sentence": "The observation of a positive relationship between plasma leptin and insulin concentrations suggests that the insulin-leptin axis may be related to the increased energy expenditure observed in patients with congestive heart failure.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1998 Oct"
                    },
                    "PMID:12848074": {
                      "sentence": "[Cardiocirculatory effects of insulin in patients with heart failure].",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 May"
                    },
                    "PMID:13678929": {
                      "sentence": "Diabetes and heart failure: is insulin therapy the answer?",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2003 Sep 17"
                    },
                    "PMID:15531002": {
                      "sentence": "CONCLUSIONS: In this retrospective analysis of data from patients with type 2 diabetes, pioglitazone therapy was associated with significantly lower incidence rates of CHF and inpatient hospitalization compared with insulin therapy.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2004 Sep"
                    },
                    "PMID:18568311": {
                      "sentence": "Retrospective analyses indicate a rather positive effect of the insulin sensitizers metformin and glitazones and a neutral or rather negative effect of insulin and sulfonylureas in diabetic patients with heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Apr"
                    },
                    "PMID:20407209": {
                      "sentence": "We therefore suggest that the use of insulin to control hyperglycemia could be harmful in the setting of pressure overload and that modulation of insulin signaling is crucial for the treatment of HF.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2010 May"
                    },
                    "PMID:22187237": {
                      "sentence": "Higher concentrations of apoB (p=0.017), apoB/A1 ratio (p<0.001), blood urea nitrogen (p=0.034), creatinine (p=0.003), and fasting insulin (p=0.004) were observed in HF patients with MetS compared with those without MetS.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "2012 Jan"
                    },
                    "PMID:22785609": {
                      "sentence": "METHODS AND RESULTS: Serum levels of RBP4, insulin, and fasting glucose were assessed in 58 patients with severe heart failure at the time of left ventricular assist device (LVAD) implantation and in 44 patients at the time of explantation, as well as in 10 normal control subjects.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:24916838": {
                      "sentence": "CONCLUSIONS: There were modest, transient differences in glucose control between IV and SQ insulin in hospitalized CHF patients.",
                      "object score": 893,
                      "subject score": 888,
                      "publication date": "2015 Jan"
                    },
                    "PMID:27230644": {
                      "sentence": "Although no HF harm was seen in CVOTs for insulin or sulfonylureas, they should be used only with caution in patients with HF, given their established high risk for hypoglycemia and some uncertainties on their safety in patients with HF derived from epidemiological observations.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 05 27"
                    },
                    "PMID:27792213": {
                      "sentence": "BACKGROUND: Diabetic patients with heart failure (HF) treated with insulin appear to have a worse prognosis compared to oral anti-diabetic (OAD) agents.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Dec"
                    },
                    "PMID:29625946": {
                      "sentence": "Average insulin to glucose ratio was 0.10+/-0.044 in NDHF patients which was significantly (p<0.0001) lowered in controls i.e., 0.073+/-0.039.",
                      "object score": 798,
                      "subject score": 888,
                      "publication date": "2018 Mar"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:affects-MESH:D014664": {
              "object": "MESH:D014664",
              "subject": "CHEBI:35530",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:affects---UMLS:C0042401---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15148268",
                    "PMID:2535249",
                    "PMID:7857754",
                    "PMID:6147080",
                    "PMID:27113048",
                    "PMID:28162002",
                    "PMID:11193133",
                    "PMID:14555604",
                    "PMID:6202966",
                    "PMID:10434801",
                    "PMID:1657496",
                    "PMID:30876665",
                    "PMID:16884657",
                    "PMID:7848340",
                    "PMID:18370439",
                    "PMID:21126627",
                    "PMID:1671189",
                    "PMID:11515986"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1657496": {
                      "sentence": "Thus these data indicate that sub-chronic atenolol treatment stimulates vasodepressor prostaglandin generation in the kidney and in the aortic vessels, and this shares the antihypertensive effects of this drug with the mechanism of beta-adrenergic antagonism probably mediated through vasorelaxation and natriuresis.",
                      "object score": 1000,
                      "subject score": 966,
                      "publication date": "1991 Oct"
                    },
                    "PMID:1671189": {
                      "sentence": "Celiprolol, a beta-blocker with vasodilatory effects, appears to favorably affect lipid and lipoprotein levels as do the alpha 1-adrenergic blockers.",
                      "object score": 836,
                      "subject score": 1000,
                      "publication date": "1991 Feb"
                    },
                    "PMID:2535249": {
                      "sentence": "The aim of this prospective multicenter study is to determine the efficacy and tolerance of a new, highly cardioselective beta-blocking agent with vasodilatation effects, Celiprolol.",
                      "object score": 872,
                      "subject score": 836,
                      "publication date": "1989 Dec"
                    },
                    "PMID:6147080": {
                      "sentence": "Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension.",
                      "object score": 623,
                      "subject score": 890,
                      "publication date": "1984 Aug 01"
                    },
                    "PMID:6202966": {
                      "sentence": "Acute hemodynamic effects of bufuralol: a beta-adrenoceptor blocking drug with vasodilatory effects.",
                      "object score": 836,
                      "subject score": 1000,
                      "publication date": "1984 May-Jun"
                    },
                    "PMID:7848340": {
                      "sentence": "The effect of long-term administration of nipradilol (NIP, Hypadil Kowa, CAS 81486-22-8), a beta-blocker with a vasodilatory action, on esophageal varices was studied in 66 patients with compensated liver cirrhosis.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "1994 Nov"
                    },
                    "PMID:7857754": {
                      "sentence": "From meta-analyses on different cardiovascular treatments, given after coronary events, only the efficacy of drugs significantly reducing heart rate is borne out (beta-blockers with sympathomimetic activity, or calcium-antagonists with a prevalent vasodilatory action do not provide a protective effect).",
                      "object score": 552,
                      "subject score": 1000,
                      "publication date": "1994 Oct"
                    },
                    "PMID:10434801": {
                      "sentence": "The estimated receptor occupancies were 87 +/- 6% or 88 +/- 10% for the beta-blockers with or without a vasodilative effect, respectively, and a significant difference was not observed between these groups.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "1999 Jul"
                    },
                    "PMID:11193133": {
                      "sentence": "CONCLUSIONS: This study showed that local infusion of different beta-blocking agents in normotensive subjects affects endothelial vasodilatory function differently.",
                      "object score": 751,
                      "subject score": 881,
                      "publication date": "2000"
                    },
                    "PMID:11515986": {
                      "sentence": "At least two mechanisms may be involved: withdrawal of a pressor effect from the beta-blocker, and calcium-channel-mediated vasodilation.",
                      "object score": 850,
                      "subject score": 1000,
                      "publication date": "2001 Jul"
                    },
                    "PMID:14555604": {
                      "sentence": "Beta-blockers with vasodilatory actions.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2003 Oct"
                    },
                    "PMID:15148268": {
                      "sentence": "BACKGROUND: Carvedilol is a beta-adrenoceptor blocker with a vasodilatory action that is more effective for the treatment of congestive heart failure than other beta-blockers.",
                      "object score": 623,
                      "subject score": 890,
                      "publication date": "2004 Jun 08"
                    },
                    "PMID:16884657": {
                      "sentence": "However, the beta-blocker class is heterogeneous, and some newer beta-blockers, which exhibit vasodilatory effects independent of beta-blockade, provide beneficial effects on arterial stiffness and endothelial dysfunction, which may lead to reductions in central aortic pressure and improvements in clinical outcomes.",
                      "object score": 836,
                      "subject score": 884,
                      "publication date": "2006 Aug"
                    },
                    "PMID:18370439": {
                      "sentence": "Beta-blockers and coronary flow reserve: the importance of a vasodilatory action.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2008"
                    },
                    "PMID:21126627": {
                      "sentence": "In conclusion, it is time for a reexamination of the clinical evidence for the use of beta blockers in hypertension, recognizing that there are patients for whom beta blockers, particularly those with vasodilatory actions, are an appropriate treatment option.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2010 Dec 15"
                    },
                    "PMID:27113048": {
                      "sentence": "In addition, nebivolol-induced reduction in ET-1-mediated vasoconstrictor tone underlies the favorable effects of this beta-blocker on endothelial vasodilation.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2016 06"
                    },
                    "PMID:28162002": {
                      "sentence": "As beta-blockade is effective inF and may be useful in presence of AF, bucindolol, a non-selective beta-blocker with alpha-1 vasodilatory effect, may be used.",
                      "object score": 751,
                      "subject score": 861,
                      "publication date": "2017 Apr"
                    },
                    "PMID:30876665": {
                      "sentence": "Although carvedilol is frequently classified as a beta-blocker, its vasodilatory effect via alpha1-adrenergic blockade plays an important role in AP reduction or heart failure treatment.",
                      "object score": 713,
                      "subject score": 1000,
                      "publication date": "2019 06 15"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35674-biolink:affects-MESH:D006439": {
              "object": "MESH:D006439",
              "subject": "CHEBI:35674",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003364---SEMMEDDB:affects---UMLS:C0019010---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:731930",
                    "PMID:19442328",
                    "PMID:24915052",
                    "PMID:33311577",
                    "PMID:16364836",
                    "PMID:3824208",
                    "PMID:12821956",
                    "PMID:1496965",
                    "PMID:33768709",
                    "PMID:6712858",
                    "PMID:21575919",
                    "PMID:13337860",
                    "PMID:3416726",
                    "PMID:7882602",
                    "PMID:12176406",
                    "PMID:7768582",
                    "PMID:1485459",
                    "PMID:2220799",
                    "PMID:12959311",
                    "PMID:6318224"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:731930": {
                      "sentence": "Effects of antihypertensive drugs on the hemodynamics of SHR.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1978 Jul"
                    },
                    "PMID:1485459": {
                      "sentence": "To evaluate the hypotensive efficacy and effects of some hypotensive drugs on the hemodynamics and concentration of testosterone in its blood plasma the authors examined 205 patients with juvenile hypertension (JH): main group--134 patients; comparison group--71 patients).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Oct"
                    },
                    "PMID:1496965": {
                      "sentence": "This phenomenon was used to study the influence of two commonly used antihypertensive agents, captopril and nifedipine, on renal hemodynamics at rest and during glomerular hyperfiltration.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1992 Aug"
                    },
                    "PMID:2220799": {
                      "sentence": "These differences and others lead to the recommendation that hypertension among blacks should be managed initially with salt restriction; if dietary control is insufficient, administration of an antihypertensive agent with 24-hour efficacy, which lowers vascular peripheral resistance, promotes sodium excretion, and potentially improves renal hemodynamics, is recommended.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1990 Oct"
                    },
                    "PMID:3416726": {
                      "sentence": "Cicletanine is an antihypertensive agent which has no effect on cardiovascular haemodynamics and is able to prevent some rheological and vascular-linked cardiac risks of hypertension.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1988"
                    },
                    "PMID:3824208": {
                      "sentence": "Multimodality therapy including antihypertensive drugs (Cordanum, clonidine, hydrochlorothiazide, hydrolasin) significantly improved regional hemodynamics.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1986"
                    },
                    "PMID:6318224": {
                      "sentence": "Enalapril is an effective anti-hypertensive agent with a favourable effect on renal haemodynamics.",
                      "object score": 888,
                      "subject score": 908,
                      "publication date": "1983"
                    },
                    "PMID:6712858": {
                      "sentence": "It is concluded that prizidilol is an effective hypotensive agent with no deleterious effects on renal haemodynamics.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "1984 Mar"
                    },
                    "PMID:7768582": {
                      "sentence": "From these results, together with those reported in our previous studies, it is clear that the various classes of antihypertensive agents affect hemodynamics differently.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1995 Jun"
                    },
                    "PMID:7882602": {
                      "sentence": "We conclude that the impact of antihypertensive agents on renal hemodynamics during stress cannot a priori be delineated from measurements at rest.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1994 Dec"
                    },
                    "PMID:7898095": {
                      "sentence": "A further criterion for assessing the potential nephroprotective properties of antihypertensive agents is their influence on intraglomerular hemodynamics.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1994"
                    },
                    "PMID:8487246": {
                      "sentence": "Antihypertensive agents affect central haemodynamics differently.",
                      "object score": 790,
                      "subject score": 1000,
                      "publication date": "1993 Feb"
                    },
                    "PMID:8571752": {
                      "sentence": "Additionally in chronic kidney disease one has to consider the variable effects of different antihypertensive drugs on intrarenal hemodynamics.",
                      "object score": 861,
                      "subject score": 877,
                      "publication date": "1995"
                    },
                    "PMID:8721331": {
                      "sentence": "Influence of anti-hypertensive drugs on glomerular hemodynamics.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996 Mar"
                    },
                    "PMID:8868123": {
                      "sentence": "In conclusion, in antihypertensive treatment of elderly hypertensive patients it is important to consider the effects of the antihypertensive drugs on the hemodynamics, although the comparable decrease in blood pressure is expected.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jan"
                    },
                    "PMID:8872296": {
                      "sentence": "Most antihypertensive agents given for periods of several months in monotherapy have no consistent effect on renal function and hemodynamics.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1996"
                    },
                    "PMID:9336341": {
                      "sentence": "Antihypertensive drugs have differing effects on renal hemodynamics and morphology.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997 Oct"
                    },
                    "PMID:9745606": {
                      "sentence": "Effects of antihypertensive drugs on renal hemodynamics of kidney transplant recipients.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998 Sep"
                    },
                    "PMID:12821956": {
                      "sentence": "Antihypertensive drugs may have an important effect on glomerular haemodynamics.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2003 Jul"
                    },
                    "PMID:13337860": {
                      "sentence": "The effect of hypotensive agents on renal hemodynamics in hypertensive patients.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1956 Feb 25"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35942-biolink:treats-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "CHEBI:35942",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0597049---SEMMEDDB:treats---UMLS:C0018801---SEMMEDDB:",
                    "UMLS:C0597049---SEMMEDDB:treats---UMLS:C0242698---SEMMEDDB:",
                    "UMLS:C0597049---SEMMEDDB:treats---UMLS:C0018802---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11012115",
                    "PMID:11665788",
                    "PMID:24364017",
                    "PMID:17086095",
                    "PMID:10946035",
                    "PMID:11526351",
                    "PMID:12473986",
                    "PMID:16125499",
                    "PMID:17696565",
                    "PMID:7781336",
                    "PMID:12559539",
                    "PMID:12427411",
                    "PMID:17045179",
                    "PMID:16621149",
                    "PMID:8631044",
                    "PMID:15723576",
                    "PMID:8005128",
                    "PMID:8798111",
                    "PMID:9731691",
                    "PMID:21972336"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1329481": {
                      "sentence": "The increase in neurohormonal activity, seen in some patients with heart failure, may result in a loss of circadian variation in heart rate and blood pressure and deprive the heart of a needed reduction in work load during the night.",
                      "object score": 1000,
                      "subject score": 853,
                      "publication date": "1992 Oct 08"
                    },
                    "PMID:9595286": {
                      "sentence": "This study determined the effects of additive spironolactone on exercise capacity and neurohormonal factors in patients with mild CHF.",
                      "object score": 916,
                      "subject score": 836,
                      "publication date": "1998 Jul"
                    },
                    "PMID:9731691": {
                      "sentence": "As our understanding of the neuroendocrine response to diminished cardiac performance improves, novel and even more imaginative neurohormonal and cytokine antagonists are likely to emerge as important new treatments for both hypertension and heart failure.",
                      "object score": 1000,
                      "subject score": 678,
                      "publication date": "1998"
                    },
                    "PMID:11012115": {
                      "sentence": "The purpose of this study was to determine the effects of a low-sodium diet on clinical, echocardiographic, and neurohormonal parameters in dogs with heart failure.",
                      "object score": 1000,
                      "subject score": 853,
                      "publication date": "2000 Sep-Oct"
                    },
                    "PMID:12390293": {
                      "sentence": "Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure.",
                      "object score": 893,
                      "subject score": 836,
                      "publication date": "2002 Dec"
                    },
                    "PMID:12559539": {
                      "sentence": "Herein, we compared the effects of growth hormone versus placebo upon resting left ventricular ejection fraction, exercise capacity and neurohormonal status in patients with advanced heart failure.",
                      "object score": 901,
                      "subject score": 853,
                      "publication date": "2003 Feb"
                    },
                    "PMID:15259379": {
                      "sentence": "The concentrations of all CNHs and neurohormones were higher in patients with heart failure compared to normal subjects, except for free triiodothyronine (FT3), which was below normal values.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004"
                    },
                    "PMID:15723576": {
                      "sentence": "Brain natriuretic peptide has emerged as a neurohormone with multiple roles in heart failure management.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2005 Jan"
                    },
                    "PMID:15913496": {
                      "sentence": "The use of ARAs for the treatment of myocardial failure and selected cases of hypertension, in combination with the current therapy, has been strongly supported by trials such as the Randomized Aldactone Evaluation Study (RALES) and the Eplerenone Neurohormonal Efficacy and Survival Study (EPHESUS).",
                      "object score": 1000,
                      "subject score": 587,
                      "publication date": "2005 Jun"
                    },
                    "PMID:15950581": {
                      "sentence": "Relative lymphocyte count, clinical variables, neurohormones, and cytokines were measured in 129 outpatients with HF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Jun 15"
                    },
                    "PMID:16125499": {
                      "sentence": "This study examined temporal changes in neurohormones related to cardiac remodeling and prognosis in patients with systolic dysfunction and heart failure receiving therapeutic inhibition of the renin-angiotensin-aldosterone system.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Sep 01"
                    },
                    "PMID:16183564": {
                      "sentence": "Administration of exogenous B-type natriuretic peptide (BNP) has beneficial hemodynamic effects and reduces the level of several neurohormones in HF patients.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "2005"
                    },
                    "PMID:16621149": {
                      "sentence": "Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: time courses and prediction of response.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Jul"
                    },
                    "PMID:17445084": {
                      "sentence": "Tolvaptan reduced cardiac preload without unfavorable effects on renal functions, systemic hemodynamics, or circulating neurohormones in dogs with heart failure (HF).",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2007"
                    },
                    "PMID:17541312": {
                      "sentence": "The use of hypertonic saline solution mixed with a high dose of loop diuretics produces, probably by indirect mechanisms, a reduction or inhibition of the activated neurohormonal systems in HF patients.",
                      "object score": 901,
                      "subject score": 816,
                      "publication date": "2007 May-Jun"
                    },
                    "PMID:17696565": {
                      "sentence": "As a result, the neurohormonal system has provided a key target for pharmacologic therapy in patients with heart failure secondary to systolic dysfunction.",
                      "object score": 1000,
                      "subject score": 853,
                      "publication date": "2007"
                    },
                    "PMID:19961889": {
                      "sentence": "As expected, the other neurohormones were also significantly increased in HF patients (Nt-proBNP: 3501 pg/ml [2356-5202] vs 35 [24-51], Nt-proANP: 5498 pg/ml [4336-6971] vs 324 [255-411] and Big ET-1: 15.8 pg/ml [13.6-18.4] vs 5.9 [5.2-6.8]; p<0.01 for all vs controls).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2010 Feb"
                    },
                    "PMID:21972336": {
                      "sentence": "Neurohormonal control of heart failure.",
                      "object score": 1000,
                      "subject score": 853,
                      "publication date": "2011 Aug"
                    },
                    "PMID:24364017": {
                      "sentence": "Levosimendan also has favourable effects on neurohormone levels in heart failure patients.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "2013"
                    },
                    "PMID:25160238": {
                      "sentence": "Correlation between symbolic dynamics analysis indexes and neurohormonal and functional parameters in heart failure patients.",
                      "object score": 901,
                      "subject score": 928,
                      "publication date": "2014"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:8031-biolink:affects-MESH:D009154": {
              "object": "MESH:D009154",
              "subject": "RXNORM:8031",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0030946---SEMMEDDB:affects---UMLS:C0026882---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10092679",
                    "PMID:23144597",
                    "PMID:11101140",
                    "PMID:23316057",
                    "PMID:10026173",
                    "PMID:15597954",
                    "PMID:25198162",
                    "PMID:11364970",
                    "PMID:12112662",
                    "PMID:23986451",
                    "PMID:10596454",
                    "PMID:11295497",
                    "PMID:20738301",
                    "PMID:31311021",
                    "PMID:11961279",
                    "PMID:11350662",
                    "PMID:19506019",
                    "PMID:10092683",
                    "PMID:14654359",
                    "PMID:10404778"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:3530879": {
                      "sentence": "The mutation is associated with a proteolytic deficiency.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1986"
                    },
                    "PMID:7441209": {
                      "sentence": "Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicity.",
                      "object score": 836,
                      "subject score": 888,
                      "publication date": "1980 Sep"
                    },
                    "PMID:7744777": {
                      "sentence": "The mutation caused no effect on the critical concentration of polymerization but resulted in an actin with an increased rate of polymerization, an altered protease susceptibility, and a decreased filament ATPase activity.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "1995 May 12"
                    },
                    "PMID:8112584": {
                      "sentence": "The effects of mutations in noncoding regions, as well as the capsid protein coding region TYA, and the regions encoding the protease, integrase and reverse transcriptase proteins are described.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Feb 11"
                    },
                    "PMID:8945604": {
                      "sentence": "Mutations in the A subunit affect yield, stability, and protease sensitivity of nontoxic derivatives of heat-labile enterotoxin.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1996 Dec"
                    },
                    "PMID:8975934": {
                      "sentence": "Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loop.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1997 Jan"
                    },
                    "PMID:10026173": {
                      "sentence": "This structure of the protease combined with modeling of peptide substrates into the active site suggests identities of residues involved in substrate recognition as well as providing a structural basis for several mutational effects on enzyme activity.",
                      "object score": 816,
                      "subject score": 1000,
                      "publication date": "1999 Feb 26"
                    },
                    "PMID:10092679": {
                      "sentence": "Mutations within this sequence reduced the susceptibility of the 3C protease toward ubiquitination and degradation in rabbit reticulocyte lysate.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1999 Apr 02"
                    },
                    "PMID:10092683": {
                      "sentence": "Mutations within this sequence reduced the susceptibility of the 3C protease toward ubiquitination and degradation in rabbit reticulocyte lysate.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1999 Apr 02"
                    },
                    "PMID:10404778": {
                      "sentence": "In conclusion, the mutations present in the A2 domain of vWF result in an enhanced proteolytic sensitivity to a divalent ion-dependent protease.",
                      "object score": 1000,
                      "subject score": 775,
                      "publication date": "1999 Jun"
                    },
                    "PMID:11101140": {
                      "sentence": "In order to identify the active-site residues of the TVMV NIa protease, the putative active-site residues, His-46, Asp-81 and Cys-151, were mutated individually to generate H46R, H46A, D81E, D81N, C151S, and C151A, and their mutational effects on the proteolytic activities were examined.",
                      "object score": 836,
                      "subject score": 790,
                      "publication date": "2000 Oct 31"
                    },
                    "PMID:11295497": {
                      "sentence": "Though mutations in viral Fos proteins confer full resistance to proteasomal degradation, stabilization is limited because mutations also entail sensitivity to an unidentified proteolytic system.",
                      "object score": 1000,
                      "subject score": 790,
                      "publication date": "2001"
                    },
                    "PMID:11350662": {
                      "sentence": "However, mutations at cleavage site p7/p1 (p = 0.01) and C-terminal p6* mutations (p = 0.02) were both associated with primary protease mutations.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "2001 Apr 10"
                    },
                    "PMID:11364970": {
                      "sentence": "HIV reproduces very rapidly and mutates often during the process of reverse transcription, and protease enzymes can lead to mutations later in the replication process.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1998 Jan"
                    },
                    "PMID:11961279": {
                      "sentence": "To assess the effect of mutations at and around this hydrophobic sequence on protease resistance, the sequence was replaced either by alanines or by glycines and, in a third mutant, a large part surrounding this region was removed.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2002 May"
                    },
                    "PMID:12112662": {
                      "sentence": "All mutations were associated with dramatically reduced CTSC protease enzyme activity.",
                      "object score": 1000,
                      "subject score": 796,
                      "publication date": "2002 Jul"
                    },
                    "PMID:23144597": {
                      "sentence": "The impact of these mutations on the dynamics in the unliganded form in comparison with the wild-type protease was elucidated with Molecular Dynamic simulations and NMR relaxation experiments.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "2012 Oct 09"
                    },
                    "PMID:23316057": {
                      "sentence": "The effects of this mutation on specific GAS virulence determinants have been assessed, with emphasis on expression of the extracellular protease, streptococcal pyrogenic exotoxin B (SpeB), capsular hyaluronic acid, and proteins that allow host plasmin assembly on the bacterial surface, viz. a high affinity plasminogen (Pg)/plasmin receptor, Pg-binding group A streptococcal M protein (PAM), and the human Pg activator streptokinase.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2013 Mar 01"
                    },
                    "PMID:23986451": {
                      "sentence": "Mutation of the lower hinge region of an IgG1 resulted in protease resistance but also resulted in a profound loss of Fc-mediated cell-killing functions.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2013 Oct 25"
                    },
                    "PMID:25198162": {
                      "sentence": "Although structural assessment revealed that the protein fold is not perturbed by mutations, both variants have decreased thermal stabilities and higher proteolytic susceptibilities.",
                      "object score": 1000,
                      "subject score": 829,
                      "publication date": "2014"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0039005-biolink:has_part-FMA:67303": {
              "object": "FMA:67303",
              "subject": "UMLS:C0039005",
              "predicate": "biolink:has_part",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0041194---SEMMEDDB:part_of---UMLS:C0039005---SEMMEDDB:",
                    "UMLS:C0013765---SEMMEDDB:part_of---UMLS:C0039005---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8748705",
                    "PMID:6426853",
                    "PMID:6320824",
                    "PMID:22447518",
                    "PMID:3707587",
                    "PMID:3665402",
                    "PMID:20171732",
                    "PMID:7387627",
                    "PMID:2992576",
                    "PMID:3039501",
                    "PMID:868641",
                    "PMID:70322",
                    "PMID:3839997",
                    "PMID:20853312",
                    "PMID:3973023",
                    "PMID:868640",
                    "PMID:1879511",
                    "PMID:1879515",
                    "PMID:1783045",
                    "PMID:5000644"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:70322": {
                      "sentence": "The antigenicity of soluble porcine elastins: I.",
                      "object score": 790,
                      "subject score": 790,
                      "publication date": "1977"
                    },
                    "PMID:868640": {
                      "sentence": "The isolation and amino acid sequence of some thrombin produced porcine tropoelastin peptides.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1977"
                    },
                    "PMID:868641": {
                      "sentence": "Primary structure of porcine tropoelastin.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1977"
                    },
                    "PMID:1783045": {
                      "sentence": "Experimental immunization of rabbits with soluble porcine elastin was performed.",
                      "object score": 790,
                      "subject score": 790,
                      "publication date": "1991"
                    },
                    "PMID:1879511": {
                      "sentence": "Experimental immunization of rabbits with soluble porcine elastin was performed.",
                      "object score": 790,
                      "subject score": 790,
                      "publication date": "1991"
                    },
                    "PMID:1879515": {
                      "sentence": "Estimations of soluble collagen fractions showed the rise of both salt-soluble and acid-soluble collagen in the aorta of rabbits immunized with soluble porcine elastin.",
                      "object score": 790,
                      "subject score": 790,
                      "publication date": "1991"
                    },
                    "PMID:2992576": {
                      "sentence": "In addition to identification of sequences homologous to those found in porcine tropoelastin, the analyses defined a 58 amino acid sequence that forms the carboxy-terminal region of tropoelastin, and this sequence, which contains two cysteine residues, was previously not observed in the protein sequence data.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1985 Jun 18"
                    },
                    "PMID:3039501": {
                      "sentence": "Complete sequence analysis of the six clones demonstrated that: the cDNA encompassed the entire translated portion of the mRNA encoding 786 amino acids, including several unusual hydrophilic amino acid sequences not previously identified in porcine tropoelastin, exons encoding either hydrophobic or crosslinking domains in the protein alternated in the gene, and a great abundance of Alu repetitive sequences occurred throughout the introns.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1987 Aug"
                    },
                    "PMID:3665402": {
                      "sentence": "The analyses: (i) showed that the cDNA encompassed the great majority of the translated sequence, (ii) ordered the tryptic peptides of porcine tropoelastin, (iii) determined new amino acid sequences not previously found in the porcine peptides and (iv) demonstrated that alternative splicing of the primary transcript leads to significant variation in the sequence of the translated portion of the mRNA.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1987 Sep"
                    },
                    "PMID:3707587": {
                      "sentence": "Digestion of insoluble porcine elastin with thermolysin produces a number of discrete small peptides.",
                      "object score": 790,
                      "subject score": 790,
                      "publication date": "1986 Apr 29"
                    },
                    "PMID:3839997": {
                      "sentence": "A portion of this sequence showed strong homology to known sequences of pig tropoelastin, but most of the sequence had not been previously determined through protein sequencing.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1985 Sep"
                    },
                    "PMID:3973023": {
                      "sentence": "Elastase activity was increased and porcine tropoelastin was degraded four times faster, on a per-cell basis, in lesional fibroblast cultures than in cells derived from an unaffected site.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1985 Feb"
                    },
                    "PMID:5000644": {
                      "sentence": "The porcine tropoelastin contained virtually no carbohydrate.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1971 Jan"
                    },
                    "PMID:6320824": {
                      "sentence": "Nucleotide sequencing of the 5' end of the cDNA demonstrated a sequence which was extremely GC rich and which corresponded to an amino acid sequence partially homologous to that previously identified in porcine tropoelastin (Foster et al. (1973) J. Biol. Chem. 248, 2876-2879).",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1984 Jan 13"
                    },
                    "PMID:6426853": {
                      "sentence": "Extensive cross-reactivity was found with both human alpha-elastin and porcine beta-elastin, while porcine tropoelastin was able to compete with 80% of the alpha-elastin determinants.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1984 Jan"
                    },
                    "PMID:7387627": {
                      "sentence": "Apparently all the tyrosine residues C-terminal to lysine residues in pig tropoelastin are replaced with phenylalanine in bovine tropoelastin.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1980 Mar 01"
                    },
                    "PMID:8748705": {
                      "sentence": "Physical characterizations such as stress/strain, thermolelasticity, acid-base titration and inverse temperature transition studies have been carried out on this elastomer, which is homologous to the striking, poly(VPGVG), W4 sequence of bovine and porcine elastins.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1995 Dec"
                    },
                    "PMID:20171732": {
                      "sentence": "This low immunogenic potential of porcine elastin suggests its suitability for the creation of new tissue engineering heart valve scaffolds in the future.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2010 May"
                    },
                    "PMID:20853312": {
                      "sentence": "Bovine and porcine elastin peptides stimulated the migration of fibroblasts, with the optimal response occurring at 10(-1) ug/ml, while maximal response was at 10(2) ug/ml for bonito elastin peptides.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2010 Nov"
                    },
                    "PMID:22447518": {
                      "sentence": "Histological analysis revealed structural differences between the species: the human and porcine leaflets contained more collagen and elastin than the ovine leaflets.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2012 Jun"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:subclass_of-FMA:83365": {
              "object": "FMA:83365",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:affects-UMLS:C0232164": {
              "object": "UMLS:C0232164",
              "subject": "CHEBI:35457",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:affects---UMLS:C0232164---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16053783",
                    "PMID:1887340",
                    "PMID:29262413",
                    "PMID:15524163",
                    "PMID:27520661",
                    "PMID:10471350",
                    "PMID:11882576",
                    "PMID:16864930",
                    "PMID:15638741",
                    "PMID:23279916",
                    "PMID:17802698",
                    "PMID:11375278",
                    "PMID:17229371",
                    "PMID:2989349",
                    "PMID:24175564",
                    "PMID:19667605",
                    "PMID:10684476",
                    "PMID:15899134",
                    "PMID:7528303",
                    "PMID:12215461"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1887340": {
                      "sentence": "ACE inhibitors improve cardiac function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Sep 07"
                    },
                    "PMID:2989349": {
                      "sentence": "Enalapril is a recently developed angiotensin-converting enzyme inhibitor that improves cardiac function at rest in patients with congestive heart failure.",
                      "object score": 1000,
                      "subject score": 870,
                      "publication date": "1985 Jul"
                    },
                    "PMID:7528303": {
                      "sentence": "Angiotensin-converting enzyme (ACE) inhibitors can improve cardiac function independent of their blood pressure (BP)-lowering actions.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Sep"
                    },
                    "PMID:7634300": {
                      "sentence": "In clinical conditions, ACE-inhibitors have important effects on cardioreparation and are able to improve cardiac function and reduce early and late mortality.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Dec"
                    },
                    "PMID:8961071": {
                      "sentence": "Angiotensin-converting enzyme (ACE) inhibitors reduce myocardial remodeling and improve cardiac function after myocardial infarction.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Dec"
                    },
                    "PMID:9109437": {
                      "sentence": "Left ventricular remodeling and cardiac function were improved by the ACEi and AT1-ant.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Apr 15"
                    },
                    "PMID:9293963": {
                      "sentence": "In SHR-SP, long-term treatment with either an ACE inhibitor or an AT1 receptor antagonist improved cardiac function and metabolism.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Aug 04"
                    },
                    "PMID:9530191": {
                      "sentence": "These species differences in receptor expression raise questions as to the role of angiotensin as a mediator of collagen formation across species and as a direct target of angiotensin-converting enzyme inhibitors to regulate cardiac fibroblast function.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1998 Mar"
                    },
                    "PMID:10471350": {
                      "sentence": "Although captopril, an angiotensin-converting enzyme (ACE) inhibitor, has been shown to exert a beneficial effect on cardiac function in heart failure, its effect on the status of sarcoplasmic reticulum (SR) Ca(2+) transport in the failing heart has not been examined previously.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Sep"
                    },
                    "PMID:10684476": {
                      "sentence": "BACKGROUND: Various angiotensin-converting enzyme inhibitors are known to improve heart function and prolong survival in patients and animals after myocardial infarction.",
                      "object score": 1000,
                      "subject score": 937,
                      "publication date": "1998 Jan"
                    },
                    "PMID:11375278": {
                      "sentence": "The ACEi improved cardiac function and remodeling in both strains; however, its effects were attenuated in B(2)(-/-) mice (respective values for B(2)(+/+) versus B(2)(-/-) mice: overall increase in ejection fraction, 64+/-10% versus 21+/-5% [P<0.01]; increase in CO, 69+/-17% versus 23+/-9% [P<0.01]; overall decrease in LVDd, -24+/-3% versus -7+/-4% [P<0.01]; and decrease in LV mass, -38+/-3% versus -6+/-6% [P<0.01]).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 May 25"
                    },
                    "PMID:11882576": {
                      "sentence": "We found that (1) compared with C57 mice, eNOS-/- mice that underwent sham surgery had significantly increased systolic blood pressure (P<0.05) and increased LV mass both initially and at 1 to 3 months, although cardiac function and histological findings did not differ between strains; (2) the development of HF and myocardial remodeling were similar after MI in both strains; and (3) ACEi improved cardiac function and remodeling in C57 mice, as evidenced by increased LV ejection fraction (LVEF) and LV shortening fraction (LVSF) and decreased diastolic LV dimension, mass, myocyte cross-sectional area, and interstitial collagen fraction, but these benefits were absent or diminished in eNOS-/- mice (for C57 versus eNOS-/-: increase in LVEF after ACEi, 14.2 +/- 2% versus -4.9 +/- 2.5%, respectively [P<0.001]; increase in LVSF, 8.6 +/- 2.1% versus -7.2 +/- 2.8%, respectively [P<0.01]; and decrease in LV mass, -16.6 +/- 15 versus 73 +/- 23 mm(3), respectively [P<0.01]).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Feb"
                    },
                    "PMID:12215461": {
                      "sentence": "ACE inhibitors improved cardiac function and remodeling similarly in both strains.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Sep"
                    },
                    "PMID:15524163": {
                      "sentence": "Alterations in cardiac function, positive inotropic effect of isoproterenol, beta1-AR density and isoproterenol-stimulated AC activity in the failing heart were also attenuated by treatment with another ACE inhibitor, enalapril and an angiotensin II receptor antagonist, losartan.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Aug"
                    },
                    "PMID:15638741": {
                      "sentence": "Angiotensin-converting enzyme 2 (ACE2), a carboxypeptidase structurally related to ACE but resistant to ACE inhibitors, has a protective effect on cardiac function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Jan"
                    },
                    "PMID:15899134": {
                      "sentence": "CONCLUSION: ACE inhibitor could improve cardiac function of failing heart through directly enhancing the contractility of single cardiomyocyte, and these effects are probably mediated by its roles in preventing the deleterious changes of calcium transients and calcium handling proteins in CHF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 May 05"
                    },
                    "PMID:17802698": {
                      "sentence": "Combined therapy with weight loss (BMI 46.0 to 30.8) and amiodarone (200 mg/day) was instituted in addition to the previous regimen including angiotensin converting enzyme inhibitor, beta blocker, diuretics and pimobendan, improved cardiac function, exercise tolerance, and cardiac sympathetic nerve activity evaluated by cardiac 123I-metaiodobenzylguanidine scintigraphy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Aug"
                    },
                    "PMID:19667605": {
                      "sentence": "Angiotensin-converting enzyme (ACE) inhibitors and ss-adrenergic-receptor antagonists have been shown to slow down and, in many cases, reverse the process of cardiac remodeling, thus leading to improved cardiac function and clinical outcomes in patients with heart failure.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2002 Nov"
                    },
                    "PMID:23279916": {
                      "sentence": "She was treated for peripartum cardiomyopathy (PPCM) with angiotensin converting enzyme inhibitors (ACEi), beta-blockers and diuretics with normalisation of her cardiac function within six months.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Aug"
                    },
                    "PMID:27520661": {
                      "sentence": "Alterations in cardiac function, positive inotropic effect of isoproterenol, beta1-AR density and isoproterenol-stimulated AC activity in the failing heart were also attenuated by treatment with another ACE inhibitor, enalapril and an angiotensin II receptor antagonist, losartan.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:affects-UMLS:C0600520": {
              "object": "UMLS:C0600520",
              "subject": "CHEBI:35457",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:affects---UMLS:C0600520---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8869135",
                    "PMID:9109437",
                    "PMID:8011563",
                    "PMID:9013371",
                    "PMID:22040494",
                    "PMID:9562938",
                    "PMID:16462910",
                    "PMID:15202297",
                    "PMID:25796267",
                    "PMID:21296328"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8011563": {
                      "sentence": "However, studies comparing the effect of different doses of ACE inhibitors on left ventricular remodeling are missing.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Dec"
                    },
                    "PMID:8869135": {
                      "sentence": "Mechanisms for the effects of ACE inhibitors on LV remodelling may be dependent on changes in myocardial load, may be load independent, or both.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Nov"
                    },
                    "PMID:9013371": {
                      "sentence": "Although angiotensin-converting enzyme inhibitors have been shown to affect left ventricular (LV) remodeling favorably in several conditions, it remains unclear whether they can influence LV geometric pattern in hypertension.",
                      "object score": 923,
                      "subject score": 1000,
                      "publication date": "1996 Dec"
                    },
                    "PMID:9109437": {
                      "sentence": "Left ventricular remodeling and cardiac function were improved by the ACEi and AT1-ant.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Apr 15"
                    },
                    "PMID:9562938": {
                      "sentence": "Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Apr"
                    },
                    "PMID:15202297": {
                      "sentence": "It is showed that ACE inhibitors, beta-blockers and aldosterone antagonists had preventive effects on left ventricle remodelling.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004"
                    },
                    "PMID:16462910": {
                      "sentence": "We demonstrated the ability of MRI to detect the early beneficial impact of angiotensin-converting enzyme (ACE) inhibitors on LV remodeling.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Dec"
                    },
                    "PMID:21296328": {
                      "sentence": "Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and beta blockers in patients with idiopathic dilated cardiomyopathy.",
                      "object score": 905,
                      "subject score": 1000,
                      "publication date": "2011 Apr 01"
                    },
                    "PMID:22040494": {
                      "sentence": "BACKGROUND: Angiotensin converting enzyme (ACE) inhibitors and beta-blockers (betaB) have beneficial effects on left ventricular (LV) remodeling, alleviate symptoms and reduce morbidity and mortality in patients with chronic heart failure (CHF).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Sep"
                    },
                    "PMID:25796267": {
                      "sentence": "AIMS: Angiotensin-converting enzyme (ACE) inhibitors improve left ventricular (LV) remodelling and outcome in heart failure and hypertensive heart disease.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35674-biolink:affects-UMLS:C0232804": {
              "object": "UMLS:C0232804",
              "subject": "CHEBI:35674",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003364---SEMMEDDB:affects---UMLS:C0232804---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:13812314",
                    "PMID:11131272",
                    "PMID:17868793",
                    "PMID:28575879",
                    "PMID:1519633",
                    "PMID:34106629",
                    "PMID:2245881",
                    "PMID:2220796",
                    "PMID:6994769",
                    "PMID:2882952",
                    "PMID:1377114",
                    "PMID:13386277",
                    "PMID:5612499",
                    "PMID:2675558",
                    "PMID:28421556",
                    "PMID:7903212",
                    "PMID:10608112",
                    "PMID:2528846",
                    "PMID:18693359",
                    "PMID:2573378"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1377114": {
                      "sentence": "Several clinical variables, such as the presence or absence of hypertension, overt nephropathy and microalbuminuria, or a combination of variables should be accounted for when evaluating critically the cumulative data on the effects of antihypertensive drugs on kidney function and albuminuria in the variety of diabetic patient groups.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Apr"
                    },
                    "PMID:1519633": {
                      "sentence": "Since antihypertensive agents have such varied effects on systemic and renal hemodynamics, an understanding of the antihypertensive actions in a given patient may have significant influence on renal function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Aug 31"
                    },
                    "PMID:2220796": {
                      "sentence": "Angiotensin-converting enzyme (ACE) inhibitors and calcium channel blockers are two classes of antihypertensive agents with novel effects on renal function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 Oct"
                    },
                    "PMID:2245881": {
                      "sentence": "Human studies comparing the effects of different classes of antihypertensive drugs on kidney function, proteinuria, and glomerular morphology are warranted.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 Dec"
                    },
                    "PMID:2528846": {
                      "sentence": "Effects of antihypertensive drugs on renal function and atrial natriuretic polypeptide in spontaneously hypertensive rats with renal ablation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 May"
                    },
                    "PMID:2573378": {
                      "sentence": "Thus, this large-scale study confirms that tertatolol is an efficient and well-tolerated antihypertensive drug, which improves renal function, especially when initially reduced.",
                      "object score": 1000,
                      "subject score": 824,
                      "publication date": "1989 Nov"
                    },
                    "PMID:2675558": {
                      "sentence": "Effect of antihypertensive agents on renal function and on sodium-volume status.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989"
                    },
                    "PMID:2882952": {
                      "sentence": "Effect of antihypertensive agents on renal function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987"
                    },
                    "PMID:5612499": {
                      "sentence": "[Recent progress in the knowledge of arterial hypertension. VII. Acute effects of antihypertensive drugs on kidney function].",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1967 Feb"
                    },
                    "PMID:6994769": {
                      "sentence": "Antihypertensive drugs may influence renal function, due to haemodynamic effects and altered release of hormones.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1980"
                    },
                    "PMID:7903212": {
                      "sentence": "This study confirms that tertatolol is an efficient and well-tolerated antihypertensive drug, which improves renal function.",
                      "object score": 1000,
                      "subject score": 824,
                      "publication date": "1993"
                    },
                    "PMID:8743517": {
                      "sentence": "DTZ is an effective antihypertensive agent which does not significantly affect renal function.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1996 Jun"
                    },
                    "PMID:8872296": {
                      "sentence": "Most antihypertensive agents given for periods of several months in monotherapy have no consistent effect on renal function and hemodynamics.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1996"
                    },
                    "PMID:8911724": {
                      "sentence": "There are a wide range of potential sites and mechanisms through which centrally acting antihypertensive agents can affect renal function, including actions mediated within the central nervous system, heart, systemic circulation and within the kidneys themselves.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Oct-Nov"
                    },
                    "PMID:9324124": {
                      "sentence": "Effects of antihypertensive drugs on renal function in patients with diabetic nephropathy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Sep"
                    },
                    "PMID:9413342": {
                      "sentence": "Normalization of systolic blood pressure using the antihypertensive drugs improved renal function and produced a nonuniform alteration in renal AOEs; only glutathione peroxidase activity increased significantly with the use of all three drug regimens.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Dec"
                    },
                    "PMID:10608112": {
                      "sentence": "Several commonly used, efficacious and well tolerated antihypertensive agents act by blocking the renin-angiotensin system, thus normalising kidney function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Nov 24"
                    },
                    "PMID:11131272": {
                      "sentence": "These results suggest that although Japanese physicians are considering the effects of hypotensive agents on metabolism and renal function when they treat diabetic hypertensives, the achieved blood pressure in both hypertensives with and those without diabetes is insufficient, with only one of ten patients having a blood pressure less than 130/85 mmHg even among diabetics.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Nov"
                    },
                    "PMID:13386277": {
                      "sentence": "Effect of hypotensive drugs on renal function in chronic renal disease.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1957 Jan 12"
                    },
                    "PMID:13812314": {
                      "sentence": "[Comparative study on the effect of various hypotensive agents on the blood pressure and kidney function after prolonged therapy].",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1959 Nov"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D009154-biolink:causes-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MESH:D009154",
              "predicate": "biolink:causes",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0026882---SEMMEDDB:causes---UMLS:C0024796---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11139245",
                    "PMID:11933199",
                    "PMID:11702223",
                    "PMID:11524736",
                    "PMID:10694921",
                    "PMID:12206553",
                    "PMID:10464652",
                    "PMID:12413333",
                    "PMID:10885576",
                    "PMID:11722462",
                    "PMID:11748851",
                    "PMID:12598898",
                    "PMID:11829507",
                    "PMID:12511552",
                    "PMID:10189222",
                    "PMID:11108952",
                    "PMID:11700157",
                    "PMID:12068374",
                    "PMID:11143906",
                    "PMID:10865210"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:16571647": {
                      "sentence": "Marfan syndrome (MFS), a relatively common autosomal dominant hereditary disorder of connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular systems, is caused by mutations in the gene for fibrillin-1 (FBN1).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Oct"
                    },
                    "PMID:16607458": {
                      "sentence": "Marfan syndrome is an autosomal dominant fibrillinopathy caused by mutations of the fibrillin-1 (FBN1) gene.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Dec"
                    },
                    "PMID:16677079": {
                      "sentence": "MFS is a connective tissue disease caused by mutations in the fibrillin-1 gene FBN1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006"
                    },
                    "PMID:23100322": {
                      "sentence": "Marfan syndrome (MFS) is an inherited disorder of connective tissue caused by mutations in the gene for fibrillin-1 (FBN1).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Feb 01"
                    },
                    "PMID:23121584": {
                      "sentence": "Marfan syndrome is a multisystem disorder of connective tissue that is inherited in an autosomal dominant fashion, and results from mutation of the FBN1 gene on human chromosome 15.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Nov 05"
                    },
                    "PMID:23613326": {
                      "sentence": "Thoracic aortic aneurysm and dissection (TAAD) are associated with connective tissue disorders like Marfan syndrome and Loeys-Dietz syndrome, caused by mutations in the fibrillin-1, the TGFbeta-receptor 1- and -2 genes, the SMAD3 and TGFbeta2 genes, but have also been ascribed to ACTA2 gene mutations in adults, spread throughout the gene.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Jun"
                    },
                    "PMID:24093072": {
                      "sentence": "Marfan's syndrome is a systemic disorder of the connective tissue caused by mutations in the extracellular matrix protein fibrillin-1, with aortic dissection and aneurysm being its most life-threatening manifestations.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:24504995": {
                      "sentence": "Marfan syndrome is an autosomal dominant disease caused by mutations in the gene encoding for fibrillin-1 (FBN1).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jun"
                    },
                    "PMID:24555249": {
                      "sentence": "Marfan syndrome is a genetic disorder of the connective tissue caused by mutations in FBN1 gene.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Dec"
                    },
                    "PMID:24610719": {
                      "sentence": "Marfan syndrome (MFS) is caused by mutations in the FBN1 (fibrillin-1) gene, but approximately 10% of MFS cases remain genetically unsolved.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 May"
                    },
                    "PMID:24668922": {
                      "sentence": "Marfan syndrome (MFS) is an autosomal dominant disorder caused by mutations in the fibrillin 1 gene (FBN1).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jun"
                    },
                    "PMID:24753820": {
                      "sentence": "Marfan syndrome (MFS) is a dominantly inherited connective tissue disorder caused by mutations in the gene encoding fibrillin-1 (FBN1) and is characterized by aortic dilatation and dissection, which is the primary cause of death in untreated MFS patients.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Feb"
                    },
                    "PMID:24925629": {
                      "sentence": "Marfan syndrome (MFS) is an inherited autosomal dominant multisystem disease caused by mutations in the FBN1 gene encoding fibrillin-1, an extracellular matrix glycoprotein widely distributed in mesenchymal-derived tissues that provide a scaffold for elastin deposition.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Sep-Oct"
                    },
                    "PMID:24931486": {
                      "sentence": "Marfan syndrome is an autosomal dominant heritable disorder of the connective tissue, caused by mutations of the gene FBN1, which encodes fibrillin-1, a major component of the microfibrils of the extracellular matrix.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Aug"
                    },
                    "PMID:25174594": {
                      "sentence": "Although mutations in the fibrillin-1 (FBN1) gene have been recognized as the genetic cause of MS a long time ago, only recently deeper knowledge of the molecular mechanisms underlying fibrillin-1 biology and the crucial role of transforming growth factor-beta and angiotensin II receptor type 1 antagonists have been elucidated.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jul-Aug"
                    },
                    "PMID:25337071": {
                      "sentence": "Marfan syndrome is an autosomal dominant disorder of the connective tissue, characterized by early development of thoracic aortic aneurysms and/or dissections, accompanied by ocular and/or skeletal involvement, and is caused by mutations in the fibrillin 1 (FBN1) gene.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Aug"
                    },
                    "PMID:25493702": {
                      "sentence": "Beals syndrome is caused by a mutation in the fibrillin-2 gene (FBN2) in 5q23; MFS is caused by mutations in fibrillin-1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 May"
                    },
                    "PMID:25541192": {
                      "sentence": "Marfan syndrome (MFS) is a genetic disorder caused by mutations in the FBN1 gene that codifies for fibrilin-1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Feb 01"
                    },
                    "PMID:25606393": {
                      "sentence": "Marfan syndrome (MFS), a relatively common autosomal dominant hereditary disorder of connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular systems, is caused by mutations in the glycoprotein gene fibrillin-1 (FBN1).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Dec"
                    },
                    "PMID:26494287": {
                      "sentence": "Marfan syndrome (MFS) is an autosomal dominant disorder of connective tissue, caused by mutations of the microfibrillar protein fibrillin-1, that predisposes affected individuals to aortic aneurysm and rupture and is associated with increased TGFbeta signaling.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Nov 10"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:causes-MESH:D014664": {
              "object": "MESH:D014664",
              "subject": "VANDF:4021566",
              "predicate": "biolink:causes",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:causes---UMLS:C0042401---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1953288",
                    "PMID:2482601",
                    "PMID:2441155",
                    "PMID:1661893",
                    "PMID:24050970",
                    "PMID:2821847",
                    "PMID:2441183",
                    "PMID:3330030",
                    "PMID:2099034",
                    "PMID:2574642",
                    "PMID:11129125",
                    "PMID:11515885",
                    "PMID:21899206",
                    "PMID:2360470",
                    "PMID:3154679",
                    "PMID:11849657",
                    "PMID:27154409",
                    "PMID:2409361",
                    "PMID:11693466",
                    "PMID:23007713"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1661893": {
                      "sentence": "In the heart, calcium antagonists cause vasodilatation of the coronary vessels, thus increasing coronary blood flow, and reduce myocardial contractility, which in turn reduces myocardial oxygen consumption.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1991"
                    },
                    "PMID:1953288": {
                      "sentence": "The vasodilatation caused by calcium antagonists and potassium agonists is largely related to the phenomenon of flow-dependency whilst that induced by nitroglycerin is totally independent.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1991 Sep"
                    },
                    "PMID:2099034": {
                      "sentence": "Hence, although in isolated human coronary arteries high concentrations of calcium antagonists were shown to induce a considerably greater vasodilation than nitrocompounds, the early drop in blood pressure prohibits a higher dosage of calcium antagonists in vivo.",
                      "object score": 790,
                      "subject score": 983,
                      "publication date": "1990"
                    },
                    "PMID:2360470": {
                      "sentence": "The extent of maximal vasodilation achieved by HA1077 was significantly greater than that induced by such conventional calcium channel blockers as diltiazem, verapamil, nifedipine and nimodipine (about 50% each in a previous report from our laboratory).",
                      "object score": 888,
                      "subject score": 916,
                      "publication date": "1990"
                    },
                    "PMID:2409361": {
                      "sentence": "Calcium antagonists induce vasodilation and a consequent fall in blood pressure that initially is associated with baroreflex-mediated stimulation of the sympathetic nervous and renin-angiotensin system, resulting in increased heart rate and cardiac output.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1985"
                    },
                    "PMID:2441155": {
                      "sentence": "MDL 72567, a dihydropyridine calcium-antagonist, that causes vasodilation and direct sinus bradycardia.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1987 Jul"
                    },
                    "PMID:2441183": {
                      "sentence": "The influence of renal perfusion pressure on the vasodilation of the kidney caused by a calcium antagonist, nitrendipine, was studied.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987"
                    },
                    "PMID:2482601": {
                      "sentence": "Calcium antagonists effect a preglomerular vasodilation and block renal autoregulation, whereas atrionatriuretic peptide (ANF) dilates preglomerular vessels and leaves autoregulation intact.",
                      "object score": 861,
                      "subject score": 983,
                      "publication date": "1989"
                    },
                    "PMID:2574642": {
                      "sentence": "Calcium antagonists block the entry of calcium into vascular smooth muscle cells, producing pharmacological vasodilation.",
                      "object score": 888,
                      "subject score": 983,
                      "publication date": "1989 Dec"
                    },
                    "PMID:2821847": {
                      "sentence": "Calcium entry blocking drugs (CaEBs) produce vasodilation and, in high doses, modify alpha adrenergic receptor function.",
                      "object score": 1000,
                      "subject score": 912,
                      "publication date": "1987 Oct"
                    },
                    "PMID:3154679": {
                      "sentence": "Calcium channel blockers, which induce vasodilation by relaxing vascular smooth muscle cells, have proven effective in the treatment of angina pectoris.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988 Jan"
                    },
                    "PMID:3330030": {
                      "sentence": "Calcium antagonist induced vasodilation in peripheral, coronary and cerebral vasculature as important factors in the treatment of elderly hypertensives.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987 Nov"
                    },
                    "PMID:3330988": {
                      "sentence": "Nifedipine is a calcium-channel blocker that produces vasodilatation and decreased peripheral resistance in humans.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987 Dec"
                    },
                    "PMID:3552312": {
                      "sentence": "The effectiveness of the calcium-channel blockers in hypertension appears to be primarily due to their ability to induce systemic vasodilation.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1987 Jun"
                    },
                    "PMID:3881908": {
                      "sentence": "Calcium-channel blockers have been shown to produce arteriolar vasodilation and an increase in peripheral blood flow.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "1985 Jan 25"
                    },
                    "PMID:6134398": {
                      "sentence": "Peripheral vasodilation is caused by calcium antagonists and thus elevated blood pressure can be lowered effectively.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1983 Mar 31"
                    },
                    "PMID:6307126": {
                      "sentence": "Mechanisms of calcium antagonist-induced vasodilation.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "1983"
                    },
                    "PMID:9076842": {
                      "sentence": "Thus intrinsic activation of SNS set by circadian rhythm and extrinsic activation secondary to direct vasodilatation induced by calcium antagonists may overlap, which could increase cardiovascular risks and therefore result in poor clinical outcome.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1996"
                    },
                    "PMID:11849657": {
                      "sentence": "We have examined the ability of nitrovasodilators, calcium channel blockers, and K(ATP) channel openers to cause vasodilation, and to attenuate contractions due to depolarisation and receptor activation in radial and mammary arteries used in coronary artery bypass graft surgery.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Feb"
                    },
                    "PMID:23007713": {
                      "sentence": "And ion channels are often targeted by therapeutic agents either intentionally (e.g. calcium channel blockers used to induce vasodilation and lower blood pressure) or unintentionally (e.g. to induce unwanted cardiovascular side effects).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Sep 14"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:disrupts-UMLS:C0011065": {
              "object": "UMLS:C0011065",
              "subject": "CHEBI:35457",
              "predicate": "biolink:disrupts",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:disrupts---UMLS:C0011065---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:31776309",
                    "PMID:8995000",
                    "PMID:15584126",
                    "PMID:11838348",
                    "PMID:16481415",
                    "PMID:10423106",
                    "PMID:9070169",
                    "PMID:32011324",
                    "PMID:10687108",
                    "PMID:15102591",
                    "PMID:23235603",
                    "PMID:33737435",
                    "PMID:12816171",
                    "PMID:23219304",
                    "PMID:12699134",
                    "PMID:11076126",
                    "PMID:16431259",
                    "PMID:11835907"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8995000": {
                      "sentence": "How ACE inhibitors reduce death from myocardial infarction: hypotheses from the AIRE study.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1996 Jul"
                    },
                    "PMID:9070169": {
                      "sentence": "Over the past 10 years, several clinical studies have concluded that, in patients already receiving conventional therapies, angiotensin-converting enzyme (ACE) inhibitors further reduce the risk of death following myocardial infarction (MI).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Feb"
                    },
                    "PMID:10423106": {
                      "sentence": "Angiotensin converting enzyme (ACE) inhibitors have been shown to reduce the risk of death, worsening heart failure and recurrent infarction in patients with left ventricular dysfunction and heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999"
                    },
                    "PMID:10687108": {
                      "sentence": "RESULTS: In comparison to Group 1, Group 2 was treated more frequently with ACE-inhibitors and beta-blockers (p < 0.0001) and showed a better long-term survival (p = 0.0034), resulting from a reduction of death for refractory HF or need for heart transplant (p = 0.011).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Dec"
                    },
                    "PMID:11076126": {
                      "sentence": "ACE inhibitors significantly reduce the risk of death from myocardial infarction in patients with coronary artery disease with or without myocardial infarction.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Mar 09"
                    },
                    "PMID:11835907": {
                      "sentence": "The Heart Outcomes Prevention Evaluation (HOPE) study conclusively demonstrated that ramipril, an angiotensin-converting enzyme (ACE) inhibitor, reduces the risk of cardiovascular death, myocardial infarction (MI), and death in patients at risk for cardiovascular events but without heart failure.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2002 Jan 24"
                    },
                    "PMID:11838348": {
                      "sentence": "ACE-inhibitors can significantly reduce global death in heart failure patients, but their impact on sudden death appears to be limited.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2001 Dec"
                    },
                    "PMID:12699134": {
                      "sentence": "On the other hand, the use of ACE inhibitors was associated with a marked reduction of in-hospital death (ORa 0.44, p = 0.045).",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2003"
                    },
                    "PMID:12816171": {
                      "sentence": "BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors reduce heart failure death and hospitalization.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2003 Jun"
                    },
                    "PMID:15102591": {
                      "sentence": "It has been established from multiple randomised, placebo-controlled trials that angiotensin-converting enzyme inhibitors reduce the risk of death and major non-fatal cardiovascular events after acute myocardial infarction, especially when these agents are used for long-term treatment in high-risk patients.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Apr"
                    },
                    "PMID:15584126": {
                      "sentence": "ACE inhibitors reduce heart-related death in type 2 diabetics.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2004 Oct"
                    },
                    "PMID:16431259": {
                      "sentence": "Only ACE inhibitors and/or ARBs were associated with a reduced risk for death at 1 year in this population.",
                      "object score": 1000,
                      "subject score": 937,
                      "publication date": "2006 Feb"
                    },
                    "PMID:16481415": {
                      "sentence": "Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II type 1 receptor blockers (ARB) reduce cardiovascular death in the general population, but data for renal transplant recipients remain elusive.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2006 Mar"
                    },
                    "PMID:23219304": {
                      "sentence": "ACE-Is also reduced the risk of all-cause death, new-onset HF, and new-onset DM.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "2013 Jan 15"
                    },
                    "PMID:23235603": {
                      "sentence": "ACEi reduced the risk of death when compared to placebo (6 studies, 11,350 participants: RR 0.84, 95% CI 0.73 to 0.97).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Dec 12"
                    },
                    "PMID:31776309": {
                      "sentence": "Cox regression analysis showed that using ACEI or ARB was independently associated with reduced risk of all-cause death after adjusting for confounding factors.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "2019 Nov 28"
                    },
                    "PMID:32011324": {
                      "sentence": "CONCLUSION: ACEIs were a preferred treatment modality when compared to ARBs for patients with AMI with dyslipidemia who underwent a successful stent implantation to reduce the incidences of all-cause death during a 2-year follow-up.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2020 Jan"
                    },
                    "PMID:33737435": {
                      "sentence": "ACEis were associated with reduced risk of death, but with minimal or no reduction in risk of other complications.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021 Mar 17"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:disrupts-UMLS:C0011065": {
              "object": "UMLS:C0011065",
              "subject": "CHEBI:35530",
              "predicate": "biolink:disrupts",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:disrupts---UMLS:C0011065---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25281417",
                    "PMID:23790500",
                    "PMID:27867524",
                    "PMID:25156833",
                    "PMID:25862157",
                    "PMID:19645208",
                    "PMID:1967956",
                    "PMID:14770250",
                    "PMID:26817946",
                    "PMID:24377458",
                    "PMID:10853624",
                    "PMID:17338123",
                    "PMID:15093878",
                    "PMID:27098105",
                    "PMID:10687108",
                    "PMID:19576338",
                    "PMID:10097243",
                    "PMID:17134722",
                    "PMID:29684191",
                    "PMID:11563684"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1967956": {
                      "sentence": "A logistic regression model used to adjust for factors predictive of cardiac death at 28 days confirmed that patients taking a beta blocker at the time of admission had a significantly reduced risk of death (relative risk 0.50; 95% confidence interval 0.34 to 0.76).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 Jan 13"
                    },
                    "PMID:9545849": {
                      "sentence": "Drugs (nonselective beta-adrenergic blockers and long-acting nitrates) are almost equivalent to endoscopic sclerotherapy for the prevention of recurrent bleeding, while band ligation offers both increased efficacy (reduced rate of rebleeding and death) and decreased complication rates when compared to sclerotherapy.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "1998 Feb"
                    },
                    "PMID:10097243": {
                      "sentence": "beta-Blockers reduce cardiovascular death and reinfarction in patients with a history of myocardial infarction (MI), and angiotensin-converting enzyme (ACE) inhibitors provide an overall survival benefit in patients with signs or symptoms of left ventricular (LV) dysfunction and a history of acute MI.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1999 Apr"
                    },
                    "PMID:10687108": {
                      "sentence": "RESULTS: In comparison to Group 1, Group 2 was treated more frequently with ACE-inhibitors and beta-blockers (p < 0.0001) and showed a better long-term survival (p = 0.0034), resulting from a reduction of death for refractory HF or need for heart transplant (p = 0.011).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Dec"
                    },
                    "PMID:10853624": {
                      "sentence": "Beta-blockers reduce the risk of death in patients with heart failure and are recommended in those with stable class II or III disease despite optimal standard therapy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Jun"
                    },
                    "PMID:14770250": {
                      "sentence": "There is now overwhelming evidence that beta-blockers are safe for heart failure patients but that they reduce the risk of death for these patients by approximately 30%.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Jan"
                    },
                    "PMID:15093878": {
                      "sentence": "BACKGROUND: Although beta-blockers reduce the risk of death in CHF, there is little reported experience with these drugs in patients with a low pretreatment SBP, who may respond poorly to beta-blockade.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Apr 21"
                    },
                    "PMID:17134722": {
                      "sentence": "CONCLUSION: In a retrospective series the use of beta-blockers was associated with reduced risk of early death in patients with ischemic stroke.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2007 Jan 15"
                    },
                    "PMID:17338123": {
                      "sentence": "UNLABELLED: Beta-blocking agents (B-A) in patients with postinfarction left ventricular dysfunction or heart failure reduce the risk of death.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "2006"
                    },
                    "PMID:19576338": {
                      "sentence": "These results have further confirmed that beta blockers reduce the risk of death and nonfatal cardiovascular events in patients with heart failure or systolic left ventricular dysfunction after myocardial infarction.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Jul 15"
                    },
                    "PMID:19645208": {
                      "sentence": "A post hoc analysis of the SOLVD Prevention trial demonstrated that beta blockers reduced death and development of heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Mar"
                    },
                    "PMID:23790500": {
                      "sentence": "CONCLUSIONS: beta-blockers reduced the 1-year risk of death, and this effect seemed greater than the risk of inducing a stroke.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    },
                    "PMID:24377458": {
                      "sentence": "In the SHIFT trial, which enrolled patients with LVSD, HF and HR >= 70 bpm, ivabradine administration (on top of guideline-based therapy, including beta-blockers [BB]) was associated with a reduction of cardiovascular death and hospitalizations for HF, but BB were underutilized.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2014 Feb"
                    },
                    "PMID:25156833": {
                      "sentence": "CONCLUSIONS: In the real world scenarios, for patients undergoing non-cardiac surgery, the routine use of beta-blockers does not seem to reduce the risk of death.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Oct 20"
                    },
                    "PMID:25862157": {
                      "sentence": "Use of beta-blockers was associated with a reduced risk of all-cause death (unadjusted relative risk 0.58, 95% confidential interval 0.48 to 0.71; adjusted hazard ratio 0.76, 95% confidential interval 0.62 to 0.94).",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "2015 Jun 01"
                    },
                    "PMID:26817946": {
                      "sentence": "This is an important result since pump failure death is currently the main cause of death in HF, and also because the reductions in mortality obtained with beta-blockers and spironolactone in the last 20 years appear to be mainly due to reduction in sudden death rather than reduction in pump failure death.",
                      "object score": 827,
                      "subject score": 1000,
                      "publication date": "2016 Apr"
                    },
                    "PMID:27098105": {
                      "sentence": "CONCLUSION: Irrespective of age or sex, patients with HFrEF in sinus rhythm should receive beta blockers to reduce the risk of death and admission to hospital.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Apr 20"
                    },
                    "PMID:27867524": {
                      "sentence": "Drugs targeting the renin-angiotensin-aldosterone system, beta-blockers, cardiac resynchronization therapy (CRT), and intracardiac defibrillator devices (ICDs) significantly reduced the risk of death with reductions of 14-19, 23, 20, and 20%, respectively.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Dec"
                    },
                    "PMID:29684191": {
                      "sentence": "As compared with patients not on beta-blockers, low, intermediate, and high dose had significantly reduced risk of HF hospitalizations {hazard ratio (HR) = 0.68 [0.54-0.87], P = 0.002; HR = 0.53 [0.42-0.66], P < 0.001; HR = 0.43 [0.34-0.54], P < 0.001} and death (HR = 0.47 [0.35-0.64], P < 0.001; HR = 0.29 [0.22-0.39], P = 0.001; HR = 0.24 [0.18-0.33], P < 0.001).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Sep 01"
                    },
                    "PMID:30468042": {
                      "sentence": "CONCLUSIONS: In Korean patients with HFpEF, use of beta-blockers is associated with reduced all-cause death but not with reduced rehospitalization.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "2018 Nov 12"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:67238-biolink:affects-UniProtKB:P00441": {
              "object": "UniProtKB:P00441",
              "subject": "FMA:67238",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:74644-biolink:affects-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "FMA:74644",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL45---DGIdb:affects---NCBIGene:7040---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9649124"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:83365-biolink:affects-UniProtKB:P51787": {
              "object": "UniProtKB:P51787",
              "subject": "FMA:83365",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL1201631---DGIdb:affects---NCBIGene:3784---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17182020"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D006439-biolink:affects-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "MESH:D006439",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0019010---SEMMEDDB:affects---UMLS:C0018802---SEMMEDDB:",
                    "UMLS:C0019010---SEMMEDDB:affects---UMLS:C0023212---SEMMEDDB:",
                    "UMLS:C0019010---SEMMEDDB:affects---UMLS:C0242698---SEMMEDDB:",
                    "UMLS:C0019010---SEMMEDDB:affects---UMLS:C0018801---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9355910",
                    "PMID:25067799",
                    "PMID:19100447",
                    "PMID:32746370",
                    "PMID:32393068",
                    "PMID:10761810",
                    "PMID:29744001",
                    "PMID:32997214",
                    "PMID:31960146",
                    "PMID:14691038",
                    "PMID:15466632",
                    "PMID:2994990",
                    "PMID:23363644",
                    "PMID:2048568",
                    "PMID:29931908",
                    "PMID:12776594",
                    "PMID:30354556",
                    "PMID:7685451",
                    "PMID:8678641",
                    "PMID:2480483"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2048568": {
                      "sentence": "Knowledge of the basic alterations of central hemodynamics in congestive heart failure has failed to explain many aspects of this important syndrome.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1991 May 29"
                    },
                    "PMID:2480483": {
                      "sentence": "Knowledge of the basic alterations of central hemodynamics in congestive heart failure (CHF) has failed to explain many aspects of this important syndrome.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1989"
                    },
                    "PMID:2994990": {
                      "sentence": "Effects of enalapril on clinical status, biochemistry, exercise performance and haemodynamics in heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1985"
                    },
                    "PMID:7685451": {
                      "sentence": "Converting enzyme inhibition or renin inhibition had similar beneficial effects on cardiorenal function, suggesting that both classes of compounds act by a similar mechanism to improve renal hemodynamics in congestive heart failure.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1993 May"
                    },
                    "PMID:8678641": {
                      "sentence": "Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jul"
                    },
                    "PMID:9355910": {
                      "sentence": "We tested whether daily exercise training improves systemic hemodynamics and preserves endothelium-mediated vasodilator function during development of heart failure.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1997 Oct 21"
                    },
                    "PMID:10761810": {
                      "sentence": "HYPOTHESIS: This study was undertaken to investigate the effects of L-arginine on heart rate, hemodynamics, and left ventricular (LV) function in CHF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Mar"
                    },
                    "PMID:12776594": {
                      "sentence": "OBJECTIVE: To observe the effect of Zhimu and Huangqi used singly or combinatively on improving experimental cardiac dysfunction, and mainly to observe zhimu's effect on restraining sympathetic nerve and blocking beta-adrenergic-recepter and huangqi's effect of improving hemodynamics on heart failure.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2002 Nov"
                    },
                    "PMID:14691038": {
                      "sentence": "We next evaluated the effects of chronic oral ET-A receptor antagonism on neurohumoral function, renal hemodynamics, and sodium excretion in pacing-induced CHF.",
                      "object score": 854,
                      "subject score": 888,
                      "publication date": "2004 Jan 20"
                    },
                    "PMID:15466632": {
                      "sentence": "Differential effects of theophylline on sympathetic excitation, hemodynamics, and breathing in congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Oct 12"
                    },
                    "PMID:19100447": {
                      "sentence": "CONCLUSION: Rapid operating room or bedside placement of ECMO allowed stabilization of hemodynamics with potential myocardial recovery in patients with cardiac graft failure.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2008 Dec"
                    },
                    "PMID:23363644": {
                      "sentence": "We compared the hemodynamics of control and HF patients, and identified the predictors for acute effects of ASV in HF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:25067799": {
                      "sentence": "Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2014 Sep"
                    },
                    "PMID:29744001": {
                      "sentence": "We also attempt to explain the underlying hemodynamics responsible for LV failure and recovery in this patient.",
                      "object score": 976,
                      "subject score": 861,
                      "publication date": "2017 Jul-Sep"
                    },
                    "PMID:29931908": {
                      "sentence": "CONCLUSIONS: Therapeutic effect of LXD on CHF by doxorubicin-induced in rats is confirmed, the mechanisms are associated with improved hemodynamics and myocardial tissue.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2017 Jun 08"
                    },
                    "PMID:30354556": {
                      "sentence": "Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2018 Aug"
                    },
                    "PMID:31960146": {
                      "sentence": "We aimed to identify the plasma levels of RTKs and related proteins and their association with haemodynamic alterations in heart failure (HF) and related pulmonary hypertension (PH) following heart transplantation (HT).",
                      "object score": 1000,
                      "subject score": 872,
                      "publication date": "2020 Jan 20"
                    },
                    "PMID:32393068": {
                      "sentence": "In this review, we discuss different mechanisms by which SGLT2 inhibitors play hemodynamic, metabolic, and cellular roles in different HF phenotypes.",
                      "object score": 861,
                      "subject score": 888,
                      "publication date": "2020 May 12"
                    },
                    "PMID:32746370": {
                      "sentence": "Any irregularities in the hemodynamics may lead to lethal cardiovascular disease like heart attack, heart failure and ischemia.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Jul 22"
                    },
                    "PMID:32997214": {
                      "sentence": "Graphical abstract Illustration of the beneficial and deleterious hemodynamic effects of intravenous inotropes in advanced heart failure, and the positive effects of adding ivabradine.",
                      "object score": 901,
                      "subject score": 790,
                      "publication date": "2020 Sep 30"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0007412-biolink:causes-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UMLS:C0007412",
              "predicate": "biolink:causes",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0007412---SEMMEDDB:causes---UMLS:C0242698---SEMMEDDB:",
                    "UMLS:C0007412---SEMMEDDB:causes---UMLS:C0018801---SEMMEDDB:",
                    "UMLS:C0007412---SEMMEDDB:causes---UMLS:C0018802---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23810075",
                    "PMID:12025908",
                    "PMID:2151869",
                    "PMID:28662012",
                    "PMID:87282",
                    "PMID:12892164",
                    "PMID:19889504",
                    "PMID:30641325",
                    "PMID:1415603",
                    "PMID:30625797",
                    "PMID:34130840",
                    "PMID:29884661",
                    "PMID:21741786"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:87282": {
                      "sentence": "The relationship from group 3 (patients with increased left ventricular EDDs and depressed pressure indices, two of whom were in clinical heart failure) resumbled those induced in normal muscles exposed to high levels of catecholamines, and those obtained from experimentally induced heart failure.",
                      "object score": 824,
                      "subject score": 1000,
                      "publication date": "1979 Aug"
                    },
                    "PMID:1415603": {
                      "sentence": "We conclude that toxic concentrations of catecholamines are responsible for SNS-induced LV dysfunction and that hypertension, most likely because of its ability to increase myocardial energy demand, is one of the important events that leads to depressed cardiac function.",
                      "object score": 875,
                      "subject score": 1000,
                      "publication date": "1992 Sep"
                    },
                    "PMID:2151869": {
                      "sentence": "Continuing the treatment of the animals with catecholamine caused a decompensated heart failure by the 21st day.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:12025908": {
                      "sentence": "A case of catecholamine induced heart failure with left ventricular hypertrophy accompanied by mid-ventricular obstruction.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Mar"
                    },
                    "PMID:12892164": {
                      "sentence": "Hypercontractile heart failure caused by catecholamine therapy in premature neonates.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "2003 Jul"
                    },
                    "PMID:19889504": {
                      "sentence": "Clinical signs of catecholamine-induced heart failure can present with a wide range of symptoms reaching from subtle histological changes with preserved myocardial pump function to severe heart failure exhibiting a distinctive echocardiographic pattern which became known as \"Takotsubo\"-like cardiomyopathy or the left ventricular apical ballooning syndrome.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "2010 Mar"
                    },
                    "PMID:21741786": {
                      "sentence": "Young patients with catecholamine-induced cardiac failure refractory to medical therapy are ideal candidates for short-term ECMO support, as the underlying cause is imminently reversible.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "2012 Jul"
                    },
                    "PMID:23810075": {
                      "sentence": "Most importantly, widely used intravenous catecholamines may cause severe transient left ventricular dysfunction, and consideration should be given to noncatecholamine vasopressors.",
                      "object score": 875,
                      "subject score": 888,
                      "publication date": "2013 Nov"
                    },
                    "PMID:28662012": {
                      "sentence": "Sepsis is an exception, regardless of the etiologic pathogen, in which case an excess of catecholamines may result in acute left ventricular dysfunction.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "2017 Jun 23"
                    },
                    "PMID:29884661": {
                      "sentence": "Phaeochromocytoma can lead to cardiac involvement in the form of left ventricular dysfunction, or catecholamine-induced myocarditis.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "2018 Jun 08"
                    },
                    "PMID:30625797": {
                      "sentence": "Anesthetic experience of pheochromocytoma resection with catecholamine-induced cardiomyopathy and congestive heart failure : A case report.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "2009 May"
                    },
                    "PMID:30641325": {
                      "sentence": "DISCUSSION: Alpha and beta adrenergic blockade are used in a critical care setting to prevent perioperative hemodynamic instability as well as catecholamine-induced heart failure in the setting of pheochromocytoma.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "2019"
                    },
                    "PMID:34130840": {
                      "sentence": "Meanwhile, 15-week of real-ambient PM     2.5       exposure decreased the heart rate and amounts of associated catecholamines to induce heart failure in Sirt3 KO mice.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2021 Jul"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0597357-biolink:affects-MESH:D009154": {
              "object": "MESH:D009154",
              "subject": "UMLS:C0597357",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0597357---SEMMEDDB:affects---UMLS:C0026882---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21389213",
                    "PMID:8700116",
                    "PMID:19931869",
                    "PMID:8662820",
                    "PMID:16433250",
                    "PMID:8880932",
                    "PMID:29343553",
                    "PMID:20966081",
                    "PMID:29666363",
                    "PMID:1569088",
                    "PMID:18219446",
                    "PMID:20811900",
                    "PMID:23916476",
                    "PMID:8911609",
                    "PMID:20599922",
                    "PMID:9379130",
                    "PMID:9016347"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1569088": {
                      "sentence": "To further study the effects of these mutations on activation, the responses of the receptors to the partial agonists phenyltrimethylammonium (PTMA) and tetramethylammonium (TMA) were examined.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Apr 25"
                    },
                    "PMID:8662820": {
                      "sentence": "Agonists, but not antagonists, promote the transitions of the receptor from the resting state to the higher affinity active and desensitized states, and the greater effects of the mutations of gammaAsp-174 and deltaAsp-180 on the apparent affinities of agonists could reflect the involvement of these residues in the conformational changes of the receptor corresponding to its transitions to higher affinity states.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jun 07"
                    },
                    "PMID:8700116": {
                      "sentence": "By studying both receptors, the direct and indirect effects of mutations on affinity and selectivity can be distinguished.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jul"
                    },
                    "PMID:8880932": {
                      "sentence": "Mutation data on the receptors were collected from the literature and a database of mutants and effects of mutations was developed.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Sep"
                    },
                    "PMID:8911609": {
                      "sentence": "This mutation was described previously as a receptor-negative founder mutation in Norway (FH-Elverum) and subsequently in 6 unrelated heterozygous English patients, creating a severe phenotype of familial hypercholesterolemia.",
                      "object score": 833,
                      "subject score": 833,
                      "publication date": "1996 Oct 16"
                    },
                    "PMID:9016347": {
                      "sentence": "Charged amino acid residues within the transmembrane (TM) domains of the receptor were mutated, and the resulting receptor proteins were analyzed for the effects of these mutations on receptor structure and/or function.",
                      "object score": 1000,
                      "subject score": 890,
                      "publication date": "1997 Jan"
                    },
                    "PMID:9379130": {
                      "sentence": "Thus heterodimerizations with RXRs and TRAPs are differently affected by RTH mutations.",
                      "object score": 787,
                      "subject score": 1000,
                      "publication date": "1997 Sep"
                    },
                    "PMID:16433250": {
                      "sentence": "The molecular effects of the mutations were investigated by heterologous expression of the WT LHR, the double mutant LHR, or receptors with either the I374T or the T392I mutation, and measuring hormone binding and cAMP signaling.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005"
                    },
                    "PMID:18219446": {
                      "sentence": "The major advantage of these approaches is that they explicitly utilize the 3D structures of small molecules or peptides as well as their macromolecular targets, to extract position-specific information about important interactions between the ligand and receptor, which can assist the medicinal and computational chemists in designing new molecules, and biologists in studying the influence of mutations in the target receptor on ligand binding.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Feb"
                    },
                    "PMID:19931869": {
                      "sentence": "An atomic structure model of the human P2X(7)R, based on the crystal structure of the zebrafish P2X(4) receptor, suggests that the SNP mutational effects may result from changes in subunit interaction, agonist binding and/or channel gating.",
                      "object score": 816,
                      "subject score": 1000,
                      "publication date": "2010 Apr"
                    },
                    "PMID:20599922": {
                      "sentence": "Compared to wild-type P2Y(12) receptor, mutations in Arg 256 or/and Arg 265 significantly increased the sensitivity to antagonist AR-C69931MX.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Oct 10"
                    },
                    "PMID:20811900": {
                      "sentence": "Four receptors (FGFR 1, FGFR 2, FGFR 3, FGFR 4) involving mutation in the fibroblast growth factor have been identified.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2011 Apr"
                    },
                    "PMID:20966081": {
                      "sentence": "Anti-UNC-63 antibody staining in both cultured adult muscle and embryonic cells showed that L-nAChRs were expressed at similar levels in the mutant and wild-type cells, suggesting that the functional changes in the receptor, rather than changes in expression, are the predominant effect of the mutation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Jan 28"
                    },
                    "PMID:21389213": {
                      "sentence": "Effects of these mutations on the maturation of heteromeric NMDA-Rs were investigated using a receptor trafficking assay.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Mar 09"
                    },
                    "PMID:23916476": {
                      "sentence": "Using site-directed mutagenesis, we further demonstrated that mutations at Glu155 of beta2 subunit and Phe64 of alpha1 subunit, both located inside the GABA binding pocket, profoundly decreased the sensitivity of the receptor to both GABA and GMQ.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Dec"
                    },
                    "PMID:29343553": {
                      "sentence": "These diverse effects of mutations suggest the existence of ligand- and pathway-specific receptor conformations and give new insights in the sophisticated signaling machinery between allosteric ligands, chemokines, and their receptors, which can provide a powerful platform for the development of new allosteric drugs with improved pharmacological properties.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 04"
                    },
                    "PMID:29666363": {
                      "sentence": "We identified changes in mRNA expression profiles, especially in ion channels, receptors, and transporters that may underlie the neurophysiological effects of this mutation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 04 18"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:affects-MESH:D014664": {
              "object": "MESH:D014664",
              "subject": "VANDF:4021566",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:affects---UMLS:C0042401---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15849877",
                    "PMID:1530432",
                    "PMID:28143473",
                    "PMID:7857754",
                    "PMID:1280569",
                    "PMID:12417269",
                    "PMID:15242970",
                    "PMID:1977305",
                    "PMID:7865916",
                    "PMID:9577945",
                    "PMID:9049543",
                    "PMID:22653165",
                    "PMID:15517514",
                    "PMID:26544729",
                    "PMID:24979307",
                    "PMID:16387169"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1280569": {
                      "sentence": "Bepridil is a calcium antagonist with direct negative chronotropic, dromotropic, inotropic and vasodilatory actions which reduces myocardial oxygen consumption and increases coronary blood flow, leading to a significant anti-ischaemic and antianginal effect in the absence of reflex tachycardia.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "1992 Nov"
                    },
                    "PMID:1530432": {
                      "sentence": "On the other hand, arterial vasodilators, like calcium antagonists or potassium agonists have decreased vasodilatory effects on these conductance vessels in the presence of endothelial lesions as their action is partially or entirely endothelium-dependent.",
                      "object score": 816,
                      "subject score": 983,
                      "publication date": "1992 Apr"
                    },
                    "PMID:1977305": {
                      "sentence": "As a consequence, cardiac effects can be minimized by selecting a calcium channel blocker with more potent peripheral vasodilatory effects.",
                      "object score": 799,
                      "subject score": 1000,
                      "publication date": "1990 Oct"
                    },
                    "PMID:7857754": {
                      "sentence": "From meta-analyses on different cardiovascular treatments, given after coronary events, only the efficacy of drugs significantly reducing heart rate is borne out (beta-blockers with sympathomimetic activity, or calcium-antagonists with a prevalent vasodilatory action do not provide a protective effect).",
                      "object score": 552,
                      "subject score": 983,
                      "publication date": "1994 Oct"
                    },
                    "PMID:7865916": {
                      "sentence": "Calcium-channel blockers, because of their vasodilatory effects on the renal afferent arteriole, may be the anti-hypertensive agents of choice in this population.",
                      "object score": 836,
                      "subject score": 1000,
                      "publication date": "1994 Dec"
                    },
                    "PMID:9049543": {
                      "sentence": "The use of calcium antagonists in the treatment of left ventricular dysfunction or congestive heart failure has been proposed for many years now, mainly because of their potent vasodilatory effect.",
                      "object score": 794,
                      "subject score": 983,
                      "publication date": "1997 Jan"
                    },
                    "PMID:9577945": {
                      "sentence": "Administration of calcium antagonists normalizes exercise-induced vasodilation and thus eliminates cholesterol-induced abnormal vasomotion, probably by a direct effect on the smooth muscles of the vasculature.",
                      "object score": 901,
                      "subject score": 983,
                      "publication date": "1998 Apr 14"
                    },
                    "PMID:12417269": {
                      "sentence": "This observation has led to interest in a potential antiatherogenic role for calcium channel blockers (CCBs), independent of their effects on vasodilation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Dec"
                    },
                    "PMID:15242970": {
                      "sentence": "Nevertheless, the utility of calcium channel blockers for heart disease is limited because of the potent vasodilatory effect that causes hypotension, and other side effects attributable to blockade of noncardiac channels.",
                      "object score": 794,
                      "subject score": 1000,
                      "publication date": "2004 Aug 20"
                    },
                    "PMID:15517514": {
                      "sentence": "Calcium antagonists lower blood pressure mainly through vasodilation and reduction of peripheral resistance.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "2004 Jul-Aug"
                    },
                    "PMID:15849877": {
                      "sentence": "These results coupled with the in vivo effects of ethanol extract reveal that the Alstonia scholaris leaves possess broncho-vasodilatory activity mediated presumably by prostaglandins, calcium antagonism and endothelium-derived relaxing factor(s).",
                      "object score": 754,
                      "subject score": 950,
                      "publication date": "2005 Mar 21"
                    },
                    "PMID:16387169": {
                      "sentence": "Therefore, we hypothesized that calcium antagonists protected a liver from IR injury by a vasodilatory action rather than by the inhibition of an increase in Ca2+ within parenchymal cells.",
                      "object score": 623,
                      "subject score": 983,
                      "publication date": "2005 Dec"
                    },
                    "PMID:22653165": {
                      "sentence": "Dihydropyridine CCBs lower blood pressure mainly through vasodilation and reduction of peripheral resistance, and several clinical studies have demonstrated that they have clinical benefits in patients with cardiovascular diseases.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "2012"
                    },
                    "PMID:24979307": {
                      "sentence": "OBJECTIVE: Calcium channel blockers (CCBs) are used as antihypertensive agents and have a strong vasodilatory effect; however, the sympathetic activation mediated by baroreflex might cause adverse effects.",
                      "object score": 828,
                      "subject score": 1000,
                      "publication date": "2014 Sep"
                    },
                    "PMID:26544729": {
                      "sentence": "CONCLUSIONS: The new halopedidol derivatives X1, X2 and X3 are novel calcium antagonists with stronger vasodilation effect and less cardiac side effect.",
                      "object score": 840,
                      "subject score": 890,
                      "publication date": "2015 Dec 22"
                    },
                    "PMID:28143473": {
                      "sentence": "The mechanism of action of the vasorelaxant effect was studied by using the cellular blockers specified to explore the involvement of NO/GC pathway and in the presence of calcium channels blockers and potassium channels blockers.",
                      "object score": 853,
                      "subject score": 988,
                      "publication date": "2017 Jan 31"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0011065-biolink:affects-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UMLS:C0011065",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0011065---SEMMEDDB:affects---UMLS:C0242698---SEMMEDDB:",
                    "UMLS:C0011065---SEMMEDDB:affects---UMLS:C0018802---SEMMEDDB:",
                    "UMLS:C0011065---SEMMEDDB:affects---UMLS:C0018801---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21030937",
                    "PMID:22508833",
                    "PMID:30366889",
                    "PMID:31602351",
                    "PMID:3237505",
                    "PMID:11386263",
                    "PMID:10900165",
                    "PMID:11174339",
                    "PMID:21883118",
                    "PMID:10634672",
                    "PMID:27155237",
                    "PMID:29252053",
                    "PMID:27649879",
                    "PMID:25919061",
                    "PMID:27317347",
                    "PMID:29911005",
                    "PMID:21311494",
                    "PMID:27714717",
                    "PMID:12958145",
                    "PMID:24621972"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:10634672": {
                      "sentence": "Eight hearts obtained at autopsy approximately 6 hours after death from patients who died of non-cardiovascular disease causes served as non-heart failure controls.",
                      "object score": 808,
                      "subject score": 1000,
                      "publication date": "1999 Dec"
                    },
                    "PMID:10668685": {
                      "sentence": "The stroke rate alone is too low to be used as a primary endpoint, but an endpoint combining stroke and death (as WARCEF and WATCH propose) should allow an assessment of the effect of antithrombotics in cardiac failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Jan 25"
                    },
                    "PMID:10900165": {
                      "sentence": "In vivo, the death of ventricular myocytes leads to heart failure, and downregulation of survival signals and/or augmentation of pro-apoptotic signals are likely to be important components of disease processes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Aug"
                    },
                    "PMID:11174339": {
                      "sentence": "BACKGROUND: Myocyte death could play a role in heart failure (HF) irrespective of the presence of coronary artery disease.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2001 Feb"
                    },
                    "PMID:11386263": {
                      "sentence": "BACKGROUND: Beta-blocking agents reduce the risk of hospitalization and death in patients with mild-to-moderate heart failure, but little is known about their effects in severe heart failure.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2001 May 31"
                    },
                    "PMID:12958145": {
                      "sentence": "Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Oct 03"
                    },
                    "PMID:16043941": {
                      "sentence": "Cardiac events including death and re-admission for HF exacerbation after discharge were analyzed in relation to the plasma BNP levels at predischarge.",
                      "object score": 812,
                      "subject score": 1000,
                      "publication date": "2005 May"
                    },
                    "PMID:21030937": {
                      "sentence": "Current treatments can not prevent the loss of cardiac contractility caused by cardiomyocyte death, and therefore patients that do survive MI are prone to develop progressive impaired cardiac function, which may lead to heart failure.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2010 Aug"
                    },
                    "PMID:21883118": {
                      "sentence": "MEASUREMENTS: Multiple regression and Cox models were used to determine the effect of heart failure (HF), chronic obstructive pulmonary disease (COPD), osteoarthritis, depression, and cognitive impairment on self-rated health, 12 basic and instrumental activities of daily living (ADLs and IADLs), six-item symptom burden scale, and death.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Sep"
                    },
                    "PMID:22508833": {
                      "sentence": "Since apoptosis plays an important role in heart failure and postinfarction left ventricular remodeling, we examined whether low-dose mineralocorticoid receptor antagonists modulate cardiomyocyte death by regulating the apoptosis repressor protein apoptosis repressor with caspase recruitment domain to lessen the extent of apoptosis.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2012 Jun"
                    },
                    "PMID:24533700": {
                      "sentence": "Four categories of mortality were examined: cardiac mortality; and death related to arrhythmia, cerebrovascular disease, and heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Apr"
                    },
                    "PMID:24621972": {
                      "sentence": "OBJECTIVES: This study sought to assess the effect of the addition of coronary artery bypass grafting (CABG) to medical therapy on mode of death in heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    },
                    "PMID:25919061": {
                      "sentence": "Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Jul"
                    },
                    "PMID:26415898": {
                      "sentence": "Loss of dysferlin causes death of cardiomyocytes, notably in ageing hearts, leading to dilated cardiomyopathy and heart failure in LGM2B patients.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Dec 01"
                    },
                    "PMID:27155237": {
                      "sentence": "A major limitation of this drug is the induction of death in cardiomyocytes leading to heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Apr 15"
                    },
                    "PMID:27317347": {
                      "sentence": "Inadequate adherence leads to increased HF exacerbations, reduced physical function, and higher risk for hospital admission and death.",
                      "object score": 658,
                      "subject score": 1000,
                      "publication date": "2016 06 17"
                    },
                    "PMID:27649879": {
                      "sentence": "The primary outcome was a composite of appropriate shock, acute coronary syndrome, ischemic stroke, coronary revascularization, heart failure exacerbation, CV hospitalization, or all-cause death.",
                      "object score": 734,
                      "subject score": 872,
                      "publication date": "2016 Nov 15"
                    },
                    "PMID:29252053": {
                      "sentence": "However, among other comorbidities, LVAD recipients face a risk of renal dysfunction, related to either the residual effects of HF or to LVAD support, which complicates the management of these patients and increases the risk of an adverse clinical outcome, including death.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Jan"
                    },
                    "PMID:29911005": {
                      "sentence": "We considered a composite endpoint as follows: all-cause death, acute myocardial infarction, stroke, and HF exacerbation.",
                      "object score": 734,
                      "subject score": 872,
                      "publication date": "2018 Apr-Jun"
                    },
                    "PMID:30366889": {
                      "sentence": "We thought that the cause of his death was the exacerbation of heart failure associated with bradycardia.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Oct 25"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0232164-biolink:affects-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UMLS:C0232164",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0232164---SEMMEDDB:affects---UMLS:C0018802---SEMMEDDB:",
                    "UMLS:C0232164---SEMMEDDB:affects---UMLS:C0018801---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19028502",
                    "PMID:31222260",
                    "PMID:27813591",
                    "PMID:30364138",
                    "PMID:23007906",
                    "PMID:21412678",
                    "PMID:26391145",
                    "PMID:15336974",
                    "PMID:17655944",
                    "PMID:28714796",
                    "PMID:1826184",
                    "PMID:14665520",
                    "PMID:20425496",
                    "PMID:19703657",
                    "PMID:32968936",
                    "PMID:16938661",
                    "PMID:12429867",
                    "PMID:25645295",
                    "PMID:19569260",
                    "PMID:11767995"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1826184": {
                      "sentence": "Such LV dilatation may adversely affect subsequent cardiac function, leading to heart failure and death.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1991 Apr"
                    },
                    "PMID:8096671": {
                      "sentence": "An understanding of the important role of neurohormonal compensatory mechanisms in heart failure has been translated into therapeutic options that can improve cardiac function, alter disease progression, and improve survival.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Mar 25"
                    },
                    "PMID:8613228": {
                      "sentence": "Attenuation of the contractile effect of isoproterenol by angiotensin II may help explain why cardiac function improves in heart failure after blockade of the renin-angiotensin system.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1996 Mar"
                    },
                    "PMID:12132283": {
                      "sentence": "Although frequently regarded as an useless appendage, data from animal and human investigations show that the left atrial appendage may play an important role in the maintenance and regulation of the cardiac function, especially in arterial hypertension, atrial fibrillation, coronary heart disease, valvular heart disease and heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 May"
                    },
                    "PMID:12429867": {
                      "sentence": "To contribute to an improved comprehension of normal cardiac function and the molecular events leading to heart failure, we performed large-scale gene expression analysis of failing and nonfailing human ventricle.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2003 Jan 15"
                    },
                    "PMID:14665520": {
                      "sentence": "The LAA, however, plays an important role in the maintenance and regulation of the cardiac function, in arterial hypertension, atrial fibrillation, coronary heart disease, valvular heart disease, and heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Dec"
                    },
                    "PMID:15259379": {
                      "sentence": "Furthermore, CNH circulating levels in heart failure are affected not only by cardiac function and disease severity, but also by activation of neuro-hormonal and stress-related cytokine systems, as well as by the thyroid hormones, even on usual medical treatment.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004"
                    },
                    "PMID:15336974": {
                      "sentence": "Altered cardiac ryanodine receptor (RyR2) function has an important role in heart failure and genetic forms of arrhythmias.",
                      "object score": 1000,
                      "subject score": 857,
                      "publication date": "2004 Oct 01"
                    },
                    "PMID:17655944": {
                      "sentence": "These change may induce a direct effect on the progressive deterioration of cardiac function in the fibrillation and failure heart.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Aug 01"
                    },
                    "PMID:19028502": {
                      "sentence": "We previously showed that conditional myocyte-specific deletion of FAK (MFKO) in the adult heart did not affect basal cardiomyocyte survival or cardiac function but led to dilated cardiomyopathy and heart failure following pressure overload.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Feb"
                    },
                    "PMID:19703657": {
                      "sentence": "Ca(2+) signaling is of vital importance to cardiac cell function and plays an important role in heart failure.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2009 Oct"
                    },
                    "PMID:20425496": {
                      "sentence": "However, the contribution of these effects to the restoration of cardiac function remains to be estimated, and it may depend on the specific events that led to heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Mar"
                    },
                    "PMID:21412678": {
                      "sentence": "Calcium is of vital importance to cardiac cell function and plays an important role in heart failure.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2011 Mar"
                    },
                    "PMID:22626847": {
                      "sentence": "Thus, arginylation is essential for maintaining the heart function by regulation of the major myofibril proteins and myofibril forces, and its absence in the heart muscle leads to progressive heart failure through cardiomyocyte-specific defects.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2012 Sep"
                    },
                    "PMID:23007906": {
                      "sentence": "All peripartum cardiomyopathy patients should be counseled that repeat pregnancy can negatively impact cardiac function and lead to recurrent heart failure or even death.",
                      "object score": 901,
                      "subject score": 824,
                      "publication date": "2012 Dec"
                    },
                    "PMID:23103827": {
                      "sentence": "This implicates a series of modulatory cardiac signaling events that could alter normal heart function and may occur with chronic stimulation of the atria beta(1)-AR, which could lead to heart failure.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2012 Dec"
                    },
                    "PMID:25645295": {
                      "sentence": "This investigation determined if compromised cardiac mitochondrial function contributed to heart failure (HF) in the New Zealand wrasse Notolabrus celidotus acclimated at their mean summer and winter ocean temperatures.",
                      "object score": 1000,
                      "subject score": 843,
                      "publication date": "2015 Jun"
                    },
                    "PMID:26687129": {
                      "sentence": "Cardiomyocyte apoptosis disrupts cardiac function and leads to cardiac decompensation and terminal heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Mar"
                    },
                    "PMID:27813591": {
                      "sentence": "Cardiac microvascular endothelial barrier function can lead to heart failure.",
                      "object score": 1000,
                      "subject score": 794,
                      "publication date": "2016 Oct 17"
                    },
                    "PMID:28714796": {
                      "sentence": "There is poor evidence of the beneficial long-term effect of small nonsurgical intentional weight loss on HF outcomes, in contrast to the field of HF accompanying severe obesity where observational studies have shown that bariatric surgery is associated with improved cardiac structure/function in severely obese patients with HF and preserved ejection fraction (HFpEF) as well as with improved cardiac structure/function in those with HF and reduced ejection fraction (HFrEF).",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2017 Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0232804-biolink:affects-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UMLS:C0232804",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0232804---SEMMEDDB:affects---UMLS:C0018801---SEMMEDDB:",
                    "UMLS:C0232804---SEMMEDDB:affects---UMLS:C0018802---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:31908120",
                    "PMID:9440136",
                    "PMID:9741739",
                    "PMID:11923791",
                    "PMID:7586237",
                    "PMID:30768732",
                    "PMID:15741202",
                    "PMID:21693504",
                    "PMID:29873513",
                    "PMID:28209765"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7586237": {
                      "sentence": "To define the role of natriuretic peptides (NPs) in the regulation of renal function in CHF, the renal responses to HS-142-1 (HS), a potent NP receptor antagonist, were studied in anesthetized rats subjected to coronary ligation that developed left ventricular infarction and CHF or in sham-operated (SO) control rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Dec"
                    },
                    "PMID:9440136": {
                      "sentence": "The pathophysiological role of endogenous leukotrienes in cardiovascular control and the regulation of renal function in congestive heart failure is not known.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997"
                    },
                    "PMID:9741739": {
                      "sentence": "These findings suggest that endogenous ANP plays a critical role in regulating venovascular tone, inhibiting activation of RAAS, and maintaining renal functions in early-stage HF.",
                      "object score": 861,
                      "subject score": 879,
                      "publication date": "1998 Aug"
                    },
                    "PMID:11923791": {
                      "sentence": "RESULTS: Revascularization of a stenosed renal artery is associated with preservation of renal function and better control of hypertension, unstable angina, and congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Apr"
                    },
                    "PMID:15741202": {
                      "sentence": "Symptoms of heart failure, however, were associated with kidney function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 May"
                    },
                    "PMID:21693504": {
                      "sentence": "CONCLUSION: During the treatment of decompensated heart failure, significant blood pressure reduction is strongly associated with WRF.",
                      "object score": 901,
                      "subject score": 901,
                      "publication date": "2011 Aug"
                    },
                    "PMID:28209765": {
                      "sentence": "METHODS AND RESULTS: Random effect meta-analysis was performed to investigate the relationship between RAAS inhibitor therapy, WRF in both HF phenotypes, and mortality.",
                      "object score": 901,
                      "subject score": 901,
                      "publication date": "2017 Feb"
                    },
                    "PMID:29873513": {
                      "sentence": "Increased central venous pressure and renal venous pressure (RVP) are associated with worsening of renal function in acute exacerbation of congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Sep 01"
                    },
                    "PMID:30768732": {
                      "sentence": "CONCLUSION: In EMPHASIS-HF the eplerenone dose was stratified according to renal function and the treatment effect was not influenced by renal function: 25 mg/day in patients with eGFR 30-49 mL/min/1.73 m2 was as effective as 50 mg/day in patients with eGFR > =50 mL/min/1.73 m2 .",
                      "object score": 706,
                      "subject score": 1000,
                      "publication date": "2019 03"
                    },
                    "PMID:31908120": {
                      "sentence": "Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2020 Jan 07"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0600520-biolink:affects-MONDO:0001298": {
              "object": "MONDO:0001298",
              "subject": "UMLS:C0600520",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0600520---SEMMEDDB:affects---UMLS:C0026266---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19815380",
                    "PMID:32083424",
                    "PMID:27406842",
                    "PMID:20826595",
                    "PMID:20501482",
                    "PMID:26846946",
                    "PMID:25118123",
                    "PMID:15364844",
                    "PMID:22305962",
                    "PMID:18440348"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:15364844": {
                      "sentence": "CONCLUSIONS: Recurrent MR late after ring annuloplasty is associated with continued LV remodeling, emphasizing its dynamic relation to the LV.",
                      "object score": 861,
                      "subject score": 916,
                      "publication date": "2004 Sep 14"
                    },
                    "PMID:18440348": {
                      "sentence": "CONCLUSIONS: After an inaugural anterior MI, MR is associated with LV remodeling and adverse clinical outcome.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 May"
                    },
                    "PMID:19815380": {
                      "sentence": "CONCLUSION: Although recurrent MR is often associated with continued adverse LV remodeling after restrictive MVA, this mechanism fails to explain all recurrences.",
                      "object score": 901,
                      "subject score": 850,
                      "publication date": "2009 Nov"
                    },
                    "PMID:20501482": {
                      "sentence": "The improvement in early- and late-systolic MR was also associated with LV reverse remodelling, in which improvement in early-systolic MR had higher sensitivity, specificity, and AUC than late-systolic MR.",
                      "object score": 861,
                      "subject score": 905,
                      "publication date": "2010 Oct"
                    },
                    "PMID:20826595": {
                      "sentence": "BACKGROUND: one of the key targets in treating mitral regurgitation (MR) is reducing the otherwise progressive left ventricular (LV) remodeling that exacerbates MR and conveys adverse prognosis.",
                      "object score": 1000,
                      "subject score": 854,
                      "publication date": "2010 Nov"
                    },
                    "PMID:22305962": {
                      "sentence": "Although LV remodeling itself contributes to ischemic MR, this influence is directly dependent on alterations in mitral geometry.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2012 May"
                    },
                    "PMID:25118123": {
                      "sentence": "Improvement in IMR was associated with left ventricular reverse remodeling.",
                      "object score": 901,
                      "subject score": 905,
                      "publication date": "2014 Oct 01"
                    },
                    "PMID:26846946": {
                      "sentence": "Recurrence of moderate or greater MR was associated with adverse left ventricular remodeling and increased likelihood of death (hazard ratio: 1.72).",
                      "object score": 901,
                      "subject score": 923,
                      "publication date": "2016 Feb 09"
                    },
                    "PMID:27406842": {
                      "sentence": "CONCLUSIONS: IMR frequently increases in severity, and progression is independently associated with adverse left ventricular remodeling and infarct size, as assessed by cardiac magnetic resonance.",
                      "object score": 901,
                      "subject score": 923,
                      "publication date": "2016 Jul"
                    },
                    "PMID:32083424": {
                      "sentence": "Although LV remodelling itself contributes to IMR, this influence is directly dependent on alterations in mitral geometry.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2020 Feb 20"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:affects-UMLS:C0232804": {
              "object": "UMLS:C0232804",
              "subject": "VANDF:4021566",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:affects---UMLS:C0232804---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:2023618",
                    "PMID:1910642",
                    "PMID:2100825",
                    "PMID:1725538",
                    "PMID:1412439",
                    "PMID:10718277",
                    "PMID:1497390",
                    "PMID:1647960",
                    "PMID:1910641",
                    "PMID:15717638",
                    "PMID:16640171",
                    "PMID:1794210",
                    "PMID:20144066",
                    "PMID:1382165",
                    "PMID:1725007",
                    "PMID:1932641",
                    "PMID:18555114",
                    "PMID:1614071",
                    "PMID:1746992",
                    "PMID:1735675"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1497390": {
                      "sentence": "During the past decade, considerable attention has been focused on the effects of calcium antagonists on renal function.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1992 Aug"
                    },
                    "PMID:1614071": {
                      "sentence": "During the past decade, attention has focused on the effects of calcium antagonists on renal function.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1992 May"
                    },
                    "PMID:1647960": {
                      "sentence": "The aim of the present study was to determine the effect of a calcium channel blocker on renal function, urinary endothelin excretion and endothelin receptor number in rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Feb 26"
                    },
                    "PMID:1735675": {
                      "sentence": "Effects of calcium channel blockers on renal function in mice.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992"
                    },
                    "PMID:1794210": {
                      "sentence": "Recently, attention has focussed on the effects of calcium antagonists on renal function.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1991 Dec"
                    },
                    "PMID:2100825": {
                      "sentence": "Influence of calcium antagonists on renal function and secondary hyperparathyroidism in acute renal failure in rats.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1990"
                    },
                    "PMID:2184731": {
                      "sentence": "Effects of calcium channel blockers on renal function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:2220795": {
                      "sentence": "Recent attention has been focused on the effects of calcium antagonists on renal function.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1990 Oct"
                    },
                    "PMID:2220796": {
                      "sentence": "Angiotensin-converting enzyme (ACE) inhibitors and calcium channel blockers are two classes of antihypertensive agents with novel effects on renal function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 Oct"
                    },
                    "PMID:2278868": {
                      "sentence": "This review focuses on the effects of calcium antagonists on renal function in hypertensive human subjects.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1990 Oct"
                    },
                    "PMID:2665786": {
                      "sentence": "Recently, attention has focused on the effects of calcium antagonists on renal function.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1989 Jun"
                    },
                    "PMID:8345486": {
                      "sentence": "In addition, calcium channel blockers appear to have a positive effect on renal haemodynamic function in the setting of diabetes mellitus; prospective trials have demonstrated reductions in urinary protein excretion in these patients.",
                      "object score": 913,
                      "subject score": 1000,
                      "publication date": "1993 Jun"
                    },
                    "PMID:8398009": {
                      "sentence": "During the past decade, attention has focused on the effects of calcium antagonists on renal function.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1993 Jul"
                    },
                    "PMID:8430609": {
                      "sentence": "The effects of 5 to 20 mg/day of manidipine, a dihydropyridine-type calcium channel blocker, on blood pressure and renal function were studied in 71 hypertensive patients with renal impairment (serum creatinine levels between 1.4 and 5 mg/dl).",
                      "object score": 1000,
                      "subject score": 875,
                      "publication date": "1993 Feb"
                    },
                    "PMID:8441843": {
                      "sentence": "Effect of calcium antagonist on renal graft function.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1993"
                    },
                    "PMID:8503430": {
                      "sentence": "During the past decade, attention has focused on the effects of calcium antagonists on renal function.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1993 Jun"
                    },
                    "PMID:8689267": {
                      "sentence": "Investigations show that calcium antagonists have a role in altering renal functions.",
                      "object score": 879,
                      "subject score": 983,
                      "publication date": "1996 Feb"
                    },
                    "PMID:9270802": {
                      "sentence": "Calcium antagonists improve kidney function in the rat after cold storage in high-Na UW but not in high-K UW solution.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1997 Aug"
                    },
                    "PMID:9808096": {
                      "sentence": "Dihydropyridine-type calcium channel blockers (dihydropyridine CCB) adversely affect renal function in diabetes.",
                      "object score": 1000,
                      "subject score": 875,
                      "publication date": "1998 Nov"
                    },
                    "PMID:16640171": {
                      "sentence": "This paper reviews the main pathophysiological aspects of renal damage in hypertension, the effects of various types of calcium channel blockers (CCBs) on renal function, and their role in nephroprotection.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:affects-UniProtKB:P08069": {
              "object": "UniProtKB:P08069",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021557-biolink:affects-UBERON:0000178": {
              "object": "UBERON:0000178",
              "subject": "VANDF:4021557",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003280---SEMMEDDB:affects---UMLS:C0005767---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21735676",
                    "PMID:19568692",
                    "PMID:25917201",
                    "PMID:16461305",
                    "PMID:22763042",
                    "PMID:13240525",
                    "PMID:18362344",
                    "PMID:17484616",
                    "PMID:1794231",
                    "PMID:17883701",
                    "PMID:3101729",
                    "PMID:22712289"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1794231": {
                      "sentence": "We compared the effect of different concentrations of both anticoagulants on normal blood.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1991"
                    },
                    "PMID:3101729": {
                      "sentence": "Thus, the buoyant IgG-rich particles found in blood anticoagulated with solid K2EDTA appear to contribute to the high PAIgG levels associated with this anticoagulant.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987 Jan"
                    },
                    "PMID:13240525": {
                      "sentence": "The anticoagulant action in blood of sulphated derivatives of laminarin.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1955 Jul"
                    },
                    "PMID:16461305": {
                      "sentence": "While the mechanisms of their anticoagulant actions in blood have been extensively studied, their effects on the hemostatic properties of the endothelium are still under investigation.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2006 Feb"
                    },
                    "PMID:17484616": {
                      "sentence": "The remarkable expansion in laboratory test volume and complexity over recent decades has amplified the potential spectrum of applications for this anticoagulant, which can be used to stabilize blood for a variety of traditional and innovative tests.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007"
                    },
                    "PMID:17883701": {
                      "sentence": "BACKGROUND: Sodium citrate has been used as an anticoagulant to stabilize blood and blood products for over 100 years, presumably by sequestering Ca(++) ions in vitro.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Oct"
                    },
                    "PMID:18362344": {
                      "sentence": "Protein C inhibitor (PCI) is a serpin with many roles in biology, including a dual role as pro- and anticoagulant in blood.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Mar 25"
                    },
                    "PMID:19568692": {
                      "sentence": "Application of intravenous thrombolysis significantly increased the D-dimer levels and decreased the fibrinogen level 6 h after stroke onset in comparison with patients treated with antiplatelets or anticoagulants (P < 0.01), with normalization of blood levels over a 24 h period.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2010 May"
                    },
                    "PMID:21735676": {
                      "sentence": "The paper reviews literature updates on the examination of platelets by the flow cytofluorometric technique; it analyzes in detail the effect of various anticoagulants used to stabilize blood, the time and conditions of sample storage at the preanalytical stage of studies on the results of an analysis.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2011 Apr"
                    },
                    "PMID:22712289": {
                      "sentence": "A single part is dedicated to such characteristics of pre-analytical stage as impact of different anticoagulants used to stabilize blood, time and conditions of storage of samples before beginning of study of analysis results.",
                      "object score": 1000,
                      "subject score": 853,
                      "publication date": "2012 Mar"
                    },
                    "PMID:22763042": {
                      "sentence": "While the mechanisms of their anticoagulant actions in blood have been extensively studied, their effects on the inflammation of the endothelium are still under investigation since the endothelium plays a central role in sepsis.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2012 Oct"
                    },
                    "PMID:25917201": {
                      "sentence": "The effect of anticoagulants on the blood was simulated by setting three different levels of viscosity in the Newtonian model (MU/MUinfinity=0.60, 0.80 and 1 with MUinfinity=3.45*10(-3) Pas).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Jul 16"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:10759-biolink:affects-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "RXNORM:10759",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:DOID:0080685-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "DOID:0080685",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU017249---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D014945-biolink:has_participant-FMA:63018": {
              "object": "FMA:63018",
              "subject": "MESH:D014945",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0001210-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0001210",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU036831---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0001298-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0001298",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU008431---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0001384-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0001384",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU036427---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0002076-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0002076",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU016219---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0004910-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0004910",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU001468---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0005009-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0005009",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU005753---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0005392-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0005392",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU000036---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0005648-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0005648",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU001469---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0008213-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0008213",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU000191---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0008375-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0008375",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU000607---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0008475-biolink:subclass_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0008475",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:154700---OMIM:has_manifestation---OMIM:MTHU009825---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0597357-biolink:has_part-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "UMLS:C0597357",
              "predicate": "biolink:has_part",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:part_of---UMLS:C0597357---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25715477",
                    "PMID:30298006",
                    "PMID:24880985",
                    "PMID:26091707",
                    "PMID:25856002",
                    "PMID:14747750",
                    "PMID:28826664",
                    "PMID:11458815",
                    "PMID:29998113",
                    "PMID:26202915",
                    "PMID:30115383",
                    "PMID:23958169",
                    "PMID:30471101",
                    "PMID:29588073",
                    "PMID:19604562",
                    "PMID:30100246",
                    "PMID:30513140",
                    "PMID:25110237",
                    "PMID:17607123",
                    "PMID:30294794"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:11458815": {
                      "sentence": "This bimodal effect of TGF-beta forms was associated with a greater level of TGF-beta receptor 1 mRNA in confluent HCS-2/8 than in sparse cultures, suggesting that the growth response to TGF-beta forms is dependent on the receptor profile expressed.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2001"
                    },
                    "PMID:14747750": {
                      "sentence": "VEGF receptor Flk-1 and TGF-beta receptor 1 (T beta R1) expression were reduced in the Eng+/- mouse brain compared with control.",
                      "object score": 875,
                      "subject score": 875,
                      "publication date": "2004 Feb"
                    },
                    "PMID:17607123": {
                      "sentence": "INTRODUCTION: TGFBR1*6A, a functionally polymorphic allele in the transforming growth factor [beta] receptor 1 gene (TGFBR1), has been hypothesized to increase risk of various cancers.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2007 Jul"
                    },
                    "PMID:19604562": {
                      "sentence": "TGF-beta receptor 1 mRNA expression in the plaques was significantly different between the EMDT and therapy-naive patients (P = .023), but no difference was found for TGF-beta receptor 2 mRNA (P = .292).",
                      "object score": 881,
                      "subject score": 881,
                      "publication date": "2009 Sep"
                    },
                    "PMID:23958169": {
                      "sentence": "RESULT: WB-F344 cells rarely express CXCR4 under conventional circumstance, but this receptor can be up-regulated when the culture medium contain a modest amount of TGF-beta1 (the rate of CXCR4 positive cell increased by 39.5%).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 May 01"
                    },
                    "PMID:24880985": {
                      "sentence": "There is conflicting data regarding the role of the transforming growth factor beta receptor 1 polymorphism 6A (TGFBR1*6A) in the increased incidence of CRC.",
                      "object score": 875,
                      "subject score": 875,
                      "publication date": "2014 Dec"
                    },
                    "PMID:25110237": {
                      "sentence": "Aggressively prophylactic David procedure may be not necessary at a smaller aortic size in familial TAAD patients with TGFBR1 mutation and further observation is warranted.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2014 Nov"
                    },
                    "PMID:25715477": {
                      "sentence": "[Examination of structural changes in the transforming growth factor beta receptor 1 (TGFbetaR1) gene in patients with chronic heart failure].",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2014 May"
                    },
                    "PMID:25856002": {
                      "sentence": "A case-control study comprising 2012 hypertension cases and 2210 controls was used to generate the hypothesis of the association of TGFBRAP1 gene with EH and another case-control study in a children population then proceeds to further replicate the association.",
                      "object score": 793,
                      "subject score": 793,
                      "publication date": "2015"
                    },
                    "PMID:26091707": {
                      "sentence": "METHODS: The levels of TGF-beta1 protein, of its receptors (TGFBR1 and TGFBR2), of Smad2/3 (canonical signaling pathway protein) and of p21 (cell cycle protein) were assessed in ovarian tissues, epithelial ovarian cancer cell lines (A2780) and control cell lines (HOSE) through the use of immunohistochemistry and immunocytochemistry.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2016 Jan"
                    },
                    "PMID:26202915": {
                      "sentence": "WHAT IS KNOWN ALREADY: TGF-beta1 and its receptors are expressed in human granulosa cells, and follicular fluid contains TGF-beta1 protein.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2015 Sep"
                    },
                    "PMID:28826664": {
                      "sentence": "Our recent studies suggested an important pathophysiologic role for reduced TGF-beta receptor 1 (TGFbetaR1) signaling in mesenchymal stem cells (MSCs) and their mesenchymal fibroblast progeny in the development of interstitial fibrosis.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2017 Oct"
                    },
                    "PMID:29588073": {
                      "sentence": "The TGFBR1 protein level was significantly elevated in C2C12 cells treated with TGF-beta1.",
                      "object score": 693,
                      "subject score": 693,
                      "publication date": "2018 May"
                    },
                    "PMID:29998113": {
                      "sentence": "The gene-based tests also pointed to TGFBR1 to be associated with suicide severity (p = 0.0001).",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2018 Jun"
                    },
                    "PMID:30100246": {
                      "sentence": "Controlled inhibition of TbetaRI signaling and concomitant PGE2 stimulation has the potential to promote beige adipogenesis and improve metabolism.",
                      "object score": 875,
                      "subject score": 875,
                      "publication date": "2018 Oct"
                    },
                    "PMID:30115383": {
                      "sentence": "Subsequently, transforming growth factor beta receptor 1 (TGFBR1) was certified as a direct target of miR-140-5p and enforcing SBF2-AS1 expression elevated TGFBR1 expression in HCC.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2018 Sep 18"
                    },
                    "PMID:30294794": {
                      "sentence": "Furthermore, the effects of BaP and CsA were evaluated regarding the crosstalk of AhR, NFAT1 and TGF-beta receptor 1 signaling.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2018 Oct 07"
                    },
                    "PMID:30298006": {
                      "sentence": "Collectively, these data demonstrated that luteolin might inhibit VSMC proliferation and migration by suppressing TGFBR1 signaling.",
                      "object score": 868,
                      "subject score": 868,
                      "publication date": "2018"
                    },
                    "PMID:30471101": {
                      "sentence": "In addition, we found that the expression levels of miRNA-1 significantly affected the expression of histone deacetylase 4 ( HDAC4), and miRNA-133 affected serum response factor ( SRF) and transforming growth factor beta receptor 1 ( TGFBR1) levels.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2018 Nov 23"
                    },
                    "PMID:30513140": {
                      "sentence": "Multiple self-healing squamous epithelioma (MSSE, Ferguson-Smith disease) and Loeys-Dietz syndrome (LDS) are allelic conditions associated with pathogenic variants in the transforming growth factor beta receptor 1 gene (TGFBR1).",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2018 Dec 04"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0597357-biolink:has_part-UniProtKB:P61812": {
              "object": "UniProtKB:P61812",
              "subject": "UMLS:C0597357",
              "predicate": "biolink:has_part",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0079441---SEMMEDDB:part_of---UMLS:C0597357---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16885183",
                    "PMID:24284203",
                    "PMID:22095581",
                    "PMID:19604562",
                    "PMID:24713395",
                    "PMID:12110407",
                    "PMID:1730634",
                    "PMID:27763636",
                    "PMID:25443138",
                    "PMID:17692120",
                    "PMID:21324918",
                    "PMID:26730954"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1730634": {
                      "sentence": "Saturation of the type I receptor with native TGF-beta 2 induces a 7-fold increase in binding of radiolabeled TGF-beta 1 at the type II protein.",
                      "object score": 1000,
                      "subject score": 938,
                      "publication date": "1992 Jan 15"
                    },
                    "PMID:12110407": {
                      "sentence": "Based on chromosomal localization to 3p22-24.1, the transforming growth factor-beta receptor 2 gene and the parathyroid hormone/parathyroid hormone-related peptide receptor were tested, but were excluded as being associated with the phenotype.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2002 Jul"
                    },
                    "PMID:16885183": {
                      "sentence": "OBJECTIVES: To describe the clinical findings and natural history in 22 carriers of an R460H mutation in the transforming growth factor beta receptor 2 gene (TGFbetaR2) from a five-generation kindred ascertained by familial aortic dissection.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2006 Dec"
                    },
                    "PMID:17692120": {
                      "sentence": "Stromal TGF-beta receptor 2 expression was an independent prognostic factor for cancer related survival.",
                      "object score": 860,
                      "subject score": 860,
                      "publication date": "2007 Aug 10"
                    },
                    "PMID:19604562": {
                      "sentence": "TGF-beta receptor 1 mRNA expression in the plaques was significantly different between the EMDT and therapy-naive patients (P = .023), but no difference was found for TGF-beta receptor 2 mRNA (P = .292).",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2009 Sep"
                    },
                    "PMID:21324918": {
                      "sentence": "Familial aortic aneurysm and dissection due to transforming growth factor-beta receptor 2 mutation.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2011 May"
                    },
                    "PMID:22095581": {
                      "sentence": "Low bone mass and high material bone density in two patients with Loeys-Dietz syndrome caused by transforming growth factor beta receptor 2 mutations.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2012 Mar"
                    },
                    "PMID:24284203": {
                      "sentence": "CCAAT/enhancer binding protein-mediated regulation of TGFbeta receptor 2 expression determines the hepatoblast fate decision.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2014 Jan"
                    },
                    "PMID:24713395": {
                      "sentence": "We demonstrated that phenotypically different cellular constituents of uterine fibroids differentially express cellular RA-binding protein 2 (CRABP2), progesterone receptor B (PRB) and TGFB receptor 2 mRNA in fibroid-derived cells of VSMC and SMC phenotype.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "2014 May"
                    },
                    "PMID:25443138": {
                      "sentence": "Moreover, repressed expression of miR-19a increased SMAD3 phosphorylation through TGF-beta receptor 2 signaling and abrogated BEC proliferation.",
                      "object score": 875,
                      "subject score": 875,
                      "publication date": "2015 Feb"
                    },
                    "PMID:26730954": {
                      "sentence": "TGF-beta1 down-regulated TGF-beta1 and TGF-beta receptor (R) 1 and receptor (R) 2 gene expression, while PDGF selectively down-regulated TGF-beta receptor 2 gene expression.",
                      "object score": 864,
                      "subject score": 864,
                      "publication date": "2016"
                    },
                    "PMID:27763636": {
                      "sentence": "ZNF32 contributes to the induction of multidrug resistance by regulating TGF-beta receptor 2 signaling in lung adenocarcinoma.",
                      "object score": 875,
                      "subject score": 875,
                      "publication date": "2016 10 20"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UBERON:0000178-biolink:has_part-UniProtKB:P04040": {
              "object": "UniProtKB:P04040",
              "subject": "UBERON:0000178",
              "predicate": "biolink:has_part",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C1413138---SEMMEDDB:part_of---UMLS:C0005767---SEMMEDDB:",
                    "UMLS:C0007367---SEMMEDDB:part_of---UMLS:C0005767---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:13049413",
                    "PMID:13878447",
                    "PMID:13522436",
                    "PMID:15442046",
                    "PMID:1121782",
                    "PMID:25726767",
                    "PMID:13979494",
                    "PMID:11182520",
                    "PMID:19867358",
                    "PMID:12094909",
                    "PMID:4778664",
                    "PMID:21947853",
                    "PMID:25214274",
                    "PMID:14878870",
                    "PMID:13041890",
                    "PMID:377685",
                    "PMID:14472028",
                    "PMID:13573404",
                    "PMID:11315162",
                    "PMID:4374976"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:111418": {
                      "sentence": "[Clinical evaluation of blood catalase and carbonic anhydrase activity in rheumatism in children].",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1979 Apr-Jun"
                    },
                    "PMID:377685": {
                      "sentence": "Normal blood catalase levels were achieved permanently in congenitally acatalasemic mice by transplantation of bone marrow cells from congeneic normal catalasemic mice using relatively small numbers of cells following whole body irradiation.",
                      "object score": 833,
                      "subject score": 833,
                      "publication date": "1979 Mar"
                    },
                    "PMID:726679": {
                      "sentence": "Blood catalase as an index of dietary protein quality.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1978 Oct"
                    },
                    "PMID:945750": {
                      "sentence": "In compound II of horse radish peroxidase and horse blood catalase, and in the enzyme-substrate complex of cytochrome c peroxidase, this band appears at 1587-1590 cm-1 and indicates the iron atom is now in-plane with the porphyrin ring.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1976 May 20"
                    },
                    "PMID:1121782": {
                      "sentence": "[Blood catalase in acute pneumonias in mature and premature infants in the neonatal period].",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1975 Mar"
                    },
                    "PMID:2093192": {
                      "sentence": "These results indicated that the formation of methemoglobin from hemoglobin with nitrogen monoxide, nitrogen dioxide and nitrite ion appears to be controlled by the blood catalase.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1990"
                    },
                    "PMID:2823214": {
                      "sentence": "The chromosomic micro-deletion can be shown by using highly sophisticated cytogenetic techniques, or suspected by blood enzymatic dosage (mainly catalase).",
                      "object score": 828,
                      "subject score": 861,
                      "publication date": "1987"
                    },
                    "PMID:4055607": {
                      "sentence": "After 21 wk, trained animals, regardless of drug status, had elevated blood CAT and SOD activity and increased liver CAT and GP.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1985 Oct"
                    },
                    "PMID:4183875": {
                      "sentence": "[Method of simultaneous color development of catalase and hemoglobin of blood on paper].",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1967"
                    },
                    "PMID:5127856": {
                      "sentence": "Heat and urea stability of blood catalase of catalase-mutant mouse strains.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1971 Oct 15"
                    },
                    "PMID:5707677": {
                      "sentence": "Nature of the heterozygote blood catalase in a hypocatalasemic mouse mutant.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1968 Jan"
                    },
                    "PMID:5880963": {
                      "sentence": "[Changes in blood catalase levels following muscular effort].",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1965"
                    },
                    "PMID:5977985": {
                      "sentence": "[On blood catalase, its participation in oxybiotic processes and significance in the evaluation of efficiency in sports].",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1966 Dec 29"
                    },
                    "PMID:6066242": {
                      "sentence": "Comparative heat stability of blood catalase.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1967 Nov"
                    },
                    "PMID:8351792": {
                      "sentence": "No significant differences in erythrocyte superoxide dismutase, blood catalase and serum-lipid peroxide occurred from the PQ dosing; however, lung lipid peroxide increased 4-fold.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1993 Jun"
                    },
                    "PMID:9101552": {
                      "sentence": "Extract feeding caused an accumulation of carotenoids in the liver, a substantial decrease in spontaneous erythrocyte hemolysis, and lowered plasma glutathione, blood superoxide dismutase, and blood catalase.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1997"
                    },
                    "PMID:9187503": {
                      "sentence": "The decrease of blood catalase with age was greater in males (b = -0.084 MU/l year) than in females (b = -0.016 MU/l year).",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1997 May 06"
                    },
                    "PMID:24338155": {
                      "sentence": "Stored in cold environment, blood catalase was accumulated; however, obvious changes were not found in the liver.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2014 Jun"
                    },
                    "PMID:24766461": {
                      "sentence": "We found lower blood catalase and glutathione peroxidase activity to be correlated with lower iron and selenium respectively.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2014 Aug"
                    },
                    "PMID:25214274": {
                      "sentence": "Activity of blood catalase increased and activity of blood SOD decreased with increasing severity of psoriasis.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2014 Jul-Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:treats-CHEMBL.TARGET:CHEMBL376": {
              "object": "CHEMBL.TARGET:CHEMBL376",
              "subject": "CHEBI:35457",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:treats---UMLS:C0034693---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10435026",
                    "PMID:10666082",
                    "PMID:10818079",
                    "PMID:11126403",
                    "PMID:11408382",
                    "PMID:10076921",
                    "PMID:10898446",
                    "PMID:11729225",
                    "PMID:10997692",
                    "PMID:10602319",
                    "PMID:10604539",
                    "PMID:11340236",
                    "PMID:10082499",
                    "PMID:11566913",
                    "PMID:11300648",
                    "PMID:11040239",
                    "PMID:10567852",
                    "PMID:10469358",
                    "PMID:11230997",
                    "PMID:10703899"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:41720": {
                      "sentence": "The following evidence indicates that the rebound increase in blood pressure was due to increased activity of the renin-angiotensin system: (1) plasma renin activity was increased approximately four-fold by SNP, (2) rebound did not occur in nephrectomized rats, (3) rebound was markedly attenuated in animals treated with an angiotensin converting enzyme inhibitor, SQ14225, (D-3-mercapto-2-methylpropanoyl-L-proline) and (4) beta-adrenergic receptor blockade with propranolol reduced the rebound response.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1979 Oct 01"
                    },
                    "PMID:223615": {
                      "sentence": "1 Prolonged infusion (11 h) of both saralasin and angiotensin-converting enzyme inhibitor (SQ20881) gradually lowered BP in two-kidney hypertensive rats to levels similar to that in normotensive rats infused with dextrose.",
                      "object score": 833,
                      "subject score": 1000,
                      "publication date": "1979"
                    },
                    "PMID:8436803": {
                      "sentence": "In conscious 14-week-old male sympathectomized (guanethidine at 1-13 weeks of age) and sinoaortic denervated (2 weeks before study) rats, arterial pressure was recorded beat-to-beat during 30-min consecutive periods; control; ganglionic blockade in sinoaortic denervated rats and angiotensin converting enzyme inhibition plus vasopressin antagonism in sympathectomized rats; and restoration of the initial arterial pressure with continuous infusions of phenylephrine and angiotensin II.",
                      "object score": 861,
                      "subject score": 843,
                      "publication date": "1993 Jan"
                    },
                    "PMID:8922744": {
                      "sentence": "Concurrent administration of an ACE inhibitor reduces the early renal response to E-24.11 inhibition in the A-V fistula rat, an effect attributable to the hypotensive action of this combination.",
                      "object score": 750,
                      "subject score": 1000,
                      "publication date": "1996 Nov"
                    },
                    "PMID:8951569": {
                      "sentence": "Recently, others have used the rat MI model to study the effects of 2-weeks' of GH started at 4-weeks' post-MI, as well as IGF/GH for 2-weeks in rats treated with an ACE inhibitor for 3-month's post-MI.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Dec"
                    },
                    "PMID:9021525": {
                      "sentence": "The nephrectomized rats were treated with ACEI (enalapril 100 mg/l), AIIRA (L-158,809 10 mg/l) or TRX (reserpine 5 mg/ l, hydralazine 80 mg/l, and hydrochlorothiazide 25 mg/l) and euthanized at 16 weeks after renal ablation.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1997"
                    },
                    "PMID:9109437": {
                      "sentence": "Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Apr 15"
                    },
                    "PMID:9151293": {
                      "sentence": "Lisinopril (10(-5) M), and angiotensin-converting enzyme inhibitor, increased the duration of the hyperalgesia elicited in normal rats.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997 May"
                    },
                    "PMID:9362308": {
                      "sentence": "Neonatal treatment of rats with angiotensin-converting enzyme inhibitors or the angiotensin II type 1 receptor antagonist losartan induces irreversible renal histological abnormalities, mainly papillary atrophy, in association with an impairment in urinary concentrating ability.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Oct"
                    },
                    "PMID:9421286": {
                      "sentence": "The effect of systemic administration of the nitric oxide synthase inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME) on the antihypertensive effects of the angiotensin AT1 receptor antagonist, GR138950, the angiotensin-converting enzyme (ACE) inhibitor, enalapril, or hydralazine has been evaluated in unrestrained, conscious renal artery ligated hypertensive (RALH) rats.",
                      "object score": 723,
                      "subject score": 1000,
                      "publication date": "1997 Dec"
                    },
                    "PMID:9523172": {
                      "sentence": "Beneficial effect of the long-term treatment with the combination of an ACE inhibitor and a calcium channel blocker on renal injury in rats with 5/6 nephrectomy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jan-Feb"
                    },
                    "PMID:9554562": {
                      "sentence": "We determined the effect of losartan (Los), a specific Ang-II receptor antagonist, and compared its effect to that of enalapril (En), an ACEI, on DPA-induced increase in U(alb)V in rats with passive Heymann nephritis (HN).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:19940035": {
                      "sentence": "Adult male Sprague-Dawley rats were randomized into three groups: untreated uninephrectomized (UNX) rats, UNX rats treated with an angiotensin-converting enzyme inhibitor (ACEI), lisinopril, and sham-operated rats.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2010 Feb"
                    },
                    "PMID:19952417": {
                      "sentence": "Combination therapy with SMP-534 and an angiotensin-converting enzyme inhibitor provides additional renoprotection in 5/6 nephrectomized rats.",
                      "object score": 791,
                      "subject score": 1000,
                      "publication date": "2009 Dec"
                    },
                    "PMID:23489008": {
                      "sentence": "We investigated the effect of etoricoxib, a selective COX-2 inhibitor on the antihypertensive efficacy of atenolol; beta-blocker, ramipril; angiotensin converting enzyme inhibitor and telmisartan; angiotensin receptor blocker in deoxycorticosterone acetate (DOCA)-salt hypertensive rats, a mineralocorticoid volume expansion model.",
                      "object score": 840,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:23586864": {
                      "sentence": "Protective effects of enalapril, an angiotensin-converting enzyme inhibitor, on multiple organ damage following scald injury in rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jul-Aug"
                    },
                    "PMID:23674974": {
                      "sentence": "The ACE inhibitors and ROS scavengers treatment regimens for studied rats in addition to significantly lowering their systolic blood pressure and urinary protein excretion values to normal levels, have significantly increased their in vitro hydraulic and Darcy permeability, which is a measure of the intrinsic hydraulic conductance of the GBM, either in the absence or presence of albumin; in comparison with control animals.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2006 Jun"
                    },
                    "PMID:24450223": {
                      "sentence": "[Effect of angiotensin-converting enzyme inhibitors, beta-adrenoblockers, and their combinations on survival and plasma catecholamine levels in rats with chronic heart failure with induced exacerbations].",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:24637920": {
                      "sentence": "Increased renal SDF-1 expression was, however, observed following the treatment of SNx rats with the ACE inhibitor, perindopril.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2014"
                    },
                    "PMID:25144992": {
                      "sentence": "The rats with UUO were treated with ACE inhibitor (cilazapril) or AT1 receptor antagonists (losartan) and control group was treated with H2O.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jun"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q9BYF1-biolink:has_part-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "UniProtKB:Q9BYF1",
              "predicate": "biolink:has_part",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:affects-FMA:81101": {
              "object": "FMA:81101",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:DOID:0080685-biolink:manifestation_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "DOID:0080685",
              "predicate": "biolink:manifestation_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU017249---OMIM:manifestation_of---OMIM:154700---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0001210-biolink:manifestation_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0001210",
              "predicate": "biolink:manifestation_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU036831---OMIM:manifestation_of---OMIM:154700---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0001298-biolink:manifestation_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0001298",
              "predicate": "biolink:manifestation_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU008431---OMIM:manifestation_of---OMIM:154700---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0001384-biolink:manifestation_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0001384",
              "predicate": "biolink:manifestation_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU036427---OMIM:manifestation_of---OMIM:154700---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0002076-biolink:manifestation_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0002076",
              "predicate": "biolink:manifestation_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU016219---OMIM:manifestation_of---OMIM:154700---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0004910-biolink:manifestation_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0004910",
              "predicate": "biolink:manifestation_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU001468---OMIM:manifestation_of---OMIM:154700---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0005009-biolink:manifestation_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0005009",
              "predicate": "biolink:manifestation_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU005753---OMIM:manifestation_of---OMIM:154700---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0005392-biolink:manifestation_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0005392",
              "predicate": "biolink:manifestation_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU000036---OMIM:manifestation_of---OMIM:154700---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0005648-biolink:manifestation_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0005648",
              "predicate": "biolink:manifestation_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003504---SEMMEDDB:manifestation_of---UMLS:C0024796---SEMMEDDB:",
                    "OMIM:MTHU001469---OMIM:manifestation_of---OMIM:154700---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1925352"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1925352": {
                      "sentence": "These aneurysms complicate the infra-renal terminal atherosclerosis of smokers or the parietal elastic dystrophy of the ascending aorta, where a few subjects in their twenties with Marfan's disease join the older men, and which clinically presents as severe aortic incompetence.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1991 Sep 01"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0008213-biolink:manifestation_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0008213",
              "predicate": "biolink:manifestation_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU000191---OMIM:manifestation_of---OMIM:154700---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MONDO:0008375-biolink:manifestation_of-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "MONDO:0008375",
              "predicate": "biolink:manifestation_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU000607---OMIM:manifestation_of---OMIM:154700---umls_source:OMIM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:treats-CHEMBL.TARGET:CHEMBL376": {
              "object": "CHEMBL.TARGET:CHEMBL376",
              "subject": "VANDF:4021566",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:treats---UMLS:C0034693---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11435024",
                    "PMID:11742591",
                    "PMID:10084375",
                    "PMID:11675952",
                    "PMID:10509387",
                    "PMID:1406299",
                    "PMID:1347964",
                    "PMID:14633142",
                    "PMID:1459596",
                    "PMID:11932068",
                    "PMID:10845190",
                    "PMID:11495288",
                    "PMID:12840599",
                    "PMID:1450930",
                    "PMID:15061647",
                    "PMID:12013484",
                    "PMID:15581678",
                    "PMID:1436130",
                    "PMID:10330709",
                    "PMID:1280733"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:224248": {
                      "sentence": "Effect of calcium antagonist on glucose-induced insulin and glucagon secretion in rats with insulin-secreting tumors induced by streptozotocin and nicotinamide.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1979 Jun"
                    },
                    "PMID:343251": {
                      "sentence": "Calcium, other divalent cations, and calcium antagonists were tested for their ability to alter ethanol-induced sleeping time, hypothermia, and behavioral intoxication in mice and rats.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1978 Mar 17"
                    },
                    "PMID:1280733": {
                      "sentence": "Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.",
                      "object score": 851,
                      "subject score": 901,
                      "publication date": "1992"
                    },
                    "PMID:2094542": {
                      "sentence": "Antinociceptive effects of calcium channel blockers in the rat.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:2124469": {
                      "sentence": "To test the possibility that calcium antagonists affect extracellular fluid partition between plasma and interstitium, we compared the effects of a benzothiazepine derivate diltiazem, a dihydropyridine derivate nicardipine and vehicle in binephrectomized anesthetized rats by measuring changes in hematocrit and plasma protein concentration.",
                      "object score": 827,
                      "subject score": 983,
                      "publication date": "1990 Jul"
                    },
                    "PMID:8480573": {
                      "sentence": "Aggravation of left ventricular dilatation and reduction of survival by a calcium channel blocker in rats with chronic myocardial infarction.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 May"
                    },
                    "PMID:8500844": {
                      "sentence": "Lipid lowering effect of calcium antagonists is well documented in high fat fed rats and in hypertensive patients.",
                      "object score": 825,
                      "subject score": 983,
                      "publication date": "1993 Mar"
                    },
                    "PMID:8658552": {
                      "sentence": "Reversal of acute theophylline toxicity by calcium channel blockers in dogs and rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jun 17"
                    },
                    "PMID:8707372": {
                      "sentence": "Effects of calcium channel blockers were investigated on withdrawal signs in lorazepam dependent rats.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1996 Jun"
                    },
                    "PMID:8726828": {
                      "sentence": "It is possible that the vascular responses to calcium antagonists are altered in portal vein-ligated rats.",
                      "object score": 824,
                      "subject score": 983,
                      "publication date": "1996 Jun"
                    },
                    "PMID:8738803": {
                      "sentence": "This study examined the effects of angiotensin II Type 1 (AT1) receptor antagonists and calcium antagonists on glomerular phenotypic changes in rats with subtotal renal ablation.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1996 May"
                    },
                    "PMID:9055098": {
                      "sentence": "Effect of antiepileptic drugs and calcium channel blocker on hyperthermic seizures in rats: animal model for hot water epilepsy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Oct"
                    },
                    "PMID:9062805": {
                      "sentence": "DOCA-saline hypertensive rats chronically treated with various CCBs showed variable responses to H and 5-HT suggesting that these changes may be due to different isoforms of L-type calcium channels.",
                      "object score": 833,
                      "subject score": 923,
                      "publication date": "1996 Apr"
                    },
                    "PMID:9460592": {
                      "sentence": "[Comparison of the tocolytic and hemodynamic effects of calcium channel blockers in pregnant rats].",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1997 Nov-Dec"
                    },
                    "PMID:9523172": {
                      "sentence": "Beneficial effect of the long-term treatment with the combination of an ACE inhibitor and a calcium channel blocker on renal injury in rats with 5/6 nephrectomy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jan-Feb"
                    },
                    "PMID:9570719": {
                      "sentence": "Dose-finding study with nimodipine: a selective central nervous system calcium channel blocker on aminophylline induced seizure models in rats.",
                      "object score": 1000,
                      "subject score": 843,
                      "publication date": "1998 Mar 15"
                    },
                    "PMID:23105255": {
                      "sentence": "In the present study effects of five commonly used calcium channel blockers (CCBs) belonging to different chemical classes have been investigated on stress-induced modulation of some visceral, endocrinological and immunological parameters in rats and mice.",
                      "object score": 1000,
                      "subject score": 793,
                      "publication date": "2000 Jul"
                    },
                    "PMID:23206755": {
                      "sentence": "Recently, we reported that calcium channel blockers prevent the oxaliplatin-induced cold hyperalgesia in rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Feb"
                    },
                    "PMID:23823933": {
                      "sentence": "The in vivo effectiveness of 4-dihydropyridine (bis-1,4-DHP), a new calcium-channel blocker, as a nephroprotector in isolated perfused kidney was evaluated by determining its effects on parameters associated with renal injury in diabetic rats.",
                      "object score": 888,
                      "subject score": 916,
                      "publication date": "2013"
                    },
                    "PMID:24220874": {
                      "sentence": "In the carbon tetrachloride (CCl4) model, rats were pretreated with CCBs and prednisolone for 7 days before inducing nephrotoxicity with 20% CCl4 (1.5 ml kg(-1)).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D000375-biolink:has_participant-UniProtKB:P10600": {
              "object": "UniProtKB:P10600",
              "subject": "MESH:D000375",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P10600---GO:involved_in---GO:0007568---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "GO_REF:0000107"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D000375-biolink:has_participant-UniProtKB:P37173": {
              "object": "UniProtKB:P37173",
              "subject": "MESH:D000375",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P37173---GO:involved_in---GO:0007568---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "GO_REF:0000107"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D013091-biolink:has_participant-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "MESH:D013091",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P12821---GO:involved_in---GO:0007283---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "GO_REF:0000024"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D014664-biolink:has_participant-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "MESH:D014664",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C40867---NCIT:process_involves_gene---NCIT:C91295---umls_source:NCI"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D014664-biolink:has_participant-UniProtKB:P50052": {
              "object": "UniProtKB:P50052",
              "subject": "MESH:D014664",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P50052---GO:involved_in---GO:0042311---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15117835"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P02452": {
              "object": "UniProtKB:P02452",
              "subject": "MESH:D014945",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P02452---GO:involved_in---GO:0042060---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "GO_REF:0000107"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P02461": {
              "object": "UniProtKB:P02461",
              "subject": "MESH:D014945",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P02461---GO:involved_in---GO:0042060---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1466622"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P10600": {
              "object": "UniProtKB:P10600",
              "subject": "MESH:D014945",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P10600---GO:involved_in---GO:0042060---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "GO_REF:0000107"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P36897": {
              "object": "UniProtKB:P36897",
              "subject": "MESH:D014945",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P36897---GO:involved_in---GO:0042060---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9759503"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P37173": {
              "object": "UniProtKB:P37173",
              "subject": "MESH:D014945",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P37173---GO:involved_in---GO:0042060---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "GO_REF:0000107"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P61812": {
              "object": "UniProtKB:P61812",
              "subject": "MESH:D014945",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P61812---GO:involved_in---GO:0042060---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "GO_REF:0000024"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "MESH:D014945",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P84022---GO:involved_in---GO:0042060---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19018011"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D014945-biolink:has_participant-UniProtKB:Q15796": {
              "object": "UniProtKB:Q15796",
              "subject": "MESH:D014945",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:Q15796---GO:involved_in---GO:0042060---identifiers_org_registry:goa"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "GO_REF:0000107"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:goa",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:MESH:D015539-biolink:has_participant-UniProtKB:P02461": {
              "object": "UniProtKB:P02461",
              "subject": "MESH:D015539",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P02461---GO:involved_in---GO:0030168---identifiers_org_registry:goa",
                    "NCIT:C40854---NCIT:process_involves_gene---NCIT:C143052---umls_source:NCI"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9573018"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q9BYF1-biolink:subclass_of-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "UniProtKB:Q9BYF1",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0302600-biolink:has_participant-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "UMLS:C0302600",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C20425---NCIT:gene_product_plays_role_in_biological_process---NCIT:C17932---umls_source:NCI",
                    "NCIT:C24359---NCIT:gene_plays_role_in_process---NCIT:C17932---umls_source:NCI"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0302600-biolink:has_participant-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "UMLS:C0302600",
              "predicate": "biolink:has_participant",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C17932---NCIT:process_involves_gene---NCIT:C26514---umls_source:NCI"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-FMA:67243": {
              "object": "FMA:67243",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-FMA:83365": {
              "object": "FMA:83365",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:physically_interacts_with-FMA:61799": {
              "object": "FMA:61799",
              "subject": "CHEBI:35530",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:interacts_with---UMLS:C0028351---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:6728124",
                    "PMID:7806548",
                    "PMID:986322",
                    "PMID:6251200",
                    "PMID:6759143",
                    "PMID:19282",
                    "PMID:21419838",
                    "PMID:2858957",
                    "PMID:5591515",
                    "PMID:1199813",
                    "PMID:2897867",
                    "PMID:10731686",
                    "PMID:6339540"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:19282": {
                      "sentence": "Effects of alpha- and beta-adrenergic blockers on the actions of noradrenaline on body temperature in the newborn guinea-pig.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1977 Aug 15"
                    },
                    "PMID:986322": {
                      "sentence": "Propranolol, a beta-blocker, slightly (less than 10%) potentiated the stimulatory effects of NE and EPI.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1976 Aug"
                    },
                    "PMID:1199813": {
                      "sentence": "Treatment with alprenolol, a beta-adrenergic blocking agent, did not influence noradrenaline and adrenaline in plasma in the basal state or the urinary excretion of the three catecholamines.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1975 Nov"
                    },
                    "PMID:2858957": {
                      "sentence": "The effect of systemically applied NA could be blocked by systemically applied beta-adrenergic receptor blockers, while beta-blockers administered centrally or alpha-adrenergic blockers injected systemically or centrally had no effect on the action of systemically applied NA.",
                      "object score": 827,
                      "subject score": 1000,
                      "publication date": "1985"
                    },
                    "PMID:2897867": {
                      "sentence": "The enhancement by NA of the glutamate or aspartate response was blocked by beta-adrenergic antagonists, propranolol or pindolol, and extracellularly applied cAMP mimicked the NA action.",
                      "object score": 694,
                      "subject score": 988,
                      "publication date": "1988 May 17"
                    },
                    "PMID:5591515": {
                      "sentence": "Effect of beta adrenergic blocking agents on the noradrenaline content of rat heart before and after noradrenaline infusion.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1967 Dec"
                    },
                    "PMID:6251200": {
                      "sentence": "Phentolamine (10 microM), an alpha-blocker, but not MJ-1999 (10 microM), a beta-blocker, antagonized the action of noradrenaline.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1980 Apr"
                    },
                    "PMID:6339540": {
                      "sentence": "Neither of the two beta-blockers influenced the concentrations of glucagon, norepinephrine, and PRL.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1983 May"
                    },
                    "PMID:6728124": {
                      "sentence": "Timolol, a beta-adrenergic antagonist, blocked the excitatory action of NA, but did not modify either the effect of DA or the inhibition induced by NA.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1984 Mar"
                    },
                    "PMID:6759143": {
                      "sentence": "Neither acute intravenous nor chronic oral administration of the beta-blocker affected the resting plasma levels of noradrenaline and adrenaline.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1982"
                    },
                    "PMID:7806548": {
                      "sentence": "The norepinephrine effect could be blocked by both alpha 1- and beta-adrenergic antagonists.",
                      "object score": 888,
                      "subject score": 988,
                      "publication date": "1994 Dec 30"
                    },
                    "PMID:10731686": {
                      "sentence": "The stimulatory effect of NE was inhibited by the combined use of alpha- and beta-adrenergic antagonists.",
                      "object score": 1000,
                      "subject score": 988,
                      "publication date": "2000 Feb"
                    },
                    "PMID:21419838": {
                      "sentence": "Phentolamine, an alpha-adrenergic receptor antagonist, negated the effects of NE on conjugation more strongly than propranolol, a beta-adrenergic receptor antagonist.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "2011 Jul-Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:physically_interacts_with-FMA:67243": {
              "object": "FMA:67243",
              "subject": "CHEBI:35530",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:interacts_with---UMLS:C0014563---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15070161",
                    "PMID:9226135",
                    "PMID:986322",
                    "PMID:21043971",
                    "PMID:6148865",
                    "PMID:6759143",
                    "PMID:4380204",
                    "PMID:1190340",
                    "PMID:8934951",
                    "PMID:1199813",
                    "PMID:33189",
                    "PMID:2871760",
                    "PMID:7911769",
                    "PMID:12518920"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:33189": {
                      "sentence": "Propranolol, a beta-adrenergic blocking agent which inhibits epinephrine action, blocks both the epinephrine-stimulated phosphorylation and the inactivation of the carboxylase.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1979 Mar 10"
                    },
                    "PMID:986322": {
                      "sentence": "Propranolol, a beta-blocker, slightly (less than 10%) potentiated the stimulatory effects of NE and EPI.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1976 Aug"
                    },
                    "PMID:1190340": {
                      "sentence": "Both actions of epinephrine were partly inhibited by either an alpha or beta blocker and completely abolished by combination of both blockers in normal rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1975 Oct"
                    },
                    "PMID:1199813": {
                      "sentence": "Treatment with alprenolol, a beta-adrenergic blocking agent, did not influence noradrenaline and adrenaline in plasma in the basal state or the urinary excretion of the three catecholamines.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1975 Nov"
                    },
                    "PMID:2871760": {
                      "sentence": "However, the inhibition pattern of the epinephrine effect by a beta-adrenergic antagonist, 1-propranolol, and the characteristics of the secretory response observed when selectively stimulating the alpha 1- and beta-adrenergic receptors, either separately or simultaneously, suggest that 1) a simultaneous activation of both receptors is necessary to produce a maximal secretory response to catecholamines; and 2) a synergism may exist between these two routes of stimulation, leading to an amount of protein discharge higher than that expected in the case of additive effects.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1986 May"
                    },
                    "PMID:4380204": {
                      "sentence": "The effect of adrenaline on h.f.c. in skin, lung and skeletal muscle was not abolished by alpha- or beta-adrenergic blocking agents either injected separately or together before the injection of adrenaline.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1966 Mar"
                    },
                    "PMID:6148865": {
                      "sentence": "Recent studies, however, have suggested that the use of a nonselective beta blocker may be desirable to antagonize some beta-2-mediated metabolic effects, such as hypokalemia, induced by epinephrine.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1984 Oct"
                    },
                    "PMID:6759143": {
                      "sentence": "Neither acute intravenous nor chronic oral administration of the beta-blocker affected the resting plasma levels of noradrenaline and adrenaline.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1982"
                    },
                    "PMID:7911769": {
                      "sentence": "Epinephrine interactions with beta-blockers.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1994 Jan-Feb"
                    },
                    "PMID:8934951": {
                      "sentence": "If epinephrine-containing local anesthetics are administered to such patients, interactions between epinephrine and the beta-blocking agent may induce cardiovascular complications.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995"
                    },
                    "PMID:9226135": {
                      "sentence": "Moreover, the effect of epinephrine on the activation of protein kinase C was inhibited by preincubation with propranolol, a beta-adrenergic antagonist.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Jun"
                    },
                    "PMID:12518920": {
                      "sentence": "The adrenaline effects were however, abolished by pretreating the animal with propranolol, a beta-adrenergic blocker.",
                      "object score": 872,
                      "subject score": 988,
                      "publication date": "2002 Mar"
                    },
                    "PMID:15070161": {
                      "sentence": "The derivatives acted as beta-adrenergic antagonists, blocking the effect of adrenaline and isoprenaline.",
                      "object score": 1000,
                      "subject score": 988,
                      "publication date": "2004 Feb"
                    },
                    "PMID:21043971": {
                      "sentence": "Ingestion of yohimbine, an alpha(2)-adrenergic antagonist, or atenolol, a beta blocker, prevented the corrective influence of epinephrine on aspirin-treated refractory platelets.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:50949-biolink:physically_interacts_with-FMA:67238": {
              "object": "FMA:67238",
              "subject": "CHEBI:50949",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0162758---SEMMEDDB:interacts_with---UMLS:C0013030---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19512977",
                    "PMID:12883138",
                    "PMID:12064644",
                    "PMID:12201648",
                    "PMID:11338177",
                    "PMID:29981749",
                    "PMID:31804922",
                    "PMID:18925655",
                    "PMID:2999402",
                    "PMID:2409454"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2409454": {
                      "sentence": "Behavioural effects on dopaminergic transmission of a phenylindane derivative, Lu 19-005 [(+/-)-trans-3-(3,4-dichlorophenyl)-N-methyl-l-indanamine, HCI], with potent inhibitory effect on dopamine (DA), noradrenaline (NA) and serotonin (5-HT) uptake in rats and the effect on DA, NA and 5-HT activity in mice have been studied and compared with those of other known DA, NA and 5-HT uptake inhibitors with different selectivity ratios.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1985 Apr"
                    },
                    "PMID:2999402": {
                      "sentence": "Finally, comparison of the structures of the 3-phenyl-1-indanamines with other newer bicyclic catecholamine- and/or serotonin-uptake inhibitors revealed common structural elements important for potent DA-, NE-, and/or 5-HT-uptake inhibition.",
                      "object score": 838,
                      "subject score": 1000,
                      "publication date": "1985 Dec"
                    },
                    "PMID:11338177": {
                      "sentence": "We investigated the effect of fluoxetine, a selective serotonin reuptake inhibitor (SSRI), on L-DOPA-derived extracellular dopamine (DA) levels in the striatum of rats with nigrostriatal dopaminergic denervation using in vivo microdialysis.",
                      "object score": 827,
                      "subject score": 923,
                      "publication date": "2001 May 08"
                    },
                    "PMID:12064644": {
                      "sentence": "It is a highly selective serotonin reuptake inhibitor that appears to have little effect on noradrenaline or dopamine reuptake.",
                      "object score": 888,
                      "subject score": 884,
                      "publication date": "2002 Jan"
                    },
                    "PMID:12201648": {
                      "sentence": "Numerous factors should be considered when prescribing medications from an ever-growing antidepressant armamentarium, including selective serotonin-reuptake inhibitors, serotonin norepinephrine-reuptake inhibitors, serotonin antagonist-reuptake inhibitors, norepinephrine dopamine modulators, monoamine oxidase inhibitors, reversible inhibitors of monoamine oxidase type A, tricyclic antidepressants, and psychostimulants.",
                      "object score": 623,
                      "subject score": 923,
                      "publication date": "2002 Aug"
                    },
                    "PMID:12883138": {
                      "sentence": "However, 40 to 60 percent of patients with obsessive-compulsive disorder do not respond to adequate treatment trials with SRIs, and agents that alter serotonin receptors and other neurotransmitter systems, such as dopamine, norepinephrine, and second-messenger systems, may play a role in treatment.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Aug"
                    },
                    "PMID:18925655": {
                      "sentence": "Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.",
                      "object score": 853,
                      "subject score": 717,
                      "publication date": "2009 Jan"
                    },
                    "PMID:19512977": {
                      "sentence": "Selective serotonin reuptake inhibitors are the most widely prescribed antidepressants and have significant effects on arousal and orgasm compared with antidepressants that target norepinephrine, dopamine, and melatonin systems.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2009 Apr"
                    },
                    "PMID:29981749": {
                      "sentence": "However, the effect of serotonin reuptake inhibitors on dopamine levels and its consequent impact on emotional processing is unclear.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2018 Sep 05"
                    },
                    "PMID:31804922": {
                      "sentence": "Inhibitory and Stimulatory Effects of Selective Serotonin Reuptake Inhibitors on Cytochrome P450 2D6-mediated Dopamine Formation from p-Tyramine.",
                      "object score": 845,
                      "subject score": 923,
                      "publication date": "2019"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:8031-biolink:physically_interacts_with-FMA:67303": {
              "object": "FMA:67303",
              "subject": "RXNORM:8031",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0030946---SEMMEDDB:interacts_with---UMLS:C0013765---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16347395",
                    "PMID:7037851",
                    "PMID:28123132",
                    "PMID:29420065",
                    "PMID:24319016",
                    "PMID:8618042",
                    "PMID:1696313",
                    "PMID:2498122",
                    "PMID:9747347",
                    "PMID:6899953",
                    "PMID:18498520",
                    "PMID:21990366",
                    "PMID:10816468"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1696313": {
                      "sentence": "Proteolytic activity was also analysed by electrophoresis of culture medium on gelatin and elastin substrate gels.",
                      "object score": 802,
                      "subject score": 888,
                      "publication date": "1990"
                    },
                    "PMID:2498122": {
                      "sentence": "Elastase, a protease which controls the metabolism of elastin in the arterial wall, likewise reduced RV pressure, RV/LV + S, and pulmonary vascular remodeling, with a significant decrease in elastosis of the small pulmonary arteries histologically.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Jun"
                    },
                    "PMID:6899953": {
                      "sentence": "Peritoneal exudative and alveolar macrophages secrete a nonlysosomal neutral protease which hydrolyses particulate elastin suspended in agar.",
                      "object score": 888,
                      "subject score": 827,
                      "publication date": "1980 Mar-Apr"
                    },
                    "PMID:7037851": {
                      "sentence": "MUCH OF THE PROTEOLYTIC ACTIVITY OF THE BAL FLUID FROM ARDS PATIENTS WAS IDENTIFIED AS NEUTROPHIL ELASTASE: the fluids cleaved elastin and synthetic peptide substrate of neutrophil elastase, neutrophil elastase antigen was present in the BAL fluids as determined immunologically using antineutrophil elastase, alpha1-PI was the major inhibitor in plasma, and the enzyme was inhibited by diisopropylphosphofluoridate but not chelation.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1982 Mar"
                    },
                    "PMID:8618042": {
                      "sentence": "Instead, by binding to elastin, lysozyme prevented the protease from interacting with the elastin substrate in ways that normally favor proteolysis.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1996 May"
                    },
                    "PMID:9747347": {
                      "sentence": "The protease hydrolyzed casein, gelatin, elastin, collagen and hemoglobin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Nov"
                    },
                    "PMID:10816468": {
                      "sentence": "The protease hydrolyzed casein and elastin and showed a high sequence similarity to other metalloproteases, especially with the mature form of the Pseudomonas aeruginosa elastase (52% identity), Helicobacter pylori zinc metalloprotease (61% identity), or proteases from several species of Vibrio (52 to 53% identity).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Jun"
                    },
                    "PMID:16347395": {
                      "sentence": "Its enzymatic activity was that of an endopeptidase which hydrolyzed elastin, casein, and gelatin but was much less active on bovine serum albumin and collagen.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987 Jul"
                    },
                    "PMID:18498520": {
                      "sentence": "Elastin, hydrolysable with greater difficulty, was subsequently hydrolysed by commercial endopeptidase (Bacillus licheniformis), under more drastic conditions, to a product of average molecular mass M(a) = 0.448 +/- 1.514 kDa.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2002 Oct"
                    },
                    "PMID:21990366": {
                      "sentence": "Mutation of two residues around the S1 pocket of BprB to the equivalent residues in BprV dramatically enhanced its proteolytic activity against elastin substrates.",
                      "object score": 694,
                      "subject score": 888,
                      "publication date": "2011 Dec 09"
                    },
                    "PMID:24319016": {
                      "sentence": "AIMS: Cathepsin S (Cat S) is a potent lysosomal protease that is secreted into the extracellular space and has been implicated in elastin and collagen degradation in diseases such as atherosclerosis.",
                      "object score": 1000,
                      "subject score": 818,
                      "publication date": "2014 Mar 01"
                    },
                    "PMID:28123132": {
                      "sentence": "However, the protease did not detectably hydrolyze keratin or elastin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Mar 17"
                    },
                    "PMID:29420065": {
                      "sentence": "Chymotrypsin-like elastase 1 (Cela1) is a digestive protease that is expressed during lung development in association with regions of elastin remodeling, exhibits stretch-dependent expression during lung regeneration, and binds lung elastin in a stretch-dependent manner.",
                      "object score": 888,
                      "subject score": 861,
                      "publication date": "2018 08"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01106-biolink:interacts_with-UniProtKB:P53814": {
              "object": "UniProtKB:P53814",
              "subject": "UniProtKB:P01106",
              "predicate": "biolink:interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P01106---MI:0914---UniProtKB:P53814---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21150319"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:interacts_with-UniProtKB:P11047": {
              "object": "UniProtKB:P11047",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P01137---MI:0914---UniProtKB:P11047---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28514442"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P04083-biolink:interacts_with-UniProtKB:P02452": {
              "object": "UniProtKB:P02452",
              "subject": "UniProtKB:P04083",
              "predicate": "biolink:interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P04083---MI:0914---UniProtKB:P02452---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23754495"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:physically_interacts_with-CHEBI:35457": {
              "object": "CHEBI:35457",
              "subject": "CHEBI:35530",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:interacts_with---UMLS:C0003015---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12534856",
                    "PMID:23328521",
                    "PMID:30121238",
                    "PMID:29847487",
                    "PMID:27398980",
                    "PMID:21314866",
                    "PMID:17719282",
                    "PMID:14610334",
                    "PMID:31544164",
                    "PMID:11810791",
                    "PMID:30586770",
                    "PMID:16835669",
                    "PMID:11419108",
                    "PMID:11060822",
                    "PMID:22209214",
                    "PMID:27378313",
                    "PMID:30563873",
                    "PMID:19043802",
                    "PMID:15599834",
                    "PMID:16736996"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8059624": {
                      "sentence": "The favorable cardioprotective effects of angiotensin-converting enzyme inhibitors, calcium channel blockers, alpha-blockers, and alpha-beta-blockers often make them a more appropriate choice than diuretics or beta-blockers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 May-Jun"
                    },
                    "PMID:8781825": {
                      "sentence": "However, very little information exists about the direct effect of increased afterload on cardiac performance in these patients and the possible favourable effects of angiotensin-converting enzyme inhibitors as adjunctive treatment to thrombolysis, beta-blockers and nitrates.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jun"
                    },
                    "PMID:11060822": {
                      "sentence": "The nephroprotective action of conventional antihypertensive drugs, such as beta-blockers, calcium antagonists and angiotensin-converting enzyme inhibitors is briefly reviewed.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Nov"
                    },
                    "PMID:11419108": {
                      "sentence": "BACKGROUND: Until recently no morbidity-mortality study had examined the effects of newer drugs like angiotensin-converting enzyme inhibitors, calcium-antagonists and alpha-blockers compared to \"old\" but well-proven thiazide diuretics and beta-blockers in the treatment of essential hypertension.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Apr 30"
                    },
                    "PMID:11810791": {
                      "sentence": "Until recently, no morbidity-mortality study had examined the effects of \"newer\" drugs, like angiotensin-converting enzyme inhibitors, calcium antagonists, and alpha-blockers compared to \"old\", but well-proven, thiazide diuretics, and beta-blockers in the treatment of essential hypertension.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Dec 31"
                    },
                    "PMID:12534856": {
                      "sentence": "Randomized controlled trials have demonstrated the beneficial effects of angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers, beta-blockers, and spironolactone on survival and quality of life of HF patients, but there is evidence of underuse of evidence-based care for HF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Jan"
                    },
                    "PMID:14610334": {
                      "sentence": "Beneficial renal effects of some medications, such as angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor antagonists, calcium channel blockers, beta-blockers and lipid lowering agents depend at least partially on the ability to alleviate oxidative stress.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003"
                    },
                    "PMID:15599834": {
                      "sentence": "Thus regardless of ACEI and digitalis dose and whether patients are treated with digitalis or not, it is very important to add a beta-blocker to the existing heart failure therapy. beta-blockers should not be withheld until target doses of ACEI have been achieved.",
                      "object score": 1000,
                      "subject score": 805,
                      "publication date": "2004 Dec"
                    },
                    "PMID:16736996": {
                      "sentence": "Anti-ischemic effect of angiotensin-converting enzyme inhibitor--chinapril was examined by exercise tolerance test [ETT] in randomised, cross-over double blind comparison in 20 pts with coronary artery disease treated with beta-blockers and nitrates.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Nov"
                    },
                    "PMID:16835669": {
                      "sentence": "Risk factor modification with the use of cardioprotective medications such as angiotensin-converting enzyme inhibitors (ACEIs), beta-adrenergic antagonists (beta-blockers), acetylsalicylic acid (ASA) and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) has been shown to reduce mortality in the general population.",
                      "object score": 1000,
                      "subject score": 988,
                      "publication date": "2006 Jul"
                    },
                    "PMID:17719282": {
                      "sentence": "METHODS: Using the Medline database and online clinical trial databases, we reviewed all randomized controlled trials (RCTs) and observational studies examining the effect of perioperative angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, antilipid agents (including statins), aspirin, beta-blockers, and calcium-channel blockers on clinical outcomes.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2007 Sep"
                    },
                    "PMID:19043802": {
                      "sentence": "CONCLUSION: Furthermore, cases more often used beta-blockers and calcium-antagonists, whereas controls more often used thiazide diuretics, ACE-inhibitors, and angiotensin-II receptor blockers.",
                      "object score": 1000,
                      "subject score": 763,
                      "publication date": "2009 Apr"
                    },
                    "PMID:21314866": {
                      "sentence": "There were eight trials evaluating the effect of beta-blockers, five trials evaluating the effect of ace-inhibitors or angiotensin-receptor-blockers and one trial evaluating the effect of diuretics on erectile function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Mar"
                    },
                    "PMID:22209214": {
                      "sentence": "METHODS: MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception to May 2011 on randomised controlled trials (RCTs) which assessed the effect of ACEIs on arterial stiffness vs. placebo or no treatment and ACEIs vs. angiotensin receptor blockers (ARBs), calcium channel blockers (CCBs), beta-blockers and diuretics.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Mar"
                    },
                    "PMID:23328521": {
                      "sentence": "MEASUREMENTS AND MAIN RESULTS: Time-dependent effects of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, antiplatelet drugs, beta-blockers, and statins on all-cause mortality were measured.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Apr 01"
                    },
                    "PMID:27378313": {
                      "sentence": "The authors performed a systematic review and meta-analysis of studies that compared the effects of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) with calcium channel blockers (CCBs), diuretics, and beta-blockers in hypertensive black patients on cardiovascular outcomes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Apr"
                    },
                    "PMID:27398980": {
                      "sentence": "METHODS: Consecutive outpatients with late-onset Alzheimer's disease (AD) at various stages and their respective caregivers were assessed for score variations in 1 year of tests assessing caregiver burden, functionality and cognition according to blood pressure (BP) variations and APOE haplotypes, while also taking into account differential effects of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, calcium channel blockers, diuretics, or no antihypertensive medication on score changes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016"
                    },
                    "PMID:29847487": {
                      "sentence": "However, in head-to-head comparisons, no significant difference was found between older and younger patients in the effects of diuretics, calcium antagonists, ACE inhibitors and angiotensin receptor blockers on all cardiovascular outcomes, whereas beta-blockers revealed an age-dependent effectiveness, being equally effective as the other agents at an age below 65 years, but less effective at an older age.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Aug"
                    },
                    "PMID:30121238": {
                      "sentence": "We performed a systematic review and meta-analysis to assess the effect of angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARBs), beta blockers, and aldosterone antagonists in adults with systemic RVs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Aug 09"
                    },
                    "PMID:30563873": {
                      "sentence": "Among hypertensive populations, there were no detectable differences in the SBP-lowering effects of ACE-I, ARB, beta-blocker and diuretic medications when compared with endurance or dynamic resistance exercise.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Jul"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:treats-MESH:D000375": {
              "object": "MESH:D000375",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL650---biolink:treats---MESH:D000375---identifiers_org_registry:chembl.compound"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL25-biolink:affects-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.COMPOUND:CHEMBL25",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL25---DGIdb:affects---NCBIGene:7040---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19138248"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.TARGET:CHEMBL376",
              "predicate": "biolink:has_part",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:part_of---UMLS:C0034693---SEMMEDDB:",
                    "UMLS:C1366557---SEMMEDDB:part_of---UMLS:C0034693---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15291119",
                    "PMID:12206991",
                    "PMID:1859854",
                    "PMID:18189272",
                    "PMID:32965022",
                    "PMID:29750635",
                    "PMID:25137849",
                    "PMID:1940322",
                    "PMID:12845761",
                    "PMID:24777409",
                    "PMID:18197501",
                    "PMID:11028906",
                    "PMID:8526873",
                    "PMID:16330873"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1859854": {
                      "sentence": "The junction between the shared and unique 3' sequence in the 1.9-kb mRNA occurred only two nucleotides before the proposed polyadenylation site of the rat TGF-beta 1 2.4-kb mRNA.",
                      "object score": 830,
                      "subject score": 830,
                      "publication date": "1991 Mar"
                    },
                    "PMID:1940322": {
                      "sentence": "On the other hand, signals for rat TGF-beta 1 mRNA were abundant in the GCT and striated duct cells but were lacking in the excretory duct cells.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "1991 Dec"
                    },
                    "PMID:8526873": {
                      "sentence": "Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Dec 01"
                    },
                    "PMID:11028906": {
                      "sentence": "Active immunization of fertile female rats with CED or CGE peptide conferred protection from pregnancy.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2000 Sep"
                    },
                    "PMID:12206991": {
                      "sentence": "Compared with rats on 0.3% NaCl diet, glomerular preparations from rats on 8.0% NaCl diet contained more NOS3 and produced greater amounts of total and active TGF-beta1 and NOx.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2002 Oct"
                    },
                    "PMID:12845761": {
                      "sentence": "It was found that the rat TGF beta 1 expression product was obviously detectable in the transfected osteoblasts in 48 h.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2000"
                    },
                    "PMID:15291119": {
                      "sentence": "RESULTS: The levels of FN, LN, Type I and III collagen, TGF-beta1, and alpha-SMA of the CCl4 damaged rats increased (P<0.01).",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "2004 Jul"
                    },
                    "PMID:16330873": {
                      "sentence": "Serum TGF-beta1 levels of pulmonary fibrosis rats were also decreased by losartan.",
                      "object score": 901,
                      "subject score": 861,
                      "publication date": "2006"
                    },
                    "PMID:18189272": {
                      "sentence": "Moreover, remarkably lower levels of tissue collagen were noted in the nephron and serum TGF-beta1 of UUO rats receiving oral SE (0.15 g/3 ml/0.25 kg/day) compared with the untreated controls.",
                      "object score": 861,
                      "subject score": 901,
                      "publication date": "2008 Jun 01"
                    },
                    "PMID:18197501": {
                      "sentence": "OBJECTIVE: To construct a recombinant adenovirus vector which regulates the expression of rat transforming growth factor beta (TGF-beta1).",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2008 Jan"
                    },
                    "PMID:24777409": {
                      "sentence": "At the same time, the plasma concentration of TGF-beta1 of the rats in each group was detected using ELISA method.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Apr 25"
                    },
                    "PMID:25137849": {
                      "sentence": "CONCLUSION: TD could obviously improve the symptoms of diabetes and down-regulate the expression of renal TGF-beta1 and Smad4 of early diabetic nephropathy rats, which suggested that TD had certain preventive effect on early diabetic nephropathy.",
                      "object score": 861,
                      "subject score": 928,
                      "publication date": "2014 Jul"
                    },
                    "PMID:29750635": {
                      "sentence": "Mechanism research of Bu-Shen-Huo-Xue formula against renal fibrosis in rats with 5/6 nephrectomy via E-cadherin, alpha-SMA, and TGF-beta1?.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Jul"
                    },
                    "PMID:32965022": {
                      "sentence": "Effects of inflammatory response on renal function and TGF-beta1 pathway of rats with aging-related kidney damage by upregulating the expression of CD36.OBJECTIVE: The aim of this study was to explore the effects of inflammatory response on renal function and TGF-beta1 pathway of rats with aging-related kidney damage by upregulating the CD36 expression.",
                      "object score": 1000,
                      "subject score": 734,
                      "publication date": "2020 Sep"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P04040": {
              "object": "UniProtKB:P04040",
              "subject": "CHEMBL.TARGET:CHEMBL376",
              "predicate": "biolink:has_part",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0007367---SEMMEDDB:part_of---UMLS:C0034693---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:2204616",
                    "PMID:16223488",
                    "PMID:11098146",
                    "PMID:11431728",
                    "PMID:11880557",
                    "PMID:1737743",
                    "PMID:17977949",
                    "PMID:17768068",
                    "PMID:18487368",
                    "PMID:12456800",
                    "PMID:14950204",
                    "PMID:1202694",
                    "PMID:18686095",
                    "PMID:17342175",
                    "PMID:19397987",
                    "PMID:14244685",
                    "PMID:15115116",
                    "PMID:11289160",
                    "PMID:20718663",
                    "PMID:11090242"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:55325": {
                      "sentence": "Immunological relationships have been investigated with acid and alkaline phosphatases, cystine aminopeptidase, beta-acetylglucosaminidase, beta-glucuronidase, catalase and L-glutamate dehydrogenase of human, monkey, mouse, rat, rabbit, dog, cattle, sheep, cat, pig, guinea-pig and chicken organ extracts by means of immunodiffusion and immunoelectrophoresis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1975 May"
                    },
                    "PMID:500584": {
                      "sentence": "Effect of Triton WR-1339 on the rates of synthesis and degradation of hepatic catalase of rat.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1979 Oct"
                    },
                    "PMID:1202694": {
                      "sentence": "Possible mechanisms of the effect of the yeast's mannans on the rat catalase are discussed.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1975 Jan-Feb"
                    },
                    "PMID:1737743": {
                      "sentence": "Oxidation-reduction-sensitive binding of lung protein to rat catalase mRNA.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1992 Feb 15"
                    },
                    "PMID:2204616": {
                      "sentence": "Recombinant rat catalase gave almost the same multiple protein bands on native polyacrylamide gel isoelectric focusing as observed with authentic rat liver catalase.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "1990 May"
                    },
                    "PMID:2373372": {
                      "sentence": "Isolation and characterization of the rat catalase-encoding gene.",
                      "object score": 775,
                      "subject score": 775,
                      "publication date": "1990 May 14"
                    },
                    "PMID:2792765": {
                      "sentence": "Isolation and characterization of the rat catalase-encoding gene.",
                      "object score": 775,
                      "subject score": 775,
                      "publication date": "1989 Jul 15"
                    },
                    "PMID:3260463": {
                      "sentence": "Early treatment of rats with either catalase or superoxide dismutase (10,000 U/kg/day) protected animals from the development of EAN.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "1988 May"
                    },
                    "PMID:3446581": {
                      "sentence": "Cat shows 48.0%, 49.7%, and 48.3% aa identity with human, bovine, and rat catalases, respectively, and 44.3% aa identity with catalase T of S. cerevisiae.",
                      "object score": 872,
                      "subject score": 872,
                      "publication date": "1987"
                    },
                    "PMID:3596984": {
                      "sentence": "Enhancement of tumor cell localization was prevented by pretreatment of the rats with catalase or by antineutrophil antisera.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987"
                    },
                    "PMID:4436284": {
                      "sentence": "Studies on rat catalase.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1974 Oct"
                    },
                    "PMID:7082324": {
                      "sentence": "Effect of disuse on the skeletal muscle catalase of rats.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1982 Apr"
                    },
                    "PMID:8957690": {
                      "sentence": "Radioactive DNA probes were synthesized using a Klenow polymerase-based specific primer synthetic procedure with a known published sequence for rat catalase.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1996"
                    },
                    "PMID:9354373": {
                      "sentence": "These results suggested that the rat catalase gene is regulated by a novel mechanism involving the inverted repeated structure of the promoter and characteristic binding factors.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1997 Jun"
                    },
                    "PMID:9397152": {
                      "sentence": "Fragments of the 5'-flanking region of the rat catalase gene ranging in length from 3,421 base pairs (bp) to 69 bp were fused to the chloramphenicol acetyltransferase (CAT) reporter gene, and the transcriptional activity of the reporter gene was measured following transient transfection in three cell lines: a human hepatoma cell line (HepG2), a porcine kidney epithelial cell line (LLCPK1), and a human glioma cell line (U-138 MG).",
                      "object score": 825,
                      "subject score": 825,
                      "publication date": "1998 Jan"
                    },
                    "PMID:11090242": {
                      "sentence": "Furthermore, one of the rat epitopes,(459)LCENIANHLK(468), was identified as the epitope for autoantibodies which were inducible by intensive immunization in rats with the homologous rat catalase.",
                      "object score": 1000,
                      "subject score": 828,
                      "publication date": "2000 Dec"
                    },
                    "PMID:11289160": {
                      "sentence": "To test whether this down-regulation plays a critical role in the mechanism of steroid-induced apoptosis, WEHI7.2 cells were transfected with rat catalase.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2001 Mar 15"
                    },
                    "PMID:11431728": {
                      "sentence": "Fatty livers of Ob rats contained significantly less GSH, TOC, and CAT, in comparison with livers of Ln rats.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2001 Jul"
                    },
                    "PMID:16223488": {
                      "sentence": "The rat catalase gene carries a TATA-less promoter and its transcriptional mechanism is interesting because of downregulation in liver injury.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2005 Oct 24"
                    },
                    "PMID:28185949": {
                      "sentence": "AS-NC treatment reduced ROS and TBARS levels, ameliorate cardiac CAT and SOD activities of infected rats, and reduced seric biomarkers of cardiac function.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2017 Apr"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL376-biolink:has_part-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "CHEMBL.TARGET:CHEMBL376",
              "predicate": "biolink:has_part",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:4843---SEMMEDDB:part_of---UMLS:C0034693---SEMMEDDB:",
                    "UMLS:C0669372---SEMMEDDB:part_of---UMLS:C0034693---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20065493",
                    "PMID:30282485",
                    "PMID:11322650",
                    "PMID:7530282",
                    "PMID:20383765",
                    "PMID:12969270",
                    "PMID:9590244",
                    "PMID:11597933",
                    "PMID:15569409",
                    "PMID:16033258",
                    "PMID:10455920",
                    "PMID:19006088",
                    "PMID:10782904",
                    "PMID:18763577",
                    "PMID:11112852",
                    "PMID:12959638",
                    "PMID:12051993",
                    "PMID:15591777",
                    "PMID:9030556",
                    "PMID:8830655"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7530282": {
                      "sentence": "Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in reversible endotoxic shock studied by a novel monoclonal antibody against rat iNOS.",
                      "object score": 928,
                      "subject score": 928,
                      "publication date": "1995 Jan"
                    },
                    "PMID:7588294": {
                      "sentence": "Reverse transcription polymerase chain reaction amplified an 807-base pair (bp) product from ROS 17/2.8 cells, which had a size and restriction enzyme-cut pattern identical to that predicted for authentic rat iNOS.",
                      "object score": 790,
                      "subject score": 790,
                      "publication date": "1995 Dec"
                    },
                    "PMID:8687469": {
                      "sentence": "We now have isolated and sequenced the rat iNOS gene promoter and determined the transcription start site.",
                      "object score": 676,
                      "subject score": 676,
                      "publication date": "1996 Jun 25"
                    },
                    "PMID:8830655": {
                      "sentence": "Cloning and sequencing of the proximal promoter of the rat iNOS gene: activation of NFkappaB is not sufficient for transcription of the iNOS gene in rat mesangial cells.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1996 Oct 07"
                    },
                    "PMID:9030556": {
                      "sentence": "This selectivity was similar to that observed in rat aortic rings, in which 1400W was greater than 1000-fold more potent against rat iNOS than eNOS.",
                      "object score": 928,
                      "subject score": 928,
                      "publication date": "1997 Feb 21"
                    },
                    "PMID:9247328": {
                      "sentence": "The nucleotide sequences of the promoter region for rat inducible nitric oxide synthase (iNOS) were elucidated.",
                      "object score": 928,
                      "subject score": 928,
                      "publication date": "1997"
                    },
                    "PMID:9433927": {
                      "sentence": "In all tissues, the 428 bp product predominated and sequence analysis revealed this to be iNOS mRNA with a very close homology (97%) to the published sequence of rat iNOS.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1997 Nov"
                    },
                    "PMID:9507788": {
                      "sentence": "Molecular analysis of the rat inducible nitric oxide synthase genes.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1998 Jan"
                    },
                    "PMID:9590244": {
                      "sentence": "The 5'-flanking region of the rat iNOS gene contains several binding sites for transcription factors potentially involved in cytokine and cAMP signaling such as nuclear factor-kappaB/Rel, CCAAT/enhancer-binding protein (C/EBP), and cyclic AMP-responsive element-binding protein/ATF.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1998 May 15"
                    },
                    "PMID:9714306": {
                      "sentence": "The present findings demonstrate that the rat iNOS gene is transcriptionally regulated by cytokines and LPS, but, unlike the mouse gene, the downstream NF-kappaB site does not appear to be a key region in responses to cytokines and LPS.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1998 Jun 01"
                    },
                    "PMID:9812920": {
                      "sentence": "Electrophoretic mobility shift assay using synthetic oligonucleotide corresponding to the downstream NF-kappaB site of rat iNOS promoter as a probe showed that NOR3 inhibited IL-1beta-induced NF-kappaB activation and its nuclear translocation, as demonstrated with immunocytochemical study.",
                      "object score": 709,
                      "subject score": 709,
                      "publication date": "1998 Nov"
                    },
                    "PMID:9881104": {
                      "sentence": "Of this series of compounds, 2-amino-5-(imidazol-1-yl)pentanoic acid was identified as the most potent member against rat iNOS, rat nNOS and a human-derived cNOS.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1998 Nov"
                    },
                    "PMID:10395902": {
                      "sentence": "Because iNOS is most likely responsible for the harmful consequences of nitric oxide (NO) in general, the cloned rat iNOS gene will further reveal the mechanisms of iNOS inducibility in different cell types during development and disease, including brain diseases, and to promote studies of pharmacological intervention in cases where extensive NO production plays a critical role.",
                      "object score": 858,
                      "subject score": 858,
                      "publication date": "1999 Jul 08"
                    },
                    "PMID:11023038": {
                      "sentence": "Northern blotting with a cDNA probe for rat iNOS, and Western blotting with a polyclonal antibody against iNOS, demonstrated that GGA did not up-regulate the iNOS mRNA expression nor induce its protein.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2000"
                    },
                    "PMID:11112852": {
                      "sentence": "It was shown that some nuclear factor(s) which bound specifically to the fragment of the rat iNOS gene containing several consensus sequences were produced after VSMC were treated with interleukin 1 (IL-1) and IFN-gamma.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2000 Nov"
                    },
                    "PMID:11304468": {
                      "sentence": "A fully functional -3.2-kb rat iNOS promoter was transfected into RASMC and macrophages.",
                      "object score": 554,
                      "subject score": 554,
                      "publication date": "2001 Apr"
                    },
                    "PMID:11322650": {
                      "sentence": "Different mechanisms in inhibition of rat macrophage nitric oxide synthase expression by FK 506 and cyclosporin A.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2001 Feb"
                    },
                    "PMID:11454939": {
                      "sentence": "Therefore, C6 cells stably expressing 1846 and 526 base fragments of the rat iNOS gene promoter fused to a luciferase reporter gene were prepared and characterized and used to study the effect of ethanol on iNOS promoter activity.",
                      "object score": 676,
                      "subject score": 676,
                      "publication date": "2001 Aug"
                    },
                    "PMID:11730812": {
                      "sentence": "7-Kchol decreased rat iNOS promoter activity, iNOS expression and NO generation, but it did not impair IL-1beta-induced VEGF synthesis.",
                      "object score": 740,
                      "subject score": 740,
                      "publication date": "2001 Dec"
                    },
                    "PMID:12951150": {
                      "sentence": "Modest inhibitory activity was shown by most of the thioureas and 4,5-dihydrothiazoles, with N-(3-aminomethylphenyl)thiourea (IC(50)=13 microM vs rat neuronal NOS and IC(50)=23 microM vs rat inducible NOS) and 2-(3-aminomethylphenylamino)-4,5-dihydrothiazole (IC(50)=13 microM vs rat neuronal NOS and IC(50)=19 microM vs human inducible NOS) being the most potent.",
                      "object score": 928,
                      "subject score": 928,
                      "publication date": "2003 Sep 15"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021557-biolink:physically_interacts_with-FMA:82839": {
              "object": "FMA:82839",
              "subject": "VANDF:4021557",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003280---SEMMEDDB:interacts_with---UMLS:C0019134---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17533420",
                    "PMID:13026966",
                    "PMID:17591284",
                    "PMID:15922935",
                    "PMID:10411593",
                    "PMID:14908875",
                    "PMID:11190904",
                    "PMID:1683659",
                    "PMID:10884521",
                    "PMID:14556454",
                    "PMID:14783096",
                    "PMID:13479259",
                    "PMID:10856974",
                    "PMID:12701115",
                    "PMID:10446894",
                    "PMID:11323028",
                    "PMID:16747150",
                    "PMID:16025136",
                    "PMID:14846769",
                    "PMID:11804293"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:240477": {
                      "sentence": "These findings suggest that the anticoagulant action of heparin may be markedly diminished in low blood flow states.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1975 Sep"
                    },
                    "PMID:373277": {
                      "sentence": "The present status of knowledge on the mechanism of the anticoagulant action of heparin is described in detail.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1979 Jan 01"
                    },
                    "PMID:1683659": {
                      "sentence": "Since heparin is an effective anticoagulant, and clotting is a major contributor to postsurgical fibrin deposition, we studied the effects of heparin delivered locally into the peritoneal cavity at the site of the injury on the subsequent formation of postsurgical adhesions.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1991 Sep-Oct"
                    },
                    "PMID:2245043": {
                      "sentence": "The anticoagulant action of heparin followed a different time course, providing evidence that these two effects of heparin are functionally distinct.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1990"
                    },
                    "PMID:2455930": {
                      "sentence": "[The non-anticoagulant action of heparins: prospects].",
                      "object score": 966,
                      "subject score": 660,
                      "publication date": "1988 May 19"
                    },
                    "PMID:2847457": {
                      "sentence": "In an attempt to provide an objective means of comparing the anticoagulant action of heparin with those of newly developed low MW heparin-like anticoagulants we have utilized the fibrinpeptide A assay as a method of determining fibrin formation during haemodialysis.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1988"
                    },
                    "PMID:3387950": {
                      "sentence": "The adverse effects of protamine sulfate, used to neutralize the anticoagulant action of heparin, include systemic hypotension, pulmonary artery hypertension, thrombocytopenia and leukopenia.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1988"
                    },
                    "PMID:3715808": {
                      "sentence": "Human endothelial cells possess antiheparin activity that neutralizes the anticoagulant action of heparin as measured by different tests of the clotting system.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1986 May 01"
                    },
                    "PMID:3995171": {
                      "sentence": "The anticoagulant mechanism of action of heparin in contact-activated plasma: inhibition of factor X activation.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1985 May"
                    },
                    "PMID:4171126": {
                      "sentence": "Anticoagulant and antimalarial action of heparin in simian malaria.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1968 Apr 13"
                    },
                    "PMID:8915986": {
                      "sentence": "The anticoagulant action of heparin is mediated by antithrombin III.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1996 Oct"
                    },
                    "PMID:8925890": {
                      "sentence": "Protamines are polycationic proteins that are widely used for neutralisation of the anticoagulant action of heparin.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1996 Apr 01"
                    },
                    "PMID:8979119": {
                      "sentence": "Current research on TFPI is mainly focused on the cell biology of TFPI, on the contribution of TFPI to the anticoagulant action of heparins, and on the role of lipoprotein-associated TFPI.",
                      "object score": 966,
                      "subject score": 694,
                      "publication date": "1996 Oct"
                    },
                    "PMID:9156415": {
                      "sentence": "Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997"
                    },
                    "PMID:14846769": {
                      "sentence": "Studies on the anticoagulant action of heparin.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1951 Jul"
                    },
                    "PMID:24264231": {
                      "sentence": "Here, we show that mechanisms that are independent of the anticoagulant properties of heparin may contribute to the observed beneficial effects of heparin in the treatment of sepsis patients.",
                      "object score": 1000,
                      "subject score": 872,
                      "publication date": "2014 Feb 13"
                    },
                    "PMID:24983639": {
                      "sentence": "For the first time we have found that HTCC effectively neutralizes anticoagulant action of heparin in rat blood in vitro as well as in rats in vivo.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2014 Jun 30"
                    },
                    "PMID:26293337": {
                      "sentence": "3'-Phosphoadenosine-5'-phosphosulfate (PAPS) is the obligate cosubstrate and source of the sulfonate group in the chemoenzymatic synthesis of heparin, a clinically used anticoagulant drug.",
                      "object score": 1000,
                      "subject score": 801,
                      "publication date": "2015 Dec"
                    },
                    "PMID:27845251": {
                      "sentence": "This study demonstrates that highly conserved Amblyomma americanum tick saliva serpin 19 (AAS19), a broad-spectrum inhibitor of hemostasis and inflammation system proteases and anticoagulant, can bind heparan sulfate/heparin (HS)GAGs and that this interaction alters its function.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2017 01"
                    },
                    "PMID:28671597": {
                      "sentence": "The anticoagulant action of heparin can be neutralized by protamine sulfate, and in this study the ability of protamine to bind and neutralize the anticoagulant activities of heparin from porcine mucosa, bovine mucosa and bovine lung were assessed.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2017 Jul 02"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:increases_activity_of-UniProtKB:P06213": {
              "object": "UniProtKB:P06213",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:increases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-RXNORM:10759": {
              "object": "RXNORM:10759",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL118-biolink:affects-UniProtKB:P14780": {
              "object": "UniProtKB:P14780",
              "subject": "CHEMBL.COMPOUND:CHEMBL118",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL118---DGIdb:affects---NCBIGene:4318---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:22336956"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL160-biolink:affects-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "CHEMBL.COMPOUND:CHEMBL160",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL160---DGIdb:affects---NCBIGene:4313---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12639820"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL160-biolink:affects-UniProtKB:P30556": {
              "object": "UniProtKB:P30556",
              "subject": "CHEMBL.COMPOUND:CHEMBL160",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL160---DGIdb:affects---NCBIGene:185---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17477024"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:affects-MESH:D013091": {
              "object": "MESH:D013091",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:has_part-CHEBI:33699": {
              "object": "CHEBI:33699",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:has_part",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:treats-UMLS:C0039005": {
              "object": "UMLS:C0039005",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:affects-UniProtKB:P01579": {
              "object": "UniProtKB:P01579",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL635---DGIdb:affects---NCBIGene:3458---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10784002"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:affects-UniProtKB:P02649": {
              "object": "UniProtKB:P02649",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL635---DGIdb:affects---NCBIGene:348---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:3185288"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:affects-UniProtKB:P04083": {
              "object": "UniProtKB:P04083",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL635---DGIdb:affects---NCBIGene:301---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:affects-UniProtKB:P18075": {
              "object": "UniProtKB:P18075",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL635---DGIdb:affects---NCBIGene:655---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:26590194"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL729-biolink:affects-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "CHEMBL.COMPOUND:CHEMBL729",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL729---DGIdb:affects---NCBIGene:4088---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:81101-biolink:directly_interacts_with-UniProtKB:P02452": {
              "object": "UniProtKB:P02452",
              "subject": "FMA:81101",
              "predicate": "biolink:directly_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB12872---DRUGBANK:binder---UniProtKB:P02452---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB13133---DRUGBANK:binder---UniProtKB:P02452---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:26239086",
                    "PMID:28379876"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:drugbank",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:colocalizes_with-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:colocalizes_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P01137---MI:2364---UniProtKB:P08253---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25241761"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:colocalizes_with-UniProtKB:Q14766": {
              "object": "UniProtKB:Q14766",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:colocalizes_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P01137---MI:0403---UniProtKB:Q14766---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12429738"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P06213-biolink:directly_interacts_with-FMA:63018": {
              "object": "FMA:63018",
              "subject": "UniProtKB:P06213",
              "predicate": "biolink:directly_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q16665-biolink:colocalizes_with-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "UniProtKB:Q16665",
              "predicate": "biolink:colocalizes_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:Q16665---MI:0403---UniProtKB:P84022---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28471448"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q9BYF1-biolink:colocalizes_with-UniProtKB:P37173": {
              "object": "UniProtKB:P37173",
              "subject": "UniProtKB:Q9BYF1",
              "predicate": "biolink:colocalizes_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:Q9BYF1---MI:0403---UniProtKB:P37173---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:26867007"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-RXNORM:235758": {
              "object": "RXNORM:235758",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:physically_interacts_with-UMLS:C0007412": {
              "object": "UMLS:C0007412",
              "subject": "CHEBI:35530",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:interacts_with---UMLS:C0007412---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17714089",
                    "PMID:29747861",
                    "PMID:25297539",
                    "PMID:2868649",
                    "PMID:29251711",
                    "PMID:2013498",
                    "PMID:17438273",
                    "PMID:170087",
                    "PMID:24621648",
                    "PMID:6092538",
                    "PMID:6763907",
                    "PMID:7502569",
                    "PMID:2861135",
                    "PMID:1363579",
                    "PMID:6141762"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:170087": {
                      "sentence": "The alpha-receptor blocking agent phentolamine inhibited the stimulatory effect of catecholamines on gluconeogenesis with a 50 times higher potency than propranolol, a beta-blocking agent.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1975 Mar 17"
                    },
                    "PMID:1363579": {
                      "sentence": "The role of beta-blockers in the treatment of manifest heart failure should not be over-looked, since by countering the deleterious effect of increased catecholamines they may improve the prognosis, thus reducing the incidence of sudden death.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1992 Dec"
                    },
                    "PMID:2013498": {
                      "sentence": "Finally, indirect evidence of the pathogenetic role played by the sympathetic system in the development of vascular disease derives from the results of experiments showing that sympatholytic agents are capable of reducing both medial hypertrophy and atherogenesis. beta-Blockers, alpha- and beta-blockers, and centrally acting sympatholytic agents not only ameliorate hemodynamics but also appear to inhibit the direct effects of catecholamines on the arterial wall.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Apr"
                    },
                    "PMID:2861135": {
                      "sentence": "Mepindolol is a newly developed beta-adrenergic blocking agent, which differs from other available beta-blockers in its ability to counteract the chronotropic effect of catecholamines without depressing myocardial contractility.",
                      "object score": 1000,
                      "subject score": 870,
                      "publication date": "1985 Feb"
                    },
                    "PMID:2868649": {
                      "sentence": "Beta blockers are attractive because they are cardioprotective, counter the end organ effect of catecholamines and reduce angina; however, some decrease cardiac output, increase peripheral resistance, decrease renal blood flow and cause fatigue.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1986 Feb 12"
                    },
                    "PMID:6092538": {
                      "sentence": "Propranolol, a beta-adrenergic blocker, could block the increase of S-100 protein release by catecholamines, indicating that the release was mediated by the beta-adrenergic effect of catecholamines.",
                      "object score": 1000,
                      "subject score": 988,
                      "publication date": "1984 Nov"
                    },
                    "PMID:6141762": {
                      "sentence": "Dichloroisoproterenol is a beta-blocker acting on the glycogenolytic effects of catecholamines.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1983 Sep"
                    },
                    "PMID:6763907": {
                      "sentence": "We conclude therefore that beta-blockers modify the pattern of the hemodynamic response to acute hypoglycaemia by interfering with the peripheral effects of circulating catecholamines in a way which depends on the degree of beta-1 selectivity of the drug used.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1982"
                    },
                    "PMID:7502569": {
                      "sentence": "Further effects of beta-blockers are protection of myocardial cells from enhanced catecholamine concentrations.",
                      "object score": 790,
                      "subject score": 1000,
                      "publication date": "1995 Oct"
                    },
                    "PMID:17438273": {
                      "sentence": "To determine whether recognition of catecholamines, which are likely to be present at the site of a tick bite, may play a role in preparing the organism for reentry into a tick from a mammalian host, we administered a beta-adrenergic blocker, propranolol, to infected mice.",
                      "object score": 1000,
                      "subject score": 988,
                      "publication date": "2007 Apr 24"
                    },
                    "PMID:17714089": {
                      "sentence": "Some beta-blockers, typified by (-)-pindolol and (-)-CGP 12177, not only block the receptor, but also activate it, albeit at much higher concentrations (approximately 2 log units) than those required to antagonize the effects of catecholamines.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Oct"
                    },
                    "PMID:24621648": {
                      "sentence": "These findings suggest that some beta-blockers display proangiogenic activity through a mechanism that is independent of their ability to antagonize catecholamine action.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2014 Jul"
                    },
                    "PMID:25297539": {
                      "sentence": "The pharmacological mechanism of action of beta-blockers results in the inhibition of the biological effects of catecholamines.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Oct 09"
                    },
                    "PMID:29251711": {
                      "sentence": "BACKGROUND: Beta blockers, a class of medications that inhibit endogenous catecholamines interaction with beta adrenergic receptors, are often administered to patients hospitalized after traumatic brain injury (TBI).",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2018 Feb"
                    },
                    "PMID:29747861": {
                      "sentence": "In this setting, beta-blockers (BBs) are used to counteract the effects of catecholamines on heart.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Jul 01"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1428-biolink:affects-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "CHEMBL.COMPOUND:CHEMBL1428",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL1428---DGIdb:affects---NCBIGene:4843---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16044358"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:affects-UniProtKB:P01019": {
              "object": "UniProtKB:P01019",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL389621---DGIdb:affects---NCBIGene:183---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15576665"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:affects-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL389621---DGIdb:affects---NCBIGene:7040---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:7895901"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:affects-UniProtKB:P04114": {
              "object": "UniProtKB:P04114",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL389621---DGIdb:affects---NCBIGene:338---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1597147"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:affects-UniProtKB:P46531": {
              "object": "UniProtKB:P46531",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL389621---DGIdb:affects---NCBIGene:4851---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11948681"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:affects-UniProtKB:Q15796": {
              "object": "UniProtKB:Q15796",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL389621---DGIdb:affects---NCBIGene:4087---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16644034"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1709-biolink:affects-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL1709",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL809---DGIdb:affects---NCBIGene:1636---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:27262302"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1711-biolink:affects-UniProtKB:P00441": {
              "object": "UniProtKB:P00441",
              "subject": "CHEMBL.COMPOUND:CHEMBL1711",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:physically_interacts_with-CHEBI:35457": {
              "object": "CHEBI:35457",
              "subject": "VANDF:4021566",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:interacts_with---UMLS:C0003015---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8576797",
                    "PMID:8643206",
                    "PMID:8228191",
                    "PMID:1920340",
                    "PMID:27398980",
                    "PMID:17719282",
                    "PMID:14610334",
                    "PMID:10821130",
                    "PMID:11468543",
                    "PMID:8069658",
                    "PMID:10353294",
                    "PMID:17917543",
                    "PMID:11060822",
                    "PMID:22209214",
                    "PMID:27378313",
                    "PMID:11710789",
                    "PMID:19043802",
                    "PMID:11336083",
                    "PMID:12013484",
                    "PMID:2698946"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1920340": {
                      "sentence": "The aim of this study was to compare the acute effects of captopril, an ACE inhibitor, and nifedipine, a calcium channel blocker, on exercise-induced microalbuminuria in hypertensive insulin-dependent (Type I) and non-insulin-dependent (Type II) diabetic patients with early stage nephropathy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Jun"
                    },
                    "PMID:2698946": {
                      "sentence": "The aim of the present study was to evaluate the acute effects of captopril, an angiotensin converting enzyme (ACE) inhibitor, and nifedipine, a calcium channel blocker, on exercise-induced micro-albuminuria in hypertensive diabetics with stage II nephropathy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Dec"
                    },
                    "PMID:8069658": {
                      "sentence": "We studied the potential renoprotective properties of a calcium channel blocker in moderately hyperglycemic diabetic rats both in the early phase of the disease and in the very long term, and compared such an effect with that of an angiotensin-I-converting enzyme (ACE) inhibitor.",
                      "object score": 983,
                      "subject score": 1000,
                      "publication date": "1994 Jul-Aug"
                    },
                    "PMID:8228191": {
                      "sentence": "CONCLUSIONS: Our data indicate that urinary kallikrein activity may represent an index to predict the chronic antihypertensive effect not only of ACE inhibition but also of calcium antagonism, and support the concept that the renal kallikrein-kinin system might play some contributory role in modulating the hypotensive action of ACE inhibitors.",
                      "object score": 1000,
                      "subject score": 950,
                      "publication date": "1993 Jul"
                    },
                    "PMID:8576797": {
                      "sentence": "CONCLUSIONS FROM LITERATURE SURVEY: There is no definitive answer to the question of whether the effects of ACE inhibitors and calcium antagonists are additive when the drugs are used together.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1995 Aug"
                    },
                    "PMID:8643206": {
                      "sentence": "Effect of ACE inhibitors, calcium channel blockers and their combination on renal and extrarenal structures in renal failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Oct"
                    },
                    "PMID:8743536": {
                      "sentence": "In this study, we investigated the effects of antihypertensive drugs such as calcium channel blocker, amlodipine, alpha 1-adrenoceptor blocker, doxazosin and angiotensin converting enzyme (ACE) inhibitor, imidapril on nitric oxide synthase (NOS) activity in the kidneys of L-NAME-induced hypertensive rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jun"
                    },
                    "PMID:8762215": {
                      "sentence": "Furthermore, for a given degree of DBP lowering, SBP and PP were more lowered by ACEI than by CA, indicating a greater effect of ACEI on arterial compliance.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996"
                    },
                    "PMID:8948517": {
                      "sentence": "Whereas the majority of available clinical trials have assessed the effects of ACE inhibitors in patients with insulin-dependent diabetes mellitus (IDDM), there are relatively few long-term studies that have evaluated the renal protective effects of ACE inhibitors and calcium antagonists in patients with nondiabetic renal disease.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1996 Nov"
                    },
                    "PMID:9744414": {
                      "sentence": "The blood pressure did not drop when a calcium-channel blocker was used, but was gradually stabilized with the angiotensin converting enzyme (ACE) antagonist.",
                      "object score": 983,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:9817188": {
                      "sentence": "Whereas the majority of available clinical trials have assessed the effects of ACE inhibitors in patients with insulin-dependent diabetes mellitus, relatively few long-term studies have evaluated the renoprotective effects of ACE inhibitors and calcium antagonists in patients with nondiabetic renal disease.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1998 Sep"
                    },
                    "PMID:10353294": {
                      "sentence": "However, it is still unclear whether this beneficial effect of ACE inhibitors is particularly evident in patients with mild and/or more advanced renal failure and whether calcium antagonists possess a similar nephroprotective effect.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1999 May"
                    },
                    "PMID:10821130": {
                      "sentence": "We examined the effects of a combination therapy using an angiotensin-converting enzyme (ACE) inhibitor plus a long-acting calcium channel blocker (amlodipine), and compared them with the effect of an ACE inhibitor alone.",
                      "object score": 1000,
                      "subject score": 864,
                      "publication date": "2000 May"
                    },
                    "PMID:11060822": {
                      "sentence": "The nephroprotective action of conventional antihypertensive drugs, such as beta-blockers, calcium antagonists and angiotensin-converting enzyme inhibitors is briefly reviewed.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "2000 Nov"
                    },
                    "PMID:11336083": {
                      "sentence": "This study was designed to investigate the effect of delapril, an ACE inhibitor, and manidipine, a long action calcium antagonist, on persistent microalbuminuria in normotensive type 2 diabetic patients.",
                      "object score": 1000,
                      "subject score": 824,
                      "publication date": "2001 Feb"
                    },
                    "PMID:11468543": {
                      "sentence": "The aim of the present study was to compare the effect of an angiotensin converting enzyme (ACE) inhibitor (lisinopril) with a calcium channel blocker (CCB) (controlled release nifedipine) in treatment of posttransplant hypertension focusing on changes in LVH.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Jul 15"
                    },
                    "PMID:11710789": {
                      "sentence": "This increase was most robust (P < .001) when comparing CCB with ACE inhibitors, consonant with proposed protective effects of ACE inhibitors on cardiovascular risk.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2001 Oct"
                    },
                    "PMID:14610334": {
                      "sentence": "Beneficial renal effects of some medications, such as angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor antagonists, calcium channel blockers, beta-blockers and lipid lowering agents depend at least partially on the ability to alleviate oxidative stress.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003"
                    },
                    "PMID:17917543": {
                      "sentence": "Modest benefits have also been shown with alpha1-antagonists and calcium channel blockers, while the effect of ACE inhibitors has been variable.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Nov"
                    },
                    "PMID:27378313": {
                      "sentence": "The authors performed a systematic review and meta-analysis of studies that compared the effects of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) with calcium channel blockers (CCBs), diuretics, and beta-blockers in hypertensive black patients on cardiovascular outcomes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Apr"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2369717-biolink:derives_from-FMA:67303": {
              "object": "FMA:67303",
              "subject": "CHEMBL.COMPOUND:CHEMBL2369717",
              "predicate": "biolink:derives_from",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0013765---SEMMEDDB:converts_to---UMLS:C0030956---SEMMEDDB:",
                    "UMLS:C0013765---SEMMEDDB:converts_to---UMLS:C1305923---SEMMEDDB:",
                    "UMLS:C0041194---SEMMEDDB:converts_to---UMLS:C1305923---SEMMEDDB:",
                    "UMLS:C0041194---SEMMEDDB:converts_to---UMLS:C0030956---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:33751927",
                    "PMID:1655335",
                    "PMID:22563211",
                    "PMID:8344932",
                    "PMID:8810611",
                    "PMID:22434583",
                    "PMID:15632106",
                    "PMID:31273243",
                    "PMID:1842305",
                    "PMID:11723829",
                    "PMID:24358962",
                    "PMID:26662843",
                    "PMID:1777436",
                    "PMID:6903115",
                    "PMID:1883631",
                    "PMID:9165080",
                    "PMID:33681610",
                    "PMID:9161702",
                    "PMID:32396850",
                    "PMID:32463311"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8344932": {
                      "sentence": "Our results suggest that, locally at the site of proteolysis, elastase activity may be regulated by elastin-derived peptide(s) during elastinolysis.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1993 Aug 05"
                    },
                    "PMID:8359459": {
                      "sentence": "The antigenicity of elastin-derived peptides obtained from atherosclerotic human aorta.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1993 May"
                    },
                    "PMID:8485861": {
                      "sentence": "The enzymatic breakdown of human lung elastin by leukocyte elastase precedes the development of pulmonary emphysema, and releases elastin-derived peptides (EDPs) into the circulation.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1993 Apr"
                    },
                    "PMID:8698831": {
                      "sentence": "Following myocardial infarction, extracellular matrix (ECM) is disrupted, which leads to the generation of collagen- and elastin-derived peptides (CDPs and EDPs, respectively).",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1996 Apr"
                    },
                    "PMID:8769947": {
                      "sentence": "Inhibition by protease inhibitors of chemotaxis induced by elastin-derived peptides.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1996 Feb 15"
                    },
                    "PMID:8810611": {
                      "sentence": "To evaluate effects of current smoking on the breakdown of lung elastin, we measured levels of elastin-derived peptides (EDP) in unconcentrated bronchoalveolar lavage (BAL) fluid from 42 community-based older asymptomatic volunteers (60 +/- 11 yr [mean +/- SD]) and examined the relationships of the concentrations of EDP with immunologically detected neutrophil elastase (NE) bound with alpha(1)-proteinase inhibitor and with esterolytic activity against the NE-sensitive synthetic substrate, methoxysuccinyl-alanyl-alanyl-prolyl-valyl paranitroanilide (MEOSAAPVNA).",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1996 Sep"
                    },
                    "PMID:8836663": {
                      "sentence": "In addition to safety parameters, MR889 efficacy was checked by a pretreatment/postreatment evaluation of levels of plasma elastin-derived peptides and urinary desmosine.",
                      "object score": 833,
                      "subject score": 833,
                      "publication date": "1996 Jul"
                    },
                    "PMID:8927483": {
                      "sentence": "The aim of the study was to examine the effects of bronchitis on elastin-derived peptides (EP) and antielastin antibodies (AEAb) in serum.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1996 Sep"
                    },
                    "PMID:9043635": {
                      "sentence": "These results suggest that the elastin-derived peptide induces monocyte chemotaxis by increasing the level of cGMP, followed by activating PKG.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1997 Jan"
                    },
                    "PMID:9161702": {
                      "sentence": "These results suggest that the elastin-derived peptide induces monocyte chemotaxis by increasing the level of cGMP, followed by activating PKG.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1997 May"
                    },
                    "PMID:9188818": {
                      "sentence": "Elastin-derived peptides (EDP) can be analyzed by two-dimensional electrophoresis after their extraction from human abdominal aortic tissue by 0.2 M sodium chloride.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1997 May 09"
                    },
                    "PMID:9216188": {
                      "sentence": "The level of neutrophil elastase was higher in asymptomatic current smokers with emphysematous changes on computed tomographic scans than in current smokers without emphysematous changes, and was found to be correlated with the level of elastin-derived peptides in BAL fluid.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1996 Dec"
                    },
                    "PMID:9596414": {
                      "sentence": "This is the first report implicating elastin-derived peptides as possible mitogens in malignant astrocytomas.",
                      "object score": 751,
                      "subject score": 751,
                      "publication date": "1998 May"
                    },
                    "PMID:23561795": {
                      "sentence": "Many studies have documented degradation of native elastin, the main extracellular matrix protein responsible for resilience and elasticity of arteries, by local release of elastases, leading to the production of elastin-derived peptides (EDP).",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2013 Aug"
                    },
                    "PMID:23919962": {
                      "sentence": "In the current study, we show that elastin-derived peptides (EDPs) may be involved in the development of insulin resistance (IRES) in mice.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2013 Nov"
                    },
                    "PMID:25245255": {
                      "sentence": "Elastin-derived peptides (EDP) can influence cell migration, invasion and protease activity, and so we hypothesized that EDP released during elastolysis promote extravillous trophoblast (EVT) invasion and further elastin breakdown.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2015 Jan"
                    },
                    "PMID:26310504": {
                      "sentence": "Although large molecular weights (>10,000 Da) are generally required for the coacervation of elastin-derived peptides, (Phe-Pro-Gly-Val-Gly)5 exhibited reversible coacervation properties despite its low molecular weight (MW = 2,305 Da).",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2015"
                    },
                    "PMID:26519205": {
                      "sentence": "Elevated levels of elastin-derived peptides (EP) reflect massive pulmonary elastin breakdown in COPD patients.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2016 Jan 01"
                    },
                    "PMID:28714016": {
                      "sentence": "The present study aimed to explore the role of elastin-derived peptides (EDPs) in human temporomandibular disorders.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2017 Sep"
                    },
                    "PMID:28727149": {
                      "sentence": "In conclusion, microcalcification co-localizes with aortic elastin degradation in MFS aortas of humans and mice, where elastin-derived peptides induce a calcification process in SMCs via the elastin receptor complex and ERK1/2 activation.",
                      "object score": 775,
                      "subject score": 775,
                      "publication date": "2017 Nov"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL46516-biolink:affects-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "CHEMBL.COMPOUND:CHEMBL46516",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL46516---DGIdb:affects---NCBIGene:4088---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL51483-biolink:affects-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.COMPOUND:CHEMBL51483",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL51483---DGIdb:affects---NCBIGene:7040---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15015581"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:62343-biolink:physically_interacts_with-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "FMA:62343",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006772---SEMMEDDB:interacts_with---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:7537723",
                    "PMID:21091651",
                    "PMID:26743203",
                    "PMID:16623711",
                    "PMID:8679637",
                    "PMID:17341110",
                    "PMID:17890165",
                    "PMID:20558778",
                    "PMID:7495792",
                    "PMID:17580957",
                    "PMID:11356143",
                    "PMID:22486744",
                    "PMID:8670224"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7495792": {
                      "sentence": "In order to probe the function of this unusually strong interaction between iNOS and CaM, a 30 amino acid peptide derived from the putative CaM binding site of iNOS was synthesized.",
                      "object score": 895,
                      "subject score": 1000,
                      "publication date": "1995 Dec 05"
                    },
                    "PMID:7537723": {
                      "sentence": "Calmodulin is already bound to inducible NOS without requiring Ca2+, while the others are Ca2+/calmodulin-dependent.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Dec"
                    },
                    "PMID:8670224": {
                      "sentence": "We conclude that calmodulin is essential to fold and stabilize mouse iNOS.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996 May 15"
                    },
                    "PMID:8679637": {
                      "sentence": "The neuronal nitric oxide synthase and the macrophage nitric oxide synthase are differently regulated by Ca2+/calmodulin.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "1996 Jul 02"
                    },
                    "PMID:11356143": {
                      "sentence": "The constitutive NOS isoforms (cNOSs) are regulated by calmodulin (CaM), which binds at elevated concentrations of free Ca(2+), whereas the inducible isoform binds CaM irreversibly.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2001 May"
                    },
                    "PMID:16623711": {
                      "sentence": "Our results show that the N-terminal EF hand pair of CaM contains important binding and activating elements for iNOS, whereas the N-terminal EF hand pair in conjunction with the central linker region is required for cNOS enzyme binding and activation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Apr"
                    },
                    "PMID:17341110": {
                      "sentence": "The effect of Ca2+ on the interaction between iNOS and CaM has been examined as well.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Apr"
                    },
                    "PMID:17580957": {
                      "sentence": "Our results show that CaM does not bind to iNOS in a sequential manner as previously proposed for the nNOS enzyme.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Jul 17"
                    },
                    "PMID:17890165": {
                      "sentence": "Our results prove for the first time without the use of chelators that apo-CaM is capable of binding to iNOS peptides and holoenzymes.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2007 Oct"
                    },
                    "PMID:20558778": {
                      "sentence": "When iNOS dimerization cofactors, including calmodulin, were added to macrophage lysates, iNOS dimerization increased, whereas incubation of the same lysates with all cofactors except calmodulin did not rescue iNOS dimer formation.",
                      "object score": 882,
                      "subject score": 1000,
                      "publication date": "2011 Apr"
                    },
                    "PMID:21091651": {
                      "sentence": "Calmodulin was found to bind eNOS after nicotine injection into NTS.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2011 Jul"
                    },
                    "PMID:22486744": {
                      "sentence": "To investigate the dynamic properties of CaM-NOS interactions, we determined the solution structure of CaM bound to the inducible NOS (iNOS) and endothelial NOS (eNOS) CaM binding region peptides.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 May 01"
                    },
                    "PMID:26743203": {
                      "sentence": "At elevated Ca(2+) concentrations, CaM binds to neuronal NOS and endothelial NOS, making them the Ca(2+)-dependent NOS enzymes.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2016 Apr"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:67238-biolink:physically_interacts_with-UniProtKB:P00441": {
              "object": "UniProtKB:P00441",
              "subject": "FMA:67238",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00988---DRUGBANK:target---UniProtKB:P00441---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:82839-biolink:physically_interacts_with-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "FMA:82839",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0019134---SEMMEDDB:interacts_with---UMLS:C0242275---SEMMEDDB:",
                    "UMLS:C0019134---SEMMEDDB:interacts_with---UMLS:C1367721---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8362977",
                    "PMID:16556679",
                    "PMID:17287395",
                    "PMID:25301368",
                    "PMID:23534509",
                    "PMID:10424781",
                    "PMID:22330337",
                    "PMID:27669890",
                    "PMID:9396739",
                    "PMID:18925469",
                    "PMID:11208719",
                    "PMID:19361505",
                    "PMID:11378066",
                    "PMID:11378044",
                    "PMID:30481486",
                    "PMID:19961362",
                    "PMID:10364479",
                    "PMID:9111309",
                    "PMID:17145750",
                    "PMID:12221095"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7706382": {
                      "sentence": "Previous studies have indicated that heparin differentially regulates heparin-binding EGF-like growth factor (HB-EGF) and amphiregulin (AR) mitogenic activity.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1995 May"
                    },
                    "PMID:15219850": {
                      "sentence": "Inhibitors of matrix metalloproteinase and heparin bound-EGF prevented the CaR-mediated increases of pERK and PTHrP, consistent with a \"triple-membrane-spanning signaling\" requirement for transactivation of the EGFR by the CaR.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Jul 23"
                    },
                    "PMID:16543233": {
                      "sentence": "It has been reported that G protein-coupled receptor (GPCR) activation induces epidermal growth factor (EGF) receptor (EGFR) transactivation through the shedding of heparin-binding EGF-like growth factor (HB-EGF).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 May 12"
                    },
                    "PMID:16556679": {
                      "sentence": "We demonstrate that heparin, like epidermal growth factor (EGF) and heparin-binding EGF (HB-EGF), elicits phosphorylation of the EGF receptor and activation of the phosphatidyl inositol 3-kinase (PI3K)-, the extracellular signal-related kinase 1/2 (ERK1/2)- and the c-Jun NH2 terminal kinase (JNK)-signal transduction pathways in primary villous trophoblast.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Apr"
                    },
                    "PMID:20847549": {
                      "sentence": "Heparin-binding epidermal growth factor EGF-like growth factor (HB-EGF) is a member of the epidermal growth factor family that is expressed in many cell types.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "2010"
                    },
                    "PMID:23791975": {
                      "sentence": "The MN patch induced epidermal hyperplasia and marked expression of heparin-binding epidermal growth factor-like growth factor mRNA and protein corresponding to ATRA activity in the skin of HR-1 hairless mice.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Oct 28"
                    },
                    "PMID:23917679": {
                      "sentence": "We evaluated the possible roles of heparin-binding EGF-like growth factor (HB-EGF), a member of the epidermal growth factor (EGF) family, in cell growth and invasion of thyroid cancer cells, and demonstrated that HB-EGF is not only a potent mitogen but also a chemotactic factor in the thyroid cancer cells 8305C and SW579.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    },
                    "PMID:24244689": {
                      "sentence": "Furthermore, whether stress impairs implantation by decreasing the heparin-binding epidermal growth factor-like growth factor (HB-EGF), estrogen and/or progesterone and whether by acting on embryos or on the uterus need further investigations.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:25432160": {
                      "sentence": "Heparin-binding epidermal growth factor-like growth factor (HB-EGF), a ligand of EGF receptor, is involved in the growth and malignant progression of cancers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 May"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:83365-biolink:physically_interacts_with-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "FMA:83365",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0021641---SEMMEDDB:interacts_with---UMLS:C1367721---SEMMEDDB:",
                    "UMLS:C0021641---SEMMEDDB:interacts_with---UMLS:C0242275---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:2982801",
                    "PMID:2094129",
                    "PMID:4355377",
                    "PMID:3542512",
                    "PMID:16769812",
                    "PMID:8676049",
                    "PMID:2532289",
                    "PMID:8775066",
                    "PMID:29890195",
                    "PMID:8760113",
                    "PMID:15317909",
                    "PMID:3027108",
                    "PMID:2177144",
                    "PMID:3896628",
                    "PMID:3289969",
                    "PMID:29579036",
                    "PMID:8420953",
                    "PMID:8106558",
                    "PMID:2455703",
                    "PMID:3493842"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1764070": {
                      "sentence": "The simultaneous presence of insulin increased the sensitivity for EGF predominantly in the periportal hepatocytes.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1991 Dec 31"
                    },
                    "PMID:1947790": {
                      "sentence": "The present study demonstrates that insulin, at concentrations that are not mitogenic, will enhance the proliferative effects of EGF and TGF alpha on the growth of primary cultures of guinea pig gastric surface mucous epithelial cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Sep"
                    },
                    "PMID:2094129": {
                      "sentence": "To study the effect of both epidermal growth factor and insulin in terms of possible regulation of the repair process in cells, the time-course dependence of SSB and DSB repair have been investigated either in the presence of EGF (10 micrograms/ml) and insulin (1 microgram/ml) or without these factors in the medium (either supplemented with 10% serum or without serum) on Swiss 3T6 cells, exposed to ionizing radiation at a dose of 5-10 Gy using methods of neutral and alkaline elution as well as centrifugation on alkaline sucrose gradients.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:2455703": {
                      "sentence": "Dexamethasone abolished the effect of insulin, but not the mitogenic effect of EGF alone.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988 Jun"
                    },
                    "PMID:2899889": {
                      "sentence": "The EGF effect is apparently unique since platelet-derived growth factor, insulin, and transforming growth factor beta all fail to phosphorylate p185 at tyrosine.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1988 Aug"
                    },
                    "PMID:2982801": {
                      "sentence": "Since the receptors for insulin and epidermal growth factor (EGF) also possess tyrosine kinase activity, we have investigated possible effects of insulin and EGF on phosphoinositide metabolism in rat liver plasma membranes and rat hepatocytes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1985 Feb 25"
                    },
                    "PMID:3027108": {
                      "sentence": "This suggests that insulin supported the action of TSH by acting on its own high affinity receptors, whereas its effect on EGF action would be related to its somatomedinlike effects at high supraphysiological concentrations.",
                      "object score": 756,
                      "subject score": 1000,
                      "publication date": "1987 Jan"
                    },
                    "PMID:3289969": {
                      "sentence": "Scatchard analysis indicated that IGF-1 and insulin affected the higher-affinity component of EGF binding, an effect previously associated with the activation of protein kinase C.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1988 Jun 20"
                    },
                    "PMID:3493842": {
                      "sentence": "The binding of 125I-EGF is specific since it is abolished by excess unlabeled EGF but not by excess unlabeled platelet-derived growth factor or insulin.",
                      "object score": 923,
                      "subject score": 1000,
                      "publication date": "1987 Apr 15"
                    },
                    "PMID:3525120": {
                      "sentence": "In addition, the maximal glycogenic effect of EGF was only 40% that of insulin or IGF-I, and the effects of EGF and insulin on [14C]glucose incorporation were additive.",
                      "object score": 801,
                      "subject score": 1000,
                      "publication date": "1986 Aug"
                    },
                    "PMID:3542512": {
                      "sentence": "While EGF and insulin effects were additive, indicating discrete modes of action, the effects of insulin and multiplication-stimulating activity were not additive at maximally effective concentrations.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987 Mar"
                    },
                    "PMID:3760294": {
                      "sentence": "Phosphorylation of this protein was not induced by either epidermal growth factor or insulin, neither of which initiate 3T3 cell growth but enhance growth later in the 3T3 cell cycle.",
                      "object score": 923,
                      "subject score": 1000,
                      "publication date": "1986"
                    },
                    "PMID:3896628": {
                      "sentence": "The lipogenic responses to EGF and NGF were additive with a submaximal response induced by insulin but not with that of a maximal response to insulin, indicating a similarity in the mechanisms of action of EGF, NGF and insulin.",
                      "object score": 801,
                      "subject score": 1000,
                      "publication date": "1985"
                    },
                    "PMID:3911515": {
                      "sentence": "Insulin in the 4-85 nM concentrations also enhanced the rate of uridine phosphorilation and exerted a potential influence on EGF effect only in high concentrations.",
                      "object score": 854,
                      "subject score": 1000,
                      "publication date": "1985 Dec"
                    },
                    "PMID:8420953": {
                      "sentence": "The effect of EGF and peptide on glucose uptake was additive to that of insulin and peptide until the maximal level attained with insulin and peptide was reached.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Jan 25"
                    },
                    "PMID:8676049": {
                      "sentence": "In this study, competition with human EGF, human TGF alpha, human IGF-I, human basic fibroblast growth factor (bFGF) and insulin for 125I-human TGF alpha binding demonstrated that the avian granulosa cell TGF alpha-R binds human EGF with 300-fold lower affinity than human TGF alpha.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996 Apr"
                    },
                    "PMID:8760113": {
                      "sentence": "These results suggest that the calcium-dependent activation of PKC may participate in the potentiation of the mitogenic effect of EGF by insulin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jul"
                    },
                    "PMID:8775066": {
                      "sentence": "The most profound mitogenic effects of EGF and TGF alpha were seen when they were combined with insulin, IGF-I, or IGF-II.",
                      "object score": 801,
                      "subject score": 1000,
                      "publication date": "1995 Dec"
                    },
                    "PMID:16769812": {
                      "sentence": "We studied the effects of EGF, insulin, and other growth regulators on the expression, interaction, and signaling of ErbB receptors in primary cultures of adult rat hepatocytes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Jul"
                    },
                    "PMID:29579036": {
                      "sentence": "AKT dynamics explain S-phase entry synergy between EGF and insulin, but simulations suggest that stochastic ERK, and not AKT, dynamics seem to drive cell-to-cell proliferation variability, which in simulations is predictable from pre-stimulus fluctuations in C-Raf/B-Raf levels.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 03"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:83375-biolink:physically_interacts_with-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "FMA:83375",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0002844---SEMMEDDB:interacts_with---UMLS:C1367721---SEMMEDDB:",
                    "UMLS:C0002844---SEMMEDDB:interacts_with---UMLS:C0242275---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:6603990",
                    "PMID:8648176",
                    "PMID:1373303",
                    "PMID:7679946",
                    "PMID:9492074",
                    "PMID:3263861",
                    "PMID:3498628",
                    "PMID:7784269",
                    "PMID:8940392",
                    "PMID:2330326",
                    "PMID:29283518",
                    "PMID:2595272",
                    "PMID:16108016"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1373303": {
                      "sentence": "Estrogens and androgens can modulate in different mammalian tissues epidermal growth factor (EGF) production and/or secretion.",
                      "object score": 781,
                      "subject score": 1000,
                      "publication date": "1992 Mar"
                    },
                    "PMID:2330326": {
                      "sentence": "Moreover, metabolic labeling experiments showed no effect of the androgen on EGF synthesis by LNCaP cells.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:2595272": {
                      "sentence": "The significant difference in healing observed between female and male rats may be influenced by the known androgenic regulation of EGF production in the salivary glands.",
                      "object score": 916,
                      "subject score": 828,
                      "publication date": "1989 Nov"
                    },
                    "PMID:3263861": {
                      "sentence": "Androgenic regulation of epidermal growth factor in the mouse ventral prostate.",
                      "object score": 1000,
                      "subject score": 853,
                      "publication date": "1988 Aug"
                    },
                    "PMID:3498628": {
                      "sentence": "These results demonstrate that rat prostate contains specific binding sites for EGF and that their level is modulated by androgens.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987 Oct"
                    },
                    "PMID:6603990": {
                      "sentence": "Since ovarian androgens are obligatory precursors to estrogen formation and induce atresia, a repressive action of EGF on theca-interstitial cytodifferentiation has new implications for understanding the way in which follicles develop in the ovary.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1983 Jul"
                    },
                    "PMID:7679946": {
                      "sentence": "In the presence of androgen, some of the effects of EGF and transforming growth factor alpha on the levels of androgen-regulated mRNAs may be due to down-regulation of the expression of the hAR gene.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Mar 01"
                    },
                    "PMID:7784269": {
                      "sentence": "Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "1995 Jun"
                    },
                    "PMID:8648176": {
                      "sentence": "The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Mar"
                    },
                    "PMID:8940392": {
                      "sentence": "Thus, 2 weeks after orchiectomy, the responses in EGF expression, EGF mRNA polyadenylation, and the activities of the 47-kDa 3' UTR binding protein are the reciprocal of the responses produced by injecting female mice with testosterone for 5 days, providing further evidence that circulating androgens regulate EGF expression posttranscriptionally in a sexually dimorphic, tissue-specific fashion.",
                      "object score": 854,
                      "subject score": 888,
                      "publication date": "1996 Dec"
                    },
                    "PMID:9492074": {
                      "sentence": "The expression of epidermal growth factor receptor (EGFR), which is the receptor of TGF-alpha and EGF, also may be regulated by androgen.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Mar"
                    },
                    "PMID:16108016": {
                      "sentence": "The results revealed that cyclopamine, alone or at a lower concentration in combination with gefitinib, inhibited the growth of sonic hedgehog- (SHH), epidermal growth factor- (EGF) and serum-stimulated androgen-sensitive LNCaP-C33 and LNCaP-LN3 and androgen-independent LNCaP-C81, DU145 and PC3 cells.",
                      "object score": 1000,
                      "subject score": 740,
                      "publication date": "2006 Feb 15"
                    },
                    "PMID:29283518": {
                      "sentence": "In turn, these biologically active factors of the salivary glands, as epidermal growth factor, and parotin, sialorphin, whose expression is regulated by androgens, have an impact on the morphological and functional state of the gonads.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Jan-Mar"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:235758-biolink:decreases_activity_of-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "RXNORM:235758",
              "predicate": "biolink:decreases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:subclass_of-CHEMBL.COMPOUND:CHEMBL2369717": {
              "object": "CHEMBL.COMPOUND:CHEMBL2369717",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL123558-biolink:affects-UniProtKB:P51787": {
              "object": "UniProtKB:P51787",
              "subject": "CHEMBL.COMPOUND:CHEMBL123558",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2108334-biolink:subclass_of-RXNORM:8031": {
              "object": "RXNORM:8031",
              "subject": "CHEMBL.COMPOUND:CHEMBL2108334",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0015505---SEMMEDDB:isa---UMLS:C0030946---SEMMEDDB:",
                    "DRUGBANK:DB00036---DRUGBANK:category---MESH:D010450---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20388709",
                    "PMID:16650817",
                    "PMID:11714090",
                    "PMID:31003762",
                    "PMID:15840825",
                    "PMID:8670099",
                    "PMID:15569823",
                    "PMID:16009717",
                    "PMID:9211891",
                    "PMID:15016732",
                    "PMID:8609163",
                    "PMID:17073711",
                    "PMID:10780319",
                    "PMID:16493004",
                    "PMID:15213840",
                    "PMID:12506724",
                    "PMID:1489892",
                    "PMID:6368733",
                    "PMID:11413047",
                    "PMID:8065454"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1489892": {
                      "sentence": "Mutant factor VII was purified to homogeneity and characterized with respect to gamma-carboxyglutamic acid content, ability to activate, tissue factor-dependent amidolytic activity and expression of factor VIIa proteolytic activity on tissue factor-bearing cells.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "1992 Dec"
                    },
                    "PMID:6368733": {
                      "sentence": "The Factor VII/VIIa protease activity represented 35-40% of the potential initiating activity for the extrinsic coagulation pathway and was demonstrated using functional coagulation assays, as well as in amidolytic assays for the activation of Factor X.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "1984 Apr 01"
                    },
                    "PMID:8065454": {
                      "sentence": "When bound to tissue factor, factor VII is readily converted to the active protease factor VIIa by trace amounts of factors Xa, IXa or VIIa.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "1994 Aug 25"
                    },
                    "PMID:8609163": {
                      "sentence": "Consistently, TF translocates from the Triton X-100-soluble membrane fractions to low-density, detergent-insoluble microdomains that inefficiently support TF-VIIa proteolytic function.",
                      "object score": 798,
                      "subject score": 798,
                      "publication date": "1996 Apr"
                    },
                    "PMID:8670099": {
                      "sentence": "Tissue Factor residue Asp44 regulates catalytic function of the bound proteinase Factor VIIa.",
                      "object score": 824,
                      "subject score": 824,
                      "publication date": "1996 Apr 01"
                    },
                    "PMID:9211891": {
                      "sentence": "Ca2+ binding to the first epidermal growth factor module of coagulation factor VIIa is important for cofactor interaction and proteolytic function.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997 Jul 11"
                    },
                    "PMID:10544046": {
                      "sentence": "Factor VIIa (FVIIa) is a crucial haemostatic protease consisting of four distinct domains termed the Gla, epidermal growth factor-1 (EGF-1), EGF-2, and protease domains (from N- to C-terminus).",
                      "object score": 827,
                      "subject score": 1000,
                      "publication date": "1999 Oct"
                    },
                    "PMID:10780319": {
                      "sentence": "The protease activity is mandatory for intracellular activities induced by coagulation factor VIIa (FVIIa), and in this way it resembles signal transduction induced by thrombin and trypsin caused by specific, proteolytic cleavage of protease activated receptors (PARs).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000 Apr"
                    },
                    "PMID:10985793": {
                      "sentence": "Chemical cross-linking studies identified that a minor population of TF forms dimers on the surface of cells, possibly influencing TF.VIIa proteolytic function as a result of dimerization.",
                      "object score": 798,
                      "subject score": 798,
                      "publication date": "2000 Sep 19"
                    },
                    "PMID:11078728": {
                      "sentence": "The initiating coagulation protease factor VIIa (VIIa) differs by remaining in a zymogen-like conformation that confers the control of catalytic activity to the obligatory cofactor and receptor tissue factor (TF).",
                      "object score": 868,
                      "subject score": 868,
                      "publication date": "2001 Mar 02"
                    },
                    "PMID:11413047": {
                      "sentence": "Recent studies suggest that TF-VIIa mediates cell signaling by two distinct mechanisms, TF cytoplasmic domain-dependent and TF-VIIa protease activity-dependent.",
                      "object score": 787,
                      "subject score": 787,
                      "publication date": "2001 Jan"
                    },
                    "PMID:11714090": {
                      "sentence": "Tissue factor (TF) is the essential cofactor for the coagulation protease factor VIIa (FVIIa), initiating the coagulation cascade.",
                      "object score": 916,
                      "subject score": 916,
                      "publication date": "2001 Apr"
                    },
                    "PMID:11796240": {
                      "sentence": "Factor VIIa (FVIIa) is the coagulation protease responsible for starting a cascade of proteolytic events that lead to thrombin generation, and hence, to fibrin deposition and platelet activation.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Jan"
                    },
                    "PMID:12506724": {
                      "sentence": "Coagulation factor VIIa (FVIIa) is a key protease initiating the coagulation cascade in the presence of its receptor, tissue factor (TF).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Nov"
                    },
                    "PMID:15016732": {
                      "sentence": "FVIIa-dependent STAT5 activation was dependent on FVIIa proteolytic activity but not on generation of the downstream coagulation factors Xa and thrombin, nor on the TF cytoplasmic domain.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "2004 Apr 30"
                    },
                    "PMID:15213840": {
                      "sentence": "Binding of the coagulation protease factor VIIa to its receptor Tissue Factor (TF) induces intracellular signals in several cell types including HaCaT keratinocytes.",
                      "object score": 916,
                      "subject score": 916,
                      "publication date": "2004 Jul"
                    },
                    "PMID:16009717": {
                      "sentence": "Blood coagulation is thought to be initiated by plasma protease factor VIIa in complex with the membrane protein tissue factor.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "2005 Jul 18"
                    },
                    "PMID:16493004": {
                      "sentence": "This process is dependent on FVIIa protease activity.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "2006 Jun 15"
                    },
                    "PMID:16650817": {
                      "sentence": "Protease-activated receptor 2 (PAR2) is a G-protein coupled receptor that is cleaved and activated by serine proteases including the coagulation protease factor VIIa (FVIIa).",
                      "object score": 916,
                      "subject score": 916,
                      "publication date": "2006 Jun 16"
                    },
                    "PMID:25344622": {
                      "sentence": "Factor VIIa (FVIIa) is a trypsin-like protease that plays an important role in initiating blood coagulation.",
                      "object score": 840,
                      "subject score": 1000,
                      "publication date": "2014 Dec 19"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL403664-biolink:affects-UniProtKB:Q15796": {
              "object": "UniProtKB:Q15796",
              "subject": "CHEMBL.COMPOUND:CHEMBL403664",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL403664---DGIdb:affects---NCBIGene:4087---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17274978"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL405110-biolink:affects-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "CHEMBL.COMPOUND:CHEMBL405110",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL405110---DGIdb:affects---NCBIGene:4088---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL506569-biolink:affects-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "CHEMBL.COMPOUND:CHEMBL506569",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL506569---DGIdb:affects---NCBIGene:4088---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264829-biolink:physically_interacts_with-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "FMA:264829",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0021760---SEMMEDDB:interacts_with---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12853969",
                    "PMID:10072879",
                    "PMID:23161414",
                    "PMID:24344329",
                    "PMID:30444930",
                    "PMID:33310048",
                    "PMID:8528940",
                    "PMID:22103462",
                    "PMID:27892604",
                    "PMID:2104224",
                    "PMID:16598747",
                    "PMID:15661740",
                    "PMID:17072955",
                    "PMID:7664978",
                    "PMID:7948746",
                    "PMID:32655793",
                    "PMID:19862334"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2104224": {
                      "sentence": "The ability of TGF beta 1 to induce IL 6 suggests that IL 6 may mediate some of the effects of TGF beta 1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 May"
                    },
                    "PMID:7664978": {
                      "sentence": "We incubated adrenal cells with 50 pM 125I-labeled TGF-beta 1 for 15 min to 3 h at 4 degree C and found that the binding of 125I-labeled TGF-beta 1 increased with time and could be inhibited in a dose-dependent manner by non-labeled TGF-beta 1 (0.05-10 nM), but not with other relevant cytokines: IL6, TNF alpha,IGF-I, IGF-II, TGF-alpha, and EGF.",
                      "object score": 881,
                      "subject score": 1000,
                      "publication date": "1995 Apr 01"
                    },
                    "PMID:7948746": {
                      "sentence": "In this study we have analysed in parallel the effects of TGF-beta 1 on both DNA synthesis and production of the cytokines IL-1, IL-2, IL-6, and TNF-alpha by pokeweed mitogen-stimulated peripheral blood mononuclear cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Jul"
                    },
                    "PMID:8528940": {
                      "sentence": "IL-2 and IL-6 were capable of abolishing the effect of TGF-beta 1 on DNA synthesis and production of IL-10 by T lymphocytes in an additive manner.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Aug"
                    },
                    "PMID:10072879": {
                      "sentence": "METHODS: RT-PCT was conducted to detect the expression of TGF alpha, TGF beta 1, IL-6, IL-8, bFGF and ANG, and the expression of receptors EGFR, IL-6R and IL-8R; 3H-TdR incorporation assay was used to determine the effects of recombinant TGF alpha, TGF beta 1 and IL-6 on the proliferation of the two cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Apr"
                    },
                    "PMID:12853969": {
                      "sentence": "Collectively, our data demonstrate that IL-6 expression is stimulated by tumor-producing TGF-beta1 in human prostate cancer cells through multiple signaling pathways including Smad2, p38, JNK, and Ras, and enhanced expression of IL-6 could contribute to the oncogenic switch of TGF-beta1 role for prostate tumorigenesis, in part by counteracting its growth suppression function.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2003 Jul 10"
                    },
                    "PMID:15661740": {
                      "sentence": "We have assessed the effect of IL-6 on TGF-beta1 signaling and defined the mechanism by which this occurred.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2005 Apr 01"
                    },
                    "PMID:16598747": {
                      "sentence": "We also demonstrated the reciprocal effect of PSCs-secreted IL-6 on autocrine TGF-beta1.",
                      "object score": 901,
                      "subject score": 780,
                      "publication date": "2006 Sep 01"
                    },
                    "PMID:17072955": {
                      "sentence": "TGF-beta1 activates IL-6 production, and the functional interaction between TGF-beta1 and IL-6 contributes to ICC cell growth by TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Oct 21"
                    },
                    "PMID:19862334": {
                      "sentence": "When the activator protein-1 binding sites of the IL-6 promoter region were deleted, the stimulation effects of TGF-beta1 decreased.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2009 Oct 21"
                    },
                    "PMID:22103462": {
                      "sentence": "Activated IL-6 (interleukin-6) signalling could be the mechanism underlying the effects of TGF-beta1 on oral cancer.",
                      "object score": 1000,
                      "subject score": 890,
                      "publication date": "2012 May 01"
                    },
                    "PMID:23161414": {
                      "sentence": "LPS also caused increased levels of IL-6, IL-8 and MCP1 without exerting any effect on TNF-alpha, IFN-alpha or TGF-beta1 at 24 h.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Mar"
                    },
                    "PMID:24344329": {
                      "sentence": "Together, these data indicate that the mechanism of IL-6 and TGF-beta1 production in renal tissue of Thy-1N rats is associated with sublytic C5b-9 up-regulated p300 and p300-mediated C/EBPbeta acetylation as well as C/EBPbeta-activated IL-6 and TGF-beta1 genes.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2014 Mar"
                    },
                    "PMID:27892604": {
                      "sentence": "It been shown that IL-6 modulates TGF-beta1 expression in fibroblasts, however, what role IL-6 plays concerning TGF-betaR expression and function in skin is unknown.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2017 08"
                    },
                    "PMID:30444930": {
                      "sentence": "Additionally, the effects of TGF-?1 on both IgE and IL-33-mediated short term activation were observed via flow cytometric analysis of both surface LAMP-1 expression and intracellular IL-6.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2018"
                    },
                    "PMID:32655793": {
                      "sentence": "Moreover, fingolimod suppressed the secretion of pro-inflammatory or inflammatory cytokines IL-17A, IL-6, and INF-gamma, but did not noticeably alter the secretion of immunosuppressive cytokines TGF-beta1 and IL-4.",
                      "object score": 824,
                      "subject score": 1000,
                      "publication date": "2020"
                    },
                    "PMID:33310048": {
                      "sentence": "In addition, the treatment reduced the concentration of IL-1beta, IL-6 and TNF-alpha (P < 0.05) but have no effects on TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Dec 10"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-UniProtKB:P06213": {
              "object": "UniProtKB:P06213",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-UniProtKB:P08069": {
              "object": "UniProtKB:P08069",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:33699-biolink:physically_interacts_with-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEBI:33699",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0035696---SEMMEDDB:interacts_with---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:2240083",
                    "PMID:29926674",
                    "PMID:7562346",
                    "PMID:11352074",
                    "PMID:11961406",
                    "PMID:21941776",
                    "PMID:20685750",
                    "PMID:27723266",
                    "PMID:9721696",
                    "PMID:11505069"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2240083": {
                      "sentence": "All tissues found at the maternal-fetal interface, including first-trimester decidua, placenta, and placental membranes, contained transforming growth factor-beta and expressed transforming growth factor-beta 1 messenger ribonucleic acid.",
                      "object score": 860,
                      "subject score": 860,
                      "publication date": "1990 Nov"
                    },
                    "PMID:7562346": {
                      "sentence": "The present study was undertaken to assess the effect of interleukin-1 beta (IL-1 beta), platelet-derived growth factor (PDGF), and transforming growth factor-beta 1 (TGF-beta) on the expression of collagenase (MMP-1) and TIMP-1 mRNA in periodontal derived fibroblasts using reverse transcription polymerase chain reaction (RT-PCR).",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1995 Jul"
                    },
                    "PMID:9721696": {
                      "sentence": "These studies suggest that this downregulation of HO-1 mRNA and protein expression and decrease in IL-1beta-induced HO enzyme activity may contribute to the beneficial effect of TGF-beta1 on endotoxic shock.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "1998 Aug 24"
                    },
                    "PMID:11352074": {
                      "sentence": "HCAEC constitutively expressed both TGF-beta-1 and TGF-beta-2 mRNA, whereas HUVEC constitutively expressed TGF-beta-1 only.",
                      "object score": 750,
                      "subject score": 893,
                      "publication date": "2001 May"
                    },
                    "PMID:11505069": {
                      "sentence": "mRNA from bone marrow stromal cultures was extracted and probed for TGF-beta1 and macrophage inflammatory protein (MIP)-1alpha.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Aug"
                    },
                    "PMID:11961406": {
                      "sentence": "We studied the expression of TSP-1 mRNA and protein during the development of glomerular and tubulointerstitial nephrosclerosis in the renal ablation model particularly in relation to TGF-beta1 expression.",
                      "object score": 928,
                      "subject score": 901,
                      "publication date": "2002 Apr"
                    },
                    "PMID:20685750": {
                      "sentence": "NOX4, alpha-SMA and procollagen I (alpha1) mRNA and protein expression, reactive oxygen species production and Smad2/3 phosphorylation were quantified, in the absence and in the presence of incubation with TGFbeta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Aug"
                    },
                    "PMID:21941776": {
                      "sentence": "CONCLUSION: Sch-B can reduce the pulmonary fibrosis induced by SiO2 through inhibition of the mRNA express of TGF-beta1 and Smad4 in the lung tissue, modulating the TGF-beta1/Smad4 signal transduction pathway and inhibiting the target gene activation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Apr"
                    },
                    "PMID:27723266": {
                      "sentence": "MTT assay, reverse transcription-polymerase chain reaction, Western blotting and enzyme-linked immunosorbant assay (ELISA) were used to detect the effect of TGF-beta1 on cell viability, mRNA and protein expression of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), plasminogen activator inhibitor-1 (PAI-1) as well as their secretion.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Apr"
                    },
                    "PMID:29926674": {
                      "sentence": "The expressions of mRNA and protein of TGF-beta1, Smad 2/3 and the level of Smad 2/3 phosphorylation were increased significantly in TGF-beta1 transfected MC, and CA could dramatically reduce the expressions of mRNA and protein of TGF-beta1, Smad 2/3 and the level of Smad 2/3 phosphorylation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Feb 08"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:physically_interacts_with-UniProtKB:P29474": {
              "object": "UniProtKB:P29474",
              "subject": "CHEBI:35457",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:interacts_with---UMLS:C0669365---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:27701500",
                    "PMID:18729004",
                    "PMID:18227404",
                    "PMID:27502043",
                    "PMID:7556274",
                    "PMID:8293771",
                    "PMID:24044029",
                    "PMID:11345361",
                    "PMID:15752944",
                    "PMID:18497479",
                    "PMID:10690283",
                    "PMID:12030350",
                    "PMID:10368123",
                    "PMID:31337127",
                    "PMID:15963975",
                    "PMID:10052865",
                    "PMID:21140270",
                    "PMID:9416943",
                    "PMID:19275271",
                    "PMID:2146221"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2146221": {
                      "sentence": "Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1990 Nov"
                    },
                    "PMID:7556274": {
                      "sentence": "The chronic effects of ACE inhibitors on endothelial function were compared with those of selective angiotensin(AT)1-receptor blockade in cyclosporin A (CsA) treated rats.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1995 May"
                    },
                    "PMID:8293771": {
                      "sentence": "This study aimed to determine the density of vascular beta-adrenergic receptors in cultured endothelial cells and to study the regulation of endothelial receptors after exposure to catecholamines and the ACE inhibitors, lisinopril and ramiprilat.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1993 Nov"
                    },
                    "PMID:9416943": {
                      "sentence": "This pilot study evaluates the effects of quinapril, an angiotensin-converting enzyme inhibitor with high tissue-binding affinity, on microvascular endothelial function in patients with mild (<40% narrowing) coronary artery disease and epicardial endothelial dysfunction.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1997 Dec 15"
                    },
                    "PMID:9734101": {
                      "sentence": "However, the endothelial effect of the pharmacologic treatment of this pathology with angiotensin converting enzyme (ACE) inhibitor is poorly understood.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997"
                    },
                    "PMID:9860785": {
                      "sentence": "Because their affinity to tissue ACE may influence the ability of ACE inhibitors to affect endothelial function, we compared the effects of quinaprilat (high affinity to tissue ACE) and enalaprilat (low affinity to tissue ACE) on FDD in patients with CHF.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998 Dec 22-29"
                    },
                    "PMID:10052865": {
                      "sentence": "In hypertensives, angiotensin-converting enzyme (ACE) inhibitors and sodium restriction may favorably influence endothelial function.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998 Dec"
                    },
                    "PMID:10690283": {
                      "sentence": "OBJECTIVES: To elucidate the relationship between renin-angiotensin system and nitric oxide in hypertensive heart failure, we evaluated the effects of long-term treatment with imidapril, angiotensin-converting enzyme inhibitor, on endothelial-cell nitric oxide synthase (eNOS) and inducible NOS (iNOS) expression in the left ventricle (LV) and its relation to myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats (DS) fed a high-salt diet.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "1999 Dec"
                    },
                    "PMID:11345361": {
                      "sentence": "BACKGROUND: The ACE genotype is a known predictor of the response to an ACE inhibitor drug; however, it is not clear whether it can modify the effect of estrogen replacement therapy (ERT) on endothelial function in postmenopausal women.",
                      "object score": 888,
                      "subject score": 928,
                      "publication date": "2001 May"
                    },
                    "PMID:12030350": {
                      "sentence": "The present data suggest that the upregulation of the M3 receptor by the ACE inhibitor and AT1 receptor antagonist is a new beneficial effect of these drugs on microvascular endothelial function.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2002 May"
                    },
                    "PMID:15752944": {
                      "sentence": "CONCLUSIONS: We conclude that ACEi and ARB may have similar effects on insulin sensitivity, irrespective of the more pronounced effects of ACEi on endothelial function.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2005 Feb"
                    },
                    "PMID:15963975": {
                      "sentence": "Coadministration of icatibant, a bradykinin B(2)-receptor antagonist (200 microg/kg/day), with enalapril blunted the stimulatory effect of the ACE inhibitor on eNOS mRNA expression, circulating levels of nitrite/nitrate, the relaxant activity of ACh and the release of 6-keto-PGF1alpha in L-NAME-treated rats.",
                      "object score": 873,
                      "subject score": 1000,
                      "publication date": "2005 Jun 15"
                    },
                    "PMID:18227404": {
                      "sentence": "Combined treatment with a selective aldosterone antagonist and an angiotensin-converting enzyme inhibitor has additive protective effects on endothelial function and on atherosclerotic changes via decreased nitrosative stress.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2008 Mar"
                    },
                    "PMID:18497479": {
                      "sentence": "In conclusion, the combined treatment with an ACEI and an ARB may have additive protective effects on endothelial function as well as atherosclerotic change.",
                      "object score": 888,
                      "subject score": 816,
                      "publication date": "2008 Mar"
                    },
                    "PMID:18729004": {
                      "sentence": "Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers that target the renin-angiotensin system slow CKD progression, possibly due to their effects on improving endothelial function, independent of controlling blood pressure.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2008 Sep"
                    },
                    "PMID:19275271": {
                      "sentence": "Accumulating preclinical evidence for the absence of a class effect for ACE inhibitors includes differences in terms of effect on eNOS and rate of endothelial apoptosis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009"
                    },
                    "PMID:21140270": {
                      "sentence": "ACE inhibitors may improve CSF through positive effects on endothelial function.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2011 Jul"
                    },
                    "PMID:24044029": {
                      "sentence": "CONCLUSION: Use of ACE inhibitors and statins before bypass surgery may influence IMA vasoreactivity by improving endothelial control of vascular tone.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:27502043": {
                      "sentence": "Then the effect of two ACE inhibitory peptides on the endothelial function of HUVECs was evaluated.",
                      "object score": 888,
                      "subject score": 871,
                      "publication date": "2016 Sep 14"
                    },
                    "PMID:27701500": {
                      "sentence": "These results support the protective effect of angiotensin converting enzyme inhibitors on the endothelial function after intensive periodontal treatment.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2016 Apr"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:physically_interacts_with-UniProtKB:P29474": {
              "object": "UniProtKB:P29474",
              "subject": "CHEBI:35530",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:interacts_with---UMLS:C0669365---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15529563",
                    "PMID:15579057",
                    "PMID:25629351",
                    "PMID:7752668",
                    "PMID:15233977",
                    "PMID:24672712",
                    "PMID:12383592",
                    "PMID:16075029",
                    "PMID:18413195",
                    "PMID:27980592",
                    "PMID:18287890",
                    "PMID:10676671",
                    "PMID:26202651",
                    "PMID:20198199"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7752668": {
                      "sentence": "There are also promising data suggesting that beta-blockade is useful in endothelial protection and atheroma prevention, and benefits patients with hypertrophic cardiomyopathy and heart failure. beta-Blockers have evolved from early nonselective agents, e.g., propranolol, to modern highly beta 1-selective agents, e.g., bisoprolol. beta 1-Blockade is the essential element that leads to the above cardiovascular benefits in addition to improving the quality of life (similar to angiotensin-converting enzyme inhibitors).",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1995"
                    },
                    "PMID:10676671": {
                      "sentence": "OBJECTIVES: The purpose of this study was to compare the effect of different antihypertensive agents, calcium antagonists, angiotensin-converting enzyme (ACE) inhibitors, beta-blockers and diuretic agents on endothelial function.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000 Feb"
                    },
                    "PMID:12383592": {
                      "sentence": "Clinical studies in which treatment with angiotensin converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) was used demonstrated correction of some of the changes in large and small arteries in hypertensive subjects, whereas identical BP lowering with beta-blockers had no effect on endothelial function.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Oct"
                    },
                    "PMID:15233977": {
                      "sentence": "The effect of vasodilating beta-blockers on endothelial function and prothrombotic state has not been investigated.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2004 Jul"
                    },
                    "PMID:15529563": {
                      "sentence": "While first-generation beta-blockers showed contrasting or null effects on endothelial function, newer beta-blockers of the third generation, such as carvedilol and nebivolol, seem to be provided with specific endothelium-mediated vasodilating effects.",
                      "object score": 888,
                      "subject score": 884,
                      "publication date": "2004 Oct"
                    },
                    "PMID:15579057": {
                      "sentence": "This is in contrast to the beta blockers and alpha adrenergic blockers that appear to indirectly influence endothelial function solely as a result of lowered blood pressure.",
                      "object score": 790,
                      "subject score": 1000,
                      "publication date": "2004"
                    },
                    "PMID:16075029": {
                      "sentence": "Finally, beta-blockers classically do not affect endothelial function.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2005 Jun"
                    },
                    "PMID:18287890": {
                      "sentence": "Effect of beta-blockers on endothelial function during biological aging: a nanotechnological approach.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2008 Feb"
                    },
                    "PMID:18413195": {
                      "sentence": "Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2008 Sep-Oct"
                    },
                    "PMID:20198199": {
                      "sentence": "OBJECTIVE: To determine the effects of two beta-blockers, nebivolol and bisoprolol, on endothelial function in newly diagnosed hypertensive patients.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2009"
                    },
                    "PMID:24672712": {
                      "sentence": "Recent studies have reported that vasodilatory beta-blockers have adequate antihypertensive efficacy and less harmful effects on the metabolic profile, and also exert beneficial effects on endothelial function and renal protection.",
                      "object score": 888,
                      "subject score": 865,
                      "publication date": "2014"
                    },
                    "PMID:25629351": {
                      "sentence": "Beta blockers are known to have favorable effects on endothelial function partly because of their capacity to reduce oxidative stress.",
                      "object score": 790,
                      "subject score": 1000,
                      "publication date": "2016 Nov/Dec"
                    },
                    "PMID:26202651": {
                      "sentence": "The comparison of FMD change between the beta-blockers and placebo groups showed a statistically significant effect of beta-blockers on endothelial function (mean difference [MD] 0.83; 95% confidence interval [CI] 0.11-1.55; p = 0.02).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2015"
                    },
                    "PMID:27980592": {
                      "sentence": "Thus, the aim of this study was to investigate effects of metoprolol, as a beta blocker, on endothelial function in CSX patients.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2016"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1200402-biolink:affects-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL1200402",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL1491---DGIdb:affects---NCBIGene:1636---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20577119"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:affects-UniProtKB:P01106": {
              "object": "UniProtKB:P01106",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL650---DGIdb:affects---NCBIGene:4609---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9169090"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:affects-UniProtKB:P01579": {
              "object": "UniProtKB:P01579",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL650---DGIdb:affects---NCBIGene:3458---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9396353"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:affects-UniProtKB:P02778": {
              "object": "UniProtKB:P02778",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL650---DGIdb:affects---NCBIGene:3627---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17220550"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:affects-UniProtKB:P04637": {
              "object": "UniProtKB:P04637",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL650---DGIdb:affects---NCBIGene:7157---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16684279"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:affects-UniProtKB:P10415": {
              "object": "UniProtKB:P10415",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL650---DGIdb:affects---NCBIGene:596---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16684279",
                    "PMID:16141680"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201082-biolink:affects-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201082",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL41---DGIdb:affects---NCBIGene:1636---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:27262302"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201082-biolink:affects-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201082",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL41---DGIdb:affects---NCBIGene:4843---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16413968"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1256940-biolink:affects-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL1256940",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1322218-biolink:affects-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.COMPOUND:CHEMBL1322218",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL24---DGIdb:affects---NCBIGene:7040---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15049387"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1322218-biolink:affects-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL1322218",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL24---DGIdb:affects---NCBIGene:1636---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8728305",
                    "PMID:12844134",
                    "PMID:11593098"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1697788-biolink:affects-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "CHEMBL.COMPOUND:CHEMBL1697788",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:affects-UniProtKB:P60953": {
              "object": "UniProtKB:P60953",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:affects-UniProtKB:P07550": {
              "object": "UniProtKB:P07550",
              "subject": "CHEMBL.COMPOUND:CHEMBL3249705",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL160519---DGIdb:affects---NCBIGene:154---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:affects-UniProtKB:Q16665": {
              "object": "UniProtKB:Q16665",
              "subject": "CHEMBL.COMPOUND:CHEMBL3249705",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3989410-biolink:affects-UniProtKB:P30556": {
              "object": "UniProtKB:P30556",
              "subject": "CHEMBL.COMPOUND:CHEMBL3989410",
              "predicate": "biolink:affects",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL6---DGIdb:affects---NCBIGene:185---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9357777"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:dgidb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-DOID:0080685": {
              "object": "DOID:0080685",
              "subject": "FMA:264829",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:63018-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "FMA:63018",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:67303-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "FMA:67303",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:81101-biolink:gene_associated_with_condition-MONDO:0001298": {
              "object": "MONDO:0001298",
              "subject": "FMA:81101",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:81101-biolink:gene_associated_with_condition-MONDO:0004910": {
              "object": "MONDO:0004910",
              "subject": "FMA:81101",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:81101-biolink:gene_associated_with_condition-MONDO:0005648": {
              "object": "MONDO:0005648",
              "subject": "FMA:81101",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:83358-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "FMA:83358",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:9445---JensenLab:associated_with---DOID:6000---JensenLab:",
                    "NCBIGene:5617---biolink:gene_associated_with_condition---UMLS:C0018801---DisGeNET:",
                    "NCBIGene:5617---biolink:gene_associated_with_condition---UMLS:C0018802---DisGeNET:",
                    "NCBIGene:5617---biolink:gene_associated_with_condition---UMLS:C1959583---DisGeNET:",
                    "NCBIGene:5617---biolink:gene_associated_with_condition---UMLS:C1961112---DisGeNET:",
                    "NCBIGene:5617---biolink:gene_associated_with_condition---UMLS:C0023212---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:22567052",
                    "PMID:30809287",
                    "PMID:23639660",
                    "PMID:24273550",
                    "PMID:25532575",
                    "PMID:25885996",
                    "PMID:31774626",
                    "PMID:27288200",
                    "PMID:23790560",
                    "PMID:18787375",
                    "PMID:24407185",
                    "PMID:28062207",
                    "PMID:28855797",
                    "PMID:21220271",
                    "PMID:18926768",
                    "PMID:29056678",
                    "PMID:28848326",
                    "PMID:23551967",
                    "PMID:28868357",
                    "PMID:21888683"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2369717-biolink:has_part-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "CHEMBL.COMPOUND:CHEMBL2369717",
              "predicate": "biolink:has_part",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0242275---SEMMEDDB:part_of---UMLS:C1305923---SEMMEDDB:",
                    "UMLS:C1509244---SEMMEDDB:part_of---UMLS:C1305923---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:2787828",
                    "PMID:9510949",
                    "PMID:9581567",
                    "PMID:24721622",
                    "PMID:3792139",
                    "PMID:3498986",
                    "PMID:9268386",
                    "PMID:3264462",
                    "PMID:2605793",
                    "PMID:8621250",
                    "PMID:1560680",
                    "PMID:7855315",
                    "PMID:2658731",
                    "PMID:19864325",
                    "PMID:6309581",
                    "PMID:2428906"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1560680": {
                      "sentence": "The in vitro replicative potential of human diploid fibroblasts can be increased by polypeptide growth factors such as epidermal growth factor (EGF).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1992 Jan"
                    },
                    "PMID:2428906": {
                      "sentence": "The proliferation of cells in vivo and in culture is regulated by polypeptide growth factors, such as epidermal growth factor (EGF) and platelet-derived growth factor (PDGF).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1986 Sep"
                    },
                    "PMID:2605793": {
                      "sentence": "Epidermal growth factor (EGF) is a polypeptide mitogen first isolated from mouse submaxillary glands and later from human urine.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1989 Aug"
                    },
                    "PMID:2658731": {
                      "sentence": "Yet, the presence of nuclear triiodothyronine receptors in experimental and human tumors and the recent discovery, by several authors, that the cellular counterpart of a viral oncogene (v-erb A) encodes a thyroid hormone receptor, suggest: either a direct influence of the hormone on the initiation and/or the progress of these tumors; or an indirect effect, via the modulation of another metabolic regulator, for example a polypeptide growth factor (Epidermal Growth Factor, Transforming Growth Factor).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1989"
                    },
                    "PMID:2787828": {
                      "sentence": "The polypeptide mitogen, epidermal growth factor (EGF), was originally isolated from mouse submaxillary gland (SMG).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1989 Jun"
                    },
                    "PMID:3264462": {
                      "sentence": "Epidermal growth factor (EGF) is a potent polypeptide mitogen with various receptor-mediated growth effects on cells from the skin, breast, and gastrointestinal tract.",
                      "object score": 818,
                      "subject score": 1000,
                      "publication date": "1988 Dec"
                    },
                    "PMID:3498986": {
                      "sentence": "Epidermal growth factor (EGF) is a potent polypeptide mitogen originally isolated from the adult male mouse submaxillary gland.",
                      "object score": 818,
                      "subject score": 1000,
                      "publication date": "1987 Oct 02"
                    },
                    "PMID:3792139": {
                      "sentence": "The proliferation of cells in vivo and in culture is regulated by polypeptide growth factors, such as epidermal growth factor (EGF) and platelet-derived growth factor (PDGF).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1986"
                    },
                    "PMID:6309581": {
                      "sentence": "Epidermal growth factor (EGF) is a polypeptide mitogen that stimulates the proliferation of epidermal and epithelial cells in intact animals and a variety of cell types in cell culture.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1983 Jul"
                    },
                    "PMID:7855315": {
                      "sentence": "Several lines of evidence indicate that tubular regeneration is mediated by polypeptide growth factors such as epidermal growth factor (EGF).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1994"
                    },
                    "PMID:8621250": {
                      "sentence": "Heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) is a member of the EGF family of polypeptide growth factors, which includes EGF, transforming growth factor alpha(TGF-alpha), amphiregulin (AR) and betacellulin (BTC).",
                      "object score": 901,
                      "subject score": 916,
                      "publication date": "1996 May 03"
                    },
                    "PMID:9268386": {
                      "sentence": "In the case of polypeptide growth factors such as the epidermal growth factor (EGF) and platelet-derived growth factor (PDGF), the steps leading to activation of MAPK require the function of the adaptor protein Grb2 (growth factor receptor binding protein 2), which can bind either directly or indirectly via its Src homology 2 domain to activated receptor tyrosine kinases.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1997 Aug 29"
                    },
                    "PMID:9510949": {
                      "sentence": "More importantly, polypeptide growth factors, such as epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I), also stimulate the ER's transcriptional activity in an estrogen-independent manner.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1998 Mar"
                    },
                    "PMID:9581567": {
                      "sentence": "Human epidermal growth factor (EGF) and human transforming growth factor alpha (TGF-alpha) are structurally related polypeptide growth factors that exert their mitogenic activity through interaction with a common cell-surface receptor, the epidermal growth factor receptor (EGFR).",
                      "object score": 798,
                      "subject score": 1000,
                      "publication date": "1997 Nov 01"
                    },
                    "PMID:19864325": {
                      "sentence": "Epidermal growth factor (EGF), a polypeptide growth factor, binds to the EGF receptor (EGFR), a receptor tyrosine kinase.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2010 Jan"
                    },
                    "PMID:24721622": {
                      "sentence": "Epidermal growth factor (EGF) is a polypeptide growth factor that binds to the EGF-receptor (EGFR).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2014"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264825-biolink:gene_associated_with_condition-MONDO:0005648": {
              "object": "MONDO:0005648",
              "subject": "FMA:264825",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264827-biolink:gene_associated_with_condition-MONDO:0002076": {
              "object": "MONDO:0002076",
              "subject": "FMA:264827",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264827-biolink:gene_associated_with_condition-MONDO:0008375": {
              "object": "MONDO:0008375",
              "subject": "FMA:264827",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-MONDO:0001298": {
              "object": "MONDO:0001298",
              "subject": "FMA:264829",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-MONDO:0002076": {
              "object": "MONDO:0002076",
              "subject": "FMA:264829",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264829-biolink:gene_associated_with_condition-MONDO:0008375": {
              "object": "MONDO:0008375",
              "subject": "FMA:264829",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0279328-biolink:subclass_of-CHEMBL.COMPOUND:CHEMBL1234886": {
              "object": "CHEMBL.COMPOUND:CHEMBL1234886",
              "subject": "UMLS:C0279328",
              "predicate": "biolink:subclass_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0279328---SEMMEDDB:isa---UMLS:C0030054---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:14214227",
                    "PMID:1575432",
                    "PMID:12974755",
                    "PMID:17520859",
                    "PMID:1872551",
                    "PMID:15970733",
                    "PMID:12370492",
                    "PMID:11733717",
                    "PMID:15337027",
                    "PMID:17173873",
                    "PMID:19152028",
                    "PMID:12011721",
                    "PMID:14595184",
                    "PMID:14756228",
                    "PMID:11704328",
                    "PMID:19179645",
                    "PMID:20123096",
                    "PMID:10966258",
                    "PMID:12538989",
                    "PMID:19287337"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:414400": {
                      "sentence": "The hormonal stimulation of sodium transport by pitressin or aldosterone was inhibited by hyperbaric oxygen but was unaffected by prolonged exposure to oxygen at 1 ATA.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1977 Dec"
                    },
                    "PMID:645161": {
                      "sentence": "In various diseases and injuries the application of hyperbaric oxygen is an additional measure of therapy using the oxygen physically dissolved in the plasma.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1978"
                    },
                    "PMID:1575432": {
                      "sentence": "Groin skin flaps were harvested, stored in either room air or HBO (100% oxygen at 2.9 atm absolute) at 23 degrees C for 18 hours, and transplanted to the contralateral groin.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1992 Mar"
                    },
                    "PMID:1872551": {
                      "sentence": "The right hindlimbs of male Sprague-Dawley rats were severed and were replanted by microvascular anastomoses after storage in either room air or hyperbaric oxygen (100% oxygen at 2.9 atm absolute) at 23 degrees C for 5 hours.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1991 Jul"
                    },
                    "PMID:2377172": {
                      "sentence": "Pure erythrocytes treated with high-pressure oxygen (HBO) at 0.7 MPa for 1 h are clastogenic for intact syngeneic lymphocytes.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1990 Aug"
                    },
                    "PMID:6163514": {
                      "sentence": "The viability of resting suspensions of Escherichia coli K12 Ymel exposed to air plus 300 psi (1 psi = 6.895 kPa) oxygen (hyperbaric oxygen) decreased as an apparent first-order process after an initial period of constant viability.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1981 Jan"
                    },
                    "PMID:8501819": {
                      "sentence": "Hyperbaric oxygen (100% oxygen, 2.8 atmospheres, 90 minutes) was delivered twice a day for 4 days, with group III receiving a fifth HBO treatment just before acrolein and group IV receiving the fifth HBO treatment just after acrolein.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1993 Jun"
                    },
                    "PMID:8861891": {
                      "sentence": "The control animals breathed normobaric air, and the others breathed normobaric 100% oxygen or hyperbaric oxygen (100% oxygen at the equivalent of 33 feet of seawater, 2.0 atmospheres absolute), respectively, for two periods of 90 minutes for 7 days.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1996 Oct"
                    },
                    "PMID:9049601": {
                      "sentence": "In these experiments rats were exposed to hyperbaric oxygen (100% oxygen; 2.5 atmospheres absolute pressure) for 1, 3 or 6 h.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1997 Feb 05"
                    },
                    "PMID:9641281": {
                      "sentence": "A temporal analysis of the effects of pressurized oxygen (HBO) on the pH of amputated muscle tissue.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1998 Jun"
                    },
                    "PMID:11733717": {
                      "sentence": "The rats under investigation were subjected to 10 min transient forebrain ischemia, and subsequently exposed to HBO (100% oxygen, 2.5 atm absolute) for 2 h.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2001 Nov 16"
                    },
                    "PMID:12370492": {
                      "sentence": "Hyperbaric oxygen (HBO) is 100% oxygen administered at elevated atmospheric pressure.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2002 Dec"
                    },
                    "PMID:12974755": {
                      "sentence": "Hyperbaric oxygen (HBO) is 100% oxygen administered at elevated atmospheric pressure to patients with inflammatory diseases.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2003 Oct"
                    },
                    "PMID:14214227": {
                      "sentence": "The single apparent and potential benefit of hyperbaric oxygen is the great increase in the blood content of dissolved oxygen achieved when pure oxygen is breathed at increased pressure.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "1964 Nov 14"
                    },
                    "PMID:14595184": {
                      "sentence": "The rats were divided into 4 groups: group 0, sham (n = 10); group I, 4 hours of ischemia followed by reperfusion (n = 30); group II, 4 hours of ischemia and hyperbaric oxygen (100% oxygen, 2.5 atm absolute, during the last 90 minutes of ischemia before reperfusion) followed by reperfusion (n = 30); and group III, 4 hours of ischemia followed by reperfusion and hyperbaric oxygen (100% oxygen, 2.5 atm absolute, after reperfusion for 90 minutes; n = 30).",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2003 Nov"
                    },
                    "PMID:14756228": {
                      "sentence": "Topical oxygen is not hyperbaric oxygen (HBO2).",
                      "object score": 861,
                      "subject score": 901,
                      "publication date": "2003"
                    },
                    "PMID:17173873": {
                      "sentence": "The present study examined the time course of neuroprotection of HBO (3.5 atmosphere absolute, 100% oxygen, 1 h for 5 consecutive days) and the changes of gene/protein expression in rats.",
                      "object score": 781,
                      "subject score": 1000,
                      "publication date": "2007 Jan 26"
                    },
                    "PMID:23086098": {
                      "sentence": "Hyperbaric oxygen (HBO2) is the inhalation of 100% oxygen at pressures > 1.4 times atmospheric pressure.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2012 Aug"
                    },
                    "PMID:24113418": {
                      "sentence": "Male NIH Swiss mice were exposed to HBO2 (100% oxygen at 3.5atm absolute) for 11min and their antinociceptive responsiveness was determined using the glacial acetic acid-induced abdominal constriction test.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2013 Dec 02"
                    },
                    "PMID:24400144": {
                      "sentence": "Ten divers each completed three protocols: (1) a SCUBA dive at 400 kPa for 30 min; (2) a 41-min duration of seawater surface head immersed finning exercise to determine the effect of immersion and moderate physical activity; and (3) a simulated 41-min dive breathing 100% oxygen (hyperbaric oxygen [HBO]) at 170 kPa in order to analyze the effect of diving-induced hyperoxia.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2013 Nov"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:235758-biolink:physically_interacts_with-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "RXNORM:235758",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:8031-biolink:entity_negatively_regulates_entity-FMA:67303": {
              "object": "FMA:67303",
              "subject": "RXNORM:8031",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0030946---SEMMEDDB:inhibits---UMLS:C0041194---SEMMEDDB:",
                    "UMLS:C0030946---SEMMEDDB:inhibits---UMLS:C0013765---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11589576",
                    "PMID:9106565",
                    "PMID:2922699",
                    "PMID:16962555",
                    "PMID:1936214",
                    "PMID:167096",
                    "PMID:8034752",
                    "PMID:17906662",
                    "PMID:16539369",
                    "PMID:21979117",
                    "PMID:22995909",
                    "PMID:758237"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:167096": {
                      "sentence": "Thioglycolate-stimulated mouse peritoneal macrophages secrete a Proteinase which degrades insoluble elastin.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1975 Aug 01"
                    },
                    "PMID:758237": {
                      "sentence": "A possible role for elastin ligands in the proteolytic degradation of arterial elastic lamellae in the rabbit.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1979 Jan"
                    },
                    "PMID:1936214": {
                      "sentence": "The susceptibility of normal skin elastin to proteolytic degradation may have implications in the study of aging skin.",
                      "object score": 851,
                      "subject score": 888,
                      "publication date": "1991 Oct"
                    },
                    "PMID:2922699": {
                      "sentence": "A different neutral proteinase activity degrading insoluble elastin was demonstrated in the culture medium following its fractionation by gel filtration high performance liquid chromatography (HPLC).",
                      "object score": 861,
                      "subject score": 751,
                      "publication date": "1989 Jan 01"
                    },
                    "PMID:8034752": {
                      "sentence": "This suggests that the EBP may also serve as a \"companion\" to intracellular tropoelastin, protecting this highly hydrophobic protein from self-aggregation and proteolytic degradation.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1994 Jul"
                    },
                    "PMID:9106565": {
                      "sentence": "OBJECTIVE: Neutrophil elastase (NE) is the only neutral protease that is able to degrade insoluble elastin and other extracellular matrix constituents, and thus, may be involved in tumor invasion and metastasis.",
                      "object score": 861,
                      "subject score": 827,
                      "publication date": "1997 Apr"
                    },
                    "PMID:11589576": {
                      "sentence": "Furthermore, the spectrum of protease activities secreted by A. niger differs from that produced by A. nidulans, as only A. niger is able to degrade elastin.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2001 Sep"
                    },
                    "PMID:16539369": {
                      "sentence": "This protease degrades elastin and likely aids neutrophils in fulfilling their immunological functions.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Mar 23"
                    },
                    "PMID:16962555": {
                      "sentence": "Incubation of insoluble human elastin with different elastases revealed that, indeed, each protease degrades elastin in a preferential way giving rise to specific peptide patterns.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Nov 15"
                    },
                    "PMID:17906662": {
                      "sentence": "In addition, cells incubated together with medin increased the production of matrix metalloproteinase-2, a protease that degrades elastin and collagen and subsequently weakens the vessel wall.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Dec"
                    },
                    "PMID:21979117": {
                      "sentence": "These predeterminants are influenced by smoking, hypertension, and atherosclerosis, and the result in an inflammatory response coupled to an accelerated proteolytic cascade that disrupts both elastin and collagen in the aortic wall.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2011 Jul-Sep"
                    },
                    "PMID:22995909": {
                      "sentence": "In this organ alpha1AT is critical for ensuring tissue integrity by inhibiting neutrophil elastase, a protease that degrades elastin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Nov 02"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "UMLS:C0597357",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0597357---SEMMEDDB:interacts_with---NCBIGene:1950---SEMMEDDB:",
                    "UMLS:C0597357---SEMMEDDB:interacts_with---UMLS:C1367721---SEMMEDDB:",
                    "UMLS:C0597357---SEMMEDDB:interacts_with---UMLS:C1509244---SEMMEDDB:",
                    "UMLS:C0597357---SEMMEDDB:interacts_with---UMLS:C0242275---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:26838410",
                    "PMID:16068160",
                    "PMID:10707088",
                    "PMID:6277944",
                    "PMID:3058311",
                    "PMID:7932377",
                    "PMID:2828244",
                    "PMID:3490664",
                    "PMID:7863010",
                    "PMID:8882285",
                    "PMID:307248",
                    "PMID:2581577",
                    "PMID:6251065",
                    "PMID:1976639",
                    "PMID:3013022",
                    "PMID:9029149",
                    "PMID:315948",
                    "PMID:10976867",
                    "PMID:6256170",
                    "PMID:6292002"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:307248": {
                      "sentence": "An affinity labeling technique used previously for identification of a membrane receptor for epidermal growth factor (EGF) was exploited to investigate the physiological fate of receptor after binding of EGF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1978 Jun"
                    },
                    "PMID:315948": {
                      "sentence": "This increase in binding was shown to be due to changes in the concentration of receptors without changes in their affinity for EGF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1979 Aug"
                    },
                    "PMID:1507185": {
                      "sentence": "Scintillation Proximity Assay (SPA), which does not require the physical separation of receptor bound and free ligand, was applied to study the interaction of Epidermal Growth Factor (EGF) with its receptor (EGFR) in membrane preparations from human placenta.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992"
                    },
                    "PMID:1654082": {
                      "sentence": "Preparation and characterization of spin-labeled derivatives of epidermal growth factor (EGF) for investigations of the interactions of EGF with its receptor by electron paramagnetic resonance spectroscopy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Sep 17"
                    },
                    "PMID:1774224": {
                      "sentence": "The results suggest that the side chain of leucine 47, because of its charge neutrality, size, and hydrophobicity, is highly important, although not absolutely essential for the interaction of EGF with its receptor.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Jul"
                    },
                    "PMID:2005111": {
                      "sentence": "All receptors bound EGF and exhibited EGF-stimulated protein tyrosine kinase activity in vivo as assayed using a 125I-labeled monoclonal anti-phosphotyrosine antibody.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Mar 25"
                    },
                    "PMID:2191051": {
                      "sentence": "Site-specific mutagenesis has established that the tyrosine-kinase activity of the receptor is essential for nearly all of the effects of EGF including its ability to elevate cellular calcium levels and to induce DNA synthesis.",
                      "object score": 801,
                      "subject score": 1000,
                      "publication date": "1990 Jun"
                    },
                    "PMID:2578126": {
                      "sentence": "High-yield elution is obtained with acidic buffer and the receptor so purified specifically binds EGF, but is devoid of the kinase activity.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1985 Jan 10"
                    },
                    "PMID:2786814": {
                      "sentence": "Although the EGF receptor appeared on the cell surface after a 30-min pulse with a 30-min chase, only half of the receptors are capable of binding EGF.",
                      "object score": 923,
                      "subject score": 1000,
                      "publication date": "1989 Jul"
                    },
                    "PMID:2828244": {
                      "sentence": "Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988 Feb 15"
                    },
                    "PMID:3058311": {
                      "sentence": "Since non-mitogenic effects of EGF, especially in mesenchymal tissues such as smooth muscle are not well-known (Nanney et al. 1984), we have examined EGF-binding and receptors in smooth muscle from many sites.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988 Oct"
                    },
                    "PMID:3490664": {
                      "sentence": "In the epidermal-derived line PAM 212, at least two populations of receptors with different affinities for EGF were found.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1986 Nov"
                    },
                    "PMID:3494473": {
                      "sentence": "Both the monomeric and dimeric forms of the receptor bind EGF and undergo self-phosphorylation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987 Mar 10"
                    },
                    "PMID:8882285": {
                      "sentence": "Steroid treatment did not alter the affinity of the receptor for EGF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jul"
                    },
                    "PMID:8911715": {
                      "sentence": "However, the binding affinity of the receptors to EGF was the same in all the three strains studied.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Sep"
                    },
                    "PMID:9177384": {
                      "sentence": "The interaction of growth factors, such as epidermal growth factor (EGF) with their receptors, on breast cancer cells can lead to the hydrolysis of phospholipids and release of fatty acids, such as arachidonic acid, which can be further metabolized by the lipoxygenase (LO) pathway.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Jun"
                    },
                    "PMID:9331427": {
                      "sentence": "Examples of such receptors include those that bind the platelet-derived growth factor (PDGF), colony stimulating factor-1 (CSF-1), and epidermal growth factor (EGF).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Oct 15"
                    },
                    "PMID:9616130": {
                      "sentence": "The interaction of growth factors such as epidermal growth factor (EGF) with their receptors on breast cancer cells can lead to the hydrolysis of phospholipids and release of fatty acids such as arachidonic acid which can be further metabolized by the lipoxygenase (LO) pathway.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jun 08"
                    },
                    "PMID:10096554": {
                      "sentence": "The E7.6.3 MAb exhibits high affinity (KD = 5 x 10(-11) M) to the receptor, blocks completely the binding of both EGF and transforming growth factor alpha (TGF-a) to various EGFr-expressing human carcinoma cell lines, and abolishes EGF-dependent cell activation, including EGFr tyrosine phosphorylation, increased extracellular acidification rate, and cell proliferation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Mar 15"
                    },
                    "PMID:24649173": {
                      "sentence": "The interaction between EGF and its receptor (EGFR), as well as subsequent internalization, is complex and may be affected by various factors including tyrosine kinase inhibitors (TKIs).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Mar"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "UMLS:C0597357",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0597357---SEMMEDDB:interacts_with---UMLS:C0080222---SEMMEDDB:",
                    "UMLS:C0597357---SEMMEDDB:interacts_with---UMLS:C1366557---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16183742",
                    "PMID:8765047",
                    "PMID:14669355",
                    "PMID:12755614",
                    "PMID:17468136",
                    "PMID:14575868",
                    "PMID:17997544",
                    "PMID:23041148",
                    "PMID:19146934",
                    "PMID:8609423",
                    "PMID:19575289",
                    "PMID:8696721",
                    "PMID:9159168",
                    "PMID:8521411",
                    "PMID:1964076",
                    "PMID:8425833",
                    "PMID:7717995",
                    "PMID:8387357"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1964076": {
                      "sentence": "Tumor cells could bind TGF-beta 1 with similar capacity as normal cells and had the same type of receptors (Mr 280,000, 85,000, and 65,000) capable of binding iodinated TGF-beta 1, suggesting that the loss of sensitivity to TGF-beta 1 in transformed liver epithelial cells involves postreceptor mechanisms.",
                      "object score": 913,
                      "subject score": 1000,
                      "publication date": "1990 Mar"
                    },
                    "PMID:7717995": {
                      "sentence": "From these data we conclude that the effects of TGF beta 1 on PGE2 production but not procollagen synthesis are mediated via a receptor linked to a pertussis toxin-sensitive G-protein.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Apr 01"
                    },
                    "PMID:8387357": {
                      "sentence": "Cross-linking studies confirmed that old SMC showed reduced binding of 125I-TGF-beta 1 to membrane sites corresponding to the high molecular weight type III receptor, as well as the 85-kDa type II and 65-kDa type I receptor.",
                      "object score": 947,
                      "subject score": 1000,
                      "publication date": "1993 Mar"
                    },
                    "PMID:8425833": {
                      "sentence": "Heparinase treatment of the trabecular cells did not change the binding affinity of the receptor for 125I-TGF-beta 1.",
                      "object score": 947,
                      "subject score": 1000,
                      "publication date": "1993 Jan"
                    },
                    "PMID:8521411": {
                      "sentence": "Type I and II in IEC-18 cells and type I receptors in ras-transformed cells have similar characteristics in terms of binding affinities for TGF-beta 1 (or TGF-beta 2) turnover rates and glycosylation states.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Dec 15"
                    },
                    "PMID:8609423": {
                      "sentence": "The growth-regulatory activity of TGF-beta 1 depends on the interaction of TGF-beta 1 with its receptors, especially the type I and II receptors.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Apr 15"
                    },
                    "PMID:8696721": {
                      "sentence": "This agrees with previous findings that type I receptor cannot bind TGF beta 1 without co-expression of the type II receptor.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Feb"
                    },
                    "PMID:8765047": {
                      "sentence": "Cross-linking of CD32 induced an increase in the concentration of intracellular Ca2+, which was reduced by 50% by TGF-beta 1, suggesting a decreased downstream signaling mediated by the receptor.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Aug"
                    },
                    "PMID:9159168": {
                      "sentence": "In contrast, all CLL cells resistant to TGF-beta1 exhibited no detectable surface type I receptors able to bind TGF-beta1, but normal expression of type II receptors.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 May 27"
                    },
                    "PMID:12755614": {
                      "sentence": "The alpha(2)M-derived peptides, which bind TGF-beta1, inhibited the interaction of TGF-beta1 with its receptors in fetal bovine heart endothelial cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 May 27"
                    },
                    "PMID:14575868": {
                      "sentence": "The present study investigates the receptor and mechanisms involved in ATP-stimulated transforming growth factor-beta 1 (TGF-beta 1) mRNA expression of a type-2 astrocyte cell line, RBA-2.",
                      "object score": 839,
                      "subject score": 1000,
                      "publication date": "2003 Dec"
                    },
                    "PMID:14669355": {
                      "sentence": "CD105, as a receptor of TGF-beta1, can regulate the biological effect of TGF-beta1 in tumor angiogenesis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Dec"
                    },
                    "PMID:16183742": {
                      "sentence": "Here we show that PIDD is a cytoplasmic protein, and that PIDD-induced apoptosis and growth suppression in embryonic fibroblasts depend on the adaptor protein receptor-interacting protein (RIP)-associated ICH-1/CED-3 homologous protein with a death domain (RAIDD).",
                      "object score": 545,
                      "subject score": 545,
                      "publication date": "2005 Oct 04"
                    },
                    "PMID:17468136": {
                      "sentence": "Our findings suggest that TGF-beta1 may act in an autocrine fashion to induce ASM hyperplasia, mediated by its receptor and several kinases including PI3K, ERK, and JNK, whereas p38 MAPK is a negative regulator.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Jul"
                    },
                    "PMID:17997544": {
                      "sentence": "The results suggested a more stable binding of TGF-beta1 with the receptor after TbetaRI is recruited and the important contribution of TbetaRI to the signaling complex formation during TGF-beta1 signaling.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Dec 06"
                    },
                    "PMID:19146934": {
                      "sentence": "CONCLUSIONS: These results suggest that the renoprotective effect of Rehmannia glutinosa might be mediated by suppressing the expression of angiotensin II and AT(1) receptor and by regulating TGF-beta1 and type IV collagen expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Feb 25"
                    },
                    "PMID:19575289": {
                      "sentence": "This study investigated the effects of NE on collagen and transforming growth factor-beta1 (TGF-beta1) gene expression in rat cardiac fibroblasts (CF) culture, and compared the anti-fibrotic effect of alpha and beta (both selective and non-selective adrenergic receptor antagonists) receptors.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2009 Aug"
                    },
                    "PMID:23041148": {
                      "sentence": "Treatment with TGFbeta1 increased sphingosine kinase (SphK) activity and S1P(3) receptor mRNA at 24h after stimulation, and pharmacological data showed the involvement of sphingomyelinase, SphK, and S1P(3) receptor in the TGFbeta1-induced up-regulation of alphaSMA with and without serum.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Dec 05"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "UMLS:C0597357",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0597357---SEMMEDDB:interacts_with---UMLS:C0919432---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:22457652",
                    "PMID:10073143",
                    "PMID:26520116",
                    "PMID:21626291",
                    "PMID:28744224",
                    "PMID:12764135",
                    "PMID:12957874",
                    "PMID:15867212",
                    "PMID:23458062",
                    "PMID:20602465",
                    "PMID:14603262",
                    "PMID:9709808",
                    "PMID:19224917",
                    "PMID:21798854"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9709808": {
                      "sentence": "Type I receptors, in turn, phosphorylate cytoplasmic transcriptional activator proteins Smad2 and Smad3, inducing their translocation to the nucleus.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:10073143": {
                      "sentence": "TGF-beta signaling is initiated when the type I receptor phosphorylates the SMAD proteins, Smad2 and Smad3.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Jan"
                    },
                    "PMID:12764135": {
                      "sentence": "Here, we show that the receptor regulated Smad proteins (Smad2 and Smad3) and common mediator Smad (Smad4) bind to different regions in Ski and SnoN.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Aug 15"
                    },
                    "PMID:12957874": {
                      "sentence": "Upon activation, the TGF-beta type I receptor phosphorylates Smad2 and Smad3, which then form complexes with Smad4 and accumulate in the nucleus to regulate transcription of a variety of genes that encode crucial determinants of cell fate, such as cell cycle components, differentiation factors and cell adhesion molecules.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Sep 01"
                    },
                    "PMID:14603262": {
                      "sentence": "Given the known interactions between the TGF-beta and RAR pathways, we have investigated the role played by RAR ligands in modulating functional interactions between Smad3 and RARs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Nov 06"
                    },
                    "PMID:15867212": {
                      "sentence": "Upon TGF-beta binding the TGF-beta type I receptor phosphorylates Smad2 and Smad3, which then complex with Smad4 and translocate to the nucleus, with subsequent activation of target genes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 May 01"
                    },
                    "PMID:19224917": {
                      "sentence": "Canonical TGFbeta signaling is mediated via the TbetaRI/ALK5 type I receptor that phosphorylates Smad2 and Smad3 in their SXS motif to facilitate their activation and subsequent role in transcriptional regulation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Apr 10"
                    },
                    "PMID:20602465": {
                      "sentence": "type I receptor (T?RI) and Ras-associated kinases differentially phosphorylate a mediator, Smad3, to become C-terminally phosphorylated Smad3 (pSmad3C), linker phosphorylated Smad3 (pSmad3L), and both C-terminally and linker phosphorylated Smad3 (pSmad3L/C).",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2011 Mar"
                    },
                    "PMID:21626291": {
                      "sentence": "TGF-beta type I receptor and pro-inflammatory cytokine-activated kinases differentially phosphorylate Smad2 and Smad3 to create phosphoisoforms phosphorylated at the COOH-terminal, linker, or both (L/C) regions.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jan"
                    },
                    "PMID:21798854": {
                      "sentence": "TGF-beta Type I receptor and Ras-associated kinases differentially phosphorylate Smad2 and Smad3 to create C-terminally (C), linker (L) or dually (L/C) phosphorylated (p) isoforms.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Nov"
                    },
                    "PMID:22457652": {
                      "sentence": "TGF-beta type I receptor and Ras-associated kinases differentially phosphorylate Smad2 and Smad3 to create COOH-terminally (C), linker (L), or dually (L/C) phosphorylated (p) isoforms.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:23458062": {
                      "sentence": "TGF-beta type I receptor and pro-inflammatory cytokine-activated kinases differentially phosphorylate Smad2 and Smad3 to create C-terminally (C), linker (L) or dually (L/C) phosphorylated (p) isoforms.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Dec"
                    },
                    "PMID:26520116": {
                      "sentence": "Subsequently, the activated TbetaRI induces the phosphorylation of receptor regulated SMAD2 and SMAD3, which can form heteromeric complexes with Smad4.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016"
                    },
                    "PMID:28744224": {
                      "sentence": "Abundance of myostatin and its receptors, and abundance and phosphorylation of smad3 were lower in LBWT LD by comparison with NBWT LD.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0597357-biolink:physically_interacts_with-UniProtKB:Q15796": {
              "object": "UniProtKB:Q15796",
              "subject": "UMLS:C0597357",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0597357---SEMMEDDB:interacts_with---UMLS:C1334468---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:22457652",
                    "PMID:22202673",
                    "PMID:12957874",
                    "PMID:15867212",
                    "PMID:24860093",
                    "PMID:26523637",
                    "PMID:19224917",
                    "PMID:31189969",
                    "PMID:26520116",
                    "PMID:10073143",
                    "PMID:9920917",
                    "PMID:21626291",
                    "PMID:12764135",
                    "PMID:14670985",
                    "PMID:30393127",
                    "PMID:8980228",
                    "PMID:23458062",
                    "PMID:21787285",
                    "PMID:9709808",
                    "PMID:21798854"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8980228": {
                      "sentence": "Interaction of MADR2 with receptors and phosphorylation requires activation of receptor I by receptor II and is mediated by the receptor I kinase.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Dec 27"
                    },
                    "PMID:9709808": {
                      "sentence": "Type I receptors, in turn, phosphorylate cytoplasmic transcriptional activator proteins Smad2 and Smad3, inducing their translocation to the nucleus.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:9920917": {
                      "sentence": "The L45 sequence of the TGF-beta type I receptor (TbetaR-I) specifies Smad2 interaction, whereas the related L45 sequence of the bone morphogenetic protein (BMP) type I receptor (BMPR-I) specifies Smad1 interactions.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1999 Feb 05"
                    },
                    "PMID:10073143": {
                      "sentence": "TGF-beta signaling is initiated when the type I receptor phosphorylates the SMAD proteins, Smad2 and Smad3.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Jan"
                    },
                    "PMID:12764135": {
                      "sentence": "Here, we show that the receptor regulated Smad proteins (Smad2 and Smad3) and common mediator Smad (Smad4) bind to different regions in Ski and SnoN.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Aug 15"
                    },
                    "PMID:12957874": {
                      "sentence": "Upon activation, the TGF-beta type I receptor phosphorylates Smad2 and Smad3, which then form complexes with Smad4 and accumulate in the nucleus to regulate transcription of a variety of genes that encode crucial determinants of cell fate, such as cell cycle components, differentiation factors and cell adhesion molecules.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Sep 01"
                    },
                    "PMID:14670985": {
                      "sentence": "In addition, GnRH neuronal cell bodies in the POA expressed both type II TGFbeta receptors (TGFbeta-RII), which selectively bind TGFbeta, and Smad2/3, one of the primary transducers of TGFbeta signaling, suggesting that they are fully capable of responding directly to TGFbeta(1) stimulation.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "2004 Apr"
                    },
                    "PMID:15867212": {
                      "sentence": "Upon TGF-beta binding the TGF-beta type I receptor phosphorylates Smad2 and Smad3, which then complex with Smad4 and translocate to the nucleus, with subsequent activation of target genes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 May 01"
                    },
                    "PMID:19224917": {
                      "sentence": "Canonical TGFbeta signaling is mediated via the TbetaRI/ALK5 type I receptor that phosphorylates Smad2 and Smad3 in their SXS motif to facilitate their activation and subsequent role in transcriptional regulation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Apr 10"
                    },
                    "PMID:21626291": {
                      "sentence": "TGF-beta type I receptor and pro-inflammatory cytokine-activated kinases differentially phosphorylate Smad2 and Smad3 to create phosphoisoforms phosphorylated at the COOH-terminal, linker, or both (L/C) regions.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jan"
                    },
                    "PMID:21787285": {
                      "sentence": "The binding of activins to activin type IIA (ActRIIA) or type IIB (ActRIIB) receptors induces the recruitment and phosphorylation of an activin type I receptor (ALK4 and/or ALK7), which then phosphorylates the Smad2 and Smad3 intracellular signaling proteins.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jun"
                    },
                    "PMID:21798854": {
                      "sentence": "TGF-beta Type I receptor and Ras-associated kinases differentially phosphorylate Smad2 and Smad3 to create C-terminally (C), linker (L) or dually (L/C) phosphorylated (p) isoforms.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Nov"
                    },
                    "PMID:22202673": {
                      "sentence": "We performed siRNA-mediated knockdown of each receptor and measured signaling activity using Smad3-dependent luciferase and Smad2 phosphorylation assays with nontargeting siRNA as control.",
                      "object score": 840,
                      "subject score": 1000,
                      "publication date": "2012 Apr"
                    },
                    "PMID:22457652": {
                      "sentence": "TGF-beta type I receptor and Ras-associated kinases differentially phosphorylate Smad2 and Smad3 to create COOH-terminally (C), linker (L), or dually (L/C) phosphorylated (p) isoforms.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:23458062": {
                      "sentence": "TGF-beta type I receptor and pro-inflammatory cytokine-activated kinases differentially phosphorylate Smad2 and Smad3 to create C-terminally (C), linker (L) or dually (L/C) phosphorylated (p) isoforms.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Dec"
                    },
                    "PMID:24860093": {
                      "sentence": "The PDGF-BB-mediated Smad2 phosphorylation was dependent on the kinase activities of both TGFbeta type I receptor (TbetaRI) and PDGF beta-receptor (PDGFRbeta), and it was prevented by inhibitory antibodies against TGFbeta.",
                      "object score": 868,
                      "subject score": 1000,
                      "publication date": "2014 Jul 11"
                    },
                    "PMID:26520116": {
                      "sentence": "Subsequently, the activated TbetaRI induces the phosphorylation of receptor regulated SMAD2 and SMAD3, which can form heteromeric complexes with Smad4.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016"
                    },
                    "PMID:26523637": {
                      "sentence": "The binding of activins to activin type IIA (ActRIIA) or type IIB (ActRIIB) receptors induces the recruitment and phosphorylation of an activin type I receptor which then phosphorylates the Smad2 and Smad3 intracellular signaling proteins.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Dec"
                    },
                    "PMID:30393127": {
                      "sentence": "While curcumin inhibited TGFbeta-receptor-mediated Smad2/3 phosphorylation in all BCa cells studied (human MDA-SA, MDA-1833, MDA-2287 and murine 4T1 cells), curcumin-glucuronide did not.",
                      "object score": 756,
                      "subject score": 756,
                      "publication date": "2018 Oct 11"
                    },
                    "PMID:31189969": {
                      "sentence": "Transient overexpression of miR-25 inhibited TGF-beta and its type 1 receptor (TGFBR1) mRNA expression, TGF-beta-induced Smad2 phosphorylation and subsequent collagen1alpha1 induction in LX-2 cells.",
                      "object score": 840,
                      "subject score": 901,
                      "publication date": "2019 Jun 12"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021557-biolink:physically_interacts_with-UniProtKB:P07204": {
              "object": "UniProtKB:P07204",
              "subject": "VANDF:4021557",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-FMA:264827": {
              "object": "FMA:264827",
              "subject": "RXNORM:3264",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-FMA:264829": {
              "object": "FMA:264829",
              "subject": "RXNORM:3264",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:3264-biolink:entity_positively_regulates_entity-FMA:264825": {
              "object": "FMA:264825",
              "subject": "RXNORM:3264",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:3264-biolink:entity_positively_regulates_entity-FMA:264829": {
              "object": "FMA:264829",
              "subject": "RXNORM:3264",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01019-biolink:directly_interacts_with-UniProtKB:P50052": {
              "object": "UniProtKB:P50052",
              "subject": "UniProtKB:P01019",
              "predicate": "biolink:directly_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P01019---MI:0407---UniProtKB:P50052---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:29967536"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:directly_interacts_with-UniProtKB:P36897": {
              "object": "UniProtKB:P36897",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:directly_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P01137---MI:0407---UniProtKB:P36897---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20856203"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:directly_interacts_with-UniProtKB:P37173": {
              "object": "UniProtKB:P37173",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:directly_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P01137---MI:0407---UniProtKB:P37173---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21054789"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-CHEBI:35942": {
              "object": "CHEBI:35942",
              "subject": "CHEBI:35457",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:inhibits---UMLS:C0597049---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16896019",
                    "PMID:16601580",
                    "PMID:20842465",
                    "PMID:12457149",
                    "PMID:31029493",
                    "PMID:24759950",
                    "PMID:16450814",
                    "PMID:15161427",
                    "PMID:15160833",
                    "PMID:15151479",
                    "PMID:15590076",
                    "PMID:16934010",
                    "PMID:17386187",
                    "PMID:11334782",
                    "PMID:15971454",
                    "PMID:9605599"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9605599": {
                      "sentence": "The antiproliferative action of ACE inhibitors on myocardium and the vascular wall, their hemodynamic effects, antiatherogenic actions, neurohormonal attenuation, and certain genetic issues may account for the ability of this class of drugs to reduce the risk for CAD-related events.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:11334782": {
                      "sentence": "Yet, the benefits of beta blockers are seen in patients already receiving ACE inhibitors, suggesting that combined blockade of two neurohormonal systems (renin-angiotensin system and sympathetic nervous system) can produce additive effects.",
                      "object score": 828,
                      "subject score": 1000,
                      "publication date": "2001 May 07"
                    },
                    "PMID:12457149": {
                      "sentence": "Recent trials with angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, aldosterone antagonists, and beta blockers have provided valuable information regarding the uses, dosing, and extent of therapeutic benefits of neurohormonal inhibition.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "2000"
                    },
                    "PMID:15151479": {
                      "sentence": "More recently, the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study has provided firm support for the use of eplerenone (Inspra, Pfizer) in heart failure following acute myocardial infarction in addition to neurohormonal blockade with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and beta-blockers.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2004 May"
                    },
                    "PMID:15160833": {
                      "sentence": "Clinical studies demonstrated that strategies of neurohormonal blockade using an ACE inhibitor, angiotensin II receptor antagonist, and beta-blocker are ineffective in reducing circulating aldosterone in patients with heart failure caused by left ventricular systolic dysfunction.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2004 May 01"
                    },
                    "PMID:15161427": {
                      "sentence": "The reasons for this failure of the clinical studies to show a longer-term benefit from TNF-alpha inhibitors are unclear, but they may include an error of the general concept, individual adverse effects of the agents used for the studies, incorrect dosage and the fact that the current therapy of heart failure with beta-blockade, ACE inhibitors and aldosterone antagonists cannot be further improved by additional blockade of neurohormones or cytokines.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Jun"
                    },
                    "PMID:15590076": {
                      "sentence": "This article will review the evidence of the use angiotensin converting enzyme inhibitors (ACEIs) and beta-blockers (BBs) in left heart failure, discuss the mechanisms of heart failure as they pertain to congenital heart disease and review the limited literature of the use of neurohormonal antagonists in congenital heart disease.",
                      "object score": 853,
                      "subject score": 928,
                      "publication date": "2004 Dec"
                    },
                    "PMID:15971454": {
                      "sentence": "Angiotensin-converting enzyme (ACE) inhibitors and beta blockers, neurohormonal antagonists that block the renin-angiotensin system (RAS) and the sympathetic nervous system, respectively, have been shown in clinical trials to reduce morbidity and mortality in patients with HF, and these therapies are now integral components of standard HF treatment.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "2005 May"
                    },
                    "PMID:16450814": {
                      "sentence": "Risk factor reduction and selective neurohormonal blockade, especially with angiotensin-converting enzyme inhibitors, are usually recommended in the presence or absence of LVD, along with early use of a beta blocker.",
                      "object score": 589,
                      "subject score": 1000,
                      "publication date": "2005 Nov"
                    },
                    "PMID:16601580": {
                      "sentence": "Clearly, scope remains for the improvement of neurohormonal blockade in patients with heart failure, and there is a particular need for alternative therapies in patients who are unable to tolerate ACE inhibitors.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2006 Mar"
                    },
                    "PMID:16896019": {
                      "sentence": "The guidelines continue to emphasize the important role of neurohormonal blockade with angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, beta-adrenergic blockers, and aldosterone antagonists.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2006 Sep"
                    },
                    "PMID:16934010": {
                      "sentence": "Both guidelines stress the importance of neurohormonal blockade with angiotensin-converting enzyme inhibitors and beta-adrenergic blockers.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2006 Jul"
                    },
                    "PMID:17386187": {
                      "sentence": "Medical therapy with beta-blockers and angiotensin-converting enzyme inhibitors has been shown to attenuate neurohormonal changes and left ventricular remodeling.",
                      "object score": 836,
                      "subject score": 1000,
                      "publication date": "2007 Mar"
                    },
                    "PMID:20842465": {
                      "sentence": "As long as there is no cardiac-specific therapy for AIC, evidence suggests that high-risk patients will benefit from prophylactic treatment with neurohormonal blockade by angiotensin-converting enzyme inhibitors and beta-adrenergic receptor blockers.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2010 Dec"
                    },
                    "PMID:24759950": {
                      "sentence": "The neurohormonal blockade, with angiotensin-converting-enzyme inhibitors and beta-blockers, had an important role in increasing survival of these patients with advanced heart failure.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2014 May"
                    },
                    "PMID:31029493": {
                      "sentence": "The current paradigm of medical therapy for heart failure with reduced ejection fraction (HFrEF) is triple neurohormonal blockade with an angiotensin-converting enzyme inhibitor (ACEI), a beta-blocker (BB) and a mineralocorticoid receptor antagonist (MRA).",
                      "object score": 587,
                      "subject score": 1000,
                      "publication date": "2019 03"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-CHEBI:35457": {
              "object": "CHEBI:35457",
              "subject": "CHEBI:35530",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:inhibits---UMLS:C0003015---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17056315",
                    "PMID:15812748",
                    "PMID:16633991",
                    "PMID:15798140",
                    "PMID:15671603",
                    "PMID:15705262",
                    "PMID:16548448",
                    "PMID:16939433",
                    "PMID:12820820",
                    "PMID:16814655",
                    "PMID:12417825",
                    "PMID:15705260",
                    "PMID:15948394",
                    "PMID:15911739",
                    "PMID:16399851",
                    "PMID:12877761",
                    "PMID:16686332",
                    "PMID:16822303",
                    "PMID:15814871",
                    "PMID:11070998"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:12417825": {
                      "sentence": "Compared to use before hospitalization, at hospital discharge the use of aspirin increased from 43% to 84% (p<0.001), the use of clopidogrel increased from 21% to 54% (p<0.001), the use of beta blockers increased from 38% to 76% (p<0.001), the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers increased from 42% to 70% (p<0.001), the use of long-acting nitrates increased from 15% to 31% (p<0.001), and the use of calcium channel blockers decreased from 28% to 23% (p=NS).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002"
                    },
                    "PMID:12820820": {
                      "sentence": "With increasing data becoming available, reexamining the use of traditional antihypertensive agents, including diuretics and beta-blockers, or the newer agents, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers, may be beneficial.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Jun"
                    },
                    "PMID:12877761": {
                      "sentence": "Class II(a) recommendations for treating HF with abnormal left ventricular ejection fraction are spironolactone in patients with class IV symptoms, preserved renal function, and normal serum potassium; exercise training as an adjunctive approach to improve clinical status in ambulatory patients; an angiotensin receptor blocker in patients who cannot be given an ACE inhibitor because of cough, rash, altered taste sensation, or angioedema; and hydralazine plus nitrates in patients being treated with diuretics, a beta-blocker, and digoxin who cannot be given an ACE inhibitor or an angiotensin receptor blocker because of hypotension or renal insufficiency.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003"
                    },
                    "PMID:15911739": {
                      "sentence": "Initial treatment with thiazide diuretic would be followed by randomization to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, beta-blocker, calcium channel blocker, or aldosterone antagonist.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Jul"
                    },
                    "PMID:15948394": {
                      "sentence": "Considerable evidence of the usefulness of antihypertensive therapy in elderly hypertensive patients has been shown by the clinical intervention studies in western countries, using diuretics, beta-blockers, Ca antagonist, angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Jun"
                    },
                    "PMID:16548448": {
                      "sentence": "Many patients with heart failure should receive an aldosterone receptor antagonist, ie, either spironolactone (Aldactone) or the newer agent eplerenone (Inspra)--in addition to an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB) or both, and a beta-blocker.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Mar"
                    },
                    "PMID:16633991": {
                      "sentence": "Beta-blockers and calcium channel blockers are effective antianginals; diuretics, angiotensin-converting enzyme (ACE) inhibitors and beta-blockers are useful for heart failure; ACE inhibitors and angiotensin receptor blockers are especially effective in preserving renal function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006"
                    },
                    "PMID:16686332": {
                      "sentence": "Pharmacogenomics thus allows to explore polymorphisms that could potentially explain heterogeneous efficacy of diuretics, ACE inhibitors or angiotensin receptor blockers, beta-blockers and calcium channel blockers among populations of varied ethnical origin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Apr 12"
                    },
                    "PMID:17056315": {
                      "sentence": "At 1 year, 95% of patients received an antiplatelet agent, 89% a beta blocker, 93% an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker, and 93% a statin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Nov 01"
                    },
                    "PMID:17145223": {
                      "sentence": "Also, there were no significant differences in serum creatinine, glomerular filtration rate, or urine output in patients who continued to receive angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, beta blockers, or digoxin therapy during nesiritide infusion.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Dec 15"
                    },
                    "PMID:17151332": {
                      "sentence": "Medications including angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, beta blockers, calcium channel blockers, other BP medications, aspirin, antibiotics, and antiarrhythmics were associated with survival and considered confounders.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Jan"
                    },
                    "PMID:18694475": {
                      "sentence": "Tacrolimus, sirolimus and beta-blockers (HR: 1.86 [1.07-3.22], p = 0.0277) were significantly associated with NODAT even after multiple adjustments, but not diuretics, angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Aug"
                    },
                    "PMID:18756340": {
                      "sentence": "The safety and value of diuretics, beta-blockers, calcium-blockers, angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in reducing blood pressure, and in reducing clinical cardiovascular outcomes, is now clearly established.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Aug"
                    },
                    "PMID:18806522": {
                      "sentence": "In 357 patients with obstructive CAD diagnosed by coronary angiography, the prevalence of use of these drugs at hospital discharge was 100% for antiplatelet drugs, 97% for beta blockers, 91% for ACE inhibitors or ARBs, 98% for lipid-lowering drugs, 17% for CCBs, and 27% for nitrates.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008"
                    },
                    "PMID:23342233": {
                      "sentence": "The importance of the renin-angiotensin-aldosterone system (RAAS) in cardiovascular and renal diseases has long been recognized: for this reason the conventional therapies, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), beta-blockers, and aldosterone antagonists represent the backbone of current antihypertensive therapy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jul"
                    },
                    "PMID:23592012": {
                      "sentence": "Beta-blockers, together with diuretics and ACE-inhibitors or angiotensin receptor blockers, are a cornerstone of HF therapy, as they reduce mortality and morbidity.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Aug"
                    },
                    "PMID:24132701": {
                      "sentence": "None of the patients who were on ACE inhibitors or on angiotensin receptor blockers (ARBs) reported any incidence of IGT or DM.To conclude, beta-blockers and thiazides increases the risk of type 2 diabetes mellitus with long term antihypertensive therapy requiring regular monitoring.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 May"
                    },
                    "PMID:24628293": {
                      "sentence": "The effect of calcium channel blockers (CCBs), beta blockers and angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) on the prognosis of patients with acute myeloid leukemia (AML) is largely unknown.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Dec"
                    },
                    "PMID:25355012": {
                      "sentence": "In this review, we aimed to summarize the recent findings on pharmacogenetics of the most commonly used antihypertensive drugs in clinical practice, including diuretics, angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers, beta-blockers and calcium channel blockers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 May"
                    },
                    "PMID:27733585": {
                      "sentence": "Overall, our exploratory findings suggest possible differential effects of antihypertensive medications on mood that merits further study: calcium antagonists and beta-blockers may be associated with increased risk, whereas angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be associated with a decreased risk of mood disorders.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 11"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-CHEBI:35942": {
              "object": "CHEBI:35942",
              "subject": "CHEBI:35530",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:inhibits---UMLS:C0597049---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23843954",
                    "PMID:20842465",
                    "PMID:2688986",
                    "PMID:24759950",
                    "PMID:27673415",
                    "PMID:15160833",
                    "PMID:15590076",
                    "PMID:16934010",
                    "PMID:29520629",
                    "PMID:15268637",
                    "PMID:31738366",
                    "PMID:9278193",
                    "PMID:17386187",
                    "PMID:12457149",
                    "PMID:22119116",
                    "PMID:15971454"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2688986": {
                      "sentence": "According to this hypothesis, a number of cardioactive drugs (including calcium channel blockers, beta-blockers, and converting enzyme inhibitors) can depress myocardial contractility, but only calcium channel blockers, which activate neurohormonal systems, adversely affect patients with left ventricular dysfunction, whereas beta-blockers and converting enzyme inhibitors, which interfere with neurohormonal activity, can favorably modify the long-term outcome of these high-risk patients.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "1989 Dec"
                    },
                    "PMID:9278193": {
                      "sentence": "This review addresses the following issues regarding beta-adrenoceptor blockers in chronic heart failure: the known adverse effects of chronic sympathetic activation in heart failure, the theoretical benefits of blockade of this neurohormonal system, the current clinical database of beta-adrenoceptor blockers in heart failure and practical issues regarding the administration of these agents to these patients.",
                      "object score": 853,
                      "subject score": 890,
                      "publication date": "1997 Aug"
                    },
                    "PMID:12457149": {
                      "sentence": "Recent trials with angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, aldosterone antagonists, and beta blockers have provided valuable information regarding the uses, dosing, and extent of therapeutic benefits of neurohormonal inhibition.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "2000"
                    },
                    "PMID:15160833": {
                      "sentence": "Clinical studies demonstrated that strategies of neurohormonal blockade using an ACE inhibitor, angiotensin II receptor antagonist, and beta-blocker are ineffective in reducing circulating aldosterone in patients with heart failure caused by left ventricular systolic dysfunction.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2004 May 01"
                    },
                    "PMID:15268637": {
                      "sentence": "Patients with HF have increased sympathetic nervous system activity that contributes to impaired cardiovascular function over time and subsequently results in death. beta-blockers prevent such impairment through inhibition of the sympathetic nervous system neurohormonal pathway.",
                      "object score": 851,
                      "subject score": 901,
                      "publication date": "2004 Aug"
                    },
                    "PMID:15590076": {
                      "sentence": "This article will review the evidence of the use angiotensin converting enzyme inhibitors (ACEIs) and beta-blockers (BBs) in left heart failure, discuss the mechanisms of heart failure as they pertain to congenital heart disease and review the limited literature of the use of neurohormonal antagonists in congenital heart disease.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "2004 Dec"
                    },
                    "PMID:15971454": {
                      "sentence": "Angiotensin-converting enzyme (ACE) inhibitors and beta blockers, neurohormonal antagonists that block the renin-angiotensin system (RAS) and the sympathetic nervous system, respectively, have been shown in clinical trials to reduce morbidity and mortality in patients with HF, and these therapies are now integral components of standard HF treatment.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "2005 May"
                    },
                    "PMID:16934010": {
                      "sentence": "Both guidelines stress the importance of neurohormonal blockade with angiotensin-converting enzyme inhibitors and beta-adrenergic blockers.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2006 Jul"
                    },
                    "PMID:17386187": {
                      "sentence": "Medical therapy with beta-blockers and angiotensin-converting enzyme inhibitors has been shown to attenuate neurohormonal changes and left ventricular remodeling.",
                      "object score": 836,
                      "subject score": 1000,
                      "publication date": "2007 Mar"
                    },
                    "PMID:20842465": {
                      "sentence": "As long as there is no cardiac-specific therapy for AIC, evidence suggests that high-risk patients will benefit from prophylactic treatment with neurohormonal blockade by angiotensin-converting enzyme inhibitors and beta-adrenergic receptor blockers.",
                      "object score": 623,
                      "subject score": 916,
                      "publication date": "2010 Dec"
                    },
                    "PMID:22119116": {
                      "sentence": "METHODS: The aims of the American Recovery & Reinvestment Act-funded National Heart, Lung, and Blood Institute-sponsored \"Neurohormonal Blockade and Outcomes in Diastolic Heart Failure\" are to study the long-term effects of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, and aldosterone antagonists in four separate propensity-matched populations of HF-PEF patients in the OPTIMIZE-HF (Organized Program to Initiate Life-Saving Treatment in Hospitalized Patients with Heart Failure) registry.",
                      "object score": 569,
                      "subject score": 1000,
                      "publication date": "2013 Jun 05"
                    },
                    "PMID:23843954": {
                      "sentence": "Carvedilol is a beta-blocker used as a multifunctional neurohormonal antagonist that has been shown to act not only as an anti-oxidant but also as an anti-inflammatory drug.",
                      "object score": 589,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:24759950": {
                      "sentence": "The neurohormonal blockade, with angiotensin-converting-enzyme inhibitors and beta-blockers, had an important role in increasing survival of these patients with advanced heart failure.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2014 May"
                    },
                    "PMID:27673415": {
                      "sentence": "Areas covered: This article discusses stages of heart failure, treatment of heart failure with general measures, and drug therapy with diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta blockers, aldosterone antagonists, isosorbide dinitrate plus hydralazine, digoxin, other neurohormonal antagonists, sacubitril/valsartan, calcium channel blockers, and ivabradine.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "2016 Dec"
                    },
                    "PMID:29520629": {
                      "sentence": "Current approaches monitoring and treating LV dysfunction related to cancer therapy-related cardiotoxicity include addressing modifiable cardiovascular risk factors especially hypertension and early initiation of neurohormonal blockade (NHB) with disease-modifying beta-blockers and renin-angiotensin-aldosterone system (RAAS) inhibitors.",
                      "object score": 623,
                      "subject score": 850,
                      "publication date": "2018 03 08"
                    },
                    "PMID:31738366": {
                      "sentence": "Exposures: Patients were stratified based on exposure to NHB and represented all permutations of the following drug classes: angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, beta-blockers, and mineralocorticoid antagonists.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2019 Nov 18"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35674-biolink:entity_negatively_regulates_entity-CHEBI:35457": {
              "object": "CHEBI:35457",
              "subject": "CHEBI:35674",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003364---SEMMEDDB:inhibits---UMLS:C0003015---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12777939",
                    "PMID:15300157",
                    "PMID:15798140",
                    "PMID:17693756",
                    "PMID:19367240",
                    "PMID:16227771",
                    "PMID:18229460",
                    "PMID:15202306",
                    "PMID:19367328",
                    "PMID:15838671",
                    "PMID:15938037",
                    "PMID:15133404",
                    "PMID:11863472",
                    "PMID:18785447",
                    "PMID:15133407",
                    "PMID:17693755",
                    "PMID:16157081",
                    "PMID:16180959",
                    "PMID:17489673",
                    "PMID:18178791"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:11863472": {
                      "sentence": "A potential for interactions with these enzymes exists with calcium channel blockers, beta-adrenergic blocking agents, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers but not with diuretic antihypertensives, which are renally eliminated and more vulnerable to drug interactions that occur in the kidney.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2002 Feb 25"
                    },
                    "PMID:15133404": {
                      "sentence": "The most common antihypertensive agent prescribed was angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers (28%), while first-line drugs, diuretics (23%) and b blockers (15%), which are recommended by national committees, were prescribed less frequently.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2004 May"
                    },
                    "PMID:15133407": {
                      "sentence": "The newer antihypertensive drugs that interfere with the renin angiotensin system, such as angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers, have the potential of improving cardiovascular outcomes in elderly persons in addition to offering effective blood pressure reduction.",
                      "object score": 1000,
                      "subject score": 890,
                      "publication date": "2004 May"
                    },
                    "PMID:15202306": {
                      "sentence": "Newer antihypertensive drugs which block the renin angiotensin system, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), may have additional benefits in high-risk individuals with normal blood pressure.",
                      "object score": 1000,
                      "subject score": 890,
                      "publication date": "2004"
                    },
                    "PMID:15798140": {
                      "sentence": "The other antihypertensive agents that promote fluid reduction, ACEIs and angiotensin receptor blockers (ARBs), are next in preference, ranking a close second to diuretics.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Mar-Apr"
                    },
                    "PMID:15838671": {
                      "sentence": "The basis of drug treatment consists of the following first line antihypertensive drugs: diuretics, beta blockers, calcium channel blockers, ACE inhibitors, and AT1 blockers.",
                      "object score": 1000,
                      "subject score": 840,
                      "publication date": "2005 May"
                    },
                    "PMID:15938037": {
                      "sentence": "Recent data from the Intervention as a Goal in Hypertension Treatment trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and African American Study of Kidney Disease and Hypertension (AASK) allow the conclusion that in hypertensive patients with preserved renal function or with CKD, calcium channel blockers are effective antihypertensive drugs to be considered alone or in combination with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2005 Mar"
                    },
                    "PMID:16157081": {
                      "sentence": "A broader overview of clinical trials comparing ACEIs and ARBs with other antihypertensive drugs fails to show any substantive blood pressure-independent effects on stroke or myocardial infarction with these classes of drugs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Oct"
                    },
                    "PMID:16180959": {
                      "sentence": "Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were the most frequently used antihypertensive agents in this study population, but they were underutilized, being used by 55.4% and 32.3%, respectively.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Sep"
                    },
                    "PMID:16227771": {
                      "sentence": "In particular, many patients with heart failure due to left ventricular systolic dysfunction fail to receive beta blockers, although this class of drugs, as well as other antihypertensive agents such as angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, are recommended as part of routine heart failure therapy by national expert consensus guidelines.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Sep"
                    },
                    "PMID:17489673": {
                      "sentence": "Nevertheless, appropriate treatment of MS components often requires pharmacologic intervention with insulin-sensitizing agents, such as metformin and thiazolidinediones, while statins and fibrates, or angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are the first-line lipid-modifying or antihypertensive drugs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 May"
                    },
                    "PMID:18178791": {
                      "sentence": "Multiple classes of antihypertensive agents, including diuretics, calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin II receptor blockers, have reduced stroke risk.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Jan"
                    },
                    "PMID:18229460": {
                      "sentence": "To achieve adequate blood pressure control, a combination therapy with different classes of antihypertensive agents is often necessary, especially including angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007"
                    },
                    "PMID:23355128": {
                      "sentence": "An ambitious programme of clinical development of this modern antihypertensive drug will investigate whether aliskiren may further limit the incidence of major CV and renal events in hypertensive patients with co-morbidities, treated with the available therapeutic strategies, including ACE inhibitors and ARBs.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2008 Oct"
                    },
                    "PMID:24308221": {
                      "sentence": "Beside other prescribed antihypertensive drugs all of them took and ACE inhibitors or ARB in order to achieve blood pressure control.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2013 Sep"
                    },
                    "PMID:25182739": {
                      "sentence": "Angiotensin converting enzyme inhibitors and angiotensin receptor blockers are widely prescribed anti-hypertensives acting on the RAAS, and there is growing evidence that they act centrally, possibly exerting their effects independent of their blood pressure lowering properties.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014"
                    },
                    "PMID:25612630": {
                      "sentence": "Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are effective and widely used antihypertensive drugs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Mar"
                    },
                    "PMID:26586276": {
                      "sentence": "ACEis and ARBs are both effective anti-hypertensive agents and have similar risk reductions in stroke - a blood pressure dependent phenomenon.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "2016 Mar-Apr"
                    },
                    "PMID:28760142": {
                      "sentence": "While no randomised clinical trials were found, case reports and observational studies showed that angiotensin-converting enzyme inhibitors or angiotensin receptor blockers had positive effects on depression, whereas other antihypertensive agents did not.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 08 01"
                    },
                    "PMID:29098020": {
                      "sentence": "Numerous evidence comes from preclinical and clinical studies on the use of antihypertensive agents targeting the RAS, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Nov"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:61799-biolink:entity_positively_regulates_entity-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "FMA:61799",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0028351---SEMMEDDB:augments---UMLS:C0018802---SEMMEDDB:",
                    "UMLS:C0028351---SEMMEDDB:augments---UMLS:C0018801---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16337838",
                    "PMID:26539521",
                    "PMID:24687133",
                    "PMID:8174160",
                    "PMID:16626691",
                    "PMID:10411857",
                    "PMID:8653872",
                    "PMID:16214845",
                    "PMID:1673586",
                    "PMID:16800896",
                    "PMID:9588412",
                    "PMID:30020242",
                    "PMID:11206722",
                    "PMID:9244219",
                    "PMID:9007513"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1673586": {
                      "sentence": "Circulating plasma concentrations of norepinephrine, renin, angiotensin and vasopressin are increased in congestive heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 May 06"
                    },
                    "PMID:8174160": {
                      "sentence": "Intrinsic heart rate, noradrenaline concentrations and cardiac filling pressures were raised at severe heart failure while cardiac output and systolic blood pressure were significantly reduced.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "1994 Mar"
                    },
                    "PMID:8653872": {
                      "sentence": "Cardiac spillover of dopa and NE turnover were increased similarly in congestive heart failure.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1996 May 01"
                    },
                    "PMID:9007513": {
                      "sentence": "Noradrenaline and phenylephrine produced concentration-dependent contractions of the dorsal pedal artery and the saphenous vein which were enhanced at end-stage heart failure.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996 Dec 27"
                    },
                    "PMID:9244219": {
                      "sentence": "The plasma levels of ANP, BNP, cGMP, and norepinephrine increased with the severity of CHF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Jul 15"
                    },
                    "PMID:9588412": {
                      "sentence": "BACKGROUND: Plasma atrial natriuretic peptide (ANP), mainly from the atrium, brain natriuretic peptide (BNP), mainly from the ventricle, norepinephrine (NE), and endothelin-1 (ET-1) levels are increased with the severity of congestive heart failure (CHF).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 May"
                    },
                    "PMID:10411857": {
                      "sentence": "Norepinephrine is one of the factors activated in heart failure and can induce myocardial cell apoptosis in culture.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Jul 20"
                    },
                    "PMID:11206722": {
                      "sentence": "The responses of LV dP/dt to ISO and NE were significantly enhanced in heart failure; however, they were not affected by inhaled NO.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000"
                    },
                    "PMID:16214845": {
                      "sentence": "In contrast, myocardial interstitial NE was increased in CHF (0.89 +/- 0.11 ng/ml) compared with the sham-operated animals (0.26 +/- 0.03 ng/ml).",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "2006 Mar"
                    },
                    "PMID:16337838": {
                      "sentence": "In this study we tested the hypothesis that arterial myofilament Ca(2+) sensitivity and/or the Ca(2+) sensitising effect of noradrenaline (NA) is enhanced in post-infarction congestive heart failure (CHF), which could contribute to the high peripheral vascular resistance in this condition.",
                      "object score": 875,
                      "subject score": 1000,
                      "publication date": "2006 Mar"
                    },
                    "PMID:16626691": {
                      "sentence": "We tested the hypothesis that arterial reactivity to noradrenaline is augmented in congestive heart failure (CHF), which could contribute to the deleterious changes in peripheral vascular resistance and compliance in this condition.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 May 10"
                    },
                    "PMID:16800896": {
                      "sentence": "Norepinephrine and epinephrine plasma levels were enhanced in heart failure and sham-operated animals, while these were not different from normal in BMSC-transplanted animals.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Jun 26"
                    },
                    "PMID:24687133": {
                      "sentence": "Ceruloplasmin, B-type natriuretic peptide, norepinephrine, and high-sensitivity C-reactive protein were increased in HF versus controls.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 May 23"
                    },
                    "PMID:26539521": {
                      "sentence": "Plasma MPO chlorinating activity, Cp, BNP, norepinephrine, and hsCRP were increased in HF versus CTR.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015"
                    },
                    "PMID:30020242": {
                      "sentence": "In contrast, plasma norepinephrine was significantly increased in heart failure with reduced ejection fraction only.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2018 Jul 16"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-FMA:62343": {
              "object": "FMA:62343",
              "subject": "VANDF:4021566",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:inhibits---UMLS:C0006772---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:2720644",
                    "PMID:2866835",
                    "PMID:1920138",
                    "PMID:2384279",
                    "PMID:2097597",
                    "PMID:16918322",
                    "PMID:2904503",
                    "PMID:10757416",
                    "PMID:10339831",
                    "PMID:2824896",
                    "PMID:2482513",
                    "PMID:19763878",
                    "PMID:2886505",
                    "PMID:11688889",
                    "PMID:2898360",
                    "PMID:3113496",
                    "PMID:2430291",
                    "PMID:2904344",
                    "PMID:2621325",
                    "PMID:17367443"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1920138": {
                      "sentence": "Calcium antagonists, sodium channel blockers and calmodulin antagonists were found to significantly improve postischemic contractile function and reduce lactate-dehydrogenase release after 25 min of global ischemia and 30 min of reperfusion.",
                      "object score": 888,
                      "subject score": 983,
                      "publication date": "1991 Oct"
                    },
                    "PMID:2097597": {
                      "sentence": "Calcium channel blockers (nifedipine, verapamil, diltiazem), calmodulin antagonists (trifluoperazine, calmidazolium, compound 48/80) and anti-free radical agents (allopurinol, desferrioxamine, mannitol, L-methionine) were tested for their potency to stabilize human erythrocytes against hypotonic hemolysis.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:2384279": {
                      "sentence": "Calcium channel blockers, calmodulin inhibitors, and some other classes of non-related compounds reverse multi-drug resistance.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1990 Aug 15"
                    },
                    "PMID:2430291": {
                      "sentence": "Induction is antagonized by extracellular calcium and the dihydropyridine calcium channel blockers, and it is attenuated in the presence of calmodulin inhibitors.",
                      "object score": 888,
                      "subject score": 916,
                      "publication date": "1986 Nov"
                    },
                    "PMID:2621325": {
                      "sentence": "Similarly, phospholipase inhibitors (mepacrine and 4-bromophenacyl bromide), putrescine, inhibitors of lysosomal activity (chloroquine and NH4Cl), calcium channel blockers (nifedipine and verapamil), calmodulin inhibitors (W-7 and calmidazolium), and inhibitors of ADP ribosylation (nicotinamide and 3-aminobenzamide) were inactive.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1989"
                    },
                    "PMID:2824896": {
                      "sentence": "Although verapamil, a calcium-antagonist, and W-7, a calmodulin inhibitor, enhanced the growth-inhibitory effect and uptake of VBL by inhibiting the VBL efflux, these drugs did not influence the effect and uptake of MMC.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "1987 Sep"
                    },
                    "PMID:2886505": {
                      "sentence": "KCl-induced vasoconstriction in RPH was found to be sensitive to the blockade of calcium entry by calcium entry blocking drugs, but not to alpha-adrenoreceptor-blocking drugs and calmodulin antagonist.",
                      "object score": 694,
                      "subject score": 912,
                      "publication date": "1987 Mar"
                    },
                    "PMID:2904344": {
                      "sentence": "Inorganic cations, organic calcium antagonists, and calmodulin antagonists were applied to olfactory epithelia of frogs (Rana pipiens) while recording electroolfactogram (EOG) responses.",
                      "object score": 888,
                      "subject score": 890,
                      "publication date": "1988"
                    },
                    "PMID:2904503": {
                      "sentence": "Comparison of inhibitory effects of calcium channel blockers and that of a calmodulin antagonist in strips of mesenteric arteries from spontaneously hypertensive and normotensive rats.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1988 Sep"
                    },
                    "PMID:3133378": {
                      "sentence": "Rhodaminephalloidin labeling of actin filaments revealed a field-induced disorganization of the stress fiber pattern, which was reduced when stimulation was conducted in calcium-depleted buffer or in buffer containing calcium antagonist CoCl2, calcium channel blocker D-600, or calmodulin antagonist trifluoperazine.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "1988 Jun"
                    },
                    "PMID:3188357": {
                      "sentence": "Calcium channel blockers (verapamil, diltiazem and lidocaine), a calmodulin antagonist (chlorpromazine), adrenergic receptor blockers (yohimbine, tolazoline and propranolol), and a cardiac glycoside (digoxin) were evaluated for their effects on monensin toxicity following their 30 min pretreatments in mice ip.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1988 Oct"
                    },
                    "PMID:3335222": {
                      "sentence": "All tested inhibitors of multidrug resistance, including weak detergent, metabolic inhibitors, calcium channel blockers, calmodulin inhibitors, and reserpine, restored normal staining of multidrug-resistant cells.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1988 Jan"
                    },
                    "PMID:3655683": {
                      "sentence": "Effects of calcium antagonists, calmodulin antagonists, and methylated xanthines on polar lobe formation and cytokinesis in fertilized eggs of Ilyanassa obsoleta.",
                      "object score": 888,
                      "subject score": 983,
                      "publication date": "1987 Aug"
                    },
                    "PMID:3663712": {
                      "sentence": "Calcium channel blockers, calmodulin inhibitors, and mitochondrial inhibitors do not alter the patterns of [Ca2+]i changes due to HgCl2.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1987 Nov 12"
                    },
                    "PMID:3917874": {
                      "sentence": "Prostaglandin output induced by angiotensin II and bradykinin were inhibited by mepacrine and indomethacin, whereas, the prostaglandin output caused by exogenous arachidonic acid (33 nmol) was abolished by indomethacin but was unaltered by mepacrine, calcium antagonists, and calmodulin inhibitors.",
                      "object score": 888,
                      "subject score": 983,
                      "publication date": "1985 Jan"
                    },
                    "PMID:3928883": {
                      "sentence": "Effects of TMB-8, an intracellular calcium antagonist, and W-7, a calmodulin antagonist, on prostaglandin output from the guinea-pig uterus.",
                      "object score": 694,
                      "subject score": 901,
                      "publication date": "1985 Sep"
                    },
                    "PMID:3934419": {
                      "sentence": "This increase was abolished by TMB-8, an intracellular calcium antagonist, and trifluoperazine, a calmodulin antagonist.",
                      "object score": 694,
                      "subject score": 901,
                      "publication date": "1985 Sep"
                    },
                    "PMID:4056904": {
                      "sentence": "The resistance to vincristine was considerably decreased by nontoxic or marginally toxic concentrations of calcium channel blockers or calmodulin inhibitors, although the former was more effective than the latter.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1985 Dec"
                    },
                    "PMID:8765130": {
                      "sentence": "The injection of alpha-adrenoceptor antagonist, phenoxybenzamine, calcium channel blocker, nifedipine or calmodulin inhibitor, trifluoperazine was also found to inhibit TK activity by the repression of its mRNA level.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "1996 Aug 13"
                    },
                    "PMID:9412996": {
                      "sentence": "Two MDR inhibitors, verapamil, a calcium channel blocker, and trifluoperazine, a calmodulin inhibitor, were assayed for their ability to modulate the potency of nine mutagens with varying mechanisms of action in various Salmonella typhimurium his- strains.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "1997 Nov"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01100-biolink:physically_interacts_with-UniProtKB:Q15796": {
              "object": "UniProtKB:Q15796",
              "subject": "UniProtKB:P01100",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P01100---MI:0915---UniProtKB:Q15796---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20195357"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01106-biolink:physically_interacts_with-UniProtKB:P37173": {
              "object": "UniProtKB:P37173",
              "subject": "UniProtKB:P01106",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P01106---MI:0915---UniProtKB:P37173---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:32814053"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:interacts_with---UMLS:C0242275---SEMMEDDB:",
                    "UMLS:C0080222---SEMMEDDB:interacts_with---UMLS:C1367721---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1560032",
                    "PMID:8238388",
                    "PMID:1531626",
                    "PMID:7873982",
                    "PMID:1647773",
                    "PMID:7622573",
                    "PMID:2563727",
                    "PMID:2087681",
                    "PMID:17467690",
                    "PMID:1880152",
                    "PMID:8454307",
                    "PMID:7556448",
                    "PMID:1525015",
                    "PMID:24861080",
                    "PMID:9390635",
                    "PMID:9083291",
                    "PMID:17516543",
                    "PMID:10660085"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1525015": {
                      "sentence": "Pre-incubation in medium containing both bFGF and TGF-beta 1 resulted in a decrease in EGF binding.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1992 Jun"
                    },
                    "PMID:1531626": {
                      "sentence": "Sites of interaction between epidermal growth factor and transforming growth factor-beta 1 in the control of steroidogenesis in cultured porcine Leydig cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Mar"
                    },
                    "PMID:1560032": {
                      "sentence": "TGF-beta 1 is a strong inhibitor of astrocyte proliferation and suppresses the mitotic effects of FGF and EGF on astrocytes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Apr"
                    },
                    "PMID:1647773": {
                      "sentence": "We report herein that transforming growth factor beta 1 (TGF beta 1), alone and in synergy with epidermal growth factor (EGF) or TGF alpha, markedly stimulates PPi elaboration by porcine articular cartilage in organ culture and monolayer culture.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Jul"
                    },
                    "PMID:1880152": {
                      "sentence": "The interactive effects of EGF, RA, and Dex on the production of TGF-beta 1 and TGF-beta 2, which were studied on NRK-49F cells, demonstrate that EGF blocks the induction of TGF-beta 2 mRNA and peptide by RA, while Dex inhibits the induction of TGF-beta 1 mRNA and peptide by EGF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Aug"
                    },
                    "PMID:2087681": {
                      "sentence": "RA exposure altered the expression of TFG-alpha, TGF-beta 1, and TGF-beta 2, but significant effects on EGF were not found.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 Dec"
                    },
                    "PMID:2563727": {
                      "sentence": "The results described here are consistent with the hypothesis that a complex program of cooperative interactions among EGF-, TGF-beta 1-, and T3-generated signals at the transcriptional level may mediate, at least in part, the combined actions of EGF, TGF-beta 1, and T3 in target cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Mar 05"
                    },
                    "PMID:7556448": {
                      "sentence": "Scatchard analysis indicates that the population of EGFR sites induced by TGF beta 1 have a low affinity for EGF (Kd = 4.08 nM) compared to the receptors present prior to TGF beta 1 treatment (Kd = 0.3 and 1.6 nM).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Oct"
                    },
                    "PMID:7622573": {
                      "sentence": "Transforming growth factor-beta 1 modulates adenylyl cyclase signaling elements and epidermal growth factor signaling in cardiomyocytes.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "1995 Aug"
                    },
                    "PMID:7873982": {
                      "sentence": "In addition, the effects of recombinant HGF and epidermal growth factor were additive, while transforming growth factor-beta 1 strongly inhibited the stimulation of DNA synthesis by recombinant HGF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Dec"
                    },
                    "PMID:8238388": {
                      "sentence": "These effects of TGF-beta 1 and EGF on CREB appear to be specific since neither TGF-beta 1 nor EGF alters expression of an activating transcription factor in LLC-PK1 cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Oct"
                    },
                    "PMID:8454307": {
                      "sentence": "Although TGF-beta s 1, 2, and 3 cause only a small reduction in the low level of astrocyte proliferation occurring in chemically defined medium, they each inhibit the effects of five astrocyte mitogens (bFGF, EGF, PDGF, IL-1 alpha, and IL-2).",
                      "object score": 1000,
                      "subject score": 927,
                      "publication date": "1993 Mar"
                    },
                    "PMID:9083291": {
                      "sentence": "TGF-beta1 (5 ng/ml) markedly inhibited proliferation of MCs incubated with PDGF, endothelin-1, bFGF, serotonin, or EGF, indicating that TGF-beta1 interferes with post-receptor signals of mitogenesis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Apr"
                    },
                    "PMID:9390635": {
                      "sentence": "Modulation of collagen gene expression by cytokines: stimulatory effect of transforming growth factor-beta1, with divergent effects of epidermal growth factor and tumor necrosis factor-alpha on collagen type I and collagen type IV.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Nov"
                    },
                    "PMID:10660085": {
                      "sentence": "Secretion and dual regulation between epidermal growth factor and transforming growth factor-beta1 in MDA-MB-231 cell line in 42-hour-long cultures.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Dec 01"
                    },
                    "PMID:17467690": {
                      "sentence": "Inhibition of the ERK1/2 activity by PD98059 abrogated the synergistic effect of EGF and TGF-beta1 on cell migration, MMP-9 production and activity, indicating that EGF and TGF-beta1 converged at the ERK signaling pathway to mediate cell migration.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Jul 01"
                    },
                    "PMID:17516543": {
                      "sentence": "Furthermore, we demonstrate that TGF-beta1 signaling can modulate EGF and FGF-induced ERK-MAP kinase activation by controlling Spry2 expression and function.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2007 Sep"
                    },
                    "PMID:24861080": {
                      "sentence": "Inhibition of TGF-beta1 does not affect either EGF or Msx-1 expression.",
                      "object score": 923,
                      "subject score": 1000,
                      "publication date": "2014"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P37173": {
              "object": "UniProtKB:P37173",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:interacts_with---UMLS:C1506219---SEMMEDDB:",
                    "UniProtKB:P01137---MI:0915---UniProtKB:P37173---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11496185",
                    "PMID:21441952"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:11496185": {
                      "sentence": "Finally, they examined the regulation of TGF-beta receptor II by TGF-beta1, TGF-beta2, and TGF-beta3 ligands.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P61812": {
              "object": "UniProtKB:P61812",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:interacts_with---UMLS:C0079441---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1846264",
                    "PMID:15466377",
                    "PMID:7608141",
                    "PMID:2021626",
                    "PMID:2899081",
                    "PMID:8198961",
                    "PMID:1310325",
                    "PMID:1572906",
                    "PMID:21087804",
                    "PMID:8119124",
                    "PMID:7634487",
                    "PMID:12911534",
                    "PMID:10375614"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1310325": {
                      "sentence": "The results from affinity labelling saturation and competition experiments with TGF-beta 1 and TGF-beta 2 suggest the existence of two distinct subtypes of betaglycan: one subtype has a lower capacity and higher affinity, binds both TGF-beta 1 and TGF-beta 2, yet has a preferential affinity for TGF-beta 2; the second subtype has a higher capacity and lower affinity and binds TGF-beta 1 exclusively.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Feb"
                    },
                    "PMID:1572906": {
                      "sentence": "While TGF beta 1 and TGF beta 2 show autoinduction, TGF beta 3 upregulates TGF beta 1 but does not affect TGF beta 2 mRNA levels.",
                      "object score": 900,
                      "subject score": 1000,
                      "publication date": "1992 May"
                    },
                    "PMID:1846264": {
                      "sentence": "In contrast, BASMC migration was enhanced by TGF-beta 1 and was not affected by TGF-beta 2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Jan"
                    },
                    "PMID:2021626": {
                      "sentence": "Competition experiments, using 125I-TGF-beta 1 or 125I-TGF-beta 2 and varying amounts of competing unlabeled TGF-beta 1 or TGF-beta 2, revealed that both the placental type III proteoglycan and its core glycoprotein belong to a novel class of type III receptors that exhibit a greater affinity for TGF-beta 2 than for TGF-beta 1.",
                      "object score": 1000,
                      "subject score": 875,
                      "publication date": "1991 Apr 30"
                    },
                    "PMID:2899081": {
                      "sentence": "They co-exist in many cell types, have high affinity for TGF-beta 1, and varying degrees of affinity for TGF-beta 2.",
                      "object score": 993,
                      "subject score": 993,
                      "publication date": "1988 Aug 05"
                    },
                    "PMID:7608141": {
                      "sentence": "Thus TGF-beta 1 and -beta 2 bind to TGF-beta receptors in different ways; TGF-beta 1 binds directly to T beta-RII, while binding of TGF-beta 2 to T beta-RII requires coexpression of T beta-RI or T beta-RIII.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Jul 07"
                    },
                    "PMID:7634487": {
                      "sentence": "Both assays detect TGF-beta 1 and TGF-beta 3 with similar sensitivity, are > 10-fold less sensitive to TGF-beta 2 and are not affected by a range of other peptide growth factors.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Feb 28"
                    },
                    "PMID:8119124": {
                      "sentence": "In addition, the efficient binding of TGF-beta 1, but not TGF-beta 2, to the cloned type II receptor strengthens the likelihood that additional type II receptor isoforms exist which display preferential binding to TGF-beta 2 and have their own defined role in development.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Jan"
                    },
                    "PMID:8198961": {
                      "sentence": "Of 50 tumours, 45 (90%) expressed TGF-beta 1 mRNA, 39 (78%) expressed TGF-beta 2, and 47 (94%) expressed TGF-beta 3.",
                      "object score": 923,
                      "subject score": 854,
                      "publication date": "1994 Jun"
                    },
                    "PMID:10375614": {
                      "sentence": "In normal breast, both TGF-beta1 and TGF-beta3 were found in most samples (88 and 89% respectively), with fewer expressing TGF-beta2 (68%).",
                      "object score": 813,
                      "subject score": 1000,
                      "publication date": "1999 Jul"
                    },
                    "PMID:12911534": {
                      "sentence": "TGF-beta2 and TGF-beta3 effects may be partially mediated by TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Sep"
                    },
                    "PMID:15466377": {
                      "sentence": "The effects of TGF-beta1 or TGF-beta2 on mucin MUC5AC protein and mRNA expression, and the impact of IL-13 on epithelial TGF-beta1, TGF-beta2, and MUC5AC were determined in cultured bronchial epithelial cells from endobronchial brushings of both subject groups.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2004 Oct"
                    },
                    "PMID:21087804": {
                      "sentence": "CONCLUSIONS: The TGF-beta1 mediated secretion of endothelin-1 and TGF-beta2 is mediated by Rho kinase activation in human HSC.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Mar"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:physically_interacts_with-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:interacts_with---NCBIGene:4088---SEMMEDDB:",
                    "UMLS:C0080222---SEMMEDDB:interacts_with---UMLS:C0529119---SEMMEDDB:",
                    "UMLS:C0080222---SEMMEDDB:interacts_with---UMLS:C0919432---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30274147",
                    "PMID:31236971",
                    "PMID:25300817",
                    "PMID:27097055",
                    "PMID:33364431",
                    "PMID:23786998",
                    "PMID:24021731",
                    "PMID:31467486",
                    "PMID:26945889",
                    "PMID:32930424",
                    "PMID:31883057",
                    "PMID:19727674",
                    "PMID:32472701",
                    "PMID:30293967",
                    "PMID:15963949",
                    "PMID:31801904",
                    "PMID:15917296",
                    "PMID:14595120",
                    "PMID:27502207",
                    "PMID:25202359"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:14595120": {
                      "sentence": "Moreover, all these apoptotic events induced by TGF-beta 1 were found to be effectively inhibited by Smad3 knockdown and also completely abrogated by Smad7 expression, suggesting the involvement of the Smad3 pathway upstream of the Fas death pathway by TGF-beta 1.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2004 Feb"
                    },
                    "PMID:15917296": {
                      "sentence": "Inhibition of the transforming growth factor beta (TGFbeta) pathway by interleukin-1beta is mediated through TGFbeta-activated kinase 1 phosphorylation of SMAD3.",
                      "object score": 1000,
                      "subject score": 868,
                      "publication date": "2005 Aug"
                    },
                    "PMID:15963949": {
                      "sentence": "Data revealed that genistein induced an evident formation of Smad-DNA complexes and phosphorylation of Smad2 and Smad3, indicating increased TGF-beta1 signaling.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2005 Aug 05"
                    },
                    "PMID:16849317": {
                      "sentence": "These results suggest that RACK1 modulates transcription of alpha2(I) collagen by TGF-beta1 through interference with Smad3 binding to the gene promoter.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2006 Sep 08"
                    },
                    "PMID:17400544": {
                      "sentence": "TGF-beta1 increased endogenous Smad3 ubiquitination, and proteasome inhibitor treatment blocked TGF-beta1-mediated Smad3 down-regulation resulting in accumulation of ubiquitinated Smad3.",
                      "object score": 833,
                      "subject score": 833,
                      "publication date": "2007 May 25"
                    },
                    "PMID:19727674": {
                      "sentence": "In conclusion, our results demonstrated that TbetaRI/ALK5-p38 MAPK phosphorylation signaling pathway could contribute to doxazosin-induced cell apoptosis, which could be further enhanced by TGF-beta1 in association with attenuating Smad3 phosphorylation in H9C2 cells.",
                      "object score": 790,
                      "subject score": 1000,
                      "publication date": "2009 Dec"
                    },
                    "PMID:20607716": {
                      "sentence": "Addition of ALK5 inhibitors prevented TGF-beta1-mediated Smad3 nuclear accumulation and NO production when given prior to the Nos2 induction stimuli, but not after.",
                      "object score": 848,
                      "subject score": 848,
                      "publication date": "2010 Aug 15"
                    },
                    "PMID:22900077": {
                      "sentence": "In addition, WF-A inhibited TGF-beta1 induced phosphorylation of TGF-beta1 receptor I, Smad3 phosphorylation and transcription of collagen genes.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2012"
                    },
                    "PMID:23555679": {
                      "sentence": "Furthermore, silencing NDRG1expression also impaired TGF-beta1 signaling by inhibiting SMAD3 phosphorylation.",
                      "object score": 840,
                      "subject score": 762,
                      "publication date": "2013"
                    },
                    "PMID:24021731": {
                      "sentence": "Zoledronic acid did not attenuate the total transforming growth factor beta 1 (TGF-beta1) production into the supernatant, but down-regulated TGF-beta receptor types I and II expression and Smad3 phosphorylation, as was also confirmed by immunofluorescence microscopy.",
                      "object score": 888,
                      "subject score": 900,
                      "publication date": "2014 Mar"
                    },
                    "PMID:25202359": {
                      "sentence": "TGFbeta1 signaling was assessed by Smad3 phosphorylation, and non-canonical signaling was analyzed by quantitative polymerase chain reaction-based regulatory gene expression profiles.",
                      "object score": 888,
                      "subject score": 928,
                      "publication date": "2014 Oct"
                    },
                    "PMID:26667039": {
                      "sentence": "SIRT3 deficiency caused induction of TGF-beta1 expression and hyperacetylation of glycogen synthase kinase 3beta (GSK3beta) at residue K15, which negatively regulated GSK3beta activity to phosphorylate the substrates Smad3 and beta-catenin.",
                      "object score": 861,
                      "subject score": 928,
                      "publication date": "2015 Dec 14"
                    },
                    "PMID:26945889": {
                      "sentence": "In addition, small-interfering RNA (siRNA) silencing of Smad3 or Nox4 significantly suppressed TGF-beta1-mediated CTGF expression in VSMC.",
                      "object score": 1000,
                      "subject score": 771,
                      "publication date": "2016 05"
                    },
                    "PMID:27502207": {
                      "sentence": "AMTN mRNA levels were induced at the initiation of apoptosis by TGFbeta1, which mediated through the Smad3 bindings to SBEs in the mouse AMTN gene promoter.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2016 10"
                    },
                    "PMID:28260007": {
                      "sentence": "The expression levels of alpha-SMA, fibronectin, collagen I, TGF-beta1, in addition to phosphorylation of Smad3 were detected by western blotting.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 May"
                    },
                    "PMID:28637791": {
                      "sentence": "In cultured human MCs, we observed that TGF-beta1 (5 ng/ml for 15 h) significantly increased Smad3 phosphorylation, as evaluated by immunoblot.",
                      "object score": 775,
                      "subject score": 1000,
                      "publication date": "2017 09 01"
                    },
                    "PMID:29383958": {
                      "sentence": "In the mouse model, CuONPs exposure markedly increased transforming growth factor-beta1 (TGF-beta1) and collagen I expression and Smad3 phosphorylation, combined with elevation of inflammatory mediators including interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha (TNF-alpha).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2018 04"
                    },
                    "PMID:30173360": {
                      "sentence": "We demonstrated that TGF-beta1 exerted its role via the canonical Smad pathway with the phosphorylation of Smad3 being crucial for TGF-beta1 dependent DF cell growth and myofibroblastic differentiation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Sep 01"
                    },
                    "PMID:30274147": {
                      "sentence": "Here we report that hyper-proliferative human PAH PAVSMC have elevated secretion of TGF-beta1 and, to a lesser extent, Activin A, but not Gremlin 1, and significantly reduced Ser465/467-Smad2 and Ser423/425-Smad3 phosphorylation compared to controls.",
                      "object score": 750,
                      "subject score": 1000,
                      "publication date": "2018 Sep 28"
                    },
                    "PMID:30293967": {
                      "sentence": "Injury to the kidney resulted in increased expression of TGF-beta1 and TGFbeta receptor I, phosphorylation of Smad3 and TGF-beta-activated kinase 1 (TAK1), and activation of multiple cell signaling pathways associated with renal fibrogenesis, including Wnt, Notch, EGFR, and nuclear factor-kappaB (NF-kappaB).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Nov 15"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P04637-biolink:physically_interacts_with-UniProtKB:Q15796": {
              "object": "UniProtKB:Q15796",
              "subject": "UniProtKB:P04637",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P04637---MI:0915---UniProtKB:Q15796---identifiers_org_registry:intact",
                    "UMLS:C0079419---SEMMEDDB:interacts_with---UMLS:C1334468---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:31666925",
                    "PMID:19345189"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:31666925": {
                      "sentence": "Moreover, we found bAP15 could suppress TP53-mutant ovarian cancer cell survival by regulating TGF-beta signaling through inhibiting UCHL5 expression and dephosphorylating Smad2, consequently inducing apoptosis.",
                      "object score": 861,
                      "subject score": 839,
                      "publication date": "2019 Oct 15"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P05019-biolink:physically_interacts_with-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "UniProtKB:P05019",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P10415-biolink:physically_interacts_with-UniProtKB:P00441": {
              "object": "UniProtKB:P00441",
              "subject": "UniProtKB:P10415",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P10415---MI:0915---UniProtKB:P00441---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:32814053"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P29474-biolink:physically_interacts_with-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "UniProtKB:P29474",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0669365---SEMMEDDB:interacts_with---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12943964",
                    "PMID:15451549",
                    "PMID:12922936",
                    "PMID:22138052",
                    "PMID:19344709",
                    "PMID:11178778",
                    "PMID:27885334",
                    "PMID:24885446",
                    "PMID:12522125",
                    "PMID:12721155",
                    "PMID:22960186",
                    "PMID:19401171",
                    "PMID:14715521",
                    "PMID:21261471",
                    "PMID:11181009",
                    "PMID:25174844",
                    "PMID:21171409",
                    "PMID:24215170",
                    "PMID:17761917",
                    "PMID:15970571"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8562436": {
                      "sentence": "These observations clearly indicate that NO inhibits NOS activity and that nNOS and eNOS are more sensitive than iNOS to the inhibitory action of NO.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995"
                    },
                    "PMID:9544420": {
                      "sentence": "Transcriptional and post-transcriptional regulation of neuronal and endothelial cNOS genes will be reviewed first, followed by the molecular regulation of the inducible NOS gene.",
                      "object score": 928,
                      "subject score": 851,
                      "publication date": "1998 Mar"
                    },
                    "PMID:11178778": {
                      "sentence": "To investigate the regulation of the ecNOS and iNOS mRNA expression in various tissues, we describe the design and validation of a reliable and efficient competitive RT-PCR approach for quantification of ecNOS and iNOS mRNA in rat tissue.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2001 Jan"
                    },
                    "PMID:11181009": {
                      "sentence": "In conclusion, in (patho)physiological conditions in rats, Q up-regulated eNOS with a bradykinin-mediated mechanism, while downregulated iNOS with a possible TNF- alpha -mediated mechanism.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2001 Mar"
                    },
                    "PMID:12522125": {
                      "sentence": "Long-term treatment with vitamin C restored endothelial NOS activity in aortas of apoE-deficient mice, but did not affect activity of inducible NOS.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2003 Jan 10"
                    },
                    "PMID:12721155": {
                      "sentence": "The present findings provide firm evidence that, upon treatment with bacterial LPS, the increase of NO production is solely dependent on iNOS, whereas that mediated by cNOS is reduced.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Oct"
                    },
                    "PMID:12922936": {
                      "sentence": "The interaction between iNOS and eNOS was reversed by the superoxide scavenger MnTMPyP.",
                      "object score": 840,
                      "subject score": 1000,
                      "publication date": "2003 Aug"
                    },
                    "PMID:12943964": {
                      "sentence": "High V(t) ventilation reduced eNOS gene expression but did not affect iNOS expression.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2003 Sep 01"
                    },
                    "PMID:14715521": {
                      "sentence": "Both increased hepatic endothelin-1 (ET-1) production and pulmonary vascular ET(B) receptor expression with stimulation of endothelial nitric oxide synthase and TNF-alpha mediated inducible nitric oxide synthase and heme oxygenase-1 expression in pulmonary intravascular macrophages occur.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Feb"
                    },
                    "PMID:15451549": {
                      "sentence": "Nicotine has been shown to induce relaxation via nitric oxide (NO) production with activation of endothelium nitric oxide synthase (eNOS), however the effect of nicotine on lipopolysaccharide/interferon-gamma (LPS/IFN-gamma)-induced NO production and inducible NOS (iNOS) gene expression is still undefined.",
                      "object score": 824,
                      "subject score": 976,
                      "publication date": "2004 Nov 02"
                    },
                    "PMID:15970571": {
                      "sentence": "We examined the temporal and spatial expressions of endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) in mouse uteri during the estrous cycle and early pregnancy, as well as the regulation of eNOS and iNOS by estradiol (E2) and progesterone (P4) in ovariectomized mouse uteri using in situ hybridization and immunohistochemistry.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Sep 01"
                    },
                    "PMID:19344709": {
                      "sentence": "L-NIL treatment of diabetic rats normalized the expression of eNOS and NT levels without any effect on iNOS expression in the heart and superior mesenteric arteries.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2009 Jun 02"
                    },
                    "PMID:19401171": {
                      "sentence": "In conclusion, our results support the hypothesis of the involvement of iNOS and nNOS, but not eNOS in neurodegenerative processes.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2009 Mar 19"
                    },
                    "PMID:21171409": {
                      "sentence": "The results of Northern blot analysis showed that hypotonic and hypertonic induced the increase of eNOS gene expression, but had no effect on iNOS gene.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2001 May"
                    },
                    "PMID:21261471": {
                      "sentence": "The mechanisms implicated in the uncoupling of eNOS include oxidation of the critical NOS cofactor tetrahydrobiopterin, depletion of L-arginine, and accumulation of methylarginines.",
                      "object score": 833,
                      "subject score": 1000,
                      "publication date": "2011 May 15"
                    },
                    "PMID:22138052": {
                      "sentence": "PKC as downstream effectors of CCK1/CCK2 receptors activation leading to Akt, ERK, p38 and endothelial NOS (eNOS) phosphorylation.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2012 Mar 05"
                    },
                    "PMID:22960186": {
                      "sentence": "Taken together, eNOS protein expression and iNOS mRNA appear to bear a coincident temporal relationship to the time course of PN-mediated protein nitrative damage after CCI-TBI suggesting that both constitutive and inducible NOS isoforms contribute *NO for PN formation and 3-NT protein modification after TBI.",
                      "object score": 771,
                      "subject score": 901,
                      "publication date": "2012 Dec"
                    },
                    "PMID:24215170": {
                      "sentence": "iNOS and eNOS levels were studied using ELISA assays and HEV viral load, genotype and combined effects of iNOS genotype, levels and parameters for disease severity were examined.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2014"
                    },
                    "PMID:24885446": {
                      "sentence": "Endothelial (e) NOS phosphorylation, and cytosolic Nrf2 and HO-1 expressions were measured using a Western blot analysis.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2014 May 07"
                    },
                    "PMID:27885334": {
                      "sentence": "In the brain, Epi increased nNOS gene expression (in the brainstem and cerebellum) and eNOS expression (in the cerebellum) but had no effect on overall NOS activity.",
                      "object score": 851,
                      "subject score": 888,
                      "publication date": "2016"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q13315-biolink:physically_interacts_with-UniProtKB:P50052": {
              "object": "UniProtKB:P50052",
              "subject": "UniProtKB:Q13315",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0919524---SEMMEDDB:interacts_with---UMLS:C0390423---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15976682",
                    "PMID:7723348",
                    "PMID:15615839",
                    "PMID:16205776",
                    "PMID:30730762",
                    "PMID:14737832",
                    "PMID:10076916",
                    "PMID:17102979",
                    "PMID:8898348",
                    "PMID:14556962",
                    "PMID:9473667",
                    "PMID:12482596",
                    "PMID:16304626",
                    "PMID:21162207",
                    "PMID:10510333",
                    "PMID:28884431",
                    "PMID:21975128",
                    "PMID:8230088",
                    "PMID:10703869",
                    "PMID:29455433"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7723348": {
                      "sentence": "KT3-671 displaced specific binding of [125I]Sar1 Ile8-AII to AT1 receptor with a Ki value of 0.71 +/- 0.14 x 10(-9) M in rat liver membranes, but had no affinity for AT2 receptor in bovine cerebellar membranes (Ki > 10(-5) M).",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1995 Jan"
                    },
                    "PMID:8230088": {
                      "sentence": "Two high-affinity receptor subtypes have been identified by radioligand binding with antagonists: losartan (DuP 753/MK954) identifies AT1 receptors; PD123177 and CGP42112A are markers for AT2 receptors.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1993 Aug"
                    },
                    "PMID:8898348": {
                      "sentence": "The effects of ANG II on [3H]thymidine incorporation were reflected by those on cell number and were prevented by the AT2 receptor antagonist, PD123177, but not influenced by the AT1 receptor antagonist, losartan.",
                      "object score": 623,
                      "subject score": 623,
                      "publication date": "1996 Aug 30"
                    },
                    "PMID:9473667": {
                      "sentence": "All ANG II effects were abolished by the AT2 receptor antagonist PD123177 (10(-5) M) but not affected by the AT1 receptor antagonist losartan (10(-5) M).",
                      "object score": 583,
                      "subject score": 775,
                      "publication date": "1998 Jan"
                    },
                    "PMID:9736262": {
                      "sentence": "In each condition, the AT2 receptor appears to down-modulate actions mediated by the AT1 receptor, resulting in decreased cellular proliferation, decreased levels of serum arginine vasopressin levels, or decreased vasoconstrictor responses.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1998 Sep"
                    },
                    "PMID:9884070": {
                      "sentence": "Furthermore, in this vascular preparation, the AT2 receptor appears to inhibit the response mediated by the AT1 receptor, although, this is not uniform between the non-pregnant and pregnant states.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1998 Dec"
                    },
                    "PMID:10076916": {
                      "sentence": "In each condition the AT2 receptor appears to down-modulate actions mediated by the AT1 receptor, resulting in decreased cellular proliferation, decreased levels of serum AVP levels or decreased vasoconstrictor responses.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1999 Jan"
                    },
                    "PMID:10510333": {
                      "sentence": "Aortic AT1 was not affected by overexpression of AT2.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1999 Oct"
                    },
                    "PMID:10703869": {
                      "sentence": "Evidence now emerges that angiotensin II exerts actions through the AT2 receptor which are directly opposed to those mediated by the AT1 receptor.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1999 Dec"
                    },
                    "PMID:12482596": {
                      "sentence": "In contrast, replacing eight more amino acids in the 3rd ICL of the AT2 (at positions 241-244, 250-251 and 255-256) with that of the AT1 in the mutant M8, not only increased the affinity of the AT2 receptor to [125I]Ang II (K(d)=0.038 nM) but also abolished AT2-mediated inhibition.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Dec 18"
                    },
                    "PMID:14556962": {
                      "sentence": "125I-Sar1,Gly8 Ang II (0.5-3 nM) bound to AT1 receptors in pituitary, liver, heart, adrenal, and hypothalamic membranes with high affinity (Kd=0.43, 1.6, 2.3, 0.96 and 1.8 nM, respectively), but showed no saturable binding to the adrenal AT2 receptor.",
                      "object score": 851,
                      "subject score": 888,
                      "publication date": "2003 Oct 15"
                    },
                    "PMID:14737832": {
                      "sentence": "When AT1 receptor is blocked and unbound Ang II may act on AT2 receptor and Ang 1-7 and Ang IV via AT4 receptor might be involved in the effects of ARB.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2004 Jan"
                    },
                    "PMID:15615839": {
                      "sentence": "Several studies have provided evidence to support the notion that the AT2 receptor may have opposing effects to those mediated by the AT1 receptor.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2005 May"
                    },
                    "PMID:15976682": {
                      "sentence": "Angiotensin II/III exerts actions through the AT2 receptor, which are directly opposed to those mediated by the AT1 receptor.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2005 Mar"
                    },
                    "PMID:16205776": {
                      "sentence": "AT1 receptor blockade prevented the isolation-induced increase in brain AT1 receptors and decrease in AT2 binding in the locus coeruleus.",
                      "object score": 694,
                      "subject score": 851,
                      "publication date": "2006 Jun"
                    },
                    "PMID:16304626": {
                      "sentence": "To determine the roles of brain AT1 and AT2 receptors in this response, the effects of the central AT1 and AT2 receptor antagonists losartan and PD123319 were investigated in chronically prepared near-term ovine fetuses.",
                      "object score": 833,
                      "subject score": 888,
                      "publication date": "2005 Dec 26"
                    },
                    "PMID:17102979": {
                      "sentence": "These findings suggested that the acute exercise-induced apoptosis in renal tubules could involve action of AT1 and AT2 receptors as well as oxidative stress, while the regular training was shown to prevent apoptosis in renal tubular cells via modulated expression of AT1 and AT2 receptors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2007 Feb"
                    },
                    "PMID:21975128": {
                      "sentence": "Therefore, the activation of AT2 receptors may be potentially protective and appear to oppose the effects mediated by the AT1 receptors.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2011 Dec"
                    },
                    "PMID:28884431": {
                      "sentence": "The molecular mechanisms involved in AT2 receptor activation, the complex interactions with AT1 receptors, and additional factors participating in the control of AT2 receptor regulation and activity in response to stressors are only partially understood.",
                      "object score": 851,
                      "subject score": 888,
                      "publication date": "2018 Jan"
                    },
                    "PMID:29455433": {
                      "sentence": "The aim of this study was to examine the presence of AT1 and AT2 receptors in nuclear membrane of human mesangial cells (HMCs) and evaluate the possible biological effects mediated by intracellular AT1 through an intracrine mechanism.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2018 Nov"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q9BYF1-biolink:physically_interacts_with-UniProtKB:P37173": {
              "object": "UniProtKB:P37173",
              "subject": "UniProtKB:Q9BYF1",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:Q9BYF1---MI:0915---UniProtKB:P37173---identifiers_org_registry:intact"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:26867007"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:intact",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-UMLS:C0007412": {
              "object": "UMLS:C0007412",
              "subject": "CHEBI:35530",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:inhibits---UMLS:C0007412---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:3333527",
                    "PMID:6151892",
                    "PMID:3741714",
                    "PMID:1019225",
                    "PMID:3256608",
                    "PMID:6369370",
                    "PMID:15251484",
                    "PMID:1686456",
                    "PMID:1671550",
                    "PMID:4155335",
                    "PMID:24458058",
                    "PMID:6141126"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1019225": {
                      "sentence": "It is inhibited or at least strongly attenuated by beta-adrenergic blocking agents and by the depletion of catecholamines.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1976"
                    },
                    "PMID:1671550": {
                      "sentence": "Rat liver ornithine decarboxylase induction by dexamethasone or laparatomy, which is dramatically impaired by catecholamine depletion, is not affected by alpha-and beta -adrenergic blockers administered simultaneously 1 h prior to steroid injection or operation.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1991 Jan 31"
                    },
                    "PMID:1686456": {
                      "sentence": "Beta-blockers reduce peak blood velocity and decrease the activity of catecholamines in plasma, which should reduce endothelial damage and the subsequent formation of plaques.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Dec"
                    },
                    "PMID:3256608": {
                      "sentence": "After catecholamine depletion by beta-blocking agent (carteolol: 15 mg a day, 5 to 12 months' duration), the variation of QTc became less marked.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1988"
                    },
                    "PMID:3333527": {
                      "sentence": "Animal data suggest that beta-blockers inhibit catecholamine induced cardiovascular damage and modify coronary atheroma formation in the presence of stress and/or high cholesterol diets (in spite of blood lipid changes).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987 Sep"
                    },
                    "PMID:3741714": {
                      "sentence": "This is best explained by a lack of effect of pindolol on the plasma clearance of catecholamines, which is impaired by beta-adrenoceptor blockers devoid of intrinsic sympathomimetic activity.",
                      "object score": 1000,
                      "subject score": 890,
                      "publication date": "1986 Jun"
                    },
                    "PMID:4155335": {
                      "sentence": "1 Drugs which release or modify the response to catecholamines were examined for their effect on the permeability of the mouse peritoneal vascular bed to circulating plasma albumin, labelled with Evans blue.2 Phenoxybenzamine, phentolamine, piperoxane, yohimbine or cocaine reduced the extravasation of Evans blue into the peritoneum, an effect which was antagonized by beta-adrenoceptor blocking drugs.",
                      "object score": 1000,
                      "subject score": 991,
                      "publication date": "1974 May"
                    },
                    "PMID:6141126": {
                      "sentence": "The inhibitory responses to catecholamines were competitively antagonized by three beta blockers, being in the following order of potency as estimated by their pA2 values: propranolol greater than atenolol much greater than butoxamine.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1983 Oct"
                    },
                    "PMID:6151892": {
                      "sentence": "Alone, alpha-adrenoceptor antagonists have no place in the treatment of angina pectoris. beta-Adrenoceptor blocking drugs competitively inhibit catecholamines at both cardiac and peripheral vascular beta-adrenergic receptors.",
                      "object score": 1000,
                      "subject score": 894,
                      "publication date": "1984"
                    },
                    "PMID:6369370": {
                      "sentence": "Behavioral responses to stress may be attenuated in rats by pharmacological blockade of peripheral CA release, suggesting a positive feedback process in which released CA augment behavioral responses, possibly analogous to use of clonidine or beta-adrenergic blocking agents to diminish somatic symptoms attending anxiety-provoking situations in humans.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1984"
                    },
                    "PMID:15251484": {
                      "sentence": "Patients with contraindications to a major surgical procedure or with malignant pheochromocytoma and metastatic disease, however, may be treated with multiple drugs--for example, alpha- and beta-adrenergic blockers and direct vasodilators to neutralize the effects of high levels of circulating catecholamines and alpha-methyl-metatyrosine to inhibit catecholamine synthesis.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997"
                    },
                    "PMID:24458058": {
                      "sentence": "We hypothesize that propranolol is the best beta-blocker (BB) to block the excess catecholamines and improve mortality in this patient population.",
                      "object score": 853,
                      "subject score": 901,
                      "publication date": "2014 Feb"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-UMLS:C0597357": {
              "object": "UMLS:C0597357",
              "subject": "CHEBI:35530",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:inhibits---UMLS:C0597357---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20923997",
                    "PMID:1233216",
                    "PMID:2867205",
                    "PMID:29566753",
                    "PMID:31309699",
                    "PMID:19240679",
                    "PMID:6148865",
                    "PMID:9192124",
                    "PMID:6133648",
                    "PMID:16368315",
                    "PMID:1760382",
                    "PMID:32221582",
                    "PMID:30844480",
                    "PMID:30025570"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1233216": {
                      "sentence": "The two beta-blockers reduced resting heart rate to the same extent, indicating the same degree of blockade of cardiac beta-receptors.",
                      "object score": 802,
                      "subject score": 901,
                      "publication date": "1975 Apr 04"
                    },
                    "PMID:1760382": {
                      "sentence": "The anti-mortality effect of the cardiac drugs known as beta-blockers is exerted by inhibition of cerebral beta-receptors, not peripheral ones.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "1991"
                    },
                    "PMID:2867205": {
                      "sentence": "Growing cells in the presence of pindolol or celiprolol induced a 50% decrease in the density of beta-2 receptors, which was inhibited by beta adrenergic antagonists.",
                      "object score": 901,
                      "subject score": 988,
                      "publication date": "1985 Dec"
                    },
                    "PMID:6133648": {
                      "sentence": "Beta-adrenergic blockers have several physiologic and pharmacologic actions that are due to a class action resulting from competitive blockade of cellular receptors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1983 Jun"
                    },
                    "PMID:6148865": {
                      "sentence": "It should be noted, however, that these selective beta blockers all block beta-2 receptors when their concentrations are high enough.",
                      "object score": 901,
                      "subject score": 901,
                      "publication date": "1984 Oct"
                    },
                    "PMID:9192124": {
                      "sentence": "OBJECTIVE: Previous studies have shown that beta 1 selective agents have fewer adverse effects on exercise metabolism than nonselective beta blockers, and this has been attributed to their reduced blockade of beta 2 receptors.",
                      "object score": 901,
                      "subject score": 901,
                      "publication date": "1997 Jun"
                    },
                    "PMID:16368315": {
                      "sentence": "The proportion of patients who discontinued medications was lowest for aspirin (18%) and BBs (22%) and highest for ACE inhibitors/angiotensin receptor blockers (28%) and statins (28%).",
                      "object score": 792,
                      "subject score": 1000,
                      "publication date": "2006 Jan"
                    },
                    "PMID:19240679": {
                      "sentence": "This inhibitory effect of leptin mediated by activation of sympathetic nervous system can be abrogated by application of blood pressure-reducing beta-blockers, which also inhibit receptors of hypothalamic adrenergic neurons.",
                      "object score": 1000,
                      "subject score": 846,
                      "publication date": "2009 Jan-Feb"
                    },
                    "PMID:20923997": {
                      "sentence": "We measured rates of aspirin, statin, beta-blocker, and angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) prescription at hospital discharge among eligible patients; 237 167 (15.9%) patients had nonobstructive CAD and 1 252 578 (84.1%) had obstructive CAD.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "2010 Nov"
                    },
                    "PMID:29566753": {
                      "sentence": "Structured education program was associated with a significant rise in beta-blockers prescription rates from a baseline of 60 to 92% (p = 0.003), but a non-sustained rise in ACEI/ARB prescription.",
                      "object score": 809,
                      "subject score": 850,
                      "publication date": "2018 03 23"
                    },
                    "PMID:30025570": {
                      "sentence": "Among eligible patients, 27%, 33%, and 67% were not prescribed ACEI/ARB/ARNI, beta-blocker, and MRA therapy, respectively.",
                      "object score": 583,
                      "subject score": 1000,
                      "publication date": "2018 Jul 24"
                    },
                    "PMID:30844480": {
                      "sentence": "Over 12 months, <1% of patients were simultaneously treated with target doses of ACEI/ARB/ARNI, beta-blocker, and MRA.",
                      "object score": 615,
                      "subject score": 1000,
                      "publication date": "2019 May 21"
                    },
                    "PMID:31309699": {
                      "sentence": "Overall, DAPA-HF patients were generally similar to those in recent registries and in relevant trials and had high levels of background therapy: 94% angiotensin-converting enzyme inhibitor/angiotensin receptor blocker/angiotensin receptor-neprilysin inhibitor, 96% beta-blocker, and 71% mineralocorticoid receptor antagonist; 26% had a defibrillator.",
                      "object score": 606,
                      "subject score": 901,
                      "publication date": "2019 Nov"
                    },
                    "PMID:32221582": {
                      "sentence": "We also examined the effect of study drug according to angiotensin-converting enzyme inhibitor/angiotensin receptor blocker dose, beta-blocker (BB) dose, and MRA (>=50% and <50% of target dose).",
                      "object score": 809,
                      "subject score": 901,
                      "publication date": "2020 Mar 28"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35942-biolink:entity_positively_regulates_entity-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "CHEBI:35942",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0597049---SEMMEDDB:augments---UMLS:C0242698---SEMMEDDB:",
                    "UMLS:C0597049---SEMMEDDB:augments---UMLS:C0018801---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20097683",
                    "PMID:19911857",
                    "PMID:29038209",
                    "PMID:15124920",
                    "PMID:26849467",
                    "PMID:29119005",
                    "PMID:17386829",
                    "PMID:20176721",
                    "PMID:15075050",
                    "PMID:21196341"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:15075050": {
                      "sentence": "A number of neurohormones and cytokines are activated in heart failure and their activity is related to the progression of heart failure.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 May"
                    },
                    "PMID:15124920": {
                      "sentence": "Another neurohormonal factor activated in heart failure is endothelin-1, which acts as a potent survival factor against myocardial cell apoptosis.",
                      "object score": 1000,
                      "subject score": 853,
                      "publication date": "2004 Apr"
                    },
                    "PMID:17386829": {
                      "sentence": "Neurohormonal upregulation in heart failure.",
                      "object score": 1000,
                      "subject score": 853,
                      "publication date": "2005 Apr"
                    },
                    "PMID:19911857": {
                      "sentence": "Multiple neurohormonal pathways are activated in heart failure, and contribute to the symptoms of fluid retention and volume overload.",
                      "object score": 1000,
                      "subject score": 587,
                      "publication date": "2009"
                    },
                    "PMID:20097683": {
                      "sentence": "AIMS: Though various neurohormonal systems are concurrently activated during heart failure (HF), their biological effectors are not always easy to measure due to their short life in vivo, instability in biological samples, or very low concentrations.",
                      "object score": 1000,
                      "subject score": 754,
                      "publication date": "2010 Apr"
                    },
                    "PMID:20176721": {
                      "sentence": "We explored sexual dimorphism in the progression of HF using a mice model of neurohormonal-dependent HF.",
                      "object score": 837,
                      "subject score": 837,
                      "publication date": "2010 Apr"
                    },
                    "PMID:21196341": {
                      "sentence": "The increase of the interest in the reversibility of the heart failure and the application of new biological alternatives has generated therapeutic strategies designed to integrate biology and medical technologies in order to act to the biomechanical, the molecular and the neurohormonal mechanisms of heart failure.",
                      "object score": 1000,
                      "subject score": 853,
                      "publication date": "2011 Jan 01"
                    },
                    "PMID:26849467": {
                      "sentence": "We have previously uncovered a neurohormonal mechanism, operating in adrenomedullary chromaffin cells, by which circulating catecholamine (CA) levels increase in heart failure: severe dysfunction of the adrenal alpha2-adrenergic receptors (ARs) due to the up-regulation of G protein-coupled receptor-kinase (GRK)-2, the kinase that desensitizes them.",
                      "object score": 1000,
                      "subject score": 853,
                      "publication date": "2016 Mar"
                    },
                    "PMID:29038209": {
                      "sentence": "Insulin insensitivity and adipokine abnormalities (the hallmarks of type 2 diabetes mellitus) are characteristic features of heart failure; conversely, neurohormonal systems activated in heart failure (norepinephrine, angiotensin II, aldosterone, and neprilysin) impair insulin sensitivity and contribute to microvascular disease in diabetes mellitus.",
                      "object score": 1000,
                      "subject score": 853,
                      "publication date": "2017 Oct 17"
                    },
                    "PMID:29119005": {
                      "sentence": "Neurohormones stimulate myocardial fibrosis and LV dysfunction.",
                      "object score": 976,
                      "subject score": 1000,
                      "publication date": "2017"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:treats-CHEMBL.TARGET:CHEMBL376": {
              "object": "CHEMBL.TARGET:CHEMBL376",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:treats",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0085826-biolink:entity_negatively_regulates_entity-CHEBI:35457": {
              "object": "CHEBI:35457",
              "subject": "UMLS:C0085826",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0085826---SEMMEDDB:inhibits---UMLS:C0003015---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17307447",
                    "PMID:26871817",
                    "PMID:18261706",
                    "PMID:28982823",
                    "PMID:29924379",
                    "PMID:24271648",
                    "PMID:23880581",
                    "PMID:24604524",
                    "PMID:31371116",
                    "PMID:29747859",
                    "PMID:28124399"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:17307447": {
                      "sentence": "RESULTS: Rates of use of antiplatelet agents and lipid-lowering agents were high at discharge and at 1 year, but use of beta-blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers was suboptimal.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Mar"
                    },
                    "PMID:18261706": {
                      "sentence": "MEASUREMENTS: Prevalence of use of antiplatelet drugs, beta-blockers, statins, and ACE inhibitors or ARBs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Feb"
                    },
                    "PMID:23880581": {
                      "sentence": "RESULTS: During the first year after coronary surgery, 94% of patients had at least two dispensed prescriptions for an antiplatelet agent, 68% for an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker, 92% for a beta-blocker, and 93% for a statin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Oct 09"
                    },
                    "PMID:24271648": {
                      "sentence": "PURPOSE: The recommended pharmacotherapy for secondary prevention of acute coronary syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta-blockers, antiplatelet agents (including aspirin), statins or other lipid-lowering agents, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Apr"
                    },
                    "PMID:24604524": {
                      "sentence": "BACKGROUND: Use of the four evidence-based medications [EBMs: antiplatelet agent, beta-blocker, statin and angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (ACEI/ARB)] after acute myocardial infarction (AMI) has a clear impact on 1-year survival.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Aug"
                    },
                    "PMID:26871817": {
                      "sentence": "The prescription of evidence-based medicines (EBMs) at discharge (antiplatelet agents, beta-blockers, statins, and angiotensin-converting enzyme inhibitors [ACEIs] or angiotensin-receptor blockers [ARBs]) was a factor in reducing the risk of all-cause death and cardiovascular death.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Feb"
                    },
                    "PMID:28124399": {
                      "sentence": "PURPOSE: The secondary prevention treatment for acute coronary syndrome (ACS) is based on the combined use of drugs from four therapeutic classes (beta-blockers, antiplatelet agents, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Mar"
                    },
                    "PMID:28982823": {
                      "sentence": "Medications were antiplatelet agents, beta-blockers, ACE inhibitors or angiotensin II receptor blockers and statins.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Oct 05"
                    },
                    "PMID:29747859": {
                      "sentence": "OMT was defined as the combination of an antiplatelet agent, statin, beta blocker, and angiotensin-converting enzyme inhibitor or angiotensin receptor blocker.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Jul 15"
                    },
                    "PMID:29924379": {
                      "sentence": "RESULTS: Some significant changes were noted in hospital management including shortening of median times from admission to PCI, increased use of drug-eluting stents, potent antiplatelet agents but also less frequent use of statin, beta-blockers and angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.",
                      "object score": 1000,
                      "subject score": 867,
                      "publication date": "2018 Jun 20"
                    },
                    "PMID:31371116": {
                      "sentence": "We analysed contact with physicians, hospital care and actual prescriptions for medication recommended in international guidelines, referring to beta-blockers, ACE inhibitors or angiotensin II receptor blockers, P2Y12-antiplatelet agents, acetylsalicylic acid and statins, one year after myocardial infarction.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2019 Jul 18"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01019-biolink:gene_associated_with_condition-DOID:0080685": {
              "object": "DOID:0080685",
              "subject": "UniProtKB:P01019",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:183---biolink:gene_associated_with_condition---UMLS:C0340643---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17502491"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P02649-biolink:gene_associated_with_condition-DOID:0080685": {
              "object": "DOID:0080685",
              "subject": "UniProtKB:P02649",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:613---JensenLab:associated_with---DOID:0080685---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28116311",
                    "PMID:21713101",
                    "PMID:29197606",
                    "PMID:26914991",
                    "PMID:30066903",
                    "PMID:21472256",
                    "PMID:26925344",
                    "PMID:23284748",
                    "PMID:29326312",
                    "PMID:25045854",
                    "PMID:22421179",
                    "PMID:27585542",
                    "PMID:28155696",
                    "PMID:24812324",
                    "PMID:22872371",
                    "PMID:25117779",
                    "PMID:24442477",
                    "PMID:23782924",
                    "PMID:28818856",
                    "PMID:22560850"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-DOID:0080685": {
              "object": "DOID:0080685",
              "subject": "UniProtKB:P30556",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:336---JensenLab:associated_with---DOID:0080685---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23868934",
                    "PMID:24449804",
                    "PMID:20067609",
                    "PMID:27283746",
                    "PMID:25405392",
                    "PMID:25238161",
                    "PMID:25941343",
                    "PMID:27069537",
                    "PMID:20687182",
                    "PMID:18242274",
                    "PMID:30602301",
                    "PMID:19635970",
                    "PMID:20300261",
                    "PMID:30158382",
                    "PMID:24329494",
                    "PMID:26506064",
                    "PMID:22783312",
                    "PMID:30255099",
                    "PMID:23782924",
                    "PMID:28818856"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P46531-biolink:gene_associated_with_condition-DOID:0080685": {
              "object": "DOID:0080685",
              "subject": "UniProtKB:P46531",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:7881---JensenLab:associated_with---DOID:0080685---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30281655",
                    "PMID:27550231",
                    "PMID:23300792",
                    "PMID:27843325",
                    "PMID:26914991",
                    "PMID:28659818",
                    "PMID:27394642",
                    "PMID:29671812",
                    "PMID:31409059",
                    "PMID:28948327",
                    "PMID:31766500",
                    "PMID:33145057",
                    "PMID:28928672",
                    "PMID:28993736",
                    "PMID:30580570",
                    "PMID:25074475",
                    "PMID:25117779",
                    "PMID:18695204",
                    "PMID:22247596",
                    "PMID:17662764"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-CHEBI:35457": {
              "object": "CHEBI:35457",
              "subject": "VANDF:4021566",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:inhibits---UMLS:C0003015---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15911742",
                    "PMID:12777939",
                    "PMID:12467154",
                    "PMID:15149313",
                    "PMID:17398315",
                    "PMID:15538095",
                    "PMID:17324732",
                    "PMID:15911739",
                    "PMID:16399851",
                    "PMID:15860966",
                    "PMID:12003700",
                    "PMID:15938037",
                    "PMID:17215651",
                    "PMID:16686332",
                    "PMID:17053529",
                    "PMID:16172420",
                    "PMID:17151332",
                    "PMID:14564133",
                    "PMID:14737846",
                    "PMID:15073471"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2527124": {
                      "sentence": "At present, indirect vasodilators, such as calcium-antagonists, ACE-inhibitors and serotonin-receptor blockers, alone or combined with diuretics, represent an intrinsic part of basic antihypertensive therapy.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1989 May 31"
                    },
                    "PMID:12003700": {
                      "sentence": "In patients with hypertension and proteinuria, angiotensin converting enzyme inhibitors or angiotensin receptor blockers must be part of the regimen, and calcium antagonists are safe and effective in this condition when used with them in combination.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "2002 Jun"
                    },
                    "PMID:12467154": {
                      "sentence": "These data have led to propose ACE inhibitors in first intention in patients exhibiting chronic nephropathies, whether hypertensive or not THE COMBINATION WITH OTHER HYPERTENSIVE DRUGS: Calcium channel blockers have a beneficial trophic effect in renoprotection and can be combined with ACE inhibitors, particularly in the case of diabetic nephropathies.",
                      "object score": 771,
                      "subject score": 1000,
                      "publication date": "2002 Nov 09"
                    },
                    "PMID:14564133": {
                      "sentence": "Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in combination with a dihydropyridine calcium channel blocker may be helpful in this regard.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "2003 Sep-Oct"
                    },
                    "PMID:14737846": {
                      "sentence": "Although both ACE inhibitors and angiotensin receptor blockers are established as a tool for improving glomerular hypertension, whether calcium antagonists ameliorate this abnormality remains unclear.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "2004 Jan"
                    },
                    "PMID:15911739": {
                      "sentence": "Initial treatment with thiazide diuretic would be followed by randomization to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, beta-blocker, calcium channel blocker, or aldosterone antagonist.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Jul"
                    },
                    "PMID:15911742": {
                      "sentence": "This can be accomplished by regular exercise and by drugs such as nitrates, calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Jul"
                    },
                    "PMID:16686332": {
                      "sentence": "Pharmacogenomics thus allows to explore polymorphisms that could potentially explain heterogeneous efficacy of diuretics, ACE inhibitors or angiotensin receptor blockers, beta-blockers and calcium channel blockers among populations of varied ethnical origin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Apr 12"
                    },
                    "PMID:17398315": {
                      "sentence": "Additional drugs (typically in the sequence, angiotensin converting-enzyme inhibitor or angiotensin receptor blocker, calcium antagonist, beta-blocker, alpha-blocker, aldosterone antagonist, direct vasodilator, and centrally acting alpha(2)-agonist) can be added to achieve the blood pressure goal (usually <140/90 mm Hg, but <130/80 mm Hg for diabetics and those with chronic kidney disease).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Apr"
                    },
                    "PMID:17496526": {
                      "sentence": "For patients without proteinuria, antihypertensive therapy should be initiated with a calcium channel blocker and for those with proteinuria, an angiotensin-converting enzyme (ACE) inhibitor or angiotensin II receptor blocker.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 May 15"
                    },
                    "PMID:18067048": {
                      "sentence": "It is concluded that CCBs are less effective than ACEIs or ARBs on preserving renal function and ameliorating proteinuria in nondiabetic CKD.",
                      "object score": 786,
                      "subject score": 1000,
                      "publication date": "2007"
                    },
                    "PMID:18078009": {
                      "sentence": "This retrospective database analysis compared the effectiveness of dihydropyridine calcium channel blockers (DHPs), angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs) added to diuretics or beta-blockers.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "2007"
                    },
                    "PMID:23342238": {
                      "sentence": "Other first-line drugs are long-acting calcium channel blockers, generally dihydropyridines, and angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers.",
                      "object score": 1000,
                      "subject score": 864,
                      "publication date": "2012 Sep"
                    },
                    "PMID:23548396": {
                      "sentence": "Calcium antagonists, along with inhibitors of angiotensin converting enzyme (ACE) inhibitors and sartans have favorable metabolic effects.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "2013"
                    },
                    "PMID:24132701": {
                      "sentence": "CCBs have lowered risks while ACE inhibitors and ARBs are relatively free of such metabolic adverse effects.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 May"
                    },
                    "PMID:24583433": {
                      "sentence": "The intravenous administration of a calcium channel blocker, the oral administration of an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker and the transfusion of fresh frozen plasma were effective for treating the thrombocytopenia and progressive kidney dysfunction.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014"
                    },
                    "PMID:24628293": {
                      "sentence": "The effect of calcium channel blockers (CCBs), beta blockers and angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) on the prognosis of patients with acute myeloid leukemia (AML) is largely unknown.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Dec"
                    },
                    "PMID:25355012": {
                      "sentence": "In this review, we aimed to summarize the recent findings on pharmacogenetics of the most commonly used antihypertensive drugs in clinical practice, including diuretics, angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers, beta-blockers and calcium channel blockers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 May"
                    },
                    "PMID:27733585": {
                      "sentence": "Overall, our exploratory findings suggest possible differential effects of antihypertensive medications on mood that merits further study: calcium antagonists and beta-blockers may be associated with increased risk, whereas angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be associated with a decreased risk of mood disorders.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "2016 11"
                    },
                    "PMID:27734656": {
                      "sentence": "As per the latest Eighth Joint National Committee (JNC 8) the goal BP in most hypertensive patients age <60 years should be <140/90 mmHg and treatment can be started by selecting drugs from among 4 specific medication classes i.e. angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB), calcium channel blocker (CCB) or diuretics.",
                      "object score": 778,
                      "subject score": 1000,
                      "publication date": "2016 Apr"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:61799": {
              "object": "FMA:61799",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB00368---identifiers_org_registry:drugbank",
                    "UMLS:C0032952---SEMMEDDB:interacts_with---UMLS:C0028351---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:5540770"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:5540770": {
                      "sentence": "The effect of prednisone on plasma norepinephrine concentration and renin activity in salt-depleted man.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1971 Feb"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:67238": {
              "object": "FMA:67238",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB00988---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:67243": {
              "object": "FMA:67243",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB00668---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:74637": {
              "object": "FMA:74637",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB00052---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:82839": {
              "object": "FMA:82839",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB01109---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-FMA:83365": {
              "object": "FMA:83365",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0032952---SEMMEDDB:interacts_with---UMLS:C0021641---SEMMEDDB:",
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB00071---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB00030---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:6749880",
                    "PMID:7002662",
                    "PMID:9229189",
                    "PMID:6997328"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:6749880": {
                      "sentence": "We have studied the effects of 3 days of hydrocortisone (30 mg every 8 h), dexamethasone (1 mg every 8 h), and prednisone (7.5 mg every 8 h) ingestion on glucose intolerance and insulin resistance in three groups of lean normal volunteers and compared these parameters to specific insulin binding in erythrocytes.",
                      "object score": 660,
                      "subject score": 1000,
                      "publication date": "1982 Nov"
                    },
                    "PMID:6997328": {
                      "sentence": "Furthermore, since dexamethasone and cortisone affect plasma insulin levels in the same fashion as previously reported with prednisone, it is suggested that the variation in insulin binding observed after glucocorticoid treatment is not due to variations in insulinemia.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1980 Sep"
                    },
                    "PMID:7002662": {
                      "sentence": "The decrease in insulin binding with both dexamethasone and prednisone was associated with decreased affinity of erythrocyte for insulin at low occupancy and the increase in the dose of unlabeled insulin resulted in 50% inhibition of specific binding without changes in the number of receptors.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1980 Oct"
                    },
                    "PMID:9229189": {
                      "sentence": "However, after stopping prednisone the urticaria reappeared and it was relieved with insulin desensitization.",
                      "object score": 694,
                      "subject score": 861,
                      "publication date": "1997 May"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:62343-biolink:entity_positively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "FMA:62343",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006772---SEMMEDDB:stimulates---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:14999813",
                    "PMID:15896003",
                    "PMID:11724213",
                    "PMID:10671564",
                    "PMID:7533126",
                    "PMID:23159936",
                    "PMID:7525816",
                    "PMID:11376599",
                    "PMID:10691776",
                    "PMID:7515875",
                    "PMID:7526942",
                    "PMID:12773144"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7515875": {
                      "sentence": "We conclude that a Ca2+/calmodulin-dependent NOS present in plasma membranes of gastric muscle cells is activated by two homologous peptide transmitters, VIP and PACAP, via a common receptor coupled to pertussis toxin (PTx)-sensitive Gi1-2.",
                      "object score": 775,
                      "subject score": 775,
                      "publication date": "1994 Jun 10"
                    },
                    "PMID:7525816": {
                      "sentence": "The iNOS from murine macrophages tightly binds calmodulin as a subunit, and its activity is not dependent on exogenous calmodulin or elevated calcium.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1994 Nov"
                    },
                    "PMID:7526942": {
                      "sentence": "The fixation-insensitive NADPHd activity, which accounts for the staining in NADPHd histochemistry, co-purifies with the insect Ca2+/calmodulin-dependent NOS.",
                      "object score": 766,
                      "subject score": 766,
                      "publication date": "1994 Aug 01"
                    },
                    "PMID:7533126": {
                      "sentence": "The form of NOS expressed in liver was independent of calcium and calmodulin, and the messenger RNA levels were first detected 2 hours after hepatectomy using a probe corresponding to the cytokine-induced macrophage NOS.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1995 Mar"
                    },
                    "PMID:10671564": {
                      "sentence": "Importantly, both cAK and cGK phosphorylation of NOS-III in vitro caused a highly reproducible partial (10-20%) NOS-III activation which was independent of Ca(2+)/CaM, and as much as a 4-fold increase in V(max) in the presence of Ca(2+)/CaM.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2000 Feb 18"
                    },
                    "PMID:10691776": {
                      "sentence": "Caveolins, the resident scaffolding proteins of caveolae, and calmodulin undergo reciprocal Ca2+-dependent association and dissociation with eNOS in the caveolar membrane that inhibits (caveolins) and activates (calmodulin) eNOS activity.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2000 Jan"
                    },
                    "PMID:11376599": {
                      "sentence": "Results show that CaM does not participate in the microglial increase of iNOS produced by LPS.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 May 25"
                    },
                    "PMID:11724213": {
                      "sentence": "Ca2+/calmodulin-dependent NOS activity was estimated in aortic endothelial lining and in heart tissue homogenates by conversion of [3H]arginine into [3H]citrulline.",
                      "object score": 771,
                      "subject score": 771,
                      "publication date": "2001 Nov"
                    },
                    "PMID:12773144": {
                      "sentence": "Protein-engineering experiments have shown that a series of unusual autoinhibitory inserts found only in the CaM-dependent NOS isoforms control both CaM binding and the structural rearrangement it induces.",
                      "object score": 608,
                      "subject score": 608,
                      "publication date": "2003 Jun"
                    },
                    "PMID:14999813": {
                      "sentence": "Exposure of cultured human astrocytes to 1 microM veratridine or 50 mM KCl produced a pronounced increase in a calmodulin-dependent NOS activity estimated from cGMP formation.",
                      "object score": 833,
                      "subject score": 833,
                      "publication date": "2004 Apr 01"
                    },
                    "PMID:15896003": {
                      "sentence": "Moreover, iNOS activation by CaM, like nNOS, is not dependent on Ca(2+) being bound to all four Ca(2+)-binding sites, but has specific and distinct requirements.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2005 May 24"
                    },
                    "PMID:23159936": {
                      "sentence": "Here we show that neuronal NOS activation by calmodulin removes constraints favoring a closed 'input state', increasing occupation of other states and facilitating conformational transitions.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2013 Jan 04"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:63891-biolink:entity_negatively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "FMA:63891",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0009325---SEMMEDDB:inhibits---UMLS:C1366557---SEMMEDDB:",
                    "UMLS:C0009325---SEMMEDDB:inhibits---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9804346",
                    "PMID:15563055",
                    "PMID:16934628",
                    "PMID:25326845",
                    "PMID:15498571",
                    "PMID:29761584",
                    "PMID:20107769",
                    "PMID:21600192",
                    "PMID:32320626",
                    "PMID:12147196",
                    "PMID:16337361",
                    "PMID:7717891",
                    "PMID:27072956",
                    "PMID:29541402",
                    "PMID:26758229",
                    "PMID:15504975",
                    "PMID:25636879",
                    "PMID:21167013",
                    "PMID:29756411",
                    "PMID:26697692"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7717891": {
                      "sentence": "In teeth implanted with TGF-beta 1, the carrier collagen remained in the cavity and little pulp tissue proliferation was seen, suggesting a possible inhibitory effect of TGF-beta 1 in pulp regeneration.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1994 Dec"
                    },
                    "PMID:9804346": {
                      "sentence": "Also, supernatants from fibroblast cultures derived from treated hypertrophic scar, showed a reduction in TGF-beta1 and PDGF expression, although apparently collagen synthesis was not affected.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "1998 Nov"
                    },
                    "PMID:12147196": {
                      "sentence": "CONCLUSION: SA-B inhibited HSC proliferation and collagen production as well as decreased the cells' TGF-beta1 autocrine and MAPK activity, which might contribute to the mechanism of SA-B action against hepatic fibrosis.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "2002 Aug"
                    },
                    "PMID:15498571": {
                      "sentence": "Here, we show that (a) there was an enhanced production of both uPA and PAI-1 in HRA cells in response to TGF-beta1; (b) the overexpression of bik in the cells or exogenous bik results in the inhibition of TGF-beta1 signaling as measured by phosphorylation of the downstream signaling effector Smad2, nuclear translocation of Smad3, and production of PAI-1 and collagen; (c) bik neither decreased expression of TGF-beta receptors (TbetaRI and TbetaRII) in either cell types nor altered the specific binding of 125I TGF-beta1 to the cells, indicating that the effects of bik in these cells are not mediated by ligand sequestration; (d) TbetaRI and TbetaRII present on the same cells exclusively form aggregates in TGF-beta1-stimulated cells; (e) co-treatment of TGF-beta1-stimulated cells with bik suppresses TGF-beta1-induced complex formation of TbetaRI and TbetaRII; and (f) a chondroitin-4-sulfate side chain-deleted bik (deglycosylated bik) does not inhibit TGF-beta1 signaling or association of",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2004 Oct 22"
                    },
                    "PMID:15504975": {
                      "sentence": "However, VEGF did not influence the production of another novel chain of collagen IV, alpha5(IV) collagen, and SU5416 failed to reverse the known inhibitory effect of TGF-beta1 on alpha5(IV) collagen production.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Nov"
                    },
                    "PMID:15563055": {
                      "sentence": "CONCLUSION: SF could decrease collagen synthesis, with mechanism may be associated with that SF intervened TGFbeta1 activity, and reduced the level of TGFbeta1 increased by oxidative stress.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2004 Aug"
                    },
                    "PMID:16337361": {
                      "sentence": "In the presence of types I and III collagens, the inhibitory effect of TGF-beta1 on the proliferation of mink lung epithelial cells was sustained, thus suggesting that the bioactivity of TGF-beta1 had been enhanced.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2006 Mar"
                    },
                    "PMID:16934628": {
                      "sentence": "This study examined the effects that TNF-alpha, IL-1beta, IL-6, and TGF-beta1 have on the collagen degradation mediated by pulp fibroblasts utilizing a cell-mediated collagen degradation assay.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2006 Sep"
                    },
                    "PMID:20107769": {
                      "sentence": "In rat tracheal and lung fibroblasts cultured in proline-free medium, arginase inhibition by N(omega)-hydroxy-nor-L-arginine caused a reduction by about one-third of basal collagen I accumulation (determined by western blot analysis) and largely attenuated transforming growth factor beta 1 (TGF-beta(1))-induced increase in collagen accumulation, whereas basal and TGF-beta(1)-induced collagen accumulation by human lung fibroblasts was not affected by arginase inhibition.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2010 Apr"
                    },
                    "PMID:21167013": {
                      "sentence": "AVE also markedly attenuated the increased mRNA expression of collagen I (P < 0.001) and collagen III (P < 0.001) and inhibited the overexpression of TGF-beta1 (P < 0.05) and TNF-alpha (P < 0.05) compared to the control group.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jun"
                    },
                    "PMID:21600192": {
                      "sentence": "A possible mechanism is through the down-regulation of TGF-beta1 expression, which could inhibit HSC activation, as well as the proliferation and collagen production of collagen reducing, so that collagen deposition in the liver is reduced.",
                      "object score": 928,
                      "subject score": 888,
                      "publication date": "2011 Jun 10"
                    },
                    "PMID:23211799": {
                      "sentence": "OMT treatment lowered the blood pressure, reduced the concentrations of serum norepinephrine and myocardium Ang II, favorably decreased the measured gravimetric parameters, decreased the interstitial and perivascular collagen deposition, attenuated the collagen of type I and III accumulation, downregulated the mRNA expression of ACE and TGF-beta1, and suppressed the phosphorylation of ERK 1/2, JNK and p38 MAPK in SHRs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Feb 15"
                    },
                    "PMID:25326845": {
                      "sentence": "RESULTS: Vitamin D significantly reduced the histological scoring, ECM and collagen productions in the colons and decreased the levels of TGF-beta1, Smad-3, p-Smad3 and Collagen I in SEMF.",
                      "object score": 1000,
                      "subject score": 872,
                      "publication date": "2015 Apr"
                    },
                    "PMID:25636879": {
                      "sentence": "Meanwhile, YTE strongly decreased the levels of HYP and Col-I, and reduced the over-expression of HMGB1, TGF-beta1, Col-I and alpha-SMA.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Jan 15"
                    },
                    "PMID:26697692": {
                      "sentence": "After being intervened with HDN, it could notably inhibit HSC-T6 proliferation and Collagen I growth, reduce TGF-beta1, Smad2, Smad3 and CTGF mRNA and TGF-beta1, CTGF protein expressions and increase Smad7 mRNA expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Jul"
                    },
                    "PMID:26758229": {
                      "sentence": "Mechanism study showed the declination of collagen I level via losartan was caused by inhibition of active transforming growth factor-beta1.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2016 Oct"
                    },
                    "PMID:27072956": {
                      "sentence": "Furthermore, SSYX treatment could significantly decrease COL I and COL III protein levels and down-regulate TGF-beta1 and MMP-2 mRNA expression levels in MI rabbits.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2016 Apr"
                    },
                    "PMID:29541402": {
                      "sentence": "Knockdown of Sema4D in WSU-HN6 cells inhibited collagen production by fibroblasts, and decreased activated TGF-beta1 levels in culture medium of HNSCC cell lines.",
                      "object score": 852,
                      "subject score": 888,
                      "publication date": "2018 Feb 16"
                    },
                    "PMID:29756411": {
                      "sentence": "A significant decrease in LV mass, interstitial collagen and collagen concentration was demonstrated with chronic HEX treatment (for 21 days), accompanied by a decrease in TGF-beta1 expression, myofibroblast differentiation and an increase in collagen-degrading MMP-13 expression levels.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "2018 May"
                    },
                    "PMID:29761584": {
                      "sentence": "Gene expression analyses showed downregulation of the profibrotic marker genes transforming growth factor beta 1, Collagen I, and vascular endothelial growth factor.",
                      "object score": 860,
                      "subject score": 1000,
                      "publication date": "2018 Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:63891-biolink:entity_negatively_regulates_entity-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "FMA:63891",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0009325---SEMMEDDB:inhibits---UMLS:C0172537---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20392987",
                    "PMID:1845565",
                    "PMID:18583211",
                    "PMID:17686880",
                    "PMID:1378028",
                    "PMID:18946018",
                    "PMID:20236589",
                    "PMID:19935079",
                    "PMID:21185415",
                    "PMID:17189319",
                    "PMID:20160069",
                    "PMID:11684074",
                    "PMID:17565550",
                    "PMID:14507513",
                    "PMID:11738059",
                    "PMID:15302515",
                    "PMID:20728951",
                    "PMID:16690877",
                    "PMID:10347097",
                    "PMID:16876394"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1845565": {
                      "sentence": "Serum levels of type IV collagen and hepatic type IV collagenase activity, as markers for formation and degradation respectively of basement membrane collagen (type IV collagen) in liver, were measured in patients with various alcoholic liver diseases.",
                      "object score": 875,
                      "subject score": 901,
                      "publication date": "1991"
                    },
                    "PMID:10347097": {
                      "sentence": "Increased elastase, MMP-2, TN, and elastin deposition, as well as SMC proliferating cell nuclear antigen positivity, correlated with progressive medial thickening on attached collagen, whereas reduced MMP-2, elastase, TN, and induction of SMC apoptosis accompanied regression of the thickened media on floating collagen.",
                      "object score": 901,
                      "subject score": 861,
                      "publication date": "1999 May 28"
                    },
                    "PMID:16876394": {
                      "sentence": "A 3-day cold chase demonstrated a significant inhibition of collagen and sGAG degradation; the reduction in collagen degradation was corroborated by the observed reduction in both pro-MMP 2 expression and activation.",
                      "object score": 861,
                      "subject score": 888,
                      "publication date": "2006 Sep"
                    },
                    "PMID:17189319": {
                      "sentence": "Collagen I and thrombin caused a synergistic increase in MMP-2 protein and total MMP activity but paradoxically decreased MMP-2 mRNA.",
                      "object score": 798,
                      "subject score": 1000,
                      "publication date": "2007 Apr"
                    },
                    "PMID:17565550": {
                      "sentence": "Two matrix metalloproteinases (MMPs), MMP-2 and MMP-9, are of major importance in terms of remodeling and degradation of the corneal stromal collagen.",
                      "object score": 1000,
                      "subject score": 877,
                      "publication date": "2007 Jul-Aug"
                    },
                    "PMID:17686880": {
                      "sentence": "Expression of collagen I and III, as well as matrix metalloproteinase-2 (MMP-2), tissue inhibitor of MMP-2 (TIMP-2), and colligin were analyzed by RNase protection assay.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Nov"
                    },
                    "PMID:18583211": {
                      "sentence": "The degradation of long bone collagen by MMP2 (but not by cathepsin K) was impaired.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2008 Sep"
                    },
                    "PMID:18946018": {
                      "sentence": "In cyclosporine A-treated renal transplant fibroblasts, azithromycin blocked the accumulation of total collagen in culture media and the increase in type I collagen mRNA level, but recovered the reduced MMP-2 mRNA level to the control.",
                      "object score": 632,
                      "subject score": 888,
                      "publication date": "2008 Nov"
                    },
                    "PMID:19935079": {
                      "sentence": "More importantly, CaMKII inhibitors, autocamtide-2-related inhibitory peptide (AIP 5 microM) or KN93 (0.5 microM), suppressed cardiac fibroblast proliferation, inhibited the excretion of transforming growth factor beta1 and tumor necrosis factor alpha, decreased the messenger RNA expression of MMP-1, 2, 9 and collagen I/III, and decreased the protein expression of MMP-2, 9.",
                      "object score": 988,
                      "subject score": 1000,
                      "publication date": "2010 Jan"
                    },
                    "PMID:20160069": {
                      "sentence": "The combined treatment increased collagen degradation, protein levels of active forms of MMP-1, MMP-2, MMP-3, and MMP-14 in conditioned media, and the low-molecular-weight fragment of MMP-14 in membrane extracts, as well as mRNA levels of MMP-1, MMP-2, and MMP-14.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2010 May"
                    },
                    "PMID:20392987": {
                      "sentence": "Collagen degradation, the hallmark of tumor invasion, was dependent on fibroblasts and active MMP-2.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "2010 Mar"
                    },
                    "PMID:21185415": {
                      "sentence": "During early scale regeneration, mmp-2 and mmp-9 transcripts increased in abundance in the scale, enzymatic MMP activity increased and collagen degradation was detected by means of hydroxyproline measurements.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2011 Apr 01"
                    },
                    "PMID:22577570": {
                      "sentence": "After treatment with quercetin, we observed an improvement in liver complications, decreased fibrosis, as analyzed by picrosirius for the quantification of collagen, and decreased levels of matrix metalloproteinase 2 (MMP-2) compared with the CCl(4) group.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:22613087": {
                      "sentence": "The collagen degradation enzymes, matrix metalloproteinase (MMP)-2 and -9 and the tissue inhibitor of MMP were markedly increased in the BAL fluid at 1 day- and subsequently declined at 28 days after exposure, but remained much higher than the controls.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "2012 Aug 01"
                    },
                    "PMID:26307436": {
                      "sentence": "Increased collagen I and III expression, decreased matrix metalloproteinase 2 (MMP2) and MMP14 expression, and increased immune response were associated with the endometrosis phenotype in the C57Bl/6N strain and the 30ppm BPA CD-1 group.",
                      "object score": 916,
                      "subject score": 888,
                      "publication date": "2015 Dec"
                    },
                    "PMID:27072956": {
                      "sentence": "Furthermore, SSYX treatment could significantly decrease COL I and COL III protein levels and down-regulate TGF-beta1 and MMP-2 mRNA expression levels in MI rabbits.",
                      "object score": 857,
                      "subject score": 861,
                      "publication date": "2016 Apr"
                    },
                    "PMID:27623803": {
                      "sentence": "On the other hand, fibronectin, collagen and gelatin decreased expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in media.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 02"
                    },
                    "PMID:28213935": {
                      "sentence": "It is concluded that the one-step self-etch adhesive investigated activates endogenous MMP-2 and MMP-9 with the dentin matrix, which may cause collagen degradation over time.",
                      "object score": 901,
                      "subject score": 775,
                      "publication date": "2017 04"
                    },
                    "PMID:28382686": {
                      "sentence": "The decrease in the collagen level may result not only from the reduced synthesis but also increased degradation owing to MP-induced activation of pro-MMP-2 (72 kDa).",
                      "object score": 901,
                      "subject score": 694,
                      "publication date": "2017 09"
                    },
                    "PMID:29302675": {
                      "sentence": "The data thus demonstrated that the reduction in cardiac fibrosis by TETA-induced Cu repletion is associated at least in part with an enhanced MMP-2 activity, leading to collagen degradation.",
                      "object score": 854,
                      "subject score": 888,
                      "publication date": "2018 01 24"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:63891-biolink:entity_positively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "FMA:63891",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0009325---SEMMEDDB:stimulates---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11488031",
                    "PMID:16952557",
                    "PMID:17569779",
                    "PMID:10389125",
                    "PMID:12224439",
                    "PMID:12087057",
                    "PMID:11297371",
                    "PMID:19024301",
                    "PMID:11453237",
                    "PMID:17044981",
                    "PMID:14757283",
                    "PMID:15882553",
                    "PMID:19292057",
                    "PMID:19639678",
                    "PMID:10725279",
                    "PMID:10527379",
                    "PMID:19229880",
                    "PMID:19252942",
                    "PMID:19321054",
                    "PMID:11863251"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2244882": {
                      "sentence": "An IL-1 beta concentration of 1 unit/ml is enough to keep pro alpha 1(I) collagen mRNA levels at control values in cells stimulated by 100 pM-TGF-beta 1.",
                      "object score": 854,
                      "subject score": 851,
                      "publication date": "1990 Nov 01"
                    },
                    "PMID:7951046": {
                      "sentence": "The effects of porcine bone morphogenetic protein (BMP) on DNA and collagen synthesis in cultured rat osteogenic sarcoma cells and mink lung epithelial cells were studied and compared with the effects induced by transforming growth factor-beta 1 (TGF-beta 1).",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1994 May"
                    },
                    "PMID:8385674": {
                      "sentence": "Pro-alpha 1(l) collagen mRNA was increased by TGF-beta 1 (1 ng/ml) and BMP 4 (50 ng/ml).",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1993 Apr"
                    },
                    "PMID:9163784": {
                      "sentence": "Collagen synthesis in human PFCs was stimulated by TGF-beta 1 and the proliferation of human PFCs was stimulated by platelet-derived growth factor.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1997 May"
                    },
                    "PMID:10389125": {
                      "sentence": "The ability of angiotensin II to induce collagen synthesis and expression of collagen in cardiac fibroblasts may be mediated by an increase in transforming growth factor-beta 1 in an autocrine/paracrine fashion.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Apr"
                    },
                    "PMID:10527379": {
                      "sentence": "There were no differences in basal collagen synthetic rate between dermal and oral mucosal fibroblasts, while the latter synthesized more collagen than dermal fibroblasts when they were stimulated with TGF-beta1.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1999 Nov"
                    },
                    "PMID:11297371": {
                      "sentence": "This reaction results from a cascade of events, including stimulation of transforming growth factor-beta1 (TGF-beta1) production by macrophages which, in turn, promotes alpha-smooth muscle actin and collagen synthesis by fibroblasts.",
                      "object score": 928,
                      "subject score": 888,
                      "publication date": "2000 Oct"
                    },
                    "PMID:11863251": {
                      "sentence": "Folic acid treatment decreases collagen expression and increases TGF-beta1.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2002 Feb"
                    },
                    "PMID:12087057": {
                      "sentence": "In KO mice, an enhancement in angiogenesis, collagen content, and reepithelialization was accelerated with the increased gene expression of TGF-beta1, CTGF, VEGF, Flt-1, and Flk-1 at the wound sites, resulting in accelerated wound healing compared with WT mice.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2002 Jul"
                    },
                    "PMID:12224439": {
                      "sentence": "Furthermore, the increased collagen production in the third-passage fibroblast offspring of the second-passage TGF-beta 1-stimulated fibroblasts could not be further stimulated by TGF-beta 1.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "2002 Jul-Aug"
                    },
                    "PMID:14757283": {
                      "sentence": "NK-355, an aminovinyl photosensitizing dye, enhances collagen production through TGF-beta1 upregulation.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "2004 Feb"
                    },
                    "PMID:15882553": {
                      "sentence": "The accumulation of cardiac collagen was associated with induction of Hcy and TGF-beta1 and with suppression of decorin.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2005 May"
                    },
                    "PMID:17569779": {
                      "sentence": "Depletion of T cells with antilymphocyte serum or pharmacological inhibition of MMPs with GM6001 abrogated accumulation of collagen and increases in the levels of tumor necrosis factor-alpha, interferon-gamma, and active transforming growth factor-beta1.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2007 Aug"
                    },
                    "PMID:19252942": {
                      "sentence": "Moreover, a significant increase in the levels of collagen I and endogenous TGF-beta1 released from bronchial epithelial cells stimulated with TGF-beta1 were observed.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 May-Jun"
                    },
                    "PMID:23597635": {
                      "sentence": "Human ASMCs were presented to surfaces coated with tropoelastin or collagen and controls, then stimulated with TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Oct-Nov"
                    },
                    "PMID:24288677": {
                      "sentence": "The results showed that the expression of nAG protein in primary human fibroblast cells suppresses the expression of collagen I and III, with or without TGF- beta 1 stimulation.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:24464750": {
                      "sentence": "This is the first study indicating that in addition to lymphangiogenesis, VEGF-C is also involved in fibrogenesis through stimulation of myofibroblast proliferation, migration, and collagen synthesis, via activation of the TGF-beta1 and ERK pathways.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2014 Mar"
                    },
                    "PMID:24962729": {
                      "sentence": "Glycated collagen strongly enhanced the expression of TGF-beta2 but not TGF-beta1 or TGF-beta3.",
                      "object score": 901,
                      "subject score": 861,
                      "publication date": "2015 Feb"
                    },
                    "PMID:25300817": {
                      "sentence": "We showed that NS5ATP9 suppressed HSC activation and collagen production, with or without TGF-beta1 induction.",
                      "object score": 928,
                      "subject score": 888,
                      "publication date": "2015 Feb"
                    },
                    "PMID:26556770": {
                      "sentence": "rhDecorin treatment effectively inhibited up-regulation of TGF-beta1, p-Smad2/3, CTGF, collagen I and pro-collagen I c-terminal propeptide after SAH.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Jan 01"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:74644-biolink:entity_negatively_regulates_entity-UniProtKB:P14780": {
              "object": "UniProtKB:P14780",
              "subject": "FMA:74644",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0025219---SEMMEDDB:inhibits---UMLS:C0165519---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20663046",
                    "PMID:21354255",
                    "PMID:26732239",
                    "PMID:28596733",
                    "PMID:31042672",
                    "PMID:23046750",
                    "PMID:23330737",
                    "PMID:20675286",
                    "PMID:22959068",
                    "PMID:18429971",
                    "PMID:22619232",
                    "PMID:27152411"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:18429971": {
                      "sentence": "Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Sep"
                    },
                    "PMID:20663046": {
                      "sentence": "We have shown that melatonin attenuated matrix metalloproteinase-9 (MMP-9) activation and decreased the risk of hemorrhagic transformation following cerebral ischemia-reperfusion.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Nov"
                    },
                    "PMID:20675286": {
                      "sentence": "Administration of melatonin also reduced the expression of VEGF and MMP-9, although no changes were detected in AQP-1 expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Jan"
                    },
                    "PMID:21354255": {
                      "sentence": "Melatonin showed hepatoprotective role by downregulation of MMP-9 and upregulation of tissue inhibitor of metalloproteases (TIMP-1) expression in liver tissue.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 May"
                    },
                    "PMID:22619232": {
                      "sentence": "Melatonin showed a barrier-protective role by downregulation of MMP9 and upregulation of tissue inhibitor of metalloproteinase-1 expression in HUVECs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Aug"
                    },
                    "PMID:22959068": {
                      "sentence": "Melatonin suppressed MMP-9 and -3 expressions and activities during prevention and healing of chronic gastric ulcers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Dec"
                    },
                    "PMID:23046750": {
                      "sentence": "Melatonin reduced the elevated matrix metalloproteinase-9 level in a rat photothrombotic stroke model.",
                      "object score": 687,
                      "subject score": 1000,
                      "publication date": "2012 Dec 15"
                    },
                    "PMID:23330737": {
                      "sentence": "In addition, a human gastric adenocarcinoma cell line (AGS) exhibited a reduced (~50%) MMP-9 expression when incubated with melatonin, supporting an inhibitory effect of melatonin on MMP-9.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 May"
                    },
                    "PMID:26732239": {
                      "sentence": "Mechanistic investigations revealed that melatonin transcriptionally inhibited MMP-9 by reducing p65- and p52-DNA-binding activities.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Apr"
                    },
                    "PMID:27152411": {
                      "sentence": "In conclusion, one of the protective effects of melatonin against BBB hyperpermeability occurs due to enhanced BBB integrity via MMP-9 inhibition.",
                      "object score": 761,
                      "subject score": 1000,
                      "publication date": "2016"
                    },
                    "PMID:28596733": {
                      "sentence": "Melatonin has been shown to preserves BBB integrity and permeability via a variety of pathways: inhibition of matrix metalloproteinase-9 (MMP-9), inhibition of NADPH oxidase-2, and impact on silent information regulator 1 (SIRT1) and nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017"
                    },
                    "PMID:31042672": {
                      "sentence": "In ovo injection of melatonin (5, 50 and 500 ug) dose-dependently decreased the mRNA expression levels of cathepsin K and matrix metalloproteinase 9 (MMP9) in chick calvariae without affecting the expression levels of receptor activator of NF-kappaB ligand or osteoprotegerin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Apr 01"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:74644-biolink:entity_negatively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "FMA:74644",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0025219---SEMMEDDB:inhibits---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21355876",
                    "PMID:17049787",
                    "PMID:16842535",
                    "PMID:18524487",
                    "PMID:23869429",
                    "PMID:31238587",
                    "PMID:16609073",
                    "PMID:9619447",
                    "PMID:22903344",
                    "PMID:15464059",
                    "PMID:15161994",
                    "PMID:10930550",
                    "PMID:20210855",
                    "PMID:17371545",
                    "PMID:12670878",
                    "PMID:12071470"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9619447": {
                      "sentence": "Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation.",
                      "object score": 878,
                      "subject score": 1000,
                      "publication date": "1998 Jun"
                    },
                    "PMID:10930550": {
                      "sentence": "It is suggested that the suppressive effect of melatonin on NADPH-d/NOS expression may be attributed to its antioxidant properties.",
                      "object score": 863,
                      "subject score": 1000,
                      "publication date": "2000 Aug 11"
                    },
                    "PMID:12071470": {
                      "sentence": "Melatonin attenuates the neuronal NADPH-d/NOS expression in the nodose ganglion of acute hypoxic rats.",
                      "object score": 731,
                      "subject score": 1000,
                      "publication date": "2002 Mar"
                    },
                    "PMID:12670878": {
                      "sentence": "Melatonin prevents mitochondrial oxidative damage and inhibits iNOS expression induced by bacterial lipopolysaccharide (LPS).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2003 May"
                    },
                    "PMID:15161994": {
                      "sentence": "The restorative effects of melatonin on this hyporeactivity may depend on its antioxidant properties and partly on its inhibitory action on the inducible nitric oxide synthase production.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2004 Jul"
                    },
                    "PMID:15464059": {
                      "sentence": "The results suggest that melatonin inhibits the expression of inducible nitric oxide synthase by modulating the nuclear factor kappaB pathway.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Oct 06"
                    },
                    "PMID:16609073": {
                      "sentence": "These results suggest that melatonin inhibits COX-2 and iNOS transcriptional activation by inhibiting p300 HAT activity, thereby suppressing p52 acetylation, binding, and transactivation.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2006 Jul 15"
                    },
                    "PMID:16842535": {
                      "sentence": "This study investigated whether the induction of inducible nitric oxide synthase (iNOS) produced by acute exercise in rat skeletal muscle could be prevented by melatonin and whether iNOS down-regulation was related to inhibition of nuclear factor kappaB (NF-kappaB) activation.",
                      "object score": 842,
                      "subject score": 1000,
                      "publication date": "2006 Aug"
                    },
                    "PMID:17049787": {
                      "sentence": "Melatonin reduced LPS-dependent iNOS expression and multiorgan failure in a similar extent in young and aged rats.",
                      "object score": 863,
                      "subject score": 1000,
                      "publication date": "2006 Nov"
                    },
                    "PMID:17371545": {
                      "sentence": "Melatonin inhibits both inducible nitric oxide synthase and inducible mitochondrial nitric oxide synthase activities, a finding related to the antiseptic properties of the indoleamine.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Apr"
                    },
                    "PMID:18524487": {
                      "sentence": "Administration of exogenous melatonin will be beneficial, as it reduces iNOS mRNA expression, and may, therefore, be able to be used as a neuroprotective agent in toxicity induced by AMPH or other immunogens.",
                      "object score": 901,
                      "subject score": 888,
                      "publication date": "2008 Jul 11"
                    },
                    "PMID:20210855": {
                      "sentence": "Melatonin in combination with exercise resulted in significantly increased hindlimb movement (P < 0.05), a reduced level of iNOS mRNA (P < 0.05) and more motor neurons in the ventral horn, versus control SCI and SCI plus exercise alone, with no effect on the other signaling molecules examined.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2010 Apr"
                    },
                    "PMID:21355876": {
                      "sentence": "Melatonin attenuated the levels of tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-6 and inducible nitric oxide synthase (iNOS) protein and mRNA expression, while the level of heme oxygenase-1 (HO-1) was augmented.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2011 May"
                    },
                    "PMID:22903344": {
                      "sentence": "The results show that melatonin significantly decreases the iNOS protein expression and TNF-alpha mRNA levels caused by METH.",
                      "object score": 873,
                      "subject score": 1000,
                      "publication date": "2013 Feb"
                    },
                    "PMID:23869429": {
                      "sentence": "Our results also show that visfatin-induced iNOS expression and NO production were significantly inhibited by melatonin, an effect that was closely associated with a reduction in phosphorylated JAK2/STAT3 levels and with the inhibition of p65 translocation into nucleus.",
                      "object score": 843,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    },
                    "PMID:31238587": {
                      "sentence": "Melatonin significantly reduced iNOS concentrations both in serum (59.7%) and liver (57.8%) but did not affect endothelial isoform enzyme activities neither in serum, nor in liver.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2019 Jun 24"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:83365-biolink:entity_positively_regulates_entity-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "FMA:83365",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0021641---SEMMEDDB:stimulates---UMLS:C0242275---SEMMEDDB:",
                    "UMLS:C0021641---SEMMEDDB:stimulates---UMLS:C1367721---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1715345",
                    "PMID:3005046",
                    "PMID:8193313",
                    "PMID:11162460",
                    "PMID:3880761",
                    "PMID:7749347",
                    "PMID:8125925",
                    "PMID:18656632",
                    "PMID:31805097",
                    "PMID:3259581",
                    "PMID:6270165",
                    "PMID:18417251",
                    "PMID:3896628",
                    "PMID:20571033",
                    "PMID:9498625",
                    "PMID:8621534",
                    "PMID:2647771",
                    "PMID:2199463",
                    "PMID:1947790"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1715345": {
                      "sentence": "At high cell density, both insulin and insulin-like growth factor 1 (IGF-1) induce DNA synthesis more effectively than EGF, FGFs and cholera toxin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Aug"
                    },
                    "PMID:1947790": {
                      "sentence": "Insulin enhances epidermal growth factor- and transforming growth factor-alpha-stimulated growth in primary cultures of guinea pig gastric mucous epithelial cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Sep"
                    },
                    "PMID:2199463": {
                      "sentence": "The effects of TSH and EGF on differentiation expression were not dependent on insulin and can therefore be dissociated from their mitogenic effects.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 Aug"
                    },
                    "PMID:2647771": {
                      "sentence": "The effect of EGF on protein 1 labeling and DNA replication is dependent on insulin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Mar"
                    },
                    "PMID:3005046": {
                      "sentence": "In sharp contrast, EGF alone, or in association with insulin, failed to induce phosphoinositide breakdown at either early or late stages of EGF stimulation or in growing cells in EGF-supplemented serum-free medium.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1986 Mar 03"
                    },
                    "PMID:3259581": {
                      "sentence": "A 24-hr exposure to TGF-beta either before or after insulin/EGF stimulation was as inhibitory on DNA synthesis between 48 and 72 hr of culture as was TGF-beta present throughout 72 hr of culture.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1988 May"
                    },
                    "PMID:3880761": {
                      "sentence": "For suckling rat hepatocytes EGF was required, but its stimulating action was dependent on insulin and/or glucagon.",
                      "object score": 825,
                      "subject score": 1000,
                      "publication date": "1985 Jan"
                    },
                    "PMID:3896628": {
                      "sentence": "The lipogenic responses to EGF and NGF were additive with a submaximal response induced by insulin but not with that of a maximal response to insulin, indicating a similarity in the mechanisms of action of EGF, NGF and insulin.",
                      "object score": 801,
                      "subject score": 1000,
                      "publication date": "1985"
                    },
                    "PMID:6270165": {
                      "sentence": "The stimulation by EGF was enhanced by insulin and glucagon, whereas these hormones by themselves exhibited only limited activity.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1981 Sep"
                    },
                    "PMID:7749347": {
                      "sentence": "IGF-I, TGF beta, and insulin all stimulated [3H] leucine incorporation into protein; FGF, EGF, triiodothyronine and dexamethasone had little or no effect.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Mar"
                    },
                    "PMID:8125925": {
                      "sentence": "The translocation of PLC-gamma 1 was specific for EGF stimulation, because a similar effect was not observed with insulin or vasopressin.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "1994 Mar 11"
                    },
                    "PMID:8193313": {
                      "sentence": "The results indicate that the secretion of EGF from the mammary glands is dependent on insulin and that the decrement in milk-EGF from diabetic rats is selective when compared to the content of protein in milk.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Sep"
                    },
                    "PMID:8621534": {
                      "sentence": "In organ culture, the DS1 activity is increased by epidermal growth factor or prolactin in combination with insulin, whereas the SS activity is enhanced by insulin, prolactin, and glucocorticoid.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Apr 12"
                    },
                    "PMID:9498625": {
                      "sentence": "It is concluded that PKB, which is activated to a greater extent by insulin than EGF, and peak 2, which is activated by insulin and counteracted by EGF, are possible candidates in mediating the stimulation of glycogen synthesis by insulin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jan"
                    },
                    "PMID:11162460": {
                      "sentence": "In vivo administration of PE, insulin, IL-6, HGF, or EGF to mice markedly stimulated PKB/Akt in the liver, with the strongest stimulation induced by insulin and PE.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Dec 29"
                    },
                    "PMID:18417251": {
                      "sentence": "We have found that the C-terminal half of IRSp53 (residues 251-521) undergoes tyrosine phosphorylation in response to insulin stimulation of the insulin beta receptor or epidermal growth factor stimulation via the epidermal growth factor receptor, and that the key residue for insulin receptor-mediated phosphorylation is tyrosine 310, located in a region between the N-terminal IRSp53/MIM homology domain (IMD, residue 1-250) and the central SH3 domain (residues 374-438) that is predicted to be natively unstructured.",
                      "object score": 687,
                      "subject score": 888,
                      "publication date": "2008 Sep"
                    },
                    "PMID:18656632": {
                      "sentence": "Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent.",
                      "object score": 656,
                      "subject score": 656,
                      "publication date": "2008 Aug"
                    },
                    "PMID:20571033": {
                      "sentence": "Insulin (35 nmol/liter) induced phosphorylation of the EGFR at position Tyr(845) and Tyr(1173), but not at Tyr(1045), suggesting that EGF is not involved in insulin-induced EGFR activation.",
                      "object score": 845,
                      "subject score": 845,
                      "publication date": "2010 Aug 20"
                    },
                    "PMID:31805097": {
                      "sentence": "Insulin can activate the epidermal growth factor (EGF) system in other species and the present study tested the hypothesis that upregulation of EGF receptor (EGFR) signalling is a key factor in laminitis pathophysiology.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "2019"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0085826-biolink:entity_negatively_regulates_entity-MESH:D015539": {
              "object": "MESH:D015539",
              "subject": "UMLS:C0085826",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0085826---SEMMEDDB:inhibits---UMLS:C0032173---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:14712893",
                    "PMID:20836572",
                    "PMID:22906905",
                    "PMID:26398717",
                    "PMID:16787383",
                    "PMID:27398626",
                    "PMID:25848131",
                    "PMID:27489245",
                    "PMID:29869943",
                    "PMID:15277785",
                    "PMID:17973080",
                    "PMID:15934859",
                    "PMID:22918734",
                    "PMID:19034035",
                    "PMID:22160877",
                    "PMID:21946947",
                    "PMID:27586412"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:14712893": {
                      "sentence": "Antiplatelet agents interfere with platelet activation and aggregation and, as such, would be expected to modify the natural history of cardiovascular disease.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Dec"
                    },
                    "PMID:15277785": {
                      "sentence": "Aspirin and the thienopyridines (ticlopidine and clopidogrel) are oral antiplatelet agents that interfere with platelet activation in complementary, but separate pathways.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2004 Feb"
                    },
                    "PMID:15934859": {
                      "sentence": "Aspirin and the thienopyridines (ticlopidine and clopidogrel) are oral antiplatelet agents that interfere with platelet activation in complementary, but separate pathways.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2005 May"
                    },
                    "PMID:16787383": {
                      "sentence": "Antiplatelet drugs are primarily directed against platelets and inhibit platelet activation by a number of different mechanisms.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Jun"
                    },
                    "PMID:17973080": {
                      "sentence": "A link between inflammatory status and clinical benefit from antiplatelet agents continues to emerge and highlights the fact that biomarkers beyond ex vivo platelet aggregation may predict the clinical benefit of antiplatelet agents that can reduce platelet activation (i.e., aspirin and thienopyridines).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Aug"
                    },
                    "PMID:19034035": {
                      "sentence": "Clopidogrel is a thienopyridine antiplatelet agent that inhibits adenosine diphosphate-dependent platelet activation and aggregation and is currently one of the most widely prescribed antiplatelet drugs for the treatment of symptomatic coronary artery disease.",
                      "object score": 857,
                      "subject score": 901,
                      "publication date": "2008 Dec"
                    },
                    "PMID:20836572": {
                      "sentence": "Thrombin receptor antagonists are a novel class of antiplatelet agents that inhibit thrombin-mediated platelet activation.",
                      "object score": 852,
                      "subject score": 1000,
                      "publication date": "2010 Oct 01"
                    },
                    "PMID:21946947": {
                      "sentence": "In this study, we report that a potent antiplatelet agent, 2-ethylthio-6-phenethylaminoadenosine (BF061), inhibits platelet activation and thrombosis via P2Y12 antagonism and PDE inhibition.",
                      "object score": 1000,
                      "subject score": 867,
                      "publication date": "2011 Dec"
                    },
                    "PMID:22160877": {
                      "sentence": "PAR-1 inhibitors are a novel class of antiplatelet agents that inhibit thrombin-mediated platelet activation.",
                      "object score": 852,
                      "subject score": 1000,
                      "publication date": "2012 Feb"
                    },
                    "PMID:22906905": {
                      "sentence": "PAR-1 inhibitors are a novel class of antiplatelet agents that inhibit thrombin-mediated platelet activation.",
                      "object score": 852,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:22918734": {
                      "sentence": "Recently, a novel class of antiplatelet agents able to inhibit thrombin-mediated platelet activation has been developed, PAR-1 inhibitors.",
                      "object score": 852,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:25848131": {
                      "sentence": "CONCLUSION: These data indicate that the combination of rivaroxaban with single or dual antiplatelet agents works synergistically to reduce platelet activation, which may in turn lead to the delayed/reduced formation of coagulation complexes and vice versa, thereby enhancing antithrombotic potency.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2015 Nov"
                    },
                    "PMID:26398717": {
                      "sentence": "Vorapaxar and atopaxar are novel antiplatelet drugs that inhibit the thrombin-induced platelet activation by antagonizing the PAR-1.",
                      "object score": 861,
                      "subject score": 901,
                      "publication date": "2017"
                    },
                    "PMID:27398626": {
                      "sentence": "Vorapaxar is a first-in-class, novel antiplatelet agent that acts by antagonizing the PAR-1 receptor, inhibiting thrombin-mediated platelet activation.",
                      "object score": 852,
                      "subject score": 781,
                      "publication date": "2016 Nov"
                    },
                    "PMID:27489245": {
                      "sentence": "Vorapaxar is a novel antiplatelet agent that targets the platelet protease-activated receptor 1 and inhibits thrombin-induced platelet activation.",
                      "object score": 861,
                      "subject score": 901,
                      "publication date": "2017 Mar"
                    },
                    "PMID:27586412": {
                      "sentence": "One reason is that it raises concern regarding the potentially significant interaction with antiplatelet agents, leading to impaired inhibition of platelet activation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 09"
                    },
                    "PMID:29869943": {
                      "sentence": "This study aimed to determine the extent to which TLR-mediated platelet activation can be inhibited by currently used antiplatelet agents.",
                      "object score": 743,
                      "subject score": 843,
                      "publication date": "2018 Jun 05"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0279328-biolink:entity_positively_regulates_entity-MESH:D014945": {
              "object": "MESH:D014945",
              "subject": "UMLS:C0279328",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0279328---SEMMEDDB:augments---UMLS:C0043240---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11030870",
                    "PMID:18337831",
                    "PMID:16794267",
                    "PMID:21134254",
                    "PMID:11070797",
                    "PMID:8045777",
                    "PMID:18656258",
                    "PMID:31736209",
                    "PMID:11134996",
                    "PMID:19829177",
                    "PMID:23600133",
                    "PMID:12426451",
                    "PMID:8488397"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8045777": {
                      "sentence": "Hyperbaric oxygen will enhance wound healing by fibroblast and capillary proliferation, suppress infection, reduce edema, reverse CNS damage from carbon monoxide and cyanide poisoning, and reduce clostridial alpha toxins.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Apr"
                    },
                    "PMID:8488397": {
                      "sentence": "Hyperbaric oxygen has been shown to improve oxygen tension and promote wound healing.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 May"
                    },
                    "PMID:11030870": {
                      "sentence": "Enhancement of wound healing by hyperbaric oxygen and transforming growth factor beta3 in a new chronic wound model in aged rabbits.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Oct"
                    },
                    "PMID:11070797": {
                      "sentence": "Exciting new products such as growth factor, hyperbaric oxygen, skin graft substitutes, and the V.A.C. can then be selectively applied to accelerate wound healing.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Oct"
                    },
                    "PMID:11134996": {
                      "sentence": "The use of hyperbaric oxygen (HBO) to accelerate wound healing.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Dec"
                    },
                    "PMID:12426451": {
                      "sentence": "Preliminary data indicate that topical hyperbaric oxygen facilitates wound healing and full closure for pressure ulcers in patients with and without diabetes mellitus.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2002 Nov"
                    },
                    "PMID:16794267": {
                      "sentence": "Hyperbaric oxygen (HBO) enhances wound healing, although the mechanisms for its therapeutic effects are incompletely understood.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Oct"
                    },
                    "PMID:18337831": {
                      "sentence": "In this study, a rat model of wound ischemia was used to test the hypothesis that HBO enhances wound healing by modulating hypoxia-inducible factor-1alpha (HIF-1alpha) signaling.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Aug"
                    },
                    "PMID:18656258": {
                      "sentence": "We review the literature for therapeutic options in hemorrhagic cystitis and try to explain how hyperbaric oxygen stimulates mucosal repair in the urinary bladder.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2009 Apr"
                    },
                    "PMID:19829177": {
                      "sentence": "It was soon recognized that HBO could also facilitate wound healing in infected ischemic extremities.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Nov-Dec"
                    },
                    "PMID:21134254": {
                      "sentence": "CONCLUSIONS: HBO significantly accelerated the repair of osteochondral defects in this rabbit model; however, the addition of fibrin produced no further improvement.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Dec 06"
                    },
                    "PMID:23600133": {
                      "sentence": "CONCLUSIONS: The hyperbaric oxygen can promote wound healing and effectively inhibit the early hyperplastic scar in rabbits ears.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Jan"
                    },
                    "PMID:31736209": {
                      "sentence": "Treatment with HBO accelerated diabetic wound healing compared to untreated mice, with more completed and extended reepithelialization.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2019 Nov 17"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P00441-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P00441",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:6647---biolink:gene_associated_with_condition---UMLS:C4721845---DisGeNET:",
                    "NCBIGene:6647---biolink:gene_associated_with_condition---UMLS:C0024796---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25101153"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01100-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UniProtKB:P01100",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:2353---biolink:gene_associated_with_condition---UMLS:C0018801---DisGeNET:",
                    "HGNC:3796---JensenLab:associated_with---DOID:6000---JensenLab:",
                    "NCBIGene:2353---biolink:gene_associated_with_condition---UMLS:C0018802---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24746050",
                    "PMID:8968192",
                    "PMID:21234399",
                    "PMID:29548686",
                    "PMID:18765947",
                    "PMID:28130202",
                    "PMID:32264928",
                    "PMID:29339713",
                    "PMID:28231183",
                    "PMID:21092187",
                    "PMID:19273391",
                    "PMID:27298828",
                    "PMID:23521790",
                    "PMID:23140119",
                    "PMID:26892968",
                    "PMID:",
                    "PMID:26858641",
                    "PMID:22405889",
                    "PMID:19712015",
                    "PMID:30283345"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01100-biolink:gene_associated_with_condition-MONDO:0005392": {
              "object": "MONDO:0005392",
              "subject": "UniProtKB:P01100",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:2353---biolink:gene_associated_with_condition---UMLS:C0036439---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01133-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P01133",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:3229---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8995426",
                    "PMID:22505936",
                    "PMID:27914124",
                    "PMID:8894692",
                    "PMID:25954202",
                    "PMID:26599408",
                    "PMID:18765947",
                    "PMID:29796325",
                    "PMID:34957211",
                    "PMID:19652764",
                    "PMID:20799254",
                    "PMID:19635970",
                    "PMID:26437621",
                    "PMID:19692420",
                    "PMID:15776436",
                    "PMID:24440155",
                    "PMID:19832981",
                    "PMID:30255099",
                    "PMID:26684006",
                    "PMID:21152435"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-FMA:67303": {
              "object": "FMA:67303",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C0013765---SEMMEDDB:",
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C0041194---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21417692",
                    "PMID:20007933",
                    "PMID:27604583",
                    "PMID:17395448",
                    "PMID:19709383",
                    "PMID:24561579",
                    "PMID:11804868",
                    "PMID:10523620",
                    "PMID:21284555",
                    "PMID:22483258",
                    "PMID:30854248",
                    "PMID:20367772",
                    "PMID:28833753",
                    "PMID:8950455",
                    "PMID:9813154",
                    "PMID:19374489",
                    "PMID:17177824",
                    "PMID:22068323",
                    "PMID:14716854",
                    "PMID:1514649"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1514649": {
                      "sentence": "When neonatal LF were supplemented with 100 pM TGF-beta 1, they showed a significant increase in the soluble elastin content of their culture medium and their steady-state elastin mRNA.",
                      "object score": 660,
                      "subject score": 892,
                      "publication date": "1992 Aug"
                    },
                    "PMID:8074694": {
                      "sentence": "To examine whether this enhancement could be explained by upregulation of the elastin promoter, TGF-beta 1 (100 ng) was injected subcutaneously into the transgenic animals.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1994 Aug 30"
                    },
                    "PMID:8950455": {
                      "sentence": "Upregulation of elastin expression by transforming growth factor beta 1 was greater in the upper dermal fibroblasts than in the middle and lower dermal fibroblasts.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996 Nov"
                    },
                    "PMID:9813154": {
                      "sentence": "However, TGF-beta1 has been shown previously to substantially increase the expression of elastin by stabilization of tropoelastin mRNA through a signaling pathway which involves a phosphatidylcholine-specific phospholipase and a protein kinase C.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Nov 09"
                    },
                    "PMID:10523620": {
                      "sentence": "Binding activity increased as tropoelastin expression dropped, being low in neonatal fibroblasts and high in adult cells, and treatment with transforming growth factor beta1 (TGF-beta1), which stimulates tropoelastin expression by stabilizing its mRNA, reduced mRNA-binding activity.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1999 Nov"
                    },
                    "PMID:11804868": {
                      "sentence": "However, there is a 4- to 6-h lag period after the addition of TGF-beta1 before significant stimulation of elastin expression is observed and the question of whether the Smads are involved has not been addressed.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Feb"
                    },
                    "PMID:14716854": {
                      "sentence": "This study was conducted to examine the effectiveness of a gene transfer of human TGF beta 1 gene into smooth muscle cells and whether the TGF beta 1 can increase elastin expression of smooth muscle cells.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2003 Dec"
                    },
                    "PMID:17177824": {
                      "sentence": "Inhibition of protein synthesis by cycloheximide showed that translation was required for maximal induction by transforming growth factor-beta1 of elastin mRNA but had no observable effect on alpha2(l) procollagen mRNA in all three cultures of fibroblasts.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996"
                    },
                    "PMID:17395448": {
                      "sentence": "TGF-beta1 activated most of the elastin promoter constructs that we studied, except for an inhibitory region contained in the region between -1500 and -1000 bp.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2007 Jul"
                    },
                    "PMID:19374489": {
                      "sentence": "We recently showed 0.2 microg/mL of hyaluronan oligomers and 1 ng/mL of transforming growth factor-beta1 (termed elastogenic factors) to dramatically enhance elastin synthesis and matrix formation by healthy aortic SMCs.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2009 Nov"
                    },
                    "PMID:19709383": {
                      "sentence": "Transforming growth factor-beta1 (TGF-beta1) stimulates synthesis of elastin by dermal fibroblasts and may mediate the increase in elastin in chronically photodamaged skin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009"
                    },
                    "PMID:20007933": {
                      "sentence": "Recombinant TGF-beta1 but not DeltaN23-KGF induced elastin gene expression in MLF.",
                      "object score": 901,
                      "subject score": 917,
                      "publication date": "2010 Apr 01"
                    },
                    "PMID:20367772": {
                      "sentence": "CONCLUSION: Both elastin and collagen are upregulated by TGF-beta1 in TADF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Jun"
                    },
                    "PMID:21284555": {
                      "sentence": "Moreover, TGF-beta1 enhanced elastin synthesis in 3D, but had no effect on cells grown on 2D surfaces.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2011 Jun"
                    },
                    "PMID:21417692": {
                      "sentence": "We recently showed hyaluronan oligomers (HA-o) and TGF-beta1 (termed elastogenic factors) to enhance elastin synthesis and matrix formation by healthy rat aortic smooth muscle cells (RASMCs).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2011 Aug"
                    },
                    "PMID:22068323": {
                      "sentence": "In vitro, TGF-beta1 increases vaginal tropoelastin production in vaginal SMC.",
                      "object score": 851,
                      "subject score": 901,
                      "publication date": "2012 Mar"
                    },
                    "PMID:24561579": {
                      "sentence": "We report that a low 4-HNE concentration (2umol/L) inhibits the upregulation of tropoelastin expression stimulated by TGF-beta1 in human and murine fibroblasts.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2014 Jun"
                    },
                    "PMID:27604583": {
                      "sentence": "We tested whether the elasto-inducing compounds IGF-1, TGF-beta1, and minoxidil could indeed augment elastin production, and whether microRNA-29a antagonism could block elastin production in adult arterial and venous fibroblasts and VSMCs.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2016 10"
                    },
                    "PMID:28833753": {
                      "sentence": "These results indicate that holo-Lf, but not apo-Lf, increases TE expression through LRP-1 in human dermal fibroblasts and suggest that holo-Lf and TGF-beta1 enhance TE expression by activating the PI3K/Akt1 and PI3K/Akt2 pathways, respectively.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2017 Dec"
                    },
                    "PMID:30854248": {
                      "sentence": "Hyaluronan oligomers and transforming growth factor beta 1 (termed elastogenic factors, EFs) have been shown to significantly enhance tropoelastin synthesis, elastic fiber assembly, and crosslinking by adult vascular smooth muscle cells (SMCs).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2012"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0001384": {
              "object": "MONDO:0001384",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:11766---JensenLab:associated_with---DOID:11830---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:29861640",
                    "PMID:22876116",
                    "PMID:27643879",
                    "PMID:19907666",
                    "PMID:21541268",
                    "PMID:24447397",
                    "PMID:29115605",
                    "PMID:27563164",
                    "PMID:27800235",
                    "PMID:23825088",
                    "PMID:29805427",
                    "PMID:24956166",
                    "PMID:21200283",
                    "PMID:24753782",
                    "PMID:30255099",
                    "PMID:23649821",
                    "PMID:26421183",
                    "PMID:19060265",
                    "PMID:12525539",
                    "PMID:29845260"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0005392": {
              "object": "MONDO:0005392",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:7040---biolink:gene_associated_with_condition---UMLS:C0036439---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0005648": {
              "object": "MONDO:0005648",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:7040---biolink:gene_associated_with_condition---UMLS:C0003504---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21216836"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:7040---biolink:gene_associated_with_condition---UMLS:C0024796---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12598898"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:gene_associated_with_condition-MONDO:0008375": {
              "object": "MONDO:0008375",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01579-biolink:gene_associated_with_condition-MONDO:0008375": {
              "object": "MONDO:0008375",
              "subject": "UniProtKB:P01579",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:5438---JensenLab:associated_with---DOID:5327---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20029145",
                    "PMID:28271611",
                    "PMID:21850157",
                    "PMID:30296277",
                    "PMID:16704689",
                    "PMID:30373226",
                    "PMID:27956845",
                    "PMID:22152278",
                    "PMID:30167573",
                    "PMID:27051493",
                    "PMID:31148854",
                    "PMID:22454753",
                    "PMID:25658618",
                    "PMID:21342215",
                    "PMID:23490191",
                    "PMID:26818010",
                    "PMID:30788635",
                    "PMID:26606532",
                    "PMID:29164419",
                    "PMID:21294791"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P02452-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P02452",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:2197---JensenLab:associated_with---DOID:14323---JensenLab:",
                    "HGNC:2198---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28232077",
                    "PMID:30037098",
                    "PMID:19798597",
                    "PMID:19035482",
                    "PMID:31663982",
                    "PMID:22648066",
                    "PMID:26657231",
                    "PMID:19387081",
                    "PMID:18765947",
                    "PMID:17850668",
                    "PMID:18812580",
                    "PMID:22914737",
                    "PMID:15934076",
                    "PMID:29911202",
                    "PMID:20587693",
                    "PMID:26444669",
                    "PMID:30255099",
                    "PMID:16611357",
                    "PMID:24616757",
                    "PMID:27089917"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P02461-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P02461",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:2201---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25835445",
                    "PMID:29960996",
                    "PMID:21331163",
                    "PMID:22648066",
                    "PMID:19123951",
                    "PMID:22345590",
                    "PMID:18765947",
                    "PMID:19652764",
                    "PMID:22113147",
                    "PMID:21270941",
                    "PMID:28715511",
                    "PMID:29911202",
                    "PMID:20587693",
                    "PMID:21936929",
                    "PMID:30255099",
                    "PMID:23852016",
                    "PMID:24453931",
                    "PMID:29940997",
                    "PMID:20958326",
                    "PMID:3411305"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P02778-biolink:gene_associated_with_condition-MONDO:0008375": {
              "object": "MONDO:0008375",
              "subject": "UniProtKB:P02778",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:10637---JensenLab:associated_with---DOID:5327---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24288441",
                    "PMID:32542038",
                    "PMID:33484732",
                    "PMID:24751757",
                    "PMID:20424229",
                    "PMID:21635964",
                    "PMID:30296277",
                    "PMID:27273720",
                    "PMID:30464383",
                    "PMID:30541880",
                    "PMID:26911327",
                    "PMID:21342215",
                    "PMID:23490191",
                    "PMID:32066796",
                    "PMID:30073000",
                    "PMID:26556395",
                    "PMID:20335622",
                    "PMID:21554091",
                    "PMID:17194635",
                    "PMID:23365490"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P04040-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P04040",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:847---biolink:gene_associated_with_condition---UMLS:C0024796---DisGeNET:",
                    "NCBIGene:847---biolink:gene_associated_with_condition---UMLS:C4721845---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25101153"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P04114-biolink:gene_associated_with_condition-MONDO:0001298": {
              "object": "MONDO:0001298",
              "subject": "UniProtKB:P04114",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:338---biolink:gene_associated_with_condition---UMLS:C0026266---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P04150-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UniProtKB:P04150",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:2908---biolink:gene_associated_with_condition---UMLS:C0018801---DisGeNET:",
                    "NCBIGene:2908---biolink:gene_associated_with_condition---UMLS:C0018802---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21737535"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P04637-biolink:gene_associated_with_condition-MONDO:0008213": {
              "object": "MONDO:0008213",
              "subject": "UniProtKB:P04637",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:7157---biolink:gene_associated_with_condition---UMLS:C0016842---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P05019-biolink:gene_associated_with_condition-MONDO:0001384": {
              "object": "MONDO:0001384",
              "subject": "UniProtKB:P05019",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:3479---biolink:gene_associated_with_condition---UMLS:C0027092---DisGeNET:",
                    "HGNC:5464---JensenLab:associated_with---DOID:11830---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23112573",
                    "PMID:21976954",
                    "PMID:28668352",
                    "PMID:24624293",
                    "PMID:28815013",
                    "PMID:24587043",
                    "PMID:29039589",
                    "PMID:26113998",
                    "PMID:27933171",
                    "PMID:26076017",
                    "PMID:21150442",
                    "PMID:30081018",
                    "PMID:20435602",
                    "PMID:23940728",
                    "PMID:29481975",
                    "PMID:31086127",
                    "PMID:31462001",
                    "PMID:",
                    "PMID:30294255",
                    "PMID:32495406"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P05019-biolink:gene_associated_with_condition-MONDO:0005392": {
              "object": "MONDO:0005392",
              "subject": "UniProtKB:P05019",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:5464---JensenLab:associated_with---DOID:0060249---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:27282461",
                    "PMID:23737090",
                    "PMID:23133744",
                    "PMID:22378296",
                    "PMID:29264563",
                    "PMID:25765448",
                    "PMID:28525404",
                    "PMID:31555216",
                    "PMID:26098633",
                    "PMID:28302169",
                    "PMID:26437621",
                    "PMID:26703581",
                    "PMID:30820643",
                    "PMID:31290289",
                    "PMID:15642178",
                    "PMID:31607116",
                    "PMID:21593863",
                    "PMID:24637311",
                    "PMID:30805484",
                    "PMID:22291494"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P05019-biolink:gene_associated_with_condition-MONDO:0008375": {
              "object": "MONDO:0008375",
              "subject": "UniProtKB:P05019",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:5464---JensenLab:associated_with---DOID:5327---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24624293",
                    "PMID:28668352",
                    "PMID:24035588",
                    "PMID:23514645",
                    "PMID:27251645",
                    "PMID:30963607",
                    "PMID:28680125",
                    "PMID:29410732",
                    "PMID:25529848",
                    "PMID:30362302",
                    "PMID:22096351",
                    "PMID:23940728",
                    "PMID:28209733",
                    "PMID:31574834",
                    "PMID:29951586",
                    "PMID:15085194",
                    "PMID:24148095",
                    "PMID:25024972",
                    "PMID:26881246",
                    "PMID:25429204"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P05362-biolink:gene_associated_with_condition-MONDO:0008375": {
              "object": "MONDO:0008375",
              "subject": "UniProtKB:P05362",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:5344---JensenLab:associated_with---DOID:5327---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23619956",
                    "PMID:29110201",
                    "PMID:24751757",
                    "PMID:30122442",
                    "PMID:29246578",
                    "PMID:29410732",
                    "PMID:21850157",
                    "PMID:24339681",
                    "PMID:25529848",
                    "PMID:30926772",
                    "PMID:30345164",
                    "PMID:29850199",
                    "PMID:24068865",
                    "PMID:28452939",
                    "PMID:28397148",
                    "PMID:18958307",
                    "PMID:26245868",
                    "PMID:23043158",
                    "PMID:26881246",
                    "PMID:26514658"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P07204-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UniProtKB:P07204",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:11784---JensenLab:associated_with---DOID:6000---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24435354",
                    "PMID:30302083",
                    "PMID:30309417",
                    "PMID:21901068",
                    "PMID:22067440",
                    "PMID:24816905",
                    "PMID:21871056",
                    "PMID:12644876",
                    "PMID:10690304",
                    "PMID:24117210",
                    "PMID:27422929",
                    "PMID:28154761",
                    "PMID:27006847",
                    "PMID:27006941",
                    "PMID:23798302",
                    "PMID:31928528",
                    "PMID:27298828",
                    "PMID:25635172",
                    "PMID:31337421",
                    "PMID:24325304"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P07550-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UniProtKB:P07550",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:154---biolink:gene_associated_with_condition---UMLS:C0018802---DisGeNET:",
                    "NCBIGene:154---biolink:gene_associated_with_condition---UMLS:C0018801---DisGeNET:",
                    "HGNC:286---JensenLab:associated_with---DOID:6000---JensenLab:",
                    "NCBIGene:154---biolink:gene_associated_with_condition---UMLS:C0242698---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20036967",
                    "PMID:25110700",
                    "PMID:26697426",
                    "PMID:22530954",
                    "PMID:21760751",
                    "PMID:16618831",
                    "PMID:28107561",
                    "PMID:20304057",
                    "PMID:24432032",
                    "PMID:24002027",
                    "PMID:20632220",
                    "PMID:24292829",
                    "PMID:30421645",
                    "PMID:9852912",
                    "PMID:28727839",
                    "PMID:18948702",
                    "PMID:23583979",
                    "PMID:28035081",
                    "PMID:31423403",
                    "PMID:28759088"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P08069-biolink:gene_associated_with_condition-MONDO:0001210": {
              "object": "MONDO:0001210",
              "subject": "UniProtKB:P08069",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:3480---biolink:gene_associated_with_condition---UMLS:C0423224---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P08069-biolink:gene_associated_with_condition-MONDO:0008213": {
              "object": "MONDO:0008213",
              "subject": "UniProtKB:P08069",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:3480---biolink:gene_associated_with_condition---UMLS:C0016842---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P08235-biolink:gene_associated_with_condition-MONDO:0001298": {
              "object": "MONDO:0001298",
              "subject": "UniProtKB:P08235",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:7979---JensenLab:associated_with---DOID:11502---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30570225",
                    "PMID:26574757",
                    "PMID:30686097",
                    "PMID:31911978",
                    "PMID:27714411",
                    "PMID:31312768",
                    "PMID:25780344",
                    "PMID:28281174",
                    "PMID:31233835",
                    "PMID:29876357",
                    "PMID:32215486",
                    "PMID:30637994",
                    "PMID:31096915",
                    "PMID:26371236",
                    "PMID:28025189",
                    "PMID:31916413",
                    "PMID:25210049",
                    "PMID:28785969",
                    "PMID:28133468",
                    "PMID:30697278"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P08253-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P08253",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:4313---biolink:gene_associated_with_condition---UMLS:C0024796---DisGeNET:",
                    "HGNC:7166---JensenLab:associated_with---DOID:14323---JensenLab:",
                    "NCBIGene:4313---biolink:gene_associated_with_condition---UMLS:C4721845---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12970255",
                    "PMID:22343558",
                    "PMID:23355960",
                    "PMID:21470594",
                    "PMID:21471368",
                    "PMID:31232392",
                    "PMID:18765947",
                    "PMID:22207127",
                    "PMID:24720641",
                    "PMID:24443024",
                    "PMID:29070037",
                    "PMID:23770527",
                    "PMID:25304030",
                    "PMID:19675790",
                    "PMID:9852923",
                    "PMID:24440155",
                    "PMID:24347665",
                    "PMID:30255099",
                    "PMID:29567669",
                    "PMID:18178469"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P08684-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UniProtKB:P08684",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:2637---JensenLab:associated_with---DOID:6000---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21694929",
                    "PMID:26512569",
                    "PMID:24160700",
                    "PMID:25855244",
                    "PMID:20443129",
                    "PMID:28379536",
                    "PMID:23829943",
                    "PMID:16570918",
                    "PMID:30177462",
                    "PMID:24833235",
                    "PMID:23790560",
                    "PMID:30613465",
                    "PMID:24733535",
                    "PMID:27062307",
                    "PMID:28537000",
                    "PMID:22915967",
                    "PMID:20717111",
                    "PMID:18827466",
                    "PMID:27125217",
                    "PMID:21814451"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P10600-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P10600",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:11769---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30037098",
                    "PMID:28099082",
                    "PMID:25835445",
                    "PMID:29312958",
                    "PMID:20691848",
                    "PMID:19798597",
                    "PMID:29249976",
                    "PMID:27688095",
                    "PMID:16403239",
                    "PMID:18765947",
                    "PMID:28240702",
                    "PMID:24157418",
                    "PMID:30071700",
                    "PMID:31991693",
                    "PMID:22911900",
                    "PMID:30255099",
                    "PMID:31795342",
                    "PMID:25488804",
                    "PMID:21618406",
                    "PMID:22904665"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P11047-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P11047",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:3915---biolink:gene_associated_with_condition---UMLS:C4721845---DisGeNET:",
                    "NCBIGene:3915---biolink:gene_associated_with_condition---UMLS:C0024796---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25101153"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P12821-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P12821",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:2707---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:18559664",
                    "PMID:19593212",
                    "PMID:29042413",
                    "PMID:21504760",
                    "PMID:32378446",
                    "PMID:23204138",
                    "PMID:23395156",
                    "PMID:20937124",
                    "PMID:11568070",
                    "PMID:23549323",
                    "PMID:22577545",
                    "PMID:27826344",
                    "PMID:19635970",
                    "PMID:18839441",
                    "PMID:29530068",
                    "PMID:29860888",
                    "PMID:28751846",
                    "PMID:28042561",
                    "PMID:21953136",
                    "PMID:18695204"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P14780-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P14780",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:4318---biolink:gene_associated_with_condition---UMLS:C4721845---DisGeNET:",
                    "HGNC:7176---JensenLab:associated_with---DOID:14323---JensenLab:",
                    "NCBIGene:4318---biolink:gene_associated_with_condition---UMLS:C0024796---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20031637",
                    "PMID:22343558",
                    "PMID:30841577",
                    "PMID:26840980",
                    "PMID:18765947",
                    "PMID:26081587",
                    "PMID:19635970",
                    "PMID:27663174",
                    "PMID:25304030",
                    "PMID:29483877",
                    "PMID:29524630",
                    "PMID:24503185",
                    "PMID:24440155",
                    "PMID:26879242",
                    "PMID:28659438",
                    "PMID:22955109",
                    "PMID:21953136",
                    "PMID:25985794",
                    "PMID:18178469",
                    "PMID:19026684"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P15692-biolink:gene_associated_with_condition-MONDO:0008375": {
              "object": "MONDO:0008375",
              "subject": "UniProtKB:P15692",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:12680---JensenLab:associated_with---DOID:5327---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30963607",
                    "PMID:21519856",
                    "PMID:29263305",
                    "PMID:17722514",
                    "PMID:23826375",
                    "PMID:24799807",
                    "PMID:26942449",
                    "PMID:20804843",
                    "PMID:31783639",
                    "PMID:29666126",
                    "PMID:30373226",
                    "PMID:27043545",
                    "PMID:28714394",
                    "PMID:26451379",
                    "PMID:17713594",
                    "PMID:12324862",
                    "PMID:30057967",
                    "PMID:26997843",
                    "PMID:25989270",
                    "PMID:30618774"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P18075-biolink:gene_associated_with_condition-MONDO:0008475": {
              "object": "MONDO:0008475",
              "subject": "UniProtKB:P18075",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:1074---JensenLab:associated_with---DOID:6682---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30745112",
                    "PMID:25083364",
                    "PMID:20887146",
                    "PMID:33269455",
                    "PMID:26933613",
                    "PMID:24886911",
                    "PMID:25580378",
                    "PMID:24672316",
                    "PMID:28342056",
                    "PMID:23878769",
                    "PMID:12908103",
                    "PMID:15672240",
                    "PMID:21119936",
                    "PMID:24198557",
                    "PMID:16371892",
                    "PMID:31561556",
                    "PMID:27669712",
                    "PMID:29433544",
                    "PMID:16582862",
                    "PMID:16648739"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P18146-biolink:gene_associated_with_condition-MONDO:0001384": {
              "object": "MONDO:0001384",
              "subject": "UniProtKB:P18146",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:3238---JensenLab:associated_with---DOID:11830---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28801261",
                    "PMID:29329973",
                    "PMID:21655358",
                    "PMID:23112573",
                    "PMID:22695224",
                    "PMID:29805564",
                    "PMID:18769560",
                    "PMID:30817827",
                    "PMID:31463372",
                    "PMID:34958689",
                    "PMID:17197510",
                    "PMID:34405458",
                    "PMID:25407019",
                    "PMID:22824538",
                    "PMID:32070426",
                    "PMID:18636116",
                    "PMID:23662966",
                    "PMID:21452224",
                    "PMID:31261724",
                    "PMID:26984843"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P29474-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UniProtKB:P29474",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:4846---biolink:gene_associated_with_condition---UMLS:C1959583---DisGeNET:",
                    "NCBIGene:4846---biolink:gene_associated_with_condition---UMLS:C1961112---DisGeNET:",
                    "HGNC:7876---JensenLab:associated_with---DOID:6000---JensenLab:",
                    "NCBIGene:4846---biolink:gene_associated_with_condition---UMLS:C0018801---DisGeNET:",
                    "NCBIGene:4846---biolink:gene_associated_with_condition---UMLS:C0023212---DisGeNET:",
                    "NCBIGene:4846---biolink:gene_associated_with_condition---UMLS:C0018802---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24999376",
                    "PMID:30787945",
                    "PMID:25373878",
                    "PMID:30717220",
                    "PMID:25610649",
                    "PMID:25447937",
                    "PMID:20304057",
                    "PMID:29089345",
                    "PMID:23710164",
                    "PMID:28867378",
                    "PMID:16953900",
                    "PMID:23698776",
                    "PMID:22783322",
                    "PMID:30421645",
                    "PMID:29351461",
                    "PMID:20372051",
                    "PMID:29632465",
                    "PMID:24355497",
                    "PMID:11686871",
                    "PMID:28759088"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UniProtKB:P30556",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:336---JensenLab:associated_with---DOID:6000---JensenLab:",
                    "NCBIGene:185---biolink:gene_associated_with_condition---UMLS:C1961112---DisGeNET:",
                    "NCBIGene:185---biolink:gene_associated_with_condition---UMLS:C0023212---DisGeNET:",
                    "NCBIGene:185---biolink:gene_associated_with_condition---UMLS:C1959583---DisGeNET:",
                    "NCBIGene:185---biolink:gene_associated_with_condition---UMLS:C0018801---DisGeNET:",
                    "NCBIGene:185---biolink:gene_associated_with_condition---UMLS:C0018802---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24999376",
                    "PMID:20597104",
                    "PMID:25076997",
                    "PMID:22784636",
                    "PMID:18021271",
                    "PMID:16777942",
                    "PMID:25610649",
                    "PMID:24000308",
                    "PMID:24002027",
                    "PMID:20514436",
                    "PMID:18586661",
                    "PMID:22915967",
                    "PMID:32674346",
                    "PMID:18214293",
                    "PMID:23829561",
                    "PMID:17208988",
                    "PMID:10993124",
                    "PMID:29259685",
                    "PMID:21436792",
                    "PMID:11835907"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0005648": {
              "object": "MONDO:0005648",
              "subject": "UniProtKB:P30556",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:336---JensenLab:associated_with---DOID:57---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28099082",
                    "PMID:25076997",
                    "PMID:27714411",
                    "PMID:30140748",
                    "PMID:24813328",
                    "PMID:25405392",
                    "PMID:30057766",
                    "PMID:20687182",
                    "PMID:25485172",
                    "PMID:21440001",
                    "PMID:29671812",
                    "PMID:27499904",
                    "PMID:21617136",
                    "PMID:30638252",
                    "PMID:23328613",
                    "PMID:25218762",
                    "PMID:21826258",
                    "PMID:27743312",
                    "PMID:21602838",
                    "PMID:17652901"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P30556-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P30556",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:336---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30147969",
                    "PMID:30841577",
                    "PMID:29249976",
                    "PMID:25405392",
                    "PMID:31620255",
                    "PMID:25954202",
                    "PMID:23395156",
                    "PMID:20687182",
                    "PMID:22949090",
                    "PMID:21152098",
                    "PMID:25779879",
                    "PMID:26081587",
                    "PMID:21440001",
                    "PMID:19635970",
                    "PMID:20300261",
                    "PMID:21944884",
                    "PMID:30255099",
                    "PMID:23852016",
                    "PMID:28659438",
                    "PMID:21618406"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P35228-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P35228",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:4843---biolink:gene_associated_with_condition---UMLS:C0024796---DisGeNET:",
                    "NCBIGene:4843---biolink:gene_associated_with_condition---UMLS:C4721845---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25101153"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P36897-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P36897",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:7046---biolink:gene_associated_with_condition---UMLS:C0024796---DisGeNET:",
                    "HGNC:11772---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30037098",
                    "PMID:25835445",
                    "PMID:20691848",
                    "PMID:29249976",
                    "PMID:18765947",
                    "PMID:21152098",
                    "PMID:20452526",
                    "PMID:31991693",
                    "PMID:19699898",
                    "PMID:22911900",
                    "PMID:25104961",
                    "PMID:30255099",
                    "PMID:24453931",
                    "PMID:25932333",
                    "PMID:22654505",
                    "PMID:",
                    "PMID:24564502",
                    "PMID:20958326",
                    "PMID:27647783",
                    "PMID:25488804"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P37173-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P37173",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:11773---JensenLab:associated_with---DOID:14323---JensenLab:",
                    "NCBIGene:7048---biolink:gene_associated_with_condition---UMLS:C0024796---DisGeNET:",
                    "NCBIGene:7048---biolink:gene_associated_with_condition---UMLS:C4721845---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21098638",
                    "PMID:30037098",
                    "PMID:28099082",
                    "PMID:25835445",
                    "PMID:23940833",
                    "PMID:20937124",
                    "PMID:18765947",
                    "PMID:24443024",
                    "PMID:28715511",
                    "PMID:20587693",
                    "PMID:19699898",
                    "PMID:25104961",
                    "PMID:30255099",
                    "PMID:29876033",
                    "PMID:25488804",
                    "PMID:25932333",
                    "PMID:",
                    "PMID:24564502",
                    "PMID:20958326",
                    "PMID:18695204"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P46531-biolink:gene_associated_with_condition-MONDO:0005648": {
              "object": "MONDO:0005648",
              "subject": "UniProtKB:P46531",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:7881---JensenLab:associated_with---DOID:57---JensenLab:",
                    "NCBIGene:4851---biolink:gene_associated_with_condition---UMLS:C0003504---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30455415",
                    "PMID:30997046",
                    "PMID:22685681",
                    "PMID:20576933",
                    "PMID:31393559",
                    "PMID:26914991",
                    "PMID:28659818",
                    "PMID:30571578",
                    "PMID:29171200",
                    "PMID:30761020",
                    "PMID:31086410",
                    "PMID:28948327",
                    "PMID:30789911",
                    "PMID:32195449",
                    "PMID:30761079",
                    "PMID:30511478",
                    "PMID:28993736",
                    "PMID:",
                    "PMID:24564502",
                    "PMID:29026447"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P50052-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P50052",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:338---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20300261",
                    "PMID:26632386",
                    "PMID:21504760",
                    "PMID:22400124",
                    "PMID:30585249",
                    "PMID:21152098",
                    "PMID:20368751",
                    "PMID:30255099",
                    "PMID:20687182",
                    "PMID:11568070",
                    "PMID:25779879",
                    "PMID:18695204",
                    "PMID:30763216"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P51787-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P51787",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:3784---biolink:gene_associated_with_condition---UMLS:C0024796---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P53814-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P53814",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:11126---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:22955109",
                    "PMID:30037098",
                    "PMID:19584318",
                    "PMID:25593132",
                    "PMID:23248645",
                    "PMID:20587693",
                    "PMID:29249976",
                    "PMID:28212800",
                    "PMID:31739395",
                    "PMID:31936351",
                    "PMID:28539832"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P60953-biolink:gene_associated_with_condition-MONDO:0005392": {
              "object": "MONDO:0005392",
              "subject": "UniProtKB:P60953",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:998---biolink:gene_associated_with_condition---UMLS:C0036439---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P61812-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P61812",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:11768---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25835445",
                    "PMID:20691848",
                    "PMID:19907666",
                    "PMID:19798597",
                    "PMID:31191903",
                    "PMID:18765947",
                    "PMID:23891907",
                    "PMID:27386793",
                    "PMID:24157418",
                    "PMID:30071700",
                    "PMID:31991693",
                    "PMID:22911900",
                    "PMID:30255099",
                    "PMID:29352010",
                    "PMID:34680857",
                    "PMID:25104961",
                    "PMID:22233626",
                    "PMID:31795342",
                    "PMID:25488804",
                    "PMID:32174750"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P62736-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P62736",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:130---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25835445",
                    "PMID:20687182",
                    "PMID:18765947",
                    "PMID:20452526",
                    "PMID:24474961",
                    "PMID:28715511",
                    "PMID:29530068",
                    "PMID:29911202",
                    "PMID:31991693",
                    "PMID:19699898",
                    "PMID:21936929",
                    "PMID:26837258",
                    "PMID:23852016",
                    "PMID:24453931",
                    "PMID:25932333",
                    "PMID:30255099",
                    "PMID:25104961",
                    "PMID:24564502",
                    "PMID:20958326",
                    "PMID:27647783"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P84022-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:P84022",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:6769---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25835445",
                    "PMID:34320838",
                    "PMID:25954202",
                    "PMID:23395156",
                    "PMID:18765947",
                    "PMID:21152098",
                    "PMID:30071700",
                    "PMID:31991693",
                    "PMID:21936929",
                    "PMID:30255099",
                    "PMID:23852016",
                    "PMID:24453931",
                    "PMID:24951767",
                    "PMID:29352010",
                    "PMID:22233626",
                    "PMID:20509926",
                    "PMID:27647783",
                    "PMID:31795342",
                    "PMID:25488804",
                    "PMID:25985794"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q13315-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UniProtKB:Q13315",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:472---biolink:gene_associated_with_condition---UMLS:C0242698---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24358288"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:disgenet",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q14766-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:Q14766",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:6714---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28099082",
                    "PMID:11104663",
                    "PMID:20691848",
                    "PMID:23355960",
                    "PMID:27688095",
                    "PMID:31936351",
                    "PMID:26263555",
                    "PMID:19635970",
                    "PMID:30071700",
                    "PMID:19584318",
                    "PMID:19692420",
                    "PMID:27923483",
                    "PMID:34411563",
                    "PMID:25613072",
                    "PMID:27149523",
                    "PMID:31991693",
                    "PMID:30255099",
                    "PMID:19965464",
                    "PMID:28546355",
                    "PMID:23259760"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q15796-biolink:gene_associated_with_condition-MONDO:0007947": {
              "object": "MONDO:0007947",
              "subject": "UniProtKB:Q15796",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:6768---JensenLab:associated_with---DOID:14323---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23833295",
                    "PMID:19798597",
                    "PMID:31191903",
                    "PMID:25954202",
                    "PMID:23395156",
                    "PMID:31936351",
                    "PMID:20687182",
                    "PMID:23891907",
                    "PMID:30763207",
                    "PMID:24157418",
                    "PMID:30071700",
                    "PMID:33059492",
                    "PMID:22654505",
                    "PMID:24347665",
                    "PMID:30255099",
                    "PMID:22233626",
                    "PMID:30637022",
                    "PMID:20509926",
                    "PMID:24753820",
                    "PMID:31795342"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q16665-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UniProtKB:Q16665",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:3091---biolink:gene_associated_with_condition---UMLS:C1959583---DisGeNET:",
                    "NCBIGene:3091---biolink:gene_associated_with_condition---UMLS:C0018802---DisGeNET:",
                    "NCBIGene:3091---biolink:gene_associated_with_condition---UMLS:C0023212---DisGeNET:",
                    "HGNC:4910---JensenLab:associated_with---DOID:6000---JensenLab:",
                    "NCBIGene:3091---biolink:gene_associated_with_condition---UMLS:C0018801---DisGeNET:",
                    "NCBIGene:3091---biolink:gene_associated_with_condition---UMLS:C1961112---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:29070518",
                    "PMID:21978991",
                    "PMID:26141605",
                    "PMID:19741501",
                    "PMID:21150872",
                    "PMID:28595161",
                    "PMID:32043180",
                    "PMID:22668785",
                    "PMID:21074126",
                    "PMID:28685447",
                    "PMID:29910735",
                    "PMID:24355497",
                    "PMID:28855075",
                    "PMID:19430954",
                    "PMID:17582388",
                    "PMID:31487864",
                    "PMID:26229536",
                    "PMID:22509165",
                    "PMID:11667980",
                    "PMID:30723719"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q16665-biolink:gene_associated_with_condition-MONDO:0008375": {
              "object": "MONDO:0008375",
              "subject": "UniProtKB:Q16665",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:4910---JensenLab:associated_with---DOID:5327---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21858246",
                    "PMID:25861671",
                    "PMID:32003125",
                    "PMID:29246890",
                    "PMID:28322323",
                    "PMID:32256044",
                    "PMID:25857227",
                    "PMID:25884496",
                    "PMID:23899539",
                    "PMID:26022148",
                    "PMID:25529848",
                    "PMID:30926772",
                    "PMID:23092791",
                    "PMID:18787502",
                    "PMID:27082295",
                    "PMID:26552368",
                    "PMID:25720826",
                    "PMID:29951586",
                    "PMID:23043158",
                    "PMID:26881246"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q9BYF1-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UniProtKB:Q9BYF1",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:59272---biolink:gene_associated_with_condition---UMLS:C0018801---DisGeNET:",
                    "HGNC:13557---JensenLab:associated_with---DOID:6000---JensenLab:",
                    "NCBIGene:59272---biolink:gene_associated_with_condition---UMLS:C0018802---DisGeNET:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25926752",
                    "PMID:31163045",
                    "PMID:21147255",
                    "PMID:32550259",
                    "PMID:29081650",
                    "PMID:30545975",
                    "PMID:25217176",
                    "PMID:29563786",
                    "PMID:22121478",
                    "PMID:28233239",
                    "PMID:19958778",
                    "PMID:27766529",
                    "PMID:23830654",
                    "PMID:27293418",
                    "PMID:",
                    "PMID:19700132",
                    "PMID:30546309",
                    "PMID:26047375",
                    "PMID:29259685",
                    "PMID:27990122"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q9H244-biolink:gene_associated_with_condition-MONDO:0005009": {
              "object": "MONDO:0005009",
              "subject": "UniProtKB:Q9H244",
              "predicate": "biolink:gene_associated_with_condition",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:18124---JensenLab:associated_with---DOID:6000---JensenLab:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30320313",
                    "PMID:29740754",
                    "PMID:30597584",
                    "PMID:27252877",
                    "PMID:31530618",
                    "PMID:29433446",
                    "PMID:21918509",
                    "PMID:23151669",
                    "PMID:31055838",
                    "PMID:24336891",
                    "PMID:26526052",
                    "PMID:25071373",
                    "PMID:28748958",
                    "PMID:29625513",
                    "PMID:26154609",
                    "PMID:33539857",
                    "PMID:25681464",
                    "PMID:30763340",
                    "PMID:24570760",
                    "PMID:27791385"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:diseases",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021557-biolink:entity_negatively_regulates_entity-MESH:D015539": {
              "object": "MESH:D015539",
              "subject": "VANDF:4021557",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003280---SEMMEDDB:inhibits---UMLS:C0032173---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10479669",
                    "PMID:12632026",
                    "PMID:15578958",
                    "PMID:25023347",
                    "PMID:11696471",
                    "PMID:19000927",
                    "PMID:29892605",
                    "PMID:26151079",
                    "PMID:17293494",
                    "PMID:3335821",
                    "PMID:15005338"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:3335821": {
                      "sentence": "We prepared platelet concentrates (PCs) in an experimental anticoagulant consisting of citrate-phosphate-dextrose-adenine formula 1 (CPDA-1) containing inhibitors of platelet activation (prostaglandin E1 and theophylline) and a specific thrombin inhibitor (hirudin or D-phenylalanyl-L-prolyl-L-arginine-chloromethyl ketone-2HCl).",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1988 Jan"
                    },
                    "PMID:10479669": {
                      "sentence": "Kininogens have recently been shown to possess antiadhesive, anticoagulant, and profibrinolytic properties and can inhibit platelet activation at low thrombin concentrations.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "1999 Sep"
                    },
                    "PMID:11696471": {
                      "sentence": "Platelet activation was decreased by anticoagulants but also displayed variability.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Nov 06"
                    },
                    "PMID:12632026": {
                      "sentence": "All anticoagulants were concentration-dependent inhibitors of thrombin-induced platelet activation and PAR-1 cleavage, but none inhibited PAR-1-AP or PAR-4-AP induced activation.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2003 Feb"
                    },
                    "PMID:15005338": {
                      "sentence": "C-type lectin-like proteins (CLPs) of snake venom have a variety of biological properties, acting for example as anticoagulants, procoagulants, and agonists/antagonists of platelet activation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Feb"
                    },
                    "PMID:15578958": {
                      "sentence": "C-type lectin-like proteins (CLPs) of snake venom have a variety of biological properties, acting for example as anticoagulants, procoagulants, and agonists/antagonists of platelet activation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Dec"
                    },
                    "PMID:17293494": {
                      "sentence": "High-molecular-weight kininogen (HK) and its domain 3 (D3) exhibit anticoagulant properties and inhibit platelet activation at low thrombin concentration in vitro.",
                      "object score": 1000,
                      "subject score": 725,
                      "publication date": "2007 Jun"
                    },
                    "PMID:19000927": {
                      "sentence": "The breeding of transgenic pigs with one or more human anticoagulant genes, such as CD39 or tissue factor pathway inhibitor, is anticipated to inhibit the procoagulant changes that take place on the graft ECs, and thus may prevent or reduce platelet activation that arises as a result of immune-mediated injury.",
                      "object score": 1000,
                      "subject score": 852,
                      "publication date": "2009 Jun"
                    },
                    "PMID:25023347": {
                      "sentence": "Antiplatelet and anticoagulant agents that inhibit platelet activation and thrombin generation can potentially slow cancer progression, although the clinical evidence thus far is not unequivocal.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jun"
                    },
                    "PMID:26151079": {
                      "sentence": "Clopidogrel is a prodrug anticoagulant with active metabolites that irreversibly inhibit the platelet surface GPCR P2Y12 and thus inhibit platelet activation.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2015 Jul 17"
                    },
                    "PMID:29892605": {
                      "sentence": "We have previously shown that addition of heparin anticoagulants to equine platelet-rich plasma (PRP) can abolish ex vivo EHV-1-induced platelet activation.",
                      "object score": 804,
                      "subject score": 888,
                      "publication date": "2018"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL25": {
              "object": "CHEMBL.COMPOUND:CHEMBL25",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264825-biolink:entity_negatively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "FMA:264825",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0085295---SEMMEDDB:inhibits---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:31557796",
                    "PMID:26518879",
                    "PMID:31649508",
                    "PMID:29358274",
                    "PMID:15710343",
                    "PMID:18453575",
                    "PMID:29916550",
                    "PMID:25625352",
                    "PMID:30408519",
                    "PMID:20180418",
                    "PMID:23680073"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:15710343": {
                      "sentence": "Nicotine treatment of the Cpn-infected cells up-regulated IL-10, but not TNF-alpha and IL-12, and also resulted in significant down-regulation of TGF-beta1 production which was marked in the Cpn-infected control cells.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2005 Apr"
                    },
                    "PMID:18453575": {
                      "sentence": "Although blockade of CTLA-4 and neutralization of IL-10 profoundly inhibited the induction of these TGF-beta1(+) T cells, their ability to suppress the effector T cell proliferation was abrogated by neutralization of TGF-beta1 alone.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 May 15"
                    },
                    "PMID:20180418": {
                      "sentence": "CONCLUSION: IL-10 could relieve inflammatory infiltration of the prostate tissue and inhibit the expressions of TNF-alpha and TGF-beta1 in EAP rats, which is suggestive of its therapeutic efficacy for autoimmune prostatitis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Dec"
                    },
                    "PMID:23680073": {
                      "sentence": "CONCLUSIONS: Increased concentrations of serum IL-10, IL-13, and IL-17A and decreased concentrations of TGF-beta1 suggested altered cell-mediated immunity that may facilitate the melanocyte cytotoxicity in vitiligo.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2013 Sep 23"
                    },
                    "PMID:25625352": {
                      "sentence": "Furthermore, BSYQF treatment caused a distinct reduction in IL-6, IL-10 and IL-17A levels in serum (p<0.05), and induced a significant improvement in IL-6 and IL-10 as well as a marked decrease in TGF-beta1 and IL-17A levels in BALF of OVA-induced asthmatic mice (p<0.05).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Apr 22"
                    },
                    "PMID:26518879": {
                      "sentence": "Deficiency in TERC or TERT causes a remarkable elevation in various proinflammatory cytokines, including IL-1, IL-6, CXCL15 (human IL-8 homolog), IL-10, TNF-alpha, and monocyte chemotactic protein 1 (chemokine ligand 2 (CCL2)); decrease in TGF-beta1 and TGFbetaRI receptor in the lungs; and spillover of IL-6 and CXCL15 into the bronchoalveolar lavage fluids.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Dec 25"
                    },
                    "PMID:29358274": {
                      "sentence": "Among L-EV subsets, only the CD8alpha+CD11c+ EV subset was positive for TGF-beta1 and IL-10 and could inhibit CD4+ T cell proliferation via TGF-beta1 in vitro and relieve murine asthmatic symptoms.",
                      "object score": 798,
                      "subject score": 1000,
                      "publication date": "2018 Mar 01"
                    },
                    "PMID:29916550": {
                      "sentence": "In addition, it increased the levels of inflammatory factors, including IL-10, diminished the percentage of Th17 cells, increased the percentage of Treg cells, and decreased the expression of TGF-beta1 and phosphorylated (p)-Smad2/3 expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Aug"
                    },
                    "PMID:30408519": {
                      "sentence": "The PLGA formulations significantly elevated titers of IgG1, IgG2a, and sIgA antibodies, as well as IL-10, and IFN-gamma cytokines and also reduced the amount of TGF-beta1 production relative to the other vaccines.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2018 Dec"
                    },
                    "PMID:31557796": {
                      "sentence": "Gene expression of AQP5, EGF, FGF2, BMP7, LYZ1 and IL-10 were upregulated, and downregulated for TNF-alpha, TGF-beta1, MMP2, CASP3, and IL-1beta.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Sep 25"
                    },
                    "PMID:31649508": {
                      "sentence": "Absence of IL-10 led to an attenuated M2 like phenotype (CD86- CD206+) and a reduced secretion of TGF-beta1 upon LPS stimulation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264825-biolink:entity_negatively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "FMA:264825",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0085295---SEMMEDDB:inhibits---UMLS:C0669372---SEMMEDDB:",
                    "UMLS:C0085295---SEMMEDDB:inhibits---UMLS:C1417760---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:7529748",
                    "PMID:12193819",
                    "PMID:9222642",
                    "PMID:17363443",
                    "PMID:33890400",
                    "PMID:25559170",
                    "PMID:22829768",
                    "PMID:11777537",
                    "PMID:10705297",
                    "PMID:32175399",
                    "PMID:19164562",
                    "PMID:11698492",
                    "PMID:25266599",
                    "PMID:11780336",
                    "PMID:25729277",
                    "PMID:12774458",
                    "PMID:33634135",
                    "PMID:32983173",
                    "PMID:22546965",
                    "PMID:28299403"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7529748": {
                      "sentence": "Interleukin-10 did not consistently reduce iNOS mRNA expression and had no effect on IFN-gamma induction of endothelial class II MHC surface antigen.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1995 Feb"
                    },
                    "PMID:9222642": {
                      "sentence": "Analysis of mRNA expression in the pancreas showed that administration of the IL-12 antagonist had dampened interferon-gamma gene expression, decreased the ratio of interferon-gamma/IL-10 mRNA levels and in parallel suppressed the expression of the inducible nitric oxide synthase.",
                      "object score": 1000,
                      "subject score": 857,
                      "publication date": "1997 Jun"
                    },
                    "PMID:9771406": {
                      "sentence": "Both interleukin (IL)-13 and IL-4, but not IL-10, are potent inhibitors of iNOS expression and activity induced by an optimal combination of cytokines, namely IL-1 alpha, tumour necrosis factor alpha and interferon gamma.",
                      "object score": 928,
                      "subject score": 901,
                      "publication date": "1998 Jul"
                    },
                    "PMID:10705297": {
                      "sentence": "Combined treatment of these monoclonal antibodies revealed that whereas on the one hand IL-10 inhibits LPS-induced iNOS expression, on the other hand IL-10 or an IL-10 inducible factor is also involved in the upregulation of iNOS expression after LPS challenge.",
                      "object score": 833,
                      "subject score": 861,
                      "publication date": "2000 Mar"
                    },
                    "PMID:11698492": {
                      "sentence": "The anti-inflammatory cytokine interleukin (IL)-10 suppresses inducible nitric oxide synthase (iNOS); therefore, NO production should increase in the absence of IL-10.",
                      "object score": 1000,
                      "subject score": 857,
                      "publication date": "2001 Nov"
                    },
                    "PMID:11777537": {
                      "sentence": "Both IL-4 and IL-10 inhibited expression of iNOS and production of NO in merozoite-stimulated monocytes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Jan 15"
                    },
                    "PMID:12009578": {
                      "sentence": "Spleen cells stimulated with alloantigens in the presence of AMT or S-ethylisothiourea (EIT), an another selective iNOS inhibitor, produced considerably more interleukin (IL)-4 and IL-10 than the cells stimulated in the absence of iNOS inhibitors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 May"
                    },
                    "PMID:12193819": {
                      "sentence": "The induction of IL-10 correlated with the suppression of TNF and iNOS suggests that IL-10 may play a role in downregulating TNF and iNOS in septic rats undergoing laparotomy and laparoscopy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Aug"
                    },
                    "PMID:12774458": {
                      "sentence": "Interleukin-10 inhibits inducible nitric oxide synthase in an animal model of necrotizing enterocolitis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999"
                    },
                    "PMID:17363443": {
                      "sentence": "This is in part due to suppression of NOS2 expression by IL-10.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2007 Sep"
                    },
                    "PMID:19164562": {
                      "sentence": "The presence of Gr-1(+) neutrophils and elevated tumor necrosis factor-alpha (TNF-alpha) expression in colon were required for increased iNOS expression and cancer, whereas interleukin-10 (IL-10) down-regulated TNF-alpha and iNOS expression and suppressed cancer.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2009 Jan 27"
                    },
                    "PMID:22546965": {
                      "sentence": "EPC transplantation significantly increased level of interleukin-10 and vascular endothelial growth factor protein and reduced levels of interleukin-1beta, E-selectin, intercellular adhesion molecule-1, and inducible nitric oxide synthase in injury lung tissues.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jun"
                    },
                    "PMID:22829768": {
                      "sentence": "betah/c-mediated activation of p38 MAPK drives expression of the anti-inflammatory and immunosuppressive cytokine IL-10, and inhibits both IL-12 and NOS2 expression in GBS-infected macrophages, which are critical factors in host defense.",
                      "object score": 888,
                      "subject score": 824,
                      "publication date": "2012"
                    },
                    "PMID:25266599": {
                      "sentence": "In the liver, alpha-LA reduced TNF-alpha and IL-6 messenger RNA (mRNA) but enhanced IL-10 mRNA. alpha-LA decreased the expression of iNOS mRNA and its antisense transcript, leading to the reduction of iNOS protein expression and resulting in the inhibition of nitric oxide production.",
                      "object score": 901,
                      "subject score": 794,
                      "publication date": "2015 Feb"
                    },
                    "PMID:25559170": {
                      "sentence": "Furthermore, the results on real time PCR and ELISA revealed that transgenic HLA-G1 induces the anti-inflammatory cytokines, such as IL-10 and TGF-beta, and suppresses iNOS mRNA expression, indicating that transgenic HLA-G1 has suppressive effects in a broad range of transplant rejection.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2015 Mar"
                    },
                    "PMID:25729277": {
                      "sentence": "The ethanol extract was found to elicit the most potent reduction of nitric oxide (NO), prostaglandin E2 (PGE2), and cytokine (IL-1beta, IL-6, IL-10, and TNF-alpha) levels, as well as inhibit the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in a concentration-dependent manner.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Mar"
                    },
                    "PMID:28299403": {
                      "sentence": "Both IFN-beta1b and IFN-beta1a treatments inhibited the pro-inflammatory cytokines (IL-6, IL-1beta, TNF-alpha and IFN-gamma), decreased the activation of astrocytes, increased the myelin protein level in the brain cortex, and improved the neurological status of EAE rats by different mechanisms; IFN-beta1a reduced iNOS expression, at least in part, by the enhancement of IL-10, while IFN-beta1b diminished IL-10 concentration and did not decrease EAE-induced iNOS expression.",
                      "object score": 863,
                      "subject score": 1000,
                      "publication date": "2017 Aug"
                    },
                    "PMID:28794630": {
                      "sentence": "Probiotic treatment decreased the M1-like macrophage phenotype indicated by downregulation of tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-6 and inducible nitric oxide synthase (iNOS) and increased the M2-like macrophage phenotype indicated by upregulation of IL-4, IL-10 and arginase.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017"
                    },
                    "PMID:32175399": {
                      "sentence": "Results: Pre-treatment with SR-A1 antibody up-regulated IL-10 expression in RAW264.7, whereas down-regulated the expression of TNF and iNOS.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2020 Feb"
                    },
                    "PMID:32983173": {
                      "sentence": "In M1 macrophages, HGF-MET signaling induced the expression of    Arg-1     mRNA and secretion of IL-10 and TGF-beta1 and downregulated the mRNA expression of    iNOS, TNF-    alpha, and    IL-6    .",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264827-biolink:entity_positively_regulates_entity-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "FMA:264827",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0079633---SEMMEDDB:stimulates---UMLS:C0172537---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9327744",
                    "PMID:34022544",
                    "PMID:11063876",
                    "PMID:18038907",
                    "PMID:12626597",
                    "PMID:32471980",
                    "PMID:33350335",
                    "PMID:24795235",
                    "PMID:28915597",
                    "PMID:9873223",
                    "PMID:16818644"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9327744": {
                      "sentence": "Activation of type IV collagenase by IL-8 can enhance the invasion of host stroma by the tumor cells and increase angiogenesis and, hence, metastasis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Oct"
                    },
                    "PMID:9873223": {
                      "sentence": "Activation of MMP-2 by IL-8 can enhance the invasion of host stroma by the tumor cells and increase angiogenesis and, hence, metastasis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999"
                    },
                    "PMID:11063876": {
                      "sentence": "Preincubation with MIP-1alpha and IL-8 also stimulated the secretion of MMP-9 and MMP-2 (BM > PB), but with respect to TIMPs, the effect was reversed (PB > BM), resulting in trans-Matrigel migration of BM but not of PB CD34(+) cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Nov"
                    },
                    "PMID:12626597": {
                      "sentence": "Furthermore, incubation of endothelial cells with IL-8 up-regulated MMP-2 and MMP-9 production and mRNA expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Mar 15"
                    },
                    "PMID:16818644": {
                      "sentence": "Our study indicates that acidic pH(e) promotes experimental pulmonary metastasis in A-07, D-12, and T-22 human melanoma cells by a common mechanism involving acidity-induced up-regulation of the proteolytic enzymes MMP-2, MMP-9, cathepsin B, and cathepsin L and acidity-induced up-regulation of the proangiogenic factors VEGF-A and IL-8.",
                      "object score": 893,
                      "subject score": 1000,
                      "publication date": "2006 Jul 01"
                    },
                    "PMID:18038907": {
                      "sentence": "LPS enhanced ROS production, as well as, expression of pro-inflammatory cytokines such as interleukin-1beta, interleukin-6, interleukin-8 and tumor necrosis factor-alpha, and the production and activation of MMP2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Oct"
                    },
                    "PMID:24795235": {
                      "sentence": "We observed that salmon trypsin enhanced the secretion of IL-8 and MMP-2 and crab trypsin enhanced the secretion of IL-8, MMP-2 and MMP-9 in a dose dependent manner.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jul"
                    },
                    "PMID:28915597": {
                      "sentence": "IL-8 promotes the migration of SCC25 cells and increases matrix metalloproteinase-2 (MMP-2) and MMP-9 expressions.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Aug 22"
                    },
                    "PMID:32471980": {
                      "sentence": "IL-8 promoted the expression of MMP2, MMP9, snail, and vimentin in HNSCC cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 May 29"
                    },
                    "PMID:33350335": {
                      "sentence": "rSjE16 also significantly increased the expression levels of interleukin (IL)-6 and IL-8, and enhanced the expression of matrix metalloproteinase (MMP)-2, MMP-9, and peroxisome proliferator-activated receptor-gamma in LX-2 cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Dec"
                    },
                    "PMID:34022544": {
                      "sentence": "IL-8 and 5-FU increased MMP-2 and MMP-3 expression, while IL-6 and MTX augmented MMP-2 expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021 May 15"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264827-biolink:entity_positively_regulates_entity-UniProtKB:P14780": {
              "object": "UniProtKB:P14780",
              "subject": "FMA:264827",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0079633---SEMMEDDB:stimulates---UMLS:C0165519---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:32066788",
                    "PMID:22507529",
                    "PMID:22739763",
                    "PMID:11063876",
                    "PMID:19380811",
                    "PMID:22195048",
                    "PMID:22985397",
                    "PMID:33350335",
                    "PMID:12139725",
                    "PMID:24795235",
                    "PMID:22987319",
                    "PMID:15831558",
                    "PMID:16818644",
                    "PMID:30015877"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:11063876": {
                      "sentence": "Preincubation with MIP-1alpha and IL-8 also stimulated the secretion of MMP-9 and MMP-2 (BM > PB), but with respect to TIMPs, the effect was reversed (PB > BM), resulting in trans-Matrigel migration of BM but not of PB CD34(+) cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Nov"
                    },
                    "PMID:12139725": {
                      "sentence": "IL-8, chemokine for neutrophils and a potent inducer of MMP-9, was also induced by ATRA in PL-21 cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Aug"
                    },
                    "PMID:15831558": {
                      "sentence": "These data suggest that IL-8-induced MMP-9 release from neutrophils is mediated through CXCR2 and involves two distinct pathways, one involving PKC and ERK1/2 and the other involving Src-family kinases.",
                      "object score": 845,
                      "subject score": 845,
                      "publication date": "2005 Jul"
                    },
                    "PMID:16818644": {
                      "sentence": "Our study indicates that acidic pH(e) promotes experimental pulmonary metastasis in A-07, D-12, and T-22 human melanoma cells by a common mechanism involving acidity-induced up-regulation of the proteolytic enzymes MMP-2, MMP-9, cathepsin B, and cathepsin L and acidity-induced up-regulation of the proangiogenic factors VEGF-A and IL-8.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Jul 01"
                    },
                    "PMID:19380811": {
                      "sentence": "Finally, we showed that induction of il1b, mmp9, and irak3 requires Myd88-dependent signaling, while ifn1 and il8 were induced Myd88 independently during Salmonella infection.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 May 01"
                    },
                    "PMID:22195048": {
                      "sentence": "Since NF-kappaB, IL-8 and MMP-9 play roles in LPS-induced invasion or metastasis, the mechanism of MTDH-promoted invasion and metastasis may be through the activation of NF-kappaB, IL-8 and MMP-9, also suggesting a role of MTDH in regulating both inflammatory responses and inflammation-associated tumor invasion.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011"
                    },
                    "PMID:22507529": {
                      "sentence": "IL-8 is known to induce Matrix metalloproteinase 9 (MMP9) which not only plays a role in tumour migration and invasion but also induces angiogenic switch.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jun 08"
                    },
                    "PMID:22739763": {
                      "sentence": "RESULTS: Preconditioning reduced interleukin-8-induced MMP-9-release by 41% (+/-13, 5%, sevoflurane) and 40% (+/-13%, desflurane).",
                      "object score": 833,
                      "subject score": 833,
                      "publication date": "2012 Aug"
                    },
                    "PMID:22985397": {
                      "sentence": "Moreover, naringin of 20, 40, and 80 mg/kg prevented CS-induced infiltration of neutrophils and activation of myeloperoxidase and matrix metalloproteinase-9, in parallel with suppression of the release of cytokines, such as tumor necrosis factor-alpha and interleukin-8 (IL-8).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Oct"
                    },
                    "PMID:22987319": {
                      "sentence": "Tension sites adjacent to canines showed significant increases in IL-1beta, IL-8, TNFalpha, MMP-9 and TIMPs 1 and 2 across all time points following force application, while compression sites exhibited increases in IL-1beta and IL-8 after 4 hours, MMP-9 after 7 and 42 days and RANKL after 42 days.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    },
                    "PMID:24795235": {
                      "sentence": "We observed that salmon trypsin enhanced the secretion of IL-8 and MMP-2 and crab trypsin enhanced the secretion of IL-8, MMP-2 and MMP-9 in a dose dependent manner.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jul"
                    },
                    "PMID:30015877": {
                      "sentence": "Furthermore, RA inhibited the production of pro-angiogenic factors, including matrix metalloproteinase (MMP)-9, pentraxin-3, interleukin-8, VEGF and placental growth factor under normoxic and hypoxic conditions, and suppressed the phorbol 12-myristate 13-acetate-induced increase in the gelatinolytic MMP-9 activity and MMP-9 expression in HT1080 cells.",
                      "object score": 854,
                      "subject score": 1000,
                      "publication date": "2018 Sep"
                    },
                    "PMID:32066788": {
                      "sentence": "Co-treatment with anti-RAGE or anti-TNF-alpha blocking antibodies and AGEs-Csn partially counteracted these changes; however, IL-8, MMP-1 and -10 expression and MMP-9 activation were difficult to prevent.",
                      "object score": 734,
                      "subject score": 1000,
                      "publication date": "2020 Feb 17"
                    },
                    "PMID:33350335": {
                      "sentence": "rSjE16 also significantly increased the expression levels of interleukin (IL)-6 and IL-8, and enhanced the expression of matrix metalloproteinase (MMP)-2, MMP-9, and peroxisome proliferator-activated receptor-gamma in LX-2 cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Dec"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264829-biolink:entity_negatively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "FMA:264829",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0021760---SEMMEDDB:inhibits---UMLS:C0080222---SEMMEDDB:",
                    "UMLS:C0021760---SEMMEDDB:inhibits---UMLS:C1366557---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:33354576",
                    "PMID:14734728",
                    "PMID:30696986",
                    "PMID:18259750",
                    "PMID:2207308",
                    "PMID:33524511",
                    "PMID:10924604",
                    "PMID:31146007",
                    "PMID:15450530",
                    "PMID:12725536",
                    "PMID:1425020",
                    "PMID:29089071",
                    "PMID:25752645",
                    "PMID:25625352",
                    "PMID:20924205",
                    "PMID:22595645",
                    "PMID:11642517"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1425020": {
                      "sentence": "Differentiation induced by IL-6 or LIF is inhibited by TGF-beta 1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992"
                    },
                    "PMID:2207308": {
                      "sentence": "The viability of normal bone marrow myeloid precursor cells induced by interleukin-6 (IL-6) or IL-1 alpha and the ability of IL-6 and IL-1 alpha to induce the formation of colonies of granulocytes, macrophages, or megakaryocytes in densely seeded bone marrow cultures was suppressed by transforming growth factor-beta 1 (TGF-beta 1).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 Oct 01"
                    },
                    "PMID:10924604": {
                      "sentence": "Prestorage filtration leads to low levels of IL-6 and IL-8 in PCs, but it does not impair the poststorage content of TGFbeta1 or anaphyla-toxins.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Jul"
                    },
                    "PMID:11642517": {
                      "sentence": "Although TNF-alpha and IL-6 stimulated each other's expression, they downregulated TGF beta1, IL-4 and IL-10 or IL-1beta, TGF beta1 and IFNdelta, respectively.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001"
                    },
                    "PMID:12725536": {
                      "sentence": "As a consequence, TGF-beta1 decreased the cell cycle entry of stem/progenitor cells stimulated by the respective ligands of these receptors, the cytokines SF, FL, IL-6, and TPO, whereas neutralization of TGF-beta1 increased the cell responsiveness to these mitogenic cytokines.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003"
                    },
                    "PMID:14734728": {
                      "sentence": "Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta 1 and restores the lymphokine-activated killing activity.",
                      "object score": 875,
                      "subject score": 1000,
                      "publication date": "2004 Feb 01"
                    },
                    "PMID:15450530": {
                      "sentence": "IL-6, but not OSM, reversed IL-1beta-induced TGF-beta1 inhibition.",
                      "object score": 836,
                      "subject score": 1000,
                      "publication date": "2004 Oct"
                    },
                    "PMID:18259750": {
                      "sentence": "We previously reported that tumor infiltrating lymphocyte (TIL)-derived IL-6 inhibits TGF-beta1 and restores natural killing (NK) activity.",
                      "object score": 1000,
                      "subject score": 864,
                      "publication date": "2008 Jul"
                    },
                    "PMID:20924205": {
                      "sentence": "In HRPTEpiC 100 ng/ml IL-17A upregulated the proinflammatory/profibrotic genes ACTA2, CCL2, CHMP1A, CTGF, FN1, IL6, FSP1, SMAD1, SMAD5, TGFB1 and TGFBR2 while treatment with a reduced concentration of IL-17A (0.1 ng/ml) decreased SMAD5, TGFB1 and PDGFRB expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011"
                    },
                    "PMID:22595645": {
                      "sentence": "RESULTS: Significantly higher levels of IL-6, E-selectin and MMP-2/MMP-9 and significantly reduced levels of TGF-beta1 were found in PAD patients (ankle-brachial index, ABI?0.9) compared to non-PAD control subjects (1.4>ABI>0.9).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Aug"
                    },
                    "PMID:25625352": {
                      "sentence": "Furthermore, BSYQF treatment caused a distinct reduction in IL-6, IL-10 and IL-17A levels in serum (p<0.05), and induced a significant improvement in IL-6 and IL-10 as well as a marked decrease in TGF-beta1 and IL-17A levels in BALF of OVA-induced asthmatic mice (p<0.05).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Apr 22"
                    },
                    "PMID:25752645": {
                      "sentence": "IL-6 deficiency could suppress TGF-beta1 and alpha-SMA, and both IL-6 siRNA and QL-mediated such effect was reversed by foresed expression of recombined IL-6.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2015 May"
                    },
                    "PMID:29089071": {
                      "sentence": "Results WGP up-regulated MHC-II and co-stimulation molecules CD86, CD80, CD40 on TEDCs, increased the levels of TNF-alpha, IL-12p40, IL-6 in TEDCs, decreased the production of TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Sep"
                    },
                    "PMID:30696986": {
                      "sentence": "RESULTS: NB caused reduction of adipose tissue, increases of IL-6 and TNF-alpha, and decreases of TGF-beta1 and -beta2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 03"
                    },
                    "PMID:31146007": {
                      "sentence": "The recombinant IL-34 produced in bacteria and HEK293T cells showed stimulatory effect on the expression of IL-1beta, IL-6 and IL-8 but inhibited expression of IL-10 and TGF-beta1 in primary head kidney macrophages.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Sep"
                    },
                    "PMID:33354576": {
                      "sentence": "Our results illustrated that HG levels induced IL-1   beta    , IL-6, TGF-   beta    1, and VEGF expression and that tangeretin significantly reduced HG-induced IL-1   beta    , IL-6, TGF-   beta    1, and VEGF expression in human RPE cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020"
                    },
                    "PMID:33524511": {
                      "sentence": "The intervention of ZJP could significantly reduce the content of G-17 and inflammatory factors IL-8, TNF- alpha, IL-6 and IL-1beta, inhibit the expression of TGF-beta1, PI3K and their downstream signals p-Akt, p-mTOR, P70S6K, and promote the expression level of PTEN, LC3-II and Beclin-1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021 Jan 29"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264829-biolink:entity_negatively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "FMA:264829",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0021760---SEMMEDDB:inhibits---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25243152",
                    "PMID:22035631",
                    "PMID:25454976",
                    "PMID:10202009",
                    "PMID:22367596",
                    "PMID:22919407",
                    "PMID:14715517",
                    "PMID:24930695",
                    "PMID:18852260",
                    "PMID:22720096",
                    "PMID:15221959",
                    "PMID:24250585",
                    "PMID:24795303",
                    "PMID:20225237",
                    "PMID:24738479",
                    "PMID:11193752",
                    "PMID:25729277",
                    "PMID:24291824",
                    "PMID:22553068",
                    "PMID:23243434"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:10202009": {
                      "sentence": "The down-regulation of iNOS expression, together with previously reported inhibitory effects on the production of the proinflammatory cytokines IL-6, TNF-alpha, and IL-12, and the stimulation of the anti-inflammatory IL-10, define VIP and PACAP as \"macrophage deactivating factors\" with significant physiological relevance.",
                      "object score": 888,
                      "subject score": 824,
                      "publication date": "1999 Apr 15"
                    },
                    "PMID:11193752": {
                      "sentence": "The mechanisms by which antiflammins protect against inflammation and allergy in these ocular models may involve inhibition of phospholipase A2 and inducible nitric oxide synthase (iNOS) as well as the production of proinflammatory cytokine, interleukin-6.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000"
                    },
                    "PMID:14715517": {
                      "sentence": "Selective iNOS inhibition in shocked animals reduced the binding activity of NF-kappaB and Stat3 and reduced mRNA levels of ICAM-1, IL-6, and G-CSF.",
                      "object score": 876,
                      "subject score": 1000,
                      "publication date": "2004 Feb"
                    },
                    "PMID:15221959": {
                      "sentence": "CEA, IL-6 and IL-10 pretreatment reduced expression of iNOS but only CEA and IL-10 strongly inhibited NO and total reactive species production by ischemic-rexoygenated liver.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Sep 01"
                    },
                    "PMID:20225237": {
                      "sentence": "Through measurement with Griess's reagent, DB reduced NO level with an IC(50) value of 2.85 +/- 0.62 microM that was due to the significant suppression of LPS-induced iNOS mRNA expression as well as IL-1beta, IL-6, and IL-10 mRNA at a concentration of 6 microM.",
                      "object score": 840,
                      "subject score": 1000,
                      "publication date": "2010 Apr 01"
                    },
                    "PMID:22367596": {
                      "sentence": "OM also dose-dependently             inhibited the release of TNF-alpha and IL-6, and decreased the expression of iNOS             in lung tissues and thus prevented NO release in response to BLM challenge.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 May"
                    },
                    "PMID:22553068": {
                      "sentence": "In this system, ACEE prominently inhibited the production of nitric oxide (NO), prostaglandin E(2) (PGE(2)), interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha, and inhibited the protein expression of inducible nitric oxide synthase and cyclooxygenase-2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Mar"
                    },
                    "PMID:22720096": {
                      "sentence": "In the present study, we show that a novel chromone derivative, DCO-6, significantly reduced lipopolysaccharide (LPS)-induced production of nitric oxide, IL-1beta and IL-6, decreased the levels of iNOS, IL-1beta and IL-6 mRNA expression in both RAW264.7 cells and mouse primary peritoneal macrophages, and inhibited LPS-induced activation of p38 MAPK but not of JNK, ERK.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:22919407": {
                      "sentence": "The results showed that Gelam honey could reduce edema in a dose-dependent fashion in inflamed rat paws, decrease the production of NO, PGE(2), TNF-alpha, and IL-6 in plasma, and suppress the expression of iNOS, COX-2, TNF-alpha, and IL-6 in paw tissue.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:23243434": {
                      "sentence": "In addition, TSAV attenuated the serum TNF-alpha and IL-6 levels and inhibited the serum iNOS and NO levels.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2012"
                    },
                    "PMID:24250585": {
                      "sentence": "It was shown that oxymatrine inhibited the productions of NO, PGE2, TNF-alpha, IL-1beta and IL-6, attenuated the mRNA levels of iNOS and COX-2, suppressed the phosphorylation of I-kappaBalpha in cytosol, decreased the nuclear levels of p65, and also blocked ERK, p38 and JNK pathway in LPS-stimulated BV2 microglial cells in a dose-dependent manner.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:24291824": {
                      "sentence": "ER stress upregulated PGE2/IFNgamma-induced IL-6 expression and down-regulated iNOS expression in glial cells.",
                      "object score": 928,
                      "subject score": 781,
                      "publication date": "2013 Dec 02"
                    },
                    "PMID:24738479": {
                      "sentence": "Furthermore, early treatment with ALA markedly inhibited the release of tumour necrosis factor-alpha, interleukin (IL)-6 and IL-1beta into the serum and reduced mRNA and protein expression of inducible nitric oxide synthase and high mobility group box 1 in kidney tissues from CLP-induced rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jul"
                    },
                    "PMID:24795303": {
                      "sentence": "The SS20 group showed significantly higher levels of transcripts for IL-1beta and IL-6 in intestine, and SS10 and SS20 groups had higher levels of transcripts for IL-8 and inducible nitric oxide synthase expression and decreased glutathione peroxidase 7 mRNA levels compared with the SS0 group.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2014 May"
                    },
                    "PMID:25243152": {
                      "sentence": "This was accompanied by reduced levels of TNF-alpha, IL-1beta, and IL-6 in lung and bronchoalveolar lavage fluid and decreased iNOS expression in lung.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2014"
                    },
                    "PMID:25729277": {
                      "sentence": "The ethanol extract was found to elicit the most potent reduction of nitric oxide (NO), prostaglandin E2 (PGE2), and cytokine (IL-1beta, IL-6, IL-10, and TNF-alpha) levels, as well as inhibit the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in a concentration-dependent manner.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Mar"
                    },
                    "PMID:26187476": {
                      "sentence": "The actions of the catechins were evidenced by the reduction in inflammatory parameters, including the suppression of TLR4, NFkappaB and iNOS protein expression, decreased release of TNF-alpha, IL-1beta and IL-6, migration capacity, MPO activity and HOCl production and the suppression of ROS, nitric oxide and peroxynitrite production, while inducing antioxidant enzyme activities and Nrf2 mRNA levels, phagocytic capacity and calcium release.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2015 Oct"
                    },
                    "PMID:27453997": {
                      "sentence": "Furthermore, pretreatment with AsIV increased endothelial nitric oxide synthase (eNOS) dimer/monomer ratio and its critical cofactor tetrahydrobiopterin (BH4) content, decreased Nox4 protein expression (the most abundant Nox isoform in HUVECs), inhibited translocation of NF-kappaB p65 subunit into nuclear fraction while enhanced the protein expression of IkappaB-alpha (the inhibitor of NF-kappaB p65), reduced the levels of IL-1beta, IL-6, and TNF-alpha in HUVECs medium, and decreased iNOS protein expression.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2016 Nov"
                    },
                    "PMID:28249220": {
                      "sentence": "In addition, the inflammatory responses induced by paraquat were inhibited after treatment with chloroquine, as indicated by the decreased number of leukocytes, the reduced levels of TNF-alpha, IL-1beta and IL-6 in the bronchoalveolar lavage fluid, the reduced NO content, and downregulation of iNOS expression in lung tissues.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2017 May"
                    },
                    "PMID:28933476": {
                      "sentence": "In vitro, piceatannol not only attenuated the over-production of inflammatory mediators and cytokines-such as nitric oxide (NO), prostaglandin E2 (PGE2), tumor necrosis factor alpha (TNF-alpha), and interleukin-6 (IL-6)-but also suppressed the expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) at both the mRNA and protein levels.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Nov 15"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "FMA:264829",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0021760---SEMMEDDB:stimulates---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:27008429",
                    "PMID:18504149",
                    "PMID:25876653",
                    "PMID:1879463",
                    "PMID:29154781",
                    "PMID:31054955",
                    "PMID:16278781",
                    "PMID:18179739",
                    "PMID:15764709",
                    "PMID:17541150",
                    "PMID:22673798",
                    "PMID:2104224",
                    "PMID:28333137",
                    "PMID:30150989",
                    "PMID:20395431",
                    "PMID:28562226",
                    "PMID:25209750",
                    "PMID:15870892",
                    "PMID:30687328",
                    "PMID:27128690"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1879463": {
                      "sentence": "Once TGF-beta 1 was removed from the culture medium after 72 h of incubation with IL-6, the kinetics of differentiation induced by IL-6 were faster in pretreated cells than in nonpretreated cells.",
                      "object score": 923,
                      "subject score": 1000,
                      "publication date": "1991 Sep"
                    },
                    "PMID:2104224": {
                      "sentence": "Induction of IL 6 by TGF beta 1 was specific, as other cytokines made by mononuclear cells (TNF and IL 1) were not induced by TGF beta 1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 May"
                    },
                    "PMID:8376781": {
                      "sentence": "Consistent with the effects on TGF-beta 1 mRNA, IL-6 increased the synthesis of TGF-beta 1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Sep 15"
                    },
                    "PMID:15764709": {
                      "sentence": "Here, we show that TGF-beta-activated kinase 1 (TAK1) interacts with STAT3, that the TAK1-Nemo-like kinase (NLK) pathway is efficiently activated by IL-6 through the YXXQ motif, and that this is the YXXQ-mediated H7-sensitive pathway that leads to STAT3 Ser-727 phosphorylation.",
                      "object score": 868,
                      "subject score": 1000,
                      "publication date": "2005 Mar 22"
                    },
                    "PMID:15870892": {
                      "sentence": "TGF-beta1 expression tended to be increased by TNF-alpha and IL-6.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2005 Jun"
                    },
                    "PMID:16278781": {
                      "sentence": "Our data show that IGF-1, TGF-beta1, bFGF and IL-6 increase PTHrP mRNA expression and its perinuclear localization, while zoledronic acid (50 muM, 100 muM for 24 h and 48 h) and dexamethasone suppress PTHrP expression in PC-3 cells.",
                      "object score": 1000,
                      "subject score": 839,
                      "publication date": "2005 Oct"
                    },
                    "PMID:17541150": {
                      "sentence": "Thus, these data indicate that oyaksungisan may be beneficial in the cessation of inflammatory processes of cerebral infarct through suppression of TNF-alpha, IL-1beta, IL-6, and IL-10 and induction of TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Jun"
                    },
                    "PMID:18179739": {
                      "sentence": "Rats instilled with CH via the trachea showed increases in TNF-alpha, IL-1beta and IL-6 in the bronchoalveolar lavage fluid (BALF) 1 day after the instillation, followed by increases in TGF-beta1 and apoptotic cells 5 days after.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Oct-Dec"
                    },
                    "PMID:18504149": {
                      "sentence": "The ELISAs revealed significant increases in TGF-beta1 in treatment groups, but no significant change in RANKL or IL-6.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Jul"
                    },
                    "PMID:20395431": {
                      "sentence": "IL-6 and IL-8 were significantly up-regulated by ciliary epithelial cells in response to hypoxia or oxidative stress in vitro, whereas IL-6, but not IL-8, induced the expression of transforming growth factor-beta1 and elastic fiber proteins.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Jun"
                    },
                    "PMID:22673798": {
                      "sentence": "Kirenol reduced the levels of TNF-alpha, IL-17A and IL-6 in synovial fluid and TNF-alpha, IL-17A and IFN-gamma in serum, and increased the serum levels of IL-4, IL-10 and TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jul 15"
                    },
                    "PMID:25209750": {
                      "sentence": "Exposure of activated CD4+ T cells to PLT-Ecto decreased their release of IFNgamma, TNFalpha and IL-6, and increased the production of TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Dec"
                    },
                    "PMID:25876653": {
                      "sentence": "HSF increased TGF-beta1 expression in the hypothalamus and hippocampus relative to other groups.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2015 Jun 15"
                    },
                    "PMID:27008429": {
                      "sentence": "Combining quercetin treatment with delayed transplantation of HUMSCs after local cerebral ischemia significantly (i) improved neurological functional recovery; (ii) reduced proinflammatory cytokines (interleukin(IL)-1beta and IL-6), increased anti-inflammatory cytokines (IL-4, IL-10, and transforming growth factor-beta1), and reduced ED-1 positive areas; (iii) inhibited cell apoptosis (caspase-3 expression); and (iv) improved the survival rate of HUMSCs in the injury site.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Oct"
                    },
                    "PMID:27128690": {
                      "sentence": "AA attenuated UVB-triggered interleukin-6 (IL-6) and promoted the expression of transforming growth factor beta1.",
                      "object score": 1000,
                      "subject score": 852,
                      "publication date": "2016 07"
                    },
                    "PMID:28333137": {
                      "sentence": "Adoptive transfer of rapamycin-treated MDSCs also downregulated the serum levels of IL-1beta, IL-6 and IFN-gamma and upregulated the serum levels of TGF-beta1 compared with the IR group and PBS-treated MDSC group.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 03 23"
                    },
                    "PMID:28562226": {
                      "sentence": "Besides, after 5 days of exogenous TGF-beta1 stimulation, the expression levels of Col 1, FN, TGF-beta1, IL-6, CTGF, and alpha-SMA in HSFs increased significantly.",
                      "object score": 873,
                      "subject score": 1000,
                      "publication date": "2018 03"
                    },
                    "PMID:29154781": {
                      "sentence": "We found that Eucalyptus globulus suppressed the expression of MMPs and IL-6, but increased the expression of TGF-beta1 and procollagen type 1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 01 01"
                    },
                    "PMID:30150989": {
                      "sentence": "Inhibition of NFkappaB signaling pathway preferentially inhibited the production of IL-6 driven by IL-17A in HD fibroblasts, while inhibition of PI3K preferentially inhibited the production of IL-6 driven by TGF-beta.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018"
                    },
                    "PMID:30687328": {
                      "sentence": "Additionally, it was observed that FCs immunization down-regulated the expression level of atherosclerosis related pro-inflammatory cytokines, including IFN-gamma, MCP-1, and IL-6 and enhanced the lesion stability with a significant increase in TGF-beta1 level and collagen content.",
                      "object score": 734,
                      "subject score": 1000,
                      "publication date": "2018"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "FMA:264829",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0021760---SEMMEDDB:stimulates---UMLS:C0172537---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:22634718",
                    "PMID:19909738",
                    "PMID:10233890",
                    "PMID:27358148",
                    "PMID:34022544",
                    "PMID:18038907",
                    "PMID:24603891",
                    "PMID:31035048",
                    "PMID:30773823",
                    "PMID:33350335",
                    "PMID:26510945",
                    "PMID:22171994",
                    "PMID:29393364",
                    "PMID:23210512",
                    "PMID:19628948"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:10233890": {
                      "sentence": "In addition TNF-alpha, GM-CSF, and IL-6 increased the secretion of a partially active form of MMP-2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 May 15"
                    },
                    "PMID:18038907": {
                      "sentence": "LPS enhanced ROS production, as well as, expression of pro-inflammatory cytokines such as interleukin-1beta, interleukin-6, interleukin-8 and tumor necrosis factor-alpha, and the production and activation of MMP2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Oct"
                    },
                    "PMID:19628948": {
                      "sentence": "Treatment of cultured WISH and primary amniotic epithelial cells with 10(-8) or 10(-7)M IL-6 or tumor necrosis factor (TNF)-alpha clearly increased the secretion of MMP-2 and -9.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2009"
                    },
                    "PMID:19909738": {
                      "sentence": "Furthermore, we also found that pro-inflammatory cytokines (IL-1, IL-6 and IL-17) increased in 85/340 mg/kg group compared with normal group, and above cytokines could induce MMP-2 and MMP-9 expression in cardiac fibroblasts.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Apr"
                    },
                    "PMID:22171994": {
                      "sentence": "Then, IL-6 in turn activated JAK2/STAT3 signaling and subsequently up-regulated its downstream targets IL-8, MMP2, and VEGF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Dec 15"
                    },
                    "PMID:22634718": {
                      "sentence": "Liver X receptor regulates rheumatoid arthritis fibroblast-like synoviocyte invasiveness, matrix metalloproteinase 2 activation, interleukin-6 and CXCL10.",
                      "object score": 756,
                      "subject score": 1000,
                      "publication date": "2012 Sep 07"
                    },
                    "PMID:23210512": {
                      "sentence": "Silibinin inhibits the invasion of IL-6-stimulated colon cancer cells via selective JNK/AP-1/MMP-2 modulation in vitro.",
                      "object score": 732,
                      "subject score": 732,
                      "publication date": "2012 Dec 26"
                    },
                    "PMID:24603891": {
                      "sentence": "Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 May"
                    },
                    "PMID:26510945": {
                      "sentence": "IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.",
                      "object score": 1000,
                      "subject score": 746,
                      "publication date": "2016 Feb"
                    },
                    "PMID:27358148": {
                      "sentence": "Therefore, IL-6 can enhance invasiveness of ectoderm cells of embryo through activation of MMP-2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Apr-Jun"
                    },
                    "PMID:29393364": {
                      "sentence": "The overexpression of miR-195 promoted the levels of IL-1beta and IL-6, induced the protein expression of MMP-2 and MMP-9, upregulated the protein expression of TNF-alpha and NF-kappaB, and suppressed the protein expression levels of VEGF, PI3K and p-Akt in angiotensin II-vascular smooth muscle cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Apr"
                    },
                    "PMID:30773823": {
                      "sentence": "Furthermore, the subgroup of patients who experienced occlusion of the vein graft during follow up had a significant increase of MMP-2, -9, IL-6, and TNF-alpha at 3, 6, and 9 months (P < 0.05), respectively.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Jun"
                    },
                    "PMID:31035048": {
                      "sentence": "RESULTS: HMA significantly inhibited IL-6-stimulated growth and colony formation of A549 cells, increased the number of apoptotic cells, and inhibited invasion associated with downregulation of expression of IL-6-induced MMP-1, MMP-2, and MMP-9 genes.",
                      "object score": 1000,
                      "subject score": 857,
                      "publication date": "2019 Aug"
                    },
                    "PMID:33350335": {
                      "sentence": "rSjE16 also significantly increased the expression levels of interleukin (IL)-6 and IL-8, and enhanced the expression of matrix metalloproteinase (MMP)-2, MMP-9, and peroxisome proliferator-activated receptor-gamma in LX-2 cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Dec"
                    },
                    "PMID:34022544": {
                      "sentence": "IL-8 and 5-FU increased MMP-2 and MMP-3 expression, while IL-6 and MTX augmented MMP-2 expression.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2021 May 15"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P14780": {
              "object": "UniProtKB:P14780",
              "subject": "FMA:264829",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0021760---SEMMEDDB:stimulates---UMLS:C0165519---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11483772",
                    "PMID:19285999",
                    "PMID:23426918",
                    "PMID:22167104",
                    "PMID:27681697",
                    "PMID:22232416",
                    "PMID:17986718",
                    "PMID:11590195",
                    "PMID:23536722",
                    "PMID:28432279",
                    "PMID:24603891",
                    "PMID:24285838",
                    "PMID:20715496",
                    "PMID:26753098",
                    "PMID:24072746",
                    "PMID:20964870",
                    "PMID:26510945",
                    "PMID:29393364",
                    "PMID:21275990",
                    "PMID:29406285"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:11483772": {
                      "sentence": "Here we show that although several mouse brain structures were infected, they exhibited a differential pattern in terms of MMP, TIMP, and cytokine expression, exemplified by (i) a large increase in pro-MMP9 levels, in particular in the hippocampus, which occurred mainly in neurons and was associated with in situ gelatinolytic activity, (ii) specific and significant upregulation of MT1-MMP mRNA expression in the cortex and hypothalamus, (iii) an MMP/TIMP imbalance, suggested by the upregulation of TIMP-1 mRNA in the cortex, hippocampus, and hypothalamus and of TIMP-3 mRNA in the cortex, and (iv) a concomitant region-specific large increase in expression of Th1-like cytokines, such as gamma interferon, tumor necrosis factor alpha, and interleukin 6 (IL-6), contrasting with weaker induction of Th2-like cytokines, such as IL-4 and IL-10.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2001 Sep"
                    },
                    "PMID:11590195": {
                      "sentence": "The expression of LE by lymphoma cells was augmented significantly by stimulation with IL-6 and IL-13, both of which also induced the expression of MMP-9.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Oct"
                    },
                    "PMID:17986718": {
                      "sentence": "RESULTS: Significant increases in MMP-9, IL-6, IL-8, TNFalpha and hsCRP were observed, and a significant decrease in MPO and MDA was also observed over the same period.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Nov"
                    },
                    "PMID:19285999": {
                      "sentence": "Our results showed clear evidence of inflammatory infiltrate in the gastrocnemius muscle and an increase of MMP-9, and the cytokines KC, IL-1 beta and IL-6 in the early periods after toxin injection.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Jul"
                    },
                    "PMID:20715496": {
                      "sentence": "Upregulated TNF-alpha, IL-6 and IL-beta induce ectopic pancreatic trypsin and pro-MMP-9 in the endothelial cells and in various organs.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2010 Aug"
                    },
                    "PMID:21275990": {
                      "sentence": "Conditioned medium from UCB-challenged neurons, although down-regulating tumor necrosis factor-alpha and interleukin-1beta promoted the release of interleukin-6 and nitric oxide, the activation of matrix metalloproteinase-9, and cell death, as compared with UCB-direct effects on microglia.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 May"
                    },
                    "PMID:22167104": {
                      "sentence": "MMP-2 expression seemed to be increased by TNF-alpha and IL-1beta while MMP-9 was enhanced by TNF-alpha and IL-6.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 May"
                    },
                    "PMID:22232416": {
                      "sentence": "Histamine-induced reduction of CD1a(+) DCs is associated with increased secretion of IL-6 and IL-10, up-regulation of a typical combination of chemokines, expression C5aR1 by the CD1a(-) DC subset and enhanced migration of both activated DC subsets supported by the production of MMP-9 and MMP-12 enzymes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Feb"
                    },
                    "PMID:23426918": {
                      "sentence": "The levels of IL-6 in the blood correlated with the tissue levels of activated MMP-9 (r=0.1691, P=0.0240).",
                      "object score": 905,
                      "subject score": 1000,
                      "publication date": "2013 Apr"
                    },
                    "PMID:23536722": {
                      "sentence": "Mechanism dissection found that coculture of prostate cancer cells with endothelial cells led to increased interleukin (IL)-6 secretion from endothelial cells, which may result in downregulation of androgen receptor (AR) signaling in prostate cancer cells and then the activation of TGF-beta/matrix metalloproteinase-9 (MMP-9) signaling.",
                      "object score": 864,
                      "subject score": 861,
                      "publication date": "2013 Jun"
                    },
                    "PMID:24072746": {
                      "sentence": "Mechanistic investigations in vivo revealed that PTHrP elevated Y418 phosphorylation levels in Src family kinases in CD11b(+)Gr1(+) cells via osteoblast-derived interleukin-6 and VEGF-A, thereby upregulating MMP-9.",
                      "object score": 988,
                      "subject score": 781,
                      "publication date": "2013 Nov 15"
                    },
                    "PMID:24285838": {
                      "sentence": "Using pharmacologic and genetic approaches, we identified JAK-dependent induction of IL-10 as a potent feedback mechanism controlling IL-6-induced MMP-9 expression.",
                      "object score": 748,
                      "subject score": 748,
                      "publication date": "2014 Jan 01"
                    },
                    "PMID:24603891": {
                      "sentence": "Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 May"
                    },
                    "PMID:26510945": {
                      "sentence": "IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.",
                      "object score": 1000,
                      "subject score": 746,
                      "publication date": "2016 Feb"
                    },
                    "PMID:26753098": {
                      "sentence": "Two immortalized human juvenile chondrocyte cell lines, T/C28a2 and C28/I2, were employed to determine the extent to which recombinant human (rh) IL-6 or rh-TNF-alpha increased the production of matrix metalloproteinase-9 (MMP-9).",
                      "object score": 1000,
                      "subject score": 852,
                      "publication date": "2015"
                    },
                    "PMID:27681697": {
                      "sentence": "Both remedial monotherapies also resulted in significant decreases of TGF-beta1, IL-6, IL-22 and their receptors together with significant increases of MMP-9 and IL-10 system compared with S-PC and L-PC groups.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Sep 29"
                    },
                    "PMID:28432279": {
                      "sentence": "By increasing the expression of G-CSF and IL-6, IL-35 could up-regulate the expression of MMP-9 and Bv8, and down-regulate TRAIL expression in neutrophils, thus augmenting the proangiogenic function of neutrophils.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 May 16"
                    },
                    "PMID:29393364": {
                      "sentence": "The overexpression of miR-195 promoted the levels of IL-1beta and IL-6, induced the protein expression of MMP-2 and MMP-9, upregulated the protein expression of TNF-alpha and NF-kappaB, and suppressed the protein expression levels of VEGF, PI3K and p-Akt in angiotensin II-vascular smooth muscle cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Apr"
                    },
                    "PMID:29406285": {
                      "sentence": "Clarithromycin significantly suppressed the induction of serum MCP-1 and MMP-9 and vascular hyperpermeability in these organs in the early phase of infection, but did not suppress the induction of trypsin, IL-6 or IFN-gamma.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Feb"
                    },
                    "PMID:30217493": {
                      "sentence": "In addition, ORMDL3 overexpression induced IL-6 and IL-8 release and activated p-ERK/MMP-9 pathway in vitro.",
                      "object score": 762,
                      "subject score": 1000,
                      "publication date": "2018 Nov 01"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:FMA:264829-biolink:entity_positively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "FMA:264829",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0021760---SEMMEDDB:stimulates---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15331356",
                    "PMID:22079154",
                    "PMID:24038509",
                    "PMID:29627244",
                    "PMID:18307254",
                    "PMID:25919005",
                    "PMID:26612840",
                    "PMID:27498764",
                    "PMID:10529016",
                    "PMID:30265541",
                    "PMID:17336407",
                    "PMID:24486195",
                    "PMID:11453434",
                    "PMID:22292032",
                    "PMID:22044578",
                    "PMID:21781759",
                    "PMID:28211306",
                    "PMID:19470750",
                    "PMID:15364614",
                    "PMID:24120956"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7508220": {
                      "sentence": "In vitro, the cytokine combination IL-6, IL-1 beta, and TNF-alpha induced hepatocyte iNOS expression but had minimal effects on AGP in the absence of dexamethasone.",
                      "object score": 888,
                      "subject score": 861,
                      "publication date": "1994 Feb"
                    },
                    "PMID:9164945": {
                      "sentence": "Mutation of the octamer motif disrupted both binding of the IL-6-induced protein-DNA interactions and transcriptional activation through region I, revealing that this motif is absolutely essential for IL-6 induction of iNOS.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1997 Jun 01"
                    },
                    "PMID:9770242": {
                      "sentence": "IL-6 does not induce iNOS, explaining why this cytokine is less often involved in this dual role protection pathology.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Oct"
                    },
                    "PMID:10529016": {
                      "sentence": "These results suggest that iNOS not eNOS plays a role in gastric cancer tumor extension, but iNOS mRNA appears not to be induced by either TNF-alpha or IL-6.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "1999 Oct 01"
                    },
                    "PMID:15331356": {
                      "sentence": "Real-time RT-PCR demonstrated a significant temporal elevation in IL-6, IL-1beta, monocyte chemoattractant protein-1, and inducible nitric oxide synthase, with higher expression levels of IL-6 and inducible nitric oxide synthase in colonic extracts compared with small intestine.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Sep"
                    },
                    "PMID:17336407": {
                      "sentence": "Tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1) and IL-6 promote expression of inducible nitric oxide synthase (iNOS) in cardiomyocytes through activation of p38 mitogen-activated protein kinase (p38 MAPK) and nuclear factor kappaB (NFkappaB).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Aug 21"
                    },
                    "PMID:18307254": {
                      "sentence": "In vitro cell system, nuclear accumulation of EGFR was observed in LMP1-expressing cells, and IL-6 induced phosphorylated STAT3 and iNOS.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Jun 01"
                    },
                    "PMID:19470750": {
                      "sentence": "Uropathogenic Escherichia coli-induced inflammation alters mouse urinary bladder contraction via an interleukin-6-activated inducible nitric oxide synthase-related pathway.",
                      "object score": 836,
                      "subject score": 836,
                      "publication date": "2009 Aug"
                    },
                    "PMID:21781759": {
                      "sentence": "Surprisingly, spores of Streptomyces sp., which are mesophilic gram-positive bacteria found in mouldy houses, stimulated RAW264.7 macrophages to produce pro-inflammatory cytokines, tumor necrosis factor alpha (TNFalpha) and interleukin-6 (IL-6), and induced the expression of inducible NO-synthase (iNOS) with a subsequent NO-production.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Feb 15"
                    },
                    "PMID:22079154": {
                      "sentence": "(1) they had more severe KA-induced seizures than apoE2 and 3 mice, (2) they exhibited neuron loss in hippocampus that was higher than in apoE2, 3 and WT mice, (3) KA administration resulted in higher counts of their head drops in the cross-area of elevated plus-maze, (4) they showed lower KA-induced rearing activity than apoE2 mice in the open-field test, (5) their KA-induced microglial expression of MHC-II and CD86 was elevated compared to apoE3 mice, (6) the KA-induced increase of microglial iNOS was higher than that in the other groups of mice, and (7) the TNF-alpha and IL-6 expression was decreased 7 days after KA application compared to untreated mice and mice treated 1 day with KA.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2012 Jan"
                    },
                    "PMID:22292032": {
                      "sentence": "The blockade of CD36 had no effect on PrP(106-126)-stimulated NF-kappaB activation and TNF-alpha protein release, abrogated the PrP(106-126)-induced iNOS stimulation, downregulated IL-1beta and IL-6 expression at both mRNA and protein levels as well as TNF-alpha mRNA expression, decreased NO production and Fyn phosphorylation, reduced caspase-1 cleavage induced by moderate PrP(106-126)-treatment, but had no effect on caspase-1 activation after treatment with a high concentration of PrP(106-126).",
                      "object score": 851,
                      "subject score": 901,
                      "publication date": "2012"
                    },
                    "PMID:24038509": {
                      "sentence": "Ovarian mRNA levels of Il1b, Il6, Tnfa, p55, p75, Ccl2, Ikbkb, and Rela were higher in obese tissue (P < 0.05), with a strong trend (P = 0.06) for an increase in Nos2 and RELA protein.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Nov"
                    },
                    "PMID:24120956": {
                      "sentence": "Enzyme-Linked Immunosorbent Assay and RT-PCR analysis demonstrated that JS-MP-1 significantly stimulates murine RAW264.7 macrophage cells to release chemokines (RANTES and MIP-1alpha) and proinflammatory cytokines (TNF-alpha and IL-6) and to induce the expression of iNOS and COX-2, which are responsible for the production of NO and prostaglandin PGE2, respectively.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Nov"
                    },
                    "PMID:24486195": {
                      "sentence": "The DXR group also had higher MDA, PCs, NT, IL-6 and Big ET-1 levels, higher iNOS and lower eNOS, Akt and AMPK activation compared to controls and the oleuropein-treated groups.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "2014 Apr"
                    },
                    "PMID:25919005": {
                      "sentence": "Even though no systemic response could be detected, Brucella induced a locally restricted inflammatory reaction with increased expression levels of interferon gamma, interleukin (IL)-6, IL-12, granzyme B and a delayed induction of Nos2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014"
                    },
                    "PMID:26612840": {
                      "sentence": "Flow cytometry and helium ion microscopy indicated that pyrogenic NM-203 interacted with macrophages more strongly than the precipitated NM-200 and triggered a more evident inflammatory response, evaluated with Nos2 induction, NO production and the secretion of TNF-alpha, IL-6 and IL-1beta.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2016 Mar"
                    },
                    "PMID:27498764": {
                      "sentence": "Overexpression of miR-939 in vitro resulted in reduction of IL-6, NOS2A and NFkappaB2 mRNAs, IL-6, VEGFA, and NOS2 proteins and NFkappaB activation.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2016 08 08"
                    },
                    "PMID:28211306": {
                      "sentence": "We noticed that while IL-6 induced a high NO production and iNOS expression, ATRA downregulated both.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2017 Apr"
                    },
                    "PMID:29627244": {
                      "sentence": "We found that the jugular LPS infusion significantly increased serum concentrations of IL-1beta, IL-6, tumor necrosis factor, inducible nitric oxide synthase, and lipopolysaccharide binding protein, whereas Arg attenuated the increase in IL-6 and inducible nitric oxide synthase levels and tended to decrease the lipopolysaccharide binding protein level.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2018 Jul"
                    },
                    "PMID:30265541": {
                      "sentence": "As a result, a mutation of IKKbetaC179A rescued the therapeutic effect of UA on Ti-particle-induced inflammation, including morphological transforms, upregulation of iNOS and COX-2, increased secretions of TNF-alpha, IL-1beta, and IL-6, and decreased secretion of IL-10.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Nov 05"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0279328-biolink:entity_positively_regulates_entity-UMLS:C0302600": {
              "object": "UMLS:C0302600",
              "subject": "UMLS:C0279328",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0279328---SEMMEDDB:augments---UMLS:C0302600---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16328781",
                    "PMID:30202037",
                    "PMID:31527941",
                    "PMID:29773856",
                    "PMID:12609710",
                    "PMID:11189538",
                    "PMID:30104981",
                    "PMID:18644387",
                    "PMID:29983419",
                    "PMID:26484702",
                    "PMID:1692972",
                    "PMID:12176040",
                    "PMID:23816249"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1692972": {
                      "sentence": "Hyperbaric oxygen stimulates angiogenesis, with increased neovascularization and optimization of cellular levels of oxygen for osteoblast and fibroblast proliferation, collagen formation, and support of ingrowing blood vessels.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:11189538": {
                      "sentence": "A prospective randomized study was performed to confirm the efficacy of topical hyperbaric oxygen at 1.004 to 1.013 atmospheres (THOT) in stimulating angiogenesis and healing of necrotic/gangrenous wounds.",
                      "object score": 861,
                      "subject score": 901,
                      "publication date": "2000 Sep"
                    },
                    "PMID:12176040": {
                      "sentence": "These data indicated that HBO-induced Ang2 expression may be through transcriptional stimulation, and requires the nitric oxide signaling pathway, which may play an important role in HBO-induced angiogenesis.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "2002 Aug 23"
                    },
                    "PMID:12609710": {
                      "sentence": "Hyperbaric oxygen (HBO) is known to induce angiogenesis in irradiated tissue and has been proven to reduce late radiation injury in several normal tissues when applied during the latent period before complications become manifest.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Feb 28"
                    },
                    "PMID:16328781": {
                      "sentence": "The beneficial effects of HBO in treating ischemia-related wounds may be mediated by stimulating angiogenesis.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2006 Jan"
                    },
                    "PMID:18644387": {
                      "sentence": "Hyperbaric oxygen preconditioning promotes angiogenesis in rat liver after partial hepatectomy.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2008 Aug 15"
                    },
                    "PMID:23816249": {
                      "sentence": "Hyperbaric oxygen is being considered for the therapy of radiated salivary glands because it has been shown to stimulate capillary angiogenesis and fibroplasia in radiation treated tissues.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2013 Jul 02"
                    },
                    "PMID:26484702": {
                      "sentence": "Hyperbaric oxygen may induce angiogenesis in patients suffering from prolonged post-concussion syndrome due to traumatic brain injury.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015"
                    },
                    "PMID:29773856": {
                      "sentence": "Hyperbaric oxygen can induce angiogenesis and recover erectile function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Nov"
                    },
                    "PMID:29983419": {
                      "sentence": "Correction: Hyperbaric oxygen can induce angiogenesis and recover erectile function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 08"
                    },
                    "PMID:30104981": {
                      "sentence": "Hyperbaric Oxygen Increases Stem Cell Proliferation, Angiogenesis and Wound-Healing Ability of WJ-MSCs in Diabetic Mice.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018"
                    },
                    "PMID:30202037": {
                      "sentence": "Comment: Hyperbaric oxygen can induce angiogenesis and recover erectile function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Nov"
                    },
                    "PMID:31527941": {
                      "sentence": "HBO2 has a myriad of other effects, including stimulating angiogenesis and new cellular in growth for healing.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2019"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL118": {
              "object": "CHEMBL.COMPOUND:CHEMBL118",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL729": {
              "object": "CHEMBL.COMPOUND:CHEMBL729",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:33699-biolink:entity_negatively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "CHEBI:33699",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0035696---SEMMEDDB:inhibits---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:32849906",
                    "PMID:15621629",
                    "PMID:15863904",
                    "PMID:16243608",
                    "PMID:24499626",
                    "PMID:20225237",
                    "PMID:15978634",
                    "PMID:9724316",
                    "PMID:23781123",
                    "PMID:16225755"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9724316": {
                      "sentence": "In a rat model of septic shock, AS oligonucleotide to iNOS mRNA inhibits NOS activity and iNOS protein expression and prevents the vascular hyporeactivity to NE, which may contribute to hypotension in shock.",
                      "object score": 888,
                      "subject score": 787,
                      "publication date": "1998 Sep"
                    },
                    "PMID:15621629": {
                      "sentence": "Furthermore, Re could enhance the expression of Bcl-2 protein and Bcl-2 mRNA, but reduce the expression of Bax, Bax mRNA, and iNOS, and weaken the cleavage of caspase-3.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2005 Jun"
                    },
                    "PMID:15863904": {
                      "sentence": "The BMD compound attenuated LPS-induced synthesis of both mRNA and protein of NO synthase (iNOS), and inhibited LPS or fibronectin-mediated iNOS promoter activity, indicating that the compound down-regulated iNOS expression at transcription level.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2005 May"
                    },
                    "PMID:15978634": {
                      "sentence": "Further, CP compound attenuated LPS-induced synthesis of mRNA and protein levels of inducible NO synthase (iNOS), in parallel, and inhibited iNOS promoter activity.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "2005 Nov 04"
                    },
                    "PMID:16225755": {
                      "sentence": "This effect may be related to the increased expression of eNOS mRNA and inhibited expression of iNOS mRNA.",
                      "object score": 928,
                      "subject score": 809,
                      "publication date": "2005 Nov"
                    },
                    "PMID:16243608": {
                      "sentence": "To investigate links existing between iNOS and REMS impairments related to aging, we examine the age-related variations occurring in: mRNA and activity of iNOS in brainstem and frontal cortex; sleep parameters under baseline and after treatment by a selective iNOS inhibitor (AMT) in Senescence Accelerated Mice (SAM).",
                      "object score": 773,
                      "subject score": 1000,
                      "publication date": "2005"
                    },
                    "PMID:20225237": {
                      "sentence": "Through measurement with Griess's reagent, DB reduced NO level with an IC(50) value of 2.85 +/- 0.62 microM that was due to the significant suppression of LPS-induced iNOS mRNA expression as well as IL-1beta, IL-6, and IL-10 mRNA at a concentration of 6 microM.",
                      "object score": 840,
                      "subject score": 901,
                      "publication date": "2010 Apr 01"
                    },
                    "PMID:23781123": {
                      "sentence": "In resolution, 24 h after LPS, HOCbl completely abrogates a major late mediator of sepsis mortality, high mobility group box 1 (HMGB1) mRNA, inhibits iNOS mRNA, and attenuates LPS-induced hepatic inhibition of eNOS mRNA, whilst showing increased, but still moderate, NOS activity, relative to LPS only. experiments (LPS+D-Galactosamine) HOCbl afforded significant, dose-dependent protection in mice.",
                      "object score": 888,
                      "subject score": 938,
                      "publication date": "2013"
                    },
                    "PMID:24499626": {
                      "sentence": "Real-time PCR analysis showed that HBO treatment increased the mRNA of type-II collagen, aggrecan, and TIMP-1 but suppressed the iNOS expression of OA chondrocytes.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2014 Feb 05"
                    },
                    "PMID:32849906": {
                      "sentence": "LP-YS4 also significantly upregulated the mRNA and protein expression of c-Kit, eNOS, nNOSe, and SCF in colitis mice while significantly downregulating the relative expression of iNOS.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:33699-biolink:entity_positively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEBI:33699",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0035696---SEMMEDDB:stimulates---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1382959",
                    "PMID:24451989",
                    "PMID:19769530",
                    "PMID:19936542",
                    "PMID:23783250",
                    "PMID:11034416",
                    "PMID:10716372",
                    "PMID:7645423",
                    "PMID:17044981",
                    "PMID:23531248",
                    "PMID:30594507",
                    "PMID:20032116",
                    "PMID:10070366",
                    "PMID:22695244",
                    "PMID:8054703",
                    "PMID:30332759",
                    "PMID:7829518",
                    "PMID:1569202",
                    "PMID:14647065",
                    "PMID:1718994"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1382959": {
                      "sentence": "Analysis of total RNA isolated from fibroblasts revealed that IGFBP-3 mRNA was increased by TGF beta 1, but not by IGF-I.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1992 Oct"
                    },
                    "PMID:1569202": {
                      "sentence": "Consistent with the immunohistochemistry, a progressive, age-dependent increase in normotensive pulmonary artery TGF-beta 1 mRNA was observed after birth, whereas TGF-beta 1 mRNA remained at low, basal levels in hypertensive, remodeling pulmonary arteries.",
                      "object score": 862,
                      "subject score": 938,
                      "publication date": "1992 May"
                    },
                    "PMID:1718994": {
                      "sentence": "Since TGF-beta 1 mRNA has been shown to be absent from hepatocytes normally and throughout liver regeneration, these results imply that the increase in intracellular TGF-beta 1 resulted from an augmented uptake.",
                      "object score": 938,
                      "subject score": 938,
                      "publication date": "1991 Nov 25"
                    },
                    "PMID:7645423": {
                      "sentence": "Also, Northern blot analysis of mRNA isolated from HKc/HPV16 demonstrated that RA treatment induced TGF-beta 1 and TGF-beta 2 expression about 3- and 50-fold, respectively.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995"
                    },
                    "PMID:7829518": {
                      "sentence": "Placing articular cartilage chondrocytes in primary monolayer culture dramatically up-regulated the expression of ED-A(+) mRNA to 25% of the total, and this expression was further increased by the addition of transforming growth factor beta 1 or fucoidan to the culture medium.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Jan 27"
                    },
                    "PMID:8054703": {
                      "sentence": "The potentiation of IL6 mRNA by TGF-beta 1 required de novo synthesis of an intermediate protein since treatment with cycloheximide abrogated the amount of mRNA enhanced by TGF-beta 1 without affecting IL1 alpha-driven mRNA production.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993"
                    },
                    "PMID:8340608": {
                      "sentence": "Furthermore, whereas the expression of the mRNAs of decorin and biglycan was stimulated by TGF beta 1 in perisinusoidal lipocytes, the synthesis of these mRNAs was stimulated in myofibroblast-like cells predominantly by TGF alpha.",
                      "object score": 1000,
                      "subject score": 966,
                      "publication date": "1993 Apr"
                    },
                    "PMID:8444890": {
                      "sentence": "The levels of both transcripts increase after transforming growth factor-beta 1 induction, however, mRNAs originating from the proximal promoter increase at an higher extent.",
                      "object score": 938,
                      "subject score": 966,
                      "publication date": "1993 Mar 05"
                    },
                    "PMID:8928787": {
                      "sentence": "The cells from the high-fat-ethanol but not low-fat ethanol rats showed an 18-fold increase in procollagen-alpha1(I) mRNA at 17 wk, which was accompanied by 2.8- and 2.3-fold enhancement of TGF-beta1 and alpha-SM transcripts.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Apr"
                    },
                    "PMID:10070366": {
                      "sentence": "In this study, cadherin-11 mRNA and protein expression were examined in primary cultures of human extravillous cytotrophoblasts cultured in the presence of increasing concentrations of transforming growth factor beta 1 using northern and western blot analysis, respectively.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1998 Nov"
                    },
                    "PMID:10716372": {
                      "sentence": "Suppression of the expression of caspase 1 mRNA, which is known to be an IL-1beta-converting enzyme and which also cleaves the precursor of IL-18, was observed in the SAC-stimulated PBMCs from healthy individuals after treatment with TGF-beta1 and in the SAC-stimulated PBMCs from HIV-1-seropositive hemophiliacs, suggesting that the decreased production of IL-18 and IL-1beta in HIV-1-seropositive hemophiliacs may be related to the downregulation of caspase 1 mRNA induced by high levels of TGF-beta1 in plasma.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2000 Mar 01"
                    },
                    "PMID:11034416": {
                      "sentence": "When compared with wild-type mice, IL-6-/- mice manifest exaggerated inflammation and eosinophilia, increased levels of IL-4, IL-5, and IL-13 protein and mRNA, exaggerated levels of eotaxin, JE/monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and -2, and mRNA, increased bronchoalveolar lavage (BAL) TGF-beta1, and exaggerated airway responses to aerosolized methacholine.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000 Oct 01"
                    },
                    "PMID:14647065": {
                      "sentence": "We show that both messenger RNA (mRNA) and protein levels of the CK2alpha catalytic subunit are down-regulated following TGF-beta1 stimulation in murine hepatocyte cells.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2003 Dec"
                    },
                    "PMID:17044981": {
                      "sentence": "[Expression of cellular phenotype switching markers-matrix protein Gla, mRNA and collagen I, III and V of human airway smooth muscle cells in vitro after TGF-beta1 stimulation].",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2006 Jul"
                    },
                    "PMID:19769530": {
                      "sentence": "Transcriptional coactivator with PDZ-binding motif (TAZ) mRNA and protein levels were elevated up to threefold following TGF-beta1 stimulation.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2010 Feb"
                    },
                    "PMID:19936542": {
                      "sentence": "The levels of fibronectin expression in both mRNA and protein increased 4- to 5-fold after TGF-beta1 stimulation, reaching an optimum level after 8 h and then gradually falling back.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2010 Jan"
                    },
                    "PMID:20032116": {
                      "sentence": "The dramatic increases in transforming growth factor-beta1, plasminogen activator inhibitor-1, FN, and collagen I mRNAs seen in disease control animals compared with normal rats were all significantly reduced by ANG-(1-7) administration (P < 0.05).",
                      "object score": 1000,
                      "subject score": 966,
                      "publication date": "2010 Mar"
                    },
                    "PMID:23783250": {
                      "sentence": "In this context, Brachyury overexpression is shown to promote upregulation of TGF-beta1 at the mRNA and protein levels, an effect mediated by activation of the TGF-beta1 promoter in the presence of high levels of Brachyury.",
                      "object score": 734,
                      "subject score": 1000,
                      "publication date": "2013 Sep"
                    },
                    "PMID:24451989": {
                      "sentence": "However, the mRNA of MMP9 was induced by TGFB1 but not follicle-stimulating hormone, luteinizing hormone, progesterone, or estrogen.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Mar"
                    },
                    "PMID:30332759": {
                      "sentence": "In the kidney tissue, the mRNA and protein expressions of vanin-1 significantly decreased, whereas there was increased expression of transforming growth factor (TGF)-beta1 and Snail-1, which plays a pivotal role in the pathogenesis of renal fibrosis via epithelial-to-mesenchymal transition (EMT).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Oct 16"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:33699-biolink:entity_positively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "CHEBI:33699",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0035696---SEMMEDDB:stimulates---UMLS:C0669372---SEMMEDDB:",
                    "UMLS:C0035696---SEMMEDDB:stimulates---UMLS:C1417760---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11093766",
                    "PMID:30391674",
                    "PMID:11792674",
                    "PMID:32585791",
                    "PMID:25936968",
                    "PMID:10231435",
                    "PMID:16880613",
                    "PMID:29224921",
                    "PMID:18095553",
                    "PMID:32288932",
                    "PMID:7515189",
                    "PMID:18791497"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7515189": {
                      "sentence": "Both pregnancy and estradiol treatment increased the amount of mRNAs for NOS isozymes eNOS and nNOS in skeletal muscle, suggesting that the increases in NOS activity result from enzyme induction.",
                      "object score": 851,
                      "subject score": 966,
                      "publication date": "1994 May 24"
                    },
                    "PMID:10231435": {
                      "sentence": "METHODS: The expression of the HO-1 gene was evaluated at the mRNA (Northern blot analysis) and protein (Western blot analysis) levels in mesangial cells treated with two NO donors, sodium nitroprusside (SNP) and S-nitroso-N-acetyl-DL-penicillamine (SNAP), or was stimulated by the combination of lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma) to induce iNOS in the presence and absence of NOS inhibitor NG-Monomethyl-L-arginine (L-NMMA).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 May"
                    },
                    "PMID:11093766": {
                      "sentence": "Dexamethasone did not affect the initial (5 h) LPS-induced increase of iNOS and CAT-2B mRNA, but down-regulated both mRNAs after prolonged (20 h) exposure and this was accompanied by partial inhibition of LPS-stimulated nitrite accumulation and L-[(3)H]arginine uptake.",
                      "object score": 1000,
                      "subject score": 966,
                      "publication date": "2000 Dec"
                    },
                    "PMID:11792674": {
                      "sentence": "In contrast, very low levels of inducible NOS (iNOS) mRNA were expressed, and cold stimulation failed to increase iNOS mRNA levels in BAT.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2002 Feb"
                    },
                    "PMID:16880613": {
                      "sentence": "In BOHF treated animals, cyclooxygenase-2 and iNOS inductions were inhibited in ischemic hemispheres at both the mRNA and protein levels.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "2006 Aug"
                    },
                    "PMID:18095553": {
                      "sentence": "CONCLUSION: LaCl3 can suppress LPS-induced iNOS overexpression at mRNA and protein level and reduce NO production, indicating that LaCl3 can antagonize the excessive activation of iNOS induced by LPS.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Aug"
                    },
                    "PMID:18791497": {
                      "sentence": "Cecal ligation and puncture and simultaneous HS + CLP caused significant inflammatory messenger RNA induction of IL-6, iNOS, IL-10, and heme oxygenase 1 compared with control and HS, and these responses were significantly suppressed in HS + delayed CLP colonic muscularis extracts.",
                      "object score": 1000,
                      "subject score": 736,
                      "publication date": "2009 Apr"
                    },
                    "PMID:25936968": {
                      "sentence": "Immediate iNOS upregulation also correlated with a concomitant increase in Ctnnb1 and Tcf7l2 mRNAs along with increased nuclear TCF transcriptional activity, while the mRNA for the repressive Tcf7l1 was downregulated, providing a possible mechanistic explanation for the noted matrix remodeling.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2015 Jul 16"
                    },
                    "PMID:29224921": {
                      "sentence": "Level of mRNA was increased for iNOS, SOD1 and SOD2, and decreased for GSTP1, Nrf2 and CYP2E1 in acrylamide-treated Rin-5F cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Feb"
                    },
                    "PMID:30391674": {
                      "sentence": "Moreover, elimination of HIF-1alpha expression and activity by CRISPR/Cas9 gene editing significantly reduced the induction of human iNOS gene promoter, mRNA and protein expression by cytokine stimulation.",
                      "object score": 658,
                      "subject score": 1000,
                      "publication date": "2018 Nov 02"
                    },
                    "PMID:32288932": {
                      "sentence": "Simvastatin inhibited LPS-induced TLR4 expression at the mRNA and protein levels in a time-dependent manner (p<0.01), and alleviated inflammation in RPMVECs by inhibiting the release of inflammatory factors such as TNF-alpha and iNOS.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014"
                    },
                    "PMID:32585791": {
                      "sentence": "Furthermore, only NOS I or II in the ventrolateral medulla exhibited an elevation in mRNA or protein levels during the sympathoexcitatory phase, with further up-regulated synthesis of NOS II during the sympathoinhibitory phase of Mev intoxication.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Jun"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEBI:35457",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:inhibits---NCBIGene:1636---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:26378927",
                    "PMID:1465596",
                    "PMID:10622092",
                    "PMID:24629970",
                    "PMID:24958603",
                    "PMID:15897343",
                    "PMID:16672906",
                    "PMID:19761414",
                    "PMID:10028949",
                    "PMID:2442548",
                    "PMID:11882622",
                    "PMID:19832845",
                    "PMID:10027924",
                    "PMID:12623931",
                    "PMID:2847929",
                    "PMID:25575522",
                    "PMID:2690907",
                    "PMID:15662077",
                    "PMID:15283675",
                    "PMID:21921804"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1465596": {
                      "sentence": "To evaluate whether ACE inhibitors may even worsen the propensity to develop hyperkalemia in this condition, we have analyzed retrospectively pre-dialytic blood pressure and serum potassium in 15 patients on chronic hemodialysis before and during long-term ACE inhibition.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1992 Dec 12"
                    },
                    "PMID:2442548": {
                      "sentence": "However, comparison of ACE inhibitors with more long-standing forms of antihypertensive therapy suggests a rather more favourable impact of ACE inhibition on the quality of life.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1987"
                    },
                    "PMID:2690907": {
                      "sentence": "Thus, -SH containing ACE inhibitors--which both inhibit ACE and scavenge cytotoxic free radicals--may offer a suitable form of treatment for myocardial ischaemia/reperfusion injury.",
                      "object score": 1000,
                      "subject score": 824,
                      "publication date": "1989"
                    },
                    "PMID:2847929": {
                      "sentence": "ACE inhibition was lost in the other patient when her compliance with enalapril therapy fell to around 75%: monitoring compliance is essential when ACE inhibitors are used in low dosages.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1988"
                    },
                    "PMID:3428839": {
                      "sentence": "The 4 ACEI inhibited plasma ACE activity to an almost similar extent.",
                      "object score": 851,
                      "subject score": 947,
                      "publication date": "1987"
                    },
                    "PMID:7751417": {
                      "sentence": "Because the various ACE inhibitors exhibit different degrees of ACE inhibition at the tissue level, we have postulated that angiotensin II-dependent aldosterone production will be inhibited to a lesser degree by agents that have low tissue affinity for the adrenal gland.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "1995 Jan"
                    },
                    "PMID:8749676": {
                      "sentence": "In the recently completed trial of ACE inhibition in diabetic nephropathy, ACE inhibitors were specifically shown to decrease dramatically the risk of doubling of serum creatinine or reaching a combined outcome of end-stage renal disease or death.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1995 Dec"
                    },
                    "PMID:9652045": {
                      "sentence": "Plasma ACE inhibition by five different ACE inhibitors.",
                      "object score": 851,
                      "subject score": 837,
                      "publication date": "1998"
                    },
                    "PMID:10028949": {
                      "sentence": "Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial.",
                      "object score": 736,
                      "subject score": 1000,
                      "publication date": "1999"
                    },
                    "PMID:10622092": {
                      "sentence": "Although ACE inhibitors have a similar mechanism of action--namely, inhibition of circulatory ACE, thereby decreasing the formation of angiotensin II--individual members differ in their physicochemical properties, enzyme-binding kinetics, pharmacokinetic profile, organ-specific affinity and selectivity, as well as in their bradykinin potentiating effect.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998 Oct"
                    },
                    "PMID:11882622": {
                      "sentence": "Because vascular AT(1) receptor expression is increased during chronic ACE inhibition, more clinical studies are required to determine whether it is necessary to combine ACE inhibitors and AT(1) receptor antagonists in clinical management of heart failure, coronary heart disease, and hypertension",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2002 Feb"
                    },
                    "PMID:12623931": {
                      "sentence": "Further considerations are that the ratio of ACE and NEP inhibition is fixed for vasopeptidase inhibitors, and there is uncertainty how these drugs should be compared with ACE inhibitors.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Mar"
                    },
                    "PMID:15283675": {
                      "sentence": "In addition, a range of ACE inhibitors failed to inhibit ACE2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Oct 01"
                    },
                    "PMID:15662077": {
                      "sentence": "Review of the literature, the British National Formulary, and the patient information leaflets for each of the 11 ACE inhibitors currently marketed in the UK suggests that this potentially life threatening complication of ACE inhibition is not yet widely recognised.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2005 Feb"
                    },
                    "PMID:16672906": {
                      "sentence": "Angiotensin-converting enzyme 2 (ACE2) is a homolog of ACE, which is not blocked by ACE inhibitors.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Jun"
                    },
                    "PMID:21921804": {
                      "sentence": "The ACEI prevented these changes, improved diastolic cardiac responses to volume overload and total power of heart rate variability, reduced the ACE1 activity and protein expression and cardiac angiotensin (Ang) II levels, and increased angiotensin-converting enzyme 2 activity, despite unchanged blood pressure.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2012 Jan"
                    },
                    "PMID:24629970": {
                      "sentence": "Although in vitro ACE inhibitory activity of VJ was below 50%, FVJ displayed ACE inhibition (80.2%) with an IC50 value of 50MUgprotein/ml.",
                      "object score": 888,
                      "subject score": 839,
                      "publication date": "2014 Aug 01"
                    },
                    "PMID:25575522": {
                      "sentence": "ACE inhibitor is associated with the inhibition of ACE and normalization of cardiac ACE2 activity.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Dec 31"
                    },
                    "PMID:26378927": {
                      "sentence": "ACE inhibitors inhibit ACE and attenuate the formation of angiotensin II from angiotensin I; ARBs block the angiotensin AT1 receptor and attenuate the actions of angiotensin II that are elicited through the receptor.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015"
                    },
                    "PMID:29425464": {
                      "sentence": "We concluded that the tissue affinity of the angiotensin converting enzyme inhibitors (ACEIs) has no impact on its antifibrotic activity and that interfering the RAS either through the inhibition of ACE or the blockade of AT1R has the same therapeutic benefit.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Jun"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:P30556": {
              "object": "UniProtKB:P30556",
              "subject": "CHEBI:35457",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:inhibits---UMLS:C1439284---SEMMEDDB:",
                    "UMLS:C0003015---SEMMEDDB:inhibits---NCBIGene:185---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15208798",
                    "PMID:15331931",
                    "PMID:28730079",
                    "PMID:30965084",
                    "PMID:19706421",
                    "PMID:16206603",
                    "PMID:32418532",
                    "PMID:18379253",
                    "PMID:11568070",
                    "PMID:8656644"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8656644": {
                      "sentence": "Comparative effects of type 1 angiotensin II-receptor blockade with angiotensin-converting-enzyme inhibitor on left ventricular distensibility and collagen metabolism in spontaneously hypertensive rats.",
                      "object score": 780,
                      "subject score": 1000,
                      "publication date": "1996 Jan"
                    },
                    "PMID:11568070": {
                      "sentence": "Furthermore, we examined the effects of an ACE inhibitor, an AT1R blocker, and an AT2R blocker on serum deprivation-induced VSMC apoptosis by organ culture system.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Sep 18"
                    },
                    "PMID:15208798": {
                      "sentence": "Furthermore, there is no sense to combine AT-1 antagonist and ACEI, while a combination of AT-1 antagonist and a beta blocker is justified.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004"
                    },
                    "PMID:15331931": {
                      "sentence": "AIMS: Effects of the blockade of renin-angiotensin system (RAS), by angiotensin-converting enzyme inhibitor (ACEi), type 1 angiotensin II receptor blocker (ARB), or a combination of both, were evaluated in Adriamycin (ADR)-induced glomerulopathy.",
                      "object score": 780,
                      "subject score": 1000,
                      "publication date": "2004"
                    },
                    "PMID:16206603": {
                      "sentence": "[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].",
                      "object score": 772,
                      "subject score": 1000,
                      "publication date": "2005"
                    },
                    "PMID:18379253": {
                      "sentence": "Furthermore, administration of BK receptor antagonists to the I/R+ACE inhibitor, I/R+AT1R antagonist, I/R+AT2R antagonist, and PC groups resulted in hepatic injury similar to the I/R group, indicating that the benefits of ACE inhibitor, AT1R antagonist, AT2R antagonist, and PC were abolished when the action of BK was inhibited.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Apr"
                    },
                    "PMID:19706421": {
                      "sentence": "Blocking AII production with ACE inhibitors or inhibiting AII signaling with AT1R blockers suppressed autoreactive TH1 and TH17 cells and promoted antigen-specific CD4+FoxP3+ regulatory T cells (Treg cells) with inhibition of the canonical NF-kappaB1 transcription factor complex and activation of the alternative NF-kappaB2 pathway.",
                      "object score": 1000,
                      "subject score": 877,
                      "publication date": "2009 Sep 01"
                    },
                    "PMID:28730079": {
                      "sentence": "CONCLUSION: Increased Ang II and AT1R in the hyperglycemic state indicate activated the intraocular renin-angiotensin system, which is inhibited more effectively by systemic ACEI than systemic ARB.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2017"
                    },
                    "PMID:30965084": {
                      "sentence": "To identify the canonical pathway of (P)RR, we administered ACE-1 inhibitor (captopril), AT1R blocker (losartan), and MAPKs inhibitors (U0126 and SB203580) to all Npr1 mice genotypes.",
                      "object score": 1000,
                      "subject score": 913,
                      "publication date": "2019 04"
                    },
                    "PMID:32418532": {
                      "sentence": "The proposed molecules are (so far) ACE inhibitors (to prevent the production of Angiotensin II from Angiotensin I), and blockers/antagonists of AT1R such as Losartan and derivatives.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 May 17"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-UniProtKB:Q13315": {
              "object": "UniProtKB:Q13315",
              "subject": "CHEBI:35457",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:inhibits---UMLS:C0919524---SEMMEDDB:",
                    "UMLS:C0003015---SEMMEDDB:inhibits---NCBIGene:472---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24075681",
                    "PMID:24075677",
                    "PMID:11928278",
                    "PMID:25650385",
                    "PMID:15536706",
                    "PMID:17406845",
                    "PMID:11026648",
                    "PMID:14689111",
                    "PMID:10951859",
                    "PMID:11998332",
                    "PMID:28425812",
                    "PMID:16033673",
                    "PMID:15274684",
                    "PMID:8993854",
                    "PMID:15131005",
                    "PMID:10836730",
                    "PMID:14669746",
                    "PMID:27747611",
                    "PMID:20465101",
                    "PMID:23089829"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8993854": {
                      "sentence": "The most common side effect of ACE inhibitors, dry cough, does not occur with AT1 antagonists, which confirms the long-held view that this untoward effect of the ACE inhibitors is due to renin-angiotensin-independent mechanisms.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996"
                    },
                    "PMID:9493125": {
                      "sentence": "SIDE EFFECTS: The relatively common problem of cough observed with ACE inhibitors does not occur with AT1 blockers.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1997 Dec"
                    },
                    "PMID:10836730": {
                      "sentence": "These data suggest that in hypertensive patients uncontrolled with an ACE inhibitor, the addition of an AT1 antagonist provides a powerful and safe antihypertensive drug combination.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2000 Jun"
                    },
                    "PMID:10951859": {
                      "sentence": "As to therapeutic possibilities, antihypertensive drugs are most suitable, i.e. angiotensin converting enzyme inhibitors, Ca blockers of the IInd generation and also blockers of AT1 receptors.",
                      "object score": 888,
                      "subject score": 811,
                      "publication date": "1999 Nov"
                    },
                    "PMID:11026648": {
                      "sentence": "Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2000 Oct"
                    },
                    "PMID:11928278": {
                      "sentence": "AT1 blockers are to be used in the cases when ACE inhibitors are not tolerated.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2002 Mar"
                    },
                    "PMID:11998332": {
                      "sentence": "Kinins play an essential role in ventricular function as they counteract the effects of angiotensin II during myocardial ischaemia, ventricular remodelling and severe cardiac failure, emphasising the value of treatment favouring local endogenic production of bradykinin such as ACE inhibitors, neutral endopeptidase inhibitors and antagonists of AT1 receptors of angiotensin II.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Mar"
                    },
                    "PMID:14669746": {
                      "sentence": "Although ACE-inhibitors seem to have slightly better results at present than AT1 blockers in the battle on heart failure patient, future trials will decide which is the definitive winner.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2003 May"
                    },
                    "PMID:14689111": {
                      "sentence": "Here are CCBs ideal partners for a therapy with ACE-inhibitors, AT1 antagonists or beta blockers (DHP) and diuretics (verapamil).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2003 Dec"
                    },
                    "PMID:15131005": {
                      "sentence": "UA patients were randomly assigned to angiotensin-converting enzyme (ACE)-inhibitor (ramipril), AT1 antagonist (valsartan), or placebo and treated during the 5 days preceding coronary bypass surgery, performed from 6 to 9 days after coronary angiography.",
                      "object score": 694,
                      "subject score": 870,
                      "publication date": "2004 Jun 25"
                    },
                    "PMID:15274684": {
                      "sentence": "All patients were assigned randomly to three groups with equal number: group I, an ACE inhibitor, enalapril 10 mg daily; group II, an AT1 antagonist, losartan 100 mg daily; group III, combination of enalapril 10 mg and losartan 100 mg daily.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2004 Aug"
                    },
                    "PMID:15536706": {
                      "sentence": "[Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2].",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2004 Oct 14"
                    },
                    "PMID:16033673": {
                      "sentence": "Thiazolidinediones, angiotensin-converting enzyme inhibitors, angiotensin receptor-AT1 blockers, and statins are widely used in the treatment of diabetes.",
                      "object score": 658,
                      "subject score": 1000,
                      "publication date": "2005 Aug"
                    },
                    "PMID:17406845": {
                      "sentence": "First-line drugs are diuretics, calcium antagonists, ACE inhibitors, AT1 blockers and beta blockers.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2007 Jun"
                    },
                    "PMID:17972241": {
                      "sentence": "Beta-blockers were given to 83 %, ACE-inhibitors to 71 %, AT1 inhibitors to 22 % and statins to 84 %.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2007 Nov"
                    },
                    "PMID:18090668": {
                      "sentence": "Targeting NF-kappaB signaling with angiotensin converting enzyme inhibitors, AT1 blockers, and specific NF-kappaB inhibitors may represent a novel approach in treating angiotensin II-induced hypertensive and renal diseases.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2008 Jan"
                    },
                    "PMID:20465101": {
                      "sentence": "Combination therapy, using AT1 blockers or ACE inhibitors in combination with calcium channel blockers or diuretics, should be utilized to its full potential in order to ensure that target values are achieved.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2010 Apr"
                    },
                    "PMID:23089829": {
                      "sentence": "For pharmacological treatment five main substance groups are available: thiazide diuretics, ACE inhibitors, AT1 blockers, calcium channel blockers and beta blockers.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2012 Nov"
                    },
                    "PMID:25650385": {
                      "sentence": "AT1 blockade caused sustained activation of cardiac ACE2 and Mas receptor, but ACE inhibitor had the limitation of such activation of Mas receptor in hydronephrotic animals.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2015 Jun"
                    },
                    "PMID:28425812": {
                      "sentence": "Blockade of the AT1-receptor, with agents such as candesartan, produces more specific and, theoretically, more complete blockade of the major negative cardiovascular effects of angiotensin II than is possible using ACE inhibitors, whilst maintaining placebo-like tolerability.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:entity_positively_regulates_entity-UniProtKB:P29474": {
              "object": "UniProtKB:P29474",
              "subject": "CHEBI:35457",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:stimulates---UMLS:C0669365---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23395155",
                    "PMID:16868034",
                    "PMID:10072715",
                    "PMID:9581728",
                    "PMID:15304551",
                    "PMID:17475504",
                    "PMID:14592556",
                    "PMID:8165541",
                    "PMID:27060232",
                    "PMID:22193759"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8165541": {
                      "sentence": "In this study, we tested whether lisinopril, an angiotensin-converting enzyme inhibitor, or verapamil, a calcium channel blocker, would suppress the PDGF gene expression in stimulated human saphenous vein ECs.",
                      "object score": 805,
                      "subject score": 1000,
                      "publication date": "1994 Apr"
                    },
                    "PMID:9581728": {
                      "sentence": "ACE inhibitors have been shown to enhance conduit artery endothelial function in animal experiments and in patients with established coronary atherosclerosis, although their effect in IDDM is not known.",
                      "object score": 775,
                      "subject score": 1000,
                      "publication date": "1998 May"
                    },
                    "PMID:10072715": {
                      "sentence": "ACE inhibitors enhance endothelial function by a bradykinin-dependent mechanism and probably also by blunting the generation of superoxide anion.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1999 Jan"
                    },
                    "PMID:14592556": {
                      "sentence": "It may well be that an increase in endothelial [Ca2+]i by ACE-I activates phospholipase A2, which supplies COX-2 with the substrate for making thrombolytic prostacyclin.",
                      "object score": 1000,
                      "subject score": 937,
                      "publication date": "2003 Jun 15"
                    },
                    "PMID:15304551": {
                      "sentence": "The peptide and the ACE inhibitor ligands activate eNOS by facilitating different signaling pathways.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2004 Nov"
                    },
                    "PMID:16868034": {
                      "sentence": "Consistently, in cultured coronary endothelial cells (CVECs), ACEI up-regulated endothelial NOS (eNOS) and FGF-2 and induced mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 activation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Nov"
                    },
                    "PMID:17475504": {
                      "sentence": "All ACE inhibitors increased endothelial nitric oxide synthase (eNOS) protein expression and activity in the aorta (both P<0.0001 versus vehicle) and in cardiac myocytes (both P<0.05 versus vehicle).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2007 Jul"
                    },
                    "PMID:22193759": {
                      "sentence": "Bradykinin is involved in the regulation of eNOS expression induced by angiotensin-converting enzyme inhibitors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2012 Jan"
                    },
                    "PMID:23395155": {
                      "sentence": "Angiotensin-converting enzyme inhibitors, AT1 receptor blockers, statins, nebivolol and resveratrol have been shown to reverse eNOS uncoupling and to stimulate eNOS activity concurrently.",
                      "object score": 790,
                      "subject score": 1000,
                      "publication date": "2013 Apr"
                    },
                    "PMID:27060232": {
                      "sentence": "The antihypertensive effects of angiotensin-converting enzyme inhibitors (ACEi) are associated with up-regulation of endothelial nitric oxide synthase (NOS3) activity.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2016 05 01"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:entity_positively_regulates_entity-UniProtKB:Q9BYF1": {
              "object": "UniProtKB:Q9BYF1",
              "subject": "CHEBI:35457",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:stimulates---NCBIGene:59272---SEMMEDDB:",
                    "UMLS:C0003015---SEMMEDDB:stimulates---UMLS:C0960880---SEMMEDDB:",
                    "UMLS:C0003015---SEMMEDDB:stimulates---UMLS:C1422064---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:33526121",
                    "PMID:32348052",
                    "PMID:32771682",
                    "PMID:33795584",
                    "PMID:32835160",
                    "PMID:19793108",
                    "PMID:32685191",
                    "PMID:33201001",
                    "PMID:32401442",
                    "PMID:33398362",
                    "PMID:33307964",
                    "PMID:27931559",
                    "PMID:32208987",
                    "PMID:32310915",
                    "PMID:32495299",
                    "PMID:33756485",
                    "PMID:32547717",
                    "PMID:33023356",
                    "PMID:32320478",
                    "PMID:33278189"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:19793108": {
                      "sentence": "The findings of the present study suggest that ACE inhibitors are able to upregulate ACE2 under conditions of liver injury both in vivo and in vitro, which may indicate potential benefits of ACE inhibitors in the therapeutic treatment of liver fibrosis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Jan"
                    },
                    "PMID:27931559": {
                      "sentence": "Here-in we reviewed how myocardial I/R injury sets in by up-regulation of angiotensin II that leads to increased infarct size, which can be reduced by the use of ACE inhibitors, ACE2 activators and angiotensin II antagonist.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Nov - Dec"
                    },
                    "PMID:32341442": {
                      "sentence": "Given that angiotensin receptor blockers (ARBs) and an ACE inhibitor (ACEI) upregulated ACE2 expression in animal studies, the concern might arise regarding whether ARBs and ACEIs would increase the morbidity and mortality of COVID-19.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2020 07"
                    },
                    "PMID:32348052": {
                      "sentence": "ACE inhibitors and sartans upregulate the expression of angiotensin-converting enzyme 2 (ACE2), the pulmonary receptor for SARS-CoV-2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Apr 29"
                    },
                    "PMID:32495299": {
                      "sentence": "RESULTS: Preclinical studies have reported that angiotensin receptor blockers (ARBs) and ACE inhibitors might increase ACE2 expression in several cell types.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2020 Aug"
                    },
                    "PMID:32511473": {
                      "sentence": "Conclusions and Relevance: Treatment with ACEIs or ARBs does not raise ACE2 levels in serum.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2020 May 25"
                    },
                    "PMID:32511516": {
                      "sentence": "We further determined whether ACE2 expression in the cilia of upper respiratory cells was influenced by patient demographics, clinical characteristics, co-morbidities, or medication use, and found no evidence that the use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARBs) increases ACE2 protein expression.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2020 May 12"
                    },
                    "PMID:32547717": {
                      "sentence": "It has therefore been postulated that angiotensin converting enzyme inhibitors and angiotensin receptor blockers may upregulate ACE2 expression and thus increase susceptibility to infection.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2020 May 26"
                    },
                    "PMID:32685191": {
                      "sentence": "Specifically, the suggestion has been made that ACE inhibitors or ARBs could theoretically contribute to infection via increasing ACE2 receptor expression and hence increase viral load.",
                      "object score": 873,
                      "subject score": 1000,
                      "publication date": "2020"
                    },
                    "PMID:32771682": {
                      "sentence": "Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) have been reported to increase ACE2 expression in animal models, and worse outcomes are reported in patients with co-morbidities commonly treated with these agents, leading to controversy during the COVID-19 pandemic over whether these drugs might be helpful or harmful.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2020 Aug"
                    },
                    "PMID:32835160": {
                      "sentence": "Body: Both ACE inhibitors and ARBs induce overexpression of the angiotensin converting enzyme 2 (ACE-2) receptor, which has been identified as the main receptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter into the alveolar cells of the lungs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020"
                    },
                    "PMID:33023356": {
                      "sentence": "Angiotensin converting enzyme inhibitors (ACEI) and angiotensin II receptor antagonists (ARB) are associated with ACE-2 upregulation.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2020 Oct 07"
                    },
                    "PMID:33116139": {
                      "sentence": "ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs.The coronavirus SARS-CoV-2 is the causative agent of the ongoing severe acute respiratory disease pandemic COVID-19.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Oct 28"
                    },
                    "PMID:33201001": {
                      "sentence": "BACKGROUND: Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are known to increase the expression of angiotensin converting enzyme 2 receptor, which has been shown to be the receptor for the acute severe respiratory syndrome coronavirus 2 (SARS-CoV-2).",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2020 Nov 10"
                    },
                    "PMID:33307964": {
                      "sentence": "Background Previous reports suggest that the use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) may upregulate angiotensin-converting enzyme 2 receptors and increase SARS-CoV-2 infectivity.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2020 Dec 14"
                    },
                    "PMID:33380345": {
                      "sentence": "Since angiotensin-converting enzyme (ACE)-2 is a receptor for SARS-CoV-2, and ACE inhibitors and angiotensin receptor blockers are predicted to increase ACE-2 expression, it was initially feared that their use might exacerbate COVID-19.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2020 12 30"
                    },
                    "PMID:33398362": {
                      "sentence": "Considering that angiotensin receptor blockers and ACE inhibitors (ACEIs) upregulate the expression of ACE2 in animal studies, there may be a concern about whether these drugs may increase COVID-19 susceptibility and severity.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021 Jan"
                    },
                    "PMID:33526121": {
                      "sentence": "BODY: Both ACE inhibitors and ARBs induce overexpression of the angiotensin converting enzyme 2 (ACE-2) receptor, which has been identified as the main receptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter into the alveolar cells of the lungs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Jul 31"
                    },
                    "PMID:33756485": {
                      "sentence": "BACKGROUND: Preclinical studies suggested that pharmacological inhibition of the renin-angiotensin-aldosterone system (RAAS) by ACE inhibitors (ACEis) or angiotensin II receptor blockers (ARBs) may increase local angiotensin-converting enzyme 2 (ACE2) expression.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2021 Mar 23"
                    },
                    "PMID:33795584": {
                      "sentence": "On the other hand, angiotensin-converting enzyme inhibitors (ACEi) and AT1R blockers have been shown to upregulate the expression of ACE2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021 May 01"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:physically_interacts_with-FMA:264829": {
              "object": "FMA:264829",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0020268---SEMMEDDB:interacts_with---UMLS:C0021760---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10888707",
                    "PMID:8842418",
                    "PMID:10443510",
                    "PMID:15708882",
                    "PMID:15756054",
                    "PMID:9215292",
                    "PMID:11155809",
                    "PMID:27846826",
                    "PMID:8403558",
                    "PMID:27865492",
                    "PMID:8050200",
                    "PMID:9496240",
                    "PMID:27930715",
                    "PMID:9100607"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8050200": {
                      "sentence": "The effect of hydrocortisone (HC) on IL-6 production by monocytes (Mo) that were cultured under either adherent or limited-adherent culture conditions was determined.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1994 Aug"
                    },
                    "PMID:8403558": {
                      "sentence": "Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes.",
                      "object score": 861,
                      "subject score": 888,
                      "publication date": "1993 Nov"
                    },
                    "PMID:8842418": {
                      "sentence": "In contrast, hydrocortisone, U-24067 and tetrahydro-S did not influence the levels of TNF-alpha and IL-6.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Aug"
                    },
                    "PMID:9100607": {
                      "sentence": "In the same patients, we detected a negative effect of cortisol upon IL-6 exerted with a delay of 5 h.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Apr"
                    },
                    "PMID:9215292": {
                      "sentence": "Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1997 Jul"
                    },
                    "PMID:9496240": {
                      "sentence": "The aim of the present investigation was to study whether cortisol regulates the expression of IL-6 and IL-1 beta in human osteoblast-like cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jan"
                    },
                    "PMID:10443510": {
                      "sentence": "If inflammatory responses play a role in sudden unexpected nocturnal death, the inability of the night time levels of cortisol to control IL-6 and TNF-alpha in the model system might reflect these interactions in vivo.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Aug 01"
                    },
                    "PMID:10888707": {
                      "sentence": "Serum levels of cortisol in relation to IL-6 were significantly lower in patients with chronic disease and long-standing corticosteroid administration as compared with patients with recent onset of the disease and without corticosteroid therapy (P < 0.01).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Jun"
                    },
                    "PMID:11155809": {
                      "sentence": "In the same patients, we detected a negative effect of cortisol upon IL-6 exerted with a delay of 5 h.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000"
                    },
                    "PMID:15708882": {
                      "sentence": "Changes of cortisol in relation to IL6 during anti-TNF treatment, seen previously, may not be related to changes of CBG.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Sep"
                    },
                    "PMID:15756054": {
                      "sentence": "The interaction between IL-6 and cortisol after surgery is associated with developing postoperative confusion in the elderly patients.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005"
                    },
                    "PMID:27846826": {
                      "sentence": "Data validation studies establish hydrocortisone and dexamethasone as suppressing multiple pro-inflammatory processes, where L-NIL suppressed NO2-, but had no effect on iNOS expression or IL-6.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Nov 15"
                    },
                    "PMID:27865492": {
                      "sentence": "Physiological cortisol concentration negatively affected the levels of IL-6 secreted by PBMC, resulting in increased cell proliferation after acute stress (24h of incubation).",
                      "object score": 1000,
                      "subject score": 623,
                      "publication date": "2017 Jan"
                    },
                    "PMID:27930715": {
                      "sentence": "CONCLUSION: In patients with systemic autoimmune diseases, apparent suppression of cortisol during glucocorticoid therapy may be partly mediated by reduced production of IL-6.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "RXNORM:3264",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-UniProtKB:P05019": {
              "object": "UniProtKB:P05019",
              "subject": "RXNORM:3264",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-UniProtKB:P05362": {
              "object": "UniProtKB:P05362",
              "subject": "RXNORM:3264",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-UniProtKB:P15692": {
              "object": "UniProtKB:P15692",
              "subject": "RXNORM:3264",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:3264-biolink:entity_negatively_regulates_entity-UniProtKB:P35354": {
              "object": "UniProtKB:P35354",
              "subject": "RXNORM:3264",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:8031-biolink:entity_positively_regulates_entity-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "RXNORM:8031",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0030946---SEMMEDDB:stimulates---UMLS:C0172537---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21718387",
                    "PMID:11114732",
                    "PMID:10776921",
                    "PMID:11716070",
                    "PMID:10623478",
                    "PMID:10597259",
                    "PMID:14665441",
                    "PMID:17189319",
                    "PMID:14559821",
                    "PMID:11426587",
                    "PMID:12795793",
                    "PMID:14617636",
                    "PMID:10553104",
                    "PMID:9109379",
                    "PMID:12581739",
                    "PMID:20589835",
                    "PMID:23357422",
                    "PMID:21544425"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9109379": {
                      "sentence": "We found that augmented secretion and proteolytic activation of MMP-2 and MMP-9 together with expression of MT1-MMP in Con A-activated 3Y1 were dramatically suppressed by S17N ras expression.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1997 Apr 07"
                    },
                    "PMID:10553104": {
                      "sentence": "Our results suggest that MMP-7 produced by myeloma cells could participate in bone destruction and tumor spreading in MM, on one hand by its own proteolytic activity and on the other hand by its capacity to activate pro-MMP-2.",
                      "object score": 901,
                      "subject score": 828,
                      "publication date": "1999 Nov 15"
                    },
                    "PMID:10597259": {
                      "sentence": "In addition, treatment of SR3Y1 with manumycin A, a potent inhibitor of Ras farnesyltransferase, strongly suppressed both augmented secretion and proteolytic activation of MMP-2.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1999 Nov 11"
                    },
                    "PMID:10623478": {
                      "sentence": "Contrary, expression of dominant negative form of MEK1 in v-src-transformed cells or in Con A-activated cells resulted in the suppression of the augmented secretion and proteolytic activation of MMP-2.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2000 Jan 10"
                    },
                    "PMID:10776921": {
                      "sentence": "Analysis of in situ protease activity in chronic adult periodontitis patients: expression of activated MMP-2 and a 40 kDa serine protease.",
                      "object score": 905,
                      "subject score": 861,
                      "publication date": "2000 Mar"
                    },
                    "PMID:11114732": {
                      "sentence": "In addition, activation of MMP-secretion and tyrosine phosphorylation of FAK by Con A, but not the proteolytic activation of MMP-2, required attachment of the cells to the extracellular matrix.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2000 Nov 16"
                    },
                    "PMID:11426587": {
                      "sentence": "Gelatin proteolytic activities were found in homogenates containing either media or intima from the injured artery, and activated matrix metalloproteinase-2 (MMP2) was detected.",
                      "object score": 905,
                      "subject score": 851,
                      "publication date": "2000"
                    },
                    "PMID:11716070": {
                      "sentence": "In addition to activation of proMMP2, MT-MMPs display intrinsic proteolytic activity towards extracellular matrix molecules (ECM), which is independent of MMP2 activation.",
                      "object score": 694,
                      "subject score": 851,
                      "publication date": "2001 Jun"
                    },
                    "PMID:12581739": {
                      "sentence": "Myoblast proliferation was also accompanied by a significant increase in c-met expression, and major adaptations of energetic and proteolytic metabolisms, including an increase in the relative contribution of glycolytic metabolism for energy production, an increase in proteasome and matrix metalloproteinases 2 and 9 activities, and a decrease in plasminogen activator activities.",
                      "object score": 988,
                      "subject score": 872,
                      "publication date": "2003 Feb 15"
                    },
                    "PMID:12795793": {
                      "sentence": "The GCF samples were examined for general proteolytic activity, gelatinolytic activity and ability to activate pro-MMP-2 by zymography.",
                      "object score": 916,
                      "subject score": 851,
                      "publication date": "2003 Jun"
                    },
                    "PMID:14559821": {
                      "sentence": "In cells expressing mutant SHP-2 in which 65 amino acids in the SH2-N domain were deleted, we found that production, secretion, and proteolytic activation of MMP-2 in response to Con A treatment was severely impaired.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2003 Oct 01"
                    },
                    "PMID:14617636": {
                      "sentence": "Clearly, PAF-mediated signaling in differentiated endothelial cells is critical to endothelial cell functions, including cell migration and proteolytic activation of MMP2.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2004 Jan 30"
                    },
                    "PMID:14665441": {
                      "sentence": "IGFBP-2 was able to potentiate endogenous and exogenous IGF-II-dependent stimulation of AP activity, and its proteolytic degradation in late stages of osteogenesis (S2 and S3) was highly correlated with the increase of active matrix metalloproteinase-2 in the CM and with the decreased efficacy of IGF-II action.",
                      "object score": 916,
                      "subject score": 888,
                      "publication date": "2004 Apr"
                    },
                    "PMID:17189319": {
                      "sentence": "Together, collagen I and thrombin strongly enhanced MMP-14 mRNA and protein but had no effect individually, suggesting increased MMP-14, the activating protease for MMP-2, may be partially responsible for MMP-2 activation.",
                      "object score": 734,
                      "subject score": 872,
                      "publication date": "2007 Apr"
                    },
                    "PMID:20589835": {
                      "sentence": "We found that beta-catenin in MDCK non-cancer cells inhibited the cell surface localization of MT1-MMP, and thus its proteolytic activity on pro-MMP2 activation, via direct interaction with the 18-amino-acid cytoplasmic tail of MT1-MMP in the cytoplasm.",
                      "object score": 623,
                      "subject score": 888,
                      "publication date": "2010 Nov"
                    },
                    "PMID:21544425": {
                      "sentence": "These results imply that enhanced secretion and proteolytic activation of MMP-2 and MMP-9 take place specifically in the esophageal carcinoma tissues.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1996 Apr"
                    },
                    "PMID:21718387": {
                      "sentence": "Membrane type-1 matrix metalloproteinase (MT1-MMP) is a protease that activates pro-MMP-2 and pro-MMP13, which are related to tumor malignancy.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2011 Oct"
                    },
                    "PMID:23357422": {
                      "sentence": "It not only promoted proteolytic activity for cancer cells per se, but also led to the activation of MMP-2.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2013 Feb 22"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:8031-biolink:entity_positively_regulates_entity-UniProtKB:P14780": {
              "object": "UniProtKB:P14780",
              "subject": "RXNORM:8031",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0030946---SEMMEDDB:stimulates---UMLS:C0165519---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11297541",
                    "PMID:16364029",
                    "PMID:19923455",
                    "PMID:1379048",
                    "PMID:11703174",
                    "PMID:19364840",
                    "PMID:21544425",
                    "PMID:9168859",
                    "PMID:18812315",
                    "PMID:16714214",
                    "PMID:18401426",
                    "PMID:18559512",
                    "PMID:9109379",
                    "PMID:10329260",
                    "PMID:12004062"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1379048": {
                      "sentence": "Eight endopeptidases (trypsin, chymotrypsin, plasmin, plasma kallikrein, thrombin, cathepsin G, neutrophil elastase and thermolysin) were tested for their ability to activate proMMP-9.",
                      "object score": 717,
                      "subject score": 888,
                      "publication date": "1992 Jul 15"
                    },
                    "PMID:9109379": {
                      "sentence": "We found that augmented secretion and proteolytic activation of MMP-2 and MMP-9 together with expression of MT1-MMP in Con A-activated 3Y1 were dramatically suppressed by S17N ras expression.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1997 Apr 07"
                    },
                    "PMID:9168859": {
                      "sentence": "In this article, we demonstrate that a proteinase isolated from the periodontopathogen Porphyromonas gingivalis can activate MMP-1, MMP-3, and MMP-9 and can catalyze the superactivation of MMP-1 by MMP-3.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Jun"
                    },
                    "PMID:10329260": {
                      "sentence": "Phorbol myristate acetate, known to induce protease activity in other endothelial cell populations, stimulated MMP1, MMP9, and TIMP1 secretion in both NDEC and PEDEC.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1999 May"
                    },
                    "PMID:11297541": {
                      "sentence": "Furthermore, TNF-alpha promotes proteolytic activation of pro-MMP-9 by conversion of the 92-kDa pro-MMP-9 to the 82-kDa active enzyme.",
                      "object score": 901,
                      "subject score": 694,
                      "publication date": "2001 Jun 22"
                    },
                    "PMID:11703174": {
                      "sentence": "This effect is not accompanied by proteolytic activation of gelatinase B and is related to release of a pro-form of the enzyme.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2001 Sep"
                    },
                    "PMID:12004062": {
                      "sentence": "Thus, these studies suggest a novel regulation for the proteolytic activation of MMP-9 in human tissue, which is mediated by tissue-bound activator and controlled by down-regulation of a specific inhibitor.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2002 Jul 26"
                    },
                    "PMID:16364029": {
                      "sentence": "In situ gelatin zymography of tumor specimens displayed a strong proteolytic activity in papillomas, and SCC putatively attributed to the increased amounts of activated MMP-9 found in tissue extracts.",
                      "object score": 905,
                      "subject score": 851,
                      "publication date": "2006 Jan"
                    },
                    "PMID:16714214": {
                      "sentence": "In conclusion C5a is an important mediator that brings about secretion and oxidative activation of MMP-9, a requisite protease for transmigration, from both eosinophils and neutrophils.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2006 Jul"
                    },
                    "PMID:18401426": {
                      "sentence": "Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2008 Sep"
                    },
                    "PMID:18559512": {
                      "sentence": "CD-induced angiogenesis requires the proteolytic activation of MMP-9.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2008 Jun 15"
                    },
                    "PMID:18812315": {
                      "sentence": "In addition, urokinase-type plasminogen activator (uPA) and uPA receptor expression levels increased, and blocking the proteolytic activation of either MMP-9 or uPA inhibited the heparanase-induced increase in syndecan-1 shedding.",
                      "object score": 901,
                      "subject score": 694,
                      "publication date": "2008 Nov 21"
                    },
                    "PMID:19364840": {
                      "sentence": "Prior studies have shown that B. burgdorferi induces the host protease, matrix metalloproteinase 9 (MMP-9), and suggested that the induction of MMP-9 may allow the organism to disseminate and produce local tissue destruction.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2009 Jul"
                    },
                    "PMID:19923455": {
                      "sentence": "Thus, proteinase-induced MMP-9 expression by macrophages is dependent on the release of TNF-alpha, induction of COX-2 expression, and PGE(2) engagement of EP4.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2009 Dec 15"
                    },
                    "PMID:21544425": {
                      "sentence": "These results imply that enhanced secretion and proteolytic activation of MMP-2 and MMP-9 take place specifically in the esophageal carcinoma tissues.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1996 Apr"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1428": {
              "object": "CHEMBL.COMPOUND:CHEMBL1428",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1641": {
              "object": "CHEMBL.COMPOUND:CHEMBL1641",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:50949-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1709": {
              "object": "CHEMBL.COMPOUND:CHEMBL1709",
              "subject": "CHEBI:50949",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0162758---SEMMEDDB:interacts_with---UMLS:C0074393---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15856081",
                    "PMID:28386654",
                    "PMID:25506746",
                    "PMID:30768407",
                    "PMID:12126338",
                    "PMID:10817524",
                    "PMID:29349647",
                    "PMID:8540763",
                    "PMID:16466332",
                    "PMID:21697858",
                    "PMID:18403212"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8540763": {
                      "sentence": "Agents that putatively increase the serotoninergic activity facilitated the down-regulation of beta-adrenoceptors induced by sertraline, suggesting that the enhancement of serotonin transmission, expected of the selective serotonin reuptake inhibitor itself, may play a role in this effect of sertraline.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "1995"
                    },
                    "PMID:10817524": {
                      "sentence": "The authors studied the effect of sertraline, one of selective serotonin reuptake inhibitors (SSRIs), and pramipexole, administered jointly, to male Wistar rats in the forced swimming test.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "1999 Nov-Dec"
                    },
                    "PMID:12126338": {
                      "sentence": "OBJECTIVES: To study the effect of Sertraline, a selective serotonin reuptake inhibitor in chronic tension type headache (CTTH) in a double blind placebo controlled randomized trial.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2002 Jul"
                    },
                    "PMID:15856081": {
                      "sentence": "This study investigated the effects of sertraline, a selective serotonin reuptake inhibitor antidepressant, on corticolimbic connectivity, using functional magnetic resonance imaging (fMRI).",
                      "object score": 1000,
                      "subject score": 854,
                      "publication date": "2005 Jul"
                    },
                    "PMID:16466332": {
                      "sentence": "Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2006 Feb"
                    },
                    "PMID:18403212": {
                      "sentence": "To identify neuroprotective compound (s) that can slow down disease progression and can be administered long term with few side effects in Huntington's disease, we investigated the effect of sertraline, a selective serotonin reuptake inhibitor (SSRI) which has been shown to upregulate BDNF levels in rodent brains.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2008 Jun"
                    },
                    "PMID:21697858": {
                      "sentence": "To identify the effects of sertraline, a selective serotonin reuptake inhibitor, for the treatment of premature ejaculation (PE), changes in brain current-source density (CSD) of the high beta frequency band (22-30 Hz) induced by sertraline administration were investigated during audiovisual erotic stimulation.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2011 Sep-Oct"
                    },
                    "PMID:25506746": {
                      "sentence": "We investigated the transgenerational effects of sertraline, a selective serotonin reuptake inhibitor, and venlafaxine, a serotonin-norepinephrine reuptake inhibitor, on the life traits of Daphnia magna over two generations under environmentally realistic concentrations.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "2015 Jan 20"
                    },
                    "PMID:28386654": {
                      "sentence": "The purpose of this study was to evaluate the steroidogenic effects of sertraline, a popular selective serotonin reuptake inhibitor, on larval fathead minnow (FHM; Pimephales promelas) and adult FHM.",
                      "object score": 1000,
                      "subject score": 832,
                      "publication date": "2017 Jun"
                    },
                    "PMID:29349647": {
                      "sentence": "The general lack of effects of sertraline on snails' activity and other behaviours in this study is interesting considering that other SSRIs have been shown to induce changes in gastropod behaviour.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2018 Mar"
                    },
                    "PMID:30768407": {
                      "sentence": "This study explored the effects of sertraline, a selective serotonin reuptake inhibitor, on resting-state functional connectivity in cortico-striatal-thalamic-cortical circuits in pediatric OCD.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2019 May"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:located_in-CHEMBL.TARGET:CHEMBL376": {
              "object": "CHEMBL.TARGET:CHEMBL376",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:located_in",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:increases_activity_of-UniProtKB:P04150": {
              "object": "UniProtKB:P04150",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:increases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL635---DGIdb:agonist---NCBIGene:2908---DGIdb:",
                    "DrugCentral:2253---DrugCentral:agonist---UniProtKB:P04150---DrugCentral:",
                    "DRUGBANK:DB00635---DRUGBANK:agonist---UniProtKB:P04150---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16597193",
                    "PMID:17121036",
                    "PMID:15634032",
                    "PMID:16707595",
                    "PMID:17504182",
                    "PMID:11752352",
                    "PMID:17062674"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-RXNORM:72260": {
              "object": "RXNORM:72260",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:decreases_activity_of-UniProtKB:P30556": {
              "object": "UniProtKB:P30556",
              "subject": "CHEMBL.COMPOUND:CHEMBL995",
              "predicate": "biolink:decreases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00678---DRUGBANK:antagonist---UniProtKB:P30556---identifiers_org_registry:drugbank",
                    "CHEMBL.COMPOUND:CHEMBL995---DGIdb:antagonist---NCBIGene:185---DGIdb:",
                    "CHEMBL.COMPOUND:CHEMBL191---DGIdb:antagonist---NCBIGene:185---DGIdb:",
                    "DrugCentral:1610---DrugCentral:antagonist---UniProtKB:P30556---DrugCentral:",
                    "CHEMBL.COMPOUND:CHEMBL995---CHEMBL.MECHANISM:antagonist---CHEMBL.TARGET:CHEMBL227---identifiers_org_registry:chembl.compound"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12710529",
                    "PMID:12719755",
                    "PMID:15026875",
                    "PMID:15573751",
                    "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ac32c20-169d-475a-fc8a-934f758d6ab0",
                    "PMID:11752352",
                    "PMID:15991937"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:72260-biolink:entity_negatively_regulates_entity-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "RXNORM:72260",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P04637-biolink:entity_positively_regulates_entity-MESH:D009154": {
              "object": "MESH:D009154",
              "subject": "UniProtKB:P04637",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0079419---SEMMEDDB:augments---UMLS:C0026882---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:30948335",
                    "PMID:8632910",
                    "PMID:8649766",
                    "PMID:9816043",
                    "PMID:18256546",
                    "PMID:11906841",
                    "PMID:31088544",
                    "PMID:9508372",
                    "PMID:23533526",
                    "PMID:21643018",
                    "PMID:16696029",
                    "PMID:10467414"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8632910": {
                      "sentence": "Our results show that mutant p53 proteins are to some extent submitted to the control of the cellular environment in cancer cells with wild type p53 alleles, but with an efficacy that depends on the mutation.",
                      "object score": 1000,
                      "subject score": 833,
                      "publication date": "1996 Feb 15"
                    },
                    "PMID:8649766": {
                      "sentence": "We conclude, therefore, that p53(wt/mut) LFS cells contain an activity that promotes mutations.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jun 06"
                    },
                    "PMID:9508372": {
                      "sentence": "Our results suggest that chemotherapy-induced apoptosis in melanoma cells is p53 dependent, and mutation of the p53 gene is an indicator of drug resistance in melanoma.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Feb"
                    },
                    "PMID:9816043": {
                      "sentence": "Tumor-associated p53 mutations often show characteristic tissue-specific profiles which may infer environmentally induced mutational mechanisms.",
                      "object score": 853,
                      "subject score": 775,
                      "publication date": "1995 Jul"
                    },
                    "PMID:10467414": {
                      "sentence": "This suggests that the chemical mutagens produce, in a dose-dependent fashion, two kinds of DNA damage, one subject to p53-dependent mutation frequency reduction and the other not.",
                      "object score": 604,
                      "subject score": 604,
                      "publication date": "1999 Aug 19"
                    },
                    "PMID:11906841": {
                      "sentence": "However, studies that have examined the effect of p53 status on mutation in the adenine phosphoribosyl transferase (APRT) gene in transgenic mice also suggest that loss of p53 function results in an increase in mutation resulting from non-homologous recombination.",
                      "object score": 1000,
                      "subject score": 840,
                      "publication date": "2002 Mar"
                    },
                    "PMID:16696029": {
                      "sentence": "Aims-To determine possible associations between p53 allelic deletion, c-Ki-ras mutational activation, immunohistochemical detection of p53 and ras proteins, various clinicopathological variables, and patient outcome in 168 Dukes' stage B colorectal carcinomas.",
                      "object score": 595,
                      "subject score": 802,
                      "publication date": "1995 Dec"
                    },
                    "PMID:18256546": {
                      "sentence": "In agreement with computational predictions, the binding to phosphorylated p53 peptide, in comparison to the unphosphorylated p53 peptide, was enhanced upon mutation of 3 key residues on the MDM2 surface.",
                      "object score": 1000,
                      "subject score": 790,
                      "publication date": "2008 Mar 01"
                    },
                    "PMID:21643018": {
                      "sentence": "Genotoxic stresses (for example, ionizing and ultraviolet radiation or chemotherapeutic drug treatment) can activate p53, but also induce mutations in the P53 gene, and thus select for p53-mutated cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Nov 17"
                    },
                    "PMID:23533526": {
                      "sentence": "The antioxidant, EUK8, significantly decreased mitotic catastrophe by inhibiting ATM activation, ATF3 expression, and p53 phosphorylation.",
                      "object score": 728,
                      "subject score": 888,
                      "publication date": "2013"
                    },
                    "PMID:30948335": {
                      "sentence": "p53 isoforms can be differentially expressed depending on p53 mutational status.",
                      "object score": 828,
                      "subject score": 694,
                      "publication date": "2019 Sep"
                    },
                    "PMID:31088544": {
                      "sentence": "However, it is unclear whether p53 regulates expression or methylation of L1 differently depending on the mutational status of TP53.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "2019 05 14"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL46516": {
              "object": "CHEMBL.COMPOUND:CHEMBL46516",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-FMA:83365": {
              "object": "FMA:83365",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB14644---DRUGBANK:drug-interaction---DRUGBANK:DB00030---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB14644---DRUGBANK:drug-interaction---DRUGBANK:DB00071---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB14643---DRUGBANK:drug-interaction---DRUGBANK:DB00071---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB00959---DRUGBANK:drug-interaction---DRUGBANK:DB00071---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB00959---DRUGBANK:drug-interaction---DRUGBANK:DB00030---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB14643---DRUGBANK:drug-interaction---DRUGBANK:DB00030---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:increases_activity_of-UniProtKB:P04083": {
              "object": "UniProtKB:P04083",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:increases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00741---DRUGBANK:agonist---UniProtKB:P04083---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17139284",
                    "PMID:17016423",
                    "PMID:8060156",
                    "PMID:11142771",
                    "PMID:1712816"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:drugbank",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:increases_activity_of-UniProtKB:P08235": {
              "object": "UniProtKB:P08235",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:increases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL389621---DGIdb:agonist---NCBIGene:4306---DGIdb:",
                    "DrugCentral:1388---DrugCentral:agonist---UniProtKB:P08235---DrugCentral:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:physically_interacts_with-FMA:74644": {
              "object": "FMA:74644",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:235758-biolink:entity_negatively_regulates_entity-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "RXNORM:235758",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0085826-biolink:entity_negatively_regulates_entity-UniProtKB:Q9H244": {
              "object": "UniProtKB:Q9H244",
              "subject": "UMLS:C0085826",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0085826---SEMMEDDB:inhibits---NCBIGene:64805---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23966569",
                    "PMID:30646761",
                    "PMID:21068525",
                    "PMID:22724411",
                    "PMID:24885437",
                    "PMID:20089227",
                    "PMID:29398917",
                    "PMID:31055838",
                    "PMID:25440595",
                    "PMID:23467639",
                    "PMID:21068524",
                    "PMID:30395148",
                    "PMID:22057689",
                    "PMID:24142066",
                    "PMID:26311628",
                    "PMID:26120548",
                    "PMID:24793666",
                    "PMID:31662237"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:20089227": {
                      "sentence": "The aim of this manuscript is to provide an overview on the current status and future directions in P2Y12 receptor antagonism, with particular emphasis on interindividual variability in response to clopidogrel and strategies, including novel antiplatelet agents, to improve platelet P2Y12 inhibition.",
                      "object score": 802,
                      "subject score": 901,
                      "publication date": "2010 Jan"
                    },
                    "PMID:21068524": {
                      "sentence": "Novel oral antiplatelet agents in advanced clinical development include a direct and more readily reversible P2Y12 antagonist, ticagrelor, as well as a new class of PAR-1 antagonists, which includes vorapaxar and atopaxar.",
                      "object score": 575,
                      "subject score": 861,
                      "publication date": "2010 Nov"
                    },
                    "PMID:21068525": {
                      "sentence": "The present article reviews data on the clinical impact of enhanced P2Y12 inhibition with either higher clopidogrel dosing or new oral antiplatelet agents, including prasugrel and ticagrelor, in the setting of STEMI, focusing on results in the setting of primary PCI.",
                      "object score": 827,
                      "subject score": 861,
                      "publication date": "2010 Nov"
                    },
                    "PMID:22057689": {
                      "sentence": "The present review aims to provide a current appraisal of antiplatelet therapy use after ACS and to summarize available scientific evidence for an optimal use of antiplatelet agents in daily practice, including the new P2Y12 blockers.",
                      "object score": 660,
                      "subject score": 1000,
                      "publication date": "2012 Feb"
                    },
                    "PMID:22724411": {
                      "sentence": "As a result clopidogrel's long lasting monopole as the only antiplatelet agent in patients undergoing coronary stenting is currently challenged by the newer P2Y12 blockers such as prasugrel and ticagrelor, which provide a stronger and more consistent inhibition of platelets.",
                      "object score": 627,
                      "subject score": 901,
                      "publication date": "2012"
                    },
                    "PMID:23467639": {
                      "sentence": "Studies of aspirin, P2Y12 inhibitors and other antiplatelet drugs clearly demonstrate how inhibition of platelet function increases bleeding risk.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2013 May"
                    },
                    "PMID:23966569": {
                      "sentence": "Antiplatelet agents, including thienopyridines and the new P2Y12 inhibitors, have been shown to improve survival in the secondary prevention setting.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "2014 Jul"
                    },
                    "PMID:24142066": {
                      "sentence": "Thienopyridines are a class of antiplatelet drugs that are metabolized in the liver to several metabolites, of which only one active metabolite can irreversibly antagonize the platelet P2Y12 receptor.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "2014 Feb"
                    },
                    "PMID:24793666": {
                      "sentence": "Platelet reactivity variability before P2Y12 blockade and its evolution over time, genetic predisposition, antiplatelet agent used, timing, and method of platelet function testing significantly affect the rates of high on-treatment platelet reactivity.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jun 15"
                    },
                    "PMID:24885437": {
                      "sentence": "A novel antiplatelet agent, ticagrelor, is a non-thienopyridine, direct P2Y12 blocker that has shown greater, more rapid and more consistent platelet inhibition than clopidogrel.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2014 May 01"
                    },
                    "PMID:25440595": {
                      "sentence": "We provide an evidence-based review on the pharmacological and clinical performance of clopidogrel and novel antiplatelet agents that antagonize P2Y12 receptors.",
                      "object score": 861,
                      "subject score": 901,
                      "publication date": "2015"
                    },
                    "PMID:26120548": {
                      "sentence": "The present overview discusses the currently known hypersensitivity reactions to anticoagulant and antiplatelet agents, with particular attention to the newer substance classes including P2Y12 inhibitors, glycoprotein IIb/IIIb receptor antagonists, direct factor Xa inhibitors and direct thrombin inhibitors.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2015"
                    },
                    "PMID:26311628": {
                      "sentence": "AIMS: We aim to evaluate whether ticagrelor, a potent antiplatelet agent that blocks the P2Y12 receptor without requiring metabolic activation, reduces the risk of major vascular events compared with aspirin when randomization occurs within 24 h after symptom onset of a nonsevere ischemic stroke or high-risk transient ischemic attack.",
                      "object score": 861,
                      "subject score": 867,
                      "publication date": "2015 Dec"
                    },
                    "PMID:29398917": {
                      "sentence": "A P2Y12 receptor antagonist, ticagrelor, is unique among antiplatelet drugs, because ticagrelor inhibits the platelet P2Y12 receptor in a reversible manner, and because it demonstrates a wide palette of advantageous pleiotropic effects associated with the increased concentration of adenosine.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "2018"
                    },
                    "PMID:30395148": {
                      "sentence": "Objectives: To review the use of laboratory tests for antiplatelet agents to determine escalation of antiplatelet therapy and for emergent reversal of P2Y12 inhibitors.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2018 Nov 03"
                    },
                    "PMID:30646761": {
                      "sentence": "OBJECTIVE: To review the efficacy and safety of perioperative administration of intravenous (IV) antiplatelet agents as a substitute for oral P2Y12 inhibitors and to provide clinicians guidance on optimal and cost-effective use of these medications.",
                      "object score": 802,
                      "subject score": 901,
                      "publication date": "2019 Jul"
                    },
                    "PMID:31055838": {
                      "sentence": "It has been shown that TH can alter the effectiveness of antiplatelet agents, including P2Y12 inhibitors, through multiple mechanisms, hence, special attention should be paid while implementing antiplatelet therapy in patients under TH conditions.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2019 Nov"
                    },
                    "PMID:31662237": {
                      "sentence": "Ticagrelor is an antiplatelet agent used for treatment of coronary artery disease via inhibition of the P2Y12 receptor.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2019 Oct 26"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0597357-biolink:entity_positively_regulates_entity-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "UMLS:C0597357",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0597357---SEMMEDDB:stimulates---NCBIGene:1950---SEMMEDDB:",
                    "UMLS:C0597357---SEMMEDDB:stimulates---UMLS:C0242275---SEMMEDDB:",
                    "UMLS:C0597357---SEMMEDDB:stimulates---UMLS:C1367721---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15228094",
                    "PMID:2783883",
                    "PMID:8578218",
                    "PMID:28791635",
                    "PMID:3001110",
                    "PMID:20181835",
                    "PMID:30803944",
                    "PMID:27426127",
                    "PMID:30794990",
                    "PMID:21448670",
                    "PMID:10075741",
                    "PMID:12373311"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2783883": {
                      "sentence": "The autophosphorylation activity of both receptors was stimulated by addition of EGF to isolated membrane preparations and intact cells, although the EGF receptor of the 1483 cells was much less responsive to EGF than the receptor from 183A cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Mar 01"
                    },
                    "PMID:3001110": {
                      "sentence": "On EGF stimulation, the receptor undergoes a self-phosphorylation reaction at tyrosine residues located primarily in the extreme carboxyl-terminal region of the protein.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "1985"
                    },
                    "PMID:8578218": {
                      "sentence": "In the most recent studies, we demonstrated that treatment with sucralfate activates genes for EGF, bFGF, and their receptors, significantly increasing (vs placebo and omeprazole) expression of EGF and its receptor in ulcerated gastric mucosa.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995"
                    },
                    "PMID:10075741": {
                      "sentence": "Here we provide evidence that association between c-Src and EGFR can occur directly, as shown by receptor overlay experiments, and that it results in the appearance of two novel tyrosine phosphorylations on the receptor that are seen both in vitro and in vivo following EGF stimulation.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1999 Mar 19"
                    },
                    "PMID:12373311": {
                      "sentence": "This observation could be explained by the fact that the PLCgamma1 association sites in the EGFR, tyrosine residues 992 and 1173, were phosphorylated to a lower degree when the receptor was stimulated with EGF-dextran as compared to with EGF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Nov"
                    },
                    "PMID:15228094": {
                      "sentence": "This demonstrates that the induction of the EGF system is mediated by an increased expression of a subset of the ligands, whereas the four receptors are reduced.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2004 May"
                    },
                    "PMID:20181835": {
                      "sentence": "Although both TGF-alpha and EGF were able to induce EGFR internalization and phosphorylation, only those receptors that were stimulated with EGF progressed to lysosomal degradation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Jul"
                    },
                    "PMID:21448670": {
                      "sentence": "Growth factors genes Egf, Fgf, Pdgf, and Vegf associated with tumour angiogenesis had significantly lower expression following treatment with anti-lymphoma effective IDN5109 and their receptors were unaffected, whereas inefficient IDN5390 increased expression of the most important Vegf.",
                      "object score": 660,
                      "subject score": 1000,
                      "publication date": "2012 Jun"
                    },
                    "PMID:27426127": {
                      "sentence": "Physiologically, these receptors are activated by the ligands of the EGF family.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2016"
                    },
                    "PMID:28791635": {
                      "sentence": "Ubiquitination of the epidermal growth factor receptor (EGFR) is an important intracellular signal that occurs upon EGF stimulation and controls EGFR trafficking at multiple steps, finally destining the receptor to lysosomal degradation.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2017"
                    },
                    "PMID:30794990": {
                      "sentence": "(1) In contrast to the rapid diffusion of activated EGF receptor after the soluble EGF stimulation, the receptor is confined within membrane rafts upon binding to the EGF-GNPs.",
                      "object score": 854,
                      "subject score": 1000,
                      "publication date": "2019 04 01"
                    },
                    "PMID:30803944": {
                      "sentence": "Current studies suggest that LH binds on to its receptor on granulosa cells of the follicular wall to promote the production of EGF-like factors, which activate various signaling cascades and induce oocyte maturation and development.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Feb 20"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UMLS:C0597357-biolink:entity_positively_regulates_entity-UniProtKB:Q15796": {
              "object": "UniProtKB:Q15796",
              "subject": "UMLS:C0597357",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0597357---SEMMEDDB:stimulates---UMLS:C1334468---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9215638",
                    "PMID:18471442",
                    "PMID:21437904",
                    "PMID:25998442",
                    "PMID:18729074",
                    "PMID:24485922",
                    "PMID:17276343",
                    "PMID:19172185",
                    "PMID:20430497",
                    "PMID:25564677",
                    "PMID:9389648",
                    "PMID:15087470"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9215638": {
                      "sentence": "Smad7 interacts stably with the activated TGFbeta type I receptor, thereby blocking the association, phosphorylation, and activation of Smad2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Jun 27"
                    },
                    "PMID:9389648": {
                      "sentence": "Receptor-activated Smad2 takes Smad4 into the nucleus where they form a complex with FAST-1 that requires these three components to activate transcription.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "1997 Dec 01"
                    },
                    "PMID:15087470": {
                      "sentence": "Activated by type II receptors, the type I receptor phosphorylates, thereby activating its effectors Smad2 and Smad3.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2004 Jul"
                    },
                    "PMID:17276343": {
                      "sentence": "Our results reveal that kinesin-mediated transport of Smad2 along microtubules to the receptors is an essential step in ligand-induced Smad2 activation.",
                      "object score": 608,
                      "subject score": 1000,
                      "publication date": "2007 Feb"
                    },
                    "PMID:18471442": {
                      "sentence": "These results suggest that receptor-activated Smad2 and Smad3 and co-Smad4 critically mediate TGF-beta-stimulated TIMP-3 expression in human chondrocytes and TIMP-3 gene is a target of Smad signaling pathway.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "2008 Sep"
                    },
                    "PMID:18729074": {
                      "sentence": "TGF-beta1 signals through the TGF-beta type I and type II receptors, and activates the Smad pathway via phosphorylation of Smad2 and Smad3.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2008 Oct 01"
                    },
                    "PMID:19172185": {
                      "sentence": "Smad2 and Smad3 are effectors of the Nodal/Activin branch of TGFbeta signalling: they are activated by receptors, enter the nucleus and directly transcribe target genes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009"
                    },
                    "PMID:20430497": {
                      "sentence": "In comparison to hemodialysis patients and healthy participants, we found increased messenger RNA levels for TGF-beta, the profibrotic receptor-activated SMAD2 and SMAD3, CTGF, and TIMP-1 in NSF and systemic sclerosis lesions.",
                      "object score": 764,
                      "subject score": 764,
                      "publication date": "2010 Jun"
                    },
                    "PMID:21437904": {
                      "sentence": "Here we demonstrate that TGF-beta1 is able to downregulate LPS-induced HO-1 in mouse macrophages, and this reduction in HO-1 occurred through signaling of TGF-beta1 via its type I receptor, and activation of Smad2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jan"
                    },
                    "PMID:24485922": {
                      "sentence": "Transforming growth factor-beta (TGF-beta) promotes tissue fibrosis via receptor-mediated phosphorylation of the receptor-activated Smad2/3, together with Smad4.",
                      "object score": 764,
                      "subject score": 764,
                      "publication date": "2014 Apr"
                    },
                    "PMID:25564677": {
                      "sentence": "Upon binding TGF-beta, the type I receptor (TGFBRI) binds TGFBRII, leading to the activation of the transcription factors SMAD2 and SMAD3.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2015 Jan 06"
                    },
                    "PMID:25998442": {
                      "sentence": "This phosphorylation primes receptor-activated Smad2/3 for recruitment of the E3 ubiquitin ligase Nedd4L, which in turn leads to their degradation.",
                      "object score": 764,
                      "subject score": 764,
                      "publication date": "2015 May 22"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-UniProtKB:P08684": {
              "object": "UniProtKB:P08684",
              "subject": "VANDF:4021566",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:inhibits---UMLS:C1142644---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19007592",
                    "PMID:26765458",
                    "PMID:21834799",
                    "PMID:19687016",
                    "PMID:30865134",
                    "PMID:11145223",
                    "PMID:20352154",
                    "PMID:12875231",
                    "PMID:23400261",
                    "PMID:11550401"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:11145223": {
                      "sentence": "PURPOSE: Recently, we clarified the inhibitory effects of 13 kinds of 1,4-dihydropyridine calcium antagonists on human cytochrome P450 (CYP) 3A4.",
                      "object score": 928,
                      "subject score": 813,
                      "publication date": "2000 Oct"
                    },
                    "PMID:11550401": {
                      "sentence": "Calcium channel blockers are weak inhibitors of the CYP3A4 enzyme.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2001 Sep"
                    },
                    "PMID:12875231": {
                      "sentence": "Azole antifungals, macrolide antibiotics, calcium antagonists and grapefruit juice inhibit CYP3A4 activity, while antiepileptics and rifampicin induce the activity.",
                      "object score": 888,
                      "subject score": 983,
                      "publication date": "2003"
                    },
                    "PMID:19007592": {
                      "sentence": "OBJECTIVES: Because of the known CYP3A4 inhibition by calcium-channel blockers (CCBs), we hypothesized that there might be a drug-drug interaction between clopidogrel and dihydropyridines in patients with coronary artery disease.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2008 Nov 04"
                    },
                    "PMID:19687016": {
                      "sentence": "Dihydropyridine calcium-channel blockers (CCBs) inhibit the cytochrome P450 3A4 enzyme, which metabolises clopidogrel to its active form.",
                      "object score": 928,
                      "subject score": 916,
                      "publication date": "2010 Feb"
                    },
                    "PMID:20352154": {
                      "sentence": "As calcium channel blockers (CCBs) are inhibitors of CYP3A4, concomitant use of these drugs might play a role in the wide inter-individual variability in the response to clopidogrel.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 May"
                    },
                    "PMID:21834799": {
                      "sentence": "BACKGROUND: The CYP3A4 inhibition by calcium channel blockers (CCBs) may attenuate the effectiveness of clopidogrel.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2012 Mar"
                    },
                    "PMID:23400261": {
                      "sentence": "BACKGROUND: Calcium-channel blockers (CCBs) inhibit the CYP3A4 enzyme, which is involved in clopidogrel activation.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:26765458": {
                      "sentence": "Therefore, it is important to take into account the potential adverse events while coprescribing CYP3A4-metabolized statins and CCBs that inhibit CYP3A4.",
                      "object score": 988,
                      "subject score": 1000,
                      "publication date": "2016 Jan"
                    },
                    "PMID:30865134": {
                      "sentence": "Treatments include ACE inhibitors, calcium channel blockers (avoiding verapamil and diltiazem, which are CYP3A4 inhibitors), and beta blockers.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2019 May"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL160": {
              "object": "CHEMBL.COMPOUND:CHEMBL160",
              "subject": "VANDF:4021566",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:interacts_with---UMLS:C0010592---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:2236731",
                    "PMID:2208899",
                    "PMID:15171009",
                    "PMID:8348391",
                    "PMID:9403215",
                    "PMID:7849332",
                    "PMID:12671294",
                    "PMID:14621737",
                    "PMID:10994829",
                    "PMID:10023642",
                    "PMID:3063481"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2208899": {
                      "sentence": "Two calcium channel blockers which have not been reported to interact with cyclosporin are nifedipine and nitrendipine.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "1990 Oct"
                    },
                    "PMID:2236731": {
                      "sentence": "The effect of calcium channel blockers on the cyclosporine dose requirement in renal transplant recipients.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:3063481": {
                      "sentence": "The interaction between cyclosporine and the calcium-channel blocking agents along with a possible nephroprotective effect of the calcium-channel blocking agents when used with cyclosporine are discussed.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988 Sep"
                    },
                    "PMID:7849332": {
                      "sentence": "Further work is needed to determine the effect of CCBs on cyclosporine pharmacokinetics, especially with respect to their metabolism by gut and hepatic cytochrome P-450 enzymes, and their effect on patient outcome.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1994 Nov"
                    },
                    "PMID:8348391": {
                      "sentence": "Cyclosporine pharmacokinetics were not affected by either calcium antagonist to a clinically significant extent.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "1993 Jun"
                    },
                    "PMID:9403215": {
                      "sentence": "This study was undertaken to see if the calcium channel blocker, isradipine, could improve renal hemodynamics by decreasing renal vascular resistance and to determine its effects on cyclosporine pharmacokinetics.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997 Nov"
                    },
                    "PMID:10023642": {
                      "sentence": "We examined the effect of different doses of calcium channel blockers on plasma cyclosporine levels.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1999 Feb"
                    },
                    "PMID:10994829": {
                      "sentence": "Most notable are its effects on cyclosporine, some 1,4-dihydropyridine calcium antagonists, and some 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.",
                      "object score": 1000,
                      "subject score": 813,
                      "publication date": "2000 Sep"
                    },
                    "PMID:12671294": {
                      "sentence": "In addition, we examined the effect of cyclosporin A and Nimodipine, a calcium channel blocker, on survival of adult motoneurons following hypoglossal nerve avulsion.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:14621737": {
                      "sentence": "To investigate the effect of oral nifedipine, a calcium channel blocker known not to modify cyclosporin A (CyA) pharmacokinetics, on immediate transplant function and CyA nephrotoxicity, 68 adult renal transplant recipients were pre-operatively randomized to one of three regimes: A (high-dose CyA, initial dose 17 mg/kg per day, maintenance dose 7 mg/kg per day); B (regime A plus oral nifedipine); C low-dose CyA, initial dose 10 mg/kg per day, maintenance 4 mg/kg per day plus azathioprine 1 mg/kg per day).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992"
                    },
                    "PMID:15171009": {
                      "sentence": "The influence of CsA dosage and its trough level, HLA phenotype, gender and the administered calcium channel blocker on incidence and severity of overgrowth were studied.",
                      "object score": 901,
                      "subject score": 923,
                      "publication date": "2003"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL405110": {
              "object": "CHEMBL.COMPOUND:CHEMBL405110",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35674-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL408403": {
              "object": "CHEMBL.COMPOUND:CHEMBL408403",
              "subject": "CHEBI:35674",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003364---SEMMEDDB:interacts_with---UMLS:C0003009---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11022902",
                    "PMID:20488233",
                    "PMID:6997332",
                    "PMID:10361427",
                    "PMID:3020439",
                    "PMID:25556973",
                    "PMID:8542682",
                    "PMID:9797176",
                    "PMID:12462282",
                    "PMID:30481537"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:3020439": {
                      "sentence": "Interactions of MEN 935 (adimolol), a long acting beta- and alpha-adrenolytic antihypertensive agent, with postsynaptic alpha-adrenoceptors in different isolated blood vessels--influence of angiotensin II.",
                      "object score": 1000,
                      "subject score": 852,
                      "publication date": "1986 Jul"
                    },
                    "PMID:6997332": {
                      "sentence": "Captopril is a potent hypotensive agent whose efficacy has hitherto been attributed to its ability to alter either angiotensin II formation or kinin degradation.",
                      "object score": 824,
                      "subject score": 867,
                      "publication date": "1980 Jun"
                    },
                    "PMID:8542682": {
                      "sentence": "Effect of an antihypertensive drug on brain angiotensin II levels in renal and spontaneously hypertensive rats.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1995 Sep"
                    },
                    "PMID:9797176": {
                      "sentence": "CONCLUSIONS: ZD7155 is a potent antihypertensive agent in two-kidney, one-clip Goldblatt hypertensive rats and this effect is accompanied by sustained inhibition of tissue angiotensin II binding.",
                      "object score": 694,
                      "subject score": 867,
                      "publication date": "1998 May"
                    },
                    "PMID:10361427": {
                      "sentence": "Angiotensin II receptor antagonists are a new class of anti-hypertensive drugs that provide a specific blockade of the effects of angiotensin II.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 May"
                    },
                    "PMID:11022902": {
                      "sentence": "Although administration of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II antagonists lead to functional loss of glomerular filtration rate (GFR) beyond a stenotic lesion because of the removal of efferent actions of angiotensin II, other antihypertensive agents reduce renal perfusion also.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Sep"
                    },
                    "PMID:12462282": {
                      "sentence": "BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II (ATII)-receptor antagonists suppress the effects of ATII and are effective antihypertensive agents.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2002 Oct"
                    },
                    "PMID:20488233": {
                      "sentence": "AIM OF THE STUDY: The high prevalence of this illness and the side effects of antihypertensive drugs conducted us to the evaluation of the Salvia elegans extract on angiotensin II action.",
                      "object score": 734,
                      "subject score": 1000,
                      "publication date": "2010 Jul 20"
                    },
                    "PMID:25556973": {
                      "sentence": "Clinical studies of large human populations and pharmacological interventions in rodent models have recently suggested that anti-hypertensive drugs that target angiotensin II (Ang II) activity may also reduce loss of bone mineral density.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2015 Jul"
                    },
                    "PMID:30481537": {
                      "sentence": "Several natural and synthetic peptides are being used as antihypertensive agents, which target angiotensin converting enzyme (ACE), the master regulator of angiotensin (Ang) II production.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2018 Nov 24"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1428": {
              "object": "CHEMBL.COMPOUND:CHEMBL1428",
              "subject": "VANDF:4021566",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:interacts_with---UMLS:C0028094---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:2911839",
                    "PMID:10368871",
                    "PMID:11900774",
                    "PMID:12671294",
                    "PMID:3951256",
                    "PMID:10208366",
                    "PMID:4010872",
                    "PMID:4083464",
                    "PMID:3147476",
                    "PMID:1533936",
                    "PMID:6891592",
                    "PMID:1311493",
                    "PMID:6951113",
                    "PMID:3146899",
                    "PMID:2812040",
                    "PMID:23716891",
                    "PMID:6631515",
                    "PMID:15123017",
                    "PMID:1296669",
                    "PMID:1839931"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1296669": {
                      "sentence": "The effects of nimodipine, a 1,4-dihydropyridine calcium channel blocker, on multiunit activity (MUA) of several brain structures were investigated in cats during 6 h immediately following acute global cerebral ischemia-anoxia induced by a 10 min cardiorespiratory arrest (CRA), as well as in cats exposed to sham procedures corresponding to CRA.",
                      "object score": 1000,
                      "subject score": 854,
                      "publication date": "1992"
                    },
                    "PMID:1311493": {
                      "sentence": "The interaction between nimodipine, a calcium channel blocker, used for the treatment of subarachnoid haemorrhage, and atracurium, was studied in rabbits.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Jan"
                    },
                    "PMID:1533936": {
                      "sentence": "The effect of isradipine and nimodipine, two dihydropyridine calcium antagonists, on intravenous self-administration of cocaine and morphine in naive mice has been investigated.",
                      "object score": 1000,
                      "subject score": 852,
                      "publication date": "1992 Mar"
                    },
                    "PMID:1839931": {
                      "sentence": "The study was undertaken to examine the effect of nimodipine, calcium channels blocker, on the morphological alterations induced by quinolinic acid (QUIN).",
                      "object score": 1000,
                      "subject score": 988,
                      "publication date": "1991"
                    },
                    "PMID:2812040": {
                      "sentence": "Comparison of the effects of cromakalim, a potassium conductance enhancer, and nimodipine, a calcium antagonist, on 5-hydroxytryptamine responses in a variety of vascular smooth muscle preparations.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Sep"
                    },
                    "PMID:2911839": {
                      "sentence": "We examine the effect of nilvadipine, a new calcium channel blocker, on protein degradation in gerbil brains after 5 minutes of bilateral carotid artery occlusion and compare this effect with those of nimodipine and nicardipine.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "1989 Jan"
                    },
                    "PMID:3146899": {
                      "sentence": "Haemodynamic, respiratory, metabolic and endocrine investigations were performed in a total number of 124 patients, divided into four different groups, during opiate anaesthesia for neurosurgical operations in order to characterize general effects of nimodipine, a calcium channel blocking agent with a preferential cerebrovascular action.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988"
                    },
                    "PMID:3147476": {
                      "sentence": "The present study examined the influence of nimodipine, a calcium channel blocker, on the DS properties of AMP.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988"
                    },
                    "PMID:3951256": {
                      "sentence": "We report herein the influence of nimodipine, a selective central nervous system calcium channel blocker, in 60 rabbits with seizures that had been induced through ischemia, postischemia reperfusion, pentylenetetrazol, and bicuculline.",
                      "object score": 1000,
                      "subject score": 843,
                      "publication date": "1986 Apr"
                    },
                    "PMID:4010872": {
                      "sentence": "The effects of nimodipine, a calcium antagonist with preferential cerebrovascular activity, on the global and regional cerebral blood flow (CBF and rCBF), the intracranial pressure (ICP), and the cerebral perfusion pressure (CPP), were investigated in an acute study.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1985 May"
                    },
                    "PMID:4083464": {
                      "sentence": "In order to ascertain the effect of nimodipine, a new strong acting calcium channel blocker on plasma levels of various stress hormones twenty patients undergoing cardiovascular surgery where investigated in two groups.",
                      "object score": 1000,
                      "subject score": 804,
                      "publication date": "1985 Sep"
                    },
                    "PMID:6631515": {
                      "sentence": "In contrast, the calcium antagonists, verapamil and diltiazem, had complex interactions with 3H-nimodipine binding.",
                      "object score": 623,
                      "subject score": 983,
                      "publication date": "1983 Dec"
                    },
                    "PMID:6891592": {
                      "sentence": "Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1982"
                    },
                    "PMID:6951113": {
                      "sentence": "Because calcium antagonists may have specific blocking actions, whereas the origin of vasospasm is likely to be multiplex, the effect of nimodipine on the contractions of isolated canine basilar arteries that are produced by serotonin, prostaglandin F2 alpha, thrombin, and whole blood was studied.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1982 Mar"
                    },
                    "PMID:8875596": {
                      "sentence": "The purpose of this study was to determine the effects of nimodipine, a calcium antagonist, on regional cerebral blood flow (CBF) in experimental subarachnoid hemorrhage (SAH) rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jul"
                    },
                    "PMID:9203010": {
                      "sentence": "An additional five male subjects (age 26-36) participated in an auditory P3 study of the effects of nimodipine, a calcium channel blocker, on brain electrical activity.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Jun"
                    },
                    "PMID:9231349": {
                      "sentence": "The effect of nimodipine, a vasoactive calcium antagonist, on the disappearance of soman from blood was studied in anaesthetized rabbits intoxicated with soman (10.8 micrograms kg-1 i.v.).",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1997 Mar"
                    },
                    "PMID:9682816": {
                      "sentence": "The effects of nimodipine, a calcium channel blocker, on noise-induced hearing loss were examined in gerbils.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jul"
                    },
                    "PMID:9689485": {
                      "sentence": "We studied the antiepileptic effects of nimodipine and two novel dihydropyridines, a calcium antagonist (PCA 50922) and a calcium agonist (PCA 50941), on pentylenetetrazole seizure and maximal electroshock seizure (MES) in mice.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jun 15"
                    },
                    "PMID:10368871": {
                      "sentence": "Since sex related differences are a common feature in the pharmacological properties of several centrally active drugs, the authors decided to investigate the effects of verapamil (VER), flunarizine (FLU) and nimodipine (NIM), three pharmacologically different CCBs, on neuroleptic-induced catalepsy in male and female albino mice.",
                      "object score": 1000,
                      "subject score": 793,
                      "publication date": "1999 Feb"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1200382": {
              "object": "CHEMBL.COMPOUND:CHEMBL1200382",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1256940": {
              "object": "CHEMBL.COMPOUND:CHEMBL1256940",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1697788": {
              "object": "CHEMBL.COMPOUND:CHEMBL1697788",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:ATC:A10AB05-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL3989410": {
              "object": "CHEMBL.COMPOUND:CHEMBL3989410",
              "subject": "ATC:A10AB05",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:50949-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1201082": {
              "object": "CHEMBL.COMPOUND:CHEMBL1201082",
              "subject": "CHEBI:50949",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0162758---SEMMEDDB:interacts_with---UMLS:C0733380---SEMMEDDB:",
                    "UMLS:C0162758---SEMMEDDB:interacts_with---UMLS:C0016365---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15203297",
                    "PMID:9165497",
                    "PMID:16531634",
                    "PMID:1805294",
                    "PMID:20716970",
                    "PMID:24353997",
                    "PMID:24952232",
                    "PMID:18666329",
                    "PMID:11595211",
                    "PMID:27379928",
                    "PMID:2328557",
                    "PMID:18469543",
                    "PMID:9043962",
                    "PMID:18765858",
                    "PMID:1495689",
                    "PMID:18187934",
                    "PMID:15698887",
                    "PMID:22441536",
                    "PMID:10235690",
                    "PMID:7480536"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2328557": {
                      "sentence": "The effects of fluoxetine, a relatively selective long-acting serotonin uptake inhibitor, on the consumption of alcoholic and nonalcoholic drinks, cigarette smoking, and body weight were assessed in 29 men who were early stage problem drinkers.",
                      "object score": 1000,
                      "subject score": 782,
                      "publication date": "1990 Apr"
                    },
                    "PMID:3874037": {
                      "sentence": "The effects of fluoxetine, a specific serotonin reuptake inhibitor, on the psychomotor performance, physiologic response, and kinetic disposition of ethanol were examined.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "1985 Jun"
                    },
                    "PMID:6413229": {
                      "sentence": "Effect of fluoxetine, a serotonin reuptake inhibitor, on the pituitary-thyroid axis in rat.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1983 Jul 22"
                    },
                    "PMID:7480536": {
                      "sentence": "In order to evaluate further the possibility that the MDTB may represent an effective animal model of panic attacks, the present study investigated the behavioral effect of imipramine and fluoxetine, two serotonin reuptake inhibitors (SRIs) known to alleviate panic symptoms when given on a repeated basis.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "1995 Jul"
                    },
                    "PMID:8665662": {
                      "sentence": "By comparing the effects of fluoxetine, a serotonin uptake inhibitor, and GBR12909, a dopamine uptake inhibitor, to the effects of cocaine, the contributions of these pharmacologic actions to the neurochemical effects of cocaine were determined.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Sep 29"
                    },
                    "PMID:9165497": {
                      "sentence": "The present study examined the effect of fluoxetine, a selective serotonin reuptake inhibitor (SSRI) known to be a clinically effective antidepressant, on basal and stress-induced norepinephrine (NE) release.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "1997 Jun"
                    },
                    "PMID:9711461": {
                      "sentence": "Recent clinical studies have reported a beneficial effect of fluoxetine, a serotonin reuptake inhibitor, in patients with severe refractory orthostatic hypotension.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:9756980": {
                      "sentence": "Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "1998 Oct"
                    },
                    "PMID:10095039": {
                      "sentence": "We studied the effect of fluoxetine, a selective serotonin reuptake inhibitor, in the development and lesion-induced plasticity of retinotectal axons in pigmented rats.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "1999 Apr 03"
                    },
                    "PMID:10235690": {
                      "sentence": "A meta-analysis of 20 short term comparative studies of 5 selective serotonin reuptake inhibitors (SSRIs; citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline) has shown no difference in efficacy between individual compounds but a slower onset of action of fluoxetine.",
                      "object score": 1000,
                      "subject score": 850,
                      "publication date": "1999 Apr"
                    },
                    "PMID:11595211": {
                      "sentence": "On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2001 Oct 12"
                    },
                    "PMID:12044798": {
                      "sentence": "To test for the contribution of the 5-HT(1B) receptor subtype in mediating the effects of fluoxetine, a selective serotonin reuptake inhibitor (SSRI), we used intracerebral in vivo microdialysis in awake, freely moving 5-HT(1B) receptor knock-out mice.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2002 May 17"
                    },
                    "PMID:12907793": {
                      "sentence": "Serotonin 1A receptor null mice were insensitive to the neurogenic and behavioral effects of fluoxetine, a serotonin selective reuptake inhibitor.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2003 Aug 08"
                    },
                    "PMID:15496293": {
                      "sentence": "Since locus coeruleus dysfunction has been involved in different types of anxiety disorders and considering the modulating action of serotonergic transmission on locus coeruleus activity, we assessed the effect of fluoxetine, a selective serotonin reuptake inhibitor (SSRI), on locus coeruleus activity as measured by the firing rate and the number of spontaneously active cells/track.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2004 Oct 25"
                    },
                    "PMID:15698887": {
                      "sentence": "The present study evaluated the effect of risperidone, an atypical neuroleptic, and fluoxetine, a selective serotonin reuptake inhibitor, on histological and functional outcome after experimental stroke in aged rats, which might be more vulnerable to brain insults.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2005 Mar 30"
                    },
                    "PMID:16531634": {
                      "sentence": "The present study was designed to investigate the effects of fluoxetine (FXT), a selective serotonin reuptake inhibitor, on the effect of antiepileptic drugs (AEDs) in the maximal electroshock seizure (MES) model in mice.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2006"
                    },
                    "PMID:18765858": {
                      "sentence": "We investigated the effects of fluoxetine, a selective serotonin reuptake inhibitor, on neuroendocrine function and the reproductive axis in female goldfish.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2008 Nov 12"
                    },
                    "PMID:23962390": {
                      "sentence": "We performed an open-label study to investigate the effects of fluoxetine, a selective serotonin reuptake inhibitor, on mini-mental state examination (MMSE) score and serum BDNF level in VaD patients.",
                      "object score": 1000,
                      "subject score": 923,
                      "publication date": "2013 Aug 19"
                    },
                    "PMID:24952232": {
                      "sentence": "In this study, we assessed the effects of fluoxetine, a selective serotonin reuptake inhibitor antidepressant, on adult animals exposed to arsenic during development.",
                      "object score": 1000,
                      "subject score": 854,
                      "publication date": "2014 Sep"
                    },
                    "PMID:28684088": {
                      "sentence": "In this study, the interaction of fluoxetine, a well-known selective serotonin reuptake inhibitor antidepressant and lipid bilayers composed of 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) was studied from the aspect of electrostatics using second derivative spectrophotometry and Fourier transform infrared spectroscopy (FTIR) in order to provide insights into the drug behavior.",
                      "object score": 1000,
                      "subject score": 786,
                      "publication date": "2017 10"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:physically_interacts_with-CHEBI:33699": {
              "object": "CHEBI:33699",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:same_as-CHEMBL.COMPOUND:CHEMBL1322218": {
              "object": "CHEMBL.COMPOUND:CHEMBL1322218",
              "subject": "CHEMBL.COMPOUND:CHEMBL3249705",
              "predicate": "biolink:same_as",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:increases_activity_of-UniProtKB:P30556": {
              "object": "UniProtKB:P30556",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:increases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DrugCentral:5272---DrugCentral:agonist---UniProtKB:P30556---DrugCentral:",
                    "CHEMBL.COMPOUND:CHEMBL3989932---CHEMBL.MECHANISM:agonist---CHEMBL.TARGET:CHEMBL227---identifiers_org_registry:chembl.compound",
                    "DRUGBANK:DB11842---DRUGBANK:agonist---UniProtKB:P30556---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209360s000lbl.pdf"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:increases_activity_of-UniProtKB:P50052": {
              "object": "UniProtKB:P50052",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:increases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DrugCentral:5272---DrugCentral:agonist---UniProtKB:P50052---DrugCentral:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1200382-biolink:decreases_activity_of-UniProtKB:P51787": {
              "object": "UniProtKB:P51787",
              "subject": "CHEMBL.COMPOUND:CHEMBL1200382",
              "predicate": "biolink:decreases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:increases_activity_of-UniProtKB:P04083": {
              "object": "UniProtKB:P04083",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:increases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00959---DRUGBANK:agonist---UniProtKB:P04083---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-RXNORM:72260": {
              "object": "RXNORM:72260",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201365-biolink:decreases_activity_of-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201365",
              "predicate": "biolink:decreases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL1168---DGIdb:inhibitor---NCBIGene:1636---DGIdb:",
                    "CHEMBL.COMPOUND:CHEMBL1201365---DGIdb:inhibitor---NCBIGene:1636---DGIdb:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1697788-biolink:decreases_activity_of-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "CHEMBL.COMPOUND:CHEMBL1697788",
              "predicate": "biolink:decreases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2367706-biolink:increases_activity_of-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "CHEMBL.COMPOUND:CHEMBL2367706",
              "predicate": "biolink:increases_activity_of",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00364---DRUGBANK:inducer---UniProtKB:P01133---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8578218",
                    "PMID:1957124",
                    "PMID:1970337"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:drugbank",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:physically_interacts_with-UniProtKB:P30556": {
              "object": "UniProtKB:P30556",
              "subject": "CHEMBL.COMPOUND:CHEMBL995",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0126174---SEMMEDDB:interacts_with---NCBIGene:185---SEMMEDDB:",
                    "CHEMBL.COMPOUND:CHEMBL995---biolink:physically_interacts_with---CHEMBL.TARGET:CHEMBL227---identifiers_org_registry:chembl.compound",
                    "UMLS:C0126174---SEMMEDDB:interacts_with---UMLS:C1439284---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:18946500",
                    "PMID:28976133",
                    "PMID:8746201",
                    "PMID:30478450"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8746201": {
                      "sentence": "CONCLUSIONS: Losartan had no effect on baseline pulmonary haemodynamics but significantly attenuated acute hypoxic pulmonary vasoconstriction, suggesting that angiotensin II plays a role in modulating this response in man via its effects on the type 1 angiotensin II receptor.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Dec"
                    },
                    "PMID:18946500": {
                      "sentence": "We previously showed, using a renal ablation model, that the renoprotective effect of the AT-1 receptor blocker, losartan, is dose-dependent.",
                      "object score": 645,
                      "subject score": 1000,
                      "publication date": "2009 Jan"
                    },
                    "PMID:28976133": {
                      "sentence": "Losartan had no significant effect on AT1R or AT2R expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Sep"
                    },
                    "PMID:30478450": {
                      "sentence": "Consistent with this hypothesis, antagonism of AT1R using losartan or shRNA-mediated knockdown in melanoma cell lines expressing AGTR1 resulted in acquisition of the ability to proliferate in serum-free conditions.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Nov 26"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:DRUGBANK:DB06205-biolink:entity_negatively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "DRUGBANK:DB06205",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB06205---DRUGBANK:inhibitor---UniProtKB:P01137---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9435505",
                    "PMID:7648625",
                    "PMID:11327694",
                    "PMID:9850732"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:drugbank",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:inhibits---UMLS:C0172537---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15257104",
                    "PMID:24962629",
                    "PMID:30403832",
                    "PMID:26896736",
                    "PMID:23711955",
                    "PMID:16690877",
                    "PMID:29322806",
                    "PMID:12479636",
                    "PMID:12021584",
                    "PMID:9231071",
                    "PMID:28090659"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9231071": {
                      "sentence": "In addition, expression of TGF beta 1 in lymphocytes reduced the levels of gelatinase (MMP2) activity in inflamed joints.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Jun"
                    },
                    "PMID:12021584": {
                      "sentence": "BMS decreased (p < 0.01) expression of TGF-beta1, bFGF, and procollagen I and reduced MMP-2 activity.",
                      "object score": 875,
                      "subject score": 1000,
                      "publication date": "2002 Jun"
                    },
                    "PMID:12479636": {
                      "sentence": "RESULTS: CsA simultaneously stimulated TGF-beta1 expression and production and inhibited expression of MMP-1 and MMP-2 by human gingival fibroblasts, whereas CsA has a slight effect on TIMP-1 and TIMP-2 expression.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2002 Nov"
                    },
                    "PMID:15257104": {
                      "sentence": "GM inhibited not only the enzymatic activities of TAT and u-PA but also the production of MMP-2, and u-PA, all of which have been known to be secondarily down-regulated by TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Aug"
                    },
                    "PMID:16690877": {
                      "sentence": "Interestingly, in old untreated rings or VSMCs, the increased TGF-beta1, fibronectin, and collagen were also substantially reduced by inhibition of MMP-2.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2006 Jul"
                    },
                    "PMID:23711955": {
                      "sentence": "Cell proliferation and TGF-beta1 mRNA levels were examined after treating VSMC with PVAT homogenates +/- MMP-2 inhibitors (batimastat, ARP 100 or TIMP-2) and SB-431542, a selective inhibitor of the TGF-beta-type 1 receptor.",
                      "object score": 778,
                      "subject score": 888,
                      "publication date": "2013"
                    },
                    "PMID:24962629": {
                      "sentence": "We found that flexor tendon tenocytes treated with TGF-beta1 had significantly reduced levels of active MMP-2 and plasmin.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2015 Feb"
                    },
                    "PMID:26896736": {
                      "sentence": "In the present study, we showed that Sal reversed transforming growth factor-beta1 (TGF-beta1) induced invasion and metastasis accompanied with down-regulation of MMP-2 by experiments on human breast cancer cell line MCF-7.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Mar 25"
                    },
                    "PMID:28090659": {
                      "sentence": "AIMS: The aim of this study was to determine the value of urine nerve growth factor (NGF), transforming growth factor beta 1 (TGF-Beta-1), tissue inhibitor of matrix metalloproteinase 2 (TIMP-2) levels to predict the urodynamic profile before and after botulinum neurotoxin type A (BoNT-A) treatment in children with myelodysplasia.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Sep"
                    },
                    "PMID:29322806": {
                      "sentence": "The possible mechanism might lie in downregulation of MMP2 and upregulation of MMP inhibitor, TIMP1, and TGF-beta1 (Tab. 1, Fig. 4, Ref. 16).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017"
                    },
                    "PMID:30403832": {
                      "sentence": "Sequentially treated groups elevated lubricin synthesis, whereas only groups receiving IL-1beta and TNF-alpha for 2 days followed by TGF-beta1 for 1 day reduced active MMP-2 to unstimulated control levels.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "2018 Nov 07"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:inhibits---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11831438",
                    "PMID:17920060",
                    "PMID:30753884",
                    "PMID:17977565",
                    "PMID:7514175",
                    "PMID:32973948",
                    "PMID:12398809",
                    "PMID:7688028",
                    "PMID:31241125",
                    "PMID:8662809",
                    "PMID:23970162",
                    "PMID:7539224",
                    "PMID:16866871",
                    "PMID:11312101",
                    "PMID:19614923",
                    "PMID:19691848",
                    "PMID:11025760",
                    "PMID:32983173",
                    "PMID:17655656",
                    "PMID:18759245"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7514175": {
                      "sentence": "In nuclear run-on experiments, we found that the down-regulation of iNOS mRNA by TGF-beta 1 in RASMC occurred at the transcriptional level.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1994 May 20"
                    },
                    "PMID:7539224": {
                      "sentence": "Complete suppression of iNOS protein expression was evident even when TGF-beta 1 was added at postinduction time points.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1995 May"
                    },
                    "PMID:7688028": {
                      "sentence": "The potency of TGF-beta as a deactivator of NO production (50% inhibitory concentration, 5.6 +/- 2 pM) may reflect its ability to suppress iNOS expression by three distinct mechanisms: decreased stability and translation of iNOS mRNA, and increased degradation of iNOS protein.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1993 Aug 01"
                    },
                    "PMID:8662809": {
                      "sentence": "We demonstrated previously that transforming growth factor (TGF)-beta1 down-regulates inducible NOS after its induction by interleukin (IL)-1beta by decreasing the rate of inducible NOS gene transcription.",
                      "object score": 988,
                      "subject score": 1000,
                      "publication date": "1996 Jun 07"
                    },
                    "PMID:8700884": {
                      "sentence": "Thus these studies suggest that TGF-beta1 inhibits iNOS in vivo and that TGF-beta1 may be of future benefit in the therapy of septic shock.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Mar 05"
                    },
                    "PMID:8773588": {
                      "sentence": "Both in vivo and in vitro experiments demonstrate that transforming growth factor-beta1 (TGF-beta1) suppresses expression of the inducible form of nitric oxide synthase (iNOS).",
                      "object score": 812,
                      "subject score": 1000,
                      "publication date": "1996 Aug"
                    },
                    "PMID:11025760": {
                      "sentence": "TGF-beta1 inhibited iNOS protein and nitric oxide, whereas an anti-TGF-beta antibody enhanced iNOS.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000 Nov"
                    },
                    "PMID:11312101": {
                      "sentence": "NOS inhibition reduced the basal expression of VEGF isoforms, while it markedly potentiated TGF-beta1 expression.",
                      "object score": 888,
                      "subject score": 794,
                      "publication date": "2001 Apr"
                    },
                    "PMID:11831438": {
                      "sentence": "The failure of atRA treatment to reduce proteinuria could be due to the increase in TGF-beta1 levels and to inhibition of iNOS-driven NO production.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2001 Dec"
                    },
                    "PMID:12398809": {
                      "sentence": "TGF-beta1 was found to significantly decrease HGF-induced iNOS expression therefore suggesting a novel mechanism by which TGF-beta1 could regulate motility and invasion.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2002 Nov"
                    },
                    "PMID:16866871": {
                      "sentence": "Using murine macrophage-like cell line RAW 264.7, we demonstrated that TGF-beta1 not only reduced the inducible NO synthase (iNOS) protein stability but also suppressed the iNOS gene transcription.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Aug"
                    },
                    "PMID:17655656": {
                      "sentence": "In TAG, there was no significant change in TGF-beta1 and eNOS levels, but there was a significant decrease in iNOS at 1 year.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Sep"
                    },
                    "PMID:17920060": {
                      "sentence": "Transforming growth factor (TGF)-beta1 suppresses iNOS in cells in vitro as well as in vivo in mice, but paradoxically severe malaria in humans is associated with low levels of TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Feb"
                    },
                    "PMID:17977565": {
                      "sentence": "This bystander MN induction was eliminated by treating the cells with either aminoguanidine (AG), an iNOS inhibitor, or anti-transforming growth factor-beta1 (anti-TGF-beta1).",
                      "object score": 872,
                      "subject score": 937,
                      "publication date": "2008 Feb 01"
                    },
                    "PMID:18759245": {
                      "sentence": "In cervical, gastric, colorectal, breast, and lung cancer, the cause of this failure is the inadequate expression of inducible nitric oxide synthase (iNOS), resulting from the inhibition of iNOS expression by TGF-beta1 at the mRNA level.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2008 Oct"
                    },
                    "PMID:19614923": {
                      "sentence": "The inducible nitric oxide (NO) synthase and the cytokine transforming growth factor-beta1 (TGF-beta1), both central modulators of wound healing, interact reciprocally: TGF-beta1 generally suppresses iNOS expression, while NO can induce and activate latent TGF-beta1.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2009"
                    },
                    "PMID:19691848": {
                      "sentence": "These results support the hypothesis that TGF-beta1 can suppress iNOS expression associated with bladder inflammation and reduce systemic levels of NO2-/NO3-, and further suggest that this feature of TGF-beta1 can be harnessed for therapy and diagnosis of interstitial cystitis.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2009 Aug 19"
                    },
                    "PMID:23970162": {
                      "sentence": "iNOS mRNA and protein expression in the PMPhi from CIA rats may be suppressed by TGF-beta1.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    },
                    "PMID:30753884": {
                      "sentence": "Accordingly, downregulation of iNOS expression by exogenous TGF-beta1 was impaired in TAp73-/- fibroblasts.",
                      "object score": 928,
                      "subject score": 901,
                      "publication date": "2019 04"
                    },
                    "PMID:31241125": {
                      "sentence": "(2) Dietary putrescine increased the lysozyme and acid phosphatase activities and the amount of immunoglobulin M, antibacterial peptides, and transforming growth factor beta1, but decreased the mRNA levels of tumor necrosis factor alpha, interleukin-6, interleukin-8 and inducible nitric oxide synthase (P < 0.05).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Jul 17"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P61812": {
              "object": "UniProtKB:P61812",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:inhibits---UMLS:C0079441---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1846264",
                    "PMID:21199732",
                    "PMID:1638993",
                    "PMID:17013806",
                    "PMID:10326621",
                    "PMID:8916368",
                    "PMID:30297828",
                    "PMID:12607775",
                    "PMID:7918451",
                    "PMID:16574941"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1638993": {
                      "sentence": "The down-regulation of intracellular TGF beta 1 was observed up to 48 hours after initial exposure to retinoic acid while some down-regulation of TGF beta 2 was still seen up to 60 hours after initial exposure.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "1992 May"
                    },
                    "PMID:1846264": {
                      "sentence": "Bovine aortic endothelial cell migration was significantly inhibited by TGF-beta 1, but only slightly inhibited by TGF-beta 2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Jan"
                    },
                    "PMID:7918451": {
                      "sentence": "Although both of these molecules inhibited the growth of Mv1Lu mink lung epithelial cells and LS1034 colorectal cancer cells, which are affected equally by TGF-beta 1 and TGF-beta 2, TGF-beta 1 (delta 69-73) was much less potent than TGF-beta 1 or TGF-beta 1 (71 Trp) at inhibiting the growth of LS513 colorectal cancer cells which are growth-inhibited by TGF-beta 1 but not TGF-beta 2.",
                      "object score": 938,
                      "subject score": 1000,
                      "publication date": "1994 Oct 11"
                    },
                    "PMID:8916368": {
                      "sentence": "During mouse palate development, significant increases in TGF-beta 1 and TGF-beta 3 mRNA levels, as well as significant decrease in TGF-beta 2 mRNA levels, are detected; no significant difference in EGF-R transcript level is observed with progressive development.",
                      "object score": 875,
                      "subject score": 1000,
                      "publication date": "1996 Jul"
                    },
                    "PMID:10326621": {
                      "sentence": "METHOD OF STUDY: PBLs were cultured with TGF-beta 1, TGF-beta 2, PGE 2, PGI 2, or day-12 rabbit blastocoelic fluid (BF) that was or was not depleted of TGF-beta 2 and/or PGE 2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Mar"
                    },
                    "PMID:12607775": {
                      "sentence": "TGF-beta1 treatment resulted in a significant increase in TGF-beta1 (35%; P < 0.05), but a decrease in TGF-beta2 (22%; P < 0.05) and no effect on TGF-beta3, TGF-betaIR or TGF-betaIIR.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Dec"
                    },
                    "PMID:16574941": {
                      "sentence": "Although these cells secreted large amounts of TGF-beta2 and small amounts of TGF-beta1, blockade of TGF-beta1 enhanced the degree of wound closure, whereas blockade of TGF-beta2 had no effect.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Aug"
                    },
                    "PMID:17013806": {
                      "sentence": "JAK inhibitor selectively inhibited IFN-gamma induced TGF-beta1 secretion and mRNA levels while reversing the inhibitory effects of IFN-gamma on TGF-beta2.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2007 Jan"
                    },
                    "PMID:21199732": {
                      "sentence": "RESULTS: MM-MSCs exhibited increased expression of TGF-beta1, IL-6, IL-3, TNF-alpha and RANKL and decreased expression of TGF-beta2, TGF-beta3 and FasL.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Nov"
                    },
                    "PMID:30297828": {
                      "sentence": "TGF-beta1 expression was also increased after inhibition of TGF-beta2.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2018 Oct 09"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_negatively_regulates_entity-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:inhibits---UMLS:C0529119---SEMMEDDB:",
                    "UMLS:C0080222---SEMMEDDB:inhibits---UMLS:C0919432---SEMMEDDB:",
                    "UMLS:C1366557---SEMMEDDB:inhibits---UMLS:C0919432---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24590056",
                    "PMID:33363388",
                    "PMID:20943464",
                    "PMID:28810620",
                    "PMID:23926286",
                    "PMID:31115505",
                    "PMID:30713572",
                    "PMID:27217701",
                    "PMID:18753451",
                    "PMID:29406185",
                    "PMID:17400544",
                    "PMID:19151339",
                    "PMID:33089282",
                    "PMID:28884513",
                    "PMID:11518734",
                    "PMID:10504488",
                    "PMID:31900718",
                    "PMID:20506210",
                    "PMID:26660509",
                    "PMID:29668937"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:10504488": {
                      "sentence": "TGF-beta1 down-regulated Smad3 mRNA and protein expression, respectively, after 4 and 24 hours of treatment, whereas Smad2 and Smad4 were less affected.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1999 Oct"
                    },
                    "PMID:10896788": {
                      "sentence": "The levels of SMAD3 and Smad3 mRNA were profoundly down-regulated by TGF-beta1 or TGF-beta3 in a time-dependent manner, whereas expression of antagonistic Smad7 was rapidly and transiently induced.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000 Aug 01"
                    },
                    "PMID:11518734": {
                      "sentence": "In inflamed mucosal tissue explants from patients with CD, inhibition of Smad7 also restores p-Smad3 and decreases proinflammatory cytokine production, an effect that is partially blocked by anti-TGF-beta1.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2001 Aug"
                    },
                    "PMID:17400544": {
                      "sentence": "TGF-beta1 did not decrease Smad3 mRNA stability, but it significantly inhibited Smad3 promoter activity.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "2007 May 25"
                    },
                    "PMID:18753451": {
                      "sentence": "The addition of TGF-beta1 reduced Smad3 expression, but did not affect the expression of Smad7.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2008 Sep"
                    },
                    "PMID:19151339": {
                      "sentence": "Smad3 expression was reduced by TGF-beta1 from 10 ED to 1 wk posthatch in normal p. major muscle.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2009 Feb"
                    },
                    "PMID:20506210": {
                      "sentence": "TGFbeta-activated kinase 1 (TAK1)/ATF-2 signaling was disrupted in Smad3(-/-) mouse chondrocytes at the level of p38 MAP kinase (MAPK) activation, resulting in reduced ATF-2 phosphorylation and transcriptional activity.",
                      "object score": 1000,
                      "subject score": 891,
                      "publication date": "2010 Aug"
                    },
                    "PMID:20943464": {
                      "sentence": "In contrast, high-dose TGF-beta1 downregulates the expression of Smad3 in completely activated PSCs.",
                      "object score": 1000,
                      "subject score": 909,
                      "publication date": "2010 Oct"
                    },
                    "PMID:22727959": {
                      "sentence": "We found that methylprednisolone not only significantly decreased serum TGF-beta1, CTGF and troponin T, but also reduced myocardial expressions of TGF-beta1, CTGF and Smad3 after CME.",
                      "object score": 1000,
                      "subject score": 819,
                      "publication date": "2013 Sep 01"
                    },
                    "PMID:23926286": {
                      "sentence": "The inhibition of TGF-B1 showed reduced levels of phosphorylated SMAD3.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    },
                    "PMID:26660509": {
                      "sentence": "Finally, diode laser stimulation and TRPC1 functionality negatively affected fibroblast-myofibroblast transition by interfering with TGF-beta1 signaling, namely reducing the expression of Smad3, the TGF-beta1 downstream signaling molecule.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2016 Mar"
                    },
                    "PMID:26950486": {
                      "sentence": "mRNA expression of inflammation-related factors, that is, vascular endothelial growth factor (VEGF), macrophage-chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6) and TGFbeta1 in choroidal tissues was suppressed by the loss of Smad3.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 06"
                    },
                    "PMID:27217701": {
                      "sentence": "In addition, the TGF-beta1/Smad signaling pathway was activated in ALF rats, as evidenced by the increase in TGF-beta1 and snail levels (mRNA: 1.76 +/- 0.12 vs 1.00 +/- 0.05 and 6.98 +/- 0.41 vs 1.00 +/- 0.10, respectively, P < 0.01; protein: 1.43 +/- 0.05 vs 0.12 +/- 0.03 and 1.07 +/- 0.29 vs 0.07 +/- 0.02, respectively, P < 0.01) and the decrease in Smad3 levels (mRNA: 0.05 +/- 0.01 vs 1.00 +/- 0.12, P < 0.01; protein: 0.06 +/- 0.05 vs 0.89 +/- 0.12, P < 0.01).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2016 May 21"
                    },
                    "PMID:28884513": {
                      "sentence": "We harvested and cultured submandibular salivary glands (SMGs) from murine embryos, which were then treated with exogenous TGF-beta1, or its neutralized antibody, Smad3 inhibitor, or Smad3 small interfering RNA (siRNA).",
                      "object score": 872,
                      "subject score": 928,
                      "publication date": "2017 Dec"
                    },
                    "PMID:29406185": {
                      "sentence": "In RCC4, TGF-betaRII and OPN were upregulated, while TGF-beta1 was over- expressed with reduced nuclear Smad3.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2018 Feb"
                    },
                    "PMID:29668937": {
                      "sentence": "These findings were associated with diminished synthesis of TGF-beta1 and reduced p-Smad3 protein expression.",
                      "object score": 840,
                      "subject score": 1000,
                      "publication date": "2018 May 18"
                    },
                    "PMID:30713572": {
                      "sentence": "Ginsenoside Re administration also resulted in decreased expression of transforming growth factor (TGF)-beta1 in serum and decreased expression of Smad3 and collagen I in heart tissue.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019"
                    },
                    "PMID:31115505": {
                      "sentence": "In addition, following stimulation of HSCs with recombinant SDC1, the expression of TGF-beta1, Smad3 and alpha-SMA in HSCs was downregulated, whereas small interfering RNA targeting Smad3 antagonized the effects of recombinant SDC1 on alpha-SMA.",
                      "object score": 875,
                      "subject score": 1000,
                      "publication date": "2019 Jul"
                    },
                    "PMID:31900718": {
                      "sentence": "Conversely, ferulic acid, but not astragaloside IV, suppressed TGF-beta1 and its receptors expression, which resulted in downregulation of Smad3 and Smad4.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2020 Jan 03"
                    },
                    "PMID:33089282": {
                      "sentence": "20 MUmol/L Cur significantly decreased mRNA expression of TGF-beta1, alpha-SMA and collagen type I in gingival fibroblasts, and Western blot suggested significantly down-regulated expression of TGF-beta1, p-Smad3, alpha-SMA, and collagen typeI.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2020 Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P02452": {
              "object": "UniProtKB:P02452",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C0972255---SEMMEDDB:",
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C0766823---SEMMEDDB:",
                    "UMLS:C0080222---SEMMEDDB:stimulates---NCBIGene:1277---SEMMEDDB:",
                    "UMLS:C1366557---SEMMEDDB:stimulates---UMLS:C1332772---SEMMEDDB:",
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C1332772---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17868111",
                    "PMID:33463102",
                    "PMID:26631499",
                    "PMID:21236582",
                    "PMID:8530522",
                    "PMID:29293543",
                    "PMID:27881410",
                    "PMID:17360662",
                    "PMID:32771890",
                    "PMID:26786786",
                    "PMID:23236489",
                    "PMID:31208666",
                    "PMID:15153536",
                    "PMID:20397200",
                    "PMID:32012313",
                    "PMID:21612641",
                    "PMID:16187293",
                    "PMID:20713358",
                    "PMID:8524247",
                    "PMID:22033529"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8182090": {
                      "sentence": "Thus, the results strongly suggest a functional interaction between Sp1 and other components of the TbRE complex in mediating TGF-beta stimulation of COL1A2 gene expression.",
                      "object score": 901,
                      "subject score": 938,
                      "publication date": "1994 May 20"
                    },
                    "PMID:8524247": {
                      "sentence": "Our experiments have shown that TGF-beta 1 stimulates COL1A2 transcription by increasing binding of an Sp1-containing complex (TbRC) to the TbRE.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1995 Dec"
                    },
                    "PMID:8530522": {
                      "sentence": "TGF-beta 1 increased steady state lysyl oxidase and COL1A1 mRNA levels in a dose- and time-dependent manner.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1995 Dec 22"
                    },
                    "PMID:11007770": {
                      "sentence": "Here we report that the CAGA box of the TbRE is the binding site of the Smad3/Smad4 complex, and that the binding of the complex is required for TGFbeta-induced COL1A2 up-regulation.",
                      "object score": 817,
                      "subject score": 817,
                      "publication date": "2000 Dec 15"
                    },
                    "PMID:14610066": {
                      "sentence": "Similarly, LY294002 or an Akt dominant negative construct blocks TGF-beta1 induction of COL1A2 promoter activity.",
                      "object score": 802,
                      "subject score": 779,
                      "publication date": "2004 Jan 23"
                    },
                    "PMID:15153536": {
                      "sentence": "The TGF-beta1-induced COL1A2 promoter activity, but not the basal activity, was significantly attenuated by LY294002 or the dominant negative mutant of p85 subunit of PI3K, while the constitutive active mutant of p110 subunit of PI3K did not affect the basal or the TGF-beta1-induced COL1A2 promoter activity.",
                      "object score": 781,
                      "subject score": 781,
                      "publication date": "2004 Jun 01"
                    },
                    "PMID:16126788": {
                      "sentence": "COL1A2 promoter activity was dose dependently induced by TGF-beta1, which was further augmented by adenoviral overexpression of Smad3, but was downregulated by Smad7.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "2006 Jan"
                    },
                    "PMID:16187293": {
                      "sentence": "Both Bleomycin and TGF-beta1 increase the transcription of the COL1A1 gene.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Apr 01"
                    },
                    "PMID:17868111": {
                      "sentence": "TGF-beta1 increased COL1A1 and decorin mRNA in CTFs, but decreased the mRNA of all four genes in day 7 healing tendon fibroblasts.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Mar"
                    },
                    "PMID:20397200": {
                      "sentence": "The HF diets also decreased the skin mRNA expression of transforming growth factor (TGF)-beta1, which enhances the expression of COL1A1 and rhas2 mRNA and decreases rhas3 mRNA expression, and decreased the hepatic mRNA expression of insulin-like growth factor (IGF)-I, which enhances COL1A1, rhas2, and TGF-beta1 mRNA expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 May"
                    },
                    "PMID:22033529": {
                      "sentence": "TGF-beta1 stimulated mRNA expression of TGFB1, CTGF, aSMA, and Col1A1 in keloid fibroblasts, while pirfenidone significantly inhibited mRNA expression of CTGF and aSMA in the identical cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Apr"
                    },
                    "PMID:23236489": {
                      "sentence": "TGF-beta1-induced Col1A1 production seems to be independent of EMT-like transition and miR-29 expression.",
                      "object score": 875,
                      "subject score": 875,
                      "publication date": "2012"
                    },
                    "PMID:23560091": {
                      "sentence": "These findings suggested that the DNMT-mediated DNA methylation is an important mechanism in regulating the TGF-beta1-induced COL1A1 gene expression.",
                      "object score": 839,
                      "subject score": 839,
                      "publication date": "2013"
                    },
                    "PMID:25975023": {
                      "sentence": "COL1A1 promoter activity was detected by Dual-Luciferase Reporter Assay System, it came that the relative luciferase activity of COL1A1 promoter was 15.98 times higher than that of control group induced by TGF-beta1, showing the recombined plasmid could be used in cell model.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2015 Feb"
                    },
                    "PMID:26631499": {
                      "sentence": "TGF-beta1 induced expression of TGFBI, COL1A1, COL5A1, COL8A1, FN1, ITGA5, ITGAM and TIMP1 in a renal cell carcinoma derived cell line.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 06"
                    },
                    "PMID:26786786": {
                      "sentence": "In CD fibroblasts, TGF-beta1 and TNF-alpha increased Col1A1, Col3A1 and alpha-SMA transcripts and collagen secretion and this effect was reduced by Ficz and upregulated by CH22319.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Apr"
                    },
                    "PMID:27740527": {
                      "sentence": "TGF- beta1 enhanced alpha-SMA and COL1A1 protein expression in HSCs and stimulated proliferation of these cells compared with cells transfected with inhibitor NC.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2016 Nov-Dec 2016"
                    },
                    "PMID:27881410": {
                      "sentence": "TAZ4SA enhancement of Col1a1 expression on soft matrices was potentiated by TGF-beta1, while on stiff matrices it was abrogated by inhibition of myocardin-related transcription factor, demonstrating context-dependent crosstalk of TAZ with these pathways.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2017 Mar 01"
                    },
                    "PMID:29999195": {
                      "sentence": "We observed that in cultured NPCs TGF-beta1 stimulated COL1A1 expression, encoding collagen I, and in MSCs stimulated COL1A1 and SOX9 expressions.",
                      "object score": 888,
                      "subject score": 851,
                      "publication date": "2018 Jul 12"
                    },
                    "PMID:31208666": {
                      "sentence": "TGF-beta1 enhanced a-SMA and COL1A1 protein expression in HSCs and stimulated proliferation of these cells compared with cells transfected with inhibitor NC.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2016"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:stimulates---NCBIGene:4313---SEMMEDDB:",
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C0172537---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:31729763",
                    "PMID:12735637",
                    "PMID:30203551",
                    "PMID:8291614",
                    "PMID:19082463",
                    "PMID:11866926",
                    "PMID:8063786",
                    "PMID:22359633",
                    "PMID:9626812",
                    "PMID:12114891",
                    "PMID:15247230",
                    "PMID:15226662",
                    "PMID:18368029",
                    "PMID:11592306",
                    "PMID:12164864",
                    "PMID:1646806",
                    "PMID:25539192",
                    "PMID:23734997",
                    "PMID:21347430",
                    "PMID:21518085"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1646806": {
                      "sentence": "Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "1991 Jun 25"
                    },
                    "PMID:8063786": {
                      "sentence": "Cell coincubation with CAI (2 microM) and TGF-beta 1 (5 ng/ml) caused a decrease in the overall amount of latent and activated MMP-2 by zymogram and immunoblot analysis and showed that CAI inhibited TGF-beta 1 stimulation of MMP-2 production at the level of RNA expression.",
                      "object score": 905,
                      "subject score": 1000,
                      "publication date": "1994 Aug 26"
                    },
                    "PMID:8291614": {
                      "sentence": "Concentrations of TGF-beta 1 of 5 ng/ml and above specifically stimulated the synthesis of the 72-kd type IV collagenase.",
                      "object score": 854,
                      "subject score": 1000,
                      "publication date": "1994 Jan"
                    },
                    "PMID:9626812": {
                      "sentence": "In this paper, ELISAs and Western blots showed that TGF-beta1 stimulated the secretion of a 72 kDa matrix metalloproteinase 2 (MMP-2) to enhance the solubilization of radiolabeled collagen 1 by metastatic human prostate PC-3 ML cells.",
                      "object score": 854,
                      "subject score": 1000,
                      "publication date": "1998 May"
                    },
                    "PMID:9821184": {
                      "sentence": "These findings suggest that TGF beta 1 induced in pancreatic duct cells also induced MMP-2 in an autocrine or paracrine manner, and that this MMP-2 decomposed Col-IV of the BM of pancreatic ducts in chronic pancreatitis.",
                      "object score": 776,
                      "subject score": 1000,
                      "publication date": "1998 Nov"
                    },
                    "PMID:10194407": {
                      "sentence": "The low constitutive expression of gelatinase A/MMP-2 was upregulated by TGF-beta1 in a dose-dependent manner.",
                      "object score": 988,
                      "subject score": 1000,
                      "publication date": "1999 May"
                    },
                    "PMID:11262418": {
                      "sentence": "Moreover, TGF-beta1-mediated induction of matrix metalloproteinase-2 was selectively dependent on Smad2, whereas induction of c-fos, Smad7, and TGF-beta1 autoinduction relied on expression of Smad3.",
                      "object score": 1000,
                      "subject score": 771,
                      "publication date": "2001 Jun 08"
                    },
                    "PMID:11592306": {
                      "sentence": "TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000"
                    },
                    "PMID:12735637": {
                      "sentence": "Moreover, TGF-beta1, TNF-alpha, or epidermal growth factor augmented the secretion of MMP-2 from fibroblasts.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003"
                    },
                    "PMID:15247230": {
                      "sentence": "Treatment of oral squamous cell carcinoma cells with TGF-beta1 promoted MMP-dependent cell scattering and collagen invasion, increased expression of MMP-2 and MT1-MMP, and enhanced MMP-2 activation.",
                      "object score": 717,
                      "subject score": 1000,
                      "publication date": "2004 Sep 10"
                    },
                    "PMID:15632190": {
                      "sentence": "In this study, we demonstrated that TGF-beta1 stimulated the production of matrix metalloproteinase-2 (MMP-2) in a time- and dose-dependent manner in a human monocytic THP-1 cell line.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Mar 04"
                    },
                    "PMID:15770602": {
                      "sentence": "The following significant changes are described herein: high glucose solution and TGF-beta1 i) decreased HGF production from HPMCs and ii) up-regulated expression of c-Met on HPMCs, and addition of HGF iii) restored viability of HPMCs damaged by glucose, iv) suppressed TGF-beta1 production by HGF, and v) induced up-regulation of MMP-2 and decreased TIMP-2 production by HPMCs.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2005 Feb"
                    },
                    "PMID:16447244": {
                      "sentence": "TGF-beta1 stimulated the de novo synthesis of pro-MMP-2 in both cell types.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "2006 May"
                    },
                    "PMID:18368029": {
                      "sentence": "In the knockout mice there was increased PAI-1 and MCP-1 expression, marked induction of MMP-2 and MMP-9, but similar expression of PDGF alpha, IGF-1, TGF-beta1, VEGF, and osteopontin compared to wild type mice.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Jul"
                    },
                    "PMID:19082463": {
                      "sentence": "Exogenous TGF-beta1 up-regulated the activity of type IV collagenase (gelatinase A and gelatinase B), whereas TRI down-regulated the activity of these matrix metalloproteinases.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2009 Jan"
                    },
                    "PMID:21219858": {
                      "sentence": "The multifunctional cytokine transforming growth factor beta 1 (TGF-beta1) has been shown to increase both secretion of MMP-2 and invasion by several pancreatic cancer cell types.",
                      "object score": 1000,
                      "subject score": 892,
                      "publication date": "2011 Feb 04"
                    },
                    "PMID:21518085": {
                      "sentence": "Taken together, our results demonstrate that TNF-alpha induced an increase of MMP-2 and TGF-beta1 in lung fibroblasts, and the TGF-beta1 attenuated the up-regulation of MMP-2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 May-Jun"
                    },
                    "PMID:23734997": {
                      "sentence": "The high-dose berberine (9 mg/kg) ameliorated oxidative stress, decreased TNF-alpha and TGF-beta1 expression, increased the levels of matrix metalloproteinase (MMP)-2, and stimulated the elimination of fibrous deposits.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2013 Jun"
                    },
                    "PMID:28645189": {
                      "sentence": "Further experiments indicated that RARalpha inhibited the accumulation of TGF-beta1, alpha-smooth muscle actin, collagen IV, and fibronectin, while it induced MMP2 and MMP9 excessive expression in podocytes in vitro.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Aug 01"
                    },
                    "PMID:28817313": {
                      "sentence": "Our results indicate that CCR7 mediates TGF-beta1-induced MMP2/9 expression through NF-kappaB signaling, thus facilitating glioma cell migration, invasion, and EMT, all of which progressively increase with glioblastoma progression.",
                      "object score": 821,
                      "subject score": 821,
                      "publication date": "2017 Oct"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P14780": {
              "object": "UniProtKB:P14780",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C0165519---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19669587",
                    "PMID:21134288",
                    "PMID:22033246",
                    "PMID:19371720",
                    "PMID:20845081",
                    "PMID:18457660",
                    "PMID:15728539",
                    "PMID:23275087",
                    "PMID:12393094",
                    "PMID:24255890",
                    "PMID:15854510",
                    "PMID:22260435",
                    "PMID:16301820",
                    "PMID:18368029",
                    "PMID:21577212",
                    "PMID:12163012",
                    "PMID:19422858",
                    "PMID:22664874",
                    "PMID:19681038",
                    "PMID:17053163"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8764134": {
                      "sentence": "We have found that tumor cell lines derived from focal pulmonary metastasis secreted relatively greater quantities of total TGF-betas, lost most or all TGF-beta1 growth inhibition, but responded to TGF-beta1 through induction of the type IV collagenase matrix metalloproteinase-9, whereas cell lines derived from tumors which proliferated at the primary site retained the growth inhibition but lacked collagenase activity.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996 Jul 15"
                    },
                    "PMID:8995752": {
                      "sentence": "Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Jan"
                    },
                    "PMID:12163012": {
                      "sentence": "In this work, we present evidence showing that TGF-beta1 stimulates cellular production of MMP-9 (Gelatinase B), a metalloproteinase that plays an important role in tumoral invasion.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Aug 16"
                    },
                    "PMID:17053163": {
                      "sentence": "TGF-beta1 also increased the expression of fetal liver kinase-1 (Flk-1), a major VEGF receptor, and TGF-beta1 and VEGF stimulated pro-matrix metalloproteinase 9 (MMP-9) and active-MMP-9 expression, respectively.",
                      "object score": 875,
                      "subject score": 1000,
                      "publication date": "2007 Feb"
                    },
                    "PMID:18368029": {
                      "sentence": "In the knockout mice there was increased PAI-1 and MCP-1 expression, marked induction of MMP-2 and MMP-9, but similar expression of PDGF alpha, IGF-1, TGF-beta1, VEGF, and osteopontin compared to wild type mice.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Jul"
                    },
                    "PMID:18457660": {
                      "sentence": "In conclusion, these results describe a novel mechanism for the potentiation of TGF-beta1 signaling to induce MMP-9 expression via Smad and MLCK.",
                      "object score": 651,
                      "subject score": 928,
                      "publication date": "2008 Jul 11"
                    },
                    "PMID:19681038": {
                      "sentence": "Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2009 Oct 15"
                    },
                    "PMID:21577212": {
                      "sentence": "TGF-beta1-induced MMP-9 in Thy-1 (-) fibroblasts depended on the activation of ERK1/2 signaling pathway.",
                      "object score": 857,
                      "subject score": 857,
                      "publication date": "2011 Aug"
                    },
                    "PMID:22033246": {
                      "sentence": "EGF- or TGF-beta1-induced MMP-9 expression was completely decreased by adenoviral-smad7 (Ad-smad7) over-expression.",
                      "object score": 839,
                      "subject score": 839,
                      "publication date": "2012 Jan 28"
                    },
                    "PMID:22664874": {
                      "sentence": "These results demonstrate that TAM/Ms enhance the invasiveness of CD133(+) GSLCs via the release of TGF-beta1, which increases the production of MMP-9 by GSLCs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jul 01"
                    },
                    "PMID:23275087": {
                      "sentence": "Thus, we investigated the molecular mechanisms underlying TGF-beta1-induced MMP-9 expression in VSMC, the involvement of intracellular ROS and signaling molecules, including ERK1/2 and NF-kappaB.",
                      "object score": 850,
                      "subject score": 850,
                      "publication date": "2013 Mar"
                    },
                    "PMID:24255890": {
                      "sentence": "However, MMP-9 was found by us and others to be up-regulated by TGF-beta1 in kidney tubular epithelial cells and secreted by activated macrophages, resulting in EMT and ultimately kidney fibrosis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Aug 06"
                    },
                    "PMID:24278749": {
                      "sentence": "Thus, we propose SKIP as a regulatory protein in TGF-beta1-induced MMP-9 expression acting by controlling ERK1,2 signaling in transformed cells.",
                      "object score": 845,
                      "subject score": 845,
                      "publication date": "2012"
                    },
                    "PMID:24451989": {
                      "sentence": "Luciferase reporter and mutagenesis analysis indicated the AP1 and NFkappaB elements located in the promoter region from -1700 to -2400 bp were critical for both basal and TGFB1-induced MMP9 transcription.",
                      "object score": 875,
                      "subject score": 875,
                      "publication date": "2014 Mar"
                    },
                    "PMID:25074038": {
                      "sentence": "MLP significantly decreased the serum concentrations of ALT, AST, Hyp, HA, LN, PC-III, C-IV, MMP-2, TIMP-1, alpha-SMA and TGF-beta1, while increasing the contents of Alb and MMP-9.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jul 30"
                    },
                    "PMID:26637807": {
                      "sentence": "TGF-beta1-induced MMP-9 expression was decreased by both a MEK inhibitor, UO126, and a smad3 inhibitor, SIS3.",
                      "object score": 839,
                      "subject score": 839,
                      "publication date": "2016 Jan 12"
                    },
                    "PMID:26722450": {
                      "sentence": "Here we found that matrix metalloproteinase-9 (MMP-9), induced by TGF-beta1, upregulated s-KitL and s-ICAM-1, permitting the transfer of c-kit(+) hematopoietic stem cells (HSCs) from the quiescent to proliferative niche in CML.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015"
                    },
                    "PMID:28645189": {
                      "sentence": "Further experiments indicated that RARalpha inhibited the accumulation of TGF-beta1, alpha-smooth muscle actin, collagen IV, and fibronectin, while it induced MMP2 and MMP9 excessive expression in podocytes in vitro.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2017 Aug 01"
                    },
                    "PMID:29116196": {
                      "sentence": "THL inhibited the TGF-beta1 induction of alpha-SMA, vimentin, MMP-2/-9 and collagen type IV expression and restored the morphological changes in primary alveolar epithelial cells caused by TGF-beta1.",
                      "object score": 913,
                      "subject score": 901,
                      "publication date": "2017 Nov 07"
                    },
                    "PMID:30230565": {
                      "sentence": "Overexpression of wild-type SIRT6 but not the H133Y mutant inhibits the expression of NF-kappaB-dependent genes including interleukin (IL)-1beta, IL-6 and matrix metalloproteinase-9 (MMP-9) induced by TGF-beta1, all of which have been demonstrated to promote myofibroblast differentiation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Jan"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P61812": {
              "object": "UniProtKB:P61812",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C0079441---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12546137",
                    "PMID:8383514",
                    "PMID:8651574",
                    "PMID:18040277",
                    "PMID:9000208",
                    "PMID:12772773",
                    "PMID:8082724",
                    "PMID:17013806",
                    "PMID:10804017",
                    "PMID:18694919",
                    "PMID:32826874"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8082724": {
                      "sentence": "Increased TGF-beta 1 mRNA levels appeared to be exclusively due to an increase in stability, while increased TGF-beta 2 mRNA levels were due to increased transcription.",
                      "object score": 900,
                      "subject score": 900,
                      "publication date": "1994 Sep"
                    },
                    "PMID:8383514": {
                      "sentence": "However, TGF-beta 1 does not increase the amount of TGF-beta 2 or TGF-beta 3 mRNA in these cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993"
                    },
                    "PMID:8651574": {
                      "sentence": "The influence of antiestrogens on the secretion of transforming growth factor beta (TGF beta) proteins that have an autoinhibitory potential for human cancer cells was studied in the estrogen-responsive human breast cancer cell line, MCF-7: Antiestrogens induce the secretion of TGF beta-1 via a nontranscriptional pathway; TGF beta-1 itself induces TGF beta-2 by a direct transcriptional mechanism; and TGF beta-2 is a marker of antiestrogen action.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Apr 30"
                    },
                    "PMID:9000208": {
                      "sentence": "Plasma TGF-beta2 levels, like plasma TGF-beta1 levels, were similar for both the study and control groups, but when stratified by pathologic stage or Gleason grade, patients with prostate cancer with pathologic Stage T2a and Gleason grade of 3 or less had significantly increased plasma TGF-beta2 levels as compared with either control patients or patients with prostate cancer with pathologic Stages T2b/T2c and T3/T4 or Gleason grade of 4 or more, suggesting that early prostate cancer may contribute to plasma TGF-beta2 levels.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "1997 Jan"
                    },
                    "PMID:10804017": {
                      "sentence": "Parathyroid hormone 1-34 [PTH(1-34)] was shown to increase transforming growth factor beta1 (TGF-beta1) and TGF-beta2 concentrations in supernatants of cultured human osteoblasts and to increase TGF-beta1 and TGF-beta2 messenger RNA (mRNA) concentrations and gene transcription in these cells.",
                      "object score": 857,
                      "subject score": 1000,
                      "publication date": "2000 May"
                    },
                    "PMID:12546137": {
                      "sentence": "TGF-beta1 stimulated TGF-beta2 production (p < 0.01 relative to control).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2002 Dec"
                    },
                    "PMID:12772773": {
                      "sentence": "Glucocorticoids significantly inhibited TGF-beta1 and TGF-beta2 production and reduced expression of the up-regulated TGF-beta1 and TGF-beta2 mRNA induced by exogenous TGF-beta1, -beta2, or -beta3 (p < 0.01 for each) but had no effect on Smads.",
                      "object score": 901,
                      "subject score": 901,
                      "publication date": "2003 Feb"
                    },
                    "PMID:17013806": {
                      "sentence": "The TGF-beta1 and TGF-beta2 secretion was induced by TGF-beta2 and TGF-beta1, respectively.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2007 Jan"
                    },
                    "PMID:18040277": {
                      "sentence": "CONCLUSION: The early induction of TGF-beta1 at the point of SCI suggests a role in the acute inflammatory response and formation of the glial scar, while the later induction of TGF-beta2 may indicate a role in the maintenance of the scar.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 May"
                    },
                    "PMID:18694919": {
                      "sentence": "A dominant increase in TGF-beta2 expression was seen in the cord tissue, whereas TGF-beta1 and TGF-beta3 were found not to be significantly up-regulated.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2008 Dec"
                    },
                    "PMID:32826874": {
                      "sentence": "Importantly, Sema7A overexpression upregulated activating transcription factor 3 (ATF3) that was found to selectively bind the promotor region of TGF-beta2, but not TGF-beta1, promoting TGF-beta2 transcription, which was further confirmed by ATF3-siRNA knockdown approach.",
                      "object score": 901,
                      "subject score": 901,
                      "publication date": "2020 Aug 10"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P62736": {
              "object": "UniProtKB:P62736",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C2716282---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:32550106",
                    "PMID:31991519",
                    "PMID:34076990",
                    "PMID:34093237",
                    "PMID:33407872",
                    "PMID:33663392",
                    "PMID:33025706",
                    "PMID:33854158",
                    "PMID:32104972",
                    "PMID:31927599",
                    "PMID:33899116",
                    "PMID:33579280",
                    "PMID:32868830",
                    "PMID:31933903",
                    "PMID:32338120",
                    "PMID:32296336"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:31927599": {
                      "sentence": "Knockdown of FHL2 remarkably suppressed TGF-beta1-induced alpha-SMA, type I collagen, and fibronectin expression, while overexpression of FHL2 was sufficient to activate fibroblasts.",
                      "object score": 780,
                      "subject score": 780,
                      "publication date": "2020 Jan 11"
                    },
                    "PMID:31933903": {
                      "sentence": "TGF-beta1 can increase collagen and alpha-SMA expression in NECs, and HGF can antagonize the remodeling action of TGF-beta1.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2019"
                    },
                    "PMID:31991519": {
                      "sentence": "In MRC5 cells, miR-30a was not only involved in regulating the expression of FAP-alpha, col1a and alpha-SMA induced by TGF-beta1 but also had a role in cell proliferation with or without TGF-beta1 treatment via regulating FAP-alpha expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Jan 28"
                    },
                    "PMID:32104972": {
                      "sentence": "Expression levels of alpha-SMA, collagen type 1, and fibronectin stimulated by TGF-beta1 were significantly downregulated in the ATRA-pretreated fibroblasts.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Feb 27"
                    },
                    "PMID:32296336": {
                      "sentence": "Treatment with BA-5 inhibited TGF-beta1-induced alpha-SMA, collagen1a2, and phosphorylated smad2/3 expression in HSCs.",
                      "object score": 881,
                      "subject score": 881,
                      "publication date": "2020"
                    },
                    "PMID:32338120": {
                      "sentence": "We found TGF-beta1 increased the levels of Col I, FN, alpha-SMA and vimentin in HK-2 cells compared with control, and decreased E-Cadherin level, however, IL-22 restored their expressions partly.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Nov"
                    },
                    "PMID:32550106": {
                      "sentence": "The protein expressions of TG2, Col I and alpha-SMA stimulated by TGF-beta1 were decreased after metformin intervention, which was confirmed in both siRNAs and plasmids treatment conditions.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Jun"
                    },
                    "PMID:32868830": {
                      "sentence": "Additionally, trehalose attenuated the increase of alpha-SMA and ColIalpha     1       mRNA expression induced by TGF-beta     1       through Snail protein degradation, which was dependent on autophagy in PMCs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Aug 31"
                    },
                    "PMID:33025706": {
                      "sentence": "Stearic acid significantly reduced TGF-beta1-induced alpha-SMA and collagen type 1 expression in MRC-5 cells.",
                      "object score": 770,
                      "subject score": 770,
                      "publication date": "2020 Oct 06"
                    },
                    "PMID:33407872": {
                      "sentence": "In vitro, Hypo-EVs decreased the expression of p-smad2/3, alpha-SMA, and collagen-1 in HLF-1 cells (human lung fibroblasts) stimulated by TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021 Jan 06"
                    },
                    "PMID:33579280": {
                      "sentence": "It also overcomes corticosteroids insensitivity in TGF-beta1-induced alpha-SMA induction.",
                      "object score": 839,
                      "subject score": 839,
                      "publication date": "2021 Feb 12"
                    },
                    "PMID:33663392": {
                      "sentence": "CONCLUSION: The EMT and fibrotic effect of TGF-beta1 is dependent on acetylated C/EBPbeta-mediated regulation of alpha-SMA gene activity.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2021 Mar 04"
                    },
                    "PMID:33854158": {
                      "sentence": "The addition of sodium nitrite (1 mM) to TGF-beta1-stimulated keratocytes significantly decreased alphaSMA and N cadherin expression.",
                      "object score": 792,
                      "subject score": 792,
                      "publication date": "2021 Apr 14"
                    },
                    "PMID:33899116": {
                      "sentence": "The results indicated that Sal B significantly downregulated TGF-beta1-induced alpha-SMA, fibronectin and collagen III expression levels in NPFs.",
                      "object score": 766,
                      "subject score": 766,
                      "publication date": "2021 Jun"
                    },
                    "PMID:34076990": {
                      "sentence": "RESULTS: TGF-beta1 activated LX-2 cells, as evidenced by up-regulated alpha-SMA and F-actin expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021 Mar-Apr"
                    },
                    "PMID:34093237": {
                      "sentence": "We propose that TGF-beta1 may promote    in vitro     the fibroblasts-to-myofibroblasts transition    via     the morphological and molecular modifications, as the induction of alpha-SMA, Vimentin, E-cadherin, beta-catenin, and Smad 2/3.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:stimulates---NCBIGene:4088---SEMMEDDB:",
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C0919432---SEMMEDDB:",
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C0529119---SEMMEDDB:",
                    "UMLS:C1366557---SEMMEDDB:stimulates---UMLS:C0919432---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20943464",
                    "PMID:21057546",
                    "PMID:30290314",
                    "PMID:25962701",
                    "PMID:28110342",
                    "PMID:25068659",
                    "PMID:12065755",
                    "PMID:28103144",
                    "PMID:24338442",
                    "PMID:26945889",
                    "PMID:20016942",
                    "PMID:32200666",
                    "PMID:25392233",
                    "PMID:17623674",
                    "PMID:21868450",
                    "PMID:26088859",
                    "PMID:26956045",
                    "PMID:26497676",
                    "PMID:31686852",
                    "PMID:21344492"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:11262418": {
                      "sentence": "Investigation of transcriptional activation of TGF-beta-sensitive reporter genes in the different fibroblasts showed that activation of the (Smad binding element)(4)-Lux reporter by TGF-beta1 was dependent on expression of Smad3, but not Smad2, whereas activation of the activin response element-Lux reporter was strongly suppressed in S2KO fibroblasts but, on the contrary, enhanced in S3KO cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Jun 08"
                    },
                    "PMID:12065755": {
                      "sentence": "It inhibited TGF-beta1-induced nuclear Smad3 localization.",
                      "object score": 847,
                      "subject score": 847,
                      "publication date": "2002 Jul"
                    },
                    "PMID:12824291": {
                      "sentence": "In a heterologous DNA binding transcription assay, biochemical or dominant-negative ERK blockade reduced TGF-beta1 induced Smad3 activity.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2003 Aug"
                    },
                    "PMID:15153536": {
                      "sentence": "LY294002 significantly decreased the phosphorylation of Smad3 induced by TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Jun 01"
                    },
                    "PMID:18322023": {
                      "sentence": "Transforming growth factor-beta1, on the other hand, induced early activation of Smad3 and its translocation to the nucleus, Erk1/2 phosphorylation, and early disruption of membrane E-cadherin localization.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 May"
                    },
                    "PMID:18353861": {
                      "sentence": "Using both a reporter assay and Northern blot analysis, we showed that TGF-beta1 repressed miR-24 transcription which was dependent on the presence of Smad3 and a Smads binding site in the promoter region of miR-24.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 May"
                    },
                    "PMID:18835815": {
                      "sentence": "Furthermore, LOX suppressed TGF-beta1-induced Smad3 phosphorylation likely through its amine oxidase activity.",
                      "object score": 847,
                      "subject score": 847,
                      "publication date": "2008 Dec 05"
                    },
                    "PMID:19955655": {
                      "sentence": "Additionally, TGF-beta1 expression led to Smad3 activation and murine double minute 2 (Mdm2) expression in murine mammary epithelial cells during epithelial-to-mesenchymal transition (EMT).",
                      "object score": 694,
                      "subject score": 901,
                      "publication date": "2010 Jan"
                    },
                    "PMID:20016942": {
                      "sentence": "Overexpression of Stat1 diminished TGF-beta1-induced, Smad3/4-and Runx3-mediated GL alpha promoter activity.",
                      "object score": 798,
                      "subject score": 798,
                      "publication date": "2010 Jan"
                    },
                    "PMID:23877620": {
                      "sentence": "p38 MAPK inhibitors (SB 203580) can attenuate TGF-beta1-induced Smad3 expression and suppress the activation of smad3.",
                      "object score": 863,
                      "subject score": 863,
                      "publication date": "2013 Oct"
                    },
                    "PMID:24338442": {
                      "sentence": "Our results indicate that EMT of porcine bladder UC cells is TGF-beta1 dependent and is mediated through Smad2 and Smad3.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Mar"
                    },
                    "PMID:24471776": {
                      "sentence": "The TGF-beta1-induced Smad2 and Smad3 phosphorylation levels were abrogated by simvastatin pretreatment.",
                      "object score": 851,
                      "subject score": 888,
                      "publication date": "2014 Jan-Feb"
                    },
                    "PMID:24573038": {
                      "sentence": "Importantly, the JAK2/STAT3-specific inhibitor AG490 blocked Stat3 phosphorylation, resulting in attenuated levels of TGF-beta1-induced p-Smad3, Snail, MMP2, and Smad-mediated PAI-1 promoter reporter gene activity in A549 and H1650 cells.",
                      "object score": 751,
                      "subject score": 751,
                      "publication date": "2014 May"
                    },
                    "PMID:25068659": {
                      "sentence": "The lack of TRPA1 in cultured ocular fibroblasts attenuated expression of TGF-beta1, interleukin-6, and alpha-smooth muscle actin, a myofibroblast the marker, but suppressed the activation of Smad3, p38 MAPK, ERK, and JNK.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Sep"
                    },
                    "PMID:25392233": {
                      "sentence": "Here, we identified GQ5, a small molecular phenolic compound isolated from the dried resin of Toxicodendron vernicifluum, as a potent and selective inhibitor of TGF-beta1-induced Smad3 phosphorylation.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "2015 Aug"
                    },
                    "PMID:25550698": {
                      "sentence": "Next, we tested the effect of the E3 ligase PIASy on TGF-beta1-induced, Smad3/4-mediated GLalpha promoter activity.",
                      "object score": 735,
                      "subject score": 735,
                      "publication date": "2014 Dec"
                    },
                    "PMID:26316705": {
                      "sentence": "Lefty-1 further induced remarkable reductions in TGF-beta1-induced Smad3 and mitogen-activated protein kinase-10/c-Jun N-terminal kinase (JNK-3) signaling, and enhanced expression of the antifibrotic factor bone morphogenetic protein (BMP)-5.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2015"
                    },
                    "PMID:26464640": {
                      "sentence": "Furthermore, knockdown of eIF3a attenuated TGF-beta1-induced Smad3 activation in HK-2 cells.",
                      "object score": 744,
                      "subject score": 744,
                      "publication date": "2015"
                    },
                    "PMID:26497676": {
                      "sentence": "Mechanism study revealed that LTB4-mediated suppression of TGF-beta1-induced Smad3 activation and growth inhibition was due to enhanced phosphorylation of Smad3 linker region (pSmad3L) through activation of BLT1-NAD(P)H oxidase (NOX)-reactive oxygen species (ROS)-epidermal growth factor receptor (EGFR)-phosphatidylinositol 3-kinase (PI3-K)-extracellular signal-activated kinase1/2 (ERK1/2)-linked signaling cascade.",
                      "object score": 676,
                      "subject score": 676,
                      "publication date": "2015 Dec 08"
                    },
                    "PMID:27895151": {
                      "sentence": "Increased transforming growth factor beta1 (TGF-beta1) in mammary adipose tissue in obese mice activates SMAD3 signaling, causing phospho-SMAD3 to bind to the miR-140 locus and inhibit miR-140 transcription.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2017 02 15"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P01137-biolink:entity_positively_regulates_entity-UniProtKB:Q15796": {
              "object": "UniProtKB:Q15796",
              "subject": "UniProtKB:P01137",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0080222---SEMMEDDB:stimulates---UMLS:C1334468---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:18838125",
                    "PMID:15657445",
                    "PMID:17498122",
                    "PMID:10505717",
                    "PMID:11262418",
                    "PMID:11762872",
                    "PMID:15469966",
                    "PMID:12200968",
                    "PMID:16596245",
                    "PMID:18456797",
                    "PMID:11448947",
                    "PMID:16528248",
                    "PMID:17197570",
                    "PMID:18471442",
                    "PMID:10670756",
                    "PMID:15249209",
                    "PMID:15961403",
                    "PMID:10504488",
                    "PMID:15067346",
                    "PMID:16949833"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:10505717": {
                      "sentence": "Furthermore, TGF-beta1 increases steady-state levels of Smad2 mRNA in the TGF-beta1-sensitive pancreatic cancer cell line COLO-357.",
                      "object score": 888,
                      "subject score": 832,
                      "publication date": "1999 Sep"
                    },
                    "PMID:10670756": {
                      "sentence": "Northern blot analysis showed that TGF-beta1 significantly increased the mRNA level of Smad2 but not of Smad4 in a dose- and time-dependent manner, suggesting that the augmentation of TGF-beta1 action is caused by increasing the expression of the downstream signalling molecule.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Oct"
                    },
                    "PMID:11262418": {
                      "sentence": "Investigation of transcriptional activation of TGF-beta-sensitive reporter genes in the different fibroblasts showed that activation of the (Smad binding element)(4)-Lux reporter by TGF-beta1 was dependent on expression of Smad3, but not Smad2, whereas activation of the activin response element-Lux reporter was strongly suppressed in S2KO fibroblasts but, on the contrary, enhanced in S3KO cells.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2001 Jun 08"
                    },
                    "PMID:11448947": {
                      "sentence": "Activation of Smad2 by MEK1 or TGF beta 1 resulted in an enhanced nuclear localization of Smad2, which was inhibited upon blocking MEK1 activity.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Sep 07"
                    },
                    "PMID:11762872": {
                      "sentence": "Spurred by this finding, we assayed for TGF-beta1, a ligand for one receptor associated with smad2 activation, and detected significant levels in EMD preparations.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2001 Dec"
                    },
                    "PMID:12200968": {
                      "sentence": "Anti-TGF-beta antibody, at levels which completely blocked TGF-beta 1-induced smad2 translocation, strongly blocked EMD-induced smad2 translocation.",
                      "object score": 608,
                      "subject score": 608,
                      "publication date": "2002 Aug"
                    },
                    "PMID:16528248": {
                      "sentence": "Tranilast reduced CTGF mRNA and phosphorylation of Smad2, which were induced by TGF-beta1 in PTCs and CFs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Mar"
                    },
                    "PMID:16596245": {
                      "sentence": "A markedly elevated level of TGF-beta1-induced Smad3 signalling was observed in one cell line (H357), whilst four cell lines (BICR31, H314, BICR56, BICR19) demonstrated absence of Smad3-dependent transcription that correlated with loss of TGF-beta1 growth inhibition; TGF-beta1-induced Smad2-dependent transcription was retained in two of these cell lines (H314, BICR31).",
                      "object score": 847,
                      "subject score": 847,
                      "publication date": "2006 May"
                    },
                    "PMID:23328619": {
                      "sentence": "Propolis prevents the effects of TGF-beta1-induced Smad2 and AKT activation pathways and Snail expression.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2013 Mar"
                    },
                    "PMID:23864386": {
                      "sentence": "We also show that TA could exert this effect on cancer cell lines from several different origins and that TA is much better than other non-steroidal anti-inflammatory drugs with respect to inhibition of TGF-beta1-induced Smad2 phosphorylation.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "2013 Dec"
                    },
                    "PMID:23872073": {
                      "sentence": "While transforming growth factor-beta (TGF-beta1)-induced SMAD2/3 signaling is a critical event in the progression of chronic kidney disease, the role of non-SMAD mechanisms in the orchestration of fibrotic gene changes remains largely unexplored.",
                      "object score": 775,
                      "subject score": 1000,
                      "publication date": "2013 Nov"
                    },
                    "PMID:24338442": {
                      "sentence": "Our results indicate that EMT of porcine bladder UC cells is TGF-beta1 dependent and is mediated through Smad2 and Smad3.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Mar"
                    },
                    "PMID:24471776": {
                      "sentence": "The TGF-beta1-induced Smad2 and Smad3 phosphorylation levels were abrogated by simvastatin pretreatment.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2014 Jan-Feb"
                    },
                    "PMID:24508536": {
                      "sentence": "Then, the release of TGF-beta1 was detected by ELISA and quantitative real-time PCR, and the activation of the TGF-beta1-Smad2 pathway was analyzed by Western blotting.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2014 Apr"
                    },
                    "PMID:24512120": {
                      "sentence": "Our results shows that FK506 effectively blocked the TGF-beta/Smad signaling pathway by downregulation of TGF-beta receptor, and played an important role in TGF-beta1-induced Smad2 expression in mice mesangial cells.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "2014 May"
                    },
                    "PMID:24573955": {
                      "sentence": "Gli1 inhibited alphavbeta6 expression by suppressing TGF-beta1-induced Smad2/3 activation, blocking a positive feedback loop maintaining high alphavbeta6 levels.",
                      "object score": 580,
                      "subject score": 580,
                      "publication date": "2014 Jun"
                    },
                    "PMID:24720953": {
                      "sentence": "Moreover, the absence of LAMA1 increased transforming growth factor (TGF)-beta1-induced Smad2 phosphorylation, and inhibitors of TGF-beta1 receptor I kinase blocked Smad2 phosphorylation in both control and Lama1(CKO) mesangial cells, indicating that the increased Smad2 phosphorylation occurred in the absence of LAMA1 via the TGF-beta1 receptor.",
                      "object score": 863,
                      "subject score": 863,
                      "publication date": "2014 Jun"
                    },
                    "PMID:26173585": {
                      "sentence": "These changes were associated with impaired TGF-beta1-induced Smad2 and Erk1/2 phosphorylation and upregulated TGF-beta1 ligand mRNA expression, compatible with G357W as a loss-of-function mutation in the TGF-beta type 2 receptor.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "2015 Oct"
                    },
                    "PMID:26249143": {
                      "sentence": "Furthermore, TGF-beta1 stimulated the expression of periostin, and siRNA-periostin attenuated TGF-beta1-induced Smad2/3 activation in HSCs.",
                      "object score": 645,
                      "subject score": 645,
                      "publication date": "2015 Oct"
                    },
                    "PMID:27717887": {
                      "sentence": "Emodin also inhibited TGF-beta1-induced Smad2/3 and STAT3 activation, indicating that Smad2/3 and STAT3 inactivation mediates emodin-induced effects on TGF-beta1-induced myofibroblast differentiation.",
                      "object score": 798,
                      "subject score": 798,
                      "publication date": "2016 Nov 16"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P05019-biolink:entity_positively_regulates_entity-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "UniProtKB:P05019",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P05019-biolink:entity_positively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "UniProtKB:P05019",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P15692-biolink:entity_negatively_regulates_entity-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "UniProtKB:P15692",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C1171892---SEMMEDDB:inhibits---UMLS:C0172537---SEMMEDDB:",
                    "NCBIGene:7422---SEMMEDDB:inhibits---UMLS:C0172537---SEMMEDDB:",
                    "UMLS:C1823619---SEMMEDDB:inhibits---UMLS:C0172537---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17322177",
                    "PMID:19483477",
                    "PMID:17650671",
                    "PMID:28633655",
                    "PMID:20075389",
                    "PMID:24850176",
                    "PMID:20092995",
                    "PMID:27241143",
                    "PMID:16100286",
                    "PMID:30825266",
                    "PMID:26097685"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:16100286": {
                      "sentence": "This report provides the first evidence that connective tissue growth factor may anchor vascular endothelial growth factor to the extracellular matrix and that this deposition is decreased by matrix metalloproteinase-2 and prostaglandin E2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Jan"
                    },
                    "PMID:17322177": {
                      "sentence": "At day 7, plasma and ischemic tissues of vascular endothelial growth factor protein were reduced in MMP-2(-/-).",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2007 Mar 30"
                    },
                    "PMID:17650671": {
                      "sentence": "CONCLUSIONS: As2 O3 may down-regulate the expression of VEGF and inhibit the activity of MMP-2 and 9.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Feb"
                    },
                    "PMID:19483477": {
                      "sentence": "Taken together, these results demonstrate that HS has antimetastasic properties possibly via its antiangiogenesis induced by downregulation of VEGF and suppression of invasive ability of cancer cells mediated by downregulation of MMP-2, -9 and their activities.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Aug"
                    },
                    "PMID:20075389": {
                      "sentence": "MEASUREMENTS AND MAIN RESULTS: After corrections for false discovery rates, only 2 of 10 genes (serpin peptidase inhibitor/plasminogen activator inhibitor member 2 and matrix metalloproteinase [MMP] 10) increased, whereas 8 (MMP2, integrin-alpha1, vascular endothelial growth factor, a disintegrin and metallopeptidase domain 33, scatter factor/hepatocyte growth factor, tissue inhibitor of matrix metalloproteinase-2, fibronectin, and collagen 3alpha1) decreased in small airways in association with FEV(1).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Jun 15"
                    },
                    "PMID:20092995": {
                      "sentence": "Hormone-induced 3T3 L1 differentiation in the presence of L. obtusiloba extract resulted in a reduced accumulation of intracellular lipid droplets by 70%, in down-regulated expression of the adipogenesis-associated proteins glucose transporter-4 and vascular endothelial growth factor, in reduced secretion of the proadipogenic matrix metalloproteinase-2, and in dampened phosphorylation of the Wnt pathway effector protein beta-catenin with subsequent diminished expression of the peroxisome proliferator-activated receptor-gamma.",
                      "object score": 923,
                      "subject score": 1000,
                      "publication date": "2010 Dec"
                    },
                    "PMID:24850176": {
                      "sentence": "We found that overexpression of VEGFa in SNU-5 cells increased expression of MMP2, while inhibition of VEGFa in SNU-5 cells decreased expression of MMP2.",
                      "object score": 988,
                      "subject score": 1000,
                      "publication date": "2014 Aug"
                    },
                    "PMID:26097685": {
                      "sentence": "However there are many other effects, partially dependent and independent of those mentioned, that may be useful in cancer treatment, including MMP-9 and MMP-2 inhibition, down-regulation of CDK-2, VEGF, bFGF, NF-kB, STAT-3, HIF-1 alfa, IGF, EGFR, survivin, BCRP, androgen receptor, proteasome, fatty acid synthase (FAS), decrease in cellular ATP concentration and upregulation of TRAIL receptor DR5, Bax, increased radiosensitivity, and autophagy.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2015"
                    },
                    "PMID:27241143": {
                      "sentence": "CONCLUSION: Through the inhibitory effect on EGFR-TPK, APN and MMP-2, osthole can decrease COX-2, VEGF and NF-kappaB expression while increase the activity of caspase-3, eventually blocking the growth and invasion of bladder cancer cell.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Apr"
                    },
                    "PMID:28633655": {
                      "sentence": "In Weri-1 cells, VEGF was significantly reduced and cell viability was decreased by both MMP-2 and MMP-9 inhibitors.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Jun 20"
                    },
                    "PMID:30825266": {
                      "sentence": "Knockdown of Sox-2 by siRNA transfection suppressed cell proliferation and migration, constrained VEGF secretion and inhibited pro-MMP1 and pro-MMP2 expression.",
                      "object score": 875,
                      "subject score": 928,
                      "publication date": "2019 May"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P15692-biolink:entity_positively_regulates_entity-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "UniProtKB:P15692",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C1171892---SEMMEDDB:stimulates---UMLS:C0172537---SEMMEDDB:",
                    "NCBIGene:7422---SEMMEDDB:stimulates---UMLS:C0172537---SEMMEDDB:",
                    "UMLS:C1823619---SEMMEDDB:stimulates---UMLS:C0172537---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16672691",
                    "PMID:26013382",
                    "PMID:16033879",
                    "PMID:24850176",
                    "PMID:19763043",
                    "PMID:23382918",
                    "PMID:16152587",
                    "PMID:19150341",
                    "PMID:17469009",
                    "PMID:12133405",
                    "PMID:21885032",
                    "PMID:21839074",
                    "PMID:16584583",
                    "PMID:18368029",
                    "PMID:21130856",
                    "PMID:18171938",
                    "PMID:23884892",
                    "PMID:17219986",
                    "PMID:12044329",
                    "PMID:22270366"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:12044329": {
                      "sentence": "In addition, VEGF stimulated endothelial MMP-2 and MMP-9 release in a concentration- and time-dependent (6-24 h) manner.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "2001"
                    },
                    "PMID:12133405": {
                      "sentence": "CONCLUSION: The expression of VEGF correlates to the in vitro invasion of ovarian tumor cell and induction of MMP-2 by VEGF is a key component of VEGF-induced ovarian tumor cell invasion.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 May"
                    },
                    "PMID:16033879": {
                      "sentence": "This proangiogenic activity was exerted only in the presence of VEGF, at least partly mediated via induction of MMP-2 and MMP-9 in the tumour.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Dec"
                    },
                    "PMID:16152587": {
                      "sentence": "Using Western blotting, we show that VEGF, at 20-80 ng/ml, induced secretion of pro-MMP-7 and pro-MMP-9 and activation of pro-MMP-2 in DOV13 conditioned medium in a concentration-dependent manner.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "2006 Feb 15"
                    },
                    "PMID:16584583": {
                      "sentence": "VEGF can upregulate the expression of MMP-2, MMP-9 in HL-60 and a part of the primary leukemic cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Feb"
                    },
                    "PMID:16672691": {
                      "sentence": "VEGF-induced MMP-2 mRNA expression was reduced by inhibition of JNK or by treatment with c-Jun siRNA.",
                      "object score": 818,
                      "subject score": 818,
                      "publication date": "2006 Oct"
                    },
                    "PMID:17219986": {
                      "sentence": "It was concluded that the expression of VEGF was correlated to the in vitro invasion of NPC cells, and the induction of MMP-2 by VEGF was a key process of NPC cell invasion.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006"
                    },
                    "PMID:17469009": {
                      "sentence": "Vascular endothelial growth factor induces endothelin-1 production via matrix metalloproteinase-2 rather than endothelin-converting enzyme-1.",
                      "object score": 793,
                      "subject score": 1000,
                      "publication date": "2007"
                    },
                    "PMID:18171938": {
                      "sentence": "To assess the importance of androgen-regulated, VEGF-induced MMP2 to adult angiogenesis and neurogenesis, we treated testosterone-implanted females with the gelatinase inhibitor SB-3CT.",
                      "object score": 817,
                      "subject score": 817,
                      "publication date": "2008 Jan 02"
                    },
                    "PMID:18368029": {
                      "sentence": "In the knockout mice there was increased PAI-1 and MCP-1 expression, marked induction of MMP-2 and MMP-9, but similar expression of PDGF alpha, IGF-1, TGF-beta1, VEGF, and osteopontin compared to wild type mice.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Jul"
                    },
                    "PMID:19150341": {
                      "sentence": "In mechanistic studies, both baseline and VEGF-induced MMP-2 activation and Matrigel invasion were inhibited by ADAM-17 depletion.",
                      "object score": 619,
                      "subject score": 619,
                      "publication date": "2009 Feb 27"
                    },
                    "PMID:19763043": {
                      "sentence": "In addition, the effects of TROG on VEGF-induced MMP-2 and MT1-MMP expression were comparable to those of the NADPH oxidase inhibitor diphenylene iodium (10 muM) and ERK inhibitor PD98056 (10 muM).",
                      "object score": 868,
                      "subject score": 868,
                      "publication date": "2009 Sep"
                    },
                    "PMID:21130856": {
                      "sentence": "Additionally, gelatin zymography assays showed that TS extracts and gallic acid suppressed the activity of metalloproteinase (MMP)-9 and MMP-2 activated by VEGF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Mar 08"
                    },
                    "PMID:21839074": {
                      "sentence": "Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Oct 15"
                    },
                    "PMID:21885032": {
                      "sentence": "PERIOSTIN promotes angiogenesis through upregulation of matrix metalloproteinase (MMP)-2, which has been shown to be expressed via alphavbeta3 integrin/extracellular signal-related kinase (ERK) signalling pathway and vascular endothelial growth factor (VEGF).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jan"
                    },
                    "PMID:22270366": {
                      "sentence": "VEGF induced the expression of MMP-2, MMP-9, and MMP-13 and hence regulated the metastasis of SKOV-3 ovarian cancer cells, and the activities of these MMPs were reduced after inhibition of PI3K/AKT and p38 MAPK pathways.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Apr 27"
                    },
                    "PMID:23382918": {
                      "sentence": "NCe treatment also inhibited VEGF(165) induced proliferation, capillary tube formation, activation of VEGFR2 and MMP2 in human umbilical vascular endothelial cells (HUVEC).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:23884892": {
                      "sentence": "We demonstrate that accumulation of hypoxia-inducible factor-1alpha in Muller cells induces the expression of VEGF, which, in turn, promotes increased MMP-2 expression and activity in neighboring endothelial cells (ECs).",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2013 Nov"
                    },
                    "PMID:24850176": {
                      "sentence": "Application of a specific Akt inhibitor to VEGFa-overexpressing SNU-5 cells substantially abolished the effect of VEGFa on MMP2 activation, suggesting that VEGFa may increase expression of MMP2 via PI3K/Akt signaling pathway.",
                      "object score": 745,
                      "subject score": 1000,
                      "publication date": "2014 Aug"
                    },
                    "PMID:26013382": {
                      "sentence": "Furthermore, BIX01294 suppressed VEGF-induced matrix metalloproteinase 2 (MMP2) activity and inhibited VEGF-induced phosphorylation of VEGF receptor 2 (VEGFR-2), focal adhesion kinase (FAK), and paxillin in HUVECs.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2015 Jun"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P18075-biolink:entity_negatively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "UniProtKB:P18075",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P29474-biolink:entity_negatively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "UniProtKB:P29474",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0669365---SEMMEDDB:inhibits---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19066340",
                    "PMID:16952382",
                    "PMID:10415143",
                    "PMID:17895290",
                    "PMID:10226333",
                    "PMID:14551061",
                    "PMID:18830972",
                    "PMID:15130878",
                    "PMID:11040251",
                    "PMID:10514518",
                    "PMID:15914111",
                    "PMID:12060581",
                    "PMID:11117379",
                    "PMID:18551111",
                    "PMID:12869534",
                    "PMID:17179207",
                    "PMID:17113219",
                    "PMID:12370098",
                    "PMID:15840037",
                    "PMID:17655656"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9288162": {
                      "sentence": "All of the dipeptides and dipeptide esters are competitive inhibitors of nNOS, macrophage nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS), except for the ones that contain D-ArgNO2 (8-10, 12, 13), which are uncompetitive inhibitors of iNOS but competitive inhibitors of nNOS and eNOS.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Aug 29"
                    },
                    "PMID:9647329": {
                      "sentence": "These results suggest that WEB 2170 is effective in preserving endothelial function, prevents the development of neo-intima and blocks iNOS expression in the neo-intima in this model.",
                      "object score": 928,
                      "subject score": 851,
                      "publication date": "1998"
                    },
                    "PMID:10226333": {
                      "sentence": "The decrease in eNOS activity was completely prevented by selective iNOS inhibition in vivo and in vitro.",
                      "object score": 790,
                      "subject score": 888,
                      "publication date": "1999 May"
                    },
                    "PMID:10415143": {
                      "sentence": "The separate contributions of iNOS and cNOS to RGC degeneration were examined with intraocular injections of the specific iNOS inhibitor L-N(6)-(I-iminoethyl)lysine hydrochloride or the specific cNOS inhibitor L-thiocitrulline.",
                      "object score": 807,
                      "subject score": 1000,
                      "publication date": "1999 Aug"
                    },
                    "PMID:10514518": {
                      "sentence": "Although neurons and endothelial cells express proteins that interact with and inhibit neuronal NOS and endothelial NOS, macrophage proteins that inhibit NOS2 have not been identified.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Oct 15"
                    },
                    "PMID:11040251": {
                      "sentence": "The administration of cyclosporine was associated with nephrotoxicity and hepatotoxicity, increased endothelial nitric oxide synthase mRNA levels in renal cortex and liver, and a decrease in inducible nitric oxide synthase and neuronal nitric oxide synthase in renal medulla.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2000 Oct"
                    },
                    "PMID:11117379": {
                      "sentence": "The combination of TKL and MMF appears to be superior to TKL and azathioprine (and comparable to CyA and azathioprine) concerning preservation of early coronary vasomotor function, eNOS expression, iNOS suppression as well as cardiac interleukin-6 release.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2000 Dec"
                    },
                    "PMID:12060581": {
                      "sentence": "Caveolin-1 coimmunoprecipitates with eNOS; interaction with eNOS occurs via the caveolin-1 scaffolding domain and appears to result in the inhibition of NOS activity.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Jul"
                    },
                    "PMID:12869534": {
                      "sentence": "PKC phosphorylated eNOS specifically at Thr497 with a concomitant decrease in the NOS activity.",
                      "object score": 888,
                      "subject score": 937,
                      "publication date": "2003 Jun"
                    },
                    "PMID:14551061": {
                      "sentence": "NOS inhibition reduces CCK-stimulated in vivo pancreatic secretion, but it is unclear which NOS isoform is responsible, because NOS inhibitors lack specificity and three NOS isoforms exist: neuronal (nNOS), endothelial (eNOS), and inducible (iNOS).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2004 Mar"
                    },
                    "PMID:16952382": {
                      "sentence": "While MLTC-1 expressed mRNA for endothelial and neuronal, but not inducible NOS, various stimulators and inhibitors of L-arginine-NOS pathway had no effect on basal testosterone production in MLTC-1 or fresh Balb/c Leydig cells.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2006 Nov"
                    },
                    "PMID:18551111": {
                      "sentence": "Furthermore, chronic intake of the higher dose of quercetin enhanced VAT eNOS expression among obese Zucker rats, whereas it downregulated VAT iNOS expression.",
                      "object score": 868,
                      "subject score": 868,
                      "publication date": "2008 Sep"
                    },
                    "PMID:23140764": {
                      "sentence": "KMUP-1 inhibition of hypertension-induced LVH with associated upregulation of eNOS, downregulation of iNOS in both the aorta and left ventricle, and attenuation of calcineurin A and ERK1/2 signaling in the left ventricle.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Nov"
                    },
                    "PMID:23239437": {
                      "sentence": "Moreover, THPA enhanced the expression of endothelial nitric oxide synthase (NOS), and reduced the expression of inducible NOS and lectin-like oxidized LDL receptor-1 in the aorta, suggesting that THPA can exert endothelial protection effects.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Nov"
                    },
                    "PMID:23255592": {
                      "sentence": "This high output NO stimulated with BK was blocked with a B2R antagonist, eNOS siRNA, or eNOS inhibitor but not iNOS inhibitor.",
                      "object score": 882,
                      "subject score": 901,
                      "publication date": "2013 Feb 08"
                    },
                    "PMID:23826653": {
                      "sentence": "These were associated with increased levels of eNOS expression in vascular and muscle tissues, but reductions in nitrotyrosine, endothelin, NAD(P)H oxidase, and iNOS expressions.",
                      "object score": 872,
                      "subject score": 888,
                      "publication date": "2013 Jul"
                    },
                    "PMID:23978788": {
                      "sentence": "Exogenous nesfatin-1 (5-40MUg/kg i.p.) significantly decreased gastric acid secretion and attenuated gastric lesions induced by WRS, and this was accompanied by a significant rise in plasma NUCB2/nefatin-1 levels, the gastric mucosal blood flow (GBF), luminal NO concentration, generation of PGE2 in the gastric mucosa, an overexpression of mRNA for NUBC2 and cNOS, as well as a suppression of iNOS and proinflammatory cytokine IL-1beta and TNF-alpha mRNAs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Nov"
                    },
                    "PMID:24463049": {
                      "sentence": "Compared with old controls, long-term administration of atorvastatin to old rats inhibited the senescent phenotype (p<0.05), improved endothelium-dependent relaxation (p<0.05 or 0.01), decreased MDA (p<0.01), increased SOD, NO, eNOS, and SIRT1 expression (p<0.01), and inhibited iNOS expression (not detectable) in aged rat aortas.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2014 Apr"
                    },
                    "PMID:25183664": {
                      "sentence": "Results demonstrated that WIRS-exposed mice produced several injuries and showed an increased iNOS and eNOS mRNA expression in testes, whereas pretreatment with Big-leaf mulberry down-regulated iNOS and eNOS mRNA expressions and up-regulated T-AOC activities.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2014 Oct"
                    },
                    "PMID:27717985": {
                      "sentence": "Furthermore, they up-regulated eNOS and down-regulated iNOS and NOSTRIN expressions.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Jan"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P29474-biolink:entity_positively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "UniProtKB:P29474",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:4846---SEMMEDDB:stimulates---UMLS:C0669372---SEMMEDDB:",
                    "UMLS:C1328053---SEMMEDDB:stimulates---UMLS:C0669372---SEMMEDDB:",
                    "UMLS:C0669365---SEMMEDDB:stimulates---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20551918",
                    "PMID:11395903",
                    "PMID:31007752",
                    "PMID:10453504",
                    "PMID:23161371",
                    "PMID:20953358",
                    "PMID:31479717",
                    "PMID:17628538",
                    "PMID:10587420",
                    "PMID:12412619",
                    "PMID:15082754",
                    "PMID:16472125",
                    "PMID:17082483",
                    "PMID:17545029",
                    "PMID:15492465",
                    "PMID:25294342",
                    "PMID:15138276",
                    "PMID:20674563",
                    "PMID:15220775",
                    "PMID:11226286"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:10453504": {
                      "sentence": "These results suggested that the inhibited endothelium-derived relaxing factor (EDRF)/NO-dependent vasodilation after hypoxic exposure might be induced by decreased activity of cNOS in the endothelium of pulmonary vessels, and hypoxia-induced upregulation of iNOS expression and activity in the rat lung might play an important role in the adaptation of pulmonary circulation to hypoxia.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997 Apr"
                    },
                    "PMID:10587420": {
                      "sentence": "In contrast to nNOS and eNOS, activation of iNOS does not require an increase in intracellular Ca(2+) concentration.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "1999 Dec"
                    },
                    "PMID:11045973": {
                      "sentence": "Taken together, these results demonstrate that, in conscious animals, ischemic PC elicits a biphasic response in cardiac NOS activity, i. e., an immediate activation of cNOS (most likely eNOS) followed 24 h later by a delayed upregulation of iNOS.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Nov"
                    },
                    "PMID:11226286": {
                      "sentence": "The contribution of eNOS was assessed by using an eNOS-deficient mouse, and iNOS contribution was assessed by using a selective inhibitor [l-N(6)-(1-iminoethyl) lysine, l-NIL] and an iNOS-deficient mouse.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2001 Feb 27"
                    },
                    "PMID:11395903": {
                      "sentence": "The increased activation of the inflammatory response is evidenced from the increased levels of circulating proinflammatory cytokines in the blood, increased endothelial activation with increased expression of inducible nitric oxide synthase, and increased de novo CD11b expression on circulating immune effector cells, such as PMNs, monocytes and lymphocytes.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2001"
                    },
                    "PMID:11428906": {
                      "sentence": "An increase in iNOS activation leading to excessive nitric oxide synthesis, possibly non-endothelial in origin, may account for this defect.",
                      "object score": 819,
                      "subject score": 802,
                      "publication date": "2001 Jul"
                    },
                    "PMID:11547933": {
                      "sentence": "Immunohistochemical and Western blot analyses showed that repeated, short-term ischemia significantly increased the levels of bNOS in tumor cells and eNOS in tumor capillaries, but neither induced iNOS nor affected B2 receptor levels in tumor cells in vivo, as compared with nonischemic controls.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2001 Sep"
                    },
                    "PMID:11888919": {
                      "sentence": "These results indicate that single irradiation does not affect Ca(2+) mobilization and eNOS expression but induces the expression of iNOS in BAECs, and the latter property would be beneficial to induce apoptosis in the adjacent tumor cells.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2002 Mar 01"
                    },
                    "PMID:11914582": {
                      "sentence": "We found that (1) expression of iNOS and eNOS mRNA in endothelial cells was increased by chronic exercise and (2) chronic exercise blunted phenylephrine-induced vascular responses, probably by increasing NO release via iNOS.",
                      "object score": 870,
                      "subject score": 928,
                      "publication date": "2002 Mar-Apr"
                    },
                    "PMID:12412619": {
                      "sentence": "Livers from CLP rats showed no significant change in levels of eNOS mRNA, but showed a significant increase in iNOS expression (13.5-fold over sham).",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2002 Nov"
                    },
                    "PMID:12569550": {
                      "sentence": "With increasing spheroid size, eNOS expression was downregulated, whereas an upregulation of iNOS expression was observed.",
                      "object score": 928,
                      "subject score": 928,
                      "publication date": "2003 Apr 10"
                    },
                    "PMID:15492465": {
                      "sentence": "SNO-PEG-Hb altered NOS features observed in the vehicle-treated 2VO rat, upregulation of eNOS, nNOS, and iNOS expressions at mRNA and protein levels; SNO-PEG-Hb further upregulated eNOS and nNOS and downregulated iNOS expressions.",
                      "object score": 872,
                      "subject score": 794,
                      "publication date": "2004 Oct"
                    },
                    "PMID:16238546": {
                      "sentence": "Similarly, eNOS protein expression was attenuated more in young than in adult SHRs, although NAC treatment increased NOS activity to a similar extent in both young and adult rats.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2006 Feb"
                    },
                    "PMID:16472125": {
                      "sentence": "Data obtained in the present study show that the exposure for 5 days to high glucose increases oxidative stress, reduces DDAH-2 and eNOS expression and increases iNOS expression.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2006 Feb"
                    },
                    "PMID:17628538": {
                      "sentence": "Hyperlipidemia induced with this cholesterol-enriched diet leads to decreases in endogenous scavenger and cNOS activities, results in iNOS and NF-kappaB activation and stimulates ONOO(-) generation in the pancreas, which may be responsible for the aggravation of acute necrotizing pancreatitis.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2007 Oct 15"
                    },
                    "PMID:18259860": {
                      "sentence": "These results could indicate 1 that nNOS and eNOS mRNA and protein expression can be age-dependent, and confirmed the nNOS origin for the mitochondrial NOS.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2008 Jul"
                    },
                    "PMID:18712112": {
                      "sentence": "It has been shown that the activation of iNOS activity, cNOS activity inhibition and increase of the stable NO metabolites content takes place in the red blood cells (RBC) of diabetic rats.",
                      "object score": 888,
                      "subject score": 851,
                      "publication date": "2007 Nov-Dec"
                    },
                    "PMID:23161371": {
                      "sentence": "Pre-ischaemic delta-OR agonism with BW373U86 improved recoveries in CD hearts in association with phosphorylation of Akt (+40%), eNOS (+75%) and GSK3beta (+30%), yet failed to further enhance RISK-NOS activation or I-R outcomes in OB hearts.",
                      "object score": 620,
                      "subject score": 1000,
                      "publication date": "2013 Mar"
                    },
                    "PMID:23872130": {
                      "sentence": "In conclusion, dietary HFCS causes vascular insulin resistance and endothelial dysfunction through attenuating IRS-1 and eNOS expressions as well as increasing iNOS in rats.",
                      "object score": 802,
                      "subject score": 920,
                      "publication date": "2013 Oct"
                    },
                    "PMID:25294342": {
                      "sentence": "The treatment had varied effect on endothelial nitric oxide synthase (eNOS), sGC, and PDE5 but showed an increase in inducible NOS (iNOS) mRNA expression and plasma asymmetric dimethyl arginine levels.",
                      "object score": 824,
                      "subject score": 840,
                      "publication date": "2015 Jan-Feb"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:P35354-biolink:entity_negatively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "UniProtKB:P35354",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C1367485---SEMMEDDB:inhibits---UMLS:C0669372---SEMMEDDB:",
                    "UMLS:C1565860---SEMMEDDB:inhibits---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:33798849",
                    "PMID:10698360",
                    "PMID:20430633",
                    "PMID:20840057",
                    "PMID:31152813",
                    "PMID:24930695",
                    "PMID:17549372",
                    "PMID:31958453",
                    "PMID:32120079",
                    "PMID:19339484",
                    "PMID:24360561",
                    "PMID:27087648",
                    "PMID:24497037",
                    "PMID:21434881"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:10698360": {
                      "sentence": "None of these active compounds affected iNOS, COX-2, COX-1 or PLA2 activities, although some reduced iNOS or COX-2 expression.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000 Jan 21"
                    },
                    "PMID:17549372": {
                      "sentence": "RT-PCR analyses showed that SD at a dilution of 1/2000 did not affect TNFalpha, IL-1 beta, iNOS and COX-2 mRNA expression in RAW 264.7 cells compared to the unstimulated controls, but significantly reduced (p<0.05) iNOS and its mRNA expression in LPS-activated cells.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2007 Jul"
                    },
                    "PMID:19339484": {
                      "sentence": "Results indicated SHXT inhibited LPS-induced inflammation of BV-2 cells by downregulation of iNOS, NO, COX-2, PGE(2), gp91(phox), iROS, TNF-alpha, IL-1beta, inhibition of IkappaBalpha degradation and upregulation of HO-1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011"
                    },
                    "PMID:20430633": {
                      "sentence": "Compounds 1-3, 7-9, 12, and 13 at concentration of 10microM did not inhibit the COX-2 protein expression, but significantly reduced the levels of the iNOS protein (55.2+/-14.6%, 18.6+/-6.7%, 10.6+/-4.6%, 66.9+/-5.2%, 10.2+/-5.1%, 17.4+/-7.2%, 47.2+/-11.9%, and 56.3+/-5.1%, respectively) by LPS stimulation.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2010 May 15"
                    },
                    "PMID:20840057": {
                      "sentence": "Results demonstrate that the isolated Cyclo-pentano phenanthrenol inhibits TNF-alpha, IL-1beta and IL-6 expression, NO release via iNOS suppression, prostaglandin biosynthesis via PLA2 and COX-2 inhibition and the activation of intracellular targets, MAPK and NF-kappaB.",
                      "object score": 775,
                      "subject score": 888,
                      "publication date": "2010"
                    },
                    "PMID:21434881": {
                      "sentence": "KEY RESULTS: Promoter assays for iNOS and COX-2 revealed that arvelexin inhibited LPS-induced NO and prostaglandin E(2) production through the suppression of iNOS and COX-2 at the level of gene transcription.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Sep"
                    },
                    "PMID:24360561": {
                      "sentence": "Compound 1g not only inhibited COX-2 activity but also reduced expressions of COX-2 and iNOS.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2014 Jan 15"
                    },
                    "PMID:24497037": {
                      "sentence": "In order to understand the mechanism of this anti-inflammatory activity, the transcriptional level of 7 was found to down regulate mRNA expressions of iNOS and COX-2 in dose-dependent manners, whereas 8 inhibited only iNOS mRNA expression but did not affect on that of COX-2 gene.",
                      "object score": 824,
                      "subject score": 1000,
                      "publication date": "2014 Oct"
                    },
                    "PMID:24930695": {
                      "sentence": "Stimulation of microglia cells with supernatant of Poly I:C-treated RPE cells further elevated IL-6, IL-1beta and Cox2 expression, while it reduced the expression of iNOS.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2014 Dec"
                    },
                    "PMID:27087648": {
                      "sentence": "Trans-Cinnamaldehyde, An Essential Oil in Cinnamon Powder, Ameliorates Cerebral Ischemia-Induced Brain Injury via Inhibition of Neuroinflammation Through Attenuation of iNOS, COX-2 Expression and NFkappa-B Signaling Pathway.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2016 Sep"
                    },
                    "PMID:31152813": {
                      "sentence": "We also demonstrated that HWG significantly decreased the LPS-induced mRNA expression of iNOS, COX-2, TNF-alpha, IL-6, and IL-1beta in RAW264.7 macrophages, and reduced the LPS-induced protein expression of iNOS and COX-2 in RAW264.7 macrophages.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Aug 15"
                    },
                    "PMID:31958453": {
                      "sentence": "The results showed ER significantly suppressed the expressions of IL-1beta-induced the production of inflammatory factors in a dose-dependent pattern (4.30-fold decrease in COX-2, p < 0.05; 4.77-fold decrease in iNOS, p < 0.05 at 40 MUM in protein levels).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Jan 17"
                    },
                    "PMID:32120079": {
                      "sentence": "Western blot showed that pulvones A significantly decreased the levels of iNOS and COX-2 proteins and pulvones C only decreased the level of iNOS protein.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2020 Feb 22"
                    },
                    "PMID:33798849": {
                      "sentence": "Moreover, compound 2 significantly downregulated the mRNA expression of iNOS, COX-2, IL-1beta, NF-kappaB, IL-6 and TNF-alpha in LPS-mediated RAW 264.7 cells and markedly suppressed the protein expression of iNOS, NF-kappaB/p65, and COX-2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021 Mar 22"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q13315-biolink:entity_negatively_regulates_entity-UniProtKB:P50052": {
              "object": "UniProtKB:P50052",
              "subject": "UniProtKB:Q13315",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0919524---SEMMEDDB:inhibits---UMLS:C0390423---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8778741",
                    "PMID:17959957",
                    "PMID:8473497",
                    "PMID:9720792",
                    "PMID:9072342",
                    "PMID:21841547",
                    "PMID:26666666",
                    "PMID:18008188",
                    "PMID:17878754",
                    "PMID:9700980",
                    "PMID:9227601",
                    "PMID:15927719",
                    "PMID:24586922",
                    "PMID:12482596",
                    "PMID:9886894",
                    "PMID:17081374",
                    "PMID:9355068",
                    "PMID:8904632",
                    "PMID:9143779",
                    "PMID:1279763"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1279763": {
                      "sentence": "AT1 receptors, as determined in the presence of an excess concentration (10 microM) of the AT2 antagonist, PD 123177, account for 95% of total renal Ang II receptors, whereas AT2 receptors, as determined in the presence of an excess concentration (10 microM) of the AT1 antagonist, DuP 753, represent approximately 5% of total renal Ang II receptors.",
                      "object score": 694,
                      "subject score": 888,
                      "publication date": "1992"
                    },
                    "PMID:8473497": {
                      "sentence": "In the present study the effects of losartan, a selective AT1 receptor antagonist, and PD 123319, a selective AT2 antagonist, on the cardiac baroreflex response to Ang II were investigated in conscious rabbits with chronically implanted arterial and venous catheters.",
                      "object score": 660,
                      "subject score": 583,
                      "publication date": "1993 Apr"
                    },
                    "PMID:8778741": {
                      "sentence": "Some of the AT1 receptor-mediated effects have been shown to be enhanced by blockade of AT2 receptors in the brain suggesting that the central AT2 receptor can exert an inhibitory control on AT1 receptor-mediated actions in the brain.",
                      "object score": 888,
                      "subject score": 816,
                      "publication date": "1995 Nov"
                    },
                    "PMID:8904632": {
                      "sentence": "Addition of losartan, a nonpeptide AT1 receptor blocker, to intratubular fluid increased fluid uptake by 15.7 +/- 3.9% (10(-5) M) and 24.7 +/- 9.4% (10(-4) M) whereas the AT2 inhibitor, PD123319 had no effect.",
                      "object score": 872,
                      "subject score": 583,
                      "publication date": "1996 Oct"
                    },
                    "PMID:9072342": {
                      "sentence": "CV-11974, a specific AT1 receptor antagonist, and CGP42112B, a specific AT2 antagonist, were used in competition with [125I]-[Sar1,Ile8]AII to differentiate AT1 and AT2 receptor binding.",
                      "object score": 660,
                      "subject score": 583,
                      "publication date": "1995 Dec"
                    },
                    "PMID:9143779": {
                      "sentence": "During gestation, the AngII receptor density was decreased and the AT1 receptor became predominant in the last part of gestation as a result of a down-regulation of the AT2 receptor.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1997 May"
                    },
                    "PMID:9227601": {
                      "sentence": "To test this hypothesis, we studied the effects of systemic and central administration of losartan, a selective AT1 receptor antagonist, and PD-123319, a selective AT2 antagonist, on baroreflex-mediated control of HR and RSNA in conscious newborn lambs.",
                      "object score": 660,
                      "subject score": 583,
                      "publication date": "1997 Jun"
                    },
                    "PMID:9355068": {
                      "sentence": "The Ang II-induced calcium responses were totally abolished by the AT1 receptor antagonist losartan (1 mumol/L) but not by the AT2 antagonist PD 123319 (1 mumol/L).",
                      "object score": 824,
                      "subject score": 775,
                      "publication date": "1997 Nov"
                    },
                    "PMID:9700980": {
                      "sentence": "In contrast, neither the AT1-receptor antagonist CV11974, the AT2 antagonist PD123319, nor the angiotensin-converting enzyme inhibitor lisinopril, each at concentrations of 1 microM, had any effect on the U46619-induced constriction in aortic rings.",
                      "object score": 802,
                      "subject score": 775,
                      "publication date": "1998 Aug"
                    },
                    "PMID:9720792": {
                      "sentence": "It is concluded that in both vessels: (1) pre- and postjunctional receptors belong to a different subtype, since they are differently antagonized by the same antagonists; (2) postjunctional receptors belong to AT1 subtype, since they are blocked by losartan but not by AT2 antagonists; (3) prejunctional receptors apparently belong to neither AT1 or AT2 subtype since they are blocked by neither AT1 nor AT2 antagonists.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998 Jul"
                    },
                    "PMID:9886894": {
                      "sentence": "To define whether AT2 plays a role in the BP response observed during AT1 antagonism, 17 Los treated rats were divided into two groups: seven were treated with both antagonists (Los + PD) and 10 rats received Los + vehicle.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1998 Dec"
                    },
                    "PMID:12482596": {
                      "sentence": "Increase in the intracellular inositol triphosphate (IP3) levels in Xenopus oocytes in response to expression and activation of rat angiotensin II (Ang II) receptor AT1 was inhibited by co-expression of rat AT2 receptor.",
                      "object score": 851,
                      "subject score": 875,
                      "publication date": "2002 Dec 18"
                    },
                    "PMID:15927719": {
                      "sentence": "The inhibitory effect of Ang-(1-7) was not affected by the AT2 receptor selective antagonist PD123319 (from 10(-10) to 10(-7) M) but was blocked in a dose-dependent manner by the AT1 receptor selective antagonists losartan (10(-10) M), candesartan (10(-17) M), irbesartan (2 x 10(-12) M) and telmisartan (2 x 10(-16) M).",
                      "object score": 762,
                      "subject score": 757,
                      "publication date": "2005 Jul 15"
                    },
                    "PMID:17081374": {
                      "sentence": "These effects could be blocked by AT1 and NF-kappaB inhibitors but not by AT2 inhibitor.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "2006 Jul"
                    },
                    "PMID:17878754": {
                      "sentence": "The effects of Ang II on glucose uptake and actin reorganization were blocked by AT1 receptor antagonist, but not by AT2 antagonist.",
                      "object score": 694,
                      "subject score": 623,
                      "publication date": "2007 Sep"
                    },
                    "PMID:17959957": {
                      "sentence": "Zoletil anesthesia did not interfere with the effects of angiotensin II, AT1, AT2 antagonists, or nitric oxide synthetase inhibitors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2007 Nov"
                    },
                    "PMID:18008188": {
                      "sentence": "The blocking effects of the angiotensin-(1-7) receptor antagonist, D-[Alanine7]-Ang-(1-7), and angiotensin II receptor AT1 and AT2 antagonists, losartan and PD123319, on tube formation were measured by counting tube branch points.",
                      "object score": 888,
                      "subject score": 916,
                      "publication date": "2007 Oct"
                    },
                    "PMID:21841547": {
                      "sentence": "RESULTS: Selective blockade of either AT1 or AT2 receptors by telmisartan or PD 123319, respectively, resulted in mild forearm blood flow increase (15 +/- 5% and 10 +/- 4, respectively; both P > 0.05); combined AT1 and AT2 receptor antagonism, however, was associated with greater vasodilator response (25 +/- 5%; P = 0.02).",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2011 Sep"
                    },
                    "PMID:24586922": {
                      "sentence": "Losartan, an AT1 receptor blocker, but not PD123319, the AT2 inhibitor, was found to significantly reduce mechanical stretch-induced LC3b-II upregulation.",
                      "object score": 872,
                      "subject score": 623,
                      "publication date": "2014"
                    },
                    "PMID:26666666": {
                      "sentence": "In addition, increased AT1 receptor (AT1R) and decreased AT2 receptor (AT2R) expression was observed in LPS-induced neuroinflammation in both in vitro and in vivo studies.",
                      "object score": 861,
                      "subject score": 851,
                      "publication date": "2016 12"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:UniProtKB:Q13315-biolink:entity_positively_regulates_entity-UniProtKB:P50052": {
              "object": "UniProtKB:P50052",
              "subject": "UniProtKB:Q13315",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0919524---SEMMEDDB:stimulates---UMLS:C0390423---SEMMEDDB:",
                    "NCBIGene:472---SEMMEDDB:stimulates---UMLS:C0390423---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9344883",
                    "PMID:9109437",
                    "PMID:9760076",
                    "PMID:15178697",
                    "PMID:17483670",
                    "PMID:22392065",
                    "PMID:19907343",
                    "PMID:11393681",
                    "PMID:31801296",
                    "PMID:9886894",
                    "PMID:15228092",
                    "PMID:18001553",
                    "PMID:11314602",
                    "PMID:31811859",
                    "PMID:24247418",
                    "PMID:17636004",
                    "PMID:16380540",
                    "PMID:12397677",
                    "PMID:16223512",
                    "PMID:12215461"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7768295": {
                      "sentence": "Stimulation of angiotensin II AT2 receptors has been shown to inhibit AT1 receptor-mediated actions in peripheral tissues.",
                      "object score": 912,
                      "subject score": 597,
                      "publication date": "1995 Mar 14"
                    },
                    "PMID:9109437": {
                      "sentence": "In addition to inhibition of the RAS, ACEi may also act by inhibiting kinin destruction, whereas AT1-ant may block the RAS at the level of the AT1 receptor and activate the angiotensin II type 2 (AT2) receptor.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1997 Apr 15"
                    },
                    "PMID:9344883": {
                      "sentence": "The up-regulation of AT2 receptor mRNA was antagonized by PD123319, an AT2 receptor antagonist, but not by SC-52458, an AT1 receptor antagonist, thus suggesting that the increase in AT2 receptor mRNA is mediated via AT2 receptor.",
                      "object score": 851,
                      "subject score": 623,
                      "publication date": "1997 Oct 20"
                    },
                    "PMID:9425996": {
                      "sentence": "Administration of specific ligands for the AT1 and AT2 receptors in the presence or absence of Ang II indicates that the increased cellularity and collagen deposition are mediated via the AT1 receptor, are inhibited via stimulation of the AT2 receptor, and that the angiogenesis may be mediated via the AT2 receptor.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1997 Nov-Dec"
                    },
                    "PMID:9760076": {
                      "sentence": "This AII mediated neurogenic hypertension and antinatriuresis is transduced by activation of CNS AT1 receptors and not by activation of central AT2 receptors.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1998 Aug 06"
                    },
                    "PMID:10360191": {
                      "sentence": "Angiotensin converting enzyme inhibitors (ACEI) decrease the synthesis of All and therefore the stimulation of both receptor types whereas AT1-receptor antagonists (AT1RA) block only the stimulation of these latter and increase the stimulation of AT2 receptor since they increase the production of All secondarily to the inhibition of the feedback of renin secretion by All.",
                      "object score": 888,
                      "subject score": 851,
                      "publication date": "1999 May 1-8"
                    },
                    "PMID:11314602": {
                      "sentence": "Specific receptor blockade has demonstrated that the beneficial effects of AT1 blockers arise from two mechanisms: the reduction of the AT1 receptor mediated response and the increase in plasma levels of Ang II through the AT1-receptor blockade, which leads to increased stimulation of the AT2 receptor (the so-called yin-yang effect).",
                      "object score": 888,
                      "subject score": 623,
                      "publication date": "2001"
                    },
                    "PMID:12215461": {
                      "sentence": "We tested the hypothesis that the cardioprotective effects of AT1 receptor antagonists (AT1-ant) after myocardial infarction (MI) are partially mediated by activation of AT2 receptors; thus in AT2 receptor gene knockout mice (AT2-/Y), the effect of AT1-ant will be diminished or absent.",
                      "object score": 888,
                      "subject score": 851,
                      "publication date": "2002 Sep"
                    },
                    "PMID:12397677": {
                      "sentence": "AT1 and AT2 receptors seem to be mutually antagonistic and the upregulation of AT2 receptor would play a role in the pathogenesis and remodeling of cardiovascular and renal diseases.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Oct"
                    },
                    "PMID:15178697": {
                      "sentence": "Angiotensin II-induced relaxation of anococcygeus smooth muscle via desensitization of AT1 receptor, and activation of AT2 receptor associated with nitric-oxide synthase pathway.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2004 Oct"
                    },
                    "PMID:15228092": {
                      "sentence": "AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.",
                      "object score": 888,
                      "subject score": 623,
                      "publication date": "2004 May"
                    },
                    "PMID:16223512": {
                      "sentence": "These results suggest that the contraction induced by Ang II might be mediated via the activation of AT1 receptors on the basilar arterial smooth muscle cells and be modulated via the activation of AT2 receptors on the endothelial cells, followed by NO production.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2006 Jan 25"
                    },
                    "PMID:16380540": {
                      "sentence": "These results suggest that intrarenal AT1 receptor blockade engenders natriuresis by activation of AT2 receptors.",
                      "object score": 888,
                      "subject score": 583,
                      "publication date": "2006 Mar"
                    },
                    "PMID:17125268": {
                      "sentence": "On the contrary to the findings with AT1 receptor agonists, the impact of structural modifications in the 5-position of the AT2 selective compounds were less pronounced regarding activation of the AT2 receptor.",
                      "object score": 888,
                      "subject score": 851,
                      "publication date": "2006 Nov 30"
                    },
                    "PMID:17483670": {
                      "sentence": "This finding has been attributed to the unique property of sustained blockade of the AT1 receptor, combined with simultaneous activation of the AT2 receptors.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2007 May-Jun"
                    },
                    "PMID:17636004": {
                      "sentence": "We conclude that AT1 receptor blockade provides cardioprotection against myocardial ischemia-reperfusion injury through stimulation of AT2 receptors.",
                      "object score": 888,
                      "subject score": 623,
                      "publication date": "2007 Oct"
                    },
                    "PMID:20580712": {
                      "sentence": "We also observed that estrogen replacement induces significant downregulation of the activity of the angiotensin converting enzyme as well as downregulation of AT1 receptors, upregulation of AT2 receptors and downregulation of the NADPH complex activity in the substantia nigra in comparison with ovariectomized rats.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2010 Aug"
                    },
                    "PMID:22392065": {
                      "sentence": "Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARgamma activation.",
                      "object score": 888,
                      "subject score": 740,
                      "publication date": "2012 Jun"
                    },
                    "PMID:23176210": {
                      "sentence": "However, in some pathological situations, AT2 receptor shows an increase in tissue expression and functions to antagonize the actions induced by AT1 receptor.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2013"
                    },
                    "PMID:25487516": {
                      "sentence": "Activation of the cell membrane AT2 receptors by a concomitant treatment with angiotensin II and the AT1 receptor antagonist, losartan, induces apoptosis but does not affect the rate of cell death.",
                      "object score": 894,
                      "subject score": 623,
                      "publication date": "2015 May"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:physically_interacts_with-UniProtKB:P05019": {
              "object": "UniProtKB:P05019",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:physically_interacts_with-UniProtKB:P08235": {
              "object": "UniProtKB:P08235",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1711-biolink:physically_interacts_with-UniProtKB:P00441": {
              "object": "UniProtKB:P00441",
              "subject": "CHEMBL.COMPOUND:CHEMBL1711",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB01064---DRUGBANK:target---UniProtKB:P00441---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:physically_interacts_with-UMLS:C0597357": {
              "object": "UMLS:C0597357",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1200402": {
              "object": "CHEMBL.COMPOUND:CHEMBL1200402",
              "subject": "VANDF:4021566",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:interacts_with---UMLS:C0051696---SEMMEDDB:",
                    "UMLS:C0006684---SEMMEDDB:interacts_with---UMLS:C0354468---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24851066",
                    "PMID:2970788",
                    "PMID:29134979",
                    "PMID:14508205",
                    "PMID:2530867",
                    "PMID:8225698",
                    "PMID:19493262",
                    "PMID:9019211",
                    "PMID:8743536",
                    "PMID:29301757",
                    "PMID:1830107",
                    "PMID:1839444",
                    "PMID:10535758",
                    "PMID:15374267",
                    "PMID:1830287",
                    "PMID:19393774",
                    "PMID:23706099",
                    "PMID:24253615",
                    "PMID:7760451",
                    "PMID:2969930"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1830107": {
                      "sentence": "We studied the effect of amlodipine, a long-acting dihydropyridine calcium antagonist, on blood pressure, urinary sodium excretion, plasma renin activity, aldosterone and atrial natriuretic peptide in six patients (aged 47-63 yrs) with essential hypertension.",
                      "object score": 1000,
                      "subject score": 831,
                      "publication date": "1991 Apr"
                    },
                    "PMID:1830287": {
                      "sentence": "Earlier clinical trials demonstrated the anti-hypertensive effect of amlodipine, a new calcium channel blocker of the dihydropyridine type.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "1991 May 20"
                    },
                    "PMID:1839444": {
                      "sentence": "Haemodynamic and electrophysiological effects of amlodipine, a new long-acting calcium antagonist.",
                      "object score": 1000,
                      "subject score": 831,
                      "publication date": "1991"
                    },
                    "PMID:2142447": {
                      "sentence": "Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition.",
                      "object score": 1000,
                      "subject score": 831,
                      "publication date": "1990 Jul"
                    },
                    "PMID:2530867": {
                      "sentence": "Hemodynamic and electrophysiologic effects of amlodipine, a new long-acting calcium antagonist: preliminary observations.",
                      "object score": 1000,
                      "subject score": 831,
                      "publication date": "1989 Nov"
                    },
                    "PMID:2530888": {
                      "sentence": "Hemodynamic and electrophysiologic effects of amlodipine, a new calcium channel blocker.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "1989 Nov 07"
                    },
                    "PMID:2969266": {
                      "sentence": "Normotensive Sprague-Dawley and spontaneously hypertensive rats anaesthetized with sodium pentobarbitone were used to determine the systemic and renal actions of amlodipine, a new calcium channel blocking drug.",
                      "object score": 1000,
                      "subject score": 920,
                      "publication date": "1988 Jun"
                    },
                    "PMID:2969930": {
                      "sentence": "The utility of using an endurance test as well as a maximal exercise test to assess the effect of amlodipine, a dihydropyridine calcium antagonist, was evaluated in 16 patients with angina pectoris.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1988 Sep"
                    },
                    "PMID:2970788": {
                      "sentence": "This study evaluated the safety, antianginal and antiischemic effects of amlodipine, a dihydropyridine calcium antagonist, in patients with chronic stable angina pectoris.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1988 Sep 15"
                    },
                    "PMID:7760451": {
                      "sentence": "Although poisoning with calcium channel blocking agents is frequent, to our knowledge no cases involving amlodipine have been published.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995"
                    },
                    "PMID:8225698": {
                      "sentence": "In order to evaluate the mid-term effects of amlodipine, a 1,4-dihydropyridine calcium antagonist, as well as its effects on the renin-angiotensin-aldosterone system (RAAS), on water and electrolyte balance, on urinary excretion of albumin (UAE) and on lipid metabolism, thirteen hypertensive patients (2 M, 11 F, mean age 54 years) were studied in the course of 24 weeks of therapy with amlodipine at 5-10 mg/day.",
                      "object score": 1000,
                      "subject score": 824,
                      "publication date": "1993"
                    },
                    "PMID:8496831": {
                      "sentence": "The effect of amlodipine, a dihydropyridine calcium antagonist which is largely ionized at physiological pH, was studied in human resistance arteries.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1993 May"
                    },
                    "PMID:8743536": {
                      "sentence": "In this study, we investigated the effects of antihypertensive drugs such as calcium channel blocker, amlodipine, alpha 1-adrenoceptor blocker, doxazosin and angiotensin converting enzyme (ACE) inhibitor, imidapril on nitric oxide synthase (NOS) activity in the kidneys of L-NAME-induced hypertensive rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jun"
                    },
                    "PMID:8824928": {
                      "sentence": "This study was designed to evaluate the effects of amlodipine, a new calcium channel blocker, on the development of right ventricular hypertrophy and thickening of the media of the pulmonary arteries in a rat model of pulmonary hypertension.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "1996 Jan"
                    },
                    "PMID:10535758": {
                      "sentence": "The effect of amlodipine, a novel calcium channel blocker of the dihydropyridine type, on rabbit platelet aggregation, and the possible antiaggregatory mechanisms of amlodipine, especially on the nitric oxide (NO) guanosine 3',5'-cyclic monophosphate (cyclic GMP)-mediated pathway, were investigated.",
                      "object score": 1000,
                      "subject score": 916,
                      "publication date": "1999 Nov 15"
                    },
                    "PMID:14508205": {
                      "sentence": "AIMS: To compare the effect of amlodipine, a prototype dihydropyridine calcium-channel blocker with lercanidipine, a newer dihydropyridine compound with lipophilic properties, on dependent oedema generation and interference with skin blood flow vasomotion in hypertensive patients.",
                      "object score": 1000,
                      "subject score": 854,
                      "publication date": "2003 Oct"
                    },
                    "PMID:15374267": {
                      "sentence": "This study determined the effect of amlodipine, a calcium antagonist, which is the only class of antihypertensive agent that has little or no influence on the renin-angiotensin system (Bauer and Reams, 1988) on plasma ANP in a group of 18 elderly hypertensives and a placebo (vit B complex) on a further group of 6 elderly hypertensives.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994"
                    },
                    "PMID:19393774": {
                      "sentence": "The purpose of the present study was to evaluate therapeutic effect and possible mechanism of action of amlodipine, one of the widely used CCBs, on rat cardiac dysfunction during sepsis induced by lipopolysaccharide (LPS).",
                      "object score": 1000,
                      "subject score": 818,
                      "publication date": "2009 Aug"
                    },
                    "PMID:22032983": {
                      "sentence": "The anti-fertility effects of amlodipine, a calcium channel blocker, are well-illustrated in in vivo experiments but lack an in vitro proof.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jan 01"
                    },
                    "PMID:29134979": {
                      "sentence": "Following reports that Calcium Channel Blockers may exhibit differences in the response of blood vessels to pressor agents,this study sought to test the effects of amlodipine on blood pressure (BP) and baroreceptor reflex sensitivity (BRS) responsesto high salt ingestion.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Jun 30"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL2146121": {
              "object": "CHEMBL.COMPOUND:CHEMBL2146121",
              "subject": "VANDF:4021566",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:interacts_with---UMLS:C0006675---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1756142",
                    "PMID:2273634",
                    "PMID:1753918",
                    "PMID:21197683",
                    "PMID:10400399",
                    "PMID:11347708",
                    "PMID:20933604",
                    "PMID:11897387",
                    "PMID:2408484",
                    "PMID:2220798",
                    "PMID:21251955",
                    "PMID:1377114",
                    "PMID:17853772",
                    "PMID:1283581",
                    "PMID:2425846",
                    "PMID:17402291",
                    "PMID:15692164",
                    "PMID:16712775",
                    "PMID:11473690",
                    "PMID:2418195"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1283581": {
                      "sentence": "With the advent of specific calcium antagonists, the pathogenic effects of calcium overload and its deleterious consequences have become, for the first time, accessible to therapeutic intervention.",
                      "object score": 1000,
                      "subject score": 884,
                      "publication date": "1992"
                    },
                    "PMID:1377114": {
                      "sentence": "Despite the widespread involvement of calcium in hormone secretion and action, calcium antagonists appear to have little effects on the glucoregulatory and calcium-regulatory hormones within the drug dosages used in clinical practice.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1992 Apr"
                    },
                    "PMID:1753918": {
                      "sentence": "Calcium channel blockers and other interventions designed to modulate calcium changes may have a role in the treatment of acute renal failure.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "1991"
                    },
                    "PMID:1756142": {
                      "sentence": "These data suggest that calcium-channel blockers exert a direct effect on the previously ischemic tissue, perhaps by subtle modulation of calcium transport or flux within the stunned myocytes.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1991 Oct"
                    },
                    "PMID:2220798": {
                      "sentence": "The antiatherogenic properties of CCBs may be related in part to the protection of arterial cells from calcium overload through inhibition of calcium flux across voltage-regulated ion channels.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 Oct"
                    },
                    "PMID:2408484": {
                      "sentence": "Effects of 1,25(OH)2D3 and calcium channel blockers on cecal calcium transport in the rat.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "1985 Jun"
                    },
                    "PMID:2425846": {
                      "sentence": "Comparison of the number of reconstituted calcium antagonist receptors and functional channels supports the conclusion that only a few percent of the purified calcium antagonist receptor polypeptides are capable of mediating calcium transport as previously demonstrated for calcium antagonist receptors in intact T-tubules.",
                      "object score": 694,
                      "subject score": 798,
                      "publication date": "1986 Jun 03"
                    },
                    "PMID:2438147": {
                      "sentence": "Extracellular calcium dependence of the neurotensin-induced relaxation of intestinal smooth muscles: studies with calcium channel blockers and BAY K-8644.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1987 Mar 31"
                    },
                    "PMID:2468907": {
                      "sentence": "Potential mechanisms for the salt/diuretic-calcium antagonist interactions include (i) intrinsic natriuretic property of calcium antagonists, (ii) interaction of volume control and hormonal calcium control systems, and (iii) modulation of--at least dihydropyridine--binding sites by dietary sodium.",
                      "object score": 852,
                      "subject score": 983,
                      "publication date": "1988"
                    },
                    "PMID:2470461": {
                      "sentence": "The effects of calcium antagonists on calcium overload contractures in embryonic chick myocytes induced by ouabain and veratrine.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1989 May"
                    },
                    "PMID:2550033": {
                      "sentence": "In vascular muscle cells, two distinct types of functionally important calcium (Ca2+) channels, called transient (T) and sustained (L), are differentiated by dihydropyridine calcium antagonists (CaA).",
                      "object score": 827,
                      "subject score": 890,
                      "publication date": "1989 Aug"
                    },
                    "PMID:2675378": {
                      "sentence": "Many experiments have studied the effects of calcium channel blockers on intracellular calcium overload during the periods of cardiac ischemia and reperfusion.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1989"
                    },
                    "PMID:2897319": {
                      "sentence": "Magnesium is a natural calcium antagonist that can influence the intracellular calcium concentration in the myometrium.",
                      "object score": 623,
                      "subject score": 901,
                      "publication date": "1988 Mar"
                    },
                    "PMID:3529151": {
                      "sentence": "However, the effectiveness of calcium antagonist drugs could also be related to some property other than interference with the action of calcium within brain neurons.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1986 Aug"
                    },
                    "PMID:3563107": {
                      "sentence": "The calcium channel blocker, verapamil given into brain ventricles prevents the depressor effect of calcium suggesting that the hypotensive action of calcium is initiated intracellularly.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987 Jan"
                    },
                    "PMID:3770073": {
                      "sentence": "Direct effects of calcium channel blockers on duodenal calcium transport in vivo.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1986 Sep 23"
                    },
                    "PMID:3947399": {
                      "sentence": "Effects of calcium channel blocking agents on calcium and centrilobular necrosis in the liver of rats treated with hepatotoxic agents.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1986 Feb 15"
                    },
                    "PMID:8842675": {
                      "sentence": "Investigations performed in skeletal muscle have suggested that phenylalkylamine calcium antagonists, particularly gallopamil, affect excitation-contraction coupling independently of their effect on the sarcolemmal calcium current.",
                      "object score": 828,
                      "subject score": 890,
                      "publication date": "1996 Jul"
                    },
                    "PMID:9004157": {
                      "sentence": "In ischemic LV diastolic dysfunction without major systolic dysfunction, calcium antagonists may be appropriate therapy which could point to a role for abnormalities in the regulation of cytosolic calcium.",
                      "object score": 853,
                      "subject score": 983,
                      "publication date": "1996 Dec"
                    },
                    "PMID:9782369": {
                      "sentence": "The aim of the study was to ultrastructurally visualize the distribution of Ca2+ and to compare binding of calcium by the sarcolemma and calcium accumulation in mitochondria under therapy with an OH scavenger, dimethylthiourea (DMTU), Na+/H+ exchange inhibitor, amiloride, and calcium channel blocker, diltiazem, given alone or in combination to ischemic/reperfused hearts.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-FMA:63891": {
              "object": "FMA:63891",
              "subject": "CHEMBL.COMPOUND:CHEMBL995",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0126174---SEMMEDDB:inhibits---UMLS:C0009325---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:25845545",
                    "PMID:17347483",
                    "PMID:23868934",
                    "PMID:26675124",
                    "PMID:24084631",
                    "PMID:27128791",
                    "PMID:19175863",
                    "PMID:12601879",
                    "PMID:20044807",
                    "PMID:27884084",
                    "PMID:27853186",
                    "PMID:11881038",
                    "PMID:21282607",
                    "PMID:15782494",
                    "PMID:15277331",
                    "PMID:26758229",
                    "PMID:28423507",
                    "PMID:15573751",
                    "PMID:12874189",
                    "PMID:19673944"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:11881038": {
                      "sentence": "These data indicate that losartan reduces vascular collagen content and inhibits intimal thickening after balloon injury.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2000 Sep"
                    },
                    "PMID:12601879": {
                      "sentence": "(3) Losartan and benazapril reduce vascular collagen content and inhibit intimal thickening after balloon injury.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2002 Aug"
                    },
                    "PMID:12874189": {
                      "sentence": "Furthermore, treatment with losartan reduced myocardial collagen content and reduced the incidence of myocyte apoptosis.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2003 Aug 05"
                    },
                    "PMID:15573751": {
                      "sentence": "CONCLUSION: Losartan could reduce pulmonary arterial collagen I expression, it may be one of the therapeutic mechanisms on hypoxic pulmonary hypertension of losartan.",
                      "object score": 877,
                      "subject score": 1000,
                      "publication date": "2004 Nov"
                    },
                    "PMID:15782494": {
                      "sentence": "[Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2005 Feb"
                    },
                    "PMID:17347483": {
                      "sentence": "EXP3179 and LOS inhibited collagen-I (P<0.01) and GPVI-dependent PAC-1 expression (P<0.01).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 May"
                    },
                    "PMID:19175863": {
                      "sentence": "However, losartan could not elevate the reduced smooth muscle/collagen ratio in diabetic rats.",
                      "object score": 840,
                      "subject score": 1000,
                      "publication date": "2009 Mar"
                    },
                    "PMID:19673944": {
                      "sentence": "Spironolactone treatment decreased collagen content in the media of thoracic aortas from prehypertensive SHR, whereas losartan decreased collagen content in the media of aortas from hypertensive SHR.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2009 May"
                    },
                    "PMID:20044807": {
                      "sentence": "Losartan-M6PHSA, but not oral losartan, reduced collagen deposition, accumulation of myofibroblasts, inflammation and procollagen alpha2(I) gene expression.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "2010 Mar"
                    },
                    "PMID:21282607": {
                      "sentence": "We found that losartan inhibited collagen I production by carcinoma-associated fibroblasts isolated from breast cancer biopsies.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Feb 15"
                    },
                    "PMID:23868934": {
                      "sentence": "CONCLUSIONS: Inhibition of the angiotensin II type 1 receptor using losartan significantly attenuated the vascular remodeling associated with TAC but did not completely block the increased transforming growth factor-beta1 expression, adventitial Smad2 signaling, and collagen accumulation.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2013 Sep"
                    },
                    "PMID:24084631": {
                      "sentence": "We demonstrate that the angiotensin inhibitor losartan reduces stromal collagen and hyaluronan production, associated with decreased expression of profibrotic signals TGF-beta1, CCN2 and ET-1, downstream of angiotensin-II-receptor-1 inhibition.",
                      "object score": 853,
                      "subject score": 840,
                      "publication date": "2013"
                    },
                    "PMID:25845545": {
                      "sentence": "All results suggested that depletion of collagen I by losartan dramatically increased the penetration of PTX-Cl-Lip and combination of free losartan and PTX-CL-Lip could lead to better antitumor efficacy of chemical drugs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 May 13"
                    },
                    "PMID:26675124": {
                      "sentence": "In vivo, pretreatment with losartan significantly decrease the collagen level and improve the tumor penetration.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2016 Feb"
                    },
                    "PMID:26758229": {
                      "sentence": "Since losartan could inhibit the level of collagen I which was related to tumor metastasis, this strategy was further applied to suppress tumor metastasis this time.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Oct"
                    },
                    "PMID:27128791": {
                      "sentence": "Treatment with losartan, an angiotensin II receptor antagonist, decreased the collagen density and fiber length in the TIC, consistent with the known activity of this drug.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2016 05 21"
                    },
                    "PMID:27853186": {
                      "sentence": "Furthermore, losartan, which can inhibit collagen I synthesis, attenuated the compactness of spheroids and increased the therapeutic efficacy of anticancer therapies in MCTS.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 11 17"
                    },
                    "PMID:27884084": {
                      "sentence": "Free losartan could inhibit collagen, but it would cause hypotension at the dosage of 10 mg/kg/d.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2018 Jan"
                    },
                    "PMID:28423507": {
                      "sentence": "Furthermore, losartan, which inhibits collagen I synthesis, impaired the compactness of spheroids via disruption of cell-cell contacts and increased the efficacy of anticancer therapeutics in HCC cell line- and HCC patient-derived tumor spheroids.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Mar 28"
                    },
                    "PMID:30519023": {
                      "sentence": "Conclusion: This study provides a proof of principle that the implantation of nanoparticles/Los-loaded hydrogel can increase the intratumoral distribution and antitumor efficacy of nanoparticles, owing to collagen depletion by Los.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2018"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL123558-biolink:physically_interacts_with-UniProtKB:P51787": {
              "object": "UniProtKB:P51787",
              "subject": "CHEMBL.COMPOUND:CHEMBL123558",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB04957---DRUGBANK:target---UniProtKB:P51787---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11573692",
                    "PMID:11060832"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:drugbank",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:interacts_with---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9737942",
                    "PMID:16182431",
                    "PMID:22964022",
                    "PMID:10494801",
                    "PMID:8872947",
                    "PMID:27520486",
                    "PMID:15682830",
                    "PMID:7492983",
                    "PMID:30345862",
                    "PMID:24155898",
                    "PMID:11967815",
                    "PMID:17601799",
                    "PMID:23137784",
                    "PMID:15487702",
                    "PMID:17765135",
                    "PMID:15770925",
                    "PMID:10701820"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7492983": {
                      "sentence": "In addition, angiotensin II infusion or 24 h at a rate of 50 ng/min did not alter the level of TGF-beta1 mRNA which was measured 6 d after the infusion.",
                      "object score": 901,
                      "subject score": 901,
                      "publication date": "1995 May"
                    },
                    "PMID:8872947": {
                      "sentence": "Ang II alone also had no significant effects on TGF-beta 1 and extracellular matrix message levels in quiescent rat mesangial cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Sep"
                    },
                    "PMID:9737942": {
                      "sentence": "The mechanism responsible for the role of AngII in TGF-beta1 remains to be elucidated.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Aug"
                    },
                    "PMID:10494801": {
                      "sentence": "Coincubation with ANG II and an AT1 receptor antagonist abolished this increase in 125I-labeled TGF-beta1 binding.",
                      "object score": 607,
                      "subject score": 1000,
                      "publication date": "1999 Jul"
                    },
                    "PMID:10701820": {
                      "sentence": "TGF-beta binding data showed that Ang II increased the specific binding of 125I-TGF-beta1 by enhancing the expression of lower affinity receptors and increasing the number of binding sites.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2000 Feb"
                    },
                    "PMID:11967815": {
                      "sentence": "De novo generation of Ang II modulates expression of TGF-beta1 whose autocrine/paracrine properties regulate collagen turnover at sites of fibrous tissue formation that appear in response to various forms of injury in diverse tissues.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Dec"
                    },
                    "PMID:15487702": {
                      "sentence": "We hypothesized that 2 EGFR-activated pathways, PI3 kinase and MAP kinase, are stimulated by the AT-1 receptor and, in part, regulate the effects of AngII on TGF-beta1 levels in mesangial cells.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2004"
                    },
                    "PMID:15682830": {
                      "sentence": "Perianastomotic intimal hyperplasia in synthetic arterial graft is considered to be related to TGF-beta1, the expression of which is locally mediated by angiotensin II and, therefore, suppressed by ACEI.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004"
                    },
                    "PMID:15770925": {
                      "sentence": "Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species.",
                      "object score": 863,
                      "subject score": 1000,
                      "publication date": "2005 Jan-Feb"
                    },
                    "PMID:16182431": {
                      "sentence": "Angiotensin II (Ang II) is an inducer of TGF-beta1 in cells of the heart and kidneys, and the regulation of TGF-beta1 by Ang II has not yet been confirmed in lung tissue.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Dec 15"
                    },
                    "PMID:17601799": {
                      "sentence": "Interactions between the renin-angiotensin system (RAS) and TGF-beta1 have been well documented, with most studies describing the effect of ANG II on TGF-beta1 expression.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2007 Sep"
                    },
                    "PMID:17765135": {
                      "sentence": "BACKGROUND: Angiotensin II (Ang) has been shown to induce expression of transforming growth factor-beta1 (TGF-beta1) in cardiovascular cells in vitro, but the regulation of TGF-beta1 by Ang has not been shown in cerebral vessels in vivo.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Sep"
                    },
                    "PMID:22964022": {
                      "sentence": "These results strongly suggest that the fibrotic response to Ang-II is mediated by the AT-1 receptor and requires the p38MAPK phosphorylation, NOX-induced ROS, and TGF-beta1 expression increase mediated by Ang-II in skeletal muscle cells.",
                      "object score": 900,
                      "subject score": 1000,
                      "publication date": "2012 Nov"
                    },
                    "PMID:23137784": {
                      "sentence": "Since angiotensin-2 (AG2), modulates TGFbeta1 production, we determined whether angiotensin converting enzyme insertion/deletion (ACE I/D) genotype affects urinary TGFbeta1 phenotype as well as renal outcome.",
                      "object score": 900,
                      "subject score": 1000,
                      "publication date": "2013 Jan"
                    },
                    "PMID:24155898": {
                      "sentence": "Firstly, the synergistic effects of angiotensin II, TGF-beta1 and LPS on collagen 1alpha production were confirmed in vitro by ELISA, in which angiotensin II, LPS and TGF-beta1 were treated sequentially, and in vivo by immunofluorescence, in the experiments single or multiple intra-peritoneally implanted osmotic mini-pumps administrating angiotensin II or LPS combined with intra-peritoneal injections of TGF-beta1 were used.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:27520486": {
                      "sentence": "In isolated neonatal rat cardiac fibroblasts (NCF), VCP746 stimulated potent inhibition of both TGF-beta1- and angiotensin II-mediated collagen synthesis.",
                      "object score": 1000,
                      "subject score": 831,
                      "publication date": "2016 Oct 01"
                    },
                    "PMID:30345862": {
                      "sentence": "As AT-II stimulates the effects of TGF-beta1 in mammals, the results of this study suggest an indirect profibrotic effect of AT-II besides the demonstrated profibrotic effect of TGF-beta1 and thus the development of feline renal fibrosis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Oct 22"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P30556": {
              "object": "UniProtKB:P30556",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:interacts_with---UMLS:C1439284---SEMMEDDB:",
                    "CHEMBL.COMPOUND:CHEMBL3989932---biolink:physically_interacts_with---CHEMBL.TARGET:CHEMBL227---identifiers_org_registry:chembl.compound",
                    "UMLS:C0003009---SEMMEDDB:interacts_with---NCBIGene:185---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21450123",
                    "PMID:16036315",
                    "PMID:23942780",
                    "PMID:20353822",
                    "PMID:19724024",
                    "PMID:28034895",
                    "PMID:30231858",
                    "PMID:33795351",
                    "PMID:7738168",
                    "PMID:22116365",
                    "PMID:16503205",
                    "PMID:9892146",
                    "PMID:27588004",
                    "PMID:33952303",
                    "PMID:33745438",
                    "PMID:29178049",
                    "PMID:15498265"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7738168": {
                      "sentence": "These results indicate that proximal tubule AT1R expression is regulated by ambient Ang II levels, and Ang II increases AT1R mRNA at least in part by decreasing proximal tubule cAMP generation through a pertussis toxin-sensitive mechanism.",
                      "object score": 824,
                      "subject score": 1000,
                      "publication date": "1995 May"
                    },
                    "PMID:9892146": {
                      "sentence": "AngII of circulating origin has ready access to the subfornical organ and area postrema, where it can bind to type 1 AngII receptors on neurons whose connections to the nucleus tractus solitarius and rostral ventrolateral medulla result in sympathoexcitation.",
                      "object score": 991,
                      "subject score": 1000,
                      "publication date": "1999 Jan"
                    },
                    "PMID:15498265": {
                      "sentence": "CONCLUSION: CIHO can cause the levels of circulating RA and ATII to increase, but has no effects on AT1R mRNA expression in tissue, which suggests that activated renin-angiotensin system may contribute to the pathogenesis of CIHO-induced hypertension.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2004 Sep"
                    },
                    "PMID:16036315": {
                      "sentence": "The authors conclude that (a) the net effect of pregnancy may be an increase in the AT1R/AT2R ratio in both UA Endo and VSM but through apparently distinct mechanisms, (b) the ovariectomized animal model is similar to the luteal state for AT1R and AT2R expression, while the E2beta-primed model does not resemble the nonpregnant or pregnant state, and (c) there is a real possibility that AII may mediate its effects either through a complex AT1R-AT2R interaction or via an as-yet unidentified non-AT1, non-AT2 receptor.",
                      "object score": 791,
                      "subject score": 1000,
                      "publication date": "2005 Jan-Apr"
                    },
                    "PMID:16503205": {
                      "sentence": "The binding capacity and affinity of the AT-1 receptors were also evaluated in aortic homogenates using 125I-angiotensin II.",
                      "object score": 827,
                      "subject score": 901,
                      "publication date": "2006 Apr"
                    },
                    "PMID:19724024": {
                      "sentence": "We postulated that rosuvastatin, a potent HMG-CoA reductase inhibitor, may reduce Ang II-mediated cardiomyocyte growth via AT1R and LOX-1 inhibition.",
                      "object score": 578,
                      "subject score": 578,
                      "publication date": "2009 Dec"
                    },
                    "PMID:20353822": {
                      "sentence": "These data suggest Ang II-mediated signaling transduction via AT1R is involved in hyperoxia-induced collagen synthesis in human lung fibroblasts.",
                      "object score": 588,
                      "subject score": 588,
                      "publication date": "2010 Jul 01"
                    },
                    "PMID:21450123": {
                      "sentence": "Ang II mediates effects through complex signalling pathways on binding to its G-protein-coupled receptors (GPCRs) AT1R and AT2R.",
                      "object score": 771,
                      "subject score": 1000,
                      "publication date": "2011 Mar 30"
                    },
                    "PMID:22116365": {
                      "sentence": "The effect of angiotensin II was mediated through type 1 angiotensin II receptors (AT(1)-receptors) because it could be blocked by saralasin.",
                      "object score": 991,
                      "subject score": 1000,
                      "publication date": "2011"
                    },
                    "PMID:23942780": {
                      "sentence": "Whereas it is well established that Ang II, by binding to AT1R, impairs glucose-stimulated insulin secretion and insulin signaling, the contribution of alternative RAS axes to beta-cell function remains to be fully elucidated.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    },
                    "PMID:27588004": {
                      "sentence": "Therefore, the present study investigated the involvement of angiotensin II (Ang II) acting on the type 1 Ang II receptor (AT1) in the cardiovascular dysfunctions evoked by both homotypic and heterotypic chronic emotional stresses in rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016"
                    },
                    "PMID:28034895": {
                      "sentence": "In addition, desensitization of AT1R by prior Ang II (100 nM) exposure had no effect on Up4A-induced aortic contraction.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2017 Mar 01"
                    },
                    "PMID:29178049": {
                      "sentence": "Angiotensin II (Ang II), the main active peptide of the renin-angiotensin system (RAS), binds to type 1 Ang II receptor (AT1R) and subsequently promotes cardiac hypertrophy and the inflammatory response with NF-kappaB activation underlying the cardiovascular effects.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Mar"
                    },
                    "PMID:30231858": {
                      "sentence": "The direct effect of angiotensin II (ANGII) on the AT-1 receptor in the proximal tubules is partly responsible for the sodium retention.",
                      "object score": 827,
                      "subject score": 1000,
                      "publication date": "2018 Sep 19"
                    },
                    "PMID:33745438": {
                      "sentence": "ANG II stimulates VP release via angiotensin receptor 1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021 Mar 19"
                    },
                    "PMID:33795351": {
                      "sentence": "These characteristics classify AT2R as part of the protective arm of the RAS that, along with functions of Ang (1-7) through Mas receptor signaling modulates the harmful effects of Ang II on AT1R in the activated classical arm of the RAS.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021 Apr 01"
                    },
                    "PMID:33952303": {
                      "sentence": "CONCLUSION: Our results indicated that Ang II activated the ERK1/2 and JNK pathways via AT1R, thus upregulating RANKL and NFATC1 expressions in RA synovial cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2021 May 05"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:physically_interacts_with-UniProtKB:P50052": {
              "object": "UniProtKB:P50052",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:interacts_with---UMLS:C0390423---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11286399",
                    "PMID:12379765",
                    "PMID:15485557",
                    "PMID:12411466",
                    "PMID:11256235",
                    "PMID:12623989",
                    "PMID:11035211",
                    "PMID:12924622",
                    "PMID:10537123",
                    "PMID:12969125",
                    "PMID:10353402",
                    "PMID:10100078",
                    "PMID:12608526",
                    "PMID:12911547",
                    "PMID:11301056",
                    "PMID:12945228",
                    "PMID:10794504",
                    "PMID:11162895",
                    "PMID:11743233",
                    "PMID:10619406"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1632771": {
                      "sentence": "Also, the two subtypes of Ang II receptors mediate opposite effects on PI hydrolysis: Ang II binding to AT1 receptors increases inositol phosphate production, while Ang II binding to AT2 receptors decreases inositol phosphate production.",
                      "object score": 888,
                      "subject score": 734,
                      "publication date": "1992 Jul 15"
                    },
                    "PMID:1639112": {
                      "sentence": "Conversely, in the ventral and mediodorsal thalamic, medial geniculate, and oculomotor nuclei, the superior colliculus and the cerebellar cortex, incubation with 5 mM dithiothreitol significantly decreased angiotensin II binding to AT2 receptors to about 40% of control.",
                      "object score": 888,
                      "subject score": 566,
                      "publication date": "1992 Jun 05"
                    },
                    "PMID:2041570": {
                      "sentence": "Angiotensin II interacts with two pharmacologically distinct subtypes of cell-surface receptors, AT1 and AT2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 May 16"
                    },
                    "PMID:8453029": {
                      "sentence": "CGP 42112A, angiotensin II, angiotensin III and PD 123177 competed for [125I] CGP 42112A binding, with potencies consistent with high affinity and specific binding to AT2 receptors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1993 Jan"
                    },
                    "PMID:8665267": {
                      "sentence": "Our results further demonstrate the presence of two ANG receptor subtypes in adrenal medulla: ANG binding to AT, receptor stimulates inositol phospholipid metabolism, whereas ANG binding to AT2 receptors decreases both inositol phosphate production and cGMP formation.",
                      "object score": 888,
                      "subject score": 734,
                      "publication date": "1995"
                    },
                    "PMID:8726701": {
                      "sentence": "This effect of Ang II involved AT2 receptors, since it was inhibited by the AT2 receptor selective ligand PD123319 (1 microM), but not by the Ang II type 1 receptor antagonist losartan (1 microM).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996"
                    },
                    "PMID:9072342": {
                      "sentence": "CV-11974, a specific AT1 receptor antagonist, and CGP42112B, a specific AT2 antagonist, were used in competition with [125I]-[Sar1,Ile8]AII to differentiate AT1 and AT2 receptor binding.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1995 Dec"
                    },
                    "PMID:9101313": {
                      "sentence": "These results suggest that newly developed antibodies for AT1 and AT2 receptors are useful in elucidating the regulation of subtype-specific receptor expression, and that AT1 but not AT2 receptors in adrenal tissue are regulated by angiotensin II.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1997 Mar"
                    },
                    "PMID:9259318": {
                      "sentence": "Angiotensin II (Ang II) binds to two different receptor subtypes, AT1 and AT2 receptors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997 Aug"
                    },
                    "PMID:9389507": {
                      "sentence": "Based on Losartan displacement, we calculated that [125I]AII bound to AT1 and to AT2 receptors was increased in both ZG and ZFR + M cell preparations under sodium restriction.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997 Dec"
                    },
                    "PMID:9449684": {
                      "sentence": "Treatment with AT1 antagonists causes elevation of plasma Ang II which selectively binds to AT2 and exerts as yet undefined effects.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1998 Feb 01"
                    },
                    "PMID:9453004": {
                      "sentence": "125I-[Sar1, Ile8]Ang II specifically bound to AT1 and AT2 receptors on ERMICs, and their mRNAs were detected by reverse transcription--polymerase chain reaction (RT-PCR).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998 Jan"
                    },
                    "PMID:9521484": {
                      "sentence": "Thus, injection of ANGII into the SC causes complex haemodynamic changes which are sensitive to AT2 receptor antagonism.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1998 Feb"
                    },
                    "PMID:9727708": {
                      "sentence": "Neither ANG II nor blockade of AT1 receptors significantly alter the expression of AT1 or AT2 mRNA in the fetal heart.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998 Sep"
                    },
                    "PMID:9833171": {
                      "sentence": "Angiotensin II acts on AT1 and AT2 receptors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:9878677": {
                      "sentence": "The selective AT2 receptor subtype antagonist PD 123319 (10 microM) was used to inhibit 125I-SI Ang II binding to AT2 receptors to determine AT1 receptor density in brain sections.",
                      "object score": 888,
                      "subject score": 619,
                      "publication date": "1999 Jan 16"
                    },
                    "PMID:9888501": {
                      "sentence": "In conclusion, the present results demonstrated that: 1/ cell proliferation is not correlated with AT2 expression; 2/ growth factors regulate, positively or negatively, AT2 transcription rate, whereas AngII regulates the translation rate of AT2 mRNA; 3/ all the effects of AngII on R3T3 are mediated by AT2 receptors since they are mimicked by the AT2 agonist CGP42112 and blocked by the AT2 antagonist PD123177.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:11035211": {
                      "sentence": "We further sought to answer the question whether ang II Type 1 receptor blockade by antagonizing the potential beneficial effects mediated through this receptor and producing more ang II binding to the ang II Type 2 receptors, would lead to cardiac apoptosis.",
                      "object score": 991,
                      "subject score": 673,
                      "publication date": "2000 Aug"
                    },
                    "PMID:23336117": {
                      "sentence": "Angiotensin (Ang) II, the major angiotensin effector peptide, binds to two major receptors, namely AT1 and AT2 receptors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2013 Aug"
                    },
                    "PMID:24041943": {
                      "sentence": "Angiotensin II acts classically by binding to the AT1 and AT2 receptors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2013 Nov"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-DRUGBANK:DB06205": {
              "object": "DRUGBANK:DB06205",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00959---DRUGBANK:drug-interaction---DRUGBANK:DB06205---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB14644---DRUGBANK:drug-interaction---DRUGBANK:DB06205---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB14643---DRUGBANK:drug-interaction---DRUGBANK:DB06205---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1234886-biolink:physically_interacts_with-UniProtKB:P04040": {
              "object": "UniProtKB:P04040",
              "subject": "CHEMBL.COMPOUND:CHEMBL1234886",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0030054---SEMMEDDB:interacts_with---UMLS:C0007367---SEMMEDDB:",
                    "UMLS:C0074565---SEMMEDDB:interacts_with---UMLS:C0007367---SEMMEDDB:",
                    "UMLS:C0302920---SEMMEDDB:interacts_with---UMLS:C0007367---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:29228161",
                    "PMID:8000856",
                    "PMID:11171085",
                    "PMID:26825775",
                    "PMID:22918833",
                    "PMID:10628300",
                    "PMID:9553125",
                    "PMID:18755568",
                    "PMID:12033445",
                    "PMID:7587800",
                    "PMID:3897793",
                    "PMID:15760714",
                    "PMID:22698962",
                    "PMID:31442912",
                    "PMID:21791",
                    "PMID:31487955",
                    "PMID:8992503",
                    "PMID:7733529"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:21791": {
                      "sentence": "Addition of 3-amino-1,2,4-triazole, an inhibitor of catalase, reduced the formation of formaldehyde to half the amount without change in the amount of oxygen consumed, indicating the synergic action of alcohol oxidase and catalase in methanol oxidation in the microbodies of living yeast cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1977 Oct 17"
                    },
                    "PMID:3897793": {
                      "sentence": "As a first step in an analysis of the DNA regions involved in the control of the catalase A gene of Saccharomyces cerevisiae by glucose, heme, and oxygen this gene has been cloned.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1985"
                    },
                    "PMID:7587800": {
                      "sentence": "The mechanism is independent of reactive oxygen metabolites and proteases, as shown by the lack of effect of the free radical scavengers superoxide dismutase and catalase and the general serine protease inhibitor soybean trypsin inhibitor.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "1995 Oct"
                    },
                    "PMID:7733529": {
                      "sentence": "The release of gaseous oxygen under the effect of tissue catalase and the membrane peroxydasic activity of hydrogen peroxide initiate such complications.",
                      "object score": 861,
                      "subject score": 853,
                      "publication date": "1994"
                    },
                    "PMID:8000856": {
                      "sentence": "The co-immobilization of glycolate oxidase and catalase on oxirane acrylic beads produced a catalyst which was stable to the reaction conditions used for the oxidation, where glycolic acid and oxygen are reacted in aqueous solution in the presence of the immobilized enzyme catalyst and ethylenediamine.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Jun"
                    },
                    "PMID:8992503": {
                      "sentence": "This suggests that both singlet oxygen and hydroxyl radical formation may be involved in near-UV damage to lens epithelial cell catalase.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1996 Jun"
                    },
                    "PMID:9553125": {
                      "sentence": "Oxidation of catalase by singlet oxygen.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Apr 24"
                    },
                    "PMID:10628300": {
                      "sentence": "Under some photosensitization conditions, catalase modification can be used as a marker to detect intracellular singlet oxygen.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "1999 Dec"
                    },
                    "PMID:11171085": {
                      "sentence": "There are several pathways that maintain the activity of the enzyme by recovering the ferric form, one of which is the decomposition of H2O2 to molecular oxygen in a similar way to the action of catalase.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Feb 15"
                    },
                    "PMID:12033445": {
                      "sentence": "These and all other catalases tested so far are oxidized by singlet oxygen, probably at the heme moiety.",
                      "object score": 966,
                      "subject score": 1000,
                      "publication date": "2002"
                    },
                    "PMID:15760714": {
                      "sentence": "Functional and structural analysis of catalase oxidized by singlet oxygen.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Feb"
                    },
                    "PMID:18755568": {
                      "sentence": "The release of gaseous oxygen under the effect of tissue catalase and the vascular diffusion of this oxygen bubbles can explain such complication.",
                      "object score": 861,
                      "subject score": 853,
                      "publication date": "2008 Sep"
                    },
                    "PMID:22698962": {
                      "sentence": "A pure source of singlet oxygen oxidizes catalases purified from different sources and singlet oxygen quenchers prevent oxidation.",
                      "object score": 966,
                      "subject score": 1000,
                      "publication date": "2012 Sep 15"
                    },
                    "PMID:22918833": {
                      "sentence": "Release of molecular oxygen and regeneration of resting enzyme are thereby catalyzed in the last step of a proposed catalase reaction.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2012 Oct 26"
                    },
                    "PMID:26825775": {
                      "sentence": "METHODS: Cyclooctaoxygen sodium was synthesized in vitro from atmospheric oxygen, or catalase effect-generated oxygen, under catalysis of cytosine nucleosides and either ninhydrin or eukaryotic low-molecular weight RNA.",
                      "object score": 775,
                      "subject score": 861,
                      "publication date": "2016 Apr"
                    },
                    "PMID:29228161": {
                      "sentence": "Analysis of the proteome revealed that superoxide reductase and cytochrome peroxidase amounts increased with 5% oxygen in the gas phase, while the response to atmospheric oxygen concentrations involved catalase and hydrogen peroxide reductase.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2018 Jan 01"
                    },
                    "PMID:31442912": {
                      "sentence": "Transmission of bystander signaling between pretreated and untreated tumor cells depends on the generation of secondary singlet oxygen by the pretreated cells and singlet oxygen-mediated catalase inactivation of the untreated recipient cells.",
                      "object score": 831,
                      "subject score": 831,
                      "publication date": "2019 09"
                    },
                    "PMID:31487955": {
                      "sentence": "Fruits Contain an Atypical Peroxisomal Catalase That is Modulated by Reactive Oxygen and Nitrogen Species.",
                      "object score": 828,
                      "subject score": 888,
                      "publication date": "2019 Sep 04"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:entity_negatively_regulates_entity-FMA:264829": {
              "object": "FMA:264829",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0020268---SEMMEDDB:inhibits---UMLS:C0021760---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8434535",
                    "PMID:18475434",
                    "PMID:1319763",
                    "PMID:19956406",
                    "PMID:10449154",
                    "PMID:12969113",
                    "PMID:11251036",
                    "PMID:17992512",
                    "PMID:9496240",
                    "PMID:33743405",
                    "PMID:19839871",
                    "PMID:8403558",
                    "PMID:18434350",
                    "PMID:31918707",
                    "PMID:8805670",
                    "PMID:8050200",
                    "PMID:11957164",
                    "PMID:31695682",
                    "PMID:33045197",
                    "PMID:12697042"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1319763": {
                      "sentence": "Supernatant levels of IL-6 were only slightly diminished by hydrocortisone.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Jan"
                    },
                    "PMID:8050200": {
                      "sentence": "Although freshly isolated Mo produced more IL-6 in response to LPS than Mo cultured 24 hr, culture had little effect on inhibition of IL-6 by HC.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Aug"
                    },
                    "PMID:8403558": {
                      "sentence": "The inhibitory effect of HC on LPS-stimulated IL-6 production was GC specific and receptor mediated because: (i) equivalent inhibition was not observed with other endogenous steroids and (ii) equimolar amounts of the GC antagonist RU 486 blocked the GC-mediated effect.",
                      "object score": 794,
                      "subject score": 1000,
                      "publication date": "1993 Nov"
                    },
                    "PMID:8434535": {
                      "sentence": "Hydrocortisone reduced the production of the LPS-stimulated IL-6 to a half level.",
                      "object score": 824,
                      "subject score": 1000,
                      "publication date": "1993 Jan"
                    },
                    "PMID:8805670": {
                      "sentence": "IL-13 pretreatment of monocytes significantly diminished (p = 0.005) the suppressive effects of hydrocortisone on LPS-induced IL-6 production.",
                      "object score": 840,
                      "subject score": 1000,
                      "publication date": "1996 Sep 15"
                    },
                    "PMID:9496240": {
                      "sentence": "To summarize, cortisol decreases the expression of IL-6 as well as IL-1 beta in human osteoblast-like cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jan"
                    },
                    "PMID:9749865": {
                      "sentence": "Hydrocortisone significantly suppressed the production of IL-6, IL-8, and GM-CSF by TCCs from AH of VKH patients.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jul-Aug"
                    },
                    "PMID:10449154": {
                      "sentence": "We report that the endogenous CS hydrocortisone and the synthetic CS clobetasol-17-propionate strongly inhibited the production of the inflammatory mediators interleukin (IL)-12 p70, tumor necrosis factor alpha (TNF-alpha), and IL-6 by lipopolysaccharide (LPS)-stimulated monocyte-derived immature DC (iDC) in vitro.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "1999 Aug"
                    },
                    "PMID:11251036": {
                      "sentence": "The infusion of hydrocortisone was associated with significant reductions in serum IL-6 and IL-8 levels and with earlier resolution of the sepsis-induced organ dysfunction syndrome.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2001 Feb"
                    },
                    "PMID:11957164": {
                      "sentence": "Etomidate, given to lower cortisol during surgery, was associated with significantly decreased IL-6 and IL-10 responses to surgery compared with the placebo group, whereas methylprednisolone alone, given to healthy nonsurgical volunteers, had no effect on these cytokines.",
                      "object score": 824,
                      "subject score": 1000,
                      "publication date": "2002 Apr"
                    },
                    "PMID:12697042": {
                      "sentence": "Similar to IL-6, both constitutive and IL-1beta-inducible IL-11 release were dose-dependently inhibited by cortisol (P<0.01); at variance with IL-6, exogenous IL-11 dose-dependently decreased GR numbers in MG-63 cells (P<0.05), while anti-IL-11 antibody significantly increased GR numbers in both cell lines (P<0.05).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Apr"
                    },
                    "PMID:12969113": {
                      "sentence": "RESULTS: Hydrocortisone reduced the plasma levels of IL-6 (P < 0.05); non-significant reductions of TNF-alpha (P = 0.12) and IL-10 (P = 0.44) were noted.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Oct"
                    },
                    "PMID:17992512": {
                      "sentence": "In randomly selected animals 48 h after the highest E. coli dose, compared with the control, hydrocortisone (125 mg/kg) significantly decreased IL-6, INFgamma, and nitric oxide levels.",
                      "object score": 824,
                      "subject score": 1000,
                      "publication date": "2008 Mar"
                    },
                    "PMID:18434350": {
                      "sentence": "A comparison between conventional end point assays and real-time measurement showed similar effects for dexamethasone and hydrocortisone, with a less effective inhibition of IL-6 seen with corticosterone.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 May"
                    },
                    "PMID:18475434": {
                      "sentence": "Hydrocortisone (10(-10) M to 10(-3) M) inhibited LPS-stimulated IL-6 production in a dose-dependent manner.",
                      "object score": 794,
                      "subject score": 1000,
                      "publication date": "1992"
                    },
                    "PMID:19839871": {
                      "sentence": "The result of ELISA also showed the release of IL-6 and IL-8 can be inhibited by hydrocortisone.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Sep"
                    },
                    "PMID:19956406": {
                      "sentence": "The result of ELISA also showed the release of IL-6 and IL-8 can also be inhibited by hydrocortisone.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Nov 20"
                    },
                    "PMID:31695682": {
                      "sentence": "Cortisol inhibited IL-6, IL-8, MCP-1, and MMP-2 secretion induced by B. abortus infection in synovial fibroblast.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019"
                    },
                    "PMID:31918707": {
                      "sentence": "RESULTS: Cortisol decreased the expressions of IL1beta, IL6, TNF-alpha, IL8, and TLR4 mRNA in BEEC treated with LPS or heat-killed E.coli, but up-regulated these gene expressions in BEEC stimulated by live E.coli.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Jan 09"
                    },
                    "PMID:33045197": {
                      "sentence": "The results showed HC inhibited TNF-alpha and IL-6 mRNA expressions and their release, but AS (2.5 MUg/ml) could increase TNF-alpha and IL-6 mRNA expressions and their release.",
                      "object score": 877,
                      "subject score": 1000,
                      "publication date": "2020 Oct 10"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2146121-biolink:physically_interacts_with-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "CHEMBL.COMPOUND:CHEMBL2146121",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006675---SEMMEDDB:interacts_with---NCBIGene:1950---SEMMEDDB:",
                    "UMLS:C0006675---SEMMEDDB:interacts_with---UMLS:C1367721---SEMMEDDB:",
                    "UMLS:C0006675---SEMMEDDB:interacts_with---UMLS:C0242275---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12402346",
                    "PMID:12618961",
                    "PMID:21976953",
                    "PMID:11726670",
                    "PMID:15721620",
                    "PMID:10708848",
                    "PMID:16677079",
                    "PMID:17158881",
                    "PMID:17426025",
                    "PMID:16939220",
                    "PMID:26178717",
                    "PMID:11722462",
                    "PMID:26281765",
                    "PMID:8955192",
                    "PMID:8253800",
                    "PMID:8393775",
                    "PMID:11108952",
                    "PMID:28379158",
                    "PMID:31125616",
                    "PMID:29388706"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1527084": {
                      "sentence": "In the case of coagulation factors IX and X and anticoagulants proteins C and S, calcium has been found to bind to the EGF-like domains.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Sep 25"
                    },
                    "PMID:1554749": {
                      "sentence": "Removal of extracellular calcium by chelation with excess EGTA or use of the non-specific calcium channel blocker lanthanide, both of which abolish the EGF-induced calcium transient in HER-14 cells, had no effect on the PMA or EGF induced c-jun or c-fos response.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1992 Mar 16"
                    },
                    "PMID:2439377": {
                      "sentence": "Modulation of stimulatory action of follicle stimulating hormone (FSH) and inhibitory action of epidermal growth factor (EGF) on aromatase activity in Sertoli cells by calcium.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987 Jun 22"
                    },
                    "PMID:8393775": {
                      "sentence": "To define the calcium- and/or D3-sensitive mechanisms associated with liver growth, a study of the initial events transduced by EGF was initiated by probing EGF receptor (EGFR) density and affinity, its subsequent autophosphorylation, and the level of its steady state transcript.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Aug"
                    },
                    "PMID:8639264": {
                      "sentence": "The EGF-like domain of BA46 is similar to the calcium-binding EGF-like domains of several coagulation factors, but the BA46 domain lacks a residue required for calcium binding and the coagulation factor domains do not include an RGD sequence.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Apr"
                    },
                    "PMID:8894692": {
                      "sentence": "All skipped exons encode calcium binding epidermal growth factor (EGF)-like domains and maintain the reading frame.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Oct"
                    },
                    "PMID:8900230": {
                      "sentence": "Here we report an A-->T transversion at the -2 position of the consensus acceptor splice site, resulting in the missplicing of exon 34, a calcium-binding epidermal growth factor-like repeat in fibrillin-2 in a mother and daughter with CCA.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Nov"
                    },
                    "PMID:8955192": {
                      "sentence": "CD97alpha exists in three alternatively spliced isoforms that contain between three and five epidermal growth factor (EGF)-like repeats that are related to the calcium binding EGF-like repeats in the microfibril protein fibrillin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Dec 15"
                    },
                    "PMID:9254848": {
                      "sentence": "The mutation, G1760A, is predicted to result in the amino acid substitution C587Y and thus to disrupt one of the disulfide bonds of the calcium-binding epidermal growth factor-like module encoded by exon 14.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Aug"
                    },
                    "PMID:9278415": {
                      "sentence": "The self-association and fibronectin-binding sites of fibulin-1 map to calcium-binding epidermal growth factor-like domains.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Sep 05"
                    },
                    "PMID:9299350": {
                      "sentence": "Binding of fibulin-1 to nidogen depends on its C-terminal globular domain and a specific array of calcium-binding epidermal growth factor-like (EG) modules.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Sep 19"
                    },
                    "PMID:9525872": {
                      "sentence": "The calcium-binding epidermal growth factor-like (cbEGF) domain is a common motif found in extracellular proteins.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Apr 03"
                    },
                    "PMID:9566191": {
                      "sentence": "The effects of the removal and replacement of divalent cations on the ultrastructure of 10 to 12 nm fibrillin-1-containing microfibrils have been studied, in order to investigate the conformation of fibrillin-1 calcium-binding epidermal growth factor-like (cbEGF-like) domains within the microfibril.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1998 Mar 13"
                    },
                    "PMID:9887276": {
                      "sentence": "Fibrillin-1 is a major structural component of 10-12 nm connective tissue microfibrils and has a modular organisation that includes 43 calcium binding epidermal growth factor-like (cbEGF) domains and seven transforming growth factor beta-binding protein-like (TB) domains.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "1999 Jan 22"
                    },
                    "PMID:16677079": {
                      "sentence": "The structure of fibrillin-1 is dominated by two types of disulfide-rich motifs, the calcium- binding epidermal growth factor-like (cbEGF) and transforming growth factor beta binding protein-like (TB) domains.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006"
                    },
                    "PMID:17660513": {
                      "sentence": "The calcium-binding epidermal growth factor-like (cbEGF) domain is a widely occurring module in proteins of diverse function.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Sep 28"
                    },
                    "PMID:25337071": {
                      "sentence": "We report on a patient with ectopia lentis and a nonprogressive aortic root dilatation who presented with a novel mutation affecting a conserved cysteine residue present in a calcium-binding epidermal growth factor-like domain of FBN1 (ENSP00000325527, p.Cys538Phe; Chr15:48,805,751 G>T), as revealed by complete sequencing of the FBN1 gene exons and flanking sequences.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Aug"
                    },
                    "PMID:26178717": {
                      "sentence": "Through the course of screening, a novel gene that contains three alternate repeats of fibronectin domain 2 and epidermal growth factor (EGF)-like domains, as well as an additional calcium-binding EGF-like domain (EGF-CA), was identified and tentatively named euphy after the scientific name of the coral, E. ancora.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2015 Sep"
                    },
                    "PMID:26281765": {
                      "sentence": "They are multi-domain proteins, containing primarily calcium binding epidermal growth factor-like (cbEGF) domains and 8-cysteine/transforming growth factor-beta binding protein-like (TB) domains.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2015"
                    },
                    "PMID:27914124": {
                      "sentence": "Molecular analysis revealed a missense mutation at nucleotide 3217 (c.3217G>A) in exon 26 of the fibrillin-1 (FBN1) gene, resulting in the substitution of a glutamate for a lysine at codon 1073 (E1073K) in the 12th calcium binding epidermal growth factor-like domain of the FBN1 protein.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2017 Jan"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2369717-biolink:physically_interacts_with-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "CHEMBL.COMPOUND:CHEMBL2369717",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0030956---SEMMEDDB:interacts_with---UMLS:C0242275---SEMMEDDB:",
                    "UMLS:C1305923---SEMMEDDB:interacts_with---UMLS:C0242275---SEMMEDDB:",
                    "UMLS:C1305923---SEMMEDDB:interacts_with---UMLS:C1509244---SEMMEDDB:",
                    "UMLS:C0030956---SEMMEDDB:interacts_with---UMLS:C1367721---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:26677067",
                    "PMID:1649188",
                    "PMID:8227181",
                    "PMID:8420953",
                    "PMID:8923874",
                    "PMID:24523339",
                    "PMID:31268623",
                    "PMID:6968072",
                    "PMID:24709418",
                    "PMID:2985623",
                    "PMID:2682237",
                    "PMID:944704"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:944704": {
                      "sentence": "The effect of human epidermal growth factor (hEGF), a 5,400 molecular weight polypeptide isolated from human urine, on the growth of human foreskin fibroblasts (HF cells) was studied by measuring cell numbers and the incorporation of labeled thymidine.",
                      "object score": 1000,
                      "subject score": 794,
                      "publication date": "1976 Jun"
                    },
                    "PMID:1649188": {
                      "sentence": "The effect of EGF on [35S]GTP gamma S association was blocked by boiling the peptide for 5 min in 5 mM dithiothreitol or by incubation of the membranes with guanosine 5'-O-(2-thiodiphosphate) (GDP beta S).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Jul 15"
                    },
                    "PMID:2682237": {
                      "sentence": "This polypeptide is one of only two polypeptides in parasite extracts that bind EGF.",
                      "object score": 1000,
                      "subject score": 790,
                      "publication date": "1989 Aug"
                    },
                    "PMID:2985623": {
                      "sentence": "The ability of EGF and its analogue TGF-alpha to induce the transformed phenotype in NRK cells is greatly potentiated by TGF-beta, a polypeptide that does not interact directly with binding sites for EGF or TGF-alpha.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1985 May"
                    },
                    "PMID:6968072": {
                      "sentence": "Genetics of cell surface receptors for bioactive polypeptides: binding of epidermal growth factor is associated with the presence of human chromosome 7 in human-mouse cell hybrids.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "1980 Jun"
                    },
                    "PMID:8227181": {
                      "sentence": "Both peptides induced a concentration-dependent increase in EGF binding, with a maximal effect at the physiological concentration of 1 nM.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1993 Sep"
                    },
                    "PMID:8420953": {
                      "sentence": "The effect of EGF and peptide on glucose uptake was additive to that of insulin and peptide until the maximal level attained with insulin and peptide was reached.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Jan 25"
                    },
                    "PMID:8923874": {
                      "sentence": "To add information on the mechanism of action of EGF and transforming growth factor-alpha (TGF alpha), a peptide correlated to EGF, and the EGF receptor (EGF-R) in the human prostate, we studied the expression and cellular localization of messenger ribonucleic acid (RNA) encoding EGF, EGF-R, and TGF alpha in BPH tissue.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Nov"
                    },
                    "PMID:24523339": {
                      "sentence": "PEP7 also had no effect on epidermal growth factor- and phorbol methyl ester-induced Erk1/2 activation, suggesting PEP7 selectively inhibits AT1aR-mediated Erk1/2 signaling.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Apr 15"
                    },
                    "PMID:24709418": {
                      "sentence": "We have recently synthesized a peptide called Disruptin, which comprised the SVDNPHVC segment of the epidermal growth factor receptor (EGFR) that inhibits binding of heat shock protein 90 (Hsp90) to the EGFR and EGF-dependent EGFR dimerization to cause EGFR degradation.",
                      "object score": 863,
                      "subject score": 1000,
                      "publication date": "2014 Feb"
                    },
                    "PMID:26677067": {
                      "sentence": "Both design methods identified peptides able to bind EGF, and the capacity of these peptides to inhibit the interaction between EGF and EGFR was demonstrated in two in vitro systems.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Apr 15"
                    },
                    "PMID:31268623": {
                      "sentence": "The d versions of these peptides bound to natural EGF, as confirmed by surface acoustic waves (SAWs).",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "2019 Aug 16"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3989410-biolink:physically_interacts_with-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "CHEMBL.COMPOUND:CHEMBL3989410",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0021246---SEMMEDDB:interacts_with---UMLS:C1367721---SEMMEDDB:",
                    "UMLS:C0021246---SEMMEDDB:interacts_with---UMLS:C0242275---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12190125",
                    "PMID:2506336",
                    "PMID:3259262",
                    "PMID:2086243",
                    "PMID:9227600",
                    "PMID:2134279",
                    "PMID:3051323",
                    "PMID:3877079",
                    "PMID:1294264",
                    "PMID:8549878"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1294264": {
                      "sentence": "Pretreatment with 10(-4) M indomethacin (the dose which does not affect SEC viability but inhibit PGE2 and PGI2 generation), significantly reduced protective action of EGF against 8% ethanol injury.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1992 Dec"
                    },
                    "PMID:2086243": {
                      "sentence": "The contractile action of EGF, which was not abolished by the removal of extracellular calcium, was not affected by atropine, tetrodotoxin, phentolamine and indomethacin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 Dec 04"
                    },
                    "PMID:2134279": {
                      "sentence": "The inhibitory effect was not blocked by indomethacin, indicating that the EGF effect is not mediated by prostaglandins.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:2506336": {
                      "sentence": "At the maximum doses which do not affect contractile responses to prostaglandin E2 or carbachol, indomethacin (10 microM) alone or NGA (1 microM) alone only decrease the effect of EGF by 60 to 80%, but indomethacin and NGA in combination abolish totally the response to the growth factor.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Sep"
                    },
                    "PMID:3051323": {
                      "sentence": "The aim of this study was to ascertain whether rats with gastric lesions, induced by cold-water stress, ethanol, or indomethacin, have altered EGF levels in their gastrointestinal tract compared with controls.",
                      "object score": 916,
                      "subject score": 1000,
                      "publication date": "1988 Aug"
                    },
                    "PMID:3259262": {
                      "sentence": "Distinctive actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: differential inhibition by indomethacin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988 May"
                    },
                    "PMID:3877079": {
                      "sentence": "The effects of both TGF-alpha and EGF in calvaria, but not those of parathyroid hormone, were inhibited by 5 X 10(-7) M indomethacin.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1985 Nov"
                    },
                    "PMID:8549878": {
                      "sentence": "In conclusion, indomethacin, in a dose which does not affect cell viability, decreased binding of EGF to cultured gastric KATO III cells and decreased their proliferative response to EGF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995"
                    },
                    "PMID:9227600": {
                      "sentence": "The aims of our study were 1) to investigate whether the renal effects of intravenous infusion of EGF were species specific and 2) to determine the mechanism of these effects by studying the interaction between EGF and indomethacin (a prostaglandin synthase inhibitor) in the conscious rat.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Jun"
                    },
                    "PMID:12190125": {
                      "sentence": "Indomethacin (Indo), administered 15 min before AE to inhibit prostanoids biosynthesis, significantly (p < 0.001) reduced the cytoprotective effects of TGFalpha, EGF and UG and aggravated the ulcer index when administered s.c.",
                      "object score": 833,
                      "subject score": 1000,
                      "publication date": "2002 Jul"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_negatively_regulates_entity-FMA:83358": {
              "object": "FMA:83358",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_negatively_regulates_entity-FMA:83375": {
              "object": "FMA:83375",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_positively_regulates_entity-FMA:83358": {
              "object": "FMA:83358",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_positively_regulates_entity-FMA:83375": {
              "object": "FMA:83375",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:entity_negatively_regulates_entity-FMA:61799": {
              "object": "FMA:61799",
              "subject": "CHEMBL.COMPOUND:CHEMBL3249705",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-UMLS:C0597357": {
              "object": "UMLS:C0597357",
              "subject": "CHEMBL.COMPOUND:CHEMBL995",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0126174---SEMMEDDB:inhibits---UMLS:C0597357---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11711498",
                    "PMID:11900765",
                    "PMID:31062639",
                    "PMID:9180634",
                    "PMID:15345478",
                    "PMID:11174028",
                    "PMID:18940180",
                    "PMID:8613264",
                    "PMID:9535424",
                    "PMID:8365363",
                    "PMID:15793251",
                    "PMID:12942541",
                    "PMID:10409296"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8365363": {
                      "sentence": "This [Na+]i response was mediated by receptors of the AT1 subtype, because it was abolished by losartan (DuP 753).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Sep"
                    },
                    "PMID:8613264": {
                      "sentence": "Thus, the AT1 receptor antagonist losartan and the angiotensin-converting enzyme inhibitors quinaprilat and captopril diminished the ET-1-mediated effects, whereas, the ETA receptor antagonist BQ-123 diminished the Ang II-induced fibronectin synthesis and mesangial cell proliferation.",
                      "object score": 790,
                      "subject score": 870,
                      "publication date": "1996 Apr"
                    },
                    "PMID:9180634": {
                      "sentence": "This stimulation was clearly blocked by the Ang II type 1 receptor antagonist losartan but not by the type 2 receptor antagonist PD 123319.",
                      "object score": 786,
                      "subject score": 940,
                      "publication date": "1997 Jun"
                    },
                    "PMID:9535424": {
                      "sentence": "Losartan, an angiotensin type 1 (AT1) receptor antagonist, blocked the synergistic interaction between Ang II and oleic acid, whereas the AT2 receptor antagonist PD 123319 did not.",
                      "object score": 785,
                      "subject score": 1000,
                      "publication date": "1998 Apr"
                    },
                    "PMID:10409296": {
                      "sentence": "To examine the renal cellular response to 3-day UUO in the neonatal and adult rat, AT(1) and AT(2) receptors were inhibited by losartan and PD-123319, respectively.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 07"
                    },
                    "PMID:11174028": {
                      "sentence": "We examined how the AT1 receptor is modulated and whether blockade of the receptor with losartan could prevent the phenotypic and cellular changes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Jan"
                    },
                    "PMID:11711498": {
                      "sentence": "The Ang II type 1 receptor blocker losartan, but not the type 2 receptor blocker PD 123,319, completely blocked the effect of Ang II.",
                      "object score": 740,
                      "subject score": 940,
                      "publication date": "2001 Nov"
                    },
                    "PMID:11900765": {
                      "sentence": "Losartan, an AT1 receptor antagonist (25 microg/mouse i.c.v.), enhanced the antinociceptive effect of CPA, while the AT2 receptor antagonist 1-[-4-(dimethylamino)-3-methylphenylmethyl]-5-diphenylacetyl)-4,5,6,7-tetrahydro 1H-4-imidazol [4,5c]pyridine-6 carboxylic acid, ditrifluoroacetate, dihydrate (PD 123319; 10 microg/mouse) had less effect.",
                      "object score": 750,
                      "subject score": 1000,
                      "publication date": "2002 May"
                    },
                    "PMID:12942541": {
                      "sentence": "All these effects were due to the activation of the Ang II type I receptor (AT1) since they were blocked by the AT1 antagonist losartan.",
                      "object score": 1000,
                      "subject score": 802,
                      "publication date": "2003 Oct"
                    },
                    "PMID:15345478": {
                      "sentence": "HG levels may cause these effects via the upregulation of AT(1) receptors, which can be blocked by losartan.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Jan"
                    },
                    "PMID:15793251": {
                      "sentence": "Similar results were obtained in diabetic animals treated with losartan, which blocks the type 1 receptor for angiotensin II (AngII).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2005 Apr"
                    },
                    "PMID:18940180": {
                      "sentence": "The data indicate that Ang II may mediate the inflammatory process in LPS-induced ALI through AT(1) receptor, which can be blocked by losartan.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Jan 01"
                    },
                    "PMID:31062639": {
                      "sentence": "In this study, we investigated effects of AT1 receptor antagonist losartan, novel AT2 receptor agonist novokinin and AT2 receptor antagonist PD 123319 in a mouse model of asthma.",
                      "object score": 785,
                      "subject score": 940,
                      "publication date": "2019 Jun"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL406291": {
              "object": "CHEMBL.COMPOUND:CHEMBL406291",
              "subject": "CHEBI:35457",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:inhibits---UMLS:C0006100---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15747307",
                    "PMID:11035213",
                    "PMID:12093312",
                    "PMID:12110002",
                    "PMID:15883759",
                    "PMID:11229087",
                    "PMID:10821135",
                    "PMID:16770319",
                    "PMID:17192135",
                    "PMID:1462857",
                    "PMID:18160362",
                    "PMID:11288962",
                    "PMID:11509473",
                    "PMID:1934322",
                    "PMID:2185292",
                    "PMID:1728438",
                    "PMID:10803488",
                    "PMID:10392595",
                    "PMID:10458510",
                    "PMID:15250031"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1462857": {
                      "sentence": "We conclude that the ACE inhibitor can attenuate vascular bradykinin degradation not only by inhibition of endothelial ACE but also by inhibition of other bradykinin degrading enzymes in deeper layers of the vascular wall.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1992"
                    },
                    "PMID:1934322": {
                      "sentence": "Addition of ACEI during BK infusion reduced the amount of BK necessary to induce a comparable response (125 to 2 micrograms/kg/hr).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991 Jun"
                    },
                    "PMID:2185292": {
                      "sentence": "We conclude that inhibition of bradykinin metabolism by ACE inhibitors is the probable cause of ACE inhibitor-related angioedema and that substance P is not the predominant mediator in this process.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1990 May"
                    },
                    "PMID:7631443": {
                      "sentence": "Inhibition of bradykinin degradation by ACE inhibitors alters the kinin-kallikrein arachidonic acid system leading to increased concentrations of inflammatory metabolites.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1995 Jun 05"
                    },
                    "PMID:7775412": {
                      "sentence": "We have identified an apparent single-domain (67 kDa) insect angiotensin converting enzyme (AnCE) in embryos of Drosophila melanogaster which converts angiotensin I to angiotensin II (Km, 365 microM), removes Phe-Arg from the C terminus of bradykinin (Km, 22 microM), and is inhibited by ACE inhibitors, captopril (IC50 = 1.1 x 10(-9) M) and trandolaprilat (IC50 = 1.6 x 10(-8) M).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Jun 09"
                    },
                    "PMID:8590256": {
                      "sentence": "Angiotensin converting enzyme (ACE) -inhibitors inhibit degradation of inflammatory mediators substance P (SP) and bradykinin, which may further stimulate the synthesis of prostaglandins.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995"
                    },
                    "PMID:8819483": {
                      "sentence": "The protective effects of angiotensin converting enzyme inhibitors may be due to inhibition of bradykinin (BK) degradation, rather than inhibition of angiotensin II formation.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996 Sep"
                    },
                    "PMID:8930174": {
                      "sentence": "Angiotensin converting enzyme (ACE) inhibitors block degradation of bradykinin and bradykinin stimulates prostacyclin production.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Nov"
                    },
                    "PMID:9289376": {
                      "sentence": "ACE-inhibitors antagonize both angiotensin production and bradykinin breakdown, resulting in enhancement of vasodilating prostaglandin release.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1997 Jun"
                    },
                    "PMID:10392595": {
                      "sentence": "These drugs are selective for angiotensin II (type 1 receptor); unlike angiotensin-converting enzyme inhibitors, they do not inhibit bradykinin metabolism or enhance prostaglandin synthesis.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1999 Jun"
                    },
                    "PMID:10458510": {
                      "sentence": "In conclusion, HSR in hemodialyzed patients who are concomitantly treated with a negatively charged membrane and an ACE inhibitor can be considered as a multifactorial disease in that a decreased APP activity resulting in reduced degradation of des-Arg9-BK may lead to the accumulation of this B1 agonist that could be responsible, at least in part, for the signs and symptoms of HSR.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "1999"
                    },
                    "PMID:10803488": {
                      "sentence": "Angiotensin-converting enzyme inhibitors (ACEI) block degradation of bradykinin, and bradykinin stimulates prostacyclin synthesis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999"
                    },
                    "PMID:10821135": {
                      "sentence": "Angiotensin converting enzyme (ACE) inhibitors inhibit the degradation of bradykinin and contribute to accumulation of bradykinin and NO, both of which may be beneficial for diseased hearts.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 May"
                    },
                    "PMID:11035213": {
                      "sentence": "ACE inhibitors added at the peak of the contraction immediately enhanced it further (343 +/- 40%), although the ileum inactivated BK slowly (t(1/2) = 12-16 min).",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2000 Aug"
                    },
                    "PMID:11229087": {
                      "sentence": "Angiotensin-converting enzyme (ACE) inhibitors reduce degradation of bradykinin and thus increase the risk of hypotensive reactions.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Jan 31"
                    },
                    "PMID:11288962": {
                      "sentence": "The ACE inhibitors also block the degradation of bradykinin that may have potential benefits in cardiovascular disease.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Mar"
                    },
                    "PMID:11509473": {
                      "sentence": "Because the effect of ARBs on BK is constrained by the short half-life of BK and because ACE inhibitors block the degradation of BK, this study was designed to test the hypothesis that an ACE inhibitor can potentiate ARB-induced increases in renal interstitial fluid (RIF) BK levels.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Aug"
                    },
                    "PMID:12093312": {
                      "sentence": "Nonetheless, ACE inhibitors provide incomplete blockade of the RAAS and also inhibit the degradation of bradykinin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002"
                    },
                    "PMID:15747307": {
                      "sentence": "Patients taking ACE inhibitors may be at risk for treatments involved with contact phase activation as ACE inhibitors also block the degradation of bradykinin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004"
                    },
                    "PMID:18160362": {
                      "sentence": "Some of the beneficial effects of ACE inhibitors are thought to be due to reduced degradation of bradykinin.",
                      "object score": 1000,
                      "subject score": 840,
                      "publication date": "2007 Dec"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35457-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL408403": {
              "object": "CHEMBL.COMPOUND:CHEMBL408403",
              "subject": "CHEBI:35457",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015---SEMMEDDB:inhibits---UMLS:C0003009---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10076921",
                    "PMID:10652037",
                    "PMID:10863341",
                    "PMID:10619571",
                    "PMID:10547087",
                    "PMID:10436967",
                    "PMID:10373219",
                    "PMID:10618583",
                    "PMID:10839554",
                    "PMID:10338459",
                    "PMID:10410812",
                    "PMID:10193713",
                    "PMID:10618581",
                    "PMID:10076922",
                    "PMID:10620545",
                    "PMID:10718781",
                    "PMID:10619573",
                    "PMID:10830791",
                    "PMID:10368719",
                    "PMID:10234113"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8381736": {
                      "sentence": "It is suggested that the main determinant of the rate of renin synthesis after administration of an ACE inhibitor may be post-transcriptional factors, and that unknown mechanisms may be involved in the increase in plasma renin level after long-term administration of ACE inhibitor in addition to the short feedback mechanism brought about by the decrease in angiotensin II.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Jan"
                    },
                    "PMID:8583482": {
                      "sentence": "ACE inhibitors, angiotensin II antagonists and cough.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1995 Nov"
                    },
                    "PMID:8950017": {
                      "sentence": "Angiotensin-converting enzyme (ACE) inhibitors, which block the formation of AII from AI, improve acquisition and/or retention of basal performance inhibited by the muscarinic receptor antagonist, scopolamine, in conditioned avoidance and habituation tasks.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Nov"
                    },
                    "PMID:9016898": {
                      "sentence": "These results indicate that ACE inhibitors and Ang II receptor antagonists are equally effective in preventing renal injury in PHN and suggest that the renoprotective effects of ACE inhibitors in this model are solely due to inhibition of Ang II.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Feb"
                    },
                    "PMID:9336392": {
                      "sentence": "The beneficial therapeutic effects of angiotensin-converting enzyme (ACE) inhibitors are the result of reduced angiotensin II formation and possibly also of an accumulation of bradykinin that is inactivated by ACE.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1997 Oct"
                    },
                    "PMID:9429844": {
                      "sentence": "Angiotensin converting enzyme (ACE) inhibitors not only reduce angiotensin II, but also increase bradykinin levels, since the angiotensin converting enzyme is identical to kininase II, an enzyme that degrades bradykinin.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997"
                    },
                    "PMID:9490465": {
                      "sentence": "Prognosis in heart failure depends on sympathetic activation, which can be decreased by inhibition of angiotensin II synthesis by ACE-inhibitors.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1997 Nov 29"
                    },
                    "PMID:9554562": {
                      "sentence": "En reduced the DPA-mediated increase in U(alb)V regardless of dietary NaCl, while Los was effective only in when dietary NaCl was reduced (0.2%), suggesting that under these conditions ACEI reduces U(alb)V by a mechanism that is independent of inhibition of Ang-II and that high protein diets augment U(alb)V by both Ang-II-independent and Ang-II-dependent mechanisms.",
                      "object score": 1000,
                      "subject score": 912,
                      "publication date": "1998"
                    },
                    "PMID:9667759": {
                      "sentence": "Inhibition of Ang-II formation by angiotensin converting enzyme inhibitors reduced LDL peroxidation in hypertensive patients as well as in the atherosclerotic apo E deficient mice.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:16568131": {
                      "sentence": "ACE inhibitors decrease angiotensin II concentration; angiotension II stimulates mitogen-activated protein kinases, which in turn activate fibrosis formation and lead to conduction heterogeneity and induction of AF.",
                      "object score": 734,
                      "subject score": 1000,
                      "publication date": "2006 Apr"
                    },
                    "PMID:16611050": {
                      "sentence": "Angiotensin converting enzyme inhibitors and angiotensin II receptor type 1 antagonists decrease angiotensin II stimulated superoxide production thus decreasing not only blood pressure but also inflammation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Apr"
                    },
                    "PMID:16679098": {
                      "sentence": "Because ACE inhibitors block the production of angiotensin II, which is a potent inhibitor of insulin-like growth factor-1 (IGF-1) production, it was hypothesized that treatment with ACE inhibitors is associated with higher levels of IGF-1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 May 15"
                    },
                    "PMID:23097668": {
                      "sentence": "However, the efficacy of angiotensin II blockade by such drugs is sometimes diminished by the so-called \"aldosterone breakthrough\" effect, by which ACE-Is or ARBs (renin-angiotensin system (RAS) inhibitors) gradually lose their effectiveness against hypertension due to the overproduction of aldosterone, known as primary aldosteronism.",
                      "object score": 734,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:23698111": {
                      "sentence": "Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:23901294": {
                      "sentence": "The antihypertensive agents reviewed include diuretics, aldosterone receptor blockers, beta blockers, combined alpha and beta blockers, angiotensin-converting enzyme inhibitors, angiotensin II antagonists, calcium channel blockers, alpha-1 blockers, centrally acting drugs, direct vasodilators, and combinations of these drugs.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:24143271": {
                      "sentence": "Direct renin inhibitors (DRIs) may be useful in combination with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) as they provide a more complete blockade of the renin-angiotensin-aldosterone system (RAAS), effectively suppressing residual angiotensin II production and the counter-regulatory increase in plasma renin activity observed in patients receiving monotherapy with ACEIs or ARBs.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    },
                    "PMID:24385337": {
                      "sentence": "PubMed was searched for human epidemiological and clinical studies published until early 2013, investigating the relationship between vitamin D blood levels and use of drugs from one of the following groups: proton pump inhibitors (PPIs), biguanides, vitamin K antagonists, platelet aggregation inhibitors, thiazide diuretics, loop diuretics, beta-blocking agents, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin-II antagonists, statins, benzodiazepines, and antidepressants.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2014 Feb"
                    },
                    "PMID:25564475": {
                      "sentence": "Remarkably, angiotensin-converting enzyme inhibitors, suppressing the synthesis of angiotensin II (ANG II), and angiotensin receptor blockers, targeting the ANG II type 1 receptor, prevent diabetes in patients with hypertensive or ischemic cardiopathy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Mar 15"
                    },
                    "PMID:26175230": {
                      "sentence": "Certain drugs such as ACE inhibitors, ANG II antagonists, and even statins could interfere with the renin angiotensin system and modulate its deleterious effects.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2015 Sep"
                    },
                    "PMID:27722846": {
                      "sentence": "ACE inhibitors suppress angiotensin II formation, reducing its vasoconstrictive action, its ability to increase aldosterone secretion and the consequent salt retention and expansion of plasma volume.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1988 Nov"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL408403": {
              "object": "CHEMBL.COMPOUND:CHEMBL408403",
              "subject": "CHEBI:35530",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:inhibits---UMLS:C0003009---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23921840",
                    "PMID:11094549",
                    "PMID:15750990",
                    "PMID:12365076",
                    "PMID:16187132",
                    "PMID:24385337",
                    "PMID:10342782",
                    "PMID:16791484",
                    "PMID:15195836",
                    "PMID:12834362",
                    "PMID:10839554",
                    "PMID:1978646",
                    "PMID:12037702",
                    "PMID:16407011",
                    "PMID:27120907",
                    "PMID:17955827",
                    "PMID:12352316",
                    "PMID:10812953",
                    "PMID:16097204",
                    "PMID:10718781"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1978646": {
                      "sentence": "Animals treated with any one of the following agents, alpha- or beta-blockers, diazepam or competitive inhibitors of angiotensin II [Sar-1-ile-8] and [Sar-1-thr-8] angiotensin II, presented myocardial infarction.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1990 May-Jun"
                    },
                    "PMID:9372994": {
                      "sentence": "This article reviews recent clinical drug trials for HF, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II antagonists, vasodilators, beta-adrenergic blockers, positive inotropic agents, calcium antagonists, and antiarrhythmics.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1997 Oct 30"
                    },
                    "PMID:9444298": {
                      "sentence": "Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1997 Dec"
                    },
                    "PMID:10342782": {
                      "sentence": "These results indicate that beta-blockers suppress plasma angiotensin II levels, in parallel with the marked reductions in PRA and urinary aldosterone levels in normotensive and hypertensive subjects.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1999 May"
                    },
                    "PMID:10718781": {
                      "sentence": "To evaluate HDFs' concurrence with national guidelines and compliance with the WHO EDL, nine drug groups were studied in detail: benzodiazepines, calcium channel blockers, beta-adrenoceptor blocking agents, ACE-inhibitors, angiotensin-II inhibitors, NSAIDs, H2-receptor antagonists, 5HT3-antagonists, and H+-pump inhibitors.",
                      "object score": 901,
                      "subject score": 991,
                      "publication date": "2000 Mar"
                    },
                    "PMID:10812953": {
                      "sentence": "Catecholamines receptors ligands, mainly beta-blockers, and the new angiotensin II antagonists represent the most important classes among the established therapies.",
                      "object score": 861,
                      "subject score": 901,
                      "publication date": "2000 Mar"
                    },
                    "PMID:10839554": {
                      "sentence": "Combination antihypertensives include combined agents from the following pharmacologic classes: diuretics and potassium-sparing diuretics, beta blockers and diuretics, angiotensin-converting enzyme (ACE) inhibitors and diuretics, angiotensin-II antagonists and diuretics, and calcium channel blockers and ACE inhibitors.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2000 May 15"
                    },
                    "PMID:11094549": {
                      "sentence": "The part played by the sympathetic nervous system and the renin-angiotensin-aldosterone system and the beneficial effects of beta-blockers, ACE inhibitors, and angiotensin II antagonists are well-established.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2000 Oct 30"
                    },
                    "PMID:12037702": {
                      "sentence": "The drugs prescribed were predominantly ACE-inhibitors, followed by calcium channel blockers, diuretics, beta-blockers and angiotensin II antagonists.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2002 Jun"
                    },
                    "PMID:12352316": {
                      "sentence": "The use of beta-blockers reduces angiotensin II levels, but could not adequately suppress aldosterone production.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2002 Oct"
                    },
                    "PMID:12365076": {
                      "sentence": "Apart from hypertension, the main risk factors associated with each kind of prescription was micro or macroalbuminuria for ACE-I (OR = 1.5), coronary artery disease for beta-blockers and calcium channel blockers (OR = 3.8 and 2.5 respectively), and age for diuretics and angiotensin II antagonists (OR = 1.05 and 1.03).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2002 Jul-Aug"
                    },
                    "PMID:12834362": {
                      "sentence": "Blood pressure reduction can be achieved with several classes of drugs, including diuretics, beta-blockers, ACE inhibitors, angiotensin II antagonists and calcium channel antagonists.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2003"
                    },
                    "PMID:15195836": {
                      "sentence": "ACE inhibitors, angiotensin II antagonists, calcium antagonists, alpha-blockers, central adrenergic inhibitors, and after a delay also diuretics and beta-blockers decrease peripheral resistance.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2004 May 12"
                    },
                    "PMID:15750990": {
                      "sentence": "The patients were on antihypertensive therapy: angiotensin-converting enzyme (ACE)-inhibitors, beta blockers, calcium antagonists and angiotensin II (ATII) antagonists.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2004"
                    },
                    "PMID:16097204": {
                      "sentence": "The drugs mentioned most often were benzodiazepines, diuretics, conversion enzyme inhibitors, angiotensin II inhibitors, and beta-blockers.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2005 Jul 02"
                    },
                    "PMID:16187132": {
                      "sentence": "METHODS: In 2002, we studied prescribing patterns of beta-blockers, calcium channel blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin-II antagonists and statins in the County of Funen, Denmark (180 general practices, 472,000 inhabitants).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2005 Oct"
                    },
                    "PMID:17955827": {
                      "sentence": "With regard to antihypertensive treatment, diuretics, beta-blockers, calcium antagonists, angiotensin converting enzyme inhibitors and angiotensin II antagonists are still considered as first line options.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2007 Sep 12"
                    },
                    "PMID:24385337": {
                      "sentence": "PubMed was searched for human epidemiological and clinical studies published until early 2013, investigating the relationship between vitamin D blood levels and use of drugs from one of the following groups: proton pump inhibitors (PPIs), biguanides, vitamin K antagonists, platelet aggregation inhibitors, thiazide diuretics, loop diuretics, beta-blocking agents, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin-II antagonists, statins, benzodiazepines, and antidepressants.",
                      "object score": 901,
                      "subject score": 983,
                      "publication date": "2014 Feb"
                    },
                    "PMID:27120907": {
                      "sentence": "Impact of ACE inhibitors, angiotensin 2 antagonists, and beta-blockers are small while that of cardiac resynchronization and multidisciplinary management programmes are more efficient.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2014 Oct"
                    },
                    "PMID:30259390": {
                      "sentence": "An extensive literature search was performed containing search terms for the marketed DAAs and CVDs (beta-blocking agents, ACE inhibitors, angiotensin II antagonists, renin inhibitors, diuretics, calcium channel blockers, statins/ezetimibe, fibrates, platelet aggregation inhibitors, vitamin K antagonists, heparins, direct Xa inhibitors, nitrates, amiodarone, and digoxin).",
                      "object score": 901,
                      "subject score": 983,
                      "publication date": "2018 Sep 27"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35674-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL408403": {
              "object": "CHEMBL.COMPOUND:CHEMBL408403",
              "subject": "CHEBI:35674",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003364---SEMMEDDB:inhibits---UMLS:C0003009---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12419170",
                    "PMID:16755142",
                    "PMID:8686197",
                    "PMID:16250855",
                    "PMID:11862298",
                    "PMID:19769445",
                    "PMID:27846309",
                    "PMID:12851994",
                    "PMID:9773797",
                    "PMID:9233121",
                    "PMID:7965266",
                    "PMID:16014045",
                    "PMID:2043107",
                    "PMID:16050414",
                    "PMID:8572837"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:2043107": {
                      "sentence": "DuP 532 is a more potent antihypertensive agent in renal hypertensive rats (ED30 = 0.042 mg/kg, i.v.) and displays a similar or longer duration of action than the previously described AII antagonist, DuP 753.",
                      "object score": 619,
                      "subject score": 836,
                      "publication date": "1991 May 31"
                    },
                    "PMID:7965266": {
                      "sentence": "CONCLUSIONS: It is expected that the new class of antihypertensive agents, angiotensin II antagonists, will not be associated with the high incidence of dry cough associated with the use of ACE inhibitors.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1994 Jul"
                    },
                    "PMID:8572837": {
                      "sentence": "Losartan is the first of a new class of antihypertensive agents that specifically block angiotensin II at AT-1 receptors.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Feb 12"
                    },
                    "PMID:8686197": {
                      "sentence": "ACEI form a group of antihypertensives which inhibit the angiotensin II (A II) production and thus not only reduce the blood pressure but exert also a positive metabolic and antiproliferative effect (A II is a proliferative hormone).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1996 Feb"
                    },
                    "PMID:9233121": {
                      "sentence": "While the treatment for hypertension includes both nonpharmacological and pharmacological therapy, this article will explore losartan or Cozaar, which falls under the newest class of antihypertensive drugs, angiotensin II antagonists.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1997 Jun"
                    },
                    "PMID:9773797": {
                      "sentence": "This study investigates whether blockade of angiotensin II activity prevented chronic allograft injury in the Fisher 344 --> Lewis rat kidney transplant model, and compares its effect with that of calcium channel blockers, the main antihypertensive agents used in transplant patients to control BP.",
                      "object score": 901,
                      "subject score": 901,
                      "publication date": "1998 Oct"
                    },
                    "PMID:11862298": {
                      "sentence": "Novel classes of antihypertensives, with a mechanism of action different from existing agents, such as the recently introduced angiotensin II antagonists, are of particular interest because they affect a different pathogenetic aspect of the disease.",
                      "object score": 831,
                      "subject score": 1000,
                      "publication date": "1996 Aug"
                    },
                    "PMID:12419170": {
                      "sentence": "Three separate sources of evidence--postmarket surveillance studies, medical/prescription database studies, and discontinuation of study medication in long-term endpoint clinical trials--support the proposition that angiotensin II antagonists, the newest class of antihypertensives, are well tolerated, and that patients whose initial treatment is an angiotensin II antagonist are more likely to persist with therapy than patients who use other classes of antihypertensives.",
                      "object score": 734,
                      "subject score": 1000,
                      "publication date": "2002 Dec"
                    },
                    "PMID:12851994": {
                      "sentence": "Irbesartan, an angiotensin II receptor antagonist (AIIRA), is an antihypertensive agent that inhibits the activity of angiotensin II by selectively binding to angiotensin II type 1 (AT1) receptors.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Dec"
                    },
                    "PMID:16014045": {
                      "sentence": "Although several antihypertensive drugs that inhibit angiotensin-converting enzyme (ACE) and angiotensin II (Ang II) type 1 (AT(1)) receptors are available, they are short-lasting and have side effects.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2005 Aug"
                    },
                    "PMID:16050414": {
                      "sentence": "Currently, the drugs most widely used are the inhibitors of the HMG-CoA reductase (statins) and the antihypertensive drugs, mainly angiotensin II blockers.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2005"
                    },
                    "PMID:16250855": {
                      "sentence": "Of particular clinical relevance, a number of clinical trials point to the somewhat provocative conclusion that beyond their blood pressure lowering effect antihypertensive drugs that decrease angiotensin II formation are less stroke protective than the ones that increase angiotensin levels.",
                      "object score": 901,
                      "subject score": 832,
                      "publication date": "2005"
                    },
                    "PMID:16755142": {
                      "sentence": "The patients were divided into 2 groups: an ACEI group, in which imidapril was used in addition to antihypertensive drugs such as Ca channel blockers, beta-blockers, diuretics or angiotensin II antagonist; and a non-ACEI group, in which Ca channel blockers and diuretics were used.",
                      "object score": 734,
                      "subject score": 1000,
                      "publication date": "2006 Feb"
                    },
                    "PMID:19769445": {
                      "sentence": "Second, experimental data is presented to support the hypothesis that antihypertensive drugs that increase angiotensin II formation, such as diuretics, AT1-receptor blockers and dihydropyridines, may have greater brain anti-ischemic effects than antihypertensive drugs that decrease angiotensin II formation, such as beta-blockers and angiotensin-converting enzyme inhibitors, because they increase activation of angiotensin AT2 and AT4 receptors.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2009 Sep"
                    },
                    "PMID:27846309": {
                      "sentence": "CONCLUSION: In our study, we found that use of antihypertensive drugs that increase Ang II formation was not associated with less severe ischemic stroke as compared to use of antihypertensive drugs that suppress Ang II formation.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2016"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEBI:35530-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL2391146": {
              "object": "CHEMBL.COMPOUND:CHEMBL2391146",
              "subject": "CHEBI:35530",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001645---SEMMEDDB:inhibits---UMLS:C0003018---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23706982",
                    "PMID:30617000",
                    "PMID:23096582",
                    "PMID:23537459",
                    "PMID:19260636",
                    "PMID:19145207",
                    "PMID:16014062",
                    "PMID:12448597",
                    "PMID:30658921",
                    "PMID:29608495",
                    "PMID:26542498",
                    "PMID:28299613",
                    "PMID:29844642",
                    "PMID:12704493",
                    "PMID:31707469",
                    "PMID:25050976",
                    "PMID:15807887",
                    "PMID:27957818",
                    "PMID:22660924",
                    "PMID:20875630"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:12448597": {
                      "sentence": "These are younger Caucasians who respond best to angiotensin-converting enzyme (ACE) inhibitors, angiotensin blockers and beta-blockers.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2002 Sep-Oct"
                    },
                    "PMID:12704493": {
                      "sentence": "At discharge, 61.3% of survivors were prescribed angiotensin-converting enzyme (ACE) inhibitors, 6.0% angiotensin blockers, 42.1% beta-blockers, 75.6% diuretics, 26.1% calcium channel blockers and 19.3% warfarin.",
                      "object score": 645,
                      "subject score": 861,
                      "publication date": "2003 Mar 31"
                    },
                    "PMID:15807887": {
                      "sentence": "The therapy of LV DD and HF is not well established but ACE-inhibitors, angiotensin inhibitors, aldosterone antagonists and beta-blockers show potential beneficial effect on diastolic properties.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2005 Apr 04"
                    },
                    "PMID:16014062": {
                      "sentence": "Prescription rates within 6 months of discharge for CABG were obtained for four classes of medicines: beta blockers, lipid-lowering agents, antiplatelet agents, and angiotensin antagonists.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2005 Aug"
                    },
                    "PMID:19145207": {
                      "sentence": "BBs were associated with increased risk for CV mortality 1.39 (95% CI 1.07-1.804; P ,0.01) when compared with renin angiotensin blockade (RAS) therapy.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2009"
                    },
                    "PMID:19260636": {
                      "sentence": "Secondary prevention was started early (thromboprophylaxis, selective beta-blocker, angiotensin inhibitors and statins).",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2008 Sep-Oct"
                    },
                    "PMID:20875630": {
                      "sentence": "Even with the advent of beta-blockers, angiotensin inhibitors and calcium modulating agents, heart failure (HF) still remains a seriously debilitating and life-threatening condition.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2010"
                    },
                    "PMID:22660924": {
                      "sentence": "Lifestyle modification and pharmacological therapy with renin-angiotensin blockers, beta-blockers, diuretics, statins, and aspirin should be encouraged in the early stages of CKD.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2012 Aug"
                    },
                    "PMID:23096582": {
                      "sentence": "This secondary prevention treatment, based upon the combined administration of statins, aspirin, beta-blockers and renin-angiotensin blockers, might avert great part of the relapses contributing substantially to the overall incidence of acute coronary syndromes in the general population.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2012 Nov"
                    },
                    "PMID:23537459": {
                      "sentence": "We evaluated medication adherence by determining the proportion of days covered (PDC) for each therapeutic group (antiplatelet agents, beta-blockers, angiotensin antagonists, and statins) in the 9 months following hospital discharge.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2013 Apr"
                    },
                    "PMID:23706982": {
                      "sentence": "INTERPRETATION: Prophylactic treatment with dexrazoxane, beta-blocker, statin or angiotensin antagonists appear to have similar efficacy for reducing cardiotoxicity.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2013 Sep"
                    },
                    "PMID:25050976": {
                      "sentence": "Statins, renin-angiotensin inhibitors, beta-blockers, and dual antiplatelet therapy all have roles in mitigating long-term risk, but given recurrent thrombotic events on contemporary pharmacologic agents, novel therapies inhibiting thrombin formation have been explored.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2015 Mar-Apr"
                    },
                    "PMID:26542498": {
                      "sentence": "The primary outcome, defined as the proportion of participants taking (persistence) all 4-cardiovascular medication classes (acetylsalicylic acid, angiotensin blockers, statin, and beta-blocker) at 12 months, was 58.4% (intervention) and 58.9% (control; adjusted odds ratio 1.03, 95% CI 0.77-1.36).",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2015 Nov"
                    },
                    "PMID:27957818": {
                      "sentence": "INTRODUCTION: Despite the large amount of evidence supporting the use of antiplatelet agents, beta-blockers, angiotensin antagonists, and lipid-lowering statins in patients with stable coronary artery disease, several studies have documented underprescription of optimal medical treatment (OMT) in Spain.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2017 Apr"
                    },
                    "PMID:28299613": {
                      "sentence": "Recent studies suggest that cardioprotective medications such as renin-angiotensin inhibitors and beta blockers, among others, may be beneficial in the primary prevention of cardiotoxicity.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2017 Mar"
                    },
                    "PMID:29608495": {
                      "sentence": "Diuretics, angiotensin blockade and beta-blockers for left ventricular dysfunction, and beta-blockers and If inhibitors for rate control in mitral stenosis reduced symptoms and improved left ventricular function, but did not alter disease progression.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2018"
                    },
                    "PMID:29844642": {
                      "sentence": "Results: Compared to the DM patients in the Taiwan ACS-FS Registry, even though reperfusion therapy was carried out in significantly fewer patients, the primary percutaneous coronary intervention (PCI) rate for ST-segment elevation myocardial infarction (STEMI) and the prescription rates of GDMT for ACS including P2Y12 inhibitors, renin-angiotensin blockers, beta-blockers, and statins were significantly higher in those in the TSOC ACS-DM Registry.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2018 May"
                    },
                    "PMID:30617000": {
                      "sentence": "Patients with symptomatic PLG-SAS received beta-blockers, angiotensin blockers, and diuretics more frequently and showed higher levels of B-type natriuretic peptide than patients with asymptomatic PLG-SAS.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2019 Jun"
                    },
                    "PMID:30658921": {
                      "sentence": "In comparison with patients managed routinely, patients treated in a dedicated clinic achieved better guideline-recommended pharmacological treatment (65% vs 85% receiving beta blockers, p <0.001, 65% vs 82% receiving renin-angiotensin inhibitors, p = 0.0006, 31% vs 45% receiving mineralocorticoid receptor antagonists, p <0.001).",
                      "object score": 762,
                      "subject score": 808,
                      "publication date": "2019 Apr 01"
                    },
                    "PMID:31707469": {
                      "sentence": "Considering effects and side-effects of any cardiac stimulating treatment strategy, co-medication with beta-blockers, angiotensin converting inhibitors (ACEIs), angiotensin blockers (ARBs) and mineralocorticoid receptor antagonists (MRAs) is not a contradiction, but a senseful measure, even still during the acute inotropic treatment.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2019 Nov 10"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_positively_regulates_entity-CHEBI:33699": {
              "object": "CHEBI:33699",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:RXNORM:3264-biolink:entity_positively_regulates_entity-CHEMBL.COMPOUND:CHEMBL3322001": {
              "object": "CHEMBL.COMPOUND:CHEMBL3322001",
              "subject": "RXNORM:3264",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL160-biolink:entity_positively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.COMPOUND:CHEMBL160",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0010592---SEMMEDDB:stimulates---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15716327",
                    "PMID:7828718",
                    "PMID:9112364",
                    "PMID:15007308",
                    "PMID:10071036",
                    "PMID:15167603",
                    "PMID:9636621",
                    "PMID:9484745",
                    "PMID:10693638",
                    "PMID:16770245",
                    "PMID:12890451",
                    "PMID:10480422",
                    "PMID:8931986",
                    "PMID:12198207",
                    "PMID:14682659",
                    "PMID:22194945",
                    "PMID:11290556",
                    "PMID:16458528",
                    "PMID:11338306"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7828718": {
                      "sentence": "In searching for a candidate mechanism for the immunosuppressive as well as fibrogenic consequences of cyclosporine usage, we have explored the hypothesis that cyclosporine stimulates transcription of transforming growth factor-beta 1 (TGF-beta 1), a multifunctional cytokine endowed with immunosuppressive and fibrogenic properties.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Jan 23"
                    },
                    "PMID:8931986": {
                      "sentence": "Furthermore, nuclear runoff experiments demonstrate that Cs-A directly stimulates the transcriptional activity of the TGF-beta1 gene in MCT cells.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1996"
                    },
                    "PMID:9112364": {
                      "sentence": "BACKGROUND: We have demonstrated that cyclosporine (CsA) stimulates transforming growth factor (TGF) beta1 expression in vitro and that growth of mammalian cells can be arrested by CsA via a TGF-beta1-dependent mechanism.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "1997 Apr 15"
                    },
                    "PMID:9484745": {
                      "sentence": "In an earlier in vitro study, we demonstrated that cyclosporine (CsA) increases TGF-beta1 transcription rate in human T lymphocytes.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998 Feb 15"
                    },
                    "PMID:9636621": {
                      "sentence": "Does cyclosporin promote the secretion of transforming growth factor-beta 1 following pulmonary transplantation?",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jun"
                    },
                    "PMID:10071036": {
                      "sentence": "BACKGROUND: We and others have reported that cyclosporine (CsA) induces increased expression of transforming growth factor-beta1 (TGF-beta1) in vitro as well as in vivo.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Feb 27"
                    },
                    "PMID:10480422": {
                      "sentence": "Cyclosporine (cyclosporin A[CsA]) has been found to increase circulating TGFbeta1 levels in patients (1, 2).",
                      "object score": 900,
                      "subject score": 1000,
                      "publication date": "1999 Aug 27"
                    },
                    "PMID:10693638": {
                      "sentence": "Cyclosporine (CsA) is thought to enhance transforming growth factor (TGF)-beta1 production in vitro and in vivo and this may have a negative effect on long-term graft survival.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2000 Feb"
                    },
                    "PMID:11290556": {
                      "sentence": "The results show that cyclosporine, but not tacrolimus, stimulates BEC TGF-beta1 production, which in turn, causes BEC mito-inhibition and up-regulation of nuclear p21(WAF1/Cip1).",
                      "object score": 876,
                      "subject score": 1000,
                      "publication date": "2001 Apr"
                    },
                    "PMID:11338306": {
                      "sentence": "CONCLUSIONS: The results of the present study support the theory that CsA increases the synthesis of TGF-beta 1 in GCF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Apr"
                    },
                    "PMID:12198207": {
                      "sentence": "Whereas up-regulation of PAI-1 is mediated by TGF-beta1, up-regulation of FN is-at least in part-either directly induced by CsA or mediated by factors other than TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Sep"
                    },
                    "PMID:12890451": {
                      "sentence": "We have recently shown that CsA up-regulates the expression of TGF-beta1 and its receptors type I (TbetaR-I) and type II (TbetaR-II) in rat mesangial cells (MCs).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Jun 21"
                    },
                    "PMID:14682659": {
                      "sentence": "In this study, we evaluated the effects of CsA and TGF-beta1 on human normal gingival (NG) fibroblast proliferation, and explored a possible autocrine stimulation of TGF-beta1 as a cellular regulator of proliferation induced by CsA in NG fibroblasts.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Nov"
                    },
                    "PMID:15007308": {
                      "sentence": "Quantitative analysis revealed that CsA induced a significant (twofold) increase in betaig-h3 mRNA and protein, and this increase was correlated with up-regulation of TGF-beta1 expression (r =.943, P <.001) and the tubulointerstitial fibrosis score (r =.746, P =.05).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2004 Mar"
                    },
                    "PMID:15167603": {
                      "sentence": "Suppression of tubulointerstitial changes was evident at 3 weeks when renal TGF beta 1 mRNA and protein were comparable to those with CsA alone, indicating that early anti-TGF beta intervention is effective in suppressing the progression of CsA nephrotoxicity despite persistent increases in renal TGF beta 1 expression.",
                      "object score": 900,
                      "subject score": 901,
                      "publication date": "2004 May 15"
                    },
                    "PMID:15716327": {
                      "sentence": "Our results indicate that CsA and FK506 are not general inducers of TGF-beta1 biosynthesis but can cause different effects on TGF-beta1 depending on the cell type and concentrations used.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2005 May"
                    },
                    "PMID:16458528": {
                      "sentence": "Recently, we demonstrated that CsA up-regulates the expression of transforming growth factor-beta1 (TGF-beta1), its receptors type I (TbetaR-I) and type II (TbetaR-II), as well as related matrix protein synthesis in mesangial cells (MCs).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Jan 21"
                    },
                    "PMID:16770245": {
                      "sentence": "Use of CsA was able to facilitate TGF-beta1 expression and the subsequent TGF-beta-mediated random migration was blocked by the use of the specific signaling inhibitor SB431542 in vitro.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2006 Jun 15"
                    },
                    "PMID:22194945": {
                      "sentence": "Cyclosporine A (CsA) promotes tissue accumulation and induces TGF -beta1 and, could thereby exert beneficial effects on AAA remodelling and expansion.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL578-biolink:entity_negatively_regulates_entity-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL578",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DrugCentral:1005---DrugCentral:inhibitor---UniProtKB:P12821---DrugCentral:",
                    "DRUGBANK:DB09477---DRUGBANK:inhibitor---UniProtKB:P12821---identifiers_org_registry:drugbank",
                    "UMLS:C0014025---SEMMEDDB:inhibits---NCBIGene:1636---SEMMEDDB:",
                    "DrugCentral:1006---DrugCentral:inhibitor---UniProtKB:P12821---DrugCentral:",
                    "DRUGBANK:DB00584---DRUGBANK:inhibitor---UniProtKB:P12821---identifiers_org_registry:drugbank",
                    "UMLS:C0014027---SEMMEDDB:inhibits---NCBIGene:1636---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:7858555",
                    "PMID:1317125",
                    "PMID:25771846",
                    "PMID:10596866",
                    "PMID:15236580",
                    "PMID:17618628",
                    "PMID:11300367",
                    "PMID:16424790",
                    "PMID:10712274",
                    "PMID:2181637",
                    "PMID:2821452",
                    "PMID:3038430",
                    "PMID:2831117",
                    "PMID:10912779",
                    "PMID:2010559",
                    "PMID:14734637",
                    "PMID:6325220",
                    "PMID:11358938",
                    "PMID:11752352",
                    "PMID:11827728"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1317125": {
                      "sentence": "In rats fed normal chow, infusion of enalaprilat for 1 h abolished plasma ACE activity but decreased renal ACE activity by only 58%.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1992 May"
                    },
                    "PMID:2010559": {
                      "sentence": "Thus, this study shows that ACE inhibition by enalapril improves regional hemodynamics in patients with Type II diabetes.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1991 Feb"
                    },
                    "PMID:2181637": {
                      "sentence": "The urinary albumin excretion measured by the albumin creatinine clearance ratio (Calb/Ccreat) and the mean supine arterial blood pressure (MAP) were studied before the start of ACE inhibition, at the start and during up to 1 year of ACE inhibition with Captopril or Enalapril in 35 patients with various chronic proteinuric renal disorders with or without renal failure, arterial hypertension and nephrotic syndrome.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:2556283": {
                      "sentence": "Milrinone and enalapril, which inhibit PDE-III and ACE, respectively, are able to prolong survival of myocardially infarcted (MI) rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Aug 22"
                    },
                    "PMID:2821452": {
                      "sentence": "[Effects of ACE inhibition with enalapril on the renal function of patients with essential arterial hypertension].",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1987 Jun"
                    },
                    "PMID:2831117": {
                      "sentence": "Rationale for ACE inhibition in the elderly: treatment of arterial hypertension with enalapril.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1987"
                    },
                    "PMID:3038430": {
                      "sentence": "On the contrary, hypoglycaemia induced a sharp increase of ACTH before enalapril (from 19.5 +/- 4.1 to 74.4 +/- 13.0 pg/ml, p less than 0.01 60 min after insulin) but not during ACE inhibition (from 26.1 +/- 6.2 to 34.6 +/- 5.9 pg/ml, NS, at min 60 of the study).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1987"
                    },
                    "PMID:6325220": {
                      "sentence": "Serum ACE activity was greater than 90% inhibited by enalapril throughout the experiment.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1984 Feb 17"
                    },
                    "PMID:7858555": {
                      "sentence": "In the first treatment period, enalapril (mean dose 19mg/day) reduced serum free ACE activity by 40% and had a greater effect than doxazosin (mean dose 5.2mg/day) on clinic supine blood pressure (systolic and diastolic).",
                      "object score": 757,
                      "subject score": 1000,
                      "publication date": "1994 Nov"
                    },
                    "PMID:8959800": {
                      "sentence": "These results demonstrated, in a model of rat liver transplantation, that ACE inhibition by enalapril is effective in reducing hepatic ischemia/reperfusion damage as assessed by the leukocyte-endothelium interaction using in vivo microscopy and postreperfusion bile production.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996"
                    },
                    "PMID:9049577": {
                      "sentence": "CONCLUSION: These results indicate that when quinapril and enalapril are administered as single 20 mg doses, each of which produces the same degree of plasma ACE inhibition and blood pressure reduction- quinapril inhibits vascular ACE to a greater degree than both enalapril and placebo.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1997"
                    },
                    "PMID:10389851": {
                      "sentence": "To assess whether this could be pharmacologically prevented, we administered enalapril to inhibit ACE during the 6 months of glucose intolerance to group 3.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Jul"
                    },
                    "PMID:10712274": {
                      "sentence": "These findings support our previous reports on the enalapril- and captopril-induced enhancement of endogenous antioxidant defenses and include new data on glutathione-dependent defenses, thus furthering current knowledge on the association of ACE inhibition and antioxidants.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000 Mar"
                    },
                    "PMID:10912779": {
                      "sentence": "As expected, enalapril inhibited the local renal ACE activity and significantly decreased angiotensin II (p< 0.01).",
                      "object score": 833,
                      "subject score": 1000,
                      "publication date": "2000 Jul"
                    },
                    "PMID:11205963": {
                      "sentence": "Enalapril at doses, which maximally inhibit ACE activity, reduced MAP dose dependently.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000"
                    },
                    "PMID:11358938": {
                      "sentence": "Itatibant only blunted the antihypertensive effects of enalapril but did not attenuate the beneficial effects of ACE inhibition on the L-NAME-induced nephrosclerosis.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2001 May"
                    },
                    "PMID:12744488": {
                      "sentence": "Inhibition of ACE activity by enalapril does not influence plasma indices of endothelial activation after endotoxin infusion in healthy individuals.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2003 May"
                    },
                    "PMID:14734637": {
                      "sentence": "ACE activity was inhibited equally by NCX and enalapril in the CM hamster, and plasma nitrate levels were increased only in NCX (P<0.05 vs. enalapril and vehicle).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2004 Mar"
                    },
                    "PMID:23894285": {
                      "sentence": "CONCLUSION: Our findings indicate that ACE inhibition with enalapril attenuated several of the deleterious effects of the HF diet.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:25771846": {
                      "sentence": "Enalapril decreased plasma ACE activity; however, it did not suppress furosemide-induced RAAS activation, as determined by the UAldo:C.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2015 Oct"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL578": {
              "object": "CHEMBL.COMPOUND:CHEMBL578",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB09477---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.COMPOUND:CHEMBL995",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0126174---SEMMEDDB:inhibits---UMLS:C0080222---SEMMEDDB:",
                    "UMLS:C0126174---SEMMEDDB:inhibits---UMLS:C1366557---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11369837",
                    "PMID:10432413",
                    "PMID:23868934",
                    "PMID:25099136",
                    "PMID:31540546",
                    "PMID:18812657",
                    "PMID:25882007",
                    "PMID:18457832",
                    "PMID:24591528",
                    "PMID:12748343",
                    "PMID:25360706",
                    "PMID:30610922",
                    "PMID:22479508",
                    "PMID:31216320",
                    "PMID:15573910",
                    "PMID:18182718",
                    "PMID:11025760",
                    "PMID:15349718",
                    "PMID:19304546",
                    "PMID:16330873"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:10432413": {
                      "sentence": "CONCLUSIONS: This study demonstrates that losartan significantly decreases the plasma levels of TGF-beta1, the most important fibrogenetic factor.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Aug"
                    },
                    "PMID:11025760": {
                      "sentence": "The nitric oxide synthase inhibitor, N-nitro-L-arginine (L-NAME) or angiotensin II type I receptor blocker, losartan, inhibited nitric oxide and TGF-beta1 induced by angiotensin II.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Nov"
                    },
                    "PMID:11369837": {
                      "sentence": "With respect to the profibrogenetic cytokines, losartan decreased the plasma levels of TGF-beta1 and ET-1, while amlodipine did not significantly change TGF-beta1 and slightly increased ET-1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001"
                    },
                    "PMID:12748343": {
                      "sentence": "Both losartan and amlodipine failed to reduce serum TGF-beta1 levels.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2003 Jun"
                    },
                    "PMID:15349718": {
                      "sentence": "In conclusion, losartan significantly decreases the intra-graft expression of TGF-beta1 and proteinuria in KTPs with CAN.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Oct"
                    },
                    "PMID:15573910": {
                      "sentence": "In in vitro experiments, losartan (1 x 10(-9) - 1 x 10(-5) M) significantly reduced TNF-alpha and TGF-beta1 levels in culture supernatants of KCs, but captopril (1 x 10(-5) M) did not.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2004 Oct"
                    },
                    "PMID:16330873": {
                      "sentence": "Serum TGF-beta1 levels of pulmonary fibrosis rats were also decreased by losartan.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2006"
                    },
                    "PMID:18182718": {
                      "sentence": "The expressions of TGF-beta1 and p-Smad2/3 were just at a low level in the renal tissues of the rats in the sham-operated group, and were strongly positive in the model group; but losartan could decrease the expressions of TGF-beta1 and p-Smad2/3 (P<0.01).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Dec"
                    },
                    "PMID:18457832": {
                      "sentence": "Benidipine and losartan also reduced the aortic expression of transforming growth factor-beta1 mRNA and thickening of the vascular wall to a similar extent.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2008 Jun 10"
                    },
                    "PMID:18812657": {
                      "sentence": "Losartan could suppress the expression of COX2 and TGF-beta1 in the kidney of DN rats and attenuate the renal lesions caused by DN.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Sep"
                    },
                    "PMID:19304546": {
                      "sentence": "CONCLUSION: Losartan can reversed LVH in elderly patients with EH partially by lowering plasma TGF-beta1 level.",
                      "object score": 668,
                      "subject score": 1000,
                      "publication date": "2009 Mar"
                    },
                    "PMID:22479508": {
                      "sentence": "Losartan significantly attenuated the expression of TGF-beta1 and Snail, and decreased kidney fibrosis induced by IS and PCS in vivo.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:23868934": {
                      "sentence": "In contrast, the increased Tgfb1 expression and adventitial phospho-Smad2 staining were only partially attenuated by losartan.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2013 Sep"
                    },
                    "PMID:24591528": {
                      "sentence": "Losartan reduced TGF-beta1 in the tubules, but not in the glomeruli.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Sep"
                    },
                    "PMID:25099136": {
                      "sentence": "We cautiously conclude that TGFbeta1 inhibition with losartan deserves further evaluation in the clinical management of Camurati-Engelmann disease.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2014 Oct"
                    },
                    "PMID:25233898": {
                      "sentence": "PQ caused a significant increase in hydroxyproline content, mRNA expression of TGF-beta1, Mmp9, and TIMP-1, and relative expression levels of collagen type I and III ( p < 0.05), while losartan significantly decreased the amount of hydroxyproline and downregulated TGF-beta1, Mmp9, and TIMP-1 mRNA and collagen type I and III expressions ( p < 0.05).",
                      "object score": 937,
                      "subject score": 1000,
                      "publication date": "2015 May"
                    },
                    "PMID:25360706": {
                      "sentence": "Combining use of captopril and losartan attenuates the progress of Streptococcus pneumoniae-induced tympanosclerosis through the suppression of TGF-beta1 expression.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2014"
                    },
                    "PMID:25882007": {
                      "sentence": "Moreover, losartan significantly attenuated the expression of TGF-beta1 and EMT of NRK-52E cells treated under hyperglycemic condition.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Aug"
                    },
                    "PMID:30610922": {
                      "sentence": "The purpose of this study was to explore the ability of Losartan to inhibit the inflammatory signaling pathway of TGF-beta1 observed during osteoarthritic progression in the temporomandibular joint (TMJ) and knee joint using a genetic mouse model.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 04"
                    },
                    "PMID:31216320": {
                      "sentence": "CONCLUSION: Losartan inhibited the expression of TGF-beta1 and fibrogenic molecules in human TM cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-UniProtKB:P30556": {
              "object": "UniProtKB:P30556",
              "subject": "CHEMBL.COMPOUND:CHEMBL995",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0126174---SEMMEDDB:inhibits---NCBIGene:185---SEMMEDDB:",
                    "UMLS:C0126174---SEMMEDDB:inhibits---UMLS:C1439284---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15640279",
                    "PMID:25770238",
                    "PMID:31772704",
                    "PMID:34042283",
                    "PMID:17630322",
                    "PMID:19724024",
                    "PMID:27030624",
                    "PMID:22875344",
                    "PMID:27483989",
                    "PMID:23761196",
                    "PMID:30531435",
                    "PMID:23840884",
                    "PMID:19797979",
                    "PMID:30186574",
                    "PMID:9059545",
                    "PMID:19604148",
                    "PMID:27122805",
                    "PMID:26763849",
                    "PMID:25861809",
                    "PMID:30030219"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9369275": {
                      "sentence": "In the aortic rings with endothelium, either inhibition of the AT-1 receptor with losartan or blocking of angiotensin II generation with fosinopril enhanced interleukin-1beta-stimulated inducible nitric oxide synthase protein expression.",
                      "object score": 827,
                      "subject score": 1000,
                      "publication date": "1997 Nov"
                    },
                    "PMID:10533984": {
                      "sentence": "Losartan [1 microM], an AT1R antagonist, inhibited Ang II-stimulated protein tyrosine phosphorylation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Nov"
                    },
                    "PMID:10836725": {
                      "sentence": "Losartan or irbesartan reduced the binding of [3H]-U46619 to platelets, an effect that was observed with lower ability with the other AT-1 antagonists.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2000 Jun"
                    },
                    "PMID:11079465": {
                      "sentence": "We conclude the following: (1) AT-1 blockade by losartan exacerbates acidosis by inducing a distal-tubular acidification defect.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Nov"
                    },
                    "PMID:15640279": {
                      "sentence": "A relationship was suggested between AT 1R A1166C polymorphism and the humoral and renal haemodynamic responses to losartan, an AT-1 blocker, as well as with enhanced Ang II vascular reactivity or sensitivity.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 May"
                    },
                    "PMID:17630322": {
                      "sentence": "ANGII treatment of normal fibroblasts led to enhanced migration and proliferation, which was abrogated after pretreatment with losartan (LOS), an AGTR1 inhibitor.",
                      "object score": 827,
                      "subject score": 1000,
                      "publication date": "2007 Dec"
                    },
                    "PMID:19487683": {
                      "sentence": "AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Jun 23"
                    },
                    "PMID:19604148": {
                      "sentence": "These effects were abrogated by losartan, an AT-1R antagonist, but not by [Sar1,Thr8]-Ang II (Sar is sarcosine), an inactive analogue of Ang II, or by a neutralizing antibody against Ang I/II.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Sep 14"
                    },
                    "PMID:19724024": {
                      "sentence": "HL-1 adult mouse cardiomyocytes were incubated overnight in serum-free medium, and then treated with rosuvastatin, the AT1R inhibitor losartan or anti-LOX-1 antibody for 3 hours.",
                      "object score": 773,
                      "subject score": 773,
                      "publication date": "2009 Dec"
                    },
                    "PMID:21704122": {
                      "sentence": "Similarly, when the AT1R was blocked by losartan, no significant alteration of Abeta secretion, PS1 levels or secretase activity was detected.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Aug 15"
                    },
                    "PMID:22306536": {
                      "sentence": "Similarly to losartan, ASA, and its SA moiety suppressed Ang II-mediated AT1R transcription and fibroblast proliferation as well as expression of collagens and MMPs.",
                      "object score": 783,
                      "subject score": 1000,
                      "publication date": "2012 Mar 15"
                    },
                    "PMID:23761196": {
                      "sentence": "Whereas SHR VSMCs exposure to angiotensin II overexpressed AT1R and Nox4 nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase and slightly downregulated caveolin-1 expression, losartan decreased AT1R protein levels and increased caveolin-1 and Hsp70 expression in SHR VSMC membranes.",
                      "object score": 790,
                      "subject score": 1000,
                      "publication date": "2014 Jan"
                    },
                    "PMID:23840884": {
                      "sentence": "In response to both AngII infusion and AT1R blockade via losartan, renal hemodynamic responses and tubular sodium excretion were significantly attenuated in uni-x animals compared to sham.",
                      "object score": 812,
                      "subject score": 812,
                      "publication date": "2013"
                    },
                    "PMID:23873795": {
                      "sentence": "In the present study, we compared the cardioprotective effects of TRV120023, a novel angiotensin II (ANG II) type 1 receptor (AT1R) ligand, which blocks G protein coupling but stimulates beta-arrestin signaling, against treatment with losartan, a conventional AT1R blocker in the treatment of cardiac hypertrophy and regulation of myofilament activity and phosphorylation.",
                      "object score": 660,
                      "subject score": 1000,
                      "publication date": "2013 Sep 15"
                    },
                    "PMID:24008754": {
                      "sentence": "Human islets from 13 donors were cultured in 5.5 mM (controls) or 16.7 mM glucose [high glucose (HG)] for 4 d with or without losartan (5 MUM), a selective AT1R blocker, and/or U73122 (2 MUM), a selective PLC inhibitor, during the last 2 d.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Dec"
                    },
                    "PMID:25413327": {
                      "sentence": "Losartan reduced AT1R expression in daytime (1.18 +/- 0.1 vs. 0.85 +/- 0.1; P < 0.05) with a trend toward a reduction in the AT1R mRNA expression in the nighttime (1.2 +/- 0.1 vs. 1.0 +/- 0.1; P > 0.05) but failed to restore circadian variability.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2014 Nov 01"
                    },
                    "PMID:25770238": {
                      "sentence": "Two microdialysis (MD) fibers were placed in the forearm skin of 10 young (Y; 24 +/- 1 yr) and 10 older (O; 70 +/- 2 yr) individuals for infusion of 1) lactated Ringer's solution (switched to fasudil, a ROCK antagonist, after cooling); and 2) AT1R blockade with losartan.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 May 15"
                    },
                    "PMID:27030624": {
                      "sentence": "In anaesthetized male and female Wistar rats, the effects of saline as vehicle and MasR blockade (A779) were tested on mean arterial pressure (MAP), renal perfusion pressure (RPP), renal blood flow (RBF), and renal vascular resistance (RVR) when both AT1R and AT2R were blocked by losartan and PD123319, respectively.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Mar"
                    },
                    "PMID:27483989": {
                      "sentence": "Losartan and PD123319 are antagonists of AT1R and angiotensin II type 2 receptor, respectively.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Sep"
                    },
                    "PMID:28976133": {
                      "sentence": "The objective of this pilot study was to explore that potential role by determining whether the AT1R blocker, losartan, would reduce the growth of LAPC-4 prostate cancer xenografts in nude mice.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Sep"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-UniProtKB:Q13315": {
              "object": "UniProtKB:Q13315",
              "subject": "CHEMBL.COMPOUND:CHEMBL995",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0126174---SEMMEDDB:inhibits---NCBIGene:472---SEMMEDDB:",
                    "UMLS:C0126174---SEMMEDDB:inhibits---UMLS:C0919524---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15640279",
                    "PMID:9003008",
                    "PMID:11928278",
                    "PMID:16601194",
                    "PMID:8162955",
                    "PMID:31422694",
                    "PMID:1632771",
                    "PMID:9950833",
                    "PMID:8610501",
                    "PMID:8925571",
                    "PMID:26884836",
                    "PMID:31368573",
                    "PMID:8164437",
                    "PMID:20817619",
                    "PMID:29429366",
                    "PMID:7634560",
                    "PMID:12235231",
                    "PMID:7900784",
                    "PMID:9295162",
                    "PMID:8637181"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:8498969": {
                      "sentence": "On the other hand in whole body experiments, chronic infusion of angiotensin II was shown to upregulate adrenal AT1, and bilateral nephrectomy or losartan (CAS 124750-99-8) administration reduced AT1 mRNA expression.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1993 Feb"
                    },
                    "PMID:8532590": {
                      "sentence": "We demonstrated previously that hippocampal dentate gyrus neurons were sensitive to angiotensin II (AII) and recently discovered that AII applied directly to the dentate gyrus inhibited granule cell long-term potentiation induction and that the inhibition is mediated by the AT1 receptor and can be blocked by losartan, a specific AT1 antagonist.",
                      "object score": 660,
                      "subject score": 1000,
                      "publication date": "1995"
                    },
                    "PMID:8800576": {
                      "sentence": "Further, PD123177, a selective antagonist of the AT2 receptor subtype, showed three orders of magnitude higher affinity for [125I]-AngII binding sites in both normal and hypertrophied myocardium than losartan, a selective antagonist of the AT1 receptor subtype; the Hill coefficients for these drugs were close to one.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1996"
                    },
                    "PMID:8899891": {
                      "sentence": "Central blockade of AT1 receptor with KR 31080 and cholinergic receptor with atropine attenuated water intake more than 50% which was significantly greater than inhibition produced by losartan and CGP 42112A.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996 Oct 08"
                    },
                    "PMID:8925571": {
                      "sentence": "Losartan, an AT1 antagonist, not only blocked the Ang II effect but also inhibited the transmural pressure effect.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1996 Jul"
                    },
                    "PMID:9011633": {
                      "sentence": "This increase in RNA synthesis could be blocked by PD123319, an AT2 antagonist, but not by losartan, an AT1 antagonist.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1996 Mar"
                    },
                    "PMID:9048337": {
                      "sentence": "Blockade of the AT1 receptor by losartan was found to upregulate AT1 mRNA but to down-regulate the AT1 receptor, suggesting that AT1 receptor-mediated intracellular events are necessary to sustain functional AT1 receptor expression in the kidney.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997 Feb"
                    },
                    "PMID:9152365": {
                      "sentence": "Losartan, a selective antagonist of AT1 receptors for angiotensin II, is widely used clinically to manage hypertension.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997 May"
                    },
                    "PMID:9295162": {
                      "sentence": "Losartan at concentrations which block AT1 receptors did not effect phosphatidylcholine biosynthesis mediated by angiotensin II.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997 Aug 16"
                    },
                    "PMID:9362337": {
                      "sentence": "Addition of 10(-6) M losartan, an AT1 inhibitor, to the luminal perfusate inhibited volume absorption (0.95 +/- 0.14 vs. 0.72 +/- 0.11 nl x mm(-1) x min(-1), P < 0.05) and bicarbonate transport (65.0 +/- 7.3 vs. 54.7 +/- 9.2 pmol x mm(-1) x min(-1), P < 0.05).",
                      "object score": 872,
                      "subject score": 888,
                      "publication date": "1997 Oct"
                    },
                    "PMID:9525975": {
                      "sentence": "The AT1 blocker, losartan, abolished apoptosis in stretched myocytes.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1998 Apr 01"
                    },
                    "PMID:9700751": {
                      "sentence": "The coadministration of losartan, a competitive antagonist of the AT1 receptor subtype, concomitant with angiotensin II was also able to block this inhibition.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:9760076": {
                      "sentence": "Subsequent ICV AT1 blockade with losartan abolished both the pressor and antinatriuretic responses to low dose ICV AII.",
                      "object score": 597,
                      "subject score": 1000,
                      "publication date": "1998 Aug 06"
                    },
                    "PMID:9796075": {
                      "sentence": "Recent studies from the authors' laboratory have demonstrated that Ang II induces apoptosis in cultured human coronary artery endothelial cells via activation of AT1 receptors and this can be blocked by losartan.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:16601194": {
                      "sentence": "Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2006 Apr 07"
                    },
                    "PMID:23564180": {
                      "sentence": "Blockade of the AT1 receptor with losartan (2.5 mg/kg/day) prevented tactile hyperalgesia and attenuated cold hyperalgesia, but did not affect the response to noxious heat stimulus.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2013 Jul"
                    },
                    "PMID:23646169": {
                      "sentence": "The upregulation of AT1 expression was reduced by losartan (80%) but not by captopril.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:24552291": {
                      "sentence": "Losartan blocks the AT1 receptor which is expressed on the cell surface, while captopril inhibits ACE, preventing production of angiotensin II, which is present in both the plasma and on the cell surface, especially on endothelial and smooth muscle cells.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2013 Dec"
                    },
                    "PMID:24692718": {
                      "sentence": "We herein provide additional evidence that breast cancer chemotherapy can be influenced by losartan and PD123319, antagonists of angiotensin receptors AT1 and AT2, respectively.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2014 Apr"
                    },
                    "PMID:25046593": {
                      "sentence": "In these animals treated in the same way, bearing intra-cerebral cannula, the locomotor activity was tested 21 days later, after an amphetamine challenge injection and the animals received an AT1 blocker, losartan, or saline 5min before the amphetamine challenge.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2014 Oct 01"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL408403": {
              "object": "CHEMBL.COMPOUND:CHEMBL408403",
              "subject": "VANDF:4021566",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:inhibits---UMLS:C0003009---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11700832",
                    "PMID:11062596",
                    "PMID:15750990",
                    "PMID:10821351",
                    "PMID:12365076",
                    "PMID:16153374",
                    "PMID:16187132",
                    "PMID:16791484",
                    "PMID:15195836",
                    "PMID:10839554",
                    "PMID:11394730",
                    "PMID:17559858",
                    "PMID:12369043",
                    "PMID:16932899",
                    "PMID:12037702",
                    "PMID:10340841",
                    "PMID:17955827",
                    "PMID:10718781",
                    "PMID:16356784",
                    "PMID:12466316"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:217676": {
                      "sentence": "This steroidogenic effect of angiotensin II was completely abolished by calcium antagonists added to the incubation medium without any inhibitory effect on the calcium-induced accumulation of tissue cAMP.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1978 Oct"
                    },
                    "PMID:2632703": {
                      "sentence": "In the pithed rat, the increase in diastolic blood pressure induced by Ang II could only be inhibited by the calcium antagonists by approximately 40%.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1989 Dec"
                    },
                    "PMID:9313622": {
                      "sentence": "Calcium antagonists counteract angiotensin II and endothelin-1 at the level of vascular smooth muscle by reducing Ca2+ inflow and facilitating the vasodilator effects of NO.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1997 Aug"
                    },
                    "PMID:9372994": {
                      "sentence": "This article reviews recent clinical drug trials for HF, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II antagonists, vasodilators, beta-adrenergic blockers, positive inotropic agents, calcium antagonists, and antiarrhythmics.",
                      "object score": 901,
                      "subject score": 983,
                      "publication date": "1997 Oct 30"
                    },
                    "PMID:9397288": {
                      "sentence": "Whereas nitrates partly substitute deficient endogenous nitric oxide, calcium antagonists counteract angiotensin II and endothelin-1 at the level of vascular smooth muscle by reducing Ca2+ inflow and facilitating the vasodilator effects of nitric oxide.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1997"
                    },
                    "PMID:10340841": {
                      "sentence": "Calcium antagonists counteract angiotensin II and endothelin-1 at the level of vascular smooth muscle by reducing the inflow of Ca2+ and facilitating the vasodilator effects of NO.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "1999 Feb"
                    },
                    "PMID:10821351": {
                      "sentence": "New pathways of research are emerging for drugs, such as beta-blockers, ACE inhibitors, the calcium-antagonists, and the receptor antagonist of angiotensin II, all of which have beneficial effects on cardiovascular remodeling.",
                      "object score": 1000,
                      "subject score": 983,
                      "publication date": "2000 Apr"
                    },
                    "PMID:10839554": {
                      "sentence": "Combination antihypertensives include combined agents from the following pharmacologic classes: diuretics and potassium-sparing diuretics, beta blockers and diuretics, angiotensin-converting enzyme (ACE) inhibitors and diuretics, angiotensin-II antagonists and diuretics, and calcium channel blockers and ACE inhibitors.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2000 May 15"
                    },
                    "PMID:11062596": {
                      "sentence": "In addition, it appears that initial treatment with newer classes of drugs, such as angiotensin II antagonists, angiotensin converting enzyme inhibitors, and calcium channel blockers favors treatment adherence.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2000 Dec"
                    },
                    "PMID:11394730": {
                      "sentence": "BACKGROUND: Outside the experimental environment of clinical trials, the tolerability of angiotensin-converting enzyme inhibitors (ACEIs), calcium channel blockers (CCBs), and the angiotensin II antagonist losartan has not been compared.",
                      "object score": 824,
                      "subject score": 1000,
                      "publication date": "2001 May"
                    },
                    "PMID:11700832": {
                      "sentence": "Specialists initiated 29% of prescriptions for beta-blockers, 26% for calcium-channel blockers, 20% for statins and 19% for angiotensin-converting enzyme inhibitors or angiotensin II antagonists.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2001 Oct 15"
                    },
                    "PMID:12037702": {
                      "sentence": "The drugs prescribed were predominantly ACE-inhibitors, followed by calcium channel blockers, diuretics, beta-blockers and angiotensin II antagonists.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2002 Jun"
                    },
                    "PMID:12466316": {
                      "sentence": "Recently published actively controlled outcome trials in hypertension compared conventional therapy (diuretics and beta-blockers) with newer antihypertensive drug classes, including angiotensin-converting enzyme inhibitors, calcium channel blockers, alpha-blockers, and angiotensin II antagonists.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2002 Nov"
                    },
                    "PMID:15195836": {
                      "sentence": "ACE inhibitors, angiotensin II antagonists, calcium antagonists, alpha-blockers, central adrenergic inhibitors, and after a delay also diuretics and beta-blockers decrease peripheral resistance.",
                      "object score": 901,
                      "subject score": 983,
                      "publication date": "2004 May 12"
                    },
                    "PMID:16356784": {
                      "sentence": "Angiotensin-converting enzyme inhibitors and beta blockers have been most frequently studied, followed by angiotensin II blockers, diuretics, adrenergic alpha-agonists, and calcium channel blockers.",
                      "object score": 734,
                      "subject score": 1000,
                      "publication date": "2006 Feb"
                    },
                    "PMID:16932899": {
                      "sentence": "Calcium channel blockers and angiotensin-converting-enzyme inhibitors, blockade of angiotensin II, or anti-TGF-beta1 antibodies might limit nephrotoxicity.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2007 Mar"
                    },
                    "PMID:17559858": {
                      "sentence": "The paper presents the development and validation of a new multi-residue method for the determination of 28 basic/neutral pharmaceuticals (antiepileptics, antibacterial drugs, beta-blockers, analgesics, lipid-regulating agents, bronchodilators, histamine-2-blockers, anti-inflammatory agents, calcium channel blockers, angiotensin-II antagonists and antidepressants) and illicit drugs in surface water with the usage of a new technique: ultra performance liquid chromatography-positive electrospray tandem mass spectrometry (UPLC-MS/MS).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2007 Aug 17"
                    },
                    "PMID:17955827": {
                      "sentence": "With regard to antihypertensive treatment, diuretics, beta-blockers, calcium antagonists, angiotensin converting enzyme inhibitors and angiotensin II antagonists are still considered as first line options.",
                      "object score": 901,
                      "subject score": 983,
                      "publication date": "2007 Sep 12"
                    },
                    "PMID:24385337": {
                      "sentence": "PubMed was searched for human epidemiological and clinical studies published until early 2013, investigating the relationship between vitamin D blood levels and use of drugs from one of the following groups: proton pump inhibitors (PPIs), biguanides, vitamin K antagonists, platelet aggregation inhibitors, thiazide diuretics, loop diuretics, beta-blocking agents, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin-II antagonists, statins, benzodiazepines, and antidepressants.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2014 Feb"
                    },
                    "PMID:30259390": {
                      "sentence": "An extensive literature search was performed containing search terms for the marketed DAAs and CVDs (beta-blocking agents, ACE inhibitors, angiotensin II antagonists, renin inhibitors, diuretics, calcium channel blockers, statins/ezetimibe, fibrates, platelet aggregation inhibitors, vitamin K antagonists, heparins, direct Xa inhibitors, nitrates, amiodarone, and digoxin).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2018 Sep 27"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:entity_negatively_regulates_entity-UniProtKB:P05019": {
              "object": "UniProtKB:P05019",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1641-biolink:entity_positively_regulates_entity-UniProtKB:P08235": {
              "object": "UniProtKB:P08235",
              "subject": "CHEMBL.COMPOUND:CHEMBL1641",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL2146121": {
              "object": "CHEMBL.COMPOUND:CHEMBL2146121",
              "subject": "VANDF:4021566",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:inhibits---UMLS:C0006675---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17689567",
                    "PMID:11281512",
                    "PMID:1716675",
                    "PMID:1817816",
                    "PMID:23602525",
                    "PMID:2444801",
                    "PMID:1352973",
                    "PMID:16635102",
                    "PMID:25443747",
                    "PMID:236526",
                    "PMID:2581302",
                    "PMID:2215079",
                    "PMID:24086855",
                    "PMID:1748649",
                    "PMID:3089642",
                    "PMID:2302257",
                    "PMID:20464581",
                    "PMID:28901117",
                    "PMID:2846548",
                    "PMID:10787054"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:236526": {
                      "sentence": "Verapamil is a novel antiarrhythmic agent which appears to act as a calcium-ion antagonist, blocking calcium transport across the myocardial cell membrane.",
                      "object score": 694,
                      "subject score": 901,
                      "publication date": "1975 May 26"
                    },
                    "PMID:1352973": {
                      "sentence": "Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein.",
                      "object score": 694,
                      "subject score": 983,
                      "publication date": "1992 Jun 23"
                    },
                    "PMID:1716675": {
                      "sentence": "Thus, concentrations of quinpirole that abolished stimulated hormone secretion did not alter calcium currents; conversely, concentrations of calcium channel blockers that partially or completely inhibited calcium currents did not alter basal or stimulated secretion.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "1991 Aug"
                    },
                    "PMID:1748649": {
                      "sentence": "The FSH-induced rise in cytosolic calcium required extracellular calcium and was abolished by calcium channel blockers specific for dihydropyridine (verapamil, nicardipine), nonvoltage-gated (ruthenium red) or all calcium channels (cobalt).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1991 Dec 15"
                    },
                    "PMID:1817816": {
                      "sentence": "It is known that insulin release is calcium-dependent and that calcium-antagonists, blocking calcium transport across cell membranes, inhibit it, especially interfering with the second phase of insulin secretion.",
                      "object score": 694,
                      "subject score": 983,
                      "publication date": "1991 Jun"
                    },
                    "PMID:2215079": {
                      "sentence": "Ethanol-stimulated beta-EP secretion required extracellular calcium and was blocked by a calcium channel blocker; a sodium channel blocker did not affect ethanol-stimulated secretion.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:2302257": {
                      "sentence": "The possibility that organophosphates increase phosphorylase-a in intact cells by releasing Ca2+ from intracellular binding sites is supported by the following findings: organophosphate-induced increases in phosphorylase-a did not correlate with changes in cyclic AMP in the two cell types studied; in PC12 cells, increases in this activity occurred in the absence of extracellular calcium and were not inhibited by the calcium channel blocker, verapamil; fluorescence of the calcium sensitive dye, Quin-2, in PC12 cells preloaded with the acetoxymethyl ester of the dye was increased by soman; finally, addition of the calcium ionophore, A23187, to PC12 cells maintained in calcium-free medium caused sarin-stimulated phosphorylase-a activity to return rapidly to basal levels.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1990 Jan 15"
                    },
                    "PMID:2444801": {
                      "sentence": "Although inhibition of the Ca current by Ca antagonists modifies the functional adaptation to elevated [Ca2+]0, the Ca antagonists with the exception of La3+, do not influence the change in total Ca content.",
                      "object score": 888,
                      "subject score": 983,
                      "publication date": "1987 Oct"
                    },
                    "PMID:2581302": {
                      "sentence": "In studies of the calcium paradox, we have used an isolated rat heart preparation to investigate the relationship between myocardial creatine kinase leakage and the concentration of slow-calcium-channel blockers (nifedipine or verapamil) in the perfusion fluid during a cycle of calcium reduction and repletion.",
                      "object score": 694,
                      "subject score": 916,
                      "publication date": "1985"
                    },
                    "PMID:2846548": {
                      "sentence": "Isoproterenol increased only the influx of calcium from the outside by a channel which was blocked by calcium channel blockers or 8-Br-cGMP.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988 Nov 15"
                    },
                    "PMID:3089642": {
                      "sentence": "Removal of extracellular calcium with EGTA reduced the calcium response to arachidonate, adenosine diphosphate, and 1-oleoyl-2-acetyl glycerol, and the calcium response and aggregation were further inhibited by the calcium antagonists.",
                      "object score": 888,
                      "subject score": 983,
                      "publication date": "1986 Jul"
                    },
                    "PMID:3669187": {
                      "sentence": "The contraction is highly dependent on extracellular calcium and can partly be inhibited by CCBs.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1987 Nov"
                    },
                    "PMID:3795042": {
                      "sentence": "Calcium channel blockers reduced potassium- and calcium-induced contractions, the IC50 being 6 X 10(-8) M for verapamil, 5 X 10(-7) M for diltiazem and 3 X 10(-9) M for nifedipine.",
                      "object score": 840,
                      "subject score": 1000,
                      "publication date": "1986 Dec"
                    },
                    "PMID:3839127": {
                      "sentence": "Verapamil, a calcium-channel blocker, decreased calcium influx into the organ-cultured duodenum and inhibited the induction of CaBP by 1,25(OH)2D3.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "1985 Jun 01"
                    },
                    "PMID:8667218": {
                      "sentence": "Mibefradil is a new calcium antagonist that can inhibit cardiac calcium current without reducing myocardial force development.",
                      "object score": 851,
                      "subject score": 901,
                      "publication date": "1996 Jun"
                    },
                    "PMID:8706374": {
                      "sentence": "If the cause enhanced impulse generation is related to triggered activity, and since both EAD and DAD are dependent on calcium currents that can appear during a delayed repolarization, the therapeutic options are to shorten the repolarization phase through K-channel openers or Ca antagonists, or to suppress the inward currents directly responsible for the afterdepolarization with Ca blockers.",
                      "object score": 694,
                      "subject score": 983,
                      "publication date": "1996 Apr"
                    },
                    "PMID:8806983": {
                      "sentence": "Calcium channel blockers can block calcium signals that trigger cell differentiation and apoptosis, which are important mechanisms of cancer growth regulation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Jul"
                    },
                    "PMID:16635102": {
                      "sentence": "This indicates that nimodipine, a centrally acting calcium channel blocker, may contribute to the amelioration of dichlorvos induced neurotoxicity by attenuation of calcium mediated disruption of cytoskeletal proteins and hence, calcium channel blockers like nimodipine have great future as new therapeutic agents for OPIDN.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 May"
                    },
                    "PMID:17689567": {
                      "sentence": "Augmented behavioral response and enhanced synaptosomal calcium transport induced by repeated cocaine administration are decreased by calcium channel blockers.",
                      "object score": 547,
                      "subject score": 1000,
                      "publication date": "2007 Jul 26"
                    },
                    "PMID:23602525": {
                      "sentence": "Design, synthesis and pharmacological characterization of analogs of 2-aminoethyl diphenylborinate (2-APB), a known store-operated calcium channel blocker, for inhibition of TRPV6-mediated calcium transport.",
                      "object score": 566,
                      "subject score": 836,
                      "publication date": "2013 Jun 01"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL2391146": {
              "object": "CHEMBL.COMPOUND:CHEMBL2391146",
              "subject": "VANDF:4021566",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:inhibits---UMLS:C0003018---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16397346",
                    "PMID:23067322",
                    "PMID:16041861",
                    "PMID:12135327",
                    "PMID:12704493",
                    "PMID:11565742",
                    "PMID:26237563",
                    "PMID:16939678",
                    "PMID:26952938",
                    "PMID:33031170",
                    "PMID:28404666"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:11565742": {
                      "sentence": "Although renin-angiotensin blockers are now the key components of such regimens, calcium antagonists can play an important role as well, given their demonstrated efficacy in controlling blood pressure.",
                      "object score": 623,
                      "subject score": 983,
                      "publication date": "2001 Sep 15"
                    },
                    "PMID:12135327": {
                      "sentence": "We compared the effect of an angiotensin-converting enzyme inhibitor (cilazapril, 10 mg/kg), an angiotensin receptor blocker (candesartan, 3 mg/kg), a calcium channel blocker (benidipine, 1, 3 or 6 mg/kg), and the same calcium channel blocker combined with renin-angiotensin blockers on systolic heart failure in Dahl salt-sensitive (DS) rats.",
                      "object score": 623,
                      "subject score": 916,
                      "publication date": "2002 May"
                    },
                    "PMID:12704493": {
                      "sentence": "At discharge, 61.3% of survivors were prescribed angiotensin-converting enzyme (ACE) inhibitors, 6.0% angiotensin blockers, 42.1% beta-blockers, 75.6% diuretics, 26.1% calcium channel blockers and 19.3% warfarin.",
                      "object score": 645,
                      "subject score": 884,
                      "publication date": "2003 Mar 31"
                    },
                    "PMID:16041861": {
                      "sentence": "Renin-angiotensin blockers constitute the main drug therapy in such patients associated with diuretics or betablocker if angina pectoris is present or even calcium channel blocker when large arteries abnormalities exist.",
                      "object score": 623,
                      "subject score": 923,
                      "publication date": "2005 May-Jun"
                    },
                    "PMID:16397346": {
                      "sentence": "As specified to the kidney disease, renin-angiotensin (RA) inhibition by ARB or ACE-I is much effective than Ca blockade, however, Ca channel blocker is thought to be the first choice as for the blood pressure lowering of ischemic heart disease patients.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2006 Jan"
                    },
                    "PMID:16939678": {
                      "sentence": "Medical therapy with beta blockers, calcium channel blockers, and/or angiotensin inhibitors has been shown to be somewhat effective in slowing the rate of growth of the aorta.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2006 Sep"
                    },
                    "PMID:23067322": {
                      "sentence": "Combining an agent in renin-angiotensin blockade with a dihydropyridine calcium channel blocker (CCB) and a thiazide diuretic has plausibility in maximizing blood pressure reduction and minimizing side effects.",
                      "object score": 623,
                      "subject score": 916,
                      "publication date": "2012 Nov"
                    },
                    "PMID:26237563": {
                      "sentence": "Pharmacological strategies to date have included progressive withdrawal of alpha-blocking agents; efficacy of beta-blockers for coronary prevention; use of angiotensin blockade in HTN with glomerular injury, using angiotensin-converting enzyme inhibition or receptor blockade, as mono but never double-blockade, to avoid major complications; development of combination therapies with diuretics and/or calcium channel blockers.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2015 Oct"
                    },
                    "PMID:26952938": {
                      "sentence": "Renin-angiotensin blockade, some calcium channel blockers and statins are thought to possess neuroprotective action.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2007 Oct"
                    },
                    "PMID:28404666": {
                      "sentence": "The medication classes examined were peripheral vasodilators, diuretics, ?-blockers (overall, selective and non-selective), calcium channel blockers, renin-angiotensin blockers (overall, ACE inhibitors and angiotensin-receptor blockers), nitrates, other antihypertensive medications, aspirin and statins.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2017 12"
                    },
                    "PMID:33031170": {
                      "sentence": "Patients receiving monotherapy with RAB, CCB or CAH had 2.2 (95% CI 1.4-3.0), 3.0 (1.9-4.1) and 3.0 (1.7-4.7) mmHg higher SBP compared with those on BB (adjusted model, P = 0.007, 0.008 and 0.017, respectively).",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2021 Feb 01"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:VANDF:4021566-biolink:entity_positively_regulates_entity-CHEMBL.COMPOUND:CHEMBL2146121": {
              "object": "CHEMBL.COMPOUND:CHEMBL2146121",
              "subject": "VANDF:4021566",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006684---SEMMEDDB:stimulates---UMLS:C0006675---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:2341719",
                    "PMID:2831717",
                    "PMID:3716828",
                    "PMID:12628373",
                    "PMID:6428925",
                    "PMID:17654703",
                    "PMID:2482371",
                    "PMID:17365858",
                    "PMID:2419167",
                    "PMID:1707708",
                    "PMID:1724998",
                    "PMID:12752012",
                    "PMID:15629258",
                    "PMID:3821475",
                    "PMID:2500011",
                    "PMID:7542885",
                    "PMID:11693466",
                    "PMID:7515314",
                    "PMID:7505582",
                    "PMID:1378782"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1378782": {
                      "sentence": "Calcium antagonists, by preventing the increase in myocardial cytosolic calcium during acute ischaemic episodes, defer cell necrosis; in this respect, they are unique among currently available antianginal drugs.",
                      "object score": 828,
                      "subject score": 983,
                      "publication date": "1992"
                    },
                    "PMID:1707708": {
                      "sentence": "The effects of three calcium antagonists (nifedipine, verapamil, diltiazem) and the calcium agonist Bay K 8644 were compared on contractile responses of similar amplitude elicited by noradrenaline (NA) and electrical nerve stimulation (ENS) in the rabbit isolated ear artery.",
                      "object score": 875,
                      "subject score": 890,
                      "publication date": "1990 Dec"
                    },
                    "PMID:1724998": {
                      "sentence": "Calcium antagonists reduce, whereas calcium agonists enhance, the susceptibility to ventricular fibrillation induced by the combination of exercise and acute myocardial ischemia.",
                      "object score": 888,
                      "subject score": 983,
                      "publication date": "1991"
                    },
                    "PMID:2341719": {
                      "sentence": "Calcium channel-blocking agents interfere with the initial increase of cytosolic calcium that follows mitogenic stimulation of T lymphocytes.",
                      "object score": 853,
                      "subject score": 1000,
                      "publication date": "1990 Jun 01"
                    },
                    "PMID:2419167": {
                      "sentence": "Moreover, this effect is not reversed, even partially by calcium antagonists, by alpha 1 antagonists and is not mimicked by Ca2+ ionophores such as A23187 or calcium agonists such as Bay-K 8644.",
                      "object score": 888,
                      "subject score": 983,
                      "publication date": "1986 Mar 03"
                    },
                    "PMID:2482371": {
                      "sentence": "Effect of calcium-channel blockers and salbutamol on the isolated mare uterus--interaction with the calcium agonist Bay K 8644.",
                      "object score": 875,
                      "subject score": 1000,
                      "publication date": "1989 Dec"
                    },
                    "PMID:2500011": {
                      "sentence": "Since TMB-8 is an intracellular calcium antagonist, this provides evidence to support the suggestion that these inflammatory agents increase the concentration of intracellular calcium which brings about a contraction of the actin-myosin complex resulting in endothelial cell shape changes, and the formation of interendothelial cell gaps.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "1989 Mar"
                    },
                    "PMID:2831717": {
                      "sentence": "The use of intracellular calcium antagonists further suggests that intracellular calcium mobilization is the primary mechanism responsible for increases in macula densa cytosolic calcium with increases in tubular fluid osmolality.",
                      "object score": 837,
                      "subject score": 890,
                      "publication date": "1987"
                    },
                    "PMID:3716828": {
                      "sentence": "Calcium channel blockers (CCB) suppress contractile activity, and block both resting and stimulated calcium influx.",
                      "object score": 660,
                      "subject score": 1000,
                      "publication date": "1986"
                    },
                    "PMID:3821475": {
                      "sentence": "Barbiturates showed effects similar to calcium antagonists, whereas calcium agonists showed the opposite.",
                      "object score": 888,
                      "subject score": 983,
                      "publication date": "1987 Jan"
                    },
                    "PMID:6428925": {
                      "sentence": "In light of the relative ineffectiveness of the above calcium antagonists on the LTD4 dose-response curves, it is suggested that airways contraction is dependent on mobilization of intracellular calcium and that the action of nitrendipine and verapamil as inhibitors of antigen- and A23187-induced contractions is at the point of blocking mediator (i.e. LTC4 and LTD4) release.",
                      "object score": 888,
                      "subject score": 890,
                      "publication date": "1984 Apr 06"
                    },
                    "PMID:7505582": {
                      "sentence": "Protective effect of various calcium antagonists against an experimentally induced calcium overload in isolated hepatocytes.",
                      "object score": 790,
                      "subject score": 884,
                      "publication date": "1993 Dec 03"
                    },
                    "PMID:7515314": {
                      "sentence": "We investigate the modulatory effects of subcutaneous administration of different doses of KB-2796 (1, 5 and 15 mg/kg), a new calcium channel blocker, and BAY K 8644 (0.25, 0.5 and 1 mg/kg), a calcium agonist, on fentanyl-induced analgesia (20 micrograms/kg) in rats.",
                      "object score": 888,
                      "subject score": 916,
                      "publication date": "1994 Mar"
                    },
                    "PMID:7542885": {
                      "sentence": "However, the calcium elevation was sensitive to modulation by an intracellular calcium antagonist, TMB-8, suggesting that the cytosolic calcium elevation was due to mobilization of this cation from an intracellular store.",
                      "object score": 828,
                      "subject score": 901,
                      "publication date": "1995 Jul 17"
                    },
                    "PMID:8645529": {
                      "sentence": "It is believed that some classes of anti-hypertensive drugs have a direct pharmacological depressive effect on cell growth factors that lead to mesangial sclerosis: ACE-inhibitors would thus depress angiotensin II, and the calcium channel blockers would inhibit the increase in intracellular calcium of the mesangial cells which increases gene expression of early growth.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996"
                    },
                    "PMID:12628373": {
                      "sentence": "This increase in intracellular calcium concentration was dependent on the presence of extracellular calcium ion and was inhibited by treatment with gadolinium ion, a stretch-activated calcium channel blocker.",
                      "object score": 623,
                      "subject score": 853,
                      "publication date": "2003 Mar"
                    },
                    "PMID:12752012": {
                      "sentence": "Is long-term use of a calcium channel blocker associated with an exacerbated response of an insulinoma during selective intraarterial calcium stimulation?",
                      "object score": 775,
                      "subject score": 1000,
                      "publication date": "2003 May"
                    },
                    "PMID:15629258": {
                      "sentence": "We performed experiments to examine whether isradipine (Isr), a calcium antagonist, would raise the intracellular calcium concentration ([Ca2+]i) in Gin-1 cells and, if so, to elucidate the mechanism of the [Ca2+]i rise.",
                      "object score": 623,
                      "subject score": 1000,
                      "publication date": "2005 Feb"
                    },
                    "PMID:17365858": {
                      "sentence": "Hypoglycaemia led to an increase in intraplatelet calcium that could be prevented 2-aminoethoxydiphenylborate (2-APB), a store operated calcium channel (SOCC) blocker.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "2007 Mar"
                    },
                    "PMID:17654703": {
                      "sentence": "Application of L-VGCC blockers selectively reduces stress-induced calcium influx and AChE release, mitigates changes in gene expression, and facilitates recovery from protein synthesis suppression.",
                      "object score": 608,
                      "subject score": 771,
                      "publication date": "2007 Oct"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL51483": {
              "object": "CHEMBL.COMPOUND:CHEMBL51483",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB13044---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL3988637-biolink:entity_negatively_regulates_entity-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "CHEMBL.TARGET:CHEMBL3988637",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0040690---SEMMEDDB:inhibits---UMLS:C0242275---SEMMEDDB:",
                    "UMLS:C0040690---SEMMEDDB:inhibits---UMLS:C1367721---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8132740",
                    "PMID:2472412",
                    "PMID:9102915",
                    "PMID:2445478",
                    "PMID:2789121",
                    "PMID:16727844",
                    "PMID:7705776",
                    "PMID:3265111",
                    "PMID:2890433",
                    "PMID:9492075",
                    "PMID:10216124",
                    "PMID:1480019",
                    "PMID:22018398",
                    "PMID:1958520"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1480019": {
                      "sentence": "Expression of the rat stromelysin (transin) gene is stimulated by growth factors such as epidermal growth factor (EGF) and platelet-derived growth factor (PDGF), and inhibited by transforming growth factor-beta (TGF beta).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992"
                    },
                    "PMID:1958520": {
                      "sentence": "TGF-beta (0.02 ng/ml), which did not affect cell proliferation when added alone to the culture medium, inhibited the EGF- and TGF-alpha-induced growth.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1991"
                    },
                    "PMID:2445478": {
                      "sentence": "Growth of three of four squamous carcinomas in the presence of EGF was not inhibited by TGF beta.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1987 Dec 15"
                    },
                    "PMID:2472412": {
                      "sentence": "These data suggest that TGF-beta inhibits EGF and PDGF mitogenicity by blocking EGF- and PDGF-stimulated tyrosine kinase activity and attenuates HBGF-1 mitogenicity by decreasing its receptor affinity.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Jun"
                    },
                    "PMID:2789121": {
                      "sentence": "Furthermore, TGF-beta antagonizes the mitogenic effect of epidermal growth factor (EGF) on DNA synthesis.",
                      "object score": 754,
                      "subject score": 1000,
                      "publication date": "1989 Aug"
                    },
                    "PMID:2890433": {
                      "sentence": "TGF beta inhibition of A549 cell growth was reversed by the antibodies, which also neutralized the growth inhibitory effects of TGF beta on AKR-2B cells in a monolayer [3H]thymidine incorporation assay as demonstrated by prevention of TGF beta inhibition of insulin and epidermal growth factor-stimulated DNA synthesis.",
                      "object score": 822,
                      "subject score": 928,
                      "publication date": "1987 Dec 15"
                    },
                    "PMID:3265111": {
                      "sentence": "The synergistic effect of androgen and EGF was inhibited by TGF beta (0.05 ng/ml).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988 Nov"
                    },
                    "PMID:7705776": {
                      "sentence": "Transforming growth factor beta (TGF-beta), a known antagonist of EGF on hepatocytes, blocked the EGF-induced MT accumulation and stimulation of DNA synthesis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Apr"
                    },
                    "PMID:8132740": {
                      "sentence": "VACO-235, a human colon adenoma cell line, is at early passages nontumorigenic in the nude mouse, unable to grow in soft agar, growth stimulated by serum and EGF, and growth inhibited by TGF-beta.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Mar"
                    },
                    "PMID:9102915": {
                      "sentence": "TGF-beta shows marked loos of inhibitory activity with regard to EGF.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996"
                    },
                    "PMID:9492075": {
                      "sentence": "TGFbeta inhibited both testosterone- and EGF-stimulated prostatic stromal and epithelial cell growth.",
                      "object score": 798,
                      "subject score": 1000,
                      "publication date": "1998 Mar"
                    },
                    "PMID:10216124": {
                      "sentence": "Stimulation of hepatocyte proliferation by epidermal growth factor (EGF) and insulin is inhibited by transforming growth factor beta (TGF-beta) and by glucagon.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 May"
                    },
                    "PMID:16727844": {
                      "sentence": "The hypothesis was tested that bovine preantral follicles can be stimulated to grow in vitro by FSH and by the mitogens, epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF), but not by transforming growth factor-beta (TGFbeta), which generally inhibits EGF and bFGF action.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Mar"
                    },
                    "PMID:22018398": {
                      "sentence": "TGF-beta and PTPN9 can downregulate prolactin- and EGF-mediated STAT5 activation, respectively.",
                      "object score": 597,
                      "subject score": 1000,
                      "publication date": "2011 Oct 12"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL3988637-biolink:entity_negatively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.TARGET:CHEMBL3988637",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0040690---SEMMEDDB:inhibits---NCBIGene:7040---SEMMEDDB:",
                    "UMLS:C0040690---SEMMEDDB:inhibits---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23727812",
                    "PMID:10561136",
                    "PMID:24854279",
                    "PMID:14707053",
                    "PMID:19374154",
                    "PMID:18199825",
                    "PMID:7516043",
                    "PMID:19913506",
                    "PMID:30008374",
                    "PMID:22857993",
                    "PMID:32674108",
                    "PMID:12646048",
                    "PMID:19079339",
                    "PMID:21030067",
                    "PMID:9617573",
                    "PMID:24464750",
                    "PMID:1543679"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1543679": {
                      "sentence": "Moreover, the secretion of TGF-beta like activity assayed by two different methods was estradiol insensitive and the growth of both cell lines was dose-dependently inhibited by TGF-beta 1 (ED50:2 x 10(-11) M).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1992 Feb"
                    },
                    "PMID:7516043": {
                      "sentence": "Culture supernatants were untreated or acid-activated to quantify the active or total TGF-beta, and neutralized with anti-TGF-beta 1 and/or anti-TGF-beta 2 antibody to measure the activity.",
                      "object score": 947,
                      "subject score": 928,
                      "publication date": "1994 Mar"
                    },
                    "PMID:9617573": {
                      "sentence": "(1) the migration of subconfluent fetal cells was unaffected by TGF-beta 1 and -beta 2, but inhibited by TGF-beta 3, whilst the migration of subconfluent adult cells was inhibited by all three isoforms, and (2) the migration of confluent fetal cells was inhibited by all three TGF-beta isoforms, whilst the migration of confluent adult cells was unaffected by TGF-beta 1 and -beta 2, but stimulated by TGF-beta 3.",
                      "object score": 1000,
                      "subject score": 709,
                      "publication date": "1998 Apr"
                    },
                    "PMID:10561136": {
                      "sentence": "Because angiotensin II is known to stimulate the prosclerotic cytokine, transforming growth factor-beta (TGF-beta), we postulated that the renoprotective effect may be due to inhibition of TGF-beta1 production.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1999 Nov"
                    },
                    "PMID:12646048": {
                      "sentence": "TGF-beta activity in the Sertoli cell culture supernatant was inhibited slightly by either the TGF-beta1 and TGF-beta2 neutralizing antibody.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2003 Feb 05"
                    },
                    "PMID:14707053": {
                      "sentence": "In previous studies, we have shown that murine CD4+CD25+ regulatory T cells produce high levels of TGF-beta1 in a cell surface and/or secreted form, and blockade of such TGF-beta1 by anti-TGF-beta curtails the ability of these cells to suppress CD25- T cell proliferation and B cell Ig production in in vitro suppressor assays.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2004 Jan 15"
                    },
                    "PMID:18199825": {
                      "sentence": "These data suggest a mechanism whereby KSHV evades both the antiproliferative effects of TGF-beta signaling by silencing TbetaRII gene expression and immune recognition by suppressing TGF-beta-responsive immune cells through the elevated secretion of TGF-beta1.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2008 May 01"
                    },
                    "PMID:19079339": {
                      "sentence": "We demonstrate that expression of a TGF-beta ligand trap, which neutralizes TGF-beta1 and TGF-beta3, in MDA-MB-231 breast cancer cells diminished their outgrowth in bone and reduced the severity of osteolytic lesion formation when compared with controls.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2009 Feb 19"
                    },
                    "PMID:19374154": {
                      "sentence": "Prolonged exposure to TGF-beta decreased TGF-beta1 gene expression.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2009 Mar"
                    },
                    "PMID:19913506": {
                      "sentence": "TGF-beta induced IL-11 secretion that was blocked by TGF-beta receptor 1 inhibitor but not by IFN-gamma.",
                      "object score": 868,
                      "subject score": 1000,
                      "publication date": "2010 Jan 01"
                    },
                    "PMID:21030067": {
                      "sentence": "Blockade of TGF-beta signaling resulted in a significant decrease in TGF-beta1 expression in malignant cells, but not in benign cells.",
                      "object score": 928,
                      "subject score": 928,
                      "publication date": "2010 Dec"
                    },
                    "PMID:22857993": {
                      "sentence": "Dilated aortas from BAV and TAV patients showed both shared and distinct alterations concerning the TGFbeta pathway, including an increased TGFbeta and TGFbetaR2 (TGFbeta receptor 2) expression in both groups and a decreased TGFbetaR1 expression in BAV samples only.",
                      "object score": 802,
                      "subject score": 888,
                      "publication date": "2013 Jan"
                    },
                    "PMID:23727812": {
                      "sentence": "When TGF-beta signaling was blocked by the TGF-beta receptor 1 kinase inhibitor, LTA failed to suppress the proliferation of effector CD4+ T cells.",
                      "object score": 881,
                      "subject score": 928,
                      "publication date": "2013"
                    },
                    "PMID:24464750": {
                      "sentence": "Furthermore, VEGF-C activated the TGF-beta1 pathway and ERK phosphorylation, which was significantly suppressed by TGF-beta or ERK blockade.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2014 Mar"
                    },
                    "PMID:24854279": {
                      "sentence": "The dual functions of TGF-beta1, as an inducer of TGF-beta1 autoinduction and an inducer of autophagy and TGF-beta degradation, underscore the multifunctionality of TGF-beta1.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2014 Dec"
                    },
                    "PMID:30008374": {
                      "sentence": "This effect on fibrosis markers was partially mediated by targeting TGF-beta signaling, seeing that LY2109761 inhibited TGF-beta1 gene expression and SMAD2 protein phosphorylation.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2018 Sep 15"
                    },
                    "PMID:32674108": {
                      "sentence": "Triphala Ameliorates Nephropathy via Inhibition of TGF-beta1 and Oxidative Stress in Diabetic Rats.INTRODUCTION: Advanced glycation end products, oxidative stress, and TGF-beta expression play a crucial role in pathophysiology of diabetic nephropathy.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2020 Jul 16"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL3988637-biolink:entity_negatively_regulates_entity-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "CHEMBL.TARGET:CHEMBL3988637",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0040690---SEMMEDDB:inhibits---UMLS:C0919432---SEMMEDDB:",
                    "UMLS:C0040690---SEMMEDDB:inhibits---NCBIGene:4088---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:33022778",
                    "PMID:18821706",
                    "PMID:20071455",
                    "PMID:17881189",
                    "PMID:25009639",
                    "PMID:20739403",
                    "PMID:9834202",
                    "PMID:25132073",
                    "PMID:22878587",
                    "PMID:23929772",
                    "PMID:14521923",
                    "PMID:33629553",
                    "PMID:28437189",
                    "PMID:24569463",
                    "PMID:24622514",
                    "PMID:25120713",
                    "PMID:33342034",
                    "PMID:27722012",
                    "PMID:27683030",
                    "PMID:22395235"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9834202": {
                      "sentence": "Taken together, AML1/Evi-1 acts as an inhibitor of TGF-beta signaling by interfering with Smad3 through the Evi-1 portion, and both AML1/Evi-1 and Evi-1 repress TGF-beta-mediated growth suppression in hematopoietic cells.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "1998 Dec 01"
                    },
                    "PMID:11587364": {
                      "sentence": "Through this domain, Evi-1 physically interacts with Smad3, an intracellular mediator of TGF-beta signaling, thereby suppressing the transcriptional activity of Smad3.",
                      "object score": 1000,
                      "subject score": 928,
                      "publication date": "2001 Aug"
                    },
                    "PMID:12051713": {
                      "sentence": "Our results show an immediate translocation of Smad3 protein from the cytoplasm to the nucleus and a delayed down-regulation of Smad3 mRNA by TGF-beta in lung fibroblasts.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Jun 07"
                    },
                    "PMID:14521923": {
                      "sentence": "Inhibition of TGFbeta signaling is dose dependent and results in reduced Smad2 and Smad3 phosphorylation, nuclear translocation, and up-regulation of the TGFbeta target gene Smad7.",
                      "object score": 888,
                      "subject score": 928,
                      "publication date": "2003 Oct 17"
                    },
                    "PMID:17881189": {
                      "sentence": "Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Jan"
                    },
                    "PMID:20071455": {
                      "sentence": "We showed that miR-140 suppressed the TGFbeta pathway through repression of Smad3 and that TGFbeta suppressed the accumulation of miR-140 forming a double negative feedback loop.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2010 Mar"
                    },
                    "PMID:20739403": {
                      "sentence": "Together, these findings suggest that deregulated/enhanced expression and activation of AR in prostate carcinomas may intercept the tumor suppressor function of TGF-beta through transcriptional suppression of Smad3, thereby providing new mechanistic insight into the development of castration-resistant prostate cancer.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Oct"
                    },
                    "PMID:22395235": {
                      "sentence": "HL60 and U937 cells were treated with TGF-beta, tumor necrosis factor-alpha (TNF-alpha) and specific inhibitor of Smad3 (SIS3).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 May"
                    },
                    "PMID:22878587": {
                      "sentence": "Our results suggest that different biologic responses to TGF-beta in the mammary epithelium are differentially affected by Smad3 dosage and that a mere two-fold reduction in Smad3 is sufficient to promote metastasis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Oct"
                    },
                    "PMID:23929772": {
                      "sentence": "Furthermore, CDA1 deletion reduced gene expression of TGF-beta1 receptors in the kidney, resulting in a functionally attenuated response to exogenous TGF-beta, including reduced levels of phosphorylated Smad3 and ERK1/2, in primary kidney cells from CDA1 knockout animals.",
                      "object score": 861,
                      "subject score": 901,
                      "publication date": "2013 Nov"
                    },
                    "PMID:24569463": {
                      "sentence": "In the TGF-beta induced EMT model, eribulin treatment reversed EMT, coincident with inhibition of Smad2 and Smad3 phosphorylation.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2014 Mar 18"
                    },
                    "PMID:24622514": {
                      "sentence": "Antagonism of transforming growth factor-beta (TGF-beta) signaling by TGF-beta neutralizing antibody, short hairpin RNA-mediated Smad3 or Smad2 knockdown, Smad3 haploinsufficiency, or endothelial cell-specific Smad2 deletion resulted in decreased EndMT and less neointimal formation compared to controls.",
                      "object score": 758,
                      "subject score": 928,
                      "publication date": "2014 03 12"
                    },
                    "PMID:25009639": {
                      "sentence": "KG-1 cells were treated with TGF-beta, tumor necrosis factor (TNF)-alpha and specific inhibitor of smad3 (SIS3).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Aug"
                    },
                    "PMID:25120713": {
                      "sentence": "Blockade of the TGF-beta and p38 MAPK pathways attenuated the expression of Smad3, TGF-beta receptor type I (TbetaRI) and TbetaRII, and inhibited their expression in a dose-dependent manner.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Sep"
                    },
                    "PMID:25132073": {
                      "sentence": "This was tested in a mouse model of K5.TGF-beta(WT) transgenic mice by blocking TGF-beta signalling with a specific Smad3 inhibitor.",
                      "object score": 773,
                      "subject score": 937,
                      "publication date": "2014 Nov"
                    },
                    "PMID:27683030": {
                      "sentence": "These findings indicate that miR-142-5p plays as a negative regulator in TGF-beta pathway by targeting SMAD3 and suppresses TGF-beta-induced growth inhibition in cancer cells.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2016 Nov 01"
                    },
                    "PMID:27722012": {
                      "sentence": "Finally, we demonstrated that the anti-fibrotic effect of RVS was associated with the inactivation of Smad3, the key downstream target of a major fibrogenic cytokine, i.e., transforming growth factor beta (TGF-beta).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 Sep"
                    },
                    "PMID:28437189": {
                      "sentence": "In addition, metformin was found to significantly decrease collagen 1a and TGF-beta expression and inhibit p-Smad2 and p-Smad3 expression compared to that of the irradiated group alone.",
                      "object score": 851,
                      "subject score": 901,
                      "publication date": "2017 07"
                    },
                    "PMID:31951824": {
                      "sentence": "They also show that HCMV-infected cells become resistant to TGF-beta signaling through targeting of SMAD3 by miR-UL22-A-3p and -5p.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2020 Jan 08"
                    },
                    "PMID:33022778": {
                      "sentence": "SIS3, a good candidate for the reverse of type 2 diabetes mellitus in mice.TGF-beta signaling plays an extremely important role in the occurrence and development of type 2 diabetes mellitus (T2DM), and the blockade of TGF-beta/Smad3 pathway protests against the high-fat diet-induced obesity and diabetes.",
                      "object score": 645,
                      "subject score": 851,
                      "publication date": "2020 Oct 06"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.TARGET:CHEMBL3988637-biolink:entity_positively_regulates_entity-UniProtKB:P84022": {
              "object": "UniProtKB:P84022",
              "subject": "CHEMBL.TARGET:CHEMBL3988637",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0040690---SEMMEDDB:stimulates---NCBIGene:4088---SEMMEDDB:",
                    "UMLS:C0040690---SEMMEDDB:stimulates---UMLS:C0919432---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:33510050",
                    "PMID:33363388",
                    "PMID:31059054",
                    "PMID:27746021",
                    "PMID:18321991",
                    "PMID:18508541",
                    "PMID:26555261",
                    "PMID:28103144",
                    "PMID:27898661",
                    "PMID:30150789",
                    "PMID:10973944",
                    "PMID:28666867",
                    "PMID:24500985",
                    "PMID:25951457",
                    "PMID:33050985",
                    "PMID:30808624",
                    "PMID:29577454",
                    "PMID:19758997",
                    "PMID:20147459",
                    "PMID:25341890"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9380693": {
                      "sentence": "Either attachment of an epitope tag to the C terminus or replacement of these three serine residues with alanine abolishes TGF-beta-induced Smad3 phosphorylation; these proteins act in a dominant-negative fashion to block the antiproliferative effect of TGF-beta in mink lung epithelial cells.",
                      "object score": 863,
                      "subject score": 863,
                      "publication date": "1997 Sep 30"
                    },
                    "PMID:10092624": {
                      "sentence": "Both elements were required for TGFbeta-induced, Smad3- and Smad4-dependent activation of PAI-1 transcription.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1999 Apr 02"
                    },
                    "PMID:19951945": {
                      "sentence": "Hypoxia attenuated the nuclear accumulation of TGF-beta-induced Smad3 but did not affect Smad2.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2010 Feb 05"
                    },
                    "PMID:19995910": {
                      "sentence": "This Smad7-NLS did not repress Smad3 activation by TGF-beta but did retain its ability to enhance myogenic gene activation and phenotypic myogenesis, indicating that the nuclear, receptor-independent function of Smad7 is sufficient to promote myogenesis.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2010 Feb"
                    },
                    "PMID:20010874": {
                      "sentence": "The TGF-beta-induced Smad3-mediated transcriptional response was mitigated and enhanced by Smad3 and Smad2 knockdown, respectively.",
                      "object score": 823,
                      "subject score": 823,
                      "publication date": "2010 Mar 04"
                    },
                    "PMID:23142729": {
                      "sentence": "Interestingly, W-8 synergistically increased the level of TGF-beta-induced p-Smad3 through inhibition of the AKT/mTOR pathway and enhanced the demethylation of the promoter region of the Foxp3 through inhibition of the ERK pathway and DNMT1 expression.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "2013 Jan"
                    },
                    "PMID:23467611": {
                      "sentence": "Stable reexpression of Arkadia in lung carcinoma NCI-H460 cells, which we show contain a hemizygous nonsense mutation in the Arkadia/RNF111 gene, efficiently restored TGF-beta-induced Smad3-dependent transcription, and substantially decreased the ability of these cells to grow in soft agar in vitro.",
                      "object score": 750,
                      "subject score": 750,
                      "publication date": "2013 Mar 15"
                    },
                    "PMID:23723426": {
                      "sentence": "Knockdown of Kindlin-2 significantly suppressed the engagement of TbetaRI with Smad3 and inhibited TGF-beta-induced Smad3 activation, as well as the expression of its target genes.",
                      "object score": 632,
                      "subject score": 632,
                      "publication date": "2013 Sep"
                    },
                    "PMID:23779087": {
                      "sentence": "Signaling by transforming growth factor-beta (TGF-beta) is critical for various developmental processes and culminates in the activation of the transcription factors Smad2 and Smad3.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Jun 18"
                    },
                    "PMID:23877620": {
                      "sentence": "Our data demonstrated that TGF-beta can activate Smad3 and induce Smad3 translocation into the nucleus in JEG-3 cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    },
                    "PMID:23970797": {
                      "sentence": "In CSC, TLR2 was activated by endogenous high-mobility-group box 1 (HMGB1), inducing IkappaBalpha phosphorylation, IL-6 and TGFbeta secretion, and, consequently, STAT3 and Smad3 activation.",
                      "object score": 694,
                      "subject score": 888,
                      "publication date": "2013 Dec"
                    },
                    "PMID:24382352": {
                      "sentence": "Loss of FOXM1 abolished TGF-beta-induced SMAD3/SMAD4 formation.",
                      "object score": 827,
                      "subject score": 827,
                      "publication date": "2014 Feb"
                    },
                    "PMID:24500985": {
                      "sentence": "Moreover, ATRA reversed the translocation of Smad3 and Smad7 induced by TGF-beta.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Mar"
                    },
                    "PMID:25482449": {
                      "sentence": "ELK-1 binds to the first intron (+1037 to +1294) of the TMEPAI gene together with TGF-beta activated Smad3 and enhances the transcription of TMEPAI.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Jan 09"
                    },
                    "PMID:25501935": {
                      "sentence": "Interestingly, combined TGFbeta and dasatinib treatment resulted in a transient increase in p-Smad3 (seen after 3 hours).",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2014"
                    },
                    "PMID:25526531": {
                      "sentence": "Activated IRF3 interacts with Smad3, thus inhibiting TGF-beta-induced Smad3 activation and, in the nucleus, disrupts functional Smad3 transcription complexes by competing with coregulators.",
                      "object score": 632,
                      "subject score": 632,
                      "publication date": "2014 Dec 18"
                    },
                    "PMID:26275994": {
                      "sentence": "Transforming growth factor-beta (TGF-beta)-activated Smad3 and interleukin-2 (IL-2)-activated Stat5 facilitated Tet1 and Tet2 binding to Foxp3.",
                      "object score": 877,
                      "subject score": 877,
                      "publication date": "2015 Aug 18"
                    },
                    "PMID:26555261": {
                      "sentence": "Although necessary, MRTF is insufficient; Nox4 expression also requires TGFbeta-activated Smad3 and TAZ/YAP, two contact- and cytoskeleton-regulated Smad3-interacting coactivators.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "2016 Jan 01"
                    },
                    "PMID:27746021": {
                      "sentence": "We show that TGF-beta and EGF respectively induce SMAD3 and PCBP1 to colocalize in SC35-positive nuclear speckles, and the two proteins interact in the variable exon region of CD44 pre-mRNA to inhibit spliceosome assembly in favor of expressing the mesenchymal isoform CD44s over the epithelial isoform CD44E.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2016 11 03"
                    },
                    "PMID:28666867": {
                      "sentence": "Enhancement of TGF-beta-induced Smad3 activity by c-Abl-mediated tyrosine phosphorylation of its coactivator SKI-interacting protein (SKIP).",
                      "object score": 863,
                      "subject score": 863,
                      "publication date": "2017 08 26"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL228792-biolink:entity_negatively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.COMPOUND:CHEMBL228792",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00070---DRUGBANK:inhibitor---UniProtKB:P01137---identifiers_org_registry:drugbank",
                    "UMLS:C0020197---SEMMEDDB:inhibits---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11327694",
                    "PMID:9435505",
                    "PMID:7648625",
                    "PMID:9850732"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9435505": {
                      "sentence": "Overall, it is demonstrated in this study that hyaluronidase reciprocally antagonized TGF-beta 1 in the modulation of cell proliferation and TNF-mediated death.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Dec"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL403664-biolink:entity_positively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.COMPOUND:CHEMBL403664",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0005740---SEMMEDDB:stimulates---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:31173491",
                    "PMID:19080365",
                    "PMID:26002989",
                    "PMID:26520185",
                    "PMID:32440328",
                    "PMID:31085231",
                    "PMID:23997916",
                    "PMID:18174229",
                    "PMID:22708497",
                    "PMID:12761881",
                    "PMID:21467638",
                    "PMID:31617733",
                    "PMID:31868203",
                    "PMID:19056849",
                    "PMID:14694243",
                    "PMID:24028731",
                    "PMID:33144389"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:12761881": {
                      "sentence": "Treatment of IMR-90 human embryonic lung fibroblasts with bleomycin at 0.5 microg/ml results in a 1.6-fold increase of TGF-beta1 as determined by a specific ELISA assay for TGF-beta1 after acidification of the conditioned media.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Jun 01"
                    },
                    "PMID:14694243": {
                      "sentence": "In addition, BLM increased the expression of transforming growth factor (TGF)-beta1 in BAL fluid on day 7; this increase was significantly reduced by candesartan cilexetil.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Jan"
                    },
                    "PMID:18174229": {
                      "sentence": "RESULTS: BLM increased serum TGF-beta1, tissue hydroxyproline levels and expression of alpha-smooth muscle actin (alpha-SMA), and dermal fibrosis was histopathologically prominent.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2008 Feb"
                    },
                    "PMID:19056849": {
                      "sentence": "Bleomycin-induced TGF-beta1 activation required LTBP-4, since lung fibroblasts deficient in LTBP-4 did not activate TGF-beta1.",
                      "object score": 676,
                      "subject score": 676,
                      "publication date": "2009 Jan"
                    },
                    "PMID:19080365": {
                      "sentence": "Moreover, simvastatin down-regulated the increased expression of transforming growth factor-beta1 (TGF-beta1) and connective tissue growth factor (CTGF) induced by bleomycin at both gene and protein levels.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Sep 20"
                    },
                    "PMID:21467638": {
                      "sentence": "SY also prevented the increase of alpha-SMA positive cells and TGF-beta1 expression induced by BLM.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2011"
                    },
                    "PMID:22708497": {
                      "sentence": "These changes were associated with the increased production of IL-10, a critical element of the counter-regulatory process triggered by CpG ODN, and the concomitant down-regulation of BLM-induced IL-17A and TGF-beta1 (which promote pulmonary toxicity).",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2012 Jun 18"
                    },
                    "PMID:23997916": {
                      "sentence": "RESULTS: BLM could significantly increase the levels of TNF-alpha and TGF-beta1 and decrease the PGE2 concentration compared to the saline control group.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Jul"
                    },
                    "PMID:24028731": {
                      "sentence": "TGF-beta1 mRNA, alpha-collagenI mRNA and alpha-collagenI protein level were up-regulated by BLM (4.45 +/- 0.45 vs 1.00 +/- 0.20, 5.14 +/- 0.55 vs 1.00 +/- 0.08, 1.48 +/- 0.34 vs 0.23 +/- 0.11) (all P < 0.05); while compared with BLM group, those of BLM+Ang1-7 group were down-regulated (2.80 +/- 0.35, 3.10 +/- 0.52, 0.49 +/- 0.11) (all P < 0.05).",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2013 May 28"
                    },
                    "PMID:26002989": {
                      "sentence": "Bleomycin induced a significant elevation of PRA with a significant increase in hydroxyproline and TGF-beta1 in group III.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Aug"
                    },
                    "PMID:26520185": {
                      "sentence": "BLM-induced transforming growth factor-beta 1 (TGF-beta1) up-regulation and Smad phosphorylation were attenuated by calcitriol.",
                      "object score": 832,
                      "subject score": 832,
                      "publication date": "2016 Jan 05"
                    },
                    "PMID:31085231": {
                      "sentence": "Probucol treatment attenuated bleomycin-induced TGF-beta1 production, EMT and pulmonary fibrosis, meanwhile it suppressed bleomycin-induced oxidative stress.",
                      "object score": 863,
                      "subject score": 863,
                      "publication date": "2019 08"
                    },
                    "PMID:31173491": {
                      "sentence": "Injection of bleomycin induced expression of pSmad3 and TGFbeta1 in the skin, which was inhibited by anti-CX3 CL1 mAb.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Nov"
                    },
                    "PMID:31617733": {
                      "sentence": "At 21 days after bleomycin, compared to male and female C57BL/6 mice, male and female Neu3-/-mice had significantly less inflammation, less upregulation of other sialidases and the profibrotic cytokine active TGF-beta1, and less fibrosis in the lungs.",
                      "object score": 798,
                      "subject score": 1000,
                      "publication date": "2019 Oct 16"
                    },
                    "PMID:31868203": {
                      "sentence": "Here, we identified that the pulmonary fibrosis inducer bleomycin simultaneously increased the expression of bFGF and TGF-beta1 and inhibited epithelial-specific regulatory protein (ESRP1) expression in vivo and in vitro.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2019 Dec 23"
                    },
                    "PMID:32440328": {
                      "sentence": "Moreover, NAC attenuated bleomycin-induced increased expression of TGF-beta1 and total lung collagen levels.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2020 Mar"
                    },
                    "PMID:33144389": {
                      "sentence": "The sialidase NEU3 is upregulated in fibrosis, and mice lacking Neu3 show attenuated bleomycin-induced increases in active TGF-   beta    1 in the lungs and attenuated pulmonary fibrosis.",
                      "object score": 781,
                      "subject score": 781,
                      "publication date": "2020 Nov 03"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL406291-biolink:entity_negatively_regulates_entity-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL406291",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0006100---SEMMEDDB:inhibits---NCBIGene:1636---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11046100",
                    "PMID:18405793",
                    "PMID:12208785",
                    "PMID:15655136",
                    "PMID:30537422",
                    "PMID:9475274",
                    "PMID:11304515",
                    "PMID:16166273",
                    "PMID:29884969",
                    "PMID:10879671",
                    "PMID:1338565",
                    "PMID:1973098",
                    "PMID:24390175",
                    "PMID:1810815",
                    "PMID:8143302",
                    "PMID:9429846",
                    "PMID:11509924",
                    "PMID:1697370",
                    "PMID:24138103",
                    "PMID:19275271"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1338565": {
                      "sentence": "This partial normalization of myocyte Ca(++)-homeostasis in overload hypertrophy by non-hypotensive chronic ACE-inhibition is attenuated by concomitant chronic application of bradykinin-2 receptor blockade, indicating an involvement of altered bradykinin metabolism in the phenotype modulation due to chronic ACE inhibition.",
                      "object score": 851,
                      "subject score": 851,
                      "publication date": "1992"
                    },
                    "PMID:1697370": {
                      "sentence": "The cardioprotective effects produced by perfusion with BK or by reduction of BK degradation through local interference with ACE favor a role for BK in ischemia-reperfusion injuries in rats and dogs.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "1990"
                    },
                    "PMID:1810815": {
                      "sentence": "The failure of ACE inhibitors to potentiate the cardiodepressant and hypotensive effects of bradykinin in a dose-dependent manner is explained with some other mechanism(s) independent of ACE inhibition.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1991"
                    },
                    "PMID:1973098": {
                      "sentence": "In addition to these effects on circulating neurohormones, ACE inhibition could affect myocardial ischaemia through a number of local actions, e.g. modulation of tissue (cardiac) angiotensin II formation and bradykinin breakdown, stimulation of prostaglandin synthesis and, in the use of sulphydryl compounds, by affecting EDRF formation.",
                      "object score": 888,
                      "subject score": 694,
                      "publication date": "1990 Apr"
                    },
                    "PMID:8143302": {
                      "sentence": "HOE-140 strongly antagonised the effects of infused bradykinin and prevented the potentiation of acetylcholine responses by ACE inhibition.",
                      "object score": 888,
                      "subject score": 861,
                      "publication date": "1994 Feb"
                    },
                    "PMID:9429846": {
                      "sentence": "It is of importance that, in both clinical experiments and human studies, the role of bradykinin appears central in the structural and functional cardiovascular effects of ACE inhibition.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997"
                    },
                    "PMID:9475274": {
                      "sentence": "Kininase I carboxypeptidase, and not ACE, is the main enzyme responsible for bradykinin degradation in these vessels.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1998 Feb"
                    },
                    "PMID:9833158": {
                      "sentence": "Bradykinin may accumulate during ACE inhibition and is able to stimulate catecholamine release via B2 receptors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:10879671": {
                      "sentence": "Underlying reasons are mainly the induction of bradykinin release due to the negatively charged membrane and the reduced degradation of bradykinin due to ACE inhibition.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000 Jun"
                    },
                    "PMID:11046100": {
                      "sentence": "In humans, bradykinin contributes to the acute renin response after ACE inhibition.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000 Nov"
                    },
                    "PMID:11304515": {
                      "sentence": "Studies in isolated vessels and rat models of hypertension suggest that angiotensin (Ang)-(1-7) potentiates the vasodilator effect of bradykinin, possibly through ACE inhibition.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2001 Apr"
                    },
                    "PMID:11509924": {
                      "sentence": "Increased bradykinin by ACE inhibition may be responsible for this improved vascular endothelial function.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2001 Apr"
                    },
                    "PMID:12208785": {
                      "sentence": "NEP inhibition with phosphoramidon did not affect the bradykinin concentration-response curve (CRC), nor did combined NEP/ACE inhibition with omapatrilat exert a further leftward shift on top of the approximately 10 fold leftward shift of the bradykinin CRC observed with ACE inhibition alone.",
                      "object score": 840,
                      "subject score": 751,
                      "publication date": "2002 Sep"
                    },
                    "PMID:15655136": {
                      "sentence": "The reductions in BK-(1-7)/BK-(1-9), Ang II/Ang I, and Ang-(1-7)/Ang I ratios suggest that the increased bradykinin levels were the result of reduced metabolism by ACE and neutral endopeptidase.",
                      "object score": 1000,
                      "subject score": 851,
                      "publication date": "2005 Jan 25"
                    },
                    "PMID:16166273": {
                      "sentence": "The inhibition of ACE in plasma is responsible for an accumulation of bradykinin and des-arginine9-bradykinin generated during activation of the contact system with glass beads.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Dec"
                    },
                    "PMID:18405793": {
                      "sentence": "ACE inhibitor-induced cough is believed to be related to the accumulation of bradykinin,substance P,and prostaglandins resulting from the inhibition of ACE.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Mar"
                    },
                    "PMID:19275271": {
                      "sentence": "A concomitant decrease in the degradation of bradykinin as a result of ACE inhibition raises levels of this kinin, leading to vasodilation and an antiapoptotic action, as well as opposition of the negative actions of angiotensin II.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2009"
                    },
                    "PMID:24138103": {
                      "sentence": "CONCLUSIONS: NEP inhibition with thiorphan modestly augmented the vasodilator action of bradykinin, but did not potentiate the response to adrenomedullin; dual ACE and NEP inhibition with omapatrilat, as expected, markedly augmented the response to bradykinin and also potentiated the effect of adrenomedullin.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2014 Feb"
                    },
                    "PMID:24390175": {
                      "sentence": "These results suggest that in coronary arteries, angiotensin-(1-7) and captopril both improves NO bioavailability and enhances endothelium-dependent hyperpolarization to bradykinin solely by ACE1 inhibition.",
                      "object score": 861,
                      "subject score": 861,
                      "publication date": "2014 May"
                    },
                    "PMID:29884969": {
                      "sentence": "The pathophysiology of ACE-I-induced angioedema involves inhibition of bradykinin and substance P degradation by ACE (kininase II) leading to vasodilator and plasma extravasation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Jun 08"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:inhibits---NCBIGene:1636---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:18192335",
                    "PMID:1651180",
                    "PMID:22513176",
                    "PMID:18370649",
                    "PMID:1689424",
                    "PMID:18855265",
                    "PMID:24332999",
                    "PMID:25009501",
                    "PMID:10818068",
                    "PMID:17179902",
                    "PMID:17532087",
                    "PMID:21937997",
                    "PMID:11799091",
                    "PMID:1874031",
                    "PMID:11882622",
                    "PMID:12713448",
                    "PMID:17229979",
                    "PMID:12829650",
                    "PMID:1973098",
                    "PMID:16337046"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1651180": {
                      "sentence": "To determine which of the two methods provided a more reliable indication of ACE inhibition in vivo, we measured plasma ACE, angiotensin I (ANG I), and angiotensin II (ANG II) in patients receiving the CEI perindopril.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1991 Aug"
                    },
                    "PMID:1689424": {
                      "sentence": "Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "1990 Feb"
                    },
                    "PMID:1874031": {
                      "sentence": "Superimposed administration of either ANG II or ANG III during ACE inhibition completely reverses the GFR and renal excretory responses to ACE inhibition.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "1991"
                    },
                    "PMID:1973098": {
                      "sentence": "In addition to these effects on circulating neurohormones, ACE inhibition could affect myocardial ischaemia through a number of local actions, e.g. modulation of tissue (cardiac) angiotensin II formation and bradykinin breakdown, stimulation of prostaglandin synthesis and, in the use of sulphydryl compounds, by affecting EDRF formation.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "1990 Apr"
                    },
                    "PMID:2690904": {
                      "sentence": "New methods of determination of plasma angiotensin II have now allowed demonstration of the complete disappearance of plasma angiotensin II following acute ACE inhibition.",
                      "object score": 851,
                      "subject score": 901,
                      "publication date": "1989"
                    },
                    "PMID:2828645": {
                      "sentence": "The mechanism of protection was ascribed to reduced production of angiotensin II by ACE inhibition and increased prostacyclin release in the myocardium.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1987 Sep"
                    },
                    "PMID:2848974": {
                      "sentence": "Furthermore, ACE inhibition attenuates SFP but not SNGFR feedback responses, and systemic angiotensin II infusions can restore SFP feedback responsiveness towards normal.",
                      "object score": 888,
                      "subject score": 850,
                      "publication date": "1988 Nov"
                    },
                    "PMID:6100876": {
                      "sentence": "Thus, in nearly half of the patients with essential hypertension, ACE inhibition appears to correct an abnormality in the sodium-mediated modulation of adrenal responses to angiotensin II, suggesting that this abnormality reflects an alteration in the interaction of angiotensin II and its receptor.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1984 Dec"
                    },
                    "PMID:8272217": {
                      "sentence": "Plasma renin activity (PRA) and plasma concentrations of angiotensin II (AngII), atrial natriuretic peptide (ANP) and arginine vasopressin (AVP) were determined in the abdominal aorta and the renal veins before and 1 h after peroral ingestion of captopril 25 mg in 29 patients with arterial hypertension and unilateral renal artery stenosis or occlusion, in order to study the effect of ACE inhibition on single-kidney extraction ratio (ER) of PRA, AngII, ANP, and AVP, and on renal vein renin ratio (RVRR).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1993"
                    },
                    "PMID:8701189": {
                      "sentence": "Aldosterone raises upon stimulation by angiotensin II and upon reduction of angiotensin-II generation subsequent to ACE inhibition through an escape mechanism.",
                      "object score": 888,
                      "subject score": 884,
                      "publication date": "1996 Feb 20"
                    },
                    "PMID:8718563": {
                      "sentence": "The mechanism by which ACE-I exerts an antidipsogenic action may, in part, be accounted for by the reduction in plasma concentration of AII, as a result of the ACE inhibition.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996"
                    },
                    "PMID:9313758": {
                      "sentence": "These findings suggest that the blockade of angiotensin II is the major pathway responsible for renoprotection afforded by ACE inhibition in experimental diabetic nephropathy.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1997 Oct"
                    },
                    "PMID:10818068": {
                      "sentence": "Studies have demonstrated that local angiotensin II (Ang II) generation is enhanced in repairing kidney and that ACE inhibition or AT(1) receptor blockade attenuates renal fibrosis.",
                      "object score": 888,
                      "subject score": 850,
                      "publication date": "2000 May"
                    },
                    "PMID:11799091": {
                      "sentence": "Furthermore, the fact that the high interstitial fluid concentrations of Ang II are not responsive to acute ACE inhibition or volume expansion suggests the compartmentalization and independent regulation of renal interstitial fluid Ang II.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2002 Jan"
                    },
                    "PMID:11882622": {
                      "sentence": "Perindopril decreased plasma ACE by 70% and the plasma angiotensin II to angiotensin I ratio by 57% and reduced vascular ACE to approximately 65% of control levels in both endothelium and adventitia.",
                      "object score": 851,
                      "subject score": 901,
                      "publication date": "2002 Feb"
                    },
                    "PMID:12829650": {
                      "sentence": "However, the observed deleterious hemodynamic responses to high glucose and Ang II and the insensitivity to ACE inhibition may, taken together, provide an explanation for the adverse renal outcomes in patients with type 1 diabetes and high N/D ratio.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2003 Jul"
                    },
                    "PMID:18192335": {
                      "sentence": "ACE and ACE2 are key enzymes in the formation and degradation of angiotensin II (Ang II) and angiotensin-(1-7)(Ang-(1-7)).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 May"
                    },
                    "PMID:18855265": {
                      "sentence": "Pulsatile stretch induces release of angiotensin II and oxidative stress in human endothelial cells: effects of ACE inhibition and AT1 receptor antagonism.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2008 Oct"
                    },
                    "PMID:24332999": {
                      "sentence": "We hypothesize that Ang II suppresses ACE2 by increasing TNF-alpha converting enzyme (TACE) activity and ACE2 cleavage.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jan"
                    },
                    "PMID:25009501": {
                      "sentence": "An \"alternate\" arm of the RAS now exists in which ACE2 counterbalances the effects of the classic RAS through degradation of Ang II, and generation of the vasodilator Ang 1-7.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P30556": {
              "object": "UniProtKB:P30556",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:inhibits---NCBIGene:185---SEMMEDDB:",
                    "UMLS:C0003009---SEMMEDDB:inhibits---UMLS:C1439284---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1599449",
                    "PMID:11692164",
                    "PMID:10639182",
                    "PMID:26271886",
                    "PMID:31466304",
                    "PMID:34065702",
                    "PMID:19816747",
                    "PMID:17486447",
                    "PMID:30510587",
                    "PMID:23064712",
                    "PMID:31054884",
                    "PMID:24760518",
                    "PMID:20878072",
                    "PMID:23840884",
                    "PMID:9814617",
                    "PMID:19261744",
                    "PMID:28697804",
                    "PMID:31468138",
                    "PMID:25861809",
                    "PMID:24964843"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9814617": {
                      "sentence": "This lack of response to angiotensin II in SHR smooth muscle cells was not due to decreased expression or responsiveness of the AT1aR, since SHR smooth muscle cells had more AT1aR mRNA than Sprague-Dawley smooth muscle cells, and angiotensin II-induced activation of c-myc was faster and greater in smooth muscle cells derived from 4- or 18-week-old SHR than in Sprague-Dawley smooth muscle cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Oct"
                    },
                    "PMID:10639182": {
                      "sentence": "AII has also been implicated in the development of cardiac hypertrophy because angiotensin I-converting enzyme inhibitors and AT1R antagonists prevent or regress ventricular hypertrophy in animal models and in human.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2000 Jan 18"
                    },
                    "PMID:11692164": {
                      "sentence": "Proliferation was not significantly lower in AT2R expressing pFib than in antisense-transduced controls (TA2) upon stimulation with Ang II (AT2R 110.5+/-4.8% vs. TA2 110.2+/-5.5%), Ang II plus the AT1R blocker Irbesartan (97.1+/-1.4% vs. 108.0+/-5.0; P=0.052) and the partial AT2R antagonist CGP42112 at the agonistic concentration of 50 nM (92.1+/-2.7% vs. 99.8+/-3.1%; P=0.053).",
                      "object score": 827,
                      "subject score": 1000,
                      "publication date": "2001 Sep"
                    },
                    "PMID:17486447": {
                      "sentence": "Furthermore, Ang II promoted the expression of MMP2 and MMP9 in MKN-28 cells, and the stimulatory effects of Ang II could be blocked by AT1R antagonist.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Jan"
                    },
                    "PMID:17666345": {
                      "sentence": "METHODS: Cultured human umbilical vein endothelial cells (HUVECs) were treated with AngII, PPAR gamma ligand troglitazone, AngII plus troglitazone, and AngII plus AT1R antagonist losartan, respectively, and the concentrations of NO and ET-1 in the cell culture supernatant were measured to evaluate the effects of troglitazone and losartan on AngII-induced NO and ET-1 production by human endothelial cells.",
                      "object score": 780,
                      "subject score": 1000,
                      "publication date": "2007 Jul"
                    },
                    "PMID:19261744": {
                      "sentence": "The inverse agonistic activity of this AT1R blocker may be useful for the prevention of mesangial proliferation and renal damage caused by mechanical strain/oxidative stress regardless of circulating or tissue Ang II levels.",
                      "object score": 1000,
                      "subject score": 824,
                      "publication date": "2009 May"
                    },
                    "PMID:19706421": {
                      "sentence": "Blocking AII production with ACE inhibitors or inhibiting AII signaling with AT1R blockers suppressed autoreactive TH1 and TH17 cells and promoted antigen-specific CD4+FoxP3+ regulatory T cells (Treg cells) with inhibition of the canonical NF-kappaB1 transcription factor complex and activation of the alternative NF-kappaB2 pathway.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2009 Sep 01"
                    },
                    "PMID:19816747": {
                      "sentence": "AngII induced the activation and nuclear translocation of nuclear factor-kappaB (NF-kappaB), an effect that was inhibited by AT1R blockade.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Dec"
                    },
                    "PMID:19906946": {
                      "sentence": "Indeed, podocyte stretching induced both angiotensin II secretion and AT(1) receptor overexpression, podocyte exposure to angiotensin II reduced nephrin protein expression, and both the AT-1 receptor antagonist candesartan and a specific anti-angiotensin II antibody completely abolished stretch-induced nephrin downregulation.",
                      "object score": 742,
                      "subject score": 1000,
                      "publication date": "2010 Feb"
                    },
                    "PMID:20878072": {
                      "sentence": "The proliferative activity of ICC cells and HSCs to which AngII was added dose-dependently increased and AT-1 antagonist inhibited the proliferative effects.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Nov"
                    },
                    "PMID:22805546": {
                      "sentence": "METHODS: Mouse BMSCs were isolated and treated with AngII, an AT1R antagonist, and a type 2 angiotensin II receptor (AT2R) antagonist.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Sep 10"
                    },
                    "PMID:23064712": {
                      "sentence": "Compared to untreated SHRs, the albuminuria excretion in SHR-Los at week 46 was markedly decreased, the plasma, myocardium and renal tissue Ang II and Aldo levels in SHR-Los at week 46 were markedly decreased; AT1R and TGF-beta1 protein expression was downregulated and AT2R protein was upregulated.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2012 Dec"
                    },
                    "PMID:23840884": {
                      "sentence": "However, increasing the availability of AngII to AT2R by AT1R blockade improved renal blood flow in uni-x sheep.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:24760518": {
                      "sentence": "Exogenous Ang II was degraded less efficiently by kidneys from ACE2KO mice than WT mice, and administration of an AT1R blocker (losartan 30 mg/kg/day) resulted in normalization of NADPH oxidase activity in the ACE2KO.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2014"
                    },
                    "PMID:24964843": {
                      "sentence": "These results suggest that exogenous H2S can ameliorate the age-related changes of aortic morphology, decrease the concentration of AngII in plasma, down-regulate the expression of AT1R in vascular tissue, and mitigate the level of oxidative stress.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jun 25"
                    },
                    "PMID:25527780": {
                      "sentence": "When Cav1 was silenced, the amount of membrane-associated AT1R was significantly reduced by a short-term ANG II exposure.",
                      "object score": 660,
                      "subject score": 660,
                      "publication date": "2015 Mar 01"
                    },
                    "PMID:26238503": {
                      "sentence": "In addition, YQ inhibited the high mRNA expression level of renal renin, angiotensin II (Ang II), and Ang II receptor, type 1 (AT1R), and inhibited the protein expression of renal AT1R and Ang II receptor type 2, which had been induced by the HSF diet.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2015 Oct"
                    },
                    "PMID:26271886": {
                      "sentence": "ACE2, a protective monocarboxypeptidase, responsible for conversion of Ang II to Ang1-7, opposes the deleterious effects of RAS pathway but how its expression is altered with blockade of AT1R and AT2R is not yet known.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Nov"
                    },
                    "PMID:27010897": {
                      "sentence": "We studied the effects of the Ang-(1-7)/Mas receptor axis on the healing rate of acetic-acid-induced gastric ulcers with or without the blockade of Mas receptors by A 779 and compared it with the effects of activation and blockade of the AT-1 receptor by the treatment with Ang II and losartan, respectively, the inhibition of ACE by lisinopril, the NO/cNOS inhibition by L-NAME and inhibition of prostaglandin/COX system by indomethacin in the presence of Ang-(1-7).",
                      "object score": 827,
                      "subject score": 1000,
                      "publication date": "2016 Feb"
                    },
                    "PMID:30510587": {
                      "sentence": "Importantly, the attenuation of EPC bioactivities by Ang II was restored by treatment with an AT1R antagonist (telmisartan; TERT).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_negatively_regulates_entity-UniProtKB:P50052": {
              "object": "UniProtKB:P50052",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:inhibits---UMLS:C0390423---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24433468",
                    "PMID:11384773",
                    "PMID:17959957",
                    "PMID:26186568",
                    "PMID:12969125",
                    "PMID:12127057",
                    "PMID:11963634",
                    "PMID:20888078",
                    "PMID:23637941",
                    "PMID:15831814",
                    "PMID:15172193",
                    "PMID:19281810",
                    "PMID:17291529",
                    "PMID:1554376",
                    "PMID:1830456",
                    "PMID:25511041",
                    "PMID:12846741",
                    "PMID:1327066",
                    "PMID:11358952",
                    "PMID:21801966"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1327066": {
                      "sentence": "Similarly, the potentiating action of A-II on corticotropin-induced cAMP production was blocked by DUP 753, but not by AT2 antagonists.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1992 Oct"
                    },
                    "PMID:1554376": {
                      "sentence": "The stimulatory effect of angiotensin II (AT) on the accumulation of inositol phosphates and on aldosterone production is abolished by the AT1 selective receptor antagonist DuP753 while PD123177, an AT2 antagonist, is ineffective.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1992 Mar 03"
                    },
                    "PMID:1830456": {
                      "sentence": "The effect of ANG II on [Ca2+]i was blocked by the selective AT1 receptor subtype antagonist Du Pont 753 but not by the AT2 antagonist PD 123319.",
                      "object score": 824,
                      "subject score": 1000,
                      "publication date": "1991 Jul"
                    },
                    "PMID:8238298": {
                      "sentence": "This stimulation was completely abolished by the presence of the type 1 ANG II (AT1) receptor antagonist losartan but not by the type 2 ANG II receptor blocker PD-123177.",
                      "object score": 858,
                      "subject score": 888,
                      "publication date": "1993 Oct"
                    },
                    "PMID:8831515": {
                      "sentence": "Stretch-induced expression of AT1-R and AT2-R mRNAs was further increased by 27% and 31%, respectively, after pretreatment with AT1-R antagonists, suggesting that Ang II secreted from stretched myocytes downregulates both AT1-R and AT2-R.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "1996 Oct"
                    },
                    "PMID:8869000": {
                      "sentence": "Blockade by the AT1 receptor antagonist L-159,282 sufficiently increased the plasma levels of angiotensin II to block the AT2 receptor.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996 Feb"
                    },
                    "PMID:9003008": {
                      "sentence": "These results indicate that AngII, through the AT1 receptor, down-regulates both AT1 and AT2, but by different mechanisms; AT1 receptor is regulated through internalization-degradation of the occupied receptor and inhibition of transcription, whereas AT2 receptor is regulated mainly by decreasing the stability of its mRNA.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Feb"
                    },
                    "PMID:9407460": {
                      "sentence": "In the present study, we microperfused rabbit Ef-Art in vitro, and examined the effect of angiotensin II (Ang II; 10(-11) to 10(-8) M) on the luminal diameter in the presence or absence of an AT-2R antagonist PD123319 (PD; 10(-7) M).",
                      "object score": 886,
                      "subject score": 1000,
                      "publication date": "1997 Dec"
                    },
                    "PMID:9815151": {
                      "sentence": "Mitogen-activated protein kinase (MAPK) activation by Ang II was significantly decreased in fibroblast compartment from the failing hearts, and pretreatment with AT2-R antagonist caused an additional significant increase in Ang II-induced MAPK activity (36%).",
                      "object score": 660,
                      "subject score": 1000,
                      "publication date": "1998 Nov 16"
                    },
                    "PMID:11358952": {
                      "sentence": "Concentration-response curves to angiotensin I or angiotensin II (10(-)(10) to 3x10(-)(7) mol/L) were almost abolished in the losartan-treated group and were not modified by preincubation with the angiotensin type 2 receptor antagonist PD 123,319.",
                      "object score": 819,
                      "subject score": 1000,
                      "publication date": "2001 May"
                    },
                    "PMID:11384773": {
                      "sentence": "Thus, 24-h infusions of Ang II selectively down-regulated AT2 receptors in the uterine artery, resulting in heightened Ang II reactivity.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2001 Jun 15"
                    },
                    "PMID:11963634": {
                      "sentence": "Angiotensin II receptor blockers selectively inhibit AT1 receptors whose stimulation mediates the hypertensive and proliferative effects of angiotensin II while do not interfere with AT2 receptors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Jan-Feb"
                    },
                    "PMID:12127057": {
                      "sentence": "Type I Ang II receptor subtype (AT1) mediates Ang II-dependent [Ca2+]i increase, since losartan, an AT1 inhibitor, blunted [Ca2+]i increase induced by Ang II in a dose-dependent manner, while CGP 4221A, an AT2 inhibitor, does not.",
                      "object score": 872,
                      "subject score": 1000,
                      "publication date": "2002 Jul"
                    },
                    "PMID:15831814": {
                      "sentence": "Ang II activates NF-kappaB via AT1 and AT2 receptors, but AT1 or AT2 antagonists did not inhibit NF-kappaB activation caused by Ang IV.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2005 May 13"
                    },
                    "PMID:19281810": {
                      "sentence": "In contrast, the type IV collagen response to Ang II was prevented by blockade of AT2 receptors, but not AT1 receptors.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2009 Jun 15"
                    },
                    "PMID:20888078": {
                      "sentence": "This is associated with increased expression of AT1 receptors and decreased expression of AT2 receptors in aged rats, and is reduced by treatment with the AT1 antagonist candesartan.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2012 Jan"
                    },
                    "PMID:23637941": {
                      "sentence": "Vascular reactivity studies showed that denuded aortic rings from Hyper rats exhibited decreased maximal contractile response to angiotensin II (AngII), which was attenuated in aortic rings pre-incubated with an AT2R blocker.",
                      "object score": 771,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:25511041": {
                      "sentence": "Hypoxia up-regulated angiotensin II, angiotensin-converting enzyme (ACE), and angiotensin II type 1 receptor (AT1R), and down-regulated ACE2 and angiotensin II type 2 receptor in LLC cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Dec 12"
                    },
                    "PMID:26186568": {
                      "sentence": "During low-level AT1R blockade, both Ang III and beta-Pro(7) Ang III, but not Ang II, lowered MAP (by ~30 mmHg) at equimolar infusions (150 pmol/kg/min for 4 h) and these depressor effects were abolished by the co-administration of the AT2R antagonist PD123319.",
                      "object score": 886,
                      "subject score": 901,
                      "publication date": "2015 Sep"
                    },
                    "PMID:27637162": {
                      "sentence": "In addition, by producing hemorrhagic-hypotension and bilateral blockade of AT2 receptors of the PVN, we found that AngII regulates arterial pressure toward normal during hypotension.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2017 Jan"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P01133": {
              "object": "UniProtKB:P01133",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:stimulates---UMLS:C1367721---SEMMEDDB:",
                    "UMLS:C0003009---SEMMEDDB:stimulates---UMLS:C0242275---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15280379",
                    "PMID:12952982",
                    "PMID:8770101",
                    "PMID:10429449",
                    "PMID:23850346",
                    "PMID:9657631",
                    "PMID:15905175",
                    "PMID:7611452",
                    "PMID:14985098",
                    "PMID:8898348",
                    "PMID:27480833",
                    "PMID:17688958",
                    "PMID:23688779"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7611452": {
                      "sentence": "Through AT1 receptors, endogenous ANG II stimulates EGF and inhibits clusterin expression.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1995 Jun"
                    },
                    "PMID:8770101": {
                      "sentence": "In cultured VSMC, ANG II activated Ras comparably to epidermal growth factor.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Aug"
                    },
                    "PMID:8898348": {
                      "sentence": "In the other half of the experiments, EGF had an antimitogenic effect which was further enhanced by ANG II (maximally at 10(-6) M).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Aug 30"
                    },
                    "PMID:9657631": {
                      "sentence": "By stimulating cellular proliferation, selective stimulation by ANG II of EGF in renal tubules may amplify the effects of TGF-beta1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jun"
                    },
                    "PMID:10429449": {
                      "sentence": "Angiotensin II activates a diversity of intracellular signal transduction cascades, and transactivation of epidermal growth factor and platelet-derived growth factor receptors via AT1 receptor seems to be responsible for the development of vascular remodeling.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Jul"
                    },
                    "PMID:12952982": {
                      "sentence": "Furthermore, knockdown of endogenous PACSIN3 by small interfering RNA in HT1080 cells significantly attenuated the shedding of proHB-EGF induced by TPA and angiotensin II.",
                      "object score": 923,
                      "subject score": 1000,
                      "publication date": "2003 Nov 14"
                    },
                    "PMID:14985098": {
                      "sentence": "These results indicate that Ang II stimulates PSC proliferation through EGF receptor transactivation-ERK activation pathway.",
                      "object score": 831,
                      "subject score": 1000,
                      "publication date": "2004 Mar 19"
                    },
                    "PMID:15280379": {
                      "sentence": "Knockdown of Eve-1 by small interfering RNA in HT1080 cells reduced the shedding of proHB-EGF induced by angiotensin II and 12-O-tetradecanoylphorbol-13-acetate, as well as the shedding of pro-transforming growth factor-alpha, promphiregulin, and proepiregulin by 12-O-tetradecanoylphorbol-13-acetate, suggesting that Eve-1 plays a role in positively regulating the activity of ADAMs in the signaling of EGFR-ligand shedding.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2004 Oct 01"
                    },
                    "PMID:15905175": {
                      "sentence": "Conversely, pretreatment with an intracellular Ca2+ antagonist or an antioxidant blocked AngII-induced HB-EGF shedding.",
                      "object score": 639,
                      "subject score": 639,
                      "publication date": "2005 Jul 15"
                    },
                    "PMID:17688958": {
                      "sentence": "Moreover, 1 microM AG1478 and 0.25 microM PDGFRInhib attenuated Ang II stimulation of the EGF and PDGF receptors, respectively.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2007 Dec 04"
                    },
                    "PMID:23688779": {
                      "sentence": "mi/siRNA-ADAM17 but not mi/siRNA-control inhibited angiotensin II-induced epidermal growth factor receptor trans-activation and subsequent extracellular signal-regulated kinase activation and hypertrophic response in the cells.",
                      "object score": 797,
                      "subject score": 797,
                      "publication date": "2013 Sep"
                    },
                    "PMID:23850346": {
                      "sentence": "Enzyme-linked immunosorbent assay studies revealed that Nox4 and ADAM17 mediated the release of mature heparin-binding EGF-like growth factor (HB-EGF), which played a critical role in the Ang II-induced EGFR activation.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "2013 Oct"
                    },
                    "PMID:27480833": {
                      "sentence": "In conclusion, vascular ADAM17 mediates AngII-induced cardiovascular remodeling via epidermal growth factor receptor activation independent of blood pressure regulation.",
                      "object score": 760,
                      "subject score": 760,
                      "publication date": "2016 10"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:stimulates---UMLS:C0080222---SEMMEDDB:",
                    "UMLS:C0003009---SEMMEDDB:stimulates---UMLS:C1366557---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28209920",
                    "PMID:12499886",
                    "PMID:10417744",
                    "PMID:17640965",
                    "PMID:18220694",
                    "PMID:9236148",
                    "PMID:28849131",
                    "PMID:18239590",
                    "PMID:10841915",
                    "PMID:30995068",
                    "PMID:26063200",
                    "PMID:15836856",
                    "PMID:26717915",
                    "PMID:18278065",
                    "PMID:17504233",
                    "PMID:10872558",
                    "PMID:14642613",
                    "PMID:15472513",
                    "PMID:20571281",
                    "PMID:33676887"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1644917": {
                      "sentence": "We conclude that: (a) Ang II induces increased TGF beta 1 gene expression via a PKC dependent pathway involving de novo protein synthesis; (b) Ang II promotes the conversion of latent TGF beta 1 to its biologically active form; (c) Ang II modulates VSMC growth by activating both proliferative and antiproliferative pathways; and (d) Autocrine active TGF beta 1 appears to be an important determinant of VSMC growth by hypertrophy or hyperplasia.",
                      "object score": 679,
                      "subject score": 1000,
                      "publication date": "1992 Aug"
                    },
                    "PMID:7635988": {
                      "sentence": "An important role has also been attributed to angiotensin II (AII), which, in addition to its hemodynamic effects, can stimulate transcription of TGF-beta 1.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Aug"
                    },
                    "PMID:7999008": {
                      "sentence": "ANG II up-regulated the expression of TGF-beta 1, which became apparent after 1 hr of incubation and reached a plateau between 16-48 hrs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Nov 30"
                    },
                    "PMID:8440178": {
                      "sentence": "In this study, we investigated the effects of TGF beta 1 on potassium- and angiotensin-II (A-II)-stimulated aldosterone and the mechanisms by which TGF beta 1 inhibits aldosterone biosynthesis.",
                      "object score": 1000,
                      "subject score": 824,
                      "publication date": "1993 Mar"
                    },
                    "PMID:8576949": {
                      "sentence": "Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Oct"
                    },
                    "PMID:8866400": {
                      "sentence": "The latter results in part because of activation of transforming growth factor-beta 1 by angiotensin II.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Aug"
                    },
                    "PMID:8872947": {
                      "sentence": "Ang II alone (1 microM) added to quiescent, murine mesangial cells in serum-free, insulin-free media slightly but not significantly increased TGF-beta 1, fibronectin, collagen I, collagen IV and laminin message levels.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Sep"
                    },
                    "PMID:9236148": {
                      "sentence": "Ang II stimulates TGF-beta1 gene expression and/or protein production in cardiac fibroblast-like cells which may act as an autocrine/paracrine stimulus to collagen formation.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1997 Jul"
                    },
                    "PMID:9261254": {
                      "sentence": "Autocrine release of TGF-beta 1 induced by angiotensin II exerts an antimigratory effect in rat and human VSMCs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Jul"
                    },
                    "PMID:9291185": {
                      "sentence": "These results suggest that CsA-induced fibrosis in this model is independent of renal hemodynamics and is mediated, at least partly, through Ang II induction of TGF-beta1 expression.",
                      "object score": 901,
                      "subject score": 901,
                      "publication date": "1997 Sep"
                    },
                    "PMID:9407495": {
                      "sentence": "Ang II may initiate a positive feedback regulation of fibroblasts growth, inducing the expression of TGF-beta 1 and angiotensinogen genes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Dec"
                    },
                    "PMID:9618387": {
                      "sentence": "Furthermore, steady-state mRNA levels of TGF-beta1 were upregulated by Ang II after 4 h and reached peak levels at 16 h of incubation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998 Jun"
                    },
                    "PMID:9657631": {
                      "sentence": "We conclude that ANG II selectively stimulates TGF-beta1 mRNA in the heart and kidney, which may contribute to cardiac and renal interstitial fibrosis resulting from activation of the renin-angiotensin system independent of hypertension.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "1998 Jun"
                    },
                    "PMID:10841915": {
                      "sentence": "Interestingly, it could be demonstrated that angiotensin II also stimulates TGF-beta1 production possibly via the same signal transduction pathway.",
                      "object score": 676,
                      "subject score": 1000,
                      "publication date": "2000 Jul"
                    },
                    "PMID:11369837": {
                      "sentence": "Production of TGF-beta1 in these circumstances may be modulated by the intrarenal renin-angiotensin system (angiotensin II induces TGF-beta1 production and secretion by the mesangial cells) and by a direct effect of cyclosporin A, which stimulates the synthesis and expression of TGF-beta1.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2001"
                    },
                    "PMID:23646205": {
                      "sentence": "It is known that Ang II induces TGF-beta1 expression.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:23840758": {
                      "sentence": "In in vitro studies, overexpressing Twinkle using an adenovirus vector in cultured cardiac fibroblasts significantly suppressed mRNA of collagen 1a, collagen 3a and connective tissue growth factor, and angiotensin II-induced transforming growth factor beta1 expression.",
                      "object score": 854,
                      "subject score": 854,
                      "publication date": "2013"
                    },
                    "PMID:25398788": {
                      "sentence": "SREBP-1 Mediates Angiotensin II-Induced TGF-beta1 Upregulation and Glomerular Fibrosis.",
                      "object score": 839,
                      "subject score": 839,
                      "publication date": "2015 Aug"
                    },
                    "PMID:25451261": {
                      "sentence": "In neonatal rat atrial myocytes, quantitative PCR and Western blotting revealed that Ang II upregulated TGF-beta1, synapse-associated protein 97 (SAP97) and Kv1.5 expression in a time- and concentration-dependent manner.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 11 21"
                    },
                    "PMID:28660748": {
                      "sentence": "Angiotensin II enhanced TGF-beta1 expression in Kupffer cells.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2017 Sep"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P08253": {
              "object": "UniProtKB:P08253",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:stimulates---UMLS:C0172537---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28179581",
                    "PMID:26071572",
                    "PMID:19082717",
                    "PMID:25955575",
                    "PMID:16728425",
                    "PMID:28645608",
                    "PMID:23006733",
                    "PMID:17380010",
                    "PMID:27670594",
                    "PMID:17486447",
                    "PMID:21641389",
                    "PMID:14644777",
                    "PMID:22590832",
                    "PMID:15284191",
                    "PMID:11788425",
                    "PMID:18354258",
                    "PMID:18619957",
                    "PMID:24194850",
                    "PMID:24907869",
                    "PMID:15670768"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:11788425": {
                      "sentence": "Although ANG II augmented the latent matrix metalloproteinase-2 (MMP-2) activity of the pericyte by 35%, it also doubled tissue inhibitors of MMPs.",
                      "object score": 875,
                      "subject score": 1000,
                      "publication date": "2002 Feb"
                    },
                    "PMID:14644777": {
                      "sentence": "Furthermore, AT(1)R antagonism with candesartan prevented the formation of MMP-2 and TNF-alpha and the reduction of TIMP-2 induced by ANG II.",
                      "object score": 757,
                      "subject score": 1000,
                      "publication date": "2004 Apr"
                    },
                    "PMID:15284191": {
                      "sentence": "In TSP2 knockout mice, angiotensin II increased matrix metalloproteinase (MMP)-2 and MMP-9 activity by 120% and 390% compared with wild-type mice (P<0.05).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2004 Sep 03"
                    },
                    "PMID:15670768": {
                      "sentence": "Since reactive oxygen species (ROS) induce MMP-2 and angiotensin II (ANG II) enhances NADPH-oxidase-dependent ROS formation, we assessed whether ANG II induces MMP-2 in a NADPH-oxidase-dependent manner.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2005 Mar 04"
                    },
                    "PMID:17380010": {
                      "sentence": "From these data in L6 myotube, we conclude that Ang II negatively regulates the insulin signal not through MMP signaling pathway but specifically through MMP-independent ERK1/2 activation pathway, providing an alternative molecular mechanism for angiotensin-induced insulin resistance.",
                      "object score": 799,
                      "subject score": 1000,
                      "publication date": "2007 Feb"
                    },
                    "PMID:17486447": {
                      "sentence": "Furthermore, Ang II promoted the expression of MMP2 and MMP9 in MKN-28 cells, and the stimulatory effects of Ang II could be blocked by AT1R antagonist.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Jan"
                    },
                    "PMID:18619957": {
                      "sentence": "Pre-exposure of cells to simvastatin concentration-dependently blocked angiotensin II-stimulated MMP2 release.",
                      "object score": 735,
                      "subject score": 735,
                      "publication date": "2008 Sep 04"
                    },
                    "PMID:19082717": {
                      "sentence": "To examine the role of Stat3 in angiotensin II-induced MMP2 expression, A JAK-specific inhibitor and AG490 were used.",
                      "object score": 845,
                      "subject score": 845,
                      "publication date": "2009 Oct"
                    },
                    "PMID:21641389": {
                      "sentence": "Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration.",
                      "object score": 845,
                      "subject score": 845,
                      "publication date": "2011 Jun"
                    },
                    "PMID:22590832": {
                      "sentence": "As a result, angiotensin II through activation of AT1 receptors can stimulate the expression of MMP-2, MMP-13 and VEGF in B16F10 melanoma cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Sep 01"
                    },
                    "PMID:23006733": {
                      "sentence": "Angiotensin II induces both matrix metalloproteinase 2 (MMP2) and calpain-1 expression and activity in the arterial wall.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Nov"
                    },
                    "PMID:24194850": {
                      "sentence": "Long term in vivo experiments confirmed that Ang II could enhance NA release and up-regulate MMP-2.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013"
                    },
                    "PMID:24907869": {
                      "sentence": "Using western blotting, we demonstrate that ANGII (1 umol/L) significantly (P < 0.01) increases pro-MMP-2 protein expression after 8 h not only in endothelial and smooth muscle cells, but also in isolated rat aorta.",
                      "object score": 864,
                      "subject score": 1000,
                      "publication date": "2014 Jul"
                    },
                    "PMID:25955575": {
                      "sentence": "In conclusion, these results indicate that Ang II can induce MMP-2 expression elevation through AT1R and MAPK pathways in ASMCs and suggest that there is therapeutic potential for angiotensin receptor blocker drugs and MAPK inhibitors in the prevention and treatment of ATAAs.",
                      "object score": 875,
                      "subject score": 1000,
                      "publication date": "2015 Sep"
                    },
                    "PMID:26071572": {
                      "sentence": "The aim of this study was to elucidate the role of the angiotensin II (Ang II) pathway in MMP-2 induction in IAAA aortic walls.",
                      "object score": 916,
                      "subject score": 901,
                      "publication date": "2015 Jul"
                    },
                    "PMID:27670594": {
                      "sentence": "Mechanistically, VSMC-SIRT1-dependent deacetylation of histone H3 lysine 9 on the matrix metallopeptidase 2 (Mmp2) promoter was required for CR-mediated suppression of AngII-induced MMP2 expression.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "2016 10 17"
                    },
                    "PMID:28179581": {
                      "sentence": "HuR is required for angiotensin II-induced MMP2 and MMP9 expression.",
                      "object score": 864,
                      "subject score": 864,
                      "publication date": "2017 Feb 28"
                    },
                    "PMID:28645608": {
                      "sentence": "Angiotensin II significantly increased the expressions of MMP-2, MMP-9 and the concentrations of H2O2 and hypochlorous acid (HOCl) in vascular smooth muscle cells (VSMCs).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 11 04"
                    },
                    "PMID:29016715": {
                      "sentence": "Ang II increased Mmp2 expression in immune cells infiltrating the aorta and perivascular fat.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2017 Dec 01"
                    },
                    "PMID:29369845": {
                      "sentence": "These findings suggest that Ang-II can enhance MMP-2 mainly through AT2 receptors in endothelial cells, but the significance of circulating MMP-2 as a cardiovascular biomarker requires confirmation in further clinical studies.",
                      "object score": 923,
                      "subject score": 1000,
                      "publication date": "2018 Apr"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P14780": {
              "object": "UniProtKB:P14780",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:stimulates---UMLS:C0165519---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28179581",
                    "PMID:29590657",
                    "PMID:24799613",
                    "PMID:21271181",
                    "PMID:20145375",
                    "PMID:32321956",
                    "PMID:23407651",
                    "PMID:18252266",
                    "PMID:31318113",
                    "PMID:30536349",
                    "PMID:27278287",
                    "PMID:21881526",
                    "PMID:17486447",
                    "PMID:33103451",
                    "PMID:22822546"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:17486447": {
                      "sentence": "Furthermore, Ang II promoted the expression of MMP2 and MMP9 in MKN-28 cells, and the stimulatory effects of Ang II could be blocked by AT1R antagonist.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Jan"
                    },
                    "PMID:18252266": {
                      "sentence": "AngII increases the expression of MMP-9 in VSMC, and AT1 and NF-kappaB pathways have an important role in this response.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 Apr 10"
                    },
                    "PMID:20145375": {
                      "sentence": "These results suggest that angiotensin II enhances IL-1beta-induced MMP-9 secretion through the augmentation of ERK phosphorylation via AT1R in adult rat cardiac fibroblasts.",
                      "object score": 845,
                      "subject score": 1000,
                      "publication date": "2010 Jun"
                    },
                    "PMID:21271181": {
                      "sentence": "ANG II-induced MMP-9 expression was significantly reduced by 75 and 67%, respectively, by co-incubation of the cells with a selective inhibitor of protein kinase C (GF109203X, 5 uM) or of rho kinase (Y-27632, 15 uM), but not with inhibitors of phosphoinositide 3-kinase (wortmannin, 200 nM), tyrosine kinases (genistein, 100 uM) or of reactive oxygen species (alpha-tocopherol, 100 uM).",
                      "object score": 839,
                      "subject score": 839,
                      "publication date": "2011 Mar"
                    },
                    "PMID:21881526": {
                      "sentence": "On the contrary, TIMP-2 and MMP-9 were upregulated by angiotensin-II and downregulated by rosuvastatin; the effects on TIMP-1 were negligible.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Oct"
                    },
                    "PMID:22822546": {
                      "sentence": "With a lentiviral shRNA specifically targeting OPN and transwell migration assay, we find that blockade of OPN with shRNA inhibits Ang-II-induced MMP9 upregulation and VSMCs migration.",
                      "object score": 840,
                      "subject score": 840,
                      "publication date": "2012 Jun"
                    },
                    "PMID:23407651": {
                      "sentence": "Incubation of the cells with angiotensin II for 12 hr increased MMP-9 and TIMP-1 gene expression 2.7 and 1.8 folds, respectively (p < 0.05).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2010 Apr"
                    },
                    "PMID:24799613": {
                      "sentence": "Ang 1-7 increased the expression of cyclooxygenase-2 and decreased the expression of matrix metalloproteinase-9 induced by elastase+Ang II (P<0.05).",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2014 Aug"
                    },
                    "PMID:27278287": {
                      "sentence": "Further, TSA inhibited Ang-II-induced MMP9 and Il18 transcription by blocking NF-kappaB and AP-1 binding to their respective promoter regions.",
                      "object score": 827,
                      "subject score": 827,
                      "publication date": "2016 Oct"
                    },
                    "PMID:28179581": {
                      "sentence": "HuR is required for angiotensin II-induced MMP2 and MMP9 expression.",
                      "object score": 888,
                      "subject score": 864,
                      "publication date": "2017 Feb 28"
                    },
                    "PMID:29590657": {
                      "sentence": "MMP-9 mRNA expressions were significantly suppressed by SR9009 in THP-1 and RAW264.7 macrophages; moreover, SR9009-treatment significantly reduced Ang II-induced MMP-9 protein expressions in two types of macrophages.",
                      "object score": 758,
                      "subject score": 758,
                      "publication date": "2018"
                    },
                    "PMID:30536349": {
                      "sentence": "However, telmisartan could effectively repress the Ang II-induced MMP-9 synthesis and release in the macrophages, and suppress the COX2/mPEG1 pathway in the macrophages activated by Ang II.",
                      "object score": 845,
                      "subject score": 845,
                      "publication date": "2018 11"
                    },
                    "PMID:31318113": {
                      "sentence": "The Ang II-induced increased levels of matrix metalloproteinase (MMP)-2, and MMP-9 were reduced by PCA.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Sep"
                    },
                    "PMID:32321956": {
                      "sentence": "In addition, BAPN/AngII induced interleukin-6, interleukin-1beta, matrix metalloproteinase-2 and matrix metalloproteinase-9 in WT mice, all of which were significantly reduced in CD44     -/-       mice (all p < 0.01).",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2020 Apr 22"
                    },
                    "PMID:33103451": {
                      "sentence": "Ang II promoted the expressions of cathepsin K and MMP9 in RAW 264.7 cells, while Ang(1-7) repressed these osteoclastogenesis factors.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2020 Oct 26"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P30556": {
              "object": "UniProtKB:P30556",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:stimulates---NCBIGene:185---SEMMEDDB:",
                    "UMLS:C0003009---SEMMEDDB:stimulates---UMLS:C1439284---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11692164",
                    "PMID:21861069",
                    "PMID:10639182",
                    "PMID:29136335",
                    "PMID:25955575",
                    "PMID:28400916",
                    "PMID:23354398",
                    "PMID:30181481",
                    "PMID:29676623",
                    "PMID:28976133",
                    "PMID:15142861",
                    "PMID:28461606",
                    "PMID:31755934",
                    "PMID:7738168",
                    "PMID:29278298",
                    "PMID:24976017",
                    "PMID:18566341",
                    "PMID:9892168",
                    "PMID:30608150",
                    "PMID:12270869"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7738168": {
                      "sentence": "Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule.",
                      "object score": 991,
                      "subject score": 1000,
                      "publication date": "1995 May"
                    },
                    "PMID:8640285": {
                      "sentence": "Expression of AT1A appears to be induced by angiotensin II in vascular smooth-muscle cells but is inhibited in the adrenal gland.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Apr"
                    },
                    "PMID:9806212": {
                      "sentence": "Results suggest Ang II stimulates aldosterone secretion via AT1a and AT1b in the zona glomerulosa and corticosterone secretion via AT1a in the zona fasciculata, and provide first evidence for differential roles of AT1a and AT1b in the adrenals.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:10070060": {
                      "sentence": "Thus AT1R activation appears to be responsible for apoptosis caused by ANG II in HCAEC, and AT1R activation-mediated apoptosis involves activation of PKC.",
                      "object score": 733,
                      "subject score": 1000,
                      "publication date": "1999 Mar"
                    },
                    "PMID:10639182": {
                      "sentence": "To determine whether AII can induce cardiac hypertrophy directly via myocardial AT1R in the absence of vascular changes, transgenic mice overexpressing the human AT1R under the control of the mouse alpha-myosin heavy chain promoter were generated.",
                      "object score": 620,
                      "subject score": 1000,
                      "publication date": "2000 Jan 18"
                    },
                    "PMID:11692164": {
                      "sentence": "Ang II stimulation of the endogenous AT1R increased extracellular signal regulated kinase 1/2 activities.",
                      "object score": 694,
                      "subject score": 901,
                      "publication date": "2001 Sep"
                    },
                    "PMID:12623991": {
                      "sentence": "This transduction was accompanied by an increase in neuronal firing rate, an effect similar to that observed with angiotensin II stimulation of the neuronal AT1R.",
                      "object score": 694,
                      "subject score": 901,
                      "publication date": "2003 Mar"
                    },
                    "PMID:18566341": {
                      "sentence": "Tempol and Apocynin reversed the increased expression of AT1R mRNA, c-Jun mRNA, c-fos mRNA, and superoxide production induced by Ang II.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2008 Jul 18"
                    },
                    "PMID:21054097": {
                      "sentence": "These studies demonstrate that Ang II-induced AT1R lysosomal degradation through its association with LAMP1 is regulated by Rab5/7 via mechanisms that are dependent on intact actin cytoskeletons.",
                      "object score": 769,
                      "subject score": 769,
                      "publication date": "2010 Sep-Oct"
                    },
                    "PMID:21861069": {
                      "sentence": "Most of the known pathophysiological effects of Ang II are mediated by AT1R activation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Oct"
                    },
                    "PMID:22306536": {
                      "sentence": "As expected, Ang II induced AT1R expression, and stimulated cardiac fibroblast growth and collagen synthesis.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2012 Mar 15"
                    },
                    "PMID:23354398": {
                      "sentence": "These studies show that both Ang II and inflammation mediator LPS up-regulate AT1R, AT2R and LOX-1 expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Dec"
                    },
                    "PMID:24444314": {
                      "sentence": "It also reduced AngII-induced AT1R up-regulation by 30% (P < 0.05) and enhanced AMPK phosphorylation by 99% (P < 0.01) and P-eNOS levels by 3.3-fold (P < 0.01).",
                      "object score": 744,
                      "subject score": 744,
                      "publication date": "2014 Apr"
                    },
                    "PMID:24976017": {
                      "sentence": "To report differential miRNA expression following AT1R activation by AngII, we performed microarray analysis in 23 biological and technical replicates derived from humans, rats and mice.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Oct"
                    },
                    "PMID:25063220": {
                      "sentence": "Furthermore, Ang II enhanced AT1R and NAD(P)H oxidase (NOX) p22(phox) and p67(phox) expression and activity in osteoblasts.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Nov"
                    },
                    "PMID:25955575": {
                      "sentence": "In conclusion, these results indicate that Ang II can induce MMP-2 expression elevation through AT1R and MAPK pathways in ASMCs and suggest that there is therapeutic potential for angiotensin receptor blocker drugs and MAPK inhibitors in the prevention and treatment of ATAAs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015 Sep"
                    },
                    "PMID:28400916": {
                      "sentence": "This spurred the comparison of all of the currently marketed angiotensin receptor blockers (ARBs, AT1R antagonists or sartans) at blocking activation of the two signaling modes (G protein-, and betaarr1-dependent) at the AngII-activated AT1R and hence, at suppression of aldosterone in vitro and in vivo.",
                      "object score": 641,
                      "subject score": 641,
                      "publication date": "2017 Mar 26"
                    },
                    "PMID:28461606": {
                      "sentence": "In vitro, 2-ME suppressed both basal and Ang II-induced AT1R levels in a peroxisome proliferator-activated receptor gamma-dependent manner.",
                      "object score": 794,
                      "subject score": 794,
                      "publication date": "2017 06"
                    },
                    "PMID:29061726": {
                      "sentence": "To determine whether activation of the AT1R recruits RGS5, an in situ proximity ligation assay was performed in primary cultures of cremaster muscle arteriolar vascular smooth muscle cells treated with angiotensin II or hypotonic solution in the absence or presence of candesartan (an AT1R blocker).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 12"
                    },
                    "PMID:29136335": {
                      "sentence": "Excessive activation of AT1R by angiotensin II (Ang II) leads to cardiovascular disease and may be involved in the development of insulin resistance and diabetes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 May"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:stimulates---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10646512",
                    "PMID:11810036",
                    "PMID:17081374",
                    "PMID:7512570",
                    "PMID:18408363",
                    "PMID:17959704",
                    "PMID:12524222",
                    "PMID:20386492",
                    "PMID:7586373",
                    "PMID:28259956",
                    "PMID:10495784",
                    "PMID:21826167"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7512570": {
                      "sentence": "The presence of Ang II during the early induction phase of iNOS was required for this inhibition.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1994 Apr 15"
                    },
                    "PMID:7586373": {
                      "sentence": "CONCLUSIONS: These results indicate that Ang II upregulates IL-1 beta-induced iNOS expression in cardiac myocytes, which is mediated at least partially via activation of protein kinase C.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1995 Nov 01"
                    },
                    "PMID:10495784": {
                      "sentence": "Because vasoconstrictors may interfere with the induction of iNOS and the subsequent generation of NO, in the study presented here, whether exogenous angiotensin II (ANG II) influences bacterial lipopolysaccharide (LPS)/gamma-interferon (gamma-IF)-stimulated NO synthesis and iNOS protein and mRNA expression in MCT cells was tested.",
                      "object score": 895,
                      "subject score": 901,
                      "publication date": "1997 Apr"
                    },
                    "PMID:10646512": {
                      "sentence": "The inhibitory effects of Ang II on lipopolysaccharide-induced expression of iNOS mRNA and protein and nitrite accumulation were mimicked by the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2000 Feb"
                    },
                    "PMID:11810036": {
                      "sentence": "Immunoprecipitation with antiphosphotyrosine antibodies showed that Ang II induced NOS activity and increased cGMP production through a Gi-dependent pathway.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Jan"
                    },
                    "PMID:12524222": {
                      "sentence": "Our data indicate that AII increased the expression of endothelial NOS, inducible NOS, and NAD(P)H oxidase in a dose-dependent manner, which was attenuated by incubation with either E2, superoxide dismutase, or the AII type 1 receptor (AT1R) inhibitor candesartan.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2003 Jan 01"
                    },
                    "PMID:17081374": {
                      "sentence": "CONCLUSION: Angiotensin II can upregulate the expression of inducible nitric oxide synthase through NF-kappaB pathway in human umbilical endothelial cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Jul"
                    },
                    "PMID:17959704": {
                      "sentence": "The response to angiotensin II was enhanced in nNOS(-/-) mice (41% and 25% at 10(-8) and 10(-6) mol/l) and even more enhanced in eNOS(-/-) mice (12% and 9%) compared with nNOS(+/+) and eNOS(+/+).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2008 Feb"
                    },
                    "PMID:18408363": {
                      "sentence": "CONCLUSION: Our study is the first to demonstrate that the heightened ANG II in IR, via stimulation of ANG II receptor type 1, suppresses DHFR and eNOS dimer, while activating both iNOS mRNA and protein levels.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2008"
                    },
                    "PMID:20386492": {
                      "sentence": "ANG II increased NOS activity and eNOS expression at all ages, but nNOS expression only in developing afferents.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2010 Jul"
                    },
                    "PMID:21826167": {
                      "sentence": "Angiotensin II increased expression levels of vascular iNOS; EGCG counteracted this effect.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2011 Jun"
                    },
                    "PMID:28259956": {
                      "sentence": "The present study demonstrated that AngII not only upregulated the expression levels of inducible nitric oxide synthase (iNOS), stimulated ROS production and increased cell apoptosis, but also downregulated the expression levels of phosphorylated-endothelial nitric oxide synthase, decreased the expression and activity of cystathionine-c-lyase (CSE) and decreased cell viability.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2017 Apr"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL408403-biolink:entity_positively_regulates_entity-UniProtKB:P50052": {
              "object": "UniProtKB:P50052",
              "subject": "CHEMBL.COMPOUND:CHEMBL408403",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003009---SEMMEDDB:stimulates---UMLS:C0390423---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17000928",
                    "PMID:17173190",
                    "PMID:1618259",
                    "PMID:12609747",
                    "PMID:10537123",
                    "PMID:16049519",
                    "PMID:16043661",
                    "PMID:11026648",
                    "PMID:10588088",
                    "PMID:12881481",
                    "PMID:10691781",
                    "PMID:16091404",
                    "PMID:17541331",
                    "PMID:17190872",
                    "PMID:15093864",
                    "PMID:10750587",
                    "PMID:12135744",
                    "PMID:12397677",
                    "PMID:15817699",
                    "PMID:15833268"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1618259": {
                      "sentence": "The role of AT1 and AT2 receptors in mediating the drinking response induced by angiotensin II in the rat was examined.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1992 Jan 28"
                    },
                    "PMID:1887916": {
                      "sentence": "Our observations suggest that AT may exert its effects on cerebral circulation by stimulation of AT2 receptors and that these receptors may play a role during cerebrovascular development.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1991 Sep"
                    },
                    "PMID:7477267": {
                      "sentence": "Our results show that angiotensin II activates AT1 and AT2, which have mutually counteracting haemodynamic effects, and that AT2 regulates central nervous system functions, including behaviour.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Oct 26"
                    },
                    "PMID:7840157": {
                      "sentence": "This is direct evidence to link the cloned AT2 receptor to a defined response elicited by ANG II.",
                      "object score": 840,
                      "subject score": 1000,
                      "publication date": "1995 Jan"
                    },
                    "PMID:7864848": {
                      "sentence": "This AII-induced augmentation was suppressed by the AT2-selective antagonist PD123319 but not by Dup753, an antagonist specific for type 1 receptor, suggesting that AII up-regulates the AT2 expression via AT2 itself.",
                      "object score": 583,
                      "subject score": 1000,
                      "publication date": "1995 Feb 15"
                    },
                    "PMID:7898077": {
                      "sentence": "Losartan, an AT1 antagonist, also improved survival, possibly through renin release and AT2 stimulation by endogenous AII.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "1994 Dec"
                    },
                    "PMID:7965267": {
                      "sentence": "This increase in circulating angiotensin II might theoretically lead to an excessive stimulation of the AT2 receptor subtype, but since the function of this receptor is not known it is impossible to evaluate the implications of this reactive rise.",
                      "object score": 851,
                      "subject score": 901,
                      "publication date": "1994 Jul"
                    },
                    "PMID:9112419": {
                      "sentence": "Second, Ang II elicited an AT2 receptor-mediated increase in I(K) followed by an AT1 receptor-mediated decrease in I(K).",
                      "object score": 825,
                      "subject score": 901,
                      "publication date": "1997 May"
                    },
                    "PMID:9124492": {
                      "sentence": "The presence of both subtypes of receptors capable of binding ANG II during early nephrogenesis and the time-dependent and structure-specific regulation of receptor localization confirm a regulated developmental program for receptor expression and suggest important roles for AT1 and AT2 in renal morphogenesis.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "1997 Feb"
                    },
                    "PMID:9425010": {
                      "sentence": "Here, we determined that Ang II stimulates [3H]arachidonic acid (AA) release from cultured neurons via AT2 receptors.",
                      "object score": 739,
                      "subject score": 1000,
                      "publication date": "1998 Jan 15"
                    },
                    "PMID:9702075": {
                      "sentence": "Clinical application of AT1-R antagonist started and this causes elevation of plasma Ang II levels, which selectively stimulates AT2-R.",
                      "object score": 694,
                      "subject score": 861,
                      "publication date": "1998 Jul"
                    },
                    "PMID:9888501": {
                      "sentence": "In contrast, IGF-1 and AngII increased about 4-fold AT2 receptor number, but only IGF-1 increased AT2 mRNA.",
                      "object score": 771,
                      "subject score": 1000,
                      "publication date": "1998"
                    },
                    "PMID:9892147": {
                      "sentence": "The present results suggest that pressor responses to AngII are mediated by the activation of AT1 receptors, and that AT2 receptors do not appear to modulate hemodynamic responses to AngII in the anesthetized rat.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1999 Jan"
                    },
                    "PMID:10588088": {
                      "sentence": "With the AT1 receptor blocked, angiotensin II is available to activate the angiotensin type 2 (AT2) receptor, which mediates several potentially beneficial effects in the cardiovascular system, including vasodilation, antiproliferation, and apoptosis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1999 Nov 18"
                    },
                    "PMID:10750587": {
                      "sentence": "Here we review current data on these controversies, including new data that support the notion that angiotensin II activation of the cardiac AT2 receptor subtype inhibits the effects of angiotensin II on the immediate growth response in the adult heart.",
                      "object score": 833,
                      "subject score": 734,
                      "publication date": "1999 Jun 17"
                    },
                    "PMID:11026648": {
                      "sentence": "During treatment with AT1-ant, increased angiotensin II could activate AT2 receptors, with an antitrophic effect.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2000 Oct"
                    },
                    "PMID:23165302": {
                      "sentence": "The increase in angiotensin II levels that occurs during AT(1)-receptor blockade might result in beneficial effects via stimulation of type 2 angiotensin II receptors.",
                      "object score": 991,
                      "subject score": 901,
                      "publication date": "2013 Jan"
                    },
                    "PMID:23806715": {
                      "sentence": "In addition, Ang II appears to inhibit and induce TNF-alpha expression via the AT1 receptor and the AT2 receptor in DRG neurons, respectively.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2013 Sep 17"
                    },
                    "PMID:24914880": {
                      "sentence": "However, angiotensin II also stimulates angiotensin II type 2 receptor (AT2R)s and they may as well contribute to TF expression, a possibility in need of further evaluation.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2014 Jul"
                    },
                    "PMID:25487516": {
                      "sentence": "Activation of the cell membrane AT2 receptors by a concomitant treatment with angiotensin II and the AT1 receptor antagonist, losartan, induces apoptosis but does not affect the rate of cell death.",
                      "object score": 894,
                      "subject score": 1000,
                      "publication date": "2015 May"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL403664": {
              "object": "CHEMBL.COMPOUND:CHEMBL403664",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB00290---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1200382-biolink:entity_negatively_regulates_entity-UniProtKB:P51787": {
              "object": "UniProtKB:P51787",
              "subject": "CHEMBL.COMPOUND:CHEMBL1200382",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB01244---DRUGBANK:inhibitor---UniProtKB:P51787---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9765513",
                    "PMID:10860024",
                    "PMID:14716203"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:drugbank",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL160": {
              "object": "CHEMBL.COMPOUND:CHEMBL160",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB14643---DRUGBANK:drug-interaction---DRUGBANK:DB00091---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB00959---DRUGBANK:drug-interaction---DRUGBANK:DB00091---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB14644---DRUGBANK:drug-interaction---DRUGBANK:DB00091---identifiers_org_registry:drugbank",
                    "UMLS:C0025815---SEMMEDDB:interacts_with---UMLS:C0010592---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:3341550",
                    "PMID:7844470"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:3341550": {
                      "sentence": "The effects of cyclosporin A on the regenerating liver were studied in rats after partial hepatectomy and were compared with those of conventional immunosuppressants such as methylprednisolone and azathioprine.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988 Feb"
                    },
                    "PMID:7844470": {
                      "sentence": "The aim of this study was to evaluate in rats the effects of cyclosporine, methylprednisolone, and the combination of both (CyP) on plasma lipids and lipoproteins levels.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1995 Feb"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201365-biolink:entity_negatively_regulates_entity-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201365",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0072973---SEMMEDDB:inhibits---NCBIGene:1636---SEMMEDDB:",
                    "DrugCentral:2356---DrugCentral:inhibitor---UniProtKB:P12821---DrugCentral:",
                    "DRUGBANK:DB00178---DRUGBANK:inhibitor---UniProtKB:P12821---identifiers_org_registry:drugbank",
                    "UMLS:C0072970---SEMMEDDB:inhibits---NCBIGene:1636---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11804984",
                    "PMID:12694342",
                    "PMID:11030016",
                    "PMID:1646621",
                    "PMID:7856280",
                    "PMID:22776970",
                    "PMID:11715355",
                    "PMID:10543928",
                    "PMID:11752352",
                    "PMID:8781754",
                    "PMID:7784479",
                    "PMID:19810392",
                    "PMID:16398929",
                    "PMID:9853269",
                    "PMID:14727978",
                    "PMID:11929321",
                    "PMID:19436659",
                    "PMID:7768254",
                    "PMID:9699040",
                    "PMID:9150805"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1646621": {
                      "sentence": "Plasma ACE inhibition by ramiprilat was unaffected by concurrent felodipine.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1991 Feb"
                    },
                    "PMID:7768254": {
                      "sentence": "The biological availability of ramipril can best be judged by ramiprilat AUC, urinary recovery of ramipril and metabolites, or ACE inhibition over 24 h.",
                      "object score": 785,
                      "subject score": 1000,
                      "publication date": "1995"
                    },
                    "PMID:7784479": {
                      "sentence": "ACE inhibition with ramipril, in the antihypertensive dose of 1 mg/kg/day for 6 weeks, prevented the increase in blood pressure and the development of LVH.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1995 Mar"
                    },
                    "PMID:7856280": {
                      "sentence": "ACE inhibition with ramiprilat increases kinin concentrations during normoxia, ischemia and reperfusion, whereas deendothelialization markedly reduces kinin and prostacyclin outflow in controls as well as in ACE inhibitor-treated hearts.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1994"
                    },
                    "PMID:8781754": {
                      "sentence": "Both, increased survival in hypertensive and reduction in infarct size in normotensive rats by ACE inhibition with ramipril was accompanied by an improved myocardial metabolism.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996 Jul"
                    },
                    "PMID:9150805": {
                      "sentence": "In conclusion, patients with liver cirrhosis had enough capacity to metabolize and excrete the parent compound ramipril, but had not enough capacity to form ramiprilat, although enough ramiprilat was formed for sufficient ACE inhibition of about 90%.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1997"
                    },
                    "PMID:9699040": {
                      "sentence": "In conclusion, ACE inhibition with Ramipril and calcium channel blocking with Isradipin lead to a moderate improvement of blood rheology in patients with hypertension.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1998 Jul"
                    },
                    "PMID:9853269": {
                      "sentence": "Nephroprotection by long-term ACE inhibition with ramipril in spontaneously hypertensive stroke prone rats.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1998 Dec"
                    },
                    "PMID:10543928": {
                      "sentence": "ACE inhibition with ramipril improves left ventricular function at rest and post exercise in patients with stable ischaemic heart disease and preserved left ventricular systolic function.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1999 Nov"
                    },
                    "PMID:11347755": {
                      "sentence": "RESULTS: Both doses of ramipril were sufficient to reduce ACE activity and to increase PRA significantly as compared with placebo (P < 0.05 for both).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2001 May"
                    },
                    "PMID:11715355": {
                      "sentence": "High dose ACE inhibition with ramipril is applicable to a far wider population of patients at high risk of cardiovascular events than the current indications of hypertension and left ventricular dysfunction.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2001 Jan"
                    },
                    "PMID:11804984": {
                      "sentence": "CONCLUSIONS: ACE inhibition with ramipril and conjugated estrogens similarly decrease PAI-1 antigen concentrations in postmenopausal women.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002 Jan 22"
                    },
                    "PMID:12694342": {
                      "sentence": "Subgroup analyses of the HOPE study indicate that ACE inhibition with ramipril is beneficial without an increased risk for side effects like acute renal failure or hyperkalemia.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2003 May"
                    },
                    "PMID:14727978": {
                      "sentence": "Subgroup analyses of the HOPE study indicate that ACE inhibition with ramipril is beneficial without an increased risk of adverse effects like acute renal failure or hyperkalemia.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2002"
                    },
                    "PMID:19436659": {
                      "sentence": "The ONTARGET study showed that the ARB telmisartan conserved 95% of the vascular protective properties of the ACEi ramipril, given at similar doses to a similar patient group as had been previously shownin the HOPE study to benefit from ACE inhibition with ramipril.",
                      "object score": 888,
                      "subject score": 928,
                      "publication date": "2009"
                    },
                    "PMID:19810392": {
                      "sentence": "Although, there are no data at present to precisely suggest the efficacy differences between all available ACEIs, there are trials which support that ramipril, a long acting ACEI with good tissue penetration, potent long-lasting inhibition of ACE may not be applicable to other available ACEIs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2009 Mar"
                    },
                    "PMID:22715807": {
                      "sentence": "Although ramipril inhibited ACE, and valsartan blocked the angiotensin receptor, neither treatment alone nor in combination augmented cardiac ACE2 expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Dec"
                    },
                    "PMID:22776970": {
                      "sentence": "While results did not show a treatment effect on CSF Abeta(1-42) (p = 0.836), data revealed that ramipril can inhibit CSF ACE activity (p = 0.009) and improve blood pressure, however, there were no differences between groups in arterial function or cognition.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2012"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1234886-biolink:entity_negatively_regulates_entity-UniProtKB:P04040": {
              "object": "UniProtKB:P04040",
              "subject": "CHEMBL.COMPOUND:CHEMBL1234886",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0030054---SEMMEDDB:inhibits---UMLS:C0007367---SEMMEDDB:",
                    "UMLS:C0302920---SEMMEDDB:inhibits---UMLS:C0007367---SEMMEDDB:",
                    "UMLS:C0074565---SEMMEDDB:inhibits---UMLS:C0007367---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28162275",
                    "PMID:29607258",
                    "PMID:26225731",
                    "PMID:16745692",
                    "PMID:20355325",
                    "PMID:8720898",
                    "PMID:3234858",
                    "PMID:10852820",
                    "PMID:8852426",
                    "PMID:16202884",
                    "PMID:25619142",
                    "PMID:29431084",
                    "PMID:31558835",
                    "PMID:28762315",
                    "PMID:31442912",
                    "PMID:3505241",
                    "PMID:29137940",
                    "PMID:19872400",
                    "PMID:24023284",
                    "PMID:26342455"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:3234858": {
                      "sentence": "Lipid peroxidation is probably initiated by activated forms of oxygen as it is increased by an inhibitor of catalase and reduced by hydroxyl radical scavengers.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1988"
                    },
                    "PMID:3505241": {
                      "sentence": "This deleterious process requires oxygen and can be inhibited with catalase, indicating that H2O2 is involved, via the reduction of oxygen.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1986"
                    },
                    "PMID:8720898": {
                      "sentence": "Sod and catalase inactivation by singlet oxygen and peroxyl radicals.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996"
                    },
                    "PMID:8852426": {
                      "sentence": "The generation of AP-sites and SSB was dependent on molecular oxygen and could be suppressed by the addition of catalase.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1996 Mar-Apr"
                    },
                    "PMID:10852820": {
                      "sentence": "One marker enzyme of this single membrane-bound organelle is catalase, which is responsible for the degradation of hydrogen peroxide to water and oxygen.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Jul"
                    },
                    "PMID:12408595": {
                      "sentence": "Results indicate that Cu only induces an imbalance in the oxygen metabolism during the first week of Cu exposure due to a decrease in mitochondrial SOD and CAT, selenium-dependent and total glutathion peroxidase activities.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2002"
                    },
                    "PMID:16202884": {
                      "sentence": "The principle of the measurements was based on the determination of the decrease in the differentiation of oxygen level which had been caused by the inhibition of catalase in the bioactive layer of the biosensor by azide.",
                      "object score": 1000,
                      "subject score": 694,
                      "publication date": "2005 Oct 15"
                    },
                    "PMID:19872400": {
                      "sentence": "The decomposition of hydrogen peroxide by catalase is regarded as involving two reactions, namely, the catalytic decomposition of hydrogen peroxide, which is a maximum at the optimum pH 6.8 to 7.0, and the \"induced inactivation\" of catalase by the \"nascent\" oxygen produced by the hydrogen peroxide and still adhering to the catalase surface.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "1928 Mar 20"
                    },
                    "PMID:20355325": {
                      "sentence": "The activities of the oxygen-scavenging enzymes catalase (CAT), peroxidase (POD), and superoxide dismutase (SOD) in infected leaves were significantly higher than those in the healthy leaves, and the enzyme activities in DGIs were always lower than in the yellow leaf tissues.",
                      "object score": 775,
                      "subject score": 775,
                      "publication date": "2010"
                    },
                    "PMID:24023284": {
                      "sentence": "Higher concentrations of singlet oxygen inactivate membrane-associated catalase and thus lead to partial inhibition of apoptosis induction by exogenous HOCl, due to consumption of HOCl by H2O2.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "2013 Sep"
                    },
                    "PMID:25619142": {
                      "sentence": "Singlet-oxygen-dependent activation of the FAS receptor and caspase-8 increased superoxide anion generation by NOX1 and amplification of singlet oxygen generation, which allowed singlet-oxygen-dependent inactivation of catalase.",
                      "object score": 1000,
                      "subject score": 884,
                      "publication date": "2015 Apr"
                    },
                    "PMID:26225731": {
                      "sentence": "This amplificatory mechanism led to the formation of singlet oxygen at a sufficiently high concentration for optimal inactivation of membrane-associated catalase.",
                      "object score": 802,
                      "subject score": 1000,
                      "publication date": "2015 Dec"
                    },
                    "PMID:26342455": {
                      "sentence": "Finally, singlet oxygen is generated at sufficiently high concentration to inactivate protective catalase and to reactivate intercellular apoptosis-inducing ROS signaling.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2015 Dec"
                    },
                    "PMID:28162275": {
                      "sentence": "As a result, high concentrations of cell-derived singlet oxygen inactivated catalase and reactivated apoptosis inducing intercellular signaling.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2015 08"
                    },
                    "PMID:28762315": {
                      "sentence": "Model experiments using extracellular singlet oxygen were analyzed with respect to catalase inactivation and their relevance for the antitumor action of cold atmospheric plasma.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2018"
                    },
                    "PMID:29137940": {
                      "sentence": "Inactivation of further catalase molecules by secondary singlet oxygen leads to auto-amplification of singlet oxygen generation and catalase inactivation.",
                      "object score": 840,
                      "subject score": 901,
                      "publication date": "2018 06"
                    },
                    "PMID:29431084": {
                      "sentence": "Then the interaction between free peroxynitrite and H2O2 allows the generation of singlet oxygen, which inactivates additional catalase molecules, allowing for the generation of additional singlet oxygen.",
                      "object score": 840,
                      "subject score": 1000,
                      "publication date": "2016"
                    },
                    "PMID:29607258": {
                      "sentence": "Catalase (CAT) is an antioxidant enzyme that plays a significant role in cellular protection against oxidative damage by degradation of hydrogen peroxide to oxygen and water.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018"
                    },
                    "PMID:31442912": {
                      "sentence": "The induction of bystander effect-inducing potential requires the generation of \"primary singlet oxygen\" through the reactions following the interaction between nitrite and H2O2, followed by local inactivation of a few catalase molecules.",
                      "object score": 840,
                      "subject score": 901,
                      "publication date": "2019 09"
                    },
                    "PMID:31558835": {
                      "sentence": "As sustained generation of secondary singlet oxygen by the tumor cells is activated at the site of the imprint, a rapid bystander effect-like spreading of secondary singlet oxygen generation and catalase inactivation within the cell population is thus induced.",
                      "object score": 888,
                      "subject score": 901,
                      "publication date": "2019 Sep 26"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1256391-biolink:entity_negatively_regulates_entity-UniProtKB:P01137": {
              "object": "UniProtKB:P01137",
              "subject": "CHEMBL.COMPOUND:CHEMBL1256391",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0298067---SEMMEDDB:inhibits---UMLS:C0080222---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:22694981",
                    "PMID:32218695",
                    "PMID:30016220",
                    "PMID:23002925",
                    "PMID:30186404",
                    "PMID:16675785",
                    "PMID:31719931",
                    "PMID:26640402",
                    "PMID:12099512",
                    "PMID:21866107",
                    "PMID:30394303",
                    "PMID:32448163",
                    "PMID:31185973",
                    "PMID:28921394",
                    "PMID:17086734"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:12099512": {
                      "sentence": "PFD was associated with a decrease in TGF-beta1 expression, which, in turn, was associated with a decrease in matrix deposition.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2002 Feb"
                    },
                    "PMID:16675785": {
                      "sentence": "Pirfenidone reduced the expression of transforming growth factor-beta1, the development of goblet cell hyperplasia and subepithelial collagenization, and the increases in contractile elements in the lung.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2006 Sep"
                    },
                    "PMID:17086734": {
                      "sentence": "Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycina.",
                      "object score": 1000,
                      "subject score": 901,
                      "publication date": "2006 Sep"
                    },
                    "PMID:21866107": {
                      "sentence": "In the vehicle group, the mRNA expressions of atrial natriuretic peptide, brain natriuretic peptide and transforming growth factor-beta1 were increased, which was significantly inhibited by pirfenidone.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jan"
                    },
                    "PMID:22694981": {
                      "sentence": "Pirfenidone inhibits TGF-beta1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012 Jun 13"
                    },
                    "PMID:23002925": {
                      "sentence": "Further, PDGF-BB, which has been implicated in renal interstitial fibrosis, potently activated PAI-1 expression under TGF-beta1 stimulation, and pirfenidone significantly inhibited TGF-beta1- and PDGF-BB-induced increases in PAI-1 expression.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:26640402": {
                      "sentence": "Pirfenidone (PFD) is a non-peptide synthetic molecule issued as a broad-spectrum anti-fibrotic drug with the ability to decrease TGF-beta1, TNF-alpha, PDGF and COL1A1 expression, which is highly related to prevent or remove excessive deposition of scar tissue in several organs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2015"
                    },
                    "PMID:28921394": {
                      "sentence": "Co-treatment with pirfenidone and prednisolone suppressed lung hydroxyproline content, TGF-beta1, and TNF-alpha; however, prednisolone alone could not suppress pulmonary fibrosis which was significantly suppressed only by pirfenidone.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Feb"
                    },
                    "PMID:30016220": {
                      "sentence": "Pirfenidone also reduced the expression of TGF-beta1 and phosphorylation of Smad3 in lung tissues.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Oct"
                    },
                    "PMID:30186404": {
                      "sentence": "Furthermore, the bleomycin-induced increased protein expression of periostin and TGF-beta1 was also significantly suppressed by pirfenidone on days 14 (P<0.01) and 28 (data not shown).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Sep"
                    },
                    "PMID:30394303": {
                      "sentence": "In addition, the TGF-beta1/smad2/3 pathway was activated at 14 days and 28 days after silica instillation, and pirfenidone reduced the expression of TGF-beta1 and smad2/3 in the lungs.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Jan"
                    },
                    "PMID:31185973": {
                      "sentence": "Furthermore, pirfenidone attenuated TGF-beta1- and CTHRC1-induced fibroblast activity, upregulation of bone morphogenic protein-4(BMP-4)/Gremlin1, and downregulation of alpha-smooth muscle actin, fibronectin, and FHL2, similar to that observed post-CTHRC1 inhibition.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Jun 11"
                    },
                    "PMID:31719931": {
                      "sentence": "In contrast, Pirfenidone was able to fully inhibit both TGF-beta1 induced force increase and stretching-induced force increase.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 Oct"
                    },
                    "PMID:32218695": {
                      "sentence": "After treatment with 0.2 mg/ml pirfenidone for 24 hours, HPFs were at G0/G1 cell cycle arrest, with significantly reduced cell migration capability and collagen contraction, decreased mRNA and protein expressions of TGF-beta1, TGF-beta2 and MMP-1, and no alterations of TIMP-1 expression.",
                      "object score": 1000,
                      "subject score": 857,
                      "publication date": "2020"
                    },
                    "PMID:32448163": {
                      "sentence": "In both tissues and cells, Wnt/GSK-3beta/beta-catenin and TGF-beta1/Smad2/3 signaling pathways were activated, which could be suppressed by PFD.",
                      "object score": 786,
                      "subject score": 1000,
                      "publication date": "2020 May 24"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1697788-biolink:entity_negatively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "CHEMBL.COMPOUND:CHEMBL1697788",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL2391146-biolink:entity_negatively_regulates_entity-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL2391146",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003018---SEMMEDDB:inhibits---NCBIGene:1636---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15671045",
                    "PMID:18192335",
                    "PMID:2149311",
                    "PMID:2225846",
                    "PMID:12193663",
                    "PMID:10642323",
                    "PMID:24390175",
                    "PMID:1334346",
                    "PMID:15772526",
                    "PMID:3037157",
                    "PMID:9118513",
                    "PMID:11904521",
                    "PMID:7946800",
                    "PMID:12676166"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1334346": {
                      "sentence": "This effect of ACE inhibition was even more remarkeable, since no exogenous angiotensin was infused in this experiment.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1992"
                    },
                    "PMID:2149311": {
                      "sentence": "The reduction of angiotensin and aldosterone plasma levels during treatment was not correlated to diminished blood pressure values, indicating that the antihypertensive effect can occur via pathways different from ACE inhibition.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1990 Sep 15"
                    },
                    "PMID:2225846": {
                      "sentence": "Angiotensin, ACE inhibition, and the renal circulation: pathogenesis of nonmodulation in essential hypertension.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1990"
                    },
                    "PMID:3037157": {
                      "sentence": "Angiotensin, ACE inhibition and the kidney.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1987 May"
                    },
                    "PMID:7946800": {
                      "sentence": "Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "1994 Sep"
                    },
                    "PMID:9118513": {
                      "sentence": "Similarly, both heart ACE- and IF ACE-mediated Ang II formation appear to be inhibited by the endogenous inhibitor Ang-(1-9) formed by heart CPA-like activity.",
                      "object score": 888,
                      "subject score": 840,
                      "publication date": "1997 Mar 18"
                    },
                    "PMID:10642323": {
                      "sentence": "The release of Ang-(1-7) is significantly influenced by inhibition of ACE, which may reflect both increased substrate (Ang I) levels and reduced metabolism of the peptide.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Jan"
                    },
                    "PMID:11904521": {
                      "sentence": "Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2002 Apr"
                    },
                    "PMID:12193663": {
                      "sentence": "To evaluate the role of endogenous angiotensin in cardiac development, the relationship between ACE inhibition, cell proliferation, apoptosis, several modulators of apoptosis (bcl-2, bcl-xl, and clusterin) was examined in the developing rat heart.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2002 Sep"
                    },
                    "PMID:12676166": {
                      "sentence": "The levels of angiotensin-(1-7) are increased during ACE inhibition, and most studies suggest that its hypotensive effects are mediated in a bradykinin-dependent manner.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2003 Jun"
                    },
                    "PMID:15671045": {
                      "sentence": "CONCLUSION: The increase in ACE2 after MI suggests that it plays an important role in the negative modulation of the renin angiotensin system in the generation and degradation of angiotensin peptides after cardiac injury.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2005 Feb"
                    },
                    "PMID:15772526": {
                      "sentence": "The aim of this study was to evaluate whether a block of the angiotensin system achieved both by ACE inhibition and angiotensin II-AT1 receptor blockade could affect the plasma lipid profile and, if so, what relationship exists between these possible changes and glucose metabolism and blood pressure.",
                      "object score": 888,
                      "subject score": 888,
                      "publication date": "2005 Apr"
                    },
                    "PMID:18192335": {
                      "sentence": "ACE and ACE2 are key enzymes in the formation and degradation of angiotensin II (Ang II) and angiotensin-(1-7)(Ang-(1-7)).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2008 May"
                    },
                    "PMID:24390175": {
                      "sentence": "This in vitro study compared the direct and indirect effects of angiotensin-(1-7), the ACE1 inhibitor captopril, and diminazene aceturate (DIZE) an alleged ACE2 activator in rings of porcine coronary arteries, by measuring changes of isometric tension.",
                      "object score": 773,
                      "subject score": 1000,
                      "publication date": "2014 May"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3039598-biolink:entity_negatively_regulates_entity-UniProtKB:P12821": {
              "object": "UniProtKB:P12821",
              "subject": "CHEMBL.COMPOUND:CHEMBL3039598",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0118168---SEMMEDDB:inhibits---NCBIGene:1636---SEMMEDDB:",
                    "DrugCentral:1245---DrugCentral:inhibitor---UniProtKB:P12821---DrugCentral:",
                    "UMLS:C0075061---SEMMEDDB:inhibits---NCBIGene:1636---SEMMEDDB:",
                    "DRUGBANK:DB00492---DRUGBANK:inhibitor---UniProtKB:P12821---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:1533588",
                    "PMID:2148357",
                    "PMID:11030016",
                    "PMID:8522635",
                    "PMID:2481187",
                    "PMID:8656660",
                    "PMID:11329095",
                    "PMID:11509474",
                    "PMID:11752352",
                    "PMID:2836111",
                    "PMID:8941121"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:1533588": {
                      "sentence": "The findings indicate that in healthy lean humans, ACE inhibition with fosinopril is neutral with regard to lipoprotein and carbohydrate metabolism, and that it may slightly enhance cellular glucose disposal.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1992"
                    },
                    "PMID:2148357": {
                      "sentence": "Reduction of GFR, restoration of response to API and reduction of proteinuria, indicate that ACE inhibition with fosinopril ameliorates HF and GH.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1990 Nov"
                    },
                    "PMID:2481187": {
                      "sentence": "We conclude that fosinopril is a potent and long-lasting inhibitor of ACE in conscious animal models that does not impair adrenergic function or reflexes.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1989 Nov"
                    },
                    "PMID:8522635": {
                      "sentence": "The mean elimination half-life of fosinoprilat was 11.3 +/- 0.7 hours, and median Tmax occurred at 3 hours, corresponding to maximum plasma ACE inhibition.",
                      "object score": 833,
                      "subject score": 1000,
                      "publication date": "1995 Aug"
                    },
                    "PMID:8656660": {
                      "sentence": "Together with previously published morphological data demonstrating an inhibition of interstitial and perivascular fibrosis in hearts of diabetic rats with fosinopril, our observations suggest that ACE inhibition by fosinopril is cardioprotective in diabetes.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1996 Jan"
                    },
                    "PMID:8941121": {
                      "sentence": "BACKGROUND: We have previously shown that long-term ACE inhibition with fosinopril prolongs survival and improves ventricular function despite persistent severe left ventricular pressure overload in ascending aortic-banded rats with left ventricular hypertrophy during the transition from compensation to failure.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "1996 Dec 01"
                    },
                    "PMID:11509474": {
                      "sentence": "In a well-characterized canine model of mild heart failure produced by ventricular pacing at 180 bpm for 10 days, we defined the renal and humoral actions of acute VP inhibition with omapatrilat (OMA, n=6) and acute ACE inhibition (n=5) alone with fosinoprilat.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "2001 Aug"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_positively_regulates_entity-UniProtKB:P01100": {
              "object": "UniProtKB:P01100",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3182731-biolink:entity_positively_regulates_entity-UniProtKB:P18146": {
              "object": "UniProtKB:P18146",
              "subject": "CHEMBL.COMPOUND:CHEMBL3182731",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3322001-biolink:entity_positively_regulates_entity-UniProtKB:P35228": {
              "object": "UniProtKB:P35228",
              "subject": "CHEMBL.COMPOUND:CHEMBL3322001",
              "predicate": "biolink:entity_positively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0299583---SEMMEDDB:stimulates---UMLS:C0669372---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17935739",
                    "PMID:30818874",
                    "PMID:30949067",
                    "PMID:15845924",
                    "PMID:15772123",
                    "PMID:29449623",
                    "PMID:22580898",
                    "PMID:16343770",
                    "PMID:16442319",
                    "PMID:17038553"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:15772123": {
                      "sentence": "On the whole, these experiments demonstrate that NOS activity is a novel target for leptin in adipocytes and that the leptin-induced NOS activity is at least in part the result of NOS III phosphorylations via both protein kinase A and p42/p44 MAPK activation.",
                      "object score": 833,
                      "subject score": 833,
                      "publication date": "2005 Aug"
                    },
                    "PMID:15845924": {
                      "sentence": "Both leptin and NO donor inhibited PGE2 release, whereas they enhanced PGF2alpha release; NOS inhibitor alone or with leptin increased PGE2 and decreased PGF2alpha production; NOS activity was enhanced by leptin, while PGs did not affect this enzyme.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2005 May"
                    },
                    "PMID:16343770": {
                      "sentence": "Leptin induced a concentration-dependent increase of NO release, related to iNOS induction.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2006 Mar 27"
                    },
                    "PMID:16442319": {
                      "sentence": "Incubation of 3T3-L1 adipocytes for 12h with a mixture of IFN-gamma and LPS caused not only a 55% reduction in leptin secretion and a 52% reduction in leptin mRNA, but also significant induction of iNOS at both protein and mRNA levels.",
                      "object score": 1000,
                      "subject score": 888,
                      "publication date": "2006 Sep"
                    },
                    "PMID:17038553": {
                      "sentence": "Accordingly, leptin increased iNOS protein expression, with a comparable time course with that of NO production and NOS activity.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2007 Jan"
                    },
                    "PMID:17935739": {
                      "sentence": "Pre-treatment with Wortmannin, LY 294002, PD 098,059 and SB 203580 caused a significant decrease in nitrite production, NOS type II protein expression and NOS type II mRNA expression induced by leptin and interferon-gamma co-stimulation.",
                      "object score": 893,
                      "subject score": 1000,
                      "publication date": "2007 Oct 27"
                    },
                    "PMID:22580898": {
                      "sentence": "CONCLUSIONS: Leptin induces endothelial nNOS expression, which compensates, in part, for a lack of NO production by eNOS to maintain endothelium-dependent relaxation.",
                      "object score": 833,
                      "subject score": 1000,
                      "publication date": "2012 Jul"
                    },
                    "PMID:29449623": {
                      "sentence": "The activation of iNOS by leptin is necessary for the synthesis and secretion of TNC in adipocytes, suggesting an important role of this alarmin in the development of AT inflammation and fibrosis.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Aug"
                    },
                    "PMID:30818874": {
                      "sentence": "The activation of iNOS by leptin is necessary for the synthesis and secretion of TNC in hepatocytes, suggesting an important role of this alarmin in the development of NAFLD.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2019 02 27"
                    },
                    "PMID:30949067": {
                      "sentence": "Moreover, our results suggest that the increase in NO production occurs through the increase in NOS activation by leptin and is partially mediated by the Akt pathway.",
                      "object score": 694,
                      "subject score": 1000,
                      "publication date": "2019"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1201365": {
              "object": "CHEMBL.COMPOUND:CHEMBL1201365",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB00178---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL2367706": {
              "object": "CHEMBL.COMPOUND:CHEMBL2367706",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB00364---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL635-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL3039598": {
              "object": "CHEMBL.COMPOUND:CHEMBL3039598",
              "subject": "CHEMBL.COMPOUND:CHEMBL635",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00635---DRUGBANK:drug-interaction---DRUGBANK:DB00492---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1711": {
              "object": "CHEMBL.COMPOUND:CHEMBL1711",
              "subject": "CHEMBL.COMPOUND:CHEMBL3249705",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB01366---DRUGBANK:drug-interaction---DRUGBANK:DB01064---identifiers_org_registry:drugbank",
                    "UMLS:C0072032---SEMMEDDB:interacts_with---UMLS:C0022245---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23360304",
                    "PMID:9062649"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9062649": {
                      "sentence": "Actions of procaterol (0.1 mumol/l) were weak, attained only 15-35% of the maximal effects of IPN and could be blocked by ICI 118,551 (0.03 mumol/l).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Feb"
                    },
                    "PMID:23360304": {
                      "sentence": "In functional studies, the relaxant effects of isoproterenol, procaterol, TRK-380, salbutamol and BRL 37344 on KCl-induced contraction of the human ureter were evaluated, and the inhibitory effects of isoproterenol, procaterol and TRK-380 on electrical field stimulation-induced contractions were determined.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": null,
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL123558": {
              "object": "CHEMBL.COMPOUND:CHEMBL123558",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB14644---DRUGBANK:drug-interaction---DRUGBANK:DB04957---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL228792": {
              "object": "CHEMBL.COMPOUND:CHEMBL228792",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB14644---DRUGBANK:drug-interaction---DRUGBANK:DB14740---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB00959---DRUGBANK:drug-interaction---DRUGBANK:DB00070---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB00959---DRUGBANK:drug-interaction---DRUGBANK:DB14740---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB14643---DRUGBANK:drug-interaction---DRUGBANK:DB00070---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB14643---DRUGBANK:drug-interaction---DRUGBANK:DB14740---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB14644---DRUGBANK:drug-interaction---DRUGBANK:DB00070---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL403664": {
              "object": "CHEMBL.COMPOUND:CHEMBL403664",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00959---DRUGBANK:drug-interaction---DRUGBANK:DB00290---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL506569": {
              "object": "CHEMBL.COMPOUND:CHEMBL506569",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB14644---DRUGBANK:drug-interaction---DRUGBANK:DB13467---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB14643---DRUGBANK:drug-interaction---DRUGBANK:DB13467---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB00959---DRUGBANK:drug-interaction---DRUGBANK:DB13467---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1201365": {
              "object": "CHEMBL.COMPOUND:CHEMBL1201365",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB14643---DRUGBANK:drug-interaction---DRUGBANK:DB00178---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB00959---DRUGBANK:drug-interaction---DRUGBANK:DB00178---identifiers_org_registry:drugbank",
                    "DRUGBANK:DB14644---DRUGBANK:drug-interaction---DRUGBANK:DB00178---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:physically_interacts_with-CHEMBL.COMPOUND:CHEMBL1256391": {
              "object": "CHEMBL.COMPOUND:CHEMBL1256391",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:physically_interacts_with",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00959---DRUGBANK:drug-interaction---DRUGBANK:DB04951---identifiers_org_registry:drugbank"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL995-biolink:entity_negatively_regulates_entity-CHEMBL.TARGET:CHEMBL3988637": {
              "object": "CHEMBL.TARGET:CHEMBL3988637",
              "subject": "CHEMBL.COMPOUND:CHEMBL995",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0700492---SEMMEDDB:inhibits---UMLS:C0040690---SEMMEDDB:",
                    "UMLS:C0126174---SEMMEDDB:inhibits---UMLS:C0040690---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21535912",
                    "PMID:18631342",
                    "PMID:24659129",
                    "PMID:26497927",
                    "PMID:10840457",
                    "PMID:22182843",
                    "PMID:25346269",
                    "PMID:21125406",
                    "PMID:30245178",
                    "PMID:22348081",
                    "PMID:9844133",
                    "PMID:24398790",
                    "PMID:25614286",
                    "PMID:21403023",
                    "PMID:21641384",
                    "PMID:20189193",
                    "PMID:11274244",
                    "PMID:15487702",
                    "PMID:31350823",
                    "PMID:30116202"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:9844133": {
                      "sentence": "A maximal reduction in TGF-beta expression of approximately 45% was seen for both drugs starting at 100 mg/liter enalapril and 500 mg/liter losartan, with no further reduction at doses of enalapril up to 1000 mg/liter or losartan up to 2500 mg/liter.",
                      "object score": 928,
                      "subject score": 775,
                      "publication date": "1998 Nov"
                    },
                    "PMID:10760085": {
                      "sentence": "RESULTS: Compared with untreated nephritic animals on a normal-protein diet, a single treatment with enalapril, losartan, or low-protein diet significantly reduced glomerular TGF-beta production, albeit to a similar degree of approximately 45%.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000 Apr"
                    },
                    "PMID:10840457": {
                      "sentence": "CONCLUSIONS: Losartan is associated with downregulation of TGF-beta, IFN-gamma and IL-6 and may, in combination with antimicrobial therapy, reduce the risk of cortical renal scarring in recurrent acute pyelonephritis in infants.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2000 Jul"
                    },
                    "PMID:11274244": {
                      "sentence": "In contrast, losartan reduced the plasma levels of TGF-beta(1) by approximately by 50% (from baseline, 5.2 to 2.6 ng/ml; P: = 0.01); the majority of the patients reached normal levels of TGF-beta(1).",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2001 Apr"
                    },
                    "PMID:15487702": {
                      "sentence": "Finally, AngII-mediated increase in TGF-beta mRNA was inhibited by losartan, AG1478, LY249002, and U0126.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2004"
                    },
                    "PMID:18631342": {
                      "sentence": "Pirfenidone and losartan reduce TGF-beta expression and decrease postinflammatory fibrosis in the lungs, kidneys, heart and liver.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2008 Sep"
                    },
                    "PMID:21125406": {
                      "sentence": "Ros or Los reduced the renal expression of PCNA, TGF-beta, ATR1, and ICAM-1 in IgAN rats with nephrectomy.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2011 Feb"
                    },
                    "PMID:21403023": {
                      "sentence": "Losartan is known to inhibit transforming growth factor beta signaling and may be a specific modulator of disease expression in this syndrome.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2011 Mar"
                    },
                    "PMID:21535912": {
                      "sentence": "Our aim was to verify whether the success of human myoblast transplantation in immunodeficient dystrophic mice is enhanced with losartan, a molecule that downregulates TGF-beta expression.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:21641384": {
                      "sentence": "To determine whether therapeutic attenuation of TGF-beta signaling improves respiratory function, mdx mice were treated from 2 weeks of age to 2 months or 9 months of age with either 1D11 (a neutralizing antibody to all three isoforms of TGF-beta), losartan (an angiotensin receptor antagonist), or a combination of the two agents.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2011 Jun"
                    },
                    "PMID:22182843": {
                      "sentence": "Use of losartan, an angiotensin receptor type 1 blocker used widely in the clinic and known to antagonize TGF-beta signaling, also improved oxidative stress, inflammation, metalloprotease activation and elastin remodeling.",
                      "object score": 901,
                      "subject score": 1000,
                      "publication date": "2012 Jan"
                    },
                    "PMID:22348081": {
                      "sentence": "In addition, losartan abrogated TGFbeta induced gene expression, reduced local invasion and metastasis, decreased vascular permeability and altered the immune profile of tumors grown in SPARC-null mice.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2012"
                    },
                    "PMID:24398790": {
                      "sentence": "Increased TGF-beta signaling and progression of aortic root dilation in Marfan syndrome can be prevented by the antihypertensive drug losartan, a TGF-beta antagonists and angiotensin-II type 1 receptor blocker.",
                      "object score": 928,
                      "subject score": 901,
                      "publication date": "2014 Aug"
                    },
                    "PMID:24659129": {
                      "sentence": "We further show that the angiotensin II type 1 receptor antagonist, losartan, previously identified as a blocker of peripheral TGF-beta signaling, effectively blocks albumin-induced TGF-beta activation in the brain.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2014 Jun"
                    },
                    "PMID:25346269": {
                      "sentence": "We further showed that the FDA approved angiotensin II type 1 receptor antagonist, losartan, blocks brain TGF-beta signaling and prevents epilepsy in the albumin or blood-brain barrier breakdown models of epileptogenesis.",
                      "object score": 861,
                      "subject score": 1000,
                      "publication date": "2014 Dec"
                    },
                    "PMID:25614286": {
                      "sentence": "In contrast to the beneficial effect of losartan, TGFbeta neutralization either exacerbated or mitigated TAA formation depending on whether treatment was initiated before (postnatal day 16; P16) or after (P45) aneurysm formation, respectively.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2015 Apr"
                    },
                    "PMID:26497927": {
                      "sentence": "AIMS: Losartan, an angiotensin II type 1 receptor blocker, attenuates transforming growth factor-beta (TGF-beta) signaling, which inhibits myogenic regeneration.",
                      "object score": 928,
                      "subject score": 1000,
                      "publication date": "2015 Dec 15"
                    },
                    "PMID:30116202": {
                      "sentence": "NX rats presented hypertension that was blunted by both losartan and propranolol, however, only losartan was able to reduce the expression levels of fibronectin FSP1 and TGF-beta in the remnant kidney.",
                      "object score": 1000,
                      "subject score": 861,
                      "publication date": "2018"
                    },
                    "PMID:30245178": {
                      "sentence": "Administration of losartan reduced the levels of TGF-beta, TSP-1 and fibronectin in castrated rats.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2018 Sep 20"
                    },
                    "PMID:31350823": {
                      "sentence": "Treatment of GPHYSD fibroblasts carrying FBN1 mutations with the angiotensin II receptor type 1 inhibitor losartan that inhibits TGF-beta signaling did not reduce the storage but improved the extracellular deposition of fibrillin-1 microfibrils.",
                      "object score": 901,
                      "subject score": 840,
                      "publication date": "2019 Sep"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201081-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL1641": {
              "object": "CHEMBL.COMPOUND:CHEMBL1641",
              "subject": "CHEMBL.COMPOUND:CHEMBL1201081",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0025815---SEMMEDDB:inhibits---UMLS:C0020268---SEMMEDDB:",
                    "UMLS:C0600901---SEMMEDDB:inhibits---UMLS:C0020268---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11422002",
                    "PMID:9115056",
                    "PMID:16554448",
                    "PMID:29394207",
                    "PMID:7886801",
                    "PMID:8222483",
                    "PMID:8227476",
                    "PMID:10567952",
                    "PMID:7570972",
                    "PMID:7358206",
                    "PMID:11153446",
                    "PMID:11005270"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:7358206": {
                      "sentence": "Two of the preparations, betamethasone dipropionate and methylprednisolone acetate, suppressed endogenous cortisol for more than 14 days, while betamethasone phosphate/acetate did not suppress cortisol beyond 12 days.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1980"
                    },
                    "PMID:7570972": {
                      "sentence": "Similar cyclosporine doses result in higher plasma levels of the drug and similar methylprednisolone doses result in more inhibited adrenal cortisol production in liver transplant recipients.",
                      "object score": 851,
                      "subject score": 828,
                      "publication date": "1995 Oct 15"
                    },
                    "PMID:7886801": {
                      "sentence": "Standard pharmacokinetic parameters for methylprednisolone were determined and cortisol responses were characterized by total cortisol area under the concentration curve (AUC), return cortisol AUC, and cortisol suppression half-life.",
                      "object score": 851,
                      "subject score": 1000,
                      "publication date": "1995 Mar 15"
                    },
                    "PMID:8222483": {
                      "sentence": "Although women are more sensitive to methylprednisolone as measured by cortisol suppression, they eliminate the drug more quickly, generally producing a similar net response.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1993 Oct"
                    },
                    "PMID:8227476": {
                      "sentence": "The suppression t1/2 of cortisol after MPHS was longer (3.9 vs. 1.9 hr) indicating metabolic pathways for cortisol and MP are affected differently in CLD.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1993 Sep"
                    },
                    "PMID:9115056": {
                      "sentence": "The greater exposure to methylprednisolone noted in the elderly yielded significant combined correlations for both groups with AUC, return AUC, and suppression ratio of cortisol.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "1997 Apr"
                    },
                    "PMID:10567952": {
                      "sentence": "Higher cortisol suppression compared to these single and multiple dosing regimens of the inhaled corticosteroids was predicted after oral doses of only 1 mg and 2 mg methylprednisolone, respectively.",
                      "object score": 840,
                      "subject score": 790,
                      "publication date": "1999 Apr"
                    },
                    "PMID:11005270": {
                      "sentence": "To test the ability of the transplanted kidney to normalise the patient's cortisol metabolism, we gave, in two different experiments, 25 and 50 mg/day of cortisone acetate or 15 and 30 mg/day of cortisol after inhibition of the endogenous cortisol by synthetic glucocorticoid (methylprednisolone and dexamethasone).",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2000"
                    },
                    "PMID:11153446": {
                      "sentence": "The potency of MP for suppression of cortisol secretion was estimated as IC50 = 0.8 ng/ml.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "1999 Dec"
                    },
                    "PMID:11422002": {
                      "sentence": "CONCLUSIONS: Itraconazole increased methylprednisolone concentrations markedly with enhanced suppression of endogenous cortisol secretion, but had no effect on prednisolone pharmacokinetics.",
                      "object score": 851,
                      "subject score": 822,
                      "publication date": "2001 May"
                    },
                    "PMID:16554448": {
                      "sentence": "Subjects who are heterozygous for the T314 variant allele thus appeared less sensitive to the suppressive effects of methylprednisolone on cortisol secretion.",
                      "object score": 888,
                      "subject score": 1000,
                      "publication date": "2006 Apr"
                    },
                    "PMID:29394207": {
                      "sentence": "Those treated with methylprednisolone or triamcinolone had an average 3-week cortisol reduction of 41.0% (P = 0.005) and 41.6% (P < 0.001) from baseline, respectively, whereas patients treated with betamethasone or dexamethasone were not significantly different than comparable patients in the lidocaine arm.",
                      "object score": 574,
                      "subject score": 1000,
                      "publication date": "2018 May"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            },
            "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL3249705-biolink:entity_negatively_regulates_entity-CHEMBL.COMPOUND:CHEMBL1711": {
              "object": "CHEMBL.COMPOUND:CHEMBL1711",
              "subject": "CHEMBL.COMPOUND:CHEMBL3249705",
              "predicate": "biolink:entity_negatively_regulates_entity",
              "attributes": [
                {
                  "value": "infores:rtx-kg2",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:InformationResource",
                  "attribute_source": "infores:rtx-kg2",
                  "attribute_type_id": "biolink:aggregator_knowledge_source",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0072032---SEMMEDDB:inhibits---UMLS:C0022245---SEMMEDDB:"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "The original RTX-KG2pre edge(s) corresponding to this edge prior to any synonymization or remapping. Listed in (subject)--(relation)--(object)--(source) format.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:original_edge_information",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23360304",
                    "PMID:12099994"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                },
                {
                  "value": {
                    "PMID:12099994": {
                      "sentence": "After exposure to procaterol (0.0003-3 micromol/L) for 45 min, the inhibitory effect of 0.03 micromol/L procaterol on 1 micromol/L MCh-induced contraction was attenuated in a concentration-dependent manner, whereas after exposure to isoprenaline (0.0003-3 micromol/L) for an equivalent time, the inhibitory effect of isoprenaline was markedly attenuated at each concentration.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2002 Aug"
                    },
                    "PMID:23360304": {
                      "sentence": "Furthermore, isoproterenol, procaterol and TRK-380 significantly decreased the amplitude of electrical field stimulation-induced contractions with a rank order of inhibitory effects of isoproterenol > procaterol > TRK-380.",
                      "object score": 1000,
                      "subject score": 1000,
                      "publication date": "2013 Oct"
                    }
                  },
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": null,
                  "attribute_source": "infores:semmeddb",
                  "attribute_type_id": "bts:sentence",
                  "original_attribute_name": null
                }
              ]
            }
          },
          "nodes": {
            "FMA:61799": {
              "name": "Norepinephrine",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_61799",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_61799",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Norepinephrine is the precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic. Norepinephrine is elevated in the urine of people who consume bananas. Norepinephrine is also a microbial metabolite; urinary noradrenaline is produced by Escherichia, Bacillus, and Saccharomyces (PMID: 24621061). Norepinephrine is found in alcoholic beverages, banana peels and pulp (Musa paradisiaca), red plum fruit (Prunus domestica), orange pulp (Citrus sinensis), potato tubers (Solanum tuberosum), and whole purslane (Portulaca oleracea). P. oleracea is the richest of these sources. Norepinephrine has also been identified as a uremic toxin according to the European Uremic Toxin Working Group (PMID: 22626821).",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:BiologicalEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NAd [secretory granule lumen]",
                    "norepinephrine bitartrate",
                    "Norepinephrine Hydrochloride",
                    "Norepinephrine, (+)-Isomer",
                    "Arterenol",
                    "Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer",
                    "Noradrenaline (JP18)",
                    "Norepinephrine l-Tartrate (1:2)",
                    "NAd [cytosol]",
                    "Norepinephrine l-Tartrate (1:1), Monohydrate",
                    "NAd [extracellular region]",
                    "Levonor",
                    "Norepinephrine, (+,-)-Isomer",
                    "NAd [clathrin-sculpted glutamate transport vesicle lumen]",
                    "Norepinephrine d-Tartrate (1:1)",
                    "NOREPINEPHRINE BITARTRATE",
                    "Norepinephrine l-Tartrate (1:1), (+,-)-Isomer",
                    "norepinephrine",
                    "NOREPINEPHRINE",
                    "Noradrenaline tartrate renaudin",
                    "NAd [clathrin-coated endocytic vesicle membrane]",
                    "L(-)-Norepinephrine bitartrate",
                    "NAd [clathrin-sculpted monoamine transport vesicle lumen]",
                    "Norepinephrine bitartrate",
                    "Norepinephrine Hydrochloride, (+)-Isomer",
                    "Norepinephrine l-Tartrate, (+)-Isomer",
                    "Norepinephrine Hydrochloride, (+,-)-Isomer",
                    "(R)-noradrenaline",
                    "Norepinephrine Bitartrate",
                    "L-Noradrenaline",
                    "Levophed",
                    "Norepinephrine"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C48646",
                    "REACT:R-ALL-209789",
                    "UMLS:C0887103",
                    "HMDB:HMDB0000216",
                    "MESH:D009638",
                    "PDQ:CDR0000691834",
                    "UMLS:C0887099",
                    "UMLS:C0887101",
                    "NDDF:004718",
                    "UMLS:C0887097",
                    "LOINC:LP15271-7",
                    "UMLS:C0205860",
                    "RXNORM:7512",
                    "VANDF:4018242",
                    "DRUGBANK:DB00368",
                    "UMLS:C0733815",
                    "KEGG.COMPOUND:C00547",
                    "UMLS:C0887096",
                    "CHEMBL.COMPOUND:CHEMBL1356607",
                    "PathWhiz.Compound:142",
                    "REACT:R-ALL-444150",
                    "RXNORM:227559",
                    "PSY:34410",
                    "UMLS:C0917761",
                    "VANDF:4019859",
                    "REACT:R-ALL-372509",
                    "FMA:61799",
                    "UMLS:C1450037",
                    "UMLS:C0887102",
                    "DrugCentral:1960",
                    "RXNORM:7508",
                    "ATC:C01CA03",
                    "KEGG.DRUG:D00076",
                    "UMLS:C0887098",
                    "UMLS:C0772489",
                    "REACT:R-ALL-374935",
                    "UMLS:C0028333",
                    "UMLS:C0917760",
                    "CHEBI:18357",
                    "LOINC:MTHU003447",
                    "CHEMBL.COMPOUND:CHEMBL1434513",
                    "REACT:R-ALL-351597",
                    "CHEMBL.COMPOUND:CHEMBL2062274",
                    "UMLS:C0702008",
                    "UMLS:C0887100",
                    "CHEMBL.COMPOUND:CHEMBL1437",
                    "UMLS:C0028351",
                    "REACT:R-ALL-8869062"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9830022",
                    "PMID:195059",
                    "PMID:2066997",
                    "PMID:3065003",
                    "PMID:7328589",
                    "PMID:10447956",
                    "PMID:671451",
                    "PMID:2870187",
                    "PMID:8815165",
                    "PMID:9849813"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "FMA:62343": {
              "name": "Calmodulin",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_62343",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_62343",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A protein that is a translation product of the human CALM1, CALM2, or CALM3 genes, 1:1 orthologs thereof, or a semi-ortholog thereof.; A protein that is a translation product of the human CALM1, CALM2, or CALM3 genes, 1:1 orthologs thereof, or a semi-ortholog thereof. // COMMENTS: Category=gene. Note: The human CALM1, CALM2, and CALM3 genes encode identical proteins.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Protein",
                    "biolink:MolecularEntity",
                    "biolink:SmallMolecule"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Calmodulin",
                    "calmodulin (human)",
                    "calmodulin"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C16375",
                    "CHEMBL.TARGET:CHEMBL1667687",
                    "PR:000004978",
                    "PathWhiz.ProteinComplex:11414",
                    "PathWhiz.ProteinComplex:223",
                    "FMA:62343",
                    "UMLS:C0006772",
                    "CHEMBL.TARGET:CHEMBL6092",
                    "MESH:D002147",
                    "KEGG.COMPOUND:C00391",
                    "CHEMBL.TARGET:CHEMBL5945",
                    "CHEMBL.TARGET:CHEMBL6093",
                    "CHEMBL.TARGET:CHEMBL3562176",
                    "PR:000049859",
                    "PathWhiz.ProteinComplex:11166",
                    "PathWhiz.ProteinComplex:11290"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "FMA:63018": {
              "name": "Decorin",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_63018",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_63018",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Decorin (359 aa, ~40 kDa) is encoded by the human DCN gene. This protein plays a role in both the metabolism of proteoglycans and collagen fibril formation.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Polypeptide",
                    "biolink:BiologicalEntity",
                    "biolink:Protein",
                    "biolink:Gene"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "decorin",
                    "Decorin"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C112875",
                    "ORPHANET:121034",
                    "MESH:D058575",
                    "FMA:63018",
                    "PR:000000094",
                    "UMLS:C0057252"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "FMA:63891": {
              "name": "Collagen",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_63891",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_63891",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A family of large fibrous proteins that are the main components of connective tissue and are responsible for maintaining tissue structure.; A topical hemostatic agent prepared from collagen.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Protein",
                    "biolink:Drug",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "collagen",
                    "Collagen"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HMDB:HMDB0303213",
                    "CHEMBL.TARGET:CHEMBL2285350",
                    "ATC:B02BC07",
                    "LOINC:LP18176-5",
                    "FMA:63891",
                    "NCIT:C16447",
                    "CHEBI:3815",
                    "MESH:D003094",
                    "UMLS:C0009325",
                    "RXNORM:2714",
                    "KEGG.COMPOUND:C00211",
                    "ATC:G04BX11",
                    "CHEMBL.TARGET:CHEMBL2364188"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "FMA:67238": {
              "name": "Dopamine",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_67238",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_67238",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Dopamine is a member of the catecholamine family of neurotransmitters in the brain and is a precursor to epinephrine (adrenaline) and norepinephrine (noradrenaline). Dopamine is synthesized in the body (mainly by nervous tissue and adrenal glands) first by the hydration of the amino acid tyrosine to DOPA by tyrosine hydroxylase and then by the decarboxylation of DOPA by aromatic-L-amino-acid decarboxylase. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (dopamine receptors) mediates its action, which plays a major role in reward-motivated behaviour. Dopamine has many other functions outside the brain. In blood vessels, dopamine inhibits norepinephrine release and acts as a vasodilator (at normal concentrations); in the kidneys, it increases sodium excretion and urine output; in the pancreas, it reduces insulin production; in the digestive system, it reduces gastrointestinal motility and protects intestinal mucosa; and in the immune system, it reduces the activity of lymphocytes. Parkinson's disease, a degenerative condition causing tremor and motor impairment, is caused by a loss of dopamine-secreting neurons in an area of the midbrain called the substantia nigra. There is evidence that schizophrenia involves altered levels of dopamine activity, and most antipsychotic drugs used to treat this are dopamine antagonists, which reduce dopamine activity. Attention deficit hyperactivity disorder, bipolar disorder, and addiction are also characterized by defects in dopamine production or metabolism. It has been suggested that animals derived their dopamine-synthesizing machinery from bacteria via horizontal gene transfer that may have occurred relatively late in evolutionary time. This is perhaps a result of the symbiotic incorporation of bacteria into eukaryotic cells that gave rise to mitochondria. Dopamine is elevated in the urine of people who consume bananas. When present in sufficiently high levels, dopamine can be a neurotoxin and a metabotoxin. A neurotoxin is a compound that disrupts or attacks neural tissue. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of dopamine are associated with neuroblastoma, Costello syndrome, leukemia, phaeochromocytoma, aromatic L-amino acid decarboxylase deficiency, and Menkes disease (MNK). High levels of dopamine can lead to hyperactivity, insomnia, agitation and anxiety, depression, delusions, excessive salivation, nausea, and digestive problems. A study has shown that urinary dopamine is produced by Bacillus and Serratia (PMID: 24621061)",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug",
                    "biolink:NamedThing",
                    "biolink:MolecularEntity",
                    "biolink:BiologicalEntity",
                    "biolink:NucleicAcidEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Bendopa",
                    "L-Dopa [cytosol]",
                    "Doprin",
                    "Dopa, DL-",
                    "Dopastral",
                    "Dopamine",
                    "dA [extracellular region]",
                    "Melevodopa",
                    "Dopamine (INN)",
                    "Dihydroxyphenylalanine",
                    "Dopamine hydrochloride (JP18/USP)",
                    "dA [mitochondrial matrix]",
                    "L-dopa",
                    "2'-deoxyformycin A",
                    "MELEVODOPA",
                    "Dopalina",
                    "DOPAMINE",
                    "Dopaflex",
                    "Docarpamine (JAN/INN)",
                    "LEVODOPA",
                    "Larodopa",
                    "Eurodopa",
                    "DOPAMINE HYDROCHLORIDE",
                    "Maipedopa",
                    "Dopal",
                    "Veldopa",
                    "Eldopatec",
                    "L-dopa zwitterion",
                    "docarpamine",
                    "Dopamine hydrochloride",
                    "DA [cytosol]",
                    "dopamine",
                    "Levodopa",
                    "3,4-Dihydroxy-L-phenylalanine",
                    "Eldopar",
                    "Levopa",
                    "levodopa methyl ester",
                    "Cidandopa",
                    "Ledopa",
                    "DOCARPAMINE",
                    "melevodopa",
                    "levodopa",
                    "Docarpamine",
                    "deoxyadenosine [cytoplasm]",
                    "Deadopa",
                    "L-Dopa [melanosome lumen]",
                    "Dopar",
                    "L-Dopa [extracellular region]",
                    "Dopaidan",
                    "Melevodopa (INN)",
                    "2'-deoxyadenosine",
                    "Laradopa",
                    "dopa",
                    "DA [clathrin-sculpted monoamine transport vesicle lumen]",
                    "L-Dopa",
                    "Eldopal",
                    "DL-Dopa",
                    "Levodopa (JP18/USP/INN)",
                    "dA [cytosol]",
                    "Dopasol",
                    "DOPamine",
                    "Doparl",
                    "Dopaston",
                    "2-amino-3-(3,4-dihydroxyphenyl)propanoic acid",
                    "DEOXYADENOSINE",
                    "DA [extracellular region]",
                    "Deoxyadenosine",
                    "Parda",
                    "Doparkine"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEBI:31513",
                    "REACT:R-ALL-380873",
                    "KEGG.DRUG:D00059",
                    "CHEBI:4698",
                    "CHEBI:15765",
                    "ATC:C01CA04",
                    "LOINC:MTHU062948",
                    "MESH:D004295",
                    "REACT:R-ALL-351601",
                    "REACT:R-ALL-109731",
                    "UMLS:C0624727",
                    "CHEBI:17256",
                    "UMLS:C0023570",
                    "UMLS:C1517861",
                    "NCIT:C1503",
                    "MESH:C035420",
                    "VANDF:4017790",
                    "UMLS:C1517853",
                    "REACT:R-ALL-159362",
                    "HMDB:HMDB0000609",
                    "NCIT:C611",
                    "CHEMBL.COMPOUND:CHEMBL1557",
                    "DrugCentral:947",
                    "UMLS:C1517864",
                    "CHEBI:134880",
                    "KEGG.DRUG:D00633",
                    "CHEMBL.COMPOUND:CHEMBL59",
                    "LOINC:MTHU015998",
                    "DrugCentral:938",
                    "UMLS:C1517849",
                    "CHEMBL.COMPOUND:CHEMBL351042",
                    "UMLS:C1517851",
                    "PSY:28290",
                    "MESH:D004298",
                    "UMLS:C1449995",
                    "UMLS:C1517860",
                    "KEGG.COMPOUND:C00355",
                    "UMLS:C0720022",
                    "DRUGBANK:DB13313",
                    "HMDB:HMDB0000181",
                    "UMLS:C1517852",
                    "UMLS:C1517848",
                    "REACT:R-ALL-83925",
                    "RXNORM:6375",
                    "UMLS:C1517854",
                    "UMLS:C0013030",
                    "UMLS:C1517846",
                    "PathWhiz.Compound:68",
                    "NCIT:C81078",
                    "CHEMBL.COMPOUND:CHEMBL2106351",
                    "UMLS:C1517847",
                    "PathWhiz.Compound:52",
                    "DRUGBANK:DB01235",
                    "PDQ:CDR0000042622",
                    "UMLS:C1517862",
                    "CHEBI:18243",
                    "CHEMBL.TARGET:CHEMBL2364177",
                    "UMLS:C1517863",
                    "DrugCentral:1673",
                    "UMLS:C1517856",
                    "RXNORM:3628",
                    "CHEBI:49168",
                    "LOINC:LA16923-7",
                    "LOINC:LP99925-7",
                    "PathWhiz.Compound:117",
                    "UMLS:C1517865",
                    "NCIT:C62025",
                    "FMA:67238",
                    "LOINC:LP15543-9",
                    "MESH:D007980",
                    "HMDB:HMDB0000101",
                    "KEGG.DRUG:D07304",
                    "PSY:14950",
                    "ATC:N04BA01",
                    "HMDB:HMDB0000073",
                    "LOINC:LP16328-4",
                    "KEGG.DRUG:D01903",
                    "CHEMBL.COMPOUND:CHEMBL1328898",
                    "UMLS:C0700880",
                    "LOINC:LP32555-2",
                    "UMLS:C1517859",
                    "UMLS:C1517857",
                    "LOINC:MTHU047917",
                    "UMLS:C1517845",
                    "CHEMBL.COMPOUND:CHEMBL1009",
                    "NDDF:001639",
                    "REACT:R-ALL-1131748",
                    "REACT:R-ALL-209849",
                    "UMLS:C1517855",
                    "UMLS:C0045183",
                    "UMLS:C0699991",
                    "UMLS:C1517858",
                    "DRUGBANK:DB00988",
                    "DrugCentral:1567",
                    "UMLS:C1517850",
                    "KEGG.COMPOUND:C03758",
                    "CHEMBL.COMPOUND:CHEMBL449329",
                    "KEGG.COMPOUND:C00559",
                    "CHEBI:57504",
                    "MESH:C045970",
                    "KEGG.DRUG:D07870",
                    "MESH:C058118",
                    "REACT:R-ALL-83919",
                    "VANDF:4019733",
                    "REACT:R-ALL-8851314",
                    "MESH:C052143",
                    "REACT:R-ALL-5668568"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21458999",
                    "PMID:24138311",
                    "PMID:15801855",
                    "PMID:7484057",
                    "PMID:6788955",
                    "PMID:27343851",
                    "PMID:671451",
                    "PMID:10479303",
                    "PMID:9849813",
                    "PMID:30431269"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "FMA:67243": {
              "name": "Epinephrine",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_67243",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_67243",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Epinephrine is a catecholamine, a sympathomimetic monoamine derived from the amino acids phenylalanine and tyrosine. It is the active sympathomimetic hormone secreted from the adrenal medulla in most species. It stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. It is used in asthma and cardiac failure and to delay absorption of local anesthetics. Epinephrine also constricts arterioles in the skin and gut while dilating arterioles in leg muscles. It elevates the blood sugar level by increasing hydrolysis of glycogen to glucose in the liver, and at the same time begins the breakdown of lipids in adipocytes. Epinephrine has a suppressive effect on the immune system.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:BiologicalEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "dipivefrin monophosphate, (+-)-isomer",
                    "ADR [cytosol]",
                    "Erythromycin stearate (JP18/USP)",
                    "EPINEPHRINE HYDROCHLORIDE",
                    "dipivefrin propanoate, (+-)-isomer",
                    "Erythromycin lactobionate",
                    "dipivefrine",
                    "Erythromycin gluceptate",
                    "Epinephrine",
                    "dipivefrin hydrochloride",
                    "(S)-adrenaline",
                    "EPINEPHRINE BITARTRATE",
                    "Erythromycin Stearate",
                    "Dipivefrin (USAN)",
                    "ADR [clathrin-coated endocytic vesicle membrane]",
                    "Epinephrine Acetate",
                    "Epinephrine hydrochloride (JAN)",
                    "(R)-adrenaline",
                    "DIPIVEFRIN",
                    "Gallimycin",
                    "Erythromycin stearate",
                    "DIPIVEFRIN HYDROCHLORIDE",
                    "(R)-adrenaline hydrochloride",
                    "dipivefrin",
                    "Dipivefrin Hydrochloride",
                    "L-Adrenaline",
                    "EPINEPHrine",
                    "erythromycin lactobionate",
                    "Dipivefrin hydrochloride",
                    "(-)-adrenaline",
                    "ERYTHROMYCIN LACTOBIONATE",
                    "Erythromycin gluceptate (USP)",
                    "Erythromycin lactobionate (JP18/USP)",
                    "Propine",
                    "Erythromycin Lactobionate",
                    "d Epifrin",
                    "Dipivefrin hydrochloride (JAN/USP)",
                    "ERYTHROMYCIN STEARATE",
                    "dipivefrin tartrate (1:1), (+-)-(R-(R*,R*))-isomer",
                    "erythromycin gluceptate",
                    "PMS-Dipivefrin",
                    "Erythromycin Gluceptate",
                    "EPINEPHRINE",
                    "dipivefrin acetate, (+-)-isomer",
                    "erythromycin glucoheptonate",
                    "L-ADRENALINE",
                    "ERYTHROMYCIN GLUCEPTATE",
                    "Epinephrine (USP/INN)",
                    "ADR [extracellular region]",
                    "Erythromycin",
                    "epinephrine",
                    "Dipivefrin",
                    "erythromycin stearate",
                    "ADR [clathrin-sculpted monoamine transport vesicle lumen]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "RXNORM:203156",
                    "ATC:R01AA14",
                    "UMLS:C0521932",
                    "RXNORM:3992",
                    "ATC:A01AD01",
                    "CHEMBL.COMPOUND:CHEMBL3545060",
                    "CHEMBL.COMPOUND:CHEMBL1200506",
                    "MESH:C028896",
                    "NCIT:C47495",
                    "UMLS:C0059562",
                    "DRUGBANK:DB00668",
                    "RXNORM:24346",
                    "VANDF:4017596",
                    "CHEBI:4646",
                    "UMLS:C1529985",
                    "KEGG.DRUG:D00095",
                    "MESH:D004837",
                    "ATC:B02BC09",
                    "ATC:R03AA01",
                    "RXNORM:24351",
                    "CHEBI:34742",
                    "ATC:S01EA01",
                    "FMA:67243",
                    "NCIT:C61729",
                    "NDDF:002758",
                    "UMLS:C0059561",
                    "VANDF:4018034",
                    "DrugCentral:922",
                    "UMLS:C4255548",
                    "UMLS:C3540739",
                    "REACT:R-ALL-8869056",
                    "UMLS:C0138647",
                    "DRUGBANK:DB00449",
                    "KEGG.COMPOUND:C00788",
                    "UMLS:C0058415",
                    "MESH:C010948",
                    "CHEBI:28918",
                    "UMLS:C0014563",
                    "REACT:R-ALL-390625",
                    "CHEMBL.COMPOUND:CHEMBL42280",
                    "CHEBI:6213",
                    "CHEMBL.COMPOUND:CHEMBL1200510",
                    "NCIT:C47989",
                    "CHEBI:4647",
                    "CHEMBL.COMPOUND:CHEMBL1201262",
                    "PSY:17700",
                    "REACT:R-ALL-549254",
                    "KEGG.DRUG:D00996",
                    "CHEMBL.COMPOUND:CHEMBL3183376",
                    "KEGG.DRUG:D02349",
                    "KEGG.DRUG:D02524",
                    "HMDB:HMDB0014592",
                    "NCIT:C47988",
                    "UMLS:C0889645",
                    "CHEMBL.COMPOUND:CHEMBL679",
                    "KEGG.COMPOUND:C06963",
                    "PathWhiz.Compound:48",
                    "UMLS:C0889647",
                    "VANDF:4019152",
                    "HMDB:HMDB0000068",
                    "MESH:C015173",
                    "CHEBI:40751",
                    "DrugCentral:1028",
                    "NCIT:C65533",
                    "REACT:R-ALL-444148",
                    "VANDF:4017595",
                    "RXNORM:23410",
                    "MESH:C011462",
                    "LOINC:LP15027-3",
                    "UMLS:C0700488",
                    "ATC:S01EA02",
                    "UMLS:C0889649",
                    "HMDB:HMDB0014344",
                    "UMLS:C0889648",
                    "KEGG.DRUG:D02184",
                    "CHEMBL.COMPOUND:CHEMBL1256958",
                    "KEGG.DRUG:D01017",
                    "LOINC:MTHU060431",
                    "CHEMBL.COMPOUND:CHEMBL1200833",
                    "REACT:R-ALL-209794",
                    "UMLS:C0059566",
                    "NDDF:001788",
                    "NDDF:002759",
                    "RXNORM:24347",
                    "KEGG.DRUG:D02009",
                    "ATC:C01CA24",
                    "NCIT:C2292",
                    "UMLS:C1529988",
                    "VANDF:4017591",
                    "LOINC:MTHU002341",
                    "NDDF:002760",
                    "VANDF:4019728"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28836556",
                    "PMID:21458999",
                    "PMID:195059",
                    "PMID:7769131",
                    "PMID:17127057",
                    "PMID:7328589",
                    "PMID:10447956",
                    "PMID:671451",
                    "PMID:17417631",
                    "PMID:10891117"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "FMA:67303": {
              "name": "Elastin",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_67303",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_67303",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Elastin (786 aa, ~68 kDa) is encoded by the human ELN gene. This protein is involved in the elasticity of the extracellular matrix.; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Polypeptide",
                    "biolink:NamedThing",
                    "biolink:Protein",
                    "biolink:MolecularEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug",
                    "biolink:Gene"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Astin I",
                    "Tropoelastin",
                    "Elastin",
                    "elastin",
                    "N-Acetyl-L-leucyl-L-isoleucylglycyl-L-valyl-N-methyl-L-prolinamide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HMDB:HMDB0251736",
                    "CHEBI:177837",
                    "CHEMBL.TARGET:CHEMBL3713712",
                    "ORPHANET:121517",
                    "HMDB:HMDB0041419",
                    "UMLS:C0041194",
                    "MESH:D004549",
                    "NCIT:C75335",
                    "UMLS:C0013765",
                    "KEGG.COMPOUND:C00373",
                    "FMA:67303",
                    "PR:000007034",
                    "RXNORM:1730435",
                    "MESH:D014333",
                    "CHEBI:4767"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:31557052"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "FMA:74637": {
              "name": "Somatotropin",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_74637",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_74637",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A recombinant form of endogenous human growth hormone (GH), a polypeptide produced by the anterior lobe of the human pituitary gland. GH exhibits growth-promoting effects and metabolic effects on carbohydrate, fat, protein and bone metabolism. GH stimulates protein synthesis and the uptake of amino acids into cells, and induces lipolysis in adipose tissues. The secretion of GH increases with sexual maturation and then declines steadily. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C837\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C837\" NCI Thesaurus); A recombinant form of endogenous human growth hormone (GH), a polypeptide produced by the anterior lobe of the human pituitary gland. GH exhibits growth-promoting effects and metabolic effects on carbohydrate, fat, protein and bone metabolism. GH stimulates protein synthesis and the uptake of amino acids into cells, and induces lipolysis in adipose tissues. The secretion of GH increases with sexual maturation and then declines steadily.; Mammalian-cell derived recombinant human growth hormone.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:ChemicalEntity",
                    "biolink:BiologicalEntity",
                    "biolink:Drug",
                    "biolink:Protein",
                    "biolink:SmallMolecule"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Cryo-Tropin",
                    "somatropin",
                    "Omnitrope",
                    "somatotropin",
                    "Human Growth Hormone",
                    "SOMATROPIN",
                    "Somatotropin",
                    "Genotropin",
                    "Somatropin",
                    "Somatropin (USP/INN)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "FMA:74637",
                    "ATC:H01AC01",
                    "RXNORM:202828",
                    "MESH:D019382",
                    "LOINC:LP14695-8",
                    "KEGG.DRUG:D02691",
                    "VANDF:4019293",
                    "UMLS:C1724675",
                    "RXNORM:61148",
                    "UMLS:C0169964",
                    "LOINC:MTHU002890",
                    "NCIT:C837",
                    "UMLS:C0699616",
                    "RXNORM:644964",
                    "PR:000007968",
                    "NCIT:C2288",
                    "DRUGBANK:DB00052",
                    "NDDF:002104",
                    "PDQ:CDR0000456264",
                    "UMLS:C1564130",
                    "VANDF:4020552",
                    "DrugCentral:4848",
                    "CHEMBL.COMPOUND:CHEMBL1201621",
                    "PSY:48650"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16702112",
                    "PMID:2688",
                    "PMID:2903866",
                    "PMID:5675428"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "FMA:74644": {
              "name": "Melatonin",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_74644",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_74644",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and. lowering the body temperature. Melatonin is also implicated in the regulation of mood,learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant. Most of the actions of melatonin are mediated through the binding and activation of melatonin receptors. Individuals with autism spectrum disorders(ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits. were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis. Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:BiologicalEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Melatonin (JAN)",
                    "melatonin",
                    "MELATONIN",
                    "Circadin",
                    "MLT [extracellular region]",
                    "Melatonin",
                    "MLT [cytosol]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C2267",
                    "LOINC:LP15036-4",
                    "VANDF:4021324",
                    "FMA:74644",
                    "KEGG.DRUG:D08170",
                    "MESH:D008550",
                    "UMLS:C0025219",
                    "REACT:R-ALL-419339",
                    "ATC:N05CH01",
                    "LOINC:MTHU002350",
                    "CHEBI:16796",
                    "CHEMBL.COMPOUND:CHEMBL45",
                    "UMLS:C1710381",
                    "HMDB:HMDB0001389",
                    "PSY:30540",
                    "PathWhiz.Compound:1074",
                    "DrugCentral:1672",
                    "RXNORM:6711",
                    "DRUGBANK:DB01065",
                    "KEGG.COMPOUND:C01598",
                    "REACT:R-ALL-209934"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:26367450",
                    "PMID:29420891",
                    "PMID:7707316",
                    "PMID:16150115",
                    "PMID:11063602",
                    "PMID:11339508",
                    "PMID:21190861",
                    "PMID:16759094",
                    "PMID:19117642",
                    "PMID:423184"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "FMA:81101": {
              "name": "Von Willebrand factor",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_81101",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_81101",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:BiologicalEntity",
                    "biolink:Drug",
                    "biolink:Protein",
                    "biolink:Gene"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "von Willebrand Factor",
                    "Von willebrand factor",
                    "VONICOG ALFA",
                    "Vonicog Alfa",
                    "VON WILLEBRAND FACTOR HUMAN",
                    "Vonicog alfa (USAN)",
                    "Von Willebrand factor",
                    "von Willebrand factor",
                    "vonicog alfa",
                    "Von Willebrand Factor Human"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C16572",
                    "UMLS:C4291409",
                    "ORPHANET:120487",
                    "DRUGBANK:DB12872",
                    "UMLS:C0042971",
                    "KEGG.DRUG:D08681",
                    "NDDF:016621",
                    "CHEMBL.COMPOUND:CHEMBL4298126",
                    "MESH:D014841",
                    "FMA:81101",
                    "LOINC:LP16906-7",
                    "RXNORM:1812589",
                    "DRUGBANK:DB13133",
                    "NCIT:C152910",
                    "CHEMBL.COMPOUND:CHEMBL2107873",
                    "CHEMBL.TARGET:CHEMBL2021748",
                    "PR:000017364",
                    "RXNORM:11274",
                    "VANDF:4025436",
                    "DrugCentral:5173",
                    "NCIT:C81465",
                    "ATC:B02BD10"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16449527",
                    "PMID:25712991",
                    "PMID:28276537",
                    "PMID:26239086",
                    "PMID:18263586",
                    "PMID:21725579",
                    "PMID:28379876",
                    "PMID:21220152",
                    "PMID:19768705"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "FMA:82839": {
              "name": "Heparin",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_82839",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_82839",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Heparin is a highly acidic heterogeneous mucopolysaccharide consisting of a variably sulfated repeating disaccharide unit. The most common repeating unit is a trisulfated disaccharide composed of a 2-O-sulfated iduronic acid and 6-O-sulfated, N-sulfated glucosamine, IdoA(2S)-GlcNS(6S). Heparin is formed from equal parts sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lungs, and mast cells of vertebrates. Its function is unknown, but it is used to prevent blood clotting, in vivo and in vitro, in the form of many different salts. Enoxaparin is a low molecular weight heparin. It is used to prevent and treat deep vein thrombosis or pulmonary embolism, and is given as a subcutaneous injection. Enoxaparin binds to and accelerates the activity of antithrombin III. By activating antithrombin III, enoxaparin preferentially potentiates the inhibition of coagulation factors Xa and IIa. Factor Xa catalyzes the conversion of prothrombin to thrombin, so enoxaparin's inhibition of this process results in decreased thrombin and ultimately the prevention of fibrin clot formation. Low molecular weight heparins are less effective at inactivating factor IIa due to their shorter length compared to unfractionated heparin.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:BiologicalEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Heparin calcium",
                    "Sodium heparin",
                    "Heparinsodiumsalt",
                    "Heparin Sodium",
                    "Heparin",
                    "heparin, porcine",
                    "Heparin sodium (JP18/USP/INN)",
                    "heparin",
                    "HEPARIN SODIUM",
                    "HEPARIN",
                    "heparin sodium",
                    "heparin calcium",
                    "ENOXAPARIN",
                    "SODIUM HEPARIN",
                    "HEPARIN CALCIUM",
                    "Adomiparin (USAN)",
                    "Heparin sodium",
                    "Heparin Calcium"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "RXNORM:235473",
                    "VANDF:4017549",
                    "ATC:B01AB01",
                    "KEGG.GLYCAN:G05144",
                    "KEGG.DRUG:D07510",
                    "NCIT:C539",
                    "RXNORM:5224",
                    "ttd.target:Heparin_Sodium",
                    "KEGG.GLYCAN:G03495",
                    "CHEMBL.COMPOUND:CHEMBL4128407",
                    "KEGG.GLYCAN:G00932",
                    "FMA:82839",
                    "UMLS:C0770546",
                    "PDQ:CDR0000791439",
                    "CHEMBL.COMPOUND:CHEMBL1201685",
                    "MESH:D006493",
                    "LOINC:LA24058-2",
                    "PSY:22750",
                    "ttd.target:Heparin_Calcium",
                    "LOINC:MTHU003766",
                    "ATC:C05BA03",
                    "VANDF:4018538",
                    "CHEBI:151315",
                    "UMLS:C0019134",
                    "CHEBI:28304",
                    "HMDB:HMDB0001394",
                    "DrugCentral:1358",
                    "CHEMBL.COMPOUND:CHEMBL526514",
                    "CHEMBL.TARGET:CHEMBL2364712",
                    "UMLS:C0037513",
                    "DRUGBANK:DB01109",
                    "LOINC:LP15998-5",
                    "CHEMBL.COMPOUND:CHEMBL1909300",
                    "PathWhiz.Compound:1078",
                    "RXNORM:9877",
                    "CHEMBL.COMPOUND:CHEMBL1201657",
                    "CHEMBL.COMPOUND:CHEMBL1201513",
                    "KEGG.GLYCAN:G00797",
                    "KEGG.GLYCAN:G00338",
                    "NDDF:015153",
                    "KEGG.COMPOUND:C00374",
                    "KEGG.GLYCAN:G01158",
                    "KEGG.GLYCAN:G00609",
                    "RXNORM:20044",
                    "VANDF:4017546",
                    "PDQ:CDR0000040848",
                    "NCIT:C1034",
                    "NCIT:C833",
                    "UMLS:C0054452",
                    "HMDB:HMDB0258358",
                    "ATC:S01XA14",
                    "KEGG.DRUG:D02112"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:6889041",
                    "PMID:16305714",
                    "PMID:1710653",
                    "PMID:8891437",
                    "PMID:16709700",
                    "PMID:16044416",
                    "PMID:29631958",
                    "PMID:2118944",
                    "PMID:1505142",
                    "PMID:12175393"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "FMA:83358": {
              "name": "Prolactin",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_83358",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_83358",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A somatotropin hormone family member that is a translation product of the human PRL gene or a 1:1 ortholog thereof.; A somatotropin hormone family member that is a translation product of the human PRL gene or a 1:1 ortholog thereof. // COMMENTS: Category=gene.; A somatotropin hormone family member that is a translation product of the human PRL gene or a 1:1 ortholog thereof. // COMMENTS: Category=gene.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Gene",
                    "biolink:BiologicalEntity",
                    "biolink:Protein",
                    "biolink:Drug",
                    "biolink:MolecularEntity",
                    "biolink:SmallMolecule"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "prolactin",
                    "PRL",
                    "Prolactin",
                    "prolactin (chicken)",
                    "PRL (chicken)",
                    "PRL Gene",
                    "PRL gene",
                    "prolactin (human)",
                    "PRL (human)",
                    "Prl (rat)",
                    "PRL [endosome lumen]",
                    "PRL [extracellular region]",
                    "prolactin (rat)",
                    "Prl (mouse)",
                    "DNA replication licensing factor MCM7 (Arabidopsis thaliana)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PR:000013246",
                    "PR:P14676",
                    "MESH:D011388",
                    "UMLS:C0033371",
                    "REACT:R-HSA-976984",
                    "UniProtKB:P01236",
                    "LOINC:LP14688-3",
                    "NCBIGene:5617",
                    "PR:P43299",
                    "PR:P01236",
                    "KEGG.COMPOUND:C18201",
                    "NCIT:C778",
                    "REACT:R-HSA-8942967",
                    "PSY:41020",
                    "LOINC:LP70338-6",
                    "FMA:83358",
                    "NCIT:C39655",
                    "LOINC:MTHU003168",
                    "CHEBI:81580",
                    "RGD:3403",
                    "HGNC:9445",
                    "MGI:97762",
                    "PR:P01237",
                    "UMLS:C1418938",
                    "ENSEMBL:ENSG00000172179",
                    "OMIM:176760",
                    "NCBIGene:396453",
                    "RXNORM:1426890"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1023/a:1005879103367",
                    "PMID:6325171",
                    "DOI:10.1074/jbc.m801202200",
                    "PMID:15687336",
                    "PMID:6146607",
                    "DOI:10.1016/j.jmb.2005.06.042",
                    "DOI:10.1101/gr.2596504",
                    "DOI:10.1074/jbc.m704364200",
                    "DOI:10.1016/0303-7207(91)90247-p",
                    "PMID:16045928"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "FMA:83365": {
              "name": "Insulin",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_83365",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_83365",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A recombinant form of the naturally occurring human pancreatic hormone insulin. Upon administration, regular insulin mimics the action of endogenous human insulin and binds to insulin receptors located on muscle and fat cells. This both facilitates the cellular uptake of glucose and lowers blood glucose levels. In addition, insulin inhibits the liver's conversion of stored glycogen into glucose, which also decreases blood glucose levels. Insulin also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C29125\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29125\" NCI Thesaurus); A recombinant form of the naturally occurring human pancreatic hormone insulin. Upon administration, regular insulin mimics the action of endogenous human insulin and binds to insulin receptors located on muscle and fat cells. This both facilitates the cellular uptake of glucose and lowers blood glucose levels. In addition, insulin inhibits the liver's conversion of stored glycogen into glucose, which also decreases blood glucose levels. Insulin also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis.; Regular insulin preparations that contain the HUMAN insulin peptide sequence.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T125; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug",
                    "biolink:BiologicalEntity",
                    "biolink:Protein",
                    "biolink:MolecularEntity",
                    "biolink:Gene"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Insulin,regular,human/semisynthetic",
                    "INSULIN ZINC SUSP PROMPT PURIFIED PORK",
                    "Insulin Human",
                    "Novolin",
                    "INSULIN SUSP PROTAMINE ZINC PURIFIED PORK",
                    "insulin, neutral",
                    "Insulin",
                    "insulin human",
                    "INSULIN ZINC SUSP PURIFIED PORK",
                    "INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN",
                    "Iletin",
                    "Insulin pork",
                    "Insulin, Regular, Pork",
                    "insulin (human)",
                    "Insulin Pork",
                    "Humulin R",
                    "INSULIN, NEUTRAL",
                    "INSULIN ZINC SUSP EXTENDED RECOMBINANT HUMAN",
                    "Insulin human (USP/INN)",
                    "Novolin R",
                    "INSULIN PORK",
                    "INSULIN,REGULAR,HUMAN/rDNA",
                    "INSULIN SUSP ISOPHANE PURIFIED PORK",
                    "INSULIN ZINC SUSP RECOMBINANT HUMAN",
                    "Insulin Zinc Susp Recombinant Human",
                    "insulin, regular, human",
                    "INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN",
                    "insulin",
                    "Insulin Susp Isophane Recombinant Human",
                    "Insulin B Chain",
                    "Velosulin",
                    "Insulin A Chain",
                    "Insulin human",
                    "Insulin (JAN/USP)",
                    "insulin pork",
                    "INSULIN SUSP ISOPHANE RECOMBINANT HUMAN",
                    "INSULIN PURIFIED PORK",
                    "INSULIN"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PathWhiz.Compound:104593",
                    "PathWhiz.ProteinComplex:10509",
                    "CHEMBL.COMPOUND:CHEMBL1201644",
                    "NCIT:C65923",
                    "RXNORM:92881",
                    "CHEMBL.COMPOUND:CHEMBL1201627",
                    "LOINC:LA15805-7",
                    "LOINC:MTHU002108",
                    "UMLS:C0021642",
                    "CHEMBL.COMPOUND:CHEMBL2108966",
                    "VANDF:4019786",
                    "CHEMBL.COMPOUND:CHEMBL3963594",
                    "LOINC:LP14676-8",
                    "RXNORM:1372723",
                    "DRUGBANK:DB00071",
                    "CHEMBL.COMPOUND:CHEMBL1201638",
                    "UMLS:C0306371",
                    "MESH:D061389",
                    "PathWhiz.ProteinComplex:5236",
                    "UMLS:C0042456",
                    "MESH:C000006",
                    "VANDF:4017559",
                    "RXNORM:93560",
                    "CHEMBL.COMPOUND:CHEMBL1201543",
                    "CHEMBL.TARGET:CHEMBL5881",
                    "UMLS:C0063657",
                    "PSY:25800",
                    "PathWhiz.ProteinComplex:999",
                    "ORPHANET:168345",
                    "VANDF:4021631",
                    "RXNORM:253182",
                    "DRUGBANK:DB00030",
                    "CHEMBL.COMPOUND:CHEMBL1201631",
                    "CHEMBL.COMPOUND:CHEMBL1201630",
                    "KEGG.DRUG:D03230",
                    "HMDB:HMDB0243503",
                    "UMLS:C0028467",
                    "CHEMBL.COMPOUND:CHEMBL1201643",
                    "CHEMBL.COMPOUND:CHEMBL1201540",
                    "ttd.target:Insulin_Susp_Isophane_Recombinant_Human",
                    "LOINC:LP17001-6",
                    "CHEMBL.COMPOUND:CHEMBL1201641",
                    "CHEMBL.COMPOUND:CHEMBL1201539",
                    "DrugCentral:5003",
                    "FMA:83365",
                    "KEGG.COMPOUND:C00723",
                    "UMLS:C3179172",
                    "KEGG.DRUG:D00085",
                    "NCIT:C65922",
                    "LOINC:LP70329-5",
                    "UMLS:C0021641",
                    "CHEBI:5931",
                    "PathWhiz.ProteinComplex:10596",
                    "CHEMBL.COMPOUND:CHEMBL1201656",
                    "LOINC:LP32542-0",
                    "VANDF:4017569",
                    "UMLS:C0020884",
                    "UMLS:C0307073",
                    "DrugCentral:5191",
                    "UMLS:C0795635",
                    "MESH:D007328",
                    "CHEBI:145810",
                    "ttd.target:Insulin_Zinc_Susp_Recombinant_Human",
                    "CHEMBL.COMPOUND:CHEMBL1201653",
                    "NCIT:C2271"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11118018",
                    "PMID:9182539",
                    "PMID:10841002",
                    "PMID:27574374",
                    "PMID:14578244",
                    "PMID:23512415",
                    "PMID:15646539",
                    "PMID:31557052",
                    "PMID:18715209"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "FMA:83375": {
              "name": "Androgen",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_83375",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_83375",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.; A steroid hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.; A sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.; A sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:NamedThing",
                    "biolink:MolecularEntity",
                    "biolink:BiologicalEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Androgens",
                    "androgen",
                    "Androgen"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "FMA:83375",
                    "PSY:02440",
                    "CHEBI:50113",
                    "UMLS:C0002844",
                    "NCIT:C2298",
                    "LOINC:LP31654-4",
                    "MESH:D000728",
                    "ATC:G03B"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "FMA:264825": {
              "name": "Interleukin-10",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_264825",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_264825",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A class 2 cytokine, IL-10 type that is a translation product of the human IL10 gene or a 1:1 ortholog thereof. Active interleukin-10 inhibits the synthesis of a number of cytokines, including IFN-gamma, IL-2, IL-3, TNF and GM-CSF produced by activated macrophages and by helper T cells. Structurally, IL-10 is a protein of about 160 amino acids that contains four conserved cysteines involved in disulfide bonds.; A class 2 cytokine, IL-10 type that is a translation product of the human IL10 gene or a 1:1 ortholog thereof. Active interleukin-10 inhibits the synthesis of a number of cytokines, including IFN-gamma, IL-2, IL-3, TNF and GM-CSF produced by activated macrophages and by helper T cells. Structurally, IL-10 is a protein of about 160 amino acids that contains four conserved cysteines involved in disulfide bonds. // COMMENTS: Category=gene.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:ChemicalEntity",
                    "biolink:Protein",
                    "biolink:Drug",
                    "biolink:SmallMolecule"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "interleukin-10",
                    "INTERLEUKIN-10",
                    "Interleukin-10"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0085295",
                    "CHEMBL.COMPOUND:CHEMBL4297771",
                    "PDQ:CDR0000043226",
                    "DRUGBANK:DB12880",
                    "PR:000001471",
                    "MESH:D016753",
                    "NCIT:C20512",
                    "CHEMBL.TARGET:CHEMBL3712920",
                    "RXNORM:1311299",
                    "FMA:264825"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "FMA:264827": {
              "name": "Interleukin-8",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_264827",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_264827",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells.; UMLS Semantic Type: STY:T129; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Protein",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "interleukin-8",
                    "Interleukin-8"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "RXNORM:1426866",
                    "MESH:D016209",
                    "FMA:264827",
                    "NCIT:C20473",
                    "PR:000001395",
                    "UMLS:C0079633",
                    "CHEMBL.TARGET:CHEMBL2157"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "FMA:264829": {
              "name": "Interleukin-6",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/FMA_264829",
                  "value_url": "http://purl.obolibrary.org/obo/FMA_264829",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS.; UMLS Semantic Type: STY:T129; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Protein",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "interleukin-6",
                    "Interleukin-6"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MESH:D015850",
                    "RXNORM:1367185",
                    "FMA:264829",
                    "PR:000001393",
                    "NCIT:C20451",
                    "UMLS:C0021760",
                    "CHEMBL.TARGET:CHEMBL1795129"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "ATC:A10AB05": {
              "name": "INSULIN ASPART",
              "attributes": [
                {
                  "value": "http://purl.bioontology.org/ontology/ATC/A10AB05",
                  "value_url": "http://purl.bioontology.org/ontology/ATC/A10AB05",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A recombinant human insulin analog with rapid-acting, blood glucose-lowering activity. Insulin aspart, acting faster than regular human insulin, regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, thereby facilitating the cellular uptake of glucose. This lowers blood glucose levels. At the same time, insulin aspart inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. Insulin aspart also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. (NCI05); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T125; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "insulin aspart",
                    "Insulin Aspart"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ATC:A10AB05",
                    "ATC:A10AD05",
                    "NCIT:C47563",
                    "NDDF:007992"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:NamedThing",
                "biolink:NamedThing"
              ]
            },
            "CHEBI:33699": {
              "name": "messenger RNA",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/CHEBI_33699",
                  "value_url": "http://purl.obolibrary.org/obo/CHEBI_33699",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein.; RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:RNAProduct",
                    "biolink:Transcript",
                    "biolink:InformationContentEntity",
                    "biolink:MolecularEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Poly(A) Tail",
                    "RNA, Polyadenylated",
                    "messenger rna",
                    "RNA, Messenger",
                    "Messenger RNA",
                    "mRNA",
                    "messenger RNA"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PathWhiz.ElementCollection:490",
                    "UMLS:C0137714",
                    "SO:0000234",
                    "NCIT:C813",
                    "UMLS:C0035696",
                    "CHEBI:33699",
                    "MI:0324",
                    "MESH:D012333",
                    "UMLS:C0242494"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:14755292"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:RNAProduct",
                "biolink:NamedThing"
              ]
            },
            "CHEBI:35457": {
              "name": "EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/CHEBI_35457",
                  "value_url": "http://purl.obolibrary.org/obo/CHEBI_35457",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Any substance that inhibits angiotensin-converting enzyme (ACE), an enzyme that catalyzes the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in a reduction in angiotensin II and angiotensin II-induced aldosterone secretion, causing vasodilation and natriuresis.; A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.; UMLS Semantic Type: STY:T121",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Angiotensin-Converting Enzyme Inhibitors",
                    "EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003015",
                    "MESH:D000806",
                    "CHEBI:35457"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "CHEBI:35530": {
              "name": "beta-adrenergic antagonist",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/CHEBI_35530",
                  "value_url": "http://purl.obolibrary.org/obo/CHEBI_35530",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Natural or synthetic beta adrenergic antagonists selectively or non-selectively blocking or diminishing physiologic beta-adrenergic agonist actions on the sympathetic system. This group of antagonists are generally used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.; Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.; UMLS Semantic Type: STY:T121",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Beta-Adrenergic Antagonist",
                    "beta-adrenergic antagonist",
                    "Adrenergic beta-Antagonists"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MESH:D000319",
                    "UMLS:C0001645",
                    "NCIT:C29576",
                    "CHEBI:35530"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "CHEBI:35674": {
              "name": "antihypertensive agent",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/CHEBI_35674",
                  "value_url": "http://purl.obolibrary.org/obo/CHEBI_35674",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Any substance used in the treatment of acute or chronic hypertension regardless of pharmacological mechanism. Antihypertensive agents include diuretics, alpha-adrenergic and beta-adrenergic antagonists, angiotensin-converting enzyme inhibitors, calcium channel blockers, ganglionic blockers, and vasodilator agents.; Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.; UMLS Semantic Type: STY:T121",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Antihypertensive Agent",
                    "antihypertensive agent",
                    "Antihypertensive Agents"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0003364",
                    "CHEBI:35674",
                    "MESH:D000959",
                    "NCIT:C270"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "CHEBI:35942": {
              "name": "Neurohormones",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/CHEBI_35942",
                  "value_url": "http://purl.obolibrary.org/obo/CHEBI_35942",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Endogenous signaling molecules secreted by neurons that alter the behavior of neurons or effector cells. Neurotransmitter is used here in its most general sense, including not only messengers that act directly to regulate ion channels, but also those that act through second messenger systems, and those that act at a distance from their site of release. Included are neuromodulators, neuroregulators, neuromediators, neurohormones, and neurohumors, whether or not acting at synapses.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Drug",
                    "biolink:ChemicalEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "neurotransmitter agent",
                    "Neurohormones",
                    "Neurotransmitter Agents"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0597049",
                    "CHEBI:35942",
                    "UMLS:C0243051",
                    "MESH:D018377"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "CHEBI:50949": {
              "name": "serotonin uptake inhibitor",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/CHEBI_50949",
                  "value_url": "http://purl.obolibrary.org/obo/CHEBI_50949",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A compound that specifically inhibits the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "serotonin uptake inhibitor",
                    "Serotonin Uptake Inhibitors"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MESH:D017367",
                    "CHEBI:50949",
                    "UMLS:C0162758"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "RXNORM:3264": {
              "name": "Dexamethasone",
              "attributes": [
                {
                  "value": "http://purl.bioontology.org/ontology/RXNORM/3264",
                  "value_url": "http://purl.bioontology.org/ontology/RXNORM/3264",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C422\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C422\" NCI Thesaurus); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Dexamethasone",
                    "dexamethasone"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ATC:R01AD03",
                    "PDQ:CDR0000039789",
                    "ATC:D07AB19",
                    "ATC:D07XB05",
                    "NCIT:C422",
                    "ATC:D10AA03",
                    "LOINC:MTHU004621",
                    "ATC:S03BA01",
                    "ATC:S01BA01",
                    "PSY:13905",
                    "ATC:C05AA09",
                    "ATC:H02AB02",
                    "ATC:S01CB01",
                    "RXNORM:3264",
                    "LOINC:LP32530-5",
                    "VANDF:4017922",
                    "LOINC:LP18549-3",
                    "ATC:S02BA06",
                    "ATC:A01AC02"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "RXNORM:8031": {
              "name": "Endopeptidases",
              "attributes": [
                {
                  "value": "http://purl.bioontology.org/ontology/RXNORM/8031",
                  "value_url": "http://purl.bioontology.org/ontology/RXNORM/8031",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A class of enzymes that catalyze the hydrolysis of peptide bonds in the interior of a polypeptide chain or protein molecule.; A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Endopeptidases"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0030946",
                    "MESH:D010450",
                    "RXNORM:8031"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "DOID:0080685": {
              "name": "aortic dissection",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/DOID_0080685",
                  "value_url": "http://purl.obolibrary.org/obo/DOID_0080685",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A progressive tear in the tissue lining the aorta, characterized by the passage of blood from the tunica intima into, and partially through, the tunica media.; An aneurysm caused by a tear in the TUNICA INTIMA of a blood vessel leading to interstitial HEMORRHAGE, and splitting (dissecting) of the vessel wall, often involving the AORTA. Dissection between the tunica intima and TUNICA MEDIA causes luminal occlusion. Dissection at the media, or between the media and the outer ADVENTITIA causes aneurismal dilation.; Aortic dissection refers to a tear in the intimal layer of the aorta causing a separation between the intima and the medial layers of the aorta. [HPO:curators]; UMLS Semantic Type: STY:T047; UMLS Semantic Type: STY:T047",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Disease",
                    "biolink:PhenotypicFeature",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Dissection of aorta",
                    "Aortic dissection",
                    "Aortic Dissection",
                    "aortic dissection"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0340643",
                    "NCIT:C50461",
                    "HP:0002647",
                    "OMIM:MTHU017249",
                    "DOID:0080685"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "https://orcid.org/0000-0002-6548-5200",
                    "https://www.ncbi.nlm.nih.gov/books/nbk441963/"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "MESH:D000375": {
              "name": "Aging",
              "attributes": [
                {
                  "value": "http://id.nlm.nih.gov/mesh/D000375",
                  "value_url": "http://id.nlm.nih.gov/mesh/D000375",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). [GOC:PO_curators]; A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).; The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.; A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).; UMLS Semantic Type: STY:T040",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess",
                    "biolink:BiologicalProcess",
                    "biolink:DiseaseOrPhenotypicFeature",
                    "biolink:BiologicalEntity",
                    "biolink:BehavioralFeature"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Senility",
                    "Aging",
                    "aging",
                    "senility"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0001811",
                    "GO:0007568",
                    "PSY:01413",
                    "MESH:D000375",
                    "NBO:0000572",
                    "UMLS:C0231337",
                    "NCIT:C16269"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:BiologicalEntity",
                "biolink:NamedThing"
              ]
            },
            "MESH:D006439": {
              "name": "Hemodynamics",
              "attributes": [
                {
                  "value": "http://id.nlm.nih.gov/mesh/D006439",
                  "value_url": "http://id.nlm.nih.gov/mesh/D006439",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM.; UMLS Semantic Type: STY:T042",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Hemodynamics"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "LOINC:LP34042-9",
                    "LOINC:LP249281-9",
                    "MESH:D006439",
                    "UMLS:C0019010"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:PhysiologicalProcess",
                "biolink:NamedThing"
              ]
            },
            "MESH:D009154": {
              "name": "Mutation",
              "attributes": [
                {
                  "value": "http://id.nlm.nih.gov/mesh/D009154",
                  "value_url": "http://id.nlm.nih.gov/mesh/D009154",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Individual, strain, or species genetic variation resulting from an abrupt or unusual change in gene structure. Also, an externally induced or naturally occurring change in gene characteristics that is propagated in subsequent divisions of the cell.; Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.; UMLS Semantic Type: STY:T045",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess",
                    "biolink:InformationContentEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Mutation",
                    "mutation"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MI:0118",
                    "MESH:D009154",
                    "LOINC:LP32514-9",
                    "UMLS:C0026882"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:14755292"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:PhysiologicalProcess",
                "biolink:NamedThing"
              ]
            },
            "MESH:D013091": {
              "name": "Spermatogenesis",
              "attributes": [
                {
                  "value": "http://id.nlm.nih.gov/mesh/D013091",
                  "value_url": "http://id.nlm.nih.gov/mesh/D013091",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis. [GOC:jid, ISBN:9780878933846]; The developmental process by which male germ line stem cells self renew or give rise to successive cell types resulting in the development of a spermatozoa.; The developmental process by which male germ line stem cells self renew or give rise to successive cell types resulting in the development of a spermatozoa.; The developmental process by which male germ line stem cells self renew or give rise to successive cell types resulting in the development of a spermatozoa.; The developmental process by which male germ line stem cells self renew or give rise to successive cell types resulting in the development of a spermatozoa.; UMLS Semantic Type: STY:T043",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess",
                    "biolink:BiologicalProcess"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "spermatogenesis",
                    "Spermatogenesis"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "GO:0007283",
                    "UMLS:C0037864",
                    "NCIT:C17161",
                    "MESH:D013091"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ISBN:9780878933846",
                    "PMID:30990821",
                    "PMID:28073824"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:PhysiologicalProcess",
                "biolink:NamedThing"
              ]
            },
            "MESH:D014664": {
              "name": "Vasodilation",
              "attributes": [
                {
                  "value": "http://id.nlm.nih.gov/mesh/D014664",
                  "value_url": "http://id.nlm.nih.gov/mesh/D014664",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Vasodilation involves widening of a blood vessel lumen due to smooth muscle relaxation in the vessel wall and leads to increased blood flow.; VASODILATION that is mediated via the ENDOTHELIUM-DEPENDENT RELAXING FACTORS or their processes.; An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure. [GOC:pr, ISBN:0192800981]; UMLS Semantic Type: STY:T042",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess",
                    "biolink:BiologicalProcess"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Vasodilation",
                    "vasodilation"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PSY:55380",
                    "NCIT:C40867",
                    "UMLS:C0042401",
                    "GO:0042311",
                    "MESH:D014664"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ISBN:0192800981"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:PhysiologicalProcess",
                "biolink:NamedThing"
              ]
            },
            "MESH:D014945": {
              "name": "Wound Healing",
              "attributes": [
                {
                  "value": "http://id.nlm.nih.gov/mesh/D014945",
                  "value_url": "http://id.nlm.nih.gov/mesh/D014945",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The series of events that restore integrity to a damaged tissue, following an injury. [GOC:bf, PMID:15269788]; The series of events that restore integrity to a damaged tissue, following an injury.; The series of events that restore integrity to a damaged tissue, following an injury.; The series of events that restore integrity to a damaged tissue, following an injury.; The series of events that restore integrity to a damaged tissue, following an injury.; UMLS Semantic Type: STY:T040",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess",
                    "biolink:BiologicalProcess"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Wound Healing",
                    "wound healing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MESH:D014945",
                    "GO:0042060",
                    "UMLS:C0043240"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15269788"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:PhysiologicalProcess",
                "biolink:NamedThing"
              ]
            },
            "MESH:D015539": {
              "name": "Platelet Activation",
              "attributes": [
                {
                  "value": "http://id.nlm.nih.gov/mesh/D015539",
                  "value_url": "http://id.nlm.nih.gov/mesh/D015539",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Platelet activation begins with the initial binding of adhesive ligands and of the excitatory platelet agonists (released or generated at the sites of vascular trauma) to cognate receptors on the platelet membrane (Ruggeri 2002). Intracellular signaling reactions then enhance the adhesive and procoagulant properties of tethered platelets or of platelets circulating in the proximity. Once platelets have adhered they degranulate, releasing stored secondary agents such as ADP, ATP, and synthesize thromboxane A2. These amplify the response, activating and recruiting further platelets to the area and promoting platelet aggregation. These amplify the response, activating and recruiting further platelets to the area and promoting platelet aggregation. Adenosine nucleotides signal through P2 purinergic receptors on the platelet membrane. ADP activates P2Y1 and P2Y12, which signal via  both the alpha and gamma:beta components of the heterotrimeric G-protein (Hirsch et al. 2001, 2006), while ATP activates the ionotropic P2X1 receptor (Kunapuli et al. 2003). Activation of these receptors initiates a complex signaling cascade that ultimately results in platelet activation, aggregation and thrombus formation (Kahner et al. 2006).  Integrin AlphaIIbBeta3 is the most abundant platelet receptor, with 40 000 to 80 000 copies per resting platelet, acting as a major receptor for fibrinogen and other adhesive molecules (Wagner et al. 1996). Activation of AlphaIIbBeta3 enhances adhesion and leads to platelet-platelet interactions, and thus aggregation (Philips et al. 1991). GP VI is the most potent collagen receptor initiating signal generation, an ability derived from its interaction with the FcRI gamma chain. This results in the phosphorylation of the gamma-chain by non-receptor tyrosine kinases of the Src family (1). The phosphotyrosine motif is recognized by the SH2 domains of Syk, a tyrosine kinase. This association activates the Syk enzyme, leading to activation (by tyrosine phosphorylation) of PLC gamma2 (2). Thrombin is an important platelet agonist generated on the membrane of stimulated platelets. Thrombin acts via cell surface Protease Activated Receptors (PARs). PARs are G-protein coupled receptors activated by a proteolytic cleavage in an extracellular loop (Vu, 1991) (3). Activated PARs signal via G alpha q (4) and via the beta:gamma component of the G-protein (5). Both stimulate PLC giving rise to PIP2 hydrolysis and consequent activation of PI3K (6). PLCgamma2 activation also gives rise to IP3 (7) which stimulates the IP3 receptor (8) leading to increased intracellular calcium. Platelet activation further results in the scramblase-mediated transport of negatively-charged phospholipids to the platelet surface. These phospholipids provide a catalytic surface (with the charge provided by phosphatidylserine and phosphatidylethanolamine) for the tenase complex (formed by the activated forms of the blood coagulation factors factor VIII and factor I).",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess",
                    "biolink:BiologicalProcess",
                    "biolink:Pathway"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Platelet activation, signaling and aggregation",
                    "Platelet activation",
                    "Adrenaline signalling through Alpha-2 adrenergic receptor",
                    "platelet activation",
                    "Platelet Activation",
                    "ADP signalling through P2Y purinoceptor 1",
                    "ADP signalling through P2Y purinoceptor 12"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-76002",
                    "UMLS:C0032173",
                    "REACT:R-HSA-392170",
                    "KEGG:04611",
                    "GO:0030168",
                    "NCIT:C40854",
                    "REACT:R-HSA-418592",
                    "REACT:R-HSA-392023",
                    "MESH:D015539"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17158345",
                    "PMID:18550847",
                    "PMID:20002545",
                    "PMID:22701130",
                    "PMID:16149014",
                    "PMID:16543958",
                    "PMID:23106920",
                    "PMID:19630797",
                    "PMID:18641368",
                    "PMID:2018971"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:PhysiologicalProcess",
                "biolink:NamedThing"
              ]
            },
            "RXNORM:10759": {
              "name": "TRIAMCINOLONE",
              "attributes": [
                {
                  "value": "http://purl.bioontology.org/ontology/RXNORM/10759",
                  "value_url": "http://purl.bioontology.org/ontology/RXNORM/10759",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. Upon cell entry, triamcinolone binds to and activates the glucocorticoid receptor, which leads to translocation of the ligand-receptor complex to the nucleus and induces expression of glucocorticoid-responsive genes such as lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes, both mediators of inflammation. In addition, pro-inflammatory cytokine production, including interleukin (IL)-1and IL-6, and the activation of cytotoxic T-lymphocytes is also inhibited. T-cells are prevented from making IL-2 and proliferating. This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis through increasing Ikappa-B expression and curtailing activation of nuclear factor (NF)kappa-B. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C901\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C901\" NCI Thesaurus); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Triamcinolone",
                    "triamcinolone"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ATC:S01BA05",
                    "ATC:A01AC01",
                    "ATC:D07XB02",
                    "ATC:H02AB08",
                    "PDQ:CDR0000039275",
                    "LOINC:LP35873-6",
                    "RXNORM:10759",
                    "LOINC:MTHU018764",
                    "ATC:C05AA12",
                    "ATC:R01AD11",
                    "ATC:R03BA06",
                    "NCIT:C901",
                    "ATC:D07AB09",
                    "VANDF:4017599"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "RXNORM:72260": {
              "name": "PERINDOPRIL ERBUMINE",
              "attributes": [
                {
                  "value": "http://purl.bioontology.org/ontology/RXNORM/72260",
                  "value_url": "http://purl.bioontology.org/ontology/RXNORM/72260",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The tert-butylamine salt of perindopril, the ethyl ester of a non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Upon hydrolysis, perindopril erbumine is converted to its active form perindoprilat, inhibiting ACE and the conversion of angiotensin I to angiotensin II; consequently, angiotensin II-mediated vasoconstriction and angiotensin II-stimulated aldosterone secretion from the adrenal cortex are inhibited and diuresis and natriuresis ensue. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47666\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47666\" NCI Thesaurus); The tert-butylamine salt of perindopril, the ethyl ester of a non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Upon hydrolysis, perindopril erbumine is converted to its active form perindoprilat, inhibiting ACE and the conversion of angiotensin I to angiotensin II; consequently, angiotensin II-mediated vasoconstriction and angiotensin II-stimulated aldosterone secretion from the adrenal cortex are inhibited and diuresis and natriuresis ensue.; An angiotensin-converting enzyme inhibitor. It is used in patients with hypertension and heart failure.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "perindopril erbumine",
                    "Perindopril Erbumine",
                    "Perindopril erbumine"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0244718",
                    "RXNORM:72260",
                    "PDQ:CDR0000660818",
                    "VANDF:4021180",
                    "NCIT:C47666",
                    "NDDF:004019"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "MONDO:0001210": {
              "name": "enophthalmos",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0001210",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0001210",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "An eye that is more deeply recessed into the plane of the face than is typical. [PMID:19125427]; An eye that is more deeply recessed into the plane of the face than is typical. // COMMENTS: This finding should be distinguished from a prominent supraorbital ridge or inferior orbital margin. In Deeply set eyes, the globe is recessed in comparison to the overall prominence of the face. There is no known objective measurement, and diagnosing this feature depends heavily on the experience of the observer.; An eye that is more deeply recessed into the plane of the face than is typical. // COMMENTS: This finding should be distinguished from a prominent supraorbital ridge or inferior orbital margin. In Deeply set eyes, the globe is recessed in comparison to the overall prominence of the face. There is no known objective measurement, and diagnosing this feature depends heavily on the experience of the observer.; UMLS Semantic Type: STY:T047; UMLS Semantic Type: STY:T033",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:DiseaseOrPhenotypicFeature",
                    "biolink:Disease",
                    "biolink:PhenotypicFeature",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "enophthalmos",
                    "Enophthalmos",
                    "Deeply set eye",
                    "Sunken eyes"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU034405",
                    "MESH:D015841",
                    "UMLS:C0014306",
                    "UMLS:C0423224",
                    "HP:0000490",
                    "MONDO:0001210",
                    "ICD9:376.5",
                    "OMIM:MTHU036831",
                    "NCIT:C79552",
                    "DOID:11175"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "https://orcid.org/0000-0002-6601-2165",
                    "PMID:19125427"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "MONDO:0001298": {
              "name": "congenital mitral valve insufficiency",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0001298",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0001298",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.; UMLS Semantic Type: STY:T046",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PathologicalProcess",
                    "biolink:Disease",
                    "biolink:DiseaseOrPhenotypicFeature",
                    "biolink:PhenotypicFeature",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Mitral Valve Insufficiency",
                    "mitral valve insufficiency",
                    "Mitral Valve Regurgitation",
                    "Mitral valve regurgitation",
                    "Mitral and aortic incompetence",
                    "Mitral valve insufficiency",
                    "Congenital mitral insufficiency",
                    "congenital mitral valve insufficiency",
                    "Mitral regurgitation",
                    "Congenital insufficiency of mitral valve",
                    "Mitral valve insufficiency and aortic valve insufficiency",
                    "Mitral regurgitation, mild"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:MTHU002341",
                    "OMIM:MTHU020244",
                    "ICD9:396.3",
                    "UMLS:C0158619",
                    "UMLS:C0026266",
                    "NCIT:C50852",
                    "DOID:11502",
                    "MESH:D008944",
                    "HP:0001653",
                    "NCIT:C50888",
                    "OMIM:MTHU038620",
                    "OMIM:MTHU008431",
                    "MONDO:0001298",
                    "UMLS:C0264774",
                    "ICD9:746.6",
                    "UMLS:C3551535"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "MONDO:0001384": {
              "name": "myopia",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0001384",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0001384",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The condition in which the individual does not see far distances clearly.; A refractive error in which rays of light entering the EYE parallel to the optic axis are brought to a focus in front of the RETINA when accommodation (ACCOMMODATION, OCULAR) is relaxed. This results from an overly curved CORNEA or from the eyeball being too long from front to back. It is also called nearsightedness.; An abnormality of refraction characterized by the ability to see objects nearby clearly, while objects in the distance appear blurry. [HPO:probinson]; UMLS Semantic Type: STY:T047",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Disease",
                    "biolink:NamedThing",
                    "biolink:PhenotypicFeature"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "obsolete_myopia",
                    "Myopia",
                    "myopia"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0027092",
                    "ICD9:367.1",
                    "HP:0000545",
                    "NCIT:C102533",
                    "EFO:0003927",
                    "MONDO:0001384",
                    "DOID:11830",
                    "PSY:32850",
                    "OMIM:MTHU036427",
                    "MESH:D009216"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "https://orcid.org/0000-0002-6601-2165",
                    "http://en.wikipedia.org/wiki/myopia",
                    "http://ghr.nlm.nih.gov/glossary=myopia",
                    "http://www.mayoclinic.org/diseases-conditions/nearsightedness/basics/definition/con-20027548"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "MONDO:0002076": {
              "name": "pneumothorax",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0002076",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0002076",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Accumulation of air in the pleural cavity leading to a partially or completely collapsed lung. [HPO:probinson]; Accumulation of air in the pleural cavity leading to a partially or completely collapsed lung.; Accumulation of air in the pleural cavity leading to a partially or completely collapsed lung.; Accumulation of air in the pleural cavity leading to a partially or completely collapsed lung.; UMLS Semantic Type: STY:T047",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Disease",
                    "biolink:NamedThing",
                    "biolink:PhenotypicFeature"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Pneumothorax",
                    "pneumothorax",
                    "Tension Pneumothorax"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "LOINC:LA7466-1",
                    "MONDO:0002076",
                    "UMLS:C0029850",
                    "OMIM:MTHU016219",
                    "UMLS:C0032326",
                    "HP:0002107",
                    "UMLS:C0264558",
                    "MESH:D011030",
                    "DOID:1673",
                    "NCIT:C38006"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "https://orcid.org/0000-0002-6601-2165",
                    "https://medlineplus.gov/ency/article/000087.htm",
                    "https://en.wikipedia.org/wiki/pneumothorax"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "MONDO:0004910": {
              "name": "mitral valve prolapse",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0004910",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0004910",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A fairly common and often benign valvular heart disorder characterized by redundancy or hooding of mitral valve leaflets so that they prolapse into the left atrium, often causing mitral regurgitation. It is often a symptomless condition but may be marked by varied symptoms (e.g. chest pain, fatigue, dizziness, dyspnea, or palpitations) leading in some cases to endocarditis or ventricular tachycardia.; Abnormal protrusion or billowing of one or both of the leaflets of MITRAL VALVE into the LEFT ATRIUM during SYSTOLE. This allows the backflow of blood into left atrium leading to MITRAL VALVE INSUFFICIENCY; SYSTOLIC MURMURS; or CARDIAC ARRHYTHMIA.; One or both of the leaflets (cusps) of the mitral valve bulges back into the left atrium upon contraction of the left ventricle. [HPO:probinson]",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Disease",
                    "biolink:PhenotypicFeature",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Mitral valve prolapse",
                    "Mitral Valve Prolapse Syndrome",
                    "Mitral Valve Prolapse",
                    "mitral valve prolapse"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C50655",
                    "DOID:988",
                    "MESH:D008945",
                    "HP:0001634",
                    "UMLS:C0026267",
                    "MONDO:0004910",
                    "OMIM:MTHU001468"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "http://ghr.nlm.nih.gov/glossary=mitralvalveprolapse",
                    "https://orcid.org/0000-0002-6601-2165",
                    "https://www.rarediseases.org/rare-disease-information/rare-diseases/byid/564/viewabstract",
                    "http://www.merckmanuals.com/professional/cardiovascular_disorders/valvular_disorders/mitral_valve_prolapse_mvp.htm",
                    "http://en.wikipedia.org/wiki/mitral_valve_prolapse"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "MONDO:0005009": {
              "name": "congestive heart failure",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0005009",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0005009",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The presence of an abnormality of cardiac function that is responsible for the failure of the heart to pump blood at a rate that is commensurate with the needs of the tissues or a state in which abnormally elevated filling pressures are required for the heart to do so. Heart failure is frequently related to a defect in myocardial contraction. [HPO:probinson]; The presence of an abnormality of cardiac function that is responsible for the failure of the heart to pump blood at a rate that is commensurate with the needs of the tissues or a state in which abnormally elevated filling pressures are required for the heart to do so. Heart failure is frequently related to a defect in myocardial contraction.; The presence of an abnormality of cardiac function that is responsible for the failure of the heart to pump blood at a rate that is commensurate with the needs of the tissues or a state in which abnormally elevated filling pressures are required for the heart to do so. Heart failure is frequently related to a defect in myocardial contraction.; The presence of an abnormality of cardiac function that is responsible for the failure of the heart to pump blood at a rate that is commensurate with the needs of the tissues or a state in which abnormally elevated filling pressures are required for the heart to do so. Heart failure is frequently related to a defect in myocardial contraction.; UMLS Semantic Type: STY:T047",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PathologicalProcess",
                    "biolink:Disease",
                    "biolink:BiologicalEntity",
                    "biolink:PhenotypicFeature",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "congestive heart failure",
                    "Congestive heart failure, unspecified",
                    "Heart failure",
                    "Left Ventricular Dysfunction",
                    "Ventricular Dysfunction, Left",
                    "Left ventricular failure",
                    "Left ventricular dysfunction",
                    "Congestive heart failure",
                    "Heart Decompensation",
                    "Congestive Heart Failure",
                    "heart failure",
                    "Left Ventricular Failure",
                    "Myocardial Failure",
                    "Heart Failure",
                    "Left-Sided Heart Failure"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "EFO:0003144",
                    "DOID:6000",
                    "OMIM:MTHU036737",
                    "UMLS:C0018801",
                    "HP:0005162",
                    "HP:0001635",
                    "LOINC:LP269421-6",
                    "MESH:D018487",
                    "NCIT:C50630",
                    "MESH:D006333",
                    "LOINC:MTHU020787",
                    "UMLS:C0023212",
                    "UMLS:C1961112",
                    "NCIT:C3080",
                    "UMLS:C0018802",
                    "SYMP:0000292",
                    "NCIT:C50577",
                    "MONDO:0005252",
                    "NCIT:C50629",
                    "OMIM:MTHU009472",
                    "PDQ:CDR0000038915",
                    "UMLS:C1959583",
                    "EFO:0000373",
                    "OMIM:MTHU044064",
                    "OMIM:MTHU005753",
                    "UMLS:C0242698",
                    "ICD9:428",
                    "MONDO:0005009",
                    "ICD9:428.0"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "http://www.heart.org/heartorg/conditions/heartfailure/aboutheartfailure/types-of-heart-failure_ucm_306323_article.jsp#.wmekyjm-dl4",
                    "PMID:10956313",
                    "https://en.wikipedia.org/wiki/heart_failure",
                    "http://en.wikipedia.org/wiki/heart_disease"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "MONDO:0005392": {
              "name": "scoliosis",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0005392",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0005392",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A congenital or acquired spinal deformity characterized by lateral curvature of the spine.; An appreciable lateral deviation in the normally straight vertical line of the spine. (Dorland, 27th ed); The presence of an abnormal lateral curvature of the spine. [HPO:probinson]; Scoliosis causes a sideways curve of your backbone, or spine. These curves are often S- or C-shaped. Scoliosis is most common in late childhood and the early teens, when children grow fast. Girls are more likely to have it than boys. It can run in families. Symptoms include leaning to one side and having uneven shoulders and hips. Sometimes it is easy to notice, but not always. Children may get screening for scoliosis at school or during a checkup. If it looks like there is a problem, your doctor will use your medical and family history, a physical exam, and imaging tests to make a diagnosis. Treatment depends on your age, how much more you're likely to grow, how much curving there is, and whether the curve is temporary or permanent. People with mild scoliosis might only need checkups to see if the curve is getting worse. Others might need to wear a brace or have surgery.  NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases; UMLS Semantic Type: STY:T047; UMLS Semantic Type: STY:T047",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:DiseaseOrPhenotypicFeature",
                    "biolink:Disease",
                    "biolink:PhenotypicFeature",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Acquired scoliosis",
                    "Scoliosis",
                    "scoliosis",
                    "Spinal Curvatures",
                    "Curvature of spine"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "EFO:0004273",
                    "MESH:D013121",
                    "MONDO:0005392",
                    "MESH:D012600",
                    "UMLS:C0036439",
                    "DOID:0060249",
                    "UMLS:C0037932",
                    "LOINC:LA22278-8",
                    "LOINC:LP266363-3",
                    "UMLS:C0700208",
                    "HP:0002650",
                    "ICD9:737",
                    "OMIM:MTHU000036",
                    "NCIT:C78603"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "http://en.wikipedia.org/wiki/scoliosis",
                    "http://www.mayoclinic.org/diseases-conditions/scoliosis/basics/definition/con-20030140"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "MONDO:0005648": {
              "name": "aortic valve insufficiency",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0005648",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0005648",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Dysfunction of the aortic valve characterized by incomplete valve closure.; The backward flow of blood from the aorta into the left ventricle, owing to insufficiency of the aortic semilunar valve; it may be chronic or acute.; Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).; An insufficiency of the aortic valve, leading to regurgitation (backward flow) of blood from the aorta into the left ventricle. [HPO:probinson]; UMLS Semantic Type: STY:T047",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Disease",
                    "biolink:PhenotypicFeature",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Aortic Valve Insufficiency",
                    "Rheumatic aortic insufficiency",
                    "Aortic valve regurgitation",
                    "aortic valve insufficiency",
                    "Aortic regurgitation",
                    "Rheumatic aortic regurgitation",
                    "Aortic valve insufficiency",
                    "Aortic Valve Regurgitation"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C51223",
                    "DOID:57",
                    "OMIM:MTHU001469",
                    "UMLS:C0155568",
                    "ICD9:395.1",
                    "OMIM:MTHU024258",
                    "UMLS:C0003504",
                    "MESH:D001022",
                    "EFO:0007148",
                    "OMIM:MTHU035286",
                    "NCIT:C50861",
                    "MONDO:0005648",
                    "HP:0001659"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "http://en.wikipedia.org/wiki/aortic_insufficiency"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "MONDO:0007947": {
              "name": "Marfan syndrome",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0007947",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0007947",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A genetic syndrome inherited as an autosomal dominant trait. It is caused by mutations in the FBN1 gene. It is characterized by tall stature, elongated extremities, mitral valve prolapse, aortic dilatation, aortic dissection, and subluxation of the lens.; An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome is associated with mutations in the gene encoding fibrillin, a major element of extracellular microfibrils of connective tissue.; Marfan syndrome; Marfan syndrome is a disorder that affects connective tissue. Connective tissues are proteins that support skin, bones, blood vessels, and other organs. One of these proteins is fibrillin. A problem with the fibrillin gene causes Marfan syndrome.  Marfan syndrome can be mild to severe, and the symptoms can vary. People with Marfan syndrome are often very tall, thin, and loose jointed. Most people with Marfan syndrome have heart and blood vessel problems, such as a weakness in the aorta or heart valves that leak. They may also have problems with their bones, eyes, skin, nervous system, and lungs. There is no single test to diagnose Marfan syndrome. Your doctor may use your medical history, family history, and a physical exam to diagnose it. Marfan syndrome has no cure, but treatments can help delay or prevent complications. Treatments include medicines, surgery, and other therapies. NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases; UMLS Semantic Type: STY:T047; UMLS Semantic Type: STY:T047; UMLS Semantic Type: STY:T047",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Disease",
                    "biolink:PhenotypicFeature"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Marfan syndrome related phenotypic feature",
                    "Marfan Syndrome, Type I",
                    "Marfan Syndrome",
                    "Marfan syndrome",
                    "Marfan syndrome type 1"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOID:14323",
                    "OMIM:154700",
                    "ORPHANET:558",
                    "LOINC:LA29643-6",
                    "ICD9:759.82",
                    "UMLS:C0024796",
                    "MESH:D008382",
                    "NCIT:C34807",
                    "MONDO:0007947",
                    "UMLS:C4721845",
                    "ORPHANET:284963"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "https://rarediseases.info.nih.gov/diseases/6975/marfan-syndrome",
                    "https://ghr.nlm.nih.gov/condition/marfan-syndrome#inheritance",
                    "https://ncit.nci.nih.gov/ncitbrowser/conceptreport.jsp?dictionary=nci_thesaurus&version=16.12d&ns=nci_thesaurus&code=c34807",
                    "https://rarediseases.org/rare-diseases/marfan-syndrome/"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:DiseaseOrPhenotypicFeature",
                "biolink:PhenotypicFeature",
                "biolink:NamedThing",
                "biolink:BiologicalEntity",
                "biolink:Disease",
                "biolink:ThingWithTaxon"
              ]
            },
            "MONDO:0008213": {
              "name": "pectus excavatum",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0008213",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0008213",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A defect of the chest wall characterized by a depression of the sternum, giving the chest (pectus\") a caved-in (\"excavatum\") appearance.\" [HPO:probinson]; UMLS Semantic Type: STY:T190",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Disease",
                    "biolink:PhenotypicFeature",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Pectus excavatum related phenotypic feature",
                    "Congenital pectus excavatum",
                    "pectus excavatum",
                    "Funnel chest",
                    "Funnel Chest",
                    "Pectus excavatum"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0016842",
                    "OMIM:169300",
                    "HP:0000767",
                    "OMIM:MTHU000191",
                    "MONDO:0008213",
                    "MESH:D005660",
                    "ICD9:754.81",
                    "UMLS:C2051831",
                    "OMIM:MTHU010439"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "https://orcid.org/0000-0002-6601-2165"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "MONDO:0008375": {
              "name": "retinal detachment",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0008375",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0008375",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "An eye emergency condition which may lead to blindness if left untreated. It is characterized by the separation of the inner retina layers from the underlying pigment epithelium. Causes include trauma, advanced diabetes mellitus, high myopia, and choroid tumors. Symptoms include sudden appearance of floaters, sudden light flushes, and blurred vision.; Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).; Separation of the inner layers of the retina (neural retina) from the pigment epithelium. [HPO:probinson]; The retina is a layer of tissue in the back of your eye that senses light and sends images to your brain. It provides the sharp, central vision needed for reading, driving, and seeing fine detail. A retinal detachment lifts or pulls the retina from its normal position. It can occur at any age, but it is more common in people over age 40. It affects men more than women and whites more than African Americans. A retinal detachment is also more likely to occur in people who  Are extremely nearsighted Have had a retinal detachment in the other eye Have a family history of retinal detachment Have had cataract surgery Have other eye diseases or disorders Have had an eye injury  Symptoms include an increase in the number of floaters, which are little \"cobwebs\" or specks that float about in your field of vision, and/or light flashes in the eye. It may also seem like there is a \"curtain\" over your field of vision. A retinal detachment is a medical emergency. If not promptly treated, it can cause permanent vision loss. If you have any symptoms, see an eye care professional immediately. Treatment includes different types of surgery. NIH: National Eye Institute; UMLS Semantic Type: STY:T047",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Disease",
                    "biolink:PhenotypicFeature",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Retinal detachment",
                    "Retinal Pigment Epithelial Detachment",
                    "Unspecified retinal detachment",
                    "retinal detachment",
                    "Separation of retinal layers",
                    "Retinal detachment related phenotypic feature",
                    "Retinal Detachment"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0339546",
                    "MESH:D012163",
                    "HP:0000541",
                    "OMIM:MTHU000607",
                    "ICD9:361.9",
                    "ICD9:362.4",
                    "OMIM:180050",
                    "EFO:0005773",
                    "LOINC:LA24876-7",
                    "UMLS:C0035305",
                    "NCIT:C26874",
                    "MONDO:0008375",
                    "DOID:5327",
                    "UMLS:C0154844"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "MONDO:0008475": {
              "name": "spondylolisthesis",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/MONDO_0008475",
                  "value_url": "http://purl.obolibrary.org/obo/MONDO_0008475",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A condition in which there is forward displacement of a vertebral bone over the on below it.; Forward displacement of a superior vertebral body over the vertebral body below.; Complete bilateral fractures of the pars interarticularis resulting in the anterior slippage of the vertebra. [HPO:probinson, PMID:20411054]; UMLS Semantic Type: STY:T047; UMLS Semantic Type: STY:T047",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Disease",
                    "biolink:PhenotypicFeature",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "spondylolisthesis",
                    "Spondylolisthesis",
                    "Spondylolisthesis related phenotypic feature"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MONDO:0008475",
                    "HP:0003302",
                    "ICD9:756.12",
                    "OMIM:184200",
                    "MESH:D013168",
                    "DOID:6682",
                    "OMIM:MTHU009825",
                    "UMLS:C0038016",
                    "EFO:0007493",
                    "NCIT:C35033"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "http://en.wikipedia.org/wiki/spondylolisthesis",
                    "http://www.umm.edu/spinecenter/education/spondylolysis_spondylolisthesis.htm",
                    "https://orcid.org/0000-0002-6601-2165",
                    "PMID:20411054",
                    "http://www.nlm.nih.gov/medlineplus/ency/article/001260.htm"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Disease",
                "biolink:NamedThing"
              ]
            },
            "RXNORM:235758": {
              "name": "BENAZEPRIL HYDROCHLORIDE",
              "attributes": [
                {
                  "value": "http://purl.bioontology.org/ontology/RXNORM/235758",
                  "value_url": "http://purl.bioontology.org/ontology/RXNORM/235758",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The hydrochloride salt of benazepril, a carboxyl-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, benazepril is metabolized to its active form benazeprilat. Benazeprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II, resulting in vasodilation. Benazeprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C28862\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C28862\" NCI Thesaurus); The hydrochloride salt of benazepril, a carboxyl-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, benazepril is metabolized to its active form benazeprilat. Benazeprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II, resulting in vasodilation. Benazeprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Benazepril hydrochloride",
                    "benazepril hydrochloride",
                    "Benazepril Hydrochloride"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0770917",
                    "RXNORM:235758",
                    "VANDF:4020025",
                    "PDQ:CDR0000686949",
                    "NCIT:C28862"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "UMLS:C0007412": {
              "name": "Catecholamines",
              "attributes": [
                {
                  "value": "https://identifiers.org/umls:C0007412",
                  "value_url": "https://identifiers.org/umls:C0007412",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A group of sympathetic amines containing a catechol group derived from the amino acid tyrosine. Catecholamines are hormones and neuromodulators synthesized in the chromaffin cells of the adrenal glands and the postganglionic fibers of the sympathetic nervous system in response to stress. Examples of catecholamines are epinephrine (adrenaline), norepinephrine (noradrenaline) and dopamine, all of which participate in a wide variety of functions throughout the body.; A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T121",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Catecholamines"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "LOINC:MTHU003446",
                    "LOINC:LP15090-1",
                    "PSY:07920",
                    "UMLS:C0007412"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:ChemicalEntity",
                "biolink:NamedThing"
              ]
            },
            "UMLS:C0011065": {
              "name": "Cessation of life",
              "attributes": [
                {
                  "value": "https://identifiers.org/umls:C0011065",
                  "value_url": "https://identifiers.org/umls:C0011065",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The cessation of life.; Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.; UMLS Semantic Type: STY:T040",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Cessation of life"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0011065"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:PhysiologicalProcess",
                "biolink:NamedThing"
              ]
            },
            "UMLS:C0039005": {
              "name": "Family suidae",
              "attributes": [
                {
                  "value": "https://identifiers.org/umls:C0039005",
                  "value_url": "https://identifiers.org/umls:C0039005",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Taxonomic family which includes the domestic pig.; Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA).; UMLS Semantic Type: STY:T015",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:OrganismTaxon"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Family suidae"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0039005"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:OrganismTaxon",
                "biolink:NamedThing"
              ]
            },
            "UMLS:C0085826": {
              "name": "Antiplatelet Agents",
              "attributes": [
                {
                  "value": "https://identifiers.org/umls:C0085826",
                  "value_url": "https://identifiers.org/umls:C0085826",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "An agent that inhibits platelet aggregation and reduces coagulation in the circulatory system.; Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Antiplatelet Agents",
                    "Antiplatelet agents"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0085826",
                    "LOINC:LP31458-0"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "UMLS:C0232164": {
              "name": "Cardiac function",
              "attributes": [
                {
                  "value": "https://identifiers.org/umls:C0232164",
                  "value_url": "https://identifiers.org/umls:C0232164",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "UMLS Semantic Type: STY:T042",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Cardiac function"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0232164"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:PhysiologicalProcess",
                "biolink:NamedThing"
              ]
            },
            "UMLS:C0232804": {
              "name": "Renal function",
              "attributes": [
                {
                  "value": "https://identifiers.org/umls:C0232804",
                  "value_url": "https://identifiers.org/umls:C0232804",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "UMLS Semantic Type: STY:T042",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Renal function"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "LOINC:LP31398-8",
                    "UMLS:C0232804"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:PhysiologicalProcess",
                "biolink:NamedThing"
              ]
            },
            "UMLS:C0279328": {
              "name": "Hyperbaric Oxygen (substance)",
              "attributes": [
                {
                  "value": "https://identifiers.org/umls:C0279328",
                  "value_url": "https://identifiers.org/umls:C0279328",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Oxygen that is administered at a higher pressure compared to standard (i.e. sea-level) atmospheric pressure. Administration of oxygen under hyperbaric conditions enhances the delivery of oxygen to hypoxic tumor cells, thereby increasing their sensitivity to radiation and chemotherapy. In addition, hyperbaric oxygen may improve the healing of radiation-induced injuries by improving oxygen delivery to damaged tissue. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2351\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2351\" NCI Thesaurus); Oxygen that is administered at a higher pressure compared to standard (i.e. sea-level) atmospheric pressure. Administration of oxygen under hyperbaric conditions enhances the delivery of oxygen to hypoxic tumor cells, thereby increasing their sensitivity to radiation and chemotherapy. In addition, hyperbaric oxygen may improve the healing of radiation-induced injuries by improving oxygen delivery to damaged tissue. (NCI04); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T121",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Hyperbaric Oxygen (substance)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0279328"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "UMLS:C0302600": {
              "name": "Angiogenic Process",
              "attributes": [
                {
                  "value": "https://identifiers.org/umls:C0302600",
                  "value_url": "https://identifiers.org/umls:C0302600",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A process that results in the development of new blood vessels.; Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. [ISBN:0878932453]; UMLS Semantic Type: STY:T042",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess",
                    "biolink:BiologicalProcess"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Angiogenic Process"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0302600",
                    "NCIT:C17932"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ISBN:0878932453"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:PhysiologicalProcess",
                "biolink:NamedThing"
              ]
            },
            "UMLS:C0597357": {
              "name": "receptor",
              "attributes": [
                {
                  "value": "https://identifiers.org/umls:C0597357",
                  "value_url": "https://identifiers.org/umls:C0597357",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A protein located on the cell surface, or in the cytoplasm, that binds to a specific signaling factor, such as a hormone, antigen, or neurotransmitter, causing a conformational and functional change in the receptor molecule. The ligand-bound receptor then alters its interaction with target molecules, which leads to changes in cellular physiology through modification of the activity of one or more signal transduction pathways.; UMLS Semantic Type: STY:T192; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Polypeptide",
                    "biolink:Protein"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Receptor",
                    "receptor"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "LOINC:LP21071-3",
                    "STY:T192",
                    "UMLS:C0597357",
                    "NCIT:C18106"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Polypeptide",
                "biolink:NamedThing"
              ]
            },
            "UMLS:C0600520": {
              "name": "Left Ventricle Remodeling",
              "attributes": [
                {
                  "value": "https://identifiers.org/umls:C0600520",
                  "value_url": "https://identifiers.org/umls:C0600520",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The geometric and structural changes that the HEART VENTRICLES undergo, usually following MYOCARDIAL INFARCTION. It comprises expansion of the infarct and dilatation of the healthy ventricle segments. While most prevalent in the left ventricle, it can also occur in the right ventricle.; UMLS Semantic Type: STY:T042",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:PhysiologicalProcess"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Left Ventricle Remodeling"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0600520"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:PhysiologicalProcess",
                "biolink:NamedThing"
              ]
            },
            "VANDF:4021557": {
              "name": "Anticoagulants",
              "attributes": [
                {
                  "value": "http://purl.bioontology.org/ontology/VANDF/4021557",
                  "value_url": "http://purl.bioontology.org/ontology/VANDF/4021557",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Any agent capable of preventing blood clot formation.; Agents that prevent BLOOD CLOTTING.; UMLS Semantic Type: STY:T121",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Anticoagulants",
                    "anticoagulant",
                    "Anticoagulant"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "LOINC:LP20761-0",
                    "MESH:D000925",
                    "LOINC:LP232085-3",
                    "LOINC:LA30298-6",
                    "VANDF:4021557",
                    "CHEBI:50249",
                    "UMLS:C0003280"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "VANDF:4021566": {
              "name": "Calcium channel blockers",
              "attributes": [
                {
                  "value": "http://purl.bioontology.org/ontology/VANDF/4021566",
                  "value_url": "http://purl.bioontology.org/ontology/VANDF/4021566",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A pharmaceutical agent that inhibits the movement of calcium across through calcium channels in the cell membrane, preventing or decreasing the amount of calcium able to enter the cell. These drugs are used for their chronotropic, antihypertensive and vasodilatory effects.; A class of drugs that act by selective inhibition of calcium influx through cellular membranes.; UMLS Semantic Type: STY:T121",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:Drug",
                    "biolink:BiologicalEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Calcium Channel Blockers",
                    "calcium channel blocker",
                    "Calcium Channel Blocker",
                    "Calcium channel blockers"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C333",
                    "CHEBI:38215",
                    "ATC:C08",
                    "PSY:07250",
                    "VANDF:4021566",
                    "UMLS:C0006684",
                    "LOINC:LP31438-2",
                    "MESH:D002121"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Drug",
                "biolink:NamedThing"
              ]
            },
            "UBERON:0000178": {
              "name": "blood",
              "attributes": [
                {
                  "value": "http://purl.obolibrary.org/obo/UBERON_0000178",
                  "value_url": "http://purl.obolibrary.org/obo/UBERON_0000178",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.; Portion of body substance which has as its parts plasma and blood cells.; Your blood is made up of liquid and solids. The liquid part, called plasma, is made of water, salts, and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells, and platelets. Red blood cells (RBC) deliver oxygen from your lungs to your tissues and organs. White blood cells (WBC) fight infection and are part of your immune system. Platelets help blood to clot when you have a cut or wound. Bone marrow, the spongy material inside your bones, makes new blood cells. Blood cells constantly die and your body makes new ones. Red blood cells live about 120 days, and platelets live about 6 days. Some white blood cells live less than a day, but others live much longer. There are four blood types: A, B, AB, or O. Also, blood is either Rh-positive or Rh-negative. So if you have type A blood, it's either A positive or A negative. Which type you are is important if you need a blood transfusion. And your Rh factor could be important if you become pregnant - an incompatibility between your type and the baby's could create problems.  Blood tests such as blood count tests help doctors check for certain diseases and conditions. They also help check the function of your organs and show how well treatments are working. Problems with your blood may include bleeding disorders, excessive clotting and platelet disorders. If you lose too much blood, you may need a transfusion. NIH: National Heart, Lung, and Blood Institute; UMLS Semantic Type: STY:T031; UMLS Semantic Type: STY:T031",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:AnatomicalEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Blood",
                    "blood"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MESH:Q000097",
                    "MESH:D001769",
                    "LOINC:LA17759-4",
                    "LOINC:MTHU029981",
                    "UBERON:0000178",
                    "CHEMBL.TARGET:CHEMBL613615",
                    "LOINC:LP71680-0",
                    "CHEMBL.TARGET:CHEMBL613444",
                    "PSY:06200",
                    "CHEMBL.TARGET:CHEMBL613416",
                    "CHEMBL.TARGET:CHEMBL4296529",
                    "CHEMBL.TARGET:CHEMBL613408",
                    "CHEMBL.TARGET:CHEMBL613397",
                    "EHDAA2:0000176",
                    "CHEMBL.TARGET:CHEMBL613561",
                    "UMLS:C0005767",
                    "NCIT:C12434"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "https://github.com/obophenotype/uberon/issues/9",
                    "http://en.wikipedia.org/wiki/blood",
                    "http://orcid.org/0000-0002-6601-2165"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:AnatomicalEntity",
                "biolink:NamedThing"
              ]
            },
            "DRUGBANK:DB06205": {
              "name": "Vorhyaluronidase alfa",
              "attributes": [
                {
                  "value": "https://identifiers.org/drugbank:DB06205",
                  "value_url": "https://identifiers.org/drugbank:DB06205",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A human recombinant form of the naturally occurring human enzyme hyaluronidase with potential chemoadjuvant activity. Upon local administration, recombinant human hyaluronidase hydrolyzes hyaluronic acid, a glucosaminoglycan responsible for the viscosity of the interstitial barrier. The digestion of hyaluronic acid lowers the viscosity in the interstitial space, thereby increasing permeability and facilitating local penetration of chemotherapeutic agents into cancer cells. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C61504\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61504\" NCI Thesaurus); A human recombinant form of the naturally occurring human enzyme hyaluronidase with potential chemoadjuvant activity. Upon local administration, recombinant human hyaluronidase hydrolyzes hyaluronic acid, a glucosaminoglycan responsible for the viscosity of the interstitial barrier. The digestion of hyaluronic acid lowers the viscosity in the interstitial space, thereby increasing permeability and facilitating local penetration of chemotherapeutic agents into cancer cells.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:ChemicalEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "hyaluronidase-oysk",
                    "Vorhyaluronidase alfa",
                    "hyaluronidase, human recombinant",
                    "Hylenex",
                    "Chemophase",
                    "Hyaluronidase-oysk"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C4764383",
                    "UMLS:C1699394",
                    "VANDF:4038411",
                    "DRUGBANK:DB06205",
                    "RXNORM:1300478",
                    "NDDF:011274",
                    "RXNORM:2119708",
                    "UMLS:C1720035",
                    "UMLS:C1831846",
                    "RXNORM:615870"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17683255",
                    "PMID:16876899"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:ChemicalEntity",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P00441": {
              "name": "SOD1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P00441",
                  "value_url": "https://identifiers.org/uniprot:P00441",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Superoxide dismutase [Cu-Zn] (154 aa, ~16 kDa) is encoded by the human SOD1 gene. This protein is involved in the conversion of superoxides into oxygen and hydrogen peroxide.; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "SOD1 [cytosol]",
                    "Sod1 (mouse)",
                    "SOD1 gene [nucleoplasm]",
                    "SOD1 Gene",
                    "2xHC-SOD1 [cytosol]",
                    "SOD1 [mitochondrial intermembrane space]",
                    "Sod1 (rat)",
                    "SOD1",
                    "SOD1 (human)",
                    "Cu-Zn Superoxide Dismutase",
                    "superoxide dismutase [Cu-Zn] (zebrafish)",
                    "superoxide dismutase [Cu-Zn] (yeast)",
                    "superoxide dismutase [Cu-Zn] (human)",
                    "SOD1 [extracellular region]",
                    "superoxide dismutase [Cu-Zn] (Schizosaccharomyces pombe 972h-)",
                    "superoxide dismutase [Cu-Zn] (mouse)",
                    "superoxide dismutase [Cu-Zn] (chicken)",
                    "2xHC-SOD1 [mitochondrial intermembrane space]",
                    "superoxide dismutase [Cu-Zn] (rat)",
                    "SOD1 gene",
                    "superoxide dismutase [Cu-Zn] (fruit fly)",
                    "SOD1 (chicken)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PR:P61851",
                    "REACT:R-HSA-8950473",
                    "REACT:R-HSA-3777108",
                    "UniProtKB:P00441",
                    "OMIM:147450",
                    "PR:P00445",
                    "REACT:R-HSA-350697",
                    "RGD:3731",
                    "ENSEMBL:LRG_652",
                    "MGI:98351",
                    "NCIT:C54578",
                    "REACT:R-HSA-350705",
                    "NCBIGene:395938",
                    "UMLS:C0010461",
                    "UMLS:C1420306",
                    "REACT:R-HSA-3299726",
                    "PR:P08228",
                    "LOINC:LP35626-8",
                    "ENSEMBL:ENSG00000142168",
                    "PR:P28758",
                    "PR:P80566",
                    "PR:O73872",
                    "NCBIGene:6647",
                    "PR:P07632",
                    "HGNC:11179",
                    "REACT:R-HSA-3777082",
                    "PR:P00441"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1006/bbrc.1994.2497",
                    "DOI:10.1093/hmg/3.4.649",
                    "PMID:15326189",
                    "DOI:10.1161/circresaha.112.269514",
                    "PMID:17888947",
                    "PMID:8938700",
                    "DOI:10.1136/jmg.32.11.841",
                    "PMID:8332197",
                    "PMID:12145308",
                    "DOI:10.1007/s004390050157"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P01019": {
              "name": "AGT",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P01019",
                  "value_url": "https://identifiers.org/uniprot:P01019",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Angiotensinogen (485 aa, ~53 kDa) is encoded by the human AGT gene. This protein plays a role in the regulation of blood pressure, body fluid and electrolyte homeostasis.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "AGT Gene",
                    "AGT(34-43) [extracellular region]",
                    "Angiotensin-1, human",
                    "AGT(36-41) [extracellular region]",
                    "Agt (rat)",
                    "AGT gene [nucleoplasm]",
                    "AGT(36-41) [cytosol]",
                    "AGT",
                    "angiotensinogen (human)",
                    "AGT(34-42) [extracellular region]",
                    "AGT [extracellular region]",
                    "AGT(35-41) [extracellular region]",
                    "AGT (human)",
                    "AGT protein, human",
                    "Angiotensin-2, Human",
                    "AGT gene",
                    "AGT(34-40) [extracellular region]",
                    "AGT(34-41) [extracellular region]",
                    "serine--glyoxylate aminotransferase (Arabidopsis thaliana)",
                    "Agt (mouse)",
                    "angiotensinogen (rat)",
                    "AGT(35-41) [cytosol]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-2022346",
                    "HGNC:333",
                    "REACT:R-HSA-2022355",
                    "REACT:R-HSA-5649924",
                    "REACT:R-HSA-8852195",
                    "REACT:R-HSA-2022351",
                    "UMLS:C3714928",
                    "REACT:R-HSA-374187",
                    "RGD:2069",
                    "ENSEMBL:ENSG00000135744",
                    "UMLS:C1366631",
                    "PR:Q56YA5",
                    "REACT:R-HSA-2022354",
                    "REACT:R-HSA-1998759",
                    "UMLS:C4521302",
                    "REACT:R-HSA-8852193",
                    "PR:P01015",
                    "UniProtKB:P01019",
                    "REACT:R-HSA-2022348",
                    "MESH:C534931",
                    "UMLS:C2713666",
                    "NCIT:C38185",
                    "PR:P01019",
                    "OMIM:106150",
                    "MGI:87963",
                    "NCBIGene:183"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19159218",
                    "DOI:10.1161/01.res.36.6.38",
                    "PMID:3579322",
                    "DOI:10.1046/j.1432-1327.1998.2510448.x",
                    "DOI:10.1038/ng0593-59",
                    "DOI:10.1007/bf00214197",
                    "PMID:9492317",
                    "PMID:10969042",
                    "PMID:1692023",
                    "DOI:10.1074/jbc.m200581200"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P01100": {
              "name": "FOS",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P01100",
                  "value_url": "https://identifiers.org/uniprot:P01100",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Cellular DNA-binding proteins encoded by the c-fos genes (GENES, FOS). They are involved in growth-related transcriptional control. c-fos combines with c-jun (PROTO-ONCOGENE PROTEINS C-JUN) to form a c-fos/c-jun heterodimer (TRANSCRIPTION FACTOR AP-1) that binds to the TRE (TPA-responsive element) in promoters of certain genes.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "p-T325,T331,S362,S374-FOS [nucleoplasm]",
                    "proto-oncogene c-Fos (chicken)",
                    "FOS Gene",
                    "Fos (mouse)",
                    "FOS [nucleoplasm]",
                    "Fos (rat)",
                    "FOS",
                    "proto-oncogene c-Fos (mouse)",
                    "FOS gene",
                    "proto-oncogene c-Fos (rat)",
                    "FOS gene [nucleoplasm]",
                    "proto-oncogene c-Fos (human)",
                    "Proto-Oncogene Proteins c-fos",
                    "Proto-Oncogene c-Fos, human",
                    "FOS (human)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-450216",
                    "REACT:R-HSA-8948462",
                    "PR:P11939",
                    "REACT:R-HSA-450283",
                    "UMLS:C0085301",
                    "HGNC:3796",
                    "PR:P12841",
                    "OMIM:164810",
                    "NCBIGene:2353",
                    "MGI:95574",
                    "RGD:2626",
                    "UMLS:C4082333",
                    "NCIT:C19532",
                    "PR:P01100",
                    "MESH:D016760",
                    "UMLS:C0087140",
                    "PR:P01101",
                    "ENSEMBL:ENSG00000170345",
                    "UniProtKB:P01100"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1016/j.celrep.2015.02.033",
                    "DOI:10.1002/j.1460-2075.1995.tb00187.x",
                    "DOI:10.1038/nature01348",
                    "PMID:1658710",
                    "PMID:2511004",
                    "DOI:10.1038/sj.onc.1210137",
                    "PMID:16055710",
                    "PMID:19690332",
                    "PMID:17160021",
                    "DOI:10.1126/scisignal.2000007"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P01106": {
              "name": "MYC",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P01106",
                  "value_url": "https://identifiers.org/uniprot:P01106",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Basic helix-loop-helix transcription factors encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated (constitutive) expression of c-myc proteins can cause tumorigenesis.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Proto-Oncogene Proteins c-myc",
                    "Myc (rat)",
                    "MYC (human)",
                    "MYC Gene",
                    "MYC (chicken)",
                    "Myc (mouse)",
                    "MYC gene",
                    "Myc proto-oncogene protein (mouse)",
                    "MYC gene [nucleoplasm]",
                    "PolyUb-MYC [nucleoplasm]",
                    "Myc proto-oncogene protein (human)",
                    "c-myc protein isoform 2 (mouse)",
                    "Myc protein (fruit fly)",
                    "MYC [nucleoplasm]",
                    "Myc proto-oncogene protein (rat)",
                    "MYC",
                    "Myc",
                    "Myc proto-oncogene protein (chicken)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MGI:97250",
                    "PR:P09416",
                    "REACT:R-HSA-6783169",
                    "LOINC:LP34539-4",
                    "MESH:D016271",
                    "NCBIGene:4609",
                    "PR:P01106",
                    "PR:P01108",
                    "PR:B2RSN1",
                    "ENSEMBL:ENSG00000136997",
                    "REACT:R-HSA-188379",
                    "OMIM:190080",
                    "PR:Q9W4S7",
                    "REACT:R-HSA-2127254",
                    "NCIT:C16887",
                    "UMLS:C0080065",
                    "RGD:3130",
                    "UMLS:C0086661",
                    "LOINC:LP36232-4",
                    "PR:P01109",
                    "NCBIGene:420332",
                    "UniProtKB:P01106",
                    "HGNC:7553"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19413330",
                    "PMID:7642555",
                    "DOI:10.1158/1535-7163.mct-06-0659",
                    "DOI:10.1021/ac9004309",
                    "PMID:14702039",
                    "PMID:6321164",
                    "PMID:15103331",
                    "DOI:10.1073/pnas.0805139105",
                    "DOI:10.4161/cc.6.19.4804",
                    "PMID:15674325"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P01133": {
              "name": "EGF",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P01133",
                  "value_url": "https://identifiers.org/uniprot:P01133",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "-!- FUNCTION: EGF stimulates the growth of various epidermal and epithelial tissues in vivo and in vitro and of some fibroblasts in cell culture. Magnesiotropic hormone that stimulates magnesium reabsorption in the renal distal convoluted tubule via engagement of EGFR and activation of the magnesium channel TRPM6. Can induce neurite outgrowth in motoneurons of the pond snail Lymnaea stagnalis in vitro (PubMed:10964941). {ECO:0000269|PubMed:10964941, ECO:0000269|PubMed:17671655}. -!- SUBUNIT: Interacts with EGFR and promotes EGFR dimerization. Interacts with RHBDF2 (By similarity). Interacts with RHBDF1; may retain EGF in the endoplasmic reticulum and regulates its degradation through the endoplasmic reticulum-associated degradation (ERAD). {ECO:0000250, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:20837704, ECO:0000269|PubMed:21029725, ECO:0000269|PubMed:21439629}. -!- INTERACTION: P01133; P00533: EGFR; NbExp=29; IntAct=EBI-640857, EBI-297353; P01133; P10620: MGST1; NbExp=3; IntAct=EBI-640857, EBI-2691601; P01133; Q01279: Egfr; Xeno; NbExp=3; IntAct=EBI-640857, EBI-6296235; PRO_0000007541; PRO_0000018520 [P28300]: LOX; NbExp=2; IntAct=EBI-9076336, EBI-20724846; -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein. -!- ALTERNATIVE PRODUCTS: Event=Alternative splicing; Named isoforms=3; Name=1; IsoId=P01133-1; Sequence=Displayed; Name=2; IsoId=P01133-2; Sequence=VSP_041586; Name=3; IsoId=P01133-3; Sequence=VSP_047190; -!- TISSUE SPECIFICITY: Expressed in kidney, salivary gland, cerebrum and prostate. {ECO:0000269|PubMed:17671655}. -!- PTM: O-glycosylated with core 1-like and core 2-like glycans. It is uncertain if Ser-954 or Thr-955 is O-glycosylated. The modification here shows glycan heterogeneity: HexHexNAc (major) and Hex2HexNAc2 (minor). {ECO:0000269|PubMed:22171320}. -!- DISEASE: Hypomagnesemia 4 (HOMG4) [MIM:611718]: A disorder characterized by massive renal hypomagnesemia and normal levels of serum calcium and calcium excretion. Clinical features include seizures, mild-to moderate psychomotor retardation, and brisk tendon reflexes. {ECO:0000269|PubMed:17671655}. Note=The disease is caused by variants affecting the gene represented in this entry. -!- SEQUENCE CAUTION: Sequence=AAR84237.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; -!- WEB RESOURCE: Name=NIEHS-SNPs; URL=\"http://egp.gs.washington.edu/data/egf/\"; -!- WEB RESOURCE: Name=Wikipedia; Note=Epidermal growth factor entry; URL=\"https://en.wikipedia.org/wiki/Epidermal_growth_factor\"; ; Short=EGFEvidence Codes from Name:  ",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing",
                    "biolink:Drug",
                    "biolink:MolecularEntity",
                    "biolink:SmallMolecule"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "EGF [extracellular region]",
                    "pro-epidermal growth factor (rat)",
                    "Epidermal Growth Factor",
                    "Epidermal growth factor",
                    "pro-epidermal growth factor (human)",
                    "Pro-EGF [plasma membrane]",
                    "recombinant human epidermal growth factor",
                    "EGF Gene",
                    "Pro-EGF [platelet alpha granule lumen]",
                    "Egf (mouse)",
                    "EGF (human)",
                    "pro-epidermal growth factor (mouse)",
                    "EGF",
                    "pro-epidermal growth factor",
                    "EGF [clathrin-coated endocytic vesicle membrane]",
                    "Pro-Epidermal Growth Factor",
                    "Pro-epidermal growth factor",
                    "epidermal growth factor",
                    "Egf (rat)",
                    "EGF gene",
                    "human epidermal growth factor",
                    "Recombinant Human Epidermal Growth Factor",
                    "Pro-EGF [extracellular region]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "RXNORM:1427158",
                    "REACT:R-HSA-179863",
                    "PR:P01133",
                    "UniProtKB:P01133",
                    "RXNORM:1427157",
                    "UMLS:C2825836",
                    "HMDB:HMDB0251846",
                    "MGI:95290",
                    "REACT:R-HSA-54209",
                    "PathWhiz.ProteinComplex:5205",
                    "PDQ:CDR0000354196",
                    "REACT:R-HSA-8869086",
                    "LOINC:LP18547-7",
                    "REACT:R-HSA-139875",
                    "UMLS:C1367721",
                    "CHEMBL.TARGET:CHEMBL5734",
                    "NCBIGene:1950",
                    "ORPHANET:201089",
                    "NCIT:C20425",
                    "REACT:R-HSA-179888",
                    "LOINC:MTHU004615",
                    "RGD:2542",
                    "NCIT:C24359",
                    "EFO:0003298",
                    "MESH:D004815",
                    "UMLS:C0242275",
                    "OMIM:131530",
                    "ttd.target:Epidermal_growth_factor",
                    "NCIT:C118403",
                    "PathWhiz.ProteinComplex:12507",
                    "UMLS:C3897855",
                    "UMLS:C1509244",
                    "PathWhiz.ProteinComplex:12073",
                    "PathWhiz.ProteinComplex:12289",
                    "PR:P07522",
                    "PR:000006928",
                    "PDQ:CDR0000637721",
                    "ENSEMBL:ENSG00000138798",
                    "HGNC:3229",
                    "PR:P01132"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1074/jbc.m102874200",
                    "DOI:10.1101/gr.2596504",
                    "PMID:15815621",
                    "PMID:10964941",
                    "PMID:14702039",
                    "DOI:10.1016/s1097-2765(03)00047-9",
                    "PMID:11438527",
                    "PMID:3491360",
                    "DOI:10.1016/s0092-8674(02)00963-7",
                    "DOI:10.1016/0006-291x(89)92334-6"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P01137": {
              "name": "TGFB1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P01137",
                  "value_url": "https://identifiers.org/uniprot:P01137",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "This gene plays a role in cell growth, proliferation and biogenesis/organization. It is also involved in the inhibition of apoptosis.; UMLS Semantic Type: STY:T028",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "transforming growth factor beta-1 proprotein (mouse)",
                    "Tgfb1 (mouse)",
                    "TGFB1 [plasma membrane]",
                    "TGFB1",
                    "TGFB1 (human)",
                    "TGFB1 [Golgi lumen]",
                    "TGFB1(30-278) [platelet alpha granule lumen]",
                    "TGFB1(30-278) [Golgi lumen]",
                    "TGFB1(30-390) [Golgi lumen]",
                    "TGFB1 gene [nucleoplasm]",
                    "TGFB1 Gene",
                    "TGFB1 protein, human",
                    "transforming growth factor beta-1 (human)",
                    "transforming growth factor beta-1 (rat)",
                    "TGFB1 [extracellular region]",
                    "TGFB1 gene",
                    "Tgfb1 (rat)",
                    "TGFB1(30-278) [extracellular region]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-177108",
                    "REACT:R-HSA-114705",
                    "MESH:C508960",
                    "NCBIGene:7040",
                    "NCIT:C24856",
                    "REACT:R-HSA-65936",
                    "UMLS:C1366557",
                    "PR:P04202",
                    "RGD:69051",
                    "UMLS:C0080222",
                    "REACT:R-HSA-6793987",
                    "REACT:R-HSA-170838",
                    "PR:P01137",
                    "REACT:R-HSA-5146781",
                    "OMIM:190180",
                    "HGNC:11766",
                    "REACT:R-HSA-9736812",
                    "MGI:98725",
                    "ENSEMBL:ENSG00000105329",
                    "UniProtKB:P01137",
                    "REACT:R-HSA-2395367",
                    "PR:P17246"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1021/bi00055a022",
                    "PMID:20207738",
                    "DOI:10.1210/jc.2002-020564",
                    "PMID:16754747",
                    "PMID:25209176",
                    "PMID:14702039",
                    "DOI:10.1359/jbmr.1998.13.10.1569",
                    "DOI:10.1074/mcp.m500324-mcp200",
                    "DOI:10.1038/onc.2015.100",
                    "DOI:10.1007/s100380200069"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P01579": {
              "name": "IFNG",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P01579",
                  "value_url": "https://identifiers.org/uniprot:P01579",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "This gene plays a role in signal transduction and immunoregulation. It is also involved in cell communication, migration, growth and proliferation.; UMLS Semantic Type: STY:T028",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Gene",
                    "biolink:BiologicalEntity",
                    "biolink:Protein",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Ifng (rat)",
                    "interferon type II",
                    "IFNG (chicken)",
                    "IFNG gene [nucleoplasm]",
                    "interferon gamma (rat)",
                    "interferon gamma (human)",
                    "IFNG (human)",
                    "IFNG gene",
                    "Interferon-gamma",
                    "Interferon Type II",
                    "Ifng (mouse)",
                    "interferon gamma (mouse)",
                    "IFNG [extracellular region]",
                    "interferon gamma (chicken)",
                    "IFNG Gene",
                    "IFNG"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PR:P49708",
                    "MGI:107656",
                    "REACT:R-HSA-8877362",
                    "NCIT:C28603",
                    "UMLS:C1334085",
                    "PR:P01579",
                    "MESH:D007371",
                    "OMIM:147570",
                    "PR:P01581",
                    "PR:P01580",
                    "RGD:2866",
                    "NCBIGene:396054",
                    "UniProtKB:P01579",
                    "RXNORM:5885",
                    "ENSEMBL:ENSG00000111537",
                    "UMLS:C0021745",
                    "NCBIGene:3458",
                    "REACT:R-HSA-629621",
                    "HGNC:5438"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:6427223",
                    "PMID:10860730",
                    "PMID:6176945",
                    "PMID:6329718",
                    "DOI:10.1111/j.1432-1033.1987.tb13494.x",
                    "DOI:10.1084/jem.183.4.1807",
                    "DOI:10.1006/jmbi.2000.3734",
                    "PMID:16914093",
                    "PMID:7617032",
                    "DOI:10.1093/oxfordjournals.jbchem.a135039"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P02452": {
              "name": "COL1A1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P02452",
                  "value_url": "https://identifiers.org/uniprot:P02452",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Collagen alpha-1(I) chain (1464 aa, ~139 kDa) is encoded by the human COL1A1 gene. This protein is involved in the formation of fibrillar collagen.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "3x4Hyp-GalHyl-COL1A1(23-1464) [extracellular region]",
                    "Dehydrolysinonorlysyl 4-Hyp 5-Gal-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-5Hyl-COL1A2(80-?) [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 4-Hyp Glu-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "Lysyl-pyrrolyl 4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 3,4-Hyp 5-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-GalHyl-COL1A2(80-953) [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl Glu-Gal-Hyl-collagen alpha-2(I) chain [extracellular region]",
                    "Dehydrolysinonorlysyl 4-Hyp 5-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "Hydroxylysyl-pyrrolyl 5-hydroxylysyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A2(80-953) [extracellular region]",
                    "GlcGalHyl-COL1A1 [extracellular region]",
                    "COL1A2 (human)",
                    "GalHyl-COL1A2(25-1366) [endoplasmic reticulum lumen]",
                    "COL1A1 gene",
                    "Dehydrohydroxylysinonorlysyl 3,4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL1A2(954-1102) [extracellular region]",
                    "Dehydrolysinonorlysyl 4-Hyp Glu-Gal-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "COL1A1 Gene",
                    "Lysyl-pyridinolyl 3,4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "GalHyl-COL1A1(162-953) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A1(162-953) [extracellular region]",
                    "5Hyl-COL1A1(954-1218) [extracellular region]",
                    "3x4Hyp-3Hyp-COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "GlcGalHyl-COL1A2(25-1366) [endoplasmic reticulum lumen]",
                    "Dehydrolysinonorlysyl 5-hydroxylysyl collagen alpha-2(I) chain [extracellular region]",
                    "Alys-GalHyl-COL1A2 [extracellular region]",
                    "5Hyl-Alys-COL1A1 [extracellular region]",
                    "3x4Hyp-COL1A1(23-1464) [extracellular region]",
                    "Hydroxylysino-5-ketonorlysyl 5-hydroxylysyl collagen alpha-2(I) chain [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 3,4-hydroxyprolyl collagen alpha-1(I) chain [extracellular region]",
                    "COL1A2 [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A2(80-953) [extracellular region]",
                    "type I collagen alpha 1",
                    "3x4Hyp-COL1A1 [extracellular region]",
                    "Lysino-5-ketonorlysyl 5-hydroxylysl-collagen alpha-1(I) chain [extracellular region]",
                    "5Hyl-COL1A1 [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL1A2 [extracellular region]",
                    "5Hyl-COL1A1(23-1464) [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 4-hydroxyprolyl collagen alpha-2(I) chain [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 3,4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "5Hyl-COL1A1(162-953) [extracellular region]",
                    "3x4Hyp-3Hyp-COL1A1(23-1464) [extracellular region]",
                    "Dehydrolysinonorlysyl Glu-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "Lysino-5-ketonorlysyl 4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A2(954-1102) [extracellular region]",
                    "COL1A2(25-1366) [extracellular region]",
                    "Dehydrolysinonorlysyl 4-hydroxyprolyl collagen alpha-1(I) chain [extracellular region]",
                    "5Hyl-COL1A2(954-1102) [extracellular region]",
                    "3x4Hyp-COL1A1(162-1464) [extracellular region]",
                    "3x4Hyp-GalHyl-COL1A1(162-953) [extracellular region]",
                    "COL1A1(23-1464) [extracellular region]",
                    "3x4Hyp-5Hyl-Alys-COL1A1 [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A2 [extracellular region]",
                    "3x4Hyp-5Hyl-COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "3x4Hyp-5Hyl-COL1A1 [extracellular region]",
                    "COL1A1 (human)",
                    "Hydroxylysino-5-ketonorlysyl 4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL1A1(23-1464) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A1(23-1464) [extracellular region]",
                    "3x4Hyp-COL1A2(80-953) [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A1(162-953) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A2(954-1102) [extracellular region]",
                    "3x4Hyp-GalHyl-COL1A2(25-1366) [endoplasmic reticulum lumen]",
                    "GlcGalHyl-COL1A2(80-1366) [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 5-Gal-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "Hydroxylysyl-pyridinolyl 3,4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "Lysino-5-ketonorlysyl 4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL1A2(25-1366) [extracellular region]",
                    "3x4Hyp-GalHyl-COL1A2(80-1366) [extracellular region]",
                    "3x4Hyp-5Hyl-Alys-COL1A2 [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 5-hydroxylysl-collagen alpha-1(I) chain [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 3,4-Hyp Glu-Gal-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL1A2(25-1366) [endoplasmic reticulum lumen]",
                    "Col1a1 (mouse)",
                    "Hydroxyallysyl 4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL1A2 [extracellular region]",
                    "Hydroxylysino-5-ketonorlysyl 3,4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-5Hyl-COL1A2(80-1366) [extracellular region]",
                    "3x4Hyp-COL1A2 [extracellular region]",
                    "3x4Hyp-5Hyl-COL1A2(25-1366) [extracellular region]",
                    "Alys-GlcGalHyl-COL1A1 [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL1A1(23-1464) [extracellular region]",
                    "GalHyl-COL1A2 [extracellular region]",
                    "COL1A2(80-1366) [extracellular region]",
                    "3x4Hyp-3Hyp-COL1A2(25-1366) [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 5-hydroxylysyl collagen alpha-2(I) chain [extracellular region]",
                    "GlcGalHyl-COL1A1(162-953) [extracellular region]",
                    "3x4Hyp-5Hyl-COL1A2 [extracellular region]",
                    "5Hyl-Alys-COL1A2 [extracellular region]",
                    "3x4Hyp-3Hyp-Alys-GlcGalHyl-COL1A2 [extracellular region]",
                    "Lysyl-pyridinolyl 4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "GlcGalHyl-COL1A2(954-1102) [extracellular region]",
                    "COL1A2",
                    "3x4Hyp-GalHyl-COL1A1(162-1464) [extracellular region]",
                    "Hydroxylysyl-pyridinolyl 3,4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "5Hyl-COL1A2(25-1366) [endoplasmic reticulum lumen]",
                    "Lysyl-pyridinolyl 5-hydroxylysyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-5Hyl-COL1A1(162-953) [extracellular region]",
                    "3x4Hyp-COL1A2(80-1366) [extracellular region]",
                    "GalHyl-COL1A2(80-1366) [extracellular region]",
                    "3x4Hyp-GalHyl-COL1A1(954-1218) [extracellular region]",
                    "Alys-GalHyl-COL1A1 [extracellular region]",
                    "3x4Hyp-3Hyp-COL1A1 [extracellular region]",
                    "3x4Hyp-3Hyp-COL1A1(162-953) [extracellular region]",
                    "Dehydrolysinonorlysyl 3,4-Hyp 5-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "Lysino-5-ketonorlysyl 3,4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "Dehydrolysinonorlysyl 3,4-hydroxyprolyl collagen alpha-1(I) chain [extracellular region]",
                    "5Hyl-COL1A2(25-1366) [extracellular region]",
                    "3x4Hyp-3Hyp-Alys-COL1A1 [extracellular region]",
                    "Hydroxyallysyl 5-hydroxylysyl collagen alpha-1(I) chain [extracellular region]",
                    "COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "Hydroxylysyl-pyrrolyl 5-hydroxylysyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-GalHyl-COL1A2 [extracellular region]",
                    "3x4Hyp-Alys-GalHyl-COL1A1 [extracellular region]",
                    "Lysyl-pyridinolyl 5-hydroxylysyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-COL1A1(954-1218) [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A2(25-1366) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-Alys-COL1A1 [extracellular region]",
                    "Dehydrolysinonorlysyl 3,4-Hyp Glu-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL1A2(80-953) [extracellular region]",
                    "3x4Hyp-3Hyp-COL1A2(80-953) [extracellular region]",
                    "GlcGalHyl-COL1A2(80-953) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A2(25-1366) [endoplasmic reticulum lumen]",
                    "Hydroxylysyl-pyrrolyl 4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "GlcGalHyl-COL1A1(162-1464) [extracellular region]",
                    "GalHyl-COL1A1 [extracellular region]",
                    "3x4Hyp-3Hyp-Alys-GalHyl-COL1A2 [extracellular region]",
                    "GlcGalHyl-COL1A1(23-1464) [extracellular region]",
                    "Hydroxylysyl-pyridinolyl 5-hydroxylysyl collagen alpha-2(I) chain [extracellular region]",
                    "5Hyl-COL1A2 [extracellular region]",
                    "GalHyl-COL1A1(23-1464) [extracellular region]",
                    "Dehydrolysinonorlysyl 3,4-hydroxyprolyl collagen alpha-2(I) chain [extracellular region]",
                    "COL1A2 Gene",
                    "Col1a2 (rat)",
                    "3x4Hyp-3Hyp-GalHyl-COL1A2(25-1366) [extracellular region]",
                    "COL1A2 gene",
                    "collagen alpha-1(I) chain (rat)",
                    "3x4Hyp-3Hyp-COL1A2(80-1366) [extracellular region]",
                    "Hydroxylysino-5-ketonorlysyl 5-hydroxylysyl-collagen alpha-1(I) chain [extracellular region]",
                    "COL1A1(162-1464) [extracellular region]",
                    "Dehydrolysinonorlysyl 3,4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL1A1(162-953) [extracellular region]",
                    "COL1A2(25-1366) [endoplasmic reticulum lumen]",
                    "Hydroxyallysyl 5-hydroxylysyl collagen alpha-2(I) chain [extracellular region]",
                    "5Hyl-COL1A2(80-953) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A1 [extracellular region]",
                    "Dehydrolysinonorlysyl 4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "Hydroxylysyl-pyridinolyl 4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-Alys-COL1A2 [extracellular region]",
                    "COL1A2(80-954) [extracellular region]",
                    "Hydroxyallysyl 3,4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "GlcGalHyl-COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A2 [extracellular region]",
                    "Dehydrolysinonorlysyl 5-hydroxylysl-collagen alpha-1(I) chain [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 4-Hyp 5-Gal-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A1(23-1464) [extracellular region]",
                    "GlcGalHyl-COL1A2 [extracellular region]",
                    "3x4Hyp-GalHyl-COL1A2(25-1366) [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL1A2(80-1366) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A1(162-1464) [extracellular region]",
                    "COL1A1(162-953) [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL1A1(954-1218) [extracellular region]",
                    "Alys-GlcGalHyl-COL1A2 [extracellular region]",
                    "3x4Hyp-3Hyp-COL1A2(25-1366) [endoplasmic reticulum lumen]",
                    "Dehydrolysinonorlysyl 3,4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "GalHyl-COL1A2(80-953) [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "Dehydrohydroxylysinonorlysyl 4-Hyp 5-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 3,4-Hyp Glu-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-GalHyl-COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "Hydroxylysino-5-ketonorlysyl 3,4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A2(80-1366) [extracellular region]",
                    "Lysyl-pyrrolyl 5-hydroxylysyl collagen alpha-1(I) chain [extracellular region]",
                    "collagen alpha-2(I) chain (mouse)",
                    "Lysyl-pyridinolyl 4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "collagen alpha-2(I) chain (human)",
                    "Hydroxyallysyl 4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "GlcGalHyl-COL1A2(25-1366) [extracellular region]",
                    "3x4Hyp-Alys-GlcGalHyl-COL1A1 [extracellular region]",
                    "GalHyl-COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "Hydroxylysyl-pyrrolyl 3,4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "Hydroxylysyl-pyridinolyl 4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "collagen alpha-1(I) chain (mouse)",
                    "Dehydrolysinonorlysyl Glu-Gal-Hyl-collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL1A1(162-953) [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL1A1 [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL1A2(954-1102) [extracellular region]",
                    "Lysyl-pyrrolyl 4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A1(954-1218) [extracellular region]",
                    "3x4Hyp-5Hyl-COL1A1(954-1218) [extracellular region]",
                    "GalHyl-COL1A2(954-1102) [extracellular region]",
                    "GalHyl-COL1A1(954-1218) [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL1A1(954-1218) [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 3,4-Hyp 5-Gal-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-Alys-COL1A2 [extracellular region]",
                    "3x4Hyp-3Hyp-COL1A2 [extracellular region]",
                    "3x4Hyp-COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "3x4Hyp-GlcGalHyl-COL1A1 [extracellular region]",
                    "Col1a2 (mouse)",
                    "collagen alpha-1(I) chain (human)",
                    "Hydroxylysyl-pyrrolyl 3,4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "Dehydrolysinonorlysyl 4-Hyp Glu-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "GalHyl-COL1A1(162-1464) [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 4-hydroxyprolyl collagen alpha-1(I) chain [extracellular region]",
                    "Lysyl-pyrrolyl 5-hydroxylysyl collagen alpha-2(I) chain [extracellular region]",
                    "5Hyl-COL1A1(162-1464) [extracellular region]",
                    "Hydroxyallysyl 3,4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "Lysyl-pyridinolyl 3,4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-COL1A1(162-953) [extracellular region]",
                    "Dehydrolysinonorlysyl 4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "COL1A1(954-1218) [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 5-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "GlcGalHyl-COL1A1(954-1218) [extracellular region]",
                    "Dehydrolysinonorlysyl 4-hydroxyprolyl collagen alpha-2(I) chain [extracellular region]",
                    "Dehydrolysinonorlysyl 3,4-Hyp Glu-Gal-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-GalHyl-COL1A2(954-1102) [extracellular region]",
                    "COL1A1",
                    "3x4Hyp-COL1A2(954-1102) [extracellular region]",
                    "3x4Hyp-Alys-COL1A2 [extracellular region]",
                    "COL1A1 gene [nucleoplasm]",
                    "3x4Hyp-Alys-GlcGalHyl-COL1A2 [extracellular region]",
                    "GalHyl-COL1A2(25-1366) [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL1A2(80-1366) [extracellular region]",
                    "Hydroxylysino-5-ketonorlysyl 4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl Collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A2(25-1366) [extracellular region]",
                    "3x4Hyp-5Hyl-COL1A1(162-1464) [extracellular region]",
                    "3x4Hyp-3Hyp-COL1A2(954-1102) [extracellular region]",
                    "3x4Hyp-3Hyp-Alys-GalHyl-COL1A1 [extracellular region]",
                    "COL1A1 [extracellular region]",
                    "3x4Hyp-Alys-GalHyl-COL1A2 [extracellular region]",
                    "3x4Hyp-COL1A2(25-1366) [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL1A1(162-1464) [extracellular region]",
                    "Dehydrolysinonorlysyl 5-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "collagen alpha-2(I) chain (rat)",
                    "Dehydrolysinonorlysyl 5-Gal-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl Collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-COL1A1(162-1464) [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 4-Hyp Glu-Gal-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "COL1A2(954-1102) [extracellular region]",
                    "COL1A2 gene [nucleoplasm]",
                    "3x4Hyp-5Hyl-COL1A2(1-954) [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 3,4-hydroxyprolyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A1(954-1218) [extracellular region]",
                    "5Hyl-COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "Hydroxylysyl-pyridinolyl 5-hydroxylysyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A1 [extracellular region]",
                    "Dehydrolysinonorlysyl 3,4-Hyp 5-Gal-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL1A2(80-1366) [extracellular region]",
                    "3x4Hyp-GalHyl-COL1A1 [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl Glu-Gal-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A1(23-1464) [endoplasmic reticulum lumen]",
                    "3x4Hyp-GlcGalHyl-COL1A2(25-1366) [endoplasmic reticulum lumen]",
                    "5Hyl-COL1A2(80-1366) [extracellular region]",
                    "Hydroxylysyl-pyrrolyl 4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL1A1(162-1464) [extracellular region]",
                    "Lysyl-pyrrolyl 3,4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "Dehydrolysinonorlysyl Collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL1A2(80-953) [extracellular region]",
                    "3x4Hyp-Alys-COL1A1 [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A2(25-1366) [endoplasmic reticulum lumen]",
                    "Col1a1 (rat)",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL1A1(162-1464) [extracellular region]",
                    "Lysyl-pyrrolyl 3,4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "Alys-COL1A2 [extracellular region]",
                    "3x4Hyp-COL1A1(954-1218) [extracellular region]",
                    "Alys-COL1A1 [extracellular region]",
                    "Dehydrohydroxylysinonorlysyl 4-Hyp 5-Hyl collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-5Hyl-COL1A1(23-1464) [extracellular region]",
                    "Lysino-5-ketonorlysyl 3,4-Hyp 5-Hyl collagen alpha-1(I) chain [extracellular region]",
                    "3x4Hyp-5Hyl-COL1A2(25-1366) [endoplasmic reticulum lumen]",
                    "Dehydrolysinonorlysyl Collagen alpha-2(I) chain [extracellular region]",
                    "3x4Hyp-3Hyp-Alys-GlcGalHyl-COL1A1 [extracellular region]",
                    "alpha 2 collagen type I",
                    "3x4Hyp-COL1A2(25-1366) [endoplasmic reticulum lumen]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-2467165",
                    "REACT:R-HSA-2396310",
                    "REACT:R-HSA-2396369",
                    "REACT:R-HSA-2268895",
                    "REACT:R-HSA-2467179",
                    "REACT:R-HSA-2023547",
                    "REACT:R-HSA-2089987",
                    "REACT:R-HSA-2396064",
                    "REACT:R-HSA-2268691",
                    "REACT:R-HSA-2396115",
                    "REACT:R-HSA-2467172",
                    "REACT:R-HSA-2268654",
                    "REACT:R-HSA-2467136",
                    "REACT:R-HSA-2467173",
                    "NCBIGene:1277",
                    "REACT:R-HSA-2268760",
                    "REACT:R-HSA-2396066",
                    "REACT:R-HSA-2396241",
                    "REACT:R-HSA-2228727",
                    "REACT:R-HSA-2396426",
                    "REACT:R-HSA-2467159",
                    "REACT:R-HSA-2022455",
                    "REACT:R-HSA-2022501",
                    "OMIM:120150",
                    "REACT:R-HSA-2396182",
                    "REACT:R-HSA-2467166",
                    "REACT:R-HSA-2396065",
                    "REACT:R-HSA-2396386",
                    "REACT:R-HSA-141093",
                    "REACT:R-HSA-2268893",
                    "REACT:R-HSA-2268649",
                    "REACT:R-HSA-2467144",
                    "REACT:R-HSA-2467176",
                    "REACT:R-HSA-2467177",
                    "REACT:R-HSA-8985634",
                    "REACT:R-HSA-2268624",
                    "REACT:R-HSA-2228719",
                    "REACT:R-HSA-2396439",
                    "REACT:R-HSA-2396278",
                    "REACT:R-HSA-2089982",
                    "REACT:R-HSA-2268685",
                    "UMLS:C1332773",
                    "REACT:R-HSA-2089989",
                    "REACT:R-HSA-2268913",
                    "REACT:R-HSA-2396303",
                    "REACT:R-HSA-2467142",
                    "REACT:R-HSA-2467171",
                    "RGD:621351",
                    "REACT:R-HSA-2396023",
                    "MGI:88468",
                    "REACT:R-HSA-2268743",
                    "RGD:61817",
                    "REACT:R-HSA-2228695",
                    "REACT:R-HSA-2396173",
                    "REACT:R-HSA-2396440",
                    "REACT:R-HSA-2268918",
                    "REACT:R-HSA-2396080",
                    "REACT:R-HSA-2268784",
                    "REACT:R-HSA-2089978",
                    "REACT:R-HSA-2396314",
                    "REACT:R-HSA-2396402",
                    "REACT:R-HSA-2268742",
                    "PR:P02466",
                    "REACT:R-HSA-2268741",
                    "REACT:R-HSA-2228732",
                    "REACT:R-HSA-2467132",
                    "REACT:R-HSA-2396375",
                    "REACT:R-HSA-2396258",
                    "REACT:R-HSA-2089979",
                    "REACT:R-HSA-2467140",
                    "UniProtKB:P02452",
                    "REACT:R-HSA-2228737",
                    "REACT:R-HSA-2023580",
                    "REACT:R-HSA-2467149",
                    "REACT:R-HSA-2396413",
                    "REACT:R-HSA-2396302",
                    "REACT:R-HSA-2268633",
                    "REACT:R-HSA-2396043",
                    "REACT:R-HSA-2396270",
                    "REACT:R-HSA-2022954",
                    "REACT:R-HSA-2228697",
                    "REACT:R-HSA-2396315",
                    "REACT:R-HSA-2396434",
                    "REACT:R-HSA-2467152",
                    "REACT:R-HSA-2268636",
                    "REACT:R-HSA-2396214",
                    "REACT:R-HSA-2396431",
                    "REACT:R-HSA-2268933",
                    "REACT:R-HSA-2396247",
                    "REACT:R-HSA-2268867",
                    "REACT:R-HSA-2396291",
                    "HGNC:2197",
                    "REACT:R-HSA-2089991",
                    "REACT:R-HSA-2396211",
                    "UMLS:C1332772",
                    "REACT:R-HSA-2467174",
                    "REACT:R-HSA-2396086",
                    "REACT:R-HSA-2396269",
                    "REACT:R-HSA-2396388",
                    "REACT:R-HSA-2396336",
                    "REACT:R-HSA-2228736",
                    "REACT:R-HSA-2089974",
                    "REACT:R-HSA-2396166",
                    "REACT:R-HSA-2022999",
                    "REACT:R-HSA-2467178",
                    "REACT:R-HSA-2023667",
                    "REACT:R-HSA-2089985",
                    "REACT:R-HSA-2396368",
                    "REACT:R-HSA-2228725",
                    "REACT:R-HSA-2089981",
                    "OMIM:120160",
                    "REACT:R-HSA-2467134",
                    "REACT:R-HSA-2268635",
                    "REACT:R-HSA-2467163",
                    "REACT:R-HSA-2396344",
                    "PR:P02452",
                    "REACT:R-HSA-2396137",
                    "REACT:R-HSA-2228740",
                    "REACT:R-HSA-2396389",
                    "REACT:R-HSA-2268828",
                    "REACT:R-HSA-2467161",
                    "REACT:R-HSA-2396493",
                    "REACT:R-HSA-2396245",
                    "REACT:R-HSA-2396112",
                    "REACT:R-HSA-2022977",
                    "REACT:R-HSA-2089966",
                    "REACT:R-HSA-2396174",
                    "REACT:R-HSA-2228690",
                    "REACT:R-HSA-2396272",
                    "REACT:R-HSA-2396424",
                    "REACT:R-HSA-2467148",
                    "REACT:R-HSA-2396081",
                    "REACT:R-HSA-2396134",
                    "REACT:R-HSA-2396464",
                    "REACT:R-HSA-1985659",
                    "REACT:R-HSA-2023602",
                    "REACT:R-HSA-2023558",
                    "REACT:R-HSA-2228696",
                    "REACT:R-HSA-2089972",
                    "PR:P08123",
                    "REACT:R-HSA-2396373",
                    "PR:Q01149",
                    "REACT:R-HSA-1980213",
                    "REACT:R-HSA-2089976",
                    "REACT:R-HSA-2228706",
                    "ENSEMBL:LRG_1",
                    "REACT:R-HSA-2396068",
                    "REACT:R-HSA-2268848",
                    "REACT:R-HSA-2396242",
                    "REACT:R-HSA-2268815",
                    "REACT:R-HSA-2396096",
                    "REACT:R-HSA-2228729",
                    "REACT:R-HSA-2467147",
                    "REACT:R-HSA-2467168",
                    "REACT:R-HSA-2396471",
                    "REACT:R-HSA-2023648",
                    "REACT:R-HSA-2467154",
                    "REACT:R-HSA-2396238",
                    "REACT:R-HSA-2268637",
                    "REACT:R-HSA-2396257",
                    "REACT:R-HSA-2023674",
                    "REACT:R-HSA-2228722",
                    "REACT:R-HSA-2467167",
                    "REACT:R-HSA-2089990",
                    "REACT:R-HSA-2022966",
                    "REACT:R-HSA-2023559",
                    "REACT:R-HSA-2396050",
                    "REACT:R-HSA-2228743",
                    "REACT:R-HSA-2396026",
                    "REACT:R-HSA-2396377",
                    "REACT:R-HSA-2268935",
                    "REACT:R-HSA-2268643",
                    "UMLS:C0766823",
                    "REACT:R-HSA-2396266",
                    "REACT:R-HSA-2396210",
                    "ENSEMBL:ENSG00000108821",
                    "REACT:R-HSA-2396213",
                    "REACT:R-HSA-2023663",
                    "REACT:R-HSA-2396196",
                    "REACT:R-HSA-2089984",
                    "REACT:R-HSA-2396359",
                    "REACT:R-HSA-2396309",
                    "REACT:R-HSA-2467137",
                    "REACT:R-HSA-2396076",
                    "REACT:R-HSA-2268656",
                    "REACT:R-HSA-2089968",
                    "REACT:R-HSA-2228709",
                    "REACT:R-HSA-2396342",
                    "REACT:R-HSA-2396490",
                    "REACT:R-HSA-2467162",
                    "REACT:R-HSA-2396441",
                    "REACT:R-HSA-2467160",
                    "REACT:R-HSA-2268642",
                    "REACT:R-HSA-2396380",
                    "REACT:R-HSA-2228703",
                    "REACT:R-HSA-2467155",
                    "MGI:88467",
                    "REACT:R-HSA-2268681",
                    "REACT:R-HSA-2089992",
                    "REACT:R-HSA-2228712",
                    "UniProtKB:P08123",
                    "REACT:R-HSA-2268639",
                    "REACT:R-HSA-2396021",
                    "REACT:R-HSA-2228744",
                    "REACT:R-HSA-2268652",
                    "REACT:R-HSA-2467143",
                    "REACT:R-HSA-2467151",
                    "NCBIGene:1278",
                    "REACT:R-HSA-2268626",
                    "REACT:R-HSA-1650777",
                    "REACT:R-HSA-2228701",
                    "REACT:R-HSA-2268687",
                    "REACT:R-HSA-2396297",
                    "REACT:R-HSA-2268705",
                    "REACT:R-HSA-2467145",
                    "REACT:R-HSA-6789344",
                    "REACT:R-HSA-2396206",
                    "REACT:R-HSA-2467164",
                    "REACT:R-HSA-2467146",
                    "REACT:R-HSA-2228692",
                    "REACT:R-HSA-2396361",
                    "ENSEMBL:ENSG00000164692",
                    "REACT:R-HSA-2268813",
                    "UMLS:C0972255",
                    "REACT:R-HSA-2396215",
                    "REACT:R-HSA-2396492",
                    "REACT:R-HSA-2467128",
                    "REACT:R-HSA-2089988",
                    "REACT:R-HSA-2268719",
                    "REACT:R-HSA-2467129",
                    "REACT:R-HSA-2467157",
                    "REACT:R-HSA-2089980",
                    "REACT:R-HSA-2268807",
                    "REACT:R-HSA-2268634",
                    "REACT:R-HSA-2396104",
                    "REACT:R-HSA-2467131",
                    "REACT:R-HSA-2089967",
                    "REACT:R-HSA-2228710",
                    "REACT:R-HSA-2268709",
                    "REACT:R-HSA-1985663",
                    "REACT:R-HSA-2268861",
                    "REACT:R-HSA-2467169",
                    "REACT:R-HSA-2268648",
                    "REACT:R-HSA-2396452",
                    "REACT:R-HSA-2467170",
                    "REACT:R-HSA-2396138",
                    "REACT:R-HSA-2023582",
                    "HGNC:2198",
                    "REACT:R-HSA-2396384",
                    "REACT:R-HSA-2022951",
                    "REACT:R-HSA-2228686",
                    "REACT:R-HSA-2268673",
                    "REACT:R-HSA-2268892",
                    "REACT:R-HSA-2467130",
                    "REACT:R-HSA-2268811",
                    "REACT:R-HSA-2396396",
                    "REACT:R-HSA-2396305",
                    "NCIT:C29949",
                    "REACT:R-HSA-2467127",
                    "ENSEMBL:LRG_2",
                    "REACT:R-HSA-2022070",
                    "REACT:R-HSA-2467180",
                    "REACT:R-HSA-2396249",
                    "REACT:R-HSA-2396455",
                    "REACT:R-HSA-2268623",
                    "PR:P11087",
                    "REACT:R-HSA-2467135",
                    "REACT:R-HSA-2396090",
                    "REACT:R-HSA-2396237",
                    "REACT:R-HSA-2396072",
                    "REACT:R-HSA-2268739",
                    "REACT:R-HSA-2268870",
                    "REACT:R-HSA-2228741",
                    "NCIT:C29950",
                    "REACT:R-HSA-2467158",
                    "REACT:R-HSA-2023604",
                    "REACT:R-HSA-2089965",
                    "REACT:R-HSA-2396169",
                    "REACT:R-HSA-2268792",
                    "REACT:R-HSA-2089969",
                    "REACT:R-HSA-2089986",
                    "REACT:R-HSA-2268929",
                    "REACT:R-HSA-2467153",
                    "REACT:R-HSA-2022446",
                    "REACT:R-HSA-2467156",
                    "PR:P02454",
                    "REACT:R-HSA-51125",
                    "REACT:R-HSA-2396479"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1002/humu.1380020308",
                    "PMID:3170557",
                    "DOI:10.1093/oxfordjournals.jbchem.a124429",
                    "DOI:10.1136/jmg.31.12.965",
                    "PMID:6267597",
                    "DOI:10.1002/ajmg.1320450217",
                    "2-4",
                    "PMID:1634225",
                    "DOI:10.1172/jci114286",
                    "DOI:10.1093/nar/16.1.349"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P02461": {
              "name": "COL3A1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P02461",
                  "value_url": "https://identifiers.org/uniprot:P02461",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Collagen alpha-1(III) chain (1466 aa, ~139 kDa) is encoded by the human COL3A1 gene. This protein plays a role in connective tissue organization.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "COL3A1(154-1466) [extracellular region]",
                    "Col3a1 (mouse)",
                    "3x4Hyp-5Hyl-COL3A1(949-1221) [extracellular region]",
                    "GalHyl-COL3A1(24-1466) [extracellular region]",
                    "COL3A1 protein, human",
                    "collagen alpha-1(III) chain (human)",
                    "3x4Hyp-5Hyl-COL3A1(154-1466) [extracellular region]",
                    "3x4Hyp-COL3A1(24-1466) [extracellular region]",
                    "5Hyl-COL3A1(154-948) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL3A1 [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL3A1(154-948) [extracellular region]",
                    "Col3a1 (rat)",
                    "5Hyl-COL3A1(154-1466) [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL3A1(24-1466) [extracellular region]",
                    "3x4Hyp-3Hyp-COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "3x4Hyp-GalHyl-COL3A1(154-948) [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL3A1(949-1221) [extracellular region]",
                    "COL3A1 [extracellular region]",
                    "3x4Hyp-3Hyp-COL3A1(154-948) [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "GlcGalHyl-COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "GlcGalHyl-COL3A1(154-1241) [extracellular region]",
                    "3x4Hyp-5Hyl-COL3A1(24-1466) [extracellular region]",
                    "5Hyl-COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "3x4Hyp-GalHyl-COL3A1 [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL3A1(154-1466) [extracellular region]",
                    "3x4Hyp-COL3A1 [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "3x4Hyp-GalHyl-COL3A1(949-1221) [extracellular region]",
                    "3x4Hyp-3Hyp-COL3A1(24-1466) [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL3A1(949-1221) [extracellular region]",
                    "COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "3x4Hyp-GalHyl-COL3A1(154-1466) [extracellular region]",
                    "GlcGalHyl-COL3A1(154-1466) [extracellular region]",
                    "3x4Hyp-3Hyp-COL3A1(154-1466) [extracellular region]",
                    "5Hyl-COL3A1(24-1466) [extracellular region]",
                    "collagen alpha-1(III) chain (rat)",
                    "5Hyl-COL3A1 [extracellular region]",
                    "5Hyl-COL3A1(949-1221) [extracellular region]",
                    "3x4Hyp-5Hyl-COL3A1 [extracellular region]",
                    "GalHyl-COL3A1(154-1466) [extracellular region]",
                    "GalHyl-COL3A1 [extracellular region]",
                    "COL3A1(949-1221) [extracellular region]",
                    "3x4Hyp-5Hyl-COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "collagen alpha-1(III) chain (mouse)",
                    "COL3A1(24-1466) [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL3A1(154-948) [extracellular region]",
                    "3x4Hyp-3Hyp-COL3A1 [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL3A1 [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL3A1(24-1466) [extracellular region]",
                    "3x4Hyp-GalHyl-COL3A1(24-1466) [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL3A1(24-1466) [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL3A1 [extracellular region]",
                    "3x4Hyp-COL3A1(154-1466) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL3A1(154-1466) [extracellular region]",
                    "3x4Hyp-3Hyp-COL3A1(949-1221) [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL3A1(154-948) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL3A1(949-1221) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL3A1(154-948) [extracellular region]",
                    "COL3A1(154-948) [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL3A1(154-1466) [extracellular region]",
                    "3x4Hyp-COL3A1(949-1221) [extracellular region]",
                    "3x4Hyp-3Hyp-5Hyl-COL3A1(24-1466) [extracellular region]",
                    "COL3A1",
                    "3x4Hyp-GalHyl-COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "3x4Hyp-COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "GalHyl-COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "COL3A1 Gene",
                    "GlcGalHyl-COL3A1(24-1466) [extracellular region]",
                    "3x4Hyp-3Hyp-GalHyl-COL3A1(24-1466) [endoplasmic reticulum lumen]",
                    "3x4Hyp-3Hyp-GalHyl-COL3A1(949-1221) [extracellular region]",
                    "GlcGalHyl-COL3A1(154-948) [extracellular region]",
                    "3x4Hyp-GlcGalHyl-COL3A1 [extracellular region]",
                    "3x4Hyp-3Hyp-GlcGalHyl-COL3A1(154-1466) [extracellular region]",
                    "3x4Hyp-COL3A1(154-948) [extracellular region]",
                    "GalHyl-COL3A1(154-948) [extracellular region]",
                    "GalHyl-COL3A1(949-1221) [extracellular region]",
                    "3x4Hyp-5Hyl-COL3A1(154-948) [extracellular region]",
                    "COL3A1 gene",
                    "COL3A1 (human)",
                    "GlcGalHyl-COL3A1(949-1241) [extracellular region]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-2022484",
                    "REACT:R-HSA-2468108",
                    "REACT:R-HSA-2022463",
                    "REACT:R-HSA-2468095",
                    "LOINC:LP35859-5",
                    "PR:P02461",
                    "REACT:R-HSA-2468111",
                    "REACT:R-HSA-2468110",
                    "REACT:R-HSA-2468097",
                    "REACT:R-HSA-2268890",
                    "REACT:R-HSA-2268661",
                    "REACT:R-HSA-2268683",
                    "REACT:R-HSA-2268744",
                    "UMLS:C1413581",
                    "MGI:88453",
                    "REACT:R-HSA-1980165",
                    "REACT:R-HSA-2468100",
                    "REACT:R-HSA-2468090",
                    "REACT:R-HSA-2127355",
                    "RGD:71029",
                    "NCBIGene:1281",
                    "REACT:R-HSA-2268891",
                    "REACT:R-HSA-2468096",
                    "OMIM:120180",
                    "REACT:R-HSA-2468109",
                    "REACT:R-HSA-2468088",
                    "REACT:R-HSA-2468086",
                    "REACT:R-HSA-2268735",
                    "REACT:R-HSA-2268869",
                    "REACT:R-HSA-2468099",
                    "REACT:R-HSA-375054",
                    "REACT:R-HSA-2127331",
                    "REACT:R-HSA-2127442",
                    "REACT:R-HSA-2468102",
                    "HGNC:2201",
                    "REACT:R-HSA-2468092",
                    "REACT:R-HSA-2127319",
                    "REACT:R-HSA-2268694",
                    "PR:P08121",
                    "REACT:R-HSA-2127340",
                    "REACT:R-HSA-2268766",
                    "REACT:R-HSA-2023666",
                    "REACT:R-HSA-2127352",
                    "REACT:R-HSA-2268677",
                    "REACT:R-HSA-2023556",
                    "REACT:R-HSA-2268837",
                    "ENSEMBL:ENSG00000168542",
                    "REACT:R-HSA-2268682",
                    "REACT:R-HSA-2023577",
                    "REACT:R-HSA-2468106",
                    "REACT:R-HSA-2268775",
                    "REACT:R-HSA-2268771",
                    "REACT:R-HSA-2468084",
                    "REACT:R-HSA-2268816",
                    "REACT:R-HSA-2127358",
                    "REACT:R-HSA-2268678",
                    "ENSEMBL:LRG_3",
                    "REACT:R-HSA-2468089",
                    "REACT:R-HSA-2468094",
                    "PR:P13941",
                    "REACT:R-HSA-2022957",
                    "REACT:R-HSA-2468085",
                    "REACT:R-HSA-2127382",
                    "MESH:C439971",
                    "NCIT:C143052",
                    "REACT:R-HSA-2268695",
                    "REACT:R-HSA-2268622",
                    "REACT:R-HSA-2268647",
                    "REACT:R-HSA-2268671",
                    "REACT:R-HSA-2468093",
                    "REACT:R-HSA-2127369",
                    "REACT:R-HSA-2023612",
                    "REACT:R-HSA-2468103",
                    "REACT:R-HSA-2127385",
                    "REACT:R-HSA-2023530",
                    "UniProtKB:P02461",
                    "REACT:R-HSA-2268690",
                    "REACT:R-HSA-2468087",
                    "REACT:R-HSA-2023668",
                    "REACT:R-HSA-2022942",
                    "REACT:R-HSA-2022108",
                    "REACT:R-HSA-2468098",
                    "UMLS:C1448187",
                    "REACT:R-HSA-2127418",
                    "REACT:R-HSA-2268818",
                    "REACT:R-HSA-2468105",
                    "REACT:R-HSA-2268669",
                    "REACT:R-HSA-2268749"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1002/humu.1380060408",
                    "2-e",
                    "DOI:10.1016/0378-1119(89)90228-x",
                    "PMID:9452103",
                    "PMID:1895316",
                    "PMID:15815621",
                    "PMID:8514866",
                    "DOI:10.1002/1098-1004(200008)16:2<176::aid-humu12>3.0.co",
                    "PMID:9036918",
                    "2-k"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P02649": {
              "name": "APOE",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P02649",
                  "value_url": "https://identifiers.org/uniprot:P02649",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Apolipoprotein E (317 aa, ~36 kDa) is encoded by the human APOE gene. This protein is involved in lipid metabolism and transport.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "APOE [early endosome]",
                    "Apoe (mouse)",
                    "APOE [extracellular region]",
                    "APOE [endosome membrane]",
                    "APOE-4 [extracellular region]",
                    "APOE",
                    "apolipoprotein E",
                    "APOE [endocytic vesicle lumen]",
                    "APOE [plasma membrane]",
                    "apolipoprotein E (human)",
                    "Apolipoprotein E",
                    "APOE (human)",
                    "apolipoprotein E (mouse)",
                    "p-APOE [endoplasmic reticulum lumen]",
                    "apolipoprotein E (rat)",
                    "Apolipoprotein E4, human",
                    "APOE Gene",
                    "APOE [endosome lumen]",
                    "APOE gene [nucleoplasm]",
                    "APOE gene",
                    "APOE [clathrin-coated endocytic vesicle membrane]",
                    "Apoe (rat)",
                    "APOE [endoplasmic reticulum lumen]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C1412481",
                    "NCIT:C84468",
                    "REACT:R-HSA-6784908",
                    "PR:000004155",
                    "LOINC:MTHU007600",
                    "UniProtKB:P02649",
                    "REACT:R-HSA-174766",
                    "RGD:2138",
                    "REACT:R-HSA-2429687",
                    "REACT:R-HSA-8956980",
                    "REACT:R-HSA-174646",
                    "REACT:R-HSA-8869591",
                    "LOINC:LP19650-8",
                    "PR:P02649",
                    "UMLS:C4721561",
                    "MGI:88057",
                    "NCBIGene:348",
                    "OMIM:107741",
                    "PR:P02650",
                    "REACT:R-HSA-3221641",
                    "REACT:R-HSA-174651",
                    "REACT:R-HSA-9711070",
                    "UMLS:C0003595",
                    "LOINC:LP15412-7",
                    "NCIT:C84470",
                    "ENSEMBL:ENSG00000130203",
                    "PR:P08226",
                    "ORPHANET:121390",
                    "REACT:R-HSA-174615",
                    "REACT:R-HSA-174804",
                    "HGNC:613"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.2169/internalmedicine1962.29.587",
                    "PMID:12950167",
                    "DOI:10.1021/pr300963h",
                    "PMID:19838169",
                    "PMID:25173806",
                    "DOI:10.1002/humu.1380040303",
                    "PMID:8125051",
                    "DOI:10.1016/j.cell.2016.12.044",
                    "DOI:10.1007/s00109-018-1632-y",
                    "PMID:11258893"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P02778": {
              "name": "CXCL10",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P02778",
                  "value_url": "https://identifiers.org/uniprot:P02778",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "C-X-C motif chemokine 10 (98 aa, ~11 kDa) is encoded by the human CXCL10 gene. This protein is involved in chemotaxis of monocytes and T-lymphocytes.; UMLS Semantic Type: STY:T129; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CXCL10 gene",
                    "C-X-C motif chemokine 10 (mouse)",
                    "CXCL10 (human)",
                    "CXCL10 gene [nucleoplasm]",
                    "C-X-C motif chemokine 10 (human)",
                    "C-X-C motif chemokine 10 (rat)",
                    "CXCL10",
                    "Cxcl10 (mouse)",
                    "Cxcl10 (rat)",
                    "CXCL10 Gene",
                    "CXCL10(22-98) [extracellular region]",
                    "CXCL10 protein, human"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-373853",
                    "MESH:C114753",
                    "UMLS:C1367714",
                    "PR:P02778",
                    "NCIT:C24788",
                    "RGD:620209",
                    "MGI:1352450",
                    "PR:P48973",
                    "HGNC:10637",
                    "OMIM:147310",
                    "PR:P17515",
                    "UniProtKB:P02778",
                    "ENSEMBL:ENSG00000169245",
                    "REACT:R-HSA-6785009",
                    "UMLS:C1308752",
                    "NCBIGene:3627"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1038/315672a0",
                    "DOI:10.1021/bi026020q",
                    "PMID:18645041",
                    "PMID:12750173",
                    "DOI:10.1084/jem.182.1.155",
                    "PMID:12663757",
                    "DOI:10.1046/j.0014-2956.2001.02433.x",
                    "PMID:21183794",
                    "DOI:10.1046/j.1523-1747.1999.00581.x",
                    "DOI:10.1101/gr.2596504"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P04040": {
              "name": "CAT",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P04040",
                  "value_url": "https://identifiers.org/uniprot:P04040",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Catalase (527 aa, ~60 kDa) is encoded by the human CAT gene. This protein plays a role in the detoxification of hydrogen peroxide.; An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA.; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide",
                    "biolink:NamedThing",
                    "biolink:OrganismTaxon",
                    "biolink:Drug",
                    "biolink:MolecularEntity",
                    "biolink:SmallMolecule"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CAT gene",
                    "CAT (cow)",
                    "CAT (human)",
                    "catalase (fruit fly)",
                    "CAT [cytosol]",
                    "catalase (rat)",
                    "Cat",
                    "CAT [secretory granule lumen]",
                    "CAT Gene",
                    "CAT gene [nucleoplasm]",
                    "catalase (human)",
                    "catalase (mouse)",
                    "Manganese Catalase",
                    "catalase",
                    "CAT [extracellular region]",
                    "Cat (rat)",
                    "catalase (cow)",
                    "CAT [ficolin-1-rich granule lumen]",
                    "CAT",
                    "Cat (mouse)",
                    "CAT [peroxisomal matrix]",
                    "Catalase",
                    "cat Gene"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.TARGET:CHEMBL3627594",
                    "ORPHANET:119192",
                    "OMIM:115500",
                    "PR:P04040",
                    "REACT:R-HSA-9622733",
                    "UMLS:C1413138",
                    "NCIT:C14191",
                    "KEGG.COMPOUND:C05784",
                    "PathWhiz.ProteinComplex:9579",
                    "KEGG.ENZYME:1.11.1.6",
                    "PathWhiz.ProteinComplex:10004",
                    "REACT:R-HSA-51417",
                    "UniProtKB:P04040",
                    "NCBIGene:531682",
                    "LOINC:LP15478-8",
                    "NCIT:C61060",
                    "UMLS:C0007367",
                    "UMLS:C0024707",
                    "NCIT:C61062",
                    "LOINC:LA14179-8",
                    "CHEMBL.TARGET:CHEMBL1075216",
                    "REACT:R-HSA-6806458",
                    "HGNC:1516",
                    "LOINC:LP19344-8",
                    "PathWhiz.ProteinComplex:8277",
                    "LOINC:MTHU009224",
                    "NCIT:C19450",
                    "PathWhiz.ProteinComplex:219",
                    "RXNORM:2133",
                    "NCBIGene:847",
                    "PathWhiz.ProteinComplex:8935",
                    "PR:P24270",
                    "MESH:D002374",
                    "PR:P04762",
                    "NDDF:005134",
                    "MGI:88271",
                    "PR:P17336",
                    "VANDF:4020880",
                    "REACT:R-HSA-6801311",
                    "ENSEMBL:ENSG00000121691",
                    "PR:000005061",
                    "PR:P00432",
                    "RGD:2279",
                    "PathWhiz.ProteinComplex:6905",
                    "CHEMBL.TARGET:CHEMBL2227489",
                    "REACT:R-HSA-9033141",
                    "REACT:R-HSA-6801279"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:18088087",
                    "DOI:10.1038/nature04632",
                    "PMID:3755526",
                    "PMID:23186163",
                    "DOI:10.1107/s0907444900013767",
                    "DOI:10.1016/s0891-5849(01)00734-1",
                    "PMID:21269460",
                    "PMID:2308162",
                    "PMID:7882369",
                    "PMID:16554811"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P04083": {
              "name": "ANXA1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P04083",
                  "value_url": "https://identifiers.org/uniprot:P04083",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "An annexin A1 that is encoded in the genome of human. // COMMENTS: Category=organism-gene.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "annexin A1 (rat)",
                    "ANXA1",
                    "ANXA1 (human)",
                    "annexin A1 (human)",
                    "annexin A1 (mouse)",
                    "ANXA1 [extracellular region]",
                    "ANXA1 gene [nucleoplasm]",
                    "Anxa1 (mouse)",
                    "ANXA1 gene",
                    "ANXA1 [cytosol]",
                    "Anxa1 (rat)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-444539",
                    "PR:P07150",
                    "UniProtKB:P04083",
                    "PR:P04083",
                    "UMLS:C1412417",
                    "REACT:R-HSA-5263630",
                    "REACT:R-HSA-6789507",
                    "OMIM:151690",
                    "NCBIGene:301",
                    "MGI:96819",
                    "PR:P10107",
                    "RGD:2118",
                    "ENSEMBL:ENSG00000135046",
                    "HGNC:533"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1016/j.celrep.2015.02.033",
                    "DOI:10.1042/bj2630097",
                    "PMID:9915835",
                    "PMID:23186163",
                    "DOI:10.1002/pro.5560020317",
                    "DOI:10.1021/bi00101a015",
                    "DOI:10.1126/science.1175371",
                    "DOI:10.1021/bi00410a024",
                    "PMID:21269460",
                    "PMID:15485879"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P04114": {
              "name": "APOB",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P04114",
                  "value_url": "https://identifiers.org/uniprot:P04114",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Apolipoprotein B-100 (4563 aa, ~516 kDa) is encoded by the human APOB gene. This protein plays a role in both transport and cellular uptake of LDL particles.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "APOB(28-2179) [endosome lumen]",
                    "apolipoprotein B-100 (human)",
                    "APOB(28-2179) [plasma membrane]",
                    "APOB(28-2179) [endoplasmic reticulum lumen]",
                    "AcK-APOB(28-4563) [endocytic vesicle lumen]",
                    "APOB",
                    "APOB(28-2179) [extracellular region]",
                    "p-APOB(28-4563) [endoplasmic reticulum lumen]",
                    "AcK-APOB(28-4563) [extracellular region]",
                    "10xdHF-10xglutamyl semialdehyde (Pro)-6xL-tyrosine residue-3xOxoH-2xmodified L-lysine residue-N'-formyl-L-kynurenine-APOB(28-4563) [endocytic vesicle lumen]",
                    "APOB(28-2179) [endoplasmic reticulum membrane]",
                    "APOB(28-4563) [plasma membrane]",
                    "APOB(28-2179) [clathrin-coated endocytic vesicle membrane]",
                    "APOB(28-4563) [lysosomal lumen]",
                    "APOB Gene",
                    "APOB(28-2179) [endosome membrane]",
                    "apolipoprotein B-100 (mouse)",
                    "APOB(28-4563) [endosome membrane]",
                    "APOB(28-4563) [smooth endoplasmic reticulum]",
                    "APOB (human)",
                    "APOB(28-4563) [clathrin-coated endocytic vesicle membrane]",
                    "APOB(28-4563) [endocytic vesicle lumen]",
                    "Apob (rat)",
                    "APOB(28-4563) [endoplasmic reticulum membrane]",
                    "APOB protein, human",
                    "APOB gene",
                    "APOB(28-4563) [endosome lumen]",
                    "apolipoprotein B-100 (rat)",
                    "APOB(28-2179) [early endosome]",
                    "APOB(28-4563) [extracellular region]",
                    "APOB(28-2179) [cytosol]",
                    "10xdHF-10xglutamyl semialdehyde (Pro)-6xL-tyrosine residue-3xOxoH-2xmodified L-lysine residue-N'-formyl-L-kynurenine-APOB(28-4563) [extracellular region]",
                    "Apob (mouse)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PR:Q7TMA5",
                    "REACT:R-HSA-2429651",
                    "REACT:R-HSA-174620",
                    "HGNC:603",
                    "REACT:R-HSA-171119",
                    "REACT:R-HSA-171065",
                    "REACT:R-HSA-2395786",
                    "REACT:R-HSA-8866317",
                    "MGI:88052",
                    "PR:E9Q414",
                    "REACT:R-HSA-2239461",
                    "REACT:R-HSA-171089",
                    "OMIM:107730",
                    "REACT:R-HSA-2512789",
                    "REACT:R-HSA-2173751",
                    "RGD:2129",
                    "REACT:R-HSA-174716",
                    "NCBIGene:338",
                    "PR:P04114",
                    "REACT:R-HSA-6784882",
                    "REACT:R-HSA-2173702",
                    "REACT:R-HSA-174625",
                    "UMLS:C1412471",
                    "REACT:R-HSA-8957068",
                    "REACT:R-HSA-2239446",
                    "REACT:R-HSA-174788",
                    "REACT:R-HSA-171155",
                    "LOINC:LP96191-9",
                    "UniProtKB:P04114",
                    "REACT:R-HSA-8876369",
                    "MESH:C569471",
                    "UMLS:C3252643",
                    "REACT:R-HSA-174770",
                    "NCIT:C106030",
                    "ENSEMBL:ENSG00000084674",
                    "REACT:R-HSA-174637",
                    "REACT:R-HSA-174762",
                    "REACT:R-HSA-171121"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1172/jci117772",
                    "PMID:6088540",
                    "DOI:10.1515/bchm3.1986.367.2.1077",
                    "PMID:3903660",
                    "DOI:10.1126/science.3659919",
                    "PMID:14732481",
                    "DOI:10.1016/j.bbadis.2003.11.002",
                    "DOI:10.1007/s004390050651",
                    "PMID:15815621",
                    "DOI:10.1161/circgenetics.115.001106"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P04150": {
              "name": "NR3C1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P04150",
                  "value_url": "https://identifiers.org/uniprot:P04150",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Glucocorticoid receptor (777 aa, ~86 kDa) is encoded by the human NR3C1 gene. This protein plays a role in both chromatin remodeling and transcriptional regulation.; UMLS Semantic Type: STY:T192; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "glucocorticoid receptor (human)",
                    "NR3C1-4 [nucleoplasm]",
                    "NR3C1 [nucleoplasm]",
                    "SUMO1-K277,K293-NR3C1 [nucleoplasm]",
                    "NR3C1-3 [nucleoplasm]",
                    "Nr3c1 (mouse)",
                    "NR3C1 gene",
                    "NR3C1-9 [nucleoplasm]",
                    "NR3C1 Gene",
                    "Nr3c1 (rat)",
                    "NR3C1-8 [nucleoplasm]",
                    "NR3C1-2 [nucleoplasm]",
                    "NR3C1-1 [nucleoplasm]",
                    "NR3C1 [cytosol]",
                    "glucocorticoid receptor (rat)",
                    "NR3C1-6 [nucleoplasm]",
                    "NR3C1 protein, human",
                    "NR3C1 (human)",
                    "NR3C1",
                    "NR3C1-7 [nucleoplasm]",
                    "NR3C1-5 [nucleoplasm]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C1334899",
                    "PR:P04150",
                    "MGI:95824",
                    "REACT:R-HSA-4341106",
                    "REACT:R-HSA-3196173",
                    "REACT:R-HSA-3196159",
                    "REACT:R-HSA-5618118",
                    "REACT:R-HSA-3196151",
                    "NCBIGene:2908",
                    "REACT:R-HSA-3196152",
                    "NCIT:C28571",
                    "REACT:R-HSA-3196163",
                    "MESH:C497713",
                    "REACT:R-HSA-3196158",
                    "ENSEMBL:ENSG00000113580",
                    "REACT:R-HSA-3196167",
                    "REACT:R-HSA-3196155",
                    "REACT:R-HSA-3196175",
                    "REACT:R-HSA-879837",
                    "UMLS:C1370369",
                    "UniProtKB:P04150",
                    "HGNC:7978",
                    "OMIM:138040",
                    "RGD:2741",
                    "PR:P06536"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:24483153",
                    "PMID:18483179",
                    "DOI:10.1038/nature10700",
                    "PMID:16478993",
                    "PMID:9353307",
                    "PMID:19141540",
                    "PMID:12351458",
                    "PMID:26031419",
                    "DOI:10.1038/ncomms12037",
                    "DOI:10.1038/318670a0"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P04637": {
              "name": "TP53",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P04637",
                  "value_url": "https://identifiers.org/uniprot:P04637",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Cellular tumor antigen p53 (393 aa, ~44 kDa) is encoded by the human TP53 gene. This protein plays a role in the regulation of both the cell cycle and apoptosis.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "TP53 S99Pfs*24 [nucleoplasm]",
                    "TP53 T123Dfs*26 [nucleoplasm]",
                    "TP53 A83Gfs*65 [nucleoplasm]",
                    "TP53 S261Tfs*2 [nucleoplasm]",
                    "TP53 K351* [nucleoplasm]",
                    "TP53 Y205Sfs*4 [nucleoplasm]",
                    "TP53 P87Lfs*59 [nucleoplasm]",
                    "TP53 Q317* [nucleoplasm]",
                    "TP53 I232Qfs*5 [nucleoplasm]",
                    "TP53 P60Vfs*64 [nucleoplasm]",
                    "TP53 E171Mfs*61 [nucleoplasm]",
                    "TP53 G112Lfs*36 [nucleoplasm]",
                    "TP53 Q52Lfs*68 [nucleoplasm]",
                    "TP53 M66Qfs*56 [nucleoplasm]",
                    "TP53 W53* [nucleoplasm]",
                    "TP53 T256Kfs*87 [nucleoplasm]",
                    "TP53 Y234Sfs*15 [nucleoplasm]",
                    "TP53 A39Mfs*3 [nucleoplasm]",
                    "TP53 C275Lfs*31 [nucleoplasm]",
                    "TP53 W146Ifs*22 [nucleoplasm]",
                    "TP53 S269Kfs*3 [nucleoplasm]",
                    "TP53 L206Ffs*35 [nucleoplasm]",
                    "TP53 I254Tfs*7 [nucleoplasm]",
                    "TP53 C124Lfs*25 [nucleoplasm]",
                    "TP53 L194Sfs*52 [nucleoplasm]",
                    "TP53 E56Rfs*6 [nucleoplasm]",
                    "TP53 G108Rfs*41 [nucleoplasm]",
                    "TP53 Q144Rfs*26 [nucleoplasm]",
                    "TP53 V73Afs*76 [nucleoplasm]",
                    "TP53 H296Tfs*49 [nucleoplasm]",
                    "TP53 V172Lfs*2 [nucleoplasm]",
                    "TP53 H115Qfs*4 [nucleoplasm]",
                    "TP53 C238* [nucleoplasm]",
                    "TP53 V225Wfs*3 [nucleoplasm]",
                    "TP53 P128Lfs*42 [nucleoplasm]",
                    "TP53 H214Qfs*7 [nucleoplasm]",
                    "TP53 K101Lfs*42 [nucleoplasm]",
                    "TP53 H115Lfs*8 [nucleoplasm]",
                    "TP53 L299Rfs*46 [nucleoplasm]",
                    "cellular tumor antigen p53 (human)",
                    "TP53 H214Cfs*29 [nucleoplasm]",
                    "TP53 G154Pfs*25 [nucleoplasm]",
                    "TP53 P153Rfs*22 [nucleoplasm]",
                    "TP53 H233Lfs*6 [nucleoplasm]",
                    "TP53 Q144Afs*5 [nucleoplasm]",
                    "TP53 L114* [nucleoplasm]",
                    "TP53 S106Rfs*16 [nucleoplasm]",
                    "TP53 R158Afs*12 [nucleoplasm]",
                    "TP53 L299Cfs*46 [nucleoplasm]",
                    "TP53 D207Lfs*41 [nucleoplasm]",
                    "TP53 M243Hfs*18 [nucleoplasm]",
                    "TP53 T304Lfs*3 [nucleoplasm]",
                    "TP53 S46Pfs*77 [nucleoplasm]",
                    "TP53 V157Hfs*19 [nucleoplasm]",
                    "TP53 N263Tfs*8 [nucleoplasm]",
                    "TP53 S149Pfs*17 [nucleoplasm]",
                    "TP53 R209Ffs*35 [nucleoplasm]",
                    "TP53 T253Qfs*3 [nucleoplasm]",
                    "TP53 T284Rfs*21 [nucleoplasm]",
                    "TP53 D148Ifs*22 [nucleoplasm]",
                    "TP53 H168Rfs*23 [nucleoplasm]",
                    "TP53 I162Sfs*8 [nucleoplasm]",
                    "TP53 Y107Tfs*44 [nucleoplasm]",
                    "TP53 S33Ffs*10 [nucleoplasm]",
                    "TP53 L206Wfs*41 [nucleoplasm]",
                    "TP53 N288Qfs*15 [nucleoplasm]",
                    "TP53 K164Sfs*6 [nucleoplasm]",
                    "TP53 Q136Sfs*13 [nucleoplasm]",
                    "TP53 P75Yfs*68 [nucleoplasm]",
                    "TP53 L188Pfs*19 [nucleoplasm]",
                    "TP53 E285Rfs*13 [nucleoplasm]",
                    "cellular tumor antigen p53 (zebrafish)",
                    "Ac-K120,p-S15,S20-TP53 [nucleoplasm]",
                    "TP53 Y163Tfs*14 [nucleoplasm]",
                    "TP53 F341L [nucleoplasm]",
                    "TP53 P152Afs*28 [nucleoplasm]",
                    "TP53 Q167Hfs*4 [nucleoplasm]",
                    "TP53 H178Tfs*69 [nucleoplasm]",
                    "TP53 L257Gfs*6 [nucleoplasm]",
                    "TP53 E286Sfs*17 [nucleoplasm]",
                    "TP53 W146Lfs*23 [nucleoplasm]",
                    "TP53 L206* [nucleoplasm]",
                    "TP53 L344R [nucleoplasm]",
                    "TP53 S227* [nucleoplasm]",
                    "TP53 Q38* [nucleoplasm]",
                    "TP53 R202Afs*7 [nucleoplasm]",
                    "TP53 Q136Sfs*26 [nucleoplasm]",
                    "TP53 T155Hfs*26 [nucleoplasm]",
                    "TP53 S149Afs*72 [nucleoplasm]",
                    "TP53 P85Cfs*63 [nucleoplasm]",
                    "TP53 A119Qfs*5 [nucleoplasm]",
                    "TP53 V157Sfs*13 [nucleoplasm]",
                    "TP53 A129Rfs*38 [nucleoplasm]",
                    "TP53 G279Pfs*24 [nucleoplasm]",
                    "TP53 E204Wfs*44 [nucleoplasm]",
                    "TP53 Y107Sfs*38 [nucleoplasm]",
                    "TP53 H214Lfs*33 [nucleoplasm]",
                    "TP53 T123Ifs*47 [nucleoplasm]",
                    "TP53 P47Rfs*76 [nucleoplasm]",
                    "TP53 D208* [nucleoplasm]",
                    "TP53 L308Pfs*15 [nucleoplasm]",
                    "TP53 L265Pfs*5 [nucleoplasm]",
                    "TP53 Y107Vfs*13 [nucleoplasm]",
                    "TP53 H178Pfs*69 [nucleoplasm]",
                    "TP53 I255Hfs*8 [nucleoplasm]",
                    "TP53 N288Kfs*15 [nucleoplasm]",
                    "TP53 E287* [nucleoplasm]",
                    "TP53 S33Vfs*6 [nucleoplasm]",
                    "TP53 S127Pfs*43 [nucleoplasm]",
                    "TP53 D184Efs*24 [nucleoplasm]",
                    "TP53 R213* [nucleoplasm]",
                    "TP53 E298Dfs*47 [nucleoplasm]",
                    "TP53 R283Sfs*56 [nucleoplasm]",
                    "TP53 Y163Qfs*17 [nucleoplasm]",
                    "TP53 P152Rfs*24 [nucleoplasm]",
                    "p-S15,S20,Me-R333,Me2-R335,R337-TP53 [nucleoplasm]",
                    "TP53 Q38Wfs*4 [nucleoplasm]",
                    "TP53 S166Ifs*15 [nucleoplasm]",
                    "TP53 P316Lfs*21 [nucleoplasm]",
                    "TP53 E62* [nucleoplasm]",
                    "TP53 R337G [nucleoplasm]",
                    "TP53 F341V [nucleoplasm]",
                    "TP53 V143Afs*4 [nucleoplasm]",
                    "TP53 R267Tfs*5 [nucleoplasm]",
                    "TP53 E285* [nucleoplasm]",
                    "TP53 P82Rfs*41 [nucleoplasm]",
                    "TP53 E294* [nucleoplasm]",
                    "TP53 Y234Lfs*4 [nucleoplasm]",
                    "TP53 L257Wfs*88 [nucleoplasm]",
                    "TP53 L93Afs*57 [nucleoplasm]",
                    "TP53 Y163Hfs*4 [nucleoplasm]",
                    "TP53 P82Gfs*66 [nucleoplasm]",
                    "TP53 M133Pfs*13 [nucleoplasm]",
                    "TP53 K291Tfs*48 [nucleoplasm]",
                    "TP53 T304Ifs*41 [nucleoplasm]",
                    "TP53 N29Tfs*15 [nucleoplasm]",
                    "TP53 Q136* [nucleoplasm]",
                    "TP53 L35* [nucleoplasm]",
                    "TP53 I254Sfs*91 [nucleoplasm]",
                    "TP53 I195Cfs*46 [nucleoplasm]",
                    "TP53 Y205Tfs*37 [nucleoplasm]",
                    "TP53 L130Pfs*41 [nucleoplasm]",
                    "TP53 P316Sfs*21 [nucleoplasm]",
                    "TP53 F54Lfs*69 [nucleoplasm]",
                    "TP53 T155Hfs*21 [nucleoplasm]",
                    "TP53 Q144* [nucleoplasm]",
                    "TP53 R175Afs*72 [nucleoplasm]",
                    "TP53 F109Sfs*14 [nucleoplasm]",
                    "TP53 L194Hfs*14 [nucleoplasm]",
                    "TP53 Y103Lfs*46 [nucleoplasm]",
                    "TP53 R158Pfs*11 [nucleoplasm]",
                    "p-S15,S33,S46-TP53 [nucleoplasm]",
                    "TP53 P75Lfs*74 [nucleoplasm]",
                    "TP53 H178Afs*65 [nucleoplasm]",
                    "TP53 C124Yfs*24 [nucleoplasm]",
                    "TP53 G154Wfs*10 [nucleoplasm]",
                    "TP53 P152Rfs*27 [nucleoplasm]",
                    "TP53 G245Vfs*19 [nucleoplasm]",
                    "TP53 K292Lfs*54 [nucleoplasm]",
                    "TP53 R196Pfs*13 [nucleoplasm]",
                    "TP53 P128Rfs*20 [nucleoplasm]",
                    "TP53 A86Cfs*63 [nucleoplasm]",
                    "TP53 S90Pfs*33 [nucleoplasm]",
                    "TP53 K291Qfs*15 [nucleoplasm]",
                    "TP53 L35Ffs*7 [nucleoplasm]",
                    "TP53 Q165Hfs*4 [nucleoplasm]",
                    "TP53 S94Ffs*55 [nucleoplasm]",
                    "TP53 P72Rfs*76 [nucleoplasm]",
                    "TP53 R158Hfs*21 [nucleoplasm]",
                    "TP53 Y126Sfs*44 [nucleoplasm]",
                    "TP53 E198* [nucleoplasm]",
                    "TP53 K321* [nucleoplasm]",
                    "TP53 P13Lfs*2 [nucleoplasm]",
                    "TP53 S99Ffs*55 [nucleoplasm]",
                    "TP53 T102Pfs*45 [nucleoplasm]",
                    "TP53 L265Wfs*80 [nucleoplasm]",
                    "TP53 E258Pfs*85 [nucleoplasm]",
                    "TP53 G108Vfs*13 [nucleoplasm]",
                    "TP53 G245Efs*17 [nucleoplasm]",
                    "TP53 V218Wfs*30 [nucleoplasm]",
                    "TP53 Q317Pfs*20 [nucleoplasm]",
                    "TP53 S240Vfs*7 [nucleoplasm]",
                    "TP53 L130Sfs*40 [nucleoplasm]",
                    "TP53 R110Pfs*39 [nucleoplasm]",
                    "TP53 L14Sfs*15 [nucleoplasm]",
                    "Ac-K120,K382,p-S15,S20-TP53 [nucleoplasm]",
                    "TP53 L93Ffs*53 [nucleoplasm]",
                    "TP53 D42Qfs*5 [nucleoplasm]",
                    "TP53 D324Afs*29 [nucleoplasm]",
                    "TP53 G154Vfs*18 [nucleoplasm]",
                    "TP53 H179Qfs*64 [nucleoplasm]",
                    "TP53 C124* [nucleoplasm]",
                    "TP53 C176Afs*65 [nucleoplasm]",
                    "TP53 D228* [nucleoplasm]",
                    "TP53 G199Rfs*10 [nucleoplasm]",
                    "TP53 P47Hfs*2 [nucleoplasm]",
                    "TP53 D259Qfs*3 [nucleoplasm]",
                    "TP53 K139Afs*4 [nucleoplasm]",
                    "TP53 R209Kfs*38 [nucleoplasm]",
                    "TP53 V272Gfs*73 [nucleoplasm]",
                    "TP53 L32Pfs*11 [nucleoplasm]",
                    "TP53 S96Cfs*52 [nucleoplasm]",
                    "TP53 M169Ifs*12 [nucleoplasm]",
                    "TP53 T140Mfs*28 [nucleoplasm]",
                    "TP53 C238Vfs*9 [nucleoplasm]",
                    "TP53 R337P [nucleoplasm]",
                    "TP53 G302Afs*42 [nucleoplasm]",
                    "TP53 S95Lfs*28 [nucleoplasm]",
                    "TP53 P300Qfs*44 [nucleoplasm]",
                    "TP53 W53Cfs*4 [nucleoplasm]",
                    "TP53 C135* [nucleoplasm]",
                    "TP53 L111Ifs*8 [nucleoplasm]",
                    "TP53 F270Lfs*2 [nucleoplasm]",
                    "TP53 K292Gfs*52 [nucleoplasm]",
                    "TP53 A138Pfs*30 [nucleoplasm]",
                    "TP53 T312Pfs*20 [nucleoplasm]",
                    "TP53 G302Vfs*44 [nucleoplasm]",
                    "TP53 N200Kfs*9 [nucleoplasm]",
                    "TP53 L257Pfs*85 [nucleoplasm]",
                    "TP53 S303Efs*3 [nucleoplasm]",
                    "TP53 Q165Afs*6 [nucleoplasm]",
                    "TP53 K351N [nucleoplasm]",
                    "TP53 T256Nfs*89 [nucleoplasm]",
                    "TP53 A276Vfs*68 [nucleoplasm]",
                    "TP53 G334E [nucleoplasm]",
                    "TP53 I195Nfs*14 [nucleoplasm]",
                    "TP53 R196Sfs*12 [nucleoplasm]",
                    "TP53 Q104* [nucleoplasm]",
                    "TP53 R248* [nucleoplasm]",
                    "TP53 P72Lfs*48 [nucleoplasm]",
                    "TP53 K132Cfs*37 [nucleoplasm]",
                    "TP53 A69Gfs*80 [nucleoplasm]",
                    "TP53 P71Sfs*78 [nucleoplasm]",
                    "TP53 R110Wfs*12 [nucleoplasm]",
                    "TP53 G266Dfs*79 [nucleoplasm]",
                    "TP53 A189Pfs*19 [nucleoplasm]",
                    "TP53 S95Gfs*37 [nucleoplasm]",
                    "TP53 Y205* [nucleoplasm]",
                    "TP53 Q144Pfs*5 [nucleoplasm]",
                    "TP53 R280Efs*65 [nucleoplasm]",
                    "TP53 S94* [nucleoplasm]",
                    "TP53 D184Afs*62 [nucleoplasm]",
                    "TP53 T118Qfs*5 [nucleoplasm]",
                    "TP53 S215Kfs*7 [nucleoplasm]",
                    "TP53 L188* [nucleoplasm]",
                    "TP53 G226Pfs*17 [nucleoplasm]",
                    "TP53 S215Ifs*33 [nucleoplasm]",
                    "TP53 D48* [nucleoplasm]",
                    "TP53 Q52Hfs*71 [nucleoplasm]",
                    "TP53 P92Hfs*57 [nucleoplasm]",
                    "TP53 R209Hfs*5 [nucleoplasm]",
                    "TP53 A86Vfs*55 [nucleoplasm]",
                    "TP53 D148Efs*23 [nucleoplasm]",
                    "TP53 Y234Ifs*6 [nucleoplasm]",
                    "TP53 Q165Hfs*5 [nucleoplasm]",
                    "TP53 F113Qfs*5 [nucleoplasm]",
                    "TP53 P309Lfs*31 [nucleoplasm]",
                    "TP53 T211Lfs*36 [nucleoplasm]",
                    "TP53 Q136Pfs*30 [nucleoplasm]",
                    "TP53 P77Rfs*71 [nucleoplasm]",
                    "TP53 W53Gfs*70 [nucleoplasm]",
                    "TP53 C275Lfs*67 [nucleoplasm]",
                    "TP53 R65Kfs*84 [nucleoplasm]",
                    "TP53 A347D [nucleoplasm]",
                    "TP53 D57Sfs*86 [nucleoplasm]",
                    "TP53 D57Tfs*72 [nucleoplasm]",
                    "TP53 S95Ffs*53 [nucleoplasm]",
                    "TP53 A76Hfs*47 [nucleoplasm]",
                    "TP53 M133Lfs*42 [nucleoplasm]",
                    "TP53 A83Pfs*39 [nucleoplasm]",
                    "TP53 D186* [nucleoplasm]",
                    "TP53 E204Sfs*43 [nucleoplasm]",
                    "TP53 M169Dfs*11 [nucleoplasm]",
                    "TP53 N268Efs*4 [nucleoplasm]",
                    "TP53 H179* [nucleoplasm]",
                    "TP53 R249Sfs*96 [nucleoplasm]",
                    "TP53 P190Sfs*12 [nucleoplasm]",
                    "TP53 E180Sfs*67 [nucleoplasm]",
                    "TP53 S106Tfs*17 [nucleoplasm]",
                    "TP53 M66Tfs*60 [nucleoplasm]",
                    "TP53 R174* [nucleoplasm]",
                    "TP53 Q144Afs*16 [nucleoplasm]",
                    "TP53 R196Ffs*35 [nucleoplasm]",
                    "TP53 L93Rfs*30 [nucleoplasm]",
                    "TP53 H115Ifs*8 [nucleoplasm]",
                    "TP53 N30Kfs*13 [nucleoplasm]",
                    "TP53 N30Tfs*14 [nucleoplasm]",
                    "TP53 V203Wfs*44 [nucleoplasm]",
                    "TP53 P85Lfs*59 [nucleoplasm]",
                    "TP53 C124Afs*46 [nucleoplasm]",
                    "TP53 Q144Gfs*2 [nucleoplasm]",
                    "TP53 C275Vfs*70 [nucleoplasm]",
                    "TP53 E298Dfs*7 [nucleoplasm]",
                    "TP53 A88Sfs*61 [nucleoplasm]",
                    "TP53 H233Vfs*8 [nucleoplasm]",
                    "TP53 E56Vfs*73 [nucleoplasm]",
                    "TP53 A189Vfs*53 [nucleoplasm]",
                    "TP53 S240Kfs*24 [nucleoplasm]",
                    "TP53 P87Ifs*54 [nucleoplasm]",
                    "TP53 Q317Sfs*28 [nucleoplasm]",
                    "TP53 M44Sfs*79 [nucleoplasm]",
                    "TP53 A189Dfs*14 [nucleoplasm]",
                    "TP53 T304Qfs*44 [nucleoplasm]",
                    "TP53 S241Pfs*6 [nucleoplasm]",
                    "TP53 E271Gfs*34 [nucleoplasm]",
                    "TP53 G154Afs*28 [nucleoplasm]",
                    "TP53 W91Cfs*32 [nucleoplasm]",
                    "TP53 A307Lfs*32 [nucleoplasm]",
                    "TP53 L130Pfs*39 [nucleoplasm]",
                    "TP53 A347T [nucleoplasm]",
                    "TP53 M243Wfs*4 [nucleoplasm]",
                    "TP53 H178Pfs*2 [nucleoplasm]",
                    "TP53 N288Sfs*17 [nucleoplasm]",
                    "TP53 S185Tfs*62 [nucleoplasm]",
                    "p-S37-TP53 [nucleoplasm]",
                    "TP53 A69Lfs*54 [nucleoplasm]",
                    "TP53 S46Vfs*6 [nucleoplasm]",
                    "TP53 P152Afs*14 [nucleoplasm]",
                    "TP53 R209Sfs*5 [nucleoplasm]",
                    "TP53 L22Yfs*22 [nucleoplasm]",
                    "TP53 N239Kfs*25 [nucleoplasm]",
                    "TP53 A78Gfs*73 [nucleoplasm]",
                    "TP53 C141Afs*29 [nucleoplasm]",
                    "TP53 N247Tfs*98 [nucleoplasm]",
                    "TP53 V73Rfs*76 [nucleoplasm]",
                    "TP53 P222Gfs*4 [nucleoplasm]",
                    "TP53 G244Afs*3 [nucleoplasm]",
                    "TP53 Q52Nfs*71 [nucleoplasm]",
                    "TP53 T150Afs*16 [nucleoplasm]",
                    "TP53 K164* [nucleoplasm]",
                    "TP53 R283Pfs*16 [nucleoplasm]",
                    "TP53 E11* [nucleoplasm]",
                    "TP53 L289Pfs*56 [nucleoplasm]",
                    "TP53 T304Yfs*2 [nucleoplasm]",
                    "TP53 Q100Lfs*42 [nucleoplasm]",
                    "TP53 L330I [nucleoplasm]",
                    "TP53 L201* [nucleoplasm]",
                    "TP53 E221Vfs*4 [nucleoplasm]",
                    "TP53 R280Efs*26 [nucleoplasm]",
                    "PolyUb-TP53 [nucleoplasm]",
                    "TP53 Y126Qfs*18 [nucleoplasm]",
                    "TP53 W146* [nucleoplasm]",
                    "TP53 R209Cfs*6 [nucleoplasm]",
                    "TP53 R175Lfs*5 [nucleoplasm]",
                    "TP53 N239Wfs*4 [nucleoplasm]",
                    "TP53 A88Gfs*32 [nucleoplasm]",
                    "TP53 P322Tfs*15 [nucleoplasm]",
                    "TP53 M44Afs*7 [nucleoplasm]",
                    "TP53 K120Tfs*2 [nucleoplasm]",
                    "TP53 A39Qfs*5 [nucleoplasm]",
                    "TP53 R65Tfs*84 [nucleoplasm]",
                    "TP53 R290Kfs*53 [nucleoplasm]",
                    "TP53 Q136Hfs*34 [nucleoplasm]",
                    "TP53 L206Yfs*4 [nucleoplasm]",
                    "TP53 S20* [nucleoplasm]",
                    "TP53 L93Vfs*55 [nucleoplasm]",
                    "TP53 R174Kfs*24 [nucleoplasm]",
                    "TP53 K320Efs*17 [nucleoplasm]",
                    "TP53 E204Vfs*4 [nucleoplasm]",
                    "TP53 R280* [nucleoplasm]",
                    "TP53 N310Tfs*35 [nucleoplasm]",
                    "TP53 H179Pfs*2 [nucleoplasm]",
                    "TP53 A74Gfs*50 [nucleoplasm]",
                    "TP53 W146Vfs*3 [nucleoplasm]",
                    "TP53 C135Ffs*36 [nucleoplasm]",
                    "TP53 L114Ffs*33 [nucleoplasm]",
                    "TP53 T211Pfs*28 [nucleoplasm]",
                    "TP53 T256Hfs*8 [nucleoplasm]",
                    "TP53 R273Lfs*72 [nucleoplasm]",
                    "TP53 P77Sfs*71 [nucleoplasm]",
                    "TP53 N200Ifs*47 [nucleoplasm]",
                    "TP53 Y220Rfs*25 [nucleoplasm]",
                    "TP53 A119Rfs*6 [nucleoplasm]",
                    "TP53 C277Ffs*68 [nucleoplasm]",
                    "TP53 P142Afs*5 [nucleoplasm]",
                    "TP53 P80Lfs*43 [nucleoplasm]",
                    "TP53 Y234* [nucleoplasm]",
                    "TP53 P60Qfs*63 [nucleoplasm]",
                    "TP53 R209* [nucleoplasm]",
                    "TP53 G154Rfs*27 [nucleoplasm]",
                    "TP53 L43* [nucleoplasm]",
                    "TP53 S166* [nucleoplasm]",
                    "TP53 N268Tfs*77 [nucleoplasm]",
                    "TP53 R283Sfs*23 [nucleoplasm]",
                    "TP53 K132Rfs*38 [nucleoplasm]",
                    "TP53 C141Afs*5 [nucleoplasm]",
                    "TP53 A161Sfs*8 [nucleoplasm]",
                    "TP53 Q136Pfs*13 [nucleoplasm]",
                    "TP53 Q38Sfs*4 [nucleoplasm]",
                    "TP53 P301Lfs*41 [nucleoplasm]",
                    "TP53 E180* [nucleoplasm]",
                    "TP53 A307Sfs*30 [nucleoplasm]",
                    "TP53 [nucleoplasm]",
                    "TP53 P128Tfs*21 [nucleoplasm]",
                    "TP53 E198Ifs*47 [nucleoplasm]",
                    "TP53 C275* [nucleoplasm]",
                    "TP53 W91Gfs*32 [nucleoplasm]",
                    "TP53 F113Sfs*10 [nucleoplasm]",
                    "TP53 Q167Hfs*12 [nucleoplasm]",
                    "TP53 P153Sfs*28 [nucleoplasm]",
                    "p-T55-TP53 [nucleoplasm]",
                    "TP53 S315Nfs*24 [nucleoplasm]",
                    "Me-K382,p-S15,S20-TP53 [nucleoplasm]",
                    "TP53 E51Gfs*6 [nucleoplasm]",
                    "TP53 D61* [nucleoplasm]",
                    "TP53 T304Lfs*41 [nucleoplasm]",
                    "TP53 R290Qfs*15 [nucleoplasm]",
                    "TP53 Y236* [nucleoplasm]",
                    "TP53 A69Cfs*79 [nucleoplasm]",
                    "TP53 C176* [nucleoplasm]",
                    "TP53 V173Rfs*23 [nucleoplasm]",
                    "TP53 L348S [nucleoplasm]",
                    "TP53 D148* [nucleoplasm]",
                    "TP53 T211Ifs*33 [nucleoplasm]",
                    "TP53 Q317Rfs*28 [nucleoplasm]",
                    "TP53 P223Sfs*26 [nucleoplasm]",
                    "TP53 H297Tfs*48 [nucleoplasm]",
                    "TP53 R280Afs*62 [nucleoplasm]",
                    "TP53 G279Kfs*59 [nucleoplasm]",
                    "p-S315-TP53 [nucleoplasm]",
                    "TP53 E287Sfs*17 [nucleoplasm]",
                    "TP53 P278Lfs*28 [nucleoplasm]",
                    "TP53 G244Efs*17 [nucleoplasm]",
                    "TP53 A74Sfs*71 [nucleoplasm]",
                    "p-S15,S20-TP53 [nucleoplasm]",
                    "TP53 T155Pfs*15 [nucleoplasm]",
                    "TP53 S314Lfs*22 [nucleoplasm]",
                    "TP53 D21Tfs*23 [nucleoplasm]",
                    "TP53 C275Gfs*20 [nucleoplasm]",
                    "TP53 M160Wfs*10 [nucleoplasm]",
                    "TP53 E294Vfs*12 [nucleoplasm]",
                    "TP53 P222Sfs*26 [nucleoplasm]",
                    "TP53 E298Gfs*43 [nucleoplasm]",
                    "TP53 G226Dfs*3 [nucleoplasm]",
                    "TP53 L257Hfs*9 [nucleoplasm]",
                    "TP53 D57Kfs*67 [nucleoplasm]",
                    "TP53 T170Lfs*2 [nucleoplasm]",
                    "TP53 E51Dfs*72 [nucleoplasm]",
                    "TP53 R249Gfs*96 [nucleoplasm]",
                    "TP53 Q5* [nucleoplasm]",
                    "TP53 S96Lfs*27 [nucleoplasm]",
                    "TP53 V274Afs*33 [nucleoplasm]",
                    "TP53 R65Qfs*84 [nucleoplasm]",
                    "TP53 M66Gfs*80 [nucleoplasm]",
                    "TP53 V143Gfs*2 [nucleoplasm]",
                    "TP53 I251Hfs*11 [nucleoplasm]",
                    "TP53 Q167Rfs*3 [nucleoplasm]",
                    "TP53 S95Ifs*54 [nucleoplasm]",
                    "TP53 G244Rfs*19 [nucleoplasm]",
                    "TP53 A83Cfs*30 [nucleoplasm]",
                    "TP53 D186Mfs*61 [nucleoplasm]",
                    "TP53 A119Sfs*3 [nucleoplasm]",
                    "TP53 A159Pfs*11 [nucleoplasm]",
                    "TP53 E171Rfs*3 [nucleoplasm]",
                    "TP53 K164Sfs*5 [nucleoplasm]",
                    "TP53 D184Vfs*63 [nucleoplasm]",
                    "TP53 E224Afs*2 [nucleoplasm]",
                    "TP53 R273Cfs*32 [nucleoplasm]",
                    "TP53 V122Cfs*27 [nucleoplasm]",
                    "TP53 T81Pfs*49 [nucleoplasm]",
                    "TP53 G245Afs*14 [nucleoplasm]",
                    "TP53 E171Lfs*2 [nucleoplasm]",
                    "TP53 D324Vfs*21 [nucleoplasm]",
                    "TP53 G199Ifs*42 [nucleoplasm]",
                    "TP53 P85Hfs*37 [nucleoplasm]",
                    "TP53 E68* [nucleoplasm]",
                    "TP53 R249Kfs*15 [nucleoplasm]",
                    "TP53 Q100Gfs*37 [nucleoplasm]",
                    "TP53 P82Hfs*42 [nucleoplasm]",
                    "TP53 C135Yfs*9 [nucleoplasm]",
                    "TP53 S269Cfs*32 [nucleoplasm]",
                    "TP53 V274Ffs*71 [nucleoplasm]",
                    "TP53 Q100* [nucleoplasm]",
                    "TP53 Y163Tfs*7 [nucleoplasm]",
                    "TP53 P92Afs*57 [nucleoplasm]",
                    "Me2K-370,382-TP53 [nucleoplasm]",
                    "TP53 K351E [nucleoplasm]",
                    "TP53 G108Afs*39 [nucleoplasm]",
                    "TP53 K319Nfs*18 [nucleoplasm]",
                    "TP53 D259Tfs*86 [nucleoplasm]",
                    "TP53 P142Afs*7 [nucleoplasm]",
                    "TP53 V218Sfs*26 [nucleoplasm]",
                    "TP53 E198Gfs*11 [nucleoplasm]",
                    "TP53 Y163Lfs*18 [nucleoplasm]",
                    "TP53 F109Lfs*36 [nucleoplasm]",
                    "TP53 P223Lfs*24 [nucleoplasm]",
                    "TP53 Y220Mfs*27 [nucleoplasm]",
                    "TP53 R280Tfs*64 [nucleoplasm]",
                    "TP53 D48Efs*75 [nucleoplasm]",
                    "TP53 T256Hfs*89 [nucleoplasm]",
                    "SUMO2,3-K386-TP53 [nucleoplasm]",
                    "TP53 P316Lfs*30 [nucleoplasm]",
                    "TP53 I195Sfs*12 [nucleoplasm]",
                    "TP53 T81Nfs*68 [nucleoplasm]",
                    "TP53 T284Hfs*22 [nucleoplasm]",
                    "TP53 K291Gfs*12 [nucleoplasm]",
                    "TP53 A86Pfs*33 [nucleoplasm]",
                    "TP53 S90Lfs*59 [nucleoplasm]",
                    "TP53 R209Kfs*6 [nucleoplasm]",
                    "TP53 Q167Hfs*3 [nucleoplasm]",
                    "TP53 P190Lfs*53 [nucleoplasm]",
                    "TP53 D228Lfs*11 [nucleoplasm]",
                    "TP53 V274Cfs*32 [nucleoplasm]",
                    "TP53 Y103Rfs*19 [nucleoplasm]",
                    "TP53 C277* [nucleoplasm]",
                    "TP53 V97Sfs*26 [nucleoplasm]",
                    "TP53 V157Pfs*23 [nucleoplasm]",
                    "TP53 F113Pfs*37 [nucleoplasm]",
                    "TP53 A307Tfs*29 [nucleoplasm]",
                    "TP53 R283Hfs*22 [nucleoplasm]",
                    "TP53 G154Rfs*22 [nucleoplasm]",
                    "TP53 V122Afs*46 [nucleoplasm]",
                    "TP53 M237Vfs*9 [nucleoplasm]",
                    "TP53 W91Cfs*52 [nucleoplasm]",
                    "TP53 P301Qfs*44 [nucleoplasm]",
                    "TP53 N131Pfs*19 [nucleoplasm]",
                    "TP53 G334V [nucleoplasm]",
                    "TP53 M133Sfs*37 [nucleoplasm]",
                    "TP53 G112Afs*11 [nucleoplasm]",
                    "TP53 D281Tfs*64 [nucleoplasm]",
                    "TP53 N288Ifs*18 [nucleoplasm]",
                    "TP53 W146Pfs*19 [nucleoplasm]",
                    "TP53 A129Vfs*20 [nucleoplasm]",
                    "TP53 D228Vfs*18 [nucleoplasm]",
                    "TP53 E258Gfs*6 [nucleoplasm]",
                    "TP53 S227Lfs*20 [nucleoplasm]",
                    "TP53 A63Tfs*66 [nucleoplasm]",
                    "TP53 A129Pfs*41 [nucleoplasm]",
                    "TP53 V173* [nucleoplasm]",
                    "TP53 S241Lfs*22 [nucleoplasm]",
                    "MeK-370,p-S15,S20-TP53 [nucleoplasm]",
                    "TP53 S37Cfs*79 [nucleoplasm]",
                    "TP53 P128Tfs*12 [nucleoplasm]",
                    "TP53 L114Cfs*30 [nucleoplasm]",
                    "TP53 P80Rfs*41 [nucleoplasm]",
                    "TP53 H297Sfs*10 [nucleoplasm]",
                    "TP53 A161Gfs*20 [nucleoplasm]",
                    "TP53 V73Lfs*43 [nucleoplasm]",
                    "TP53 Y103Lfs*42 [nucleoplasm]",
                    "TP53 V147Rfs*27 [nucleoplasm]",
                    "TP53 R306* [nucleoplasm]",
                    "TP53 K321Nfs*24 [nucleoplasm]",
                    "TP53 N263Ifs*82 [nucleoplasm]",
                    "TP53 E68Rfs*55 [nucleoplasm]",
                    "TP53 T118Gfs*6 [nucleoplasm]",
                    "TP53 T256Nfs*8 [nucleoplasm]",
                    "TP53 P75Lfs*48 [nucleoplasm]",
                    "TP53 C124Ffs*47 [nucleoplasm]",
                    "TP53 L188Tfs*21 [nucleoplasm]",
                    "TP53 K24Nfs*20 [nucleoplasm]",
                    "TP53 C242Gfs*20 [nucleoplasm]",
                    "TP53 Q144Ffs*32 [nucleoplasm]",
                    "TP53 L26Qfs*13 [nucleoplasm]",
                    "TP53 D228Tfs*12 [nucleoplasm]",
                    "TP53 A161Pfs*9 [nucleoplasm]",
                    "TP53 R175Afs*6 [nucleoplasm]",
                    "TP53 P151Tfs*30 [nucleoplasm]",
                    "TP53 P152Lfs*29 [nucleoplasm]",
                    "TP53 R65Cfs*79 [nucleoplasm]",
                    "TP53 F270Vfs*72 [nucleoplasm]",
                    "TP53 K120Sfs*3 [nucleoplasm]",
                    "TP53 E258* [nucleoplasm]",
                    "TP53 A84Pfs*39 [nucleoplasm]",
                    "TP53 P36Rfs*8 [nucleoplasm]",
                    "TP53 M237Sfs*10 [nucleoplasm]",
                    "TP53 P77Cfs*73 [nucleoplasm]",
                    "TP53 M237Cfs*10 [nucleoplasm]",
                    "TP53 L130Cfs*20 [nucleoplasm]",
                    "TP53 Q144Sfs*26 [nucleoplasm]",
                    "TP53 F341C [nucleoplasm]",
                    "TP53 E204Gfs*46 [nucleoplasm]",
                    "TP53 Y163* [nucleoplasm]",
                    "TP53 F109Sfs*38 [nucleoplasm]",
                    "TP53 F109Gfs*37 [nucleoplasm]",
                    "TP53 A70Rfs*76 [nucleoplasm]",
                    "TP53 P278Lfs*67 [nucleoplasm]",
                    "TP53 V225Lfs*22 [nucleoplasm]",
                    "TP53 K292* [nucleoplasm]",
                    "TP53 T125Rfs*45 [nucleoplasm]",
                    "TP53 R342P [nucleoplasm]",
                    "TP53 G293Efs*3 [nucleoplasm]",
                    "TP53 R249Tfs*14 [nucleoplasm]",
                    "TP53 P71Gfs*75 [nucleoplasm]",
                    "TP53 S94Hfs*29 [nucleoplasm]",
                    "TP53 N311Tfs*34 [nucleoplasm]",
                    "TP53 G245Afs*2 [nucleoplasm]",
                    "TP53 N310Qfs*27 [nucleoplasm]",
                    "TP53 D207Efs*6 [nucleoplasm]",
                    "TP53 D184Ifs*63 [nucleoplasm]",
                    "TP53 L35Ffs*8 [nucleoplasm]",
                    "TP53 H297Pfs*48 [nucleoplasm]",
                    "TP53 E198Kfs*49 [nucleoplasm]",
                    "TP53 Q144Hfs*4 [nucleoplasm]",
                    "TP53 A83Gfs*66 [nucleoplasm]",
                    "TP53 Q52Kfs*67 [nucleoplasm]",
                    "TP53 S185Rfs*23 [nucleoplasm]",
                    "TP53 Y107* [nucleoplasm]",
                    "TP53 Q167Tfs*14 [nucleoplasm]",
                    "TP53 P27Lfs*17 [nucleoplasm]",
                    "TP53 F54Sfs*69 [nucleoplasm]",
                    "TP53 R213Tfs*2 [nucleoplasm]",
                    "TP53 S261* [nucleoplasm]",
                    "TP53 P67Rfs*81 [nucleoplasm]",
                    "TP53 N239Pfs*6 [nucleoplasm]",
                    "TP53 S240* [nucleoplasm]",
                    "TP53 G334W [nucleoplasm]",
                    "TP53 H168Rfs*4 [nucleoplasm]",
                    "TP53 F109Tfs*16 [nucleoplasm]",
                    "TP53 H115Ffs*33 [nucleoplasm]",
                    "TP53 S269Lfs*75 [nucleoplasm]",
                    "Ac-K382,p-S15,S20-TP53 [nucleoplasm]",
                    "TP53 C124Wfs*25 [nucleoplasm]",
                    "TP53 C176Sfs*67 [nucleoplasm]",
                    "TP53 E271* [nucleoplasm]",
                    "TP53 P142Lfs*28 [nucleoplasm]",
                    "TP53 R248Pfs*16 [nucleoplasm]",
                    "TP53 A276Lfs*29 [nucleoplasm]",
                    "TP53 V157Afs*24 [nucleoplasm]",
                    "TP53 Q52Pfs*5 [nucleoplasm]",
                    "TP53 Q136Nfs*34 [nucleoplasm]",
                    "TP53 T256Ifs*90 [nucleoplasm]",
                    "TP53 G105Afs*18 [nucleoplasm]",
                    "TP53 L289Sfs*56 [nucleoplasm]",
                    "TP53 N311Kfs*26 [nucleoplasm]",
                    "TP53 S106Qfs*43 [nucleoplasm]",
                    "TP53 Q144Hfs*26 [nucleoplasm]",
                    "TP53 S315Lfs*30 [nucleoplasm]",
                    "TP53 T55Mfs*68 [nucleoplasm]",
                    "TP53 P177Lfs*3 [nucleoplasm]",
                    "TP53 T230Pfs*17 [nucleoplasm]",
                    "TP53 E204* [nucleoplasm]",
                    "TP53 I50Mfs*4 [nucleoplasm]",
                    "TP53 C135Lfs*14 [nucleoplasm]",
                    "TP53 Q100Sfs*54 [nucleoplasm]",
                    "TP53 M169Ifs*5 [nucleoplasm]",
                    "TP53 D208Efs*38 [nucleoplasm]",
                    "TP53 P190Lfs*57 [nucleoplasm]",
                    "TP53 P222Rfs*25 [nucleoplasm]",
                    "TP53 G108Afs*34 [nucleoplasm]",
                    "TP53 A347P [nucleoplasm]",
                    "TP53 W53Mfs*4 [nucleoplasm]",
                    "TP53 S95Hfs*29 [nucleoplasm]",
                    "TP53 V122Hfs*24 [nucleoplasm]",
                    "TP53 V157Wfs*10 [nucleoplasm]",
                    "TP53 T123Hfs*24 [nucleoplasm]",
                    "TP53 A276Tfs*64 [nucleoplasm]",
                    "TP53 G325* [nucleoplasm]",
                    "TP53 D186Wfs*22 [nucleoplasm]",
                    "TP53 R267Efs*65 [nucleoplasm]",
                    "TP53 C242Tfs*98 [nucleoplasm]",
                    "TP53 P278Wfs*27 [nucleoplasm]",
                    "TP53 C182* [nucleoplasm]",
                    "TP53 R248Pfs*95 [nucleoplasm]",
                    "TP53 H168Rfs*5 [nucleoplasm]",
                    "TP53 G279* [nucleoplasm]",
                    "TP53 S240Ffs*23 [nucleoplasm]",
                    "TP53 L308Sfs*30 [nucleoplasm]",
                    "TP53 S215Wfs*31 [nucleoplasm]",
                    "TP53 T231Ffs*15 [nucleoplasm]",
                    "TP53 N235Tfs*12 [nucleoplasm]",
                    "TP53 R337H [nucleoplasm]",
                    "TP53 V73Rfs*51 [nucleoplasm]",
                    "TP53 R174Gfs*73 [nucleoplasm]",
                    "TP53 L114Ffs*35 [nucleoplasm]",
                    "TP53 E56Kfs*67 [nucleoplasm]",
                    "TP53 D61Vfs*62 [nucleoplasm]",
                    "TP53 K139Nfs*9 [nucleoplasm]",
                    "TP53 P87Qfs*36 [nucleoplasm]",
                    "TP53 V272Afs*33 [nucleoplasm]",
                    "TP53 S106Vfs*15 [nucleoplasm]",
                    "TP53 D148Pfs*21 [nucleoplasm]",
                    "TP53 P98Lfs*25 [nucleoplasm]",
                    "TP53 A69Vfs*54 [nucleoplasm]",
                    "TP53 N288Afs*55 [nucleoplasm]",
                    "TP53 V173Tfs*69 [nucleoplasm]",
                    "TP53 V122Dfs*26 [nucleoplasm]",
                    "TP53 I195Lfs*53 [nucleoplasm]",
                    "TP53 S121Ifs*28 [nucleoplasm]",
                    "TP53 D207Ffs*3 [nucleoplasm]",
                    "TP53 L257Hfs*89 [nucleoplasm]",
                    "TP53 G154Afs*16 [nucleoplasm]",
                    "TP53 A189Cfs*20 [nucleoplasm]",
                    "TP53 G199Efs*48 [nucleoplasm]",
                    "TP53 M237Vfs*2 [nucleoplasm]",
                    "TP53 N288Ifs*57 [nucleoplasm]",
                    "TP53 T284Qfs*61 [nucleoplasm]",
                    "TP53 E286* [nucleoplasm]",
                    "Me1-K372,p-S15,S20-TP53 [nucleoplasm]",
                    "TP53 Y103* [nucleoplasm]",
                    "TP53 Q52* [nucleoplasm]",
                    "TP53 S227Hfs*9 [nucleoplasm]",
                    "TP53 S185Afs*62 [nucleoplasm]",
                    "TP53 V216Afs*28 [nucleoplasm]",
                    "TP53 N311Qfs*26 [nucleoplasm]",
                    "TP53 T150Nfs*20 [nucleoplasm]",
                    "TP53 D148Gfs*2 [nucleoplasm]",
                    "TP53 H168Rfs*3 [nucleoplasm]",
                    "TP53 L252Pfs*12 [nucleoplasm]",
                    "TP53 N210Kfs*37 [nucleoplasm]",
                    "TP53 S149Hfs*31 [nucleoplasm]",
                    "TP53 V216Gfs*31 [nucleoplasm]",
                    "TP53 N239Kfs*15 [nucleoplasm]",
                    "TP53 K305* [nucleoplasm]",
                    "TP53 Q167Lfs*2 [nucleoplasm]",
                    "TP53 A78Qfs*45 [nucleoplasm]",
                    "TP53 N288Kfs*59 [nucleoplasm]",
                    "TP53 R337C [nucleoplasm]",
                    "TP53 P295Lfs*50 [nucleoplasm]",
                    "TP53 G279Efs*26 [nucleoplasm]",
                    "TP53 T211Ifs*4 [nucleoplasm]",
                    "TP53 P36Wfs*4 [nucleoplasm]",
                    "TP53 L264Sfs*8 [nucleoplasm]",
                    "TP53 M133Cfs*37 [nucleoplasm]",
                    "TP53 E271Gfs*73 [nucleoplasm]",
                    "TP53 R181Pfs*66 [nucleoplasm]",
                    "TP53 L201Ffs*8 [nucleoplasm]",
                    "TP53 C182Afs*66 [nucleoplasm]",
                    "TP53 S15Rfs*28 [nucleoplasm]",
                    "TP53 C141Sfs*26 [nucleoplasm]",
                    "TP53 S269Tfs*76 [nucleoplasm]",
                    "TP53 T150Hfs*20 [nucleoplasm]",
                    "TP53 N288Tfs*55 [nucleoplasm]",
                    "TP53 E285Gfs*20 [nucleoplasm]",
                    "TP53 T253Nfs*11 [nucleoplasm]",
                    "Tp53 (rat)",
                    "PolyUb-TP53 [cytosol]",
                    "TP53 L111Qfs*13 [nucleoplasm]",
                    "TP53 Y107Tfs*16 [nucleoplasm]",
                    "TP53 L188Rfs*59 [nucleoplasm]",
                    "TP53 R156Afs*12 [nucleoplasm]",
                    "TP53 R156Lfs*25 [nucleoplasm]",
                    "TP53 D148Ffs*32 [nucleoplasm]",
                    "TP53 I195Kfs*9 [nucleoplasm]",
                    "TP53 D207Afs*39 [nucleoplasm]",
                    "TP53 V73Afs*51 [nucleoplasm]",
                    "TP53 R267Gfs*78 [nucleoplasm]",
                    "TP53 F338I [nucleoplasm]",
                    "TP53 G154Afs*18 [nucleoplasm]",
                    "TP53 G108Ffs*40 [nucleoplasm]",
                    "TP53 A189Pfs*58 [nucleoplasm]",
                    "TP53 P82Afs*70 [nucleoplasm]",
                    "TP53 R65Efs*58 [nucleoplasm]",
                    "TP53 L32Cfs*12 [nucleoplasm]",
                    "TP53 K319Rfs*26 [nucleoplasm]",
                    "TP53 S149Yfs*31 [nucleoplasm]",
                    "TP53 P71Wfs*50 [nucleoplasm]",
                    "TP53 Q16Rfs*28 [nucleoplasm]",
                    "TP53 G199* [nucleoplasm]",
                    "TP53 G154Pfs*28 [nucleoplasm]",
                    "TP53 V97Tfs*66 [nucleoplasm]",
                    "TP53 R156Afs*14 [nucleoplasm]",
                    "TP53 C277Lfs*67 [nucleoplasm]",
                    "TP53 P58Qfs*65 [nucleoplasm]",
                    "TP53 D207Gfs*8 [nucleoplasm]",
                    "TP53 P278Sfs*28 [nucleoplasm]",
                    "TP53 T123Rfs*48 [nucleoplasm]",
                    "TP53 D208Ffs*35 [nucleoplasm]",
                    "TP53 Q165Hfs*17 [nucleoplasm]",
                    "TP53 T18Hfs*26 [nucleoplasm]",
                    "TP53 P191Sfs*18 [nucleoplasm]",
                    "TP53 M66Nfs*83 [nucleoplasm]",
                    "TP53 S116Vfs*23 [nucleoplasm]",
                    "TP53 H214Qfs*2 [nucleoplasm]",
                    "TP53 C229Vfs*18 [nucleoplasm]",
                    "TP53 R213Ffs*35 [nucleoplasm]",
                    "TP53 Y103Vfs*15 [nucleoplasm]",
                    "TP53 Q100Rfs*23 [nucleoplasm]",
                    "TP53 W53Yfs*2 [nucleoplasm]",
                    "TP53 M246Rfs*19 [nucleoplasm]",
                    "TP53 Q136Wfs*33 [nucleoplasm]",
                    "TP53 P92Vfs*55 [nucleoplasm]",
                    "TP53 P77Qfs*46 [nucleoplasm]",
                    "TP53 V173Afs*6 [nucleoplasm]",
                    "TP53 D259Afs*86 [nucleoplasm]",
                    "TP53 K319* [nucleoplasm]",
                    "TP53 N239Tfs*8 [nucleoplasm]",
                    "TP53 S94Yfs*29 [nucleoplasm]",
                    "TP53 Y236Tfs*11 [nucleoplasm]",
                    "TP53 V225Ffs*23 [nucleoplasm]",
                    "TP53 T118Nfs*31 [nucleoplasm]",
                    "TP53 R156Pfs*25 [nucleoplasm]",
                    "TP53 L264Tfs*7 [nucleoplasm]",
                    "TP53 C242Hfs*21 [nucleoplasm]",
                    "TP53 L35Pfs*10 [nucleoplasm]",
                    "TP53 H214Gfs*5 [nucleoplasm]",
                    "TP53 K291Sfs*51 [nucleoplasm]",
                    "TP53 L111Nfs*14 [nucleoplasm]",
                    "TP53 G244Afs*4 [nucleoplasm]",
                    "TP53 Y205Lfs*4 [nucleoplasm]",
                    "TP53 L257Vfs*84 [nucleoplasm]",
                    "TP53 A88Gfs*44 [nucleoplasm]",
                    "TP53 M133Ifs*36 [nucleoplasm]",
                    "TP53 V217Gfs*30 [nucleoplasm]",
                    "TP53 P153Lfs*28 [nucleoplasm]",
                    "TP53 N29Kfs*14 [nucleoplasm]",
                    "TP53 E62Kfs*65 [nucleoplasm]",
                    "TP53 R196Cfs*46 [nucleoplasm]",
                    "TP53 R65* [nucleoplasm]",
                    "TP53 R337L [nucleoplasm]",
                    "TP53 T140Cfs*6 [nucleoplasm]",
                    "TP53 [cytosol]",
                    "TP53 Y126* [nucleoplasm]",
                    "TP53 S215Mfs*32 [nucleoplasm]",
                    "TP53 Q192* [nucleoplasm]",
                    "TP53 A307Gfs*30 [nucleoplasm]",
                    "TP53 L252Pfs*92 [nucleoplasm]",
                    "TP53 R283Lfs*23 [nucleoplasm]",
                    "TP53 S240Qfs*24 [nucleoplasm]",
                    "TP53 E204Wfs*41 [nucleoplasm]",
                    "TP53 N239* [nucleoplasm]",
                    "TP53 P77Lfs*44 [nucleoplasm]",
                    "TP53 T55Pfs*52 [nucleoplasm]",
                    "TP53 I251Pfs*12 [nucleoplasm]",
                    "TP53 L130Dfs*16 [nucleoplasm]",
                    "TP53 V157Pfs*9 [nucleoplasm]",
                    "TP53 H115Afs*34 [nucleoplasm]",
                    "TP53 K101* [nucleoplasm]",
                    "TP53 P278Lfs*68 [nucleoplasm]",
                    "TP53 E221Sfs*26 [nucleoplasm]",
                    "TP53 V143Afs*21 [nucleoplasm]",
                    "TP53 Y234Tfs*11 [nucleoplasm]",
                    "TP53 H168Pfs*2 [nucleoplasm]",
                    "TP53 E68Gfs*80 [nucleoplasm]",
                    "TP53 E204Tfs*39 [nucleoplasm]",
                    "TP53 P177Tfs*69 [nucleoplasm]",
                    "TP53 S260Qfs*3 [nucleoplasm]",
                    "TP53 S96Yfs*53 [nucleoplasm]",
                    "TP53 R273Vfs*72 [nucleoplasm]",
                    "TP53 D48Tfs*75 [nucleoplasm]",
                    "TP53 (human)",
                    "TP53 N235Lfs*4 [nucleoplasm]",
                    "TP53 E285Rfs*60 [nucleoplasm]",
                    "TP53 T284Rfs*19 [nucleoplasm]",
                    "TP53 R174Pfs*70 [nucleoplasm]",
                    "TP53 I162Tfs*8 [nucleoplasm]",
                    "TP53 T125Sfs*45 [nucleoplasm]",
                    "TP53 I195Tfs*52 [nucleoplasm]",
                    "TP53 S20Qfs*24 [nucleoplasm]",
                    "TP53 S215Cfs*6 [nucleoplasm]",
                    "TP53 A84Gfs*65 [nucleoplasm]",
                    "TP53 L201Ifs*47 [nucleoplasm]",
                    "TP53 P301Rfs*4 [nucleoplasm]",
                    "TP53 N268Qfs*3 [nucleoplasm]",
                    "TP53 P36Tfs*75 [nucleoplasm]",
                    "TP53 I162Vfs*15 [nucleoplasm]",
                    "p-S15,S20,S392-TP53 [nucleoplasm]",
                    "TP53 D207Mfs*40 [nucleoplasm]",
                    "TP53 S260Lfs*4 [nucleoplasm]",
                    "TP53 A161Dfs*19 [nucleoplasm]",
                    "TP53 K292Rfs*13 [nucleoplasm]",
                    "TP53 D281Efs*26 [nucleoplasm]",
                    "TP53 P191Sfs*15 [nucleoplasm]",
                    "TP53 G262Lfs*2 [nucleoplasm]",
                    "TP53 V216Gfs*5 [nucleoplasm]",
                    "TP53 G112Lfs*7 [nucleoplasm]",
                    "TP53 M66Ifs*76 [nucleoplasm]",
                    "TP53 A138Rfs*31 [nucleoplasm]",
                    "TP53 L45Pfs*5 [nucleoplasm]",
                    "TP53 G262Wfs*80 [nucleoplasm]",
                    "TP53 G245Pfs*16 [nucleoplasm]",
                    "TP53 A129Pfs*42 [nucleoplasm]",
                    "TP53 S260Pfs*85 [nucleoplasm]",
                    "TP53 L330H [nucleoplasm]",
                    "TP53 L26Pfs*11 [nucleoplasm]",
                    "p-S15,S20,S46-TP53 [nucleoplasm]",
                    "TP53 R174Sfs*73 [nucleoplasm]",
                    "TP53 T102Nfs*47 [nucleoplasm]",
                    "TP53 E221Gfs*26 [nucleoplasm]",
                    "TP53 V218Gfs*30 [nucleoplasm]",
                    "TP53 P36Afs*7 [nucleoplasm]",
                    "TP53 K319Afs*19 [nucleoplasm]",
                    "TP53 V218Gfs*4 [nucleoplasm]",
                    "TP53 T312Nfs*25 [nucleoplasm]",
                    "TP53 L130Pfs*19 [nucleoplasm]",
                    "TP53 L257Rfs*6 [nucleoplasm]",
                    "TP53 T230Lfs*6 [nucleoplasm]",
                    "TP53 L264Hfs*81 [nucleoplasm]",
                    "TP53 R156Hfs*26 [nucleoplasm]",
                    "TP53 A84Pfs*35 [nucleoplasm]",
                    "TP53 M44Cfs*79 [nucleoplasm]",
                    "TP53 D41Gfs*2 [nucleoplasm]",
                    "TP53 M133Ifs*12 [nucleoplasm]",
                    "TP53 N210Kfs*6 [nucleoplasm]",
                    "TP53 L35Cfs*9 [nucleoplasm]",
                    "TP53 N210Hfs*5 [nucleoplasm]",
                    "Unfolded TP53 [cytosol]",
                    "TP53 R110Qfs*15 [nucleoplasm]",
                    "TP53 S96Ffs*53 [nucleoplasm]",
                    "TP53 N263Tfs*7 [nucleoplasm]",
                    "TP53 G293* [nucleoplasm]",
                    "TP53 A63Lfs*60 [nucleoplasm]",
                    "TP53 Y220* [nucleoplasm]",
                    "TP53 E56* [nucleoplasm]",
                    "TP53 S215Ifs*36 [nucleoplasm]",
                    "TP53 A161Hfs*19 [nucleoplasm]",
                    "TP53 L114Cfs*9 [nucleoplasm]",
                    "TP53 T170Rfs*4 [nucleoplasm]",
                    "TP53 H168Tfs*69 [nucleoplasm]",
                    "TP53 R290Afs*55 [nucleoplasm]",
                    "TP53 R110Lfs*13 [nucleoplasm]",
                    "TP53 C242Hfs*18 [nucleoplasm]",
                    "TP53 C229Yfs*10 [nucleoplasm]",
                    "TP53 L188Pfs*58 [nucleoplasm]",
                    "TP53 S33Pfs*11 [nucleoplasm]",
                    "TP53 R158Sfs*23 [nucleoplasm]",
                    "TP53 G199Ffs*8 [nucleoplasm]",
                    "TP53 S269Rfs*74 [nucleoplasm]",
                    "TP53 gene",
                    "TP53 S315Wfs*22 [nucleoplasm]",
                    "TP53 F270Lfs*72 [nucleoplasm]",
                    "TP53 P316Afs*19 [nucleoplasm]",
                    "TP53 A78Sfs*71 [nucleoplasm]",
                    "TP53 D208Efs*7 [nucleoplasm]",
                    "TP53 E224* [nucleoplasm]",
                    "TP53 G293Rfs*13 [nucleoplasm]",
                    "TP53 P142Gfs*24 [nucleoplasm]",
                    "TP53 Y103Efs*23 [nucleoplasm]",
                    "TP53 Y234Qfs*5 [nucleoplasm]",
                    "TP53 Q354* [nucleoplasm]",
                    "TP53 T253Ifs*93 [nucleoplasm]",
                    "TP53 R306Efs*39 [nucleoplasm]",
                    "TP53 Y205Ffs*8 [nucleoplasm]",
                    "TP53 T253Sfs*91 [nucleoplasm]",
                    "TP53 P191Lfs*56 [nucleoplasm]",
                    "TP53 P295Rfs*12 [nucleoplasm]",
                    "TP53 A189Gfs*20 [nucleoplasm]",
                    "TP53 R213Vfs*32 [nucleoplasm]",
                    "TP53 E298Tfs*48 [nucleoplasm]",
                    "TP53 A83Rfs*40 [nucleoplasm]",
                    "TP53 E221Gfs*25 [nucleoplasm]",
                    "TP53 P85Lfs*58 [nucleoplasm]",
                    "TP53 D208Afs*39 [nucleoplasm]",
                    "TP53 T211Ffs*4 [nucleoplasm]",
                    "TP53 A76Vfs*55 [nucleoplasm]",
                    "PolyUb,p-S15,S20-TP53 [nucleoplasm]",
                    "TP53 E198Wfs*44 [nucleoplasm]",
                    "TP53 Q38Kfs*6 [nucleoplasm]",
                    "TP53 H233Tfs*14 [nucleoplasm]",
                    "TP53 P309Qfs*26 [nucleoplasm]",
                    "TP53 K164Nfs*6 [nucleoplasm]",
                    "TP53 A138Cfs*27 [nucleoplasm]",
                    "TP53 Q167Nfs*4 [nucleoplasm]",
                    "TP53 D281Efs*18 [nucleoplasm]",
                    "TP53 S261Vfs*84 [nucleoplasm]",
                    "TP53 R290Sfs*56 [nucleoplasm]",
                    "TP53 T140Pfs*30 [nucleoplasm]",
                    "TP53 E298* [nucleoplasm]",
                    "TP53 F19Ifs*10 [nucleoplasm]",
                    "TP53 G302Hfs*2 [nucleoplasm]",
                    "TP53 K320Rfs*25 [nucleoplasm]",
                    "cellular tumor antigen p53 (rat)",
                    "TP53 P85Lfs*38 [nucleoplasm]",
                    "TP53 Q192Sfs*55 [nucleoplasm]",
                    "TP53 R209Lfs*36 [nucleoplasm]",
                    "TP53 L265Tfs*7 [nucleoplasm]",
                    "TP53 S183Rfs*2 [nucleoplasm]",
                    "TP53 Q104Afs*18 [nucleoplasm]",
                    "TP53 Q167* [nucleoplasm]",
                    "TP53 M133Rfs*38 [nucleoplasm]",
                    "TP53 L137Wfs*33 [nucleoplasm]",
                    "TP53 P67Lfs*54 [nucleoplasm]",
                    "TP53 T140Dfs*9 [nucleoplasm]",
                    "TP53 I195Mfs*13 [nucleoplasm]",
                    "TP53 L344P [nucleoplasm]",
                    "TP53 C277Vfs*68 [nucleoplasm]",
                    "TP53 V143Afs*29 [nucleoplasm]",
                    "TP53 D41Mfs*3 [nucleoplasm]",
                    "TP53 S227Wfs*3 [nucleoplasm]",
                    "TP53 N131Cfs*27 [nucleoplasm]",
                    "TP53 F134Lfs*14 [nucleoplasm]",
                    "TP53 N200Vfs*4 [nucleoplasm]",
                    "TP53 Q144Cfs*25 [nucleoplasm]",
                    "TP53 L130Qfs*17 [nucleoplasm]",
                    "TP53 R248Pfs*92 [nucleoplasm]",
                    "TP53 K320Mfs*21 [nucleoplasm]",
                    "TP53 S94Cfs*30 [nucleoplasm]",
                    "TP53 T230Hfs*9 [nucleoplasm]",
                    "TP53 Y103Tfs*20 [nucleoplasm]",
                    "TP53 L45Vfs*6 [nucleoplasm]",
                    "TP53 A88Pfs*35 [nucleoplasm]",
                    "TP53 R290Lfs*50 [nucleoplasm]",
                    "TP53 E286Kfs*59 [nucleoplasm]",
                    "TP53 K291Nfs*49 [nucleoplasm]",
                    "TP53 E285Rfs*21 [nucleoplasm]",
                    "TP53 F113Lfs*11 [nucleoplasm]",
                    "TP53 I232Sfs*15 [nucleoplasm]",
                    "TP53 H178Pfs*3 [nucleoplasm]",
                    "TP53 T155Pfs*23 [nucleoplasm]",
                    "TP53 I195Wfs*50 [nucleoplasm]",
                    "cellular tumor antigen p53 (chicken)",
                    "TP53 G154Afs*14 [nucleoplasm]",
                    "TP53 L201Cfs*46 [nucleoplasm]",
                    "TP53 C242Lfs*22 [nucleoplasm]",
                    "TP53 H179Lfs*68 [nucleoplasm]",
                    "TP53 A161Tfs*7 [nucleoplasm]",
                    "TP53 L43Cfs*9 [nucleoplasm]",
                    "TP53 I195Pfs*13 [nucleoplasm]",
                    "TP53 K120* [nucleoplasm]",
                    "TP53 P153Sfs*13 [nucleoplasm]",
                    "TP53 H214Tfs*2 [nucleoplasm]",
                    "TP53 T253Hfs*11 [nucleoplasm]",
                    "TP53 C242Afs*5 [nucleoplasm]",
                    "TP53 D281Pfs*24 [nucleoplasm]",
                    "TP53 G112Cfs*9 [nucleoplasm]",
                    "TP53 L323Wfs*22 [nucleoplasm]",
                    "TP53 H168Qfs*2 [nucleoplasm]",
                    "TP53 S33* [nucleoplasm]",
                    "TP53 P191Lfs*53 [nucleoplasm]",
                    "TP53 N288Rfs*13 [nucleoplasm]",
                    "TP53 R283Afs*62 [nucleoplasm]",
                    "TP53 N210Tfs*37 [nucleoplasm]",
                    "TP53 K132* [nucleoplasm]",
                    "TP53 S94Pfs*24 [nucleoplasm]",
                    "TP53 V97Lfs*25 [nucleoplasm]",
                    "TP53 R283Pfs*24 [nucleoplasm]",
                    "TP53 T312Pfs*33 [nucleoplasm]",
                    "TP53 G108Vfs*15 [nucleoplasm]",
                    "TP53 A74Pfs*49 [nucleoplasm]",
                    "TP53 C141* [nucleoplasm]",
                    "TP53 G187Afs*21 [nucleoplasm]",
                    "TP53 L299Hfs*2 [nucleoplasm]",
                    "TP53 Q104Rfs*19 [nucleoplasm]",
                    "TP53 E51Nfs*72 [nucleoplasm]",
                    "TP53 T155Afs*28 [nucleoplasm]",
                    "TP53 L130Tfs*39 [nucleoplasm]",
                    "TP53 G279Efs*65 [nucleoplasm]",
                    "TP53 D57Vfs*64 [nucleoplasm]",
                    "TP53 H214Ifs*33 [nucleoplasm]",
                    "TP53 I50Mfs*73 [nucleoplasm]",
                    "TP53 R181Lfs*4 [nucleoplasm]",
                    "TP53 I195Sfs*52 [nucleoplasm]",
                    "TP53 P190Sfs*17 [nucleoplasm]",
                    "TP53 P98Yfs*26 [nucleoplasm]",
                    "TP53 S90Pfs*34 [nucleoplasm]",
                    "TP53 N288Efs*14 [nucleoplasm]",
                    "TP53 M40Lfs*7 [nucleoplasm]",
                    "TP53 L111Rfs*37 [nucleoplasm]",
                    "TP53 H233Pfs*6 [nucleoplasm]",
                    "TP53 P151Rfs*27 [nucleoplasm]",
                    "TP53 S215Cfs*29 [nucleoplasm]",
                    "TP53 A138Gfs*11 [nucleoplasm]",
                    "TP53 I50Nfs*72 [nucleoplasm]",
                    "TP53 E298Cfs*46 [nucleoplasm]",
                    "TP53 L330R [nucleoplasm]",
                    "TP53 V143Lfs*28 [nucleoplasm]",
                    "TP53 S215Vfs*32 [nucleoplasm]",
                    "TP53 A86Lfs*59 [nucleoplasm]",
                    "TP53 P219Afs*3 [nucleoplasm]",
                    "TP53 N268* [nucleoplasm]",
                    "TP53 A129Cfs*20 [nucleoplasm]",
                    "TP53 T81Sfs*43 [nucleoplasm]",
                    "TP53 G226Afs*21 [nucleoplasm]",
                    "TP53 S121Cfs*27 [nucleoplasm]",
                    "TP53 V217Gfs*31 [nucleoplasm]",
                    "TP53 L330P [nucleoplasm]",
                    "TP53 L145Afs*4 [nucleoplasm]",
                    "TP53 W91Vfs*13 [nucleoplasm]",
                    "TP53 I251Tfs*94 [nucleoplasm]",
                    "TP53 P128Qfs*18 [nucleoplasm]",
                    "TP53 I162Wfs*10 [nucleoplasm]",
                    "TP53 S269Rfs*21 [nucleoplasm]",
                    "TP53 K139Dfs*9 [nucleoplasm]",
                    "TP53 S127Ffs*36 [nucleoplasm]",
                    "TP53 C176Mfs*68 [nucleoplasm]",
                    "TP53 C275Lfs*70 [nucleoplasm]",
                    "TP53 H179Mfs*68 [nucleoplasm]",
                    "TP53 G262Vfs*83 [nucleoplasm]",
                    "TP53 T231Nfs*9 [nucleoplasm]",
                    "TP53 Q52Lfs*73 [nucleoplasm]",
                    "TP53 T125Afs*46 [nucleoplasm]",
                    "TP53 P152Hfs*29 [nucleoplasm]",
                    "TP53 Q167Afs*13 [nucleoplasm]",
                    "TP53 T231Pfs*16 [nucleoplasm]",
                    "TP53 E286Hfs*22 [nucleoplasm]",
                    "TP53 I50* [nucleoplasm]",
                    "TP53 F212Sfs*3 [nucleoplasm]",
                    "TP53 E294Gfs*12 [nucleoplasm]",
                    "TP53 S106Gfs*44 [nucleoplasm]",
                    "TP53 G279Sfs*68 [nucleoplasm]",
                    "TP53 R273Lfs*33 [nucleoplasm]",
                    "TP53 E258Kfs*87 [nucleoplasm]",
                    "TP53 Y126Tfs*44 [nucleoplasm]",
                    "TP53 A74Gfs*75 [nucleoplasm]",
                    "TP53 H214Rfs*25 [nucleoplasm]",
                    "TP53 A86Gfs*63 [nucleoplasm]",
                    "TP53 P128Qfs*17 [nucleoplasm]",
                    "TP53 K291Rfs*54 [nucleoplasm]",
                    "TP53 L206Ffs*42 [nucleoplasm]",
                    "TP53 L43Afs*7 [nucleoplasm]",
                    "TP53 E294Afs*11 [nucleoplasm]",
                    "TP53 D259Rfs*5 [nucleoplasm]",
                    "TP53 S215Mfs*27 [nucleoplasm]",
                    "TP53 T253Pfs*92 [nucleoplasm]",
                    "TP53 N311Kfs*34 [nucleoplasm]",
                    "TP53 E51* [nucleoplasm]",
                    "TP53 D207Kfs*6 [nucleoplasm]",
                    "TP53 A74Qfs*45 [nucleoplasm]",
                    "TP53 M133Nfs*34 [nucleoplasm]",
                    "TP53 Q16* [nucleoplasm]",
                    "Me2-K373-TP53 [nucleoplasm]",
                    "TP53 R174Mfs*68 [nucleoplasm]",
                    "TP53 N131Tfs*39 [nucleoplasm]",
                    "TP53 E224Rfs*23 [nucleoplasm]",
                    "TP53 R196Efs*51 [nucleoplasm]",
                    "TP53 R282Afs*23 [nucleoplasm]",
                    "TP53 E285Rfs*54 [nucleoplasm]",
                    "TP53 E224Gfs*4 [nucleoplasm]",
                    "TP53 V147Lfs*23 [nucleoplasm]",
                    "TP53 N131Kfs*39 [nucleoplasm]",
                    "TP53 protein, human",
                    "TP53 S94Ffs*28 [nucleoplasm]",
                    "TP53 R248Qfs*15 [nucleoplasm]",
                    "TP53 D148Pfs*23 [nucleoplasm]",
                    "TP53 Q167Sfs*3 [nucleoplasm]",
                    "TP53 N268Kfs*4 [nucleoplasm]",
                    "TP53 L264Yfs*81 [nucleoplasm]",
                    "TP53 L252Sfs*93 [nucleoplasm]",
                    "TP53 G279Pfs*69 [nucleoplasm]",
                    "TP53 K320* [nucleoplasm]",
                    "TP53 L137Rfs*33 [nucleoplasm]",
                    "TP53 P47Gfs*4 [nucleoplasm]",
                    "TP53 S99Rfs*23 [nucleoplasm]",
                    "TP53 E171* [nucleoplasm]",
                    "TP53 N263Tfs*5 [nucleoplasm]",
                    "TP53 R196* [nucleoplasm]",
                    "TP53 P152Rfs*18 [nucleoplasm]",
                    "TP53 Q104Pfs*45 [nucleoplasm]",
                    "TP53 V173Efs*7 [nucleoplasm]",
                    "TP53 E198Afs*7 [nucleoplasm]",
                    "TP53 G266Efs*4 [nucleoplasm]",
                    "TP53 Y205Ifs*42 [nucleoplasm]",
                    "TP53 S303Afs*42 [nucleoplasm]",
                    "TP53 T125Lfs*25 [nucleoplasm]",
                    "TP53 D49Efs*3 [nucleoplasm]",
                    "TP53 E171Gfs*4 [nucleoplasm]",
                    "TP53 R249Afs*14 [nucleoplasm]",
                    "TP53 P153Afs*16 [nucleoplasm]",
                    "TP53 V157Rfs*22 [nucleoplasm]",
                    "TP53 T125Hfs*24 [nucleoplasm]",
                    "TP53 P34Lfs*8 [nucleoplasm]",
                    "TP53 P318Efs*16 [nucleoplasm]",
                    "TP53 R283Kfs*59 [nucleoplasm]",
                    "TP53 Q165* [nucleoplasm]",
                    "TP53 K292Nfs*7 [nucleoplasm]",
                    "TP53 K120Qfs*29 [nucleoplasm]",
                    "TP53 M246Ifs*99 [nucleoplasm]",
                    "TP53 E271Gfs*74 [nucleoplasm]",
                    "TP53 R282Pfs*64 [nucleoplasm]",
                    "TP53 T81Nfs*42 [nucleoplasm]",
                    "p-S15,S20,S269,T284-TP53 [nucleoplasm]",
                    "TP53 T102Pfs*21 [nucleoplasm]",
                    "TP53 D49Yfs*2 [nucleoplasm]",
                    "TP53 T170Sfs*8 [nucleoplasm]",
                    "TP53 R282Gfs*63 [nucleoplasm]",
                    "TP53 K120Mfs*25 [nucleoplasm]",
                    "TP53 Q317Hfs*28 [nucleoplasm]",
                    "TP53 Q165Sfs*5 [nucleoplasm]",
                    "TP53 P191Yfs*14 [nucleoplasm]",
                    "TP53 R110Sfs*14 [nucleoplasm]",
                    "TP53 V272Cfs*73 [nucleoplasm]",
                    "TP53 R110Vfs*13 [nucleoplasm]",
                    "TP53 A83Cfs*63 [nucleoplasm]",
                    "TP53 D184Rfs*2 [nucleoplasm]",
                    "TP53 V218Cfs*29 [nucleoplasm]",
                    "TP53 P223* [nucleoplasm]",
                    "TP53 L308Afs*6 [nucleoplasm]",
                    "TP53 Y220Hfs*5 [nucleoplasm]",
                    "TP53 W91Cfs*57 [nucleoplasm]",
                    "TP53 G117Wfs*32 [nucleoplasm]",
                    "TP53 Q192Afs*16 [nucleoplasm]",
                    "TP53 S116Afs*34 [nucleoplasm]",
                    "TP53 W23* [nucleoplasm]",
                    "TP53 N288Kfs*18 [nucleoplasm]",
                    "TP53 Q144Afs*4 [nucleoplasm]",
                    "TP53 R306Lfs*32 [nucleoplasm]",
                    "TP53 D207Gfs*2 [nucleoplasm]",
                    "TP53 Q192Pfs*17 [nucleoplasm]",
                    "TP53 V203Gfs*5 [nucleoplasm]",
                    "TP53 R280Sfs*66 [nucleoplasm]",
                    "TP53 S315* [nucleoplasm]",
                    "TP53 L201Afs*7 [nucleoplasm]",
                    "TP53 Q317Afs*19 [nucleoplasm]",
                    "TP53 M44Tfs*75 [nucleoplasm]",
                    "TP53 P322Hfs*23 [nucleoplasm]",
                    "TP53 R156Pfs*14 [nucleoplasm]",
                    "TP53 C229Yfs*8 [nucleoplasm]",
                    "TP53 G59Qfs*84 [nucleoplasm]",
                    "TP53 C229Lfs*18 [nucleoplasm]",
                    "TP53 D208Ffs*42 [nucleoplasm]",
                    "p-S15-TP53 [nucleoplasm]",
                    "TP53 H296Rfs*8 [nucleoplasm]",
                    "TP53 H178Pfs*70 [nucleoplasm]",
                    "TP53 N310Kfs*26 [nucleoplasm]",
                    "TP53 A276Lfs*31 [nucleoplasm]",
                    "TP53 A159Hfs*21 [nucleoplasm]",
                    "TP53 R156Sfs*8 [nucleoplasm]",
                    "TP53 W91* [nucleoplasm]",
                    "TP53 Gene",
                    "TP53 A86Gfs*32 [nucleoplasm]",
                    "TP53 H178Qfs*3 [nucleoplasm]",
                    "TP53 D281Afs*26 [nucleoplasm]",
                    "TP53 M160Rfs*10 [nucleoplasm]",
                    "TP53 T230Sfs*11 [nucleoplasm]",
                    "TP53 R337S [nucleoplasm]",
                    "TP53 N310Kfs*27 [nucleoplasm]",
                    "TP53 R175Pfs*72 [nucleoplasm]",
                    "TP53 S313Afs*32 [nucleoplasm]",
                    "TP53 F341S [nucleoplasm]",
                    "TP53 I251Sfs*94 [nucleoplasm]",
                    "TP53 C176Afs*71 [nucleoplasm]",
                    "TP53 A138Pfs*32 [nucleoplasm]",
                    "TP53 E221Afs*2 [nucleoplasm]",
                    "TP53 T284Ifs*57 [nucleoplasm]",
                    "TP53 P222Lfs*24 [nucleoplasm]",
                    "TP53 A84Vfs*65 [nucleoplasm]",
                    "TP53 G244Tfs*19 [nucleoplasm]",
                    "TP53 R273Ffs*71 [nucleoplasm]",
                    "TP53 L299Afs*7 [nucleoplasm]",
                    "TP53 A86Pfs*34 [nucleoplasm]",
                    "TP53 K139Rfs*31 [nucleoplasm]",
                    "TP53 N210Tfs*7 [nucleoplasm]",
                    "TP53 I254Hfs*8 [nucleoplasm]",
                    "TP53 R196Ffs*8 [nucleoplasm]",
                    "TP53 H115Cfs*27 [nucleoplasm]",
                    "TP53 P223Rfs*4 [nucleoplasm]",
                    "TP53 A307Rfs*39 [nucleoplasm]",
                    "TP53 T118Cfs*27 [nucleoplasm]",
                    "TP53 C135Afs*35 [nucleoplasm]",
                    "TP53 D324Rfs*13 [nucleoplasm]",
                    "TP53 S314Rfs*25 [nucleoplasm]",
                    "TP53 L308Afs*28 [nucleoplasm]",
                    "TP53 G302Rfs*4 [nucleoplasm]",
                    "TP53 I255Nfs*9 [nucleoplasm]",
                    "TP53 S227Vfs*2 [nucleoplasm]",
                    "TP53 L93Cfs*30 [nucleoplasm]",
                    "TP53 K164Sfs*3 [nucleoplasm]",
                    "TP53 D228Tfs*19 [nucleoplasm]",
                    "TP53 Y220Lfs*2 [nucleoplasm]",
                    "TP53 V143Rfs*6 [nucleoplasm]",
                    "TP53 R282Pfs*24 [nucleoplasm]",
                    "TP53 V157Hfs*21 [nucleoplasm]",
                    "TP53 E294Sfs*51 [nucleoplasm]",
                    "TP53 E287Kfs*53 [nucleoplasm]",
                    "TP53 G59Vfs*64 [nucleoplasm]",
                    "TP53 M246Ifs*92 [nucleoplasm]",
                    "TP53 S149Ffs*32 [nucleoplasm]",
                    "TP53 S94Ifs*54 [nucleoplasm]",
                    "TP53 H297Lfs*9 [nucleoplasm]",
                    "TP53 S149Pfs*21 [nucleoplasm]",
                    "TP53 C238Hfs*21 [nucleoplasm]",
                    "TP53 S269Gfs*34 [nucleoplasm]",
                    "TP53 R213Dfs*34 [nucleoplasm]",
                    "TP53 gene [nucleoplasm]",
                    "TP53 G266* [nucleoplasm]",
                    "TP53 D48Gfs*4 [nucleoplasm]",
                    "TP53 Y234Pfs*7 [nucleoplasm]",
                    "TP53 G187Vfs*60 [nucleoplasm]",
                    "TP53 R213Sfs*3 [nucleoplasm]",
                    "TP53 E298Sfs*47 [nucleoplasm]",
                    "TP53 N239Afs*5 [nucleoplasm]",
                    "TP53 M66Sfs*57 [nucleoplasm]",
                    "TP53 S121Lfs*2 [nucleoplasm]",
                    "TP53 R248Gfs*97 [nucleoplasm]",
                    "TP53 S183Tfs*65 [nucleoplasm]",
                    "TP53 M40Ifs*3 [nucleoplasm]",
                    "TP53 N268Pfs*45 [nucleoplasm]",
                    "TP53 C242* [nucleoplasm]",
                    "TP53 R290Gfs*12 [nucleoplasm]",
                    "TP53 N247Rfs*97 [nucleoplasm]",
                    "TP53 R158Sfs*8 [nucleoplasm]",
                    "TP53 S313Pfs*33 [nucleoplasm]",
                    "TP53 V216Gfs*4 [nucleoplasm]",
                    "TP53 K139* [nucleoplasm]",
                    "TP53 D184Efs*64 [nucleoplasm]",
                    "TP53 E221* [nucleoplasm]",
                    "TP53 P153Hfs*26 [nucleoplasm]",
                    "TP53 T125Ifs*47 [nucleoplasm]",
                    "TP53 L188Wfs*59 [nucleoplasm]",
                    "TP53 M133Dfs*16 [nucleoplasm]",
                    "TP53 V73Wfs*50 [nucleoplasm]",
                    "TP53 P152Tfs*30 [nucleoplasm]",
                    "TP53 C135Sfs*35 [nucleoplasm]",
                    "TP53 Y327* [nucleoplasm]",
                    "TP53 E51Pfs*59 [nucleoplasm]",
                    "TP53 L111Ffs*40 [nucleoplasm]",
                    "TP53 K291* [nucleoplasm]",
                    "TP53 H193Qfs*48 [nucleoplasm]",
                    "TP53 L330F [nucleoplasm]",
                    "TP53 L93Pfs*59 [nucleoplasm]",
                    "TP53 K321Efs*16 [nucleoplasm]",
                    "TP53 R110Pfs*14 [nucleoplasm]",
                    "TP53 P67Qfs*56 [nucleoplasm]",
                    "TP53 L299Afs*6 [nucleoplasm]",
                    "TP53 R202Kfs*9 [nucleoplasm]",
                    "TP53 C141Wfs*8 [nucleoplasm]",
                    "TP53 Y103Gfs*44 [nucleoplasm]",
                    "TP53 V157Rfs*24 [nucleoplasm]",
                    "TP53 M237* [nucleoplasm]",
                    "TP53 S241Wfs*19 [nucleoplasm]",
                    "TP53 A88Vfs*55 [nucleoplasm]",
                    "TP53 E68Rfs*81 [nucleoplasm]",
                    "TP53 K351R [nucleoplasm]",
                    "TP53 A83Pfs*35 [nucleoplasm]",
                    "TP53 N210Ffs*35 [nucleoplasm]",
                    "TP53 A78Yfs*68 [nucleoplasm]",
                    "TP53 R306Afs*31 [nucleoplasm]",
                    "TP53 G117Dfs*26 [nucleoplasm]",
                    "TP53 R273Cfs*73 [nucleoplasm]",
                    "TP53 T118Dfs*31 [nucleoplasm]",
                    "TP53 R158Pfs*12 [nucleoplasm]",
                    "p-S15,S392-TP53 [nucleoplasm]",
                    "TP53 P153Afs*28 [nucleoplasm]",
                    "TP53",
                    "TP53 L206Ffs*3 [nucleoplasm]",
                    "TP53 C182Afs*65 [nucleoplasm]",
                    "TP53 S127Lfs*42 [nucleoplasm]",
                    "TP53 M246Afs*19 [nucleoplasm]",
                    "TP53 E171Gfs*9 [nucleoplasm]",
                    "TP53 S315Pfs*31 [nucleoplasm]",
                    "TP53 M246* [nucleoplasm]",
                    "TP53 N239Lfs*22 [nucleoplasm]",
                    "TP53 V143Afs*5 [nucleoplasm]",
                    "TP53 P58Rfs*6 [nucleoplasm]",
                    "TP53 N29Kfs*13 [nucleoplasm]",
                    "TP53 V225Gfs*20 [nucleoplasm]",
                    "TP53 E180Afs*65 [nucleoplasm]",
                    "TP53 T155Pfs*25 [nucleoplasm]",
                    "TP53 I255Sfs*90 [nucleoplasm]",
                    "TP53 V143Cfs*27 [nucleoplasm]",
                    "TP53 G59Efs*58 [nucleoplasm]",
                    "TP53 M243* [nucleoplasm]",
                    "TP53 C229* [nucleoplasm]",
                    "TP53 R156Lfs*18 [nucleoplasm]",
                    "TP53 I195Yfs*14 [nucleoplasm]",
                    "TP53 S183* [nucleoplasm]",
                    "TP53 S313Lfs*45 [nucleoplasm]",
                    "TP53 V73Gfs*50 [nucleoplasm]",
                    "TP53 N239Kfs*22 [nucleoplasm]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-9718677",
                    "REACT:R-HSA-9718792",
                    "REACT:R-HSA-9718744",
                    "REACT:R-HSA-9719104",
                    "REACT:R-HSA-9719729",
                    "REACT:R-HSA-9719769",
                    "REACT:R-HSA-9718627",
                    "REACT:R-HSA-9720561",
                    "REACT:R-HSA-9720584",
                    "REACT:R-HSA-9726133",
                    "REACT:R-HSA-9721093",
                    "REACT:R-HSA-9721593",
                    "REACT:R-HSA-6805759",
                    "REACT:R-HSA-9721082",
                    "REACT:R-HSA-9721224",
                    "REACT:R-HSA-9721292",
                    "REACT:R-HSA-9722040",
                    "REACT:R-HSA-9718636",
                    "REACT:R-HSA-9719423",
                    "REACT:R-HSA-9721730",
                    "REACT:R-HSA-9719031",
                    "REACT:R-HSA-9720675",
                    "REACT:R-HSA-9723477",
                    "REACT:R-HSA-9721768",
                    "REACT:R-HSA-9720976",
                    "REACT:R-HSA-9723635",
                    "REACT:R-HSA-9720029",
                    "REACT:R-HSA-9720275",
                    "REACT:R-HSA-9718725",
                    "REACT:R-HSA-9721047",
                    "REACT:R-HSA-9721299",
                    "REACT:R-HSA-9719375",
                    "REACT:R-HSA-9719710",
                    "REACT:R-HSA-9721774",
                    "REACT:R-HSA-9718956",
                    "REACT:R-HSA-9719430",
                    "REACT:R-HSA-9720723",
                    "REACT:R-HSA-9721882",
                    "REACT:R-HSA-9719467",
                    "REACT:R-HSA-9719285",
                    "REACT:R-HSA-9720676",
                    "REACT:R-HSA-9718585",
                    "REACT:R-HSA-9721975",
                    "REACT:R-HSA-9722077",
                    "REACT:R-HSA-9719373",
                    "REACT:R-HSA-9720593",
                    "REACT:R-HSA-9718872",
                    "ENSEMBL:ENSG00000141510",
                    "REACT:R-HSA-9719816",
                    "REACT:R-HSA-9720848",
                    "REACT:R-HSA-9720137",
                    "REACT:R-HSA-9722049",
                    "REACT:R-HSA-9719705",
                    "REACT:R-HSA-9721426",
                    "REACT:R-HSA-9721837",
                    "REACT:R-HSA-9723622",
                    "REACT:R-HSA-9719146",
                    "REACT:R-HSA-9719323",
                    "REACT:R-HSA-9723594",
                    "REACT:R-HSA-9720753",
                    "REACT:R-HSA-9721889",
                    "REACT:R-HSA-9723317",
                    "REACT:R-HSA-9719578",
                    "REACT:R-HSA-9721439",
                    "REACT:R-HSA-9720075",
                    "REACT:R-HSA-9721156",
                    "REACT:R-HSA-9720001",
                    "REACT:R-HSA-9726166",
                    "REACT:R-HSA-9720332",
                    "REACT:R-HSA-9719657",
                    "REACT:R-HSA-9719137",
                    "REACT:R-HSA-9720066",
                    "REACT:R-HSA-9718566",
                    "REACT:R-HSA-9719425",
                    "REACT:R-HSA-9720835",
                    "REACT:R-HSA-9720989",
                    "REACT:R-HSA-9721616",
                    "REACT:R-HSA-9723699",
                    "REACT:R-HSA-9726156",
                    "REACT:R-HSA-9723381",
                    "REACT:R-HSA-9723464",
                    "REACT:R-HSA-9718911",
                    "REACT:R-HSA-9723332",
                    "REACT:R-HSA-9718775",
                    "REACT:R-HSA-9719683",
                    "REACT:R-HSA-9720661",
                    "REACT:R-HSA-9721804",
                    "REACT:R-HSA-9722007",
                    "REACT:R-HSA-9721393",
                    "REACT:R-HSA-9721468",
                    "REACT:R-HSA-9722024",
                    "REACT:R-HSA-9723596",
                    "REACT:R-HSA-9726328",
                    "REACT:R-HSA-9721388",
                    "REACT:R-HSA-9720388",
                    "REACT:R-HSA-9719843",
                    "REACT:R-HSA-9720522",
                    "REACT:R-HSA-9718742",
                    "REACT:R-HSA-9718896",
                    "REACT:R-HSA-9719511",
                    "REACT:R-HSA-9719456",
                    "REACT:R-HSA-9721914",
                    "REACT:R-HSA-9721977",
                    "REACT:R-HSA-9720089",
                    "REACT:R-HSA-9720106",
                    "REACT:R-HSA-9719858",
                    "REACT:R-HSA-9723333",
                    "REACT:R-HSA-9720846",
                    "REACT:R-HSA-9723438",
                    "REACT:R-HSA-9723493",
                    "REACT:R-HSA-9720312",
                    "REACT:R-HSA-9719771",
                    "REACT:R-HSA-9722025",
                    "REACT:R-HSA-9721483",
                    "REACT:R-HSA-9719434",
                    "REACT:R-HSA-9719517",
                    "REACT:R-HSA-9721830",
                    "REACT:R-HSA-69683",
                    "REACT:R-HSA-9721358",
                    "REACT:R-HSA-9721991",
                    "REACT:R-HSA-9723566",
                    "REACT:R-HSA-9721010",
                    "REACT:R-HSA-9721133",
                    "REACT:R-HSA-9719983",
                    "REACT:R-HSA-9721765",
                    "REACT:R-HSA-9723540",
                    "REACT:R-HSA-9719682",
                    "REACT:R-HSA-9720527",
                    "REACT:R-HSA-9721785",
                    "REACT:R-HSA-9719860",
                    "REACT:R-HSA-9722088",
                    "REACT:R-HSA-9723388",
                    "REACT:R-HSA-9721397",
                    "REACT:R-HSA-9720410",
                    "REACT:R-HSA-9719762",
                    "REACT:R-HSA-9721609",
                    "REACT:R-HSA-9720491",
                    "REACT:R-HSA-9721094",
                    "REACT:R-HSA-9721906",
                    "REACT:R-HSA-9721107",
                    "REACT:R-HSA-9718521",
                    "REACT:R-HSA-9719971",
                    "REACT:R-HSA-9723641",
                    "REACT:R-HSA-9721145",
                    "REACT:R-HSA-9720724",
                    "REACT:R-HSA-9718979",
                    "REACT:R-HSA-9718970",
                    "REACT:R-HSA-9719620",
                    "REACT:R-HSA-9720485",
                    "REACT:R-HSA-9726169",
                    "REACT:R-HSA-9721258",
                    "REACT:R-HSA-9719756",
                    "REACT:R-HSA-9719129",
                    "REACT:R-HSA-9723371",
                    "REACT:R-HSA-9719023",
                    "REACT:R-HSA-9721090",
                    "REACT:R-HSA-9721340",
                    "REACT:R-HSA-9720211",
                    "REACT:R-HSA-9721207",
                    "REACT:R-HSA-9719079",
                    "REACT:R-HSA-9719937",
                    "REACT:R-HSA-9723392",
                    "REACT:R-HSA-9719123",
                    "REACT:R-HSA-9719161",
                    "REACT:R-HSA-9720859",
                    "REACT:R-HSA-9723457",
                    "REACT:R-HSA-9720959",
                    "REACT:R-HSA-9718645",
                    "REACT:R-HSA-9723348",
                    "REACT:R-HSA-9720623",
                    "REACT:R-HSA-9723658",
                    "REACT:R-HSA-9718651",
                    "REACT:R-HSA-9719985",
                    "REACT:R-HSA-6797244",
                    "REACT:R-HSA-9718578",
                    "REACT:R-HSA-9723643",
                    "REACT:R-HSA-9720060",
                    "REACT:R-HSA-9720588",
                    "REACT:R-HSA-9718733",
                    "REACT:R-HSA-9719703",
                    "REACT:R-HSA-9720131",
                    "REACT:R-HSA-2997661",
                    "REACT:R-HSA-9720120",
                    "REACT:R-HSA-9720173",
                    "REACT:R-HSA-9720244",
                    "REACT:R-HSA-9718571",
                    "REACT:R-HSA-9718932",
                    "REACT:R-HSA-9719670",
                    "REACT:R-HSA-9719855",
                    "REACT:R-HSA-9720102",
                    "REACT:R-HSA-9720542",
                    "REACT:R-HSA-9720657",
                    "REACT:R-HSA-9721701",
                    "REACT:R-HSA-9721840",
                    "REACT:R-HSA-9720027",
                    "REACT:R-HSA-9721538",
                    "REACT:R-HSA-9721996",
                    "REACT:R-HSA-9719735",
                    "REACT:R-HSA-9723569",
                    "REACT:R-HSA-9719916",
                    "REACT:R-HSA-9718514",
                    "REACT:R-HSA-9719324",
                    "REACT:R-HSA-9719310",
                    "REACT:R-HSA-9718538",
                    "REACT:R-HSA-9719041",
                    "REACT:R-HSA-9721178",
                    "REACT:R-HSA-9720810",
                    "REACT:R-HSA-9721911",
                    "REACT:R-HSA-9721485",
                    "REACT:R-HSA-9721938",
                    "REACT:R-HSA-9720700",
                    "REACT:R-HSA-9719044",
                    "REACT:R-HSA-9719110",
                    "REACT:R-HSA-9720214",
                    "REACT:R-HSA-9720071",
                    "REACT:R-HSA-9721067",
                    "REACT:R-HSA-9721149",
                    "REACT:R-HSA-9721608",
                    "REACT:R-HSA-9719523",
                    "REACT:R-HSA-9719574",
                    "REACT:R-HSA-9722038",
                    "REACT:R-HSA-9718818",
                    "REACT:R-HSA-9719510",
                    "REACT:R-HSA-9718739",
                    "REACT:R-HSA-9718821",
                    "REACT:R-HSA-9719445",
                    "REACT:R-HSA-9719785",
                    "REACT:R-HSA-9721440",
                    "REACT:R-HSA-9721665",
                    "REACT:R-HSA-9719443",
                    "REACT:R-HSA-9719959",
                    "REACT:R-HSA-9719693",
                    "REACT:R-HSA-9719836",
                    "REACT:R-HSA-9718703",
                    "REACT:R-HSA-9718942",
                    "REACT:R-HSA-9719076",
                    "REACT:R-HSA-9720935",
                    "REACT:R-HSA-9726330",
                    "REACT:R-HSA-9721959",
                    "REACT:R-HSA-9721683",
                    "REACT:R-HSA-9719016",
                    "REACT:R-HSA-9720587",
                    "REACT:R-HSA-9718549",
                    "REACT:R-HSA-9718500",
                    "REACT:R-HSA-9719513",
                    "REACT:R-HSA-9719564",
                    "REACT:R-HSA-9719685",
                    "REACT:R-HSA-9720183",
                    "REACT:R-HSA-9720272",
                    "REACT:R-HSA-9719758",
                    "REACT:R-HSA-9720663",
                    "REACT:R-HSA-9721689",
                    "REACT:R-HSA-9720436",
                    "REACT:R-HSA-9721918",
                    "REACT:R-HSA-9723600",
                    "REACT:R-HSA-9721536",
                    "REACT:R-HSA-9719819",
                    "REACT:R-HSA-9719239",
                    "REACT:R-HSA-9721081",
                    "REACT:R-HSA-9721776",
                    "REACT:R-HSA-9723462",
                    "REACT:R-HSA-9721449",
                    "REACT:R-HSA-9720746",
                    "REACT:R-HSA-9719235",
                    "REACT:R-HSA-9721971",
                    "REACT:R-HSA-9719938",
                    "REACT:R-HSA-9723624",
                    "REACT:R-HSA-9720609",
                    "REACT:R-HSA-9721215",
                    "REACT:R-HSA-9721190",
                    "REACT:R-HSA-9722095",
                    "REACT:R-HSA-9721651",
                    "REACT:R-HSA-9719504",
                    "REACT:R-HSA-9719521",
                    "REACT:R-HSA-69507",
                    "REACT:R-HSA-9718520",
                    "REACT:R-HSA-9718776",
                    "REACT:R-HSA-9721796",
                    "REACT:R-HSA-9719005",
                    "REACT:R-HSA-9719764",
                    "REACT:R-HSA-9719274",
                    "REACT:R-HSA-9718600",
                    "REACT:R-HSA-9719232",
                    "REACT:R-HSA-9721534",
                    "REACT:R-HSA-9723664",
                    "REACT:R-HSA-9720406",
                    "REACT:R-HSA-9718760",
                    "REACT:R-HSA-9719458",
                    "REACT:R-HSA-9721433",
                    "REACT:R-HSA-9721425",
                    "REACT:R-HSA-9721191",
                    "REACT:R-HSA-9718991",
                    "REACT:R-HSA-9720287",
                    "REACT:R-HSA-9719777",
                    "REACT:R-HSA-9723430",
                    "REACT:R-HSA-9719471",
                    "REACT:R-HSA-9720956",
                    "REACT:R-HSA-9723458",
                    "REACT:R-HSA-9721762",
                    "REACT:R-HSA-9720647",
                    "REACT:R-HSA-9719499",
                    "REACT:R-HSA-9719387",
                    "REACT:R-HSA-9720104",
                    "REACT:R-HSA-9720442",
                    "REACT:R-HSA-9718858",
                    "REACT:R-HSA-9719747",
                    "REACT:R-HSA-9718617",
                    "REACT:R-HSA-9718668",
                    "REACT:R-HSA-9723616",
                    "REACT:R-HSA-9723335",
                    "REACT:R-HSA-9718879",
                    "REACT:R-HSA-9721786",
                    "REACT:R-HSA-9720050",
                    "REACT:R-HSA-9719526",
                    "REACT:R-HSA-9719374",
                    "REACT:R-HSA-9721585",
                    "REACT:R-HSA-9722101",
                    "REACT:R-HSA-9721880",
                    "REACT:R-HSA-9721544",
                    "REACT:R-HSA-9723550",
                    "REACT:R-HSA-9718894",
                    "REACT:R-HSA-9720155",
                    "REACT:R-HSA-9718732",
                    "REACT:R-HSA-9719236",
                    "REACT:R-HSA-9719582",
                    "REACT:R-HSA-9721789",
                    "REACT:R-HSA-9719101",
                    "REACT:R-HSA-9719053",
                    "REACT:R-HSA-9720965",
                    "REACT:R-HSA-9721000",
                    "REACT:R-HSA-9722048",
                    "REACT:R-HSA-9718753",
                    "REACT:R-HSA-9718499",
                    "REACT:R-HSA-9720901",
                    "REACT:R-HSA-9721943",
                    "REACT:R-HSA-9719035",
                    "REACT:R-HSA-9719554",
                    "REACT:R-HSA-9723354",
                    "REACT:R-HSA-9723443",
                    "REACT:R-HSA-9723563",
                    "REACT:R-HSA-9720568",
                    "REACT:R-HSA-9720765",
                    "REACT:R-HSA-9720916",
                    "REACT:R-HSA-9720322",
                    "REACT:R-HSA-9719868",
                    "NCBIGene:7157",
                    "REACT:R-HSA-9720112",
                    "REACT:R-HSA-9719678",
                    "REACT:R-HSA-9720347",
                    "REACT:R-HSA-9721230",
                    "REACT:R-HSA-9718713",
                    "REACT:R-HSA-9718807",
                    "REACT:R-HSA-9718591",
                    "REACT:R-HSA-9718878",
                    "REACT:R-HSA-9718639",
                    "REACT:R-HSA-9721098",
                    "REACT:R-HSA-9721139",
                    "REACT:R-HSA-9721537",
                    "REACT:R-HSA-9721601",
                    "REACT:R-HSA-9721656",
                    "REACT:R-HSA-9721851",
                    "REACT:R-HSA-9723393",
                    "REACT:R-HSA-9718926",
                    "REACT:R-HSA-9721254",
                    "REACT:R-HSA-9723595",
                    "UMLS:C0146283",
                    "REACT:R-HSA-9719563",
                    "REACT:R-HSA-9719808",
                    "REACT:R-HSA-9721663",
                    "REACT:R-HSA-9720206",
                    "REACT:R-HSA-9721691",
                    "REACT:R-HSA-9721813",
                    "REACT:R-HSA-9721221",
                    "REACT:R-HSA-6813797",
                    "REACT:R-HSA-9720285",
                    "REACT:R-HSA-9719519",
                    "REACT:R-HSA-9718935",
                    "REACT:R-HSA-9720444",
                    "REACT:R-HSA-9719313",
                    "REACT:R-HSA-9721814",
                    "REACT:R-HSA-9718749",
                    "REACT:R-HSA-9718780",
                    "REACT:R-HSA-9720807",
                    "REACT:R-HSA-9721150",
                    "REACT:R-HSA-9719228",
                    "REACT:R-HSA-9721655",
                    "REACT:R-HSA-9723556",
                    "REACT:R-HSA-9718754",
                    "REACT:R-HSA-9718586",
                    "REACT:R-HSA-9721644",
                    "REACT:R-HSA-9718596",
                    "REACT:R-HSA-9720035",
                    "REACT:R-HSA-9719446",
                    "REACT:R-HSA-9721898",
                    "REACT:R-HSA-9720116",
                    "REACT:R-HSA-9719050",
                    "REACT:R-HSA-9718556",
                    "REACT:R-HSA-9718745",
                    "REACT:R-HSA-9719320",
                    "REACT:R-HSA-9721566",
                    "REACT:R-HSA-9721799",
                    "REACT:R-HSA-9721856",
                    "REACT:R-HSA-9719606",
                    "REACT:R-HSA-9718861",
                    "REACT:R-HSA-9719977",
                    "REACT:R-HSA-9721035",
                    "REACT:R-HSA-9720446",
                    "REACT:R-HSA-9720182",
                    "REACT:R-HSA-9719500",
                    "REACT:R-HSA-9719483",
                    "REACT:R-HSA-9719027",
                    "REACT:R-HSA-9720824",
                    "REACT:R-HSA-9720296",
                    "REACT:R-HSA-9723538",
                    "REACT:R-HSA-9719536",
                    "REACT:R-HSA-9720947",
                    "REACT:R-HSA-9721495",
                    "REACT:R-HSA-9719192",
                    "REACT:R-HSA-9721607",
                    "REACT:R-HSA-9721162",
                    "REACT:R-HSA-9720803",
                    "REACT:R-HSA-9720346",
                    "PR:P04637",
                    "REACT:R-HSA-9719580",
                    "REACT:R-HSA-9718515",
                    "REACT:R-HSA-9721417",
                    "REACT:R-HSA-9719226",
                    "REACT:R-HSA-9718786",
                    "REACT:R-HSA-9721441",
                    "REACT:R-HSA-9721036",
                    "REACT:R-HSA-9719250",
                    "REACT:R-HSA-9718850",
                    "REACT:R-HSA-9721574",
                    "REACT:R-HSA-9720422",
                    "REACT:R-HSA-9721617",
                    "REACT:R-HSA-9720478",
                    "REACT:R-HSA-9722073",
                    "REACT:R-HSA-9721927",
                    "REACT:R-HSA-9723529",
                    "REACT:R-HSA-9720790",
                    "REACT:R-HSA-9720538",
                    "REACT:R-HSA-9721777",
                    "REACT:R-HSA-9719171",
                    "REACT:R-HSA-9726342",
                    "REACT:R-HSA-9719806",
                    "REACT:R-HSA-9720247",
                    "REACT:R-HSA-9719061",
                    "REACT:R-HSA-9718621",
                    "REACT:R-HSA-9721042",
                    "REACT:R-HSA-9720439",
                    "REACT:R-HSA-9722085",
                    "REACT:R-HSA-9721378",
                    "REACT:R-HSA-9719396",
                    "REACT:R-HSA-9719090",
                    "REACT:R-HSA-9719386",
                    "REACT:R-HSA-9720713",
                    "REACT:R-HSA-9721222",
                    "REACT:R-HSA-9719351",
                    "REACT:R-HSA-9721881",
                    "REACT:R-HSA-9719283",
                    "REACT:R-HSA-9720521",
                    "REACT:R-HSA-9720427",
                    "REACT:R-HSA-9721250",
                    "REACT:R-HSA-9721464",
                    "REACT:R-HSA-9719912",
                    "REACT:R-HSA-9720031",
                    "REACT:R-HSA-9719113",
                    "REACT:R-HSA-69488",
                    "REACT:R-HSA-9726075",
                    "REACT:R-HSA-9721899",
                    "REACT:R-HSA-9720167",
                    "REACT:R-HSA-9722054",
                    "REACT:R-HSA-9721715",
                    "REACT:R-HSA-9718853",
                    "REACT:R-HSA-9720042",
                    "REACT:R-HSA-9721779",
                    "REACT:R-HSA-9720925",
                    "REACT:R-HSA-9719392",
                    "REACT:R-HSA-9722039",
                    "REACT:R-HSA-9722042",
                    "REACT:R-HSA-9721006",
                    "REACT:R-HSA-9718817",
                    "REACT:R-HSA-9721476",
                    "REACT:R-HSA-9720289",
                    "REACT:R-HSA-9719690",
                    "REACT:R-HSA-9720268",
                    "REACT:R-HSA-9721809",
                    "REACT:R-HSA-9720998",
                    "REACT:R-HSA-9721682",
                    "REACT:R-HSA-9719887",
                    "REACT:R-HSA-9723487",
                    "REACT:R-HSA-9721937",
                    "REACT:R-HSA-9720048",
                    "REACT:R-HSA-9720074",
                    "REACT:R-HSA-9719541",
                    "REACT:R-HSA-9720651",
                    "REACT:R-HSA-9719962",
                    "REACT:R-HSA-9721864",
                    "REACT:R-HSA-9721693",
                    "REACT:R-HSA-9721026",
                    "REACT:R-HSA-9723611",
                    "REACT:R-HSA-9720294",
                    "REACT:R-HSA-9718519",
                    "REACT:R-HSA-9723586",
                    "REACT:R-HSA-9719915",
                    "REACT:R-HSA-9721750",
                    "REACT:R-HSA-9722051",
                    "REACT:R-HSA-9719885",
                    "REACT:R-HSA-9719160",
                    "REACT:R-HSA-9718644",
                    "REACT:R-HSA-9721933",
                    "REACT:R-HSA-9722012",
                    "REACT:R-HSA-9721198",
                    "REACT:R-HSA-9720689",
                    "REACT:R-HSA-9726073",
                    "REACT:R-HSA-9723437",
                    "REACT:R-HSA-9723461",
                    "REACT:R-HSA-9719045",
                    "REACT:R-HSA-9723469",
                    "REACT:R-HSA-9723593",
                    "REACT:R-HSA-9718870",
                    "REACT:R-HSA-9721273",
                    "REACT:R-HSA-9721457",
                    "REACT:R-HSA-9720357",
                    "REACT:R-HSA-9718874",
                    "REACT:R-HSA-9718630",
                    "REACT:R-HSA-9718959",
                    "REACT:R-HSA-9721020",
                    "REACT:R-HSA-9718743",
                    "REACT:R-HSA-9721863",
                    "REACT:R-HSA-9722067",
                    "REACT:R-HSA-9721511",
                    "REACT:R-HSA-9719350",
                    "REACT:R-HSA-9719567",
                    "REACT:R-HSA-9718657",
                    "REACT:R-HSA-9719322",
                    "REACT:R-HSA-9719302",
                    "REACT:R-HSA-9720562",
                    "REACT:R-HSA-9720079",
                    "REACT:R-HSA-9719562",
                    "REACT:R-HSA-9720857",
                    "REACT:R-HSA-9721091",
                    "REACT:R-HSA-9721362",
                    "REACT:R-HSA-9721992",
                    "REACT:R-HSA-9721879",
                    "REACT:R-HSA-9719473",
                    "REACT:R-HSA-9719852",
                    "REACT:R-HSA-9723609",
                    "REACT:R-HSA-9720400",
                    "REACT:R-HSA-9723634",
                    "REACT:R-HSA-9726319",
                    "REACT:R-HSA-9718758",
                    "REACT:R-HSA-9719478",
                    "REACT:R-HSA-9719330",
                    "REACT:R-HSA-9720336",
                    "UMLS:C0079419",
                    "REACT:R-HSA-9718783",
                    "REACT:R-HSA-9723670",
                    "REACT:R-HSA-9719134",
                    "REACT:R-HSA-9720489",
                    "REACT:R-HSA-9720633",
                    "REACT:R-HSA-9719644",
                    "REACT:R-HSA-9718653",
                    "REACT:R-HSA-9718761",
                    "REACT:R-HSA-9720021",
                    "REACT:R-HSA-9719416",
                    "REACT:R-HSA-9720311",
                    "REACT:R-HSA-9720088",
                    "REACT:R-HSA-9719641",
                    "REACT:R-HSA-9723368",
                    "REACT:R-HSA-9719759",
                    "REACT:R-HSA-9721873",
                    "REACT:R-HSA-9726266",
                    "REACT:R-HSA-9723626",
                    "REACT:R-HSA-9723693",
                    "REACT:R-HSA-9718509",
                    "REACT:R-HSA-9720577",
                    "REACT:R-HSA-9723656",
                    "REACT:R-HSA-9721060",
                    "REACT:R-HSA-9719877",
                    "REACT:R-HSA-9720759",
                    "REACT:R-HSA-9721129",
                    "REACT:R-HSA-9721989",
                    "REACT:R-HSA-9720393",
                    "REACT:R-HSA-9719638",
                    "REACT:R-HSA-9718582",
                    "REACT:R-HSA-9718794",
                    "REACT:R-HSA-9719566",
                    "REACT:R-HSA-9721163",
                    "REACT:R-HSA-9721624",
                    "REACT:R-HSA-9723394",
                    "REACT:R-HSA-9718917",
                    "REACT:R-HSA-9721803",
                    "REACT:R-HSA-9718997",
                    "REACT:R-HSA-9718808",
                    "REACT:R-HSA-9721643",
                    "REACT:R-HSA-9720059",
                    "REACT:R-HSA-9718737",
                    "REACT:R-HSA-9719256",
                    "REACT:R-HSA-9721446",
                    "REACT:R-HSA-9721451",
                    "REACT:R-HSA-9722045",
                    "REACT:R-HSA-6793679",
                    "REACT:R-HSA-9720775",
                    "REACT:R-HSA-9720818",
                    "REACT:R-HSA-9718666",
                    "REACT:R-HSA-9721352",
                    "REACT:R-HSA-9721521",
                    "REACT:R-HSA-9718839",
                    "REACT:R-HSA-9720258",
                    "REACT:R-HSA-9720327",
                    "REACT:R-HSA-9718602",
                    "REACT:R-HSA-9719832",
                    "REACT:R-HSA-9721860",
                    "REACT:R-HSA-9719706",
                    "REACT:R-HSA-9721753",
                    "REACT:R-HSA-9721930",
                    "REACT:R-HSA-9720996",
                    "REACT:R-HSA-9721303",
                    "REACT:R-HSA-9721591",
                    "REACT:R-HSA-9720646",
                    "REACT:R-HSA-9723407",
                    "REACT:R-HSA-9720022",
                    "REACT:R-HSA-9722076",
                    "REACT:R-HSA-9719673",
                    "REACT:R-HSA-9721782",
                    "REACT:R-HSA-9723416",
                    "REACT:R-HSA-9720282",
                    "REACT:R-HSA-9720845",
                    "REACT:R-HSA-9721729",
                    "REACT:R-HSA-9721723",
                    "REACT:R-HSA-9721572",
                    "OMIM:191170",
                    "REACT:R-HSA-9719537",
                    "REACT:R-HSA-9721003",
                    "REACT:R-HSA-9719717",
                    "REACT:R-HSA-9719782",
                    "REACT:R-HSA-9718689",
                    "REACT:R-HSA-9718996",
                    "REACT:R-HSA-9719254",
                    "REACT:R-HSA-9720480",
                    "REACT:R-HSA-9720507",
                    "REACT:R-HSA-9719468",
                    "REACT:R-HSA-9719661",
                    "REACT:R-HSA-9723580",
                    "REACT:R-HSA-9719933",
                    "REACT:R-HSA-9721120",
                    "REACT:R-HSA-9726358",
                    "REACT:R-HSA-9721961",
                    "REACT:R-HSA-9720026",
                    "REACT:R-HSA-3239022",
                    "REACT:R-HSA-9718752",
                    "REACT:R-HSA-9721872",
                    "REACT:R-HSA-9720162",
                    "REACT:R-HSA-5628868",
                    "REACT:R-HSA-9723674",
                    "REACT:R-HSA-9719189",
                    "REACT:R-HSA-9720172",
                    "REACT:R-HSA-9718923",
                    "REACT:R-HSA-9726101",
                    "REACT:R-HSA-9726136",
                    "REACT:R-HSA-9720826",
                    "REACT:R-HSA-9721103",
                    "REACT:R-HSA-9718559",
                    "REACT:R-HSA-9720175",
                    "REACT:R-HSA-9719659",
                    "REACT:R-HSA-6805400",
                    "REACT:R-HSA-9719068",
                    "REACT:R-HSA-9719876",
                    "REACT:R-HSA-9720968",
                    "REACT:R-HSA-9721142",
                    "REACT:R-HSA-9721382",
                    "REACT:R-HSA-9721448",
                    "REACT:R-HSA-9720917",
                    "REACT:R-HSA-9718934",
                    "REACT:R-HSA-9720309",
                    "REACT:R-HSA-9719162",
                    "REACT:R-HSA-9719932",
                    "REACT:R-HSA-9720305",
                    "REACT:R-HSA-9718938",
                    "REACT:R-HSA-9719300",
                    "REACT:R-HSA-9719424",
                    "REACT:R-HSA-9721171",
                    "REACT:R-HSA-6805719",
                    "REACT:R-HSA-9719854",
                    "REACT:R-HSA-9721582",
                    "REACT:R-HSA-9719628",
                    "REACT:R-HSA-9720523",
                    "REACT:R-HSA-9720498",
                    "REACT:R-HSA-9721319",
                    "REACT:R-HSA-9721535",
                    "REACT:R-HSA-9718951",
                    "REACT:R-HSA-9718813",
                    "REACT:R-HSA-9719371",
                    "REACT:R-HSA-9719532",
                    "REACT:R-HSA-9719833",
                    "REACT:R-HSA-9720115",
                    "REACT:R-HSA-9720205",
                    "REACT:R-HSA-9719017",
                    "REACT:R-HSA-9723620",
                    "REACT:R-HSA-9720101",
                    "REACT:R-HSA-9719742",
                    "REACT:R-HSA-9721949",
                    "REACT:R-HSA-9726153",
                    "REACT:R-HSA-9726134",
                    "REACT:R-HSA-9718548",
                    "REACT:R-HSA-9718927",
                    "REACT:R-HSA-9718560",
                    "REACT:R-HSA-9721931",
                    "REACT:R-HSA-9722019",
                    "REACT:R-HSA-9719893",
                    "REACT:R-HSA-9723639",
                    "REACT:R-HSA-9720343",
                    "REACT:R-HSA-9720371",
                    "REACT:R-HSA-9720756",
                    "REACT:R-HSA-9720891",
                    "REACT:R-HSA-9723691",
                    "REACT:R-HSA-9720063",
                    "REACT:R-HSA-9719996",
                    "REACT:R-HSA-9718592",
                    "REACT:R-HSA-9719524",
                    "REACT:R-HSA-9719010",
                    "REACT:R-HSA-9720605",
                    "REACT:R-HSA-9720045",
                    "REACT:R-HSA-9719203",
                    "REACT:R-HSA-9720698",
                    "REACT:R-HSA-9721321",
                    "REACT:R-HSA-9720321",
                    "REACT:R-HSA-9719100",
                    "REACT:R-HSA-9721510",
                    "REACT:R-HSA-9721982",
                    "REACT:R-HSA-9720402",
                    "REACT:R-HSA-9718815",
                    "REACT:R-HSA-9718551",
                    "REACT:R-HSA-9720487",
                    "REACT:R-HSA-9723357",
                    "REACT:R-HSA-9726163",
                    "REACT:R-HSA-9719333",
                    "REACT:R-HSA-9721121",
                    "REACT:R-HSA-9721514",
                    "REACT:R-HSA-9718985",
                    "REACT:R-HSA-9726274",
                    "REACT:R-HSA-6805053",
                    "REACT:R-HSA-9721132",
                    "REACT:R-HSA-9719117",
                    "REACT:R-HSA-9718526",
                    "REACT:R-HSA-9719372",
                    "REACT:R-HSA-9719781",
                    "REACT:R-HSA-9720902",
                    "REACT:R-HSA-9720260",
                    "REACT:R-HSA-9722093",
                    "REACT:R-HSA-9720980",
                    "REACT:R-HSA-9721798",
                    "REACT:R-HSA-9719669",
                    "REACT:R-HSA-9723627",
                    "REACT:R-HSA-9718944",
                    "REACT:R-HSA-9721625",
                    "REACT:R-HSA-9719201",
                    "REACT:R-HSA-9719948",
                    "REACT:R-HSA-9720010",
                    "REACT:R-HSA-9721559",
                    "REACT:R-HSA-9718516",
                    "REACT:R-HSA-9719619",
                    "REACT:R-HSA-9720313",
                    "REACT:R-HSA-9719849",
                    "REACT:R-HSA-9720565",
                    "REACT:R-HSA-9720741",
                    "REACT:R-HSA-9720990",
                    "REACT:R-HSA-9721890",
                    "REACT:R-HSA-9721037",
                    "REACT:R-HSA-9722062",
                    "REACT:R-HSA-6805133",
                    "REACT:R-HSA-9719847",
                    "REACT:R-HSA-6782509",
                    "REACT:R-HSA-9720530",
                    "REACT:R-HSA-9721212",
                    "REACT:R-HSA-9719871",
                    "REACT:R-HSA-9719966",
                    "REACT:R-HSA-9721839",
                    "REACT:R-HSA-9718842",
                    "REACT:R-HSA-9720238",
                    "REACT:R-HSA-9723343",
                    "REACT:R-HSA-9720389",
                    "REACT:R-HSA-9721367",
                    "REACT:R-HSA-9721921",
                    "REACT:R-HSA-9721941",
                    "REACT:R-HSA-9721161",
                    "REACT:R-HSA-9721564",
                    "REACT:R-HSA-9719626",
                    "REACT:R-HSA-9719498",
                    "REACT:R-HSA-9720606",
                    "REACT:R-HSA-9719839",
                    "REACT:R-HSA-9720709",
                    "REACT:R-HSA-9720777",
                    "REACT:R-HSA-9721435",
                    "REACT:R-HSA-9722023",
                    "REACT:R-HSA-9723432",
                    "REACT:R-HSA-9720688",
                    "REACT:R-HSA-9718898",
                    "REACT:R-HSA-9719631",
                    "REACT:R-HSA-9719413",
                    "REACT:R-HSA-9720951",
                    "REACT:R-HSA-9719714",
                    "REACT:R-HSA-9718697",
                    "REACT:R-HSA-9719028",
                    "REACT:R-HSA-9721859",
                    "REACT:R-HSA-9721948",
                    "REACT:R-HSA-9721323",
                    "REACT:R-HSA-9720255",
                    "REACT:R-HSA-8869337",
                    "REACT:R-HSA-9719022",
                    "REACT:R-HSA-9720426",
                    "REACT:R-HSA-9720488",
                    "REACT:R-HSA-6798369",
                    "REACT:R-HSA-9721543",
                    "REACT:R-HSA-9721759",
                    "REACT:R-HSA-9722021",
                    "REACT:R-HSA-9718513",
                    "REACT:R-HSA-9719329",
                    "REACT:R-HSA-9721962",
                    "REACT:R-HSA-9720911",
                    "REACT:R-HSA-9721106",
                    "REACT:R-HSA-9721113",
                    "REACT:R-HSA-9719660",
                    "REACT:R-HSA-9721403",
                    "REACT:R-HSA-9721743",
                    "REACT:R-HSA-9721910",
                    "REACT:R-HSA-9720415",
                    "REACT:R-HSA-9720084",
                    "REACT:R-HSA-9718798",
                    "REACT:R-HSA-9723532",
                    "REACT:R-HSA-9721248",
                    "REACT:R-HSA-9719512",
                    "REACT:R-HSA-9718857",
                    "REACT:R-HSA-9720204",
                    "REACT:R-HSA-9719664",
                    "REACT:R-HSA-9721654",
                    "REACT:R-HSA-9723476",
                    "REACT:R-HSA-9718680",
                    "REACT:R-HSA-3222015",
                    "REACT:R-HSA-9719198",
                    "REACT:R-HSA-9723425",
                    "REACT:R-HSA-9719822",
                    "REACT:R-HSA-9722070",
                    "REACT:R-HSA-9719904",
                    "REACT:R-HSA-9720582",
                    "REACT:R-HSA-9719230",
                    "REACT:R-HSA-9721741",
                    "REACT:R-HSA-9719311",
                    "REACT:R-HSA-9719581",
                    "REACT:R-HSA-9721865",
                    "REACT:R-HSA-9719086",
                    "REACT:R-HSA-9721245",
                    "REACT:R-HSA-6793681",
                    "REACT:R-HSA-9720784",
                    "REACT:R-HSA-9720918",
                    "REACT:R-HSA-9721849",
                    "REACT:R-HSA-9718660",
                    "REACT:R-HSA-9721670",
                    "REACT:R-HSA-9719148",
                    "REACT:R-HSA-9719998",
                    "REACT:R-HSA-9719237",
                    "REACT:R-HSA-9719525",
                    "REACT:R-HSA-9719479",
                    "REACT:R-HSA-9719549",
                    "REACT:R-HSA-9718778",
                    "REACT:R-HSA-9719866",
                    "REACT:R-HSA-9719243",
                    "REACT:R-HSA-9719496",
                    "REACT:R-HSA-9719627",
                    "REACT:R-HSA-9723465",
                    "REACT:R-HSA-9720625",
                    "REACT:R-HSA-9721203",
                    "REACT:R-HSA-9719555",
                    "REACT:R-HSA-6804378",
                    "REACT:R-HSA-9719011",
                    "REACT:R-HSA-9718628",
                    "REACT:R-HSA-9722091",
                    "REACT:R-HSA-9721836",
                    "REACT:R-HSA-6804446",
                    "REACT:R-HSA-9721068",
                    "REACT:R-HSA-9721516",
                    "REACT:R-HSA-9719393",
                    "REACT:R-HSA-9720352",
                    "REACT:R-HSA-9720223",
                    "REACT:R-HSA-9720534",
                    "REACT:R-HSA-9720235",
                    "REACT:R-HSA-9721118",
                    "REACT:R-HSA-9720877",
                    "REACT:R-HSA-9721164",
                    "REACT:R-HSA-9721266",
                    "REACT:R-HSA-9721478",
                    "REACT:R-HSA-9723339",
                    "PR:P10360",
                    "REACT:R-HSA-9719321",
                    "REACT:R-HSA-9718939",
                    "REACT:R-HSA-9723667",
                    "REACT:R-HSA-9720865",
                    "REACT:R-HSA-9723685",
                    "REACT:R-HSA-9720958",
                    "REACT:R-HSA-9720043",
                    "REACT:R-HSA-9720502",
                    "REACT:R-HSA-9718656",
                    "REACT:R-HSA-9719730",
                    "REACT:R-HSA-9720516",
                    "REACT:R-HSA-9718830",
                    "REACT:R-HSA-9721030",
                    "REACT:R-HSA-9718599",
                    "REACT:R-HSA-9721434",
                    "REACT:R-HSA-9719820",
                    "REACT:R-HSA-9718767",
                    "REACT:R-HSA-9719522",
                    "REACT:R-HSA-9720370",
                    "REACT:R-HSA-9721628",
                    "REACT:R-HSA-9719509",
                    "REACT:R-HSA-9720194",
                    "REACT:R-HSA-9719992",
                    "REACT:R-HSA-9719339",
                    "REACT:R-HSA-9721413",
                    "RGD:3889",
                    "REACT:R-HSA-9722066",
                    "REACT:R-HSA-9720188",
                    "REACT:R-HSA-9720340",
                    "REACT:R-HSA-9720793",
                    "REACT:R-HSA-9723557",
                    "REACT:R-HSA-9721214",
                    "REACT:R-HSA-9721823",
                    "REACT:R-HSA-9721901",
                    "REACT:R-HSA-9720842",
                    "REACT:R-HSA-9719888",
                    "REACT:R-HSA-9720397",
                    "REACT:R-HSA-9719138",
                    "REACT:R-HSA-9722013",
                    "REACT:R-HSA-9721074",
                    "REACT:R-HSA-9721673",
                    "REACT:R-HSA-9721764",
                    "REACT:R-HSA-9718983",
                    "REACT:R-HSA-9719527",
                    "REACT:R-HSA-9720875",
                    "REACT:R-HSA-9722084",
                    "REACT:R-HSA-9721769",
                    "REACT:R-HSA-9721808",
                    "REACT:R-HSA-9718604",
                    "REACT:R-HSA-9720615",
                    "REACT:R-HSA-9720391",
                    "REACT:R-HSA-9721379",
                    "REACT:R-HSA-9721660",
                    "REACT:R-HSA-9718736",
                    "REACT:R-HSA-9720153",
                    "REACT:R-HSA-9720108",
                    "REACT:R-HSA-9719121",
                    "REACT:R-HSA-9719474",
                    "REACT:R-HSA-9720780",
                    "REACT:R-HSA-9721576",
                    "REACT:R-HSA-9719941",
                    "REACT:R-HSA-9719859",
                    "REACT:R-HSA-9718558",
                    "REACT:R-HSA-9719094",
                    "REACT:R-HSA-9720472",
                    "REACT:R-HSA-9721570",
                    "REACT:R-HSA-9718683",
                    "REACT:R-HSA-9719666",
                    "REACT:R-HSA-9719477",
                    "REACT:R-HSA-9720279",
                    "REACT:R-HSA-9720504",
                    "REACT:R-HSA-9722096",
                    "REACT:R-HSA-9718716",
                    "REACT:R-HSA-9719308",
                    "REACT:R-HSA-9719217",
                    "REACT:R-HSA-9720812",
                    "REACT:R-HSA-9721128",
                    "REACT:R-HSA-9718844",
                    "REACT:R-HSA-9720445",
                    "REACT:R-HSA-9720732",
                    "REACT:R-HSA-9722047",
                    "REACT:R-HSA-9720217",
                    "REACT:R-HSA-9718800",
                    "REACT:R-HSA-9723338",
                    "REACT:R-HSA-9721810",
                    "REACT:R-HSA-9720662",
                    "REACT:R-HSA-9722098",
                    "REACT:R-HSA-9721788",
                    "REACT:R-HSA-9720770",
                    "REACT:R-HSA-9719075",
                    "LOINC:LP19769-6",
                    "REACT:R-HSA-9719040",
                    "REACT:R-HSA-9719999",
                    "REACT:R-HSA-9720044",
                    "REACT:R-HSA-9719665",
                    "REACT:R-HSA-9719501",
                    "REACT:R-HSA-9719790",
                    "REACT:R-HSA-9719345",
                    "REACT:R-HSA-9721260",
                    "REACT:R-HSA-9721334",
                    "REACT:R-HSA-9718623",
                    "REACT:R-HSA-9720722",
                    "REACT:R-HSA-9720248",
                    "REACT:R-HSA-9719791",
                    "REACT:R-HSA-9718746",
                    "REACT:R-HSA-9721558",
                    "REACT:R-HSA-9720994",
                    "REACT:R-HSA-9720828",
                    "REACT:R-HSA-9720619",
                    "REACT:R-HSA-9721337",
                    "REACT:R-HSA-9723325",
                    "PR:P79734",
                    "REACT:R-HSA-9719707",
                    "REACT:R-HSA-9718698",
                    "REACT:R-HSA-9719280",
                    "REACT:R-HSA-9720005",
                    "REACT:R-HSA-9723398",
                    "REACT:R-HSA-9719429",
                    "REACT:R-HSA-9721631",
                    "REACT:R-HSA-9719974",
                    "REACT:R-HSA-9720207",
                    "REACT:R-HSA-9719176",
                    "NCIT:C17359",
                    "REACT:R-HSA-9723356",
                    "REACT:R-HSA-9721546",
                    "REACT:R-HSA-9723413",
                    "REACT:R-HSA-9719331",
                    "REACT:R-HSA-9719077",
                    "REACT:R-HSA-9719403",
                    "REACT:R-HSA-9721603",
                    "REACT:R-HSA-9720094",
                    "REACT:R-HSA-9720243",
                    "REACT:R-HSA-9719528",
                    "REACT:R-HSA-9721507",
                    "REACT:R-HSA-9723408",
                    "REACT:R-HSA-9719610",
                    "REACT:R-HSA-9718827",
                    "REACT:R-HSA-9723651",
                    "REACT:R-HSA-9720679",
                    "REACT:R-HSA-9718787",
                    "REACT:R-HSA-9719450",
                    "REACT:R-HSA-9719738",
                    "HGNC:11998",
                    "REACT:R-HSA-9723483",
                    "REACT:R-HSA-9720645",
                    "REACT:R-HSA-9719263",
                    "REACT:R-HSA-9721313",
                    "REACT:R-HSA-9719773",
                    "REACT:R-HSA-9718835",
                    "REACT:R-HSA-9722071",
                    "REACT:R-HSA-9723549",
                    "REACT:R-HSA-9720096",
                    "REACT:R-HSA-9719993",
                    "REACT:R-HSA-9720783",
                    "REACT:R-HSA-9720563",
                    "REACT:R-HSA-9726275",
                    "REACT:R-HSA-9720254",
                    "REACT:R-HSA-9721364",
                    "REACT:R-HSA-3222242",
                    "REACT:R-HSA-9718992",
                    "REACT:R-HSA-9718884",
                    "REACT:R-HSA-9719927",
                    "REACT:R-HSA-9718974",
                    "REACT:R-HSA-9718496",
                    "REACT:R-HSA-9721297",
                    "REACT:R-HSA-3222124",
                    "REACT:R-HSA-9721326",
                    "REACT:R-HSA-9719995",
                    "REACT:R-HSA-9721366",
                    "REACT:R-HSA-9721802",
                    "REACT:R-HSA-9718505",
                    "REACT:R-HSA-9719540",
                    "REACT:R-HSA-9722078",
                    "REACT:R-HSA-9719863",
                    "REACT:R-HSA-9723642",
                    "REACT:R-HSA-9718999",
                    "REACT:R-HSA-9720333",
                    "REACT:R-HSA-9721259",
                    "REACT:R-HSA-9721499",
                    "REACT:R-HSA-9720165",
                    "REACT:R-HSA-9719642",
                    "REACT:R-HSA-9720545",
                    "REACT:R-HSA-9719271",
                    "REACT:R-HSA-9720871",
                    "REACT:R-HSA-9720369",
                    "REACT:R-HSA-9726126",
                    "REACT:R-HSA-9720597",
                    "REACT:R-HSA-9718918",
                    "REACT:R-HSA-9720271",
                    "REACT:R-HSA-9718809",
                    "REACT:R-HSA-9719119",
                    "REACT:R-HSA-9718945",
                    "REACT:R-HSA-9718532",
                    "REACT:R-HSA-9719067",
                    "REACT:R-HSA-9719878",
                    "REACT:R-HSA-9723360",
                    "REACT:R-HSA-9719776",
                    "REACT:R-HSA-9718568",
                    "REACT:R-HSA-9719716",
                    "REACT:R-HSA-9720949",
                    "REACT:R-HSA-9722063",
                    "REACT:R-HSA-9720409",
                    "REACT:R-HSA-9721973",
                    "REACT:R-HSA-9719379",
                    "REACT:R-HSA-9720714",
                    "REACT:R-HSA-9720339",
                    "REACT:R-HSA-9721111",
                    "REACT:R-HSA-9721610",
                    "REACT:R-HSA-9721712",
                    "REACT:R-HSA-9721766",
                    "REACT:R-HSA-9719826",
                    "REACT:R-HSA-9721104",
                    "REACT:R-HSA-9719625",
                    "REACT:R-HSA-9720506",
                    "REACT:R-HSA-9726118",
                    "REACT:R-HSA-9726258",
                    "REACT:R-HSA-9726366",
                    "REACT:R-HSA-9720944",
                    "REACT:R-HSA-9719590",
                    "REACT:R-HSA-9718936",
                    "REACT:R-HSA-9723318",
                    "REACT:R-HSA-9720692",
                    "REACT:R-HSA-9719397",
                    "REACT:R-HSA-9719390",
                    "REACT:R-HSA-9720644",
                    "REACT:R-HSA-9719700",
                    "REACT:R-HSA-9720602",
                    "REACT:R-HSA-9719967",
                    "REACT:R-HSA-9721904",
                    "REACT:R-HSA-6805268",
                    "REACT:R-HSA-9720532",
                    "REACT:R-HSA-9721456",
                    "REACT:R-HSA-9719295",
                    "REACT:R-HSA-9726339",
                    "REACT:R-HSA-9720159",
                    "REACT:R-HSA-9720583",
                    "REACT:R-HSA-9719986",
                    "REACT:R-HSA-9721702",
                    "REACT:R-HSA-9720046",
                    "REACT:R-HSA-9722027",
                    "REACT:R-HSA-9721414",
                    "REACT:R-HSA-9722034",
                    "REACT:R-HSA-9721726",
                    "REACT:R-HSA-9723578",
                    "REACT:R-HSA-9719152",
                    "REACT:R-HSA-9721475",
                    "REACT:R-HSA-9720500",
                    "REACT:R-HSA-9721246",
                    "REACT:R-HSA-9720133",
                    "REACT:R-HSA-9721472",
                    "REACT:R-HSA-9726171",
                    "REACT:R-HSA-9718687",
                    "REACT:R-HSA-9723577",
                    "REACT:R-HSA-9718564",
                    "REACT:R-HSA-9723650",
                    "REACT:R-HSA-9720127",
                    "REACT:R-HSA-9721640",
                    "REACT:R-HSA-9720076",
                    "REACT:R-HSA-9720178",
                    "REACT:R-HSA-9719917",
                    "REACT:R-HSA-9719366",
                    "REACT:R-HSA-9721852",
                    "REACT:R-HSA-9721780",
                    "REACT:R-HSA-9718607",
                    "REACT:R-HSA-9721842",
                    "REACT:R-HSA-9719231",
                    "REACT:R-HSA-9720501",
                    "REACT:R-HSA-9721442",
                    "REACT:R-HSA-9721450",
                    "REACT:R-HSA-6805631",
                    "REACT:R-HSA-9718584",
                    "REACT:R-HSA-9720612",
                    "REACT:R-HSA-9723666",
                    "REACT:R-HSA-9720421",
                    "REACT:R-HSA-9718539",
                    "REACT:R-HSA-9719156",
                    "REACT:R-HSA-9719752",
                    "REACT:R-HSA-9720874",
                    "REACT:R-HSA-9721411",
                    "REACT:R-HSA-9721399",
                    "REACT:R-HSA-9721527",
                    "REACT:R-HSA-9720924",
                    "REACT:R-HSA-9720008",
                    "REACT:R-HSA-9721637",
                    "PR:P10361",
                    "REACT:R-HSA-9720850",
                    "REACT:R-HSA-9721679",
                    "REACT:R-HSA-9718503",
                    "REACT:R-HSA-9720284",
                    "REACT:R-HSA-9720220",
                    "REACT:R-HSA-9721920",
                    "REACT:R-HSA-9719183",
                    "REACT:R-HSA-9718534",
                    "REACT:R-HSA-9721460",
                    "REACT:R-HSA-9721577",
                    "REACT:R-HSA-9721871",
                    "REACT:R-HSA-9720809",
                    "REACT:R-HSA-9721926",
                    "MESH:C495901",
                    "REACT:R-HSA-9720808",
                    "REACT:R-HSA-9719481",
                    "REACT:R-HSA-9719149",
                    "REACT:R-HSA-9721598",
                    "REACT:R-HSA-9719292",
                    "REACT:R-HSA-9719750",
                    "REACT:R-HSA-9720380",
                    "REACT:R-HSA-9721318",
                    "REACT:R-HSA-9720559",
                    "REACT:R-HSA-9719038",
                    "REACT:R-HSA-9720099",
                    "REACT:R-HSA-9720301",
                    "REACT:R-HSA-9719518",
                    "REACT:R-HSA-9720682",
                    "REACT:R-HSA-9721117",
                    "REACT:R-HSA-9720475",
                    "REACT:R-HSA-9718682",
                    "REACT:R-HSA-9718888",
                    "REACT:R-HSA-9721187",
                    "REACT:R-HSA-9726338",
                    "REACT:R-HSA-9723601",
                    "REACT:R-HSA-9726124",
                    "REACT:R-HSA-9720599",
                    "REACT:R-HSA-9718976",
                    "REACT:R-HSA-9719898",
                    "REACT:R-HSA-9719157",
                    "REACT:R-HSA-9719462",
                    "REACT:R-HSA-9721528",
                    "REACT:R-HSA-9721742",
                    "REACT:R-HSA-9718508",
                    "REACT:R-HSA-9726144",
                    "REACT:R-HSA-9718851",
                    "REACT:R-HSA-9721217",
                    "REACT:R-HSA-9719828",
                    "REACT:R-HSA-9720129",
                    "REACT:R-HSA-9723436",
                    "REACT:R-HSA-9718734",
                    "REACT:R-HSA-9721416",
                    "REACT:R-HSA-9720012",
                    "REACT:R-HSA-9723342",
                    "REACT:R-HSA-9719377",
                    "REACT:R-HSA-9720931",
                    "REACT:R-HSA-9721105",
                    "REACT:R-HSA-9723689",
                    "REACT:R-HSA-9721284",
                    "REACT:R-HSA-9721295",
                    "REACT:R-HSA-9720253",
                    "REACT:R-HSA-9721563",
                    "REACT:R-HSA-9719378",
                    "REACT:R-HSA-9726318",
                    "REACT:R-HSA-9721462",
                    "REACT:R-HSA-9723608",
                    "REACT:R-HSA-9718987",
                    "REACT:R-HSA-9721928",
                    "REACT:R-HSA-9723640",
                    "REACT:R-HSA-9722037",
                    "REACT:R-HSA-9720246",
                    "REACT:R-HSA-9718606",
                    "REACT:R-HSA-9720196",
                    "REACT:R-HSA-9719282",
                    "REACT:R-HSA-9720476",
                    "REACT:R-HSA-9720548",
                    "REACT:R-HSA-9721370",
                    "REACT:R-HSA-9721586",
                    "REACT:R-HSA-9720905",
                    "REACT:R-HSA-9721923",
                    "REACT:R-HSA-9720659",
                    "REACT:R-HSA-9721972",
                    "REACT:R-HSA-9723427",
                    "REACT:R-HSA-9720303",
                    "UniProtKB:P04637",
                    "REACT:R-HSA-9721552",
                    "REACT:R-HSA-9719343",
                    "REACT:R-HSA-9721369",
                    "REACT:R-HSA-9726263",
                    "REACT:R-HSA-9721491",
                    "REACT:R-HSA-9722100",
                    "REACT:R-HSA-9721690",
                    "REACT:R-HSA-9720872",
                    "REACT:R-HSA-9723445",
                    "REACT:R-HSA-9721542",
                    "REACT:R-HSA-9720737",
                    "REACT:R-HSA-9718883",
                    "REACT:R-HSA-9721304",
                    "REACT:R-HSA-9721662",
                    "REACT:R-HSA-9719223",
                    "REACT:R-HSA-9721327",
                    "REACT:R-HSA-9720384",
                    "REACT:R-HSA-9719009",
                    "REACT:R-HSA-9720800",
                    "REACT:R-HSA-9718998",
                    "REACT:R-HSA-9720718",
                    "REACT:R-HSA-9722055",
                    "REACT:R-HSA-9721963",
                    "REACT:R-HSA-9723584",
                    "REACT:R-HSA-9721733",
                    "REACT:R-HSA-9721612",
                    "REACT:R-HSA-9723349",
                    "REACT:R-HSA-9718504",
                    "REACT:R-HSA-9722001",
                    "REACT:R-HSA-9720125",
                    "REACT:R-HSA-9719369",
                    "REACT:R-HSA-9719557",
                    "REACT:R-HSA-9719530",
                    "REACT:R-HSA-9721960",
                    "REACT:R-HSA-9720484",
                    "REACT:R-HSA-9723509",
                    "REACT:R-HSA-9721108",
                    "REACT:R-HSA-9719344",
                    "REACT:R-HSA-9721287",
                    "REACT:R-HSA-9721386",
                    "REACT:R-HSA-9719305",
                    "REACT:R-HSA-9718633",
                    "REACT:R-HSA-9719695",
                    "REACT:R-HSA-9720423",
                    "REACT:R-HSA-9718855",
                    "REACT:R-HSA-9719097",
                    "REACT:R-HSA-6805656",
                    "REACT:R-HSA-9721956",
                    "REACT:R-HSA-9723555",
                    "REACT:R-HSA-9723440",
                    "REACT:R-HSA-9723372",
                    "REACT:R-HSA-6805106",
                    "REACT:R-HSA-9721518",
                    "REACT:R-HSA-9721745",
                    "REACT:R-HSA-9719755",
                    "REACT:R-HSA-9721233",
                    "REACT:R-HSA-9719692",
                    "REACT:R-HSA-9722033",
                    "REACT:R-HSA-9718619",
                    "REACT:R-HSA-9723619",
                    "REACT:R-HSA-9726168",
                    "REACT:R-HSA-9719185",
                    "REACT:R-HSA-9719211",
                    "REACT:R-HSA-9721125",
                    "REACT:R-HSA-9719391",
                    "REACT:R-HSA-9721493",
                    "REACT:R-HSA-9723328",
                    "REACT:R-HSA-9720544",
                    "ENSEMBL:LRG_321",
                    "REACT:R-HSA-3222226",
                    "REACT:R-HSA-9721744",
                    "REACT:R-HSA-9720537",
                    "REACT:R-HSA-9721719",
                    "REACT:R-HSA-9719214",
                    "REACT:R-HSA-9719265",
                    "REACT:R-HSA-9719684",
                    "REACT:R-HSA-9721934",
                    "REACT:R-HSA-9720915",
                    "REACT:R-HSA-9721374",
                    "REACT:R-HSA-9719656",
                    "REACT:R-HSA-9718593"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1016/s0092-8674(01)00527-x",
                    "PMID:20142040",
                    "PMID:10606744",
                    "DOI:10.1158/0008-5472.can-06-0999",
                    "PMID:12085209",
                    "PMID:7887414",
                    "PMID:17317671",
                    "PMID:19880522",
                    "PMID:19509332",
                    "PMID:19913028"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P05019": {
              "name": "IGF1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P05019",
                  "value_url": "https://identifiers.org/uniprot:P05019",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "An insulin-like growth factor I that is encoded in the genome of human. // COMMENTS: Category=organism-gene.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "IGF1 gene",
                    "IGF1 protein, human",
                    "IGF1",
                    "insulin-like growth factor I (rat)",
                    "IGF1 [platelet alpha granule lumen]",
                    "IGF1 (chicken)",
                    "Igf1 (rat)",
                    "IGF1 [extracellular region]",
                    "IGF1 (human)",
                    "insulin-like growth factor I (mouse)",
                    "insulin-like growth factor I (human)",
                    "Igf1 (mouse)",
                    "insulin-like growth factor I (chicken)",
                    "IGF1 Gene"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PR:P08025",
                    "REACT:R-HSA-139878",
                    "OMIM:147440",
                    "REACT:R-HSA-2404178",
                    "MESH:C583557",
                    "PR:P18254",
                    "NCBIGene:3479",
                    "NCIT:C24485",
                    "REACT:R-HSA-57187",
                    "NCBIGene:418090",
                    "ENSEMBL:ENSG00000017427",
                    "PR:P05017",
                    "HGNC:5464",
                    "UniProtKB:P05019",
                    "UMLS:C1334089",
                    "MGI:96432",
                    "PR:P05019",
                    "RGD:2868",
                    "UMLS:C3712803"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23243309",
                    "DOI:10.1007/s11010-010-0634-z",
                    "DOI:10.1016/0006-291x(91)91593-2",
                    "DOI:10.1016/0169-328x(92)90094-r",
                    "DOI:10.1038/nature12618",
                    "PMID:1319992",
                    "DOI:10.1016/0014-5793(86)80156-9",
                    "PMID:19578119",
                    "PMID:6382022",
                    "PMID:6358902"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P05362": {
              "name": "ICAM1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P05362",
                  "value_url": "https://identifiers.org/uniprot:P05362",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Intercellular adhesion molecule 1 (532 aa, ~58 kDa) is encoded by the human ICAM1 gene. This protein plays a role in integrin binding, immune signaling and leukocyte transendothelial migration.; UMLS Semantic Type: STY:T129; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ICAM1",
                    "ICAM1 Gene",
                    "intercellular adhesion molecule 1 (rat)",
                    "Icam1 (mouse)",
                    "intercellular adhesion molecule 1 (mouse)",
                    "ICAM1 protein, human",
                    "ICAM1 [plasma membrane]",
                    "ICAM1 (human)",
                    "Icam1 (rat)",
                    "ICAM1 gene [nucleoplasm]",
                    "intercellular adhesion molecule 1 (human)",
                    "ICAM1 gene"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:5344",
                    "REACT:R-HSA-197683",
                    "UMLS:C3493229",
                    "MESH:C573420",
                    "PR:Q00238",
                    "UniProtKB:P05362",
                    "PR:P05362",
                    "REACT:R-HSA-6785070",
                    "NCBIGene:3383",
                    "MGI:96392",
                    "ENSEMBL:ENSG00000090339",
                    "RGD:2857",
                    "NCIT:C21006",
                    "PR:P13597",
                    "OMIM:147840",
                    "UMLS:C1334074"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10391210",
                    "PMID:9539702",
                    "DOI:10.1172/jci12432",
                    "PMID:23186163",
                    "PMID:15099525",
                    "PMID:7525451",
                    "PMID:11413168",
                    "DOI:10.1006/geno.1994.1303",
                    "DOI:10.1074/mcp.m800504-mcp200",
                    "DOI:10.1159/000051917"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P06213": {
              "name": "INSR",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P06213",
                  "value_url": "https://identifiers.org/uniprot:P06213",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Insulin receptor (1382 aa, ~156 kDa) is encoded by the human INSR gene. This protein plays a role in both signal transduction and glucose homeostasis.; UMLS Semantic Type: STY:T192; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "INSR(763-1382) [plasma membrane]",
                    "Insr (mouse)",
                    "INSR protein, human",
                    "INSR(28-758) [endosome membrane]",
                    "INSR(28-758) [plasma membrane]",
                    "p-6Y-INSR(763-1382) [endosome membrane]",
                    "INSR Gene",
                    "INSR(763-1382) [endosome membrane]",
                    "INSR gene",
                    "Insr (rat)",
                    "Insulin receptor beta subunit, human",
                    "INSR (human)",
                    "insulin receptor (human)",
                    "p-6Y-INSR(763-1382) [plasma membrane]",
                    "insulin receptor (mouse)",
                    "insulin receptor alpha subunit, human",
                    "INSR"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-74670",
                    "UMLS:C1448132",
                    "PR:P15208",
                    "NCBIGene:3643",
                    "HGNC:6091",
                    "REACT:R-HSA-141719",
                    "REACT:R-HSA-74669",
                    "UniProtKB:P06213",
                    "UMLS:C1334133",
                    "UMLS:C1721315",
                    "RGD:2917",
                    "PR:P06213",
                    "REACT:R-HSA-141718",
                    "REACT:R-HSA-141722",
                    "UMLS:C1721314",
                    "NCIT:C24516",
                    "OMIM:147670",
                    "MESH:C435941",
                    "ENSEMBL:ENSG00000171105",
                    "MGI:96575",
                    "REACT:R-HSA-74668"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8276809",
                    "PMID:3447155",
                    "PMID:1321605",
                    "PMID:18278056",
                    "DOI:10.1074/jbc.m106574200",
                    "PMID:12493740",
                    "PMID:8458533",
                    "DOI:10.1038/nature02399",
                    "DOI:10.1210/en.2002-220815",
                    "PMID:20348418"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P07204": {
              "name": "THBD",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P07204",
                  "value_url": "https://identifiers.org/uniprot:P07204",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Thrombomodulin (575 aa, ~60 kDa) is encoded by the human THBD gene. This protein plays a role in thrombin binding, fibrinolysis and coagulation.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "THBD [plasma membrane]",
                    "Thbd (mouse)",
                    "thrombomodulin (human)",
                    "THBD protein, human",
                    "THBD",
                    "thrombomodulin (mouse)",
                    "THBD gene",
                    "THBD Gene",
                    "THBD (human)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-141030",
                    "OMIM:188040",
                    "MESH:C546931",
                    "LOINC:LP345003-0",
                    "UMLS:C2744539",
                    "PR:P15306",
                    "UniProtKB:P07204",
                    "PR:P07204",
                    "UMLS:C1420720",
                    "NCBIGene:7056",
                    "HGNC:11784",
                    "NCIT:C101378",
                    "MGI:98736",
                    "ENSEMBL:LRG_168",
                    "ENSEMBL:ENSG00000178726"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19625716",
                    "PMID:8528067",
                    "DOI:10.1042/bj2950131",
                    "PMID:7947766",
                    "DOI:10.1056/nejmoa0810739",
                    "PMID:8390446",
                    "PMID:20513133",
                    "PMID:9157575",
                    "PMID:2822087",
                    "PMID:2836377"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P07550": {
              "name": "ADRB2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P07550",
                  "value_url": "https://identifiers.org/uniprot:P07550",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "This gene is involved in maintaining the integrity and rate of G protein-coupled receptor signal transduction.; UMLS Semantic Type: STY:T028",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "beta-2 adrenergic receptor (Mesocricetus auratus)",
                    "ADRB2",
                    "PolyUb-ADRB2 [endosome membrane]",
                    "beta-2 adrenergic receptor (human)",
                    "beta-2 adrenergic receptor (pig)",
                    "ADRB2 (human)",
                    "ADRB2 [plasma membrane]",
                    "ADRB2 (cow)",
                    "ADRB2 (dog)",
                    "beta-2 adrenergic receptor (mouse)",
                    "ADRB2 (pig)",
                    "beta-2 Adrenergic Receptors",
                    "Adrb2 (mouse)",
                    "ADRB2 (Mesocricetus auratus)",
                    "ADRB2 gene",
                    "beta-2 adrenergic receptor (dog)",
                    "pS-ADRB2 [plasma membrane]",
                    "ADRB2 [endosome membrane]",
                    "Adrb2 (guinea pig)",
                    "beta-2 adrenergic receptor (guinea pig)",
                    "Adrb2 (rat)",
                    "beta-2 adrenergic receptor (cow)",
                    "ADRB2 Gene",
                    "pS-ADRB2 [clathrin-coated endocytic vesicle membrane]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-6783036",
                    "NCBIGene:281605",
                    "UMLS:C0001643",
                    "NCBIGene:100722663",
                    "NCIT:C21293",
                    "PR:Q28044",
                    "OMIM:109690",
                    "PR:Q8K4Z4",
                    "NCBIGene:101836719",
                    "NCBIGene:403910",
                    "RGD:2060",
                    "NCBIGene:397357",
                    "PR:P54833",
                    "PR:P07550",
                    "ENSEMBL:ENSG00000169252",
                    "REACT:R-HSA-8869143",
                    "PR:P18762",
                    "HGNC:286",
                    "REACT:R-HSA-8852158",
                    "NCBIGene:154",
                    "PR:Q28997",
                    "PR:P04274",
                    "UMLS:C1367657",
                    "MGI:87938",
                    "UniProtKB:P07550",
                    "REACT:R-HSA-6783066",
                    "REACT:R-HSA-390647"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20733053",
                    "DOI:10.1016/j.str.2008.05.001",
                    "DOI:10.1126/science.1150577",
                    "DOI:10.1172/jci117838",
                    "DOI:10.1074/jbc.270.2.720",
                    "PMID:17962520",
                    "DOI:10.1021/bi00198a006",
                    "DOI:10.1017/s0003480000008009",
                    "PMID:2823249",
                    "DOI:10.1074/jbc.272.49.31051"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P08069": {
              "name": "IGF1R",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P08069",
                  "value_url": "https://identifiers.org/uniprot:P08069",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Binding of IGF1 (IGF-I) or IGF2 (IGF-II) to the extracellular alpha peptides of the type 1 insulin-like growth factor receptor (IGF1R) triggers the activation of two major signaling pathways: the SOS-RAS-RAF-MAPK (ERK) pathway and the PI3K-PKB (AKT) pathway (recently reviewed in Pavelic et al. 2007, Chitnis et al. 2008, Maki et al. 2010, Parella et al. 2010, Annunziata et al. 2011, Siddle et al. 2012, Holzenberger 2012).",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide",
                    "biolink:Pathway"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "IGF1R Gene",
                    "IGF1R (human)",
                    "Igf1r (rat)",
                    "IGF1R(31-736) [plasma membrane]",
                    "p-Y1161,Y1165,Y1166-IGF1R(741-1367) [plasma membrane]",
                    "insulin-like growth factor 1 receptor (human)",
                    "insulin-like growth factor 1 receptor (rat)",
                    "Igf1r (mouse)",
                    "IGF1R protein, human",
                    "IGF1R gene",
                    "Insulin-Like Growth Factor 1 Receptor Beta Chain, Human",
                    "IGF1R",
                    "Igf1r",
                    "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)",
                    "insulin-like growth factor 1 receptor (mouse)",
                    "IGF1R(741-1367) [plasma membrane]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "OMIM:147370",
                    "PDQ:CDR0000257793",
                    "PR:P08069",
                    "NCIT:C20135",
                    "MESH:C000597236",
                    "RGD:2869",
                    "UniProtKB:P08069",
                    "REACT:R-HSA-2404180",
                    "HGNC:5465",
                    "ENSEMBL:ENSG00000140443",
                    "NCBIGene:3480",
                    "PR:P24062",
                    "REACT:R-HSA-2404172",
                    "REACT:R-HSA-2404192",
                    "UMLS:C4049897",
                    "REACT:R-HSA-2404169",
                    "MGI:96433",
                    "PR:Q60751",
                    "UMLS:C1334088",
                    "UMLS:C4044495"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20675137",
                    "DOI:10.1158/0008-5472.can-03-2522",
                    "DOI:10.1038/28668",
                    "DOI:10.1074/jbc.m501316200",
                    "DOI:10.1038/emboj.2008.116",
                    "DOI:10.1016/j.bbrc.2007.05.062",
                    "PMID:12138094",
                    "PMID:11884618",
                    "PMID:9690478",
                    "DOI:10.1016/s0969-2126(01)00655-4"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P08235": {
              "name": "NR3C2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P08235",
                  "value_url": "https://identifiers.org/uniprot:P08235",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "-!- FUNCTION: Receptor for both mineralocorticoids (MC) such as aldosterone and glucocorticoids (GC) such as corticosterone or cortisol. Binds to mineralocorticoid response elements (MRE) and transactivates target genes. The effect of MC is to increase ion and water transport and thus raise extracellular fluid volume and blood pressure and lower potassium levels. {ECO:0000269|PubMed:3037703}. -!- SUBUNIT: Heteromultimeric cytoplasmic complex with HSP90, HSP70, and FKBP4, in the absence of ligand. After ligand binding, it translocates to the nucleus and binds to DNA as a homodimer and as a heterodimer with NR3C1. May interact with HSD11B2 in the absence of ligand. Binds the coactivators NCOA1, NCOA2, TIF1 and NRIP1. {ECO:0000269|PubMed:10935545, ECO:0000269|PubMed:11350956, ECO:0000269|PubMed:11518808, ECO:0000269|PubMed:16061183}. -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Endoplasmic reticulum membrane; Peripheral membrane protein. Note=Cytoplasmic and nuclear in the absence of ligand; nuclear after ligand-binding. When bound to HSD11B2, it is found associated with the endoplasmic reticulum membrane. -!- ALTERNATIVE PRODUCTS: Event=Alternative splicing; Named isoforms=4; Comment=Additional isoforms seem to exist.; Name=1; IsoId=P08235-1; Sequence=Displayed; Name=2; IsoId=P08235-2; Sequence=VSP_007358, VSP_007359; Name=3; IsoId=P08235-3; Sequence=VSP_007357; Name=4; Synonyms=Delta; IsoId=P08235-4; Sequence=VSP_007360; -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in distal tubules, convoluted tubules and cortical collecting duct in kidney, and in sweat glands. Detected at lower levels in cardiomyocytes, in epidermis and in colon enterocytes. {ECO:0000269|PubMed:11518808, ECO:0000269|PubMed:9141514}. -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. -!- PTM: Phosphorylated. {ECO:0000269|PubMed:1655735}. -!- DISEASE: Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]: A salt wasting disease resulting from target organ unresponsiveness to mineralocorticoids. PHA1A is a mild form characterized by target organ defects confined to kidney. Patients may present with neonatal renal salt wasting with hyperkalaemic acidosis despite high aldosterone levels. These patients improve with age and usually become asymptomatic without treatment. {ECO:0000269|PubMed:11134129, ECO:0000269|PubMed:12788847, ECO:0000269|PubMed:16954160, ECO:0000269|PubMed:16972228}. Note=The disease is caused by variants affecting the gene represented in this entry. -!- DISEASE: Early-onset hypertension with severe exacerbation in pregnancy (EOHSEP) [MIM:605115]: Inheritance is autosomal dominant. The disease is characterized by the onset of severe hypertension before the age of 20, and by suppression of aldosterone secretion. {ECO:0000269|PubMed:10884226, ECO:0000269|PubMed:15908963, ECO:0000269|PubMed:15967794}. Note=The disease is caused by variants affecting the gene represented in this entry. -!- MISCELLANEOUS: [Isoform 2]: Lacks steroid-binding activity and acts as ligand-independent transactivator. {ECO:0000305}. -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3 subfamily. {ECO:0000305}. -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL=\"http://atlasgeneticsoncology.org/Genes/NR3C2ID44262ch4q31.html\"; -!- WEB RESOURCE: Name=Wikipedia; Note=Mineralocorticoid receptor entry; URL=\"https://en.wikipedia.org/wiki/Mineralocorticoid_receptor\"; ; Short=MREvidence Codes from Name:  ",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "SUMO1-K89,K399,K428.K494-NR3C2 [nucleoplasm]",
                    "NR3C2 protein, human",
                    "Nr3c2 (mouse)",
                    "mineralocorticoid receptor (human)",
                    "NR3C2-2 [nucleoplasm]",
                    "NR3C2-4 [nucleoplasm]",
                    "mineralocorticoid receptor (rat)",
                    "Nr3c2 (rat)",
                    "NR3C2-1 [nucleoplasm]",
                    "NR3C2-3 [nucleoplasm]",
                    "NR3C2 [cytosol]",
                    "NR3C2 Gene",
                    "NR3C2 gene",
                    "NR3C2 (human)",
                    "NR3C2",
                    "NR3C2 [nucleoplasm]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "RGD:3094",
                    "MESH:C561839",
                    "REACT:R-HSA-3008717",
                    "REACT:R-HSA-5618122",
                    "NCIT:C39645",
                    "PR:P08235",
                    "ENSEMBL:ENSG00000151623",
                    "UMLS:C1417835",
                    "REACT:R-HSA-3196153",
                    "PR:P22199",
                    "UMLS:C3254418",
                    "OMIM:600983",
                    "UniProtKB:P08235",
                    "NCBIGene:4306",
                    "REACT:R-HSA-4341098",
                    "REACT:R-HSA-3196178",
                    "REACT:R-HSA-4341124",
                    "REACT:R-HSA-3196183",
                    "HGNC:7979",
                    "MGI:99459"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10391210",
                    "DOI:10.1007/s00439-002-0855-7",
                    "DOI:10.1038/nm.1879",
                    "DOI:10.1210/jc.2002-021932",
                    "PMID:11518808",
                    "PMID:10935545",
                    "DOI:10.1210/mend.14.8.0502",
                    "PMID:7495694",
                    "PMID:1939532",
                    "DOI:10.1101/gr.2596504"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P08253": {
              "name": "MMP2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P08253",
                  "value_url": "https://identifiers.org/uniprot:P08253",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A protein that is a translation product of the human MMP2 gene or a 1:1 ortholog thereof. // COMMENTS: Category=gene.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MMP2 gene",
                    "Matrix Metalloproteinase 2",
                    "Mmp2 (rat)",
                    "matrix metalloproteinase-2 (fruit fly)",
                    "MMP2",
                    "Mmp2 (mouse)",
                    "MMP2(110-660) [extracellular region]",
                    "72 kDa type IV collagenase (human)",
                    "MMP2 (chicken)",
                    "MMP2(30-66) [extracellular region]",
                    "MMP2(67-109) [extracellular region]",
                    "MMP2 (human)",
                    "72 kDa type IV collagenase (chicken)",
                    "72 kDa type IV collagenase (rat)",
                    "MMP2(67-660) [extracellular region]",
                    "72 kDa type IV collagenase (mouse)",
                    "MMP2 gene [nucleoplasm]",
                    "72 kDa type IV collagenase",
                    "MMP2 Gene",
                    "MMP2(30-660) [extracellular region]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MGI:97009",
                    "PR:Q8MPP3",
                    "REACT:R-HSA-1604371",
                    "PR:Q90611",
                    "UniProtKB:P08253",
                    "PR:000010479",
                    "PR:P33434",
                    "REACT:R-HSA-1604347",
                    "PR:P08253",
                    "REACT:R-HSA-381456",
                    "REACT:R-HSA-5686986",
                    "OMIM:120360",
                    "RGD:621316",
                    "UMLS:C0172537",
                    "REACT:R-HSA-1604364",
                    "ENSEMBL:ENSG00000087245",
                    "HGNC:7166",
                    "REACT:R-HSA-1604345",
                    "NCBIGene:386583",
                    "UMLS:C1334522",
                    "CHEMBL.TARGET:CHEMBL1075175",
                    "PR:P33436",
                    "NCBIGene:4313",
                    "MESH:D020778",
                    "NCIT:C26514"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11928808",
                    "PMID:2158484",
                    "DOI:10.1093/cvr/cvp175",
                    "DOI:10.1038/sj.onc.1206542",
                    "DOI:10.1016/0014-5793(95)01435-7",
                    "DOI:10.1038/nature03187",
                    "DOI:10.1038/90100",
                    "DOI:10.1111/j.1432-1033.1997.t01-1-00653.x",
                    "DOI:10.1167/iovs.02-0662",
                    "PMID:12032297"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P08684": {
              "name": "CYP3A4",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P08684",
                  "value_url": "https://identifiers.org/uniprot:P08684",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Cytochrome P450 3A4 (503 aa, ~57 kDa) is encoded by the human CYP3A4 gene. This protein is involved in the oxidation of steroids, fatty acids and xenobiotics.; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CYP3A4 gene",
                    "CYP3A4 [endoplasmic reticulum membrane]",
                    "CYP3A4 (human)",
                    "cytochrome P450 3A4 (human)",
                    "cytochrome P450 3A4 protein, human",
                    "CYP3A4 protein, human",
                    "Cyp3a4",
                    "CYP3A4",
                    "CYP3A4 Gene"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HGNC:2637",
                    "OMIM:124010",
                    "MESH:C510163",
                    "PR:P08684",
                    "UMLS:C1142644",
                    "PDQ:CDR0000257797",
                    "UniProtKB:P08684",
                    "LOINC:LP173520-0",
                    "NCBIGene:1576",
                    "ENSEMBL:ENSG00000160868",
                    "NCIT:C24328",
                    "UMLS:C1176140",
                    "REACT:R-HSA-52639"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:3243766",
                    "DOI:10.1016/j.abb.2008.12.001",
                    "DOI:10.1111/j.1432-1033.2004.04339.x",
                    "DOI:10.1111/j.1471-4159.2008.05720.x",
                    "DOI:10.1038/clpt.2011.53",
                    "PMID:15256616",
                    "PMID:3460094",
                    "PMID:3898085",
                    "DOI:10.1073/pnas.83.21.8064",
                    "DOI:10.1089/dna.1988.7.79"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P10415": {
              "name": "BCL2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P10415",
                  "value_url": "https://identifiers.org/uniprot:P10415",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Apoptosis regulator Bcl-2 (239 aa, ~26 kDa) is encoded by the human BCL2 gene. This protein plays a role in cellular survival.; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Bcl2 (mouse)",
                    "Bcl2",
                    "Bcl2 (rat)",
                    "apoptosis regulator Bcl-2 (chicken)",
                    "BCL2 gene [nucleoplasm]",
                    "BCL2 (human)",
                    "BCL2 Gene",
                    "BCL2 (chicken)",
                    "apoptosis regulator Bcl-2 (rat)",
                    "apoptosis regulator Bcl-2 (mouse)",
                    "BCL2 [mitochondrial outer membrane]",
                    "BCL2 gene",
                    "BCL2 protein, human",
                    "apoptosis regulator Bcl-2 (human)",
                    "BCL2"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C17963",
                    "NCBIGene:396282",
                    "REACT:R-HSA-8948460",
                    "RGD:2199",
                    "NCBIGene:596",
                    "UniProtKB:P10415",
                    "HGNC:990",
                    "OMIM:151430",
                    "UMLS:C0376515",
                    "MESH:C000595707",
                    "LOINC:LP28446-0",
                    "LOINC:LP32777-2",
                    "MGI:88138",
                    "PR:Q00709",
                    "PR:P10415",
                    "PR:P49950",
                    "REACT:R-HSA-50757",
                    "UMLS:C4042483",
                    "ENSEMBL:ENSG00000171791",
                    "PR:P10417"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1002/j.1460-2075.1988.tb02791.x",
                    "DOI:10.1074/jbc.m413374200",
                    "DOI:10.1038/nature03579",
                    "DOI:10.1093/nar/20.16.4187",
                    "PMID:11368354",
                    "DOI:10.1128/mcb.19.12.8469",
                    "PMID:23431138",
                    "PMID:25609812",
                    "DOI:10.1007/s13238-012-2069-7",
                    "DOI:10.1074/jbc.m606181200"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P10600": {
              "name": "TGFB3",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P10600",
                  "value_url": "https://identifiers.org/uniprot:P10600",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Transforming growth factor beta-3 (412 aa, ~47 kDa) is encoded by the human TGFB3 gene. This protein is involved in cell proliferation, cell death and embryogenesis.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "transforming growth factor beta-3 proprotein (rat)",
                    "TGFB3 protein, human",
                    "TGFB3 gene",
                    "TGFB3 Gene",
                    "TGFB3 (chicken)",
                    "TGFB3 [extracellular region]",
                    "TGFB3 [platelet alpha granule lumen]",
                    "TGFB3(21-300) [extracellular region]",
                    "transforming growth factor beta-3 (human)",
                    "Tgfb3 (rat)",
                    "Tgfb3 (mouse)",
                    "TGFB3",
                    "transforming growth factor beta-3 proprotein (chicken)",
                    "TGFB3 (human)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-114707",
                    "NCIT:C20913",
                    "NCBIGene:7043",
                    "UniProtKB:P10600",
                    "NCBIGene:396438",
                    "UMLS:C1703303",
                    "UMLS:C1336622",
                    "MESH:C509044",
                    "PR:P16047",
                    "PR:Q07258",
                    "MGI:98727",
                    "RGD:3851",
                    "HGNC:11769",
                    "ENSEMBL:LRG_399",
                    "ENSEMBL:ENSG00000119699",
                    "REACT:R-HSA-2395290",
                    "PR:P10600",
                    "LOINC:LP71406-0",
                    "REACT:R-HSA-65942",
                    "OMIM:190230"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1002/ajmg.a.36056",
                    "DOI:10.1073/pnas.85.13.4715",
                    "PMID:12508121",
                    "DOI:10.1038/nature01348",
                    "DOI:10.1002/pro.5560050705",
                    "PMID:15489334",
                    "PMID:15639475",
                    "DOI:10.1128/mcb.11.9.4306-4313.1991",
                    "DOI:10.1002/j.1460-2075.1988.tb03257.x",
                    "DOI:10.1074/jbc.m115.711952"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P11047": {
              "name": "LAMC1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P11047",
                  "value_url": "https://identifiers.org/uniprot:P11047",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "-!- FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. -!- SUBUNIT: Laminin is a complex glycoprotein, consisting of three different polypeptide chains (alpha, beta, gamma), which are bound to each other by disulfide bonds into a cross-shaped molecule comprising one long and three short arms with globules at each end. Gamma-1 is a subunit of laminin-1 (laminin-111 or EHS laminin), laminin-2 (laminin-211 or merosin), laminin-3 (laminin-121 or S-laminin), laminin-4 (laminin-221 or S-merosin), laminin-6 (laminin-311 or K-laminin), laminin-7 (laminin-321 or KS-laminin), laminin-8 (laminin-411), laminin-9 (laminin-421), laminin-10 (laminin-511) and laminin-11 (laminin-521). -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix, basement membrane. -!- TISSUE SPECIFICITY: Found in the basement membranes (major component). -!- DOMAIN: The alpha-helical domains I and II are thought to interact with other laminin chains to form a coiled coil structure. -!- DOMAIN: Domains VI and IV are globular. ; Short=S-LAM gammaEvidence Codes from Name:  ",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Lamc1 (mouse)",
                    "laminin subunit gamma-1 (human)",
                    "LAMC1 [extracellular region]",
                    "LAMC1 (human)",
                    "LAMC1 [endoplasmic reticulum lumen]",
                    "p-LAMC1 [endoplasmic reticulum lumen]",
                    "LAMC1",
                    "LAMC1 gene",
                    "laminin subunit gamma-1 (zebrafish)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PR:P11047",
                    "ENSEMBL:ENSG00000135862",
                    "REACT:R-HSA-8956921",
                    "OMIM:150290",
                    "PR:Q1LVF0",
                    "MGI:99914",
                    "UMLS:C1416785",
                    "UniProtKB:P11047",
                    "NCBIGene:3915",
                    "REACT:R-HSA-215962",
                    "HGNC:6492",
                    "REACT:R-HSA-8956712"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1126/scisignal.2001570",
                    "DOI:10.1038/nbt827",
                    "DOI:10.1016/j.cell.2015.05.028",
                    "PMID:22905912",
                    "PMID:21269460",
                    "DOI:10.1186/1752-0509-5-17",
                    "DOI:10.1126/science.1133427",
                    "PMID:3234037",
                    "DOI:10.3109/10425179109020782",
                    "PMID:24275569"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P12821": {
              "name": "ACE",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P12821",
                  "value_url": "https://identifiers.org/uniprot:P12821",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Angiotensin-converting enzyme (1306 aa, ~150 kDa) is encoded by the human ACE gene. This protein plays a role in the hydrolysis of angiotensin I to form angiotensin II and the solubilization of glycophophoinositol-anchored proteins from the plasma membrane.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing",
                    "biolink:Publication"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ACE (human)",
                    "ACE protein, human",
                    "ACE(30-1232) [extracellular region]",
                    "ACE Gene",
                    "acetylcholinesterase (fruit fly)",
                    "ACE",
                    "Ace (mouse)",
                    "Ace (rat)",
                    "ACE gene",
                    "angiotensin-converting enzyme (rat)",
                    "angiotensin-converting enzyme (human)",
                    "angiotensin-converting enzyme (mouse)",
                    "ACE(30-1306) [plasma membrane]",
                    "Ace"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PR:P12821",
                    "UniProtKB:P12821",
                    "REACT:R-HSA-508496",
                    "LOINC:LP230189-5",
                    "MGI:87874",
                    "PR:P07140",
                    "UMLS:C1413931",
                    "MESH:C488034",
                    "PR:P09470",
                    "ENSEMBL:ENSG00000159640",
                    "REACT:R-HSA-2065414",
                    "NCBIGene:1636",
                    "PR:P47820",
                    "RGD:2493",
                    "UMLS:C1452534",
                    "NCIT:C91295",
                    "OMIM:106180",
                    "HGNC:2707",
                    "LOINC:LP95187-8"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10391210",
                    "DOI:10.1016/s0014-5793(02)03640-2",
                    "DOI:10.1186/1741-7015-2-19",
                    "PMID:12459472",
                    "PMID:10319862",
                    "PMID:10969042",
                    "PMID:15534175",
                    "PMID:15671045",
                    "PMID:21269460",
                    "PMID:10924499"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P14780": {
              "name": "MMP9",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P14780",
                  "value_url": "https://identifiers.org/uniprot:P14780",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Matrix metalloproteinase-9 (707 aa, ~78 kDa) is encoded by the human MMP9 gene. This protein plays a role in collagen degradation, macrophage differentiation and cell migration.; An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MMP9(107-707) [extracellular region]",
                    "MMP9(60-106) [extracellular region]",
                    "matrix metalloproteinase-9 (mouse)",
                    "Mmp9 (rat)",
                    "MMP9 [tertiary granule lumen]",
                    "MMP9(20-59) [extracellular region]",
                    "MMP9 (cow)",
                    "MMP9 (human)",
                    "MMP9",
                    "MMP9(20-106) [extracellular region]",
                    "Mmp9 (mouse)",
                    "matrix metalloproteinase-9 (cow)",
                    "matrix metalloproteinase-9 (rat)",
                    "MMP9 [ficolin-1-rich granule lumen]",
                    "MMP9(20-707) [extracellular region]",
                    "Matrix Metalloproteinase 9",
                    "Matrix metalloproteinase 9",
                    "matrix metalloproteinase-9 (human)",
                    "MMP9(60-707) [extracellular region]",
                    "MMP9 gene",
                    "MMP9 gene [nucleoplasm]",
                    "MMP9 Gene"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-8948369",
                    "OMIM:120361",
                    "CHEMBL.TARGET:CHEMBL3870",
                    "REACT:R-HSA-1604713",
                    "UMLS:C0165519",
                    "PR:P41245",
                    "PR:P14780",
                    "NCIT:C26508",
                    "REACT:R-HSA-1604685",
                    "UMLS:C1334523",
                    "REACT:R-HSA-1604699",
                    "UniProtKB:P14780",
                    "REACT:R-HSA-1604376",
                    "RGD:621320",
                    "NCBIGene:4318",
                    "REACT:R-HSA-668812",
                    "MESH:D020780",
                    "REACT:R-HSA-1604726",
                    "REACT:R-HSA-6800181",
                    "REACT:R-HSA-6800973",
                    "PR:P50282",
                    "PR:P52176",
                    "MGI:97011",
                    "CHEMBL.TARGET:CHEMBL2214",
                    "HGNC:7176",
                    "ENSEMBL:ENSG00000100985",
                    "CHEMBL.TARGET:CHEMBL321",
                    "NCBIGene:282871"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:7669817",
                    "DOI:10.1007/s004390051124",
                    "PMID:12077439",
                    "PMID:1464361",
                    "PMID:1645657",
                    "DOI:10.1038/sj.onc.1206542",
                    "DOI:10.1111/j.0906-6705.2006.00409.x",
                    "PMID:12126625",
                    "DOI:10.1101/gr.2596504",
                    "PMID:1653055"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P15692": {
              "name": "VEGFA",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P15692",
                  "value_url": "https://identifiers.org/uniprot:P15692",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Vascular endothelial growth factor A (232 aa, ~27 kDa) is encoded by the human VEGFA gene. This protein plays a role in both cell proliferation and angiogenesis.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "VEGFA-165 [extracellular region]",
                    "VEGF protein, human",
                    "VEGFA Gene",
                    "Vegfa (rat)",
                    "VEGFA gene [nucleoplasm]",
                    "VEGF165 protein, human",
                    "VEGFA",
                    "vascular endothelial growth factor A (rat)",
                    "VEGFA [extracellular region]",
                    "VEGFA [platelet alpha granule lumen]",
                    "VEGFA gene",
                    "VEGF206 protein, human",
                    "vascular endothelial growth factor A (human)",
                    "VEGF183 protein, human",
                    "VEGF145 protein, human",
                    "Vegfa (mouse)",
                    "vascular endothelial growth factor A (mouse)",
                    "VEGFA (human)",
                    "vascular endothelial growth factor A (chicken)",
                    "VEGF189 protein, human"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "RGD:619991",
                    "ENSEMBL:ENSG00000112715",
                    "REACT:R-HSA-3132764",
                    "UMLS:C0376855",
                    "UMLS:C0376854",
                    "UniProtKB:P15692",
                    "PR:P67964",
                    "PR:P16612",
                    "PR:Q00731",
                    "UMLS:C0376856",
                    "MGI:103178",
                    "UMLS:C0525171",
                    "OMIM:192240",
                    "REACT:R-HSA-5652230",
                    "NCBIGene:7422",
                    "UMLS:C0752432",
                    "UMLS:C1823619",
                    "REACT:R-HSA-4420127",
                    "HGNC:12680",
                    "NCIT:C21408",
                    "PR:P15692",
                    "UMLS:C1171892",
                    "REACT:R-HSA-2975974"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1158/0008-5472.can-05-2217",
                    "PMID:12124351",
                    "DOI:10.1016/s0969-2126(98)00065-3",
                    "DOI:10.1111/j.1432-1033.1993.tb19865.x",
                    "DOI:10.18632/oncotarget.2870",
                    "PMID:10067980",
                    "PMID:7678805",
                    "DOI:10.1038/nature02055",
                    "DOI:10.1091/mbc.9.2.469",
                    "PMID:9634701"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P18075": {
              "name": "BMP7",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P18075",
                  "value_url": "https://identifiers.org/uniprot:P18075",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "This gene is involved in calcium regulation and bone homeostasis. It also plays a role in the control of cellular development and differentiation.; UMLS Semantic Type: STY:T028",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "BMP7(30-292) [extracellular region]",
                    "Bmp7 (mouse)",
                    "BMP7 Gene",
                    "bone morphogenetic protein 7",
                    "bone morphogenetic protein 7 (human)",
                    "BMP7 protein, human",
                    "BMP7 gene",
                    "bone morphogenetic protein 7 (mouse)",
                    "BMP7 (human)",
                    "BMP7"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ENSEMBL:ENSG00000101144",
                    "REACT:R-HSA-206223",
                    "UMLS:C1454054",
                    "NCIT:C21357",
                    "OMIM:112267",
                    "PR:P23359",
                    "UMLS:C1332428",
                    "NCBIGene:655",
                    "UniProtKB:P18075",
                    "MGI:103302",
                    "HGNC:1074",
                    "PR:P18075",
                    "PR:000000168",
                    "MESH:C525819"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15020244",
                    "PMID:12478285",
                    "PMID:31208997",
                    "DOI:10.1101/gr.2596504",
                    "DOI:10.1073/pnas.93.2.878",
                    "DOI:10.1016/j.bbrc.2004.02.075",
                    "PMID:11780052",
                    "DOI:10.1073/pnas.87.24.9843",
                    "PMID:27923061",
                    "PMID:9748228"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P18146": {
              "name": "EGR1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P18146",
                  "value_url": "https://identifiers.org/uniprot:P18146",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "-!- FUNCTION: Transcriptional regulator (PubMed:20121949). Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3'(EGR-site) in the promoter region of target genes (By similarity). Binds double-stranded target DNA, irrespective of the cytosine methylation status (PubMed:25258363, PubMed:25999311). Regulates the transcription of numerous target genes, and thereby plays an important role in regulating the response to growth factors, DNA damage, and ischemia. Plays a role in the regulation of cell survival, proliferation and cell death. Activates expression of p53/TP53 and TGFB1, and thereby helps prevent tumor formation. Required for normal progress through mitosis and normal proliferation of hepatocytes after partial hepatectomy. Mediates responses to ischemia and hypoxia; regulates the expression of proteins such as IL1B and CXCL2 that are involved in inflammatory processes and development of tissue damage after ischemia. Regulates biosynthesis of luteinizing hormone (LHB) in the pituitary (By similarity). Regulates the amplitude of the expression rhythms of clock genes: ARNTL/BMAL1, PER2 and NR1D1 in the liver via the activation of PER1 (clock repressor) transcription. Regulates the rhythmic expression of core-clock gene ARNTL/BMAL1 in the suprachiasmatic nucleus (SCN) (By similarity). {ECO:0000250|UniProtKB:P08046, ECO:0000269|PubMed:20121949, ECO:0000269|PubMed:25258363, ECO:0000269|PubMed:25999311}. -!- SUBUNIT: Interacts with SNAI1 and SP1 upon 12-O-tetradecanoylphorbol-13-acetate (TPA) induction. {ECO:0000269|PubMed:20121949}. -!- INTERACTION: P18146; Q8N726: CDKN2A; NbExp=4; IntAct=EBI-2834611, EBI-625922; P18146; P35222: CTNNB1; NbExp=7; IntAct=EBI-2834611, EBI-491549; -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20363028}. Cytoplasm {ECO:0000269|PubMed:20363028}. -!- TISSUE SPECIFICITY: Detected in neutrophils (at protein level). {ECO:0000269|PubMed:20363028}. -!- INDUCTION: By growth factors. {ECO:0000269|PubMed:20363028}. -!- DOMAIN: Binds to DNA motifs with the sequence 5'-GCG(T/G)GGGCG-3' via its C2H2-type zinc fingers (PubMed:25258363, PubMed:25999311). The first, most N-terminal zinc finger binds to the 3'-GCG motif, the middle zinc finger interacts with the central TGG motif, and the C-terminal zinc finger binds to the 5'-GCG motif. Binds double-stranded target DNA, irrespective of the cytosine methylation status. Has reduced affinity for target DNA where the cytosines have been oxidized to 5-hydroxymethylcytosine. Does not bind target DNA where the cytosines have been oxidized to 5-formylcytosine or 5-carboxylcytosine (PubMed:25258363). {ECO:0000269|PubMed:25258363, ECO:0000269|PubMed:25999311}. -!- SIMILARITY: Belongs to the EGR C2H2-type zinc-finger protein family. {ECO:0000305}. -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL=\"http://atlasgeneticsoncology.org/Genes/EGR1ID496ch5q31.html\"; ; Short=EGR-1 {ECO:0000303|PubMed:2377485}; Short=NGFI-AEvidence Codes from Name:  ",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "early growth response protein 1 (rat)",
                    "early growth response protein 1 (human)",
                    "Egr1 (rat)",
                    "early growth response protein 1 (zebrafish)",
                    "EGR1 Gene",
                    "EGR1 protein, human",
                    "EGR1 [nucleoplasm]",
                    "early growth response protein 1 (mouse)",
                    "EGR1 (human)",
                    "EGR1 gene",
                    "EGR1 gene [nucleoplasm]",
                    "EGR1",
                    "Egr1 (mouse)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ENSEMBL:ENSG00000120738",
                    "REACT:R-HSA-1031703",
                    "OMIM:128990",
                    "HGNC:3238",
                    "PR:P08046",
                    "MGI:95295",
                    "MESH:C497325",
                    "UMLS:C1414314",
                    "PR:P26632",
                    "PR:P08154",
                    "UniProtKB:P18146",
                    "PR:P18146",
                    "UMLS:C1447045",
                    "NCIT:C99599",
                    "RGD:2544",
                    "NCBIGene:1958",
                    "REACT:R-HSA-9034181"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:2110381",
                    "PMID:15489334",
                    "PMID:20121949",
                    "DOI:10.1093/nar/18.14.4283",
                    "PMID:28112733",
                    "PMID:1569051",
                    "DOI:10.1111/j.1742-4658.2009.07553.x",
                    "DOI:10.1126/science.2110381",
                    "DOI:10.1016/j.febslet.2015.05.022",
                    "DOI:10.1016/j.molimm.2010.03.003"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P29474": {
              "name": "NOS3",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P29474",
                  "value_url": "https://identifiers.org/uniprot:P29474",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Nitric oxide synthase, endothelial (1203 aa, ~133 kDa) is encoded by the human NOS3 gene. This protein plays a role in the modulation of vascular smooth muscle relaxation, VEGF-induced angiogenesis and blood coagulation.; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "nitric oxide synthase, endothelial (human)",
                    "Nos3 (rat)",
                    "NOS3",
                    "nitric oxide synthase, endothelial (mouse)",
                    "Nos3",
                    "NOS3 Gene",
                    "2xPalmC-MyrG-NOS3 [plasma membrane]",
                    "MyrG-NOS3 [Golgi membrane]",
                    "2xPalmC-MyrG-p-S1177-NOS3 [plasma membrane]",
                    "NOS3 (human)",
                    "2xPalmC-MyrG-NOS3 [endocytic vesicle membrane]",
                    "NOS3 [cytosol]",
                    "nitric oxide synthase, endothelial (rat)",
                    "NOS3 gene",
                    "Nos3 (mouse)",
                    "MyrG-NOS3 [cytosol]",
                    "2xPalmC-MyrG-NOS3 [Golgi membrane]",
                    "NOS3 protein, human"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-202139",
                    "OMIM:163729",
                    "UMLS:C0669365",
                    "REACT:R-HSA-534993",
                    "REACT:R-HSA-202114",
                    "PR:Q62600",
                    "REACT:R-HSA-534995",
                    "MESH:C496314",
                    "HGNC:7876",
                    "PDQ:CDR0000334897",
                    "RGD:3186",
                    "REACT:R-HSA-203769",
                    "REACT:R-HSA-203687",
                    "UniProtKB:P29474",
                    "NCBIGene:4846",
                    "ENSEMBL:ENSG00000164867",
                    "UMLS:C1328053",
                    "PR:P70313",
                    "PR:P29474",
                    "REACT:R-HSA-535007",
                    "MGI:97362",
                    "NCIT:C38570"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1038/nature01782",
                    "DOI:10.1038/nchembio.115",
                    "PMID:17264164",
                    "DOI:10.1006/abbi.1994.1232",
                    "PMID:23186163",
                    "PMID:1378832",
                    "DOI:10.1096/fj.06-7434com",
                    "PMID:12853948",
                    "PMID:9737779",
                    "PMID:7509596"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P30556": {
              "name": "AGTR1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P30556",
                  "value_url": "https://identifiers.org/uniprot:P30556",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "An angiotensin II receptor 1 that is encoded in the genome of rabbit. // COMMENTS: Category=organism-gene. Requested by=PubChem.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:MolecularEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "AGTR1",
                    "type-1 angiotensin II receptor (chicken)",
                    "AGTR1 gene",
                    "AGTR1 (human)",
                    "AGTR1 [plasma membrane]",
                    "AGTR1 [clathrin-coated endocytic vesicle membrane]",
                    "AGTR1 (rabbit)",
                    "AGTR1 (pig)",
                    "type-1 angiotensin II receptor (human)",
                    "Type-1 angiotensin II receptor",
                    "type-1 angiotensin II receptor (cow)",
                    "type-1 angiotensin II receptor (rabbit)",
                    "AGTR1 (cow)",
                    "type-1 angiotensin II receptor (pig)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PathWhiz.ProteinComplex:11766",
                    "REACT:R-HSA-374247",
                    "CHEMBL.TARGET:CHEMBL1671613",
                    "PathWhiz.ProteinComplex:736",
                    "PathWhiz.ProteinComplex:11608",
                    "HGNC:336",
                    "NCBIGene:100009164",
                    "OMIM:106165",
                    "CHEMBL.TARGET:CHEMBL227",
                    "NCBIGene:100519976",
                    "PR:P25104",
                    "ENSEMBL:ENSG00000144891",
                    "PR:P30556",
                    "PR:P30555",
                    "REACT:R-HSA-8869071",
                    "NCBIGene:281607",
                    "NCBIGene:185",
                    "PathWhiz.ProteinComplex:11687",
                    "PR:P34976",
                    "PR:P79785",
                    "CHEMBL.TARGET:CHEMBL5743",
                    "UniProtKB:P30556",
                    "UMLS:C1439284"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15809376",
                    "PMID:33713620",
                    "DOI:10.1016/0006-291x(92)91600-u",
                    "DOI:10.1074/mcp.m800504-mcp200",
                    "DOI:10.1161/01.cir.0000160867.23556.7d",
                    "DOI:10.1016/s0006-291x(05)80804-6",
                    "DOI:10.1101/gr.2596504",
                    "DOI:10.1016/0006-291x(92)90570-b",
                    "PMID:1378723",
                    "PMID:1550596"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P35228": {
              "name": "NOS2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P35228",
                  "value_url": "https://identifiers.org/uniprot:P35228",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Nitric oxide synthase, inducible (1153 aa, ~131 kDa) is encoded by the human NOS2A gene. This protein is involved in both nitric oxide biosynthesis and arginine metabolism.; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NOS2 (human)",
                    "Nos2 (mouse)",
                    "NOS2 [cytosol]",
                    "nitric oxide synthase, inducible (rat)",
                    "nitric oxide synthase, inducible (mouse)",
                    "NOS2 protein, human",
                    "NOS2",
                    "NOS2 gene [nucleoplasm]",
                    "NOS2 (chicken)",
                    "NOS2 [nucleoplasm]",
                    "NOS2 gene",
                    "NOS2 [peroxisomal matrix]",
                    "Nos2 (rat)",
                    "NOS2A protein, human",
                    "nitric oxide synthase, inducible (human)",
                    "nitric oxide synthase, inducible (chicken)",
                    "NOS2 Gene"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PR:P29477",
                    "UMLS:C0669372",
                    "PR:Q06518",
                    "MGI:97361",
                    "MESH:C496319",
                    "HGNC:7873",
                    "REACT:R-HSA-8948450",
                    "UMLS:C1417760",
                    "RGD:3185",
                    "UniProtKB:P35228",
                    "NCIT:C38564",
                    "REACT:R-HSA-9636250",
                    "REACT:R-HSA-9033124",
                    "NCBIGene:395807",
                    "NCBIGene:4843",
                    "PR:P35228",
                    "ENSEMBL:ENSG00000007171",
                    "PR:Q90703",
                    "OMIM:163730",
                    "REACT:R-HSA-202107"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:7528017",
                    "PMID:12433515",
                    "PMID:7531687",
                    "PMID:7522054",
                    "DOI:10.1016/j.redox.2014.06.011",
                    "DOI:10.1006/geno.1995.1086",
                    "DOI:10.1073/pnas.90.23.11419",
                    "DOI:10.1074/jbc.274.30.21276",
                    "PMID:12085352",
                    "DOI:10.1101/gr.2596504"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P35354": {
              "name": "PTGS2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P35354",
                  "value_url": "https://identifiers.org/uniprot:P35354",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Prostaglandin G/H synthase 2 (604 aa, ~69 kDa) is encoded by the human PTGS2 gene. This protein plays a role in prostaglandin metabolism.; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PTGS2 (cow)",
                    "Ptgs2 (mouse)",
                    "PTGS2 gene",
                    "prostaglandin G/H synthase 2 (mouse)",
                    "Ptgs2 (rat)",
                    "PTGS2",
                    "PTGS2 (chicken)",
                    "PTGS2 (human)",
                    "PTGS2 [endoplasmic reticulum membrane]",
                    "PTGS2 gene [nucleoplasm]",
                    "PTGS2 (sheep)",
                    "O-acetyl-L-serine-PTGS2 [endoplasmic reticulum membrane]",
                    "PTGS2 protein, human",
                    "prostaglandin G/H synthase 2 (cow)",
                    "prostaglandin G/H synthase 2 (sheep)",
                    "prostaglandin G/H synthase 2 (human)",
                    "prostaglandin G/H synthase 2 (chicken)",
                    "PTGS2 Gene",
                    "prostaglandin G/H synthase 2 (rat)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PR:P27607",
                    "PR:O62698",
                    "RGD:620349",
                    "PR:P35355",
                    "REACT:R-HSA-6785055",
                    "OMIM:600262",
                    "ENSEMBL:ENSG00000073756",
                    "NCBIGene:396451",
                    "NCIT:C26598",
                    "UniProtKB:P35354",
                    "PR:P79208",
                    "MESH:C496540",
                    "REACT:R-HSA-2161824",
                    "MGI:97798",
                    "HGNC:9605",
                    "PR:P35354",
                    "UMLS:C1367485",
                    "REACT:R-HSA-61605",
                    "PR:Q05769",
                    "NCBIGene:282023",
                    "NCBIGene:5743",
                    "UMLS:C1565860",
                    "NCBIGene:443460"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1073/pnas.89.16.7384",
                    "DOI:10.1016/j.febslet.2006.10.073",
                    "DOI:10.1074/jbc.m116.725713",
                    "PMID:7947975",
                    "PMID:22942274",
                    "PMID:8175750",
                    "PMID:24605250",
                    "DOI:10.1021/acs.biochem.5b01378",
                    "PMID:27642067",
                    "DOI:10.1021/bi962476u"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P36897": {
              "name": "TGFBR1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P36897",
                  "value_url": "https://identifiers.org/uniprot:P36897",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "-!- FUNCTION: Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation. {ECO:0000269|PubMed:15761148, ECO:0000269|PubMed:16754747, ECO:0000269|PubMed:18758450, ECO:0000269|PubMed:7774578, ECO:0000269|PubMed:8752209, ECO:0000269|PubMed:8980228, ECO:0000269|PubMed:9346908}. -!- CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[receptor-protein] = ADP + H(+) + O-phospho-L-threonyl-[receptor-protein]; Xref=Rhea:RHEA:44880, Rhea:RHEA-COMP:11024, Rhea:RHEA-COMP:11025, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.30; -!- CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[receptor-protein] = ADP + H(+) + O-phospho-L-seryl-[receptor-protein]; Xref=Rhea:RHEA:18673, Rhea:RHEA-COMP:11022, Rhea:RHEA-COMP:11023, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.30; -!- COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; -!- ACTIVITY REGULATION: Kept in an inactive conformation by FKBP1A preventing receptor activation in absence of ligand. CD109 is another inhibitor of the receptor. {ECO:0000269|PubMed:9233797}. -!- SUBUNIT: Homodimer; in the endoplasmic reticulum but also at the cell membrane. Heterohexamer; TGFB1, TGFB2 and TGFB3 homodimeric ligands assemble a functional receptor composed of two TGFBR1 and TGFBR2 heterodimers to form a ligand-receptor heterohexamer. The respective affinity of TGBRB1 and TGFBR2 for the ligands may modulate the kinetics of assembly of the receptor and may explain the different biological activities of TGFB1, TGFB2 and TGFB3. Interacts with CD109; inhibits TGF-beta receptor activation in keratinocytes. Interacts with RBPMS. Interacts (unphosphorylated) with FKBP1A; prevents TGFBR1 phosphorylation by TGFBR2 and stabilizes it in the inactive conformation. Interacts with SMAD2, SMAD3 and ZFYVE9; ZFYVE9 recruits SMAD2 and SMAD3 to the TGF-beta receptor. Interacts with TRAF6 and MAP3K7; induces MAP3K7 activation by TRAF6. Interacts with PARD6A; involved in TGF-beta induced epithelial to mesenchymal transition. Interacts with SMAD7, NEDD4L, SMURF1 and SMURF2; SMAD7 recruits NEDD4L, SMURF1 and SMURF2 to the TGF-beta receptor. Interacts with USP15 and VPS39. Interacts with SDCBP (via C-terminus) (PubMed:25893292) Interacts with CAV1 and this interaction is impaired in the presence of SDCBP (PubMed:25893292). Interacts with APPL1; interaction is TGF beta dependent; mediates trafficking of the TGFBR1 from the endosomes to the nucleus via microtubules in a TRAF6-dependent manner (PubMed:26583432). {ECO:0000269|PubMed:10025408, ECO:0000269|PubMed:11163210, ECO:0000269|PubMed:11278251, ECO:0000269|PubMed:11583628, ECO:0000269|PubMed:12941698, ECO:0000269|PubMed:15177479, ECO:0000269|PubMed:15317461, ECO:0000269|PubMed:15496141, ECO:0000269|PubMed:15761148, ECO:0000269|PubMed:16754747, ECO:0000269|PubMed:17099224, ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:18758450, ECO:0000269|PubMed:20207738, ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:26583432, ECO:0000269|PubMed:7774578, ECO:0000269|PubMed:8980228, ECO:0000269|PubMed:9233797, ECO:0000269|PubMed:9311995, ECO:0000269|PubMed:9346908, ECO:0000269|PubMed:9865696}. -!- INTERACTION: P36897; P62942: FKBP1A; NbExp=2; IntAct=EBI-1027557, EBI-1027571; P36897; P01137: TGFB1; NbExp=2; IntAct=EBI-1027557, EBI-779636; P36897; P63104: YWHAZ; NbExp=4; IntAct=EBI-1027557, EBI-347088; P36897; PRO_0000045599 [Q99IB8]; Xeno; NbExp=5; IntAct=EBI-1027557, EBI-6858501; P36897-1; P02750: LRG1; NbExp=6; IntAct=EBI-16065417, EBI-9083443; -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:9472030}; Single-pass type I membrane protein {ECO:0000269|PubMed:9472030}. Cell junction, tight junction {ECO:0000269|PubMed:15761148}. Cell surface {ECO:0000269|PubMed:25893292}. Membrane raft {ECO:0000269|PubMed:25893292}. -!- ALTERNATIVE PRODUCTS: Event=Alternative splicing; Named isoforms=3; Name=1; IsoId=P36897-1; Sequence=Displayed; Name=2; Synonyms=B; IsoId=P36897-2; Sequence=VSP_041326; Name=3; IsoId=P36897-3; Sequence=VSP_041327; -!- TISSUE SPECIFICITY: Found in all tissues examined, most abundant in placenta and least abundant in brain and heart. Expressed in a variety of cancer cell lines (PubMed:25893292). {ECO:0000269|PubMed:25893292}. -!- PTM: Phosphorylated at basal levels in the absence of ligand. Activated upon phosphorylation by TGFBR2, mainly in the GS domain. Phosphorylation in the GS domain abrogates FKBP1A-binding. {ECO:0000269|PubMed:11583628, ECO:0000269|PubMed:7774578}. -!- PTM: N-Glycosylated. {ECO:0000269|PubMed:9661882}. -!- PTM: Ubiquitinated; undergoes ubiquitination catalyzed by several E3 ubiquitin ligases including SMURF1, SMURF2 and NEDD4L2. Results in the proteasomal and/or lysosomal degradation of the receptor thereby negatively regulating its activity. Deubiquitinated by USP15, leading to stabilization of the protein and enhanced TGF-beta signal. Its ubiquitination and proteasome-mediated degradation is negatively regulated by SDCBP (PubMed:25893292). {ECO:0000269|PubMed:15496141, ECO:0000269|PubMed:22344298, ECO:0000269|PubMed:25893292}. -!- DISEASE: Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]: An aortic aneurysm syndrome with widespread systemic involvement, characterized by arterial tortuosity and aneurysms, hypertelorism, and bifid uvula or cleft palate. Physical findings include prominent joint laxity, easy bruising, wide and atrophic scars, velvety and translucent skin with easily visible veins, spontaneous rupture of the spleen or bowel, and catastrophic complications of pregnancy, including rupture of the gravid uterus and the arteries, either during pregnancy or in the immediate postpartum period. Some patients have craniosynostosis, exotropy, micrognathia and retrognathia, structural brain abnormalities, and intellectual deficit. {ECO:0000269|PubMed:15731757, ECO:0000269|PubMed:16596670, ECO:0000269|PubMed:16791849, ECO:0000269|PubMed:16928994, ECO:0000269|PubMed:19883511, ECO:0000269|PubMed:22113417}. Note=The disease is caused by variants affecting the gene represented in this entry. TGFBR1 mutation Gln-487 has been reported to be associated with thoracic aortic aneurysms and dissection (TAAD) (PubMed:16791849). This phenotype, also known as thoracic aortic aneurysms type 5 (AAT5), is distinguised from LDS1 by having aneurysms restricted to thoracic aorta. It is unclear, however, if this condition is fulfilled in individuals bearing Gln-487 mutation, that is why they are considered as LDS1 by the OMIM resource. {ECO:0000269|PubMed:16791849}. -!- DISEASE: Multiple self-healing squamous epithelioma (MSSE) [MIM:132800]: A disorder characterized by multiple skin tumors that undergo spontaneous regression. Tumors appear most often on sun-exposed regions, are locally invasive, and undergo spontaneous resolution over a period of months leaving pitted scars. {ECO:0000269|PubMed:21358634}. Note=The disease is caused by variants affecting the gene represented in this entry. -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily. {ECO:0000305}. -!- CAUTION: One report originally reported variant Ile-375 (PubMed:22113417). This variant has been subsequently corrected to Arg-375 by the same authors (Ref.49). {ECO:0000269|PubMed:22113417, ECO:0000269|Ref.49}. -!- WEB RESOURCE: Name=NIEHS-SNPs; URL=\"http://egp.gs.washington.edu/data/tgfbr1/\"; ; Short=TGFR-1; Short=ALK-5; Short=ALK5; Short=SKR4; Short=TGF-beta receptor type I; Short=TbetaR-IEvidence Codes from Name:  ",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "TGFBR1 [plasma membrane]",
                    "p-4S,T185,T186-TGFBR1 [plasma membrane]",
                    "Tgfbr1 (mouse)",
                    "Tgfbr1 (rat)",
                    "TGF-beta receptor type-1 (mouse)",
                    "TGFBR1 G52R [plasma membrane]",
                    "TGFBR1 gene",
                    "TGFBR1",
                    "TGF-beta receptor type-1 (human)",
                    "p-4S,T185,T186-TGFBR1 W242* [plasma membrane]",
                    "TGFBR1 P83L [plasma membrane]",
                    "TGFBR1 Gene",
                    "Ub-TGFBR1 [plasma membrane]",
                    "p-4S,T185,T186-TGFBR1 D269_Q324del [plasma membrane]",
                    "TGFBR1 N45S [plasma membrane]",
                    "TGF-beta receptor type-1 (rat)",
                    "TGFBR1 (human)",
                    "p-4S,T185,T186-TGFBR1 L354Nfs*4 [plasma membrane]",
                    "p-4S,T185,T186-TGFBR1 P327Qfs*8 [plasma membrane]",
                    "TGFBR1 protein, human",
                    "p-4S,T185,T186-TGFBR1 R414* [plasma membrane]",
                    "TGFBR1 P83S [plasma membrane]",
                    "TGFBR1 C41Y [plasma membrane]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "LOINC:LP61790-9",
                    "ENSEMBL:ENSG00000106799",
                    "UMLS:C1336624",
                    "NCIT:C24859",
                    "NCBIGene:7046",
                    "REACT:R-HSA-170839",
                    "PR:P80204",
                    "REACT:R-HSA-3656348",
                    "PR:Q64729",
                    "MGI:98728",
                    "REACT:R-HSA-3656504",
                    "UniProtKB:P36897",
                    "REACT:R-HSA-3656508",
                    "HGNC:11772",
                    "REACT:R-HSA-3656509",
                    "RGD:3852",
                    "REACT:R-HSA-170849",
                    "REACT:R-HSA-3656506",
                    "REACT:R-HSA-3656505",
                    "PR:P36897",
                    "REACT:R-HSA-3656341",
                    "UMLS:C1686499",
                    "REACT:R-HSA-8869461",
                    "REACT:R-HSA-3656326",
                    "REACT:R-HSA-3656368",
                    "MESH:C000625841",
                    "REACT:R-HSA-3656328",
                    "OMIM:190181"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:18758450",
                    "PMID:23525077",
                    "DOI:10.1016/s1097-2765(00)00134-9",
                    "PMID:20207738",
                    "DOI:10.1042/bj20040738",
                    "PMID:16754747",
                    "DOI:10.1074/jbc.272.44.27678",
                    "PMID:15731757",
                    "DOI:10.1074/jbc.c100008200",
                    "DOI:10.1038/onc.2015.100"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P37173": {
              "name": "TGFBR2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P37173",
                  "value_url": "https://identifiers.org/uniprot:P37173",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "TGF-beta receptor type-2 (567 aa, ~65 kDa) is encoded by the human TGFBR2 gene. This protein plays a role in both serine/threonine phosphorylation and TGF-beta-mediated signal transduction.; UMLS Semantic Type: STY:T192; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "TGFBR2 Gene",
                    "TGFBR2 E526Q [plasma membrane]",
                    "TGFBR2 protein, human",
                    "TGFBR2 D522N [plasma membrane]",
                    "TGF-beta receptor type-2 (human)",
                    "Tgfbr2 (rat)",
                    "TGFBR2 R528C [plasma membrane]",
                    "TGFBR2 gene",
                    "TGFBR2 K128fs*35 [cytosol]",
                    "TGFBR2 (chicken)",
                    "TGF-beta receptor type-2 (rat)",
                    "Tgfbr2 (mouse)",
                    "NEDD8-K556,K567-TGFBR2 [plasma membrane]",
                    "TGFBR2 Y470D [plasma membrane]",
                    "TGFBR2",
                    "TGFBR2 [plasma membrane]",
                    "TGFBR2 (human)",
                    "TGF-beta receptor type-2 (mouse)",
                    "TGFBR2 R528H [plasma membrane]",
                    "TGFBR2 K128fs*3 [cytosol]",
                    "TGF-beta receptor type-2 (chicken)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MESH:C000625845",
                    "NCBIGene:7048",
                    "REACT:R-HSA-3642173",
                    "ENSEMBL:LRG_779",
                    "MGI:98729",
                    "ENSEMBL:ENSG00000163513",
                    "REACT:R-HSA-3640907",
                    "PR:P37173",
                    "PR:Q62312",
                    "REACT:R-HSA-3640899",
                    "OMIM:190182",
                    "UniProtKB:P37173",
                    "PR:P38438",
                    "REACT:R-HSA-170842",
                    "REACT:R-HSA-3645770",
                    "REACT:R-HSA-3640905",
                    "HGNC:11773",
                    "REACT:R-HSA-3642166",
                    "REACT:R-HSA-4332222",
                    "REACT:R-HSA-3640894",
                    "LOINC:LP61791-7",
                    "PR:Q90999",
                    "NCBIGene:396399",
                    "UMLS:C1506219",
                    "NCIT:C18592",
                    "RGD:69651",
                    "UMLS:C0919538"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8812462",
                    "PMID:18691976",
                    "DOI:10.1016/s0092-8674(00)81701-8",
                    "PMID:18243111",
                    "DOI:10.1054/bjoc.1999.1178",
                    "PMID:20207738",
                    "PMID:23186163",
                    "PMID:22113417",
                    "DOI:10.1016/j.molcel.2008.07.007",
                    "DOI:10.1002/ajmg.a.32918"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P46531": {
              "name": "NOTCH1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P46531",
                  "value_url": "https://identifiers.org/uniprot:P46531",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "-!- FUNCTION: Functions as a receptor for membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs. Involved in angiogenesis; negatively regulates endothelial cell proliferation and migration and angiogenic sprouting. Involved in the maturation of both CD4(+) and CD8(+) cells in the thymus. Important for follicular differentiation and possibly cell fate selection within the follicle. During cerebellar development, functions as a receptor for neuronal DNER and is involved in the differentiation of Bergmann glia. Represses neuronal and myogenic differentiation. May play an essential role in postimplantation development, probably in some aspect of cell specification and/or differentiation. May be involved in mesoderm development, somite formation and neurogenesis. May enhance HIF1A function by sequestering HIF1AN away from HIF1A. Required for the THBS4 function in regulating protective astrogenesis from the subventricular zone (SVZ) niche after injury. Involved in determination of left/right symmetry by modulating the balance between motile and immotile (sensory) cilia at the left-right organiser (LRO). {ECO:0000269|PubMed:20616313}. -!- SUBUNIT: Heterodimer of a C-terminal fragment N(TM) and an N-terminal fragment N(EC) which are probably linked by disulfide bonds. Interacts with DNER, DTX1, DTX2 and RBPJ/RBPSUH. Also interacts with MAML1, MAML2 and MAML3 which act as transcriptional coactivators for NOTCH1 (PubMed:11101851, PubMed:12370315). The NOTCH1 intracellular domain interacts with SNW1; the interaction involves multimerized NOTCH1 NICD and is implicated in a formation of an intermediate preactivation complex which associates with DNA-bound CBF-1/RBPJ (PubMed:10713164). The activated membrane-bound form interacts with AAK1 which promotes NOTCH1 stabilization. Forms a trimeric complex with FBXW7 and SGK1. Interacts with HIF1AN. HIF1AN negatively regulates the function of notch intracellular domain (NICD), accelerating myogenic differentiation (PubMed:17573339). Interacts (via NICD) with SNAI1 (via zinc fingers); the interaction induces SNAI1 degradation via MDM2-mediated ubiquitination and inhibits SNAI1-induced cell invasion. Interacts (via NICD) with MDM2A. Interacts (via NICD) with BCL6; the interaction decreases MAML1 recruitment by NOTCH1 NICD on target genes DNA and inhibits NOTCH1 transcractivation activity. Interacts with THBS4 (By similarity). Interacts (via the EGF-like repeat region) with CCN3 (via CTCK domain) (PubMed:12050162). Interacts (via EGF-like domains) with DLL4 (via N-terminal DSL and MNNL domains) (By similarity). Interacts with ZMIZ1. Interacts (via NICD domain) with MEGF10 (via the cytoplasmic domain). Interacts with DLL1 and JAG1 (By similarity). Interacts (via NICD domain) with PRAG1 (By similarity). Forms a complex with PRAG1, N1ICD and MAML1, in a MAML1-dependent manner (By similarity). Interacts (via transmembrane region) with PSEN1; the interaction is direct (PubMed:30598546). {ECO:0000250|UniProtKB:Q01705, ECO:0000250|UniProtKB:Q07008, ECO:0000269|PubMed:10713164, ECO:0000269|PubMed:11101851, ECO:0000269|PubMed:12050162, ECO:0000269|PubMed:12370315, ECO:0000269|PubMed:17573339, ECO:0000269|PubMed:26522984, ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:9590294}. -!- INTERACTION: P46531; Q13315: ATM; NbExp=8; IntAct=EBI-636374, EBI-495465; P46531; Q969H0: FBXW7; NbExp=10; IntAct=EBI-636374, EBI-359574; P46531; Q16665: HIF1A; NbExp=2; IntAct=EBI-636374, EBI-447269; P46531; P78504: JAG1; NbExp=6; IntAct=EBI-636374, EBI-2847071; P46531; O60341: KDM1A; NbExp=8; IntAct=EBI-636374, EBI-710124; P46531; Q8N423: LILRB2; NbExp=8; IntAct=EBI-636374, EBI-2816428; P46531; Q92585: MAML1; NbExp=14; IntAct=EBI-636374, EBI-908250; P46531; P19838: NFKB1; NbExp=2; IntAct=EBI-636374, EBI-300010; P46531; P46531: NOTCH1; NbExp=6; IntAct=EBI-636374, EBI-636374; P46531; Q13526: PIN1; NbExp=9; IntAct=EBI-636374, EBI-714158; P46531; Q06330: RBPJ; NbExp=12; IntAct=EBI-636374, EBI-632552; P46531; Q06330-6: RBPJ; NbExp=6; IntAct=EBI-636374, EBI-12599287; P46531; Q13573: SNW1; NbExp=3; IntAct=EBI-636374, EBI-632715; P46531; P98170: XIAP; NbExp=4; IntAct=EBI-636374, EBI-517127; -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q01705}; Single-pass type I membrane protein {ECO:0000305|PubMed:30598546}. -!- SUBCELLULAR LOCATION: [Notch 1 intracellular domain]: Nucleus {ECO:0000250|UniProtKB:Q01705}. Note=Following proteolytical processing NICD is translocated to the nucleus. Nuclear location may require MEGF10. {ECO:0000250|UniProtKB:Q01705}. -!- TISSUE SPECIFICITY: In fetal tissues most abundant in spleen, brain stem and lung. Also present in most adult tissues where it is found mainly in lymphoid tissues. -!- DOMAIN: Interaction with PSEN1 causes partial unwinding of the transmembrane helix, facilitating access to the scissile peptide bond. {ECO:0000269|PubMed:30598546}. -!- PTM: Synthesized in the endoplasmic reticulum as an inactive form which is proteolytically cleaved by a furin-like convertase in the trans-Golgi network before it reaches the plasma membrane to yield an active, ligand-accessible form (By similarity). Cleavage results in a C-terminal fragment N(TM) and a N-terminal fragment N(EC). Following ligand binding, it is cleaved by ADAM17 to yield a membrane-associated intermediate fragment called notch extracellular truncation (NEXT) (PubMed:24226769). Following endocytosis, this fragment is then cleaved by one of the catalytic subunits of gamma-secretase (PSEN1 or PSEN2), to release a Notch-derived peptide containing the intracellular domain (NICD) from the membrane (PubMed:30598546). {ECO:0000250|UniProtKB:Q01705, ECO:0000269|PubMed:24226769, ECO:0000269|PubMed:30598546}. -!- PTM: Phosphorylated. {ECO:0000250}. -!- PTM: O-glycosylated on the EGF-like domains (PubMed:24226769). O-glucosylated at Ser-435 by KDELC1 and KDELC2 (PubMed:30127001). Contains both O-linked fucose and O-linked glucose in the EGF-like domains 11, 12 and 13, which are interacting with the residues on DLL4 (By similarity). O-linked glycosylation by GALNT11 is involved in determination of left/right symmetry: glycosylation promotes activation of NOTCH1, possibly by promoting cleavage by ADAM17, modulating the balance between motile and immotile (sensory) cilia at the left-right organiser (LRO) (PubMed:24226769). MFNG-, RFNG- and LFNG-mediated modification of O-fucose residues at specific EGF-like domains results in inhibition of its activation by JAG1 and enhancement of its activation by DLL1 via an increased binding to DLL1 (By similarity). {ECO:0000250|UniProtKB:Q01705, ECO:0000250|UniProtKB:Q07008, ECO:0000269|PubMed:24226769, ECO:0000269|PubMed:30127001}. -!- PTM: Ubiquitinated. Undergoes 'Lys-29'-linked polyubiquitination by ITCH; promotes the lysosomal degradation of non-activated internalized NOTCH1 (PubMed:18628966, PubMed:23886940). Monoubiquitination at Lys-1759 is required for activation by gamma-secretase cleavage, it promotes interaction with AAK1, which stabilizes it. Deubiquitination by EIF3F is necessary for nuclear import of activated Notch (PubMed:24226769). {ECO:0000269|PubMed:18628966, ECO:0000269|PubMed:23886940, ECO:0000269|PubMed:24226769}. -!- PTM: Hydroxylated at Asn-1955 by HIF1AN. Hydroxylated at Asn-2022 by HIF1AN (By similarity). Hydroxylation reduces affinity for HI1AN and may thus indirectly modulate negative regulation of NICD (By similarity). {ECO:0000250}. -!- DISEASE: Aortic valve disease 1 (AOVD1) [MIM:109730]: A common defect in the aortic valve in which two rather than three leaflets are present. It is often associated with aortic valve calcification, stenosis and insufficiency. In extreme cases, the blood flow may be so restricted that the left ventricle fails to grow, resulting in hypoplastic left heart syndrome. {ECO:0000269|PubMed:16025100}. Note=The disease is caused by variants affecting the gene represented in this entry. -!- DISEASE: Adams-Oliver syndrome 5 (AOS5) [MIM:616028]: A form of Adams-Oliver syndrome, a disorder characterized by the congenital absence of skin (aplasia cutis congenita) in combination with transverse limb defects. Aplasia cutis congenita can be located anywhere on the body, but in the vast majority of the cases, it is present on the posterior parietal region where it is often associated with an underlying defect of the parietal bones. Limb abnormalities are typically limb truncation defects affecting the distal phalanges or entire digits (true ectrodactyly). Only rarely, metatarsals/metacarpals or more proximal limb structures are also affected. Apart from transverse limb defects, syndactyly, most commonly of second and third toes, can also be observed. The clinical features are highly variable and can also include cardiovascular malformations, brain abnormalities and vascular defects such as cutis marmorata and dilated scalp veins. {ECO:0000269|PubMed:25132448}. Note=The disease is caused by variants affecting the gene represented in this entry. -!- SIMILARITY: Belongs to the NOTCH family. {ECO:0000305}. -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL=\"http://atlasgeneticsoncology.org/Genes/NOTCH1ID30ch9q34.html\"; ; Short=Notch 1; Short=hN1; Short=NEXT; Short=NICDEvidence Codes from Name:  ",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NOTCH1 L1574P Extracellular Fragment [extracellular region]",
                    "NOTCH1 F1592S Extracellular Fragment [extracellular region]",
                    "p-NICD1 P2514Rfs*4 [nucleoplasm]",
                    "19xFucT-14xGlcS-2xFucS-NOTCH1(19-2555) [endoplasmic reticulum membrane]",
                    "neurogenic locus notch homolog protein 1 (mouse)",
                    "NOTCH1 I1718T Transmembrane Fragment [plasma membrane]",
                    "NOTCH1 I1718T S2 cleavage fragment [extracellular region]",
                    "neurogenic locus notch homolog protein 1 (human)",
                    "Notch1 (mouse)",
                    "NEXT1 P2514Rfs*4 [plasma membrane]",
                    "19xFucT-16xGlcS-2xFucS-NOTCH1(19-1664) [extracellular region]",
                    "NOTCH1 I1680N Transmembrane Fragment [plasma membrane]",
                    "NICD1 P2514Rfs*4 [nucleoplasm]",
                    "NICD1 P2474Afs*4 [cytosol]",
                    "NOTCH1",
                    "NEXT1 Q2440* [plasma membrane]",
                    "NOTCH1(1665-2555) [plasma membrane]",
                    "NICD1 Q2395* [cytosol]",
                    "17xFucT-14xGlcS-2xFucS-NOTCH1(19-1664) [Golgi membrane]",
                    "NEXT1 P2474Afs*4 [plasma membrane]",
                    "NOTCH1 L1596H Extracellular Fragment [extracellular region]",
                    "NOTCH1 L1600P Extracellular Fragment [extracellular region]",
                    "NOTCH1 L1678P S2 cleavage fragment [extracellular region]",
                    "NOTCH1 Q2440* Transmembrane Fragment [plasma membrane]",
                    "NOTCH1 (human)",
                    "Notch1 (rat)",
                    "FRINGE-modified NOTCH1 Extracellular Fragment (NECD1) [Golgi membrane]",
                    "NEXT1 [plasma membrane]",
                    "NOTCH1 A1701P Transmembrane Fragment [plasma membrane]",
                    "NOTCH1 I1616N Extracellular Fragment [extracellular region]",
                    "NEXT1 Q2395* [plasma membrane]",
                    "NOTCH1 Gene",
                    "NOTCH1(1665-1720) [extracellular region]",
                    "Glc,GlcNAc-Fuc-Pre-NOTCH1 [Golgi membrane]",
                    "FRINGE-modified NOTCH1 Extracellular Fragment (NECD1) [plasma membrane]",
                    "NICD1 P2514Rfs*4 [cytosol]",
                    "Glc,Sia-Gal-GlcNAc-Fuc-Pre-NOTCH1 [Golgi membrane]",
                    "NOTCH1 I1616T Extracellular Fragment [extracellular region]",
                    "NICD1 [cytosol]",
                    "Glc,Gal-GlcNAc-Fuc-Pre-NOTCH1 [Golgi membrane]",
                    "17xFucT-2xFucS-NOTCH1(19-2555) [endoplasmic reticulum membrane]",
                    "p-NICD1 Q2395* [nucleoplasm]",
                    "NOTCH1(1721-1753) [plasma membrane]",
                    "NOTCH1 gene",
                    "NOTCH1 t(7;9)(NOTCH1:M1580_K2555) extracellular fragment [extracellular region]",
                    "NOTCH1 A1701P S2 cleavage fragment [plasma membrane]",
                    "NICD1 [nucleoplasm]",
                    "NOTCH1 V1576E Extracellular Fragment [extracellular region]",
                    "NOTCH1 protein, human",
                    "NOTCH1 R1598P Extracellular Fragment [extracellular region]",
                    "NOTCH1 gene [nucleoplasm]",
                    "p-NICD1 [nucleoplasm]",
                    "NOTCH1 P2514Rfs*4 Transmembrane Fragment [plasma membrane]",
                    "NOTCH1 L1593P Extracellular Fragment [extracellular region]",
                    "NOTCH1 V1676D Transmembrane Fragment [plasma membrane]",
                    "NOTCH1 P2474Afs*4 Transmembrane Fragment [plasma membrane]",
                    "Pre-NOTCH1 [endoplasmic reticulum membrane]",
                    "NICD1 P2474Afs*4 [nucleoplasm]",
                    "NICD1 Q2440* [cytosol]",
                    "NOTCH1(1665-2555) [Golgi membrane]",
                    "NOTCH1 Q2395* Transmembrane Fragment [plasma membrane]",
                    "NICD1 Q2440* [nucleoplasm]",
                    "NOTCH1 L1678P Transmembrane Fragment [plasma membrane]",
                    "p-NICD1 P2474Afs*4 [nucleoplasm]",
                    "p-NICD1 Q2440* [nucleoplasm]",
                    "17xFucT-14xGlcS-2xFucS-NOTCH1(19-2555) [Golgi membrane]",
                    "NOTCH1 I1680N S2 cleavage fragment [extracellular region]",
                    "NOTCH1 L1574Q Extracellular Fragment [extracellular region]",
                    "neurogenic locus notch homolog protein 1 (rat)",
                    "NOTCH1 V1676D S2 cleavage fragment [extracellular region]",
                    "NICD1 Q2395* [nucleoplasm]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-2684881",
                    "NCBIGene:4851",
                    "REACT:R-HSA-2902192",
                    "REACT:R-HSA-157634",
                    "REACT:R-HSA-2902200",
                    "REACT:R-HSA-1485592",
                    "REACT:R-HSA-1467396",
                    "REACT:R-HSA-2902195",
                    "REACT:R-HSA-2902207",
                    "HGNC:7881",
                    "REACT:R-HSA-1485596",
                    "REACT:R-HSA-2902208",
                    "REACT:R-HSA-2768989",
                    "REACT:R-HSA-2902196",
                    "REACT:R-HSA-1485585",
                    "REACT:R-HSA-1911503",
                    "OMIM:190198",
                    "REACT:R-HSA-2684869",
                    "REACT:R-HSA-2894873",
                    "REACT:R-HSA-2902191",
                    "REACT:R-HSA-2902205",
                    "REACT:R-HSA-2730744",
                    "REACT:R-HSA-2691203",
                    "ENSEMBL:ENSG00000148400",
                    "ENSEMBL:LRG_1122",
                    "REACT:R-HSA-157656",
                    "REACT:R-HSA-157939",
                    "MESH:C497761",
                    "UMLS:C1334889",
                    "REACT:R-HSA-1472872",
                    "REACT:R-HSA-2730757",
                    "REACT:R-HSA-2902193",
                    "REACT:R-HSA-157024",
                    "REACT:R-HSA-1604444",
                    "REACT:R-HSA-1911511",
                    "REACT:R-HSA-2220929",
                    "PR:P46531",
                    "REACT:R-HSA-2730745",
                    "REACT:R-HSA-1485582",
                    "REACT:R-HSA-1983670",
                    "REACT:R-HSA-157092",
                    "REACT:R-HSA-2684852",
                    "REACT:R-HSA-157654",
                    "REACT:R-HSA-2902201",
                    "PR:Q01705",
                    "REACT:R-HSA-2684866",
                    "NCIT:C24636",
                    "REACT:R-HSA-157239",
                    "REACT:R-HSA-2730755",
                    "UniProtKB:P46531",
                    "REACT:R-HSA-2681764",
                    "PR:Q07008",
                    "REACT:R-HSA-1485602",
                    "REACT:R-HSA-1911481",
                    "REACT:R-HSA-1485591",
                    "REACT:R-HSA-2684874",
                    "REACT:R-HSA-2769013",
                    "REACT:R-HSA-2902194",
                    "REACT:R-HSA-1911512",
                    "RGD:3187",
                    "REACT:R-HSA-2768982",
                    "REACT:R-HSA-1911415",
                    "REACT:R-HSA-2684862",
                    "UMLS:C1335068",
                    "REACT:R-HSA-2684853",
                    "REACT:R-HSA-2768996",
                    "REACT:R-HSA-2902204",
                    "REACT:R-HSA-1911426",
                    "REACT:R-HSA-1485584",
                    "REACT:R-HSA-1467425",
                    "MGI:97363",
                    "REACT:R-HSA-2684847",
                    "REACT:R-HSA-2730742",
                    "REACT:R-HSA-1983679",
                    "REACT:R-HSA-2159809",
                    "REACT:R-HSA-157200"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1038/nature03940",
                    "PMID:16530044",
                    "DOI:10.1126/sciadv.1602794",
                    "PMID:18628966",
                    "DOI:10.1128/mcb.00360-10",
                    "DOI:10.1016/j.str.2004.09.012",
                    "PMID:16011479",
                    "PMID:21464124",
                    "PMID:17573339",
                    "DOI:10.1074/jbc.m704102200"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P50052": {
              "name": "AGTR2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P50052",
                  "value_url": "https://identifiers.org/uniprot:P50052",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Type-2 angiotensin II receptor (363 aa, ~41 kDa) is encoded by the human AGTR2 gene. This protein is involved in signal transduction, apoptosis, and the regulation of blood pressure.; An angiotensin receptor subtype that is expressed at high levels in fetal tissues. Many effects of the angiotensin type 2 receptor such as VASODILATION and sodium loss are the opposite of that of the ANGIOTENSIN TYPE 1 RECEPTOR.; UMLS Semantic Type: STY:T192; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Angiotensin II Receptor, Type 2",
                    "AGTR2 gene",
                    "Agtr2 (mouse)",
                    "type-2 angiotensin II receptor (mouse)",
                    "type-2 angiotensin II receptor (rat)",
                    "type-2 angiotensin II receptor (human)",
                    "AGTR2",
                    "AGTR2 [plasma membrane]",
                    "AGTR2 Gene",
                    "AGTR2 (human)",
                    "Agtr2 (rat)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UniProtKB:P50052",
                    "PR:P35351",
                    "REACT:R-HSA-374130",
                    "HGNC:338",
                    "RGD:2072",
                    "PR:P50052",
                    "NCBIGene:186",
                    "OMIM:300034",
                    "PR:P35374",
                    "UMLS:C0390423",
                    "UMLS:C1332036",
                    "NCIT:C21387",
                    "MGI:87966",
                    "ENSEMBL:ENSG00000180772"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:7945336",
                    "PMID:15123706",
                    "PMID:7733925",
                    "DOI:10.1038/nature03440",
                    "PMID:23871722",
                    "DOI:10.1101/gr.2596504",
                    "DOI:10.1074/jbc.m403880200",
                    "PMID:14702039",
                    "DOI:10.1016/0888-7543(95)80072-t",
                    "PMID:15772651"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P51787": {
              "name": "KCNQ1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P51787",
                  "value_url": "https://identifiers.org/uniprot:P51787",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Potassium voltage-gated channel subfamily KQT member 1 (676 aa, ~75 kDa) is encoded by the human KCNQ1 gene. This protein is involved in cardiac repolarization through modulation of potassium ion transport.; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "potassium voltage-gated channel subfamily KQT member 1 (human)",
                    "potassium voltage-gated channel subfamily KQT member 1 (rat)",
                    "KCNQ1 Gene",
                    "Potassium Voltage-Gated Channel Subfamily KQT Member 1",
                    "Kcnq1 (rat)",
                    "KCNQ1 (human)",
                    "KCNQ1",
                    "KCNQ1 [plasma membrane]",
                    "potassium voltage-gated channel subfamily KQT member 1 (mouse)",
                    "KCNQ1 gene",
                    "Kcnq1 (mouse)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C75624",
                    "PR:P51787",
                    "NCBIGene:3784",
                    "OMIM:607542",
                    "ENSEMBL:ENSG00000282076",
                    "PR:Q9Z0N7",
                    "ENSEMBL:ENSG00000053918",
                    "HGNC:6294",
                    "UniProtKB:P51787",
                    "UMLS:C2698860",
                    "UMLS:C1416612",
                    "RGD:621503",
                    "NCIT:C75622",
                    "LOINC:LP36620-0",
                    "MGI:108083",
                    "ENSEMBL:LRG_287",
                    "REACT:R-HSA-977517",
                    "PR:P97414"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10024302",
                    "DOI:10.1001/jama.294.23.2975",
                    "DOI:10.1038/nature04632",
                    "PMID:9927399",
                    "DOI:10.1002/(sici)1096-8628(19990924)89:3<137::aid-ajmg4>3.0.co",
                    "PMID:18400097",
                    "DOI:10.1161/atvbaha.114.303801",
                    "PMID:20533308",
                    "PMID:9305853",
                    "PMID:25441029"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P53814": {
              "name": "SMTN",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P53814",
                  "value_url": "https://identifiers.org/uniprot:P53814",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "-!- FUNCTION: Structural protein of the cytoskeleton. -!- INTERACTION: P53814-5; Q4L180-3: FILIP1L; NbExp=3; IntAct=EBI-11100581, EBI-12221557; P53814-5; O76024: WFS1; NbExp=3; IntAct=EBI-11100581, EBI-720609; -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Note=Exhibits a filamentous organization. -!- ALTERNATIVE PRODUCTS: Event=Alternative promoter usage, Alternative splicing; Named isoforms=4; Comment=Additional isoforms seem to exist.; Name=B; Synonyms=Long, B1, L1; IsoId=P53814-1; Sequence=Displayed; Name=A; Synonyms=Short; IsoId=P53814-2; Sequence=VSP_004398; Name=B2; Synonyms=L2; IsoId=P53814-5; Sequence=VSP_007020; Name=B3; IsoId=P53814-6; Sequence=VSP_031242; -!- TISSUE SPECIFICITY: Smooth muscle; contractile or vascular (for the long form). -!- MISCELLANEOUS: [Isoform A]: Produced by alternative promoter usage. {ECO:0000305}. -!- SIMILARITY: Belongs to the smoothelin family. {ECO:0000305}. -!- SEQUENCE CAUTION: Sequence=AAL36149.1; Type=Frameshift; Evidence={ECO:0000305}; Sequence=AAL36150.1; Type=Frameshift; Evidence={ECO:0000305}; Sequence=CAA73884.2; Type=Frameshift; Evidence={ECO:0000305}; Evidence Codes from Name:  ",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "SMTN gene",
                    "smoothelin (human)",
                    "Smtn (mouse)",
                    "SMTN",
                    "smoothelin (mouse)",
                    "SMTN (human)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MGI:1354727",
                    "UMLS:C1420265",
                    "ENSEMBL:ENSG00000183963",
                    "PR:Q921U8",
                    "NCBIGene:6525",
                    "HGNC:11126",
                    "OMIM:602127",
                    "PR:P53814",
                    "UniProtKB:P53814"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1083/jcb.134.2.401",
                    "PMID:8707825",
                    "PMID:23186163",
                    "DOI:10.1007/s001090050352",
                    "PMID:12176134",
                    "DOI:10.1159/000051039",
                    "PMID:19690332",
                    "DOI:10.1126/scisignal.2000007",
                    "DOI:10.1038/990031",
                    "DOI:10.1101/gr.2596504"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P60953": {
              "name": "CDC42",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P60953",
                  "value_url": "https://identifiers.org/uniprot:P60953",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A member of the Rho family of MONOMERIC GTP-BINDING PROTEINS. It is associated with a diverse array of cellular functions including cytoskeletal changes, filopodia formation and transport through the GOLGI APPARATUS. This enzyme was formerly listed as EC 3.6.1.47.; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Cdc42 (mouse)",
                    "Cdc42 homolog (fruit fly)",
                    "cdc42 GTP-Binding Protein",
                    "CDC42 gene",
                    "CDC42 [cytosol]",
                    "CDC42 gene [nucleoplasm]",
                    "cell division control protein 42 (yeast)",
                    "Cdc42 (rat)",
                    "cell division control protein 42 homolog (mouse)",
                    "G25K GTP-Binding Protein, Placental Isoform",
                    "CDC42 (Candida albicans SC5314)",
                    "CDC42 Gene",
                    "cell division control protein 42 homolog (rat)",
                    "CDC42 (human)",
                    "CDC42",
                    "cell division control protein 42 homolog (Schizosaccharomyces pombe 972h-)",
                    "CDC42 (chicken)",
                    "cell division control protein 42 homolog (human)",
                    "cell division control protein 42 homolog (Candida albicans SC5314)",
                    "cell division control protein 42 homolog (chicken)",
                    "CDC42 [plasma membrane]",
                    "CDC42 [endoplasmic reticulum membrane]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:998",
                    "PR:P19073",
                    "PR:Q8CFN2",
                    "PR:Q90694",
                    "UMLS:C1366537",
                    "MESH:D020764",
                    "UMLS:C0082645",
                    "ENSEMBL:ENSG00000070831",
                    "NCBIGene:3646488",
                    "NCBIGene:395917",
                    "RGD:71043",
                    "REACT:R-HSA-8950770",
                    "PR:P60953",
                    "PR:P0CY33",
                    "PR:P40793",
                    "HGNC:1736",
                    "UniProtKB:P60953",
                    "NCIT:C24282",
                    "PR:Q01112",
                    "OMIM:116952",
                    "REACT:R-HSA-5672086",
                    "UMLS:C0752136",
                    "PR:P60766",
                    "MGI:106211",
                    "REACT:R-HSA-449545",
                    "REACT:R-HSA-442630"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19039103",
                    "PMID:10816584",
                    "DOI:10.1038/nm.1879",
                    "PMID:12612085",
                    "DOI:10.1021/pr100562w",
                    "PMID:26386261",
                    "PMID:10211824",
                    "DOI:10.1016/j.bbrc.2011.04.116",
                    "DOI:10.1371/journal.pgen.1000675",
                    "DOI:10.1016/j.molcel.2009.03.008"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P61812": {
              "name": "TGFB2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P61812",
                  "value_url": "https://identifiers.org/uniprot:P61812",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A TGF-beta 2 that is encoded in the genome of rat. // COMMENTS: Category=organism-gene.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "TGFB2 gene",
                    "Transforming Growth Factor Beta 2",
                    "TGFB2 [extracellular region]",
                    "TGFB2 (human)",
                    "TGFB2 Gene",
                    "transforming growth factor beta 2",
                    "TGFB2(20-302) [extracellular region]",
                    "transforming growth factor beta-2 proprotein (rat)",
                    "transforming growth factor beta-2 proprotein (mouse)",
                    "TGFB2",
                    "Tgfb2 (rat)",
                    "transforming growth factor beta-2 (human)",
                    "Tgfb2 (mouse)",
                    "TGFB2 [platelet alpha granule lumen]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ENSEMBL:ENSG00000092969",
                    "REACT:R-HSA-2395269",
                    "UMLS:C0079441",
                    "PR:P61812",
                    "REACT:R-HSA-65938",
                    "NCIT:C24857",
                    "OMIM:190220",
                    "ORPHANET:120052",
                    "UniProtKB:P61812",
                    "REACT:R-HSA-114706",
                    "PR:P27090",
                    "MGI:98726",
                    "NCBIGene:7042",
                    "RXNORM:1370419",
                    "HGNC:11768",
                    "UMLS:C1336621",
                    "PR:Q07257",
                    "RGD:70491"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1038/sj.gene.6363780",
                    "DOI:10.1016/j.cca.2014.07.016",
                    "DOI:10.1126/science.1631557",
                    "DOI:10.1089/dna.1.1988.7.493",
                    "PMID:2850146",
                    "PMID:12706107",
                    "PMID:1641027",
                    "DOI:10.1016/s0888-7543(03)00046-6",
                    "DOI:10.1101/gr.2596504",
                    "PMID:3476488"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P62736": {
              "name": "ACTA2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P62736",
                  "value_url": "https://identifiers.org/uniprot:P62736",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Actin, aortic smooth muscle (377 aa, ~42 kDa) is encoded by the human ACTA2 gene. This protein plays a role in the contraction of smooth muscle.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ACTA2 protein, human",
                    "actin, aortic smooth muscle (human)",
                    "ACTA2 Gene",
                    "ACTA2",
                    "Acta2 (mouse)",
                    "Acta2 (rat)",
                    "actin, aortic smooth muscle (mouse)",
                    "ACTA2 gene",
                    "actin, aortic smooth muscle (rat)",
                    "ACTA2 gene [nucleoplasm]",
                    "ACTA2 [cytosol]",
                    "ACTA2 (human)",
                    "actin, aortic smooth muscle (chicken)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PR:P62736",
                    "RGD:621676",
                    "PR:P62737",
                    "UMLS:C1412137",
                    "NCIT:C103970",
                    "MESH:C541116",
                    "UMLS:C2716282",
                    "UniProtKB:P62736",
                    "ENSEMBL:ENSG00000107796",
                    "ENSEMBL:LRG_781",
                    "PR:P08023",
                    "HGNC:130",
                    "REACT:R-HSA-8957900",
                    "NCBIGene:59",
                    "REACT:R-HSA-445792",
                    "OMIM:102620",
                    "MGI:87909",
                    "PR:P62738"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1111/j.1462-5822.2005.00644.x",
                    "PMID:2612915",
                    "DOI:10.1073/pnas.0808082105",
                    "PMID:19015515",
                    "DOI:10.1016/j.ajhg.2009.04.007",
                    "PMID:2701935",
                    "PMID:6330528",
                    "DOI:10.1093/nar/17.4.1767",
                    "DOI:10.1016/j.ejpn.2010.09.002",
                    "DOI:10.1038/ng.2007.6"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:P84022": {
              "name": "SMAD3",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:P84022",
                  "value_url": "https://identifiers.org/uniprot:P84022",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "This gene is involved in signal transduction and apoptosis. It also plays a role in the regulation of both steroid synthesis and T-cell response.; UMLS Semantic Type: STY:T028",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "SMAD3 (chicken)",
                    "mothers against decapentaplegic homolog 3 (mouse)",
                    "SMAD3 [cytosol]",
                    "SMAD3 protein, human",
                    "smad3",
                    "SMAD3 Q358* [cytosol]",
                    "SMAD3 Q322* [cytosol]",
                    "mothers against decapentaplegic homolog 3 (human)",
                    "p-S423,S425-SMAD3 R268H [cytosol]",
                    "SMAD3 W326* [cytosol]",
                    "2xADPRib-p-S423,S425-SMAD3 [nucleoplasm]",
                    "Ub-SMAD3 [cytosol]",
                    "SMAD3 [nucleoplasm]",
                    "p-S423,S425-SMAD3 [nucleoplasm]",
                    "p-S423,S425-SMAD3 D258N [cytosol]",
                    "mothers against decapentaplegic homolog 3 (chicken)",
                    "SMAD3 Y384* [cytosol]",
                    "Smad3 (mouse)",
                    "SMAD3 S425F [cytosol]",
                    "mothers against decapentaplegic homolog 3 (rat)",
                    "SMAD3 (human)",
                    "Smad3 (rat)",
                    "SMAD3 Gene",
                    "SMAD3 gene",
                    "SMAD3 E383* [cytosol]",
                    "p-S423,S425-SMAD3 [cytosol]",
                    "SMAD3 Q316* [cytosol]",
                    "p-T179,S423,S425-SMAD3 [nucleoplasm]",
                    "SMAD3",
                    "p-S423,S425-SMAD3 R268C [cytosol]",
                    "SMAD3 E246* [cytosol]",
                    "SMAD3 S425C [cytosol]",
                    "SMAD3 Y298* [cytosol]",
                    "SMAD3 R368* [cytosol]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCBIGene:395132",
                    "REACT:R-HSA-3315080",
                    "PR:000000365",
                    "REACT:R-HSA-9668776",
                    "UMLS:C0529119",
                    "REACT:R-HSA-177104",
                    "REACT:R-HSA-9668775",
                    "MGI:1201674",
                    "REACT:R-HSA-3315075",
                    "HGNC:6769",
                    "UniProtKB:P84022",
                    "REACT:R-HSA-171184",
                    "NCBIGene:4088",
                    "MESH:C497790",
                    "REACT:R-HSA-170855",
                    "REACT:R-HSA-206150",
                    "PR:P84022",
                    "REACT:R-HSA-9668773",
                    "UMLS:C0919432",
                    "REACT:R-HSA-9668766",
                    "REACT:R-HSA-3315470",
                    "REACT:R-HSA-8944158",
                    "REACT:R-HSA-9668782",
                    "REACT:R-HSA-9668768",
                    "OMIM:603109",
                    "NCIT:C18504",
                    "REACT:R-HSA-3308499",
                    "REACT:R-HSA-2187326",
                    "REACT:R-HSA-9668769",
                    "REACT:R-HSA-6782830",
                    "PR:Q8BUN5",
                    "REACT:R-HSA-2176471",
                    "REACT:R-HSA-9668765",
                    "PR:P84023",
                    "RGD:3032",
                    "REACT:R-HSA-9668772",
                    "ENSEMBL:ENSG00000166949",
                    "REACT:R-HSA-2187371",
                    "PR:P84025"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1016/j.molcel.2004.07.016",
                    "PMID:11278756",
                    "PMID:16862174",
                    "PMID:21217753",
                    "PMID:16200078",
                    "DOI:10.1161/circresaha.111.248161",
                    "DOI:10.1074/jbc.m609279200",
                    "DOI:10.1074/jbc.m708033200",
                    "PMID:19413330",
                    "DOI:10.1021/ac9004309"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:Q13315": {
              "name": "ATM",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:Q13315",
                  "value_url": "https://identifiers.org/uniprot:Q13315",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Serine-protein kinase ATM (3056 aa, ~351 kDa) is encoded by the human ATM gene. This protein is involved in DNA damage-induced protein phosphorylation.; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ATM protein, human",
                    "Ac-K3016-ATM [nucleoplasm]",
                    "ATM gene",
                    "serine-protein kinase ATM (human)",
                    "ATM [peroxisomal matrix]",
                    "ATM",
                    "Atm (mouse)",
                    "ATM (human)",
                    "ATM Gene",
                    "Atm",
                    "p-S1981,Ac-K3016-ATM [nucleoplasm]",
                    "ATM [nucleoplasm]",
                    "ATM [cytosol]",
                    "serine-protein kinase ATM (mouse)",
                    "ATM Gene [nucleoplasm]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ENSEMBL:ENSG00000149311",
                    "UMLS:C0919524",
                    "REACT:R-HSA-5682043",
                    "LOINC:LP19654-0",
                    "REACT:R-HSA-69484",
                    "PDQ:CDR0000043121",
                    "MESH:C576324",
                    "HGNC:795",
                    "UniProtKB:Q13315",
                    "ENSEMBL:LRG_135",
                    "MGI:107202",
                    "PR:Q62388",
                    "REACT:R-HSA-9665171",
                    "OMIM:607585",
                    "REACT:R-HSA-9665169",
                    "REACT:R-HSA-5693527",
                    "PR:Q13315",
                    "NCIT:C18583",
                    "REACT:R-HSA-6797751",
                    "NCBIGene:472",
                    "UMLS:C3711796"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1073/pnas.94.5.1840",
                    "DOI:10.1038/nature06883",
                    "DOI:10.1038/nature04632",
                    "PMID:11418864",
                    "2-e",
                    "DOI:10.1128/mcb.24.20.9207-9220.2004",
                    "PMID:10817650",
                    "PMID:18710941",
                    "2-9",
                    "DOI:10.1086/301706"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:Q14766": {
              "name": "LTBP1",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:Q14766",
                  "value_url": "https://identifiers.org/uniprot:Q14766",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "-!- FUNCTION: Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space (PubMed:2022183, PubMed:8617200, PubMed:8939931). Associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGF-beta, and regulates integrin-dependent activation of TGF-beta (PubMed:8617200, PubMed:8939931, PubMed:15184403). Outcompeted by LRRC32/GARP for binding to LAP regulatory chain of TGF-beta (PubMed:22278742). {ECO:0000269|PubMed:15184403, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931}. -!- SUBUNIT: Interacts with TGFB1; associates via disulfide bonds with the Latency-associated peptide chain (LAP) regulatory chain of TGFB1, leading to regulate activation of TGF-beta-1 (PubMed:10930463, PubMed:2022183, PubMed:8617200, PubMed:15567420, PubMed:8939931, PubMed:22278742). LTBP1 does not bind directly to TGF-beta-1, the active chain of TGFB1 (PubMed:10930463). Interacts (via C-terminal domain) with FBN1 (via N-terminal domain) (PubMed:12429738, PubMed:17293099). Interacts with FBN2 (PubMed:12429738). Interacts with ADAMTSL2 (PubMed:18677313). Interacts with EFEMP2 (PubMed:27339457). {ECO:0000269|PubMed:10930463, ECO:0000269|PubMed:12429738, ECO:0000269|PubMed:15567420, ECO:0000269|PubMed:17293099, ECO:0000269|PubMed:18677313, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:27339457, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931}. -!- INTERACTION: Q14766-1; P01137: TGFB1; NbExp=4; IntAct=EBI-11173861, EBI-779636; Q14766-2; P35555: FBN1; NbExp=2; IntAct=EBI-11173832, EBI-2505934; -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:16157329}. Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:16157329, ECO:0000269|PubMed:8617200}. -!- ALTERNATIVE PRODUCTS: Event=Alternative splicing; Named isoforms=5; Name=Long; Synonyms=LTBP-1L; IsoId=Q14766-1; Sequence=Displayed; Name=Short; Synonyms=LTBP-1S; IsoId=Q14766-2, P22064-1; Sequence=VSP_036963, VSP_036964; Name=3; IsoId=Q14766-3; Sequence=VSP_036963, VSP_036964, VSP_036965; Name=4; IsoId=Q14766-4; Sequence=VSP_040125; Name=5; IsoId=Q14766-5; Sequence=VSP_036963, VSP_036964, VSP_040125; -!- TISSUE SPECIFICITY: Expressed in the aorta (at protein level) (PubMed:17293099). Isoform Long: Expressed in fibroblasts (PubMed:17293099). {ECO:0000269|PubMed:17293099}. -!- DOMAIN: The 8-Cys3 region in the third TB domain mediates the interchain disulfide bond interaction with the Latency-associated peptide chain (LAP) regulatory chain of TGFB1. {ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931}. -!- PTM: Contains hydroxylated asparagine residues. {ECO:0000269|PubMed:2350783}. -!- PTM: Isoform Short N-terminus is blocked. {ECO:0000269|PubMed:2350783}. -!- PTM: Two intrachain disulfide bonds from the TB3 domain are rearranged upon TGFB1 binding, and form interchain bonds with TGFB1 propeptide, anchoring it to the extracellular matrix. {ECO:0000269|PubMed:14607119}. -!- SIMILARITY: Belongs to the LTBP family. {ECO:0000305}. -!- SEQUENCE CAUTION: Sequence=BAD92038.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; ; Short=LTBP-1 {ECO:0000303|PubMed:8537398}; Short=TGF-beta1-BP-1 {ECO:0000303|PubMed:2350783}Evidence Codes from Name:  ",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "latent-transforming growth factor beta-binding protein 1 (rat)",
                    "latent-transforming growth factor beta-binding protein 1 (mouse)",
                    "Ltbp1 (mouse)",
                    "LTBP1",
                    "Ltbp1 (rat)",
                    "LTBP1 [endoplasmic reticulum lumen]",
                    "LTBP1 (human)",
                    "latent-transforming growth factor beta-binding protein 1 (human)",
                    "LTBP1 [extracellular region]",
                    "p-LTBP1 [endoplasmic reticulum lumen]",
                    "LTBP1 gene"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-8957050",
                    "ENSEMBL:ENSG00000049323",
                    "HGNC:6714",
                    "NCBIGene:4052",
                    "OMIM:150390",
                    "RGD:68379",
                    "PR:Q14766",
                    "PR:Q8CG19",
                    "REACT:R-HSA-8956770",
                    "PR:Q00918",
                    "UMLS:C1416928",
                    "UniProtKB:Q14766",
                    "REACT:R-HSA-2161391",
                    "MGI:109151"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10677208",
                    "PMID:18088087",
                    "DOI:10.1074/jbc.270.52.31294",
                    "DOI:10.1016/j.jmb.2003.09.053",
                    "PMID:22278742",
                    "DOI:10.1016/j.matbio.2006.12.006",
                    "PMID:2350783",
                    "DOI:10.1038/ng.199",
                    "DOI:10.1016/j.cell.2015.05.028",
                    "PMID:18677313"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:Q15796": {
              "name": "SMAD2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:Q15796",
                  "value_url": "https://identifiers.org/uniprot:Q15796",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "This gene plays a role in signal transduction and repression of transcription.; UMLS Semantic Type: STY:T028",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "p-S465,S467-SMAD2 [nucleoplasm]",
                    "SMAD2 (human)",
                    "p-S465,S467-SMAD2 D300N [cytosol]",
                    "p-T220,S465,S467-SMAD2 [nucleoplasm]",
                    "SMAD2 W422* [cytosol]",
                    "p-S465,S467-SMAD2 A354T [cytosol]",
                    "SMAD2 Q455* [cytosol]",
                    "p-S465,S467-SMAD2 P305Q [cytosol]",
                    "SMAD2 S308* [cytosol]",
                    "mothers against decapentaplegic homolog 2 (rat)",
                    "Ub-SMAD2 [cytosol]",
                    "SMAD2 Gene",
                    "SMAD2 R427* [cytosol]",
                    "SMAD2 R321* [cytosol]",
                    "SMAD2 E439* [cytosol]",
                    "SMAD2 [cytosol]",
                    "mothers against decapentaplegic homolog 2 (mouse)",
                    "SMAD2 protein, human",
                    "p-S465,S467-SMAD2 [cytosol]",
                    "mothers against decapentaplegic homolog 2 (human)",
                    "p-S465,S467-SMAD2 D300A [cytosol]",
                    "smad2",
                    "p-S465,S467-SMAD2 D300V [cytosol]",
                    "Smad2 (mouse)",
                    "Smad2 (rat)",
                    "SMAD2 L315* [cytosol]",
                    "SMAD2 gene",
                    "SMAD2 W448* [cytosol]",
                    "SMAD2 S464L [cytosol]",
                    "SMAD2",
                    "SMAD2 C463* [cytosol]",
                    "SMAD2 [nucleoplasm]",
                    "SMAD2 S467P [cytosol]",
                    "SMAD2 Q429* [cytosol]",
                    "SMAD2 S296* [cytosol]",
                    "p-S465,S467-SMAD2 P305L [cytosol]",
                    "mothers against decapentaplegic homolog 2 (zebrafish)",
                    "SMAD2 S306* [cytosol]",
                    "SMAD2 S464* [cytosol]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-3009186",
                    "UniProtKB:Q15796",
                    "REACT:R-HSA-3006353",
                    "REACT:R-HSA-9668731",
                    "UMLS:C1566790",
                    "REACT:R-HSA-6782774",
                    "NCIT:C24566",
                    "REACT:R-HSA-3315471",
                    "RGD:3031",
                    "PR:Q15796",
                    "REACT:R-HSA-3315066",
                    "REACT:R-HSA-9668732",
                    "REACT:R-HSA-3315064",
                    "REACT:R-HSA-9668736",
                    "PR:Q62432",
                    "REACT:R-HSA-9668725",
                    "REACT:R-HSA-3006352",
                    "REACT:R-HSA-3009189",
                    "REACT:R-HSA-9668727",
                    "HGNC:6768",
                    "MESH:C497782",
                    "MGI:108051",
                    "REACT:R-HSA-9668724",
                    "REACT:R-HSA-9668734",
                    "REACT:R-HSA-3304383",
                    "OMIM:601366",
                    "PR:O70436",
                    "REACT:R-HSA-3315067",
                    "ENSEMBL:ENSG00000175387",
                    "REACT:R-HSA-3304362",
                    "REACT:R-HSA-9668733",
                    "REACT:R-HSA-3315070",
                    "REACT:R-HSA-2176443",
                    "REACT:R-HSA-9668735",
                    "REACT:R-HSA-9668729",
                    "PR:000000364",
                    "REACT:R-HSA-3009185",
                    "REACT:R-HSA-9668730",
                    "UMLS:C1334468",
                    "NCBIGene:4087",
                    "PR:Q9I9P9",
                    "REACT:R-HSA-3304375",
                    "REACT:R-HSA-3315474",
                    "REACT:R-HSA-9668728"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1016/j.molcel.2004.07.016",
                    "PMID:11278756",
                    "PMID:16862174",
                    "PMID:10708948",
                    "PMID:16200078",
                    "DOI:10.1074/jbc.m609279200",
                    "PMID:19413330",
                    "DOI:10.1021/ac9004309",
                    "DOI:10.1074/jbc.272.44.27678",
                    "DOI:10.1074/mcp.m111.015131"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:Q16665": {
              "name": "HIF1A",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:Q16665",
                  "value_url": "https://identifiers.org/uniprot:Q16665",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Hypoxia-inducible factor 1-alpha (826 aa, ~93 kDa) is encoded by the human HIF1A gene. This protein plays a role in transcriptional regulation in response to hypoxia.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:NamedThing"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "HN-HIF1A [cytosol]",
                    "hypoxia-inducible factor 1-alpha (rat)",
                    "hypoxia-inducible factor 1-alpha (mouse)",
                    "hypoxia-inducible factor 1-alpha (chicken)",
                    "HIF1A Gene",
                    "HIF1A protein, human",
                    "Hif1a (rat)",
                    "2xHP-HIF1A [nucleoplasm]",
                    "HIF1A gene [nucleoplasm]",
                    "HIF1A (chicken)",
                    "HIF1A",
                    "Hif1a (mouse)",
                    "hypoxia-inducible factor 1-alpha (human)",
                    "p-Y565-HIF1A [cytosol]",
                    "HIF1A (human)",
                    "2xHP-HIF1A [cytosol]",
                    "HIF1A gene",
                    "p-Y565,S797-HIF1A [cytosol]",
                    "HIF1A [cytosol]",
                    "HIF1A [nucleoplasm]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C26372",
                    "REACT:R-HSA-8948427",
                    "REACT:R-HSA-1234105",
                    "UMLS:C1333897",
                    "NCBIGene:3091",
                    "PR:Q16665",
                    "PR:O35800",
                    "REACT:R-HSA-8857584",
                    "REACT:R-HSA-1234102",
                    "MESH:C497442",
                    "REACT:R-HSA-9634700",
                    "REACT:R-HSA-1234110",
                    "REACT:R-HSA-1234131",
                    "NCBIGene:374177",
                    "HGNC:4910",
                    "REACT:R-HSA-1234135",
                    "RGD:61928",
                    "MGI:106918",
                    "PR:Q61221",
                    "PR:Q9YIB9",
                    "UMLS:C1528322",
                    "OMIM:603348",
                    "UniProtKB:Q16665",
                    "ENSEMBL:ENSG00000100644"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DOI:10.1038/nature01348",
                    "DOI:10.1016/s0092-8674(02)01085-1",
                    "DOI:10.1074/jbc.c200644200",
                    "DOI:10.1371/journal.pone.0057795",
                    "DOI:10.1093/emboj/19.16.4298",
                    "PMID:11959977",
                    "DOI:10.1074/jbc.272.31.19253",
                    "PMID:22128162",
                    "PMID:12914934",
                    "DOI:10.1016/j.cell.2007.07.044"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:Q9BYF1": {
              "name": "ACE2",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:Q9BYF1",
                  "value_url": "https://identifiers.org/uniprot:Q9BYF1",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Angiotensin-converting enzyme 2 (805 aa, ~92 kDa) is encoded by the human ACE2 gene. This protein plays a role in both vasodilation and protein cleavage.; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein",
                    "biolink:Polypeptide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "angiotensin converting enzyme 2",
                    "ACE2 gene",
                    "ACE2 [endocytic vesicle membrane]",
                    "ACE2 Gene",
                    "ACE2 [endoplasmic reticulum lumen]",
                    "ACE2 protein, human",
                    "Ace2 (rat)",
                    "angiotensin-converting enzyme 2 (mouse)",
                    "angiotensin-converting enzyme 2 (rat)",
                    "Ace2 (mouse)",
                    "ACE2 (human)",
                    "metallothionein expression activator (Schizosaccharomyces pombe 972h-)",
                    "angiotensin-converting enzyme 2 (human)",
                    "ACE2",
                    "ACE2 (Candida albicans SC5314)",
                    "cell wall transcription factor ACE2 (Candida albicans SC5314)",
                    "metallothionein expression activator (yeast)",
                    "glycosylated-ACE2 [plasma membrane]",
                    "glycosylated-ACE2 [endocytic vesicle membrane]",
                    "ACE2(18-805) [plasma membrane]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-9683480",
                    "HGNC:13557",
                    "NCBIGene:59272",
                    "NCIT:C102527",
                    "RGD:728890",
                    "REACT:R-HSA-9698958",
                    "REACT:R-HSA-9683474",
                    "PR:P21192",
                    "PR:Q5EGZ1",
                    "REACT:R-HSA-2022344",
                    "MGI:1917258",
                    "OMIM:300335",
                    "REACT:R-HSA-9686721",
                    "UMLS:C1422064",
                    "UMLS:C0960880",
                    "NCBIGene:3646034",
                    "PR:Q8R0I0",
                    "ENSEMBL:ENSG00000130234",
                    "PR:Q59RR0",
                    "UniProtKB:Q9BYF1",
                    "PR:O14258",
                    "UMLS:C1610422",
                    "PR:Q9BYF1",
                    "MESH:C413524"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15897467",
                    "DOI:10.1186/1741-7015-2-19",
                    "DOI:10.1007/s11684-020-0754-0",
                    "PMID:12459472",
                    "PMID:15276642",
                    "PMID:15937940",
                    "PMID:10969042",
                    "PMID:15671045",
                    "DOI:10.1073/pnas.0409465102",
                    "DOI:10.1126/science.abc0870"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "UniProtKB:Q9H244": {
              "name": "P2RY12",
              "attributes": [
                {
                  "value": "https://identifiers.org/uniprot:Q9H244",
                  "value_url": "https://identifiers.org/uniprot:Q9H244",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A P2Y purinoceptor 12 that is encoded in the genome of rat. // COMMENTS: Category=organism-gene.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:BiologicalEntity",
                    "biolink:Gene",
                    "biolink:Protein"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "P2RY12 gene",
                    "P2Y purinoceptor 12 (mouse)",
                    "P2RY12 (human)",
                    "P2Y purinoceptor 12 (human)",
                    "P2Y purinoceptor 12 (rat)",
                    "P2RY12",
                    "P2ry12 (mouse)",
                    "P2RY12 [plasma membrane]",
                    "P2ry12 (rat)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-HSA-391959",
                    "PR:Q9H244",
                    "UniProtKB:Q9H244",
                    "UMLS:C1425330",
                    "HGNC:18124",
                    "PR:Q9CPV9",
                    "RGD:621681",
                    "OMIM:600515",
                    "ENSEMBL:LRG_569",
                    "PR:Q9EPX4",
                    "NCBIGene:64805",
                    "ENSEMBL:ENSG00000169313",
                    "MGI:1918089"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:11502873",
                    "PMID:11104774",
                    "PMID:25428217",
                    "PMID:15489334",
                    "PMID:11196645",
                    "DOI:10.1038/nature13083",
                    "PMID:12578987",
                    "PMID:12044878",
                    "DOI:10.1182/blood-2013-07-517896",
                    "DOI:10.1073/pnas.0437879100"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:Protein",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.TARGET:CHEMBL376": {
              "name": "Rattus norvegicus",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.target:CHEMBL376",
                  "value_url": "https://identifiers.org/chembl.target:CHEMBL376",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The common rat, Rattus norvegicus, often used as an experimental organism.; The common name for the genus Rattus.; UMLS Semantic Type: STY:T015",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:OrganismTaxon"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Rattus norvegicus"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C14266",
                    "CHEMBL.TARGET:CHEMBL376",
                    "UMLS:C0034693",
                    "NCBITaxon:10116"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:OrganismTaxon",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL25": {
              "name": "ASPIRIN",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL25",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL25",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Aspirin is only found in individuals who have consumed this drug. Aspirin or acetylsalicylic acid (acetosal) is a drug in the family of salicylates, often used as an analgesic (against minor pains and aches), antipyretic (against fever), and anti-inflammatory. It has also an anticoagulant effect and is used in long-term low-doses to prevent heart attacks and cancer. It was isolated from meadowsweet (Filipendula ulmaria, formerly classified as Spiraea ulmaria) by German researchers in 1839. While their extract was somewhat effective, it also caused digestive problems such as irritated stomach and diarrhoea, and even death when consumed in high doses. In 1853, a French chemist named Charles Frederic Gerhardt neutralized salicylic acid by buffering it with sodium (sodium salicylate) and acetyl chloride, creating acetosalicylic anhydride. Gerhardt's product worked, but he had no desire to market it and abandoned his discovery. In 1897, researcher Arthur Eichengrun and Felix Hoffmann, a research assistant at Friedrich Bayer & Co. in Germany, derivatized one of the hydroxyl functional groups in salicylic acid with an acetyl group (forming the acetyl ester), which greatly reduced the negative effects. This was the first synthetic drug, not a copy of something that existed in nature, and the start of the pharmaceuticals industry. The name 'aspirin' is composed of a- (from the acetyl group) -spir- (from the plant genus Spiraea) and -in (a common ending for drugs at the time). It has also been stated that the name originated by another means. As referring to AcetylSalicylic and 'pir' in reference to one of the scientists who was able to isolate it in crystalline form, Raffaele Piria. Finally 'in' due to the same reasons as stated above. Salicylic acid (which is a naturally occurring substance found in many plants) can be acetylated using acetic anhydride, yielding aspirin and acetic acid as a byproduct. It is a common experiment performed in organic chemistry labs, and generally tends to produce low yields due to the relative difficulty of its extraction from an aqueous state. The trick to getting the reaction to work is to acidify with phosphoric acid and heat the reagents under reflux with a boiling water bath for between 40 minutes and an hour. Aspirin acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5).",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "acetyl salicylate",
                    "Polopiryna",
                    "Aspirin",
                    "Aspirin (JP18/USP)",
                    "acetylsalicylic acid",
                    "Acetysal",
                    "aspirin",
                    "Acetylsalicylic acid",
                    "Acetyl salicylate",
                    "ASPIRIN"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "RXNORM:91101",
                    "DRUGBANK:DB00945",
                    "KEGG.DRUG:D00109",
                    "UMLS:C0304348",
                    "UMLS:C0699278",
                    "MESH:D001241",
                    "LOINC:LA26702-3",
                    "PathWhiz.Compound:1251",
                    "NDDF:001587",
                    "HMDB:HMDB0001879",
                    "KEGG.COMPOUND:C01405",
                    "PSY:04050",
                    "UMLS:C0004057",
                    "CHEBI:15365",
                    "UMLS:C0699271",
                    "NCIT:C287",
                    "VANDF:4017536",
                    "CHEMBL.COMPOUND:CHEMBL25",
                    "RXNORM:1191",
                    "DrugCentral:74"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21458999",
                    "PMID:17451232",
                    "PMID:18986738",
                    "PMID:19628311",
                    "PMID:18547115",
                    "PMID:10866370",
                    "PMID:11374966",
                    "PMID:6972450",
                    "PMID:29421569",
                    "PMID:28400236"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL118": {
              "name": "CELECOXIB",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL118",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL118",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Celecoxib (INN) is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer under the brand name Celebrex. In some countries, it is branded Celebra. Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. Celecoxib is a highly selective COX-2 inhibitor and primarily inhibits this isoform of cyclooxygenase, whereas traditional NSAIDs inhibit both COX-1 and COX-2. Celecoxib is approximately 10-20 times more selective for COX-2 inhibition over COX-1. In theory, this specificity allows celecoxib and other COX-2 inhibitors to reduce inflammation (and pain) while minimizing gastrointestinal adverse drug reactions (e.g. stomach ulcers) that are common with non-selective NSAIDs. It also means that it has a reduced effect on platelet aggregation compared to traditional NSAIDs; Celecoxib is a highly selective COX-2 inhibitor and primarily inhibits this isoform of cyclooxygenase, whereas traditional NSAIDs inhibit both COX-1 and COX-2. Celecoxib is approximately 10-20 times more selective for COX-2 inhibition over COX-1. In theory, this specificity allows celecoxib and other COX-2 inhibitors to reduce inflammation (and pain) while minimizing gastrointestinal adverse drug reactions (e.g. stomach ulcers) that are common with non-selective NSAIDs. It also means that it has a reduced effect on platelet aggregation compared to traditional NSAIDs.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Sc 58635",
                    "celecoxib",
                    "Celecoxib (JP18/USP/INN)",
                    "Celebrex",
                    "CELECOXIB",
                    "Celecoxib"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0538926",
                    "KEGG.COMPOUND:C07589",
                    "NCIT:C1728",
                    "CHEBI:41423",
                    "DrugCentral:568",
                    "ATC:L01XX33",
                    "RXNORM:140587",
                    "LOINC:LP28519-4",
                    "RXNORM:215927",
                    "KEGG.DRUG:D00567",
                    "ATC:M01AH01",
                    "MESH:D000068579",
                    "HMDB:HMDB0005014",
                    "PathWhiz.Compound:2362",
                    "UMLS:C0719198",
                    "LOINC:MTHU013163",
                    "UMLS:C0538927",
                    "VANDF:4021143",
                    "CHEMBL.COMPOUND:CHEMBL118",
                    "DRUGBANK:DB00482",
                    "PDQ:CDR0000043023"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:22217871",
                    "PMID:10979111",
                    "PMID:22546204",
                    "PMID:28256371",
                    "PMID:24287559",
                    "PMID:11462976",
                    "PMID:19178292",
                    "PMID:26081289",
                    "PMID:27344214",
                    "PMID:26638042"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL160": {
              "name": "CYCLOSPORINE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL160",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL160",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A natural cyclic polypeptide immunosuppressant isolated from the fungus Beauveria nivea. The exact mechanism of action of cyclosporine is not known but may involve binding to the cellular protein cytophilin, resulting in inhibition of the enzyme calcineurin. This agent appears to specifically and reversibly inhibit immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited with T-helper cells as the primary target. Cyclosporine also inhibits lymphokine production and release. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C406\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C406\" NCI Thesaurus); A natural cyclic polypeptide immunosuppressant isolated from the fungus Beauveria nivea. The exact mechanism of action of cyclosporine is not known but may involve binding to the cellular protein cytophilin, resulting in inhibition of the enzyme calcineurin. This agent appears to specifically and reversibly inhibit immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited with T-helper cells as the primary target. Cyclosporine also inhibits lymphokine production and release. (NCI04); A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:SmallMolecule",
                    "biolink:Drug",
                    "biolink:ChemicalEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "cyclosporine",
                    "SID26747463",
                    "ciclosporin",
                    "Ol 27-400",
                    "cyclosporin A",
                    "Neoral",
                    "Cyclosporin A",
                    "cycloSPORINE",
                    "Sandimmune",
                    "Cyclosporine (USP)",
                    "Cyclosporine",
                    "Sangcya",
                    "CYCLOSPORINE",
                    "27-400"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0699605",
                    "KEGG.DRUG:D00184",
                    "UMLS:C1522536",
                    "LOINC:MTHU062952",
                    "UMLS:C0010592",
                    "PDQ:CDR0000039201",
                    "UMLS:C0878526",
                    "LOINC:LP16098-3",
                    "KEGG.COMPOUND:C05086",
                    "RXNORM:3008",
                    "MESH:D016572",
                    "UMLS:C0723210",
                    "RXNORM:202816",
                    "UMLS:C0699604",
                    "PathWhiz.Compound:97909",
                    "RXNORM:202817",
                    "CHEBI:4031",
                    "HMDB:HMDB0250682",
                    "DrugCentral:760",
                    "NDDF:003420",
                    "DRUGBANK:DB00091",
                    "CHEMBL.COMPOUND:CHEMBL160",
                    "VANDF:4018761",
                    "CHEMBL.COMPOUND:CHEMBL386389",
                    "LOINC:LA16776-9",
                    "NCIT:C406"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12235267",
                    "PMID:11678649",
                    "PMID:11975489",
                    "PMID:27120576",
                    "PMID:29031076",
                    "PMID:7514263",
                    "PMID:20064721",
                    "PMID:21458999",
                    "PMID:10891114",
                    "PMID:18457386"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL578": {
              "name": "ENALAPRIL",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL578",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL578",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The maleic acid salt of enalapril. It contains one molecule of maleic acid for each molecule of enalapril. Following oral administration, the ethyl ester group of enalapril is hydrolysed to afford the corresponding carboxylic acid, enalaprilat, an angiotensin-converting enzyme (ACE) inhibitor. Enalapril is thus a prodrug for enalaprilat (which, unlike enalapril, is not absorbed by mouth), and its maleate is used in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:ChemicalEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Enalapril (INN)",
                    "(2S)-1-[(2S)-2-[[(2R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-2-pyrrolidinecarboxylic acid",
                    "enalapril",
                    "1-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid",
                    "ENALAPRILAT",
                    "Enalaprilat Dihydrate",
                    "ENALAPRIL",
                    "(2S)-1-((2S)-2-(((1R)-1-(Ethoxycarbonyl)-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylic acid",
                    "enalapril maleate",
                    "enalaprilat (anhydrous)",
                    "Enalaprilat (USP)",
                    "enalaprilat dihydrate",
                    "ENALAPRIL MALEATE",
                    "Enalapril",
                    "Enalapril maleate (JP18/USP)",
                    "Enalaprilat",
                    "enalaprilat"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL578",
                    "KEGG.DRUG:D03769",
                    "CHEBI:94620",
                    "CHEBI:4785",
                    "KEGG.COMPOUND:C06977",
                    "CHEBI:59877",
                    "RXNORM:3827",
                    "KEGG.COMPOUND:C11720",
                    "NDDF:004369",
                    "VANDF:4019497",
                    "MESH:D004656",
                    "UMLS:C0014027",
                    "MESH:D015773",
                    "HMDB:HMDB0041886",
                    "VANDF:4019744",
                    "NCIT:C62027",
                    "KEGG.DRUG:D07892",
                    "UMLS:C0771174",
                    "LOINC:LP171394-2",
                    "DrugCentral:1006",
                    "DRUGBANK:DB00584",
                    "NCIT:C47510",
                    "CHEMBL.COMPOUND:CHEMBL39538",
                    "HMDB:HMDB0014722",
                    "ATC:C09AA02",
                    "PathWhiz.Compound:22647",
                    "KEGG.DRUG:D00621",
                    "DrugCentral:1005",
                    "PathWhiz.Compound:9073",
                    "CHEMBL.COMPOUND:CHEMBL3989406",
                    "RXNORM:3829",
                    "CHEMBL.COMPOUND:CHEMBL577",
                    "CHEMBL.COMPOUND:CHEMBL348537",
                    "DRUGBANK:DB09477",
                    "CHEMBL.COMPOUND:CHEMBL1200659",
                    "NDDF:007388",
                    "CHEBI:4784",
                    "UMLS:C0014025",
                    "HMDB:HMDB0249344",
                    "CHEBI:4786"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21458999",
                    "PMID:10052994",
                    "PMID:21601448",
                    "PMID:20070106",
                    "PMID:9880528",
                    "PMID:1992145",
                    "PMID:9733984",
                    "PMID:2913292",
                    "PMID:6097665",
                    "PMID:24249037"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL635": {
              "name": "PREDNISONE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL635",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL635",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Prednisone is only found in individuals that have used or taken this drug. It is a synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver. [PubChem]Prednisone is a glucocorticoid receptor agonist. It is first metabolized in the liver to its active form, prednisolone. Prednisolone crosses cell membranes and binds with high affinity to specific cytoplasmic receptors. The result includes inhibition of leukocyte infiltration at the site of inflammation, interference in the function of mediators of inflammatory response, suppression of humoral immune responses, and reduction in edema or scar tissue. The antiinflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Cortan",
                    "Prednison Hexal",
                    "Panasol",
                    "Prednison Acsis",
                    "Kortancyl",
                    "SID47193704",
                    "prednisone",
                    "Prednison Galen",
                    "Predni Tablinen",
                    "Predniment",
                    "Encortone",
                    "Ultracorten",
                    "Cutason",
                    "PREDNISONE",
                    "Prednisone (USP)",
                    "Rectodelt",
                    "Meticorten",
                    "predniSONE",
                    "Prednisone",
                    "Deltasone",
                    "Decortin",
                    "Winpred",
                    "Sone",
                    "Liquid Pred",
                    "Orasone"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0032952",
                    "ATC:H02AB07",
                    "RXNORM:227730",
                    "DRUGBANK:DB00635",
                    "CHEMBL.COMPOUND:CHEMBL635",
                    "UMLS:C1564189",
                    "UMLS:C1514369",
                    "VANDF:4017876",
                    "PathWhiz.Compound:9120",
                    "UMLS:C0740151",
                    "UMLS:C1564198",
                    "UMLS:C1564192",
                    "MESH:D011241",
                    "RXNORM:8640",
                    "UMLS:C1564200",
                    "CHEBI:8382",
                    "HMDB:HMDB0014773",
                    "DrugCentral:2253",
                    "UMLS:C1564195",
                    "LOINC:LP18109-6",
                    "PDQ:CDR0000042487",
                    "UMLS:C0740147",
                    "UMLS:C0728769",
                    "UMLS:C0728770",
                    "ATC:A07EA03",
                    "UMLS:C1564199",
                    "LOINC:MTHU062944",
                    "NDDF:002164",
                    "KEGG.COMPOUND:C07370",
                    "NCIT:C770",
                    "UMLS:C1564191",
                    "UMLS:C1564190",
                    "UMLS:C1564196",
                    "KEGG.DRUG:D00473",
                    "UMLS:C0728771",
                    "UMLS:C0740144",
                    "CHEMBL.COMPOUND:CHEMBL1731808",
                    "UMLS:C1564197",
                    "UMLS:C0740152",
                    "UMLS:C1514382"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:118258",
                    "PMID:10956200",
                    "PMID:17300161",
                    "PMID:12061889",
                    "PMID:16472241",
                    "PMID:11413487",
                    "PMID:24900570",
                    "PMID:18457386",
                    "PMID:23300763",
                    "PMID:30285357"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL729": {
              "name": "LOPINAVIR",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL729",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL729",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A protease inhibitor used against human immunodeficiency virus (HIV). Lopinavir competitively inhibits the HIV-1 protease, an enzyme that mediates the cleavage of Gag, Gag-Pol and Nef precursor polypeptides into their mature proteins, including protease, reverse transcriptase, and integrase. Inhibition of HIV-1 protease prevents cleavage of the viral polyprotein precursor and results in the release of immature, noninfectious virions. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2095\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2095\" NCI Thesaurus); A peptidomimetic HIV protease inhibitor that retains activity against HIV protease with the Val 82 mutation. Lopinavir is less affected by binding to serum proteins than the structurally-related drug ritonavir.; An HIV protease inhibitor used in a fixed-dose combination with RITONAVIR. It is also an inhibitor of CYTOCHROME P-450 CYP3A.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Abt 378",
                    "lopinavir",
                    "LOPINAVIR",
                    "Lopinavir (JAN/USP/INN)",
                    "Lopinavir",
                    "A-157378.0"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB01601",
                    "CHEBI:31781",
                    "NCIT:C2095",
                    "NDDF:008874",
                    "RXNORM:195088",
                    "LOINC:LP28756-2",
                    "HMDB:HMDB0015539",
                    "UMLS:C0674432",
                    "PDQ:CDR0000540623",
                    "DrugCentral:1601",
                    "UMLS:C1110556",
                    "UMLS:C0674433",
                    "CHEMBL.COMPOUND:CHEMBL729",
                    "KEGG.DRUG:D01425",
                    "MESH:D061466",
                    "LOINC:MTHU014678",
                    "KEGG.COMPOUND:C12871",
                    "VANDF:4021228"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:22122518",
                    "PMID:20439612",
                    "PMID:19954246",
                    "PMID:19237646",
                    "PMID:18457386",
                    "PMID:18443126",
                    "PMID:24128815",
                    "PMID:12700464",
                    "PMID:15109669",
                    "PMID:19307360"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL995": {
              "name": "LOSARTAN POTASSIUM",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL995",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL995",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Losartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. Losartan and its longer acting metabolite, E-3174, lower blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); they compete with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Losartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of systolic dysfunction, myocardial infarction, coronary artery disease, and heart failure.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Losartan (INN)",
                    "Losartan",
                    "Losartan Potassium",
                    "Losartan potassium (JP18/USP)",
                    "LOSARTAN POTASSIUM",
                    "Losartan potassium",
                    "LOSARTAN",
                    "losartan",
                    "losartan potassium"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DRUGBANK:DB00678",
                    "DrugCentral:1610",
                    "PDQ:CDR0000640981",
                    "CHEBI:6541",
                    "KEGG.DRUG:D08146",
                    "VANDF:4020913",
                    "UMLS:C0700492",
                    "VANDF:4020920",
                    "NCIT:C66869",
                    "CHEMBL.COMPOUND:CHEMBL995",
                    "LOINC:LP171619-2",
                    "KEGG.DRUG:D00357",
                    "CHEMBL.COMPOUND:CHEMBL191",
                    "NCIT:C29165",
                    "NDDF:004992",
                    "HMDB:HMDB0014816",
                    "NDDF:004991",
                    "KEGG.COMPOUND:C07072",
                    "UMLS:C0126174",
                    "RXNORM:203160",
                    "RXNORM:52175",
                    "MESH:D019808",
                    "ATC:C09CA01",
                    "PathWhiz.Compound:9156"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17064065",
                    "PMID:8258826",
                    "PMID:12182875",
                    "PMID:8057285",
                    "PMID:21601448",
                    "PMID:20070106",
                    "PMID:15537355",
                    "PMID:7636853",
                    "PMID:9083479",
                    "PMID:12593652"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1428": {
              "name": "NIMODIPINE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1428",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1428",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity. Nimodipine inhibits the transmembrane influx of calcium ions in response to depolarization in smooth muscle cells, thereby inhibiting vascular smooth muscle contraction and inducing vasodilatation. Nimodipine has a greater effect on cerebral arteries than on peripheral smooth muscle cells and myocardial cells, probably because this agent can cross the blood brain barrier due to its lipophilic nature. Furthermore, this agent also inhibits the drug efflux pump P-glycoprotein, which is overexpressed in some multi-drug resistant tumors, and may improve the efficacy of some antineoplastic agents. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C692\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C692\" NCI Thesaurus); A dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity. Nimodipine inhibits the transmembrane influx of calcium ions in response to depolarization in smooth muscle cells, thereby inhibiting vascular smooth muscle contraction and inducing vasodilatation. Nimodipine has a greater effect on cerebral arteries than on peripheral smooth muscle cells and myocardial cells, probably because this agent can cross the blood brain barrier due to its lipophilic nature. Furthermore, this agent also inhibits the drug efflux pump P-glycoprotein, which is overexpressed in some multi-drug resistant tumors, and may improve the efficacy of some antineoplastic agents.; A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Nimodipine (USP/INN)",
                    "Nimotop",
                    "Nimodipin-ISIS",
                    "Nimodipine",
                    "Calnit",
                    "Nimodipino Bayvit",
                    "NIMODIPINE",
                    "Modus",
                    "nimodipine",
                    "Nimodipin Hexal",
                    "(S)-NIMODIPINE",
                    "Bay e 9736",
                    "Nymalize"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL1428",
                    "NDDF:000713",
                    "CHEMBL.COMPOUND:CHEMBL255033",
                    "UMLS:C0733389",
                    "DRUGBANK:DB00393",
                    "DrugCentral:1937",
                    "UMLS:C0678207",
                    "UMLS:C1449953",
                    "RXNORM:7426",
                    "PDQ:CDR0000041210",
                    "UMLS:C0028094",
                    "UMLS:C1449949",
                    "MESH:D009553",
                    "NCIT:C692",
                    "RXNORM:1423768",
                    "VANDF:4019390",
                    "UMLS:C3541938",
                    "ATC:C08CA06",
                    "KEGG.DRUG:D00438",
                    "UMLS:C1449951",
                    "RXNORM:196516",
                    "UMLS:C1449955",
                    "HMDB:HMDB0014537",
                    "UMLS:C1449952",
                    "KEGG.COMPOUND:C07267",
                    "CHEBI:7575",
                    "PathWhiz.Compound:8909"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21474681",
                    "PMID:16472241",
                    "PMID:19844625",
                    "PMID:20934347",
                    "PMID:24799086",
                    "PMID:28709827",
                    "PMID:6304312",
                    "PMID:24769350",
                    "PMID:22197392",
                    "PMID:20070106"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1641": {
              "name": "HYDROCORTISONE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1641",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1641",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A 17alpha-hydroxy-C21-steroid that is pregn-4-ene substituted by oxo groups at positions 3 and 20 and hydroxy groups at positions 11, 17 and 21. Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the \"stress hormone\" as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses; Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the \"stress hormone\" as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses; A 17alpha-hydroxy-C21-steroid that is pregn-4-ene substituted by oxo groups at positions 3 and 20 and hydroxy groups at positions 11, 17 and 21. Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the \"stress hormone\" as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug",
                    "biolink:BiologicalEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "cortisol sodium phosphate",
                    "hydrocortisone valerate",
                    "CORT [nucleoplasm]",
                    "hydrocortamate",
                    "CORT [mitochondrial matrix]",
                    "Kendall's compound F",
                    "Hydrocortisone Cypionate",
                    "Hydrocortisone Valerate",
                    "HYDROCORTISONE",
                    "Hydrocortamate hydrochloride",
                    "Hydrocortisone Aceponate",
                    "HYDROCORTISONE ACEPONATE",
                    "Hydrocortisone aceponate (INN)",
                    "Hydrocortisone aceponate",
                    "Hydrocortisone sodium phosphate",
                    "hydrocortisone sodium phosphate",
                    "Reichstein's substance M",
                    "HYDROCORTISONE CYPIONATE",
                    "Hydrocortisone Sodium Phosphate",
                    "Hydrocortisone phosphate",
                    "HYDROCORTISONE PHOSPHORIC ACID",
                    "cortisol phosphate",
                    "Pentanoic acid 11-hydroxy-17-(2-hydroxy-acetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester",
                    "CORT [cytosol]",
                    "pentanoic acid [11-hydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] ester",
                    "CORT [extracellular region]",
                    "cortisol 17-valerate",
                    "Hydrocortisone valerate",
                    "Hydrocortisone cypionate",
                    "Hydrocortamate Hydrochloride",
                    "HYDROCORTAMATE HYDROCHLORIDE",
                    "Westcort",
                    "Cortisol",
                    "Hydrocortisone valerate (USP)",
                    "HYDROCORTISONE SODIUM PHOSPHATE",
                    "Hydrocortisone sodium phosphate (JP18/USP)",
                    "hydrocortisone phosphate",
                    "hydrocortisone aceponate",
                    "hydrocortamate hydrochloride",
                    "hydrocortisone cypionate",
                    "cortisol",
                    "Hydrocortisone",
                    "hydrocortisone",
                    "Hydrocortisone Phosphate",
                    "HYDROCORTAMATE",
                    "HYDROCORTISONE VALERATE",
                    "Hydrocortamate"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MESH:C038363",
                    "KEGG.DRUG:D00977",
                    "CHEBI:50854",
                    "NDDF:005250",
                    "RXNORM:235482",
                    "RXNORM:163524",
                    "DrugCentral:5193",
                    "UMLS:C1445700",
                    "CHEMBL.COMPOUND:CHEMBL1201263",
                    "PathWhiz.Compound:45",
                    "CHEMBL.COMPOUND:CHEMBL1200968",
                    "KEGG.DRUG:D00976",
                    "HMDB:HMDB0253247",
                    "KEGG.DRUG:D06876",
                    "CHEBI:5783",
                    "DrugCentral:1387",
                    "ATC:A01AC03",
                    "MESH:C039803",
                    "VANDF:4017944",
                    "KEGG.DRUG:D02288",
                    "UMLS:C0056383",
                    "RXNORM:5492",
                    "LOINC:LP14161-1",
                    "NCIT:C48024",
                    "NCIT:C83763",
                    "CHEMBL.COMPOUND:CHEMBL1200562",
                    "CHEBI:68634",
                    "DRUGBANK:DB00769",
                    "REACT:R-ALL-194011",
                    "UMLS:C4255948",
                    "NDDF:002150",
                    "CHEBI:135746",
                    "NDDF:002153",
                    "DRUGBANK:DB14541",
                    "CHEMBL.COMPOUND:CHEMBL2106309",
                    "UMLS:C0020268",
                    "DRUGBANK:DB14538",
                    "ATC:D07XA01",
                    "UMLS:C0082944",
                    "LOINC:LP97871-5",
                    "HMDB:HMDB0000063",
                    "UMLS:C0063079",
                    "RXNORM:220938",
                    "MESH:D006854",
                    "DrugCentral:1388",
                    "UMLS:C4255947",
                    "CHEBI:5781",
                    "CHEMBL.COMPOUND:CHEMBL1641",
                    "DRUGBANK:DB00741",
                    "DRUGBANK:DB14544",
                    "ATC:S01BA02",
                    "NCIT:C65865",
                    "ATC:D07AC16",
                    "UMLS:C0612688",
                    "PSY:12030",
                    "CHEBI:50851",
                    "RXNORM:41277",
                    "RXNORM:27199",
                    "DrugCentral:4504",
                    "ATC:S02BA01",
                    "DrugCentral:1390",
                    "NCIT:C65864",
                    "HMDB:HMDB0014907",
                    "REACT:R-ALL-5618097",
                    "REACT:R-ALL-193977",
                    "VANDF:4017946",
                    "CHEMBL.COMPOUND:CHEMBL389621",
                    "ATC:D07AA02",
                    "NCIT:C65863",
                    "NDDF:002147",
                    "ATC:C05AA01",
                    "ATC:A07EA02",
                    "VANDF:4017943",
                    "ATC:S01CB03",
                    "CHEMBL.COMPOUND:CHEMBL1200635",
                    "VANDF:4017941",
                    "MESH:C063919",
                    "CHEBI:17650",
                    "CHEMBL.COMPOUND:CHEMBL67128",
                    "UMLS:C0544368",
                    "NCIT:C65862",
                    "UMLS:C0770559",
                    "LOINC:MTHU001562",
                    "LOINC:MTHU035101",
                    "KEGG.COMPOUND:C08176",
                    "REACT:R-ALL-1449706",
                    "LOINC:LP70288-3",
                    "ATC:H02AB09",
                    "CHEMBL.COMPOUND:CHEMBL1549",
                    "KEGG.COMPOUND:C00735",
                    "DRUGBANK:DB14542",
                    "CHEBI:94344",
                    "NCIT:C90952",
                    "DrugCentral:1389",
                    "MESH:C029109",
                    "UMLS:C0724395",
                    "NCIT:C2290",
                    "CHEBI:50865",
                    "PSY:23640"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10956200",
                    "PMID:17418579",
                    "PMID:25515561",
                    "PMID:24592867",
                    "PMID:29420891",
                    "PMID:18666772",
                    "PMID:28218838",
                    "PMID:21458999",
                    "PMID:19856923",
                    "PMID:27256914"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1709": {
              "name": "SERTRALINE HYDROCHLORIDE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1709",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1709",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Sertraline is a selective serotonin uptake inhibitor that is used in the treatment of depression. Sertraline hydrochloride (also labeled under numerous brand names: Zoloft, Sertralin, Lustral, Apo-Sertral, Asentra, Gladem, Serlift, Stimuloton, Xydep, Serlain, Concorz) is an orally administered antidepressant of the selective serotonin reuptake inhibitor (SSRI) type. It was first approved by the Food and Drug Administration (FDA) in 1991. Sertraline is an odorless, white, sparingly soluble crystalline solid. The minimum effective dose is usually 50 mg per day (it can be still effective at 25 mg or 37.5 mg), but lower doses may be used in the initial weeks of treatment to acclimate the patient's body, especially the liver, to the drug and to minimize the severity of any side effects. Patients who do not experience relief of symptoms at 50 mg a day may have their dose increased, up to 200 mg a day. Sertraline (HCl) is used medically mainly to treat the symptoms of depression and anxiety. It is also prescribed for the treatment of obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), panic disorder (PD) and social phobia/social anxiety disorder. A study has shown that sertraline is an effective treatment for impulsive aggressive behavior in personality disordered patients.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Sertraline (INN)",
                    "Apo-Sertraline",
                    "Gen-Sertraline",
                    "Sertraline hydrochloride",
                    "sertraline hydrochloride",
                    "Sertraline hydrochloride (JAN/USP)",
                    "Sertraline",
                    "Zoloft",
                    "Sertraline Hydrochloride",
                    "SERTRALINE",
                    "SERTRALINE HYDROCHLORIDE",
                    "ratio-Sertraline",
                    "Rhoxal-sertraline",
                    "sertraline"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL1709",
                    "NCIT:C29451",
                    "UMLS:C1564121",
                    "DRUGBANK:DB01104",
                    "LOINC:LP17242-6",
                    "HMDB:HMDB0005010",
                    "DrugCentral:2436",
                    "UMLS:C1564120",
                    "RXNORM:155137",
                    "NCIT:C61939",
                    "CHEBI:9124",
                    "PDQ:CDR0000322832",
                    "UMLS:C1564117",
                    "VANDF:4020394",
                    "LOINC:MTHU004268",
                    "CHEMBL.COMPOUND:CHEMBL809",
                    "VANDF:4020551",
                    "MESH:D020280",
                    "RXNORM:36437",
                    "KEGG.DRUG:D02360",
                    "KEGG.COMPOUND:C07246",
                    "ATC:N06AB06",
                    "PSY:46765",
                    "UMLS:C0600526",
                    "NDDF:004615",
                    "KEGG.DRUG:D00825",
                    "UMLS:C1564115",
                    "CHEBI:9123",
                    "UMLS:C0284660",
                    "RXNORM:82728",
                    "UMLS:C0074393"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:21474681",
                    "PMID:10770145",
                    "PMID:3039136",
                    "PMID:16472241",
                    "PMID:25155462",
                    "PMID:8703653",
                    "PMID:9871604",
                    "PMID:3371401",
                    "PMID:10211919",
                    "PMID:16314097"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1711": {
              "name": "ISOPROTERENOL HYDROCHLORIDE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1711",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1711",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A synthetic triazole agent with antimycotic properties. Formulated for both topical and systemic use, itraconazole preferentially inhibits fugal cytochrome P450 enzymes, resulting in a decrease in fungal ergosterol synthesis. Because of its low toxicity profile, this agent can be used for long-term maintenance treatment of chronic fungal infections. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1138\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1138\" NCI Thesaurus); A synthetic triazole agent with antimycotic properties. Formulated for both topical and systemic use, itraconazole preferentially inhibits fungal cytochrome P450 enzymes, resulting in a decrease in fungal ergosterol synthesis. Because of its low toxicity profile, this agent can be used for long-term maintenance treatment of chronic fungal infections. (NCI04); A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ISOPROTERENOL SULFATE",
                    "Orungal",
                    "Cis-2-((S)-sec-Butyl)-4-[4-(4-{4-[(2R,4S)-2-(2,4-dichloro-phenyl)-2-[1,2,4]triazol-1-ylmethyl-[1,3]dioxolan-4-ylmethoxy]-phenyl}-piperazin-1-yl)-phenyl]-2,4-dihydro-[1,2,4]triazol-3-one",
                    "R-51211",
                    "Sporanox",
                    "Itraconazole (JP18/USP)",
                    "ISOPROTERENOL",
                    "Isuprel",
                    "Isoproterenol Hydrochloride",
                    "Isoprenaline (INN)",
                    "Itraconazole",
                    "Isoproterenol Sulfate",
                    "Isoproterenol hydrochloride (USP)",
                    "isoproterenol",
                    "Euspiran",
                    "DL-Isoprenaline hydrochloride",
                    "Isoproterenol sulfate (USP)",
                    "Isoproterenol",
                    "isoproterenol sulfate",
                    "Isoproterenol sulfate",
                    "ISOPROTERENOL HYDROCHLORIDE",
                    "itraconazole",
                    "Isoproterenol hydrochloride",
                    "2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one",
                    "ITRACONAZOLE",
                    "Izadrin",
                    "Isoprenaline",
                    "Novodrin",
                    "Norisodrine",
                    "isoproterenol hydrochloride",
                    "4-(4-(4-(4-((2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2-((S)-sec-butyl)-2,4-dihydro-3H-1,2,4-triazol-3-one",
                    "isoprenaline",
                    "Isadrine"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "LOINC:LP14995-2",
                    "MESH:D007545",
                    "PDQ:CDR0000039106",
                    "KEGG.DRUG:D02066",
                    "CHEBI:94366",
                    "NCIT:C1138",
                    "ATC:R03AB02",
                    "CHEMBL.COMPOUND:CHEMBL1711",
                    "VANDF:4019793",
                    "HMDB:HMDB0015298",
                    "KEGG.DRUG:D01390",
                    "RXNORM:6054",
                    "UMLS:C0064113",
                    "UMLS:C0282211",
                    "UMLS:C0701453",
                    "CHEBI:64317",
                    "NDDF:001778",
                    "UMLS:C0022245",
                    "NDDF:003915",
                    "UMLS:C0701454",
                    "UMLS:C0699614",
                    "DrugCentral:1499",
                    "KEGG.DRUG:D00350",
                    "VANDF:4018236",
                    "UMLS:C0701455",
                    "CHEMBL.COMPOUND:CHEMBL64391",
                    "UMLS:C0700056",
                    "LOINC:MTHU002298",
                    "VANDF:4020560",
                    "RXNORM:82031",
                    "RXNORM:202826",
                    "CHEMBL.COMPOUND:CHEMBL1835950",
                    "CHEMBL.COMPOUND:CHEMBL3810051",
                    "MESH:D017964",
                    "KEGG.DRUG:D08090",
                    "CHEBI:6076",
                    "DRUGBANK:DB01167",
                    "UMLS:C2350624",
                    "ATC:C01CA02",
                    "KEGG.COMPOUND:C07056",
                    "UMLS:C0701451",
                    "HMDB:HMDB0015197",
                    "RXNORM:28031",
                    "NDDF:001780",
                    "CHEMBL.COMPOUND:CHEMBL3989521",
                    "UMLS:C0701452",
                    "CHEMBL.COMPOUND:CHEMBL434",
                    "PSY:26740",
                    "DRUGBANK:DB01064",
                    "UMLS:C0282210",
                    "NCIT:C29133",
                    "ATC:J02AC02",
                    "NCIT:C62041",
                    "VANDF:4018235",
                    "NCIT:C65983",
                    "RXNORM:82030",
                    "DrugCentral:1513",
                    "RXNORM:1299683",
                    "PathWhiz.Compound:9493",
                    "UMLS:C0729171",
                    "CHEBI:31453",
                    "ATC:R03CB01"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:22460034",
                    "PMID:423210",
                    "PMID:19635955",
                    "PMID:20886871",
                    "PMID:2607347",
                    "PMID:1354264",
                    "PMID:18077343",
                    "PMID:11859007",
                    "PMID:17200113",
                    "PMID:19015352"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL46516": {
              "name": "FLUSPIRILENE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL46516",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL46516",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Fluspirilene is only found in individuals that have used or taken this drug. It is a long-acting injectable antipsychotic agent used for chronic schizophrenia.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",
                    "fluspirilene",
                    "Fluspirilene (USAN/INN)",
                    "Fluspirilen Lindo",
                    "Kivat",
                    "Imap",
                    "Fluspirilen Beta",
                    "Val-Ile-Gln",
                    "Fluspi",
                    "Fluspirilene",
                    "FLUSPIRILENE"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "RXNORM:4507",
                    "LOINC:LP183644-6",
                    "UMLS:C0592034",
                    "UMLS:C1564863",
                    "ATC:N05AG01",
                    "NDDF:003485",
                    "CHEBI:166238",
                    "CHEMBL.COMPOUND:CHEMBL46516",
                    "DrugCentral:1222",
                    "UMLS:C0016383",
                    "UMLS:C1564864",
                    "MESH:D005484",
                    "UMLS:C1564862",
                    "HMDB:HMDB0015590",
                    "DRUGBANK:DB04842",
                    "CHEBI:93369",
                    "KEGG.DRUG:D02629",
                    "UMLS:C1564865",
                    "LOINC:MTHU047891"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20843939",
                    "PMID:6094812",
                    "PMID:2859371",
                    "PMID:17417631",
                    "PMID:25790278",
                    "PMID:19734910",
                    "PMID:18024584",
                    "PMID:20553011",
                    "PMID:18027916",
                    "PMID:20958049"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL51483": {
              "name": "GOSSYPOL",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL51483",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL51483",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "An orally-active polyphenolic aldehyde with potential antineoplastic activity. Derived primarily from unrefined cottonseed oil, gossypol induces cell cycle arrest at the G0/G1 phase, thereby inhibiting DNA replication and inducing apoptosis. This agent also inhibits cell-signaling enzymes, resulting in inhibition of cell growth, and may act as a male contraceptive. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C529\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C529\" NCI Thesaurus); An orally-active polyphenolic aldehyde with potential antineoplastic activity. Derived primarily from unrefined cottonseed oil, gossypol induces cell cycle arrest at the G0/G1 phase, thereby inhibiting DNA replication and inducing apoptosis. This agent also inhibits cell-signaling enzymes, resulting in inhibition of cell growth, and may act as a male contraceptive.; A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug",
                    "biolink:MolecularEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Gossypol Dipotassium Salt",
                    "Gossypol, (-)-Isomer",
                    "Gossypol Sodium Salt",
                    "(-)-Gossypol",
                    "gossypol",
                    "GOSSYPOL",
                    "Gossypol, (+-)-Isomer",
                    "Gossypol, (+)-Isomer",
                    "Gossypol"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0887229",
                    "MESH:D006072",
                    "UMLS:C0917764",
                    "CHEMBL.COMPOUND:CHEMBL51483",
                    "CHEMBL.COMPOUND:CHEMBL4247875",
                    "UMLS:C0018096",
                    "LOINC:LP14123-1",
                    "UMLS:C0917765",
                    "KEGG.COMPOUND:C07667",
                    "UMLS:C0887228",
                    "PDQ:CDR0000505287",
                    "HMDB:HMDB0040723",
                    "DRUGBANK:DB13044",
                    "VANDF:4021343",
                    "CHEBI:28584",
                    "DrugCentral:1328",
                    "UMLS:C0887230",
                    "LOINC:MTHU009349",
                    "NCIT:C529"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:18533708",
                    "PMID:20684596",
                    "PMID:13678404",
                    "PMID:27712939",
                    "PMID:11413487",
                    "PMID:18645028",
                    "PMID:18237106",
                    "PMID:30170927",
                    "PMID:25818766",
                    "PMID:19264482"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.TARGET:CHEMBL3988637": {
              "name": "Transforming growth factor beta",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.target:CHEMBL3988637",
                  "value_url": "https://identifiers.org/chembl.target:CHEMBL3988637",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A family of structurally-related cytokines that bind to their cognate serine/threonine kinase receptors as homodimers or heterodimers linked by a single disulfide bond. These proteins play a role in embryonic development, hematopoiesis, tissue repair and extracellular matrix remodeling.; A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:GeneFamily"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Transforming growth factor beta",
                    "Transforming Growth Factor beta"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0040690",
                    "CHEMBL.TARGET:CHEMBL3988637"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:GeneFamily",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL123558": {
              "name": "AZIMILIDE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL123558",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL123558",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Azimilide is an investigational class III anti-arrhythmic drug that blocks fast and slow components of the delayed rectifier cardiac potassium channels. It is not approved for use in any country, but is currently in clinical trials in the United States.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Azimilide dihydrochloride (USAN)",
                    "AZIMILIDE",
                    "Azimilide",
                    "AZIMILIDE DIHYDROCHLORIDE",
                    "Azimilide Dihydrochloride",
                    "azimilide dihydrochloride",
                    "azimilide"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL123558",
                    "MESH:C086123",
                    "NCIT:C77977",
                    "UMLS:C1314817",
                    "CHEBI:34545",
                    "HMDB:HMDB0248805",
                    "UMLS:C0252416",
                    "KEGG.DRUG:D03037",
                    "DRUGBANK:DB04957",
                    "KEGG.COMPOUND:C13777",
                    "DrugCentral:274",
                    "NCIT:C79923",
                    "CHEMBL.COMPOUND:CHEMBL3140370",
                    "CHEMBL.COMPOUND:CHEMBL537847"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16052551",
                    "PMID:12190308",
                    "PMID:12873512",
                    "PMID:12873507",
                    "PMID:18426954",
                    "PMID:18448342",
                    "PMID:15745831",
                    "PMID:11573692",
                    "PMID:15324906",
                    "PMID:15911273"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL228792": {
              "name": "KINETIN",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL228792",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL228792",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "An injectable enzyme with potential adjuvant activity. Upon subcutaneous administration, hyaluronidase modifies the permeability of connective tissue by hydrolyzing hyaluronic acid. This temporarily decreases interstitial viscosity and allows drugs that are co-injected to spread rapidly through the interstitial space, thereby facilitating absorption and/or distribution of the co-injected agents.; An enzyme that catalyzes the random hydrolysis of 1,4-linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. (From Enzyme Nomenclature, 1992) There has been use as ANTINEOPLASTIC AGENTS to limit NEOPLASM METASTASIS.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug",
                    "biolink:GeneFamily"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "hyaluronoglucosaminidase",
                    "Hyaluronidase, Ovine",
                    "Hyaluronoglucosaminidase",
                    "kinetin",
                    "Kinetin",
                    "KINETIN",
                    "Hyaluronidase (JAN/INN)",
                    "hyaluronidase",
                    "Hyaluronidase",
                    "HYALURONIDASE",
                    "HYALURONIDASE (OVINE)",
                    "hyaluronidase, bovine",
                    "HYALURONIDASE (HUMAN RECOMBINANT)",
                    "Vitrase",
                    "hyaluronidase, ovine",
                    "Hyaluronidase, Bovine",
                    "Hyaluronidase (ovine)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.TARGET:CHEMBL3833905",
                    "ATC:B06AA03",
                    "CHEMBL.COMPOUND:CHEMBL2108607",
                    "DRUGBANK:DB00070",
                    "UMLS:C0049579",
                    "UMLS:C1577331",
                    "RXNORM:5464",
                    "KEGG.COMPOUND:C08272",
                    "CHEMBL.COMPOUND:CHEMBL1201718",
                    "LOINC:LP14923-4",
                    "RXNORM:582689",
                    "MESH:D007701",
                    "DRUGBANK:DB11336",
                    "UMLS:C1615665",
                    "DrugCentral:5033",
                    "NDDF:010831",
                    "CHEMBL.COMPOUND:CHEMBL1201636",
                    "NDDF:007754",
                    "NCIT:C65861",
                    "DRUGBANK:DB14740",
                    "VANDF:4018028",
                    "NDDF:008994",
                    "RXNORM:578350",
                    "CHEMBL.COMPOUND:CHEMBL228792",
                    "RXNORM:486164",
                    "NCIT:C87576",
                    "MESH:D006821",
                    "DrugCentral:3976",
                    "CHEBI:43130",
                    "RXNORM:16054",
                    "UMLS:C1615183",
                    "CHEBI:27407",
                    "KEGG.ENZYME:3.2.1.35",
                    "KEGG.DRUG:D04456",
                    "HMDB:HMDB0012245",
                    "UMLS:C0020197"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23062825",
                    "PMID:21044846",
                    "PMID:28323427",
                    "PMID:29604584",
                    "PMID:17300934",
                    "PMID:25467153",
                    "PMID:13271353",
                    "PMID:23571415",
                    "PMID:29494841"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL403664": {
              "name": "BLEOMYCIN SULFATE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL403664",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL403664",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A basic glycopeptide antineoplastic antibiotic isolated from Streptomyces verticillus. Bleomycin antibiotics form complexes with iron that react with molecular oxygen to produce superoxide and hydroxyl free radicals, causing single- and double-stranded breaks in DNA. These reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation.; A mixture of glycopeptide antineoplastic antibiotics isolated from the bacterium Streptomyces verticillus. Bleomycin forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals which cause single- and double-stranded breaks in DNA; these reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation.; A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors.; UMLS Semantic Type: STY:T195; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:SmallMolecule",
                    "biolink:Drug",
                    "biolink:MolecularEntity",
                    "biolink:ChemicalEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "zhengguangmycin",
                    "Bleomycin sulfate (JP18/USP)",
                    "Bleomycin",
                    "Bleomicina",
                    "BLEOMYCIN A2",
                    "bleomycin sulfate",
                    "Bleomycin A2",
                    "Bleomycin sulfate",
                    "BLEOMYCIN SULFATE",
                    "Bleomycin (INN)",
                    "BLEOMYCIN",
                    "bleomycin",
                    "bleomycin A2",
                    "Bleomycinum Mack",
                    "Bleomycin Sulfate"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "KEGG.DRUG:D02177",
                    "UMLS:C0005740",
                    "DRUGBANK:DB00290",
                    "UMLS:C0005736",
                    "NCIT:C311",
                    "CHEBI:34582",
                    "KEGG.DRUG:D07535",
                    "HMDB:HMDB0014435",
                    "NCIT:C312",
                    "CHEMBL.COMPOUND:CHEMBL2010411",
                    "ATC:L01DC01",
                    "UMLS:C1449824",
                    "KEGG.COMPOUND:C15773",
                    "UMLS:C0078763",
                    "PDQ:CDR0000039139",
                    "RXNORM:1621",
                    "CHEBI:3139",
                    "CHEMBL.COMPOUND:CHEMBL3306293",
                    "MESH:D001761",
                    "CHEMBL.COMPOUND:CHEMBL3085504",
                    "RXNORM:1622",
                    "CHEBI:22907",
                    "NCIT:C313",
                    "MESH:C021771",
                    "UMLS:C0005739",
                    "UMLS:C1449825",
                    "KEGG.GLYCAN:G09442",
                    "CHEMBL.COMPOUND:CHEMBL403664",
                    "VANDF:4019637",
                    "CHEMBL.COMPOUND:CHEMBL1744448",
                    "VANDF:4018135",
                    "DrugCentral:4742",
                    "KEGG.COMPOUND:C06854"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19615792",
                    "PMID:18519732",
                    "PMID:22257890",
                    "PMID:3351854",
                    "PMID:20014752",
                    "PMID:19586688",
                    "PMID:29730026",
                    "PMID:12477361",
                    "PMID:1812211",
                    "PMID:8691215"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL405110": {
              "name": "METHYLENE BLUE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL405110",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL405110",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A synthetic basic dye. Methylene blue stains to negatively charged cell components like nucleic acids; when administered in the lymphatic bed of a tumor during oncologic surgery, methylene blue may stain lymph nodes draining from the tumor, thereby aiding in the visual localization of tumor sentinel lymph nodes. When administered intravenously in low doses, this agent may convert methemoglobin to hemoglobin. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C644\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C644\" NCI Thesaurus); A synthetic basic dye. Methylene blue stains to negatively charged cell components like nucleic acids; when administered in the lymphatic bed of a tumor during oncologic surgery, methylene blue may stain lymph nodes draining from the tumor, thereby aiding in the visual localization of tumor sentinel lymph nodes. When administered intravenously in low doses, this agent may convert methemoglobin to hemoglobin.; A compound consisting of dark green crystals or crystalline powder, having a bronze-like luster. Solutions in water or alcohol have a deep blue color. Methylene blue is used as a bacteriologic stain and as an indicator. It inhibits GUANYLATE CYCLASE, and has been used to treat cyanide poisoning and to lower levels of METHEMOGLOBIN.; UMLS Semantic Type: STY:T130; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Methylene Blue",
                    "Methylthioninium",
                    "Methylene blue",
                    "3,7-bis(dimethylamino)phenothiazin-5-ium",
                    "methylene blue cation",
                    "methylene blue",
                    "methylene blue anhydrous",
                    "methylthioninium chloride",
                    "Methylene blue (USP)",
                    "METHYLTHIONINIUM CHLORIDE",
                    "METHYLENE BLUE"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEBI:43830",
                    "DRUGBANK:DB08167",
                    "ATC:V04CG05",
                    "DrugCentral:1763",
                    "KEGG.DRUG:D02312",
                    "PDQ:CDR0000041780",
                    "RXNORM:2198975",
                    "CHEMBL.COMPOUND:CHEMBL550495",
                    "RXNORM:1546414",
                    "MESH:D008751",
                    "RXNORM:6878",
                    "UMLS:C3848531",
                    "DRUGBANK:DB09241",
                    "CHEMBL.COMPOUND:CHEMBL405110",
                    "UMLS:C0025746",
                    "NDDF:001094",
                    "ATC:V03AB17",
                    "KEGG.COMPOUND:C00220",
                    "ttd.target:Methylene_blue",
                    "VANDF:4018579",
                    "CHEMBL.COMPOUND:CHEMBL191083",
                    "CHEBI:6872",
                    "NDDF:002877",
                    "NCIT:C644",
                    "UMLS:C5200996"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15854942",
                    "PMID:19506059",
                    "PMID:23484434",
                    "PMID:18207412",
                    "PMID:20426472",
                    "PMID:25857942",
                    "PMID:17967916",
                    "PMID:28927904",
                    "PMID:7864410",
                    "PMID:17026773"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL406291": {
              "name": "BRADYKININ",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL406291",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL406291",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Bradykinin is a vasoactive kinin that is liberated from its substrate kininogen by the action of kallikrein, and is known to be involved in a wide range of biologic processes. It may play an important role in blood pressure regulation and the maintenance of normal blood flow. Moreover, in various pathologic states of the cardiovascular system, it appears to provide protective actions against ischemic injury, ventricular hypertrophy, congestive heart failure, and thrombosis. Bradykinin is a potent vasodilator that acts through endothelial B2 kinin receptors to stimulate the release of nitric oxide and endothelium-derived hyperpolarizing factor. Bradykinin deficiency states may play a role in some forms of hypertension, and a relative deficiency in bradykinin may be a contributing factor to worsening heart failure. Experimental studies revealed that mice lacking the B2 receptor gene were more likely to develop hypertension, cardiac hypertrophy, and myocardial damage. Kinins exert several biologic actions. They are involved in nociception, inflammation, capillary permeability, reactive hyperemia, and stimulation of cellular glucose uptake. Bradykinin is a polypeptide that circulates in the plasma in very low concentrations in comparison with the amount of bradykinin found in various body tissues. Kininogens ([alpha] 2 globulins) are synthesized in the liver and circulate at high concentrations in the plasma. There are two kininogenases that convert kininogens into bradykinin: plasma kallikrein, also known as Fletcher factor, and glandular kallikrein, also known as tissue kallikrein. (PMID: 11975815).",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Gene",
                    "biolink:BiologicalEntity",
                    "biolink:Protein",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Bradykinin Triacetate",
                    "T-kininogen 2 (rat)",
                    "Bradykinin, (6-D-Ser)-Isomer",
                    "KNG1 gene",
                    "KNG1",
                    "kininogen-1 (mouse)",
                    "Bradykinin Diacetate",
                    "KNG1(19-644) [extracellular region]",
                    "KNG1(390-644) [plasma membrane]",
                    "KNG1 Gene",
                    "KNG1(19-644) [platelet alpha granule lumen]",
                    "Kng1l1 (rat)",
                    "Kininogen-1, human",
                    "kininogen-1 (human)",
                    "Bradykinin, (1-D-Arg)-Isomer",
                    "BRADYKININ",
                    "KNG1(19-380) [plasma membrane]",
                    "Bradykinin, (5-D-Phe)-Isomer",
                    "KNG1(19-644) [plasma membrane]",
                    "p-KNG1 [endoplasmic reticulum lumen]",
                    "Bradykinin, (2-D-Pro)-Isomer",
                    "bradykinin",
                    "Kng1 (mouse)",
                    "KNG1 (human)",
                    "Bradykinin [extracellular region]",
                    "KNG1 [endoplasmic reticulum lumen]",
                    "Bradykinin"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEBI:3165",
                    "MESH:D001920",
                    "PR:P01042",
                    "HGNC:6383",
                    "UMLS:C0887606",
                    "UMLS:C3811710",
                    "CHEMBL.COMPOUND:CHEMBL406291",
                    "REACT:R-HSA-158125",
                    "REACT:R-HSA-158245",
                    "NCIT:C316",
                    "UMLS:C0887611",
                    "NCBIGene:3827",
                    "LOINC:LP15453-1",
                    "LOINC:MTHU008896",
                    "UMLS:C0949240",
                    "UMLS:C0971860",
                    "RGD:1359376",
                    "ENSEMBL:ENSG00000113889",
                    "HMDB:HMDB0004246",
                    "MGI:1097705",
                    "REACT:R-HSA-158269",
                    "PR:O08677",
                    "UMLS:C0887602",
                    "KEGG.COMPOUND:C00306",
                    "UMLS:C0006100",
                    "UniProtKB:P01042",
                    "PR:P08932",
                    "REACT:R-HSA-8956767",
                    "REACT:R-HSA-8956939",
                    "REACT:R-HSA-139864",
                    "DRUGBANK:DB12126",
                    "REACT:R-HSA-158279",
                    "REACT:R-HSA-158344",
                    "UMLS:C0887605",
                    "OMIM:612358",
                    "ENSEMBL:LRG_598",
                    "UMLS:C1537501",
                    "NCIT:C38188"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:10514288",
                    "PMID:14760718",
                    "PMID:23403082",
                    "PMID:2076202",
                    "DOI:10.1038/nbt827",
                    "PMID:4952632",
                    "DOI:10.1016/j.cell.2015.05.028",
                    "PMID:16641997",
                    "PMID:19838169",
                    "PMID:6106062"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL408403": {
              "name": "ANGIOTENSIN II",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL408403",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL408403",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Angiotensin II is a hormone that may act on the central nervous system to regulate renal sympathetic nerve activity, renal function, and, therefore, blood pressure. Angiotensin II is produced locally within the kidney and mediates tissue injury through a series of nonhemodynamic effects. angiotensin II is not only involved in the regulation of blood pressure, water and sodium homeostasis, and control of other neurohumoral systems, but also leads to excessive production of reactive oxygen species and to hypertrophy, proliferation, migration, and apoptosis of vascular cells. Angiotensin II is one of the main factors involved in hypertension-induced tissue damage. This peptide regulates the inflammatory process. Angiotensin II activates circulating cells, and participates in their adhesion to the activated endothelium and subsequent transmigration through the synthesis of adhesion molecules, chemokines and cytokines. Among the intracellular signals involved in angiotensin II-induced inflammation, the production of reactive oxygen species and the activation of nuclear factor-kappaB are the best known. Classical, well-defined actions of Angiotensin II in the brain include the regulation of hormone formation and release, the control of the central and peripheral sympathoadrenal systems, and the regulation of water and sodium intake. As a consequence of changes in the hormone, sympathetic and electrolyte systems, feedback mechanisms in turn modulate the activity of the brain Angiotensin II systems. There are two Angiotensin II systems in the brain. The discovery of brain Angiotensin II receptors located in neurons inside the blood brain barrier confirmed the existence of an endogenous brain Angiotensin II system, responding to Angiotensin II generated in and/or transported into the brain. In addition, Angiotensin II receptors in circumventricular organs and in cerebrovascular endothelial cells respond to circulating Angiotensin II of peripheral origin. Thus, the brain responds to both circulating and tissue Angiotensin II, and the two systems are integrated. (PMID: 17147923, 16672146, 16601568, 16481883, 16075377).",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:ChemicalEntity",
                    "biolink:Drug",
                    "biolink:Protein"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[[(1S)-1-carboxy-2-phenylethyl]amino]-oxomethyl]-1-pyrrolidinyl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid",
                    "Angiotensin II",
                    "Ile(5)-angiotensin II dizwitterion",
                    "Giapreza",
                    "Angiotensin II Acetate",
                    "Angiotensin II (USAN)",
                    "Ile(5)-angiotensin II",
                    "ANGIOTENSIN II",
                    "ANGIOTENSIN II ACETATE",
                    "Angiotensin ii",
                    "Angiotensin II (INN)",
                    "angiotensin II"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "KEGG.COMPOUND:C02135",
                    "RXNORM:1999003",
                    "DRUGBANK:DB11842",
                    "CHEBI:58506",
                    "DrugCentral:5272",
                    "VANDF:4037288",
                    "CHEBI:2719",
                    "CHEMBL.COMPOUND:CHEMBL408403",
                    "PathWhiz.Compound:816",
                    "MESH:C000627694",
                    "ttd.target:ANGIOTENSIN_II",
                    "NCIT:C142924",
                    "LOINC:LP15389-7",
                    "CHEMBL.COMPOUND:CHEMBL3989932",
                    "UMLS:C4551140",
                    "KEGG.DRUG:D02014",
                    "UMLS:C4684910",
                    "PR:000036009",
                    "RXNORM:1999008",
                    "UMLS:C0003009",
                    "LOINC:MTHU005163",
                    "CHEBI:48432",
                    "MESH:D000804",
                    "KEGG.DRUG:D00150",
                    "CHEBI:131170",
                    "HMDB:HMDB0001035",
                    "ATC:C01CX09"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:22336384",
                    "PMID:2704034",
                    "PMID:17004728",
                    "PMID:18077343",
                    "PMID:2918497",
                    "PMID:20146480",
                    "PMID:12182875",
                    "PMID:6267278",
                    "PMID:16481883",
                    "PMID:16601568"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL506569": {
              "name": "LANATOSIDE C",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL506569",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL506569",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "LANATOSIDE C; FULL_MW:985.13; MAX_FDA_APPROVAL_PHASE: 0",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug",
                    "biolink:MolecularEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Lanatoside C",
                    "Ceglunat",
                    "SID225144390",
                    "Lanatoside C (JAN/INN)",
                    "Cedilanid",
                    "Lanocide",
                    "LANATOSIDE C",
                    "lanatoside C"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEBI:135898",
                    "UMLS:C0108916",
                    "KEGG.COMPOUND:C13470",
                    "NDDF:000594",
                    "MESH:C018548",
                    "RXNORM:27929",
                    "CHEMBL.COMPOUND:CHEMBL110309",
                    "UMLS:C0108955",
                    "CHEMBL.COMPOUND:CHEMBL3039124",
                    "DRUGBANK:DB13467",
                    "KEGG.DRUG:D01972",
                    "CHEMBL.COMPOUND:CHEMBL506569",
                    "DrugCentral:1543",
                    "UMLS:C0063986",
                    "ATC:C01AA06",
                    "UMLS:C1310655"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19894733",
                    "PMID:12109909",
                    "PMID:2089119",
                    "PMID:23571415"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1200382": {
              "name": "BEPRIDIL HYDROCHLORIDE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1200382",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1200382",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Bepridil is only found in individuals that have used or taken this drug. It is a long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist. [PubChem]Bepridil has inhibitory effects on both the slow calcium (L-type) and fast sodium inward currents in myocardial and vascular smooth muscle, interferes with calcium binding to calmodulin, and blocks both voltage and receptor operated calcium channels. Bepridil inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. This has been demonstrated in isolated myocardial and vascular smooth muscle preparations in which both the slope of the calcium dose response curve and the maximum calcium-induced inotropic response were significantly reduced by bepridil. In cardiac myocytes <i>in vitro</i>, bepridil was shown to be tightly bound to actin. Bepridil regularly reduces heart rate and arterial pressure at rest and at a given level of exercise by dilating peripheral arterioles and reducing total peripheral resistance (afterload) against which the heart works.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "BEPRIDIL",
                    "Bepridil",
                    "Vascor",
                    "bepridil",
                    "Bepridil, (+-)-Isomer",
                    "bepridil hydrochloride monohydrate",
                    "SID11532899",
                    "BEPRIDIL HYDROCHLORIDE",
                    "Cerm-1978",
                    "Bepridil hydrochloride",
                    "Bepridil, (-)-Isomer",
                    "Bepridil Monohydrochloride",
                    "Bepridil Hydrochloride",
                    "Bepridil hydrochloride (USAN)",
                    "Bepridil, alpha-Isomer",
                    "Bepridil (INN)",
                    "Bepridil, (+)-Isomer",
                    "bepridil hydrochloride"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEBI:3061",
                    "NDDF:004519",
                    "KEGG.COMPOUND:C06847",
                    "VANDF:4019549",
                    "UMLS:C0206029",
                    "UMLS:C0770909",
                    "UMLS:C0949473",
                    "HMDB:HMDB0015374",
                    "KEGG.DRUG:D00631",
                    "UMLS:C0005116",
                    "ATC:C08EA02",
                    "DrugCentral:342",
                    "UMLS:C0886803",
                    "CHEMBL.COMPOUND:CHEMBL1257078",
                    "CHEMBL.COMPOUND:CHEMBL1008",
                    "UMLS:C0917751",
                    "VANDF:4019631",
                    "RXNORM:235752",
                    "KEGG.DRUG:D07520",
                    "NCIT:C47412",
                    "UMLS:C0206027",
                    "CHEBI:52715",
                    "NCIT:C87448",
                    "UMLS:C1135736",
                    "CHEBI:52712",
                    "DRUGBANK:DB01244",
                    "RXNORM:1436",
                    "UMLS:C0917750",
                    "MESH:D015764",
                    "CHEMBL.COMPOUND:CHEMBL1200382"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:12190308",
                    "PMID:16472241",
                    "PMID:24332655",
                    "PMID:3184128",
                    "PMID:11082465",
                    "PMID:19110341",
                    "PMID:16908150",
                    "PMID:20020916",
                    "PMID:20185316",
                    "PMID:17536794"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1200402": {
              "name": "AMLODIPINE BESYLATE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1200402",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1200402",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Amlodipine is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell; A long acting dihydropyridine calcium channel blocker. It is effective in the treatment of angina pectoris and hypertension; in angina it improves blood flow to the myocardium. Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "AMLODIPINE MALEATE",
                    "AMLODIPINE BESYLATE",
                    "AMLODIPINE",
                    "amlodipine",
                    "amlodipine besylate",
                    "Amlodipine",
                    "amLODIPine",
                    "Amlodipine, (S)-Isomer, Maleate (1:1)",
                    "Astudal",
                    "amlodipine benzenesulfonate",
                    "Amlodipine Besylate",
                    "Amlodipine besylate (USP)",
                    "Amlodipine (USP/INN)",
                    "Amlodipine, (+-)-Isomer",
                    "Amlodipine, (R)-Isomer",
                    "Amlodipine besylate",
                    "Amlodipine maleate (USAN)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "VANDF:4020586",
                    "NDDF:003673",
                    "UMLS:C0886696",
                    "UMLS:C0886699",
                    "PathWhiz.Compound:2366",
                    "KEGG.DRUG:D07450",
                    "UMLS:C0354468",
                    "UMLS:C1448431",
                    "CHEBI:2669",
                    "NCIT:C28820",
                    "CHEMBL.COMPOUND:CHEMBL1200984",
                    "ATC:C08CA01",
                    "VANDF:4020813",
                    "KEGG.DRUG:D02914",
                    "HMDB:HMDB0005018",
                    "NCIT:C61635",
                    "NDDF:003672",
                    "KEGG.DRUG:D00615",
                    "KEGG.COMPOUND:C06825",
                    "CHEBI:2668",
                    "LOINC:MTHU060535",
                    "LOINC:LP28516-0",
                    "RXNORM:104416",
                    "DRUGBANK:DB00381",
                    "UMLS:C0886697",
                    "CHEMBL.COMPOUND:CHEMBL1491",
                    "DrugCentral:183",
                    "MESH:D017311",
                    "RXNORM:17767",
                    "CHEMBL.COMPOUND:CHEMBL1200402",
                    "UMLS:C0051696"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:17954702",
                    "PMID:9052891",
                    "PMID:2342074",
                    "PMID:16472241",
                    "PMID:1995904",
                    "PMID:20934347",
                    "PMID:21467212",
                    "PMID:11145223",
                    "PMID:1387168",
                    "PMID:22197392"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1201081": {
              "name": "METHYLPREDNISOLONE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1201081",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1201081",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "The acetate salt of a synthetic glucocorticoid receptor agonist with immunosuppressive and antiinflammatory effects. Methylprednisolone acetate is converted into active prednisolone in the body, which activates glucocorticoid receptor mediated gene expression. This includes inducing synthesis of anti-inflammatory protein IkappaB-alpha and inhibiting synthesis of nuclear factor kappaB (NF-kappaB). As a result, proinflammatory cytokine production such as IL-1, IL-2 and IL-6 is down-regulated and cytotoxic T-lymphocyte activation is inhibited. Therefore, an overall reduction in chronic inflammation and autoimmune reactions may be achieved. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C48003\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48003\" NCI Thesaurus); The acetate salt of a synthetic glucocorticoid receptor agonist with immunosuppressive and antiinflammatory effects. Methylprednisolone acetate is converted into active prednisolone in the body, which activates glucocorticoid receptor mediated gene expression. This includes inducing synthesis of anti-inflammatory protein IkappaB-alpha and inhibiting synthesis of nuclear factor kappaB (NF-kappaB). As a result, proinflammatory cytokine production such as IL-1, IL-2 and IL-6 is down-regulated and cytotoxic T-lymphocyte activation is inhibited. Therefore, an overall reduction in chronic inflammation and autoimmune reactions may be achieved.; Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Sodium salt 3-[2-(11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethoxycarbonyl]-propionate (Methylprednisolone sodium succinate)",
                    "A-MethaPred",
                    "SID26749858",
                    "Methylprednisolone Suleptanate",
                    "Methylprednisolone sodium succinate",
                    "Methylprednisolone",
                    "METHYLPREDNISOLONE",
                    "Methylprednisolone Aceponate",
                    "Methylprednisolone hemisuccinate",
                    "Methylprednisolone Acetate, (11beta,16beta)-isomer",
                    "METHYLPREDNISOLONE SODIUM SUCCINATE",
                    "6alpha-methylprednisolone",
                    "Methylprednisolone acetate",
                    "Solu-Medrol",
                    "methylprednisolone sodium succinate",
                    "methylprednisolone acetate",
                    "Methylprednisolone Acetate",
                    "Methylprednisolone aceponate",
                    "methylprednisolone suleptanate",
                    "Advantan",
                    "METHYLPREDNISOLONE ACEPONATE",
                    "A-Methapred",
                    "Methylprednisolone suleptanate (USAN/INN)",
                    "Methylprednisolone aceponate (INN)",
                    "methylprednisolone",
                    "methylprednisolone succinate",
                    "METHYLPREDNISOLONE ACETATE",
                    "Methylprednisolone acetate (JAN/USP)",
                    "METHYLPREDNISOLONE SULEPTANATE",
                    "Urbason-Soluble",
                    "methylprednisolone 21-suleptanic acid ester",
                    "Methylprednisolone Hemisuccinate",
                    "Methylprednisolone hemisuccinate (USP)",
                    "Pnu-67590a",
                    "METHYLPREDNISOLONE HEMISUCCINATE",
                    "methylprednisolone aceponate",
                    "Methylprednisolone sodium succinate (JAN/USP)",
                    "SID11112219",
                    "Acetic acid 2-(11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester",
                    "Depo-Medrol",
                    "Methylprednisolone Sodium Succinate"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL1364144",
                    "UMLS:C0086618",
                    "CHEBI:6889",
                    "NCIT:C48004",
                    "CHEMBL.COMPOUND:CHEMBL1201265",
                    "NCIT:C48003",
                    "UMLS:C0630597",
                    "ATC:D07AA01",
                    "CHEMBL.COMPOUND:CHEMBL1697782",
                    "CHEMBL.COMPOUND:CHEMBL346476",
                    "CHEMBL.COMPOUND:CHEMBL66870",
                    "DrugCentral:1772",
                    "RXNORM:155323",
                    "ATC:D10AA02",
                    "RXNORM:203856",
                    "UMLS:C0066429",
                    "UMLS:C0057476",
                    "DrugCentral:1768",
                    "KEGG.DRUG:D00979",
                    "NCIT:C90955",
                    "RXNORM:203189",
                    "UMLS:C0174938",
                    "UMLS:C1527920",
                    "NCIT:C77422",
                    "HMDB:HMDB0247029",
                    "CHEMBL.COMPOUND:CHEMBL1201081",
                    "KEGG.COMPOUND:C08179",
                    "HMDB:HMDB0254660",
                    "VANDF:4018069",
                    "MESH:C078007",
                    "CHEBI:6890",
                    "UMLS:C0701467",
                    "CHEMBL.COMPOUND:CHEMBL190259",
                    "VANDF:4018070",
                    "CHEBI:6888",
                    "ttd.target:Methylprednisolone_Acetate",
                    "HMDB:HMDB0254661",
                    "KEGG.DRUG:D05002",
                    "CHEMBL.COMPOUND:CHEMBL2106453",
                    "NDDF:006227",
                    "CHEMBL.COMPOUND:CHEMBL650",
                    "UMLS:C0700546",
                    "UMLS:C0893911",
                    "MESH:C052305",
                    "RXNORM:62136",
                    "DRUGBANK:DB14643",
                    "CHEMBL.COMPOUND:CHEMBL1200844",
                    "PDQ:CDR0000041528",
                    "DRUGBANK:DB14644",
                    "ATC:D07AC14",
                    "CHEMBL.COMPOUND:CHEMBL1697783",
                    "KEGG.DRUG:D05000",
                    "DRUGBANK:DB00959",
                    "MESH:D000077555",
                    "RXNORM:203857",
                    "MESH:D008776",
                    "RXNORM:6902",
                    "CHEBI:156480",
                    "DrugCentral:1769",
                    "MESH:D008775",
                    "UMLS:C0701466",
                    "RXNORM:22584",
                    "VANDF:4018068",
                    "KEGG.DRUG:D07203",
                    "CHEBI:135765",
                    "CHEBI:135762",
                    "HMDB:HMDB0015094",
                    "KEGG.DRUG:D00751",
                    "LOINC:LP18584-0",
                    "CHEMBL.COMPOUND:CHEMBL1207082",
                    "CHEBI:135864",
                    "DrugCentral:1770",
                    "ATC:H02AB04",
                    "UMLS:C0600901",
                    "UMLS:C0025815",
                    "NCIT:C647",
                    "LOINC:MTHU004699",
                    "DrugCentral:1771",
                    "CHEMBL.COMPOUND:CHEMBL1474440"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:32181990",
                    "PMID:7086844",
                    "PMID:16472241",
                    "PMID:11413487",
                    "PMID:21458999",
                    "PMID:6827553",
                    "PMID:14294877",
                    "PMID:13470731",
                    "PMID:30285357",
                    "PMID:21998403"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1201082": {
              "name": "FLUOXETINE HYDROCHLORIDE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1201082",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1201082",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Fluoxetine hydrochloride is the first agent of the class of antidepressants known as selective serotonin-reuptake inhibitors (SSRIs). Despite distinct structural differences between compounds in this class, SSRIs possess similar pharmacological activity. As with other antidepressant agents, several weeks of therapy may be required before a clinical effect is seen. SSRIs are potent inhibitors of neuronal serotonin reuptake. They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize \u03b1- or \u03b2-adrenergic, dopamine D<sub>2</sub> or histamine H<sub>1</sub> receptors. During acute use, SSRIs block serotonin reuptake and increase serotonin stimulation of somatodendritic 5-HT<sub>1A</sub> and terminal autoreceptors. Chronic use leads to desensitization of somatodendritic 5-HT<sub>1A</sub> and terminal autoreceptors. The overall clinical effect of increased mood and decreased anxiety is thought to be due to adaptive changes in neuronal function that lead to enhanced serotonergic neurotransmission. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction, and headache. Side effects generally occur within the first two weeks of therapy and are usually less severe and frequent than those observed with tricyclic antidepressants. Fluoxetine may be used to treat major depressive disorder (MDD), moderate to severe bulimia nervosa, obsessive-compulsive disorder (OCD), premenstrual dysphoric disorder (PMDD), panic disorder with or without agoraphobia, and, in combination with olanzapine, for treatment-resistant or bipolar I depression. Fluoxetine is the most anorexic and stimulating SSRI.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug",
                    "biolink:MolecularEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "FLUOXETINE",
                    "FLUoxetine",
                    "Fluoxetine",
                    "fluoxetine",
                    "Fluoxetine Hydrochloride",
                    "Prozac",
                    "Fluoxetine hydrochloride",
                    "FLUOXETINE HYDROCHLORIDE",
                    "Fluoxetine hydrochloride (JAN/USP)",
                    "N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                    "fluoxetine hydrochloride",
                    "N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine hydrochloride (1:1)",
                    "Fluoxetine (USAN/INN)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "VANDF:4019389",
                    "PathWhiz.Compound:8977",
                    "UMLS:C0016365",
                    "CHEBI:5119",
                    "RXNORM:58827",
                    "CHEBI:145458",
                    "HMDB:HMDB0014615",
                    "NCIT:C2829",
                    "DrugCentral:1209",
                    "CHEBI:86990",
                    "RXNORM:4493",
                    "ATC:N06AB03",
                    "CHEBI:5118",
                    "KEGG.DRUG:D00326",
                    "DRUGBANK:DB00472",
                    "LOINC:LP14381-5",
                    "PSY:41257",
                    "CHEMBL.COMPOUND:CHEMBL41",
                    "NDDF:004613",
                    "UMLS:C0162373",
                    "RXNORM:227224",
                    "NCIT:C506",
                    "LOINC:MTHU060451",
                    "UMLS:C0733380",
                    "PSY:19967",
                    "PDQ:CDR0000041578",
                    "MESH:D005473",
                    "KEGG.DRUG:D00823",
                    "CHEMBL.COMPOUND:CHEMBL1201082",
                    "VANDF:4019761"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20587366",
                    "PMID:23919353",
                    "PMID:24900506",
                    "PMID:21310612",
                    "PMID:9357518",
                    "PMID:18834188",
                    "PMID:17826870",
                    "PMID:17690258",
                    "PMID:9276022",
                    "PMID:26296476"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1201365": {
              "name": "RAMIPRILAT",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1201365",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1201365",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Ramiprilat, also known as ramiprilic acid, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Ramiprilat is considered to be a practically insoluble (in water) and relatively neutral molecule. Ramiprilat has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, ramiprilat is primarily located in the cytoplasm. In humans, ramiprilat is involved in the ramipril metabolism pathway and the ramipril action pathway. Ramiprilat is a metabolite of ramipril. Ramipril is an angiotensin-converting enzyme (ACE) inhibitor, used to treat high blood pressure and congestive heart failure. (Wikipedia)",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Vesdil",
                    "Ramiprilat",
                    "Ramipril",
                    "Altace",
                    "(3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid",
                    "RAMIPRILAT",
                    "ramiprilat",
                    "Hoe-498",
                    "Ramipril (USP/INN)",
                    "SID56463183",
                    "Carasel",
                    "RAMIPRIL",
                    "ramipril"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MESH:D017257",
                    "NCIT:C29411",
                    "KEGG.DRUG:D00421",
                    "DrugCentral:2356",
                    "NCIT:C72911",
                    "NDDF:003585",
                    "RXNORM:35296",
                    "HMDB:HMDB0060579",
                    "UMLS:C0878061",
                    "LOINC:LP171634-1",
                    "UMLS:C1564033",
                    "UMLS:C0733666",
                    "PDQ:CDR0000686948",
                    "VANDF:4019562",
                    "CHEMBL.COMPOUND:CHEMBL1201365",
                    "ATC:C09AA05",
                    "RXNORM:1546377",
                    "DRUGBANK:DB14208",
                    "CHEBI:77363",
                    "UMLS:C0072973",
                    "UMLS:C0072970",
                    "PathWhiz.Compound:8725",
                    "PathWhiz.Compound:40468",
                    "UMLS:C1564032",
                    "RXNORM:262418",
                    "CHEBI:8774",
                    "CHEMBL.COMPOUND:CHEMBL1168",
                    "DRUGBANK:DB00178",
                    "MESH:C052549",
                    "HMDB:HMDB0014324",
                    "CHEBI:91811",
                    "CHEMBL.COMPOUND:CHEMBL1416376"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16472241",
                    "PMID:27490827",
                    "PMID:23591995",
                    "PMID:21535409",
                    "PMID:21601448",
                    "PMID:22197392",
                    "PMID:21112128",
                    "PMID:20014752",
                    "PMID:7768254",
                    "PMID:10485736"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1234886": {
              "name": "OXYGEN",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1234886",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1234886",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Oxygen is the third most abundant element in the universe after hydrogen and helium and the most abundant element by mass in the Earth's crust. Diatomic oxygen gas constitutes 20.9% of the volume of air. All major classes of structural molecules in living organisms, such as proteins, carbohydrates, and fats, contain oxygen, as do the major inorganic compounds that comprise animal shells, teeth, and bone. Oxygen in the form of O2 is produced from water by cyanobacteria, algae and plants during photosynthesis and is used in cellular respiration for all living organisms. Green algae and cyanobacteria in marine environments provide about 70% of the free oxygen produced on earth and the rest is produced by terrestrial plants. Oxygen is used in mitochondria to help generate adenosine triphosphate (ATP) during oxidative phosphorylation. For animals, a constant supply of oxygen is indispensable for cardiac viability and function. To meet this demand, an adult human, at rest, inhales 1.8 to 2.4 grams of oxygen per minute. This amounts to more than 6 billion tonnes of oxygen inhaled by humanity per year. At a resting pulse rate, the heart consumes approximately 8-15 ml O2/min/100 g tissue. This is significantly more than that consumed by the brain (approximately 3 ml O2/min/100 g tissue) and can increase to more than 70 ml O2/min/100 g myocardial tissue during vigorous exercise. As a general rule, mammalian heart muscle cannot produce enough energy under anaerobic conditions to maintain essential cellular processes; thus, a constant supply of oxygen is indispensable to sustain cardiac function and viability. However, the role of oxygen and oxygen-associated processes in living systems is complex, and they and can be either beneficial or contribute to cardiac dysfunction and death (through reactive oxygen species). Reactive oxygen species (ROS) are a family of oxygen-derived free radicals that are produced in mammalian cells under normal and pathologic conditions. Many ROS, such as the superoxide anion (O2-)and hydrogen peroxide (H2O2), act within blood vessels, altering mechanisms mediating mechanical signal transduction and autoregulation of cerebral blood flow. Reactive oxygen species are believed to be involved in cellular signaling in blood vessels in both normal and pathologic states. The major pathway for the production of ROS is by way of the one-electron reduction of molecular oxygen to form an oxygen radical, the superoxide anion (O2-). Within the vasculature there are several enzymatic sources of O2-, including xanthine oxidase, the mitochondrial electron transport chain, and nitric oxide (NO) synthases. Studies in recent years, however, suggest that the major contributor to O2- levels in vascular cells is the membrane-bound enzyme NADPH-oxidase. Produced O2- can react with other radicals, such as NO, or spontaneously dismutate to produce hydrogen peroxide (H2O2). In cells, the latter reaction is an important pathway for normal O2- breakdown and is usually catalyzed by the enzyme superoxide dismutase (SOD). Once formed, H2O2 can undergo various reactions, both enzymatic and nonenzymatic. The antioxidant enzymes catalase and glutathione peroxidase act to limit ROS accumulation within cells by breaking down H2O2 to H2O. Metabolism of H2O2 can also produce other, more damaging ROS. For example, the endogenous enzyme myeloperoxidase uses H2O2 as a substrate to form the highly reactive compound hypochlorous acid. Alternatively, H2O2 can undergo Fenton or Haber-Weiss chemistry, reacting with Fe2+/Fe3+ ions to form toxic hydroxyl radicals (-.OH). (PMID: 17027622, 15765131).",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug",
                    "biolink:BiologicalEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "O2 [nucleoplasm]",
                    "Oxygen (JP18/USP)",
                    "monooxygen",
                    "O2 [endoplasmic reticulum lumen]",
                    "O2 [phagolysosome]",
                    "singlet dioxygen",
                    "O2 [peroxisomal matrix]",
                    "oxygen",
                    "triplet dioxygen",
                    "O2 [melanosome lumen]",
                    "O2 [cytoplasm]",
                    "Oxygen",
                    "O2 [mitochondrial matrix]",
                    "OXYGEN",
                    "O2 [cytosol]",
                    "O2 [extracellular region]",
                    "O2 [endocytic vesicle lumen]",
                    "O2 [phagocytic vesicle lumen]",
                    "O2 [mitochondrial intermembrane space]",
                    "Molecular oxygen",
                    "Dioxygen",
                    "O2 [secretory granule lumen]",
                    "oxygen atom",
                    "Singlet Oxygen",
                    "Oxygen gas"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "LOINC:LA25411-2",
                    "REACT:R-ALL-113534",
                    "CHEBI:29194",
                    "RXNORM:7806",
                    "MESH:D026082",
                    "REACT:R-ALL-113533",
                    "MESH:D010100",
                    "CHEBI:26689",
                    "PathWhiz.Compound:1065",
                    "REACT:R-ALL-113685",
                    "KEGG.COMPOUND:C00007",
                    "REACT:R-ALL-1131511",
                    "UMLS:C0074565",
                    "REACT:R-ALL-1236709",
                    "LOINC:LP14536-4",
                    "LOINC:LP99292-2",
                    "REACT:R-ALL-189461",
                    "UMLS:C0350411",
                    "REACT:R-ALL-351593",
                    "KEGG.DRUG:D00003",
                    "CHEMBL.COMPOUND:CHEMBL1234886",
                    "UMLS:C0058347",
                    "HMDB:HMDB0001377",
                    "DRUGBANK:DB09140",
                    "NDDF:000826",
                    "DrugCentral:4235",
                    "REACT:R-ALL-5668566",
                    "REACT:R-ALL-1222561",
                    "CHEBI:15379",
                    "NCIT:C722",
                    "UMLS:C0302920",
                    "REACT:R-ALL-113535",
                    "UMLS:C0030054",
                    "REACT:R-ALL-2230955",
                    "VANDF:4019105",
                    "REACT:R-ALL-29368",
                    "LOINC:MTHU002757",
                    "CHEBI:25805",
                    "CHEBI:27140",
                    "ATC:V03AN01",
                    "REACT:R-ALL-352327",
                    "PSY:36090"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:8160966",
                    "PMID:16798186",
                    "PMID:15902792",
                    "PMID:12471082",
                    "PMID:15820462",
                    "PMID:6414343",
                    "PMID:16243980",
                    "PMID:12768124",
                    "PMID:8328508",
                    "PMID:16821755"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1256391": {
              "name": "PIRFENIDONE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1256391",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1256391",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "An orally active synthetic antifibrotic agent structurally similar to pyridine 2,4-dicarboxylate. Pirfenidone inhibits fibroblast, epidermal, platelet-derived, and transforming beta-1 growth factors, thereby slowing tumor cell proliferation. This agent also inhibits DNA synthesis and the production of mRNA for collagen types I and III, resulting in a reduction in radiation-induced fibrosis. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2635\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2635\" NCI Thesaurus); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Esbriet",
                    "PIRFENIDONE",
                    "Pirfenidone (JAN/USAN/INN)",
                    "pirfenidone",
                    "Pirfenidone"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PDQ:CDR0000038334",
                    "UMLS:C3859171",
                    "KEGG.DRUG:D01583",
                    "DrugCentral:4224",
                    "ATC:L04AX05",
                    "VANDF:4033815",
                    "NDDF:014994",
                    "RXNORM:1592254",
                    "NCIT:C2635",
                    "CHEMBL.COMPOUND:CHEMBL1256391",
                    "DRUGBANK:DB04951",
                    "RXNORM:1592280",
                    "CHEBI:32016",
                    "UMLS:C0298067",
                    "MESH:C093844",
                    "HMDB:HMDB0256594"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:28122457",
                    "PMID:17906160",
                    "PMID:20014752",
                    "PMID:17417631",
                    "PMID:31557052",
                    "PMID:12010989",
                    "PMID:26896707",
                    "PMID:24332090",
                    "PMID:28414242"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1256940": {
              "name": "METHOXYVERAPAMIL HYDROCHLORIDE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1256940",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1256940",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "METHOXYVERAPAMIL HYDROCHLORIDE; FULL_MW:521.10; MAX_FDA_APPROVAL_PHASE: 0",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:SmallMolecule",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Gallopamil hydrochloride (JAN)",
                    "METHOXYVERAPAMIL HYDROCHLORIDE"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL1256940",
                    "KEGG.DRUG:D01969"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:19734910",
                    "PMID:17417631"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1322218": {
              "name": "ATENOLOL",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1322218",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1322218",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Atenolol is a so-called beta1-selective (or 'cardioselective') drug. That means that it exerts greater blocking activity on myocardial beta1-receptors than on beta2 ones in the lung. The beta2 receptors are responsible to keep the bronchial system open. If these receptors are blocked, bronchospasm with serious lack of oxygen in the body can result. However, due to its cardioselective properties, the risk of bronchospastic reactions if using atenolol is reduced compared to nonselective drugs as propranolol. Nonetheless, this reaction may also be encountered with atenolol, particularly with high doses. Extreme caution should be exerted if atenolol is given to asthma patients, who are particularly at risk; the dose should be as low as possible. If an asthma attack occurs, the inhalation of a beta2-mimetic antiasthmatic, such as hexoprenalin or salbutamol, will usually suppress the symptoms. Atenolol (trade name Tenormin) can be used to treat cardiovascular diseases such as hypertension, coronary heart disease, arrhythmias, and treatment of myocardial infarction after the acute event. Patients with compensated congestive heart failure may be treated with atenolol as a co medication (usually together with an ACE inhibitor, a diuretic and a digitalis-glycoside, if indicated). In patients with congestive heart failure, it reduces the need for and the consumption of oxygen of the heart muscle. It is very important to start with low doses, as atenolol reduces also the muscular power of the heart, which is an undesired effect in congestive heart failure.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Esatenolol",
                    "atenolol",
                    "Atenolol (JP18/USP/INN)",
                    "ATENOLOL",
                    "Procaterol hydrochloride (USAN)",
                    "esatenolol",
                    "ESATENOLOL",
                    "Atenolol",
                    "Esatenolol (JAN/INN)",
                    "PROCATEROL HYDROCHLORIDE",
                    "Procaterol hydrochloride"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEBI:2904",
                    "DrugCentral:4702",
                    "MESH:D001262",
                    "KEGG.DRUG:D01471",
                    "UMLS:C2825715",
                    "DRUGBANK:DB00335",
                    "CHEMBL.COMPOUND:CHEMBL1322218",
                    "LOINC:MTHU015491",
                    "LOINC:LP16037-1",
                    "VANDF:4018460",
                    "ATC:C07AB03",
                    "CHEMBL.COMPOUND:CHEMBL24",
                    "KEGG.DRUG:D00235",
                    "PDQ:CDR0000590657",
                    "KEGG.COMPOUND:C13235",
                    "HMDB:HMDB0001924",
                    "UMLS:C0004147",
                    "KEGG.DRUG:D02404",
                    "PathWhiz.Compound:1283",
                    "CHEMBL.COMPOUND:CHEMBL343633",
                    "CHEBI:31556",
                    "NDDF:001855",
                    "CHEBI:32056",
                    "NCIT:C81661",
                    "NCIT:C28836",
                    "DrugCentral:255",
                    "DRUGBANK:DB13443",
                    "RXNORM:1202"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23637119",
                    "PMID:24592867",
                    "PMID:26375352",
                    "PMID:18666772",
                    "PMID:18457949",
                    "PMID:21458999",
                    "PMID:27521067",
                    "PMID:28613871",
                    "PMID:20070106",
                    "PMID:18662878"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL1697788": {
              "name": "DEXAMETHASONE DIPROPIONATE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL1697788",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL1697788",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "DEXAMETHASONE DIPROPIONATE; FULL_MW:504.60; MAX_FDA_APPROVAL_PHASE: 0",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "DEXAMETHASONE DIPROPIONATE",
                    "Dexamethasone Dipropionate",
                    "Dexamethasone 17-propionate",
                    "dexamethasone dipropionate",
                    "Dexamethasone dipropionate (USAN)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0245678",
                    "MESH:C059542",
                    "NCIT:C77417",
                    "CHEBI:135805",
                    "CHEMBL.COMPOUND:CHEMBL1697788",
                    "DrugCentral:827",
                    "CHEBI:31470",
                    "KEGG.DRUG:D01632"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:16472241"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL2108334": {
              "name": "Factor VIIa",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL2108334",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL2108334",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Activated form of factor VII. Factor VIIa activates factor X in the extrinsic pathway of blood coagulation.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug",
                    "biolink:MolecularEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "EPTACOG ALFA",
                    "Factor VIIa",
                    "Coagulation Factor VIIa",
                    "COAGULATION FACTOR VIIA RECOMBINANT HUMAN",
                    "recombinant FVIIa",
                    "Coagulation factor VIIa Recombinant Human",
                    "factor VIIa",
                    "Factor viia",
                    "eptacog alfa (activated)",
                    "Eptacog alfa (INN)",
                    "Coagulation Factor VIIa Recombinant Human",
                    "EPTACOG ALFA (ACTIVATED)"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEBI:3777",
                    "RXNORM:4256",
                    "CHEMBL.COMPOUND:CHEMBL4297869",
                    "ttd.target:Factor_viia",
                    "MESH:C103587",
                    "DrugCentral:5159",
                    "DRUGBANK:DB00036",
                    "CHEMBL.COMPOUND:CHEMBL2108334",
                    "UMLS:C0015505",
                    "NCIT:C81125",
                    "MESH:D015942",
                    "KEGG.DRUG:D00172",
                    "CHEMBL.COMPOUND:CHEMBL2108405"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15328151",
                    "PMID:10584732",
                    "PMID:16418464",
                    "PMID:15728810",
                    "PMID:2155"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL2146121": {
              "name": "CALCIUM",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL2146121",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL2146121",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Calcium is essential for the normal growth and maintenance of bones and teeth, and calcium requirements must be met throughout life. Requirements are greatest during periods of growth, such as childhood, during pregnancy and when breast-feeding. Long-term calcium deficiency can lead to osteoporosis, in which the bone deteriorates and there is an increased risk of fractures. Adults need between 1,000 and 1,300 mg of calcium in their daily diet. Calcium is essential for living organisms, particularly in cell physiology, and is the most common metal in many animals. Physiologically, it exists as an ion in the body. Calcium combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Calcium is an important component of a healthy diet. A deficit can affect bone and tooth formation, while overretention can cause kidney stones. Vitamin D is needed to absorb calcium. Dairy products, such as milk and cheese, are a well-known source of calcium. However, some individuals are allergic to dairy products and even more people, particularly those of non-European descent, are lactose-intolerant, leaving them unable to consume dairy products. Fortunately, many other good sources of calcium exist. These include: seaweeds such as kelp, wakame and hijiki; nuts and seeds (like almonds and sesame); beans; amaranth; collard greens; okra; rutabaga; broccoli; kale; and fortified products such as orange juice and soy milk. Calcium has also been found to assist in the production of lymphatic fluids. Furthermore, calcium is found to be associated with primary hypomagnesemia, which is an inborn error of metabolism.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:MolecularEntity",
                    "biolink:Drug",
                    "biolink:SmallMolecule",
                    "biolink:BiologicalEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "calcium atom",
                    "Calcium cation",
                    "Ca2+ [endocytic vesicle lumen]",
                    "Ca2+ [sarcoplasmic reticulum lumen]",
                    "calcium(0)",
                    "Ca2+ [nuclear envelope]",
                    "Ca2+ [mitochondrial matrix]",
                    "Ca2+ [mitochondrial inner membrane]",
                    "calcium",
                    "Ca2+ [secretory granule lumen]",
                    "Ca2+ [extracellular region]",
                    "Ca2+ [mitochondrial intermembrane space]",
                    "PC(DiMe(11,3)/DiMe(13,5))",
                    "Ca2+ [endosome membrane]",
                    "Ca2+ [plasma membrane]",
                    "Ca2+ [platelet dense tubular network lumen]",
                    "Ca2+ [endoplasmic reticulum lumen]",
                    "calcium(2+)",
                    "Calcium",
                    "Ca2+ [cytosol]",
                    "Calcium, Dietary",
                    "Ca2+ [nucleoplasm]",
                    "Ca2+ [endoplasmic reticulum membrane]",
                    "Ca2+ [Golgi lumen]",
                    "Ca2+ [platelet dense granule lumen]",
                    "Ca2+ [platelet dense tubular network membrane]",
                    "Ca2+ [lysosomal lumen]",
                    "CALCIUM"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEBI:29108",
                    "MESH:D002136",
                    "REACT:R-ALL-74016",
                    "REACT:R-ALL-29496",
                    "PSY:07240",
                    "REACT:R-ALL-114582",
                    "CHEBI:29320",
                    "REACT:R-ALL-1524102",
                    "REACT:R-ALL-8851519",
                    "LOINC:LP70404-6",
                    "HMDB:HMDB0000464",
                    "REACT:R-ALL-1500625",
                    "REACT:R-ALL-8949232",
                    "ATC:A12AA",
                    "REACT:R-ALL-2855229",
                    "REACT:R-ALL-139827",
                    "REACT:R-ALL-140648",
                    "REACT:R-ALL-216801",
                    "HMDB:HMDB0061392",
                    "VANDF:4017652",
                    "DRUGBANK:DB14577",
                    "REACT:R-ALL-1606834",
                    "UMLS:C0006675",
                    "KEGG.COMPOUND:C00076",
                    "CHEMBL.TARGET:CHEMBL2364030",
                    "REACT:R-ALL-141090",
                    "UMLS:C0006726",
                    "CHEMBL.COMPOUND:CHEMBL2146121",
                    "REACT:R-ALL-5210949",
                    "REACT:R-ALL-8949220",
                    "RXNORM:1895",
                    "LOINC:LP15257-6",
                    "REACT:R-ALL-111875",
                    "LOINC:LP32547-9",
                    "REACT:R-ALL-74112",
                    "REACT:R-ALL-167012",
                    "NCIT:C331",
                    "NDDF:000771",
                    "VANDF:4021884",
                    "PathWhiz.Compound:353",
                    "REACT:R-ALL-2318767",
                    "CHEBI:22984",
                    "LOINC:MTHU001930",
                    "DRUGBANK:DB01373",
                    "MESH:D002118"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15885294",
                    "PMID:11413487",
                    "PMID:15860827",
                    "PMID:21475195",
                    "PMID:16481635",
                    "PMID:26306852",
                    "PMID:16034903",
                    "PMID:11683549",
                    "PMID:2104616",
                    "PMID:16296395"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL2367706": {
              "name": "SUCRALFATE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL2367706",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL2367706",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Sucralfate is only found in individuals that have used or taken this drug. It is a basic aluminum complex of sulfated sucrose. [PubChem]Although sucralfate's mechanism is not entirely understood, there are several factors that most likely contribute to its action. Sucralfate, with its strong negative charge, binds to exposed positively-charged proteins at the base of ulcers. In this way, it coats the ulcer and forms a physical barrier that protects the ulcer surface from further injury by acid and pepsin. It directly inhibits pepsin (an enzyme that breaks apart proteins) in the presence of stomach acid and binds bile salts coming from the liver via the bile thus protecting the stomach lining from injury caused by the bile acids. Sucralfate may increase prostaglandin production. Prostaglandins are known to protect the lining of the stomach and may also bind epithelial growth factor and fibroblast growth factor, both of which enhance the growth and repair mechanism of the stomach lining.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:MolecularEntity",
                    "biolink:Drug",
                    "biolink:SmallMolecule"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Sucralfate",
                    "sucralfate",
                    "SUCRALFATE"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "MESH:D013392",
                    "NCIT:C848",
                    "LOINC:LP171641-6",
                    "NDDF:001132",
                    "CHEBI:9313",
                    "VANDF:4018816",
                    "ATC:A02BX02",
                    "CHEMBL.COMPOUND:CHEMBL3989780",
                    "UMLS:C0038633",
                    "RXNORM:10156",
                    "PDQ:CDR0000039608",
                    "CHEMBL.COMPOUND:CHEMBL2367706",
                    "DrugCentral:4106",
                    "DRUGBANK:DB00364",
                    "KEGG.COMPOUND:C07314",
                    "HMDB:HMDB0014508"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:2190306",
                    "PMID:26948801",
                    "PMID:11019606",
                    "PMID:341732",
                    "PMID:1715673",
                    "PMID:2612985",
                    "PMID:6892775",
                    "PMID:7430343",
                    "PMID:22194678",
                    "PMID:22242022"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL2369717": {
              "name": "Peptide",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL2369717",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL2369717",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Polypeptide",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug",
                    "biolink:InformationContentEntity",
                    "biolink:BiologicalEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "peptide",
                    "Peptide",
                    "Exogenous soluble antigen [early endosome lumen]",
                    "Peptide [cell wall]",
                    "Exogenous soluble antigen [cytosol]",
                    "Peptide [cytoplasm]",
                    "Exogenous soluble antigen [early endosome membrane]",
                    "Peptides",
                    "Peptide [extracellular region]",
                    "Polypeptides",
                    "Exogenous soluble antigen [clathrin-coated endocytic vesicle membrane]",
                    "Peptide [endocytic vesicle lumen]",
                    "Exogenous soluble antigen [extracellular region]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "REACT:R-ALL-6789213",
                    "PathWhiz.ElementCollection:19",
                    "KEGG.COMPOUND:C00012",
                    "UMLS:C0030956",
                    "REACT:R-ALL-2239440",
                    "UMLS:C1305923",
                    "REACT:R-ALL-1236720",
                    "MESH:D010455",
                    "CHEBI:16670",
                    "LOINC:LP36815-6",
                    "MI:0327",
                    "NCIT:C735",
                    "CHEMBL.TARGET:CHEMBL2364181",
                    "REACT:R-ALL-1236723",
                    "REACT:R-ALL-1236724",
                    "REACT:R-ALL-879484",
                    "REACT:R-ALL-6789172",
                    "REACT:R-ALL-1236719",
                    "LOINC:LP21053-1",
                    "CHEMBL.COMPOUND:CHEMBL2369717",
                    "REACT:R-ALL-1236715",
                    "PSY:37330"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:15261290",
                    "PMID:15771466",
                    "PMID:14755292"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL2391146": {
              "name": "ANGIOTENSIN",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL2391146",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL2391146",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Oligopeptides which are important in the regulation of blood pressure (VASOCONSTRICTION) and fluid homeostasis via the RENIN-ANGIOTENSIN SYSTEM. These include angiotensins derived naturally from precursor ANGIOTENSINOGEN, and those synthesized.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:MolecularEntity",
                    "biolink:SmallMolecule"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ANGIOTENSIN",
                    "angiotensin",
                    "Angiotensins",
                    "Angiotensin"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEBI:48433",
                    "PSY:02550",
                    "CHEMBL.COMPOUND:CHEMBL2391146",
                    "MESH:D000809",
                    "LOINC:LP40491-0",
                    "UMLS:C0003018"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:23582449"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL3039598": {
              "name": "FOSINOPRIL",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL3039598",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL3039598",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Fosinopril is a phosphinic acid-containing ester prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is rapidly hydrolyzed to fosinoprilat, its principle active metabolite. Fosinoprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Fosinopril may be used to treat mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:NamedThing",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Fosinil",
                    "FOSINOPRIL",
                    "FOSINOPRILAT",
                    "SID50112686",
                    "Fosinopril (INN)",
                    "Fosinoprilat",
                    "fosinoprilat",
                    "SID144205989",
                    "Fosinopril sodium (USP)",
                    "Fosinoprilat (USAN/INN)",
                    "Fosinopril",
                    "fosinopril",
                    "fosinopril sodium",
                    "FOSINOPRIL SODIUM",
                    "(2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphoryl]-1-oxoethyl]-2-pyrrolidinecarboxylic acid"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEMBL.COMPOUND:CHEMBL1886787",
                    "CHEMBL.COMPOUND:CHEMBL3306578",
                    "RXNORM:1546393",
                    "KEGG.COMPOUND:C21542",
                    "KEGG.DRUG:D07992",
                    "NCIT:C65762",
                    "DRUGBANK:DB00492",
                    "LOINC:LP171400-7",
                    "UMLS:C0075061",
                    "PathWhiz.Compound:8996",
                    "NDDF:004501",
                    "CHEMBL.COMPOUND:CHEMBL3039596",
                    "CHEBI:93870",
                    "CHEBI:116962",
                    "VANDF:4020531",
                    "CHEMBL.COMPOUND:CHEMBL581",
                    "ATC:C09AA09",
                    "CHEMBL.COMPOUND:CHEMBL3188382",
                    "MESH:D017328",
                    "RXNORM:50166",
                    "DRUGBANK:DB14207",
                    "KEGG.DRUG:D00622",
                    "DrugCentral:1245",
                    "PathWhiz.Compound:40472",
                    "NCIT:C65761",
                    "CHEBI:5163",
                    "CHEBI:5164",
                    "KEGG.COMPOUND:C07016",
                    "HMDB:HMDB0014635",
                    "MESH:C046965",
                    "UMLS:C0118168",
                    "KEGG.DRUG:D03772",
                    "UMLS:C1567476",
                    "CHEMBL.COMPOUND:CHEMBL3039598"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:20014752",
                    "PMID:11329095",
                    "PMID:2836590",
                    "PMID:16472241",
                    "PMID:18426954",
                    "PMID:26948801",
                    "PMID:10669559",
                    "PMID:9171867",
                    "PMID:20190787",
                    "PMID:22194678"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL3182731": {
              "name": "GONADORELIN HYDROCHLORIDE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL3182731",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL3182731",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T125; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Drug",
                    "biolink:SmallMolecule"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "SID144206932",
                    "Gonadorelin hydrochloride",
                    "Gonadorelin Hydrochloride",
                    "gonadorelin hydrochloride"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "UMLS:C0701919",
                    "VANDF:4018487",
                    "CHEMBL.COMPOUND:CHEMBL3182731",
                    "RXNORM:204194",
                    "NCIT:C65815"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL3249705": {
              "name": "PROCATEROL HYDROCHLORIDE",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL3249705",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL3249705",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "Procaterol is only found in individuals that have used or taken this drug. It is a long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation. [PubChem]Beta(2)-receptor stimulation in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow.",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:MolecularEntity",
                    "biolink:Drug"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "Procaterol Hydrochloride",
                    "(+)-erythro-5-(1-hydroxy-2-isopropylaminobutyl)-8-hydroxycarbostyril",
                    "Procaterol",
                    "PROCATEROL",
                    "procaterol",
                    "Procaterol Monohydrochloride, (R*,S*)-(+)-Isomer",
                    "Procaterol, (R*,R*)-(+-)-Isomer",
                    "procaterol hydrochloride",
                    "8-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)butyl]-1H-quinolin-2-one",
                    "Procaterol, (R*,S*)-(-)-Isomer",
                    "Procaterol (INN)",
                    "SID11113915",
                    "Pro-Air Procaterol"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "CHEBI:91585",
                    "RXNORM:58918",
                    "ATC:R03CC08",
                    "UMLS:C0162684",
                    "UMLS:C0886744",
                    "UMLS:C0917745",
                    "CHEMBL.COMPOUND:CHEMBL3249705",
                    "DrugCentral:2273",
                    "UMLS:C0072032",
                    "MESH:D017265",
                    "CHEMBL.COMPOUND:CHEMBL1478530",
                    "UMLS:C0886743",
                    "CHEBI:135209",
                    "ATC:R03AC16",
                    "KEGG.DRUG:D08424",
                    "HMDB:HMDB0015453",
                    "CHEMBL.COMPOUND:CHEMBL160519",
                    "UMLS:C0162685",
                    "DRUGBANK:DB01366",
                    "RXNORM:34530"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:27132867",
                    "PMID:23954364",
                    "PMID:23984907",
                    "PMID:6453996",
                    "PMID:894683"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL3322001": {
              "name": "LEP",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL3322001",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL3322001",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "A 16-kDa peptide hormone secreted from WHITE ADIPOCYTES. Leptin serves as a feedback signal from fat cells to the CENTRAL NERVOUS SYSTEM in regulation of food intake, energy balance, and fat storage.; UMLS Semantic Type: STY:T125; UMLS Semantic Type: STY:T116",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:NamedThing",
                    "biolink:Gene",
                    "biolink:BiologicalEntity",
                    "biolink:Protein",
                    "biolink:SmallMolecule",
                    "biolink:Drug",
                    "biolink:MolecularEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "LEP gene",
                    "leptin",
                    "Lep (mouse)",
                    "leptin (rat)",
                    "LEP",
                    "LEP Gene",
                    "LEP (human)",
                    "leptin (mouse)",
                    "ethylene-responsive transcription factor LEP (Arabidopsis thaliana)",
                    "Leptin",
                    "Lep (rat)",
                    "LEP [extracellular region]",
                    "leptin (human)",
                    "LEP gene [nucleoplasm]"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "NCIT:C46081",
                    "PR:P50596",
                    "UMLS:C0299583",
                    "REACT:R-HSA-400490",
                    "OMIM:164160",
                    "CHEMBL.COMPOUND:CHEMBL3322001",
                    "MGI:104663",
                    "NCIT:C95047",
                    "ORPHANET:123034",
                    "RGD:3000",
                    "CHEBI:81571",
                    "MESH:D020738",
                    "ENSEMBL:ENSG00000174697",
                    "LOINC:LP19488-3",
                    "EFO:0003199",
                    "RXNORM:1441651",
                    "PR:P41159",
                    "KEGG.COMPOUND:C18188",
                    "PR:000009758",
                    "HGNC:6553",
                    "PSY:28182",
                    "LOINC:MTHU009760",
                    "UMLS:C1416825",
                    "DRUGBANK:DB05098",
                    "NCBIGene:3952",
                    "REACT:R-HSA-5640196",
                    "UniProtKB:P41159",
                    "PR:Q9M644",
                    "PR:P41160",
                    "HMDB:HMDB0303441"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:9144295",
                    "DOI:10.1074/jbc.m609798200",
                    "PMID:7499240",
                    "DOI:10.1016/j.metabol.2014.06.010",
                    "DOI:10.1038/ng0396-318",
                    "PMID:24340098",
                    "DOI:10.1186/ar1708",
                    "PMID:18162515",
                    "PMID:15122202",
                    "DOI:10.1016/j.bbrc.2007.04.004"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            },
            "CHEMBL.COMPOUND:CHEMBL3989410": {
              "name": "INDOMETHACIN",
              "attributes": [
                {
                  "value": "https://identifiers.org/chembl.compound:CHEMBL3989410",
                  "value_url": "https://identifiers.org/chembl.compound:CHEMBL3989410",
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:Uri",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:IriType",
                  "original_attribute_name": null
                },
                {
                  "value": "UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Indometacin, or indomethacin, is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic properties. NSAIDs consist of agents that are structurally unrelated; the NSAID chemical classification of indometacin is an indole-acetic acid derivative with the chemical name 1- (p-chlorobenzoyl)25-methoxy-2-methylindole-3-acetic acid.[A177871] The pharmacological effect of indometacin is not fully understood, however, it is thought to be mediated through potent and nonselective inhibition of the enzyme cyclooxygenase (COX), which is the main enzyme responsible for catalyzes the rate-limiting step in prostaglandin and thromboxane biosynthesis via the arachidonic acid (AA) pathway. Indometacin was first discovered in 1963 and it was first approved for use in the U.S. by the Food and Drug Administration in 1965, [A486] along with other acetic acid derivatives such as [diclofenac] and [sulindac] that were also developed during the 1960s.[A177871] Since then, indometacin has been extensively studied in clinical trials as one of the most potent NSAIDs in blocking prostaglandin synthesis and was among the first NSAIDs to be used in the symptomatic treatment of migraine and for headaches that eventually became known as \u201cindomethacin-responsive\u201d headache disorders.[A177871]     Most commonly used in rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, acute shoulder pains, and acute gouty arthritis, indometacin is currently available as oral capsules as well as other methods of administration, including rectal and intravenous formulations. Intravenous indometacin is administered to close a hemodynamically significant patent ductus arteriosus, as indicated by clinical evidence, in premature infants.[L10553] Ophthalmic indometacin has been studied and used in the symptomatic treatment of postoperative ocular inflammation and pain and/or complications after cataract surgery. Although deemed effective in reducing ocular inflammation in clinical studies, topical NSAIDs were also associated with a potential reduction in corneal sensitivity accompanied by an increased risk of superficial punctate keratitis and subjective symptoms of discomfort, including pain, burning or pricking, or a tingling sensation after instillation into the cul\u2010de\u2010sac.[A177949]",
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:description",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "biolink:ChemicalEntity",
                    "biolink:SmallMolecule",
                    "biolink:Drug",
                    "biolink:MolecularEntity"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Categories of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:category",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "acemetacin",
                    "Rantodil",
                    "Oldan",
                    "Indomethacin (USP)",
                    "indometacin",
                    "indomethacin",
                    "Acemetacin Stada",
                    "INDOMETHACIN SODIUM",
                    "Acemetacin (JP18/INN)",
                    "Indomet 140",
                    "acemethacin",
                    "Acemetacin Heumann",
                    "Indomethacin sodium (USP)",
                    "Acemetadoc",
                    "Indomethacin",
                    "acemetacin monohydrate",
                    "ACEMETACIN",
                    "acemetacin von ct",
                    "INDOMETHACIN",
                    "Amuno",
                    "Acemetacin",
                    "Indocin"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Names of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:String",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:synonym",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "ATC:C01EB03",
                    "RXNORM:203365",
                    "LOINC:LP16167-6",
                    "UMLS:C1529440",
                    "UMLS:C1529436",
                    "ATC:M01AB11",
                    "CHEBI:31162",
                    "RXNORM:16695",
                    "UMLS:C0050409",
                    "NDDF:002373",
                    "NDDF:003916",
                    "KEGG.DRUG:D02110",
                    "PathWhiz.Compound:8859",
                    "CHEMBL.COMPOUND:CHEMBL6",
                    "ATC:M02AA23",
                    "UMLS:C1529438",
                    "DrugCentral:1440",
                    "KEGG.COMPOUND:C01926",
                    "ATC:S01BC01",
                    "UMLS:C0701205",
                    "PDQ:CDR0000039489",
                    "KEGG.DRUG:D01582",
                    "UMLS:C1957171",
                    "MESH:D007213",
                    "LOINC:MTHU016716",
                    "RXNORM:5781",
                    "CHEMBL.COMPOUND:CHEMBL3989410",
                    "UMLS:C0700799",
                    "UMLS:C0700798",
                    "VANDF:4017890",
                    "HMDB:HMDB0247898",
                    "ATC:M01AB01",
                    "NCIT:C73068",
                    "DrugCentral:47",
                    "KEGG.DRUG:D00141",
                    "UMLS:C0954122",
                    "UMLS:C0700796",
                    "CHEBI:49662",
                    "UMLS:C1529433",
                    "CHEMBL.COMPOUND:CHEMBL189171",
                    "UMLS:C0021246",
                    "DRUGBANK:DB00328",
                    "MESH:C026784",
                    "NCIT:C576",
                    "DRUGBANK:DB13783",
                    "HMDB:HMDB0014473",
                    "UMLS:C1529437",
                    "MESH:C519896"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": "Identifiers of all nodes in this synonym set in RTX-KG2.",
                  "value_type_id": "metatype:Nodeidentifier",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:xref",
                  "original_attribute_name": null
                },
                {
                  "value": [
                    "PMID:18947903",
                    "PMID:6608000",
                    "PMID:11784135",
                    "PMID:22652053",
                    "PMID:28218838",
                    "PMID:21458999",
                    "PMID:11462976",
                    "PMID:14056924",
                    "PMID:20070106",
                    "PMID:10866370"
                  ],
                  "value_url": null,
                  "attributes": null,
                  "description": null,
                  "value_type_id": "biolink:Uriorcurie",
                  "attribute_source": null,
                  "attribute_type_id": "biolink:publications",
                  "original_attribute_name": null
                }
              ],
              "categories": [
                "biolink:SmallMolecule",
                "biolink:NamedThing"
              ]
            }
          }
        }
      },
      "datetime": "2022-08-23 20:06:09",
      "workflow": null,
      "submitter": "ars-prod.transltr.io",
      "operations": {
        "actions": [
          "expand()",
          "overlay(action=compute_ngd, virtual_relation_label=N1, subject_qnode_key=disease, object_qnode_key=drug)",
          "resultify()",
          "filter_results(action=limit_number_of_results, max_results=500)"
        ]
      },
      "description": "Normal completion",
      "reasoner_id": "ARAX",
      "tool_version": "ARAX 1.2.1",
      "query_options": {
        "query_plan": {
          "counter": 0,
          "qedge_keys": {}
        }
      },
      "schema_version": "1.2.0",
      "original_question": null,
      "restated_question": null,
      "validation_result": null,
      "table_column_names": [
        "score",
        "essence",
        "essence_category"
      ],
      "total_results_count": 17
    },
    "url": "https://arax.transltr.io/api/arax/v1.2/asyncquery",
    "ref": "fb61710c-c850-48da-963b-b61475ac5375"
  }
}